PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Martin-Sanz, RC; Callejas-Diaz, M; Tonnabel, J; Climent, JM				Martin-Sanz, Ruth C.; Callejas-Diaz, Marta; Tonnabel, Jeanne; Climent, Jose M.			Maintenance costs of serotiny in a variably serotinous pine: The role of water supply	PLOS ONE			English	Article							CANOPY SEED STORAGE; REPRODUCTIVE ALLOCATION; FIRE; HALEPENSIS; RELEASE; TRAITS; HERITABILITY; CONES	Serotiny is an important adaptation for plants in fire-prone environments. However, different mechanisms also induce the opening of serotinous cones in the absence of fire in variably serotinous species. Xeriscence-cone opening driven by dry and hot conditions- is considered to be mediated only by the external environment, but endogenous factors could also play a significant role. Using the variably serotinous Pinus halepensis as our model species, we determined the effects of cone age and scales density in cone opening, and using in-situ and ex-situ manipulative experiments we investigated the role of water availability in the opening of serotinous cones. We hypothesized that loss of connection between the cones and the branch through the peduncles or the absence of water supply could induce a faster cone opening. Results showed that older cones lost more water and opened at lower temperatures, with no influence of scales density. Both field and chamber manipulative experiments ( using paired cones of the same whorl) confirmed that water intake through the peduncles affected significantly the pace of cone opening, such that lack of water supply speeded up cone dehiscence. However, this was true for weakly serotinous provenances - more common in this species -, while highly serotinous provenances were indifferent to this effect in the field test. All our results support that cone serotiny in P. halepensis involves the allocation of water to the cones, which is highly consistent with the previously observed environmental effects. Importantly, the existence of maintenance costs of serotinous cones has strong implications on the effects of climate change in the resilience of natural populations, via modifications of the canopy seed banks and recruitment after stand-replacing fires. Moreover, evolutionary models for serotiny in P. halepensis must take into account the significant contribution of maintenance costs to the complex interaction between genotype and the environment.	[Martin-Sanz, Ruth C.; Callejas-Diaz, Marta; Climent, Jose M.] Natl Inst Agr & Food Res & Technol, Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain; [Martin-Sanz, Ruth C.; Climent, Jose M.] Univ Valladolid, Natl Inst Agr & Food Res & Technol, Sustainable Forest Management Res Inst, Palencia, Spain; [Tonnabel, Jeanne] Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, Lausanne, Switzerland	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Valladolid; University of Lausanne	Martin-Sanz, RC (corresponding author), Natl Inst Agr & Food Res & Technol, Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain.; Martin-Sanz, RC (corresponding author), Univ Valladolid, Natl Inst Agr & Food Res & Technol, Sustainable Forest Management Res Inst, Palencia, Spain.	ruth.martin.sanz@gmail.com	Climent, José/B-9090-2009; Callejas-Díaz, Marta/I-1411-2019; Martín-Sanz, Ruth C./AAA-6205-2020; Tonnabel, Jeanne/AAF-7561-2019	Climent, José/0000-0002-0815-2645; Callejas-Díaz, Marta/0000-0001-9687-1529; Martín-Sanz, Ruth C./0000-0002-0980-2283; 	Spanish "Ministerio de Economia, lndustria y Competitividad [AGL2012-40151-0O3-02, AGL2015-68274-C3-01, FPI BES-2013-064210]	Spanish "Ministerio de Economia, lndustria y Competitividad	This research was funded by the Spanish "Ministerio de Economia, lndustria y Competitividad (http://www.mineco.gob.es/), grant numbers AGL2012-40151-0O3-02 and AGL2015-68274-C3-01, both to JC, and grant number FPI BES-2013-064210 to RMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro-Sanchez R, 2015, INT J WILDLAND FIRE, V24, P507, DOI 10.1071/WF14045; Altman D.G., 1991, PRACTICAL STATISTIC; Benkman CW, 2003, AM NAT, V162, P182, DOI 10.1086/376580; Blondel J, 2010, MEDITERRANEAN REGION; Borchert M, 2003, PLANT ECOL, V168, P207, DOI 10.1023/A:1024447811238; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bradshaw SD, 2011, TRENDS PLANT SCI, V16, P69, DOI 10.1016/j.tplants.2010.10.007; Briand CH, 2015, PLANT ECOL, V216, P157, DOI 10.1007/s11258-014-0424-x; Castellanos MC, 2015, MOL ECOL, V24, P5633, DOI 10.1111/mec.13421; Causley CL, 2016, PLANT ECOL, V217, P773, DOI 10.1007/s11258-015-0552-y; Chambel M.R., 2013, FOREST TREE BREEDING, VVolume 25, P229, DOI DOI 10.1007/978-94-007-6146-9_5; Climent J, 2008, AM J BOT, V95, P833, DOI 10.3732/ajb.2007354; COWLING RM, 1985, AUST J ECOL, V10, P345, DOI 10.1111/j.1442-9993.1985.tb00895.x; Cramer MD, 2009, AUSTRAL ECOL, V34, P653, DOI 10.1111/j.1442-9993.2009.01971.x; Elliott PE, 1988, 1 U COL MOUNT RES ST; Enright NJ, 1996, J ECOL, V84, P9, DOI 10.2307/2261695; GAUTHIER S, 1993, CAN J FOREST RES, V23, P394, DOI 10.1139/x93-057; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gil L, REGIONES PROCEDENCIA; Gonzalo-Jimenez J, 2010, DIAGNOSIS FITOCLIMAT; Harris MS, 2010, J ECOL, V98, P509, DOI 10.1111/j.1365-2745.2009.01623.x; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; Hernandez-Serrano A, 2014, ANN BOT-LONDON, V114, P571, DOI 10.1093/aob/mcu142; Hernandez-Serrano A, 2013, AM J BOT, V100, P2349, DOI 10.3732/ajb.1300182; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keeley Jon E., 1998, P219; LAMONT BB, 1991, BOT REV, V57, P277, DOI 10.1007/BF02858770; LAMONT BB, 1991, OIKOS, V60, P266, DOI 10.2307/3544876; LEVYADUN S, 1995, INT J PLANT SCI, V156, P50, DOI 10.1086/297228; Espelta JM, 2011, OIKOS, V120, P1752, DOI 10.1111/j.1600-0706.2011.19570.x; Martin-Sanz RC, 2016, AM J BOT, V103, P1582, DOI 10.3732/ajb.1600199; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Moya D, 2008, TREES-STRUCT FUNCT, V22, P511, DOI 10.1007/s00468-008-0211-1; Nathan R, 1999, J ECOL, V87, P659, DOI 10.1046/j.1365-2745.1999.00382.x; Ne'eman G, 2004, PLANT ECOL, V171, P69, DOI 10.1023/B:VEGE.0000029380.04821.99; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pinol J, 1998, CLIMATIC CHANGE, V38, P345, DOI 10.1023/A:1005316632105; Poorter H., 1994, WHOLE PLANT PERSPECT, P111; R Core Team, 2016, R FDN STAT COMP; Salvatore R, 2010, NEW FOREST, V39, P329, DOI 10.1007/s11056-009-9174-3; Santos-del-Blanco L, 2010, FOREST SYST, V19, P381; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Tapias R, 2004, PLANT ECOL, V171, P53, DOI 10.1023/B:VEGE.0000029383.72609.f0; Tapias R, 2001, J ECOL, V89, P629, DOI 10.1046/j.1365-2745.2001.00575.x; Thanos CA, 2000, ECOLOGY, BIOGEOGRAPHY AND MANAGEMENT OF PINUS HALEPENSIS AND P BRUTIA FOREST ECOSYSTEMS IN THE MEDITERRANEAN BASIN, P79; Tonnabel J, 2012, J ECOL, V100, P1464, DOI 10.1111/j.1365-2745.2012.02023.x; Westerling AL, 2008, CLIMATIC CHANGE, V87, pS231, DOI 10.1007/s10584-007-9363-z	49	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181648	10.1371/journal.pone.0181648	http://dx.doi.org/10.1371/journal.pone.0181648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732015	gold, Green Published, Green Submitted			2022-12-27	WOS:000406643100052
J	Andorsen, OF; Ahmed, LA; Emaus, N; Klouman, E				Andorsen, Ole Fredrik; Ahmed, Luai Awad; Emaus, Nina; Klouman, Elise			A prospective cohort study on risk factors of musculoskeletal complaints (pain and/or stiffness) in a general population. The Tromso study	PLOS ONE			English	Article							CHRONIC WIDESPREAD PAIN; NORD-TRONDELAG HEALTH; 11-YEAR FOLLOW-UP; WORKING POPULATION; CIGARETTE-SMOKING; BACK-PAIN; PREVALENCE; ADULTS; HUNT; EPIDEMIOLOGY	Background Female gender has been associated with musculoskeletal complaints (MSCs), but there are limited studies on how other factors may influence women and men differently. The aim of this prospective cohort study was to explore possible predictors of MSCs in women and men free of MSCs at baseline. Methods The present study included participants from the population-based Tromso study, with baseline data from 1994-1995 and follow-up data from 2007-2008. MSCs were defined as having pain and/or stiffness in muscles and joints for 3 consecutive months during the past year. Predictors of MSCs were examined through binary logistic regression analyses and presented as odds ratios with 95% confidence intervals. Results At baseline 4,496 participants reported no MSCs and among these 2,015 (44.8%) and 441 (9.8%) participants reported mild or severe MSCs, respectively, at follow-up. Female gender predicted MSCs in multivariable logistic regression analyses (odds ratio [OR] 1.46, 95% confidence interval [CI]: 1.29-1.66). Educational level of primary/secondary school (OR 1.73, 95% CI: 1.46-2.05) was the strongest predictor of MSCs, followed by poor self-perceived health (OR 1.62, 95% CI: 1.30-2.02). Other predictors were BMI >= 30 kg/m(2) (OR 1.39, 95% CI: 1.10-1.77) and smoking (OR 1.33, 95% CI: 1.16-1.52). Age and physical activity level were not significantly associated with MSCs. Gender-stratified analyses revealed that mental health complaints (i.e., depression and/or anxiety) predicted MSCs in men (OR 2.03, 95% CI: 1.18-3.50), but not in women. Current smoking (OR 1.43, 95% CI: 1.16-1.76) and poor self-perceived health ( OR 1.90, 95% CI: 1.34-2.71) showed slightly higher odds ratios among women than men, but the gender differences were not significant. Conclusion The present study demonstrates that several negative health determinants are predicting subsequent MSCs. However, the examined risk factors could not explain the higher prevalence of MSCs in women.	[Andorsen, Ole Fredrik; Klouman, Elise] Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Ahmed, Luai Awad; Emaus, Nina] Univ Tromso, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway; [Ahmed, Luai Awad] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; United Arab Emirates University	Andorsen, OF (corresponding author), Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway.	ole.f.andorsen@uit.no	Ahmed, Luai A./J-7225-2013	Ahmed, Luai A./0000-0001-5292-8212	University of Tromso - The Arctic University of Norway	University of Tromso - The Arctic University of Norway	This study was supported by an internal grant from the University of Tromso - The Arctic University of Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorsen Ole Fredrik, 2014, BMC Res Notes, V7, P506, DOI 10.1186/1756-0500-7-506; [Anonymous], 2013, TAL TOB 1973 2012; [Anonymous], 2015, STAT SICK LEAV NORW; [Anonymous], 2016, ANB TYS AKT; Bassols A, 1999, PAIN, V83, P9, DOI 10.1016/S0304-3959(99)00069-X; Bergman S, 2001, J RHEUMATOL, V28, P1369; Blyth FM, 2001, PAIN, V89, P127, DOI 10.1016/S0304-3959(00)00355-9; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; Bruce B, 2005, ARTHRITIS RES THER, V7, pR1263, DOI 10.1186/ar1825; Buskila D, 2000, J RHEUMATOL, V27, P1521; Cimmino MA, 2001, CLIN EXP RHEUMATOL, V19, P35; Cimmino MA, 2011, BEST PRACT RES CL RH, V25, P173, DOI 10.1016/j.berh.2010.01.012; Eggen AE, 2013, SCAND J PUBLIC HEALT, V41, P65, DOI 10.1177/1403494812469851; Erdogan-Ciftci E, 2010, SOC SCI MED, V71, P1981, DOI 10.1016/j.socscimed.2010.09.003; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Hagen K, 2005, SCAND J PUBLIC HEALT, V33, P268, DOI 10.1080/14034940510005699; Hagen K, 2011, PAIN MED, V12, P1657, DOI 10.1111/j.1526-4637.2011.01240.x; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holley AL, 2013, J PAIN, V14, P1131, DOI 10.1016/j.jpain.2013.04.012; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Ihlebaek C LE, 2004, PLAGER FLEST KOSTERR; Jimenez-Sanchez S, 2010, J PAIN, V11, P612, DOI 10.1016/j.jpain.2009.09.015; Jinks C, 2008, RHEUMATOLOGY, V47, P368, DOI 10.1093/rheumatology/kem374; Kjeldsberg M, 2013, SCAND J PRIM HEALTH, V31, P36, DOI 10.3109/02813432.2012.751697; Kvalheim S, 2016, EUR J PAIN, V20, P458, DOI 10.1002/ejp.747; Kvalheim S, 2013, PAIN, V154, P1073, DOI 10.1016/j.pain.2013.03.015; Lake JK, 2000, J CLIN EPIDEMIOL, V53, P245, DOI 10.1016/S0895-4356(99)00155-9; Loevinger BL, 2007, METABOLISM, V56, P87, DOI 10.1016/j.metabol.2006.09.001; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; Miyakawa M, 2012, EUR J PUBLIC HEALTH, V22, P593, DOI 10.1093/eurpub/ckr064; Morseth B, 2012, EUR J EPIDEMIOL, V27, P463, DOI 10.1007/s10654-012-9665-y; Mundal I, 2014, PAIN, V155, P1555, DOI 10.1016/j.pain.2014.04.033; Mundal I, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-213; Ng KFJ, 2002, CLIN J PAIN, V18, P275, DOI 10.1097/00002508-200209000-00001; Nilsen TIL, 2011, AM J EPIDEMIOL, V174, P267, DOI 10.1093/aje/kwr087; Palmer KT, 2003, ANN RHEUM DIS, V62, P33, DOI 10.1136/ard.62.1.33; Parajuli R, 2013, CANCER EPIDEM BIOMAR, V22, P862, DOI 10.1158/1055-9965.EPI-12-1351; Parot-Schinkel E, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-122; Paulis WD, 2014, OBES REV, V15, P52, DOI 10.1111/obr.12067; Rustoen T, 2004, EUR J PAIN, V8, P555, DOI 10.1016/j.ejpain.2004.02.002; Schou Morten Brix, 2006, Tidsskr Nor Laegeforen, V126, P2644; Sogaard AJ, 2003, NOR EPIDEMIOL, V13, P279, DOI DOI 10.5324/NJE.V13I2.296; Sommer I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2227-y; Steinsbekk A, 2007, SCAND J PRIM HEALTH, V25, P86, DOI 10.1080/02813430701267439; Tukker A, 2009, PUBLIC HEALTH NUTR, V12, P359, DOI 10.1017/S1368980008002103; van den Heuvel SG, 2005, PREV MED, V41, P260, DOI 10.1016/j.ypmed.2004.11.006; Verbunt JA, 2003, EUR J PAIN, V7, P9, DOI 10.1016/S1090-3801(02)00071-X; Wijnhoven HAH, 2006, CLIN J PAIN, V22, P717, DOI 10.1097/01.ajp.0000210912.95664.53; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zvolensky MJ, 2010, ADDICT BEHAV, V35, P1008, DOI 10.1016/j.addbeh.2010.06.019	50	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181417	10.1371/journal.pone.0181417	http://dx.doi.org/10.1371/journal.pone.0181417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727753	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500068
J	de Lestrange-Anginieur, E; Jiang, XY; Ren, QS				de Lestrange-Anginieur, Elie; Jiang, Xiaoyun; Ren, Qiushi			Optical modelling of a supplementary tunable air-spaced goggle lens for rodent eye imaging	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; RESOLUTION	Aberration variations severely degrade retinal imaging in small animal eyes. Previously, the approach of a goggle lens with a matching corneal index was proposed to overcome the onaxis resolution limit of static imaging systems, which allows the use of the full eye pupil. But this technique didn't address the problem of the large power variation, and the ensuing aberration on and off-axis, when dealing with small animal eyes. In this study, we present the concept of a tunable goggle lens, designed to compensate individual ocular aberration for different rodent eye powers. Ray tracing evidences that lens-fitted goggles permit, not only to adjust individual eyes power, but also to surpass conventional adaptive correction technique over large viewing angle, provided a minimum use of two spaced liquids. We believe that the overlooked advantage of the 3D lens function is a seminal finding for further technological advancements in widefield retinal imaging.	[de Lestrange-Anginieur, Elie; Jiang, Xiaoyun; Ren, Qiushi] Peking Univ, Dept Biomed Engn, Coll Engn, Beijing, Peoples R China	Peking University	de Lestrange-Anginieur, E (corresponding author), Peking Univ, Dept Biomed Engn, Coll Engn, Beijing, Peoples R China.	elie.delestrange@hotmail.com		de Lestrange-Anginieur, Elie/0000-0002-4940-2057				Abbott CJ, 2013, BIOMED OPT EXPRESS, V4, P364, DOI 10.1364/BOE.4.000364; Bedggood PA, 2006, OPT EXPRESS, V14, P8019, DOI 10.1364/OE.14.008019; Bedggood P, 2010, J OPT SOC AM A, V27, pA37, DOI 10.1364/JOSAA.27.000A37; CHAUDHURI A, 1983, VISION RES, V23, P1351, DOI 10.1016/0042-6989(83)90146-3; de la Cera EG, 2006, VISION RES, V46, P2546, DOI 10.1016/j.visres.2006.01.011; Geng Y, 2012, BIOMED OPT EXPRESS, V3, P715, DOI 10.1364/BOE.3.000715; Geng Y, 2011, BIOMED OPT EXPRESS, V2, P717, DOI 10.1364/BOE.2.000717; Geng Y, 2009, INVEST OPHTH VIS SCI, V50, P5872, DOI 10.1167/iovs.09-3675; Goncharov AV, 2005, OPT EXPRESS, V13, P5580, DOI 10.1364/OPEX.13.005580; Guo HQ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.036008; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; Jiang XY, 2016, CHIN OPT LETT, V14, DOI 10.3788/COL201614.031701; Khan AK, 2015, EXP EYE RES, V130, P29, DOI 10.1016/j.exer.2014.11.007; Lambert AJ, 2011, J MOD OPTIC, V58, P1716, DOI 10.1080/09500340.2011.575239; Mandell R.B., 1988, CONTACT LENS PRACTIC, V4th ed.; MARELLI RA, 1989, HEAD NECK-J SCI SPEC, V11, P137, DOI 10.1002/hed.2880110207; Marks R, 2009, OPT LETT, V34, P515, DOI 10.1364/OL.34.000515; Meitav N, 2013, OPT LETT, V38, P745, DOI 10.1364/OL.38.000745; Mishra K, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7060102; Paques M, 2006, VISION RES, V46, P1336, DOI 10.1016/j.visres.2005.09.037; Petsch S, 2016, LIGHT-SCI APPL, V5, DOI 10.1038/lsa.2016.68; Qiao W, 2009, OPT LETT, V34, P3214, DOI 10.1364/OL.34.003214; Zappe H, 2015, TUNABLE MICROOPTICS; Zhang PF, 2015, OPT LETT, V40, P5830, DOI 10.1364/OL.40.005830; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220; Zhou XL, 2012, BIOMED OPT EXPRESS, V3, P1811, DOI 10.1364/BOE.3.001811	26	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181111	10.1371/journal.pone.0181111	http://dx.doi.org/10.1371/journal.pone.0181111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727809	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500041
J	Mengesha, ZB; Perz, J; Dune, T; Ussher, J				Mengesha, Zelalem B.; Perz, Janette; Dune, Tinashe; Ussher, Jane			Refugee and migrant women's engagement with sexual and reproductive health care in Australia: A socio-ecological analysis of health care professional perspectives	PLOS ONE			English	Article							MIDDLE-EASTERN; ASIAN MIGRANTS; EXPERIENCES; VIETNAMESE; KNOWLEDGE; EDUCATION; SERVICES; YOUNG; CONTRACEPTION; CONSTRUCTIONS	Background In Australia only 2.2% of published health research has focused on multi-cultural health despite the increase of culturally and linguistically diverse populations. Research on the perceptions and experiences of health care professionals (HCPs) in engaging with refugee and migrant women is also lacking. Given the integral role of HCPs in providing sexual and reproductive health (SRH) care for these populations, an understanding of the challenges they experience is required. Therefore, this study sought to examine the perspectives and practices of Australian HCPs with regard to the provision of SRH care for refugee and migrant women. Methods Employing qualitative methods, twenty-one semi-structured interviews were conducted with HCPs representing various professions, work experiences, cultural backgrounds, age and healthcare sectors. The interviews were analysed using thematic analysis and the socio-ecological model was utilised to interpret the data. Results The complexities of HCP's engagement with refugee and migrant women were identified in three major themes: Being a Migrant; Gender Roles and SRH Decision-making; and Women in the Healthcare System. HCPs discussed the impact of accessing SRH care in women's country of origin and the influence of re-settlement contexts on their SRH knowledge, engagement with care and care provision. Perception of gender roles was integral to SRH decision-making with the need to involve male partners having an impact on the provision of women-centred care. Barriers within the healthcare system included the lack of services to address sexual functioning and relationship issues, as well as lack of resources, time constraints, cost of services, and funding. Conclusion Australian HCPs interviewed reported that migrant and refugee women do not have appropriate access to SRH care due to multifaceted challenges. These challenges are present across the entire socio-ecological arena, from individual to systemic levels. Multiple and multidimensional interventions are required to increase SRH utilisation and improve outcomes for refugee and migrant women.	[Mengesha, Zelalem B.; Perz, Janette; Dune, Tinashe; Ussher, Jane] Western Sydney Univ, Sch Med, THRI, Penrith, NSW, Australia; [Dune, Tinashe] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia	Western Sydney University; Western Sydney University	Mengesha, ZB (corresponding author), Western Sydney Univ, Sch Med, THRI, Penrith, NSW, Australia.	Z.mengesha@westernsydney.edu.au	Dune, Tinashe/M-8195-2019; Dune, Tinashe/AGR-6105-2022	Dune, Tinashe/0000-0001-5758-7525; Dune, Tinashe/0000-0001-5758-7525; Mengesha, Zelalem/0000-0003-1599-0951				Akhavan S, 2013, J IMMIGR MINOR HEALT, V15, P188, DOI 10.1007/s10903-012-9581-y; Allotey P., 2004, HLTH ISSUES, V78, P12; Aminisani N, 2012, HEALTH PROMOT PERSPE, V2, P274, DOI 10.5681/hpp.2012.033; Aminisani N, 2012, CANCER EPIDEMIOL, V36, pE394, DOI 10.1016/j.canep.2012.08.009; [Anonymous], 2012, RURAL REMOTE HLTH; Austin J, 2008, REPROD HEALTH MATTER, V16, P10, DOI 10.1016/S0968-8080(08)31351-2; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Britt H, 2014, DEBUNKING MYTH GEN P, V2; Bronfenbrenner U., 1994, INT ENCY ED; Carolan M., 2007, EVID BASED MIDWIFERY, V5, P54; Cohen SA., 2004, GUTTMACHER REP PUBLI, V7, P5; Daley E, J COMMUNITY HLTH, V36, P121; Davis K, 2007, MIRROR MIRROR WALL I; Dawson MT, 2003, WOMEN HEALTH, V38, P39, DOI 10.1300/J013v38n04_03; Drummond PD, 2011, HEALTH CARE WOMEN IN, V32, P206, DOI 10.1080/07399332.2010.529216; Dune T, 2015, ADV SOCIAL SCI RES J, V2; Gagnon AJ, 2002, REFUGE CANADAS J REF, V21; Greenaway ES, 2012, J BIOSOC SCI, V44, P733, DOI 10.1017/S0021932012000041; Guruge Sepali, 2004, Can J Nurs Res, V36, P32; Hach Maria., 2012, COMMON THREADS SEXUA; Henderson S, 2011, AUST J PRIM HEALTH, V17, P195, DOI 10.1071/PY10065; Hoang HT, 2009, RURAL REMOTE HEALTH, V9; Kalengayi FKN, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-433; Lazar JN, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/149640; Liamputtong P, 2002, MIDWIFERY, V18, P304, DOI 10.1054/midw.2002.0331; Liburd Leandris C, 2007, Prev Chronic Dis, V4, pA73; Lyons SM, 2008, ETHNIC HEALTH, V13, P261, DOI 10.1080/13557850801903020; McKeary M, 2010, J REFUG STUD; McMichael C, 2013, J YOUTH STUD, V16, P663, DOI 10.1080/13676261.2012.744813; McMichael C, 2009, SEX CULT, V13, P218, DOI 10.1007/s12119-009-9055-0; MCWH, 2010, PUTT IMM REF WOM HLT; Mengesha ZB, 2018, J IMMIGR MINOR HEALT, V20, P307, DOI 10.1007/s10903-017-0611-7; Mengesha ZB, 2016, SEX HEALTH, V13, P299, DOI 10.1071/SH15235; Newbold KB, 2009, CULT HEALTH SEX, V11, P369, DOI 10.1080/13691050802710642; Ng C, 2011, CULT HEALTH SEX, V13, P561, DOI 10.1080/13691058.2011.555927; O'Donnell CA, 2008, BRIT J GEN PRACT, V58, P870, DOI 10.3399/bjgp08X376104; O'Mahony Joyce M, 2007, Issues Ment Health Nurs, V28, P1171, DOI 10.1080/01612840701581289; Olayiwola JN, 2016, SAVING WOMEN SAVING; Quine S, 2003, RURAL REMOTE HEALTH, V3, P245, DOI DOI 10.22605/RRH245; Rawson HA, 2010, ETHNIC HEALTH, V15, P343, DOI 10.1080/13557851003728264; Rice PL, 2007, J REPROD INFANT PSYC, V17, P237; Riggs E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-117; Rogers C, 2014, HEALTH CARE WOMEN IN, V35, P334, DOI 10.1080/07399332.2013.857322; Saha S, 2003, AM J PUBLIC HEALTH, V93, P1713, DOI 10.2105/AJPH.93.10.1713; Sebo P, 2011, J IMMIGR MINOR HEALT, V13, P510, DOI 10.1007/s10903-010-9367-z; Shafiei T, 2012, MIDWIFERY, V28, P198, DOI 10.1016/j.midw.2011.02.008; Shtarkshall Ronny A, 2009, Ethn Health, V14, P459, DOI 10.1080/13557850902890522; Small R, 2002, BIRTH-ISS PERINAT C, V29, P266, DOI 10.1046/j.1523-536X.2002.00201.x; Suphanchaimat R, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1065-z; Taylor RJ, 2003, ETHNIC HEALTH, V8, P251, DOI 10.1080/1355785032000136443; Tilahun T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2057-y; Tran M, 2001, J Qual Clin Pract, V21, P135, DOI 10.1046/j.1440-1762.2001.00431.x; Tsianakas V, 2002, MIDWIFERY, V18, P25, DOI 10.1054/midw.2002.0296; United Nations, 1994, INT C POP DEV NEW YO; Ussher JM, 2012, SEX CULT, V16, P467, DOI 10.1007/s12119-012-9133-6; Watts MCNC, 2014, J CLIN NURS, V23, P2131, DOI 10.1111/jocn.12335; White K, 2016, WOMEN HLTH, P1; World Health Organization, 2001, WHO REG STRAT SEX RE; World Health Organization (WHO), 2009, MENTAL HLTH ASPECTS; Wray A, 2014, CULT HEALTH SEX, V16, P76, DOI 10.1080/13691058.2013.833651	60	49	49	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181421	10.1371/journal.pone.0181421	http://dx.doi.org/10.1371/journal.pone.0181421			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727833	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500070
J	Rosenzweig, B; Rubinstein, ND; Reznik, E; Shingarev, R; Juluru, K; Akin, O; Hsieh, JJ; Jaimes, EA; Russo, P; Susztak, K; Coleman, JA; Hakimi, AA				Rosenzweig, Barak; Rubinstein, Nimrod D.; Reznik, Ed; Shingarev, Roman; Juluru, Krishna; Akin, Oguz; Hsieh, James J.; Jaimes, Edgar A.; Russo, Paul; Susztak, Katalin; Coleman, Jonathan A.; Hakimi, A. Ari			Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ENDOTHELIAL PROGENITOR CELLS; RADICAL NEPHRECTOMY; VOLUME; MASS; HYPERTROPHY; REDUCTION; INJURY; AGE	Background and objectives Pre-operative kidney volume is an independent predictor of glomerular filtration rate in renal cell carcinoma patients. Compensatory renal growth (CRG) can ensue prior to nephrectomy in parallel to tumor growth and benign parenchyma loss. We aimed to test whether renal metabolite abundances significantly associate with CRG, suggesting a causative relationship. Design, setting, participants, and measurements Tissue metabolomics data from 49 patients, with a median age of 60 years, were previously collected and the pre-operative fold-change of their contra to ipsi-lateral benign kidney volume served as a surrogate for their CRG. Contra-lateral kidney volume fold-change within a 3.3+/-2.1 years follow-up interval was used as a surrogate for long-term CRG. Using a multivariable statistical model, we identified metabolites whose abundances significantly associate with CRG. Results Our analysis found 13 metabolites in the benign (e.g. L-urobilin, Variable Influence in Projection, VIP, score = 3.02, adjusted p = 0.017) and 163 metabolites in the malignant (e.g. 3-indoxyl-sulfate, VIP score = 1.3, adjusted p = 0.044) tissues that significantly associate with CRG. Benign/tumor fold change in metabolite abundances revealed three additional metabolites with that significantly positively associate with CRG (e.g. p-cresol sulfate, VIP score = 2.945, adjusted p = 0.033). At the pathway level, we show that fatty-acid oxidation is highly enriched with metabolites whose benign tissue abundances strongly positively associate with CRG, both pre-operatively and long term, whereas in the tumor tissue significant enrichment of dipeptides and benzoate (positive association), glycolysis/gluconeogenesis, lysolipid and nucleotide sugar pentose (negative associations) sub-pathways, were observed. Conclusion These data suggest that specific biological processes in the benign as well as in the tumor parenchyma strongly influence compensatory renal growth.	[Rosenzweig, Barak; Russo, Paul; Coleman, Jonathan A.; Hakimi, A. Ari] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA; [Rubinstein, Nimrod D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Reznik, Ed] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Shingarev, Roman; Jaimes, Edgar A.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Juluru, Krishna; Akin, Oguz] Mem Sloan Kettering Canc Ctr, Dept Radiol, Body Imaging Serv, 1275 York Ave, New York, NY 10021 USA; [Hsieh, James J.; Hakimi, A. Ari] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Susztak, Katalin] Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania	Coleman, JA; Hakimi, AA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA.; Hakimi, AA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	colemanj@mskcc.org; hakimia@mskcc.org	Susztak, Katalin/ABE-7474-2021	Susztak, Katalin/0000-0002-1005-3726; Coleman, Jonathan/0000-0002-6428-7835	Sidney Kimmel Center for Prostate and Urologic Cancers; NIH/NCI Cancer Center Support Grant [P30 CA008748, P30]; NATIONAL CANCER INSTITUTE [T32CA082088, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087635] Funding Source: NIH RePORTER	Sidney Kimmel Center for Prostate and Urologic Cancers; NIH/NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Sidney Kimmel Center for Prostate and Urologic Cancers and an NIH/NCI Cancer Center Support Grant (P30 CA008748), P30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benipal B, 2011, BIOCHEM PHARMACOL, V81, P295, DOI 10.1016/j.bcp.2010.10.010; Boon AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15482; Deguchi T, 2004, KIDNEY INT, V65, P162, DOI 10.1111/j.1523-1755.2004.00354.x; Funahashi Y, 2011, UROLOGY, V77, P1404, DOI 10.1016/j.urology.2010.03.063; Gong IH, 2012, J UROLOGY, V187, P344, DOI 10.1016/j.juro.2011.09.005; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Hauser P, 2005, KIDNEY INT, V68, P2497, DOI 10.1111/j.1523-1755.2005.00725.x; Jeon HG, 2014, EUR J CANCER, V50, P64, DOI 10.1016/j.ejca.2013.08.018; Jeon HG, 2012, BJU INT, V109, P1468, DOI 10.1111/j.1464-410X.2011.10531.x; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Lekawanvijit S, 2014, J PHYSIOL-LONDON, V592, P3969, DOI 10.1113/jphysiol.2014.273078; MOLLER JC, 1988, APMIS, V96, P82; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Park BH, 2016, WORLD J UROL, V34, P63, DOI 10.1007/s00345-015-1551-2; Sejima T, 2015, INT J UROL, V22, P14, DOI 10.1111/iju.12612; SHAPIRO JI, 1994, KIDNEY INT, V45, pS100; Song TR, 2014, INT UROL NEPHROL, V46, P743, DOI 10.1007/s11255-013-0592-y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka M, 2014, ATHEROSCLEROSIS, V234, P421, DOI 10.1016/j.atherosclerosis.2014.03.015; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; TOBACK FG, 1974, J CLIN INVEST, V54, P91, DOI 10.1172/JCI107754; Triba MN, 2015, MOL BIOSYST, V11, P13, DOI 10.1039/c4mb00414k; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Wei QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106647; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; Wu VC, 2013, ANGIOGENESIS, V16, P609, DOI 10.1007/s10456-013-9339-8; Ying Y, 2011, CIRC J, V75, P2252, DOI 10.1253/circj.CJ-11-0046; ZALUPS RK, 1990, J PHARMACOL EXP THER, V254, P962; Ziboh VA, 2000, PROSTAG OTH LIPID M, V63, P3, DOI 10.1016/S0090-6980(00)00093-9	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180350	10.1371/journal.pone.0180350	http://dx.doi.org/10.1371/journal.pone.0180350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727768	Green Published, gold			2022-12-27	WOS:000406634500019
J	Sekine, K; Hodgkin, ME				Sekine, Kazutaka; Hodgkin, Marian Ellen			Effect of child marriage on girls' school dropout in Nepal: Analysis of data from the Multiple Indicator Cluster Survey 2014	PLOS ONE			English	Article							DETERMINANTS; AFRICA; AGE	School dropout and child marriage are interrelated outcomes that have an enormous impact on adolescent girls. However, the literature reveals gaps in the empirical evidence on the link between child marriage and the dropout of girls from school. This study identifies the 'tipping point' school grades in Nepal when the risk of dropout due to marriage is highest, measures the effect of child marriage on girls' school dropout rates, and assesses associated risk factors. Weighted percentages were calculated to examine the grades at highest risk and the distribution of reasons for discontinuing school. Using the Nepal Multiple Indicator Cluster Survey (MICS) 2014 data, we estimated the effect of marriage on school attendance and dropout among girls aged 15-17 by constructing logistic regression models. A multivariate logistic regression model was used to assess risk factors of school dropout due to child marriage. It was found that early marriage is the most common reason given for leaving school. Overall, the risk of school dropout due to marriage heightens after girls complete the fifth or sixth grade. The risk of girls' dropping out peaks in the seventh and eighth grades and remains noteworthy in the ninth and tenth grades. Married girls in Nepal are 10 times more likely to drop out than their unmarried peers. Little or no education of the household head, belonging to the Kirat religion, and membership of a traditionally disadvantaged social class each elevate the risk of school dropout due to early marriage. The findings underscore the need to delay girl's marriage so as to reduce girls' school dropout in Nepal. School-based programmes aimed at preventing child marriage should target girls from the fifth grade because they are at increased risk of dropping out, as well as prioritizing girls from disadvantaged groups.	[Sekine, Kazutaka] UNICEF Nepal, Hlth Sect, Kathmandu, Nepal; [Hodgkin, Marian Ellen] UNICEF Nepal, Educ Sect, Kathmandu, Nepal; [Sekine, Kazutaka] UNICEF Nepal, Kathmandu, Nepal		Sekine, K (corresponding author), UNICEF Nepal, Hlth Sect, Kathmandu, Nepal.; Sekine, K (corresponding author), UNICEF Nepal, Kathmandu, Nepal.	kazutaka_sekine@hotmail.com		Sekine, Kazutaka/0000-0003-2413-2027				[Anonymous], 2015, FIX BROK PROM ED ALL; Aryal TR, 2007, J BIOSOC SCI, V39, P693, DOI 10.1017/S0021932006001775; Bajracharya A, 2012, STUD FAMILY PLANN, V43, P79, DOI 10.1111/j.1728-4465.2012.00307.x; Brown G., 2012, OUT WEDLOCK SCH COMB; CBS, 2015, NEP MULT IND CLUST S; Field E., 2008, J POLITICAL EC, V116; Ghimire A., 2014, CHANGE CONTINUITY SO; Glick P, 2015, POP STUD-J DEMOG, V69, P219, DOI 10.1080/00324728.2015.1053513; Kalamar AM, 2016, J ADOLESCENT HEALTH, V59, pS22, DOI 10.1016/j.jadohealth.2016.05.020; Lee-Rife S, 2012, STUD FAMILY PLANN, V43, P287, DOI 10.1111/j.1728-4465.2012.00327.x; Lloyd CB, 2008, POP STUD-J DEMOG, V62, P1, DOI 10.1080/00324720701810840; McCleary-Sills J, 2015, REV FAITH INT AFF, V13, P69, DOI 10.1080/15570274.2015.1075755; Mensch B., 2005, CHANGING TRANSITIONS; Nguyen M.C., 2014, IMPACT CHILD MARRIAG; Nour NM, 2006, EMERG INFECT DIS, V12, P1644, DOI 10.3201/eid1211.060510; Nour Nawal M, 2009, Rev Obstet Gynecol, V2, P51; Omoeva C, 2014, EFFECTS EARLY MARRIA; Raj A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106210; Sah N., 2012, NEPAL POPUL J, V17, P55; Sah N, 2008, J POPUL RES, V25, P207, DOI 10.1007/BF03031949; Streatfield PK, 2015, ASIAN POPUL STUD, V11, P94, DOI 10.1080/17441730.2015.1012785; The Government of Nepal, 2016, NAT STRAT END UNPUB; UN Economic Social Council, 2016, PROGR SUST DEV GOALS; UNESCO Institute for Statistics (UIS), 2014, PROGR GETT CHILDR SC; UNFPA, 2012, MARR TOO YOUNG END C; United Nations, 1989, CONV RIGHTS CHILDS; Ward A. C., 2009, EPIDEMIOL PERSPECT I, V6, P2, DOI [10.1186/1742-5573-6-2, DOI 10.1186/1742-5573-6-2]	27	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180176	10.1371/journal.pone.0180176	http://dx.doi.org/10.1371/journal.pone.0180176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727793	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500016
J	Qin, G; Lo, JW; Marlow, N; Calvert, SA; Greenough, A; Peacock, JL				Qin, Gordon; Lo, Jessica W.; Marlow, Neil; Calvert, Sandy A.; Greenough, Anne; Peacock, Janet L.			Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; FREQUENCY OSCILLATORY VENTILATION; CONTROLLED-TRIAL; FOLLOW-UP; AGE; CORTICOSTEROIDS; PREVENTION; THERAPY; INFANTS	Importance Postnatal dexamethasone is associated with reduction in bronchopulmonary dysplasia. There remains, however, concern that its short-term benefits are accompanied by long-term adverse effects e.g. poorer neurodevelopmental outcomes. Objective Our aim was to determine the effects of administration of postnatal dexamethasone on respiratory and neurodevelopmental outcome at two years of age after adjusting for neonatal and infant risk factors. Materials and methods The study included 412 infants born at 23-28 weeks of gestation, 29% had received postnatal dexamethasone. Two outcomes were examined, respiratory hospital admissions in the past 12 months and neurodevelopmental impairment. Logistic regression, adjusted for sex, birthweight z-score, gestation, maternal smoking, oxygen dependency at 36 weeks, airleak, patent ductus arteriosus, pulmonary haemorrhage, major ultrasound abnormality, mode of ventilation and age at assessment, was undertaken. Results After adjustment, postnatal dexamethasone was associated with significantly increased proportions of both respiratory hospital readmission: (0.35 vs 0.15, difference = 0.20; 95% CI: 0.08, 0.31) and neurodevelopmental impairment (0.59 vs 0.45, difference = 0.14; 95% CI: 0.02, 0.26). Conclusions Postnatal dexamethasone use in extremely preterm infants is associated with increased risks of respiratory hospital admissions and neurodevelopmental impairment. These associations were not explained by excess neonatal morbidities.	[Qin, Gordon; Lo, Jessica W.; Peacock, Janet L.] Kings Coll London, Div Hlth & Social Care Res, London, England; [Qin, Gordon] Queen Alexandra Hosp, Portsmouth, Hants, England; [Lo, Jessica W.; Greenough, Anne] Univ New South Wales, UNSW Med, Sch Psychiat, Randwick, NSW, Australia; [Marlow, Neil] UCL, Inst Womens Hlth, London, England; [Calvert, Sandy A.] St Georges Univ London, Dept Child Hlth, London, England; [Greenough, Anne] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England	University of London; King's College London; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of New South Wales Sydney; University of London; University College London; St Georges University London; University of London; King's College London	Peacock, JL (corresponding author), Kings Coll London, Div Hlth & Social Care Res, London, England.	janet.peacock@kcl.ac.uk	Marlow, Neil/D-2918-2009	Marlow, Neil/0000-0001-5890-2953; Peacock, Janet/0000-0002-0310-2518; Greenough, Anne/0000-0002-8672-5349	Medical Research Council; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; MRC [G1002276] Funding Source: UKRI; Medical Research Council [G1000758, G1000758B, G1002276] Funding Source: researchfish; National Institute for Health Research [NF-SI-0616-10093] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	The original UKOS Study was funded by the Medical Research Council (1997). This secondary analysis was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the UK Department of Health. JLP is an NIHR Senior Investigator.	Baud O, 1999, ARCH DIS CHILD-FETAL, V80, pF159; Baud O, 2004, ARCH DIS CHILD-FETAL, V89, P96, DOI 10.1136/adc.2003.028696; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Gross SJ, 2005, PEDIATRICS, V115, P681, DOI 10.1542/peds.2004-0956; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Johnson AH, 2002, NEW ENGL J MED, V347, P633, DOI 10.1056/NEJMoa020432; JONES R, 1991, PEDIATRICS, V88, P421; Jones RAK, 2005, PEDIATRICS, V116, P379, DOI 10.1542/peds.2004-1819; Khalife N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081394; Marlow N, 2006, ARCH DIS CHILD-FETAL, V91, P320, DOI 10.1136/adc.2005.079632; Mieskonen S, 2003, ACTA PAEDIATR, V92, P896, DOI 10.1080/08035250310003451; Nixon PA, 2007, J PEDIATR-US, V150, P345, DOI 10.1016/j.jpeds.2006.12.013; Smith LJ, 2011, J PAEDIATR CHILD H, V47, P448, DOI 10.1111/j.1440-1754.2010.01992.x; Tschanz SA, 1997, PEDIATR PULM, P247; Vyas J, 1997, ARCH DIS CHILD-FETAL, V77, pF147, DOI 10.1136/fn.77.2.F147; Wilson-Costello D, 2009, PEDIATRICS, V123, pe430, DOI 10.1542/peds.2008-1928; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089	17	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181176	10.1371/journal.pone.0181176	http://dx.doi.org/10.1371/journal.pone.0181176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723921	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000406067800038
J	Soliman, A; Soltani, K; Yin, JJ; Padmanabhan, A; Wang, SW				Soliman, Aiman; Soltani, Kiumars; Yin, Junjun; Padmanabhan, Anand; Wang, Shaowen			Social sensing of urban land use based on analysis of Twitter users' mobility patterns	PLOS ONE			English	Article								A number of recent studies showed that digital footprints around built environments, such as geo-located tweets, are promising data sources for characterizing urban land use. However, challenges for achieving this purpose exist due to the volume and unstructured nature of geo-located social media. Previous studies focused on analyzing Twitter data collectively resulting in coarse resolution maps of urban land use. We argue that the complex spatial structure of a large collection of tweets, when viewed through the lens of individual-level human mobility patterns, can be simplified to a series of key locations for each user, which could be used to characterize urban land use at a higher spatial resolution. Contingent issues that could affect our approach, such as Twitter users' biases and tendencies at locations where they tweet the most, were systematically investigated using 39 million geo-located Tweets and two independent datasets of the City of Chicago: 1) travel survey and 2) parcel-level land use map. Our results support that the majority of Twitter users show a preferential return, where their digital traces are clustered around a few key locations. However, we did not find a general relation among users between the ranks of locations for an individual-based on the density of tweets-and their land use types. On the contrary, temporal patterns of tweeting at key locations were found to be coherent among the majority of users and significantly associated with land use types of these locations. Furthermore, we used these temporal patterns to classify key locations into generic land use types with an overall classification accuracy of 0.78. The contribution of our research is twofold: a novel approach to resolving land use types at a higher resolution, and in-depth understanding of Twitter users' location-related and temporal biases, promising to benefit human mobility and urban studies in general.	[Soliman, Aiman; Soltani, Kiumars; Yin, Junjun; Padmanabhan, Anand; Wang, Shaowen] Univ Illinois, Natl Ctr Supercomp Applicat, CyberGIS Ctr Adv Digital & Spatial Studies, Champaign, IL 61820 USA; [Soltani, Kiumars; Wang, Shaowen] Univ Illinois, Illinois Informat Inst, Champaign, IL 61820 USA; [Yin, Junjun; Padmanabhan, Anand; Wang, Shaowen] Univ Illinois, Dept Geog & Geog Informat Sci, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wang, SW (corresponding author), Univ Illinois, Natl Ctr Supercomp Applicat, CyberGIS Ctr Adv Digital & Spatial Studies, Champaign, IL 61820 USA.; Wang, SW (corresponding author), Univ Illinois, Illinois Informat Inst, Champaign, IL 61820 USA.; Wang, SW (corresponding author), Univ Illinois, Dept Geog & Geog Informat Sci, Champaign, IL 61820 USA.	shaowen@illinois.edu	Yin, Junjun/H-8947-2019	Yin, Junjun/0000-0002-4196-2439	U.S. National Science Foundation [1047916, 1429699, 1443080]; Direct For Computer & Info Scie & Enginr [1429699] Funding Source: National Science Foundation; Office of Advanced Cyberinfrastructure (OAC) [1443080] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by U.S. National Science Foundation under grant numbers: 1047916,1429699, and 1443080 (SW, AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This material is based in part upon work supported by the U.S. National Science Foundation under grant numbers: 1047916, 1429699, and 1443080. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Insightful comments and feedbacks received from four anonymous reviewers and members of the CyberGIS Center for Advanced Digital and Spatial Studies are greatly appreciated.	Abbas A., 2015, 2015 IEEE 42nd Photovoltaic Specialist Conference (PVSC). Proceedings, P1, DOI 10.1109/PVSC.2015.7355622; Bawa-Cavia A., 2011, PERVASIVE PURBA WORK; Bora Nibir, 2014, Social Computing, Behavioral-Cultural Modeling and Prediction. 7th International Conference, SBP 2014. Proceedings: LNCS 8393, P11, DOI 10.1007/978-3-319-05579-4_2; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; CMAP, 2014, CHIC METR AG PLANN 2; CMAP, 2008, CHIC TRAV TRACK HOUS; Dark SJ, 2007, PROG PHYS GEOG, V31, P471, DOI 10.1177/0309133307083294; Efstathiades H, 2015, PROCEEDINGS OF THE 2015 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2015), P218, DOI 10.1145/2808797.2808877; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Frias-Martinez V, 2014, ENG APPL ARTIF INTEL, V35, P237, DOI 10.1016/j.engappai.2014.06.019; Frias-Martinez V, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P239, DOI 10.1109/SocialCom-PASSAT.2012.19; Giorgino T, 2012, PACKAGE DTW, P1; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Goodchild Michael F., 2013, DIALOGUES HUM GEOGR, V3, P280, DOI DOI 10.1177/2043820613513392; Hasan S., 2013, P 2 ACM SIGKDD INT W; Hu TY, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020151; Jiang S, 2012, DATA MIN KNOWL DISC, V25, P478, DOI 10.1007/s10618-012-0264-z; Kunze C, 2015, COMPUT ENVIRON URBAN, V53, P4, DOI 10.1016/j.compenvurbsys.2015.04.002; Liu JJ, 2015, 2015 13TH IEEE INTERNATIONAL CONFERENCE ON DATA ENGINEERING WORKSHOPS (ICDEW), P83, DOI 10.1109/ICDEW.2015.7129551; Liu XJ, 2016, ENVIRON PLANN B, V43, P341, DOI 10.1177/0265813515604767; Openshaw S., 1984, MODIFIABLE AREAL UNI; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Psyllidis A, 2015, COMM COM INF SC, V527, P21, DOI 10.1007/978-3-662-47386-3_2; R Core Team, 2021, R LANGUAGE ENV STAT; Schade S, 2012, FUTURE INTERNET, V4, P807, DOI 10.3390/fi4030807; Sila-Nowicka K, 2016, BUILT ENV, V42, P415; Silva TH, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON GREEN COMPUTING AND COMMUNICATIONS, CONFERENCE ON INTERNET OF THINGS, AND CONFERENCE ON CYBER, PHYSICAL AND SOCIAL COMPUTING (GREENCOM 2012), P382, DOI 10.1109/GreenCom.2012.62; Soliman A, 2016, ARXIV160904373; Soliman A, 2015, P 1 ACM SIGSP INT WO; Soltani K, 2015, P 8 ACM SIGSP INT WO; Soltani K, 2016, P 2016 XSEDE C SCI A; Sparks KA, 2016, P 10 WORKSH GEOGR IN, P2; Thakur GS, 2015, P 23 SIGSPATIAL INT, P11; United Nations, 2015, STESASERA366 UN DEP; Wakamiya S, 2012, P 6 INT C UB INF MAN, P26; Wakamiya S, 2011, LECT NOTES COMPUT SC, V6631, P108, DOI 10.1007/978-3-642-20630-6_7; Wang SW, 2016, GEOJOURNAL, V81, P965, DOI 10.1007/s10708-016-9740-0; Zhan XY, 2014, NETW SPAT ECON, V14, P647, DOI 10.1007/s11067-014-9264-4	42	39	40	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181657	10.1371/journal.pone.0181657	http://dx.doi.org/10.1371/journal.pone.0181657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723936	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800064
J	Martinez-Rivera, FJ; Perez-Laspiur, J; Santiago-Gascot, ME; Aleman-Reyes, AG; Garcia-Santiago, E; Rodriguez-Perez, Y; Cabo-Guadalupe, C; Otero-Pagan, I; Ayala-Pagan, RN; Martinez, M; Cantres-Rosario, YM; Melendez, LM; Barreto-Estrada, JL				Martinez-Rivera, Freddyson J.; Perez-Laspiur, Juliana; Santiago-Gascot, Maria E.; Aleman-Reyes, Abner G.; Garcia-Santiago, Emanuel; Rodriguez-Perez, Yolanda; Cabo-Guadalupe, Cristhian; Otero-Pagan, Inelia; Ayala-Pagan, Roxsana N.; Martinez, Magdiel; Cantres-Rosario, Yisel M.; Melendez, Loyda M.; Barreto-Estrada, Jennifer L.			Differential protein expression profile in the hypothalamic GT1-7 cell line after exposure to anabolic androgenic steroids	PLOS ONE			English	Article							GNRH GENE-EXPRESSION; HUMAN CYTOCHROME-P450 ENZYMES; RECEPTOR EXPRESSION; CEREBROSPINAL-FLUID; HOUSEKEEPING GENES; PROTEOMIC ANALYSIS; STATISTICAL-MODEL; HORMONE NEURONS; F-ACTIN; TESTOSTERONE	The abuse of anabolic androgenic steroids (AAS) has been considered a major public health problem during decades. Supraphysiological doses of AAS may lead to a variety of neuroendocrine problems. Precisely, the hypothalamic-pituitary-gonadal (HPG) axis is one of the body systems that is mainly influenced by steroidal hormones. Fluctuations of the hormonal milieu result in alterations of reproductive function, which are made through changes in hypothalamic neurons expressing gonadotropin-releasing hormone (GnRH). In fact, previous studies have shown that AAS modulate the activity of these neurons through steroid-sensitive afferents. To increase knowledge about the cellular mechanisms induced by AAS in GnRH neurons, we performed proteomic analyses of the murine hypothalamic GT1-7 cell line after exposure to 17a-methyltestosterone (17 alpha-meT; 1 mu M). These cells represent a good model for studying regulatory processes because they exhibit the typical characteristics of GnRH neurons, and respond to compounds that modulate GnRH in vivo. Two-dimensional difference in gel electrophoresis (2D-DIGE) and mass spectrometry analyses identified a total of 17 different proteins that were significantly affected by supraphysiological levels of AAS. Furthermore, pathway analyses showed that modulated proteins were mainly associated to glucose metabolism, drug detoxification, stress response and cell cycle. Validation of many of these proteins, such as GSTM1, ERH, GAPDH, PEBP1 and PDIA6, were confirmed by western blotting. We further demonstrated that AAS exposure decreased expression of estrogen receptors and GnRH, while two important signaling pathway proteins p-ERK, and p-p38, were modulated. Our results suggest that steroids have the capacity to directly affect the neuroendocrine system by modulating key cellular processes for the control of reproductive function.	[Martinez-Rivera, Freddyson J.; Santiago-Gascot, Maria E.; Otero-Pagan, Inelia; Barreto-Estrada, Jennifer L.] Univ Puerto Rico, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA; [Perez-Laspiur, Juliana; Rodriguez-Perez, Yolanda; Melendez, Loyda M.] Univ Puerto Rico, Translat Prote Ctr RCMI, Med Sci Campus, San Juan, PR 00936 USA; [Aleman-Reyes, Abner G.; Ayala-Pagan, Roxsana N.] Univ Puerto Rico, Dept Biol, Rio Piedras, PR USA; [Garcia-Santiago, Emanuel; Cabo-Guadalupe, Cristhian] Univ Este, Dept Biotechnol, Carolina, PR USA; [Martinez, Magdiel] Univ Puerto Rico, Dept Physiol & Biophys, Med Sci Campus, San Juan, PR 00936 USA; [Cantres-Rosario, Yisel M.; Melendez, Loyda M.] Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Barreto-Estrada, JL (corresponding author), Univ Puerto Rico, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA.	jennifer.barreto1@upr.edu		Cantres-Rosario, Yisel/0000-0002-0630-5695	RCMI Translational Proteomics Center NIMHD [8G12MD007600]; RTRN [U54MD008149]; NIH-NCRR [2P20RR016470]; NIGMS [8P20GM103475]; MBRS-RISE [R25GM061838, R25GM066250]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, P20GM103475, R25GM066250] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579, G12MD007600, U54MD008149] Funding Source: NIH RePORTER	RCMI Translational Proteomics Center NIMHD; RTRN; NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MBRS-RISE; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants, RCMI Translational Proteomics Center NIMHD (8G12MD007600), RTRN Small Grants Program (U54MD008149) to JLBE; NIH-NCRR (2P20RR016470) and NIGMS (8P20GM103475) to JLBE and MESG; MBRS-RISE (R25GM061838) to FJMR, and MBRS-RISE (R25GM066250) to EGS and CCG. Authors want to thank, Dr. Scott Shaffer, Director of Proteomics and Mass Spectrometry Facility at University of Massachusetts Medical School and Dr. Richard Noel, Director of Molecular and Genomics Core NIH-RCMI Program (NIMHD MD007579) at the Ponce Health Sciences University. We also thank Namyr Martinez for his technical assistance, and Angelica B. Rolon-Barreto for editorial revision.; This work was funded by RTRN Small Grants Program (U54MD008149) http://grants.rtm.net/index.php/SMALLGRANT20162017, to JLBE; NIH-NCRR (2P20RR016470) http://www.nems.nih.gov/teams/Pages/NCRR.aspx, to JLBE; NIGMS (8P20GM103475) https://www.nigms.nih.gov/Pages/default.aspx to JLBE; MBRS-RISE (R25GM061838) http://mbrsrise.rcm.upr.edu. to FJMR; MBRS-RISE (R25GM066250) http://www.sugam.edu/une/propuestas/rise/rise_index.html. to EGS and CCG; RCMI Translational Proteomics Center NIMHD (8G12MD007600), htp://rcmi.rcm.upr.edu/ resreso/guidelines_rcmi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele MK, 2003, AM J PHYSIOL-ENDOC M, V285, pE189, DOI 10.1152/ajpendo.00035.2003; Belsham DD, 1998, ENDOCRINOLOGY, V139, P1108, DOI 10.1210/en.139.3.1108; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Brayman MJ, 2012, MOL ENDOCRINOL, V26, P2, DOI 10.1210/me.2011-1015; BROOKS DE, 1976, BIOCHEM J, V156, P527, DOI 10.1042/bj1560527; Caraci F, 2011, J NEUROSCI RES, V89, P592, DOI 10.1002/jnr.22578; Castoria G, 2014, ROLE NONGENOMIC ANDR, V5, pe1548; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; Chen Jie, 2009, Cancer Genomics & Proteomics, V6, P331; Cheng J, 2007, ENDOCRINOLOGY, V148, P2066, DOI 10.1210/en.2006-1465; COHEN JC, 1987, J CLIN ENDOCR METAB, V64, P960, DOI 10.1210/jcem-64-5-960; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Coles BF, 2003, BIOFACTORS, V17, P115, DOI 10.1002/biof.5520170112; Cui H, 2003, MOL CELL ENDOCRINOL, V203, P13, DOI 10.1016/S0303-7207(03)00121-7; Cunningham RL, 2009, ENDOCRINOLOGY, V150, P5539, DOI 10.1210/en.2009-0640; Daly RC, 2001, ARCH GEN PSYCHIAT, V58, P172, DOI 10.1001/archpsyc.58.2.172; de Gooyer ME, 2003, STEROIDS, V68, P235, DOI 10.1016/S0039-128X(02)00184-8; Dodge T, 2011, DRUG ALCOHOL DEPENDE; Escara-Wilke J, 2012, CANCER METAST REV, V31, P615, DOI 10.1007/s10555-012-9365-9; Estrada M, 2006, J BIOL CHEM, V281, P25492, DOI 10.1074/jbc.M603193200; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Frankenfeld SP, 2014, J ENDOCRINOL, V220, P143, DOI 10.1530/JOE-13-0259; Fu Q-F, 2015, ALPHA ENOLASE PROMOT, P1; Fujimura A, 2012, BIOCHEM BIOPH RES CO, V423, P588, DOI 10.1016/j.bbrc.2012.06.018; Gao JC, 2015, COMP BIOCHEM PHYS D, V15, P20, DOI 10.1016/j.cbd.2015.05.001; Garrido P, 2014, METABOLISM, V63, P1178, DOI 10.1016/j.metabol.2014.06.003; Gore AC, 1997, FRONT NEUROENDOCRIN, V18, P209, DOI 10.1006/frne.1996.0149; Gu S, 2011, PAPADOPOULOU N MOL M, V17, P1; HALES TG, 1992, MOL PHARMACOL, V42, P197; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hazard D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-101; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Hwang K-A, 2015, J STEROID BIOCHEM, V147, P24; Imperlini E, 2010, PROTEOMICS, V10, P3165, DOI 10.1002/pmic.201000079; Jiang M, 2009, MOL ENDOCRINOL, V23, P1927, DOI 10.1210/me.2009-0103; Jin JM, 2014, GENE, V551, P15, DOI 10.1016/j.gene.2014.08.048; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Li HS, 2010, EXPERT OPIN DRUG MET, V6, P409, DOI 10.1517/17425251003598886; Liao RS, 2013, ANDROGEN RECEPTOR ME; Liu T, 2015, GENE, V555, P108, DOI 10.1016/j.gene.2014.10.051; Liu X, 2015, INT J ENDOCRINOL, P1; Malorni L, 2006, PROTEOMICS, V6, P5973, DOI 10.1002/pmic.200600333; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Martinez-Rivera FJ, 2015, BEHAV PROCESS, V113, P81, DOI 10.1016/j.beproc.2015.01.008; Mayer CM, 2009, FRONT NEUROENDOCRIN, V30, P405, DOI 10.1016/j.yfrne.2009.03.005; McNamara LE, 2010, J R SOC INTERFACE, V7, pS107, DOI 10.1098/rsif.2009.0177.focus; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Moenter SM, 2003, FRONT NEUROENDOCRIN, V24, P79, DOI 10.1016/S0091-3022(03)00013-X; Mulchahey JJ, 2001, PSYCHONEUROENDOCRINO, V26, P273, DOI 10.1016/S0306-4530(00)00052-4; Navarro CE, 2003, MOL ENDOCRINOL, V17, P1792, DOI 10.1210/me.2003-0040; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nguyen TVV, 2005, J NEUROCHEM, V94, P1639, DOI 10.1111/j.1471-4159.2005.03318.x; Nishimura M, 2006, BIOCHEM BIOPH RES CO, V346, P1033, DOI 10.1016/j.bbrc.2006.06.012; Onaran I, 2007, ARCH ANDROLOGY, V53, P13, DOI 10.1080/01485010600889134; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Payne JR, 2004, HEART, V90, P473, DOI 10.1136/hrt.2003.025783; Penatti CAA, 2011, NEUROPHARMACOLOGY, V61, P653, DOI 10.1016/j.neuropharm.2011.05.008; Penatti CAA, 2010, J NEUROSCI, V30, P6497, DOI 10.1523/JNEUROSCI.5383-09.2010; Penatti CAA, 2009, J NEUROSCI, V29, P12484, DOI 10.1523/JNEUROSCI.3108-09.2009; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Poletti A, 2001, J NEUROENDOCRINOL, V13, P353, DOI 10.1046/j.1365-2826.2001.00635.x; Rendic S, 1999, J CHROMATOGR B, V735, P73, DOI 10.1016/S0378-4347(99)00400-4; Riedmaier I, 2009, J CHROMATOGR A, V1216, P8192, DOI 10.1016/j.chroma.2009.01.094; Roy D, 1999, ENDOCRINOLOGY, V140, P5045, DOI 10.1210/en.140.11.5045; Schroder AL, 2009, ENDOCRINE, V35, P211, DOI 10.1007/s12020-009-9154-6; SCHWANZELFUKUDA M, 1992, ENDOCR REV, V13, P623, DOI 10.1210/er.13.4.623; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shakil T, 2002, MOL ENDOCRINOL, V16, P2592, DOI 10.1210/me.2002-0011; Skynner HA, 2006, BRAIN RES, V1102, P12, DOI 10.1016/j.brainres.2006.04.112; Stanton PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041718; Stefansson J, 2016, PSYCHONEUROENDOCRINO, V74, P1, DOI 10.1016/j.psyneuen.2016.08.009; Stella R, 2015, PROTEOMICS, V15, P2332, DOI 10.1002/pmic.201400468; STRAUSS RH, 1985, JAMA-J AM MED ASSOC, V254, P3337, DOI 10.1001/jama.254.23.3337; Suehara Y, 2009, PROTEOM CLIN APPL, V3, P584, DOI 10.1002/prca.200800168; TORANZO D, 1989, MOL ENDOCRINOL, V3, P1748, DOI 10.1210/mend-3-11-1748; Tufo G, 2014, CELL DEATH DIFFER, V21, P685, DOI 10.1038/cdd.2013.193; van Amsterdam J, 2010, REGUL TOXICOL PHARM, V57, P117, DOI 10.1016/j.yrtph.2010.02.001; Wada-Kiyama Y, 2013, BIOCHEM BIOPH RES CO, V434, P287, DOI 10.1016/j.bbrc.2013.02.117; WELDER AA, 1995, J PHARMACOL TOX MET, V33, P187, DOI 10.1016/1056-8719(94)00073-D; Weng MT, 2013, PROTEIN CELL, V4, P807, DOI 10.1007/s13238-013-3056-3; WETSEL WC, 1995, CELL MOL NEUROBIOL, V15, P43, DOI 10.1007/BF02069558; Wiebe JP, 2001, ENDOCRINE, V16, P7, DOI 10.1385/ENDO:16:1:07; WIERMAN ME, 1995, CELL MOL NEUROBIOL, V15, P79, DOI 10.1007/BF02069559; Winters S J, 1990, NIDA Res Monogr, V102, P113; Wood RI, 2004, PHYSIOL BEHAV, V83, P279, DOI 10.1016/j.physbeh.2004.08.012; Yamada M., 2009, J PROTEOM BIOINFORM, V2, P001; YESALIS CE, 1995, SPORTS MED, V19, P326, DOI 10.2165/00007256-199519050-00003; Yuen GS, 2011, BRAIN RES, V1379, P44, DOI 10.1016/j.brainres.2010.07.067; Zarubin T, 2005, CELL RES; Zhang BG, 2013, EUR J CANCER, V49, P3900, DOI 10.1016/j.ejca.2013.07.146; Zhang HL, 2012, CELL PHYSIOL BIOCHEM, V30, P1340, DOI 10.1159/000343323; Zhang YY, 2009, EXPERT OPIN DRUG MET, V5, P621, DOI 10.1517/17425250902967648; Zhao KK, 2013, EUR J OBSTET GYN R B, V171, P301, DOI 10.1016/j.ejogrb.2013.09.026	94	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180409	10.1371/journal.pone.0180409	http://dx.doi.org/10.1371/journal.pone.0180409			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719635	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400012
J	Cheret, A; Durier, C; Melard, A; Ploquin, M; Heitzmann, J; Lecuroux, C; Avettand-Fenoel, V; David, L; Pialoux, G; Chennebault, JM; Muller-Trutwin, M; Goujard, C; Rouzioux, C; Meyer, L				Cheret, Antoine; Durier, Christine; Melard, Adeline; Ploquin, Mickael; Heitzmann, Julia; Lecuroux, Camille; Avettand-Fenoel, Veronique; David, Ludivine; Pialoux, Gilles; Chennebault, Jean-Marie; Mueller-Trutwin, Michaela; Goujard, Cecile; Rouzioux, Christine; Meyer, Laurence		ANRS OPTIPRIM Study Grp	Impact of early cART on HIV blood and semen compartments at the time of primary infection	PLOS ONE			English	Article							SEMINAL PLASMA; IMMUNE ACTIVATION; T-CELLS; TRANSMISSION; IP-10; SEX; MEN; RNA; HERPESVIRUSES; THERAPY	Background HIV-infected cells in semen facilitate viral transmission. We studied the establishment of HIV reservoirs in semen and blood during PHI, along with systemic immune activation and the impact of early cART. Methods Patients in the ANRS-147-OPTIPRIM trial received two years of early cART. Nineteen patients of the trial were analyzed, out of which 8 had acute PHI (WB <= 1 Ab). We quantified total cell-associated (ca) HIV-DNA in blood and semen and HIV-RNA in blood and semen plasma samples, collected during PHI and at 24 months of treatment. Results At enrollment, HIV-RNA load was higher in blood than in semen (median 5.66 vs 4.22 log10 cp/mL, p<0.0001). Semen HIV-RNA load correlated strongly with blood HIV-RNA load (r = 0.81, p = 0.02, the CD4 cell count (r = -0.98, p< 0.0001), and the CD4/CD8 ratio (r = -0.85, p<0.01) in acute infection but not in later stages of PHI. Median blood and seminal cellular HIV-DNA levels were 3.59 and 0.31 log(10)cp/10 6 cells, respectively. HIV-DNA load peaked in semen later than in blood and then correlated with blood IP10 level (r = 0.62, p = 0.04). HIV-RNA was undetectable in blood and semen after two years of effective cART. Semen HIV-DNA load declined similarly, except in one patient who had persistently high IP10 and IL-6 levels and used recreational drugs. Conclusions HIV reservoir cells are found in semen during PHI, with gradual compartmentalization. Its size was linked to the plasma IP-10 level. Early treatment purges both the virus and infected cells, reducing the high risk of transmission during PHI.	[Cheret, Antoine; Goujard, Cecile] Bicetre Hosp, AP HP, Internal Med Unit, Le Kremlin Bicetre, France; [Cheret, Antoine; Melard, Adeline; Avettand-Fenoel, Veronique; David, Ludivine; Rouzioux, Christine] Paris Descartes Univ, EA 7327, Paris, France; [Durier, Christine; Heitzmann, Julia; Meyer, Laurence] INSERM, SC10 US19, Villejuif, France; [Melard, Adeline; Avettand-Fenoel, Veronique; Rouzioux, Christine] CHU Necker, AP HP, Virol Lab, Paris, France; [Ploquin, Mickael; Mueller-Trutwin, Michaela] Inst Pasteur, HIV Inflammat & Persistence Unit, Paris, France; [Lecuroux, Camille] Paris Sud Univ, Bicetre Hosp, AP HP, INSERM,U184, Le Kremlin Bicetre, France; [Pialoux, Gilles] Tenon Hosp, AP HP, Infect Dis Dept, Paris, France; [Chennebault, Jean-Marie] Angers Hosp, Infect Dis Dept, Angers, France; [Meyer, Laurence] Univ Paris Sud, INSERM, CESP U1018,Hop Bicetre,AP HP, Univ Paris Saclay,Fac Med Paris Sud,Serv Epidemio, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Cheret, A (corresponding author), Bicetre Hosp, AP HP, Internal Med Unit, Le Kremlin Bicetre, France.; Cheret, A (corresponding author), Paris Descartes Univ, EA 7327, Paris, France.	antoine.cheret@aphp.fr	Avettand-Fenoel, Véronique/O-6285-2017	Avettand-Fenoel, Véronique/0000-0002-7022-2990; , antoine/0000-0001-7295-3132; Muller-Trutwin, Michaela/0000-0002-3854-2396	ANRS; ViiV Healthcare; Gilead; Janssen; MSD; ANRS contract; Sidaction	ANRS(ANRSFrench National Research Agency (ANR)); ViiV Healthcare; Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD; ANRS contract; Sidaction	This work was supported by ANRS. ViiV Healthcare, Gilead, Janssen and MSD acted as co-sponsors through an ANRS contract. MP obtained a fellowship from Sidaction. But no funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Anderson DJ, 2014, J INFECT DIS, V210, pS606, DOI 10.1093/infdis/jiu538; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Bacchus C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064219; Berlier W, 2006, J CLIN VIROL, V36, P204, DOI 10.1016/j.jcv.2006.04.004; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Cheret A, 2015, LANCET INFECT DIS, V15, P387, DOI 10.1016/S1473-3099(15)70021-6; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Foley JF, 2005, J IMMUNOL, V174, P4892, DOI 10.4049/jimmunol.174.8.4892; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Gay C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019617; Ghosn J, 2004, AIDS, V18, P447, DOI 10.1097/00002030-200402200-00011; Ghosn J, 2014, CLIN INFECT DIS, V58, P1763, DOI 10.1093/cid/ciu187; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Gianella S, 2013, CLIN INFECT DIS, V57, P441, DOI 10.1093/cid/cit252; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Hoffman JC, 2014, AIDS RES HUM RETROV, V30, P1082, DOI [10.1089/aid.2013.0217, 10.1089/AID.2013.0217]; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Jiao YM, 2012, VIRAL IMMUNOL, V25, P333, DOI 10.1089/vim.2012.0011; Kim SG, 2013, J LEUKOCYTE BIOL, V94, P835, DOI 10.1189/jlb.1112566; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Lee S, 2015, J MED VIROL, V87, P782, DOI 10.1002/jmv.24026; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Lisco A, 2012, J INFECT DIS, V205, P97, DOI 10.1093/infdis/jir700; Mantri CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051387; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Noel N, 2014, AIDS, V28, P467, DOI 10.1097/QAD.0000000000000174; Olivier AJ, 2014, J INFECT DIS, V209, P1174, DOI 10.1093/infdis/jit649; Phanuphak N, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19470; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Ploquin MJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005774; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Pullium JK, 2001, J INFECT DIS, V183, P1023, DOI 10.1086/319293; Rasbach DA, 2013, AIDS CARE, V25, P109, DOI 10.1080/09540121.2012.687814; Robb ML, 2016, NEW ENGL J MED, V374, P2120, DOI 10.1056/NEJMoa1508952; Sheth PM, 2005, J IMMUNOL, V175, P4789, DOI 10.4049/jimmunol.175.7.4789; Stekler J, 2008, AIDS RES HUM RETROV, V24, P1269, DOI 10.1089/aid.2008.0014; Storey DF, 1999, AIDS, V13, P2169, DOI 10.1097/00002030-199910220-00023; TINDALL B, 1992, AIDS, V6, P949, DOI 10.1097/00002030-199209000-00006; Vanpouille C, 2016, AIDS, V30, P193, DOI 10.1097/QAD.0000000000000964; Weiss L, 2014, AIDS, V28, P1683, DOI 10.1097/QAD.0000000000000319	41	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180191	10.1371/journal.pone.0180191	http://dx.doi.org/10.1371/journal.pone.0180191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708873	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800014
J	Li, J; Wang, NN; Tesfaluul, N; Gao, XJ; Liu, S; Yue, BH				Li, Jia; Wang, Ningning; Tesfaluul, Nahom; Gao, Xiaojuan; Liu, Shuai; Yue, Baohong			Prognostic value of circulating plasma cells in patients with multiple myeloma: A meta-analysis	PLOS ONE			English	Article							MULTIPARAMETRIC FLOW-CYTOMETRY; PERIPHERAL-BLOOD; RISK STRATIFICATION; SURVIVAL; TRANSPLANTATION; QUANTIFICATION; PREDICTOR; DISEASE	Purpose The clinical significance and prognostic role of circulating plasma cells (CPCs) in multiple myeloma (MM) are still controversial. We conducted the first meta-analysis to clarify the correlation between CPCs and the clinicopathological features and prognosis of MM patients. Methods A comprehensive literary search for relevant studies was performed on PubMed, Embase, Medline, CNKI (Chinese) and Web of Science databases (January 1, 1950 to December 20, 2016). The associations between CPCs and survival rate and clinicopathological parameters, including International staging system (ISS) and Durie-Salm staging system (DS) stage, were evaluated. Then pooled hazard ratios (HRs) for survival with 95% confidence intervals (CIs), subgroup analysis, sensitivity analysis, and publication bias were conducted. Results 11 studies covering a total of 2943 patients were included. Pooled hazard ratios (HRs) revealed that the presence of CPCs predicted aggressive disease progression (HR = 1.78, 95% CI = 1.57-2.03) and reduced overall survival (OS) (HR = 1.82, 95% CI = 1.59-2.08). Subgroup analyses demonstrated that CPCs positive patients also had poor disease progression and OS in detection methods and sampling time subsets. Moreover, the presence of CPCs was strikingly associated with increased ISS stage (OR = 2.78% CI = 1.69-4.56), but not with DS stage(OR = 1.60; 95% CI = 0.74-3.47). Conclusions CPCs status is associated with poorer survival outcome in multiple myeloma. Additionally, increased ISS stage could be significant risk factors for the presence of CPCs.	[Li, Jia; Wang, Ningning; Tesfaluul, Nahom; Gao, Xiaojuan; Liu, Shuai; Yue, Baohong] Zhengzhou Univ, Affiliated Hosp 1, Dept Lab Med, Zhengzhou, Peoples R China; [Li, Jia; Wang, Ningning; Liu, Shuai; Yue, Baohong] Zhengzhou Univ, Fac Lab Med, Zhengzhou, Peoples R China; [Li, Jia; Wang, Ningning; Liu, Shuai; Yue, Baohong] Zhengzhou Univ, Key Lab Med Henan Prov, Fac Lab Med, Zhengzhou, Peoples R China; [Yue, Baohong] Open Lab, Henan Prov Key Subject Clin Med, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Yue, BH (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Lab Med, Zhengzhou, Peoples R China.; Yue, BH (corresponding author), Zhengzhou Univ, Fac Lab Med, Zhengzhou, Peoples R China.; Yue, BH (corresponding author), Zhengzhou Univ, Key Lab Med Henan Prov, Fac Lab Med, Zhengzhou, Peoples R China.; Yue, BH (corresponding author), Open Lab, Henan Prov Key Subject Clin Med, Zhengzhou, Peoples R China.	ybh2002@163.com		Yue, Baohong/0000-0001-6911-0177				An G, 2015, ANN HEMATOL, V94, P257, DOI 10.1007/s00277-014-2211-0; Bianchi G, 2013, LEUKEMIA, V27, P680, DOI 10.1038/leu.2012.237; Chakraborty R, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.117; Dingli D, 2006, BLOOD, V107, P3384, DOI 10.1182/blood-2005-08-3398; Sarasquete ME, 2005, HAEMATOLOGICA, V90, P1365; Gertz MA, 1997, BONE MARROW TRANSPL, V19, P337, DOI 10.1038/sj.bmt.1700670; Ghobrial IM, 2012, BLOOD, V120, P20, DOI 10.1182/blood-2012-01-379024; Gonsalves WI, 2017, LEUKEMIA, V31, P130, DOI 10.1038/leu.2016.205; Gonsalves WI, 2014, LEUKEMIA, V28, P2060, DOI 10.1038/leu.2014.98; Gonsalves WI, 2014, BRIT J HAEMATOL, V167, P500, DOI 10.1111/bjh.13067; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Korthals M, 2013, BIOL BLOOD MARROW TR, V19, P1109, DOI 10.1016/j.bbmt.2013.04.025; Kumar S, 2005, J CLIN ONCOL, V23, P5668, DOI 10.1200/JCO.2005.03.159; Kumar S, 2003, BRIT J HAEMATOL, V122, P272, DOI 10.1046/j.1365-2141.2003.04428.x; Kumar SK, 2008, AM J HEMATOL, V83, P614, DOI 10.1002/ajh.21191; Munshi NC, 2011, BLOOD, V117, P4696, DOI 10.1182/blood-2010-10-300970; Nowakowski GS, 2005, BLOOD, V106, P2276, DOI 10.1182/blood-2005-05-1858; Paiva B, 2008, BLOOD, V112, P4017, DOI 10.1182/blood-2008-05-159624; Paiva B, 2013, BLOOD, V122, P3591, DOI 10.1182/blood-2013-06-510453; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Pardanani A, 2003, BLOOD, V101, P827, DOI 10.1182/blood-2002-06-1698; Peceliunas V, 2012, LEUKEMIA LYMPHOMA, V53, P641, DOI 10.3109/10428194.2011.627481; Rajkumar SV, 2009, CURR PROB CANCER, V33, P7, DOI 10.1016/j.currproblcancer.2009.01.001; Rawstron AC, 2002, BLOOD, V100, P3095, DOI 10.1182/blood-2001-12-0297; Rawstron AC, 2008, HAEMATOLOGICA, V93, P431, DOI 10.3324/haematol.11080; San Miguel JF, 2006, EUR J CANCER, V42, P1510, DOI 10.1016/j.ejca.2005.11.039; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Vagnoni D, 2015, BRIT J HAEMATOL, V170, P523, DOI 10.1111/bjh.13484; WITZIG TE, 1994, BRIT J HAEMATOL, V87, P266, DOI 10.1111/j.1365-2141.1994.tb04908.x; Witzig TE, 1996, BLOOD, V88, P1780	32	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181447	10.1371/journal.pone.0181447	http://dx.doi.org/10.1371/journal.pone.0181447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704521	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700132
J	Barzegaran, E; Knyazeva, MG				Barzegaran, Elham; Knyazeva, Maria G.			Functional connectivity analysis in EEG source space: The choice of method	PLOS ONE			English	Article							SOURCE LOCALIZATION; BRAIN; SYNCHRONIZATION; CHALLENGES; DENSITY; EEG/MEG; MEG; OSCILLATIONS; RESPONSES; ELECTRODE	Functional connectivity (FC) is among the most informative features derived from EEG. However, the most straightforward sensor-space analysis of FC is unreliable owing to volume conductance effects. An alternative-source-space analysis of FC-is optimal for high-and mid-density EEG (hdEEG, mdEEG); however, it is questionable for widely used low-density EEG (ldEEG) because of inadequate surface sampling. Here, using simulations, we investigate the performance of the two source FC methods, the inverse-based source FC (ISFC) and the cortical partial coherence (CPC). To examine the effects of localization errors of the inverse method on the FC estimation, we simulated an oscillatory source with varying locations and SNRs. To compare the FC estimations by the two methods, we simulated two synchronized sources with varying between-source distance and SNR. The simulations were implemented for hdEEG, mdEEG, and ldEEG. We showed that the performance of both methods deteriorates for deep sources owing to their inaccurate localization and smoothing. The accuracy of both methods improves with the increasing between-source distance. The best ISFC performance was achieved using hd/mdEEG, while the best CPC performance was observed with ldEEG. In conclusion, with hdEEG, ISFC outperforms CPC and therefore should be the preferred method. In the studies based on ldEEG, the CPC is a method of choice.	[Barzegaran, Elham] CHU Vaudois, Dept Clin Neurosci, Lab Rech Neuroimagerie LREN, Lausanne, Switzerland; Univ Lausanne, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Barzegaran, E (corresponding author), CHU Vaudois, Dept Clin Neurosci, Lab Rech Neuroimagerie LREN, Lausanne, Switzerland.	e.barzegaran@gmail.com		Barzegaran, Elham/0000-0001-9337-2134	Swiss National Science Foundation; Swiss Research Program Nano-Tera grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Research Program Nano-Tera grant	This work was supported by Swiss National Science Foundation and Swiss Research Program Nano-Tera (www.nano-tera.ch) grant to Maria G. Knyazeva (BodyPoweredSenSE project).	Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Attal Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059856; Barzegaran E, 2015, J NEUROLOGY NEUROSUR; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cottereau BR, 2012, HUM BRAIN MAPP, V33, P2694, DOI 10.1002/hbm.21394; Daunizeau J, 2007, NEUROIMAGE, V38, P67, DOI 10.1016/j.neuroimage.2007.06.034; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; GEVINS A, 1990, Brain Topography, V3, P53, DOI 10.1007/BF01128862; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Grieve PG, 2003, CLIN NEUROPHYSIOL, V114, P1594, DOI 10.1016/S1388-2457(03)00122-6; Grova C, 2006, NEUROIMAGE, V29, P734, DOI 10.1016/j.neuroimage.2005.08.053; HARI R, 1984, NEUROSCI LETT, V50, P127, DOI 10.1016/0304-3940(84)90474-9; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Jalili M, 2014, IEEE T NEUR SYS REH, V22, P212, DOI 10.1109/TNSRE.2013.2289899; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kaiboriboon K, 2012, NAT REV NEUROL, V8, P498, DOI 10.1038/nrneurol.2012.150; Kiebel SJ, 2006, NEUROIMAGE, V30, P1273, DOI 10.1016/j.neuroimage.2005.12.055; Knyazeva MG, 2013, NEUROBIOL AGING, V34, P694, DOI 10.1016/j.neurobiolaging.2012.07.012; Koles ZJ, 1998, ELECTROEN CLIN NEURO, V107, P343, DOI 10.1016/S0013-4694(98)00084-4; Laarne PH, 2000, BRAIN TOPOGR, V12, P249, DOI 10.1023/A:1023422504025; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Menendez RGD, 2001, BRAIN TOPOGR, V14, P131, DOI 10.1023/A:1012944913650; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mosher JC, 1998, IEEE T BIO-MED ENG, V45, P1342, DOI 10.1109/10.725331; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; NUNEZ PL, 1991, J CLIN NEUROPHYSIOL, V8, P397, DOI 10.1097/00004691-199110000-00005; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Pascual-Marqui R.D., 1999, INT J BIOELECTROMAGN, V1, P75; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD., ARXIV07111455; Pascual-Marqui RD, 2011, ARXIV11080251; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sohrabpour A, 2016, IEEE T BIO-MED ENG, V63, P2474, DOI 10.1109/TBME.2016.2616474; Sohrabpour A, 2016, NEUROIMAGE, V142, P27, DOI 10.1016/j.neuroimage.2016.05.064; Srinivasan R, 1998, BEHAV RES METH INS C, V30, P8, DOI 10.3758/BF03209412; Tikhonov A., 1977, SOLUTION ILL POSED P; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; van Diessen E, 2015, CLIN NEUROPHYSIOL, V126, P1468, DOI 10.1016/j.clinph.2014.11.018; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vinck M, 2015, NEUROIMAGE, V108, P301, DOI 10.1016/j.neuroimage.2014.12.017; Yang L, 2011, NEUROIMAGE, V56, P1908, DOI 10.1016/j.neuroimage.2011.03.043; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068	52	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181105	10.1371/journal.pone.0181105	http://dx.doi.org/10.1371/journal.pone.0181105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727750	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500040
J	Fatehchand, K; Santhanam, R; Shen, B; Erickson, EL; Gautam, S; Elavazhagan, S; Mo, XK; Belay, T; Tridandapani, S; Butchar, JP				Fatehchand, Kavin; Santhanam, Ramasamy; Shen, Brenda; Erickson, Ericka L.; Gautam, Shalini; Elavazhagan, Saranya; Mo, Xiaokui; Belay, Tesfaye; Tridandapani, Susheela; Butchar, Jonathan P.			Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells	PLOS ONE			English	Article							NUTRITIONAL SUPPLEMENT; IMMUNE FUNCTION; CANCER; AHCC; EXPRESSION; CHEMOTHERAPY; THERAPY; SAFETY; TRANSCRIPTION; REVEALS	Active Hexose Correlated Compound (AHCC) has been shown to have many immunostimulatory and anti-cancer activities in mice and in humans. As a natural product, AHCC has potential to create safer adjuvant therapies in cancer patients. Acute Myeloid Leukemia (AML) is the least curable and second-most common leukemia in adults. AML is especially terminal to those over 60 years old, where median survival is only 5 to 10 months, due to inability to receive intensive chemotherapy. Hence, the purpose of this study was to investigate the effects of AHCC on AML cells both in vitro and in vivo. Results showed that AHCC induced Caspase-3-dependent apoptosis in AML cell lines as well as in primary AML leukopheresis samples. Additionally, AHCC induced Caspase-8 cleavage as well as Fas and TRAIL upregulation, suggesting involvement of the extrinsic apoptotic pathway. In contrast, monocytes from healthy donors showed suppressed Caspase-3 cleavage and lower cell death. When tested in a murine engraftment model of AML, AHCC led to significantly increased survival time and decreased blast counts. These results uncover a mechanism by which AHCC leads to AML-cell specific death, and also lend support for the further investigation of AHCC as a potential adjuvant for the treatment of AML.	[Fatehchand, Kavin; Tridandapani, Susheela] Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA; [Fatehchand, Kavin; Santhanam, Ramasamy; Shen, Brenda; Erickson, Ericka L.; Gautam, Shalini; Elavazhagan, Saranya; Tridandapani, Susheela; Butchar, Jonathan P.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Belay, Tesfaye] Bluefield State Univ, Sch Arts & Sci, Bluefield, WV USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Bluefield State College	Tridandapani, S (corresponding author), Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA.; Tridandapani, S; Butchar, JP (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	tridandapani.2@osu.edu; butchar.2@osu.edu			NIH [P01 CA095426, R01 CA162411, F30 CA217006, P30 CA016058, P20 GM103434, R15 A1124156]; NATIONAL CANCER INSTITUTE [R01CA203584, P30CA016058, F30CA217006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI124156] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH P01 CA095426 (S.T., J.P.B.); NIH R01 CA162411 (S.T., J.P.B.); F30 CA217006 (K.F.) P30 CA016058 (The Ohio State University Comprehensive Cancer Center); P20 GM103434 (T.B.); R15 A1124156 (T. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoedo N. D., 2013, BIOSCI REP, V33; Andersson A, 2005, LEUKEMIA, V19, P1042, DOI 10.1038/sj.leu.2403749; Aviles H, 2008, AM J SURG, V195, P537, DOI 10.1016/j.amjsurg.2007.05.045; Basmadjian C, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00020; Belay T, 2015, J NUTR MED DIET CARE, V1; Butchar JP, 2010, CLIN CANCER RES, V16, P2065, DOI 10.1158/1078-0432.CCR-09-2591; Cao ZY, 2015, NUTR RES PRACT, V9, P129, DOI 10.4162/nrp.2015.9.2.129; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Cowawintaweewat S, 2006, ASIAN PAC J ALLERGY, V24, P33; Cruijsen M, 2015, J CLIN MED, V4, P1, DOI 10.3390/jcm4010001; Daddaoua A, 2007, J NUTR, V137, P1222, DOI 10.1093/jn/137.5.1222; Daddaoua A, 2013, FOOD CHEM, V136, P1288, DOI 10.1016/j.foodchem.2012.09.039; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dombret H, 2016, BLOOD, V127, P53, DOI 10.1182/blood-2015-08-604520; Estey E, 2015, BLOOD, V125, P2461, DOI 10.1182/blood-2015-01-561373; Fatehchand K, 2016, J BIOL CHEM; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Gao YF, 2006, CANCER IMMUNOL IMMUN, V55, P1258, DOI 10.1007/s00262-005-0111-9; Hangai S, 2013, J ALTERN COMPLEM MED, V19, P905, DOI 10.1089/acm.2012.0914; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Ichim G, 2016, NAT REV CANCER, V16, P539, DOI 10.1038/nrc.2016.58; Ignacio RM, 2015, CYTOKINE, V76, P131, DOI 10.1016/j.cyto.2015.06.002; Ishizuka R., 2012, PERS MED U, V1, P39, DOI [DOI 10.1016/J.PMU.2012.05.006, 10.1016/j.pmu.2012.05.006]; Ito T, 2014, NUTR CANCER, V66, P377, DOI 10.1080/01635581.2014.884232; Kojima K, 2010, LEUKEMIA, V24, P33, DOI 10.1038/leu.2009.212; Lee WW, 2012, CELL IMMUNOL, V275, P19, DOI 10.1016/j.cellimm.2012.04.001; Lowenberg B, 2016, BLOOD, V127, P1, DOI 10.1182/blood-2015-10-662684; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Mallet JF, 2016, EUR J NUTR, V55, P139, DOI 10.1007/s00394-015-0832-2; Matsui Y, 2002, J HEPATOL, V37, P78, DOI 10.1016/S0168-8278(02)00091-0; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Matsushita K, 1998, ANTI-CANCER DRUG, V9, P343, DOI 10.1097/00001813-199804000-00008; McDonnell MA, 2003, CELL DEATH DIFFER, V10, P1005, DOI 10.1038/sj.cdd.4401271; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mrozek K, 2012, J CLIN ONCOL, V30, P4515, DOI 10.1200/JCO.2012.43.4738; Nakao M, 1996, LEUKEMIA, V10, P1911; Odero MD, 2000, GENE CHROMOSOME CANC, V29, P333, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1040>3.3.CO;2-Q; PARIDA DK, 2011, INT J CLIN MED, V2, P588, DOI DOI 10.4236/IJCM.2011.25097; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Porter AG, 2006, NAT CHEM BIOL, V2, P509, DOI 10.1038/nchembio1006-509; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Ritz BW, 2006, J NUTR, V136, P2868, DOI 10.1093/jn/136.11.2868; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; Shigama Kota, 2009, J Exp Ther Oncol, V8, P43; Spierings ELH, 2007, J NUTR SCI VITAMINOL, V53, P536, DOI 10.3177/jnsv.53.536; Stavropoulou V, 2016, CANCER CELL, V30, P43, DOI 10.1016/j.ccell.2016.05.011; Tokunaga M, 2015, ANTICANCER RES, V35, P6063; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; Vetvicka V, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.01.05; Wouters BJ, 2016, BLOOD, V127, P42, DOI 10.1182/blood-2015-07-604512; Yanagimoto H, 2016, NUTR CANCER, V68, P234, DOI 10.1080/01635581.2016.1134597	53	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181729	10.1371/journal.pone.0181729	http://dx.doi.org/10.1371/journal.pone.0181729			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727820	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500109
J	Weir, MC; Hellwig, S; Tan, L; Liu, Y; Gray, NS; Smithgall, TE				Weir, Mark C.; Hellwig, Sabine; Tan, Li; Liu, Yao; Gray, Nathanael S.; Smithgall, Thomas E.			Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; SMALL-MOLECULE INHIBITORS; THERAPEUTIC TARGET; DIFFERENTIATION; IDENTIFICATION; ANTAGONIST; EXPRESSION; MUTATIONS; FAMILY	Acute myelogenous leukemia (AML) is often associated with activating mutations in the receptor tyrosine kinase, Flt3, including internal tandem duplications (ITDs) within the regulatory juxtamembrane region. Previous studies have linked Flt3-ITD to the activation of the Fes protein tyrosine kinase in AML, and RNAi-knockdown studies suggest that Fes may be required for Flt3 function. In this study, we tested Fes inhibitors from three different chemical classes for their growth-suppressive activity against Flt3-ITD+ myeloid leukemia cell lines (MV4-11, MOLM-13 and MOLM-14) vs. myeloid cells with wild-type Flt3 (THP-1). All Fes inhibitors selectively inhibited the growth of Flt3-ITD+ AML cells, with IC50 values for diaminopyrimidine and pyrrolopyridine inhibitors ranging from 19 to 166 nM. In contrast, a pyrazolopyrimidine inhibitor was less potent in Flt3-ITD+ AML cells, with IC50 values in the 1.0 mu M range. In vitro kinase assays showed that the most potent inhibitors of Flt3-ITD+ AML cell proliferation blocked both Fes and Flt3-ITD kinase activity, while the pyrazolopyrimidine was more selective for Fes vs. Flt3-ITD. All three inhibitors induced significant apoptosis in Flt3ITD(+) AML cells, with potency equivalent to or greater than the established Flt3-ITD inhibitor, tandutinib. Transformation of TF-1 cells with Flt3-ITD resulted in constitutive activation of endogenous Fes, and rendered the cells highly sensitive to all three Fes inhibitors with IC50 values in the 30-500 nM range. The pyrrolopyridine compound also induced apoptotic responses in patient-derived Flt3-ITD+ AML bone marrow cells but not in normal bone marrow mononuclear cells. These results demonstrate that Fes kinase activity contributes to Flt3-ITD signaling in AML, and suggests that dual inhibition of both Flt3 and Fes may provide a therapeutic advantage for the treatment of Flt3-ITD+ AML.	[Weir, Mark C.; Hellwig, Sabine; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Tan, Li; Liu, Yao; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Tan, Li; Liu, Yao; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Hellwig, Sabine] ARUP Labs, Salt Lake City, UT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Utah System of Higher Education; University of Utah; ARUP Laboratories	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	tsmithga@pitt.edu		Tan, Li/0000-0002-1199-9046; Hellwig, Sabine/0000-0002-9809-947X	National Cancer Institute of the National Institutes of Health [CA185702]; NATIONAL CANCER INSTITUTE [R21CA185702] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by the National Cancer Institute of the National Institutes of Health (grant number CA185702 to T.E.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey E, 2013, P NATL ACAD SCI USA, V110, P21113, DOI 10.1073/pnas.1310559110; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DeAngelo DJ, 2006, BLOOD, V108, P3674, DOI 10.1182/blood-2006-02-005702; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dos SC, 2013, BLOOD, V122, P1900; Dos SC, 2008, BLOOD, V111, P2269, DOI DOI 10.1182/BLOOD-2007-04-082099; Drexler HG, 2004, LEUKEMIA, V18, P227, DOI 10.1038/sj.leu.2403236; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Greer Peter A, 2012, Front Biosci (Schol Ed), V4, P489; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hellwig S, 2012, CHEM BIOL, V19, P529, DOI 10.1016/j.chembiol.2012.01.020; Hellwig S, 2011, FRONT BIOSCI-LANDMRK, V16, P3146, DOI 10.2741/3902; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; Kadia TM, 2016, ANN ONCOL, V27, P770, DOI 10.1093/annonc/mdw015; Kantarjian H, 2016, AM J HEMATOL, V91, P131, DOI 10.1002/ajh.24246; Kayser S, 2014, LEUKEMIA LYMPHOMA, V55, P243, DOI 10.3109/10428194.2013.800198; Kelly LM, 2002, CANCER CELL, V1, P421, DOI 10.1016/S1535-6108(02)00070-3; Khwaja A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.10; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Klco JM, 2013, BLOOD, V121, P1633, DOI 10.1182/blood-2012-09-459313; Konig H, 2015, EXPERT OPIN THER TAR, V19, P37, DOI 10.1517/14728222.2014.960843; Leischner H, 2012, BLOOD, V119, P4026, DOI 10.1182/blood-2011-07-365726; Okamoto M, 2007, LEUKEMIA, V21, P403, DOI 10.1038/sj.leu.2404547; Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312; Pene-Dumitrescu T, 2008, ONCOGENE, V27, P7055, DOI 10.1038/onc.2008.330; Puissant A, 2014, CANCER CELL, V25, P226, DOI 10.1016/j.ccr.2014.01.022; SMITHGALL TE, 1988, J BIOL CHEM, V263, P15050; Smithgall TE, 1998, CRIT REV ONCOGENESIS, V9, P43, DOI 10.1615/CritRevOncog.v9.i1.40; Takashima Y, 2003, BIOCHEMISTRY-US, V42, P3567, DOI 10.1021/bi0272499; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Voisset E, 2010, LEUKEMIA, V24, P721, DOI 10.1038/leu.2009.301; Zheng R, 2004, BLOOD, V103, P1883, DOI 10.1182/blood-2003-06-1978	34	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181178	10.1371/journal.pone.0181178	http://dx.doi.org/10.1371/journal.pone.0181178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727840	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500043
J	Jimenez-Torres, GJ; Wojna, V; Rosario, E; Hechevarria, R; Aleman-Batista, AM; Matos, MR; Madan, A; Skolasky, RL; Acevedo, SF				Jimenez-Torres, Gladys J.; Wojna, Valerie; Rosario, Ernesto; Hechevarria, Rosa; Aleman-Batista, Ada M.; Matos, Miriam Rios; Madan, Alok; Skolasky, Richard L.; Acevedo, Summer F.			Assessing health-related resiliency in HIV plus Latin women: Preliminary psychometric findings	PLOS ONE			English	Article							CONNOR-DAVIDSON RESILIENCE; BECK DEPRESSION INVENTORY; QUALITY-OF-LIFE; SCALE CD-RISC; PUERTO-RICO; PSYCHOLOGICAL DISTRESS; COGNITIVE IMPAIRMENT; UNITED-STATES; HIV/AIDS; INFECTION	Background HIV-associated vulnerabilities-especially those linked to psychological issues-and limited mental health-treatment resources have the potential to adversely affect the health statuses of individuals. The concept of resilience has been introduced in the literature to shift the emphasis from vulnerability to protective factors. Resilience, however, is an evolving construct and is measured in various ways, though rarely among underserved, minority populations. Herein, we present the preliminary psychometric properties of a sample of HIV-seropositive Puerto Rican women, measured using a newly developed health-related resilience scale. Methods and design The Resilience Scales for Children and Adolescents, an instrument with solid test construction properties, acted as a model in the development (in both English and Spanish) of the HRRS, providing the same dimensions and most of the same subscales. The present sample was nested within the Hispanic-Latino longitudinal cohort of women (HLLC), that is part of the NeuroAIDS Research Program at the University of Puerto Rico (UPR), Medical Sciences Campus (MSC). Forty-five consecutively recruited, HIV+ women from the HLLC completed a demographic survey, the HRRS, and the Beck Depression Inventory-I, Spanish version. Results The results demonstrate excellent overall internal consistency for the total HRRS score (alpha = 0.95). Each of the dimensional scores also evidenced acceptable internal consistency (alpha >= 0.88). All the dimensional and subscale content validity indices were above the 0.42 cut-off. Analysis revealed a significant negative correlation between the HRRS total score and BDI-I-S (r(45) = -0.453, p < 0.003). Conclusion Albeit preliminary in nature, the present study provides support for the HRRS as a measure to assess resilience among individuals living with chronic medical conditions. Minority populations, especially non-English speaking ones, are understudied across the field of medicine, and when efforts are made to include these patient groups, measurement is rarely tailored to their unique cultural and linguistic experiences. The HRRS is a measure that addresses these notable voids in the medical literature.	[Jimenez-Torres, Gladys J.; Madan, Alok] Menninger Clin, Houston, TX USA; [Jimenez-Torres, Gladys J.; Madan, Alok] Baylor Coll Med, Psychiat & Behav Sci, Houston, TX 77030 USA; [Jimenez-Torres, Gladys J.; Rosario, Ernesto] Ponce Sch Med & Hlth Sci, Psychol Dept, Ponce, PR USA; [Wojna, Valerie; Hechevarria, Rosa; Matos, Miriam Rios] Univ Puerto Rico, NeuroAlDS Res Program, San Juan, PR 00936 USA; [Wojna, Valerie] Univ Puerto Rico, Dept Internal Med, Neurol Div, San Juan, PR 00936 USA; [Hechevarria, Rosa] Univ Puerto Rico, Phys Med & Rehabil, San Juan, PR 00936 USA; [Aleman-Batista, Ada M.; Skolasky, Richard L.] Univ Puerto Rico, Sch Hlth Profess, San Juan, PR 00936 USA; [Skolasky, Richard L.] Johns Hopkins Univ, Dept Orthoped Surg & Phys Med & Rehabil, Baltimore, MD USA; [Acevedo, Summer F.] UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX 75390 USA	Baylor College of Medicine; University of Puerto Rico; University of Puerto Rico; University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Acevedo, SF (corresponding author), UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX 75390 USA.	sumacea123@gmail.com		Wojna, Valerie/0000-0002-4014-9921	National Center for Research Resources (NCRR) [U54RR026139]; National Institute on Minority Health and Health Disparities (NIMHD) [U54MD007587]; National Institute of Neurological Disorders and Stroke (NINDS) [S11NS046278, U54NS43011]; National Institute of Mental Health (NIMH) Center for Novel Therapeutics [R25MH080661, G12 RR003050]; Menninger Clinic Foundation; McNair Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026139, G12RR003050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS043011, S11NS046278] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health (NIMH) Center for Novel Therapeutics; Menninger Clinic Foundation; McNair Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The study was funded by National Center for Research Resources (NCRR) grant U54RR026139, the National Institute on Minority Health and Health Disparities (NIMHD) grant U54MD007587, the National Institute of Neurological Disorders and Stroke (NINDS) S11NS046278 and U54NS43011 awarded to the University of Puerto Rico, Medical Science Campus, and National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders Pilot Project grant R25MH080661 part of the G12 RR003050 awarded to John Hopkins University. Additionally, this research was partially supported by the Menninger Clinic Foundation and McNair Medical Institute. Dr. Madan is a McNair Scholar. The study follows the guidelines on good publication practices. The study sponsors were not involved in any aspect of the research activities. Thus, the authors were independent of study sponsors in the context of the research. The authors have no other potential conflicts of interest to disclose.; The study was funded by National Center for Research Resources (NCRR) grant U54RR026139, the National Institute on Minority Health and Health Disparities (NIMHD) grant U54MD007587, the National Institute of Neurological Disorders and Stroke (NINDS) 511NS046278 and U54NS43011 awarded to the University of Puerto Rico, Medical Science Campus, and National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders Pilot Project grant R25MH080661 part of the G12 RR003050 awarded to John Hopkins University. Additionally, this research was partially supported by the Menninger Clinic Foundation and McNair Medical Institute. Dr. Madan is a McNair Scholar. The study follows the guidelines on good publication practices. The study sponsors were not involved in any aspect of the research activities. Thus, the authors were independent of study sponsors in the context of the research. The authors have no other potential conflicts of interest to disclose.	BARTONE PT, 1989, J NERV MENT DIS, V177, P317, DOI 10.1097/00005053-198906000-00001; BERNAL G, 1995, REV LAT AM PSICOL, V27, P207; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonilla J, 2004, J CLIN PSYCHOL, V60, P119, DOI 10.1002/jclp.10195; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Carrico AW, 2011, AIDS, V25, P1113, DOI 10.1097/QAD.0b013e3283463f09; Centers for Disease Control and Prevention, 2010, 40 CDCP; Ciambrone D, 2006, WOMEN HEALTH, V44, P61, DOI 10.1300/J013v44n04_04; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cooperman Nina A, 2003, J Lesbian Stud, V7, P49, DOI 10.1300/J155v07n04_04; Dale S, 2014, AIDS PATIENT CARE ST, V28, P136, DOI 10.1089/apc.2013.0329; Dale SK, 2014, SEX ROLES, V70, P221, DOI 10.1007/s11199-014-0348-x; De Santis Joseph, 2008, Res Theory Nurs Pract, V22, P273, DOI 10.1891/0889-7182.22.4.273; DeFreitas D, 2010, J NATL MED ASSOC, V102, P493, DOI 10.1016/S0027-9684(15)30558-7; DeVellis RF, 2016, SCALE DEV THEORY APP; Ebersohn L, 2011, HEALTH EDUC RES, V26, P596, DOI 10.1093/her/cyr016; Eller LS, 2014, AIDS CARE, V26, P795, DOI 10.1080/09540121.2013.841842; Emlet CA, 2011, GERONTOLOGIST, V51, P101, DOI 10.1093/geront/gnq060; Farber EW, 2000, PSYCHOSOMATICS, V41, P140, DOI 10.1176/appi.psy.41.2.140; Friborg O, 2003, INT J METH PSYCH RES, V12, P65, DOI 10.1002/mpr.143; Goldstein S., CREATING CLIN PSYCHO; Gwadz M, 2013, AIDS BEHAV, V17, P801, DOI 10.1007/s10461-012-0194-1; Hjemdal O., 2001, PSYCHOL ASSESSMENT, V38, P310, DOI DOI 10.4236/OJN.2013.32033; Hjemdal Odin, 2015, BMC Psychol, V3, P18, DOI 10.1186/s40359-015-0076-1; Jimenez JC, 2010, AIDS CARE, V22, P1314, DOI 10.1080/09540121003758481; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Leserman J, 2002, PSYCHOL MED, V32, P1059, DOI 10.1017/S0033291702005949; Luo X, 2003, NEUROLOGY, V60, P1931, DOI 10.1212/01.WNL.0000064396.54554.26; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Morales D, 2013, J NEUROVIROL, V19, P471, DOI 10.1007/s13365-013-0200-z; Morales D, 2012, J NEUROVIROL, V18, P488, DOI 10.1007/s13365-012-0128-8; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; Mutumba M, 2016, AIDS CARE, V28, P807, DOI 10.1080/09540121.2015.1131966; Norman LR, 2009, AIDS CARE, V21, P140, DOI 10.1080/09540120801932199; Oh SS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001918; Prince-Embury S., 2006, RESILIENCY SCALES CH; Rao D, 2007, AIDS PATIENT CARE ST, V21, P339, DOI 10.1089/apc.2006.0124; Roa CR, 2007, HDB STAT PSYCHOMETRI; Roisman GI, 2005, AM PSYCHOL, V60, P264, DOI 10.1037/0003-066X.60.3.264; Rutter M, 2007, CHILD ABUSE NEGLECT, V31, P205, DOI 10.1016/j.chiabu.2007.02.001; Saadat Mina, 2015, J Hum Reprod Sci, V8, P48, DOI 10.4103/0974-1208.153128; Siegel K, 2005, J BEHAV MED, V28, P403, DOI 10.1007/s10865-005-9015-6; Siegel K, 1999, AIDS EDUC PREV, V11, P53; Siegel K, 2007, AIDS BEHAV, V11, P421, DOI 10.1007/s10461-006-9186-3; Simoni Jane M, 2003, Cultur Divers Ethnic Minor Psychol, V9, P3, DOI 10.1037/1099-9809.9.1.3; Smith GC, 2012, ANNU REV GERONTOL GE, V32, P3, DOI 10.1891/0198-8794.32.3; Spector PE, 1992, SUMMATED RATING SCAL; Spies G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004200; Svanberg P.O.G., 1998, J MENT HEALTH, V7, P543, DOI [10.1080/09638239817716, DOI 10.1080/09638239817716]; Thompson B, 2003, SOC WORK HEALTH CARE, V37, P87, DOI 10.1300/J010v37n01_05; Toro GA, 2006, AM J PUBLIC HEALTH, V96, P995, DOI 10.2105/AJPH.2005.071696; Vutien P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003719; Wagnild G M, 1993, J Nurs Meas, V1, P165; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Wojna V, 2007, AIDS PATIENT CARE ST, V21, P930, DOI 10.1089/apc.2006.0180; Wojna V, 2006, J NEUROVIROL, V12, P356, DOI 10.1080/13550280600964576; Yu XN, 2014, J SEX MARITAL THER, V40, P1, DOI 10.1080/0092623X.2012.668512; Yuen WWY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-683	61	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181253	10.1371/journal.pone.0181253	http://dx.doi.org/10.1371/journal.pone.0181253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723939	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800041
J	Cao, HJ; Wu, RH; Han, M; Caldwell, PHY; Liu, JP				Cao, Huijuan; Wu, Ruohan; Han, Mei; Caldwell, Patrina Ha Yuen; Liu, Jian-Ping			Oral administration of Chinese herbal medicine during gestation period for preventing hemolytic disease of the newborn due to ABO incompatibility: A systematic review of randomized controlled trials	PLOS ONE			English	Article								Background About 85.3% of hemolytic disease of the newborn (HDN) is caused by maternal-fetal ABO blood group incompatibility. However, there is currently no recommended "best" therapy for ABO incompatibility during pregnancy. Objectives To systematically assess the safety and effectiveness of oral Chinese herbal medicine (CHM) for preventing HDN due to ABO incompatibility. Methods The protocol of this review was registered on the PROSPERO website (No. CRD42016038637). Six databases were searched from inception to April 2016. Randomized controlled trials (RCTs) of CHM for maternal-fetal ABO incompatibility were included. The primary outcome was incidence of HDN. The Cochrane risk of bias tool was used to assess the methodological quality of included trials. Risk ratios (RR) and mean differences with 95% confidence interval were used as effect measures. Meta-analyses using Revman 5.3 software were conducted if there were sufficient trials without obvious clinical or statistical heterogeneity available. Results Totally 28 RCTs involving3413 women were included in the review. The majority of the trials had unclear or high risk of bias. Our study found that the rate of HDN and the incidence of neonatal jaundice might be 70% lower in the herbal medicine group compared with the usual care group (RR from 0.25 to 0.30). After treatment with herbal medicine, women were twice as likely to have antibody titers lower than 1:64 compared with women who received usual care(RR from 2.15 to 3.14) and the umbilical cord blood bilirubin level in the herbal medicine group was 4umol/L lower than in those receiving usual care. There was no difference in Apgar scores or birthweights between the two groups. Conclusions This review found very low-quality evidence that CHM prevented HDN caused by maternal-fetal ABO incompatibility. No firm conclusions can be drawn regarding the effectiveness or safety of CHM for this condition.	[Cao, Huijuan; Wu, Ruohan; Han, Mei; Liu, Jian-Ping] Beijing Univ Chinese Med, Coll Tradit Chinese Med, Beijing, Peoples R China; [Caldwell, Patrina Ha Yuen] Univ Sydney, Ctr Kidney Res, Childrens Hosp Westmead, Sydney, NSW, Australia; [Caldwell, Patrina Ha Yuen] Univ Sydney, Discipline Paediat & Child Hlth, Childrens Hosp Westmead, Sydney, NSW, Australia; [Caldwell, Patrina Ha Yuen] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW, Australia	Beijing University of Chinese Medicine; University of Sydney; University of Sydney; University of Sydney	Liu, JP (corresponding author), Beijing Univ Chinese Med, Coll Tradit Chinese Med, Beijing, Peoples R China.	jianping_l@hotmail.com	; Caldwell, Patrina/C-4211-2013	Liu, Jianping/0000-0002-0320-061X; Caldwell, Patrina/0000-0003-1124-6578; Wu, Ruohan/0000-0002-0468-9920	Beijing Municipal Organization Department [2015000020124G083]; Beijing University of Chinese Medicine [2015-JYB-JSMS037]; State Administration of Traditional Chinese Medicine [201207012]	Beijing Municipal Organization Department; Beijing University of Chinese Medicine; State Administration of Traditional Chinese Medicine	Huijuan Cao is supported by the Beijing Municipal Organization Department talents project (Grant No. 2015000020124G083) and the Research Capacity Establishment Grant (No. 2015-JYB-JSMS037) from the Beijing University of Chinese Medicine. Jian-Ping Liu is supported by the Research Capacity Establishment Grant (No. 201207012) from the State Administration of Traditional Chinese Medicine.; The authors received no specific funding for this work. Hui-Juan Cao is supported by the Beijing Municipal Organization Department talents project (Grant No. 2015000020124G083) and the Research Capacity Establishment Grant (No. 2015-JYB-JSMS037 from the Beijing University of Chinese Medicine. Jian-Ping Liu is supported by the Research Capacity Establishment Grant (No. 201207012) from the State Administration of Traditional Chinese Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanmu AS, 2015, J BLOOD TRANSFUSION, V2015, P1; An WQ, 2014, MODERN J INTEGRATED, V23, P2572; An WQ, 2014, YI XUE MEI XUE MEI R, P11; An WQ, 2014, MODERN J INTEGRATED, V23, P2929; [Anonymous], 2005, PHARMACOPOEIA PEOPLE; Bian J., 1998, CHINESE J INFORM TCM, P42; Bian Yan-qin, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1405, DOI 10.3736/jcim20121212; Cai Zhu-Hua, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P156; Cao ZY., 2005, OBSTET GYNECOLOGY, P680; Chen L. S., 2000, THESIS; Chen XY, 2011, J NEW CHINESE MED, V43, P79; Cui L, 2014, J COMMUNITY MED, V12, p[35, 44]; Ding SJ, 2002, J SICHUAN TRADITIONA, V20, P61; Dodd JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007096.pub3; Du X., 2014, THESIS; Feng HJ, 2006, MATERN CHILD HLTH J, P1712; Feng YJ, 2010, GYNECOTOKOLOGY, P88; Han L.S., 2005, J MED PHARM CHIN MIN, V11, P20; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu FY, 2014, CHINESE J TRADITIONA, V21, P660; Huang J, 2015, GUIDING J TRADITIONA, V21, P55; HUH K, 1990, Archives of Pharmacal Research (Seoul), V13, P51, DOI 10.1007/BF02857834; Jin HY, 2013, J LIAONING U TCM, V15, P197; Li F, 2015, WORLD J INTEGRATED T, V10, P1583; Li F, 2014, MODERN J INTEGRATED, V23, P3573; Li Q, 2006, LIAONING J TRADITION, V33, P1442; Li XH, 2013, GUANGMING J CHINESE, V28, P1351; Liu FJ, 2011, YUNNAN J TRADITIONAL, V32, P37; Liu XQ, 2015, CHINESE J CLIN, V43, P83; Luo M, 2013, HEBEI MED, V19, P908; Luo YL, 2005, WORLD J GASTROENTERO, V11, P863, DOI 10.3748/wjg.v11.i6.863; Lv YD, 2012, THESIS; Mei RS, 2004, NEW J TRADITIONAL CH, V36, P42; Mei RS, 2006, CHINESE ARCH TRADITI, V24, P1486; Muluye Rekik A, 2014, J Tradit Complement Med, V4, P93, DOI 10.4103/2225-4110.126635; Ouyang X, 2005, THESIS; Song XC, 2015, J CLIN HEMOTAL, V28, P333; Su XJ, 2005, NEW J TRADITIONAL CH, V37, P47; Sun QH, 2008, SHANXI J TRADITIONAL, V29, P1030; Wang Xi-Jun, 2008, Chinese Journal of Natural Medicines, V6, P43; Xu J, 2009, HUNAN J TRADITIONAL, V25, P28; Xu LR, 2011, HEBEI J TCM, V33, P368; Xu X, 2003, SHANGHAI J TRADIT CH, V37, P56; Yang SZ, 2015, HLTH VOCATIONAL ED, V33, P146; Yang ZM., 1991, ACTA ACAD MED JIANGX, P151; Yu LP, 2013, J NEW CHINESE MED, V45, P115; Zhang YH, 2013, CHINA MODERN DOCTOR, V51, P97; Zhao L, 2012, J ZHEJIANG U CHINESE, V36, P630; Zhou Fang, 2010, Zhongguo Zhong Yao Za Zhi, V35, P908; Zhou J, 2007, ZHEJIANG J CHINESE M, V42, P712; Zhou XR, 2004, HEBEI MED, V10, P1089; Zong Y., 2012, J NEW CHINESE MED, V44, P76; Zou XY, 2002, BEIJING J CHINESE ME, V21, P69; 徐碧红, 2011, [中医杂志, Journal of Traditional Chinese Medicine], V52, P1418	55	2	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180746	10.1371/journal.pone.0180746	http://dx.doi.org/10.1371/journal.pone.0180746			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719639	gold, Green Published, Green Submitted			2022-12-27	WOS:000406061400015
J	Guan, CM; Dang, R; Cui, Y; Liu, LY; Chen, XB; Wang, XY; Zhu, JL; Li, DG; Li, JW; Wang, DC				Guan, Chunmei; Dang, Rui; Cui, Yu; Liu, Liyan; Chen, Xiaobei; Wang, Xiaoyu; Zhu, Jingli; Li, Donggang; Li, Junwei; Wang, Decai			Characterization of plasma metal profiles in Alzheimer's disease using multivariate statistical analysis	PLOS ONE			English	Article							SERUM COPPER; ALUMINUM; NEPRILYSIN; IRON; AGGREGATION; DISORDERS; PEPTIDE; EXCESS; FURIN	The exact cause of Alzheimer's disease (AD) and the role of metals in its etiology remain unclear. We have used an analytical approach, based on inductively coupled plasma mass spectrometry coupled with multivariate statistical analysis, to study the profiles of a wide range of metals in AD patients and healthy controls. AD cannot be cured and the lack of sensitive biomarkers that can be used in the early stages of the disease may contribute to this treatment failure. In the present study, we measured plasma levels of amyloid-beta(1-42)(0.142 +/- 0.029 mu g/ L) and furin(2.292 +/- 1.54 mu g/ L), together with those of the metalloproteinases, insulin-degrading enzyme(1.459 +/- 1.14 mu g/ L) and neprilysin(0.073 +/- 0.015 mu g/ L), in order to develop biomarkers for AD. Partial least squares discriminant analysis models were used to refine intergroup differences and we discovered that four metals(Mn, Al, Li, Cu) in peripheral blood were strongly associated with AD. Aberration in homeostasis of these metals may alter levels of proteinases, such as furin, which are associated with neurodegeneration in AD and can be a used as plasma- based biomarkers.	[Guan, Chunmei; Liu, Liyan; Chen, Xiaobei; Wang, Xiaoyu; Zhu, Jingli; Wang, Decai] Harbin Med Univ, Dept Nutr & Food Hyg, Publ Hlth Coll, Harbin, Heilongjiang, Peoples R China; [Dang, Rui] Xinjiang Med Univ, Hobo Coll, Xinjiang, Kelamayi, Peoples R China; [Cui, Yu] Harbin Med Univ, Dept Social Med, Publ Hlth Coll, Harbin, Heilongjiang, Peoples R China; [Li, Donggang; Li, Junwei] Inst Qual Supervis & Detect, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Xinjiang Medical University; Harbin Medical University	Wang, DC (corresponding author), Harbin Med Univ, Dept Nutr & Food Hyg, Publ Hlth Coll, Harbin, Heilongjiang, Peoples R China.	decaiwang@live.cn	张, 西京/HIK-3273-2022		National Natural Science Foundation of China;  [81273193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported by the National Natural Science Foundation of China and the Grant number is 81273193.	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Agarwal R, 2008, INDIAN J CLIN BIOCHE, V23, P369, DOI 10.1007/s12291-008-0081-8; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Bonda DJ, 2011, METALLOMICS, V3, P267, DOI 10.1039/c0mt00074d; Ekmekcioglu C, 2001, NAHRUNG, V45, P309, DOI 10.1002/1521-3803(20011001)45:5&lt;309::AID-FOOD309&gt;3.0.CO;2-0; Friedlich AL, 2004, J NEUROSCI, V24, P3453, DOI 10.1523/JNEUROSCI.0297-04.2004; Gao YX, 2007, J ANAL ATOM SPECTROM, V22, P856, DOI 10.1039/b703323k; Geddes JR, 2013, LANCET, V381, P1672, DOI 10.1016/S0140-6736(13)60857-0; Gonzalez-Dominguez R, 2014, METALLOMICS, V6, P292, DOI 10.1039/c3mt00301a; Gray JD, 2013, ACTA PSYCHIAT SCAND, V128, P347, DOI 10.1111/acps.12139; Gupta VB, 2005, CELL MOL LIFE SCI, V62, P143, DOI 10.1007/s00018-004-4317-3; Henn BC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-97; Kolosova AY, 2006, ANAL BIOANAL CHEM, V384, P286, DOI 10.1007/s00216-005-0103-9; Liu LY, 2010, J CHROMATOGR B, V878, P2817, DOI 10.1016/j.jchromb.2010.08.035; Long S.E., 2013, ANAL BIOANAL CHEM, V405, P8761; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Pal R, 2014, MOL NEUROBIOL, V49, P1181, DOI 10.1007/s12035-013-8590-8; Pfaender S, 2014, METALLOMICS, V6, P960, DOI 10.1039/c4mt00008k; Ramalingam M, 2012, J NEURAL TRANSM, V119, P891, DOI 10.1007/s00702-011-0758-7; Ricchelli F, 2005, CELL MOL LIFE SCI, V62, P1724, DOI 10.1007/s00018-005-5141-0; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Rusina R, 2011, NEUROTOX RES, V20, P329, DOI 10.1007/s12640-011-9246-y; Schwab C, 2003, ACTA NEUROPATHOL, V106, P278, DOI 10.1007/s00401-003-0735-9; Sharma AK, 2013, METALLOMICS, V5, P1529, DOI 10.1039/c3mt00161j; Silvestri L, 2008, J CELL MOL MED, V12, P1548, DOI 10.1111/j.1582-4934.2008.00356.x; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Squitti R, 2007, J NEURAL TRANSM, V114, P1589, DOI 10.1007/s00702-007-0777-6; Squitti R, 2006, NEUROLOGY, V67, P76, DOI 10.1212/01.wnl.0000223343.82809.cf; Squitti R, 2005, NEUROLOGY, V64, P1040, DOI 10.1212/01.WNL.0000154531.79362.23; Squitti R, 2006, BIOMARK INSIGHTS, V1, P205; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Wainaina MN, 2014, NEUROSCI BULL, V30, P253, DOI 10.1007/s12264-013-1425-9; Wang DC, 2012, NEUROBIOL AGING, V33, P1057, DOI 10.1016/j.neurobiolaging.2010.09.013; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; ZAPATERO MD, 1995, BIOL TRACE ELEM RES, V47, P235, DOI 10.1007/BF02790122	37	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0178271	10.1371/journal.pone.0178271	http://dx.doi.org/10.1371/journal.pone.0178271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719622	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400002
J	St Pierre, C; Guo, J; Shin, JD; Engstrom, LW; Lee, HH; Herbert, A; Surdi, L; Baker, J; Salmon, M; Shah, S; Ellis, JM; Houshyar, H; Crackower, MA; Kleinschek, MA; Jones, DC; Hicks, A; Zaller, DM; Alves, SE; Ramadas, RA				St Pierre, Cristina; Guo, Jane; Shin, John D.; Engstrom, Laura W.; Lee, Hyun-Hee; Herbert, Alan; Surdi, Laura; Baker, James; Salmon, Michael; Shah, Sanjiv; Ellis, J. Michael; Houshyar, Hani; Crackower, Michael A.; Kleinschek, Melanie A.; Jones, Dallas C.; Hicks, Alexandra; Zaller, Dennis M.; Alves, Stephen E.; Ramadas, Ravisankar A.			A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune system	PLOS ONE			English	Article							CYTOKINE PRODUCTION; PHARMACOLOGY; IMMUNOLOGY; BIOLOGY; KINASE; SYK; MECHANISMS; AUTOIMMUNE; EFFICACY; THERAPY	While the immune system is essential for the maintenance of the homeostasis, health and survival of humans, aberrant immune responses can lead to chronic inflammatory and autoimmune disorders. Pharmacological modulation of drug targets in the immune system to ameliorate disease also carry a risk of immunosuppression that could lead to adverse outcomes. Therefore, it is important to understand the 'immune fingerprint' of novel therapeutics as they relate to current and, clinically used immunological therapies to better understand their potential therapeutic benefit as well as immunosuppressive ability that might lead to adverse events such as infection risks and cancer. Since the mechanistic investigation of pharmacological modulators in a drug discovery setting is largely compound- and mechanism-centric but not comprehensive in terms of immune system impact, we developed a human tissue based functional assay platform to evaluate the impact of pharmacological modulators on a range of innate and adaptive immune functions. Here, we demonstrate that it is possible to generate a qualitative and quantitative immune system impact of pharmacological modulators, which might help better understand and predict the benefit-risk profiles of these compounds in the treatment of immune disorders.	[St Pierre, Cristina; Guo, Jane; Shin, John D.; Engstrom, Laura W.; Lee, Hyun-Hee; Salmon, Michael; Houshyar, Hani; Crackower, Michael A.; Kleinschek, Melanie A.; Jones, Dallas C.; Hicks, Alexandra; Zaller, Dennis M.; Alves, Stephen E.; Ramadas, Ravisankar A.] Merck Res Labs, Oncol & Immunol Discovery, Boston, MA 02115 USA; [Herbert, Alan] Merck Res Labs, Genet & Pharmacogen, Boston, MA USA; [Surdi, Laura; Baker, James] Merck Res Labs, Drug Metab & Pharmacokinet, Boston, MA USA; [Shah, Sanjiv] Merck Res Labs, Pharmacol, Boston, MA USA; [Ellis, J. Michael] Merck Res Labs, Exploratory Chem, Boston, MA USA; [Houshyar, Hani] Biogen, Cambridge, MA USA; [Crackower, Michael A.; Zaller, Dennis M.] Celgene, Cambridge, MA USA; [Kleinschek, Melanie A.] Theravance Biopharma, San Francisco, CA USA; [Jones, Dallas C.] Abide Therapeut, San Diego, CA USA; [Hicks, Alexandra] Oncorus, Cambridge, MA USA; [Ramadas, Ravisankar A.] Jounce Therapeut, Cambridge, MA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Biogen; Bristol-Myers Squibb; Celgene Corporation; Theravance	Ramadas, RA (corresponding author), Merck Res Labs, Oncol & Immunol Discovery, Boston, MA 02115 USA.; Ramadas, RA (corresponding author), Jounce Therapeut, Cambridge, MA USA.	ramadas.pubmed@gmail.com	Herbert, Alan/AAY-4286-2020	Ellis, John/0000-0003-4303-3972; Herbert, Alan/0000-0002-0093-1572	Merck; Sharpe Dohme Co.	Merck(Merck & Company); Sharpe Dohme Co.	All the co-authors in this manuscript are/were employees of Merck, Sharpe & Dohme Co., while this work was performed. Funding for this entire study was provided by Merck, Sharpe & Dohme Co. The funder provided support in the form of salaries for authors (CSP, JG, JDS, LWE, HHL, AH, LS, JB, MS, SS, JME, HH, MAC, MAK, DCJ, AH, DMZ, SEA, RAR), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aouar B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156063; Bai JPF, 2013, ANNU REV PHARMACOL, V53, P451, DOI 10.1146/annurev-pharmtox-011112-140248; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003; Berg EL, 2014, DRUG DISCOV TODAY, V19, P113, DOI 10.1016/j.drudis.2013.10.003; Boran ADW, 2010, MT SINAI J MED, V77, P333, DOI 10.1002/msj.20191; Brumbaugh KM, 1997, J EXP MED, V186, P1965, DOI 10.1084/jem.186.12.1965; Burel JG, 2016, TRENDS IMMUNOL, V37, P53, DOI 10.1016/j.it.2015.11.006; Butcher EC, 2004, NAT BIOTECHNOL, V22, P1253, DOI 10.1038/nbt1017; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Danks L, 2011, J BONE MINER RES, V26, P182, DOI 10.1002/jbmr.210; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Eichler HG, 2011, NAT REV DRUG DISCOV, V10, P495, DOI [10.1038/nrd3501, 10.1038/nrd3348]; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Ghoreschi K, 2014, EXP DERMATOL, V23, P7, DOI 10.1111/exd.12265; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Hood L, 2004, NAT BIOTECHNOL, V22, P1215, DOI 10.1038/nbt1004-1215; Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Kremlitzka M, 2015, CELL MOL LIFE SCI, V72, P2223, DOI 10.1007/s00018-014-1806-x; Kunkel EJ, 2004, ASSAY DRUG DEV TECHN, V2, P431, DOI 10.1089/1540658041850607; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-43; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Peterson MC, 2015, CPT-PHARMACOMET SYST, V4, P189, DOI 10.1002/psp4.20; Pirmohamed M, 2014, ANNU REV GENOM HUM G, V15, P349, DOI 10.1146/annurev-genom-090413-025419; SIMONS FER, 1994, NEW ENGL J MED, V330, P1663; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180870	10.1371/journal.pone.0180870	http://dx.doi.org/10.1371/journal.pone.0180870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719615	gold, Green Published, Green Submitted			2022-12-27	WOS:000406061400021
J	Hawcutt, DB; Bellis, J; Price, V; Povall, A; Newland, P; Richardson, P; Peak, M; Blair, J				Hawcutt, Daniel B.; Bellis, Jennifer; Price, Victoria; Povall, Anne; Newland, Paul; Richardson, Paul; Peak, Matthew; Blair, Jo			Growth hormone prescribing and initial BMI SDS: Increased biochemical adverse effects and costs in obese children without additional gain in height	PLOS ONE			English	Article							IDIOPATHIC SHORT STATURE; IGF-BINDING PROTEIN-3; BODY-SURFACE AREA; PREPUBERTAL CHILDREN; GH DEFICIENCY; WEIGHT; PHARMACOKINETICS; ADOLESCENTS; BIOACTIVITY; TRENDS	Background Recombinant human growth hormone (rhGH) treatment in children is usually prescribed using actual body weight. This may result in inappropriately high doses in obese children. Methods Retrospective audit of all paediatric patients treated with rhGH 2010-14 at a tertiary paediatric hospital in the UK. Change in height SDS and IGF-I SDS during the first year of treatment was stratified by initial BMI SDS in a mixed cohort, and a subgroup of GH deficient (GHD) patients. Alternative doses for those BMI SDS >= 2.0 (Obese) were calculated using BSA, IBW and LBW. Results 354 patients (133 female) received rhGH, including 213 (60.2%) with GHD. Obesity was present in 40 patients (11.3%) of the unselected cohort, and 32 (15.0%) of the GHD cohort. For GHD patients, gain in height SDS was directly related to BMI SDS, except in obese patients (p<0.05). For both the entire cohort, and GHD patients only, IGF-1 SDS was significantly higher in obese patients (p<0.0001 for both groups). Cross sectional data identified 265 children receiving rhGH, 81 (30.5%) with a BMI-SDS >= 1.75. Alternate prescribing strategies for rhGH prescribing in obese patients suggest a saving of 27% - 38% annually. Conclusions Gain in IGF-I SDS is greater in obese children, and is likely to be related to relatively higher doses of rhGH. Additional gain in height was not achieved at the higher doses administered to obese children. Alternative dosing strategies in the obese patient population should be examined in rigorous clinical trials.	[Hawcutt, Daniel B.] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England; [Bellis, Jennifer; Peak, Matthew] Alder Hey Childrens Hosp, Paediat Med Res Unit, Liverpool, Merseyside, England; [Bellis, Jennifer; Price, Victoria; Povall, Anne; Richardson, Paul; Peak, Matthew] Alder Hey Childrens NHS Fdn Trust Liverpool, Res Dept, Liverpool, Merseyside, England; [Newland, Paul] Alder Hey Childrens NHS Fdn Trust, Dept Biochem, Liverpool, Merseyside, England; [Blair, Jo] Alder Hey Childrens NHS Fdn Trust, Dept Endocrinol, Liverpool, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust	Blair, J (corresponding author), Alder Hey Childrens NHS Fdn Trust, Dept Endocrinol, Liverpool, Merseyside, England.	jo.blair@alderhey.nhs.uk		Hawcutt, Dan/0000-0002-8120-6507				Albertsson-Wikland K, 2014, HORM RES PAEDIAT, V82, P158, DOI 10.1159/000363106; Allen DB, 2016, EUR J ENDOCRINOL, V174, pP1, DOI 10.1530/EJE-15-0873; Andersen LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041287; Argente J, 1997, J CLIN ENDOCR METAB, V82, P2076, DOI 10.1210/jc.82.7.2076; Bakker NE, 2015, J CLIN ENDOCR METAB, V100, P3041, DOI 10.1210/jc.2015-1410; Blair JC, 2004, CLIN ENDOCRINOL, V60, P163, DOI 10.1046/j.1365-2265.2004.01957.x; Boyd E, 1935, SURFACE AREA HUMAN B; Callaghan LC, 2015, ANAESTHESIA, V70, P176, DOI 10.1111/anae.12860; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Han PY, 2007, CLIN PHARMACOL THER, V82, P505, DOI 10.1038/sj.clpt.6100381; Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000; HO KY, 1989, CLIN ENDOCRINOL, V30, P335, DOI 10.1111/j.1365-2265.1989.tb00431.x; HOCHBERG Z, 1992, METABOLISM, V41, P106, DOI 10.1016/0026-0495(92)90198-J; Hughes IP, 2014, CLIN ENDOCRINOL, V80, P384, DOI 10.1111/cen.12315; Kristrom B, 2009, J CLIN ENDOCR METAB, V94, P483, DOI 10.1210/jc.2008-1503; MAYER J, 1953, P SOC EXP BIOL MED, V82, P647; Mo DJ, 2014, PITUITARY, V17, P477, DOI 10.1007/s11102-013-0529-6; Murray PG, 2016, ARCH DIS CHILD, V101, P96, DOI 10.1136/archdischild-2014-307228; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pediatric Formulary Committee, 2014, BNF CHILDR 2014 2015; Radetti G, 1998, METABOLISM, V47, P1490, DOI 10.1016/S0026-0495(98)90075-0; Ranke MB, 1999, J CLIN ENDOCR METAB, V84, P1174, DOI 10.1210/jc.84.4.1174; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Schilbach K, 2015, BEST PRACT RES CL EN, V29, P671, DOI 10.1016/j.beem.2015.06.004; Schrier L, 2014, HORM RES PAEDIAT, V81, P319, DOI 10.1159/000357844; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Wit JM, 2005, J PEDIATR-US, V146, P45, DOI 10.1016/j.jpeds.2004.08.055	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181567	10.1371/journal.pone.0181567	http://dx.doi.org/10.1371/journal.pone.0181567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715498	Green Published, Green Submitted, gold			2022-12-27	WOS:000443975500061
J	Birth, P; Schone, S; Stelzl, U; Meijsing, SH				Birth, Petra; Schoene, Stefanie; Stelzl, Ulrich; Meijsing, Sebastiaan H.			Identification and characterization of BATF3 as a context-specific coactivator of the glucocorticoid receptor	PLOS ONE			English	Article							DNA-BINDING DOMAIN; ACTIVATION DOMAIN; TARGET GENES; PROGESTERONE-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; REGULATORY MECHANISMS; ISOFORMS; DIMERIZATION; COREGULATOR; RECRUITMENT	The ability of the glucocorticoid receptor (GR) to regulate the transcriptional output of genes relies on its interactions with transcriptional coregulators. However, which coregulators are required for GR-dependent activation is context-dependent and can be influenced by the sequence of the DNA bound by GR and by the nature of the GR isoform responsible for the regulation of a gene. Here, we screened for GR-interacting proteins for which the interaction signal differed between two GR isoforms GR alpha and GR gamma. These isoforms diverge by a single amino acid insertion in a domain, the lever arm, which adopts DNA sequence-specific conformations. We identify Basic Leucine Zipper ATF-Like Transcription Factor 3 (BATF3), an AP-1 family transcription factor, as a GR coregulator whose interaction with GR is modulated by the lever arm. Further, a combination of experiments uncovered that BATF3 acts as a gene-specific coactivator of GR whose coactivator potency is influenced by the sequence of the GR binding site. Together, our findings suggest that GR isoform and the sequence of GR binding site influence the interaction of GR with BATF3, which might direct the assembly of gene-specific regulatory complexes to fine-tune the expression of individual GR target genes.	[Birth, Petra; Schoene, Stefanie; Stelzl, Ulrich; Meijsing, Sebastiaan H.] Max Planck Inst Mol Genet, Ihnestr 63-73, Berlin, Germany; [Stelzl, Ulrich] Karl Franzens Univ Graz, Dept Pharmaceut Chem, Inst Pharmaceut Sci, Univ Pl 1, Graz, Austria; [Stelzl, Ulrich] BioTechMed Graz, Univ Pl 1, Graz, Austria	Max Planck Society; University of Graz	Meijsing, SH (corresponding author), Max Planck Inst Mol Genet, Ihnestr 63-73, Berlin, Germany.	meijsing@molgen.mpg.de	Stelzl, Ulrich/J-9506-2015	Stelzl, Ulrich/0000-0003-2500-3585	Max Planck Society and the Deutsche Forschungsgemeinschaft (DFG) [ME4154/1-1]	Max Planck Society and the Deutsche Forschungsgemeinschaft (DFG)	This work was supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft (DFG, grant number: ME4154/1-1) (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlof T, 1998, BIOCHEMISTRY-US, V37, P9586, DOI 10.1021/bi973029x; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Chodankar R, 2014, P NATL ACAD SCI USA, V111, P4007, DOI 10.1073/pnas.1400522111; Duma D, 2010, HORM MOL BIOL CLIN I, V3, P319, DOI 10.1515/HMBCI.2010.039; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Garza AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025875; Gupte R, 2013, P NATL ACAD SCI USA, V110, P14616, DOI 10.1073/pnas.1309898110; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hill KK, 2009, J BIOL CHEM, V284, P24415, DOI 10.1074/jbc.M109.003244; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Kleiman A, 2012, FASEB J, V26, P722, DOI 10.1096/fj.11-192112; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Love MI, 2016, NUCL ACIDS RES; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; MCEWAN IJ, 1993, MOL CELL BIOL, V13, P399, DOI 10.1128/MCB.13.1.399; Meijsing SH, 2015, ADV EXP MED BIOL, V872, P59, DOI 10.1007/978-1-4939-2895-8_3; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P1158, DOI 10.1210/me.2004-0331; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Schone S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12621; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; Thomas-Chollier M, 2013, P NATL ACAD SCI USA, V110, P17826, DOI 10.1073/pnas.1316235110; UEDA K, 1989, ENDOCRINOLOGY, V124, P1042, DOI 10.1210/endo-124-2-1042; VANTILBORG MAA, 1995, J MOL BIOL, V247, P689, DOI 10.1016/S0022-2836(05)80148-2; Wallberg AE, 1999, MOL CELL BIOL, V19, P5952; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wardell SE, 2005, MOL CELL BIOL, V25, P8792, DOI 10.1128/MCB.25.20.8792-8808.2005; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Worseck JM, 2012, METHODS MOL BIOL, V812, P63, DOI 10.1007/978-1-61779-455-1_4	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181219	10.1371/journal.pone.0181219	http://dx.doi.org/10.1371/journal.pone.0181219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708849	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649800049
J	Brandstorp-Boesen, J; Falk, RS; Boysen, M; Brondbo, K				Brandstorp-Boesen, Jesper; Falk, Ragnhild Sorum; Boysen, Morten; Brondbo, Kjell			Impact of stage, management and recurrence on survival rates in laryngeal cancer	PLOS ONE			English	Article							TRANSORAL LASER MICROSURGERY; SQUAMOUS-CELL CARCINOMA; ORGAN PRESERVATION; TRENDS; MORTALITY; SUBSITE; GENDER; VOLUME; HEAD	A retrospective, longitudinal study of 1,616 patients with primary laryngeal squamous cell carcinoma (LSCC) at a single center in Norway during 1983-2010 was undertaken to investigate overall survival, disease specific survival, disease-free survival, prognostic factors for overall survival, and impact of recurrence among all-stage laryngeal cancer patients over 15 years' follow-up. The prognostic impact of gender, age, smoking/alcohol, subsite, tumour, node and metastasis staging, period and modality of treatment were evaluated using Kaplan-Meier and Cox proportional hazard analyses. The importance of recurrence on survival was assessed based on case fatality rates. Five-year overall survival was 56.8%, 64.0% and 38.8%, and disease-specific survival was 80.2%, 87% and 61.6%, respectively, for the entire cohort and for glottic and supraglottic LSCC. Old age, advanced-stage LSCC and supraglottic cancer were associated with lower overall survival. The risk of disease-specific death plateaued after five years and varied significantly by subsite. Multivariate analysis of glottic LSCC revealed that surgical treatment improved overall survival, whereas old age, alcohol, T3-T4 status, positive N-status and no treatment were associated with worse survival. In supraglottic LSCC, age, alcohol, and positive N-status had a significant impact on overall survival by multivariate analysis. Five-year overall survival and disease-specific survival among patients with recurrent disease were 34% and 52%, respectively. In conclusion, marked difference in overall survival between glottic and supraglottic LSCC underline the importance of subsite-specific survival analysis. T-status and primary surgical management is essential only for glottic LSCC, emphasizing the importance of correct disease classification. Inferior outcomes in supraglottic LSCC are associated with old age, positive N-status, and improved follow-up routines are necessary. Primary tumor control is essential since recurrence impairs survival considerably in all subsites. The potential benefit of a primary surgical approach towards T3 LSCC awaits further investigation.	[Brandstorp-Boesen, Jesper; Boysen, Morten; Brondbo, Kjell] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Brandstorp-Boesen, Jesper; Boysen, Morten; Brondbo, Kjell] Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Otorhinolaryngol, Oslo, Norway; [Falk, Ragnhild Sorum] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Brandstorp-Boesen, J (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.; Brandstorp-Boesen, J (corresponding author), Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Otorhinolaryngol, Oslo, Norway.	jesper.brandstorp-boesen@medisin.uio.no	Falk, Ragnhild Sørum/H-5613-2019	Falk, Ragnhild Sørum/0000-0001-8398-3492				[Anonymous], 2015, DAHANCA RADIOTHERAPY; Bosetti C, 2006, INT J CANCER, V119, P673, DOI 10.1002/ijc.21855; Brandstorp-Boesen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164068; Brandstorp-Boesen J, 2014, EUR ARCH OTO-RHINO-L, V271, P3233, DOI 10.1007/s00405-014-3100-9; Cancer Registry of Norway, 2015, CANC NORW 2014 CANC; Canis M, 2013, EUR ARCH OTO-RHINO-L, V270, P2719, DOI 10.1007/s00405-013-2382-7; Chatenoud L, 2016, INT J CANCER, V138, P833, DOI 10.1002/ijc.29833; Chen AY, 2007, ARCH OTOLARYNGOL, V133, P1270, DOI 10.1001/archotol.133.12.1270; Chen AY, 2010, CANCER-AM CANCER SOC, V116, P4744, DOI 10.1002/cncr.25364; Dziegielewski PT, 2012, J OTOLARYNGOL-HEAD N, V41, pS56, DOI 10.2310/7070.2011.110081; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Francis E, 2014, LARYNGOSCOPE, V124, P1618, DOI 10.1002/lary.24557; Ganly I, 2009, HEAD NECK-J SCI SPEC, V31, P1489, DOI 10.1002/hed.21113; Genden EM, 2008, HEAD NECK-J SCI SPEC, V30, P103, DOI 10.1002/hed.20715; Groome PA, 2002, J CLIN EPIDEMIOL, V55, P533, DOI 10.1016/S0895-4356(02)00389-X; Haapaniemi A, 2016, HEAD NECK-J SCI SPEC, V38, P36, DOI 10.1002/hed.23834; Harris BN, 2016, HEAD NECK-J SCI SPEC, V38, P1380, DOI 10.1002/hed.24443; Higgins KM, 2009, J OTOLARYNGOL-HEAD N, V38, P603, DOI 10.2310/7070.2009.080235; Hoffman HT, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236095.97947.26; IBM, 2016, IBM SPSS STAT WINDOW; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Levi F, 2004, ANN ONCOL, V15, P1425, DOI 10.1093/annonc/mdh346; Lyhne NM, 2016, EUR J CANCER, V59, P46, DOI 10.1016/j.ejca.2016.01.020; Megwalu UC, 2014, JAMA OTOLARYNGOL, V140, P855, DOI 10.1001/jamaoto.2014.1671; Peretti G, 2016, HEAD NECK-J SCI SPEC, V38, P1107, DOI 10.1002/hed.24424; Raitiola H, 1999, ACTA OTO-LARYNGOL, V119, P847; ROBIN PE, 1991, CLIN OTOLARYNGOL, V16, P193, DOI 10.1111/j.1365-2273.1991.tb01975.x; Sessions DG, 2005, LARYNGOSCOPE, V115, P1402, DOI 10.1097/01.MLG.0000166896.67924.B7; SILVESTRI F, 1992, ORL J OTO-RHINO-LARY, V54, P43, DOI 10.1159/000276258; StatCorp, 2013, STATA STAT SOFTW REL; STEPHENSON WT, 1991, ARCH OTOLARYNGOL, V117, P774; Succo G, 2014, EUR ARCH OTO-RHINO-L, V271, P2489, DOI 10.1007/s00405-014-3024-4; Timmermans AJ, 2016, LARYNGOSCOPE, V126, pE60, DOI 10.1002/lary.25567; Timmermans AJ, 2015, HEAD NECK-J SCI SPEC, V37, P1495, DOI 10.1002/hed.23789; Vilaseca I, 2016, HEAD NECK-J SCI SPEC, V38, P1050, DOI 10.1002/hed.24408; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402	36	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179371	10.1371/journal.pone.0179371	http://dx.doi.org/10.1371/journal.pone.0179371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708883	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800003
J	Martinie, MA; Almecija, Y; Ros, C; Gil, S				Martinie, Marie-Amelie; Almecija, Yves; Ros, Christine; Gil, Sandrine			Incidental mood state before dissonance induction affects attitude change	PLOS ONE			English	Article							COGNITIVE-DISSONANCE; REDUCTION; AROUSAL; CONSISTENCY; MISATTRIBUTION; PERSUASION; ATTENTION; EXPLICIT	The way that incidental affect impacts attitude change brought about by controlled processes has so far been examined when the incidental affective state is generated after dissonance state induction. We therefore investigated attitude change when the incidental mood occurs prior to dissonance state induction. We expected a negative mood to induce systematic processing, and a positive mood to induce heuristic processing. Given that both systematic processing and attitude change are cognitively costly, we expected participants who experienced the dissonance state in a negative mood to have insufficient resources to allocate to attitude change. In our experiment, after mood induction (negative, neutral or positive), participants were divided into low-dissonance and high-dissonance groups. They then wrote a counterattitudinal essay. Analysis of their attitudes towards the essay topic indicated that attitude change did not occur in the negative incidental mood condition. Moreover, written productivity-one indicator of cognitive resource allocation-varied according to the type of incidental mood, and only predicted attitude change in the high-dissonance group. Our results suggest that incidental mood before dissonance induction influences the style of information processing and, by so doing, affects the extent of attitude change.	[Martinie, Marie-Amelie; Almecija, Yves; Ros, Christine; Gil, Sandrine] Univ Poitiers, Univ Tours, CNRS, Ctr Rech Cognit & Apprentissage,CeRCA CNRS UMR 72, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Universite de Tours	Martinie, MA (corresponding author), Univ Poitiers, Univ Tours, CNRS, Ctr Rech Cognit & Apprentissage,CeRCA CNRS UMR 72, Poitiers, France.	marie.amelie.martinie@univ-poitiers.fr		Marie-Amelie, Martinie/0000-0001-9731-6834				ABELSON RP, 1958, BEHAV SCI, V3, P1; Andreescu L, 2013, TECHNOL FORECAST SOC, V80, P711, DOI 10.1016/j.techfore.2012.09.013; [Anonymous], 1962, EXPLORATIONS COGNITI; BLESS H, 1990, PERS SOC PSYCHOL B, V16, P331, DOI 10.1177/0146167290162013; Bohner G., 1995, EUROPEAN REV SOCIAL, V6, P33, DOI [10.1080/14792779443000003, DOI 10.1080/14792779443000003]; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; BROCK TC, 1962, J ABNORM PSYCHOL, V65, P319, DOI 10.1037/h0043673; CIALDINI RB, 1995, J PERS SOC PSYCHOL, V69, P318, DOI 10.1037/0022-3514.69.2.318; COOK DA, 1977, PERS SOC PSYCHOL B, V3, P71; COOPER J, 1984, ADV EXP SOC PSYCHOL, V17, P229, DOI 10.1016/S0065-2601(08)60121-5; COOPER J, 1978, J PERS SOC PSYCHOL, V36, P280, DOI 10.1037/0022-3514.36.3.280; COOPER J, 1978, J PERS SOC PSYCHOL, V36, P1101, DOI 10.1037/0022-3514.36.10.1101; Cooper J, 2007, COGNITIVE DISSONANCE; Devine PG, 1999, SCI CON SER, P297, DOI 10.1037/10318-012; DRACHMAN D, 1976, SOCIOMETRY, V39, P53, DOI 10.2307/2786591; Eisenstadt D, 2003, J APPL SOC PSYCHOL, V33, P2123, DOI 10.1111/j.1559-1816.2003.tb01878.x; ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382; Fazio R.H., 1983, SOCIAL PSYCHOPHYSIOL, P122; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FREEDMAN JL, 1965, J EXP SOC PSYCHOL, V1, P145, DOI 10.1016/0022-1031(65)90042-9; Gawronski B, 2004, J EXP SOC PSYCHOL, V40, P535, DOI 10.1016/j.jesp.2003.10.005; Ghiglione Rodolphe, 1998, ANAL AUTOMATIQUE CON; Harmon-Jones E., 1999, COGNITIVE DISSONANCE; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Jarcho JM, 2011, SOC COGN AFFECT NEUR, V6, P460, DOI 10.1093/scan/nsq054; Jonas E, 2006, PERS SOC PSYCHOL B, V32, P3, DOI 10.1177/0146167205276118; Jones CR, 2009, J PERS SOC PSYCHOL, V96, P933, DOI 10.1037/a0014747; Kahneman D., 1973, ATTENTION EFFORT; Kemper S, 2011, EXP AGING RES, V37, P198, DOI 10.1080/0361073X.2011.554513; Kitayama S, 2013, NEUROIMAGE, V69, P206, DOI 10.1016/j.neuroimage.2012.11.034; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; Martinie MA, 2013, J EXP SOC PSYCHOL, V49, P767, DOI 10.1016/j.jesp.2013.03.003; Martinie MA, 2010, J EXP SOC PSYCHOL, V46, P587, DOI 10.1016/j.jesp.2009.10.018; MAYER JD, 1992, J PERS SOC PSYCHOL, V63, P119, DOI 10.1037/0022-3514.63.1.119; MAYER JD, 1988, J PERS SOC PSYCHOL, V55, P102, DOI 10.1037/0022-3514.55.1.102; MCGUIRE WJ, 1960, J ABNORM SOC PSYCH, V60, P345, DOI 10.1037/h0048563; Niedenthal PM, 2001, EUR J SOC PSYCHOL, V31, P737, DOI 10.1002/ejsp.66; PALLAK MS, 1968, PSYCHON SCI, V11, P197; Petty R.E., 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI [10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2, https://doi.org/10.1016/S0065-2601(08)60214-2]; RABBIE JM, 1959, J PERS, V27, P407, DOI 10.1111/j.1467-6494.1959.tb02363.x; RHODEWALT F, 1979, J EXP SOC PSYCHOL, V15, P35, DOI 10.1016/0022-1031(79)90016-7; Rottenberg J., 2007, HDB EMOTION ELICITAT; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; SCHEIER MF, 1980, J PERS SOC PSYCHOL, V39, P390, DOI 10.1037/0022-3514.39.3.390; Schwarz N., 1990, MOTIVATION COGNITION, V2, P527, DOI [10.2307/, DOI 10.2307/2072281]; Scontras G, 2015, COGNITIVE SCI, V39, P559, DOI 10.1111/cogs.12168; SIMON L, 1995, J PERS SOC PSYCHOL, V68, P247, DOI 10.1037/0022-3514.68.2.247; SINCLAIR RC, 1994, SOC COGNITION, V12, P309, DOI 10.1521/soco.1994.12.4.309; Stalder R., 1998, J PERS SOC PSYCHOL, V21, P198; STEELE CM, 1981, J PERS SOC PSYCHOL, V41, P831, DOI 10.1037/0022-3514.41.5.831; van Veen V, 2009, NAT NEUROSCI, V12, P1469, DOI 10.1038/nn.2413; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; Wicklund R.A., 1976, PERSPECTIVES COGNITI; ZANNA MP, 1976, J PERS, V44, P576; ZANNA MP, 1974, J PERS SOC PSYCHOL, V29, P703, DOI 10.1037/h0036651	56	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180531	10.1371/journal.pone.0180531	http://dx.doi.org/10.1371/journal.pone.0180531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708861	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649800015
J	Murphy, D; Mattey, D; Hutchinson, D				Murphy, Dan; Mattey, Derek; Hutchinson, David			Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; PEPTIDES; RISK; ALLELES; IGA	Objective To analyse the relationship between rheumatoid factor (RF) titre, smoking and HLA- DRB1 alleles coding a | shared epitope (SE) in relation to anti- citrullinated protein antibody (ACPA) positivity in rheumatoid arthritis (RA). Methods RA patients (n = 658) attending rheumatology clinics in Cornwall, UK (cohort 1) were stratified according to RF and ACPA titre, and smoking pack years at diagnosis. A further 409 RA patients from North Staffordshire, UK (cohort 2) were studied to confirm the relationship between RF levels, smoking and ACPA positivity in relation to SE status. Results In cohort 1 there was a trend (p<0.01) of increasing ACPA positivity rates with increasing levels of RF without statistically significant differences between patients who had never smoked and smokers (never smoked: 15/71 (21%) RF - ve, vs. 43/64 (67%) RF weak + ve, vs 88/100 (88%) RF strong + ve, ever smoked: 18/70 (26%) RF - ve vs. 66/83 (80%) RF weak + ve vs. 196/210 (93%) RF strong + ve). No significant gender difference was observed. No significant difference between smoking and ACPA positivity was seen in RF negative patients. Smoking > 20 pack years conferred an increased risk of anti- CCP positive RA (158/200 (79%)), compared to having never smoked (146/235 (62%), p = < 0.01), but this increased risk correlated with smokers' RF positivity as the principal determinant on subsequent regression analysis of cohort 2. In cohort 2, ACPA positivity rates significantly increased with RF positivity and carriage of 1 or 2 SE alleles (p<0.01). Little or no relationship was observed in patients lacking SE. Conclusions ACPA positivity in RA strongly associates with increasing RF titre independent of smoking. This relationship is dependent on carriage of SE alleles. There is no relationship between ACPA and smoking in RF negative patients.	[Murphy, Dan; Hutchinson, David] Royal Cornwall Hosp Trust, Dept Rheumatol, Truro, Cornwall, England; [Murphy, Dan; Hutchinson, David] Univ Exeter, Med Sch, Knowledge Spa, Cornwall Campus, Truro, Cornwall, England; [Mattey, Derek] Haywood Hosp, Haywood Rheumatol Ctr, Stoke On Trent, Staffs, England; [Mattey, Derek] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England	Royal Cornwall Hospital; University of Exeter; Keele University	Murphy, D (corresponding author), Royal Cornwall Hosp Trust, Dept Rheumatol, Truro, Cornwall, England.; Murphy, D (corresponding author), Univ Exeter, Med Sch, Knowledge Spa, Cornwall Campus, Truro, Cornwall, England.	Daniel.murphy8@nhs.net		Mattey, Derek/0000-0002-4676-5434	Cornwall Arthritis Trust, a registered charity; Haywood Rheumatism Research and Development Foundation	Cornwall Arthritis Trust, a registered charity; Haywood Rheumatism Research and Development Foundation	This work was funded by the the Cornwall Arthritis Trust, a registered charity, and by the Haywood Rheumatism Research and Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badillo-Soto MA, 2016, EUR J RHEUMATOL, V3, P44, DOI 10.5152/eurjrheum.2015.0055; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bengtsson C, 2005, ANN RHEUM DIS, V64, P1588, DOI 10.1136/ard.2004.031666; Brink M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0940-2; Burr ML, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3834; Costenbader KH, 2006, AM J MED, V503, pe501; Di Giuseppe D, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4218; Engelmann R, 2010, RHEUMATOLOGY, V49, P1862, DOI 10.1093/rheumatology/keq179; Humphreys JH, 2013, ANN RHEUM DIS, V72, P1315, DOI 10.1136/annrheumdis-2012-201960; Hutchinson D, 2016, ARTHRITIS RHEUMATOL, V68, P2825, DOI 10.1002/art.39832; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Martinsson K, 2017, CLIN EXP IMMUNOL, V188, P53, DOI 10.1111/cei.12901; Mattey DL, 2002, ARTHRIT RHEUM-ARTHR, V47, P403, DOI 10.1002/art.10514; Mewar D, 2008, ANN RHEUM DIS, V67, P980, DOI 10.1136/ard.2007.075382; Nell VPK, 2005, ANN RHEUM DIS, V64, P1731, DOI 10.1136/ard.2005.035691; Payne S., 1996, POVERTY DEPRIVATION; Pedersen M, 2006, J RHEUMATOL, V33, P1069; PRIGNOT J, 1987, EUR J RESPIR DIS, V70, P1; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Svard A, 2015, ARTHRITIS RHEUMATOL, V67, P2032, DOI 10.1002/art.39170; van Wesemael TJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1177-9; Wang F, 2016, CLIN RHEUMATOL, V35, P2185, DOI 10.1007/s10067-016-3247-4; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016527; Wunderlich C, 2017, SEMIN ARTHRITIS RHEU, V46, P709, DOI 10.1016/j.semarthrit.2016.09.011	25	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180655	10.1371/journal.pone.0180655	http://dx.doi.org/10.1371/journal.pone.0180655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708862	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000405649800018
J	Visseaux, B; Burdet, C; Voiriot, G; Lescure, FX; Chougar, T; Brugiere, O; Crestani, B; Casalino, E; Charpentier, C; Descamps, D; Timsit, JF; Yazdanpanah, Y; Houhou-Fidouh, N				Visseaux, Benoit; Burdet, Charles; Voiriot, Guillaume; Lescure, Francois-Xavier; Chougar, Taous; Brugiere, Olivier; Crestani, Bruno; Casalino, Enrique; Charpentier, Charlotte; Descamps, Diane; Timsit, Jean-Francois; Yazdanpanah, Yazdan; Houhou-Fidouh, Nadhira			Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE UNITS; RHINOVIRUS INFECTION; HOSPITALIZED ADULTS; INFLUENZA-A; FAST ASSAY; CHILDREN; IMPACT; PANEL	Background Multiplex PCR tests have improved our understanding of respiratory viruses' epidemiology by allowing their wide range detection. We describe here the burden of these viruses in hospital settings over a five-year period. Methods All respiratory samples from adult patients (>20 years old) tested by multiplex-PCR at the request of physicians, from May 1 2011 to April 30 2016, were included retrospectively. Viral findings are reported by season, patient age group, respiratory tract region (upper or lower) and type of clinical unit (intensive care unit, pneumology unit, lung transplantation unit and other medical units). Results In total, 7196 samples (4958 patients) were included; 29.2% tested positive, with viral coinfections detected in 1.6% of samples. Overall, two viral groups accounted for 60.2% of all viruses identified: picornaviruses (rhinovirus or enterovirus, 34.3%) and influenza (26.6%). Influenza viruses constituted the group most frequently identified in winter (34.4%), in the upper respiratory tract (32%) and in patients over the age of 70 years (36.4%). Picornavirus was the second most frequently identified viral group in these populations and in all other groups, including lower respiratory tract infections (41.3%) or patients in intensive care units (37.6%). Conclusion This study, the largest to date in Europe, provides a broad picture of the distribution of viruses over seasons, age groups, types of clinical unit and respiratory tract regions in the hospital setting. It highlights the burden associated with the neglected picornavirus group. These data have important implications for the future development of vaccines and antiviral drugs.	[Visseaux, Benoit; Chougar, Taous; Charpentier, Charlotte; Descamps, Diane; Houhou-Fidouh, Nadhira] Univ Paris Diderot, Sorbonne Paris Cite, Lab Virol, IAME,UMR 1137,INSERM,Hop Bichat,AP HP, Paris, France; [Burdet, Charles; Lescure, Francois-Xavier; Yazdanpanah, Yazdan] Univ Paris Diderot, Sorbonne Paris Cite, Serv Malad Infect & Trop, IAME,UMR 1137,INSERM,Hop Bichat,AP HP, Paris, France; [Voiriot, Guillaume; Timsit, Jean-Francois] Univ Paris Diderot, Sorbonne Paris Cite, Reanimat Med & Infect, IAME,UMR 1137,INSERM,Hop Bichat,AP HP, Paris, France; [Brugiere, Olivier] Hop Bichat Claude Bernard, AP HP, Serv Pneumol B, Paris, France; [Crestani, Bruno] Hop Bichat Claude Bernard, AP HP, Serv Pneumol A, Paris, France; [Casalino, Enrique] Hop Bichat Claude Bernard, AP HP, Serv Accueil Urgences, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Visseaux, B (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Lab Virol, IAME,UMR 1137,INSERM,Hop Bichat,AP HP, Paris, France.	benoit.visseaux@aphp.fr; nadira.houhou@aphp.fr	Burdet, Charles/AAF-6975-2021; Voiriot, Guillaume/AIB-6833-2022; Lescure, Xavier/AAM-5261-2020; Casalino, Enrique/GYU-1974-2022	Burdet, Charles/0000-0003-4138-0794; Casalino, Enrique/0000-0002-4352-6729; Visseaux, Benoit/0000-0002-9279-5538				Advani S, 2012, PEDIATR INFECT DIS J, V31, P1221, DOI 10.1097/INF.0b013e318265a804; Anton A, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.02.007; Babady NE, 2012, J CLIN MICROBIOL, V50, P2282, DOI 10.1128/JCM.06186-11; Bennett NJ, 2012, J PEDIATR-US, V161, P814, DOI 10.1016/j.jpeds.2012.05.001; Berry M, 2015, VIRUSES-BASEL, V7, P996, DOI 10.3390/v7030996; Branche AR, 2015, J INFECT DIS, V212, P1692, DOI 10.1093/infdis/jiv252; Caisse nationale d'assurance maladie, 2014, CAMP VACC GRIPP SAIS; Casalegno J-S, 2017, EURO SURVEILL B EUR, V22; Chemaly RF, 2012, BLOOD, V119, P2738, DOI 10.1182/blood-2011-08-371112; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Civardi E, 2013, AM J INFECT CONTROL, V41, P854, DOI 10.1016/j.ajic.2013.01.026; Dabisch-Ruthe M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-163; Das D, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.02.014; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Esposito S, 2015, VIRUSES-BASEL, V7, P6043, DOI 10.3390/v7112925; Gerlier L, 2017, APPL HEALTH ECON HEA, V15, P261, DOI 10.1007/s40258-016-0296-4; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Godbole G, 2013, CURR OPIN PULM MED, V19, P244, DOI 10.1097/MCP.0b013e32835f82a9; Greve FV, 2016, J CLIN VIROL, V83, P37, DOI 10.1016/j.jcv.2016.08.295; Hammond SP, 2012, J CLIN MICROBIOL, V50, P3216, DOI 10.1128/JCM.00538-12; Hofstra JJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1081-y; Hong HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095865; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC; Liu T, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0388-z; Loubet P, 2017, J CLIN VIROL, V91, P52, DOI 10.1016/j.jcv.2017.04.001; Milstone AM, 2012, AM J INFECT CONTROL, V40, P462, DOI 10.1016/j.ajic.2011.05.024; Mosnier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136186; Nolte FS, 2007, J CLIN MICROBIOL, V45, P2779, DOI 10.1128/JCM.00669-07; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Principi N, 2015, J CLIN VIROL, V66, P83, DOI 10.1016/j.jcv.2015.03.013; Rappo U, 2016, J CLIN MICROBIOL, V54, P2096, DOI 10.1128/JCM.00549-16; Rhedin S, 2015, THORAX, V70, P847, DOI 10.1136/thoraxjnl-2015-206933; Rogers BB, 2015, ARCH PATHOL LAB MED, V139, P636, DOI 10.5858/arpa.2014-0257-OA; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Self WH, 2015, J INFECT DIS; Shiley KT, 2010, INFECT CONT HOSP EP, V31, P1177, DOI 10.1086/656596; To KKW, 2016, J CLIN VIROL, V77, P85, DOI 10.1016/j.jcv.2016.02.014; To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1; To KKW, 2017, J FORMOS MED ASS; van Asten L, 2012, J INFECT DIS, V206, P628, DOI 10.1093/infdis/jis415; Visseaux B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172809; Voiriot G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1517-9; Yu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046388; Zachariah P, 2016, INFLUENZA OTHER RESP, V10, P361, DOI 10.1111/irv.12387	48	39	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180888	10.1371/journal.pone.0180888	http://dx.doi.org/10.1371/journal.pone.0180888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708843	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800027
J	Fedele, D; Bicchiega, V; Collo, A; Barutta, F; Pistone, E; Gruden, G; Bruno, G				Fedele, Debora; Bicchiega, Virginia; Collo, Alessandro; Barutta, Federica; Pistone, Erika; Gruden, Gabriella; Bruno, Graziella			Short term variation in NTproBNP after lifestyle intervention in severe obesity	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; HEART-FAILURE; WEIGHT-LOSS; MORTALITY; SURGERY; RISK	Aim Natriuretic peptides are not only involved in cardiovascular adaption to various conditions, but also in metabolic diseases. We performed this study to assess the effect of a very short time of lifestyle inpatient intervention on NTproBNP values in normotensive subjects with severe obesity and normal cardiac function. Methods We recruited 14 consecutive obese normotensive subjects with normal cardiac function who were aged 30 years and more and were referred to inpatient rehabilitation in an academic clinic over a two months period. They were examined at baseline and after a 3-weeks program including dietary intervention with hypocaloric diet and assisted personalized physical aerobic and anaerobic activities and compared to age, sex and BMI-matched control subjects under usual care. Results BMI significantly decreased (40.8 +/- 1.6 vs 42.3 +/- 1.6 kg/m(2), p < 0.0001). Median reduction in body weight was 4.9 kg (interquartile range 2.4-5.2 kg). After diet and exercise-induced weight loss, plasma NTproBNP levels showed an almost two-fold increase, which was statistically significant (28.2 +/- 12.3 vs 17.2 +/- 13.2 ng/L, p = 0.01), and particularly relevant in the subgroup with NT-proBNP values below median values compared to those with higher values (p = 0.02). No significant variations were found in control subjects (18.0 +/- 13.0 vs 16.5 +/- 11.2 ng/L, p = 0.18). The lipid profile was significantly ameliorated, and both HbA1c and insulin levels showed a marginally non-significant decrease after treatment. Conclusions An almost two-fold increase in NTproBNP levels was evident after a very short time period of lifestyle intervention in normotensive severe obese patients without cardiac disease. This finding might have clinical relevance, considering the role of NT-proBNP as risk factor of impaired glucose tolerance.	[Fedele, Debora; Collo, Alessandro; Barutta, Federica; Pistone, Erika; Gruden, Gabriella; Bruno, Graziella] Univ Turin, Dept Med Sci, Turin, Italy; [Bicchiega, Virginia] Italian Auxol Inst, Verbania, Italy	University of Turin; IRCCS Istituto Auxologico Italiano	Bruno, G (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	graziella.bruno@unito.it						Bruno G, 2013, DIABETES CARE, V36, P2677, DOI 10.2337/dc13-0353; Chainani-Wu N, 2010, AM J CARDIOL, V105, P1570, DOI 10.1016/j.amjcard.2010.01.016; Changchien EM, 2011, SURG ENDOSC, V25, P2338, DOI 10.1007/s00464-010-1565-1; Chen-Tournoux A, 2010, AM J CARDIOL, V106, P1450, DOI 10.1016/j.amjcard.2010.06.076; Clerico A, 2012, HEART FAIL REV, V17, P81, DOI 10.1007/s10741-011-9249-z; Collins S, 2014, NAT REV ENDOCRINOL, V10, P157, DOI 10.1038/nrendo.2013.234; Coue M, 2016, BIOCHIMIE, V124, P84, DOI 10.1016/j.biochi.2015.05.017; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Gabrielsen Anne-Marie, 2016, BMC Res Notes, V9, P440, DOI 10.1186/s13104-016-2241-x; Gruden G, 2014, DIABETES CARE, V37, P2899, DOI 10.2337/dc14-0669; Kim HN, 2011, CIRCULATION, V123, P2015, DOI 10.1161/CIRCULATIONAHA.110.979500; Kistorp Caroline, 2014, BMC Obes, V1, P24, DOI 10.1186/s40608-014-0024-2; Lavie CJ, 2016, PROG CARDIOVASC DIS, V58, P393, DOI 10.1016/j.pcad.2015.12.003; Lazo M, 2013, DIABETES, V62, P3189, DOI 10.2337/db13-0478; Madamanchi C, 2014, INT J CARDIOL, V176, P611, DOI 10.1016/j.ijcard.2014.08.007; Minami J, 2000, J CARDIOVASC PHARM, V36, pS83, DOI 10.1097/00005344-200000006-00018; Moro C, 2017, EBIOMEDICINE, V17, P11, DOI 10.1016/j.ebiom.2017.03.005; Moro C, 2016, EXPERT OPIN THER TAR, V20, P1445, DOI 10.1080/14728222.2016.1254198; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Nishikimi T, 2011, J CARDIOL, V57, P131, DOI 10.1016/j.jjcc.2011.01.002; Pfister R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001112; Pivovarova O, 2012, J CLIN ENDOCR METAB, V97, pE731, DOI 10.1210/jc.2011-2839; Ricci MA, 2016, CLIN NUTR; Sanchez OA, 2015, METABOLISM, V64, P857, DOI 10.1016/j.metabol.2015.04.001; Tarnow L, 2006, DIABETOLOGIA, V49, P2256, DOI 10.1007/s00125-006-0359-4; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA	26	15	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181212	10.1371/journal.pone.0181212	http://dx.doi.org/10.1371/journal.pone.0181212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704534	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700107
J	Charnaud, SC; Dixon, MWA; Nie, CQ; Chappell, L; Sanders, PR; Nebl, T; Hanssen, E; Berriman, M; Chan, JA; Blanch, AJ; Beeson, JG; Rayner, JC; Przyborski, JM; Tilley, L; Crabb, BS; Gilson, PR				Charnaud, Sarah C.; Dixon, Matthew W. A.; Nie, Catherine Q.; Chappell, Lia; Sanders, Paul R.; Nebl, Thomas; Hanssen, Eric; Berriman, Matthew; Chan, Jo-Anne; Blanch, Adam J.; Beeson, James G.; Rayner, Julian C.; Przyborski, Jude M.; Tilley, Leann; Crabb, Brendan S.; Gilson, Paul R.			The exported chaperone Hsp70-x supports virulence functions for Plasmodium falciparum blood stage parasites	PLOS ONE			English	Article							SEQUENCING-LIBRARY PREPARATION; INFECTED ERYTHROCYTES; MALARIA PARASITES; PROTEIN EXPORT; PROTEOMIC ANALYSIS; PTEX COMPONENT; GENE DELETION; REVEALS; CELL; MEMBRANE	Malaria is caused by five different Plasmodium spp. in humans each of which modifies the host erythrocyte to survive and replicate. The two main causes of malaria, P. falciparum and P. vivax, differ in their ability to cause severe disease, mainly due to differences in the cytoadhesion of infected erythrocytes (IE) in the microvasculature. Cytoadhesion of P. falciparum in the brain leads to a large number of deaths each year and is a consequence of exported parasite proteins, some of which modify the erythrocyte cytoskeleton while others such as PfEMP1 project onto the erythrocyte surface where they bind to endothelial cells. Here we investigate the effects of knocking out an exported Hsp70-type chaperone termed Hsp70-x that is present in P. falciparum but not P. vivax. Although the growth of Delta hsp70-x parasites was unaffected, the export of PfEMP1 cytoadherence proteins was delayed and Delta hsp70-x IE had reduced adhesion. The Delta hsp70-x IE were also more rigid than wild-type controls indicating changes in the way the parasites modified their host erythrocyte. To investigate the cause of this, transcriptional and translational changes in exported and chaperone proteins were monitored and some changes were observed. We propose that PfHsp70-x is not essential for survival in vitro, but may be required for the efficient export and functioning of some P. falciparum exported proteins.	[Charnaud, Sarah C.; Nie, Catherine Q.; Sanders, Paul R.; Chan, Jo-Anne; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.] Burnet Inst, Melbourne, Vic, Australia; [Dixon, Matthew W. A.; Blanch, Adam J.; Tilley, Leann; Crabb, Brendan S.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Dixon, Matthew W. A.; Hanssen, Eric; Blanch, Adam J.; Tilley, Leann] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Chappell, Lia; Berriman, Matthew; Rayner, Julian C.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton, Cambs, England; [Nebl, Thomas] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Przyborski, Jude M.] Philips Univ Marburg, FB Biol, Parasitol, Marburg, Germany; [Crabb, Brendan S.; Gilson, Paul R.] Monash Univ, Melbourne, Vic, Australia	Burnet Institute; University of Melbourne; University of Melbourne; Wellcome Trust Sanger Institute; Walter & Eliza Hall Institute; Monash University	Gilson, PR (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Gilson, PR (corresponding author), Monash Univ, Melbourne, Vic, Australia.	gilson@burnet.edu.au	Berriman, Matthew/A-7618-2011; Dixon, Matthew/N-4503-2019; Przyborski, Jude/ABC-9498-2021; Hanssen, Eric/A-7217-2013; Nebl, Thomas/N-1620-2017	Berriman, Matthew/0000-0002-9581-0377; Dixon, Matthew/0000-0001-9732-9686; Przyborski, Jude/0000-0002-3494-7767; Blanch, Adam/0000-0001-6565-2438; Charnaud, Sarah/0000-0002-9029-9696; Hanssen, Eric/0000-0002-4064-1844; Rayner, Julian/0000-0002-9835-1014; Chappell, Lia/0000-0002-2317-3524; Nebl, Thomas/0000-0003-4003-9340	National Health and Medical Research Council [1092789, 1078065]; OzEMalaR Researcher Exchange funding; Victorian Operational Infrastructure Support Program	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); OzEMalaR Researcher Exchange funding; Victorian Operational Infrastructure Support Program	The authors would like to thank National Health and Medical Research Council (grant numbers 1092789 & 1078065), OzEMalaR Researcher Exchange funding and Victorian Operational Infrastructure Support Program received by the Burnet Institute.	Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2016, WORLD MALARIA REPORT; Antinori S, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.013; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; BERMAN PA, 1991, J CLIN INVEST, V88, P1848, DOI 10.1172/JCI115506; Bouyer G, 2011, BLOOD, V118, P2305, DOI 10.1182/blood-2011-01-329300; Chan JA, 2016, CELL MOL LIFE SCI, V73, P4141, DOI 10.1007/s00018-016-2267-1; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Chappell LVL, 2014, NOVEL APPROACHES TRA; Cooke BM, 2002, BRIT J HAEMATOL, V117, P203, DOI 10.1046/j.1365-2141.2002.03404.x; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; COOKE BM, 1993, MICROVASC RES, V45, P33, DOI 10.1006/mvre.1993.1004; Crabb BS, 2010, INT J PARASITOL, V40, P509, DOI 10.1016/j.ijpara.2010.02.002; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Deplaine G, 2011, BLOOD, V117, pE88, DOI 10.1182/blood-2010-10-312801; Desai SA, 2014, TRENDS PARASITOL, V30, P151, DOI 10.1016/j.pt.2014.01.003; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Elsworth B, 2016, CELL MICROBIOL, V18, P1551, DOI 10.1111/cmi.12596; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x; Hatherley R, 2014, J BIOMOL STRUCT DYN, V32, P1766, DOI 10.1080/07391102.2013.834849; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Jha P, 2017, MOL BIOCHEM PARASIT, V214, P10, DOI 10.1016/j.molbiopara.2017.03.003; Kats LM, 2014, INT J PARASITOL, V44, P319, DOI 10.1016/j.ijpara.2014.01.003; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Larremore DB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9368; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739, DOI 10.4269/ajtmh.1993.48.739; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; McQueen PG, 2004, P NATL ACAD SCI USA, V101, P9161, DOI 10.1073/pnas.0308256101; Newbold C, 1999, INT J PARASITOL, V29, P927, DOI 10.1016/S0020-7519(99)00049-1; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Nunes MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011747; Oberli A, 2014, FASEB J, V28, P4420, DOI 10.1096/fj.14-256057; Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Pachlatko E, 2010, MOL MICROBIOL, V77, P1136, DOI 10.1111/j.1365-2958.2010.07278.x; Prieto JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004098; Proellocks NI, 2014, FASEB J, V28, P3103, DOI 10.1096/fj.14-250399; Quashie NB, 2008, BIOCHEM J, V411, P287, DOI 10.1042/BJ20071460; Rhiel M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36174; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SA D, 2013, SCI WORLD J; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Schneider AG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-30; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Zhang Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep42188; Zhang Y, 2015, P NATL ACAD SCI USA, V112, P6068, DOI 10.1073/pnas.1505584112	74	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181656	10.1371/journal.pone.0181656	http://dx.doi.org/10.1371/journal.pone.0181656			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732045	gold, Green Published, Green Submitted			2022-12-27	WOS:000406643100053
J	Whitworth, KW; Marshall, AK; Symanski, E				Whitworth, Kristina W.; Marshall, Amanda K.; Symanski, Elaine			Maternal residential proximity to unconventional gas development and perinatal outcomes among a diverse urban population in Texas	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; LOW-BIRTH-WEIGHT; PRETERM BIRTH; GESTATIONAL-AGE; WATER-QUALITY; WASTE-WATER; RISK; EXPOSURE; OIL; HEALTH	Objective To assess associations between unconventional natural gas development (UGD) and perinatal outcomes. Methods We conducted a retrospective birth cohort study among 158,894 women with a birth or fetal death from November 30, 2010-November 29, 2012 in the Barnett Shale, in North Texas. We constructed three UGD-activity metrics by calculating the inverse distance-weighted sum of active wells within three separate geographic buffers surrounding the maternal residence: <=(1/2), 2, or 10-miles. We excluded women if the nearest well to her residence was >20 miles. Metrics were categorized by tertiles among women with >= 1 well within the respective buffer; women with zero wells <= 10 miles (the largest buffer) served as a common referent group. We used logistic or linear regression with generalized estimating equations to assess associations between UGD-activity and preterm birth, small-for-gestational age (SGA), fetal death, or birthweight. Adjusted models of fetal death and birthweight included: maternal age, race/ethnicity, education, pre-pregnancy body mass index, parity, smoking, adequacy of prenatal care, previous poor pregnancy outcome, and infant sex. Preterm birth models included all of the above except parity; SGA models included all of the above except previous poor pregnancy outcome. Results We found increased adjusted odds of preterm birth associated with UGD-activity in the highest tertiles of the (1/2)-(odds ratio (OR) = 1.14; 95% confidence interval 1.03, 1.25), 2-(1.14; 1.07, 1.22), and 10-mile (1.15; 1.08, 1.22) metrics. Increased adjusted odds of fetal death were found in the second tertile of the 2- mile metric (1.56; 1.16, 2.11) and the highest tertile of the 10- mile metric (1.34; 1.04-1.72). We found little indication of an association with SGA or term birthweight. Conclusions Our results are suggestive of an association between maternal residential proximity to UGD-activity and preterm birth and fetal death. Quantifying chemical and non-chemical stressors among residents near UGD should be prioritized.	[Whitworth, Kristina W.; Marshall, Amanda K.] UTHlth Sch Publ Hlth San Antonio, Dept Epidemiol Human Genet & Environm Sci, San Antonio, TX 78229 USA; [Whitworth, Kristina W.; Marshall, Amanda K.; Symanski, Elaine] UTHlth Sch Publ Hlth, Southwest Ctr Occupat & Environm Hlth, Houston, TX 77030 USA; [Symanski, Elaine] UTHlth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA		Whitworth, KW (corresponding author), UTHlth Sch Publ Hlth San Antonio, Dept Epidemiol Human Genet & Environm Sci, San Antonio, TX 78229 USA.; Whitworth, KW (corresponding author), UTHlth Sch Publ Hlth, Southwest Ctr Occupat & Environm Hlth, Houston, TX 77030 USA.	Kristina.W.Whitworth@uth.tmc.edu		whitworth, kristina/0000-0003-2334-6066	National Institute of Environmental Health Sciences (NIEHS) [1 R03 ES023954-01]; Occupational Epidemiology Traineeship - National Institute for Occupational Safety and Health (NIOSH)/Centers for Disease Control and Prevention (CDC) [T420H008421]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008421] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Occupational Epidemiology Traineeship - National Institute for Occupational Safety and Health (NIOSH)/Centers for Disease Control and Prevention (CDC); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This study was funded by the National Institute of Environmental Health Sciences (NIEHS), Grant number 1 R03 ES023954-01. AKM was supported by an Occupational Epidemiology Traineeship funded by Grant No. T420H008421 from the National Institute for Occupational Safety and Health (NIOSH)/Centers for Disease Control and Prevention (CDC) to the Southwest Center for Occupational and Environmental Health, a NIOSH-funded Education and Research Center.	Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Armendariz A., 2009, EMISSIONS NATURAL GA; ATSDR, 2007, TOX PROF BENZ; Basso O, 2010, EPIDEMIOLOGY, V21, P521, DOI 10.1097/EDE.0b013e3181debe5e; Brou L, 2012, BJOG-INT J OBSTET GY, V119, P458, DOI 10.1111/j.1471-0528.2011.03266.x; Burton TG, 2016, SCI TOTAL ENVIRON, V545, P114, DOI 10.1016/j.scitotenv.2015.12.084; Canfield MA, 2006, J EXPO SCI ENV EPID, V16, P538, DOI 10.1038/sj.jes.7500501; Casey JA, 2016, EPIDEMIOLOGY, V27, pE37, DOI 10.1097/EDE.0000000000000537; Catalano R, 2014, SOC SCI MED, V108, P237, DOI 10.1016/j.socscimed.2014.01.050; Christopherson S., 2012, J TOWN CITY MANAGE, V2, P1; Colborn T, 2014, HUM ECOL RISK ASSESS, V20, P86, DOI 10.1080/10807039.2012.749447; Coons T., 2008, COMMUNITY HLTH RISK; Cox LA, 2013, CRIT REV TOXICOL, V43, P26, DOI 10.3109/10408444.2013.777689; Eastern Research Group, 2011, FORT WORTH NAT GAS A; Elliott EG, 2017, J EXPO SCI ENV EPID, V27, P90, DOI 10.1038/jes.2015.81; Faiz AS, 2012, AM J EPIDEMIOL, V176, P308, DOI 10.1093/aje/kws029; Ferrar KJ, 2013, ENVIRON SCI TECHNOL, V47, P3472, DOI 10.1021/es301411q; Fontenot BE, 2013, ENVIRON SCI TECHNOL, V47, P10032, DOI 10.1021/es4011724; Ingraffea AR, 2014, P NATL ACAD SCI USA, V111, P10955, DOI 10.1073/pnas.1323422111; Jacquet JB, 2014, ENVIRON SCI TECHNOL, V48, P8321, DOI 10.1021/es404647x; Kassotis CD, 2016, ENVIRON HEALTH PERSP, V124, P256, DOI 10.1289/ehp.1409535; Kassotis CD, 2016, SCI TOTAL ENVIRON, V557, P901, DOI 10.1016/j.scitotenv.2016.03.113; Korfmacher KS, 2013, NEW SOLUT, V23, P13, DOI 10.2190/NS.23.1.c; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Li XY, 2017, ENVIRON POLLUT, V227, P596, DOI 10.1016/j.envpol.2017.03.055; Lupo PJ, 2010, PAEDIATR PERINAT EP, V24, P200, DOI 10.1111/j.1365-3016.2010.01096.x; Macey GP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-82; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McKenzie LM, 2014, ENVIRON HEALTH PERSP, V122, P412, DOI 10.1289/ehp.1306722; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; Menon R, 2016, HUM REPROD UPDATE, V22, P535, DOI 10.1093/humupd/dmw022; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P1150, DOI 10.1289/ehp.8930; New York State Department of Environmental Conservation, 2011, REV DRAFT SUPPL GEN; Olaguer EP, 2012, J AIR WASTE MANAGE, V62, P966, DOI 10.1080/10962247.2012.688923; Saxton KB, 2017, J EVOLUTION BIOL, V30, P889, DOI 10.1111/jeb.13061; Siddika N, 2016, OCCUP ENVIRON MED, V73, P573, DOI 10.1136/oemed-2015-103086; Slama R, 2008, ENVIRON HEALTH PERSP, V116, P791, DOI 10.1289/ehp.11074; Stacy SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126425; Stieb DM, 2012, ENVIRON RES, V117, P100, DOI 10.1016/j.envres.2012.05.007; Talge NM, 2014, PEDIATRICS, V133, P844, DOI 10.1542/peds.2013-3285; Texas Department of State Health Services Center for Health Statistics, GUID GEOC; Texas Department of State Health Services Center for Health Statistics, 2015, TEX POP 2015 PROJ; U. S. Environmental Protection Agency, 2013, PROC HYDR FRACT 2013; US House of Representatives Committee on Energy and Commerce, 2011, CHEM US HYDR FRACT; Vengosh A, 2014, ENVIRON SCI TECHNOL, V48, P8334, DOI 10.1021/es405118y; Wallace ME, 2013, MATERN CHILD HLTH J, V17, P1025, DOI 10.1007/s10995-012-1083-y; Webb Ellen, 2014, Reviews on Environmental Health, V29, P307, DOI 10.1515/reveh-2014-0057; WHO, 2006, INDIAN J MED RES; Wilcox AJ, 2011, AM J EPIDEMIOL, V174, P1062, DOI 10.1093/aje/kwr230; Wood R, 2011, SHALE GAS PROVISIONA; Wu J, 2011, ENVIRON RES, V111, P685, DOI 10.1016/j.envres.2011.03.008; Zielinska B, 2011, MONITORING EMISSIONS, P71	54	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180966	10.1371/journal.pone.0180966	http://dx.doi.org/10.1371/journal.pone.0180966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC2BU	28732016	gold, Green Published, Green Submitted			2022-12-27	WOS:000406643100018
J	Jung, YS; Lee, BH; Yoo, SH				Jung, Yi-seul; Lee, Byung-Hoo; Yoo, Sang-Ho			Physical structure and absorption properties of tailor-made porous starch granules produced by selected amylolytic enzymes	PLOS ONE			English	Article							ALPHA-AMYLASE; CORN; HYDROLYSIS; DEGRADATION; IMPACT	Porous starch granules (PSGs) with various pores and cavity sizes were prepared by amylolysis enzymes. The greatest hydrolysis rate on corn starch granule was observed with alpha-amylase, followed by gluco- and beta-amylases. Temperature increase enhanced glucoamylase reaction rate more drastically than other enzyme treatments. Final hydrolysis level with glucoamylase reached to 66.9%, close to 67.5% of alpha-amylolysis. The alpha-amylase-treated PSGs displayed the greatest pore size and ratio of cavity-to-granule diameters. Gelatinization onset temperatures of PSGs increased to 72.1 (alpha-), 68.7 (beta-), and 68.1 degrees C (gluco-amylolysis) after 8 h; enthalpy changes of beta- and gluco-amylase-treated PSGs increased to 13.4, and 13.1 J/g but alpha-amylase-treated one showed slightly reduced value of 8.5 J/g. Water holding capacities of PSGs were 209.7 (alpha-), 94.6 (beta-), and 133.8% (gluco-amylolysis), and the untreated control had 89.1%; oil holding capacities of them showed 304.5, 182.7, and 211.5%, respectively, while the untreated control had 161.8%. Thus, enzyme types and their reaction conditions can be applied to generate desirable cavity and pore sizes in starch granules. This biocatalytic approach could contribute to develop tailor-made PSGs with distinct internal structure for specific uses in wide range of food, pharmaceutical and other industrial applications.	[Jung, Yi-seul; Yoo, Sang-Ho] Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea; [Jung, Yi-seul; Yoo, Sang-Ho] Sejong Univ, Carbohydrate Bioprod Res Ctr, Seoul, South Korea; [Lee, Byung-Hoo] Gachon Univ, Coll BioNano Technol, Dept Food Sci & Biotechnol, Sungnam, South Korea	Sejong University; Sejong University; Gachon University	Yoo, SH (corresponding author), Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea.; Yoo, SH (corresponding author), Sejong Univ, Carbohydrate Bioprod Res Ctr, Seoul, South Korea.	shyoo@sejong.ac.kr	Yoo, Sang-Ho/AAI-4446-2020	Yoo, Sang-Ho/0000-0002-7258-5090	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014M3A7B4051898]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2014M3A7B4051898). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2014M3A7B4051898).	Amylolysis of native potato and corn starches D SEM AFM nitrogen and iodine sorption investigations, 2009, LWT-FOOD SCI TECHNOL, V42, P1219; Benavent-Gil Y, 2017, CARBOHYD POLYM, V157, P533, DOI 10.1016/j.carbpol.2016.10.047; Bertofta E, 2016, CARBOHYD POLYM, V140, P113, DOI 10.1016/j.carbpol.2015.12.025; Chang PR, 2011, CARBOHYD POLYM, V83, P1016, DOI 10.1016/j.carbpol.2010.08.076; Chen G, 2012, J CEREAL SCI, V56, P316, DOI 10.1016/j.jcs.2012.01.011; Chen YS, 2011, CARBOHYD POLYM, V85, P272, DOI 10.1016/j.carbpol.2011.01.047; Chung YL, 2006, CARBOHYD POLYM, V63, P527, DOI 10.1016/j.carbpol.2005.10.031; Donald A. M., 2004, Starch in food: structure, function and applications, P156, DOI 10.1533/9781855739093.1.156; Dura A, 2014, CARBOHYD POLYM, V101, P837, DOI 10.1016/j.carbpol.2013.10.013; Genkina NK, 2007, BIOMACROMOLECULES, V8, P2329, DOI 10.1021/bm070349f; Glenn GM, 2010, J AGR FOOD CHEM, V58, P4180, DOI 10.1021/jf9037826; Helbert W, 1996, INT J BIOL MACROMOL, V19, P165, DOI 10.1016/0141-8130(96)01123-3; Huber KC, 1997, CEREAL CHEM, V74, P537, DOI 10.1094/CCHEM.1997.74.5.537; Kim JY, 2013, CARBOHYD POLYM, V91, P39, DOI 10.1016/j.carbpol.2012.07.049; Lauro M, 1999, CEREAL CHEM, V76, P925, DOI 10.1094/CCHEM.1999.76.6.925; Lazou A, 2010, FOOD RES INT, V43, P609, DOI 10.1016/j.foodres.2009.09.017; Li HY, 2013, INT J BIOL MACROMOL, V61, P156, DOI 10.1016/j.ijbiomac.2013.07.004; Li HY, 2013, INT J BIOL MACROMOL, V55, P276, DOI 10.1016/j.ijbiomac.2013.01.021; Luo ZG, 2008, STARCH-STARKE, V60, P646, DOI 10.1002/star.200800014; Miao M, 2015, FOOD CHEM, V177, P1, DOI 10.1016/j.foodchem.2014.12.101; Qian JQ, 2011, INT J FOOD SCI TECH, V46, P179, DOI 10.1111/j.1365-2621.2010.02469.x; Sarikaya E, 2000, PROCESS BIOCHEM, V35, P711, DOI 10.1016/S0032-9592(99)00133-8; Sengupta S, 2000, APPL MICROBIOL BIOT, V53, P732, DOI 10.1007/s002530000327; Shariffa YN, 2009, FOOD HYDROCOLLOID, V23, P434, DOI 10.1016/j.foodhyd.2008.03.009; Sujka M, 2007, INT AGROPHYS, V21, P107; Sumner JB, 1935, J BIOL CHEM, V108, P51; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; Te Wierik G. H. P., 1996, International Journal of Pharmaceutics (Amsterdam), V134, P27, DOI 10.1016/0378-5173(95)04383-7; Tester RF, 2006, ANIM FEED SCI TECH, V130, P39, DOI 10.1016/j.anifeedsci.2006.01.016; Uthumporn U, 2013, IND CROP PROD, V43, P441, DOI 10.1016/j.indcrop.2012.07.060; Wu Y, 2011, STARCH-STARKE, V63, P217, DOI 10.1002/star.201000036; Yan H, 2010, FOOD RES INT, V43, P767, DOI 10.1016/j.foodres.2009.11.013; Yao WR, 2002, STARCH-STARKE, V54, P260, DOI [10.1002/1521-379X(200206)54:6&lt;260::AID-STAR260&gt;3.0.CO;2-Z, 10.1002/1521-379X(200206)54:6<260::AID-STAR260>3.0.CO;2-Z]; Yuryev V, 2006, STARCH ACHIEVEMENTS; Zhang B, 2012, INT J BIOL MACROMOL, V50, P250, DOI 10.1016/j.ijbiomac.2011.11.002; Zhou X, 2010, J CEREAL SCI, V51, P57, DOI 10.1016/j.jcs.2009.09.005	36	23	24	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181372	10.1371/journal.pone.0181372	http://dx.doi.org/10.1371/journal.pone.0181372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727742	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500065
J	Saunders, WB; Greenfest-Allen, E; Ward, PD				Saunders, W. Bruce; Greenfest-Allen, Emily; Ward, Peter D.			Demographic disequilibrium in living nautiloids (Nautilus and Allonautilus): Canary in the coal mines?	PLOS ONE			English	Article							PEARLY NAUTILUS; CEPHALOPOD; BUOYANCY	Averaged demographic data from previously unfished populations of Nautilus and Allonautilus (Cephalopoda) provide a baseline to determine if a population is undisturbed and in "equilibrium" or is in "disequilibrium" as a result of fishery pressure. Data are available for previously undisturbed local nautiloid populations in Papua New Guinea, Australia, Indonesia, Fiji, Palau, American Samoa, New Caledonia and Vanuatu (total n = 2,669 live-caught, tagged and released animals). The data show that unfished populations average similar to 75% males and similar to 74% mature animals. By contrast, unpublished, anecdotal and historical records since 1900 from the heavily fished central Philippines have shown a persistent decline in trap yields and a change in demographics of N. pompilius. By 1979, a sample of fished live-caught animals (n = 353) comprised only similar to 28% males and similar to 27% mature animals. Continued uncontrolled trapping caused collapse of the fishery and the shell industry has moved elsewhere, including Indonesia. In addition, we show that estimated rates of population decline are offered by unpublished tag-release records in unfished Palau. These data show that patterns of trap yields and demographic differences between fished and unfished populations in relative age class and sex ratios can indicate disequilibria wrought by fisheries pressure that can render local populations inviable. Given adequate samples (n >= 100 live-caught animals), a threshold of < 50% males and mature animals in fished populations should signal the need to initiate curative conservation initiatives. The current trajectory of uncontrolled nautiloid fisheries can only mean trouble and possibly extinction of local populations of this ancient, iconic molluscan lineage.	[Saunders, W. Bruce] Bryn Mawr Coll, Dept Geol, Bryn Mawr, PA 19010 USA; [Greenfest-Allen, Emily] Univ Penn, Perelman Sch Med, Inst Biomed Informat, Philadelphia, PA 19104 USA; [Ward, Peter D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	Bryn Mawr College; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle	Saunders, WB (corresponding author), Bryn Mawr Coll, Dept Geol, Bryn Mawr, PA 19010 USA.	wsaunder@brynmawr.edu						[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barord GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100799; BIDDER AM, 1962, NATURE, V196, P451, DOI 10.1038/196451a0; Bonacum J, 2011, AM MALACOL BULL, V29, P77, DOI 10.4003/006.029.0221; Carlson BA, 1992, P 17 INT COR REEF S, V1, P587; Carlson BC, 2015, NAUTILUS RES PALAU 2; CITES, 1973, TEXT CONV TEXT CONV; CITES, 2016, 17 M C PART JOH S AF; COLLINS D, 1987, NAUTILUS BIOL PALEOB, P421; DAVIS RA, 1987, NAUTILUS BIOL PALEOB, P3; De Angelis P, 2012, GEOBIOS-LYON, V45, P5, DOI 10.1016/j.geobios.2011.11.005; Dean B, 1901, AM NAT, V35, P819, DOI 10.1086/278007; Del Norte-Campos A.G.C., 2005, PHUKET MAR BIO CEN R, V66, P299; DENTON EJ, 1966, J MAR BIOL ASSOC UK, V46, P723, DOI 10.1017/S0025315400033440; Dugdale H, 1976, NATL GEOGR MAG, V149, P38; Dunstan A, 2010, FISH RES, V106, P239, DOI 10.1016/j.fishres.2010.06.015; Dunstan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016716; Grandperrin R, REPORT NAUTILU UNPUB; Griffin L. E., 1900, MEMOIR NAT ACAD SCI, V8, P101; Groth JG, 2015, AM MUS NOVIT, P1; Hamada T, 1980, NAUTILUS MACROMPHALU; HAVEN N, 1972, Veliger, V15, P75; Hayasaka S, 1983, 1 KAG U RES CTR S PA; LANDMAN NH, 1987, NAUTILUS BIOL PALEOB, P401; Nijman V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140593; Owen R., 1832, OIR PEARLY NAUTILUS; Rumpf Georg Eberhard, 1705, AMBOINSCHE RARITEITK; Saunders W. B., 2009, NAUTILUS BIOL PALEOB; Saunders WB, 2017, AM MALACOL BULL, V35, P1; SAUNDERS WB, 1984, SCIENCE, V224, P990, DOI 10.1126/science.224.4652.990; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P469, DOI 10.1017/S0094837300008472; SAUNDERS WB, 1978, PALEOBIOLOGY, V4, P349, DOI 10.1017/S0094837300006047; Saunders WB, 2017, ZOOLOGICAL MORPHOM 2; Saunders WB, 2017, ZOOLOGICAL MORPHOM 1; SAUNDERS WB, 1987, NAUTILUS BIOL PALEOB, P137; SWAN ARH, 1987, NAUTILUS BIOL PALEOB, P85; Vandepas LE, 2016, ECOL EVOL, V6, P4924, DOI 10.1002/ece3.2248; Ward P. D., 1987, NATURAL HIST NAUTILU; Ward PD, 1997, J PALEONTOL, V71, P1054, DOI 10.1017/S0022336000036039; Willey A., 1902, CONTRIBUTION NATUR 6, P691; Williams RC, 2015, MOL ECOL, V24, P3316, DOI 10.1111/mec.13255; WOODRUFF DS, 1983, P ACAD NAT SCI PHILA, V135, P147; WOODRUFF DS, 1987, NAUTILUS BIOL PALEOB, P65; WRAY CG, 1995, PALEOBIOLOGY, V21, P220, DOI 10.1017/S009483730001321X	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e179811	10.1371/journal.pone.0179811	http://dx.doi.org/10.1371/journal.pone.0179811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727800	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500009
J	D'Avanzo, B; Shaw, R; Riva, S; Apostolo, J; Bobrowicz-Campos, E; Kurpas, D; Bujnowska, M; Holland, C				D'Avanzo, Barbara; Shaw, Rachel; Riva, Silvia; Apostolo, Joao; Bobrowicz-Campos, Elzbieta; Kurpas, Donata; Bujnowska, Maria; Holland, Carol			Stakeholders' views and experiences of care and interventions for addressing frailty and pre-frailty: A meta-synthesis of qualitative evidence	PLOS ONE			English	Article							OLDER-ADULTS EXPERIENCES; HEALTH-CARE; INFORMAL CAREGIVERS; ELDERS EXPERIENCES; OF-LIFE; PEOPLE; HOME; PERCEPTIONS; NURSES; AGE	Frailty is a common condition in older age and is a public health concern which requires integrated care and involves different stakeholders. This meta-synthesis focuses on experiences, understanding, and attitudes towards screening, care, intervention and prevention for frailty across frail and healthy older persons, caregivers, health and social care practitioners. Studies published since 2001 were identified through search of electronic databases; 81 eligible papers were identified and read in full, and 45 papers were finally included and synthesized. The synthesis was conducted with a meta-ethnographic approach. We identified four key themes: Uncertainty about malleability of frailty; Strategies to prevent or to respond to frailty; Capacity to care and person and family-centred service provision; Power and choice. A bottom-up approach which emphasises and works in synchrony with frail older people's and their families' values, goals, resources and optimisation strategies is necessary. A greater employment of psychological skills, enhancing communication abilities and tools to overcome disempowering attitudes should inform care organisation, resulting in more efficient and satisfactory use of services. Public health communication about prevention and management of frailty should be founded on a paradigm of resilience, balanced acceptance, and coping. Addressing stakeholders' views about the preventability of frailty was seen as a salient need.	[D'Avanzo, Barbara; Riva, Silvia] IRCCS, Ist Ric Farmcol Mario Negri, Unit Qual Care & Rights Promot Mental Hlth, Milan, Italy; [Shaw, Rachel; Holland, Carol] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham, W Midlands, England; [Riva, Silvia] Univ Milan, Dept Oncol & Hematol, Milan, Italy; [Apostolo, Joao; Bobrowicz-Campos, Elzbieta; Bujnowska, Maria] Portugal Ctr Evidence Based Practice, Hlth Sci Res Unit Nursing, Nursing Sch Coimbra, Coimbra, Portugal; [Kurpas, Donata] Wroclaw Med Univ, Dept Family Med, Wroclaw, Poland	Aston University; University of Milan; Nursing School of Coimbra; Wroclaw Medical University	D'Avanzo, B (corresponding author), IRCCS, Ist Ric Farmcol Mario Negri, Unit Qual Care & Rights Promot Mental Hlth, Milan, Italy.	barbara.davanzo@marionegri.it	Bujnowska-Fedak, Maria Magdalena/ABD-2237-2021; , Rachel/L-9107-2019; Riva, Silvia/M-3163-2013; Apostolo, Joao L A/H-6281-2012; D'Avanzo, Barbara/AAA-7654-2020; Kurpas, Donata/I-7054-2013; , Silvia/H-8838-2019; Holland, Carol/AAA-9849-2021	Bujnowska-Fedak, Maria Magdalena/0000-0002-4624-5025; , Rachel/0000-0002-0438-7666; Riva, Silvia/0000-0003-2153-0169; Apostolo, Joao L A/0000-0002-3050-4264; D'Avanzo, Barbara/0000-0002-0361-7263; Kurpas, Donata/0000-0002-6996-8920; Holland, Carol/0000-0001-7109-6554; Bobrowicz Campos, Elzbieta Malgorzata/0000-0001-5889-5642	Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) of the European Commission, under the European Union Health Programme; 'Frailty Management Optimisation through EIP-AHA Commitments and Utilisation of Stakeholders Input' [664367]	Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) of the European Commission, under the European Union Health Programme; 'Frailty Management Optimisation through EIP-AHA Commitments and Utilisation of Stakeholders Input'	This work was supported by the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) of the European Commission, under the European Union Health Programme (2014-2020). The survey forms part of a larger study, 'Frailty Management Optimisation through EIP-AHA Commitments and Utilisation of Stakeholders Input' [Grant number 664367 FOCUS].	Apostolo Joao, 2017, JBI Database System Rev Implement Rep, V15, P1154, DOI 10.11124/JBISRIR-2016-003018; Ayalon Liat, 2008, Home Health Care Serv Q, V27, P121, DOI 10.1080/01621420802022563; Baillie Lesley, 2014, Int J Integr Care, V14, pe009; Baltes P.B., 1990, SUCCESSFUL AGING PER, P1, DOI [10.1017/CBO9780511665684.003, DOI 10.1017/CBO9780511665684.003]; Baltes PB, 1997, AM PSYCHOL, V52, P366, DOI 10.1037/0003-066X.52.4.366; Bennion AE, 2012, SOC SCI MED, V75, P976, DOI 10.1016/j.socscimed.2012.04.023; Bindels J, 2015, INT J OLDER PEOPLE N, V10, P179, DOI 10.1111/opn.12066; Bindels J, 2014, J CLIN NURS, V23, P2313, DOI 10.1111/jocn.12513; Blanton PW, 2013, J INTERGENER RELATSH, V11, P18, DOI 10.1080/15350770.2013.755076; Bleijenberg N, 2013, J ADV NURS, V69, P2262, DOI 10.1111/jan.12110; Buckinx F, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0068-x; Campbell R, 2011, HEALTH TECHNOL ASSES, V15, pIII, DOI 10.3310/hta15430; Cano A, 2016, FAM MED PRIM CARE RE, V18, P373, DOI 10.5114/fmpcr/63234; Cesari M, 2016, EUR J INTERN MED, V35, P1, DOI 10.1016/j.ejim.2016.07.021; Claassens L, 2014, J AGING STUD, V31, P159, DOI 10.1016/j.jaging.2014.09.008; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Teixeira INDO, 2008, CIENC SAUDE COLETIVA, V13, P1181, DOI 10.1590/S1413-81232008000400014; Denson LA, 2013, SCAND J CARING SCI, V27, P3, DOI 10.1111/j.1471-6712.2012.00987.x; Dick K, 2006, J AM ACAD NURSE PRAC, V18, P325, DOI 10.1111/j.1745-7599.2006.00140.x; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Donlan W, 2011, INT SOC WORK, V54, P388, DOI 10.1177/0020872810396258; Ebrahimi Z, 2013, GERIATR NURS, V34, P289, DOI 10.1016/j.gerinurse.2013.04.008; Ebrahimi Z, 2012, QUAL HEALTH RES, V22, P1513, DOI 10.1177/1049732312457246; Ekelund C, 2014, QUAL AGEING OLDER AD, V15, P90, DOI 10.1108/QAOA-06-2013-0015; Ekwall Anna, 2012, Curr Aging Sci, V5, P13; Faes MC, 2010, AGING MENT HEALTH, V14, P834, DOI 10.1080/13607861003781825; Finfgeld DL, 2003, QUAL HEALTH RES, V13, P893, DOI 10.1177/1049732303253462; Fjelltun AMS, 2009, SCAND J CARING SCI, V23, P57, DOI 10.1111/j.1471-6712.2007.00590.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Froud R, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-50; Grenier A., 2012, TRANSITIONS LIFECOUR; Grenier A, 2007, CURR SOCIOL, V55, P211, DOI 10.1177/0011392107073303; Gustafsson S, 2012, J APPL GERONTOL, V31, P622, DOI 10.1177/0733464810396874; Gwyther H, 2018, AGEING SOC, V38, P1843, DOI 10.1017/S0144686X17000265; Hjaltadottir I, 2007, SCAND J CARING SCI, V21, P48, DOI 10.1111/j.1471-6712.2007.00434.x; Holland C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003428; Hoogendijk EO, 2016, MATURITAS, V83, P45, DOI 10.1016/j.maturitas.2015.09.002; Horder HM, 2013, INT J QUAL STUD HEAL, V8, DOI 10.3402/qhw.v8i0.20194; Horne R, CONCORDANCE ADHERENC; Kita M, 2013, INT J OLDER PEOPLE N, V8, P149, DOI 10.1111/j.1748-3743.2012.00337.x; Koenig TL, 2004, FAM SOC-J CONTEMP H, V85, P236, DOI 10.1606/1044-3894.319; Kristensson J, 2010, J GERONTOL NURS, V36, P20, DOI 10.3928/00989134-20100330-08; Lang PO, 2009, GERONTOLOGY, V55, P539, DOI 10.1159/000211949; Leichsenring K, 2004, INT J INTEGR CARE, V4, pe10, DOI [DOI 10.5334/ijic.107, DOI 10.5334/IJIC.107]; Levesque L, 2010, INT J NURS STUD, V47, P876, DOI 10.1016/j.ijnurstu.2009.12.006; Lindhardt T, 2008, INT J NURS STUD, V45, P668, DOI 10.1016/j.ijnurstu.2007.01.010; Littlechild R, 2000, OLDER PEOPLE PARTICI; McGeorge SJ, 2011, J PSYCHIATR MENT HLT, V18, P67, DOI 10.1111/j.1365-2850.2010.01630.x; Modig S, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-46; Morley JE, 2013, EUR GERIATR MED, V4, P215, DOI 10.1016/j.eurger.2013.08.006; Nicholas E, 2003, BRIT J SOC WORK, V33, P31, DOI 10.1093/bjsw/33.1.31; Nicholson C, 2012, SOC SCI MED, V75, P1426, DOI 10.1016/j.socscimed.2012.06.011; Nicholson C, 2013, INT J NURS STUD, V50, P1172, DOI 10.1016/j.ijnurstu.2012.01.006; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Normann H.K., 2009, NURSING SCI, V29, P23, DOI https://doi.org/10.1177/010740830902900306; Petticrew M, 2008, J EPIDEMIOL COMMUN H, V62, P552, DOI 10.1136/jech.2006.059394; Puts MTE, 2007, QUAL LIFE RES, V16, P263, DOI 10.1007/s11136-006-9121-0; Puts MTE, 2009, J AGING STUD, V23, P258, DOI 10.1016/j.jaging.2008.03.002; Robben S, 2012, FAM PRACT, V29, P742, DOI 10.1093/fampra/cms033; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Roland KP, 2011, PHYS OCCUP THER GERI, V29, P270, DOI 10.3109/02703181.2011.616986; Rush KL, 2013, INT J OLDER PEOPLE N, V8, P1, DOI 10.1111/j.1748-3743.2011.00280.x; Sandelowski M, 1997, RES NURS HEALTH, V20, P365, DOI 10.1002/(SICI)1098-240X(199708)20:4<365::AID-NUR9>3.0.CO;2-E; Sarvimaki A., 2014, NURSING ETHICS, DOI 10.1177/0969733014564908; Shaw RL, 2016, SOC SCI MED, V156, P192, DOI 10.1016/j.socscimed.2016.03.015; Shaw RL, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-014-0212-7; Shaw Rachel L, 2014, Evid Based Med, V19, P201, DOI 10.1136/eb-2014-101791; Skymne C, 2012, SCAND J OCCUP THER, V19, P194, DOI 10.3109/11038128.2011.569757; Stockwell-Smith G, 2010, J CLIN NURS, V19, P2057, DOI 10.1111/j.1365-2702.2009.03139.x; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; Themessl-Huber Markus, 2007, J Nurs Manag, V15, P222; Todres Les, 2007, Med Health Care Philos, V10, P53, DOI 10.1007/s11019-006-9012-8; Toye F, 2013, HLTH SERV DELIV RES, V12, DOI DOI 10.3310/HSDR01120; Toye F, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-80; Tutton EMM, 2005, J ADV NURS, V50, P143, DOI 10.1111/j.1365-2648.2005.03373.x; van Kempen JAL, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653606; Walker R, 2015, HEALTH SOC CARE COMM, V23, P216, DOI 10.1111/hsc.12142; Wallin M, 2008, SCAND J CARING SCI, V22, P543, DOI 10.1111/j.1471-6712.2007.00569.x; West K, 2016, AGEING SOC; Williams TL, 2016, ROUT INT HANDB, P274; Xuereb CB, 2016, PSYCHOL HEALTH, V31, P436, DOI 10.1080/08870446.2015.1116534; Young Heather M, 2003, Online J Issues Nurs, V8, P5; Ziden L, 2008, CLIN REHABIL, V22, P801, DOI 10.1177/0269215508090204	83	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180127	10.1371/journal.pone.0180127	http://dx.doi.org/10.1371/journal.pone.0180127			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723916	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000406067800011
J	Desoubeaux, G; Piqueras, MD; Pantin, A; Bhattacharya, SK; Peschke, R; Joachim, A; Cray, C				Desoubeaux, Guillaume; Piqueras, Maria del Carmen; Pantin, Ana; Bhattacharya, Sanjoy K.; Peschke, Roman; Joachim, Anja; Cray, Carolyn			Application of mass spectrometry to elucidate the pathophysiology of Encephalitozoon cuniculi infection in rabbits	PLOS ONE			English	Article							PET RABBITS; IN-VITRO; ASPERGILLUS-FUMIGATUS; PROTEIN QUANTITATION; POLAR TUBE; EXPRESSION; DIAGNOSIS; FETUIN; CELLS; MICROSPORIDIOSIS	Encephalitozoon cuniculi is a microsporidian species which can induce subclinical to serious disease in mammals including rabbits, a definitive natural host. The pathophysiology of infection has not been comprehensively elucidated. In this exploratory study, we utilized two mass spectrometry approaches: first, the analysis of the humoral response by profiling the microsporidian antigens as revealed by Western blot screening, and second, implementing the iTRAQ (R)-labeling protocol to focus on the changes within the host proteome during infection. Seven E. cuniculi proteins were identified at one-dimensional gel regions where specific seropositive reaction was observed by Western blot, including polar tube protein 3, polar tube protein 2, and for the first time reported: heat shock related 70kDa protein, polysaccharide deacetylase domain-containing protein, zinc finger protein, spore wall and anchoring disk complex protein EnP1, and translation elongation factor 1 alpha. In addition, there was a significant increase of nine host proteins in blood samples from E. cuniculi-diseased rabbits in comparison with non-diseased control subjects undergoing various inflammatory processes. This included serum paraoxonase, alpha-1-antiproteinase F precursor and alpha-1-antiproteinase S-1 which have presumptive catalytic activity likely related to infection control, and cystatin fetuin-B-type, an enzyme regulator that has been poorly studied to date. Notably, 11 proteins were found to be statistically increased in rabbits with neurological versus renal clinical presentation of E. cuniculi infection. Overall, this novel analysis based on mass spectrometry has provided new insights on the inflammatory and humoral responses during E. cuniculi infection in rabbits.	[Desoubeaux, Guillaume; Pantin, Ana; Cray, Carolyn] Univ Miami, Miller Sch Med, Div Comparat Pathol, Dept Pathol & Lab Med, Miami, FL 33136 USA; [Desoubeaux, Guillaume] CHU Tours, Serv Parasitol Mycol Med Trop, Tours, France; [Desoubeaux, Guillaume] Univ Tours, Fac Med, CEPR INSERM U1100, Equipe 3, Tours, France; [Piqueras, Maria del Carmen; Bhattacharya, Sanjoy K.] Univ Miami, Miller Sch Med, Mass Spectrometry Core Facil, Miami, FL 33136 USA; [Peschke, Roman; Joachim, Anja] Univ Vet Med, Inst Parasitol, Dept Pathobiol, Vienna, Austria	University of Miami; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Miami; University of Veterinary Medicine Vienna	Desoubeaux, G (corresponding author), Univ Miami, Miller Sch Med, Div Comparat Pathol, Dept Pathol & Lab Med, Miami, FL 33136 USA.; Desoubeaux, G (corresponding author), CHU Tours, Serv Parasitol Mycol Med Trop, Tours, France.; Desoubeaux, G (corresponding author), Univ Tours, Fac Med, CEPR INSERM U1100, Equipe 3, Tours, France.	guillaume.desoubeaux@univ-tours.fr	DESOUBEAUX, Guillaume/J-5026-2015	DESOUBEAUX, Guillaume/0000-0001-7945-9890; CRAY, CAROLYN/0000-0002-7180-153X	NIH center [P30-EY14801]	NIH center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partly supported by NIH center grant P30-EY14801. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi HI, 2014, PATHOL RES INT, V2014; Arredouani M, 2001, REDOX REP, V6, P369; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Bockmann S, 2000, J LEUKOCYTE BIOL, V68, P587; Costa LG, 2003, ANNU REV MED, V54, P371, DOI 10.1146/annurev.med.54.101601.152421; COX JC, 1979, J PROTOZOOL, V26, P260, DOI 10.1111/j.1550-7408.1979.tb02776.x; Cray C, 2015, J EXOT PET MED, V24, P356, DOI 10.1053/j.jepm.2015.06.017; Cray C, 2009, AM J VET RES, V70, P478, DOI 10.2460/ajvr.70.4.478; Csokai J, 2009, VET PARASITOL, V163, P18, DOI 10.1016/j.vetpar.2009.03.057; Deakin S, 2002, J BIOL CHEM, V277, P4301, DOI 10.1074/jbc.M107440200; Desoubeaux G, 2015, J MYCOL MED, V25, P95, DOI 10.1016/j.mycmed.2014.10.018; Desoubeaux G, 2016, PARASITOL RES; Desoubeaux G, 2014, INT J MED MICROBIOL, V304, P327, DOI 10.1016/j.ijmm.2013.11.015; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2010, MICROBES INFECT, V12, P1244, DOI 10.1016/j.micinf.2010.09.010; EATON JW, 1982, SCIENCE, V215, P691, DOI 10.1126/science.7036344; Fekkar A, 2012, J PROTEOMICS, V75, P2536, DOI 10.1016/j.jprot.2012.01.040; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gonzales DA, 2010, PROTEOMICS, V10, P4270, DOI 10.1002/pmic.200900768; Grabner DS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-170; Gruber A, 2009, J COMP PATHOL, V140, P31, DOI 10.1016/j.jcpa.2008.09.009; Harcourt-Brown FM, 2003, VET REC, V152, P427, DOI 10.1136/vr.152.14.427; Hardt M, 2005, ANAL CHEM, V77, P4947, DOI 10.1021/ac050161r; Holcapek M, 2012, J CHROMATOGR A, V1259, P3, DOI 10.1016/j.chroma.2012.08.072; Jolly CE, 2010, INT J MICROBIOL, V2010; Jung SH, 2015, CLIN SCI, V129, P27, DOI 10.1042/CS20140462; Keeble E, 2011, IN PRACTICE, V33, P426, DOI 10.1136/inp.d6077; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Khan IA, 2001, MICROBES INFECT, V3, P401, DOI 10.1016/S1286-4579(01)01397-1; Koyama S, 2000, AM J RESP CELL MOL, V22, P75, DOI 10.1165/ajrcmb.22.1.3752; Kucerova Z, 2006, J EUKARYOT MICROBIOL, V53, pS70, DOI 10.1111/j.1550-7408.2006.00177.x; Kunzel F, 2008, VET PARASITOL, V151, P115, DOI 10.1016/j.vetpar.2007.11.005; Kunzel F, 2014, PARASITOL RES, V113, P4457, DOI 10.1007/s00436-014-4130-3; Kunzel F, 2010, PARASITOL RES, V106, P299, DOI 10.1007/s00436-009-1679-3; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; Latney L, 2014, VET MED RES REP, V169; Leiro J, 2004, ANTIMICROB AGENTS CH, V48, P2497, DOI 10.1128/AAC.48.7.2497-2501.2004; Li GK, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017254; Maestrini G, 2017, COMP IMMUNOL MICROB, V50, P54, DOI 10.1016/j.cimid.2016.11.012; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Meng FS, 2009, CLIN BIOCHEM, V42, P1025, DOI 10.1016/j.clinbiochem.2009.03.012; NIEDERKORN JY, 1980, INFECT IMMUN, V27, P995, DOI 10.1128/IAI.27.3.995-1002.1980; Omalu I C J, 2007, Indian J Med Microbiol, V25, P209; Peuvel-Fanget I, 2006, INT J PARASITOL, V36, P309, DOI 10.1016/j.ijpara.2005.10.005; Rao Prahlad K, 2009, J Proteomics Bioinform, V2, P19; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schottelius J, 2000, MEM I OSWALDO CRUZ, V95, P701, DOI 10.1590/S0074-02762000000500015; SPEER CP, 1987, J PEDIATR-US, V111, P667, DOI 10.1016/S0022-3476(87)80240-8; Tao WA, 2003, CURR OPIN BIOTECH, V14, P110, DOI 10.1016/S0958-1669(02)00018-6; Toyotome T, 2012, INT J MED MICROBIOL, V302, P108, DOI 10.1016/j.ijmm.2011.12.001; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P924, DOI 10.1074/mcp.M400193-MCP200; Urch JE, 2009, PROTEIN SCI, V18, P1197, DOI 10.1002/pro.128; Varga M, 2014, VET REC, V174, P347, DOI 10.1136/vr.g2494; Wang H, 2012, CURR MOL MED, V12, P625, DOI 10.2174/156652412800620039; Wasson K, 2000, VET PATHOL, V37, P113, DOI 10.1354/vp.37-2-113; Xu YJ, 2005, INT J PARASITOL, V35, P941, DOI 10.1016/j.ijpara.2005.04.003; Zarember KA, 2009, ANTIMICROB AGENTS CH, V53, P2654, DOI 10.1128/AAC.01547-08; Zhu J, 2016, ENDOCRINE; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	59	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0177961	10.1371/journal.pone.0177961	http://dx.doi.org/10.1371/journal.pone.0177961			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723944	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800003
J	Van der Jagt, APN; Craig, T; Brewer, MJ; Pearson, DG				Van der Jagt, Alexander P. N.; Craig, Tony; Brewer, Mark J.; Pearson, David G.			A view not to be missed: Salient scene content interferes with cognitive restoration	PLOS ONE			English	Article							VISUAL-ATTENTION; TOP-DOWN; NATURAL SCENES; HUMAN CORTEX; BENEFITS; OBJECT; CATEGORIZATION; STATISTICS; ENVIRONMENTS; EXPERIENCES	Attention Restoration Theory (ART) states that built scenes place greater load on attentional resources than natural scenes. This is explained in terms of "hard" and "soft" fascination of built and natural scenes. Given a lack of direct empirical evidence for this assumption we propose that perceptual saliency of scene content can function as an empirically derived indicator of fascination. Saliency levels were established by measuring speed of scene category detection using a Go/No-Go detection paradigm. Experiment 1 shows that built scenes are more salient than natural scenes. Experiment 2 replicates these findings using grey-scale images, ruling out a colour-based response strategy, and additionally shows that built objects in natural scenes affect saliency to a greater extent than the reverse. Experiment 3 demonstrates that the saliency of scene content is directly linked to cognitive restoration using an established restoration paradigm. Overall, these findings demonstrate an important link between the saliency of scene content and related cognitive restoration.	[Van der Jagt, Alexander P. N.] Univ Aberdeen, Aberdeen, Scotland; [Van der Jagt, Alexander P. N.; Craig, Tony] James Hutton Inst, Aberdeen, Scotland; [Brewer, Mark J.] Biomath & Stat Scotland, Aberdeen, Scotland; [Pearson, David G.] Anglia Ruskin Univ, Cambridge, England; [Van der Jagt, Alexander P. N.] Univ Utrecht, Copernicus Inst Sustainable Dev, Utrecht, Netherlands	University of Aberdeen; James Hutton Institute; James Hutton Institute; Anglia Ruskin University; Utrecht University	Pearson, DG (corresponding author), Anglia Ruskin Univ, Cambridge, England.	david.pearson@anglia.ac.uk	Pearson, David G/C-4908-2008; Brewer, Mark/I-7226-2013; van der Jagt, Alexander/AAW-5556-2021; Craig, Tony/I-8353-2012	Brewer, Mark/0000-0001-7559-389X; Craig, Tony/0000-0001-9552-1682; Pearson, David/0000-0002-2912-0976; van der Jagt, Alexander/0000-0002-1365-5765	ACES (Aberdeen Centre for Environmental Sustainability); Scottish Government's Rural and Environment Science and Analytical Services Division	ACES (Aberdeen Centre for Environmental Sustainability); Scottish Government's Rural and Environment Science and Analytical Services Division	This research was partly funded by a grant from ACES (Aberdeen Centre for Environmental Sustainability) and by the Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank James Urquhart for technical support and Kathryn Shield for assisting with the data collection. This research was partly funded by a grant from ACES (Aberdeen Centre for Environmental Sustainability) and by the Scottish Government's Rural and Environment Science and Analytical Services Division.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baddeley RJ, 2006, VISION RES, V46, P2824, DOI 10.1016/j.visres.2006.02.024; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Berman MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114572; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Chun MM, 1999, PSYCHOL SCI, V10, P360, DOI 10.1111/1467-9280.00168; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Duncan J., 1996, ATTENTION PERFORM, P549; Evans KK, 2005, J EXP PSYCHOL HUMAN, V31, P1476, DOI 10.1037/0096-1523.31.6.1476; Fei-Fei L, 2007, J VISION, V7, DOI 10.1167/7.1.10; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Goffaux V, 2005, VIS COGN, V12, P878, DOI 10.1080/13506280444000562; Greene MR, 2015, ATTEN PERCEPT PSYCHO, V77, P1239, DOI 10.3758/s13414-015-0859-8; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Groen IIA, 2013, J NEUROSCI, V33, P18814, DOI 10.1523/JNEUROSCI.3128-13.2013; Gulwadi GB, 2006, ENVIRON BEHAV, V38, P503, DOI 10.1177/0013916505283420; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Hartley T. P., 2011, Proceedings of the 2011 16th International Conference on Computer Games: AI, Animation, Mobile, Interactive Multimedia, Educational & Serious Games (CGAMES 2011), P41, DOI 10.1109/CGAMES.2011.6000358; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Joubert OR, 2009, J VISION, V9, DOI 10.1167/9.1.2; Kadar I, 2012, J VISION, V12, DOI 10.1167/12.13.16; Kaplan R, 2001, ENVIRON BEHAV, V33, P507, DOI 10.1177/00139160121973115; Kaplan R, 1989, EXPERIENCE NATURE PS; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Krieger G, 2000, SPATIAL VISION, V13, P201, DOI 10.1163/156856800741216; Loschky LC, 2010, VIS COGN, V18, P513, DOI 10.1080/13506280902937606; Loschky LC, 2008, J VISION, V8, DOI 10.1167/8.1.4; Mack ML, 2010, J VISION, V10, DOI 10.1167/10.3.11; Mullin CR, 2011, J COGNITIVE NEUROSCI, V23, P4174, DOI 10.1162/jocn_a_00095; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; Oliva Aude, 2005, P251, DOI 10.1016/B978-012375731-9/50045-8; Ottosson J., 2005, Landscape Research, V30, P23, DOI 10.1080/0142639042000324758; Pearson DG, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01178; R Development Core Team, 2012, R A LANGUAGE ENV STA; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Theeuwes J, 2004, PSYCHON B REV, V11, P65, DOI 10.3758/BF03206462; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; van den Berg AE, 2003, J ENVIRON PSYCHOL, V23, P135, DOI 10.1016/S0272-4944(02)00111-1; van der Jagt A. P. N., 2014, THESIS; VanRullen R, 2001, PERCEPTION, V30, P655, DOI 10.1068/p3029; VanRullen R, 2003, J PHYSIOL-PARIS, V97, P365, DOI 10.1016/j.jphysparis.2003.09.010; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wohlwill J. F., 1983, ADV THEORY RES, V6, P5, DOI DOI 10.1007/978-1-4613-3539-9_2; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73	57	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0169997	10.1371/journal.pone.0169997	http://dx.doi.org/10.1371/journal.pone.0169997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723975	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000406067800001
J	Yang, JY; Bae, J; Jung, A; Park, S; Chung, S; Seok, J; Roh, H; Han, Y; Oh, JM; Sohn, S; Jeong, J; Cho, WS				Yang, Jun-Young; Bae, Jiyeong; Jung, Ayoung; Park, Seonyeong; Chung, Seungtae; Seok, Jihyun; Roh, Hangsik; Han, Youngju; Oh, Jae-Min; Sohn, Soojung; Jeong, Jayoung; Cho, Wan-Seob			Surface functionalization-specific binding of coagulation factors by zinc oxide nanoparticles delays coagulation time and reduces thrombin generation potential in vitro	PLOS ONE			English	Article							ZNO NANOPARTICLES; SILVER NANOPARTICLES; CANCER-CELLS; ANTIBACTERIAL ACTIVITY; INFLAMMATORY RESPONSE; CONFORMATIONAL-CHANGE; PROCOAGULANT ACTIVITY; PROTEIN CORONA; HUMAN BLOOD; HERPES	Zinc oxide nanoparticles (ZnO NPs) have many biomedical applications such as chemotherapy agents, vaccine adjuvants, and biosensors but its hemocompatibility is still poorly understood, especially in the event of direct contact of NPs with blood components. Here, we investigated the impact of size and surface functional groups on the platelet homeostasis. ZnO NPs were synthesized in two different sizes (20 and 100 nm) and with three different functional surface groups (pristine, citrate, and L-serine). ZnO NPs were incubated with plasma collected from healthy rats to evaluate the coagulation time, kinetics of thrombin generation, and profile of levels of coagulation factors in the supernatant and coronated onto the ZnO NPs. Measurements of plasma coagulation time showed that all types of ZnO NPs prolonged both active partial thromboplastin time and prothrombin time in a dose-dependent manner but there was no size-or surface functionalization-specific pattern. The kinetics data of thrombin generation showed that ZnO NPs reduced the thrombin generation potential with functionalization-specificity in the order of pristine > citrate > L-serine but there was no size-specificity. The profile of levels of coagulation factors in the supernatant and coronated onto the ZnO NPs after incubation of platelet-poor plasma with ZnO NPs showed that ZnO NPs reduced the levels of coagulation factors in the supernatant with functionalization-specificity. Interestingly, the pattern of coagulation factors in the supernatant was consistent with the levels of coagulation factors adsorbed onto the NPs, which might imply that ZnO NPs simply adsorb coagulation factors rather than stimulating these factors. The reduced levels of coagulation factors in the supernatant were consistent with the delayed coagulation time and reduced potential for thrombin generation, which imply that the adsorbed coagulation factors are not functional.	[Yang, Jun-Young; Bae, Jiyeong; Jung, Ayoung; Park, Seonyeong; Chung, Seungtae; Seok, Jihyun; Roh, Hangsik; Sohn, Soojung; Jeong, Jayoung] Minist Food & Drug Safety, Natl Inst Food & Drug Safety Evaluat, Toxicol Res Div, Osong, South Korea; [Han, Youngju; Cho, Wan-Seob] Dong A Univ, Sch Hlth Sci, Dept Med Biotechnol, Busan, South Korea; [Oh, Jae-Min] Yonsei Univ, Coll Sci & Technol, Dept Chem & Med Chem, Gangwon Do, South Korea	Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation; Dong A University; Yonsei University	Jeong, J (corresponding author), Minist Food & Drug Safety, Natl Inst Food & Drug Safety Evaluat, Toxicol Res Div, Osong, South Korea.; Cho, WS (corresponding author), Dong A Univ, Sch Hlth Sci, Dept Med Biotechnol, Busan, South Korea.	Ojjy@korea.kr; wcho@dau.ac.kr	Han, Youngju/GRO-4212-2022; Cho, Wanseob/AAP-5991-2020	Han, Youngju/0000-0002-4351-7478; 	Ministry of Food and Drug Safety [14181MFDS458]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a grant (14181MFDS458) from Ministry of Food and Drug Safety in 2014-2015.	Ahmad J, 2015, BIOPROC BIOSYST ENG, V38, P155, DOI 10.1007/s00449-014-1254-x; Ali LMA, 2013, J BIOMED NANOTECHNOL, V9, P1272, DOI 10.1166/jbn.2013.1637; Antoine TE, 2016, J IMMUNOL, V196, P4566, DOI 10.4049/jimmunol.1502373; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Ban DK, 2016, COLLOID SURFACE B, V146, P577, DOI 10.1016/j.colsurfb.2016.06.050; Burke AR, 2011, BIOMATERIALS, V32, P5970, DOI 10.1016/j.biomaterials.2011.04.059; Cho NH, 2011, NAT NANOTECHNOL, V6, P675, DOI [10.1038/NNANO.2011.149, 10.1038/nnano.2011.149]; Donaldson K, 2013, ACCOUNTS CHEM RES, V46, P723, DOI 10.1021/ar300092y; Forato LA, 1998, ANAL BIOCHEM, V259, P136, DOI 10.1006/abio.1998.2599; Frohlich E, 2016, CURR MED CHEM, V23, P408, DOI 10.2174/0929867323666160106151428; Gheshlaghi ZN, 2008, ACTA BIOCH BIOPH SIN, V40, P777, DOI 10.1111/j.1745-7270.2008.00458.x; Guildford AL, 2009, J R SOC INTERFACE, V6, P1213, DOI [10.1098/rsif.2009.0021, 10.1098/rsif.2008.0021]; Hassan HFH, 2017, CLIN EXP PHARMACOL P, V44, P235, DOI 10.1111/1440-1681.12681; Jun EA, 2011, NANOTOXICOLOGY, V5, P157, DOI 10.3109/17435390.2010.506250; Kim Kyoung-Min, 2012, Toxicology and Environmental Health Sciences, V4, P121, DOI 10.1007/s13530-012-0126-5; Krajewski S, 2013, ACTA BIOMATER, V9, P7460, DOI 10.1016/j.actbio.2013.03.016; Laloy J, 2012, NANOTOXICOLOGY, V6, P213, DOI 10.3109/17435390.2011.569096; Li JQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43126; Martinez-Gutierrez F, 2012, NANOMED-NANOTECHNOL, V8, P328, DOI 10.1016/j.nano.2011.06.014; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Mona J, 2013, DIAM RELAT MATER, V39, P73, DOI 10.1016/j.diamond.2013.08.001; Moyano DF, 2014, ACS NANO, V8, P6748, DOI 10.1021/nn5006478; Nadesh R, 2013, J BIOMED MATER RES A, V101, P2957, DOI 10.1002/jbm.a.34591; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Neun BW, 2015, NCL METHOD ITA 12 VE; OECD, 2010, ENV JM MON, V46; Oslakovic C, 2012, NANOMED-NANOTECHNOL, V8, P981, DOI 10.1016/j.nano.2011.12.001; Paino IMM, 2016, ACS APPL MATER INTER, V8, P32699, DOI 10.1021/acsami.6b11950; Pandurangan M, 2016, J PHOTOCH PHOTOBIO B, V158, P206, DOI 10.1016/j.jphotobiol.2016.03.002; Ponnuvel S, 2015, PROTEIN J, V34, P329, DOI 10.1007/s10930-015-9627-9; Ragaseema VM, 2012, BIOMATERIALS, V33, P3083, DOI 10.1016/j.biomaterials.2012.01.005; Raghavendra AJ, 2017, BIOINTERPHASES, V12, DOI 10.1116/1.4977064; Rahimi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17259; Roy R, 2014, TOXICOL LETT, V230, P421, DOI 10.1016/j.toxlet.2014.08.008; Senapati VA, 2015, FOOD CHEM TOXICOL, V85, P61, DOI 10.1016/j.fct.2015.06.018; Shrivastava S, 2009, ACS NANO, V3, P1357, DOI 10.1021/nn900277t; Tomaszewski KA, 2015, NANOMEDICINE-UK, V10, P1451, DOI [10.2217/NNM.14.232, 10.2217/nnm.14.232]; Wahab R, 2016, RSC ADV, V6, P32328, DOI 10.1039/c6ra05297e; Wahab R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19950; Wahab R, 2014, PHYSICA E, V62, P111, DOI 10.1016/j.physe.2014.04.017; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P1181, DOI 10.1166/jbn.2013.1652; Wangoo N, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2902302; Xu XL, 2013, LANGMUIR, V29, P5573, DOI 10.1021/la400378t; Yallapu MM, 2015, BIOMATERIALS, V46, P1, DOI 10.1016/j.biomaterials.2014.12.045	45	13	13	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181634	10.1371/journal.pone.0181634	http://dx.doi.org/10.1371/journal.pone.0181634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723962	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800061
J	Stevanoviv, A; Schaefer, P; Coburn, M; Rossaint, R; Stoppe, C; Boor, P; Pfister, D; Heidenreich, A; Christ, H; Hellmich, M; Fahlenkamp, AV				Stevanoviv, Ana; Schaefer, Patrick; Coburn, Mark; Rossaint, Rolf; Stoppe, Christian; Boor, Peter; Pfister, David; Heidenreich, Axel; Christ, Hildegard; Hellmich, Martin; Fahlenkamp, Astrid V.			Renal function following xenon anesthesia for partial nephrectomy-An explorative analysis of a randomized controlled study	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CYSTATIN-C; SEVOFLURANE ANESTHESIA; VOLATILE ANESTHETICS; NEONATAL ASPHYXIA; CLINICAL-PRACTICE; SURGICAL-PATIENTS; SERUM CREATININE; KIDNEY-FUNCTION; IN-VIVO	Background Perioperative preservation of renal function has a significant impact on morbidity and mortality in kidney surgery. Nephroprotective effects of the anesthetic xenon on ischemia-reperfusion injury were found in several experimental studies. Objective We aimed to explore whether xenon anesthesia can reduce renal damage in humans undergoing partial nephrectomy and to gather pilot data of possible nephroprotection in these patients. Design A prospective randomized, single-blinded, controlled study. Setting Single-center, University Hospital of Aachen, Germany between July 2013-October 2015. Patients Forty-six patients with regular renal function undergoing partial nephrectomy. Interventions Patients were randomly assigned to receive xenon-(n = 23) or isoflurane (n = 23) anesthesia. Main outcome measures Primary outcome was the maximum postoperative glomerular filtration rate (GFR) decline within seven days after surgery. Secondary outcomes included intraoperative and tumor-related data, assessment of further kidney injury markers, adverse events and optional determination of renal function after 3-6 months. Results Unexpected radical nephrectomy was performed in 5 patients, thus they were excluded from the per-protocol analysis, but included in the intention-to-treat analysis. The maximum postoperative GFR decline was attenuated by 45% in the xenon-group (10.9 ml min(-1) 1.73 cm(-2) versus 19.7 ml min-1 1.73 cm(-2) in the isoflurane group), but without significance (P = 0.084). Occurrence of adverse events was reduced (P = 0.003) in the xenon group. Renal function was similar among the groups after 3-6 months. Conclusion Xenon anesthesia was feasible and safe in patients undergoing partial nephrectomy with regard to postoperative renal function. We found no significant effect on early renal function but less adverse events in the xenon group. Larger randomized controlled studies in more heterogeneous collectives are required, to confirm or refute the possible clinical benefit on renal function by xenon.	[Stevanoviv, Ana; Coburn, Mark; Rossaint, Rolf; Stoppe, Christian; Fahlenkamp, Astrid V.] Univ Hosp RWTH Aachen, Dept Anesthesiol, Aachen, Germany; [Schaefer, Patrick] Univ RWTH Aachen, Med Fac, Aachen, Germany; [Stoppe, Christian] Univ Hosp RWTH Aachen, Dept Intens Care Med, Aachen, Germany; [Boor, Peter] Univ Hosp RWTH Aachen, Inst Pathol, Aachen, Germany; [Pfister, David; Heidenreich, Axel] Univ Hosp Cologne, Dept Urol, Cologne, Germany; [Christ, Hildegard; Hellmich, Martin] Univ Cologne, IMSIE, Cologne, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of Cologne; University of Cologne	Fahlenkamp, AV (corresponding author), Univ Hosp RWTH Aachen, Dept Anesthesiol, Aachen, Germany.	astrid.fahlenkamp@charite.de	Boor, Peter/C-7707-2011	Boor, Peter/0000-0001-9921-4284; Hellmich, Martin/0000-0001-5174-928X; Christ, Hildegard/0000-0003-3235-2994; Schaefer, Patrick/0000-0001-5301-4092; Kowark, Ana/0000-0002-7433-8675	German Research Foundation (DFG) [FA 1048/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a project grant (FA 1048/2-1) from the German Research Foundation (DFG), http://www.dfg.de, to Dr. Fahlenkamp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi D, 2015, LANCET NEUROL; Azzopardi D, 2013, ARCH DIS CHILD-FETAL, V98, pF437, DOI 10.1136/archdischild-2013-303786; Baumert JH, 2007, ANESTH ANALG, V105, P1200, DOI 10.1213/01.ane.0000284697.73471.9c; Bito H, 1997, ANESTHESIOLOGY, V86, P1231, DOI 10.1097/00000542-199706000-00003; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; De Deken J, 2016, CRIT CARE MED; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Goto T, 2003, ANESTHESIOLOGY, V98, P1, DOI 10.1097/00000542-200301000-00002; Han JS, 2011, AM J KIDNEY DIS, V58, P846, DOI 10.1053/j.ajkd.2011.07.021; Hein M, 2010, ACTA ANAESTH SCAND, V54, P470, DOI 10.1111/j.1399-6576.2009.02116.x; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jia P, 2013, ANESTHESIOLOGY, V119, P621, DOI 10.1097/ALN.0b013e318298e5f1; Ko JS, 2012, TRANSPL P, V44, P442, DOI 10.1016/j.transproceed.2012.01.016; Kork F, 2015, ANESTHESIOLOGY, V123, P1301, DOI 10.1097/ALN.0000000000000891; Laitio R, 2016, JAMA-J AM MED ASSOC, V315, P1120, DOI 10.1001/jama.2016.1933; Lane BR, 2015, EUR UROL, V68, P996, DOI 10.1016/j.eururo.2015.04.043; Law LSC, 2016, ANESTH ANALG, V122, P678, DOI 10.1213/ANE.0000000000000914; Lee HT, 2007, AM J NEPHROL, V27, P416, DOI 10.1159/000105124; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Ma DQ, 2009, J AM SOC NEPHROL, V20, P713, DOI 10.1681/ASN.2008070712; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; McWilliam A, 2009, ANAEST INTENS CARE M, V10, P296, DOI 10.1016/j.mpaic.2009.03.004; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mio Y, 2009, ANESTH ANALG, V108, P858, DOI 10.1213/ane.0b013e318192a520; Rizvi M, 2010, EXP BIOL MED, V235, P886, DOI 10.1258/ebm.2010.009366; Sanders RD, 2004, BRIT MED BULL, V71, P115, DOI 10.1093/bmb/ldh034; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Stoppe C, 2013, BRIT J ANAESTH, V111, P406, DOI 10.1093/bja/aet072; Stoppe C, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-12; Story DA, 2001, ANESTHESIOLOGY, V95, P842, DOI 10.1097/00000542-200110000-00010; Teixeira S, 2007, TRANSPL P, V39, P2486, DOI 10.1016/j.transproceed.2007.07.038; Thomas AA, 2011, UROLOGY, V77, P5, DOI 10.1016/j.urology.2010.05.004; Traynor J, 2006, BMJ-BRIT MED J, V333, P733, DOI 10.1136/bmj.38975.390370.7C; Varon J, 2008, VASC HEALTH RISK MAN, V4, P615, DOI 10.2147/VHRM.S2471; Wappler F, 2007, ANESTHESIOLOGY, V106, P463, DOI 10.1097/00000542-200703000-00010; Weber NC, 2006, BRIT J ANAESTH, V97, P298, DOI 10.1093/bja/ael153; Yossepowitch O, 2006, J UROLOGY, V176, P1339, DOI 10.1016/j.juro.2006.06.046; Zhang L, 2011, LIFE SCI, V88, P1102, DOI 10.1016/j.lfs.2011.04.004; Zhao H, 2013, AM J TRANSPLANT, V13, P2006, DOI 10.1111/ajt.12293; Zhao HL, 2014, KIDNEY INT, V85, P112, DOI 10.1038/ki.2013.334; Zhao HL, 2013, FASEB J, V27, P4076, DOI 10.1096/fj.13-232173; Znaor A, 2015, EUR UROL, V67, P519, DOI 10.1016/j.eururo.2014.10.002	46	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181022	10.1371/journal.pone.0181022	http://dx.doi.org/10.1371/journal.pone.0181022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719609	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400028
J	Itoh, Y; Voskuhl, RR				Itoh, Yuichiro; Voskuhl, Rhonda R.			Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease	PLOS ONE			English	Article							REGIONAL HIPPOCAMPAL ATROPHY; COGNITIVE DEFICITS; COMPLEMENT-SYSTEM; BRAINNET EUROPE; ACTIVATION; C1Q; ENCEPHALOMYELITIS; NEUROINFLAMMATION; MECHANISMS; MICROGLIA	Drug repurposing is an efficient approach in new treatment development since it leverages previous work from one disease to another. While multiple sclerosis (MS), Parkinson's disease (PD), and Alzheimer's disease (AD) are all neurodegenerative diseases of the central nervous system (CNS) and differ in many clinical and pathological aspects, it is possible that they may share some mechanistic features. We hypothesized that focusing on gene expression in a CNS cell type specific manner might uncover similarities between diseases that could be missed using whole tissue gene expression analyses. We found similarities and differences in gene expression in these three distinct diseases, depending upon cell type. Microglia genes were increased in all three diseases, and gene expression levels were correlated strongly among these three neurodegenerative diseases. In astrocytes and endothelia, upregulation and correlations were observed only between MS and PD, but not AD. Neuronal genes were down-regulated in all three diseases, but correlations of changes of individual genes between diseases were not strong. Oligodendrocyte showed gene expression changes that were not shared among the three diseases. Together these data suggest that treatments targeting microglia are most amenable to drug repurposing in MS, PD, and AD, while treatments targeting other CNS cells must be tailored to each disease.	[Itoh, Yuichiro; Voskuhl, Rhonda R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Voskuhl, RR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	rvoskuhl@mednet.ucla.edu			Conrad N. Hilton Foundation [20130231, 20150232]; NIH [R01NS096748]; California Community Foundation [BAPP-15-118094]; Tom Sherak MS Hope Foundation	Conrad N. Hilton Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Community Foundation; Tom Sherak MS Hope Foundation	This work was supported by grants from the Conrad N. Hilton Foundation (Grants #20130231 & #20150232), NIH grant R01NS096748, and California Community Foundation Grant #BAPP-15-118094 (each to R.V.), and funding from the Tom Sherak MS Hope Foundation.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Biundo R, 2011, J NEUROL SCI, V310, P64, DOI 10.1016/j.jns.2011.08.001; Bowen JD, 1998, CLIN PHARMACOL THER, V64, P339, DOI 10.1016/S0009-9236(98)90183-7; Chanaday NL, 2016, NEUROSCIENCE, V314, P160, DOI 10.1016/j.neuroscience.2015.11.060; Chen ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5486; De Virgilio A, 2016, AUTOIMMUN REV, V15, P1005, DOI 10.1016/j.autrev.2016.07.022; Depboylu C, 2011, J NEUROIMMUNOL, V236, P39, DOI 10.1016/j.jneuroim.2011.05.006; DIETZSCHOLD B, 1995, J NEUROL SCI, V130, P11, DOI 10.1016/0022-510X(94)00269-T; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Durrenberger PF, 2015, J NEURAL TRANSM, V122, P1055, DOI 10.1007/s00702-014-1293-0; Durrenberger PF, 2012, ACTA NEUROPATHOL, V124, P893, DOI 10.1007/s00401-012-1027-z; Eikelenboom P, 2012, NEURODEGENER DIS, V10, P271, DOI 10.1159/000334287; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hu XZ, 2010, J LEUKOCYTE BIOL, V87, P397, DOI 10.1189/jlb.1009654; Ingram G, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-53; Lackner P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-207; LEES AJ, 1983, BRAIN, V106, P257, DOI 10.1093/brain/106.2.257; Longoni G, 2015, BRAIN STRUCT FUNCT, V220, P435, DOI 10.1007/s00429-013-0665-9; Mishra MK, 2016, NAT REV NEUROL, V12, P539, DOI 10.1038/nrneurol.2016.110; Moran LB, 2006, NEUROPATH APPL NEURO, V32, P222; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Nebes RD, 1998, J INT NEUROPSYCH SOC, V4, P426; Oertel W, 2016, J NEUROCHEM, V139, P325, DOI 10.1111/jnc.13750; Robbins TW, 2014, MOVEMENT DISORD, V29, P597, DOI 10.1002/mds.25853; Rose L M, 1997, Mult Scler, V2, P259; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sicotte NL, 2008, BRAIN, V131, P1134, DOI 10.1093/brain/awn030; Skene NG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00016; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Watkins LM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0611-x; Williams PA, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0091-6; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xiao JC, 2016, BRAIN BEHAV IMMUN, V58, P52, DOI 10.1016/j.bbi.2016.04.009; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0; Yokoyama JS, 2016, JAMA NEUROL, V73, P691, DOI 10.1001/jamaneurol.2016.0150; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	40	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181349	10.1371/journal.pone.0181349	http://dx.doi.org/10.1371/journal.pone.0181349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715462	Green Submitted, Green Published, gold			2022-12-27	WOS:000443975500047
J	Jiang, SK; Sun, SC; Bai, LM; Ding, GH; Wang, TT; Xia, TS; Jiang, H; Zhang, XJ; Zhang, FM				Jiang, Shukun; Sun, Shichen; Bai, Liangming; Ding, Guohua; Wang, Tongtong; Xia, Tianshu; Jiang, Hui; Zhang, Xijuan; Zhang, Fengming			Resequencing and variation identification of whole genome of the japonica rice variety "Longdao24" with high yield	PLOS ONE			English	Article							ORYZA-SATIVA-L.; SUPER HYBRID RICE; NUCLEOTIDE POLYMORPHISMS; READ ALIGNMENT; DRAFT SEQUENCE; GRAIN-YIELD; ASSOCIATION; CULTIVATION	Japonica rice mainly distributes in north of China, which accounts for more than half of the total japonica rice cultivated area of China. High yield, good grain quality and early heading date were the main breeding traits and commercial property in this region. We performed re-sequencing and genome wide variation analysis of one typical northern japonica rice variety Longdao24 and its parents (Longdao5 and Jigeng83) using the Illumina sequencing technology. 53.17 G clean bases were generated and more than 96.8% of the reads were mapped to the genomic reference sequence. An overall average effective depth of 43.67 x coverage was achieved. We identified 420,475 SNPs, 95,624 InDels, and 14,112 SVs in Longdao24 genome with the genomic sequence of the japonica cultivar Nipponbare as reference. We identified 361,117 SNPs and 81,488 InDels between Longdao24 genome and Longdao5 genome. We also detected 428,908 SNPs and 97,209 InDels between Longdao24 genome and Jigeng83 genome. Twenty-two yield related genes, twenty-two grain quality related genes and thirty-nine heading date genes were analyzed in Longdao24. The alleles of Gn1a, EP3, SCM2, Wx, ALK, OsLF and Hd17 came from the female parent Longdao5. The other alleles of qGW8, SSIVa, SBE3, SSIIIb, SSIIc, DTH2, Ehd3 and OsMADS56 came from the male parent Jigeng83. These results will help us to research the genetics basis of yield, grain quality and early heading date in northern rice of China.	[Jiang, Shukun; Sun, Shichen; Bai, Liangming; Ding, Guohua; Wang, Tongtong; Xia, Tianshu; Jiang, Hui; Zhang, Xijuan; Zhang, Fengming] Heilongjiang Acad Agr Sci, Cultivat & Farming Res Inst, Harbin, Heilongjiang, Peoples R China	Heilongjiang Academy of Agricultural Sciences	Jiang, SK (corresponding author), Heilongjiang Acad Agr Sci, Cultivat & Farming Res Inst, Harbin, Heilongjiang, Peoples R China.	sk.jiang@hotmail.com		jiang, shukun/0000-0003-3671-4665	Natural Science Foundation of Heilongjiang Province of China [C2016050]; national key research and development program of China [2016YFD030010404]; Heilongjiang Postdoctoral Financial Assistance [LBH-Q15133]; doctoral Fund of Heilongjiang Academy of Agricultural Sciences [201507-05]; special fund for China Agricultural Research System [CARS-01-43]	Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); national key research and development program of China; Heilongjiang Postdoctoral Financial Assistance; doctoral Fund of Heilongjiang Academy of Agricultural Sciences; special fund for China Agricultural Research System	This work was supported by a grant from the Natural Science Foundation of Heilongjiang Province of China (C2016050), The national key research and development program of China (2016YFD030010404), Heilongjiang Postdoctoral Financial Assistance (LBH-Q15133), the doctoral Fund of Heilongjiang Academy of Agricultural Sciences (201507-05) and the special fund for China Agricultural Research System (CARS-01-43).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Cao LY, 2010, RICE SCI, V17, P87, DOI 10.1016/S1672-6308(08)60109-2; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; [陈温福 Chen Wenfu], 2005, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V36, P3; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Gao Q, 2012, J INTEGR PLANT BIOL, V54, P215, DOI 10.1111/j.1744-7909.2012.01115.x; Gao ZY, 2013, P NATL ACAD SCI USA, V110, P14492, DOI 10.1073/pnas.1306579110; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Han B, 2013, CURR OPIN PLANT BIOL, V16, P133, DOI 10.1016/j.pbi.2013.03.006; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; IRRI, 1994, IRRI REPORTER, V4, P1; [姜树坤 JIANG Shukun], 2006, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V37, P639; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kharabian-Masouleh A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00557; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JY, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-8; Li M, 2011, PLANT BIOTECHNOL J, V9, P1002, DOI 10.1111/j.1467-7652.2011.00610.x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Ookawa T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1132; Rao YC, 2014, PLANT CELL REP, V33, P551, DOI 10.1007/s00299-013-1551-x; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tatusov RL, 2010, NUCLEIC ACIDS RES, V28, P33; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Wang JY, 2009, THEOR APPL GENET, V119, P85, DOI 10.1007/s00122-009-1019-0; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wu WX, 2013, P NATL ACAD SCI USA, V110, P2775, DOI 10.1073/pnas.1213962110; Yu GQ, 2011, MOL BIOL EVOL, V28, P659, DOI 10.1093/molbev/msq243; Yu HH, 2011, PLOS ONE, V3; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan LP, 2015, ENGINEERING, V1, P13, DOI 10.15302/J-ENG-2015021	38	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181037	10.1371/journal.pone.0181037	http://dx.doi.org/10.1371/journal.pone.0181037			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715430	Green Published, gold, Green Submitted			2022-12-27	WOS:000443975500024
J	Zufferey, R; Pirani, K; Cheung-See-Kit, M; Lee, S; Williams, TA; Chen, DG; Hossain, MF				Zufferey, Rachel; Pirani, Karim; Cheung-See-Kit, Melanie; Lee, Sungsu; Williams, Tyler A.; Chen, Daniel G.; Hossain, Md Faruk			The Trypanosoma brucei dihydroxyacetonephosphate acyltransferase TbDAT is dispensable for normal growth but important for synthesis of ether glycerophospholipids	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; CHONDRODYSPLASIA PUNCTATA TYPE-2; LEISHMANIA-MAJOR PROMASTIGOTES; PHOSPHATE ACYLTRANSFERASE; BLOOD-STREAM; PHOSPHATIDYLETHANOLAMINE SYNTHESIS; SACCHAROMYCES-CEREVISIAE; LIPID-METABOLISM; KENNEDY PATHWAY; INITIAL STEP	Glycerophospholipids are the most abundant constituents of biological membranes in Trypanosoma brucei, which causes sleeping sickness in humans and nagana in cattle. They are essential cellular components that fulfill various important functions beyond their structural role in biological membranes such as in signal transduction, regulation of membrane trafficking or control of cell cycle progression. Our previous studies have established that the glycerol-3-phosphate acyltransferase TbGAT is dispensable for growth, viability, and ester lipid biosynthesis suggesting the existence of another initial acyltransferase(s). This work presents the characterization of the alternative, dihydroxyacetonephosphate acyltransferase TbDAT, which acylates primarily dihydroxyacetonephosphate and prefers palmitoyl-CoA as an acyl-CoA donor. TbDAT restores the viability of a yeast double null mutant that lacks glycerol-3-phosphate and dihydroxyacetonephosphate acyltransferase activities. A conditional null mutant of TbDAT in T. brucei procyclic form was created and characterized. TbDAT was important for survival during stationary phase and synthesis of ether lipids. In contrast, TbDAT was dispensable for normal growth. Our results show that in T. brucei procyclic forms i) TbDAT but not TbGAT is the physiologically relevant initial acyltransferase and ii) ether lipid precursors are primarily made by TbDAT.	[Zufferey, Rachel; Pirani, Karim] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Zufferey, Rachel; Cheung-See-Kit, Melanie; Lee, Sungsu; Williams, Tyler A.; Chen, Daniel G.; Hossain, Md Faruk] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA	Kansas State University; Saint John's University	Zufferey, R (corresponding author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.; Zufferey, R (corresponding author), St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA.	zufferer@stjohns.edu	Hossain, Faruk/J-4741-2019	Hossain, Faruk/0000-0002-3457-7903; zufferey, rachel/0000-0003-1200-3914; Cheung See Kit, Melanie/0000-0002-0511-1506	National Institute of Health [SC3GM113743, T36GM101995]; National Science Foundation [EPS 0236913, MCB 0455318, DBI 0521587]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health [P20RR16475]; Kansas State University	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University	This work was supported by the National Institute of Health, SC3GM113743 to RZ, (https://www.nih.gov); National Institute of Health, T36GM101995 to RZ (https://www.nih.gov/); The lipid analyses described in this work were performed at the Kansas Lipidomics Research Center Analytical Laboratory. Instrument acquisition and method development at the Kansas Lipidomics Research Center was supported by National Science Foundation (EPS 0236913, MCB 0455318, DBI 0521587; https://www.nsf.gov), Kansas Technology Enterprise Corporation (http://cdm16884.contentdm.oclc.org/ui/custom/default/collection/default/resources/custompages/ag), K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health (P20RR16475; https://www.nih.gov), and Kansas State University (http://www.k-state.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ani GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027802; BATES EJ, 1979, BIOCHEM J, V182, P751, DOI 10.1042/bj1820751; Biermann J, 1999, EUR J BIOCHEM, V261, P492, DOI 10.1046/j.1432-1327.1999.00295.x; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Butikofer P, 1999, J CELL SCI, V112, P1785; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Cronan JE, 2006, CELL, V126, P641, DOI 10.1016/j.cell.2006.08.001; D'Antonio EL, 2013, ARCH BIOCHEM BIOPHYS, V535, P163, DOI 10.1016/j.abb.2013.03.015; Dorninger F, 2015, BBA-MOL CELL BIOL L, V1851, P117, DOI 10.1016/j.bbalip.2014.11.005; Elias ER, 1998, AM J MED GENET, V80, P223, DOI 10.1002/(SICI)1096-8628(19981116)80:3<223::AID-AJMG9>3.0.CO;2-X; Farine L, 2013, BBA-MOL CELL BIOL L, V1831, P533, DOI 10.1016/j.bbalip.2012.09.008; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Hajra AK, 1997, BBA-LIPID LIPID MET, V1348, P27, DOI 10.1016/S0005-2760(97)00120-3; Heise N, 1997, MOL BIOCHEM PARASIT, V89, P61, DOI 10.1016/S0166-6851(97)00101-1; JONES CL, 1983, ARCH BIOCHEM BIOPHYS, V226, P155, DOI 10.1016/0003-9861(83)90280-1; KELLEHER M, 1992, P NATL ACAD SCI USA, V89, P6, DOI 10.1073/pnas.89.1.6; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Lee JH, 2007, EUKARYOT CELL, V6, P641, DOI 10.1128/EC.00411-06; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Liu DL, 2005, J LIPID RES, V46, P727, DOI 10.1194/jlr.M400364-JLR200; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Ofman R, 1998, HUM MOL GENET, V7, P847, DOI 10.1093/hmg/7.5.847; OPPERDOES FR, 1984, FEBS LETT, V169, P35, DOI 10.1016/0014-5793(84)80284-7; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; PARKER HL, 1995, MOL BIOCHEM PARASIT, V69, P269, DOI 10.1016/0166-6851(94)00208-5; Patel N, 2016, J EUKARYOT MICROBIOL, V63, P598, DOI 10.1111/jeu.12309; PATNAIK PK, 1993, MOL BIOCHEM PARASIT, V58, P97, DOI 10.1016/0166-6851(93)90094-E; Ramakrishnan S, 2013, PROG LIPID RES, V52, P488, DOI 10.1016/j.plipres.2013.06.003; Richmond GS, 2010, PARASITOLOGY, V137, P1357, DOI 10.1017/S0031182010000715; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; Serricchio M, 2011, FEBS J, V278, P1035, DOI 10.1111/j.1742-4658.2011.08012.x; Signorell A, 2008, J BIOL CHEM, V283, P23636, DOI 10.1074/jbc.M803600200; Signorell A, 2009, MOL MICROBIOL, V72, P1068, DOI 10.1111/j.1365-2958.2009.06713.x; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; SWINKELS BW, 1986, EMBO J, V5, P1291, DOI 10.1002/j.1460-2075.1986.tb04358.x; Sztriha L, 2000, DEV MED CHILD NEUROL, V42, P492, DOI 10.1017/S0012162200000918; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Vertommen D, 2008, MOL BIOCHEM PARASIT, V158, P189, DOI 10.1016/j.molbiopara.2007.12.008; VISSER N, 1980, EUR J BIOCHEM, V103, P623, DOI 10.1111/j.1432-1033.1980.tb05988.x; Watschinger K, 2013, BIOCHIMIE, V95, P59, DOI 10.1016/j.biochi.2012.06.027; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200; Zomer AWM, 1999, MOL BIOCHEM PARASIT, V104, P55, DOI 10.1016/S0166-6851(99)00141-3; ZOMER AWM, 1995, BBA-LIPID LIPID MET, V1257, P167, DOI 10.1016/0005-2760(95)00066-L; Zufferey R, 2006, J BIOL CHEM, V281, P7952, DOI 10.1074/jbc.M512911200; Zufferey R, 2005, MOL MICROBIOL, V56, P800, DOI 10.1111/j.1365-2958.2005.04579.x; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200; Zufferey R, 2009, MOL BIOCHEM PARASIT, V168, P177, DOI 10.1016/j.molbiopara.2009.08.006	54	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181432	10.1371/journal.pone.0181432	http://dx.doi.org/10.1371/journal.pone.0181432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715456	Green Published, gold, Green Submitted			2022-12-27	WOS:000443975500055
J	Zhang, CB; Lin, CJ; Fu, FY; Zhong, XF; Peng, B; Yan, H; Zhang, JY; Zhang, WL; Wang, PN; Ding, XY; Zhang, W; Zhao, LM				Zhang, Chunbao; Lin, Chunjing; Fu, Fuyou; Zhong, Xiaofang; Peng, Bao; Yan, Hao; Zhang, Jingyong; Zhang, Weilong; Wang, Pengnian; Ding, Xiaoyang; Zhang, Wei; Zhao, Limei			Comparative transcriptome analysis of flower heterosis in two soybean F1 hybrids by RNA-seq	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS-THALIANA; WATER-STRESS; RICE; CULTIVARS; METALLOENDOPEPTIDASE; IDENTIFICATION; SECRETION; REVEALS; GENOMES	Heterosis has been widely exploited as an approach to enhance crop traits during breeding. However, its underlying molecular genetic mechanisms remain unclear. Recent advances in RNA sequencing technology (RNA-seq) have provided an opportunity to conduct transcriptome profiling for heterosis studies. We used RNA-seq to analyze the flower transcriptomes of two F1 hybrid soybeans (HYBSOY-1 and HYBSOY-5) and their parents. More than 385 million high-quality reads were generated and aligned against the soybean reference genome. A total of 681 and 899 genes were identified as being differentially expressed between HYBSOY-1 and HYBSOY-5 and their parents, respectively. These differentially expressed genes (DEGs) were categorized into four major expression categories with 12 expression patterns. Furthermore, gene ontology (GO) term analysis showed that the DEGs were enriched in the categories metabolic process and catalytic activity, while Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis found that metabolic pathway and biosynthesis of secondary metabolites were enriched in the two F1 hybrids. Comparing the DEGs of the two F1 hybrids by GO term and KEGG pathway analyses identified 26 common DEGs that showed transgressive up-regulation, and which could be considered potential candidate genes for heterosis in soybean F1 hybrids. This identification of an extensive transcriptome dataset gives a comprehensive overview of the flower transcriptomes in two F1 hybrids, and provides useful information for soybean hybrid breeding. These findings lay the foundation for future studies on molecular mechanisms underlying soybean heterosis.	[Zhang, Chunbao; Lin, Chunjing; Peng, Bao; Yan, Hao; Zhang, Jingyong; Zhang, Weilong; Wang, Pengnian; Ding, Xiaoyang; Zhang, Wei; Zhao, Limei] Jilin Acad Agr Sci, Soybean Res Inst, Natl Engn Res Ctr Soybean, Changchun, Peoples R China; [Fu, Fuyou] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Zhong, Xiaofang] Jilin Acad Agr Sci, Agrobiotechnol Inst, Changchun, Peoples R China	Jilin Academy of Agricultural Sciences; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Jilin Academy of Agricultural Sciences	Zhao, LM (corresponding author), Jilin Acad Agr Sci, Soybean Res Inst, Natl Engn Res Ctr Soybean, Changchun, Peoples R China.	l_mzhao@126.com	; Fu, Fuyou/B-9754-2016	Zhang, Chunbao/0000-0001-9344-9162; Fu, Fuyou/0000-0002-5020-4496	National Key Research and Development Program of China [2016YFD0101500, 2016YFD0101502]; Returned Overseas Scholars Innovative Entrepreneurship Project of Jilin Province [2014-2]; National Natural Science Foundation of China [31601322]	National Key Research and Development Program of China; Returned Overseas Scholars Innovative Entrepreneurship Project of Jilin Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program of China (2016YFD0101500, 2016YFD0101502), the Returned Overseas Scholars Innovative Entrepreneurship Project of Jilin Province (2014-2), and the National Natural Science Foundation of China (31601322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bakir Y., 2016, PLANT GENOME, V9; Bao JY, 2005, PLANT PHYSIOL, V138, P1216, DOI 10.1104/pp.105.060988; Bruce A. B., 1910, Science New York N S, V32, DOI 10.1126/science.32.827.627-a; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; Davenport CB, 1908, SCIENCE, V28, P454, DOI 10.1126/science.28.718.454-b; Delorme VGR, 2000, PLANT PHYSIOL, V123, P917, DOI 10.1104/pp.123.3.917; Ferro ES, 1999, DNA CELL BIOL, V18, P781, DOI 10.1089/104454999314926; Fujimoto R, 2012, P NATL ACAD SCI USA, V109, P7109, DOI 10.1073/pnas.1204464109; Ge XM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-114; GRAHAM TL, 1991, PLANT PHYSIOL, V95, P594, DOI 10.1104/pp.95.2.594; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Hoecker N, 2005, THEOR APPL GENET, V112; Huang XH, 2016, NATURE, V537, P629, DOI 10.1038/nature19760; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marino G, 2014, BIOCHEM J, V457, P335, DOI 10.1042/BJ20130196; Meyer RC, 2004, PLANT PHYSIOL, V134, P1813, DOI 10.1104/pp.103.033001; Palmer RG, 2010, PLANT BREEDING REV, V21, P263; Pueppke SG, 1998, PLANT PHYSIOL, V117, P599, DOI 10.1104/pp.117.2.599; Nguyen QT, 2016, CURR GENOMICS, V17, P241, DOI 10.2174/1389202917666160202220238; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; SHULL G.H., 1908, J HERED, V4, P296; Song GS, 2010, MOL PLANT, V3, P1012, DOI 10.1093/mp/ssq046; SUN H, 1994, CHINESE SCI BULL, V39, P175; Sun H, 1994, P WORLD SOYB RES C 5; Thiemann A, 2010, THEOR APPL GENET, V120, P401, DOI 10.1007/s00122-009-1189-9; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsukuba T, 1998, J BIOL CHEM, V273, P35260, DOI 10.1074/jbc.273.52.35260; Turktas M, 2015, TURK J AGRIC FOR, V39, P361, DOI 10.3906/tar-1409-93; Wang HG, 2007, THEOR APPL GENET, V115, P1109, DOI 10.1007/s00122-007-0637-7; Wang HG, 2007, J INTEGR PLANT BIOL, V49, P1455, DOI 10.1111/j.1672-9072.2007.00553.x; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Wu Y, 2016, J INTEGR PLANT BIOL, V58, P150, DOI 10.1111/jipb.12357; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhang HY, 2008, MOL PLANT, V1, P720, DOI 10.1093/mp/ssn022; Zhang X, 2009, GENETICS, V182, P943, DOI 10.1534/genetics.109.103499; Zhao L., 2004, CHINESE J OIL CROP S, V3, P4	51	13	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e181061	10.1371/journal.pone.0181061	http://dx.doi.org/10.1371/journal.pone.0181061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708857	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800038
J	Shi, YY; Li, YQ; Wang, JJ; Wang, CJ; Fan, JJ; Zhao, JZ; Yin, L; Liu, XJ; Zhang, DD; Li, LL				Shi, Yuanyuan; Li, Yuqian; Wang, Jinjin; Wang, Chongjian; Fan, Jingjing; Zhao, Jingzhi; Yin, Lei; Liu, Xuejiao; Zhang, Dongdong; Li, Linlin			Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes	PLOS ONE			English	Article							SUBUNIT-RELATED PROTEIN; BETA-CELL FUNCTION; PLASMA-GLUCOSE; GENETIC-LOCI; INSULIN-SECRETION; CONFIDENCE-INTERVAL; ETHNIC-DIFFERENCES; GENOMIC LOCI; P VALUE; RISK	Objective To collectively evaluate the association of glucose-6-phosphatase catalytic unit 2 (G6PC2) allele variants with elevated fasting glucose (FG) and type 2 diabetes (T2D). Design Meta-analysis Data sources PubMed, Web of Knowledge and Embase databases. Study selection Full text articles of studies that identified an association of G6PC2 with T2D and elevated FG. Patient involvement There was no T2D patient involvement in the analyses on the association of FG with G6PC2, there were T2D patients and non-diabetes patient involvement in the analyses on the association of T2D with G6PC2. Statistical analysis Random-effects meta-analyses were used to calculate the pool effect sizes. I-2 metric and H-2 tests were used to calculate the heterogeneity. Begg's funnel plot and Egger's linear regression test were done to assess publication bias. Results Of the 423 studies identified, 21 were eligible and included. Data on three loci (rs560887, rs16856187 and rs573225) were available. The G allele at rs560887 in three ethnicities, the C allele at rs16856187 and the A allele at rs573225 all had a positive association with elevated FG. Per increment of G allele at rs560887 and A allele at rs573225 resulted in a FG 0.070 mmol/l and 0.075 mmol/l higher (beta(95% CI) = 0.070 (0.060, 0.079), p = 4.635e-50 and 0.075 (0.065, 0.085), p = 5.856e-48, respectively). With regard to the relationship of rs16856187 and FG, an increase of 0.152 (95% CI: 0.034-0.270; p = 0.011) and 0.317 (95% CI: 0.193-0.442, p = 6.046e-07) was found in the standardized mean difference (SMD) of FG for the AC and CC genotypes, respectively, when compared with the AA reference genotype. However, the G-allele of rs560887 in Caucasians under the additive model and the C-allele of rs16856187 under the allele and dominant models were associated with a decreased risk of T2D (OR (95% CI) = 0.964 (0.947, 0.981), p = 0.570e-4; OR (95% CI) = 0.892 (0.832, 0.956), p = 0.001; and OR (95% CI) = 0.923(0.892, 0.955), p = 5.301e-6, respectively). Conclusions Our meta-analyses demonstrate that all three allele variants of G6PC2 (rs560887, rs16856187 and rs573225) are associated with elevated FG, with two variants (rs560887 in the Caucasians subgroup and rs16856187 under the allele and dominant model) being associated with T2D as well. Further studies utilizing larger sample sizes and different ethnic populations are needed to extend and confirm these findings.	[Shi, Yuanyuan; Wang, Chongjian; Fan, Jingjing; Liu, Xuejiao; Zhang, Dongdong; Li, Linlin] Zhengzhou Univ, Dept Epidemiol & Biostat, Coll Publ Hlth, Zhengzhou, Henan, Peoples R China; [Li, Yuqian] Zhengzhou Univ, Sch Pharmaceut Sci, Dept Clin Pharmacol, Zhengzhou, Henan, Peoples R China; [Wang, Jinjin] Henan Univ Tradit Chinese Med, Ctr Prevent Med Res & Assessment, Discipline Publ Hlth & Prevent Med, Zhengzhou, Henan, Peoples R China; [Zhao, Jingzhi; Yin, Lei] Mil Hosp Henan Prov, Dept Endocrinol, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Henan University of Traditional Chinese Medicine	Li, LL (corresponding author), Zhengzhou Univ, Dept Epidemiol & Biostat, Coll Publ Hlth, Zhengzhou, Henan, Peoples R China.	lilinlin@zzu.edu.cn		Wang, Chongjian/0000-0001-5091-6621	National Natural Science Foundation of China [81502879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The author LLL was supported by the National Natural Science Foundation of China (grant no 81502879). The funder National Natural Science Foundation had a role in the decision to publish and preparation of the manuscript.	Adeva M, 2013, MITOCHONDRION, V13, P615, DOI 10.1016/j.mito.2013.08.011; Al-Daghri NM, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0897-z; Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2304; Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2090; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; Baerenwald DA, 2013, DIABETOLOGIA, V56, P1306, DOI 10.1007/s00125-013-2875-3; Barker A, 2011, DIABETES, V60, P1805, DOI 10.2337/db10-1575; Benn M, 2012, J AM COLL CARDIOL, V59, P2356, DOI 10.1016/j.jacc.2012.02.043; Bonnefond A, 2009, DIABETOLOGIA, V52, P982, DOI 10.1007/s00125-009-1299-6; Borowiec M, 2012, DIABETIC MED, V29, P1465, DOI 10.1111/j.1464-5491.2012.03671.x; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2010, DIABETES, V59, P2662, DOI 10.2337/db10-0389; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Chen P, 2014, DIABETES, V63, P2551, DOI 10.2337/db13-1815; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Demirci FY, 2010, ANN NUTR METAB, V56, P59, DOI 10.1159/000268019; Dogra RS, 2006, DIABETOLOGIA, V49, P953, DOI 10.1007/s00125-006-0185-8; Dos Santos C, 2009, DIABETES, V58, P489, DOI 10.2337/db08-0587; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Edghill EL, 2009, DIABETIC MED, V26, P113, DOI 10.1111/j.1464-5491.2008.02618.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ezzidi I, 2009, DIABETES METAB, V35, P214, DOI 10.1016/j.diabet.2008.12.002; Florez JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044424; Ghosh S, 1996, DIABETES, V45, P1, DOI 10.2337/diabetes.45.1.1; Grimsby JL, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-30; Heni M, 2010, J CLIN ENDOCR METAB, V95, pE479, DOI 10.1210/jc.2010-0860; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horikoshi M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005230; Hosokawa H, 1997, DIABETOLOGIA, V40, P392, DOI 10.1007/s001250050692; Hruby A, 2013, J NUTR, V143, P345, DOI 10.3945/jn.112.172049; Hu C, 2009, DIABETOLOGIA, V52, P451, DOI 10.1007/s00125-008-1241-3; Hu CX, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013318, 10.1371/journal.pone.0015542]; Huopio H, 2013, EUR J ENDOCRINOL, V169, P291, DOI 10.1530/EJE-13-0286; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Jensen CC, 2002, DIABETES, V51, P2170, DOI 10.2337/diabetes.51.7.2170; Jiang GZ, 2016, KIDNEY INT, V89, P411, DOI 10.1016/j.kint.2015.09.001; Kelliny C, 2009, DIABETES, V58, P2939, DOI 10.2337/db09-0374; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Langlois C, 2016, SCI REP-UK, V6, DOI 10.1038/srep36202; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Li X, 2009, DIABETES, V58, P2946, DOI 10.2337/db09-0228; Little J, 2009, EUR J CLIN INVEST, V39, P247, DOI 10.1111/j.1365-2362.2009.02125.x; Ma JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149940; Mahajan A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004876; Marcolongo P, 2013, BBA-GEN SUBJECTS, V1830, P2608, DOI 10.1016/j.bbagen.2012.12.013; Mittlbock M, 2006, STAT MED, V25, P4321, DOI 10.1002/sim.2692; Nettleton JA, 2013, AM J EPIDEMIOL, V177, P103, DOI 10.1093/aje/kws297; O'Brien RM, 2013, CURR DIABETES REP, V13, P768, DOI 10.1007/s11892-013-0422-8; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000312; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Petrolonis AJ, 2004, J BIOL CHEM, V279, P13976, DOI 10.1074/jbc.M307756200; Piche ME, 2004, DIABETES CARE, V27, P2470, DOI 10.2337/diacare.27.10.2470; Pound LD, 2013, DIABETES, V62, P1547, DOI 10.2337/db12-1067; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; Rasmussen-Torvik LJ, 2012, GENET EPIDEMIOL, V36, P384, DOI 10.1002/gepi.21632; Rasmussen-Torvik LJ, 2011, DIABETES, V60, P331, DOI 10.2337/db10-0839; Rees SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024710; Reiling E, 2009, DIABETOLOGIA, V52, P1866, DOI 10.1007/s00125-009-1413-9; Renstrom F, 2011, DIABETES, V60, P345, DOI 10.2337/db10-0933; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; Rose CS, 2009, DIABETOLOGIA, V52, P2122, DOI 10.1007/s00125-009-1463-z; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sanda S, 2013, ACTA DIABETOL, V50, P459, DOI 10.1007/s00592-012-0389-y; Service SK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004147; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Tam CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011428; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Torrens JI, 2004, DIABETES CARE, V27, P354, DOI 10.2337/diacare.27.2.354; van de Bunt M, 2010, CURR DIABETES REP, V10, P452, DOI 10.1007/s11892-010-0150-2; Wang HS, 2013, 2013 6TH INTERNATIONAL CONFERENCE ON INTELLIGENT NETWORKS AND INTELLIGENT SYSTEMS (ICINIS), P1, DOI 10.1109/ICINIS.2013.7; Wang Y, 2007, DIABETOLOGIA, V50, P774, DOI 10.1007/s00125-006-0564-1; Weber MB, 2012, ANNU REV NUTR, V32, P417, DOI 10.1146/annurev-nutr-071811-150630; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Yang QH, 1999, EPIDEMIOLOGY, V10, P167, DOI 10.1097/00001648-199903000-00014; Zheng C, 2015, OBESITY, V23, P1022, DOI 10.1002/oby.21030	80	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181232	10.1371/journal.pone.0181232	http://dx.doi.org/10.1371/journal.pone.0181232			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704540	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700112
J	Ruscitti, P; Ursini, F; Cipriani, P; Liakouli, V; Carubbi, F; Berardicurti, O; De Sarro, G; Giacomelli, R				Ruscitti, Piero; Ursini, Francesco; Cipriani, Paola; Liakouli, Vasiliki; Carubbi, Francesco; Berardicurti, Onorina; De Sarro, Giovambattista; Giacomelli, Roberto			Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study	PLOS ONE			English	Article							BODY INSULIN SENSITIVITY; IMPAIRED FASTING GLUCOSE; DISEASE-ACTIVITY; CARDIOVASCULAR-DISEASE; REDUCED INCIDENCE; AMERICAN-COLLEGE; MELLITUS RISK; PREVALENCE; RESISTANCE; ABATACEPT	Objectives Despite of the European League Against Rheumatism (EULAR) provided different sets of recommendations for the management of cardiovascular risk in inflammatory arthritis patients, it must be pointed out that cardiometabolic comorbidity, such as type 2 diabetes (T2D), remains still underdiagnosed and undertreated in patients affected by rheumatoid arthritis (RA). Methods In this work, we designed a single centre, prospective study in order to better investigate the occurrence of T2D during the course of 1 year of follow-up. Furthermore, we evaluated the role of both traditional cardiovascular and RA-specific related risk factors to predict the occurrence of new T2D. Results In this study, we evaluated 439 consecutive RA patients and we observed that 7.1% of our patients (31/439) developed T2D, after 12 month of prospective follow-up. The regression analysis showed that the presence of high blood pressure, the impaired fasting glucose (IFG) at the first observation and the poor EULAR-DAS28 response, after 12 months of follow-up, were significantly associated with an increased likelihood of being classified as T2D. Similarly, we observed that 7.7% of our patients (34/439) showed IFG after 12 months of prospective follow-up. The regression analysis showed that the presence of high blood pressure and the poor EULAR-DAS28 response after 12 months of follow-up, were significantly associated with an increased likelihood of showing IFG. Conclusions Our study supports the hypothesis of a significant short-term risk of T2D in RA patients and of a close associations between uncontrolled disease activity and glucose metabolism derangement. Further multicentre, randomised-controlled studies are surely needed in order to elucidate these findings and to better ascertain the possible contribution of different therapeutic regimens to reduce this risk.	[Ruscitti, Piero; Cipriani, Paola; Liakouli, Vasiliki; Carubbi, Francesco; Berardicurti, Onorina; Giacomelli, Roberto] Univ Laquila, Dept Biotechnol & Appl Clin Sci, Div Rheumatol, Laquila, Italy; [Ursini, Francesco; De Sarro, Giovambattista] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy	University of L'Aquila; Magna Graecia University of Catanzaro	Ruscitti, P (corresponding author), Univ Laquila, Dept Biotechnol & Appl Clin Sci, Div Rheumatol, Laquila, Italy.	pieroruscitti@live.com	Ursini, Francesco/AAC-5725-2022; Ruscitti, Piero/K-4184-2018; Cipriani, Paola/AAC-7382-2022; Giacomelli, Roberto/AAB-9962-2022; Ursini, Francesco/K-5632-2016	Ruscitti, Piero/0000-0003-3487-8551; Liakouli, Vasiliki/0000-0002-7392-9334; Berardicurti, Onorina/0000-0002-2808-1581; Ursini, Francesco/0000-0001-8194-8642				Agca R, 2017, ANN RHEUM DIS, V76, P17, DOI 10.1136/annrheumdis-2016-209775; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Antohe JL, 2012, ARTHRIT CARE RES, V64, P215, DOI 10.1002/acr.20657; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arts EEA, 2015, ANN RHEUM DIS, V74, P998, DOI 10.1136/annrheumdis-2013-204531; Baghdadi LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117952; Boo S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176291; Carubbi F, 2016, INT J IMMUNOPATH PH, V29, P252, DOI 10.1177/0394632015593220; Ceccarelli F, 2017, CLIN EXP RHEUMATOL, V35, P24; Choi HK, 2014, NAT REV RHEUMATOL, V10, P403, DOI 10.1038/nrrheum.2014.36; Cipriani P, 2017, CLIN RHEUMATOL, V36, P251, DOI 10.1007/s10067-016-3444-1; Cipriani P, 2014, EXPERT REV CLIN IMMU, V10, P1519, DOI 10.1586/1744666X.2014.962996; Cipriani P, 2014, CLIN THER, V36, P427, DOI 10.1016/j.clinthera.2014.01.014; Crepaldi G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146991; Andrade HFD, 2016, ARCH ENDOCRIN METAB, V60, P307, DOI 10.1590/2359-3997000000149; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fransen Jaap, 2016, PLoS One, V11, pe0157360, DOI 10.1371/journal.pone.0157360; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Giacomelli R, 2016, EXPERT REV CLIN IMMU, V12, P849, DOI 10.1586/1744666X.2016.1168293; Giacomelli R, 2015, RHEUMATOLOGY, V54, P792, DOI 10.1093/rheumatology/keu398; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Hallajzadeh J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170361; Hollan I, 2015, AUTOIMMUN REV, V14, P952, DOI 10.1016/j.autrev.2015.06.004; Innala L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3442; Jiang P, 2015, CLIN EXP RHEUMATOL, V33, P115; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Levitzky YS, 2008, J AM COLL CARDIOL, V51, P264, DOI 10.1016/j.jacc.2007.09.038; Meissner Y, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1077-z; Mok CC, 2011, ARTHRIT CARE RES, V63, P195, DOI 10.1002/acr.20363; Monesi L, 2012, DIABETIC MED, V29, P385, DOI 10.1111/j.1464-5491.2011.03446.x; Muntoni S, 2009, ACTA DIABETOL, V46, P227, DOI 10.1007/s00592-008-0081-4; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nurmohamed MT, 2015, NAT REV RHEUMATOL, V11, P693, DOI 10.1038/nrrheum.2015.112; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Pincus T, 2004, ANN RHEUM DIS, V63, P32, DOI 10.1136/ard.2004.028415; Ruscitti P, 2015, CLIN EXP IMMUNOL, V182, P35, DOI 10.1111/cei.12667; Ruscitti P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170108; Ruscitti Piero, 2015, J Med Case Rep, V9, P123, DOI 10.1186/s13256-015-0603-y; Ruscitti P, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/782382; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Solomon DH, 2015, ARTHRITIS RHEUMATOL, V67, P1449, DOI 10.1002/art.39098; Ursini F, 2017, CLIN EXP RHEUMATOL, V35, P18; Ursini F, 2009, REUMATISMO, V61, P254, DOI 10.4081/reumatismo.2009.254; Ursini F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163464; Ursini F, 2016, JOINT BONE SPINE, V83, P611, DOI 10.1016/j.jbspin.2016.07.006; Ursini F, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002552; Ursini F, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000888; Ursini F, 2014, CLIN RHEUMATOL, V33, P1759, DOI 10.1007/s10067-013-2366-4; Ursini F, 2013, J PHARMACOL PHARMACO, V4, pS29, DOI 10.4103/0976-500X.120943; Ursini F, 2012, CLIN RHEUMATOL, V31, P1401, DOI 10.1007/s10067-012-2034-0; Ursini F, 2010, INT IMMUNOPHARMACOL, V10, P827, DOI 10.1016/j.intimp.2010.04.016; van Breukelen-van der Stoep DF, 2016, RHEUMATOLOGY, V55, P1210, DOI 10.1093/rheumatology/kew039; van Halm VP, 2009, ANN RHEUM DIS, V68, P1395, DOI 10.1136/ard.2008.094151; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	57	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181203	10.1371/journal.pone.0181203	http://dx.doi.org/10.1371/journal.pone.0181203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704564	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600066
J	Bhangu, J; King-Kallimanis, BL; Donoghue, OA; Carroll, L; Kenny, RA				Bhangu, Jaspreet; King-Kallimanis, Bellinda L.; Donoghue, Orna A.; Carroll, Laura; Kenny, Rose Anne			Falls, non-accidental falls and syncope in community-dwelling adults aged 50 years and older: Implications for cardiovascular assessment	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; DEPRESSIVE SYMPTOMS; RISK-FACTORS; PREVALENCE; MANAGEMENT; DIAGNOSIS; ACCIDENT	Objectives To calculate the prevalence of all falls, non-accidental falls and syncope in an older population and characterize cardiovascular risk profiles. Design Prospective, longitudinal cohort study. Setting The first two waves of data from the Irish Longitudinal Study on Ageing (TILDA). Participants 8172 community-dwelling adults aged 50 years and older resident in the Republic of Ireland Measurements Self-reported history of all falls, non-accidental falls and syncope in the year preceding the first two waves of data collection. Demographic factors and self-reported cardiovascular conditions were used to characterize cardiovascular risk profiles. Results The prevalence of all falls in the past year was 19.2% or 192 per thousand persons and increased with age (50 - 64 years 17.5%; 65 - 74 years 19.4%; 75+ years 24.4%). Non-accidental falls had an estimated prevalence of 5.1% or 51 falls per thousand persons and accounted for 26.5% of all falls reported and also increased with age (50 - 64 years 4.0%; 65 - 74 years 5.5%; 75+ years 8.0%). The prevalence for syncope was estimated to be 4.4% or 44per thousand persons but did not show a similar age gradient. Participants with at least 5 cardiovascular conditions were more likely to report all falls (OR = 2.07, 95% CI 1.18 - 3.64, p< 0.05) and NAF (OR = 2.89, 95% CI 1.28 - 6.52, p< 0.05). Conclusions The prevalence of all falls and non-accidental falls increases with age but the same pattern was not consistently observed for syncope. There is an increased odds of reporting all three outcomes with increasing number of self-reported cardiovascular conditions. Further work is needed to uncover the interplay between cardiovascular disease and subsequent falls.	[Bhangu, Jaspreet; King-Kallimanis, Bellinda L.; Donoghue, Orna A.; Carroll, Laura; Kenny, Rose Anne] Trinity Coll Dublin, Irish Longitudinal Study Ageing, Dublin, Ireland	Trinity College Dublin	Bhangu, J (corresponding author), Trinity Coll Dublin, Irish Longitudinal Study Ageing, Dublin, Ireland.	jbhangu@tcd.ie	Bhangu, Jaspreet/GRF-1191-2022	Donoghue, Orna/0000-0002-2091-3478; Kenny, Rose Anne/0000-0002-9336-8124	Atlantic Philanthropies; Irish Government; Health Research Board; Department of Health; Irish Life	Atlantic Philanthropies; Irish Government; Health Research Board; Department of Health; Irish Life	Funding for TILDA was gratefully received from the Atlantic Philanthropies (www.atlantiphilanthropes.org), the Irish Government, and the Health Research Board (www.hrb.ie). TILDA was funded by the Department of Health and Atlantic Philanthropies, along with support from Irish Life in the form of a charitable gift. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alboni P, 2015, J CARDIOVASC MED, V16, P82, DOI 10.2459/JCM.0000000000000076; [Anonymous], 2014, OLD AD FALLS FALLS O; Anpalahan M, 2012, EUR J INTERN MED, V23, pE48, DOI 10.1016/j.ejim.2011.10.010; Bhangu J, 2016, HEART; Bhangu JS, 2014, AGE AGEING; CAMPBELL A J, 1981, Age and Ageing, V10, P264, DOI 10.1093/ageing/10.4.264; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Chen Lin Y, 2006, Am J Med, V119, DOI 10.1016/j.amjmed.2006.01.029; Clark DO, 2005, J AM GERIATR SOC, V53, P1582, DOI 10.1111/j.1532-5415.2005.53485.x; Cronin H, 2010, CLIN GERIATR MED, V26, P539, DOI 10.1016/j.cger.2010.07.006; Davies AJ, 1996, AGE AGEING, V25, P362, DOI 10.1093/ageing/25.5.362; Downton J H, 1991, Aging (Milano), V3, P219; Finucane C, 2017, J AM GERIATR SOC, V65, P474, DOI 10.1111/jgs.14563; Health NIoP, 2016, METH WCCFDS; Jansen S, 2015, J AM MED DIR ASS; Jansen S, 2014, AGE AGEING; Jansen S, 2015, AGE AGEING, V44, P598, DOI 10.1093/ageing/afv017; Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116; Kenny RAM, 2001, J AM COLL CARDIOL, V38, P1491, DOI 10.1016/S0735-1097(01)01537-6; Kenny RA, 2015, EUROPACE, V17, P1325, DOI 10.1093/europace/euv115; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Menant JC, 2016, J AM GERIATR SOC, V64, P1073, DOI 10.1111/jgs.14104; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Parry SW, 2008, CLIN MED, V8, P157, DOI 10.7861/clinmedicine.8-2-157; Probst MA, 2015, AM J EMERG MED, V33, P998, DOI 10.1016/j.ajem.2015.04.030; Prudham D, 1981, Age Ageing, V10, P141; Rafanelli M, 2014, AGING CLIN EXP RES, V26, P33, DOI 10.1007/s40520-013-0124-8; Rapp K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-105; Richardson DA, 1997, PACE, V20, P820, DOI 10.1111/j.1540-8159.1997.tb03912.x; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Shaw FE, 1997, POSTGRAD MED J, V73, P635, DOI 10.1136/pgmj.73.864.635; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Whelan BJ, 2013, J AM GERIATR SOC, V61, pS265, DOI 10.1111/jgs.12199	35	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180997	10.1371/journal.pone.0180997	http://dx.doi.org/10.1371/journal.pone.0180997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC2BU	28732008	gold, Green Published, Green Submitted			2022-12-27	WOS:000406643100020
J	Chang, JH; Hsu, SC; Bai, KJ; Huang, SK; Hsu, CW				Chang, Jer-Hwa; Hsu, Shih-Chang; Bai, Kuan-Jen; Huang, Shau-Ku; Hsu, Chin-Wang			Association of time-serial changes in ambient particulate matters (PMs) with respiratory emergency cases in Taipei's Wenshan District	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OUTDOOR AIR-POLLUTION; HOSPITAL ADMISSIONS; DAILY MORTALITY; CASE-CROSSOVER; PM2.5; EXPOSURE; PARTICLES; ASTHMA; PHAGOCYTOSIS	Ambient air pollution poses a significant risk for a group of common and often debilitating respiratory diseases, but its direct impact on cause-specific respiratory diseases using emergency room visit (ERV) as an indicator remains to be fully explored. In this study, we conducted a time-series study of ambient PM2.5, NO2, SO2 and their association with ERV for asthma, COPD and pneumonia in a four-year time span. Relative risks for ERV as per log increase in the level of ambient pollutants with time lags of up to 10 days were calculated, using a generalized additive model of Poisson regression. Daily 24-h average concentrations of PM2.5 and pollutant gases were obtained from a local Gutting air quality monitoring station. Results showed that the ERVs for pneumonia and asthma were associated with the level of PM2.5. The effects of PM2.5 on the risk of ERV for asthma were found to be significant at lag days 1 and 2 with increasing risk of 4.34% [RR: 1.091; CI: 1.020-1.166 (95%)] and 3.58% [RR: 1.074; CI: 1.007-1.146 (95%)], respectively. The ERV for pneumonia was associated with the level of PM2.5 at lag days 5, 6 and 7, with increasing risk of 1.92% [RR: 1.039; CI: 1.009-1.070 (95%)], 2.03% [RR: 1.041; CI: 1.009-1.075 (95%)], and 1.82% [RR: 1.037; CI: 1.001-1.075 (95%)], respectively. Further, PM2.5, but not NO2 and SO2, posed a significant risk of ERV for asthma during spring at lag days 0, 1 and 2 (17.12%, RR: 1.408, CI: 1.075-1.238; 15.30%, RR: 1.358 CI: 1.158-1.166; 11.94%, RR: 1.165, CI: 1.004-1.121), which was particularly evident for those who were younger than 75 years of age. In contrast, only PM2.5 was a significant risk of ERV for COPD, which was primarily for those who were younger than 75 years of age during summer season at lag days 3, 4 and 5. (26.66%, RR: 1.704, CI: 1.104-2.632; 26.99%; RR: 1.716, CI: 1.151-2.557; 24.09%; RR: 1.619, CI: 1.111-2.360). Collectively, these results suggested significant seasonal variation and differential time lag effects of PM2.5 on ERV for asthma, COPD and pneumonia.	[Chang, Jer-Hwa; Bai, Kuan-Jen] Taipei Med Univ, Wan Fang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan; [Chang, Jer-Hwa; Bai, Kuan-Jen] Taipei Med Univ, Sch Resp Therapy, Coll Med, Taipei, Taiwan; [Hsu, Shih-Chang; Hsu, Chin-Wang] Taipei Med Univ, Wan Fang Hosp, Emergency Dept, Dept Emergency & Crit Med, Taipei, Taiwan; [Huang, Shau-Ku] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Zhunan, Miaoli County, Taiwan; [Huang, Shau-Ku] Shen Zhen Univ, Lou Hu Hosp, Shenzhen, Peoples R China; [Huang, Shau-Ku] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Huang, Shau-Ku] Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Hsu, Chin-Wang] Taipei Med Univ, Sch Med, Dept Emergency Med, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Health Research Institutes - Taiwan; Shenzhen University; Kaohsiung Medical University; Johns Hopkins University; Johns Hopkins Medicine; Taipei Medical University	Hsu, CW (corresponding author), Taipei Med Univ, Wan Fang Hosp, Emergency Dept, Dept Emergency & Crit Med, Taipei, Taiwan.; Hsu, CW (corresponding author), Taipei Med Univ, Sch Med, Dept Emergency Med, Coll Med, Taipei, Taiwan.	wan11119@gmail.com	Hsu, Shih-Chang/I-4277-2012	Hsu, Shih-Chang/0000-0003-1010-1182	Taipei Medical University, Taiwan [105-wf-eva-13]; Kaohsiung Medical University The Talent Plan [KMU-SH000184]; National Health Research Institutes, Taiwan [EOPP10-014, EOSP07-014]	Taipei Medical University, Taiwan; Kaohsiung Medical University The Talent Plan; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the Taipei Medical University [grant number: 105-wf-eva-13 to CWH], Taiwan and, in part, by Kaohsiung Medical University The Talent Plan (KMU-SH000184 to SKH), and by grants from National Health Research Institutes (EOPP10-014 and EOSP07-014 to SKH), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Taipei Medical University [grant number: 105-wf-eva-13 to CWH], Taiwan and, in part, by Kaohsiung Medical University The Talent Plan (KMU-SH000184 to SKH), and by grants from National Health Research Institutes (EOPP10-014 and EOSP07-014 to SKH), Taiwan.	Adar SD, 2016, ANN EPIDEMIOL, V26, P355, DOI 10.1016/j.annepidem.2016.03.010; [Anonymous], 2006, Lancet, V368, P1302; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Bates JT, 2015, ENVIRON SCI TECHNOL, V49, P13605, DOI 10.1021/acs.est.5b02967; Cheng MH, 2014, J TOXICOL ENV HEAL A, V77, P1075, DOI 10.1080/15287394.2014.922387; Dai LZ, 2014, ENVIRON HEALTH PERSP, V122, P837, DOI 10.1289/ehp.1307568; Devos S, 2016, ENVIRON INT, V94, P525, DOI 10.1016/j.envint.2016.06.012; Falcon-Rodriguez CI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00003; Gasparrini A., 2014, DISTRIBUTED LAG LINE, P1; Halonen JI, 2009, EPIDEMIOLOGY, V20, P143, DOI 10.1097/EDE.0b013e31818c7237; Heo J, 2014, EPIDEMIOLOGY, V25, P379, DOI 10.1097/EDE.0000000000000044; Huang SK, 2015, J THORAC DIS, V7, P23, DOI 10.3978/j.issn.2072-1439.2014.12.13; Hwang SL, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040366; Janssen NAH, 2013, SCI TOTAL ENVIRON, V463, P20, DOI 10.1016/j.scitotenv.2013.05.062; Lee CL, 2016, J HAZARD MATER, V314, P286, DOI 10.1016/j.jhazmat.2016.04.047; Li P, 2015, ENVIRON SCI POLLUT R, V22, P358, DOI 10.1007/s11356-014-3301-1; Lundborg M, 2006, ENVIRON RES, V100, P197, DOI 10.1016/j.envres.2005.08.007; Meng ZQ, 2006, ENVIRON TOXICOL PHAR, V22, P277, DOI 10.1016/j.etap.2006.04.005; Meszaros D, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2014-000063; Mushtaq N, 2011, J ALLERGY CLIN IMMUN, V127, P1236, DOI 10.1016/j.jaci.2010.11.039; Nakhle MM, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4409-6; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Riva DR, 2011, INHAL TOXICOL, V23, P257, DOI 10.3109/08958378.2011.566290; Roy AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085011; Song QK, 2014, INT J ENV RES PUB HE, V11, P11822, DOI 10.3390/ijerph111111822; Tsai SS, 2014, J TOXICOL ENV HEAL A, V77, P192, DOI 10.1080/15287394.2013.853337; Tsai SS, 2013, INT J ENV RES PUB HE, V10, P6015, DOI 10.3390/ijerph10116015; Tunno BJ, 2016, SCI TOTAL ENVIRON, V573, P27, DOI 10.1016/j.scitotenv.2016.08.011; Vrijens K, 2015, ENVIRON HEALTH PERSP, V123, P399, DOI 10.1289/ehp.1408459; Winquist A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-68; World Health Organization, 2013, REV EV HLTH ASP AIR, P309; Xing YF, 2016, J THORAC DIS, V8, pE69, DOI 10.3978/j.issn.2072-1439.2016.01.19; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zhang SQ, 2016, ENVIRON RES, V148, P15, DOI 10.1016/j.envres.2016.03.008; Zhou HW, 2007, AM J RESP CELL MOL, V36, P460, DOI 10.1165/rcmb.2006-0293OC	35	14	15	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181106	10.1371/journal.pone.0181106	http://dx.doi.org/10.1371/journal.pone.0181106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732014	Green Published, gold, Green Submitted			2022-12-27	WOS:000406643100022
J	Ouertatani-Sakouhi, H; Kicka, S; Chiriano, G; Harrison, CF; Hilbi, H; Scapozza, L; Soldati, T; Cosson, P				Ouertatani-Sakouhi, Hajer; Kicka, Sebastien; Chiriano, Gianpaolo; Harrison, Christopher F.; Hilbi, Hubert; Scapozza, Leonardo; Soldati, Thierry; Cosson, Pierre			Inhibitors of Mycobacterium marinum virulence identified in a Dictyostelium discoideum host model	PLOS ONE			English	Article							TUBERCULOSIS; INFECTION; SECRETION; PROTEIN; BIOSYNTHESIS; LEGIONELLA; RESISTANCE; BACTERIA; SYSTEM	Tuberculosis remains one of the major threats to public health worldwide. Given the prevalence of multi drug resistance (MDR) in Mycobacterium tuberculosis strains, there is a strong need to develop new anti-mycobacterial drugs with modes of action distinct from classical antibiotics. Inhibitors of mycobacterial virulence might target new molecular processes and may represent a potential new therapeutic alternative. In this study, we used a Dictyostelium discoideum host model to assess virulence of Mycobacterium marinum and to identify compounds inhibiting mycobacterial virulence. Among 9995 chemical compounds, we selected 12 inhibitors of mycobacterial virulence that do not inhibit mycobacterial growth in synthetic medium. Further analyses revealed that 8 of them perturbed functions requiring an intact mycobacterial cell wall such as sliding motility, bacterial aggregation or cell wall permeability. Chemical analogs of two compounds were analyzed. Chemical modifications altered concomitantly their effect on sliding motility and on mycobacterial virulence, suggesting that the alteration of the mycobacterial cell wall caused the loss of virulence. We characterized further one of the selected compounds and found that it inhibited the ability of mycobacteria to replicate in infected cells. Together these results identify new antimycobacterial compounds that represent new tools to unravel the molecular mechanisms controlling mycobacterial pathogenicity. The isolation of compounds with anti-virulence activity is the first step towards developing new antibacterial treatments.	[Ouertatani-Sakouhi, Hajer; Cosson, Pierre] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland; [Kicka, Sebastien; Soldati, Thierry] Univ Geneva, Dept Biochem, Geneva, Switzerland; [Chiriano, Gianpaolo; Scapozza, Leonardo] Univ Lausanne, Pharmaceut Biochem, Sch Pharmaceut Sci, Univ Geneva, 30 Quai Ernst Ansermet, Geneva, Switzerland; [Harrison, Christopher F.; Hilbi, Hubert] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst, Dept Med, Munich, Germany; [Hilbi, Hubert] Univ Zurich, Inst Med Microbiol, Dept Med, Gloriastr 30-32, Zurich, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Lausanne; University of Munich; University of Zurich	Cosson, P (corresponding author), Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland.	Pierre.Cosson@unige.ch	SOLDATI, Thierry/U-6494-2019; SOLDATI, Thierry/A-2902-2009; Hilbi, Hubert/AAU-5815-2020; Hill, Andrew/B-4527-2009	SOLDATI, Thierry/0000-0002-2056-7931; SOLDATI, Thierry/0000-0002-2056-7931; Hilbi, Hubert/0000-0002-5462-9301; Hill, Andrew/0000-0001-5581-2354; Scapozza, Leonardo/0000-0003-1079-648X; Cosson, Pierre/0000-0002-4881-0358	Swiss National Science Foundation Grant [CRSI33_130016]; Novartis Consumer Health Foundation; Swiss National Science Foundation Grant (SystemsX HostpathX grant)	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); Novartis Consumer Health Foundation; Swiss National Science Foundation Grant (SystemsX HostpathX grant)	This work was supported by the Swiss National Science Foundation Grant (Sinergia grant CRSI33_130016 to to PC, TS, LS, HH; SystemsX HostpathX grant to PC, TS, HH) and a grant from Novartis Consumer Health Foundation (to HOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2004, J BIOL CHEM, V279, P18824, DOI 10.1074/jbc.M400791200; Alibaud L, 2008, CELL MICROBIOL, V10, P729, DOI 10.1111/j.1462-5822.2007.01080.x; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Arafah Sonia, 2013, Methods Mol Biol, V983, P403, DOI 10.1007/978-1-62703-302-2_22; Benghezal M, 2006, CELL MICROBIOL, V8, P139, DOI 10.1111/j.1462-5822.2005.00607.x; Burguiere A, 2005, MICROBIOL-SGM, V151, P2087, DOI 10.1099/mic.0.27938-0; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; CLARK HF, 1963, J BACTERIOL, V86, P1057, DOI 10.1128/JB.86.5.1057-1069.1963; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Dong DD, 2012, INFECT IMMUN, V80, P43, DOI 10.1128/IAI.05249-11; Frasinyuk MS, 2014, BIOORG MED CHEM LETT, V24, P3546, DOI 10.1016/j.bmcl.2014.05.056; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Green KD, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00208; Hagedorn M, 2007, CELL MICROBIOL, V9, P2716, DOI 10.1111/j.1462-5822.2007.00993.x; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hagele S, 2000, CELL MICROBIOL, V2, P165, DOI 10.1046/j.1462-5822.2000.00044.x; Harrison CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074813; Hoffmann C, 2014, CELL MICROBIOL, V16, P15, DOI 10.1111/cmi.12235; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Johnson BK, 2015, ANTIMICROB AGENTS CH, V59, P4436, DOI 10.1128/AAC.00719-15; Kicka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087834; Lienhardt C, 2012, J INFECT DIS, V205, pS241, DOI 10.1093/infdis/jis034; Lima WC, 2011, SEMIN CELL DEV BIOL, V22, P77, DOI 10.1016/j.semcdb.2010.11.006; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Martinez A, 1999, J BACTERIOL, V181, P7331; Mascarello A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077081; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Mori M, 2014, BIOORG MED CHEM LETT, V24, P2508, DOI 10.1016/j.bmcl.2014.04.004; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rybniker J, 2014, CELL HOST MICROBE, V16, P538, DOI 10.1016/j.chom.2014.09.008; Solomon JM, 2003, INFECT IMMUN, V71, P3578, DOI 10.1128/IAI.71.6.3578-3586.2003; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wang QL, 2015, INFECT IMMUN, V83, P2844, DOI 10.1128/IAI.03081-14; Yu J, 2012, INFECT IMMUN, V80, P1381, DOI 10.1128/IAI.06370-11	37	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181121	10.1371/journal.pone.0181121	http://dx.doi.org/10.1371/journal.pone.0181121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727774	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500042
J	Cabrera-Becerrill, A; Vargas-De-Leon, C; Hernandez, S; Miramontes, P; Peralta, R				Cabrera-Becerrill, Augusto; Vargas-De-Leon, Cruz; Hernandez, Sergio; Miramontes, Pedro; Peralta, Raul			Modeling the dynamics of chromosomal alteration progression in cervical cancer: A computational model	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; MUTATION; PREVALENCE; NEOPLASIA; EVOLUTION; SELECTION; DISEASE; GROWTH; DRIVER; GENES	Computational modeling has been applied to simulate the heterogeneity of cancer behavior. The development of Cervical Cancer (CC) is a process in which the cell acquires dynamic behavior from non-deleterious and deleterious mutations, exhibiting chromosomal alterations as a manifestation of this dynamic. To further determine the progression of chromosomal alterations in precursor lesions and CC, we introduce a computational model to study the dynamics of deleterious and non-deleterious mutations as an outcome of tumor progression. The analysis of chromosomal alterations mediated by our model reveals that multiple deleterious mutations are more frequent in precursor lesions than in CC. Cells with lethal deleterious mutations would be eliminated, which would mitigate cancer progression; on the other hand, cells with non-deleterious mutations would become dominant, which could pre-dispose them to cancer progression. The study of somatic alterations through computer simulations of cancer progression provides a feasible pathway for insights into the transformation of cell mechanisms in humans. During cancer progression, tumors may acquire new phenotype traits, such as the ability to invade and metastasize or to become clinically important when they develop drug resistance. Non-deleterious chromosomal alterations contribute to this progression.	[Cabrera-Becerrill, Augusto; Miramontes, Pedro] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Matemat, Mexico City, DF, Mexico; [Vargas-De-Leon, Cruz] Inst Politecn Nacl, Escuela Super Med, Mexico City, DF, Mexico; [Hernandez, Sergio] Univ Autonoma Ciudad Mexico, Programa Dinam Nolineal, Mexico City, DF, Mexico; [Peralta, Raul] Univ Autonoma Estado Morelos, Ctr Invest Dinam Celular, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; Universidad Autonoma del Estado de Morelos	Peralta, R (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Dinam Celular, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico.	raul.peralta@uaem.mx	Vargas-De-León, Cruz/F-8982-2012	Vargas-De-León, Cruz/0000-0001-9428-3619; Peralta, Raul/0000-0002-6900-4101	PRODEP-SEP, Mexico; PRODEP-SEP [6986]	PRODEP-SEP, Mexico; PRODEP-SEP	This work was partially supported by PRODEP-SEP, Mexico and our wages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RP wishes to thank PRODEP-SEP 6986 for the support. The authors also wish to thank Dr. Mauricio Salcedo for his constructive comments and suggestions.	Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Alloza E, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-37; Araujo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072206; Bauer B, 2014, J THEOR BIOL, V358, P52, DOI 10.1016/j.jtbi.2014.05.018; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Brown BN, 2011, MATH BIOSCI, V231, P186, DOI 10.1016/j.mbs.2011.03.005; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Caraway NP, 2008, GYNECOL ONCOL, V110, P37, DOI 10.1016/j.ygyno.2008.01.040; Chapa J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064091; Chiacchio F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/907171; Costa JL, 2008, SEMIN RADIAT ONCOL, V18, P98, DOI 10.1016/j.semradonc.2007.10.005; Ospina MEE, 2013, ARTIF INTELL MED, V57, P31, DOI 10.1016/j.artmed.2012.11.001; Gandolfi G, 2016, PIGM CELL MELANOMA R, V29, P163, DOI 10.1111/pcmr.12436; Giaretta A, 2015, IEEE ENG MED BIO, P6493, DOI 10.1109/EMBC.2015.7319880; Hidalgo A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-77; Jalan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135183; Kang H, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00264; Koutsogiannouli E, 2013, CANCER MED-US, V2, P164, DOI 10.1002/cam4.62; Laczmanska I, 2017, CANCER GENOM PROTEOM, V14, P69, DOI 10.21873/cgp.20019; Ma LN, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-17; Martincorena I, 2013, BIOESSAYS, V35, P123, DOI 10.1002/bies.201200150; Mighty KK, 2014, RECENT RESULTS CANC, V193, P135, DOI 10.1007/978-3-642-38965-8_8; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Palaniappan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156665; Pepper John W., AGENT BASED MODELS C; Peralta-Rodriguez R, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-34; Poleszczuk J, 2014, CELL PROLIFERAT, V47, P267, DOI 10.1111/cpr.12101; Policht FA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-432; Pon JR, 2015, ANNU REV PATHOL-MECH, V10, P25, DOI 10.1146/annurev-pathol-012414-040312; Rambaldi D, 2008, TRENDS GENET, V24, P427, DOI 10.1016/j.tig.2008.06.003; Rositch AF, 2014, GYNECOL ONCOL, V132, P767, DOI 10.1016/j.ygyno.2013.12.040; Szabo A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00087; Thomas LK, 2014, EUR J CANCER, V50, P85, DOI 10.1016/j.ejca.2013.08.022; Ulam S., 1974, ANN REV BIOL, P255; Wang J, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-41; Wang N, 2014, ONCOL LETT, V7, P1279, DOI 10.3892/ol.2014.1814; Wang ZH, 2015, SEMIN CANCER BIOL, V30, P70, DOI [10.1016/j.semcancer.2014.04.001, 10.1007/978-3-662-43514-4]; Zhang L, 2009, J MATH BIOL, V58, P545, DOI 10.1007/s00285-008-0211-1; Zhang YX, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/3186051	41	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180882	10.1371/journal.pone.0180882	http://dx.doi.org/10.1371/journal.pone.0180882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723940	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800031
J	Hormes, JM; Niemiec, MA				Hormes, Julia M.; Niemiec, Martha A.			Does culture create craving? Evidence from the case of menstrual chocolate craving	PLOS ONE			English	Article							RELAPSE; ASSOCIATION; ANTECEDENTS; VALIDATION; ADDICTION; WOMEN; CYCLE	Craving is considered a key characteristic of diverse pathologies, but evidence suggests it may be a culture-bound construct. Almost 50% of American women crave chocolate specifically around the onset of menstruation. Research does not support popular accounts implicating physiological factors in menstrual chocolate craving etiology. We tested the novel hypothesis that greater menstrual craving prevalence in the U.S. is the product of internalized cultural norms. Women of diverse backgrounds (n = 275) reported on craving frequency and triggers and completed validated measures of acculturation. Foreign-born women were significantly less likely to endorse menstrual chocolate craving (17.3%), compared to women born to U.S.-born parents (32.7%, p = .03) and second generation immigrants (40.9%, p = .001). Second generation immigrant and foreign-born women endorsing menstrual chocolate craving reported significantly greater U.S. acculturation and lower identification with their native culture than non-menstrual cravers (all p < .001). Findings inform our understanding of food cravings, with important implications for the study of cravings in other domains.	[Hormes, Julia M.; Niemiec, Martha A.] SUNY Albany, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Hormes, JM (corresponding author), SUNY Albany, Albany, NY 12222 USA.	jhormes@albany.edu		Hormes, Julia/0000-0002-5693-2945				American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Berlin FS, 2014, J AM ACAD PSYCHIATRY, V42, P404; Bottlender M, 2004, ALCOHOL ALCOHOLISM, V39, P357, DOI 10.1093/alcalc/agh073; Carpenter MJ, 2006, NICOTINE TOB RES, V8, P627, DOI 10.1080/14622200600910793; Cunningham SA, 2008, HEALTH PLACE, V14, P623, DOI 10.1016/j.healthplace.2007.12.002; Epstein E. E., 2006, J SUBST USE, V11, P323, DOI DOI 10.1080/14659890500419717; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Franklin TR, 2004, NICOTINE TOB RES, V6, P171, DOI 10.1080/14622200310001656984; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Greeno CG, 2000, J CONSULT CLIN PSYCH, V68, P95, DOI 10.1037/0022-006X.68.1.95; Hormes JM, 2014, HUM HEALT HANDB, P137, DOI 10.3920/978-90-8686-767-7_9; Hormes JM, 2014, ADDICTION, V109, P2079, DOI 10.1111/add.12713; Hormes JM, 2011, APPETITE, V57, P1, DOI 10.1016/j.appet.2011.03.008; Hormes JM, 2010, ADDICT BEHAV, V35, P459, DOI 10.1016/j.addbeh.2009.12.031; Hormes JM, 2009, APPETITE, V53, P256, DOI 10.1016/j.appet.2009.07.003; JOHNSON TM, 1987, CULT MED PSYCHIAT, V11, P337, DOI 10.1007/BF00048518; Lane SP, 2016, CLIN PSYCHOL SCI, V4, P775, DOI 10.1177/2167702615616132; Luhrmann TM, 2007, CULT MED PSYCHIAT, V31, P135, DOI 10.1007/s11013-007-9049-z; Meule A., 2014, CURR ADDICT REP, V1, P193, DOI [10.1007/s40429-014-0021-z, DOI 10.1007/S40429-014-0021-Z]; Orloff NC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01076; Osman JL, 2006, APPETITE, V47, P290, DOI 10.1016/j.appet.2006.04.008; Parker S, 2003, APPETITE, V40, P193, DOI 10.1016/S0195-6663(02)00160-5; Pilver CE, 2011, J AFFECT DISORDERS, V130, P334, DOI 10.1016/j.jad.2010.10.013; Potenza MN, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00164; RODIN J, 1991, APPETITE, V17, P177, DOI 10.1016/0195-6663(91)90020-S; RODIN M, 1992, SOC SCI MED, V35, P49, DOI 10.1016/0277-9536(92)90118-A; Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0; ROZIN P, 1991, APPETITE, V17, P199, DOI 10.1016/0195-6663(91)90022-K; Serre F, 2015, DRUG ALCOHOL DEPEN, V148, P1, DOI 10.1016/j.drugalcdep.2014.12.024; Sinha R, 2007, DRUG ALCOHOL REV, V26, P25, DOI 10.1080/09595230601036960; Stephenson M, 2000, PSYCHOL ASSESSMENT, V12, P77, DOI 10.1037/1040-3590.12.1.77; Tavares H, 2005, ALCOHOL CLIN EXP RES, V29, P1427, DOI 10.1097/01.alc.0000175071.22872.98; Trotzke P, 2014, PSYCHOSOM MED, V76, P694, DOI 10.1097/PSY.0000000000000126; Waters A, 2001, INT J EAT DISORDER, V29, P17, DOI 10.1002/1098-108X(200101)29:1<17::AID-EAT3>3.0.CO;2-R; Weiss F, 2005, CURR OPIN PHARMACOL, V5, P9, DOI 10.1016/j.coph.2004.11.001; White MA, 2002, OBES RES, V10, P107, DOI 10.1038/oby.2002.17; Witkiewitz K, 2010, J CONSULT CLIN PSYCH, V78, P362, DOI 10.1037/a0019172; Zea Maria Cecilia, 2003, Cultur Divers Ethnic Minor Psychol, V9, P107, DOI 10.1037/1099-9809.9.2.107; Zellner DA, 1999, APPETITE, V33, P61, DOI 10.1006/appe.1999.0234	39	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181445	10.1371/journal.pone.0181445	http://dx.doi.org/10.1371/journal.pone.0181445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723930	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800049
J	Kong, W; Mou, XY; Deng, J; Di, BT; Zhong, RX; Wang, SQ; Yang, Y; Zeng, WM				Kong, Wei; Mou, Xiaoyang; Deng, Jin; Di, Benteng; Zhong, Ruxing; Wang, Shuaiqun; Yang, Yang; Zeng, Weiming			Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; GENE-EXPRESSION DATA; RNA-BINDING PROTEIN; NF-KAPPA-B; C-FLIP; INVERSE ASSOCIATION; MULTIPLE-SCLEROSIS; CELL-DEATH; DIFFERENTIATION; COMPLEX	Although chronic inflammation and immune disorders are of great importance to the pathogenesis of both dementia and cancer, the pathophysiological mechanisms are not clearly understood. In recent years, growing epidemiological evidence and meta-analysis data suggest an inverse association between Alzheimer's disease (AD), which is the most common form of dementia, and cancer. It has been revealed that some common genes and biological processes play opposite roles in AD and cancer; however, the biological immune mechanism for the inverse association is not clearly defined. An unsupervised matrix decomposition two-stage bioinformatics procedure was adopted to investigate the opposite behaviors of the immune response in AD and breast cancer (BC) and to discover the underlying transcriptional regulatory mechanisms. Fast independent component analysis (FastICA) was applied to extract significant genes from AD and BC microarray gene expression data. Based on the extracted data, the shared transcription factors (TFs) from AD and BC were captured. Second, the network component analysis (NCA) algorithm in this study was presented to quantitatively deduce the TF activities and regulatory influences because quantitative dynamic regulatory information for TFs is not available via microarray techniques. Based on the NCA results and reconstructed transcriptional regulatory networks, inverse regulatory processes and some known innate immune responses were described in detail. Many of the shared TFs and their regulatory processes were found to be closely related to the adaptive immune response from dramatically different directions and to play crucial roles in both AD and BC pathogenesis. From the above findings, the opposing cellular behaviors demonstrate an invaluable opportunity to gain insights into the pathogenesis of these two types of diseases and to aid in developing new treatments.	[Kong, Wei; Deng, Jin; Di, Benteng; Zhong, Ruxing; Wang, Shuaiqun; Zeng, Weiming] Shanghai Maritime Univ, Coll Informat Engn, Haigang Ave, Shanghai, Peoples R China; [Mou, Xiaoyang] Rowan Univ & Guava Med, Dept Biochem, Glassboro, NJ USA; [Yang, Yang] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai, Peoples R China	Shanghai Maritime University; Rowan University; Shanghai Jiao Tong University	Kong, W (corresponding author), Shanghai Maritime Univ, Coll Informat Engn, Haigang Ave, Shanghai, Peoples R China.	weikong@shmtu.edu.cn			National Natural Science Foundation of China [61271446, 31170952]; Innovation Program of Shanghai Municipal Education Commission [15ZZ079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by the National Natural Science Foundation of China (No. 61271446 and 31170952) and Innovation Program of Shanghai Municipal Education Commission (No. 15ZZ079).	Aloe L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0395-y; Bartke T, 2001, ONCOGENE, V20, P571, DOI 10.1038/sj.onc.1204124; Behrens MI, 2009, CURR ALZHEIMER RES, V6, P196, DOI 10.2174/156720509788486608; Berer K, 2014, FEBS LETT, V588, P4207, DOI 10.1016/j.febslet.2014.04.007; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Catala-Lopez F, 2014, PSYCHOTHER PSYCHOSOM, V83, P89, DOI 10.1159/000356498; Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208; Conniot J, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00105; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Demetrius LA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0006; Driver J.A., 2015, BIOCH BIOPHYS ACTA; Driver JA, 2014, BIOGERONTOLOGY, V15, P547, DOI 10.1007/s10522-014-9523-2; Driver JA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1442; Du CG, 2005, KIDNEY INT, V67, P1397, DOI 10.1111/j.1523-1755.2005.00217.x; Gorenne I, 2006, CIRC RES, V98, P378, DOI 10.1161/01.RES.0000202802.34727.fd; Guo BQ, 2006, MOL CELL BIOL, V26, P4529, DOI 10.1128/MCB.01667-05; Hansen MDH, 2006, J BIOL CHEM, V281, P16178, DOI 10.1074/jbc.M512771200; Harris RA, 2014, BIOGERONTOLOGY, V15, P559, DOI 10.1007/s10522-014-9534-z; Hedskog L, 2012, ANTIOXID REDOX SIGN, V16, P1476, DOI 10.1089/ars.2011.4259; Huang DS, 2006, BIOINFORMATICS, V22, P1855, DOI 10.1093/bioinformatics/btl190; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Jeong SM, 2010, J BIOL CHEM, V285, P2340, DOI 10.1074/jbc.M109.026997; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kaneko T, 2012, BRAIN RES, V1466, P128, DOI 10.1016/j.brainres.2012.05.001; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kato A, 2008, BIOCHEM J, V414, P261, DOI 10.1042/BJ20071655; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; KONG W, 2014, ACTA U MED ANHUI, V49, P1365, DOI DOI 10.1093/CARCIN/BGT208; Kong W, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/340758; Kong W, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/891761; Kong Wei, 2013, Chinese Journal of Biomedical Engineering, V32, P418, DOI 10.3969/j.issn.0258-8021.2013.04.06; Kong W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S5-S7; Kong W, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-5; Levine EA, 2012, J AM COLL SURGEONS, V214, P599, DOI 10.1016/j.jamcollsurg.2011.12.028; Li Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013715; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Liu T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03467; Liu YH, 2013, DRUG DISCOV TODAY, V18, P1212, DOI 10.1016/j.drudis.2013.07.020; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Ma LL, 2014, J ALZHEIMERS DIS, V42, P565, DOI 10.3233/JAD-140168; Metz RA, 2010, CLIN PHARMACOL THER, V88, P466, DOI 10.1038/clpt.2010.180; Michaud DS, 2015, CANCER EPIDEM BIOMAR, V24, P1811, DOI 10.1158/1055-9965.EPI-15-0681; Milo R, 2010, AUTOIMMUN REV, V9, pA387, DOI 10.1016/j.autrev.2009.11.010; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nanayakkara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079763; Nemeth MJ, 2006, P NATL ACAD SCI USA, V103, P13783, DOI 10.1073/pnas.0604006103; Ngan E, 2013, J CELL SCI, V126, P1981, DOI 10.1242/jcs.118315; Romero JP, 2014, J ALZHEIMERS DIS, V40, P465, DOI 10.3233/JAD-132048; Papazoglu C, 2007, J PATHOL, V211, P124, DOI 10.1002/path.2086; Pavlides S, 2010, AGING-US, V2, P185, DOI 10.18632/aging.100134; Raposo AASF, 2015, CELL REP, V10, P1544, DOI 10.1016/j.celrep.2015.02.025; Realmuto S, 2012, J ALZHEIMERS DIS, V31, P177, DOI 10.3233/JAD-2012-120184; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Renard P, 1999, CELL BIOL TOXICOL, V15, P341, DOI 10.1023/A:1007652414175; ROCHA NP, 2017, MOL NEUROBIOL, DOI DOI 10.1007/S12035-017-0404-Y; Roe CM, 2010, NEUROLOGY, V74, P106, DOI 10.1212/WNL.0b013e3181c91873; Sakurai T, 2013, DIGEST DIS, V31, P440, DOI 10.1159/000355242; Salton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023882; Schirer Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087383; Shalapour S, 2015, J CLIN INVEST, V125, P3347, DOI 10.1172/JCI80007; Shi HB, 2015, J CANCER RES CLIN, V141, P485, DOI 10.1007/s00432-014-1773-5; Statland JM, 2011, CURR OPIN NEUROL, V24, P423, DOI 10.1097/WCO.0b013e32834959af; Stoeck K, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0170-y; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; TANG C, 2015, CELL BIOL INT, P10438; Ullman CG, 1996, BIOCHEM J, V319, P229, DOI 10.1042/bj3190229; Valencia CA, 2007, BIOCHEM BIOPH RES CO, V361, P281, DOI 10.1016/j.bbrc.2007.06.156; Vue TY, 2014, DEVELOPMENT, V141, P3721, DOI 10.1242/dev.105270; Wang J, 2014, P NATL ACAD SCI USA, V111, pE2885, DOI 10.1073/pnas.1408295111; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wylie LA, 2015, DIS MODEL MECH, V8, P429, DOI 10.1242/dmm.018630; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200; Zhang LP, 2011, COMPUT BIOL CHEM, V35, P211, DOI 10.1016/j.compbiolchem.2011.05.002; Zhou M, 2014, BBA-GEN SUBJECTS, V1840, P2253, DOI 10.1016/j.bbagen.2014.02.027	80	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180337	10.1371/journal.pone.0180337	http://dx.doi.org/10.1371/journal.pone.0180337			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719625	gold, Green Submitted, Green Published			2022-12-27	WOS:000406061400010
J	Huang, ZZ; Yu, L; Huang, P; Liang, LJ; Guo, Q				Huang, Zhong-Zhou; Yu, Liang; Huang, Ping; Liang, Li-Jun; Guo, Qing			Charged amino acid variability related to N-glyco - sylation and epitopes in A/H3N2 influenza: Hem - agglutinin and neuraminidase	PLOS ONE			English	Article							RECEPTOR-BINDING; GLOBULAR HEAD; VIRUS; HEMAGGLUTININ; EVOLUTION; SUBSTITUTIONS; VACCINE; GENES; CHINA	Background The A/H3N2 influenza viruses circulated in humans have been shown to undergo antigenic drift, a process in which amino acid mutations result from nucleotide substitutions. There are few reports regarding the charged amino acid mutations. The purpose of this paper is to explore the relations between charged amino acids, N-glycosylation and epitopes in hemagglutinin (HA) and neuraminidase (NA). Methods A total of 700 HA genes (691 NA genes) of A/H3N2 viruses were chronologically analyzed for the mutational variants in amino acid features, N-glycosylation sites and epitopes since its emergence in 1968. Results It was found that both the number of HA N-glycosylation sites and the electric charge of HA increased gradually up to 2016. The charges of HA and HA1 increased respectively 1.54fold (+7.0 /+17.8) and 1.08-fold (+8.0/+16.6) and the number of NGS in nearly doubled (7/12). As great diversities occurred in 1990s, involving Epitope A, B and D mutations, the charged amino acids in Epitopes A, B, C and D in HA(1) mutated at a high frequency in global circulating strains last decade. The charged amino acid mutations in Epitopes A (T135K) has shown high mutability in strains near years, resulting in a decrease of NGT(135-135). Both K158N and K160T not only involved mutations charged in epitope B, but also caused a gain of NYT158-160. Epitope B and its adjacent N-glycosylation site NYT158-160 mutated more frequently, which might be under greater immune pressure than the rest. Conclusions The charged amino acid mutations in A/H3N2 Influenza play a significant role in virus evolution, which might cause an important public health issue. Variability related to both the epitopes (A and B) and N-glycosylation is beneficial for understanding the evolutionary mechanisms, disease pathogenesis and vaccine research.	[Huang, Zhong-Zhou; Guo, Qing] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou, Guangdong, Peoples R China; [Huang, Zhong-Zhou; Yu, Liang; Huang, Ping; Liang, Li-Jun] Guangdong Prov Ctr Dis Control & Prevent, Key Lab Emergency Pathogen Detect, Guangzhou, Guangdong, Peoples R China; [Yu, Liang; Huang, Ping] Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Sun Yat Sen University	Guo, Q (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou, Guangdong, Peoples R China.; Huang, P (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Key Lab Emergency Pathogen Detect, Guangzhou, Guangdong, Peoples R China.; Huang, P (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.	pphuang1@163.com; guoqingzsy@163.com		HUang, Ping/0000-0002-6333-8338	Natural Science Foundation of Guangdong Province [2016A030313775]; Guangzhou Science and Technology Program planning projects [2014J4100084]; National Natural Science Foundation of China [30972757]; National Transfer Payments Funding for the 2015 Influenza Survey	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou Science and Technology Program planning projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transfer Payments Funding for the 2015 Influenza Survey	The Natural Science Foundation of Guangdong Province (2016A030313775), URL:http://www.gdstc.gov.cn/; The Guangzhou Science and Technology Program planning projects (2014J4100084), URL:http://www.gzsi.gov.cn/; The National Natural Science Foundation of China (30972757), URL:http://www.nsfc.gov.cn/; The National Transfer Payments Funding for the 2015 Influenza Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin RS, 2015, PROTEIN SCI, V24, P1820, DOI 10.1002/pro.2775; Alymova IV, 2016, SCI REP-UK, V6, DOI 10.1038/srep36216; Arinaminpathy N, 2010, DYNAMICS GLYCOPROTEI, V5; Batishchev OV, 2016, J VIROL, V90, P575, DOI 10.1128/JVI.01539-15; Beuttemmuller EA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0503-9; Broberg E, 2015, EURO SURVEILL, V20; Cai JH, 2014, J MED VIROL, V86, P1026, DOI 10.1002/jmv.23854; Chen JE, 2015, BIOINFORMATICS, V31, P1484, DOI 10.1093/bioinformatics/btu841; Cui HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep27360; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; Davlin SL, 2016, MMWR-MORBID MORTAL W, V65, P567, DOI 10.15585/mmwr.mm6522a3; Huang P, 2013, EPIDEMIOL INFECT, V141, P1061, DOI 10.1017/S0950268812001318; Huang P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-47; Iba Y, 2014, J VIROL, V88, P7130, DOI 10.1128/JVI.00420-14; Kamlangdee A, 2014, J VIROL, V88, P13300, DOI 10.1128/JVI.01532-14; Kim DS, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0468-5; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040422; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Kratsch C, 2016, VIRUS EVOLUTION, V2, pv25; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kushibuchi I, 2013, INFECT GENET EVOL, V18, P168, DOI 10.1016/j.meegid.2013.05.010; Li Y, 2013, J VIROL, V87, P9904, DOI 10.1128/JVI.01023-13; Pentiah K, 2015, GLYCOBIOLOGY, V25, P124, DOI 10.1093/glycob/cwu097; Schicker RS, 2016, MMWR-MORBID MORTAL W, V65, P1157, DOI 10.15585/mmwr.mm6542a1; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Sugaya N, 2016, EURO SURVEILL, V21; Wang X, 2016, J VIROL, P1512; Wu CL, 2016, J INFECTION, V72, P369, DOI 10.1016/j.jinf.2015.12.013; Yang H, 2015, VIROLOGY, V477, P18, DOI 10.1016/j.virol.2014.12.024; Zucs P, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-6	30	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0178231	10.1371/journal.pone.0178231	http://dx.doi.org/10.1371/journal.pone.0178231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708860	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649800001
J	Klockmann, M; Kleinschmidt, F; Fischer, K				Klockmann, Michael; Kleinschmidt, Friederike; Fischer, Klaus			Carried over: Heat stress in the egg stage reduces subsequent performance in a butterfly	PLOS ONE			English	Article							BODY-SIZE; PHENOTYPIC PLASTICITY; THERMAL TOLERANCE; TRANSGENERATIONAL PLASTICITY; ULTRAVIOLET-RADIATION; REACTION NORMS; CLIMATE-CHANGE; TEMPERATURE; RESPONSES; DROSOPHILA	Increasing heat stress caused by anthropogenic climate change may pose a substantial challenge to biodiversity due to associated detrimental effects on survival and reproduction. Therefore, heat tolerance has recently received substantial attention, but its variation throughout ontogeny and effects carried over from one developmental stage to another remained largely neglected. To explore to what extent stress experienced early in life affects later life stages, we here investigate effects of heat stress experienced in the egg stage throughout ontogeny in the tropical butterfly Bicyclus anynana. We found that detrimental effects of heat stress in the egg stage were detectable in hatchlings, larvae and even resulting adults, as evidenced by decreased survival, growth, and body mass. This study shows that even in holometabalous insects with discrete life stages effects of stress experienced early in life are carried over to later stages, substantially reducing subsequent fitness. We argue that such effects need to be considered when trying to forecast species responses to climate change.	[Klockmann, Michael; Kleinschmidt, Friederike; Fischer, Klaus] Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald	Klockmann, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany.	Michael.klockmann@uni-greifswald.de			German Research Council [DFG Fi 846/8-1, DFG GRK2010]	German Research Council(German Research Foundation (DFG))	We acknowledge financial support from the German Research Council (DFG Fi 846/8-1). MK is associated doctoral researcher of the research training group RESPONSE funded by the German Research Council (DFG GRK2010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NR, 2013, J INSECT PHYSIOL, V59, P870, DOI 10.1016/j.jinsphys.2013.06.003; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Brakefield Paul M., 1997, V83, P65; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dmitriew C, 2005, OECOLOGIA, V142, P150, DOI 10.1007/s00442-004-1712-2; Donelson JM, 2016, EVOL APPL, V9, P1072, DOI 10.1111/eva.12386; DYTHAM C., 2003, P R SOC LOND, V270, P147, DOI DOI 10.1098/RSBL.2003.0049; English S, 2016, ECOL ENTOMOL, V41, P618, DOI 10.1111/een.12333; Fischer J, 2014, GLOBAL CHANGE BIOL, V20, P2108, DOI 10.1111/gcb.12472; Fischer K, 2004, HEREDITY, V92, P163, DOI 10.1038/sj.hdy.6800382; Fischer K, 2003, ECOLOGY, V84, P3138, DOI 10.1890/02-0733; Fischer K, 2002, OECOLOGIA, V131, P375, DOI 10.1007/s00442-002-0913-9; Fischer K, 2000, OIKOS, V90, P372, DOI 10.1034/j.1600-0706.2000.900218.x; Fischer K, 2014, J EXP BIOL, V217, P2892, DOI 10.1242/jeb.106245; Fischer K, 2011, OECOLOGIA, V166, P23, DOI 10.1007/s00442-011-1917-0; Fischer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015284; Fox CW, 1997, EVOLUTION, V51, P1005, DOI 10.1111/j.1558-5646.1997.tb03683.x; Franke K, 2014, J THERM BIOL, V41, P88, DOI 10.1016/j.jtherbio.2014.02.006; Gibbs AG, 2002, COMP BIOCHEM PHYS A, V133, P781, DOI 10.1016/S1095-6433(02)00208-8; Moresino RDH, 2011, J EXP MAR BIOL ECOL, V407, P363, DOI 10.1016/j.jembe.2011.07.019; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Hopwood PE, 2016, ECOL ENTOMOL, V41, P96, DOI 10.1111/een.12275; Karl I, 2008, OECOLOGIA, V155, P215, DOI 10.1007/s00442-007-0902-0; Kaspari M, 2015, GLOBAL CHANGE BIOL, V21, P1092, DOI 10.1111/gcb.12750; Kellermann V, 2012, P NATL ACAD SCI USA, V109, P16228, DOI 10.1073/pnas.1207553109; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Kingsolver JG, 2011, INTEGR COMP BIOL, V51, P719, DOI 10.1093/icb/icr015; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Klockmann M, 2016, BIOL J LINN SOC; Klockmann M, 2017, GLOBAL CHANGE BIOL, V23, P686, DOI 10.1111/gcb.13407; Klose MK, 2004, INTEGR COMP BIOL, V44, P14, DOI 10.1093/icb/44.1.14; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Krebs RA, 1995, BIOL J LINN SOC, V56, P517, DOI 10.1111/j.1095-8312.1995.tb01108.x; Larsen T., 1999, BUTTERFLIES KENYA TH; Le Moullac G, 2000, AQUACULTURE, V191, P121, DOI 10.1016/S0044-8486(00)00422-1; Levy O, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0837; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Marshall DJ, 2008, ECOLOGY, V89, P418, DOI 10.1890/07-0449.1; Marshall DJ, 2011, CURR BIOL, V21, pR718, DOI 10.1016/j.cub.2011.08.022; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Nielsen ME, 2015, OECOLOGIA, V177, P171, DOI 10.1007/s00442-014-3123-3; Overgaard J, 2008, CRYOBIOLOGY, V56, P159, DOI 10.1016/j.cryobiol.2008.01.001; Pahkala M, 2001, P ROY SOC B-BIOL SCI, V268, P1699, DOI 10.1098/rspb.2001.1725; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pijpe J, 2007, EVOL ECOL, V21, P589, DOI 10.1007/s10682-006-9137-5; Pincebourde S, 2015, ECOLOGY, V96, P986, DOI 10.1890/14-0744.1; Potter K, 2009, J EXP BIOL, V212, P3448, DOI 10.1242/jeb.033365; Potter KA, 2011, FUNCT ECOL, V25, P548, DOI 10.1111/j.1365-2435.2010.01807.x; Radchuk V, 2013, J ANIM ECOL, V82, P275, DOI 10.1111/j.1365-2656.2012.02029.x; Rukke BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127555; Russell J, 2009, MAR BIOL, V156, P579, DOI 10.1007/s00227-008-1109-6; Sentis A, 2013, GLOBAL CHANGE BIOL, V19, P833, DOI 10.1111/gcb.12094; Sgro CM, 2016, ANNU REV ENTOMOL, V61, P433, DOI 10.1146/annurev-ento-010715-023859; SIBLY RM, 1994, FUNCT ECOL, V8, P486, DOI 10.2307/2390073; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; van't Hof AE, 2005, MOL ECOL NOTES, V5, P169, DOI 10.1111/j.1471-8286.2004.00870.x; Vonesh JR, 2005, OECOLOGIA, V143, P280, DOI 10.1007/s00442-004-1806-x; Weinig C, 2001, EVOLUTION, V55, P930, DOI 10.1554/0014-3820(2001)055[0930:PPEILC]2.0.CO;2; Wijngaarden PJ, 2002, J EVOLUTION BIOL, V15, P290, DOI 10.1046/j.1420-9101.2002.00380.x; Zhang W, 2015, OECOLOGIA, V179, P947, DOI 10.1007/s00442-015-3409-0; Zhang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep10436; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	75	22	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180968	10.1371/journal.pone.0180968	http://dx.doi.org/10.1371/journal.pone.0180968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708887	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800035
J	Moutier, W; Duforet-Gaurier, L; Thyssen, M; Loisel, H; Meriaux, X; Courcot, L; Dessailly, D; Reve, AH; Gregori, G; Alvain, S; Barani, A; Brutier, L; Dugenne, M				Moutier, William; Duforet-Gaurier, Lucile; Thyssen, Melilotus; Loisel, Hubert; Meriaux, Xavier; Courcot, Lucie; Dessailly, David; Reve, Anne-Helene; Gregori, Gerald; Alvain, Severine; Barani, Aude; Brutier, Laurent; Dugenne, Mathilde			Evolution of the scattering properties of phytoplankton cells from flow cytometry measurements	PLOS ONE			English	Article							LIGHT-SCATTERING; OPTICAL-PROPERTIES; REFRACTIVE-INDEX; DIEL VARIATIONS; INDIVIDUAL PARTICLES; MARINE-PHYTOPLANKTON; CHEMICAL-COMPOSITION; AQUATIC PARTICLES; BIOLOGICAL CELLS; SIZE	After the exponential growth phase, variability in the scattering efficiency of phytoplankton cells over their complete life cycle is not well characterised. Bulk measurements are impacted by senescent cells and detritrus. Thus the analysis of the evolution of the optical properties thanks to their morphological and/or intra-cellular variations remains poorly studied. Using the Cytosense flow cytometer (CytoBuoy b. v., NL), the temporal course of the forward and sideward efficiencies of two phytoplankton species (Thalassiosira pseudonana and Chlamydomonas concordia) were analyzed during a complete life-cycle. These two species differ considerably from a morphological point of view. Over the whole experiment, the forward and sideward efficiencies of Thalassiosira pseudonana were, on average, respectively 2.2 and 1.6 times higher than the efficiencies of Chlamydomonas concordia. Large intra-species variability of the efficiencies were observed over the life cycle of the considered species. It highlights the importance of considering the optical properties of phytoplankton cells as a function of the population growth stage of the considered species. Furthermore, flow cytometry measurements were combined with radiative transfer simulations and biogeochemical and optical measurements. Results showed that the real refractive index of the chloroplast is a key parameter driving the sideward signal and that a simplistic two-layered model (cytoplasm-chloroplast) seems particularly appropriate to represent the phytoplankton cells.	[Moutier, William; Duforet-Gaurier, Lucile; Loisel, Hubert; Meriaux, Xavier; Courcot, Lucie; Dessailly, David; Brutier, Laurent] Univ Lille, Univ Littoral Cote Opale, CNRS, LOG,UMR 8187, F-62930 Wimereux, France; [Thyssen, Melilotus; Gregori, Gerald; Barani, Aude; Dugenne, Mathilde] Aix Marseille Univ, Univ Toulon, CNRS, Mediterranean Inst Oceanog,IRD,MIO UM 110, F-13288 Marseille, France; [Reve, Anne-Helene] Univ Lille, UMR CNRS LOG 8187, F-62930 Wimereux, France; [Alvain, Severine] CNRS, UMR CNRS LOG 8187, F-62930 Wimereux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU)	Moutier, W (corresponding author), Univ Lille, Univ Littoral Cote Opale, CNRS, LOG,UMR 8187, F-62930 Wimereux, France.	william.moutier@gmail.com	Grégori, Gérald J/D-8657-2013	Grégori, Gérald J/0000-0003-1645-9468; ALVAIN, Severine/0000-0001-6316-6284	CNES/TOSCA program	CNES/TOSCA program(Centre National D'etudes Spatiales)	This work was supported by CNES/TOSCA program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas E, 1996, J PLANKTON RES, V18, P2223, DOI 10.1093/plankt/18.12.2223; ACKLESON SG, 1990, NETH J SEA RES, V25, P11, DOI 10.1016/0077-7579(90)90004-Z; ACKLESON SG, 1988, APPL OPTICS, V27, P1270, DOI 10.1364/AO.27.001270; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bernard S, 2009, BIOGEOSCIENCES DISCU, V6, P1497, DOI DOI 10.5194/BGD-6-1497-2009; BLASCO D, 1982, J PHYCOL, V18, P58, DOI 10.1111/j.0022-3646.1982.00058.x; Bohren CF, 1998, WILEY SCI PAPER BACK; Boss E, 2009, OPT EXPRESS, V17, P9408, DOI 10.1364/OE.17.009408; BRATBAK G, 1994, MICROBIAL ECOL, V28, P209, DOI 10.1007/BF00166811; BRICAUD A, 1992, P SOC PHOTO-OPT INS, V1750, P27, DOI 10.1117/12.140669; CARDER KL, 1972, LIMNOL OCEANOGR, V17, P833, DOI 10.4319/lo.1972.17.6.0833; CUNNINGHAM A, 1992, J PLANKTON RES, V14, P223, DOI 10.1093/plankt/14.2.223; Dall'Olmo G, 2009, BIOGEOSCIENCES, V6, P947, DOI 10.5194/bg-6-947-2009; DUBELAAR GBJ, 1987, CYTOMETRY, V8, P405, DOI 10.1002/cyto.990080410; Dubelaar GBJ, 2000, SCI MAR, V64, P135, DOI 10.3989/scimar.2000.64n2135; Duforet-Gaurier L, 2015, OPT EXPRESS, V23, P31510, DOI 10.1364/OE.23.031510; DuRand MD, 2002, J PHYCOL, V38, P1132, DOI 10.1046/j.1529-8817.2002.02008.x; GEIDER RJ, 1987, MAR BIOL, V96, P299, DOI 10.1007/BF00427030; Green RE, 2003, LIMNOL OCEANOGR, V48, P2377, DOI 10.4319/lo.2003.48.6.2377; Green RE, 2003, APPL OPTICS, V42, P526, DOI 10.1364/AO.42.000526; Hatcher A, 2001, J SEA RES, V46, P1, DOI 10.1016/S1385-1101(01)00066-1; HAUPT W, 1990, PLANT CELL ENVIRON, V13, P595, DOI 10.1111/j.1365-3040.1990.tb01078.x; HITCHCOCK GL, 1982, J PLANKTON RES, V4, P363, DOI 10.1093/plankt/4.2.363; Janssen Meike, 2001, International Microbiology, V4, P27; KITCHEN JC, 1992, LIMNOL OCEANOGR, V37, P1680, DOI 10.4319/lo.1992.37.8.1680; LORENZEN CARL J., 1966, DEEP SEA RES, V13, P223, DOI 10.1016/0011-7471(66)91102-8; Mas S, 2008, J PHYCOL, V44, P551, DOI 10.1111/j.1529-8817.2008.00501.x; Matthews M. W., 2013, BIOGEOSCI DISCUSS, V10, P10531, DOI DOI 10.5194/BGD-10-10531-2013; MEYER RA, 1975, BIOPHYS J, V15, P191, DOI 10.1016/S0006-3495(75)85811-5; MEYER RA, 1979, APPL OPTICS, V18, P585, DOI 10.1364/AO.18.000585; Mishchenko M.I., 2002, SCATTERING ABSORPTIO; Mishchenko MI, 2000, APPL OPTICS, V39, P1026, DOI 10.1364/AO.39.001026; Moutier W, 2016, OPT EXPRESS, V24, P24188, DOI 10.1364/OE.24.024188; OSBORNE BA, 1986, BRIT PHYCOL J, V21, P303, DOI 10.1080/00071618600650361; OSBORNE BA, 1989, MAR BIOL, V100, P151, DOI 10.1007/BF00391954; Pena O, 2009, COMPUT PHYS COMMUN, V180, P2348, DOI 10.1016/j.cpc.2009.07.010; Preisendorfer R. W., 1961, APPL RAD TRANSFER TH; Preisendorfer R. W., 1976, HYDROLOGIC OPTICS, V1; QUINBYHUNT MS, 1989, LIMNOL OCEANOGR, V34, P1587, DOI 10.4319/lo.1989.34.8.1587; Quirantes A, 2006, J QUANT SPECTROSC RA, V100, P315, DOI 10.1016/j.jqsrt.2005.11.048; Quirantes A, 2004, J QUANT SPECTROSC RA, V89, P311, DOI 10.1016/j.jqsrt.2004.05.031; ROSEN BH, 1984, J PHYCOL, V20, P173, DOI 10.1111/j.0022-3646.1984.00173.x; STEPHENS FC, 1995, MAR BIOL, V122, P325; Stramski D, 1997, LIMNOL OCEANOGR, V42, P538, DOI 10.4319/lo.1997.42.3.0538; Stramski D, 1999, DEEP-SEA RES PT I, V46, P335, DOI 10.1016/S0967-0637(98)00065-X; STRAMSKI D, 1993, LIMNOL OCEANOGR, V38, P1347, DOI 10.4319/lo.1993.38.7.1347; Sullivan J. M., 2013, MEASURING OPTICAL BA, P189; Svensen O, 2007, APPL OPTICS, V46, P5762, DOI 10.1364/AO.46.005762; Tassan S, 1995, LIMNOL OCEANOGR, V40, P1358, DOI 10.4319/lo.1995.40.8.1358; Tassan S, 2002, J PLANKTON RES, V24, P757, DOI 10.1093/plankt/24.8.757; Vaillancourt RD, 2004, J PLANKTON RES, V26, P191, DOI 10.1093/plankt/fbh012; Volten H, 1998, LIMNOL OCEANOGR, V43, P1180, DOI 10.4319/lo.1998.43.6.1180; Whitmire AL, 2010, OPT EXPRESS, V18, P15073, DOI 10.1364/OE.18.015073; Wilhelm C, 2014, MAR GENOM, V16, P5, DOI 10.1016/j.margen.2013.12.003; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Wilhelm SW, 1999, NATURE, V399, P541; Witkowski K, 1998, LIMNOL OCEANOGR, V43, P859, DOI 10.4319/lo.1998.43.5.0859; Xu YL, 2001, J QUANT SPECTROSC RA, V70, P395, DOI 10.1016/S0022-4073(01)00019-X; Yang W, 2003, APPL OPTICS, V42, P1710, DOI 10.1364/AO.42.001710; ZANEVELD JRV, 1995, J GEOPHYS RES-OCEANS, V100, P13309, DOI 10.1029/95JC00451; [No title captured]	61	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181180	10.1371/journal.pone.0181180	http://dx.doi.org/10.1371/journal.pone.0181180			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708882	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649800046
J	Ric, A; Torrents, C; Goncalves, B; Torres-Ronda, L; Sampaio, J; Hristovski, R				Ric, Angel; Torrents, Carlota; Goncalves, Bruno; Torres-Ronda, Lorena; Sampaio, Jaime; Hristovski, Robert			Dynamics of tactical behaviour in association football when manipulating players' space of interaction	PLOS ONE			English	Article							INTERPERSONAL COORDINATION; NEUROBIOLOGICAL SYSTEMS; MOVEMENT BEHAVIOR; DECISION-MAKING; TEAM SPORTS; PERFORMANCE; CONSTRAINTS; STATISTICS; CREATIVITY; POSITION	The analysis of positional data in association football allows the spatial distribution of players during matches to be described in order to improve the understanding of tactical-related constraints on the behavioural dynamics of players. The aim of this study was to identify how players' spatial restrictions affected the exploratory tactical behaviour and constrained the perceptual-motor workspace of players in possession of the ball, as well as inter-player passing interactions. Nineteen professional outfield male players were divided into two teams of 10 and 9 players, respectively. The game was played under three spatial constraints: a) players were not allowed to move out of their allocated zones, except for the player in possession of the ball; b) players were allowed to move to an adjacent zone, and; c) non-specific spatial constraints. Positional data was captured using a 5 Hz interpolated GPS tracking system and used to define the configuration states of players for each second in time. The configuration state comprised 37 categories derived from tactical actions, distance from the nearest opponent, distance from the target and movement speed. Notational analysis of players in possession of the ball allowed the mean time of ball possession and the probabilities of passing the ball between players to be calculated. The results revealed that the players' long-term exploratory behaviour decreased and their short-term exploration increased when restricting their space of interaction. Relaxing players' positional constraints seemed to increase the speed of ball flow dynamics. Allowing players to move to an adjacent sub-area increased the probabilities of interaction with the full-back during play buildup. The instability of the coordinative state defined by being free from opponents when players had the ball possession was an invariant feature under all three task constraints. By allowing players to move to adjacent sub-areas, the coordinative state became highly unstable when the distance from the target decreased. Ball location relative to the scoring zone and interpersonal distance constitute key environmental information that constrains the players' coordinative behaviour. Based on our results, dynamic overlap is presented as a good option to capture tactical performance. Moreover, the selected collective (i.e. relational) variables would allow coaches to identify the effects of training drills on teams and players' behaviour. More research is needed considering these type variables to understand how the manipulation of constraints induce a more stable or flexible dynamical structure of tactical behaviour.	[Ric, Angel; Torrents, Carlota] Univ Lleida, Natl Inst Phys Educ Catalonia INEFC, Complex Syst Sport Res Grp, Lleida, Spain; [Goncalves, Bruno; Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci, Hlth Sci & Human Dev CIDESD, CreativeLab Res Community, Vila Real, Portugal; [Torres-Ronda, Lorena] Texas A&M Univ, Dept Hlth & Kinesiol, Exercise & Sport Nutr Lab, College Stn, TX USA; [Hristovski, Robert] St Cyril & Methodious Univ, Fac Phys Educ Sport & Hlth, Skopje, Macedonia	Universitat de Lleida; University of Tras-os-Montes & Alto Douro; Texas A&M University System; Texas A&M University College Station; Saints Cyril & Methodius University of Skopje	Ric, A (corresponding author), Univ Lleida, Natl Inst Phys Educ Catalonia INEFC, Complex Syst Sport Res Grp, Lleida, Spain.	angelric10@outlook.com	Hristovski, Robert/L-4116-2015; Ric, Angel/F-8977-2016; Sampaio, Jaime/B-7392-2008; Gonçalves, Bruno/M-5361-2013; Ric, Angel/AAR-6566-2020; Torrents, Carlota/AAX-6166-2020	Hristovski, Robert/0000-0001-6805-2833; Ric, Angel/0000-0003-4944-4529; Sampaio, Jaime/0000-0003-2335-9991; Gonçalves, Bruno/0000-0001-7874-4104; Ric, Angel/0000-0003-4944-4529; Torrents, Carlota/0000-0003-4912-2802				Aguiar M, 2015, J SPORT SCI, V33, P1259, DOI 10.1080/02640414.2015.1022571; Aguiar MVD, 2013, J STRENGTH COND RES, V27, P1287, DOI 10.1519/JSC.0b013e318267a35c; Araujo D, 2006, PSYCHOL SPORT EXERC, V7, P653, DOI 10.1016/j.psychsport.2006.07.002; Balague A N, 2014, APUNT ED FISICA DEPO, V116, P60; Balescu R, 1975, NASA STI RECON TEC A, V76, P32809; Bourbousson J, 2014, INT J SPORTS SCI COA, V9, P1393, DOI 10.1260/1747-9541.9.6.1393; Bruineberg J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00599; Castellano J, 2012, J HUM KINET, V31, P139, DOI 10.2478/v10078-012-0015-7; Cintia P, 2015, PROCEEDINGS OF THE 2015 IEEE INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS (IEEE DSAA 2015), P392; Correa UC, 2016, J SPORT SCI, V34, P2321, DOI 10.1080/02640414.2016.1232488; Costa I.T., 2011, MOTRICIDADE, V7, P69, DOI [DOI 10.6063/MOTRICIDADE.7(1).121, 10.6063/motricidade.121, DOI 10.6063/MOTRICIDADE.121]; Cotta C., 2010, J SYSTEMS SCI COMPLE, V26, P21, DOI DOI 10.1007/S11424-013-2291-2; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Duarte R, 2012, J SPORT SCI, V30, P871, DOI 10.1080/02640414.2012.675081; Duch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010937; Folgado H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097145; Gama J, 2014, INT J PERF ANAL SPOR, V14, P692, DOI 10.1080/24748668.2014.11868752; Gibson J.J., 1986, ECOLOGICAL APPROACH; Goncalves B, 2016, J SPORT SCI, V34, P1346, DOI 10.1080/02640414.2016.1143111; Goncalves B, 2017, PLOONE PUBLIC LIB, V12; Grund TU, 2012, SOC NETWORKS, V34, P682, DOI 10.1016/j.socnet.2012.08.004; Gyarmati L., P 2014 KDD WORKSH LA; Haken H., 1987, APPROACH SELF ORG SE, P417; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hristovski R., 2012, OPEN SPORTS SCI J S, V5, P26, DOI [10.2174/1875399X01205010026, DOI 10.2174/1875399X01205010026]; Hristovski R., 2009, PERSPECTIVES COGNITI, P43; Hristovski R., 2013, COMPLEX SYSTEMS SPOR, P261; Hristovski R, 2011, NONLIN DYNAM PSYCHOL, V15, P175; Hughes M., 2004, NOTATIONAL ANAL SPOR; James N., 2006, INT J PERF ANAL SPOR, V6, P67, DOI [https://doi.org/10.1080/24748668.2006.11868373, DOI 10.1080/24748668.2006.11868373, 10.1080/24748668.2006.11868373]; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kempe M., 2012, SPORTS PHYS, V4, P35, DOI 10.5923/s.sports.201401.05; Kempe M., 2014, INT J SPORT SCI, V4, P35, DOI [10.5923/s.sports.201401.05, DOI 10.5923/S.SPORTS.201401.05]; Kugler PN, 1987, RESOURCES ECOLOGICAL; Liu HY, 2016, J SPORT SCI, V34, P509, DOI 10.1080/02640414.2015.1117121; McGarry T., 2009, INT J PERF ANAL SPOR, V9, P128, DOI [10.1186/s12913-016-1423-5, DOI 10.1080/24748668.2009.11868469]; Narizuka T, 2014, PHYSICA A, V412, P157, DOI 10.1016/j.physa.2014.06.037; NEWELL KM, 1991, NATO ADV SCI I D-BEH, V62, P95; Passos P, 2008, J SPORT SCI, V26, P1421, DOI 10.1080/02640410802208986; Passos P, 2009, J MOTOR BEHAV, V41, P445, DOI 10.3200/35-08-061; Pinder RA, 2012, J SCI MED SPORT, V15, P437, DOI 10.1016/j.jsams.2012.01.002; Rampinini E, 2009, J SCI MED SPORT, V12, P227, DOI 10.1016/j.jsams.2007.10.002; Ric A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyd.2016.01513; Ric A, 2016, J SPORT SCI, V34, P1723, DOI 10.1080/02640414.2015.1136068; Sampaio J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132894; Sampaio JE, 2014, J SCI MED SPORT, V17, P229, DOI 10.1016/j.jsams.2013.04.005; Santos SDL, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.2016.01282, 10.3389/fpsyg.2076.01282]; Sibani P, 2003, EUROPHYS LETT, V64, P8, DOI 10.1209/epl/i2003-00109-0; SILVA P, 2015, INT J PERF ANAL SPOR, P641; Silva P, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1813-5; Silva P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107112; Silva P, 2014, INT J SPORTS SCI COA, V9, P993, DOI 10.1260/1747-9541.9.5.993; Tenga A., 2003, INT J PERF ANAL SPOR, V3, P90; Torrents C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168866; Martin CT, 2015, PSYCHOL AESTHET CREA, V9, P65, DOI 10.1037/a0038706; Travassos B, 2012, HUM MOVEMENT SCI, V31, P932, DOI 10.1016/j.humov.2011.10.004; Travassos B, 2011, HUM MOVEMENT SCI, V30, P1245, DOI 10.1016/j.humov.2011.04.003; Travassos B, 2014, HUM MOVEMENT SCI, V38, P241, DOI 10.1016/j.humov.2014.10.005; Travassos B, 2012, INT J SPORTS SCI COA, V7, P677, DOI 10.1260/1747-9541.7.4.677; Vilar L, 2014, INT J SPORTS SCI COA, V9, P1007, DOI 10.1260/1747-9541.9.5.1007; Vilar L, 2014, EUR J SPORT SCI, V14, P28, DOI 10.1080/17461391.2012.725103; Vilar L, 2013, J SYST SCI COMPLEX, V26, P73, DOI 10.1007/s11424-013-2286-z; Wang Q, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P2197, DOI 10.1145/2783258.2788577; Yamamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029638	64	33	35	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180773	10.1371/journal.pone.0180773	http://dx.doi.org/10.1371/journal.pone.0180773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708868	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649800021
J	Lopez-Rodriguez, R; Hernandez-Bartolome, A; Borque, MJ; Rodriguez-Munoz, Y; Martin-Vilchez, S; Garcia-Buey, L; Gonzalez-Moreno, L; Real-Martinez, Y; de Rueda, PM; Salmeron, J; Vidal-Castineira, JR; Lopez-Larrea, C; Rodrigo, L; Moreno-Otero, R; Sanz-Cameno, P				Lopez-Rodriguez, Rosario; Hernandez-Bartolome, Angel; Jesus Borque, Maria; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Garcia-Buey, Luisa; Gonzalez-Moreno, Leticia; Real-Martinez, Yolanda; Munoz de Rueda, Paloma; Salmeron, Javier; Ramon Vidal-Castineira, Jose; Lopez-Larrea, Carlos; Rodrigo, Luis; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma			Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; VIRUS; RESPONSES; FIBROSIS; INNATE; IL28B; LIVER	Introduction Chronic hepatitis C (CHC) is a major cause of liver disease worldwide which often leads to progressive liver inflammation, fibrosis, cirrhosis and hepatocellular carcinoma (HCC). CHC displays heterogeneous progression depending on a broad set of factors, some of them intrinsic to each individual such as the patient's genetic profile. This study aims to evaluate the contribution of certain genetic variants of crucial interferon alpha and lambda signaling pathways to the hepatic necroinflammatory activity (NIA) grade of CHC patients. Methods NIA was evaluated in 119 CHC patients by METAVIR scale and classified as low (NIA = 0-2, n = 80) or high grade (NIA = 3, n = 39). In a candidate gene approach, 64 SNPs located in 30 different genes related to interferon pathways (IL-28B, IFNAR1-2, JAK-STAT and OAS1-3, among others) were genotyped using the Illumina GoldenGate (R) Genotyping Assay. Statistical association was determined by logistic regression and expressed as OR and 95% CI. Those SNPs significantly associated were further adjusted by other covariates. Results Seven SNPs located in IL-28B (rs12979860), JAK1 (rs11576173 and rs1497056), TYK2 (rs280519), OAS1 (rs2057778), SOCS1 (rs33932899) and RNASEL (rs3738579) genes were significantly related to severe NIA grade (p<0.05). Regarding to clinical variables, elevated NIA was notably associated with aspartate aminotransferase (AST) serum levels >40 IU/L (p<0.05) but not with other clinical factors. Multivariate logistic regression analysis of these factors reflected that AST (>40 IU/L), TYK2 rs280519 (G allele) and RNASEL rs3738579 (G allele) were factors independently associated with elevated NIA (p<0.05). AST concentration showed a moderate AUC value (AUC = 0.63), similar to TYK2 (rs280519) and RNASEL (rs3738579) SNPs (AUC = 0.61, both) in the ROC_AUC analysis. Interestingly, the model including all significant variables reached a considerable predictive value (AUC = 0.74). Conclusion The identified genetic variants in interferon signaling pathways may constitute useful prognostic markers of CHC progression. Further validation in larger cohorts of patients is needed.	[Lopez-Rodriguez, Rosario; Hernandez-Bartolome, Angel; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Garcia-Buey, Luisa; Gonzalez-Moreno, Leticia; Real-Martinez, Yolanda; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] IIS IP, Inst Invest Sanitaria Princesa, Liver Unit, Gastroenterol Serv, Madrid, Spain; [Jesus Borque, Maria] IIS IP, Inst Invest Sanitaria Princesa, Mol Biol Unit, Madrid, Spain; [Garcia-Buey, Luisa; Munoz de Rueda, Paloma; Salmeron, Javier; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] ISCIII, CIBERehd, Madrid, Spain; [Munoz de Rueda, Paloma; Salmeron, Javier] Hosp Univ San Cecilio, Gastroenterol Unit, Granada, Spain; [Ramon Vidal-Castineira, Jose; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Inmunol Serv, Oviedo, Spain; [Rodrigo, Luis] Hosp Univ Cent Asturias, Digest Serv, Oviedo, Spain; [Lopez-Rodriguez, Rosario] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Expt & Observat Rheumatol, Santiago De Compostela, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Hospital Universitario San Cecilio; Central University Hospital Asturias; Central University Hospital Asturias; Complexo Hospitalario Universitario de Santiago de Compostela	Sanz-Cameno, P (corresponding author), IIS IP, Inst Invest Sanitaria Princesa, Liver Unit, Gastroenterol Serv, Madrid, Spain.; Sanz-Cameno, P (corresponding author), ISCIII, CIBERehd, Madrid, Spain.	paloma_march@hotmail.com	Chaparro, María/I-2500-2016; Rodrigo, Luis/A-6278-2010; Lopez-Rodriguez, Rosario/M-3381-2014; Sanz, Paloma/C-7799-2014; López-Rodríguez, Rosario/AAB-2290-2022; Martin-Vilchez, Samuel/AFV-2112-2022	Chaparro, María/0000-0002-9275-4242; Rodrigo, Luis/0000-0003-1717-9345; Lopez-Rodriguez, Rosario/0000-0002-4713-0633; López-Rodríguez, Rosario/0000-0002-4713-0633; Martin-Vilchez, Samuel/0000-0003-0557-7653; Vidal-Castineira, Jose Ramon/0000-0003-4877-3566	Ayudas Investigacion Oncologica AIO; Ayudas Proyectos de Investigacion Fundacion Mutua Madrilena; Programa Estatal de Investigacion Fundamental Ministerio de Economia Industria y Competitividad SAF [2010-21805]	Ayudas Investigacion Oncologica AIO; Ayudas Proyectos de Investigacion Fundacion Mutua Madrilena; Programa Estatal de Investigacion Fundamental Ministerio de Economia Industria y Competitividad SAF	This work was supported by Ayudas Investigacion Oncologica AIO-2010 to PSC (https://www.fundacioncientifica.aecc.es/); Ayudas Proyectos de Investigacion Fundacion Mutua Madrilena 2010 to RMO; Ayudas Proyectos de Investigacion Fundacion Mutua Madrilena 2012 to PSC (http://www.fundacionmutua.es/Ayudasa -la-Investigacion.html); Programa Estatal de Investigacion Fundamental Ministerio de Economia Industria y Competitividad SAF 2010-21805 to RMO (http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801 432ea0/?vgnextoid=17aba53632295210VgnVCM 1000001d04140aRCRD).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bertino G, 2016, WORLD J HEPATOL, V8, P92, DOI 10.4254/wjh.v8.i2.92; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Castello G, 2010, CLIN IMMUNOL, V134, P237, DOI 10.1016/j.clim.2009.10.007; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Diogo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122271; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Friborg J, 2013, VIROLOGY, V444, P384, DOI 10.1016/j.virol.2013.07.005; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gremion C, 2005, REV MED VIROL, V15, P235, DOI 10.1002/rmv.466; Han JQ, 2002, RNA, V8, P512, DOI 10.1017/S1355838202020617; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jouan L, 2012, J HEPATOL, V56, P70, DOI 10.1016/j.jhep.2011.07.017; Li XL, 2011, WIRES RNA, V2, P58, DOI 10.1002/wrna.32; Lopez-Rodriguez R, 2011, CLIN PHARMACOL THER, V90, P712, DOI 10.1038/clpt.2011.189; Marcellin P, 2002, HEPATOLOGY, V36, pS47, DOI 10.1053/jhep.2002.36993; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Moghaddam A, 2011, HEPATOLOGY, V53, P746, DOI 10.1002/hep.24154; Moon J, 2016, BIOCHEM BIOPH RES CO, V474, P428, DOI 10.1016/j.bbrc.2016.05.005; de Rueda PM, 2011, AM J GASTROENTEROL, V106, P1246, DOI 10.1038/ajg.2011.82; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Reig M, 2016, J HEPATOL, Vxxx, P1; Sanz-Cameno P, 2010, J ONCOL, V2010, DOI 10.1155/2010/272170; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sato M, 2014, PLOS ONE, V9; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Taguchi T, 2004, J GEN VIROL, V85, P959, DOI 10.1099/vir.0.19513-0; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Wirth TC, 2016, ANN ONCOL, V27, P1467, DOI 10.1093/annonc/mdw219; Wong M. T., 2014, CELL MOL IMMUNOL; Zerbino DR, 2016, DATABASE-OXFORD, DOI 10.1093/database/bav119	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180927	10.1371/journal.pone.0180927	http://dx.doi.org/10.1371/journal.pone.0180927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704535	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600052
J	Schenk, D; Song, G; Ke, Y; Wang, ZH				Schenk, Desiree; Song, Gang; Ke, Yue; Wang, Zhaohui			Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2	PLOS ONE			English	Article							HYBRIDIZATION; ENRICHMENT; CAPTURE	Current PCR-based target enrichment methods for next generation sequencing (NGS) of overlapping amplicons often requires separate PCR reactions and subsequent pooling of amplicons from the different reactions. The study presents a novel method, deemed stemloop inhibition mediated amplification (SLIMamp), for amplifying overlapping or tiled amplicons in a single multiplex PCR reaction. During a SLIMamp PCR reaction, a stem loop structure formed by the overlapping amplicon suppresses additional amplification of itself by preventing the annealing of the primers. Using the SLIMamp strategy, we designed a nextgeneration sequencing (NGS) assay to enrich the exon regions of BRCA1 and BRCA2 for sequencing on an Illumina MiSeq system. We used 35 cell line DNAs and 6 patient blood DNAs in the study to evaluate the assay performance. For each sample, all targeted regions were successfully amplified and sequenced with excellent coverage uniformity and specificity. >99% of the total sequencing reads were mapped to the human reference genome (hg19) and >99% of the mapped reads were on the targeted exons. >98% of bases were covered at >0.20x of the mean coverage and >99% are covered at >0.15x of the mean depth. Among 34 independently sequenced samples, all variants were reliably detected with no false positives or false negatives. SLIMamp provides a robust method for singletube multiplex PCR amplification of numerous, overlapping amplicons that tile for targeted next-generation sequencing.	[Schenk, Desiree; Song, Gang; Ke, Yue; Wang, Zhaohui] Pillar Biosci, Dept Res & Dev, Natick, MA 01760 USA		Wang, ZH (corresponding author), Pillar Biosci, Dept Res & Dev, Natick, MA 01760 USA.	wangzh@pillar-biosciences.com			Pillar Biosciences	Pillar Biosciences	This research was supported by Pillar Biosciences. No individual authors received specific funding for this work. Pillar Biosciences provided support in the form of salaries to DS, GS, YK, and ZW.	Balabanski L, 2014, MOL CLIN ONCOL, V2, P435, DOI 10.3892/mco.2014.251; Chong HK, 2014, PLOS ONE, V9; Green A, 2015, J MOL DIAGN, V17, P31, DOI 10.1016/j.jmoldx.2014.09.006; Khodakov D, 2016, ADV DRUG DELIVER REV, V105, P3, DOI 10.1016/j.addr.2016.04.005; Li H., 2013, QUANT BIOL; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Samorodnitsky E, 2015, HUM MUTAT, V36, P903, DOI 10.1002/humu.22825; Strom CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136419; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729	10	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181062	10.1371/journal.pone.0181062	http://dx.doi.org/10.1371/journal.pone.0181062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704513	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600056
J	Luo, M; Yang, SY; Li, X; Liu, P; Xue, J; Zhou, XP; Su, KW; Xu, X; Qing, Y; Qiu, JF; Li, YL				Luo, Mei; Yang, Shiya; Li, Xuan; Liu, Pin; Xue, Jian; Zhou, Xipeng; Su, Kewen; Xu, Xuan; Qing, Ying; Qiu, Jingfu; Li, Yingli			The KP1_4563 gene is regulated by the cAMP receptor protein and controls type 3 fimbrial function in Klebsiella pneumoniae NTUH-K2044	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; PYOGENIC LIVER-ABSCESS; CAPSULAR POLYSACCHARIDE SYNTHESIS; PESTIS BIOVAR MICROTUS; ESCHERICHIA-COLI; BIOFILM FORMATION; CYCLIC-AMP; CATABOLITE REPRESSION; ACTIVATOR PROTEIN; SERRATIA-MARCESCENS	Klebsiella pneumoniae (K. pneumoniae) is an opportunistic pathogen that can adhere to host cells or extracellular matrix via type 1 and type 3 fimbriae. KP1_4563 is a gene encoding a hypothetical protein in K. pneumoniae NTUH-K2044. KP1_4563 is located between the type 1 and type 3 fimbrial gene clusters and is likely associated with fimbrial function given its putative conserved domains of unknown function (DUF1471). Cyclic AMP receptor protein (CRP) regulates virulence-related gene expression and is a crucial transcriptional regulator in many bacteria. The predicted DNA recognition motif of CRP is present in the KP1_4563 promoter region. This study aimed to investigate the function of KP1_4563 in fimbriae and its transcriptional regulation mechanism by CRP. We generated Kp1_4563 mutant and complementation strains. We utilized phenotype and adhesion assays to evaluate the role of KP1_4563 in fimbriae. We conducted quantitative RT-PCR (qRT-PCR), LacZ fusion, electrophoretic mobility shift, and DNase I footprinting assays to study the transcriptional regulation of KP1_4563 gene by CRP. We found that KP1_4563 negatively regulates the function of type 3 fimbriae. Compared with NTUH-K2044, the absence of KP1_4563 enhanced the ability of Kp_4563 to adhere to A549 cells. CRP negatively regulates KP1_4563 by directly binding to its promoter region. KP1_4563 plays an important role in type 3 fimbrial function. This novel insight will assist in the development of strategies for preventing K. pneumoniae infection.	[Luo, Mei; Li, Xuan; Liu, Pin; Zhou, Xipeng; Su, Kewen; Xu, Xuan; Qing, Ying; Qiu, Jingfu; Li, Yingli] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Yang, Shiya] Dianjiang Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Xue, Jian] Zunyi Med & Pharmaceut Coll, Zunyi City, Peoples R China	Chongqing Medical University	Qiu, JF; Li, YL (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China.	jfqiu@126.com; liylyl@126.com		jian, xue/0000-0001-6575-2295	National Natural Science Foundation of China [31200064, 31071093, 31170129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research leading to this manuscript has received funding from the National Natural Science Foundation of China (31200064, 31071093 and 31170129).	ADEGBOLA RA, 1982, INFECT IMMUN, V38, P306, DOI 10.1128/IAI.38.1.306-315.1982; ADEGBOLA RA, 1983, J GEN MICROBIOL, V129, P2175; ALLEN BL, 1991, J BACTERIOL, V173, P916, DOI 10.1128/jb.173.2.916-920.1991; Barbadoro P, 2015, AM J INFECT CONTROL, V43, P707, DOI 10.1016/j.ajic.2015.02.011; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chang Chia-Chen, 2006, Acta Neurol Taiwan, V15, P84; Deng KP, 2011, APPL ENVIRON MICROB, V77, P3952, DOI 10.1128/AEM.02420-10; DONNENBERG MS, 1992, INFECT IMMUN, V60, P3953, DOI 10.1128/IAI.60.10.3953-3961.1992; DUGUID JP, 1959, J GEN MICROBIOL, V21, P271, DOI 10.1099/00221287-21-1-271; EBRIGHT RH, 1989, NUCLEIC ACIDS RES, V17, P10295, DOI 10.1093/nar/17.24.10295; Eletsky A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101787; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; FAVREBONTE S, 1995, INFECT IMMUN, V63, P1318, DOI 10.1128/IAI.63.4.1318-1328.1995; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GUNASEKERA A, 1992, J BIOL CHEM, V267, P14713; [何礼洋 HE Liyang], 2007, [微生物学杂志, Journal of Mirobiology], V27, P15; HORNICK DB, 1991, J CLIN MICROBIOL, V29, P1795, DOI 10.1128/JCM.29.9.1795-1800.1991; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hsu CR, 2011, MICROBIOL-SGM, V157, P3446, DOI 10.1099/mic.0.050336-0; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Kabbani MS, 2016, J INFECT PUBLIC HEAL, V9, P600, DOI 10.1016/j.jiph.2015.12.017; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; Khater F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116215; Kil KS, 1997, J CLIN MICROBIOL, V35, P2370, DOI 10.1128/JCM.35.9.2370-2374.1997; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Li YL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-143; Lin CT, 2006, J BIOCHEM, V140, P429, DOI 10.1093/jb/mvj168; Lin CT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162884; Livrelli V, 1996, J CLIN MICROBIOL, V34, P1963, DOI 10.1128/JCM.34.8.1963-1969.1996; Luo M, 2016, EUR J CLIN MICROBIOL, V35, P1557, DOI 10.1007/s10096-016-2712-y; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Meyer M, 2001, J BACTERIOL, V183, P5248, DOI 10.1128/JB.183.18.5248-5256.2001; MOBLEY HLT, 1990, J INFECT DIS, V161, P525, DOI 10.1093/infdis/161.3.525; Mukhopadhyay J, 1999, FEBS LETT, V453, P215, DOI 10.1016/S0014-5793(99)00719-X; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Murphy CN, 2013, INFECT IMMUN, V81, P3009, DOI 10.1128/IAI.00348-13; OLD DC, 1982, J MED MICROBIOL, V15, P551, DOI 10.1099/00222615-15-4-551; Ou Q, 2017, J MED MICROBIOL, V66, P1, DOI 10.1099/jmm.0.000391; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; PODSCHUN R, 1993, J INFECT DIS, V168, P1415, DOI 10.1093/infdis/168.6.1415; Romling U, 2009, CONTRIB MICROBIOL, V16, P161, DOI 10.1159/000219379; Rudd KE, 1998, ELECTROPHORESIS, V19, P536, DOI 10.1002/elps.1150190413; Salazar JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057272; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Stahlhut SG, 2013, J BACTERIOL, V195, P5602, DOI 10.1128/JB.00753-13; Stahlhut SG, 2012, FEMS IMMUNOL MED MIC, V65, P350, DOI 10.1111/j.1574-695X.2012.00965.x; Stahlhut SG, 2012, J MED MICROBIOL, V61, P317, DOI 10.1099/jmm.0.036350-0; Stella NA, 2008, RES MICROBIOL, V159, P562, DOI 10.1016/j.resmic.2008.07.003; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Struve C, 2009, INFECT IMMUN, V77, P5016, DOI 10.1128/IAI.00585-09; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; TARKKANEN AM, 1992, INFECT IMMUN, V60, P1187, DOI 10.1128/IAI.60.3.1187-1192.1992; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073363; Wang ZC, 2015, MICROBIOL-SGM, V161, P2395, DOI 10.1099/mic.0.000185; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wu CC, 2010, MICROBIOL-SGM, V156, P1983, DOI 10.1099/mic.0.038158-0; Xue J, 2016, GENE, V593, P28, DOI 10.1016/j.gene.2016.08.006; Yadav KK, 2016, THER ADV INFECT DIS, V3, P83, DOI 10.1177/2049936116652326; Zhan LJ, 2008, INFECT IMMUN, V76, P5028, DOI 10.1128/IAI.00370-08; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	68	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180666	10.1371/journal.pone.0180666	http://dx.doi.org/10.1371/journal.pone.0180666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732013	Green Published, gold, Green Submitted			2022-12-27	WOS:000406643100008
J	Coquoz, S; Marchand, PJ; Bouwens, A; Mouchiroud, L; Sorrentino, V; Szlag, D; Auwerx, J; Lasser, T				Coquoz, Severine; Marchand, Paul J.; Bouwens, Arno; Mouchiroud, Laurent; Sorrentino, Vincenzo; Szlag, Daniel; Auwerx, Johan; Lasser, Theo			Label-free three-dimensional imaging of Caenorhabditis elegans with visible optical coherence microscopy	PLOS ONE			English	Article							PROJECTION TOMOGRAPHY; QUANTIFICATION; TOOL	Fast, label-free, high-resolution, three-dimensional imaging platforms are crucial for high-throughput in vivo time-lapse studies of the anatomy of Caenorhabditis elegans, one of the most commonly used model organisms in biomedical research. Despite the needs, methods combining all these characteristics have been lacking. Here, we present label-free imaging of live Caenorhabditis elegans with three-dimensional sub-micrometer resolution using visible optical coherence microscopy (visOCM). visOCM is a versatile optical imaging method which we introduced recently for tomography of cell cultures and tissue samples. Our method is based on Fourier domain optical coherence tomography, an interferometric technique that provides three-dimensional images with high sensitivity, high acquisition rate and micrometer-scale resolution. By operating in the visible wavelength range and using a high NA objective, visOCM attains lateral and axial resolutions below 1 mu m. Additionally, we use a Bessel illumination offering an extended depth of field of approximately 40 mu m. We demonstrate that visOCM's imaging properties allow rapid imaging of full sized living Caenorhabditis elegans down to the sub-cellular level. Our system opens the door to many applications such as the study of phenotypic changes related to developmental or ageing processes.	[Coquoz, Severine; Marchand, Paul J.; Bouwens, Arno; Szlag, Daniel; Lasser, Theo] Ecole Polytech Fed Lausanne, Lab Opt Biomed, Lausanne, Switzerland; [Mouchiroud, Laurent; Sorrentino, Vincenzo; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Coquoz, S (corresponding author), Ecole Polytech Fed Lausanne, Lab Opt Biomed, Lausanne, Switzerland.	severine.coquoz@alumni.epfl.ch	Auwerx, Johan/ABE-9307-2021; Sorrentino, Vincenzo/R-4403-2018; Bouwens, Arno/D-5754-2013	Sorrentino, Vincenzo/0000-0002-7212-370X; Marchand, Paul James/0000-0003-2528-3193; Auwerx, Johan/0000-0002-5065-5393; Bouwens, Arno/0000-0003-4004-3518	Horizon Framework Programme for Research and Innovation [SEFRI 16.0047, 686271]; EPFL [R01AG043930]; NIH [R01AG043930]; Systems X [SySX.ch 2013/153]; Velux Stiftung [1019]; Swiss National Science Foundation [31003A-140780]	Horizon Framework Programme for Research and Innovation; EPFL; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Systems X; Velux Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work in the T.L. laboratory is partially supported by Horizon 2020 Framework Programme for Research and Innovation (SEFRI 16.0047, 686271). The work in the J.A. laboratory is supported by the EPFL, NIH (R01AG043930), Systems X (SySX.ch 2013/153), Velux Stiftung (1019), and the Swiss National Science Foundation (31003A-140780).	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Bassi A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3640808; Berclaz C, 2016, BIOMED OPT EXPRESS, V7, P4569, DOI 10.1364/BOE.7.004569; Berclaz C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10385; Berclaz C, 2012, BIOMED OPT EXPRESS, V3, P1365, DOI 10.1364/BOE.3.001365; Bolmont T, 2012, J NEUROSCI, V32, P14548, DOI 10.1523/JNEUROSCI.0925-12.2012; Boot MJ, 2008, NAT METHODS, V5, P609, DOI 10.1038/nmeth.1219; BRENNER S, 1974, GENETICS, V77, P71; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Colas JF, 2009, ORGANOGENESIS, V5, P211, DOI 10.4161/org.5.4.10426; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Drexler W, 2001, NAT MED, V7, P502, DOI 10.1038/86589; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Isikman SO, 2011, P NATL ACAD SCI USA, V108, P7296, DOI 10.1073/pnas.1015638108; Leitgeb R, 2003, OPT EXPRESS, V11, P889, DOI 10.1364/OE.11.000889; Leitgeb RA, 2006, OPT LETT, V31, P2450, DOI 10.1364/OL.31.002450; Marchand PJ, 2017, BIOMED OPT EXPRESS, V8, P3343, DOI 10.1364/BOE.8.003343; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rieckher M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018963; Santi PA, 2011, J HISTOCHEM CYTOCHEM, V59, P129, DOI 10.1369/0022155410394857; Sharpe J, 2003, J ANAT, V202, P175, DOI 10.1046/j.1469-7580.2003.00155.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Villiger M, 2009, DIABETOLOGIA, V52, P1599, DOI 10.1007/s00125-009-1383-y; Villiger M, 2010, OPT LETT, V35, P3489, DOI 10.1364/OL.35.003489; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068056	33	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181676	10.1371/journal.pone.0181676	http://dx.doi.org/10.1371/journal.pone.0181676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727813	Green Submitted, gold, Green Published			2022-12-27	WOS:000406634500101
J	Liu, PY; Xu, YY; Tang, YH; Du, M; Yu, X; Sun, J; Xiao, L; He, MA; Wei, S; Yuan, J; Wang, YJ; Liang, Y; Wu, TC; Miao, X; Yao, P				Liu, Peiyi; Xu, Yanyan; Tang, Yuhan; Du, Min; Yu, Xiao; Sun, Jian; Xiao, Lin; He, Meian; Wei, Sheng; Yuan, Jing; Wang, Youjie; Liang, Yuan; Wu, Tangchun; Miao, Xiaoping; Yao, Ping			Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men	PLOS ONE			English	Article							ASIA-PACIFIC REGION; CIGARETTE-SMOKING; DECREASED PREVALENCE; METABOLIC SYNDROME; DIABETES-MELLITUS; POPULATION; STEATOHEPATITIS; ASSOCIATIONS; MANAGEMENT; FIBROSIS	Background Whether cigarette smoking and moderate drinking are associated with non-alcoholic fatty liver disease (NAFLD) has not been fully described. This study investigated the separate and joint effects of smoking and moderate drinking on Chinese men with NAFLD. Methods Across-sectional assay from DFTJ Cohort study was performed with a size of 9432 elderly Chinese men excluding excessive alcohol consumption (<210g/week). Fatty liver was diagnosed by standardized ultrasonographic inspection. The odds ratio (OR) of alcohol consumption and smoking for the prevalence of NAFLD were analyzed using multiple logistic regression with multiple adjustments. Results The prevalence of NAFLD in current smokers (pack-year >= 40) and drinkers (80 similar to 210g/week or drinking duration >= 35years) was significantly higher than that in non-smokers and nondrinkers, respectively. The combination of current smoking (pack-year >= 40) and drinking (80 similar to 210g/week) was associated with the highest risk of NAFLD (OR 1.85; 95% confidence interval [CI] 1.28-2.68; P<0.01). The similar combined effect was found in participants with pack-year >= 40 and drinking duration >= 35 years (OR 1.72; 95% CI 1.26 -2.34; P<0.01). Moreover, an interaction was observed between current smoking and moderate drinking in NAFLD. Conclusions In elderly Chinese men, cigarette smoking and moderate alcohol consumption exerts an evident joint effect and interaction on the prevalence of NAFLD, although both are significantly and independently associated with NAFLD prevalence. Such findings highlight particular significance of avoidance of cigarette and alcohol on NAFLD prevention.	[Liu, Peiyi; Xu, Yanyan; Tang, Yuhan; Du, Min; Yu, Xiao; Sun, Jian; Xiao, Lin; Yao, Ping] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Wuhan, Hubei, Peoples R China; [Liu, Peiyi; Xu, Yanyan; Tang, Yuhan; Du, Min; Yu, Xiao; Sun, Jian; Xiao, Lin; Yao, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China; [He, Meian; Yuan, Jing; Wang, Youjie; Liang, Yuan; Wu, Tangchun] Huazhong Univ Sci & Technol, Inst Occupat Med, Wuhan, Hubei, Peoples R China; [He, Meian; Yuan, Jing; Wang, Youjie; Liang, Yuan; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China; [Wei, Sheng; Miao, Xiaoping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China; [Wei, Sheng; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yao, P (corresponding author), Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Wuhan, Hubei, Peoples R China.; Yao, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China.; Miao, X (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China.; Miao, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China.	yaoping@mails.tjmu.edu.cn; miaoxp@hust.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722	National Natural Science Foundation of China [81472979, 81402673]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is financially supported by National Natural Science Foundation of China (No. 81472979 and 81402673). Yuhan Tang was participated in analysis and interpretation of data, and in critical revision of the manuscript. Ping Yao was involved in study concept and design, as well as critical revision of the manuscript.	ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Bataller R, 2006, HEPATOLOGY, V44, P1394, DOI 10.1002/hep.21484; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Dunn W, 2012, J HEPATOL, V57, P384, DOI 10.1016/j.jhep.2012.03.024; El-Zayadi AR, 2006, WORLD J GASTROENTERO, V12, P6098, DOI 10.3748/wjg.v12.i38.6098; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; Hamabe A, 2011, J GASTROENTEROL, V46, P769, DOI 10.1007/s00535-011-0376-z; Hannah WN, 2016, DIGEST DIS SCI, V61, P1365, DOI 10.1007/s10620-016-4153-y; Hashimoto Y, 2015, J GASTROEN HEPATOL, V30, P546, DOI 10.1111/jgh.12786; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Jia WP, 2013, BIOMED ENVIRON SCI, V26, P947, DOI 10.3967/bes2013.029; Kwon HK, 2014, LIVER INT, V34, P129, DOI 10.1111/liv.12230; Liu B, 2009, AM J EPIDEMIOL, V169, P153, DOI 10.1093/aje/kwn280; Moriya A, 2011, ALIMENT PHARM THER, V33, P378, DOI 10.1111/j.1365-2036.2010.04520.x; Moriya A, 2015, J HEPATOL, V62, P921, DOI 10.1016/j.jhep.2014.11.025; Nakashita Y, 2010, J EPIDEMIOL, V20, P391, DOI 10.2188/jea.JE20100043; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; POZZATO G, 1995, J GERONTOL A-BIOL, V50, pB135, DOI 10.1093/gerona/50A.3.B135; Schooling CM, 2009, J EPIDEMIOL COMMUN H, V63, P121, DOI 10.1136/jech.2008.077602; Wadd Sarah, 2014, BMC Res Notes, V7, P741, DOI 10.1186/1756-0500-7-741; Wang F, 2013, INT J EPIDEMIOL, V42, P731, DOI 10.1093/ije/dys053; Wang XF, 2011, HEPATOB PANCREAT DIS, V10, P276, DOI 10.1016/S1499-3872(11)60046-5; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Yalcinkaya E, 2014, EUR REV MED PHARMACO, V18, P760; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Yeung SLA, 2015, AM J EPIDEMIOL, V182, P320, DOI 10.1093/aje/kwv069; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004; Yu M, 2014, J EPIDEMIOL, V24, P361, DOI 10.2188/jea.JE20130112; Zein CO, 2010, HEPATOLOGY, V51, P1487, DOI 10.1002/hep.23694; Zhang CF, 2016, J SENSORS, V2016, DOI 10.1155/2016/9307560	39	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181497	10.1371/journal.pone.0181497	http://dx.doi.org/10.1371/journal.pone.0181497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727853	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500080
J	Malcher, SM; Pieczarka, JC; Geise, L; Rossi, RV; Pereira, AL; O'Brien, PCM; Asfora, PH; da Silva, VF; Sampaio, MI; Ferguson-Smith, MA; Nagamachi, CY				Malcher, Stella Miranda; Pieczarka, Julio Cesar; Geise, Lena; Rossi, Rogerio Vieira; Pereira, Adenilson Leao; Mary O'Brien, Patricia Caroline; Asfora, Paulo Henrique; da Silva, Victor Fonseca; Sampaio, Maria Iracilda; Ferguson-Smith, Malcolm Andrew; Nagamachi, Cleusa Yoshiko			Oecomys catherinae (Sigmodontinae, Cricetidae): Evidence for chromosomal speciation?	PLOS ONE			English	Article							WHOLE CHROMOSOME; RODENTIA; KARYOTYPE; REORGANIZATION; EVOLUTION; SEQUENCE; BRAZIL; FISH	Among the Oryzomyini (Sigmodontinae), Oecomys is the most speciose, with 17 species. This genus presents high karyotypic diversity (2n = 54 to 2n = 86) and many taxonomic issues at the species level because of the presence of cryptic species and the overlap of morphological characters. For these reasons the real number of species of Oecomys may be underestimated. With the aim of verifying if the taxon Oecomys catherinae is composed of more than one species, we made comparative studies on two populations from two regions of Brazil, one from the Amazon and another from the Atlantic Forest using both classical cytogenetics (G- and C-banding) and comparative genomic mapping with whole chromosome probes of Hylaeamys megacephalus (HME), molecular data (cytochrome b mitochondrial DNA) and morphology. Our results confirm that Oecomys catherinae occurs in the southeast Amazon, and reveal a new karyotype for the species (2n = 62, FNa = 62). The comparative genomic analysis with HME probes identified chromosomal homeologies between both populations and rearrangements that are responsible for the different karyotypes. We compared our results in Sigmodontinae genera with other studies that also used HME probes. These chromosomal differences together with the absence of consistent differentiation between the two populations on morphological and molecular analyses suggest that these populations may represent cryptic species.	[Malcher, Stella Miranda; Pieczarka, Julio Cesar; Pereira, Adenilson Leao; Nagamachi, Cleusa Yoshiko] Univ Fed Para, Inst Ciencias Biol, Lab Citogenet, Ctr Estudos Avancados Biodiversidade, Belem, Para, Brazil; [Geise, Lena] Univ Estado Rio de Janeiro, Dept Zool, Lab Mastozool, Rio De Janeiro, Brazil; [Rossi, Rogerio Vieira; da Silva, Victor Fonseca] Univ Fed Mato Grosso, Inst Biociencias, Cuiaba, Mato Grosso, Brazil; [Mary O'Brien, Patricia Caroline; Ferguson-Smith, Malcolm Andrew] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Asfora, Paulo Henrique] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Sampaio, Maria Iracilda] Univ Fed Para, Lab Genet & Biol Mol, Campus Univ Braganca, Braganca, Para, Brazil	Universidade Federal do Para; Universidade do Estado do Rio de Janeiro; Universidade Federal de Mato Grosso; University of Cambridge; Universidade Federal de Goias; Universidade Federal do Para	Nagamachi, CY (corresponding author), Univ Fed Para, Inst Ciencias Biol, Lab Citogenet, Ctr Estudos Avancados Biodiversidade, Belem, Para, Brazil.	cleusanagamachi@gmail.com	Nagamachi, Cleusa/AAV-8985-2021; Rossi, Rogerio V/I-2176-2015; /M-4245-2013; Leão Pereira, Adenilson/GRF-1622-2022; Pereira, Adenilson Leão/C-9820-2018; Pieczarka, Julio C/E-7585-2016	Pereira, Adenilson Leão/0000-0003-2687-5297; Pieczarka, Julio C/0000-0003-2951-8877; Vieira Rossi, Rogerio/0000-0003-2353-5000; Nagamachi, Cleusa Yoshiko/0000-0003-1516-2734; Geise, Lena/0000-0003-1239-8047	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308428/2013-7, 308401/2013-1]; Fundacao Amazonia Paraense; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BIONORTE-CNPq) [552032/2010-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BIONORTE-FAPESPA) [ICAAF 007/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [Edital 047/2012 PRO-AMAZONIA]; FAPESPA [2010/110447]; BNDES [2.318.697.0001]; Fundacao de Amparo a Pesquisa do Estado de Mato Grosso [477017/2011]; CAPES Doctor Scholarship in Neuroscience and Cell Biology; CAPES Doctor Scholarship in Genetics and Molecular Biology; FAPEMAT Doctor Scholarship in Bionorte	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Amazonia Paraense; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BIONORTE-CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BIONORTE-FAPESPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); BNDES; Fundacao de Amparo a Pesquisa do Estado de Mato Grosso(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); CAPES Doctor Scholarship in Neuroscience and Cell Biology(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES Doctor Scholarship in Genetics and Molecular Biology(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMAT Doctor Scholarship in Bionorte	This work was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Productivity Grants 308428/2013-7 to CYN and 308401/2013-1 to JCP; www.cnpq.br), Fundacao Amazonia Paraense (http://www.fapespa.pa.gov.br/), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Edital BIONORTE-CNPq, Proc. 552032/2010-7; BIONORTE-FAPESPA, ICAAF 007/2011; Edital 047/2012 PRO-AMAZONIA: Biodiversidade e Sustentabilidade; www.capes.gov.br) on projects coordinated by CYN, the FAPESPA (Edital Vale-Proc. 2010/110447), BNDES (Operacao 2.318.697.0001) on projects coordinated by JCP, and Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (http://www.fapemat.mt.gov.br/) on a project coordinated by RVR (Proc. 477017/2011). LG thanks UERJ/Prociencia and CNPq. SMM is recipient of a CAPES Doctor Scholarship in Neuroscience and Cell Biology, ALP is recipient of a CAPES Doctor Scholarship in Genetics and Molecular Biology, and VFS is recipient of a FAPEMAT Doctor Scholarship in Bionorte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sample collection was authorized by Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio). CYN (308428/2013-7) and JCP (308401/2013-1) are grateful to CNPq for Productivity Grants. LG receives UERJ/Prociencia Productivity Grant. SMM is recipient of CAPES Doctor Scholarship in Neuroscience and Cell Biology, ALP is recipient of CAPES Doctor Scholarship in Genetics and Molecular Biology and VFS is recipient of FAPEMAT Doctor Scholarship in Bionorte. We thank Tamara Flores for providing sequences of the Amazonian specimens of O. catherinae. We thanks to Willam Oliveira da Silva for designing the map.	Andrades-Miranda J, 2001, ACTA THERIOL, V46, P269, DOI 10.1007/BF03192433; Asfora PH, 2011, BIOTA NEOTROP, V11, P415, DOI 10.1590/S1676-06032011000200039; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bonvicino C, 2000, MAMMALIA, V64, P339, DOI 10.1515/mamm.2000.64.3.339; Carleton Michael D., 2015, P393; Costa L., 2008, IUCN RED LIST THREAT; de Andrade AFB, 2003, GENOME, V46, P195, DOI 10.1139/G02-123; Di-Nizo CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117579; Dobigny G, 2002, CYTOGENET GENOME RES, V96, P117, DOI 10.1159/000063044; Ferguson-Smith MA, 2007, NAT REV GENET, V8, P950, DOI 10.1038/nrg2199; Ferguson-Smith Malcolm A., 1998, ILAR J, V39, P68; FORD CE, 1956, STAIN TECHNOL, V31, P247, DOI 10.3109/10520295609113814; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hass I, 2011, CYTOGENET GENOME RES, V135, P42, DOI 10.1159/000330259; Hass I, 2008, CHROMOSOME RES, V16, P75, DOI 10.1007/s10577-007-1211-5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; King M., 1995, SPECIES EVOLUTION RO; Kovalskaya YM, 2011, CYTOGENET GENOME RES, V132, P271, DOI 10.1159/000322823; Lambert TD, 2005, J MAMMAL, V86, P982, DOI 10.1644/1545-1542(2005)86[982:VISMSR]2.0.CO;2; Lambert TD, 2006, J MAMMAL, V87, P766, DOI 10.1644/05-MAMM-A-261R1.1; Langguth Alfredo, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P183; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MUSSER GG, 2005, MAMMAL SPECIES WORLD, V2, P894; Nagamachi CY, 2013, CHROMOSOME RES, V21, P107, DOI 10.1007/s10577-013-9341-4; OLIVEIRA F.F., 2004, REV NORDESTINA BIOL, V18, P19; Pardinas UFJ, 2016, J MAMMAL; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; Patton JL, 1976, OCCASIONAL PAPERS MU, V49, P1; Peppers LL, 2000, J MAMMAL, V81, P332, DOI 10.1644/1545-1542(2000)081<0332:CSISHE>2.0.CO;2; Pereira AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146179; Pinheiro Paula S., 2008, Boletim do Museu de Biologia Mello Leitao, V23, P51; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rocha Rita G., 2011, Zootaxa, V2789, P1; Rosa CC, 2012, J GENET, V91, P265, DOI 10.1007/s12041-012-0182-2; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider H., METODOS ANALISE FILO; SMITH MF, 1993, BIOL J LINN SOC, V50, P149, DOI 10.1111/j.1095-8312.1993.tb00924.x; Suarez P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143482; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Swier VJ, 2009, CYTOGENET GENOME RES, V125, P54, DOI 10.1159/000218747; Thomas O., 1909, ANN MAG NAT HIST, V8, P230, DOI DOI 10.1080/00222930908692666; Ventura K, 2009, CHROMOSOME RES, V17, P1063, DOI 10.1007/s10577-009-9083-5; Verma RS, 1995, HUMAN CHROMOSOMES PR, P419; VOSS RS, 1991, B AM MUS NAT HIST, P1; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Zwickl D. J, 2006, GENETIC ALGORITHM AP	46	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181434	10.1371/journal.pone.0181434	http://dx.doi.org/10.1371/journal.pone.0181434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727788	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500074
J	Wada, H; Masumoto-Kubo, C; Tsutsumi, K; Nonami, H; Tanaka, F; Okada, H; Erra-Balsells, R; Hiraoka, K; Nakashima, T; Hakata, M; Morita, S				Wada, Hiroshi; Masumoto-Kubo, Chisato; Tsutsumi, Koichi; Nonami, Hiroshi; Tanaka, Fukuyo; Okada, Haruka; Erra-Balsells, Rosa; Hiraoka, Kenzo; Nakashima, Taiken; Hakata, Makoto; Morita, Satoshi			Turgor-responsive starch phosphorylation in Oryza sativa stems: A primary event of starch degradation associated with grain-filling ability	PLOS ONE			English	Article							APOPLASTIC SOLUTE ACCUMULATION; NONSTRUCTURAL CARBOHYDRATE; VITIS-VINIFERA; RICE; WATER; CELL; EXPRESSION; PROTEIN; METABOLISM; GROWTH	Grain filling ability is mainly affected by the translocation of carbohydrates generated from temporarily stored stem starch in most field crops including rice (Oryza sativa L.). The partitioning of non-structural stem carbohydrates has been recognized as an important trait for raising the yield ceiling, yet we still do not fully understand how carbohydrate partitioning occurs in the stems. In this study, two rice subspecies that exhibit different patterns of nonstructural stem carbohydrates partitioning, a japonica-dominant cultivar, Momiroman, and an indica-dominant cultivar, Hokuriku 193, were used as the model system to study the relationship between turgor pressure and metabolic regulation of non-structural stem carbohydrates, by combining the water status measurement with gene expression analysis and a dynamic prefixed C-13 tracer analysis using a mass spectrometer. Here, we report a clear varietal difference in turgor-associated starch phosphorylation occurred at the initiation of non-structural carbohydrate partitioning. The data indicated that starch degradation in Hokuriku 193 stems occurred at full-heading, 5 days earlier than in Momiroman, contributing to greater sink filling. Gene expression analysis revealed that expression pattern of the gene encoding alpha-glucan, water dikinase (GWD1) was similar between two varieties, and the maximum expression level in Hokuriku 193, reached at full heading (4 DAH), was greater than in Momiroman, leading to an earlier increase in a series of amylase-related gene expression in Hokuriku 193. In both varieties, peaks in turgor pressure preceded the increases in GWD1 expression, and changes in GWD1 expression was correlated with turgor pressure. Additionally, a threshold is likely to exist for GWD1 expression to facilitate starch degradation. Taken together, these results raise the possibility that turgor-associated starch phosphorylation in cells is responsible for the metabolism that leads to starch degradation. Because the two cultivars exhibited remarkable varietal differences in the pattern of non-structural carbohydrate partitioning, our findings propose that the observed difference in grain-filling ability originated from turgor-associated regulation of starch phosphorylation in stem parenchyma cells. Further understanding of the molecular mechanism of turgor-regulation may provide a new selection criterion for breaking the yield barriers in crop production.	[Wada, Hiroshi; Masumoto-Kubo, Chisato; Tsutsumi, Koichi; Hakata, Makoto; Morita, Satoshi] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Chikugo, Fukuoka, Japan; [Nonami, Hiroshi; Okada, Haruka; Nakashima, Taiken] Ehime Univ, Fac Agr, Dept Biomech Syst, Matsuyama, Ehime, Japan; [Tanaka, Fukuyo] Natl Agr & Food Res Org, Cent Reg Agr Res Ctr, Tsukuba, Ibaraki, Japan; [Erra-Balsells, Rosa] Univ Buenos Aires, Fac Exact & Nat Sci, Dept Organ Chem CIHIDECAR, Buenos Aires, DF, Argentina; [Hiraoka, Kenzo] Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi, Japan	National Agriculture & Food Research Organization - Japan; Ehime University; National Agriculture & Food Research Organization - Japan; University of Buenos Aires; University of Yamanashi	Wada, H (corresponding author), Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Chikugo, Fukuoka, Japan.	hwada@affrc.go.jp	TANAKA, Fukuyo/L-3978-2019	TANAKA, Fukuyo/0000-0002-0904-3248; Wada, Hiroshi/0000-0003-0510-5744	JSPS KAKENHI Grant [24248005, 24228004, 16H02533]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24248005 (SM) and JSPS KAKENHI Grant Number 16H02533 (HW) and in part by JSPS KAKENHI Grant Number 24228004 (HN). RE-B is a research member of National Council of Scientific and Technological Research (CONICET), Argentina.; The authors gratefully acknowledge Dr. Mark Matthews for kindly supplying the thermocouple sensors for the isopiestic psychrometry, and Dr. Hiroshi Nakano for helpful comments on the manuscript. The authors also thank Mr. Akitoshi Honbu, Mr. Keiji Miike, Ms. Fujiko Komiya, Ms. Fumie Tsuru, and Ms. Kumika Kakiuchi for their help in growing the rice plants and assistance with the experiments. This work was supported by JSPS KAKENHI Grant Number 24248005 and JSPS KAKENHI Grant Number 16H02533 and in part by JSPS KAKENHI Grant Number 24228004. RE-B is a research member of National Council of Scientific and Technological Research (CONICET), Argentina.	BOYER JS, 1995, MEASURING WATER STAT, P178; Castellarin SD, 2016, J EXP BOT, V67, P709, DOI 10.1093/jxb/erv483; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Cock J. H., 1972, Proceedings of the Crop Science Society of Japan, V41, P226; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Finan JD, 2009, ANN BIOMED ENG, V37, P477, DOI 10.1007/s10439-008-9618-5; Gambetta GA, 2013, PHYSIOL PLANTARUM, V148, P334, DOI 10.1111/ppl.12014; Godfray HCJ, 2010, PHILOS T R SOC B, V365, P2769, DOI 10.1098/rstb.2010.0180; GUERRERO FD, 1990, PLANT MOL BIOL, V15, P11, DOI 10.1007/BF00017720; Hirabayashi H., 2010, B NATL I CROP SCI, V11, P31; Hirano T, 2011, PLANT PROD SCI, V14, P318, DOI 10.1626/pps.14.318; Hirose T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00147; Hoshikawa K., 1989, GROWING RICE PLANT A, Vxvi; Jayaram B, 2004, ANNU REV BIOPH BIOM, V33, P343, DOI 10.1146/annurev.biophys.33.110502.140414; JONES JT, 1995, PLANT MOL BIOL, V28, P983, DOI 10.1007/BF00032661; Khush GS, 2011, P NARO S FUK JAP, P1; Kotting O, 2010, CURR OPIN PLANT BIOL, V13, P321, DOI 10.1016/j.pbi.2010.01.003; Kramer P.J., 1995, WATER RELATIONS PLAN; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Matsuba K., 1991, Bulletin of the Chugoku National Agricultural Experiment Station, P11; MCCAIN DC, 1995, BIOPHYS J, V69, P1105, DOI 10.1016/S0006-3495(95)79984-2; Mohapatra PK, 2004, FUNCT PLANT BIOL, V31, P131, DOI 10.1071/FP03177; MOORE PH, 1991, PLANT PHYSIOL, V96, P794, DOI 10.1104/pp.96.3.794; Morita S, 2011, CROP SCI, V51, P818, DOI 10.2135/cropsci2010.06.0373; Ohnishi M, 1999, JPN J CROP SCI, V68, P126, DOI 10.1626/jcs.68.126; OPARKA KJ, 1992, PLANT J, V2, P741, DOI 10.1111/j.1365-313X.1992.tb00143.x; Patrick JW, 1997, ANNU REV PLANT PHYS, V48, P191, DOI 10.1146/annurev.arplant.48.1.191; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Proseus TE, 1999, PLANT PHYSIOL, V119, P775, DOI 10.1104/pp.119.2.775; Proseus TE, 2005, ANN BOT-LONDON, V95, P967, DOI 10.1093/aob/mci113; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Sacks E. J., 2014, PERENNIAL CROPS FOOD, P16; SAITOH K, 1991, JPN J CROP SCI, V60, P255, DOI 10.1626/jcs.60.255; Schwabe JWR, 1997, CURR OPIN STRUC BIOL, V7, P126, DOI 10.1016/S0959-440X(97)80016-4; Scofield GN, 2007, J EXP BOT, V58, P3155, DOI 10.1093/jxb/erm153; Silver DM, 2014, TRENDS PLANT SCI, V19, P471, DOI 10.1016/j.tplants.2014.01.008; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; Sugimura Y, 2015, PLANT PROD SCI, V18, P277, DOI 10.1626/pps.18.277; Taiz L, 2010, PLANT PHYSIOL, Vxxxiv, P782; Toyota K, 2006, PLANTA, V223, P248, DOI 10.1007/s00425-005-0128-5; Tsukaguchi T, 1996, JPN J CROP SCI, V65, P445, DOI 10.1626/jcs.65.445; Uehlein N, 2008, PLANT CELL, V20, P648, DOI 10.1105/tpc.107.054023; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wada H, 2008, PLANTA, V227, P1351, DOI 10.1007/s00425-008-0707-3; Wada Hiroshi, 2004, Environment Control in Biology, V42, P193; Wada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110374; Wada H, 2014, PLANT PHYSIOL, V164, P1800, DOI 10.1104/pp.113.231688; Wada H, 2009, J EXP BOT, V60, P1773, DOI 10.1093/jxb/erp050; Wan XC, 2004, J EXP BOT, V55, P411, DOI 10.1093/jxb/erh051; Working Group I, 2014, CLIMATE CHANGE 2013, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324]; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Yoshinaga S, 2013, FIELD CROP RES, V150, P74, DOI 10.1016/j.fcr.2013.06.004; ZHU GL, 1992, PLANT PHYSIOL, V100, P2071, DOI 10.1104/pp.100.4.2071	54	11	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181272	10.1371/journal.pone.0181272	http://dx.doi.org/10.1371/journal.pone.0181272			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727805	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500052
J	Hoon, M; Krishnamoorthy, V; Gollisch, T; Falkenburger, B; Varoqueaux, F				Hoon, Mrinalini; Krishnamoorthy, Vidhyasankar; Gollisch, Tim; Falkenburger, Bjoern; Varoqueaux, Frederique			Loss of Neuroligin3 specifically downregulates retinal GABA(Aa)2 receptors without abolishing direction selectivity	PLOS ONE			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; MAMMALIAN RETINA; RAT RETINA; GLYCINE RECEPTORS; GANGLION-CELLS; MOUSE MODEL; SYNAPSES; AUTISM; PROTEIN; LOCALIZATION	The postsynaptic adhesion proteins Neuroligins (NLs) are essential for proper synapse function, and their alterations are associated with a variety of neurodevelopmental disorders. It is increasingly clear that each NL isoform occupies specific subsets of synapses and is able to regulate the function of discrete networks. Studies of NL2 and NL4 in the retina in particular have contributed towards uncovering their role in inhibitory synapse function. In this study we show that NL3 is also predominantly expressed at inhibitory postsynapses in the retinal inner plexiform layer (IPL), where it colocalizes with both GABA(A)- and glycinergic receptor clusters in a 3: 2 ratio. In the NL3 deletion-mutant (knockout or KO) mouse, we uncovered a dramatic reduction of the number of GABA(A)alpha 2-subunit containing GABA(A) receptor clusters at the IPL. Retinal activity was thereafter assessed in KO and wild-type (WT) littermates by multi-electrode-array recordings of the output cells of retina, the retinal ganglion cells (RGCs). RGCs in the NL3 KO showed reduced spontaneous activity and an altered response to white noise stimulation. Moreover, upon application of light flashes, the proportion of cells firing at light offset (OFF RGCs) was significantly lower in the NL3 KO compared to WT littermates, whereas the relative number of cells firing at light onset (ON RGCs) increased. Interestingly, although GABA(A)alpha 2-bearing receptors have been related to direction-selective circuits of the retina, features of direction selective-retinal ganglion cells recorded remained unperturbed in the NL3 KO. Together our data underscore the importance of NL3 for the integrity of specific GABA(A)ergic retinal circuits and identifies NL3 as an important regulator of retinal activity.	[Hoon, Mrinalini; Varoqueaux, Frederique] Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany; [Hoon, Mrinalini; Varoqueaux, Frederique] Deutsch Forsch Gemeinschaft, Res Ctr Mol Physiol Brain, Gottingen, Germany; [Krishnamoorthy, Vidhyasankar; Gollisch, Tim] Univ Med Ctr Gottingen, Dept Ophthalmol, Gottingen, Germany; [Krishnamoorthy, Vidhyasankar; Gollisch, Tim] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Falkenburger, Bjoern] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Varoqueaux, Frederique] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Hoon, Mrinalini] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Max Planck Society; University of Gottingen; RWTH Aachen University; University of Lausanne; University of Washington; University of Washington Seattle	Hoon, M; Varoqueaux, F (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany.; Hoon, M; Varoqueaux, F (corresponding author), Deutsch Forsch Gemeinschaft, Res Ctr Mol Physiol Brain, Gottingen, Germany.; Varoqueaux, F (corresponding author), Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland.; Hoon, M (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	mhoon@uw.edu; frederique.varoqueaux@unil.ch	889, CRC/L-1607-2018; Varoqueaux, Frederique/AAC-1834-2021	889, CRC/0000-0002-6678-3138; Varoqueaux, Frederique/0000-0002-3614-3121; Falkenburger, Bjoern/0000-0002-2387-526X; Gollisch, Tim/0000-0003-3998-533X	Cure Autism Now Foundation; Swiss National Science Foundation (Marie-Heim Vogtlin) [PMPDP3_158377]; Hertie Foundation; European Community Grants NEUREST [MEST-CT-2004-504193]; Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain; Deutsche Forschungsgemeinschaft Collaborative Research Center [889]	Cure Autism Now Foundation; Swiss National Science Foundation (Marie-Heim Vogtlin); Hertie Foundation; European Community Grants NEUREST; Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG))	This work was funded by the Cure Autism Now Foundation (F.V.) and the Swiss National Science Foundation (Marie-Heim Vogtlin grant PMPDP3_158377 to F.V.); the Hertie Foundation (M. H.); European Community Grants NEUREST MEST-CT-2004-504193 (to M.H.); the Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain (M. H., B. F. and F.V.); the Deutsche Forschungsgemeinschaft Collaborative Research Center 889, project C1 (T.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auferkorte ON, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035109; Babaev O, 2016, NEUROPHARMACOLOGY, V100, P56, DOI 10.1016/j.neuropharm.2015.06.016; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Bleckert A, 2014, CURR BIOL, V24, P310, DOI 10.1016/j.cub.2013.12.020; Bleckert A, 2011, BIOESSAYS, V33, P61, DOI 10.1002/bies.201000095; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110; Casini G, 2000, J COMP NEUROL, V421, P275; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Espinosa Felipe, 2015, Front Synaptic Neurosci, V7, P11, DOI 10.3389/fnsyn.2015.00011; Fiscella M, 2015, J NEUROPHYSIOL, V114, P2485, DOI 10.1152/jn.00919.2014; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; Garvert MM, 2013, NEURON, V77, P915, DOI 10.1016/j.neuron.2012.12.030; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Grady EF, 1996, J NEUROSCI, V16, P6975, DOI 10.1523/jneurosci.16-21-06975.1996; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hammer M, 2015, CELL REP, V13, P516, DOI 10.1016/j.celrep.2015.09.011; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hoon M, 2014, PROG RETIN EYE RES, V42, P44, DOI 10.1016/j.preteyeres.2014.06.003; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Jedlicka P, 2015, BRAIN STRUCT FUNCT, V220, P47, DOI 10.1007/s00429-013-0636-1; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Kim JYV, 2016, PAIN, V157, P1314, DOI 10.1097/j.pain.0000000000000513; Klooster J, 2009, J CHEM NEUROANAT, V37, P254, DOI 10.1016/j.jchemneu.2009.02.004; Koulen P, 1998, J NEUROSCI, V18, P10136; Koulen P, 1997, NEUROREPORT, V8, P2845, DOI 10.1097/00001756-199709080-00008; Koulen P, 1996, J NEUROSCI, V16, P2127; Krishnamoorthy V, 2017, ELIFE, V6, DOI [10.7554/eLife.22431, 10.7554/eLife.221431]; Kuhn NK, 2016, J NEUROSCI, V36, P12203, DOI 10.1523/JNEUROSCI.1971-16.2016; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Mazurek M, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00092; Nobles RD, 2012, J NEUROSCI, V32, P3321, DOI 10.1523/JNEUROSCI.5341-11.2012; Pei Z, 2015, J NEUROSCI, V35, P13219, DOI 10.1523/JNEUROSCI.0933-15.2015; Poulopoulos A, 2012, BIOCHEM J, V446, P321, DOI 10.1042/BJ20120808; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Rivlin-Etzion M, 2012, NEURON, V76, P518, DOI 10.1016/j.neuron.2012.08.041; SassoePognetto M, 1997, J COMP NEUROL, V381, P158, DOI 10.1002/(SICI)1096-9861(19970505)381:2<158::AID-CNE4>3.0.CO;2-2; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takacs VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072450; Uchigashima M, 2016, P NATL ACAD SCI USA, V113, P4206, DOI 10.1073/pnas.1514074113; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; VARDI N, 1995, J COMP NEUROL, V351, P374, DOI 10.1002/cne.903510305; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3	59	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181011	10.1371/journal.pone.0181011	http://dx.doi.org/10.1371/journal.pone.0181011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708891	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649800037
J	Loupasakis, K; Kuo, D; Sokhi, UK; Sohn, C; Syracuse, B; Giannopoulou, EG; Park, SH; Kang, H; Ratsch, G; Ivashkiv, LB; Kalliolias, GD				Loupasakis, Konstantinos; Kuo, David; Sokhi, Upneet K.; Sohn, Christopher; Syracuse, Bethany; Giannopoulou, Eugenia G.; Park, Sung Ho; Kang, Hyelim; Ratsch, Gunnar; Ivashkiv, Lionel B.; Kalliolias, George D.			Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; TRISTETRAPROLIN; TRANSCRIPTION; INFLAMMATION; BINDING	During rheumatoid arthritis (RA), Tumor Necrosis Factor (TNF) activates fibroblast-like synoviocytes (FLS) inducing in a temporal order a constellation of genes, which perpetuate synovial inflammation. Although the molecular mechanisms regulating TNF-induced transcription are well characterized, little is known about the impact of mRNA stability on gene expression and the impact of TNF on decay rates of mRNA transcripts in FLS. To address these issues we performed RNA sequencing and genome-wide analysis of the mRNA stabilome in RA FLS. We found that TNF induces a biphasic gene expression program: initially, the inducible transcriptome consists primarily of unstable transcripts but progressively switches and becomes dominated by very stable transcripts. This temporal switch is due to: a) TNF-induced prolonged stabilization of previously unstable transcripts that enables progressive transcript accumulation over days and b) sustained expression and late induction of very stable transcripts. TNF-induced mRNA stabilization in RA FLS occurs during the late phase of TNF response, is MAPK-dependent, and involves several genes with pathogenic potential such as IL6, CXCL1, CXCL3, CXCL8/IL8, CCL2, and PTGS2. These results provide the first insights into genome-wide regulation of mRNA stability in RA FLS and highlight the potential contribution of dynamic regulation of the mRNA stabilome by TNF to chronic synovitis.	[Loupasakis, Konstantinos; Sokhi, Upneet K.; Sohn, Christopher; Syracuse, Bethany; Giannopoulou, Eugenia G.; Park, Sung Ho; Ivashkiv, Lionel B.; Kalliolias, George D.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA; [Loupasakis, Konstantinos; Sokhi, Upneet K.; Sohn, Christopher; Syracuse, Bethany; Giannopoulou, Eugenia G.; Park, Sung Ho; Ivashkiv, Lionel B.; Kalliolias, George D.] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Kuo, David] Weill Cornell Grad Sch Med Sci, Grad Program Physiol Biophys & Syst Biol, New York, NY USA; [Kuo, David; Ratsch, Gunnar] Sloan Kettering Inst, Computat Biol Program, New York, NY USA; [Giannopoulou, Eugenia G.; Kang, Hyelim] CUNY, New York City Coll Technol, Biol Sci Dept, Brooklyn, NY 11210 USA; [Ratsch, Gunnar] ETH, Dept Comp Sci, Zurich, Switzerland	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kalliolias, GD (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.; Kalliolias, GD (corresponding author), Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA.	kallioliasg@hss.com	Loupasakis, Konstantinos/AAD-5330-2021; Rätsch, Gunnar/O-5914-2017; Giannopoulou, Evgenia/K-9576-2019; Kalliolias, George D./H-3136-2019	Rätsch, Gunnar/0000-0001-5486-8532; Kalliolias, George D./0000-0002-4427-8245; SOKHI, UPNEET/0000-0001-5907-5646; Kuo, David/0000-0001-9003-9993	Arthritis National Research Foundation; NIH/NIAMS; Rheumatology Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050401, R01AR046713] Funding Source: NIH RePORTER	Arthritis National Research Foundation(National Research Foundation of Korea); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rheumatology Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by Arthritis National Research Foundation provided support to GDK. NIH/NIAMS provided support to LBI. Rheumatology Research Foundation provided support to KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Buckley CD, 2011, IMMUNOL LETT, V138, P12, DOI 10.1016/j.imlet.2011.02.010; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Huynh L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31959; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee A, 2013, ARTHRITIS RHEUM-US, V65, P928, DOI 10.1002/art.37853; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Paulsen MT, 2013, P NATL ACAD SCI USA, V110, P2240, DOI 10.1073/pnas.1219192110; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sohn C, 2015, ARTHRITIS RHEUMATOL, V67, P86, DOI 10.1002/art.38871; Tiedje C, 2014, J INTERF CYTOK RES, V34, P220, DOI 10.1089/jir.2013.0146; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zhong Y, 2016, BIOINFORMATICS	34	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179762	10.1371/journal.pone.0179762	http://dx.doi.org/10.1371/journal.pone.0179762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708839	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649800006
J	Donnelly, TT; Al-Khater, AH; Al-Bader, SB; Al-Kuwari, MG; Malik, MAA; Al-Meer, N; Singh, R				Donnelly, Tam Truong; Al-Khater, Al-Hareth; Al-Bader, Salha Bujassoum; Al-Kuwari, Mohamed Ghaith; Malik, Mariam Ali Abdul; Al-Meer, Nabila; Singh, Rajvir			Perceptions of Arab men regarding female breast cancer screening examinations-Findings from a Middle East study	PLOS ONE			English	Article							WOMEN	Objectives In the Middle East, Qatar in particular, the incidence of breast cancer has substantially increased in recent years, and is expected to double by 2030. This diagnosis also occurs at a later stage in the disease. Early detection along with proper treatment reduces radical mastectomy and mortality rates, yet only one-third of Arab women in Qatar participate in breast cancer screening (BCS) activities of any sort. Many women in the conservative Qatari society rely on male family members for support and protection. This study investigates the attitudes and perceptions of Arab men in regards to breast cancer screening and what they see as both incentives and barriers to women's participation in BCS activities. Design A qualitative methodology using purposive sampling technique was chosen in order to explore participant's attitudes, beliefs and health-related actions. Individual in-depth interviews with open-ended questions were conducted with 50 Arab men during October 2011 to May 2012. Data collection, analysis, and interpretation occurred simultaneously. NVivo 9, a qualitative data analysis software program was used to organize themes and subthemes. Results It was found that most men understood the importance of regular BCS in early detection of breast cancer. They felt they had an important role in encouraging the women in their lives to participate in BCS activities, but were adamant that any examination must be done by a female health care professional. Few knew details about screening guidelines in Qatar, but most had a basic knowledge of some screening activities. Most indicated an interest in learning more about BC and screening activities in order to better help and inform their female family members. Conclusion Because Arab men perceive that their opinions and support are a major factor influencing female family members' participation in breast cancer screening, it is important that any program instituted to increase such screening participation be aimed at both men and women. More information is needed by both sexes as to the need for and benefits of regular screening activities, the techniques used, and the newly revised guidelines in Qatar. Such a program needs to be introduced in the near future in order to avert, at least partially, the expected doubling in breast cancer cases by 2030 in the Middle East.	[Donnelly, Tam Truong] Univ Calgary, Fac Nursing & Med, Calgary, AB, Canada; [Al-Khater, Al-Hareth; Al-Bader, Salha Bujassoum] Hamad Med Corp, Dept Hematol & Oncol, Doha, Qatar; [Al-Kuwari, Mohamed Ghaith] Aspetar, Hlth Lifestyle Program, Doha, Qatar; [Malik, Mariam Ali Abdul] Qatar Minist Publ Hlth, Primary Hlth Care, Doha, Qatar; [Al-Meer, Nabila] Qatar Minist Publ Hlth, Nursing, Doha, Qatar; [Singh, Rajvir] Hamad Med Corp, Res Dept, Doha, Qatar	University of Calgary; Hamad Medical Corporation; Aspetar Orthopaedic & Sports Medicine Hospital; Hamad Medical Corporation	Donnelly, TT (corresponding author), Univ Calgary, Fac Nursing & Med, Calgary, AB, Canada.	tdonnell@ucalgary.ca		Al-Kuwari, Mohamed Ghaith/0000-0002-9158-5395	Qatar National Research Fund under its National Priorities Research Program [NPRP 09-261-3-059]; Qatar National Research Fund	Qatar National Research Fund under its National Priorities Research Program(Qatar National Research Fund (QNRF)); Qatar National Research Fund(Qatar National Research Fund (QNRF))	This publication was made possible by a grant from Qatar National Research Fund under its National Priorities Research Program (NPRP 09-261-3-059). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Qatar National Research Fund. We are grateful to all the men who participated in this research, as well as to the Qatar National Research Fund which provided us with funding to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhannadi HS, 2011, THESIS; Al-Saad S, 2007, BAHRAIN MED B, V31, P1; Al-Saad S, 2009, BAHRAIN MED B, V31; Almalki A., 2010, WOMAN TODAY, P60; Almalki A., 2010, WOMAN TODAY, P66; American Cancer Society, 2013, SURV RAT BREAST CANC; ANDERSON JM, 1986, SOC SCI MED, V22, P1277, DOI 10.1016/0277-9536(86)90195-4; Bener A, 2001, J CANCER EDUC, V16, P215; Bener Abdulbari, 2002, Oncol Nurs Forum, V29, pE91, DOI 10.1188/02.ONF.E91-E98; Brown R, 2012, LANCET ONCOL, V13, pE501, DOI 10.1016/S1470-2045(12)70461-8; Cancello G, 2010, ANN ONCOL, V21, P1974, DOI 10.1093/annonc/mdq072; Cryder CE, 2010, SOC SCI MED, V70, P455, DOI 10.1016/j.socscimed.2009.10.047; Donnelly T.T., 2013, J IMMIGR MINOR HEALT, V17, P925; Donnelly TT, 2006, CAN J NURS RES, V38, P83; Donnelly TT, 2015, AVICENNA, DOI 10.5339/avi.2015.3; Donnelly TT, 2012, AVICENNA, DOI 10.5339/avi.2012.2; Donnelly TT, 2004, THESIS; El Saghir Nagi S, 2007, Int J Surg, V5, P225; GANSTER DC, 1983, ACAD MANAGE J, V26, P321, DOI 10.2307/255979; Gnerlich JL, 2009, J AM COLL SURGEONS, V208, P341, DOI 10.1016/j.jamcollsurg.2008.12.001; Green L.W., 1991, HLTH PROMOTION PLANN; Green LW, 1996, AM J HEALTH PROMOT, V10, P270, DOI 10.4278/0890-1171-10.4.270; Hamilton N., 1996, POPULATION HLTH PROM; Hwang J. J., 2015, QUAL HEALTH RES, V27, P714; Kaufman SR, 1994, QUALITATIVE METHODS, P123; Kheirelseid EAH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-383; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; Kleinman A., 1980, PATIENTS HEALERS CON; Mai V, 2009, SALUD PUBLICA MEXICO, V51, pS228, DOI 10.1590/S0036-36342009000800013; Miller A B, 2010, East Mediterr Health J, V16, P1022; Morse JM, 2015, QUAL HEALTH RES, V25, P587, DOI 10.1177/1049732315576699; National Cancer Program, 2016, BREAST CANC SCREEN; Poland BD, 2000, SETTINGS HLTH PROMOT; Qatar Supreme Council of Health, 2011, NAT CANC STRAT 2011; Sallis J.F., 2002, HLTH BEHAV HLTH ED T, V3rd ed., P462; Speziale H., 2010, QUALITATIVE RES NURS; Swanson G M, 1994, J Natl Cancer Inst Monogr, P69; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tarabeia J, 2007, EUR J CANCER PREV, V16, P36, DOI 10.1097/01.cej.0000228407.91223.85; Vollman AR, 2012, CANADIAN COMMUNITY P; World Health Organization, 2012, GLOBOCAN 2012 EST CA; World Health Organization, 2008, WORLD CANC REPORT 20	42	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180696	10.1371/journal.pone.0180696	http://dx.doi.org/10.1371/journal.pone.0180696			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC2BU	28732040	Green Submitted, gold, Green Published			2022-12-27	WOS:000406643100010
J	Sigfrid, L; Murphy, G; Haldane, V; Chuah, FLH; Ong, SE; Cervero-Liceras, F; Watt, N; Alvaro, A; Otero-Garcia, L; Balabanova, D; Hogarth, S; Maimaris, W; Buse, K; Mckee, M; Piot, P; Perel, P; Legido-Quigley, H				Sigfrid, Louise; Murphy, Georgina; Haldane, Victoria; Chuah, Fiona Leh Hoon; Ong, Suan Ee; Cervero-Liceras, Francisco; Watt, Nicola; Alvaro, Alconada; Otero-Garcia, Laura; Balabanova, Dina; Hogarth, Sue; Maimaris, Will; Buse, Kent; Mckee, Martin; Piot, Peter; Perel, Pablo; Legido-Quigley, Helena			Integrating cervical cancer with HIV healthcare services: A systematic review	PLOS ONE			English	Review							SINGLE-VISIT APPROACH; INFECTED WOMEN; VISUAL INSPECTION; TREATMENT PROGRAM; INCOME COUNTRIES; MIDDLE-INCOME; PREVENTION; SUCCESSES; LESSONS; IMPLEMENTATION	Background Cervical cancer is a major public health problem. Even though readily preventable, it is the fourth leading cause of death in women globally. Women living with HIV are at increased risk of invasive cervical cancer, highlighting the need for access to screening and treatment for this population. Integration of services has been proposed as an effective way of improving access to cervical cancer screening especially in areas of high HIV prevalence as well as lower resourced settings. This paper presents the results of a systematic review of programs integrating cervical cancer and HIV services globally, including feasibility, acceptability, clinical outcomes and facilitators for service delivery. Methods This is part of a larger systematic review on integration of services for HIV and non-communicable diseases. To be considered for inclusion studies had to report on programs to integrate cervical cancer and HIV services at the level of service delivery. We searched multiple databases including Global Health, Medline and Embase from inception until December 2015. Articles were screened independently by two reviewers for inclusion and data were extracted and assessed for risk of bias. Main results 11,057 records were identified initially. 7,616 articles were screened by title and abstract for inclusion. A total of 21 papers reporting interventions integrating cervical cancer care and HIV services met the criteria for inclusion. All but one study described integration of cervical cancer screening services into existing HIV services. Most programs also offered treatment of minor lesions, a 'screen-and-treat' approach, with some also offering treatment of larger lesions within the same visit. Three distinct models of integration were identified. One model described integration within the same clinic through training of existing staff. Another model described integration through co-location of services, with the third model describing programs of integration through complex coordination across the care pathway. The studies suggested that integration of cervical cancer services with HIV services using all models was feasible and acceptable to patients. However, several barriers were reported, including high loss to follow up for further treatment, limited human-resources, and logistical and chain management support. Using visual screening methods can facilitate screening and treatment of minor to larger lesions in a single 'screen-and-treat' visit. Complex integration in a single-visit was shown to reduce loss to follow up. The use of existing health infrastructure and funding together with comprehensive staff training and supervision, community engagement and digital technology were some of the many other facilitators for integration reported across models. Conclusions This review shows that integration of cervical cancer screening and treatment with HIV services using different models of service delivery is feasible as well as acceptable to women living with HIV. However, the descriptive nature of most papers and lack of data on the effect on long-term outcomes for HIV or cervical cancer limits the inference on the effectiveness of the integrated programs. There is a need for strengthening of health systems across the care continuum and for high quality studies evaluating the effect of integration on HIV as well as on cervical cancer outcomes.	[Sigfrid, Louise; Murphy, Georgina] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Haldane, Victoria; Chuah, Fiona Leh Hoon; Ong, Suan Ee; Cervero-Liceras, Francisco; Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Watt, Nicola; Balabanova, Dina; Maimaris, Will; Mckee, Martin; Piot, Peter; Perel, Pablo; Legido-Quigley, Helena] London Sch Hyg & Trop Med, London, England; [Alvaro, Alconada] Univ Lleida, Lleida, Spain; [Otero-Garcia, Laura] Univ Autonoma Madrid, Nursing Sect, Fac Med, Madrid, Spain; [Otero-Garcia, Laura] Ciber Epidemiol & Publ Hlth CIBERESP ISCIII Madri, Madrid, Spain; [Maimaris, Will] Haringey Council, Civ Ctr, London, England; [Buse, Kent] UNAIDS, Strateg Policy Direct, Geneva, Switzerland	University of Oxford; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; Universitat de Lleida; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; UNAIDS	Legido-Quigley, H (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Legido-Quigley, H (corresponding author), London Sch Hyg & Trop Med, London, England.	Helena_Legido_Quigley@nuhs.edu.sg	Mckee, Martin/E-6673-2018; OTERO-GARCIA, LAURA/F-3913-2016; McKee, Marc D/E-2187-2011; Buse, Kent/AAK-6688-2020; Sigfrid, Louise/AAM-1364-2020; Murphy, Georgina A V/G-6981-2016	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Buse, Kent/0000-0002-5485-0110; Sigfrid, Louise/0000-0003-2764-1177; /0000-0002-2342-301X; Murphy, Georgina A V/0000-0001-5978-483X; Ong, Suan Ee/0000-0001-7365-9015	Joint United Nations Programme on HIV/AIDS (UNAIDS) grant [ADDEVH48]	Joint United Nations Programme on HIV/AIDS (UNAIDS) grant	Funding was received from The Joint United Nations Programme on HIV/AIDS (UNAIDS) grant number ADDEVH48, which covered for HL Q's salary and payment for accessing papers.	Anderson J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139242; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Bank. TW, 2017, WORLD BANK COUNTR LE; Barlow P, 2016, INT J EPIDEMIOLOGY; Briggs CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub2; Bruni L, 2016, HUMAN PAPILLOMA VIRU; Chumworathayi B., 2012, INTERVENTIONS TARGET; Curry N, 2010, CLIN SERVICE INTEGRA; Ekong J, 2013, INTEGRATION CERVICAL; Fink V, 2012, J INT AIDS SOC, V15, P95, DOI 10.7448/IAS.15.6.18088; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Grone O, 2001, Int J Integr Care, V1, pe21; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Horo A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-237; Huchko MJ, 2011, INT J GYNECOL OBSTET, V114, P106, DOI 10.1016/j.ijgo.2011.02.009; Ibrahim FW, 2009, J FAM PLAN REPROD H, V35, P101, DOI 10.1783/147118909787931735; Khozaim K, 2014, INT J GYNECOL OBSTET, V124, P12, DOI 10.1016/j.ijgo.2013.06.035; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; Martin CE, 2014, J OBSTET GYNAECOL RE, V40, P1707, DOI 10.1111/jog.12366; McCree-Hale R, 2012, MAKING CASE BETTER I; Moher D., 2009, BMJ, V7, P889; Moon TD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17406; Morgan R, 2014, AIDS 2014 20 INT AID; Mulenga E, 2012, J INT AIDS SOC, V15, P242; MUNGO C, 2013, INT J GYNECOL OBSTET, DOI DOI 10.1016/J.YGYNO.2008.04.031; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Odafe Solomon, 2013, Niger Med J, V54, P176, DOI 10.4103/0300-1652.114590; Odendal L., 2011, CERVICAL CANC WOMEN, P314; Parham GP, 2010, PLOS ONE, V4, P703; Parham Groesbeck P., 2010, HIV Therapy, V4, P713, DOI [10.2217/hiv.10.52, 10.2217/HIV.10.52]; Pfaendler KS, 2008, GYNECOL ONCOL, V110, P402, DOI 10.1016/j.ygyno.2008.04.031; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Plotkin M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-120; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; Shiferaw N, 2016, GLOB HEALTH-SCI PRAC, V4, P87, DOI 10.9745/GHSP-D-15-00325; Sirivongrangson P, 2007, SEX TRANSM DIS, V34, P104, DOI 10.1097/01.olq.0000222716.17186.9f; The Joint United Nations Programme on HIV/AIDS (UNAIDS) New York, 2011, CHRON CAR HIV NONC D; Watt N, 2016, HLTH POLICY PLANNING, P1; WHO, 2011, 1 GLOB MIN C HLTH LI; WHO, 2014, COMPR CERV CANC CONT; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2013, GUID SCREEN TREATM P; World Health Organization [Internet], 2015, CERV CANC EST INC MO	44	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181156	10.1371/journal.pone.0181156	http://dx.doi.org/10.1371/journal.pone.0181156			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732037	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000406643100024
J	Moldeus, K; Cheng, YW; Wikstrom, AK; Stephansson, O				Moldeus, Karolina; Cheng, Yvonne W.; Wikstrom, Anna-Karin; Stephansson, Olof			Induction of labor versus expectant management of large-for-gestational-age infants in nulliparous women	PLOS ONE			English	Article							FETAL MACROSOMIA; VAGINAL DELIVERY; INCONTINENCE; FETUSES; GROWTH; RISK	Background There is no apparent consensus on obstetric management, i.e., induction of labor or expectant management of women with suspected large-for-gestational-age (LGA)-fetuses. Methods and findings To further examine the subject, a nationwide population-based cohort study from the Swedish Medical Birth Register in nulliparous non-diabetic women with singleton, vertex LGA (> 90 th centile) births, 1992-2013, was performed. Delivery of a live-born LGA infant induced at 38 completed weeks of gestation in non-preeclamptic pregnancies, was compared to those of expectant management, with delivery at 39, 40, 41, or 42 completed weeks of gestation and beyond, either by labor induction or via spontaneous labor. Primary outcome was mode of delivery. Secondary outcomes included obstetric anal sphincter injury, 5-minute Apgar< 7 and birth injury. Multivariable logistic regression analysis was performed to control for potential confounding. We found that among the 722 women induced at week 38, there was a significantly increased risk of cesarean delivery (aOR = 1.44 95% CI: 1.20-1.72), compared to those with expectant management (n = 44 081). There was no significant difference between the groups in regards to risk of instrumental vaginal delivery (aOR = 1.05, 95% CI: 0.85-1.30), obstetric anal sphincter injury (aOR = 0.81, 95% CI: 0.55-1.19), nor 5minute Apgar<7 (aOR = 1.06, 95% CI: 0.58-1.94) or birth injury (aOR = 0.82, 95% CI: 0.49- 1.38). Similar comparisons for induction of labor at 39, 40 or 41 weeks compared to expectant management with delivery at a later gestational age, showed increased rates of cesarean delivery for induced women. Conclusions In women with LGA infants, induction of labor at 38 weeks gestation is associated with increased risk of cesarean delivery compared to expectant management, with no difference in neonatal morbidity.	[Moldeus, Karolina; Wikstrom, Anna-Karin; Stephansson, Olof] Karolinska Univ Hosp & Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Moldeus, Karolina] Visby Hosp, Dept Obstet & Gynecol, Visby, Sweden; [Cheng, Yvonne W.] Univ Calif Davis, Dept Surg, Davis, CA 95616 USA; [Cheng, Yvonne W.] Calif Pacific Med Ctr, Dept Obstet & Gynecol, San Francisco, CA USA; [Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Stephansson, Olof] Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; University of California System; University of California Davis; California Pacific Medical Center; Uppsala University; Karolinska Institutet	Moldeus, K (corresponding author), Karolinska Univ Hosp & Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden.; Moldeus, K (corresponding author), Visby Hosp, Dept Obstet & Gynecol, Visby, Sweden.	karolina.moldeus@gotland.se		Stephansson, Olof/0000-0003-1528-4563; Moldeus, Karolina/0000-0002-4072-5802	Swedish Research Council [2013-2429, 2014-3561]; Stockholm County Council (ALF project) [20130156]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF project)(Stockholm County Council)	This study was supported by grants from the Swedish Research Council (2013-2429, OS and 2014-3561, AKW) and by grants provided by the Stockholm County Council (ALF project 20130156, OS). The funding sources had no involvement in conduct of the research or preparation of the article.	[Anonymous], 2014, OBSTET GYNECOL, V124, P863; Ben-Haroush A, 2004, EUR J OBSTET GYN R B, V116, P182, DOI 10.1016/j.ejogrb.2004.02.026; Boulvain M, 2015, LANCET, V385, P2600, DOI 10.1016/S0140-6736(14)61904-8; Butt K, 2014, J OBSTET GYNAECOL CA, V36, P171, DOI 10.1016/S1701-2163(15)30664-2; Centre for Epidemiology, 2003, SWED MED BIRTH REG S; Cheng YW, 2012, BJOG-INT J OBSTET GY, V119, P402, DOI 10.1111/j.1471-0528.2011.03248.x; Fenner DE, 2003, AM J OBSTET GYNECOL, V189, P1543, DOI 10.1016/j.ajog.2003.09.030; Gaudet L, 2014, J OBSTET GYNAECOL CA, V36, P776, DOI 10.1016/S1701-2163(15)30479-5; Gonen O, 1997, OBSTET GYNECOL, V89, P913, DOI 10.1016/S0029-7844(97)00149-X; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Irion O, 2009, COCHRANE DB SYST REV, V2; Khashan AS, 2009, EUR J EPIDEMIOL, V24, P697, DOI 10.1007/s10654-009-9375-2; Kramer MS, 2002, J PEDIATR-US, V141, P538, DOI 10.1067/mpd.2002.128029; Little SE, 2015, CLIN OBSTET GYNECOL, V58, P269, DOI 10.1097/GRF.0000000000000112; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Mous M, 2008, BJOG-INT J OBSTET GY, V115, P234, DOI 10.1111/j.1471-0528.2007.01502.x; Official Statistics of Sweden. Pregnancies Deliveries and Newborn Infants, 2014, PREGN DEL NEWB INF S; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Osmundson S, 2011, OBSTET GYNECOL, V117, P583, DOI 10.1097/AOG.0b013e31820caf12; Osmundson SS, 2010, OBSTET GYNECOL, V116, P601, DOI 10.1097/AOG.0b013e3181eb6e9b; Pundir J, 2009, J OBSTET GYNAECOL, V29, P200, DOI 10.1080/01443610902735140; San Aye S, 2010, OBSTET GYNAECOL, V12, P250, DOI 10.1576/toag.12.4.250.27617; Sanchez-Ramos L, 2002, OBSTET GYNECOL, V100, P997, DOI 10.1016/S0029-7844(02)02321-9; Tey A., 1995, American Journal of Obstetrics and Gynecology, V172, P293; Vasudevan C, 2011, ARCH DIS CHILD-FETAL, V96, pF378, DOI 10.1136/adc.2009.170928; Walsh CA, 2007, J OBSTET GYNAECOL, V27, P374, DOI 10.1080/01443610701327545; Wood S, 2014, BJOG-INT J OBSTET GY, V121, P674, DOI 10.1111/1471-0528.12328	27	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180748	10.1371/journal.pone.0180748	http://dx.doi.org/10.1371/journal.pone.0180748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727729	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500028
J	Nagy, G; Oostenbrink, C; Hritz, J				Nagy, Gabor; Oostenbrink, Chris; Hritz, Jozef			Exploring the binding pathways of the 14-3-3 zeta : protein Structural and free-energy profiles revealed by Hamiltonian replica exchange molecular dynamics with distancefield distance restraints	PLOS ONE			English	Article							SIMULATIONS; SITES; PHOSPHOSERINE; RECOGNITION; FORCE; NMR	The 14-3-3 zeta protein family performs regulatory functions in eukaryotic organisms by binding to a large number of phosphorylated protein partners. Whilst the binding mode of the phosphopeptides within the primary 14-3-3 zeta binding site is well established based on the crystal structures of their complexes, little is known about the binding process itself. We present a computational study of the process by which phosphopeptides bind to the 14-3-3 zeta protein. Applying a novel scheme combining Hamiltonian replica exchange molecular dynamics and distancefield restraints allowed us to map and compare the most likely phosphopeptidebinding pathways to the 14-3-3 zeta protein. The most important structural changes to the protein and peptides involved in the binding process were identified. In order to bind phosphopeptides to the primary interaction site, the 14-3-3 zeta adopted a newly found wide-opened conformation. Based on our findings we additionally propose a secondary interaction site on the inner surface of the 14-3-3 zeta dimer, and a direct interference on the binding process by the flexible C-terminal tail. A minimalistic model was designed to allow for the efficient calculation of absolute binding affinities. Binding affinities calculated from the potential of mean force along the binding pathway are in line with the available experimental estimates for two of the studied systems.	[Nagy, Gabor; Hritz, Jozef] Masaryk Univ, CEITEC MU, Brno, Czech Republic; [Oostenbrink, Chris] Univ Nat Resources & Life Sci, Inst Mol Modeling & Simulat, Vienna, Austria; [Nagy, Gabor] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, Gottingen, Germany	Masaryk University Brno; University of Natural Resources & Life Sciences, Vienna; Max Planck Society	Hritz, J (corresponding author), Masaryk Univ, CEITEC MU, Brno, Czech Republic.	jozef.hritz@ceitec.muni.cz	Oostenbrink, Chris/S-8002-2019; Hritz, Jozef/J-6887-2015	Oostenbrink, Chris/0000-0002-4232-2556; Hritz, Jozef/0000-0002-4512-9241	Czech Science Foundation [GF15-34684L]; SoMoPro II Programme; European Union; South Moravian Region (Czech Republic); Austrian Science Fund (FWF) [W1224]; Austrian Science Foundation (FWF) [I 1999-N28]; European Research Council (ERC) [240608]; Ministry of Education, Youth and Sports from the Large Infrastructures for Research, Experimental Development and Innovations project [LM2015070]	Czech Science Foundation(Grant Agency of the Czech Republic); SoMoPro II Programme; European Union(European Commission); South Moravian Region (Czech Republic); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC)European Commission); Ministry of Education, Youth and Sports from the Large Infrastructures for Research, Experimental Development and Innovations project	This work was supported by Czech Science Foundation, no. GF15-34684L (J.H., G.N.). J.H. was also supported from the SoMoPro II Programme, co-financed by the European Union and the South Moravian Region (Czech Republic). The paper reflects only the author's views and the Union is not liable for any use that may be made of the information contained therein. G.N. also acknowledges the BioTop doctoral exchange program, funded by the Austrian Science Fund (FWF; grant no. W1224). C.O. gratefully acknowledges the financial support of the Austrian Science Foundation (FWF; grant no. I 1999-N28) and the European Research Council (ERC; grant no. 240608). The computational simulations were realised in the National Supercomputing Center IT4Innovations, which was supported by The Ministry of Education, Youth and Sports from the Large Infrastructures for Research, Experimental Development and Innovations project LM2015070. Further computational resources were provided by the CESNET LM2015042 and the CERIT Scientific Cloud LM2015085, provided under the programme "Projects of Large Research, Development, and Innovations Infrastructures." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadei A, 2000, J CHEM PHYS, V112, P9, DOI 10.1063/1.480557; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; de Ruiter A, 2013, J CHEM THEORY COMPUT, V9, P883, DOI 10.1021/ct300967a; Doudou S, 2009, J CHEM THEORY COMPUT, V5, P909, DOI 10.1021/ct8002354; Eichenberger AP, 2011, J CHEM THEORY COMPUT, V7, P3379, DOI 10.1021/ct2003622; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Heinz TN, 2001, J CHEM PHYS, V115, P1125, DOI 10.1063/1.1379764; Hritz J, 2014, BIOPHYS J, V107, P2185, DOI 10.1016/j.bpj.2014.08.039; Hu GD, 2014, INT J MOL SCI, V15, P2794, DOI 10.3390/ijms15022794; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Molzan M, 2012, J MOL BIOL, V423, P486, DOI 10.1016/j.jmb.2012.08.009; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nagy G, 2014, J CHEM INF MODEL, V54, P266, DOI 10.1021/ci400541d; Oostenbrink C, 2012, CURR DRUG METAB, V13, P190, DOI 10.2174/138920012798918453; Petrov D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003154; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmid N, 2012, COMPUT PHYS COMMUN, V183, P890, DOI 10.1016/j.cpc.2011.12.014; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048; Sugita Y, 2000, J CHEM PHYS, V113, P6042, DOI 10.1063/1.1308516; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Truong AB, 2002, PROTEINS, V49, P321, DOI 10.1002/prot.10210; Williams DM, 2011, BIOCHEM J, V437, P493, DOI 10.1042/BJ20102178; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	31	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180633	10.1371/journal.pone.0180633	http://dx.doi.org/10.1371/journal.pone.0180633			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727767	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500026
J	Roussel, P; Porcherie, A; Reperant-Ferter, M; Cunha, P; Gitton, C; Rainard, P; Germon, P				Roussel, Perrine; Porcherie, Adeline; Reperant-Ferter, Maryline; Cunha, Patricia; Gitton, Christophe; Rainard, Pascal; Germon, Pierre			Escherichia coli mastitis strains: In vitro phenotypes and severity of infection in vivo	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; PERSISTENT BOVINE MASTITIS; IMMUNE-RESPONSE; ALVEOLAR MACROPHAGES; DAIRY-COWS; MILK; NEUTROPHILS; GLAND; INFLAMMATION; MODELS	Mastitis remains a major infection of dairy cows and an important issue for dairy farmers and the dairy industry, in particular infections due to Escherichia coli strains. So far, properties specific to E. coli causing mastitis remain ill defined. In an attempt to better understand the properties required for E. coli to trigger mastitis, we used a range of in vitro assays to phenotypically characterize four E. coli strains, including the prototypical E. coli mastitis strain P4, possessing different relative abilities to cause mastitis in a mouse model. Our results indicate that a certain level of serum resistance might be required for colonization of the mammary gland. Resistance to neutrophil killing is also likely to contribute to a slower clearance of bacteria and higher chances to colonize the udder. In addition, we show that the four different strains do induce a pro-inflammatory response by mammary epithelial cells but with different intensities. Interestingly, the prototypical mastitis strain P4 actually induces the less intense response while it is responsible for the most severe infections in vivo. Altogether, our results suggest that different strategies can be used by E. coli strains to colonize the mammary gland and cause mastitis.	[Roussel, Perrine; Porcherie, Adeline; Reperant-Ferter, Maryline; Cunha, Patricia; Gitton, Christophe; Rainard, Pascal; Germon, Pierre] Univ Francois Rabelais Tours, INRA, ISP, UMR 1282, Nouzilly, France	INRAE	Germon, P (corresponding author), Univ Francois Rabelais Tours, INRA, ISP, UMR 1282, Nouzilly, France.	pierre.germon@inra.fr	GERMON, Pierre/M-5264-2019; GERMON, Pierre/AAC-9111-2019	GERMON, Pierre/0000-0003-3078-876X; Porcherie, Adeline/0000-0002-8177-2461; Rainard, Pascal/0000-0002-5477-2626	"Microbiology and Food Chain"; "Animal Health" divisions of INRA; IFR136 "Agents Transmissibles et Infectiologie"; GISA metaprogram (RUMINFLAME project)	"Microbiology and Food Chain"; "Animal Health" divisions of INRA; IFR136 "Agents Transmissibles et Infectiologie"; GISA metaprogram (RUMINFLAME project)	Dr P. Roussel was recipient of a grant from the "Microbiology and Food Chain" and "Animal Health" divisions of INRA. This work was supported by grants from the IFR136 "Agents Transmissibles et Infectiologie" and from the GISA metaprogram (RUMINFLAME project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr P. Roussel was recipient of a grant from the "Microbiology and Food Chain" and "Animal Health" divisions of INRA. We thank Ghizlane Dahbi for typing of strains. We wish to thank Vanaique Guillory, Corinne Beauge, Remi Delaunay, Arnaud Faurie, Guillaume Martin and Anne Pinard for their technical assistance in mice experiments. We are also grateful to Eric Briant, Mickael Delanoue, Mickael Dupont, Ludovic Metayer for their help in selecting and milking cows. This work was supported by grants from the IFR136 "Agents Transmissibles et Infectiologie" and from the GISA metaprogram (RUMINFLAME project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANDERSON JC, 1977, VET PATHOL, V14, P618, DOI 10.1177/030098587701400608; Blum S, 2008, VET MICROBIOL, V132, P135, DOI 10.1016/j.vetmic.2008.05.012; Blum SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136387; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; Bougarn S, 2011, J DAIRY SCI, V94, P2425, DOI 10.3168/jds.2010-3859; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; BROOKER BE, 1981, EXPERIENTIA, V37, P290, DOI 10.1007/BF01991661; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; CARROLL EJ, 1973, AM J VET RES, V34, P1143; CHANDLER RL, 1970, J MED MICROBIOL, V3, P273, DOI 10.1099/00222615-3-2-273; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dopfer D, 2001, VET MICROBIOL, V80, P285, DOI 10.1016/S0378-1135(01)00307-8; Elazar S, 2010, VET RES, V41, DOI 10.1051/vetres/2010025; Elazar S, 2010, VET RES, V41, DOI 10.1051/vetres/2009058; Goldstone RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30115; Gunther J, 2016, VET RES, V47, DOI 10.1186/s13567-016-0307-3; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; HEYNEMAN R, 1990, J DAIRY SCI, V73, P985, DOI 10.3168/jds.S0022-0302(90)78756-5; HILL AW, 1981, RES VET SCI, V31, P107, DOI 10.1016/S0034-5288(18)32532-3; HILL AW, 1983, VET MICROBIOL, V8, P293, DOI 10.1016/0378-1135(83)90081-0; Hogan J, 2003, VET RES, V34, P507, DOI 10.1051/vetres:2003022; Iwaki T, 2008, CYTOTECHNOLOGY, V57, P45, DOI 10.1007/s10616-008-9129-0; Kempf F, 2015, GENOME ANNOUNCEMENTS, V3; Kempf F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147954; Kornalijnslijper JE, 2003, VET MICROBIOL, V91, P125, DOI 10.1016/S0378-1135(02)00266-3; Mehrzad J, 2004, J DAIRY SCI, V87, P4150, DOI 10.3168/jds.S0022-0302(04)73558-4; NEMETH J, 1994, VET MICROBIOL, V40, P231, DOI 10.1016/0378-1135(94)90112-0; Notebaert S, 2006, VET QUART, V28, P2, DOI 10.1080/01652176.2006.9695201; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Porcherie A, 2016, J IMMUNOL, V196, P803, DOI 10.4049/jimmunol.1500705; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Pupo E, 2013, FEBS J, V280, P1095, DOI 10.1111/febs.12104; Rainard P, 2003, VET RES, V34, P647, DOI 10.1051/vetres:2003025; Rainard P, 2008, MOL IMMUNOL, V45, P4020, DOI 10.1016/j.molimm.2008.06.010; Richards VP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119799; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Riollet C, 2000, INFLAMM RES, V49, P486, DOI 10.1007/s000110050621; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Schukken YH, 2011, VET IMMUNOL IMMUNOP, V144, P270, DOI 10.1016/j.vetimm.2011.08.022; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; VANDEPUTTEVANMESSOM G, 1993, J DAIRY RES, V60, P19, DOI 10.1017/S002202990002731X; Vangroenweghe F, 2004, J DAIRY SCI, V87, P4132, DOI 10.3168/jds.S0022-0302(04)73556-0	45	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e178285	10.1371/journal.pone.0178285	http://dx.doi.org/10.1371/journal.pone.0178285			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727781	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500002
J	Johansen, K; Persson, K; Sonnander, K; Magnusson, M; Sarkadi, A; Lucas, S				Johansen, Kine; Persson, Kristina; Sonnander, Karin; Magnusson, Margaretha; Sarkadi, Anna; Lucas, Steven			Clinical utility of the Structured Observation of Motor Performance in Infants within the child health services	PLOS ONE			English	Article							FULL-TERM INFANTS; CEREBRAL-PALSY; EARLY IDENTIFICATION; DEVELOPMENTAL SURVEILLANCE; NURSES EXPERIENCES; EARLY INTERVENTION; PRETERM; AGES; CARE; MILESTONES	Aim This study aimed to evaluate the clinical utility of the Structured Observation of Motor Performance in Infants (SOMP-I) when used by nurses in routine child healthcare by analyzing the nurses' SOMP-I assessments and the actions taken when motor problems were suspected. Method Infants from three child health centers in Uppsala County, Sweden, were consecutively enrolled in a longitudinal study. The 242 infants were assessed using SOMP-I by the nurse responsible for the infant as part of the regular well-child visits at as close to 2, 4, 6 and 10 months of age as possible. The nurses noted actions taken such as giving advice, scheduling an extra follow-up or referring the infant to specialized care. The infants' motor development was reassessed at 18 months of age through review of medical records or parental report. Results The assessments of level of motor development at 2 and 10 months showed a distribution corresponding to the percentile distribution of the SOMP-I method. Fewer infants than expected were assessed as delayed at 4 and 6 months or deficient in quality at all assessment ages. When an infant was assessed as delayed in level or deficient in quality, the likelihood of the nurse taking actions increased. This increased further if both delay and quality deficit were found at the same assessment or if one or both were found at repeated assessments. The reassessment of the motor development at 18 months did not reveal any missed infants with major motor impairments. Interpretation The use of SOMP-I appears to demonstrate favorable clinical utility in routine child healthcare as tested here. Child health nurses can assess early motor performance using this standardized assessment method, and using the method appears to support them the clinical decision-making.	[Johansen, Kine; Persson, Kristina; Magnusson, Margaretha; Lucas, Steven] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Johansen, Kine; Lucas, Steven] Uppsala Univ, Childrens Hosp, Uppsala, Sweden; [Sonnander, Karin; Sarkadi, Anna] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Johansen, K (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Johansen, K (corresponding author), Uppsala Univ, Childrens Hosp, Uppsala, Sweden.	kine.johansen@kbh.uu.se	Johansen, Kine/AAN-8208-2020	Johansen, Kine/0000-0002-9212-8452	Uppsala University; Uppsala County Council Grants for Healthcare Research; Gillbergska Foundation; Folke Bernadotte Foundation	Uppsala University; Uppsala County Council Grants for Healthcare Research; Gillbergska Foundation; Folke Bernadotte Foundation	This study was funded by Uppsala University and Uppsala County Council Grants for Healthcare Research, the Gillbergska Foundation (www.gillbergska.se) and the Folke Bernadotte Foundation (www.folkebernadottestiftelsen.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph KE, 2015, HDB CHILD PSYCHOL DE; Barbara A, 2005, AUSTR OCCUPATIONAL T, V52, P17, DOI [10.1111/j.1440-1630.2005.00476.x, DOI 10.1111/J.1440-1630.2005.00476.X]; Barbosa Vanessa M., 2003, Physical & Occupational Therapy in Pediatrics, V23, P7, DOI 10.1300/J006v23n03_02; Barlow DH, 2005, PSYCHOL ASSESSMENT, V17, P308, DOI 10.1037/1040-3590.17.3.308; Blauw-Hospers CH, 2005, DEV MED CHILD NEUROL, V47, P421, DOI 10.1017/S0012162205000824; Bosanquet M, 2013, DEV MED CHILD NEUROL, V55, P418, DOI 10.1111/dmcn.12140; Donnelly Catherine, 2002, Can J Occup Ther, V69, P84; Dosman CF, 2012, PAED CHILD HEALT-CAN, V17, P561, DOI 10.1093/pch/17.10.561; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; DWORKIN PH, 1989, PEDIATRICS, V84, P1000; Feldman DE, 2005, ARCH PEDIAT ADOL MED, V159, P882, DOI 10.1001/archpedi.159.9.882; Glad J., 2013, THESIS; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; GLASCOE FP, 1989, AM J DIS CHILD, V143, P955, DOI 10.1001/archpedi.1989.02150200115029; Guevara JP, 2013, PEDIATRICS, V131, P30, DOI 10.1542/peds.2012-0765; Hadders-Algra M, 2000, DEV MED CHILD NEUROL, V42, P707, DOI 10.1017/S0012162200001316; Hadders-Algra M, 2004, J PEDIATR-US, V145, pS12, DOI 10.1016/j.jpeds.2004.05.017; Hadders-Algra M, 2011, DEV MED CHILD NEUROL, V53, P52, DOI 10.1111/j.1469-8749.2011.04064.x; Hadders-Algra Mijna, 2001, Neural Plasticity, V8, P31, DOI 10.1155/NP.2001.31; Halfon N, 2004, PEDIATRICS, V113, P1926; Hatakenaka Y, 2016, PEDIATR NEUROL, V54, P55, DOI 10.1016/j.pediatrneurol.2015.09.008; Hatfield DR, 2007, ADM POLICY MENT HLTH, V34, P283, DOI 10.1007/s10488-006-0110-y; Heineman KR, 2008, J DEV BEHAV PEDIATR, V29, P315, DOI 10.1097/DBP.0b013e318182a4ea; Hielkema T, 2016, DEV MED CHILD NEUROL, V58, P46, DOI [10.1111/dmcn.13047, 10.1111/dmcn.13331]; Hix-Small H, 2007, PEDIATRICS, V120, P381, DOI 10.1542/peds.2006-3583; Hubermann L, 2016, J CHILD NEUROL, V31, P364, DOI 10.1177/0883073815596610; Hunsley J, 2008, GUIDE ASSESSMENTS WO, P44; Hunsley J, 2007, ANNU REV CLIN PSYCHO, V3, P29, DOI 10.1146/annurev.clinpsy.3.022806.091419; Johansen K, 2016, J EVAL CLIN PRACT, V22, P227, DOI 10.1111/jep.12459; Johansen K, 2015, J EVAL CLIN PRACT, V21, P681, DOI 10.1111/jep.12366; Johnson S, 2006, EARLY HUM DEV, V82, P173, DOI 10.1016/j.earlhumdev.2006.01.008; King TM, 2003, CURR OPIN PEDIATR, V15, P624, DOI 10.1097/00008480-200312000-00014; Law M, 2014, J CHILD NEUROL, V29, P1101, DOI 10.1177/0883073814533151; Lennartsson F, 2011, J PEDIATR NURS, V26, P541, DOI 10.1016/j.pedn.2010.04.005; Lindstrom K, 1997, ACTA PAEDIATR, V86, P736, DOI 10.1111/j.1651-2227.1997.tb08577.x; Magnusson M, 2000, J CLIN NURS, V9, P620; Magnusson M, 2012, SCAND J CARING SCI, V26, P161, DOI 10.1111/j.1471-6712.2011.00910.x; Majnemer A, 1998, Semin Pediatr Neurol, V5, P62, DOI 10.1016/S1071-9091(98)80020-X; Mash EJ, 2005, J CLIN CHILD ADOLESC, V34, P362, DOI 10.1207/s15374424jccp3403_1; McIntyre S, 2011, DEV DISABIL RES REV, V17, P114, DOI 10.1002/ddrr.1106; Montgomery C, 2017, EARLY HUM D IN PRESS; Montgomery C, 2017, ACTA PAEDIATR, V106, P740, DOI 10.1111/apa.13774; Morgan C, 2016, DEV MED CHILD NEUROL, V58, P900, DOI 10.1111/dmcn.13105; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Oberklaid F, 2013, ARCH DIS CHILD, V98, P1008, DOI 10.1136/archdischild-2013-304091; Oberklaid F, 2011, AUST FAM PHYSICIAN, V40, P666; PALFREY JS, 1987, J PEDIATR-US, V111, P651, DOI 10.1016/S0022-3476(87)80238-X; PERSSON K, 1995, EARLY HUM DEV, V40, P127, DOI 10.1016/0378-3782(94)01598-J; Persson K, 1995, EARLY HUM DEV, V43, P205, DOI 10.1016/0378-3782(95)01678-3; Persson K., 2017, STRUCTURED OBSERVATI; Persson K., 1997, PEDIAT PHYS THER, P62; Persson Kristina, 1993, Upsala Journal of Medical Sciences, V98, P65; Ronnqvist L, 2013, FYSIOTERAPI BARN UNG, P21; Rosenbaum P, 2006, EARLY HUM DEV, V82, P167, DOI 10.1016/j.earlhumdev.2006.01.007; Sices L, 2007, J DEV BEHAV PEDIATR, V28, P47, DOI 10.1097/DBP.0b013e31803084c6; Smart A, 2006, INT J QUAL HEALTH C, V18, P377, DOI 10.1093/intqhc/mzl034; Smithers-Sheedy H, 2014, DEV MED CHILD NEUROL, V56, P323, DOI 10.1111/dmcn.12262; Spittle A, 2016, SEMIN PERINATOL, V40, P542, DOI 10.1053/j.semperi.2016.09.006; Spittle A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub4; Spittle AJ, 2008, DEV MED CHILD NEUROL, V50, P254, DOI 10.1111/j.1469-8749.2008.02025.x; The National Board of Health and Welfare, 2014, VAGL BARNH; The National Board of Health and Welfare, 2013, UPPT UTV HOS BARN UN; Thelen Esther, 1996, DYNAMIC SYSTEMS APPR; Thomas RE, 2016, CHILD CARE HLTH DEV, V42, P382, DOI 10.1111/cch.12333; Trillingsgaard A, 2004, EUR CHILD ADOLES PSY, V13, P39, DOI 10.1007/s00787-004-3006-y; Ulrich BD, 2010, PHYS THER, V90, P1868, DOI 10.2522/ptj.20100040; Vereijken B, 2010, PHYS THER, V90, P1850, DOI 10.2522/ptj.20100019; Wallby T., 2012, THESIS; Woolfenden S, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-231	69	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181398	10.1371/journal.pone.0181398	http://dx.doi.org/10.1371/journal.pone.0181398			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723929	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800048
J	Leth, C; Varadharajan, A; Mester, P; Fischaleck, M; Rossmanith, P; Schmoll, F; Fink, M				Leth, Christoph; Varadharajan, Ashok; Mester, Patrick; Fischaleck, Marlis; Rossmanith, Peter; Schmoll, Friedrich; Fink, Maria			Matrixlysis, an improved sample preparation method for recovery of Mycobacteria from animal tissue material	PLOS ONE			English	Article							TUBERCULOSIS; BOVIS; CAPRAE; SEQUENCE; NUMBER; STRATEGY; REGION	Mycobacterium caprae, a member of the Mycobacterium tuberculosis complex, is the main causative agent of bovine tuberculosis in alpine regions. Bacterial culture is the gold standard in bovine tuberculosis diagnostic but takes up to twelve weeks. This increases the time and costs for stocks affected with bovine tuberculosis. Hence this study focused on the implementation of a fast and precise mycobacterial detection method and compared it with currently used methods. Matrix lysis is a chemical lysis using high concentrations of urea to solubilize bovine and red deer tissue and was used to detect even smallest amounts or non-visible lesions of mycobacteria. A total of 64 samples collected from 44 animals (37 red deer and 7 cattle) were tested by Matrix lysis. Forty-three of these samples were used for Mycobacterium tuberculosis complex detection by quantitative PCR and other 21 for subtyping the genetically different variants of M. caprae. Furthermore, three Matrix lysis samples were used for Next Generation Sequencing. Our results confirm that Matrix lysis is a fast and precise method for detecting Mycobacterium tuberculosis complex in native tissue samples. However, at the moment it reaches its limits when the samples were analyzed by Next Generation Sequencing and RD4 subtyping.	[Leth, Christoph; Schmoll, Friedrich; Fink, Maria] Austrian Agcy Hlth & Food Safety, Inst Vet Dis Control, Modling, Lower Austria, Austria; [Leth, Christoph] Univ Appl Sci, FH Campus Wien, Vienna, Austria; [Varadharajan, Ashok; Fischaleck, Marlis] Ludwig Maximilians Univ Munchen, Lab Funct Genome Anal LAFUGA, Gene Ctr, Munich, Germany; [Rossmanith, Peter] Univ Vet Med, Christian Doppler Lab Monitoring Microbial Contam, Vienna, Austria	University of Munich; University of Veterinary Medicine Vienna	Fink, M (corresponding author), Austrian Agcy Hlth & Food Safety, Inst Vet Dis Control, Modling, Lower Austria, Austria.	maria.fink@ages.at	Mester, Patrick-Julian/ABC-1614-2020	Mester, Patrick-Julian/0000-0002-3193-4987	Austrian Federal Ministry of Science, Research and Economy; National Foundation of Research, Technology and Development	Austrian Federal Ministry of Science, Research and Economy; National Foundation of Research, Technology and Development	The financial support by the Austrian Federal Ministry of Science, Research and Economy (www bmwfw gv at) and the National Foundation of Research, Technology and Development (www stiftung-teat) is gratefully acknowledged. The funders had no role in studydesign, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranaz A, 2003, INT J SYST EVOL MICR, V53, P1785, DOI 10.1099/ijs.0.02532-0; Aranaz A, 1999, INT J SYST BACTERIOL, V49, P1263, DOI 10.1099/00207713-49-3-1263; Ballesteros C, 2009, VACCINE, V27, P6662, DOI 10.1016/j.vaccine.2009.08.095; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Broeckl S, 2017, VET RES COMMUN, V41, P113, DOI 10.1007/s11259-017-9679-8; Cardoso MA, 2009, ZOONOSES PUBLIC HLTH, V56, P465, DOI 10.1111/j.1863-2378.2008.01199.x; Corner LAL, 2012, VET MICROBIOL, V156, P162, DOI 10.1016/j.vetmic.2011.10.016; Courcoul A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090334; de Lisle GW, 2009, NEW ZEAL VET J, V57, P221, DOI 10.1080/00480169.2009.36905; Domogalla J, 2013, J CLIN MICROBIOL, V51, P1381, DOI 10.1128/JCM.02966-12; Fell S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0816-2; Fink M, 2015, EMERG INFECT DIS, V21, P464, DOI 10.3201/eid2103.141119; Gavier-Widen D, 2009, NEW ZEAL VET J, V57, P122, DOI 10.1080/00480169.2009.36891; Girardot C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1284-2; Hauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117103; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mann E, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-53; Mayrl E, 2009, J FOOD PROTECT, V72, P1225, DOI 10.4315/0362-028X-72.6.1225; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Niemann S, 2000, J CLIN MICROBIOL, V38, P3231, DOI 10.1128/JCM.38.9.3231-3234.2000; Prodinger WM, 2005, J CLIN MICROBIOL, V43, P4984, DOI 10.1128/JCM.43.10.4984-4992.2005; Reddington K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023481; Rettinger A, 2015, TRANSBOUNDARY EMERGI; Rodriguez-Campos S, 2014, RES VET SCI, V97, pS5, DOI 10.1016/j.rvsc.2014.02.009; Schoepf K., 2012, ISRN VET SCI, V2012; Stewart LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058374; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; World Oranisation of Animal Health (OIE, 2009, OIE TERR MAN 2009	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181157	10.1371/journal.pone.0181157	http://dx.doi.org/10.1371/journal.pone.0181157			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723969	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800036
J	Le, MTH; Tran, TD; Holton, S; Nguyen, HT; Wolfe, R; Fisher, J				Minh Thi Hong Le; Thach Duc Tran; Holton, Sara; Huong Thanh Nguyen; Wolfe, Rory; Fisher, Jane			Reliability, convergent validity and factor structure of the DASS-21 in a sample of Vietnamese adolescents	PLOS ONE			English	Article							ANXIETY-STRESS SCALES; CROSS-CULTURAL ADAPTATION; DUKE HEALTH PROFILE; DEPRESSION-ANXIETY; PSYCHOMETRIC PROPERTIES; NORMATIVE DATA; VALIDATION; VERSION; INSTRUMENT; STATES	Objectives To assess the internal consistency, latent structure and convergent validity of the Depression, Anxiety and Stress Scale-21 (DASS-21) among adolescents in Vietnam. Method An anonymous, self-completed questionnaire was conducted among 1,745 high school students in Hanoi, Vietnam between October, 2013 and January, 2014. Confirmatory factor analyses were performed to assess the latent structure of the DASS-21. Factorial invariance between girls and boys was examined. Cronbach alphas and correlation coefficients between DASS-21 factor scores and the domain scores of the Duke Health Profile Adolescent Vietnamese validated version (ADHP-V) were calculated to assess DASS-21 internal consistency and convergent validity. Results A total of 1,606/ 1,745 (92.6%) students returned the questionnaire. Of those, 1,387 students provided complete DASS-21 data. The scale demonstrated adequate internal consistency (Cronbach a: 0.761 to 0.906). A four-factor model showed the best fit to the data. Items loaded significantly on a common general distress factor, the depression, and the anxiety factors, but few on the stress factor (p< 0.05). DASS-21 convergent validity was confirmed with moderate correlation coefficients (-0.47 to -0.66) between its factor scores and the ADHP-V mental health related domains. Conclusions The DASS-21 is reliable and suitable for use to assess symptoms of common mental health problems, especially depression and anxiety among Vietnamese adolescents. However, its ability in detecting stress among these adolescents may be limited. Further research is warrant to explore these results.	[Minh Thi Hong Le; Thach Duc Tran; Holton, Sara; Fisher, Jane] Monash Univ, Jean Hailes Res Unit, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Huong Thanh Nguyen] Hanoi Sch Publ Hlth, Fac Social Sci Behav & Hlth Educ, Hanoi, Vietnam; [Wolfe, Rory] Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia	Monash University; Hanoi University of Public Health; Monash University	Le, MTH (corresponding author), Monash Univ, Jean Hailes Res Unit, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	minh.thi.le@monash.edu	TRAN, THACH DUC/H-7734-2014; Holton, Sara/X-9883-2019; Fisher, Jane/I-1569-2014	TRAN, THACH DUC/0000-0002-4686-8601; Holton, Sara/0000-0001-9294-7872; Wolfe, Rory/0000-0002-2126-1045; Nguyen, Huong/0000-0002-9493-9590; Fisher, Jane/0000-0002-1959-6807	Monash International Postgraduate Research Scholarship; Monash University; Graduate Women Victoria; Monash Professorial Fellowship; Jean Hailes Professorial Fellowship; L and H Hecht Trust	Monash International Postgraduate Research Scholarship(Monash University); Monash University(Monash University); Graduate Women Victoria; Monash Professorial Fellowship; Jean Hailes Professorial Fellowship; L and H Hecht Trust	This study was supported by a Monash International Postgraduate Research Scholarship and a Monash Graduate Scholarship from Monash University and a Scholarship for International Students from Graduate Women Victoria to ML. JF is supported by a Monash Professorial Fellowship and the Jean Hailes Professorial Fellowship, which receives funding from the L and H Hecht Trust managed by Perpetual Trustees. The funders, however, did not have any role in study design, data collection, data analyses, interpretation of the results and decision to submit the paper for publication.	Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Clara IP, 2001, J PSYCHOPATHOL BEHAV, V23, P61, DOI 10.1023/A:1011095624717; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Daza P, 2002, J PSYCHOPATHOL BEHAV, V24, P195, DOI 10.1023/A:1016014818163; Duffy CJ, 2005, J ADOLESCENCE, V28, P677, DOI 10.1016/j.adolescence.2005.08.013; General Statistics Office of Vietnam, 2011, VIETN POP HOUS CENS; Gjersing L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-13; Hanh VTX, 2005, J ADOLESCENCE, V28, P127, DOI 10.1016/j.adolescence.2003.11.016; Hashim HA, 2011, INT J COLLAB RES INT, V3, P28; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hooper D, 2008, 7TH EUROPEAN CONFERENCE ON RESEARCH METHODOLOGY FOR BUSINESS AND MANAGEMENT STUDIES, P195; Le MTH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125189; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Neath AA, 2012, WIRES COMPUT STAT, V4, P199, DOI 10.1002/wics.199; Norton PJ, 2007, ANXIETY STRESS COPIN, V20, P253, DOI 10.1080/10615800701309279; Osman ZJ, 2014, COMPR PSYCHIAT, V55, P1720, DOI 10.1016/j.comppsych.2014.04.011; PARKERSON GR, 1990, MED CARE, V28, P1056, DOI 10.1097/00005650-199011000-00007; Patrick J, 2010, J CLIN PSYCHOL, V66, P996, DOI 10.1002/jclp.20696; StataCorp, 2011, STAT STAT SOFTW REL; Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014; Tran TD, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-24; The General Statistics Office of Vietnam, 2013, AR POP POP DENS 2013; Tully PJ, 2009, J ABNORM CHILD PSYCH, V37, P717, DOI 10.1007/s10802-009-9306-4; UNFPA, 2011, ETHN GROUPS VIET NAM; UNICEF, 2014, STAT WORLDS CHILDR N; VanNguyen H, 2014, PSYCHOL HLTH MED; Vo TXH, 2005, QUAL LIFE RES, V14, P2229, DOI 10.1007/s11136-005-7021-3; WHO, 2019, MENT DIS; World Health Organisation, 2014, CHILD ADOLESCENT MEN; World Health Organization, 2008, GLOB BURD DIS 2004 U	33	80	80	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180557	10.1371/journal.pone.0180557	http://dx.doi.org/10.1371/journal.pone.0180557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723909	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800018
J	Silva, SR; Alvarenga, DO; Aranguren, Y; Penha, HA; Fernandes, CC; Pinheiro, DG; Oliveira, MT; Michael, TP; Miranda, VFO; Varani, AM				Silva, Saura R.; Alvarenga, Danillo O.; Aranguren, Yani; Penha, Helen A.; Fernandes, Camila C.; Pinheiro, Daniel G.; Oliveira, Marcos T.; Michael, Todd P.; Miranda, Vitor F. O.; Varani, Alessandro M.			The mitochondrial genome of the terrestrial carnivorous plant Utricularia reniformis (Lentibulariaceae): Structure, comparative analysis and evolutionary landmarks	PLOS ONE			English	Article							GROUP-I INTRON; BLADDERWORT UTRICULARIA; HORIZONTAL TRANSFER; DNA; MODEL; GENES; VISUALIZATION; ARCHITECTURE; ANNOTATION; SEQUENCES	The carnivorous plants of the family Lentibulariaceae have attained recent attention not only because of their interesting lifestyle, but also because of their dynamic nuclear genome size. Lentibulariaceae genomes span an order of magnitude and include species with the smallest genomes in angiosperms, making them a powerful system to study the mechanisms of genome expansion and contraction. However, little is known about mitochondrial DNA (mtDNA) sequences of this family, and the evolutionary forces that shape this organellar genome. Here we report the sequencing and assembly of the complete mtDNA from the endemic terrestrial Brazilian species Utricularia reniformis. The 857,234bp master circle mitochondrial genome encodes 70 transcriptionaly active genes (42 protein-coding, 25 tRNAs and 3 rRNAs), covering up to 7% of the mtDNA. A ltrA-like protein related to splicing and mobility and a LAGLIDADG homing endonuclease have been identified in intronic regions, suggesting particular mechanisms of genome maintenance. RNA-seq analysis identified properties with putative diverse and important roles in genome regulation and evolution: 1) 672kbp (78%) of the mtDNA is covered by full-length reads; 2) most of the 243kbp intergenic regions exhibit transcripts; and 3) at least 69 novel RNA editing sites in the protein-coding genes. Additional genomic features are hypothetical ORFs (48%), chloroplast insertions, including truncated plastid genes that have been lost from the chloroplast DNA (5%), repeats (5%), relics of transposable elements mostly related to LTR retrotransposons (5%), and truncated mitovirus sequences (0.4%). Phylogenetic analysis based on 32 different Lamiales mitochondrial genomes corroborate that Lentibulariaceae is a monophyletic group. In summary, the U. reniformis mtDNA represents the eighth largest plant mtDNA described to date, shedding light on the genomic trends and evolutionary characteristics and phylogenetic history of the family Lentibulariaceae.	[Silva, Saura R.] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Bot, Botucatu, SP, Brazil; [Alvarenga, Danillo O.; Penha, Helen A.; Fernandes, Camila C.; Pinheiro, Daniel G.; Oliveira, Marcos T.; Varani, Alessandro M.] Univ Estadual Paulista Unesp, Dept Tecnol, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Aranguren, Yani; Miranda, Vitor F. O.] Univ Estadual Paulista Unesp, Dept Biol Aplicada Agr, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Michael, Todd P.] Ibis Biosci, Computat Genom, Carlsbad, CA USA; [Aranguren, Yani] Univ Simon Bolivar, Barranquilla, Colombia; [Michael, Todd P.] J Craig Venter Inst, La Jolla, CA USA	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; J. Craig Venter Institute	Varani, AM (corresponding author), Univ Estadual Paulista Unesp, Dept Tecnol, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.; Miranda, VFO (corresponding author), Univ Estadual Paulista Unesp, Dept Biol Aplicada Agr, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.	vmiranda@fcav.unesp.br; amvarani@fcav.unesp.br	Varani, Alessandro M/F-6887-2011; Penha, Helen/R-2585-2016; Miranda, Vitor Fernandes Oliveira/AAG-2437-2020; Oliveira, Marcos Túlio/AAN-2804-2020; Varani, Alessandro/Q-1637-2016; Miranda, Vitor F. O./B-2800-2011; Silva, Saura/I-1953-2015; Alvarenga, Danillo Oliveira/C-3439-2012; Oliveira, Marcos/B-3249-2014; Guariz Pinheiro, Daniel/H-4604-2012	Varani, Alessandro M/0000-0002-8876-3269; Penha, Helen/0000-0002-7156-444X; Miranda, Vitor Fernandes Oliveira/0000-0003-0574-9865; Varani, Alessandro/0000-0002-8876-3269; Miranda, Vitor F. O./0000-0003-0574-9865; Silva, Saura/0000-0002-6333-5268; Alvarenga, Danillo Oliveira/0000-0002-3666-2220; Oliveira, Marcos/0000-0003-4779-5755; Guariz Pinheiro, Daniel/0000-0001-7062-5936; Aranguren-Diaz, Yani/0000-0001-6475-2787	Fundacao de Amparo do Estado de Sao Paulo, FAPESP [13/25164-6]; Ibis Biosciences, an Abbott Laboratories company	Fundacao de Amparo do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ibis Biosciences, an Abbott Laboratories company	This study was funded by Fundacao de Amparo do Estado de Sao Paulo, FAPESP (13/25164-6). Ibis Biosciences, an Abbott Laboratories company, provided support to TM in the form of salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adamec L, 1997, BOT REV, V63, P273, DOI 10.1007/BF02857953; Adlassnig W, 2005, PLANT SOIL, V274, P127, DOI 10.1007/s11104-004-2754-2; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert VA, 2010, J EXP BOT, V61, P5, DOI 10.1093/jxb/erp349; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bruenn JA, 2015, PEERJ, V3, DOI 10.7717/peerj.876; Bruhs A, 2011, ADVAN PL BIO, V1, P157; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caravieri FA, 2014, AQUAT BOT, V116, P8, DOI 10.1016/j.aquabot.2013.12.008; Carlsson J, 2011, ADVAN PL BIO, V1, P469; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Cheong WH, 2015, BIOINFORMATICS, V31, P3685, DOI 10.1093/bioinformatics/btv433; Christenhusz MJM, 2015, BOT J LINN SOC, V178, P501, DOI 10.1111/boj.12285; Clivati D, 2014, PLANT BIOLOGY, V16, P677, DOI 10.1111/plb.12091; Clivati D, 2012, AM J BOT, V99, pE375, DOI 10.3732/ajb.1200080; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Alcaraz LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148979; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Ellison AM, 2011, OIKOS, V120, P1721, DOI 10.1111/j.1600-0706.2011.19604.x; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fujii S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-279; Grimes BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-31; Gualberto JM, 2014, BIOCHIMIE, V100, P107, DOI 10.1016/j.biochi.2013.09.016; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hillman BI, 2013, ADV VIRUS RES, V86, P149, DOI 10.1016/B978-0-12-394315-6.00006-4; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; Ibarra-Laclette E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-101; Iorizzo M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-61; Jackman SD, 2016, GENOME BIOL EVOL, V8, P29, DOI 10.1093/gbe/evv244; Jobson RW, 2004, P NATL ACAD SCI USA, V101, P18064, DOI 10.1073/pnas.0408092101; Jobson RW, 2002, CLADISTICS, V18, P127, DOI 10.1111/j.1096-0031.2002.tb00145.x; Juniper B, 1989, CARNIVIROROUS PLANTS; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Koopman MM, 2011, MICROB ECOL, V61, P750, DOI 10.1007/s00248-011-9832-9; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lan TY, 2017, P NATL ACAD SCI USA, V114, pE4435, DOI 10.1073/pnas.1702072114; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09040; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mills DA, 1996, J BACTERIOL, V178, P3531, DOI 10.1128/jb.178.12.3531-3538.1996; Mower J.P., 2012, PLANT GENOME DIVERSI, P123, DOI DOI 10.1007/978-3-7091-1130-7_9; Mower JP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-96; Oldenburg DJ, 1996, PLANT CELL, V8, P447, DOI 10.1105/tpc.8.3.447; Palmer J. D., 1992, MOL SYSTEMATICS PLAN, P36, DOI DOI 10.1007/978-1-4615-3276-7; Park S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-405; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rutishauser R, 2016, ANN BOT-LONDON, V117, P811, DOI 10.1093/aob/mcv172; Sanchez-Puerta MV, 2008, MOL BIOL EVOL, V25, P1762, DOI 10.1093/molbev/msn129; Sanchez-Puerta MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-277; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Silva SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165176; Sirova D, 2009, AQUAT BOT, V90, P129, DOI 10.1016/j.aquabot.2008.07.007; Sloan DB, 2013, NEW PHYTOL, V200, P978, DOI 10.1111/nph.12395; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Stone JD, 2015, MOL GENET GENOMICS, V290, P1, DOI 10.1007/s00438-014-0905-6; Takeuchi Y, 2015, SYST APPL MICROBIOL, V38, P330, DOI 10.1016/j.syapm.2015.05.006; Taylor P, 1989, GENUS UTRICULARIA TA; Treangen Todd J, 2011, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1108s33; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Wang D, 2012, MOL BIOL EVOL, V29, P1707, DOI 10.1093/molbev/mss016; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Wu ZQ, 2015, P NATL ACAD SCI USA, V112, P10185, DOI 10.1073/pnas.1421397112; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xi ZX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003265; Yoshihisa T, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00213	81	21	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e180484	10.1371/journal.pone.0180484	http://dx.doi.org/10.1371/journal.pone.0180484			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723946	gold, Green Submitted, Green Published			2022-12-27	WOS:000406067800015
J	Yallew, WW; Kumie, A; Yehuala, FM				Yallew, Walelegn Worku; Kumie, Abera; Yehuala, Feleke Moges			Risk factors for hospital-acquired infections in teaching hospitals of Amhara regional state, Ethiopia: A matched-case control study	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; BLOOD-STREAM INFECTION; VENTILATOR-ASSOCIATED PNEUMONIA; CONTROL CONSORTIUM INICC; POINT-PREVALENCE SURVEY; LENGTH-OF-STAY; DEVELOPING-COUNTRIES FINDINGS; MULTIDIMENSIONAL APPROACH; NOSOCOMIAL INFECTIONS; BACTERIAL-RESISTANCE	Background Hospital-acquired infection affects hundreds of millions of people worldwide. It is a major global issue for patient safety. Understanding the potential risk factors is important to appreciate the local context. A matched case control study design, which is the first of its kind in the study region, was undertaken to identify risk factors in teaching hospitals of Amhara regional state, Ethiopia. Method A matched case control study design matched with age and hospital type was used. The study was conducted in University of Gondar and Felege-Hiwot medical teaching hospital. Cases were patients who fulfilled the criteria based on CDC definition of hospital-acquired infection and controls were patients admitted to the hospital that stayed for more than 48 hours in the ward in the study period, but who did not develop infection. For one case, four controls were selected. Of 545 patients, 109 were cases and 436 were controls. Conditional logistic regression using STATA 13 was used for data analysis. Result The median length of stay for cases and controls was 7 and 8 days, respectively. Patients admitted in wards with the presence of medical waste container in the room had 82% less chance of developing hospital-acquired infection (AOR 0.18; 95% CI, 0.03-0.98). The odds of developing hospital-acquired infection among immune deficient patients were 2.34 times higher than their counterparts (95% CI; 1.17-4.69). Patients received antimicrobials, central vascular catheter and surgery since admission had 8.63, 6.91 and 2.35 higher odds of developing hospital-acquired infection, respectively. Conclusion Health providers and mangers should consider the provision and availability of healthcare materials and facilities in all of the ward rooms, follow appropriate safe medical procedures for use of external devices on patients, and give attention to the immunocompromised patients for the prevention and control of hospital-acquired infections.	[Yallew, Walelegn Worku] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Kumie, Abera] Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Yehuala, Feleke Moges] Univ Gondar, Dept Med Microbiol, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; Addis Ababa University; University of Gondar	Yallew, WW (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	walelegnw@gmail.com	Moges, Feleke/GXW-1995-2022; Kumie, Abera/AAC-8537-2022					Abdella NM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-96; Al-Mousa HH, 2016, AM J INFECT CONTROL, V44, P444, DOI 10.1016/j.ajic.2015.10.031; AL-Rawajfah OM, 2013, AM J INFECT CONTROL, V41, P607, DOI 10.1016/j.ajic.2012.08.014; Amenu D, 2011, ETHIOP J HEALTH SCI, V21, P91; Chan MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085973; Cuellar LE, 2008, REV PANAM SALUD PUBL, V24, P16, DOI 10.1590/S1020-49892008000700002; Rosenthal VD, 2016, AM J INFECT CONTROL, V44, P1495, DOI 10.1016/j.ajic.2016.08.007; Rosenthal VD, 2015, AM J INFECT CONTROL, V43, P1040, DOI 10.1016/j.ajic.2015.05.042; Deptula A, 2015, J HOSP INFECT, V90, P310, DOI 10.1016/j.jhin.2015.03.005; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P286, DOI 10.1016/j.ajic.2013.01.002; Durlach R, 2012, J HOSP INFECT, V80, P217, DOI 10.1016/j.jhin.2011.12.001; Gailiene G, 2012, MED LITH, V48, P399; Gravel D, 2007, J HOSP INFECT, V66, P243, DOI 10.1016/j.jhin.2007.04.008; Hansen S, 2015, CLIN MICROBIOL INFEC, V21, P1047, DOI 10.1016/j.cmi.2015.09.019; Higuera F, 2007, INFECT CONT HOSP EP, V28, P31, DOI 10.1086/510812; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hu BJ, 2013, AM J INFECT CONTROL, V41, P301, DOI 10.1016/j.ajic.2012.03.037; Humphreys H, 2008, J HOSP INFECT, V69, P249, DOI 10.1016/j.jhin.2008.04.021; Jahani-Sherafat S, 2015, J INFECT PUBLIC HEAL, V8, P553, DOI 10.1016/j.jiph.2015.04.028; JIMENEZROMANO E, 1993, EUR J EPIDEMIOL, V9, P263, DOI 10.1007/BF00146261; Leblebicioglu H, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-10; Liu JY, 2016, J HOSP INFECT, V93, P271, DOI 10.1016/j.jhin.2016.03.019; Madani Naoufel, 2009, Int Arch Med, V2, P29, DOI 10.1186/1755-7682-2-29; Monistrol O, 2012, CLIN MICROBIOL INFEC, V18, P1212, DOI 10.1111/j.1469-0691.2011.03735.x; Moreno CA, 2006, INFECT CONT HOSP EP, V27, P349, DOI 10.1086/503341; Mulu W, 2012, ETHIOP J HEALTH SCI, V22, P7; Nigatu Endalafer, 2011, Journal of Infection Prevention, V12, P38, DOI 10.1177/1757177410376680; Oldfield Margaret M, 2009, Intensive Crit Care Nurs, V25, P38, DOI 10.1016/j.iccn.2008.07.001; Rai V., 2016, CANADIAN J INFECT CO, V31, P107, DOI [10.4331/wjbc.v8.i1.95, DOI 10.4331/WJBC.V8.I1.95]; Rasslan Ossama, 2012, J Infect Public Health, V5, P394, DOI 10.1016/j.jiph.2012.07.002; Razine Rachid, 2012, Int Arch Med, V5, P26, DOI 10.1186/1755-7682-5-26; Rosenthal VD, 2012, INFECTION, V40, P517, DOI 10.1007/s15010-012-0278-x; Rosenthal VD, 2012, INFECTION, V40, P415, DOI 10.1007/s15010-012-0246-5; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P475, DOI 10.1016/j.ajic.2003.03.002; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P497, DOI 10.1016/j.ajic.2011.08.005; Rosenthal VD, 2012, INFECT CONT HOSP EP, V33, P704, DOI 10.1086/666342; Rosenthal VD, 2010, INFECT CONT HOSP EP, V31, P1264, DOI 10.1086/657140; Savolainen-Kopra C, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-10; Sheng WH, 2005, J FORMOS MED ASSOC, V104, P318; Stiller A, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0152-1; Szklo M, 2014, EPIDEMIOLOGY BASICS; TADESSE ML, 2014, BMC PUBLIC HEALTH, V14, DOI DOI 10.1186/1471-2458-14-1221; Tao LL, 2012, J CRIT CARE, V27, P440, DOI 10.1016/j.jcrc.2011.12.018; Tao LL, 2011, INT J INFECT DIS, V15, pE774, DOI 10.1016/j.ijid.2011.06.009; Phu VD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147544; World Health Organization, 2009, WHO GUID HAND HYG HL; Xie DS, 2010, J HOSP INFECT, V76, P150, DOI 10.1016/j.jhin.2010.04.003; Yallew WW, 2016, DRUG HEALTHC PATIENT, V8, P71, DOI 10.2147/DHPS.S107344; Yang CC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-289; Zarb P, 2012, EURO SURVEILL B EUR, V15, P17; Zhang X, 2015, INT J CLIN EXP MED, V8, P16682	51	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181145	10.1371/journal.pone.0181145	http://dx.doi.org/10.1371/journal.pone.0181145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719665	gold, Green Submitted, Green Published			2022-12-27	WOS:000406061400032
J	Hochman, G; Halevi-Tobias, K; Kogan, Y; Agur, Z				Hochman, Gili; Halevi-Tobias, Karin; Kogan, Yuri; Agur, Zvia			Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model	PLOS ONE			English	Article							BETA-CATENIN; SOMATIC MUTATIONS; APC GENE; CANCER; CELLS; MECHANISM; PROTEIN; LEVEL; BINDS; ACTIVATION	Background Despite considerable investigational efforts, no method to overcome the pathogenesis caused by loss of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent LoF mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial binding abilities. Objective & methods Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting upstream of the APC mutation, can restore normal levels of pathway activity in colon cancer cells. To this end, we developed and simulated a mathematical model for the Wnt pathway in different APC mutants, with or without the effects of the extracellular inhibitors, Secreted Frizzled-Related Protein1 (sFRP1) and Dickhopf1 (Dkk1). We compared our model predictions to experimental data in the literature. Results Our model accurately predicts T-cell factor (TCF) activity in mutant cells that vary in APC mutation. Model simulations suggest that both sFRP1 and DKK1 can reduce TCF activity in APC (1638N/1572T) and Apc (min/min) mutants, but restoration of normal activity levels is possible only in the former. When applied in combination, synergism between the two inhibitors can reduce their effective doses to one-fourth of the doses required under single inhibitor application. Overall, re-establishment of normal Wnt pathway activity is predicted for every APC mutant in whom TCF activity is increased by up to 11 fold. Conclusions Our work suggests that extracellular inhibitors can effectively restore normal Wnt pathway activity in APC-truncated cancer cells, even though these LoF mutations occur downstream of the inhibitory action. The insufficient activity of the truncated APC can be quantitatively balanced by the upstream intervention. This new concept of upstream intervention to control the effects of downstream mutations may be considered also for other partial LoF mutations in other signaling pathways.	[Hochman, Gili; Halevi-Tobias, Karin; Kogan, Yuri; Agur, Zvia] Inst Med BioMath, Bene Ataroth, Israel		Agur, Z (corresponding author), Inst Med BioMath, Bene Ataroth, Israel.	agur@imbm.org		Agur, Zvia/0000-0001-5701-9149				Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Athar M, 2011, CURR PHARM DESIGN, V17, P631, DOI 10.2174/138161211795222595; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barua D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003217; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Benary U, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00021; Blagodatski Artem, 2014, Mol Cell Ther, V2, P28, DOI 10.1186/2052-8426-2-28; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Calin G, 1999, EUR J HUM GENET, V7, P609, DOI 10.1038/sj.ejhg.5200350; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Clements Wilson M, 2003, Clin Colorectal Cancer, V3, P113, DOI 10.3816/CCC.2003.n.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Hannoush RN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003498; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; HIGASHI Y, 1982, J BIOCHEM-TOKYO, V91, P2021, DOI 10.1093/oxfordjournals.jbchem.a133895; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ishikawa T, 2003, DEV BIOL, V253, P230, DOI 10.1016/S0012-1606(02)00020-9; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kofahl B, 2010, BIOCHEM SOC T, V38, P1281, DOI 10.1042/BST0381281; Kogan Y, 2012, BIOCHEM J, V444, P115, DOI 10.1042/BJ20111887; Laurent-Puig P, 1998, NUCLEIC ACIDS RES, V26, P269, DOI 10.1093/nar/26.1.269; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lesko AC, 2014, CURR DRUG TARGETS, V15, P90, DOI 10.2174/1389450114666131108155418; Li Q, 2005, CANCER RES, V65, P8622, DOI 10.1158/0008-5472.CAN-05-2145; Lloyd-Lewis B, 2013, WIRES SYST BIOL MED, V5, P391, DOI 10.1002/wsbm.1221; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Melcher R, 2011, CARCINOGENESIS, V32, P636, DOI 10.1093/carcin/bgr011; MIYAKI M, 1994, CANCER RES, V54, P3011; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Prosperi JR, 2014, CURR DRUG TARGETS, V15, P1; Rubinfeld B, 1997, CANCER RES, V57, P4624; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Song JH, 2014, CELL REP, V7, P94, DOI 10.1016/j.celrep.2014.02.043; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takebe N, 2010, CLIN CANCER RES, V16, P3106, DOI 10.1158/1078-0432.CCR-09-2934; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031882; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Vargas DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005007; Virshup DM, 2015, J CLIN INVEST, V125, P975, DOI 10.1172/JCI80819; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	64	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179888	10.1371/journal.pone.0179888	http://dx.doi.org/10.1371/journal.pone.0179888			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708837	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800008
J	Wang, Y; Yu, B; Wang, L; Yang, M; Xia, ZY; Wei, W; Zhang, FY; Yuan, XC				Wang, Yao; Yu, Bo; Wang, Li; Yang, Ming; Xia, Zhiyin; Wei, Wei; Zhang, Fengyu; Yuan, Xiaochen			Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus	PLOS ONE			English	Article							NF-KAPPA-B; GLYCATION END-PRODUCTS; MESANGIAL CELLS; RENAL-DISEASE; FAT DIET; NEPHROPATHY; RATS; INHIBITION; RECEPTOR; KIDNEY	Objective The NLRP3 inflammasome plays an important role in the pathogenesis of inflammation in diabetic nephropathy (DN). Pioglitazone (PIO) has been found to exert an anti-inflammatory effect in patients with diabetes mellitus, but it is still unclear whether PIO exhibits a similar effect in DN. We aimed to explore the effect and underlying mechanism of PIO on DN, as well as investigate if NLRP3 is a pharmacologic target of PIO. Methods We divided 48 apolipoprotein E (apoE) (-/-) mice into 4 groups: apoE (-/-), apoE (-/-) with PIO, diabetic apoE (-/-), and diabetic apoE (-/-) with PIO. Wild type male C57BL/6 mice were used as controls (n = 8 per group). After 8 weeks of PIO treatment, we examined the baseline characteristics and metabolic parameters of each group, and we used enzymelinked immunosorbent assay (ELISA), western blot, and immunohistochemical staining to evaluate the expression levels of advanced glycation end products (AGEs), receptor for advanced glycation end products (RAGE), NLRP3, nuclear factor D kappa B (NF-kappa B), caspase-1, interleukin (IL)-18, and IL-1 beta in each group. Results Compared to the diabetic apoE (-/-) group, PIO treatment decreased blood glucose, cholesterol, serum blood urea nitrogen (BUN), and creatinine levels. It also depressed the glomerular mesangial expansion. PIO down-regulated expression of AGEs, RAGE, and NF-kappa B, all of which further depressed NLRP3, caspase-1, IL-18, and IL-1 beta levels. Conclusion Pioglitazone can ameliorate diabetic renal damage, and this effect is related to the inhibition of renal AGE/RAGE axis activation and the down-regulation of NF-kappa B expression. These effects lead to a decline in NLRP3 levels and downstream secretion of inflammatory cytokines.	[Wang, Yao; Yang, Ming; Xia, Zhiyin; Wei, Wei] Yangzhou Univ, Yangzhou Peoples Hosp 1, Affiliated Hosp, Dept Nephrol, Yangzhou, Jiangsu, Peoples R China; [Yu, Bo] Yangzhou Univ, Yangzhou Peoples Hosp 1, Affiliated Hosp, Dept Emergency, Yangzhou, Jiangsu, Peoples R China; [Wang, Li; Yuan, Xiaochen] Yangzhou Univ, Yangzhou Peoples Hosp 1, Affiliated Hosp, Dept Cardiol, Yangzhou, Jiangsu, Peoples R China; [Zhang, Fengyu] Yangzhou Univ, Yangzhou Peoples Hosp 1, Affiliated Hosp, Cent Lab, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University	Yuan, XC (corresponding author), Yangzhou Univ, Yangzhou Peoples Hosp 1, Affiliated Hosp, Dept Cardiol, Yangzhou, Jiangsu, Peoples R China.	1184806497@qq.com			Foundation of yangzhou-social the development of science and technology research project [YZ2012130]; National Natural Science Foundation of China [81470381]	Foundation of yangzhou-social the development of science and technology research project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Foundation of yangzhou-social the development of science and technology research project, YZ2012130 (http://kjj.yangzhou.gov.cn/kjj/index.shtml) and the National Natural Science Foundation of China, 81470381, (http://npd.nsfc.gov.cn/fundingProjectSearchAction.action). The funders had no role in study design, data collection and analysis of the manuscript.	Abais JM, 2013, ANTIOXID REDOX SIGN, V18, P1537, DOI 10.1089/ars.2012.4666; Alvarez-Guardia D, 2011, BBA-MOL CELL BIOL L, V1811, P59, DOI 10.1016/j.bbalip.2010.11.002; Ayhan M., 2013, ISRN ENDOCRINOL, V2013, DOI DOI 10.1155/2013/858690; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bock F, 2013, P NATL ACAD SCI USA, V110, P648, DOI 10.1073/pnas.1218667110; Boini KM, 2014, BBA-MOL CELL RES, V1843, P836, DOI 10.1016/j.bbamcr.2014.01.033; Chen L, 2008, INFLAMM RES, V57, P199, DOI 10.1007/s00011-006-6190-z; Collino M, 2013, BIOCHEM PHARMACOL, V85, P257, DOI 10.1016/j.bcp.2012.10.014; Coughlan MT, 2009, J AM SOC NEPHROL, V20, P742, DOI 10.1681/ASN.2008050514; Gruden G, 2005, J AM SOC NEPHROL, V16, P688, DOI 10.1681/ASN.2004030251; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hong W, 2015, MOL MED REP, V12, P6221, DOI 10.3892/mmr.2015.4145; Isshiki K, 2000, DIABETES, V49, P1022, DOI 10.2337/diabetes.49.6.1022; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Karakikes I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006474; Kim JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062068; Kim SM, 2015, AM J PHYSIOL-RENAL, V308, pF993, DOI 10.1152/ajprenal.00637.2014; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P2750, DOI 10.1093/ndt/gfn157; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Lorenz G, 2014, NEPHROL DIAL TRANSPL, V29, P41, DOI 10.1093/ndt/gft332; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Matsui T, 2010, BIOCHEM BIOPH RES CO, V398, P326, DOI 10.1016/j.bbrc.2010.06.093; Minutoli Letteria, 2016, Oxid Med Cell Longev, V2016, P2183026, DOI 10.1155/2016/2183026; Niemir ZI, 1997, KIDNEY INT, V52, P393, DOI 10.1038/ki.1997.346; Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Sarafidis PA, 2006, KIDNEY INT, V70, P1223, DOI 10.1038/sj.ki.5001620; Sun GD, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5749857; Tan ALY, 2010, AM J PHYSIOL-RENAL, V298, pF763, DOI 10.1152/ajprenal.00591.2009; Tanimoto M, 2004, METABOLISM, V53, P1473, DOI 10.1016/j.metabol.2004.06.016; Thomas MC, 2011, CONTRIB NEPHROL, V170, P66, DOI 10.1159/000324945; Turner CM, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-21; Vilahur G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00496; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Watson AMD, 2012, DIABETES, V61, P2105, DOI 10.2337/db11-1546; Yang SM, 2014, DIABETOLOGIA, V57, P424, DOI 10.1007/s00125-013-3115-6; Zhang MH, 2014, J ETHNOPHARMACOL, V151, P591, DOI 10.1016/j.jep.2013.11.015; Zhao HL, 2014, AM J PHYSIOL-RENAL, V306, pF801, DOI 10.1152/ajprenal.00469.2013; Zheng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020431	41	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181248	10.1371/journal.pone.0181248	http://dx.doi.org/10.1371/journal.pone.0181248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708885	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800052
J	Anitas, EM; Slyamov, A				Anitas, Eugen Mircea; Slyamov, Azat			Structural characterization of chaos game fractals using small-angle scattering analysis	PLOS ONE			English	Article							FRAUNHOFER-DIFFRACTION; KOCH FRACTALS; FAT FRACTALS; NANOTECHNOLOGY; SYSTEMS	Small-angle scattering (SAS) technique is applied to study the nano and microstructural properties of spatial patterns generated from chaos game representation (CGR). Using a simplified version of Debye formula, we calculate and analyze in momentum space, the monodisperse scattering structure factor from a system of randomly oriented and non-interacting 2D Sierpinski gaskets (SG). We show that within CGR approach, the main geometrical and fractal properties, such as the overall size, scaling factor, minimal distance between scattering units, fractal dimension and the number of units composing the SG, can be recovered. We confirm the numerical results, by developing a theoretical model which describes analytically the structure factor of SG. We apply our findings to scattering from single scale mass fractals, and respectively to a multiscale fractal representing DNA sequences, and for which an analytic description of the structure factor is not known a priori.	[Anitas, Eugen Mircea; Slyamov, Azat] Joint Inst Nucl Res, Dubna, Moscow Region, Russia; [Anitas, Eugen Mircea] Horia Hulubei Natl Inst Phys & Nucl Engn, Bucharest, Romania; [Slyamov, Azat] Inst Nucl Phys, Alma Ata, Kazakhstan	Joint Institute for Nuclear Research - Russia; Horia Hulubei National Institute of Physics & Nuclear Engineering; Institute of Nuclear Physics - Kazakhstan	Anitas, EM (corresponding author), Joint Inst Nucl Res, Dubna, Moscow Region, Russia.; Anitas, EM (corresponding author), Horia Hulubei Natl Inst Phys & Nucl Engn, Bucharest, Romania.	anitas@jinr.ru	Anitas, Eugen-Mircea/B-8762-2015; Anitas, Eugen M/G-7260-2011	Anitas, Eugen-Mircea/0000-0003-2693-1383; Anitas, Eugen M/0000-0003-2693-1383				ALLAIN C, 1986, PHYS REV B, V33, P3566, DOI 10.1103/PhysRevB.33.3566; Almeida JS, 2001, BIOINFORMATICS, V17, P429, DOI 10.1093/bioinformatics/17.5.429; Anitas EM, 2016, ROM J PHYS, V61, P457; Anitas EM, 2015, ROM J PHYS, V60, P647; Anitas EM, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-41066-9; BALE HD, 1984, PHYS REV LETT, V53, P596, DOI 10.1103/PhysRevLett.53.596; Barnsley M., 2000, FRACTALS EVERYWHERE; Berenschot EJW, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/5/055024; Brumberger H, 1995, MODERN ASPECTS SMALL; Cerofolini GF, 2008, NANOSCALE RES LETT, V3, P381, DOI 10.1007/s11671-008-9170-0; Cherny AY, 2014, J APPL CRYSTALLOGR, V47, P198, DOI 10.1107/S1600576713029956; Cherny AY, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036203; Cherny AY, 2017, PHYS CHEM CHEM PHYS, V19, P2261, DOI 10.1039/c6cp07496k; Debye P, 1915, ANN PHYS-BERLIN, V46, P809; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Galiceanu M, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/30/305002; Gouyet J. F., 1996, PHYS FRACTAL STRUCTU; Hausdorff F, 1919, MATH ANN, V79, P157; Huang XQ, 2010, METAMATERIALS: THEORY, DESIGN, AND APPLICATIONS, P215, DOI 10.1007/978-1-4419-0573-4_10; HUTCHINSON JE, 1981, INDIANA U MATH J, V30, P713, DOI 10.1512/iumj.1981.30.30055; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Korvin G, 2004, CHAOS SOLITON FRACT, V19, P421, DOI 10.1016/S0960-0779(03)00272-8; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; MARTIN JE, 1987, J APPL CRYSTALLOGR, V20, P61, DOI 10.1107/S0021889887087107; Mayama H, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2336200; Nakayama T., 2003, FRACTAL CONCEPTS CON; Newkome GR, 2006, SCIENCE, V312, P1782, DOI 10.1126/science.1125894; Olivi-Tran N, 2005, CHAOS SOLITON FRACT, V25, P525, DOI 10.1016/j.chaos.2004.12.043; Pantos E, 1996, J MOL STRUCT, V383, P303, DOI 10.1016/S0022-2860(96)09302-7; Roe R. J., 2000, METHODS XRAY NEUTRON; Sandru A, 2012, J MOD OPTIC, V59, P199, DOI 10.1080/09500340.2011.624646; SCHMIDT PW, 1991, J APPL CRYSTALLOGR, V24, P414, DOI 10.1107/S0021889891003400; Sotelo JA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.245113; Takeda MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.093902; TEIXEIRA J, 1988, J APPL CRYSTALLOGR, V21, P781, DOI 10.1107/S0021889888000263; UOZUMI J, 1991, J MOD OPTIC, V38, P1335, DOI 10.1080/09500349114551501; UOZUMI J, 1990, J MOD OPTIC, V37, P1011, DOI 10.1080/09500349014551081	37	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181385	10.1371/journal.pone.0181385	http://dx.doi.org/10.1371/journal.pone.0181385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704515	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700130
J	Peng, Y; Wang, SN; Li, KM; Liu, JT; Zheng, Y; Shan, S; Yang, YQ; Li, RJ; Zhang, YJ; Guo, YY				Peng, Yong; Wang, Shan-Ning; Li, Ke-Ming; Liu, Jing-Tao; Zheng, Yao; Shan, Shuang; Yang, Ye-Qing; Li, Rui-Jun; Zhang, Yong-Jun; Guo, Yu-Yuan			Identification of odorant binding proteins and chemosensory proteins in Microplitis mediator as well as functional characterization of chemosensory protein 3	PLOS ONE			English	Article							CHEMICAL COMMUNICATION; ANTENNAL TRANSCRIPTOME; PHEROMONE-BINDING; INDUCED VOLATILES; SOLUBLE-PROTEINS; PARASITOID WASP; GENE FAMILY; HYMENOPTERA; INSECT; IMMUNOLOCALIZATION	Odorant binding proteins (OBPs) and chemosensory proteins (CSPs) play important roles in transporting semiochemicals through the sensillar lymph to olfactory receptors in insect antennae. In the present study, twenty OBPs and three CSPs were identified from the antennal transcriptome of Microplitis mediator. Ten OBPs (MmedOBP11 - 20) and two CSPs (MmedCSP2-3) were newly identified. The expression patterns of these new genes in olfactory and non-olfactory tissues were investigated by real-time quantitative PCR (qPCR) measurement. The results indicated that MmedOBP14, MmedOBP18, MmedCSP2 and MmedCSP3 were primarily expressed in antennae suggesting potential olfactory roles in M. mediator. However, other genes including MmedOBP11-13, 15-17, 19 - 20 appeared to be expressed at higher levels in body parts than in antennae. Focusing on the functional characterization of MmedCSP3, immunocytochemistry and fluorescent competitive binding assays were conducted indoors. It was found that MmedCSP3 was specifically located in the sensillum lymph of olfactory sensilla basiconca type 2. The recombinant MmedCSP3 could bind several types of host insects odors and plant volatiles. Interestingly, three sex pheromone components of Noctuidae insects, cis-11-hexadecenyl aldehyde (Z11-16: Ald), cis-11-hexadecanol (Z11-16: OH), and trans-11-tetradecenyl acetate (E11-14: Ac), showed high binding affinities (Ki = 17.24 - 18.77 mu M). The MmedCSP3 may be involved in locating host insects. Our data provide a base for further investigating the physiological roles of OBPs and CSPs in M. mediator, and extend the function of MmedCSP3 in chemoreception of M. mediator.	[Peng, Yong; Yang, Ye-Qing; Li, Rui-Jun] Agr Univ Hebei, Coll Plant Protect, Baoding, Peoples R China; [Peng, Yong; Wang, Shan-Ning; Li, Ke-Ming; Liu, Jing-Tao; Zheng, Yao; Shan, Shuang; Yang, Ye-Qing; Zhang, Yong-Jun; Guo, Yu-Yuan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Li, Ke-Ming] Chinese Acad Trop Agr Sci, Inst Banana & Plantain, Haikou, Hainan, Peoples R China; [Shan, Shuang] China Agr Univ, Coll Plant Protect, Beijing, Peoples R China	Hebei Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Tropical Agricultural Sciences; China Agricultural University	Li, RJ (corresponding author), Agr Univ Hebei, Coll Plant Protect, Baoding, Peoples R China.; Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	liruijun99@sina.com; yjzhang@ippcaas.cn			National Natural Science Foundation of China [31272048, 31471778, 31672038]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [31621064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31272048, 31471778 and 31672038) and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 31621064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR AP, 1986, CAN ENTOMOL, V118, P487, DOI 10.4039/Ent118487-5; Belz E, 2013, BIOCONTROL, V58, P163, DOI 10.1007/s10526-012-9472-0; BREER H, 1994, BBA-MOL CELL RES, V1224, P277, DOI 10.1016/0167-4889(94)90201-1; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; CARDE RT, 1977, J CHEM ECOL, V3, P143, DOI 10.1007/BF00994141; Dong Wen-Xia, 2006, Acta Entomologica Sinica, V49, P1054; Field LM, 2000, INSECT MOL BIOL, V9, P545, DOI 10.1046/j.1365-2583.2000.00221.x; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Herde M, 2008, PLANT CELL, V20, P1152, DOI 10.1105/tpc.106.049478; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Horikoshi M, 1997, J CHEM ECOL, V23, P1505, DOI 10.1023/B:JOEC.0000006418.49537.5d; Hua JF, 2012, J CHEM ECOL, V38, P1163, DOI 10.1007/s10886-012-0178-7; Huang Yongping, 1996, Entomologia Sinica, V3, P172; Jansen S, 2007, ARCH INSECT BIOCHEM, V66, P135, DOI 10.1002/arch.20205; Li Ke-ming, 2012, Scientia Agricultura Sinica, V45, P3522; Li KM, 2014, J CHEM ECOL, V40, P541, DOI 10.1007/s10886-014-0458-5; Li WX, 2008, ANN ENTOMOL SOC AM, V101, P613, DOI 10.1603/0013-8746(2008)101[613:ROPATI]2.0.CO;2; Li XR, 2011, INT J BIOL SCI, V7, P848, DOI 10.7150/ijbs.7.848; Liu NY, 2013, COMP BIOCHEM PHYS A, V165, P254, DOI 10.1016/j.cbpa.2013.03.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Reddy GVP, 2002, J CHEM ECOL, V28, P131, DOI 10.1023/A:1013519003944; Snoeren TAL, 2010, J EXP BOT, V61, P3041, DOI 10.1093/jxb/erq127; Sun L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08073; Sun YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037178; Swanson JAI, 2009, J CHEM ECOL, V35, P1108, DOI 10.1007/s10886-009-9683-8; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiery D, 1995, J CHEM ECOL, V21, P2015, DOI 10.1007/BF02033859; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wang SN, 2016, J INSECT PHYSIOL, V90, P27, DOI 10.1016/j.jinsphys.2016.05.002; Wang SN, 2015, INT J BIOL SCI, V11, P737, DOI 10.7150/ijbs.11786; Wanner KW, 2005, INSECT MOL BIOL, V14, P289, DOI 10.1111/j.1365-2583.2005.00559.x; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yu HL, 2010, ENVIRON ENTOMOL, V39, P600, DOI 10.1603/EN09162; Zhang SA, 2011, J CHEM ECOL, V37, P189, DOI 10.1007/s10886-010-9902-3; Zhang SA, 2009, CHEM SENSES, V34, P503, DOI 10.1093/chemse/bjp027; Zhao YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148159; Zhou CX, 2015, COMP BIOCHEM PHYS D, V16, P10, DOI 10.1016/j.cbd.2015.06.003; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08	45	24	27	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180775	10.1371/journal.pone.0180775	http://dx.doi.org/10.1371/journal.pone.0180775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732030	Green Published, gold, Green Submitted			2022-12-27	WOS:000406643100012
J	Rao, Y; Deng, C; Su, J; Qiao, Y; Zhu, J; Wang, RC				Rao, Yuan; Deng, Cheng; Su, Jun; Qiao, Yan; Zhu, Jun; Wang, Ru-chuan			Setting strategy of delay-optimization-oriented SMAC contention window size	PLOS ONE			English	Article							WIRELESS SENSOR NETWORKS; MAC PROTOCOL	Some frame components, such as SYNC (frame synchronization) and RTS/CTS (Ready to Send/Clear to Send), are not taken into consideration when the traditional setting strategies conduct the optimization of SMAC (Sensor MAC) contention window size. This paper proposes mathematical models that allow the analysis of data packets forwarding delay within one SMAC virtual cluster. Simulation results in OMNeT++ show good agreements with the proposed mathematical models, validating the models' correctness. The curve analyses of the models confirm the existence of delay-optimization-oriented contention window size that is closely related to the number of simultaneously contending nodes. Afterwards, it is shown that SYNC, RTS/CTS and EIFS (Extended InterFrame Space) have impacts on the optimal contention window size and expected delivery delay to various degrees, as well as throughput and energy efficiency. One ideal setting strategy of delay-optimization-oriented SMAC contention window size requires the combination of the network scale, SYNC, RTS/CTS and EIFS. Additionally, it is demonstrated that the proposed setting strategy makes contributions to the improvement in the existing SMAC extensions when they are integrated with each other, in terms of the end-to-end delay, throughput and energy consumption.	[Rao, Yuan; Deng, Cheng; Su, Jun; Qiao, Yan; Zhu, Jun] Anhui Agr Univ, Coll Informat & Comp Sci, Hefei, Anhui, Peoples R China; [Rao, Yuan; Wang, Ru-chuan] Jiangsu High Technol Res Key Lab Wireless Sensor, Nanjing, Jiangsu, Peoples R China	Anhui Agricultural University	Rao, Y (corresponding author), Anhui Agr Univ, Coll Informat & Comp Sci, Hefei, Anhui, Peoples R China.; Rao, Y (corresponding author), Jiangsu High Technol Res Key Lab Wireless Sensor, Nanjing, Jiangsu, Peoples R China.	raoyuan@ahau.edu.cn		rao, yuan/0000-0002-4386-2490	National Natural Science Foundation of P. R. China; Natural Science Foundation of Anhui Province; Jiangsu High Technology Research Key Laboratory for Wireless Sensor Networks	National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Jiangsu High Technology Research Key Laboratory for Wireless Sensor Networks	The National Natural Science Foundation of P. R. China, The Natural Science Foundation of Anhui Province, The Jiangsu High Technology Research Key Laboratory for Wireless Sensor Networks, The National Natural Science Foundation of P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahzadeh S, 2016, COMPUT COMMUN, V91-92, P1, DOI 10.1016/j.comcom.2016.06.003; Asudeh A, 2016, AD HOC NETW, V36, P189, DOI 10.1016/j.adhoc.2015.07.005; Byun H, 2013, IEEE T MOBILE COMPUT, V12, P1214, DOI 10.1109/TMC.2012.102; Chang LW, 2013, INT J COMMUN SYST, V26, P1129, DOI 10.1002/dac.2520; Demirkol I, 2009, COMPUT NETW, V53, P2106, DOI 10.1016/j.comnet.2009.03.016; Donmez MY, 2013, COMPUT NETW, V57, P1101, DOI 10.1016/j.comnet.2012.11.016; Doudou M, 2014, J NETW COMPUT APPL, V38, P172, DOI 10.1016/j.jnca.2013.03.012; Du S, 2007, IEEE INFOCOM SER, P1478, DOI 10.1109/INFCOM.2007.174; Hammoudeh M, 2015, INFORM FUSION, V22, P3, DOI 10.1016/j.inffus.2013.02.005; Huang P, 2013, IEEE COMMUN SURV TUT, V15, P101, DOI 10.1109/SURV.2012.040412.00105; Jun L, 2010, SCI SINICA INFORM, V40, P1464; [李跃 Li Yue], 2012, [计算机科学, Computer Science], V39, P86; [李运鹏 LI Yun-peng], 2010, [传感器与微系统, Transducer and Microsystem Technology], V29, P49; Lin CW, 2009, J MULTI-CRITERIA DEC, V16, P5, DOI 10.1002/mcda.438; Mahmood MA, 2015, COMPUT NETW, V79, P166, DOI 10.1016/j.comnet.2014.12.016; Misbah L, 2016, PLOS ONE, V11, P1; Rao Y, 2016, COMPUT ELECTR ENG, V56, P468, DOI 10.1016/j.compeleceng.2015.11.031; Sakya G., 2013, SOCIAL INFORMATICS T, V115, P42, DOI [10.1007/978-3-642-37949-9_4, DOI 10.1007/978-3-642-37949-9_4]; Siddiqui S, 2013, IEEE INT C NETW SENS, P28, DOI 10.1109/ICNSC.2013.6548706; Tadayon N, 2013, J NETW COMPUT APPL, V36, P1008, DOI 10.1016/j.jnca.2012.01.009; Varga, 2015, OMNET DISCRETE EVENT; Wang CX, 2013, 2013 IEEE NINTH INTERNATIONAL CONFERENCE ON MOBILE AD-HOC AND SENSOR NETWORKS (MSN 2013), P437, DOI 10.1109/MSN.2013.15; Xu L, 2015, J COMMUNICATIONS, V36, P1; Ye W, 2004, IEEE ACM T NETWORK, V12, P493, DOI 10.1109/TNET.2004.828953	24	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181506	10.1371/journal.pone.0181506	http://dx.doi.org/10.1371/journal.pone.0181506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732020	Green Submitted, Green Published, gold			2022-12-27	WOS:000406643100041
J	Buchbinder, SP; Grunenberg, NA; Sanchez, BJ; Seaton, KE; Ferrari, G; Moody, MA; Frahm, N; Montefiori, DC; Hay, CM; Goepfert, PA; Baden, LR; Robinson, HL; Yu, XS; Gilbert, PB; McElrath, MJ; Huang, Y; Tomaras, GD				Buchbinder, Susan P.; Grunenberg, Nicole A.; Sanchez, Brittany J.; Seaton, Kelly E.; Ferrari, Guido; Moody, M. Anthony; Frahm, Nicole; Montefiori, David C.; Hay, Christine M.; Goepfert, Paul A.; Baden, Lindsey R.; Robinson, Harriet L.; Yu, Xuesong; Gilbert, Peter B.; McElrath, M. Juliana; Huang, Yunda; Tomaras, Georgia D.		HIV Vaccine Trials Network HVTN	Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; VIRUS-LIKE PARTICLES; EFFICACY TRIAL; DOUBLE-BLIND; DNA/MVA VACCINE; CELL RESPONSES; ANTIBODIES; TYPE-1; PROTECTION; INFECTION	Background A phase 1 trial of a clade B HIV vaccine in HIV-uninfected adults evaluated the safety and immunogenicity of a DNA prime co-expressing GM-CSF (Dg) followed by different numbers and intervals of modified vaccinia Ankara Boosts (M). Both vaccines produce virus-like particles presenting membrane-bound Env. Methods Four US sites randomized 48 participants to receiving 1/10th the DNA dose as DgDgMMM given at 0, 2, 4, 6 and 8 months, or full dose DgDgM_M or DgDgMM_M regimens, given at 0, 2, 4, and 8 months, and 0, 2, 4, 6, and 10 months, respectively. Peak immunogenicity was measured 2 weeks post-last vaccination. Background A phase 1 trial of a clade B HIV vaccine in HIV-uninfected adults evaluated the safety and immunogenicity of a DNA prime co-expressing GM-CSF (Dg) followed by different numbers and intervals of modified vaccinia Ankara Boosts (M). Both vaccines produce virus-like particles presenting membrane-bound Env. Methods Four US sites randomized 48 participants to receiving 1/10th the DNA dose as DgDgMMM given at 0, 2, 4, 6 and 8 months, or full dose DgDgM_M or DgDgMM_M regimens, given at 0, 2, 4, and 8 months, and 0, 2, 4, 6, and 10 months, respectively. Peak immunogenicity was measured 2 weeks post-last vaccination. Results All regimens were well tolerated and safe. Full dose DgDgM_M and DgDgMM_M regimens generated Env-specific IgG to HIV-1 Env in >90%, IgG3 in >80%, and IgA in <20% of participants. Responses to gp140 and gp41 targets were more common and of higher magnitude than to gp120 and V1V2. The gp41 antibody included reactivity to the conserved immunodominant region with specificities known to mediate virus capture and phagocytosis and did not cross-react with a panel of intestinal flora antigens. The 3rd dose of MVA increased the avidity of elicited antibody (7.5% to 39%), the ADCC response to Bal gp120 (14% to 64%), and the one-year durability of the IgG3 responses to gp41 by 4-fold (13% vs. 3.5% retention of peak response). The co-expressed GM-CSF did not enhance responses over those in trials testing this vaccine without GM-CSF. Conclusion This DNA/MVA prime-boost regimen induced durable, functional humoral responses that included ADCC, high antibody avidity, and Env IgG1 and IgG3 binding responses to the immunodominant region of gp41. The third, spaced MVA boost improved the overall quality of the antibody response. These products without co-expressed GM-CSF but combined with protein boosts will be considered for efficacy evaluation.	[Buchbinder, Susan P.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA 94102 USA; [Buchbinder, Susan P.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Buchbinder, Susan P.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Buchbinder, Susan P.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Grunenberg, Nicole A.; Sanchez, Brittany J.; Frahm, Nicole; Yu, Xuesong; Gilbert, Peter B.; McElrath, M. Juliana; Huang, Yunda] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Seaton, Kelly E.; Ferrari, Guido; Moody, M. Anthony; Montefiori, David C.; Tomaras, Georgia D.] Duke Human Vaccine Inst, Dept Surg, Durham, NC USA; [Frahm, Nicole; McElrath, M. Juliana; Huang, Yunda] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Hay, Christine M.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Goepfert, Paul A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Baden, Lindsey R.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Robinson, Harriet L.] GeoVax Labs Inc, Smyrna, GA USA; [Gilbert, Peter B.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Rochester; University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Buchbinder, SP (corresponding author), San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA 94102 USA.; Buchbinder, SP (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Buchbinder, SP (corresponding author), Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA.; Buchbinder, SP (corresponding author), Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA.	susan.buchbinder@sfdph.org	Ferrari, Guido/A-6088-2015; Moody, M/AAB-6947-2020; Ferrari, Guido/Z-2137-2019	Ferrari, Guido/0000-0001-7747-3349; Moody, M/0000-0002-3890-5855; Robinson, Harriet/0000-0001-6380-3458; Huang, Yunda/0000-0003-1546-6172; Seaton, Kelly/0000-0002-2009-3270; Buchbinder, Susan/0000-0003-2404-0712	National Institute of Allergy and Infectious Diseases (NIAID); U.S. Public Health Service [UM1 AI068614, UM1 AI068635, UM1 AI068618, U01 AI069452, UM1 AI069412, UM1 AI069511, UM1 AI069496]; Integrated Preclinical/Clinical AIDS Vaccine Development award [U19 AI074073]; U.S. National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069496, UM1AI068614, UM1AI068635, U01AI069511, UM1AI068618, UM1AI069412, UM1AI069511] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Integrated Preclinical/Clinical AIDS Vaccine Development award; U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) (https://www.niaid.nih.gov/) U.S. Public Health Service Grants UM1 AI068614 [LOC: HIV Vaccine Trials Network], UM1 AI068635 [SDMC: HIV Vaccine Trials Network], UM1 AI068618 [LC: HIV Vaccine Trials Network], U01 AI069452 [Birmingham], UM1 AI069412 [Boston], UM1 AI069511 [Rochester], and UM1 AI069496 [San Francisco]. Support for product was received through Integrated Preclinical/Clinical AIDS Vaccine Development award to GeoVax Labs, Inc., U19 AI074073. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or National Institutes of Health (NIH). Harriett L. Robinson (HLR) is an employee and stakeholder of GeoVax Labs, Inc. and contributed to the study design, data analysis and write up of the manuscript. The funder, U.S. National Institute of Allergy and Infectious Diseases (NIAID), provided partial salary support for the following authors: SPB, NAG, BJS, KES, GF, MAM, NF, DCM, CMH, PAG, LRB, XY, MJM, YH and GDT. The funder contributed to the study design, review of data analysis, the decision to publish, and review of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.; The authors acknowledge Emily Hansen, Nicole Yates, Vicki Ashley, Sheetal Sawant, Kristy Long, Marcella Sarzotti-Kelsoe, Yong Lin, and Aaron Deal for their assistance with laboratory studies. We thank the study participants and staff at the HVTN sites and laboratories for their contributions to the studies, and Julia Hutter for her review of the manuscript on behalf of the National Institute of Allergy and Infectious Diseases (NIAID), the study sponsor.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Archary D, 2016, MUCOSAL IMMUNOL; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carias AM, 2014, CURR OPIN HIV AIDS, V9, P271, DOI 10.1097/COH.0000000000000050; CDC (Centers for Disease Control and Prevention), 2015, ANN REPORT; Chamcha V, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw034; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; De Rosa SC, 2012, METHODS, V57, P383, DOI 10.1016/j.ymeth.2012.01.001; Desai S, 2015, EUROSURVEILLANCE, V20, P1999; Diez M, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.47.20971; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Goepfert PA, 2014, J INFECT DIS, V210, P99, DOI 10.1093/infdis/jiu003; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; GOLDING H, 1994, AIDS RES HUM RETROV, V10, P633, DOI 10.1089/aid.1994.10.633; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hellerstein M, 2012, HUM VACC IMMUNOTHER, V8, P1654, DOI 10.4161/hv.21978; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Horton H, 2006, J VIROL, V80, P9779, DOI 10.1128/JVI.00794-06; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Li QS, 2014, J IMMUNOL, V193, P3113, DOI 10.4049/jimmunol.1400820; Li SYS, 2014, J CLIN INVEST, V124, P3879, DOI 10.1172/JCI75539; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Manrique A, 2014, AIDS RES HUM RETROV, V30, P1017, DOI [10.1089/aid.2014.0040, 10.1089/AID.2014.0040]; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moog C, 2014, MUCOSAL IMMUNOL, V7, P46, DOI 10.1038/mi.2013.23; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Prentice HA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4005; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Robinson HL, 2013, EXPERT OPIN BIOL TH, V13, P197, DOI 10.1517/14712598.2012.743527; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Santra S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005042; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Seaton KE, 2012, KEYST S HIV VACC 201; Smith JM, 2004, AIDS RES HUM RETROV, V20, P1335, DOI 10.1089/aid.2004.20.1335; Smith JM, 2004, AIDS RES HUM RETROV, V20, P654, DOI 10.1089/0889222041217419; Suzuki T, 2016, CLIN CHEST MED, V37, P431, DOI 10.1016/j.ccm.2016.04.006; Tay MZ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005817; Todd CA, 2012, J IMMUNOL METHODS, V375, P57, DOI 10.1016/j.jim.2011.09.007; Tomaras GD, 2014, VACCINES, V2, P15, DOI 10.3390/vaccines2010015; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Voss JE, 2016, AIDS, V30, P2427, DOI 10.1097/QAD.0000000000001199; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Wyatt LS, 2004, AIDS RES HUM RETROV, V20, P645, DOI 10.1089/0889222041217428; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Yates NL, 2011, AIDS, V25, P2089, DOI 10.1097/QAD.0b013e32834b348e	61	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e179597	10.1371/journal.pone.0179597	http://dx.doi.org/10.1371/journal.pone.0179597			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727817	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500007
J	Herbenick, D; Bowling, J; Fu, TC; Dodge, B; Guerra-Reyes, L; Sanders, S				Herbenick, Debby; Bowling, Jessamyn; Fu, Tsung-Chieh (Jane); Dodge, Brian; Guerra-Reyes, Lucia; Sanders, Stephanie			Sexual diversity in the United States: Results from a nationally representative probability sample of adult women and men	PLOS ONE			English	Article							VIBRATOR USE; VAGINAL INTERCOURSE; PERCEIVED HEALTH; LUBRICANT USE; CONDOM USE; BEHAVIORS; PREVALENCE; MASTURBATION; EXPERIENCES; FREQUENCY	In 2015, we conducted a cross-sectional, Internet-based, U.S. nationally representative probability survey of 2,021 adults (975 men, 1,046 women) focused on a broad range of sexual behaviors. Individuals invited to participate were from the GfK KnowledgePanel (R). The survey was titled the 2015 Sexual Exploration in America Study and survey completion took about 12 to 15 minutes. The survey was confidential and the researchers never had access to respondents' identifiers. Respondents reported on demographic items, lifetime and recent sexual behaviors, and the appeal of 50+ sexual behaviors. Most (>80%) reported lifetime masturbation, vaginal sex, and oral sex. Lifetime anal sex was reported by 43% of men (insertive) and 37% of women (receptive). Common lifetime sexual behaviors included wearing sexy lingerie/underwear (75% women, 26% men), sending/receiving digital nude/ semi-nude photos (54% women, 65% men), reading erotic stories (57% of participants), public sex (>= 43%), role-playing (>= 22%), tying/being tied up (>= 20%), spanking (>= 30%), and watching sexually explicit videos/DVDs (60% women, 82% men). Having engaged in threesomes (10% women, 18% men) and playful whipping (>= 13%) were less common. Lifetime group sex, sex parties, taking a sexuality class/workshop, and going to BDSM parties were uncommon (each <8%). More Americans identified behaviors as "appealing" than had engaged in them. Romantic/affectionate behaviors were among those most commonly identified as appealing for both men and women. The appeal of particular behaviors was associated with greater odds that the individual had ever engaged in the behavior. This study contributes to our understanding of more diverse adult sexual behaviors than has previously been captured in U.S. nationally representative probability surveys. Implications for sexuality educators, clinicians, and individuals in the general population are discussed.	[Herbenick, Debby; Fu, Tsung-Chieh (Jane); Dodge, Brian; Guerra-Reyes, Lucia; Sanders, Stephanie] Indiana Univ, Sch Publ Hlth, Ctr Sexual Hlth Promot, Bloomington, IN 47405 USA; [Bowling, Jessamyn] Univ N Carolina, Coll Hlth & Human Serv, Charlotte, NC 28223 USA; [Sanders, Stephanie] Indiana Univ, Dept Gender Studies, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Charlotte; Indiana University System; Indiana University Bloomington	Dodge, B (corresponding author), Indiana Univ, Sch Publ Hlth, Ctr Sexual Hlth Promot, Bloomington, IN 47405 USA.	bmdodge@indiana.edu	Fu, Tsung-chieh/E-6136-2019; Bowling, Jessamyn/ABI-5661-2020; Dodge, Brian/H-3123-2013	Fu, Tsung-chieh/0000-0003-2118-7225; Bowling, Jessamyn/0000-0001-7410-4433; Herbenick, Debby/0000-0002-0352-2248; Guerra-Reyes, Lucia/0000-0003-3300-0720; Dodge, Brian/0000-0003-4491-6603	Ventures LLC	Ventures LLC	Funding for this study was provided by No. 9 Ventures LLC (Debby Herbenick, Principal Investigator).	[Anonymous], 2015, NEW YORK POST; [Anonymous], 2005, SEXUAL BEHAV SELECTE; [Anonymous], 2015, WASHINGTON POST; Bennett Jessica, 2009, NEWSWEEK; Bezreh T, 2012, AM J SEX EDUC, V7, P37, DOI 10.1080/15546128.2012.650984; Bost Callie, 2012, BUSINESS INSIDER; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Dodge B, 2014, J SEX MED, V11, P2396, DOI 10.1111/jsm.12640; Dodge B, 2010, J SEX MED, V7, P330, DOI 10.1111/j.1743-6109.2010.02019.x; Eisenberg D, 2011, APPL HEALTH ECON HEA, V9, P149, DOI 10.2165/11587340-000000000-00000; Fletcher C., 2012, BLOOMBERG       0607; Fortenberry JD, 2010, J SEX MED, V7, P305, DOI 10.1111/j.1743-6109.2010.02018.x; George KA, 2016, BIOL CONSERV, V201, P237, DOI 10.1016/j.biocon.2016.07.013; GfK, 2013, KNOWLEDGEPANEL DES S; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Harris KM, 2009, VACCINE, V27, P815, DOI 10.1016/j.vaccine.2008.11.052; Heiman JR, 2011, ARCH SEX BEHAV, V40, P741, DOI 10.1007/s10508-010-9703-3; Herbenick D, 2013, J SEX MED, V10, P474, DOI 10.1111/jsm.12021; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; Herbenick D, 2010, J SEX MED, V7, P277, DOI 10.1111/j.1743-6109.2010.02010.x; Herbenick D, 2010, J SEX MARITAL THER, V36, P49, DOI 10.1080/00926230903375677; Herbenick D, 2009, J SEX MED, V6, P1857, DOI 10.1111/j.1743-6109.2009.01318.x; Herek GM, 2009, J INTERPERS VIOLENCE, V24, P54, DOI 10.1177/0886260508316477; Joyal CC, 2015, J SEX MED, V12, P328, DOI 10.1111/jsm.12734; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kinsey A, 1953, SEXUAL BEHAV HUMAN F, P680; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Michael R.T., 1994, SEX AM DEFINITIVE SU; Oppenheimer M., 2011, NEW YORK TIMES  0703; Reece M, 2010, J SEX MED, V7, P291, DOI 10.1111/j.1743-6109.2010.02009.x; Reece M, 2009, J SEX MED, V6, P1867, DOI 10.1111/j.1743-6109.2009.01290.x; Rehor JE, 2015, ARCH SEX BEHAV, V44, P825, DOI 10.1007/s10508-015-0524-2; Richters J, 2003, AUST NZ J PUBL HEAL, V27, P180, DOI 10.1111/j.1467-842X.2003.tb00806.x; Richters J, 2014, SEX HEALTH, V11, P461, DOI 10.1071/SH14116; Robbins CL, 2011, ARCH PEDIAT ADOL MED, V165, P1087, DOI 10.1001/archpediatrics.2011.142; Rothman EF, 2008, PEDIATRICS, V122, pE298, DOI 10.1542/peds.2007-3412; Sanders SA, 2010, J SEX MED, V7, P362, DOI 10.1111/j.1743-6109.2010.02011.x; Waite L, 2008, ENCY LIFE COURSE HUM, V3, P362; Wright S, 2006, J HOMOSEXUAL, V50, P217, DOI 10.1300/J082v50n02_10	39	96	96	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181198	10.1371/journal.pone.0181198	http://dx.doi.org/10.1371/journal.pone.0181198			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727762	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500045
J	Noguera, PA; Grunow, B; Klinger, M; Lester, K; Collet, B; del-Pozo, J				Noguera, Patricia A.; Grunow, Bianka; Klinger, Matthias; Lester, Katherine; Collet, Bertrand; del-Pozo, Jorge			Atlantic salmon cardiac primary cultures: An in vitro model to study viral host pathogen interactions and pathogenesis	PLOS ONE			English	Article							MUSCLE INFLAMMATION HSMI; TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; PANCREAS DISEASE; ANEMIA-VIRUS; SALAR L.; CARDIOMYOPATHY SYNDROME; PATHOLOGICAL-CHANGES; HEART RESEARCH; ANIMAL-MODELS	Development of Salmon Cardiac Primary Cultures (SCPCs) from Atlantic salmon pre-hatch embryos and their application as in vitro model for cardiotropic viral infection research are described. Producing SCPCs requires plating of trypsin dissociated embryos with subsequent targeted harvest from 24h up to 3 weeks, of relevant tissues after visual identification. SCPCs are then transferred individually to chambered wells for culture in isolation, with incubation at 15-22 degrees. SCPCs production efficiency was not influenced by embryo's origin (0.75/farmed or wild embryo), but mildly influenced by embryonic developmental stage (0.3 decline between 380 and 445 accumulated thermal units), and strongly influenced by time of harvest post-plating (0.6 decline if harvested after 72 hours). Beating rate was not significantly influenced by temperature (15-22 degrees) or age (2-4 weeks), but was significantly lower on SCPCs originated from farmed embryos with a disease resistant genotype (F = 5.3, p<0.05). Two distinct morphologies suggestive of an ex vivo embryonic heart and a de novo formation were observed sub-grossly, histologically, ultra-structurally and with confocal microscopy. Both types contained cells consistent with cardiomyocytes, endothelium, and fibroblasts. Ageing of SCPCs in culture was observed with increased auto fluorescence in live imaging, and as myelin figures and cellular degeneration ultra-structurally. The SCPCs model was challenged with cardiotropic viruses and both the viral load and the mx gene expression were measurable along time by qPCR. In summary, SCPCs represent a step forward in salmon cardiac disease research as an in vitro model that partially incorporates the functional complexity of the fish heart.	[Noguera, Patricia A.; Lester, Katherine; Collet, Bertrand] Marine Scotland Sci, Aquaculture & Marine Environm, Aberdeen, Scotland; [Grunow, Bianka] Fraunhofer Res Inst Marine Biotechnol, Lubeck, Germany; [Klinger, Matthias] Univ Lubeck, Inst Anat, Lubeck, Germany; [del-Pozo, Jorge] Univ Edinburgh, Royal Dick Sch Vet Sci, Edinburgh, Midlothian, Scotland; [Grunow, Bianka] Ernst Moritz Arndt Univ Greifswald, Inst Physiol, Greifswald, Germany	Marine Scotland Science (MSS); University of Lubeck; University of Edinburgh; Ernst Moritz Arndt Universitat Greifswald	Noguera, PA (corresponding author), Marine Scotland Sci, Aquaculture & Marine Environm, Aberdeen, Scotland.	Patricia.Noguera@gov.scot		Noguera, Patricia/0000-0003-2247-6926; Grunow, Bianka/0000-0001-8503-2754	Scottish Government [AQ0030]	Scottish Government	This work was funded by the Scottish Government under project AQ0030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamelfot M, 2012, J VIROL, V86, P10571, DOI 10.1128/JVI.00047-12; Atkins GJ., 2013, ISRN VIROL, V2013, P1, DOI [10.5402/2013/861912, DOI 10.5402/2013/861912]; BBSRC, 2014, MULT APPR FISH HLTH; Biacchesi S, 2016, VET RES, V47, DOI 10.1186/s13567-015-0301-1; Carvan MJ, 2005, ENV TOXICOLOGY; Chaput G, 2012, ICES J MAR SCI, V69, P1538, DOI 10.1093/icesjms/fss013; Chen ZQ, 2015, J EXP BIOL, V218, P803, DOI 10.1242/jeb.113993; Collet B, 2015, PLOS ONE, P10; Collet B, 2013, J VIROL METHODS, V191, P113, DOI 10.1016/j.jviromet.2013.04.009; Collet B, 2009, VET IMMUNOL IMMUNOP, V130, P92, DOI 10.1016/j.vetimm.2008.12.022; Crane M, 2011, VIRUSES-BASEL, V3, P2025, DOI 10.3390/v3112025; Croce AC, 2014, EUR J HISTOCHEM, V58, P320, DOI 10.4081/ejh.2014.2461; Di Guardo G, 2015, EUR J HISTOCHEM, V59, P72, DOI 10.4081/ejh.2015.2485; Drennan JD, 2007, J FISH DIS, V30, P367, DOI 10.1111/j.1365-2761.2007.00817.x; European Parliamentary Research, 2014, AQ EU EUR PARL RES S; FAO Fisheries & Aquaculture-Species Fact Sheets-Salmo salar, 1758, FAO FISHERIES AQUACU; FERGUSON HW, 1986, J FISH DIS, V9, P95, DOI 10.1111/j.1365-2761.1986.tb00987.x; Fields S, 2005, SCIENCE, V307, P1885, DOI 10.1126/science.1108872; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; FLEMING P, 1977, J GEN VIROL, V37, P93, DOI 10.1099/0022-1317-37-1-93; Fryer J. L., 1994, Journal of Tissue Culture Methods, V16, P87, DOI 10.1007/BF01404816; Fryer JL, 1964, METHODS IN VITRO CUL; Gahlawat SK, 2009, FISH SHELLFISH IMMUN, V26, P672, DOI 10.1016/j.fsi.2009.02.021; Gibson RJ, 1993, NATURAL WATERS; Grunow B, 2010, J FISH BIOL, V76, P427, DOI 10.1111/j.1095-8649.2009.02535.x; Grunow B, 2012, OJ CELL SCI THER OMI, P3; Grunow B, 2015, J EXP BIOL, V218, P1116, DOI 10.1242/jeb.118224; Grunow B, 2011, CELL PHYSIOL BIOCHEM, V27, P1, DOI 10.1159/000325212; Haugland O, 2011, J VIROL, V85, P5275, DOI 10.1128/JVI.02154-10; Katz ML, 2002, ARCH GERONTOL GERIAT, V34, P169, DOI 10.1016/S0167-4943(02)00005-5; Kibenge FSB, 2016, AQUACULTURE VIROLOGY, P1; Lewis J, 1996, J VIROL, V70, P1828, DOI 10.1128/JVI.70.3.1828-1835.1996; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lohr JL, 2000, AM J MED GENET, V97, P248, DOI 10.1002/1096-8628(200024)97:4<248::AID-AJMG1275>3.0.CO;2-C; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Martin SAM, 2007, PHYSIOL GENOMICS, V32, P33, DOI 10.1152/physiolgenomics.00064.2007; Matejusova I, 2013, ARCH VIROL, V158, P2143, DOI 10.1007/s00705-013-1689-4; McBeath AJA, 2007, FISH SHELLFISH IMMUN, V22, P230, DOI 10.1016/j.fsi.2006.05.004; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; Mehnert JM, 2013, CELL PHYSIOL BIOCHEM, V32, P1374, DOI 10.1159/000356576; Moretti A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014027; MURPHY TM, 1992, J FISH DIS, V15, P401, DOI 10.1111/j.1365-2761.1992.tb01239.x; Nemtsas P, 2010, J MOL CELL CARDIOL, V48, P161, DOI 10.1016/j.yjmcc.2009.08.034; Pennell W., 1996, PRINCIPLES SALMONID; Perry SF, 2010, FISH PHYSIOL, V29, P1; Saltveit SJ, 2013, LIMNOLOGICA, V43, P325, DOI 10.1016/j.limno.2013.05.009; Schartl M, 2014, DIS MODEL MECH, V7, P181, DOI 10.1242/dmm.012245; Schier AF, 2013, NATURE, V496, P443, DOI 10.1038/nature12094; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; SSPO, 2015, SUST SCOTT SALM SCOT; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Verkerk AO, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00255; Vernon PS, 2005, J VIROL, V79, P3438, DOI 10.1128/JVI.79.6.3438-3447.2005; Weli SC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-5; Yousaf MN, 2013, VET IMMUNOL IMMUNOP, V151, P49, DOI 10.1016/j.vetimm.2012.10.004; Yousaf MN, 2012, FISH SHELLFISH IMMUN, V33, P305, DOI 10.1016/j.fsi.2012.05.008; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106	57	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181058	10.1371/journal.pone.0181058	http://dx.doi.org/10.1371/journal.pone.0181058			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727799	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500038
J	Yin, R; Zhao, MZ; Wang, KY; Lin, YP; Wang, YF; Sun, CY; Wang, Y; Zhang, MP				Yin, Rui; Zhao, Mingzhu; Wang, Kangyu; Lin, Yanping; Wang, Yanfang; Sun, Chunyu; Wang, Yi; Zhang, Meiping			Functional differentiation and spatial-temporal co-expression networks of the NBS-encoding gene family in Jilin ginseng, Panax ginseng CA Meyer	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; DISEASE RESISTANCE GENES; IDENTIFICATION; EXPRESSION; VISUALIZATION; REVEALS; TIR	Ginseng, Panax ginseng C.A. Meyer, is one of the most important medicinal plants for human health and medicine. It has been documented that over 80% of genes conferring resistance to bacteria, viruses, fungi and nematodes are contributed by the nucleotide binding site (NBS)-encoding gene family. Therefore, identification and characterization of NBS genes expressed in ginseng are paramount to its genetic improvement and breeding. However, little is known about the NBS-encoding genes in ginseng. Here we report genome-wide identification and systems analysis of the NBS genes actively expressed in ginseng (PgNBS genes). Four hundred twelve PgNBS gene transcripts, derived from 284 gene models, were identified from the transcriptomes of 14 ginseng tissues. These genes were classified into eight types, including TNL, TN, CNL, CN, NL, N, RPW8-NL and RPW8-N. Seven conserved motifs were identified in both the Toll/interleukine-1 receptor (TIR) and coiled-coil (CC) typed genes whereas six were identified in the RPW8 typed genes. Phylogenetic analysis showed that the PgNBS gene family is an ancient family, with a vast majority of its genes originated before ginseng originated. In spite of their belonging to a family, the PgNBS genes have functionally dramatically differentiated and been categorized into numerous functional categories. The expressions of the across tissues, different aged roots and the roots of different genotypes. However, they are coordinating in expression, forming a single co-expression network. These results provide a deeper understanding of the origin, evolution and functional differentiation and expression dynamics of the NBS-encoding gene family in plants in general and in ginseng particularly, and a NBS gene toolkit useful for isolation and characterization of disease resistance genes and for enhanced disease resistance breeding in ginseng and related species.	[Yin, Rui; Zhao, Mingzhu; Wang, Kangyu; Lin, Yanping; Sun, Chunyu; Wang, Yi; Zhang, Meiping] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Wang, Kangyu; Sun, Chunyu; Wang, Yi; Zhang, Meiping] Ctr Ginseng Germplasm Res Dev & Utilizat, Changchun, Jilin, Peoples R China; [Wang, Yanfang] Jilin Agr Univ, Coll Chinese Med Mat, Changchun, Jilin, Peoples R China	Jilin Agricultural University; Jilin Agricultural University	Wang, Y; Zhang, MP (corresponding author), Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China.; Wang, Y; Zhang, MP (corresponding author), Ctr Ginseng Germplasm Res Dev & Utilizat, Changchun, Jilin, Peoples R China.	wanglaoshi0606@163.com; meiping.zhang@jlau.edu.cn			China 863 Project [2013AA102604-3]; Development and Reform Commission of Jilin Province [2016C064]; Bureau of Science and Technology of Jilin Province [20170101010JC]	China 863 Project(National High Technology Research and Development Program of China); Development and Reform Commission of Jilin Province; Bureau of Science and Technology of Jilin Province	This work was funded by the China 863 Project (2013AA102604-3) to MPZ, and the Development and Reform Commission of Jilin Province (2016C064) and the Bureau of Science and Technology of Jilin Province (20170101010JC) to YW.	Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Lee ST, 2008, ALZ DIS ASSOC DIS, V22, P222, DOI 10.1097/WAD.0b013e31816c92e6; Li XY, 2010, PLANT SYST EVOL, V289, P101, DOI 10.1007/s00606-010-0331-0; Lozano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034775; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Monosi B, 2004, THEOR APPL GENET, V109, P1434, DOI 10.1007/s00122-004-1758-x; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Nair RA, 2007, THEOR APPL GENET, V116, P123, DOI 10.1007/s00122-007-0652-8; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Wan HJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-109; Wan HJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-502; Wang KY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18283; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Xie X, 2010, MOL MED REP, V3, P635, DOI 10.3892/mmr_00000308; Zhang MP, 2010, NUCLEIC ACIDS RES, V38, P6513, DOI 10.1093/nar/gkq524; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	30	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181596	10.1371/journal.pone.0181596	http://dx.doi.org/10.1371/journal.pone.0181596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727829	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500090
J	Navarro-Mateu, F; Salmeron, D; Vilagut, G; Tormo, MJ; Ruiz-Merino, G; Escamez, T; Judez, J; Martinez, S; Koenen, KC; Navarro, C; Alonso, J; Kessler, RC				Navarro-Mateu, Fernando; Salmeron, Diego; Vilagut, Gemma; Jose Tormo, Ma; Ruiz-Merino, Guadaiupe; Escamez, Teresa; Judez, Javier; Martinez, Salvador; Koenen, Karestan C.; Navarro, Carmen; Alonso, Jordi; Kessler, Ronald C.			Post-Traumatic Stress Disorder and other mental disorders in the general population after Lorca's earthquakes, 2011 (Murcia, Spain): A cross-sectional study	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; DSM-IV DISORDERS; RISK-FACTORS; WENCHUAN EARTHQUAKE; ADULT SURVIVORS; PREVALENCE; DEPRESSION; COMORBIDITY; VERSION; PSYCHOPATHOLOGY	Aims To describe the prevalence and severity of mental disorders and to examine differences in risk among those with and without a lifetime history prior to a moderate magnitude earthquake that took place in Lorca (Murcia, Spain) at roughly the mid-point (on May 11, 2011) of the time interval in which a regional epidemiological survey was already being carried out (June 2010-May 2012). Methods The PEGASUS-Murcia project is a cross-sectional face-to-face interview survey of a representative sample of non-institutionalized adults in Murcia. Main outcome measures are prevalence and severity of anxiety, mood, impulse and substance disorders in the 12 months previous to the survey, assessed using the Composite International Diagnostic Interview (CIDI 3.0). Sociodemographic variables, prior history of any mental disorder and earthquake-related stressors were entered as independent variables in a logistic regression analysis. Findings A total number of 412 participants (response rate: 71%) were interviewed. Significant differences in 12-month prevalence of mental disorders were found in Lorca compared to the rest of Murcia for any (12.8% vs 16.8%), PTSD (3.6% vs 0.5%) and other anxiety disorders (5.3% vs 9.2%) (p <= 0.05 for all). No differences were found for 12-month prevalence of any mood or any substance disorder. The two major predictors for developing a 12-month post-earthquake mental disorder were a prior mental disorder and the level of exposure. Other risk factors included female sex and low-average income. Conclusions PTSD and other mental disorders are commonly associated with earthquake disasters. Prior mental disorders and the level of exposure to the earthquakes are the most important for the development of a consequent mental disorder and this recognition may help to identify those individuals that may most benefit from specific therapeutic intervention.	[Navarro-Mateu, Fernando] Univ Murcia, Dept Psicol Basica & Metodol, UDIF SM, Serv Murciano Salud, Murcia, Spain; [Navarro-Mateu, Fernando; Salmeron, Diego; Jose Tormo, Ma; Ruiz-Merino, Guadaiupe; Escamez, Teresa; Navarro, Carmen] IMIB Arrixaca, Murcia, Spain; [Navarro-Mateu, Fernando; Salmeron, Diego; Vilagut, Gemma; Jose Tormo, Ma; Alonso, Jordi] CIBERESP, Madrid, Spain; [Salmeron, Diego; Navarro, Carmen] Serv Epidemiol, Consejeria Salud, Murcia, Spain; [Salmeron, Diego; Vilagut, Gemma; Jose Tormo, Ma; Navarro, Carmen; Alonso, Jordi] Univ Murcia, Dept Ciencias Sociosanitarias, Murcia, Spain; [Vilagut, Gemma] IMIM Inst Hosp Mar Invest Med, Barcelona, Spain; [Ruiz-Merino, Guadaiupe; Escamez, Teresa] Fdn Formac & Invest Sanitarias FFIS Reg Murcia, Murcia, Spain; [Escamez, Teresa] Biobanco HUVA AECC FFIS, IMIB BIOBANC MUR, Murcia, Spain; [Judez, Javier] Fdn Espanola Aparato Digest, Soc Espanola Patol Digest, Madrid, Spain; [Martinez, Salvador] Inst Neurociencias, Alicante, Spain; [Koenen, Karestan C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Alonso, Jordi] Univ Pompeu Fabra, Dept Salud & Ciencias Expt, Barcelona, Spain; [Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Murcia; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Harvard University; Harvard T.H. Chan School of Public Health; Pompeu Fabra University; Harvard University; Harvard Medical School	Navarro-Mateu, F (corresponding author), Univ Murcia, Dept Psicol Basica & Metodol, UDIF SM, Serv Murciano Salud, Murcia, Spain.; Navarro-Mateu, F (corresponding author), IMIB Arrixaca, Murcia, Spain.; Navarro-Mateu, F (corresponding author), CIBERESP, Madrid, Spain.	fernando.navarro@carm.es	Júdez, Javier/ABG-5828-2020; Alonso, Jordi/A-5514-2010; Serraino, Diego/J-3915-2018; Navarro-Mateu, Fernando/H-9055-2017; Martínez, Diego Salmerón/AAA-3403-2019; Vilagut, Gemma/N-8718-2014	Alonso, Jordi/0000-0001-8627-9636; Serraino, Diego/0000-0003-0565-8920; Navarro-Mateu, Fernando/0000-0002-3228-623X; Martínez, Diego Salmerón/0000-0002-4574-6880; Vilagut, Gemma/0000-0002-3714-226X; Judez, Javier/0000-0001-9724-5191	Regional Health Authorities of Murcia ("Servicio Murciano de Salud and Consejeria de Sanidad y Politica Social") [455/2009]; Fundacion para la Formacion e Investigacion Sanitarias (FFIS) de la Region de Murcia [CM0829 I, FFIDS/EMER09/14]; Ayudas para proyectos de Investigacion en Salud -ISCIII- del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica [PI12/00809]; United States National Institute of Mental Health [R01MH070884]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; U.S. Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03- TW006481]; Pan American Health Organization; Eli Lilly & Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Bristol-Myers Squibb; Shire	Regional Health Authorities of Murcia ("Servicio Murciano de Salud and Consejeria de Sanidad y Politica Social"); Fundacion para la Formacion e Investigacion Sanitarias (FFIS) de la Region de Murcia; Ayudas para proyectos de Investigacion en Salud -ISCIII- del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Pan American Health Organization; Eli Lilly & Company Foundation(Eli Lilly); Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Shire	The PEGASUS-Murcia Project was supported by the Regional Health Authorities of Murcia ("Servicio Murciano de Salud and Consejeria de Sanidad y Politica Social") (Decreto no 455/2009), the "Fundacion para la Formacion e Investigacion Sanitarias (FFIS) de la Region de Murcia" (No Expedientes: CM0829 I and FFIDS/EMER09/14) and the "Ayudas para proyectos de Investigacion en Salud -ISCIII- del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" (PI12/00809). The PEGASUS-Murcia project is carried out in conjunction with the WHOWMH Survey Initiative. The authors thank the WMH Coordinating Center staff at Harvard and Michigan Universities for their assistance with the instrumentation, fieldwork and data analysis. These activities were supported by the United States National Institute of Mental Health (R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the U.S. Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03- TW006481), the Pan American Health Organization, the Eli Lilly & Company Foundation, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, Bristol-Myers Squibb and Shire. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/. The direct and indirect founders had no role in study design, data collection and analysis, decision to publish,	Anwar J, 2013, J NERV MENT DIS, V201, P1045, DOI 10.1097/NMD.0000000000000060; Abeldano RA, 2014, CAD SAUDE PUBLICA, V30, P2377, DOI 10.1590/0102-311X00141313; Armenian HK, 2000, ACTA PSYCHIAT SCAND, V102, P58, DOI 10.1034/j.1600-0447.2000.102001058.x; Armenian HK, 2002, J URBAN HEALTH, V79, P373, DOI 10.1093/jurban/79.3.373; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; Basoglu M, 2002, J TRAUMA STRESS, V15, P269, DOI 10.1023/A:1016241826589; Beard JR, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-83; Bernstein KT, 2007, J NERV MENT DIS, V195, P41, DOI 10.1097/01.nmd.0000244784.36745.a5; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; BROMET E, 1995, EPIDEMIOL REV, V17, P113, DOI 10.1093/oxfordjournals.epirev.a036166; Bromet EJ, 2016, PSYCHOL MED, P1; Center for Research on the Epidemiology of Disasters-CRED. EM-DAT, 2015, INT DIS DAT; Cerda M, 2013, DEPRESS ANXIETY, V30, P413, DOI 10.1002/da.22007; Cheng YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096644; Feo P, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0270-3; Foa EB, 2006, J CLIN PSYCHIAT, V67, P15; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Galea S, 2008, INT J METH PSYCH RES, V17, pS21, DOI 10.1002/mpr.267; Guo J, 2015, J NERV MENT DIS, V203, P469, DOI 10.1097/NMD.0000000000000310; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Hong CL, 2016, TRAUMA VIOLENCE ABUS, V17, P542, DOI 10.1177/1524838015585313; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Lopez-Garcia JJ, 2014, GAC SANIT, V28, P230, DOI 10.1016/j.gaceta.2013.10.009; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2004, INT J METH PSYCH RES, V13, P122, DOI 10.1002/mpr.169; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2014, WORLD PSYCHIATRY, V13, P265, DOI 10.1002/wps.20150; Kessler RC, 2008, INT J METH PSYCH RES, V17, pS6, DOI 10.1002/mpr.269; Kun P, 2013, PUBLIC HEALTH, V127, P644, DOI 10.1016/j.puhe.2013.04.018; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Martin Julio C, 2015, Prim Care Companion CNS Disord, V17, DOI 10.4088/PCC.14m01691; Morina N, 2014, CLIN PSYCHOL REV, V34, P249, DOI 10.1016/j.cpr.2014.03.002; Navarro-Mateu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137293; Navarro-Mateu F, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004035; Navarro-Mateu F, 2013, GAC SANIT, V27, P325, DOI 10.1016/j.gaceta.2012.06.005; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Priebe S, 2009, SOC PSYCH PSYCH EPID, V44, P393, DOI 10.1007/s00127-008-0441-y; Priebe S, 2011, SOC PSYCH PSYCH EPID, V46, P615, DOI 10.1007/s00127-010-0227-x; Ramirez M, 2005, EPIDEMIOL REV, V27, P47, DOI 10.1093/epirev/mxi005; Rodriguez-Llanes JM, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-115; Sakuma A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0440-y; StataCorp, 2007, STAT STAT SOFTW REL; Tang BH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-623; Vazquez C., 2001, J ANXIETY DIORD, V19, P313; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wolter K. M., 1985, INTRO VARIANCE ESTIM; Wu ZB, 2016, PSYCHIAT RES, V237, P49, DOI 10.1016/j.psychres.2016.01.041; Wu ZB, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-126; Xu JP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2999-8; Yokoyama Yukari, 2014, PLoS One, V9, pe102497, DOI 10.1371/journal.pone.0102497; Zhang LP, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0247-z; Zhang W, 2015, ASIA-PAC J PUBLIC HE, V27, P860, DOI 10.1177/1010539515602089; Zhang Z, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029651, 10.1371/journal.pone.0046449, 10.1371/journal.pone.0030551]; Zhang Z, 2012, STRESS HEALTH, V28, P61, DOI 10.1002/smi.1403; Zhou XB, 2015, PSYCHIAT RES, V228, P468, DOI 10.1016/j.psychres.2015.05.062	58	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179690	10.1371/journal.pone.0179690	http://dx.doi.org/10.1371/journal.pone.0179690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723949	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800007
J	Sahaboglu, A; Sherif, A; Feng, LL; Secer, E; Zrenner, E; Paquet-Durand, F				Sahaboglu, Ayse; Sherif, Alaa; Feng, Lili; Secer, Enver; Zrenner, Eberhart; Paquet-Durand, Francois			Temporal progression of PARP activity in the Prph2 mutant rd2 mouse: Neuroprotective effects of the PARP inhibitor PJ34	PLOS ONE			English	Article							RETINAL DEGENERATION; POLY(ADP-RIBOSE) POLYMERASE; CELL-DEATH; RETINITIS-PIGMENTOSA; MICE; DIFFERENTIATION; CONTRIBUTES; SUBUNIT; GENOME	Peripherin (peripherin/rds) is a membrane-associated protein that plays a critical role in the morphogenesis of rod and cone photoreceptor outer segments. Mutations in the corresponding PRPH2 gene cause different types of retinal dystrophies characterized by a loss of photoreceptors. Over activation of poly-ADP-ribose polymerase (PARP) was previously shown to be involved in different animal models for hereditary retinal dystrophies. This includes the rd2 mouse, which suffers from a human homologous mutation in the PRPH2 gene. In the present study, we show that increased retinal PARP activity and poly-ADP-ribosylation of proteins occurs before the peak of rd2 photoreceptor degeneration. Inhibition of PARP activity with the well-characterized PARP inhibitor PJ34 decreased the levels of poly-ADP-ribosylation and photoreceptor cell death. These results suggest a causal involvement of PARP in photoreceptor degeneration caused by peripherin mutations and highlight the possibility to use PARP inhibition for the mutation-independent treatment of hereditary retinal dystrophies.	[Sahaboglu, Ayse; Sherif, Alaa; Feng, Lili; Zrenner, Eberhart; Paquet-Durand, Francois] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany; [Sherif, Alaa] Grad Training Ctr Neurosci, Tubingen, Germany; [Secer, Enver] Erciyes Univ, Dept Med Genet, Kayseri, Turkey; [Zrenner, Eberhart] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Erciyes University; Eberhard Karls University of Tubingen	Sahaboglu, A; Paquet-Durand, F (corresponding author), Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany.	ayse.sahaboglu-tekgoez@klinikum.uni-tuebingen.de; francois.paquet-durand@klinikum.uni-tuebingen.de	Sherif, Alaa/R-7286-2019; Paquet-Durand, Francois/G-6709-2015	Sahaboglu, Ayse/0000-0003-3241-0672; Paquet-Durand, Francois/0000-0001-7355-5742	European Union (DRUGSFORD) [HEALTH-F2-2012-304963]; Deutsche Forschungsgemeinschaft (DFG) [PA1751/7-1, SA3040/1-1]; Charlotte and Tistou Kerstan Foundation [SAH001/2016]	European Union (DRUGSFORD); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Charlotte and Tistou Kerstan Foundation	This work was supported by the European Union (DRUGSFORD; HEALTH-F2-2012-304963), Deutsche Forschungsgemeinschaft (DFG; PA1751/7-1 and SA3040/1-1), and the Charlotte and Tistou Kerstan Foundation (SAH001/2016).	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Buelow B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006339; Caffe AR, 2001, INVEST OPHTH VIS SCI, V42, P275; Cardinale A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134482; Chatterjee S, 1999, MOL CELL BIOCHEM, V193, P23, DOI 10.1023/A:1006983304079; Chizzolini M, 2011, CURR GENOMICS, V12, P260, DOI 10.2174/138920211795860071; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Goldberg AFX, 2016, PROG RETIN EYE RES, V55, P52, DOI 10.1016/j.preteyeres.2016.05.003; Greco R, 2014, EUR J PHARMACOL, P74491; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hassa PO, FRONT BIOSCI, V2008; Jiao K, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.40; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Ledermann JA, 2016, ANN ONCOL, V27, P40, DOI 10.1093/annonc/mdw094; Loewen CJR, 2003, MOL BIOL CELL, V14, P3400, DOI 10.1091/mbc.e03-02-0077; Nguewa PA, 2005, PROG BIOPHYS MOL BIO, V88, P143, DOI 10.1016/j.pbiomolbio.2004.01.001; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Renner AB, 2009, AM J OPHTHALMOL, V147, P518, DOI 10.1016/j.ajo.2008.09.007; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; Sahaboglu A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39537; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; SANYAL S, 1981, EXP EYE RES, V33, P213, DOI 10.1016/S0014-4835(81)80070-X; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SIMS JL, 1983, BIOCHEMISTRY-US, V22, P5188, DOI 10.1021/bi00291a019; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Stuck MW, 2016, PROG RETIN EYE RES, V52, P47, DOI 10.1016/j.preteyeres.2015.12.002; Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	35	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181374	10.1371/journal.pone.0181374	http://dx.doi.org/10.1371/journal.pone.0181374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723922	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800046
J	Alshahrani, S; Rapoport, RM; Zahediz, K; Jiang, M; Nieman, M; Barone, S; Meredith, AL; Lorenz, JN; Rubinstein, J; Soleimani, M				Alshahrani, Saeed; Rapoport, Robert M.; Zahedi, Kamyar; Jiang, Min; Nieman, Michelle; Barone, Sharon; Meredith, Andrea L.; Lorenz, John N.; Rubinstein, Jack; Soleimani, Manoocher			The non-diuretic hypotensive effects of thiazides are enhanced during volume depletion states	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; NA+-CL-COTRANSPORTER; LARGE-CONDUCTANCE; ESSENTIAL-HYPERTENSION; DOUBLE KNOCKOUT; BLOOD-PRESSURE; THERAPY; METHYCLOTHIAZIDE; VASODILATION; INHIBITION	Thiazide derivatives including Hydrochlorothiazide (HCTZ) represent the most common treatment of mild to moderate hypertension. Thiazides initially enhance diuresis via inhibition of the kidney Na+-Cl- Cotransporter (NCC). However, chronic volume depletion and diuresis are minimal while lowered blood pressure (BP) is maintained on thiazides. Thus, a vasodilator action of thiazides is proposed, likely via Ca2+-activated K+ (BK) channels in vascular smooth muscles. This study ascertains the role of volume depletion induced by salt restriction or salt wasting in NCC KO mice on the non-diuretic hypotensive action of HCTZ. HCTZ (20mg/kg s.c.) lowered BP in 1) NCC KO on a salt restricted diet but not with normal diet; 2) in volume depleted but not in volume resuscitated pendrin/NCC dKO mice; the BP reduction occurs without any enhancement in salt excretion or reduction in cardiac output. HCTZ still lowered BP following treatment of NCC KO on salt restricted diet with paxilline (8 mg/kg, i.p.), a BK channel blocker, and in BK KO and BK/NCC dKO mice on salt restricted diet. In aortic rings from NCC KO mice on normal and low salt diet, HCTZ did not alter and minimally decreased maximal phenylephrine contraction, respectively, while contractile sensitivity remained unchanged. These results demonstrate 1) the non-diuretic hypotensive effects of thiazides are augmented with volume depletion and 2) that the BP reduction is likely the result of HCTZ inhibition of vasoconstriction through a pathway dependent on factors present in vivo, is unrelated to BK channel activation, and involves processes associated with intravascular volume depletion.	[Alshahrani, Saeed; Rapoport, Robert M.; Soleimani, Manoocher] Univ Cincinnati, Dept Pharmacol & Cell Biophys, Coll Med, Cincinnati, OH 45220 USA; [Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH 45220 USA; [Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Univ Cincinnati, Div Nephrol, Dept Med, Coll Med, Cincinnati, OH 45220 USA; [Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA; [Jiang, Min; Rubinstein, Jack] Univ Cincinnati, Div Cardiol, Dept Med, Coll Med, Cincinnati, OH USA; [Nieman, Michelle; Lorenz, John N.] Univ Cincinnati, Dept Physiol, Coll Med, Cincinnati, OH USA; [Meredith, Andrea L.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Maryland; University of Maryland Baltimore	Soleimani, M (corresponding author), Univ Cincinnati, Dept Pharmacol & Cell Biophys, Coll Med, Cincinnati, OH 45220 USA.; Soleimani, M (corresponding author), Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH 45220 USA.; Soleimani, M (corresponding author), Univ Cincinnati, Div Nephrol, Dept Med, Coll Med, Cincinnati, OH 45220 USA.; Soleimani, M (corresponding author), Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA.	soleimm@ucmail.uc.edu	soleimani, m/U-6889-2017; Alshahrani, Saeed/AAY-8319-2021	soleimani, m/0000-0002-3446-8870; Meredith, Andrea/0000-0003-1061-2302; Soleimani, Manoocher/0000-0003-4909-4469; Rubinstein, Jack/0000-0002-8811-1551	Department of Veterans Affairs [5 I01 BX001000-06]; Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; Dialysis Clinic, Inc. (DCI); US Renal Care; NHLBI [R01-HL102758]; Jazan University, Saudi Arabia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102758] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001000] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; Dialysis Clinic, Inc. (DCI); US Renal Care; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Jazan University, Saudi Arabia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review 5 I01 BX001000-06 award from the Department of Veterans Affairs, funds from the Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati, and grants from Dialysis Clinic, Inc. (DCI) and US Renal Care (to MS) and NHLBI R01-HL102758 (to AM). S. Alshahrani was supported by a scholarship from Jazan University, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alshahrani S, 2017, KIDNEY BLOOD PRESSUR; Alshahrani S, 2017, N-S ARCH PHARMACOL, V390, P321, DOI 10.1007/s00210-017-1340-0; Amlal H, 2013, J MOL MED, V91, P561, DOI 10.1007/s00109-012-0973-1; Barone S, 2012, NEPHROL DIAL TRANSPL, V27, P1368, DOI 10.1093/ndt/gfr505; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; CALDER JA, 1994, J CARDIOVASC PHARM, V24, P158, DOI 10.1097/00005344-199407000-00024; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; CARNEY SL, 1984, CLIN EXP HYPERTENS A, V6, P1095, DOI 10.3109/10641968409039583; Carvalho-De-Souza JL, 2013, AGING DIS, V4, P38; Colas B, 2000, FUNDAM CLIN PHARM, V14, P363, DOI 10.1111/j.1472-8206.2000.tb00417.x; Colas B, 2000, EUR J PHARMACOL, V408, P63, DOI 10.1016/S0014-2999(00)00704-4; CONWAY J, 1960, CIRCULATION, V21, P21, DOI 10.1161/01.CIR.21.1.21; Cox RH, 2002, MICROCIRCULATION, V9, P243, DOI 10.1038/sj.mn.7800140; Cruz DN, 2001, HYPERTENSION, V37, P1458, DOI 10.1161/01.HYP.37.6.1458; Dostanic I, 2003, J BIOL CHEM, V278, P53026, DOI 10.1074/jbc.M308547200; Ellison DH, 2009, HYPERTENSION, V54, P196, DOI 10.1161/HYPERTENSIONAHA.109.129171; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; ENGLAND SK, 1993, AM J PHYSIOL, V264, pH1337, DOI 10.1152/ajpheart.1993.264.5.H1337; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Hill MA, 2010, FEBS LETT, V584, P2033, DOI 10.1016/j.febslet.2010.02.045; Joseph BK, 2013, PHARMACOL RES, V70, P126, DOI 10.1016/j.phrs.2013.01.008; Koch SE, 2012, J MOL CELL CARDIOL, V53, P134, DOI 10.1016/j.yjmcc.2012.04.011; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V272, pH1137, DOI 10.1152/ajpheart.1997.272.3.H1137; Luo JH, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12246; Mastroianni N, 1996, GENOMICS, V35, P486, DOI 10.1006/geno.1996.0388; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; PICKKERS P, 1995, BRIT J PHARMACOL, V114, P703, DOI 10.1111/j.1476-5381.1995.tb17195.x; Pickkers P, 1998, HYPERTENSION, V32, P1071, DOI 10.1161/01.HYP.32.6.1071; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Sinning A, 2016, J AM SOC NEPHROLOGY; Soleimani M, 2012, P NATL ACAD SCI USA, V109, P13368, DOI 10.1073/pnas.1202671109; TARAZI RC, 1970, CIRCULATION, V41, P709, DOI 10.1161/01.CIR.41.4.709; VANBRUMMELEN P, 1980, CLIN PHARMACOL THER, V27, P328, DOI 10.1038/clpt.1980.44; VARDAN S, 1983, JAMA-J AM MED ASSOC, V250, P2807, DOI 10.1001/jama.250.20.2807; VELAZQUEZ H, 1986, AM J PHYSIOL, V250, P1013, DOI 10.1152/ajprenal.1986.250.6.F1013; Wang J, 2015, J CLIN PHARMACOL, V55, P1362, DOI 10.1002/jcph.559; Xu J, 2013, CELL PHYSIOL BIOCHEM, V32, P173, DOI 10.1159/000356637; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Zahedi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079327	46	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181376	10.1371/journal.pone.0181376	http://dx.doi.org/10.1371/journal.pone.0181376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719636	Green Submitted, gold, Green Published			2022-12-27	WOS:000406061400043
J	Lei, YT; Liu, Q; Hettenhausen, C; Cao, GY; Tan, Q; Zhao, WY; Lin, HH; Wu, JQ				Lei, Yunting; Liu, Qing; Hettenhausen, Christian; Cao, Guoyan; Tan, Qing; Zhao, Weiye; Lin, Honghui; Wu, Jianqiang			Salt-tolerant and - sensitive alfalfa (Medicago sativa) cultivars have large variations in defense responses to the lepidopteran insect Spodoptera litura under normal and salt stress condition	PLOS ONE			English	Article							ABSCISIC-ACID; SALINITY STRESS; NICOTIANA-ATTENUATA; INDUCED RESISTANCE; ABIOTIC STRESSES; GENE-EXPRESSION; PLANTS; HERBIVORES; ARABIDOPSIS; JASMONATE	In nature, plants are often exposed to multiple stress factors at the same time. Yet, little is known about how plants modulate their physiology to counteract simultaneous abiotic and biotic stresses, such as soil salinity and insect herbivory. In this study, insect performance bioassays, phytohormone measurements, quantification of transcripts, and protein determination were employed to study the phenotypic variations of two alfalfa (Medicago sativa) cultivars in response to insect Spodoptera litura feeding under normal and salt stress condition. When being cultivated in normal soil, the salt-tolerant alfalfa cultivar Zhongmu-1 exhibited lower insect resistance than did the salt-sensitive cultivar Xinjiang Daye. Under salinity stress, the defense responses of Xinjiang Daye were repressed, whereas Zhongmu-1 did not show changes in resistance levels. It is likely that salinity influenced the resistance of Xinjiang Daye through suppressing the accumulation of jasmonic acid-isoleucine (JA-Ile), which is the bioactive hormone inducing herbivore defense responses, leading to attenuated trypsin proteinase inhibitor (TPI) activity. Furthermore, exogenous ABA supplementation suppressed the insect herbivory-induced JA/JA-Ile accumulation and levels of JAR1 (jasmonate resistant 1) and TPI, and further decreased the resistance of Xinjiang Daye, whereas Zhongmu-1 showed very little response to the increased ABA level. We propose a mechanism, in which high levels of abscisic acid induced by salt treatment may affect the expression levels of JAR1 and consequently decrease JA-Ile accumulation and thus partly suppress the defense of Xinjiang Daye against insects under salt stress. This study provides new insight into the mechanism by which alfalfa responds to concurrent abiotic and biotic stresses.	[Lei, Yunting; Lin, Honghui] Sichuan Univ, Minist Educ, Coll Life Sci, State Key Lab Hydraul & Mt River Engn,Key Lab Bio, Chengdu, Sichuan, Peoples R China; [Lei, Yunting; Liu, Qing] Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Lei, Yunting; Liu, Qing] Chinese Acad Sci, Ecol Restorat & Biodivers Conservat Key Lab Sichu, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Lei, Yunting; Hettenhausen, Christian; Cao, Guoyan; Tan, Qing; Zhao, Weiye; Wu, Jianqiang] Chinese Acad Sci, Dept Econ Plants & Biotechnol, Yunnan Key Lab Wild Plant Resources, Kunming Inst Bot, Kunming, Yunnan, Peoples R China	Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Lin, HH (corresponding author), Sichuan Univ, Minist Educ, Coll Life Sci, State Key Lab Hydraul & Mt River Engn,Key Lab Bio, Chengdu, Sichuan, Peoples R China.; Wu, JQ (corresponding author), Chinese Acad Sci, Dept Econ Plants & Biotechnol, Yunnan Key Lab Wild Plant Resources, Kunming Inst Bot, Kunming, Yunnan, Peoples R China.	hhlin@scu.edu.cn; wujianqiang@mail.kib.ac.cn	Wu, Jianqiang/A-7169-2019	Wu, Jianqiang/0000-0002-7726-6216	Yunnan Recruitment Program of Experts in Sciences [2012HA016]; Max Planck Partner Group Program	Yunnan Recruitment Program of Experts in Sciences; Max Planck Partner Group Program(Max Planck Society)	This work was supported by a grant from the Yunnan Recruitment Program of Experts in Sciences (No. 2012HA016) and a grant from the Max Planck Partner Group Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28941; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bodenhausen N, 2007, MOL PLANT MICROBE IN, V20, P1406, DOI 10.1094/MPMI-20-11-1406; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Dombrowski JE, 2003, PLANT PHYSIOL, V132, P2098, DOI 10.1104/pp.102.019927; Nguyen D, 2016, PLANT MOL BIOL, V91, P727, DOI 10.1007/s11103-016-0481-8; Nguyen D, 2016, PLANT CELL ENVIRON, V39, P1485, DOI 10.1111/pce.12708; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Forieri I, 2016, ENVIRON EXP BOT, V122, P68, DOI 10.1016/j.envexpbot.2015.09.007; Foyer CH, 2016, J EXP BOT, V67, P2025, DOI 10.1093/jxb/erw079; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Ginzberg I, 1998, PLANT MOL BIOL, V38, P755, DOI 10.1023/A:1006015212391; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Kitaoka N, 2011, PLANT CELL PHYSIOL, V52, P1757, DOI 10.1093/pcp/pcr110; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Long RC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00424; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Paudel JR, 2015, MOL PLANT MICROBE IN, V28, P569, DOI 10.1094/MPMI-10-14-0348-R; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Postnikova OA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123157; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Quan WL, 2016, PLANT CELL TISS ORG, V126, P105, DOI 10.1007/s11240-016-0981-x; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Schile L, 2006, ECOL ENTOMOL, V31, P345, DOI 10.1111/j.1365-2311.2006.00799.x; Stam JM, 2014, ANNU REV PLANT BIOL, V65, P689, DOI 10.1146/annurev-arplant-050213-035937; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Urano K, 2017, PLANT J, V90, P17, DOI 10.1111/tpj.13460; Van Dam NM, 2001, J CHEM ECOL, V27, P547, DOI 10.1023/A:1010341022761; VANCE CP, 1979, PLANT PHYSIOL, V64, P1, DOI 10.1104/pp.64.1.1; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129541; Wang XM, 2015, GENES GENET SYST, V90, P175, DOI 10.1266/ggs.90.175; Wu JQ, 2008, PLANT PHYSIOL, V146, P927, DOI 10.1104/pp.107.114785; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Yu LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00956	42	7	8	7	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181589	10.1371/journal.pone.0181589	http://dx.doi.org/10.1371/journal.pone.0181589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719628	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400057
J	Liu, PG; Yu, SJ; Cui, Y; He, JF; Yu, C; Wen, ZX; Pan, YY; Yang, K; Song, LL; Yang, X				Liu, Penggang; Yu, Sijiu; Cui, Yan; He, Junfeng; Yu, Chuan; Wen, Zexing; Pan, Yangyang; Yang, Kun; Song, Liangli; Yang, Xue			Cloning of HSP90, expression and localization of HSP70/90 in different tissues including lactating/non-lactating yak (Bos grunniens) breast tissue	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DIFFERENT AGES; CHAPERONE; TRAFFICKING; STRESS; KINASE; INJURY	The aim of this study is to investigate the expression and localization of HSP70/90 in different tissues and explore the regulation effects of HSP70/90 at lactation period of female yaks. HSP90 mRNA was cloned from the heart samples of female yaks, Quantitative real-time (qRT-PCR), Western blotting (WB), immunohistochemistry and immunofluorescence assays were utilized to analyze the expressions of HSP70/90 mRNA and protein in different tissues. Sequence analysis showed that HSP90 is a conserved molecular chaperone of female yaks. The qRT-PCR, WB results showed that the expressions of HSP70/90 mRNA and protein were significantly different in different tissues, and 3-fold higher expression during the lactation period than the non-lactation period of breast tissue (P < 0.01). Immunohistochemistry and immunofluorescence assays results showed that HSP70/90 were located in the cardiac muscle cells, cerebellar medulla, theca cells lining at the reproductive system, and the mammary epithelia of the breasts. In addition, the expression level of HSP70 was higher than those of HSP90 in all examined tissues. Therefore, our results strongly suggest that the expression and localization of HSP70/90 could provide significant evidence to further research in tissue specific expression, and lactation function of female yaks.	[Liu, Penggang; Yu, Sijiu; Cui, Yan; He, Junfeng; Yu, Chuan; Wen, Zexing; Pan, Yangyang; Yang, Kun; Song, Liangli; Yang, Xue] Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Cui, Y (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China.	cuiyan@gsau.edu.cn		Multhoff, Gabriele/0000-0002-2616-3137	Nature Science Foundation of China [31360594, 31572478]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Nature Science Foundation of China (grant No. 31360594, 31572478).	Bombardier E, 2009, J APPL PHYSIOL, V106, P2009, DOI 10.1152/japplphysiol.91573.2008; Cabezon F. A., 2016, Professional Animal Scientist, V32, P333, DOI 10.15232/pas.2015-01495; CARPER SW, 1987, CANCER RES, V47, P5249; CRUM CP, 1990, VIROLOGY, V178, P238, DOI 10.1016/0042-6822(90)90399-C; Cui Y, 1999, VET J, V157, P192, DOI 10.1053/tvjl.1998.0283; Cui Y, 1999, VET J, V157, P197, DOI 10.1053/tvjl.1998.0282; Dangi S.S., 2014, INT J BIOMETEOROL, P1; David JC, 2001, DEV BRAIN RES, V128, P91, DOI 10.1016/S0165-3806(01)00143-2; Driancourt MA, 1999, J REPROD FERTIL, V115, P45, DOI 10.1530/jrf.0.1150045; Duan YX, 2014, ACTA VET ZOOTECHNICA, V41, P1213; Galovic R, 2016, CLIN BIOCHEM, V49, P66, DOI 10.1016/j.clinbiochem.2015.10.006; Gandre S, 2003, MITOCHONDRION, V2, P245, DOI 10.1016/S1567-7249(02)00105-8; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Gekle M, 2014, STEROIDS, V81, P103, DOI 10.1016/j.steroids.2013.10.016; Gu Wenwen, 2015, J Immunoassay Immunochem, V36, P487, DOI 10.1080/15321819.2014.996817; He YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157558; Hu H, 2016, ANIM SCI J, V87, P84, DOI 10.1111/asj.12375; Hu R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149461; Li WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135251; Manjili MH, 2002, CANCER RES, V62, P1737; McCullagh KJA, 2016, NITRIC OXIDE-BIOL CH, V52, P41, DOI 10.1016/j.niox.2015.11.002; Mead AJ, 2012, NEW ENGL J MED, V366, P967, DOI 10.1056/NEJMc1200349; Meng XueLian, 2006, Veterinary Science in China, V36, P57; Min L, 2015, J ZHEJIANG UNIV-SC B, V16, P541, DOI 10.1631/jzus.B1400341; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Pan YY, 2015, CRYOBIOLOGY, V71, P33, DOI 10.1016/j.cryobiol.2015.06.005; PELHAM HRB, 1982, EMBO J, V1, P1473, DOI 10.1002/j.1460-2075.1982.tb01340.x; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Scieglinska D, 2011, HISTOCHEM CELL BIOL, V135, P337, DOI 10.1007/s00418-011-0791-5; Secasan CC, 2009, SAUDI J KIDNEY DIS T, V20, P355; Soleilhavoup C, 2016, MOL CELL PROTEOMICS, V15, P93, DOI 10.1074/mcp.M115.052332; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; Sun YJ, 2006, J CEREBR BLOOD F MET, V26, P937, DOI 10.1038/sj.jcbfm.9600246; Tan Juan, 2008, Zhongguo Shouyi Kexue, V38, P622; Wang QL, 2014, AQUACULT INT, V22, P1149, DOI 10.1007/s10499-013-9734-6; Wang XX, 2014, INT J ONCOL, V45, P18, DOI 10.3892/ijo.2014.2399; Wells AD, 2000, IMMUNOL TODAY, V21, P129, DOI 10.1016/S0167-5699(99)01558-3; [温泽星 Wen Zexing], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P3475; Wiener G, 2003, YAK FAO REGIONAL OFF; Yeyati PL, 2008, CURR OPIN GENET DEV, V18, P264, DOI 10.1016/j.gde.2008.07.004; Yong Yan-Hong, 2005, Acta Zoologica Sinica, V51, P1050; Zhang B, 2011, J DAIRY SCI, V94, P4174, DOI 10.3168/jds.2010-4137; Zhang JX, 2010, DEV COMP IMMUNOL, V34, P1199, DOI 10.1016/j.dci.2010.06.015; Zhao Y, 2007, CELL STRESS CHAPERON, V12, P83, DOI 10.1379/CSC-231R.1; Zugel U, 2001, INFECT IMMUN, V69, P4164, DOI 10.1128/IAI.69.6.4164-4167.2001	46	57	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0179321	10.1371/journal.pone.0179321	http://dx.doi.org/10.1371/journal.pone.0179321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3DF	28715410	Green Published, gold, Green Submitted			2022-12-27	WOS:000430382100001
J	Deyanova, D; Gullstrom, M; Lyimo, LD; Dahl, M; Hamisi, MI; Mtolera, MSP; Bjork, M				Deyanova, Diana; Gullstrom, Martin; Lyimo, Liberatus D.; Dahl, Martin; Hamisi, Mariam I.; Mtolera, Matern S. P.; Bjork, Mats			Contribution of seagrass plants to CO2 capture in a tropical seagrass meadow under experimental disturbance	PLOS ONE			English	Article							SITU LIGHT REDUCTION; THALASSIA-TESTUDINUM; PHYSIOLOGICAL-RESPONSES; POSIDONIA-OCEANICA; LEAF GROWTH; CHWAKA-BAY; PHOTOSYNTHESIS; CARBON; PRODUCTIVITY; HERBIVORY	Coastal vegetative habitats are known to be highly productive environments with a high ability to capture and store carbon. During disturbance this important function could be compromised as plant photosynthetic capacity, biomass, and/or growth are reduced. To evaluate effects of disturbance on CO2 capture in plants we performed a five-month manipulative experiment in a tropical seagrass (Thalassia hemprichii) meadow exposed to two intensity levels of shading and simulated grazing. We assessed CO2 capture potential (as net CO2 fixation) using areal productivity calculated from continuous measurements of diel photosynthetic rates, and estimates of plant morphology, biomass and productivity/respiration (P/R) ratios (from the literature). To better understand the plant capacity to coping with level of disturbance we also measured plant growth and resource allocation. We observed substantial reductions in seagrass areal productivity, biomass, and leaf area that together resulted in a negative daily carbon balance in the two shading treatments as well as in the high-intensity simulated grazing treatment. Additionally, based on the concentrations of soluble carbohydrates and starch in the rhizomes, we found that the main reserve sources for plant growth were reduced in all treatments except for the low-intensity simulated grazing treatment. If permanent, these combined adverse effects will reduce the plants' resilience and capacity to recover after disturbance. This might in turn have long-lasting and devastating effects on important ecosystem functions, including the carbon sequestration capacity of the seagrass system.	[Deyanova, Diana; Gullstrom, Martin; Dahl, Martin; Bjork, Mats] Stockholm Univ, Seagrass Ecol & Physiol Res Grp, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Lyimo, Liberatus D.] Univ Dodoma, Sch Biol Sci, Dodoma, Tanzania; [Hamisi, Mariam I.] Univ Dodoma, Coll Nat & Math Sci, Dodoma, Tanzania; [Mtolera, Matern S. P.] Univ Dar Es Salaam, Inst Marine Sci, Zanzibar, Tanzania	Stockholm University; University of Dar es Salaam	Deyanova, D (corresponding author), Stockholm Univ, Seagrass Ecol & Physiol Res Grp, Dept Ecol Environm & Plant Sci, Stockholm, Sweden.	diana.deyanova@su.se	Björk, Mats/B-4299-2010	Björk, Mats/0000-0003-0363-110X; Hamisi, Mariam Issa/0000-0002-0144-2930; Deyanova, Diana/0000-0002-6555-2047	Swedish International Development Cooperation Agency (Sida);  [SWE-2010-194]	Swedish International Development Cooperation Agency (Sida); 	The research was funded by the Swedish International Development Cooperation Agency (Sida) through the Bilateral Marine Science Program between Sweden and Tanzania and a three-year research project grant (SWE-2010-194)	Abu Hena MK., 2001, PAKISTAN J BIOL SCI, V4, P1487, DOI 10.3923/pjbs.2001.1487.1489; Agawin NSR, 2001, J EXP MAR BIOL ECOL, V260, P217, DOI 10.1016/S0022-0981(01)00253-2; Alcoverro T, 2004, ECOGRAPHY, V27, P361, DOI 10.1111/j.0906-7590.2004.03736.x; [Anonymous], 1962, CARBOHYDRATE CHEM; [Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Beer S, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P183, DOI 10.1016/B978-044450891-1/50010-4; Beer S., 2014, PHOTOSYNTHESIS MARIN; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Bjork M, 1999, MAR ECOL PROG SER, V191, P121, DOI 10.3354/meps191121; Bjork M, 2008, IUCN RESILIENCE SCI; Briske D. D., 1995, WILDLAND PLANTS PHYS, P635; BUESA R J, 1977, Aquatic Botany, V3, P203, DOI 10.1016/0304-3770(77)90023-7; Camp DK, 1973, OVERGRAZING SEAGRASS; Carlson PR, 1985, 12TH P ANN C WETL RE, P64; Cayabyab NM, 2007, NEW PHYTOL, V176, P108, DOI 10.1111/j.1469-8137.2007.02147.x; Cebrian J, 1998, J EXP MAR BIOL ECOL, V220, P67, DOI 10.1016/S0022-0981(97)00084-1; Cederlof U, 1995, AMBIO, V24, P458; Collier CJ, 2012, MAR POLLUT BULL, V65, P342, DOI 10.1016/j.marpolbul.2011.06.017; Collier CJ, 2010, AQUAT BOT, V93, P47, DOI 10.1016/j.aquabot.2010.03.003; Collier CJ, 2009, J EXP MAR BIOL ECOL, V370, P89, DOI 10.1016/j.jembe.2008.12.003; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; CZERNY AB, 1995, ESTUARIES, V18, P418, DOI 10.2307/1352324; Dahl M, 2016, J ECOL, V104, P654, DOI 10.1111/1365-2745.12564; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Eklof JS, 2008, ESTUAR COAST SHELF S, V79, P569, DOI 10.1016/j.ecss.2008.05.005; Eklof JS, 2008, AQUAT BOT, V89, P337, DOI 10.1016/j.aquabot.2008.03.009; Ferraro DO, 2002, OIKOS, V98, P125, DOI 10.1034/j.1600-0706.2002.980113.x; FOURQUREAN JW, 1991, MAR ECOL PROG SER, V69, P161, DOI 10.3354/meps069161; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; GORDON DM, 1994, AQUAT BOT, V47, P265, DOI 10.1016/0304-3770(94)90057-4; Gullstrom M, 2006, ESTUAR COAST SHELF S, V67, P399, DOI 10.1016/j.ecss.2005.11.020; Harper J. L, 1977, POPULATION BIOL PLAN; Hemminga MA, 1998, J SEA RES, V39, P183, DOI 10.1016/S1385-1101(98)00004-5; Herzka SZ, 1997, MAR ECOL PROG SER, V152, P103, DOI 10.3354/meps152103; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Kelkar N, 2013, J ECOL, V101, P1158, DOI 10.1111/1365-2745.12122; Lacey EA, 2014, REV BIOL TROP, V62, P1535, DOI 10.15517/rbt.v62i4.12844; Laffoley D., 2009, MANAGEMENT NATURAL C; Lee KS, 1997, J EXP MAR BIOL ECOL, V210, P53, DOI 10.1016/S0022-0981(96)02720-7; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Longstaff BJ, 1999, J EXP MAR BIOL ECOL, V234, P1, DOI 10.1016/S0022-0981(98)00137-3; Marba N, 2002, MAR ECOL PROG SER, V226, P287, DOI 10.3354/meps226287; Marba N, 2006, OECOLOGIA, V150, P362, DOI 10.1007/s00442-006-0524-y; MCROY CP, 1977, SEAGRASS ECOSYSTEMS, P53; Mussaka ANN, 1999, 20 ANN C ADV MAR SCI, P569; Nayar S, 2009, J EXP MAR BIOL ECOL, V373, P87, DOI 10.1016/j.jembe.2009.03.010; Olive I, 2016, ESTUAR COAST, V39, P138, DOI 10.1007/s12237-015-9973-z; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pedersen O, 2016, NEW PHYTOL, P1; Peterson BJ, 2002, OIKOS, V97, P361, DOI 10.1034/j.1600-0706.2002.970306.x; QASIM S Z, 1972, Internationale Revue der Gesamten Hydrobiologie, V57, P207, DOI 10.1002/iroh.19720570203; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Rose CD, 1999, MAR ECOL PROG SER, V190, P211, DOI 10.3354/meps190211; Ruiz JM, 2003, MAR POLLUT BULL, V46, P1523, DOI 10.1016/j.marpolbul.2003.08.021; Ruiz JM, 2001, MAR ECOL PROG SER, V215, P107, DOI 10.3354/meps215107; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P155; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Silva J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081058; Suzuki J, 1999, PLANT SPEC BIOL, P11; Thayumanavan B, 1984, PLANT FOOD HUM NUTR, V34, P253; Valentine JF, 1997, OECOLOGIA, V112, P193, DOI 10.1007/s004420050300; Verges A, 2008, OECOLOGIA, V155, P751, DOI 10.1007/s00442-007-0943-4; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	66	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181386	10.1371/journal.pone.0181386	http://dx.doi.org/10.1371/journal.pone.0181386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704565	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700131
J	Messerer, M; Fischer, W; Schubert, S				Messerer, Maxim; Fischer, Wolfgang; Schubert, Soeren			Investigation of horizontal gene transfer of pathogenicity islands in Escherichia coli using next-generation sequencing	PLOS ONE			English	Article							VIRULENCE; EVOLUTION; STRAINS	Horizontal gene transfer (HGT) contributes to the evolution of bacteria. All extraintestinal pathogenic Escherichia coli (ExPEC) harbour pathogenicity islands (PAIs), however relatively little is known about the acquisition of these PAIs. Due to these islands, ExPEC have properties to colonize and invade its hosts efficiently. Even though these PAIs are known to be acquired by HGT, only very few PAIs do carry mobilization and transfer genes required for the transmission by HGT. In this study, we apply for the first time next-generation sequencing (NGS) and in silico analyses in combination with in vitro experiments to decipher the mechanisms of PAI acquisition in ExPEC. For this, we investigated three neighbouring E. coli PAIs, namely the high-pathogenicity island (HPI), the pks and the serU island. As these PAIs contain no mobilization and transfer genes, they are immobile and dependent on transfer vehicles. By whole genome sequencing of the entire E. coli reference (ECOR) collection and by applying a phylogenetic approach we could unambiguously demonstrate that these PAIs are transmitted not only vertically, but also horizontally. Furthermore, we could prove in silico that distinct groups of PAIs were transferred "en bloc" in conjunction with the neighbouring chromosomal backbone. We traced this PAI transfer in vitro using an F'plasmid. Different lengths of transferred DNA were exactly detectable in the sequenced transconjugants indicating NGS as a powerful tool for determination of PAI transfer.	[Messerer, Maxim; Fischer, Wolfgang; Schubert, Soeren] Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany	University of Munich	Schubert, S (corresponding author), Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany.	schubert@med.uni-muenchen.de	Messerer, Maxim/GWU-5619-2022	Messerer, Maxim/0000-0003-0554-5045	ERANET "Transnational PathoGenoMics", BMBF	ERANET "Transnational PathoGenoMics", BMBF(Federal Ministry of Education & Research (BMBF))	This study was supported by a grant by the ERANET "Transnational PathoGenoMics", BMBF.; We thank Phillippe Glaser and his team for the sequencing of the E. coli isolates. This study was supported by a grant by the ERANET "Transnational PathoGenoMics", BMBF.	Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chaudhuri RR, 2012, INFECT GENET EVOL, V12, P214, DOI 10.1016/j.meegid.2012.01.005; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dobrindt U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gordienko EN, 2013, J BACTERIOL, V195, P2786, DOI 10.1128/JB.02285-12; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Griffiths AJ, 1999, MODERN GENETIC ANAL; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HACKER J, 1992, ZBL BAKT-INT J MED M, V276, P165; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2001, J INFECT DIS, V184, P1556, DOI 10.1086/323891; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Kohler CD, 2011, INT J MED MICROBIOL, V301, P642, DOI 10.1016/j.ijmm.2011.09.006; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Lecointre G, 1998, MOL BIOL EVOL, V15, P1685, DOI 10.1093/oxfordjournals.molbev.a025895; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Martin P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003437; Milkman R, 1997, GENETICS, V146, P745; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider G, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-210; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Schubert S, 2010, INT J MED MICROBIOL, V300, P429, DOI 10.1016/j.ijmm.2010.02.006; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	35	17	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0179880	10.1371/journal.pone.0179880	http://dx.doi.org/10.1371/journal.pone.0179880			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732043	gold, Green Published, Green Submitted			2022-12-27	WOS:000406643100002
J	Kadmiel, M; Matson, BC; Espenschied, ST; Lenhart, PM; Caron, KM				Kadmiel, Mahita; Matson, Brooke C.; Espenschied, Scott T.; Lenhart, Patricia M.; Caron, Kathleen M.			Loss of receptor activity-modifying protein 2 in mice causes placental dysfunction and alters PTH1R regulation	PLOS ONE			English	Article							CALCIUM-TRANSPORT; GENE-EXPRESSION; DRUG TARGETS; ADRENOMEDULLIN; DISTINCT; RAMPS; CELLS; OSTEOPOROSIS; INTERFACE; PTHRP	Receptor activity-modifying protein 2 (Ramp2) is a single-pass transmembrane protein that heterodimerizes with several family B G-protein coupled receptors to alter their function. Ramp2 has been primarily characterized in association with calcitonin receptor-like receptor (Calcrl, CLR), forming the canonical receptor complex for the endocrine peptide adrenomedullin (Adm, AM). However, we previously demonstrated that Ramp2(+/-) female mice display a constellation of endocrine-related phenotypes that are distinct from those of Adm (+/-) and Calcrl(+/-) mice, implying that RAMP2 has physiological functions beyond its canonical complex. Here, we localize Ramp2 expression in the mouse placenta, finding that Ramp2 is robustly expressed in the fetal labyrinth layer, and then characterize the effects of loss of Ramp2 on placental development. Consistent with the expression pattern of Ramp2 in the placenta, Ramp2(-/-) lacentas have a thinner labyrinth layer with significantly fewer trophoblast cells secondary to a reduction in trophoblast proliferation. We also find that absence of Ramp2 leads to failed spiral artery remodeling unaccompanied by changes in the uterine natural killer cell population. Furthermore, we assess changes in gene expression of other RAMP2-associated G-protein coupled receptors (GPCRs), concluding that Ramp2 loss decreases parathyroid hormone 1 receptor (Pthr1) expression and causes a blunted response to systemic parathyroid hormone (PTH) administration in mice. Ultimately, these studies provide in vivo evidence of a role for RAMP2 in placental development distinct from the RAMP2-CLR/AM signaling paradigm and identify additional pathways underlying the endocrine and fertility defects of the previously characterized Ramp2 heterozygous adult females.	[Kadmiel, Mahita; Matson, Brooke C.; Espenschied, Scott T.; Lenhart, Patricia M.; Caron, Kathleen M.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Caron, Kathleen M.] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Caron, KM (corresponding author), Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Caron, KM (corresponding author), Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA.	kathleen_caron@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021; Espenschied, Scott T./AAO-2900-2020	Caron, Kathleen/0000-0002-7033-9232; Espenschied, Scott T./0000-0001-8885-7532	U.S. National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD060860, F30 HD085652]; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER	U.S. National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov) R01 HD060860 (to KMC) and F30 HD085652 (to BCM) and by an American Heart Association (www.heart.org) Predoctoral Fellowship (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2010, ONCOLOGIST, V15, P61, DOI 10.1634/theoncologist.2009-0185; Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Dackor R, 2007, J BIOL CHEM, V282, P18094, DOI 10.1074/jbc.M703544200; Dunworth WP, 2009, ARTERIOSCL THROM VAS, V29, P650, DOI 10.1161/ATVBAHA.109.185066; Eastabrook G, 2008, J OBSTET GYNAECOL CA, V30, P467, DOI 10.1016/S1701-2163(16)32862-6; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Kadmiel M, 2012, ADV EXP MED BIOL, V744, P49, DOI 10.1007/978-1-4614-2364-5_5; Kadmiel M, 2011, MOL ENDOCRINOL, V25, P1244, DOI 10.1210/me.2010-0400; Kechele DO, 2016, HYPERTENSION, V68, P667, DOI 10.1161/HYPERTENSIONAHA.116.07191; Klein KR, 2016, CRIT REV BIOCHEM MOL, V51, P65, DOI 10.3109/10409238.2015.1128875; Kovacs CS, 1996, P NATL ACAD SCI USA, V93, P15233, DOI 10.1073/pnas.93.26.15233; Kovacs CS, 2001, ENDOCRINOLOGY, V142, P4983, DOI 10.1210/en.142.11.4983; Kremer R, 2012, ADV EXP MED BIOL, V720, P145, DOI 10.1007/978-1-4614-0254-1_12; Kuwasako K, 2010, BIOCHEM BIOPH RES CO, V392, P380, DOI 10.1016/j.bbrc.2010.01.030; Li M, 2008, BIOL REPROD; Li MY, 2013, J CLIN INVEST, V123, P2408, DOI 10.1172/JCI67039; Makino Y, 2001, J CLIN ENDOCR METAB, V86, P5079, DOI 10.1210/jc.86.10.5079; Matson BC, 2014, INT J DEV BIOL, V58, P199, DOI 10.1387/ijdb.140032kc; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mosekilde L, 2011, CURR DRUG SAF, V6, P62, DOI 10.2174/157488611795684712; Sexton PM, 2012, ADV EXP MED BIOL, V744, P61, DOI 10.1007/978-1-4614-2364-5_6; Simmonds CS, 2010, J BONE MINER RES, V25, P594, DOI 10.1359/jbmr.090825; Toulis KA, 2011, HORM-INT J ENDOCRINO, V10, P174, DOI 10.14310/horm.2002.1308; Tucci J, 1996, J MOL ENDOCRINOL, V17, P159, DOI 10.1677/jme.0.0170159; Watkins HA, 2014, BRIT J PHARMACOL, V171, P772, DOI 10.1111/bph.12508; Watkins HA, 2016, J BIOL CHEM, V291, P11657, DOI 10.1074/jbc.M115.688218	30	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181597	10.1371/journal.pone.0181597	http://dx.doi.org/10.1371/journal.pone.0181597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727763	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500091
J	Tamura, K; Hayashi, S				Tamura, Koichi; Hayashi, Shigehiko			Atomistic modeling of alternating access of a mitochondrial ADP/ATP membrane transporter with molecular simulations	PLOS ONE			English	Article							ADP ATP CARRIER; BINDING; MECHANISM; DYNAMICS; SUBSTRATE; YEAST; TRANSLOCATION; PROTEIN; BONGKREKATE; SPECIFICITY	The mitochondrial ADP/ATP carrier (AAC) is a membrane transporter that exchanges a cytosolic ADP for a matrix ATP. Atomic structures in an outward-facing (OF) form which binds an ADP from the intermembrane space have been solved by X-ray crystallography, and revealed their unique pseudo three-fold symmetry fold which is qualitatively different from pseudo two-fold symmetry of most transporters of which atomic structures have been solved. However, any atomic-level information on an inward-facing (IF) form, which binds an ATP from the matrix side and is fixed by binding of an inhibitor, bongkrekic acid (BA), is not available, and thus its alternating access mechanism for the transport process is unknown. Here, we report an atomic structure of the IF form predicted by atomic-level molecular dynamics (MD) simulations of the alternating access transition with a recently developed accelerating technique. We successfully obtained a significantly stable IF structure characterized by newly formed well-packed and -organized inter-domain interactions through the accelerated simulations of unprecedentedly large conformational changes of the alternating access without a prior knowledge of the target protein structure. The simulation also shed light on an atomistic mechanism of the strict transport selectivity of adenosine nucleotides over guanosine and inosine ones. Furthermore, the IF structure was shown to bind ATP and BA, and thus revealed their binding mechanisms. The present study proposes a qualitatively novel view of the alternating access of transporters having the unique three-fold symmetry in atomic details and opens the way for rational drug design targeting the transporter in the dynamic functional cycle.	[Tamura, Koichi; Hayashi, Shigehiko] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto, Japan	Kyoto University	Hayashi, S (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto, Japan.	hayashig@kuchem.kyoto-u.ac.jp		TAMURA, Koichi/0000-0002-9472-7555	Japanese Ministry of Education, Culture, Sports, Science and Technology [25104004, 25291034, 16H04776]; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	This work was financially supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (25104004, 25291034,16H04776, and "Priority Issue on Post-Kcomputer" (Building Innovative Drug Discovery Infrastructure Through Functional Control of Biomolecular Systems)), and the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruschweiler S, 2015, NAT STRUCT MOL BIOL, V22, P636, DOI 10.1038/nsmb.3059; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; DALBON P, 1988, BIOCHEMISTRY-US, V27, P5141, DOI 10.1021/bi00414a029; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; David C, 2008, BIOCHEMISTRY-US, V47, P13223, DOI 10.1021/bi8012565; Dehez F, 2008, J AM CHEM SOC, V130, P12725, DOI 10.1021/ja8033087; Gropp T, 1999, BIOPHYS J, V77, P714, DOI 10.1016/S0006-3495(99)76926-2; Gumbart J, 2007, BIOCHEMISTRY-US, V46, P11147, DOI 10.1021/bi700835d; Huber T, 1999, BIOCHEMISTRY-US, V38, P762, DOI 10.1021/bi981431l; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; Ikeguchi M, 2004, J COMPUT CHEM, V25, P529, DOI 10.1002/jcc.10402; KLINGENBERG M, 1973, EUR J BIOCHEM, V38, P346, DOI 10.1111/j.1432-1033.1973.tb03067.x; KLINGENBERG M, 1976, EUR J BIOCHEM, V65, P601, DOI 10.1111/j.1432-1033.1976.tb10377.x; Lin L, 2015, NAT REV DRUG DISCOV, V14, P543, DOI 10.1038/nrd4626; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; MAYINGER P, 1989, FEBS LETT, V244, P421, DOI 10.1016/0014-5793(89)80576-9; Mifsud J, 2013, MOL MEMBR BIOL, V30, P160, DOI 10.3109/09687688.2012.745175; Moradi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9393; Moradi M, 2013, P NATL ACAD SCI USA, V110, P18916, DOI 10.1073/pnas.1313202110; Mori T, 2010, BIOCHEMISTRY-US, V49, P945, DOI 10.1021/bi901594w; Muller V, 1997, BIOCHEMISTRY-US, V36, P16008, DOI 10.1021/bi971867l; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; PFAFF E, 1968, EUR J BIOCHEM, V6, P66, DOI 10.1111/j.1432-1033.1968.tb00420.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierri CL, 2014, CELL MOL LIFE SCI, V71, P349, DOI 10.1007/s00018-013-1389-y; Pietropaolo A, 2016, BBA-BIOENERGETICS, V1857, P772, DOI 10.1016/j.bbabio.2016.02.006; Pliotas C, 2015, NAT STRUCT MOL BIOL, V22, P991, DOI 10.1038/nsmb.3120; Rey M, 2012, BIOCHEMISTRY-US, V51, P9727, DOI 10.1021/bi300759x; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111; Shaikh SA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000905; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Tamura K, 2015, J CHEM THEORY COMPUT, V11, P2900, DOI 10.1021/acs.jctc.5b00120; The International Transporter Consortium, 2010, NAT REV DRUG DISCOVE, V9, P215; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Zhao CF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003296	44	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181489	10.1371/journal.pone.0181489	http://dx.doi.org/10.1371/journal.pone.0181489			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727843	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500079
J	Campbell, KT; Hadley, DJ; Kukis, DL; Silva, EA				Campbell, Kevin T.; Hadley, Dustin J.; Kukis, David L.; Silva, Eduardo A.			Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MOLECULAR-WEIGHT DISTRIBUTION; LYMPHATIC VASCULATURE; COVALENT INCORPORATION; MYOCARDIAL-INFARCTION; COLLAGEN MATRICES; TYROSINE KINASES; TUMOR-GROWTH; IN-VIVO; ANGIOGENESIS	Lymphatic dysfunction is associated with the progression of many cardiovascular disorders due to their role in maintaining tissue fluid homeostasis. Promoting new lymphatic vessels (lymphangiogenesis) is a promising strategy to reverse these cardiovascular disorders via restoring lymphatic function. Vascular endothelial growth factor (VEGF) members VEGF-C and VEGF-D are both potent candidates for stimulating lymphangiogenesis, though maintaining spatial and temporal control of these factors represents a challenge to developing efficient therapeutic lymphangiogenic applications. Injectable alginate hydrogels have been useful for the controlled delivery of many angiogenic factors, including VEGF-A, to stimulate new blood vasculature. However, the utility of these tunable hydrogels for delivering lymphangiogenic factors has never been closely examined. Thus, the objective of this study was to utilize ionically cross-linked alginate hydrogels to deliver VEGF-C and VEGF-D for potential lymphangiogenic applications. We demonstrated that lymphatic endothelial cells (LECs) are sensitive to temporal presentation of VEGF-C and VEGF-D but with different responses between the factors. The greatest LEC mitogenic and sprouting response was observed for constant concentrations of VEGF-C and a high initial concentration that gradually decreased over time for VEGF-D. Additionally, alginate hydrogels provided sustained release of radiolabeled VEGF-C and VEGF-D. Finally, VEGF-C and VEGF-D released from these hydrogels promoted a similar number of LEC sprouts as exogenously added growth factors and new vasculature in vivo via a chick chorioallantoic membrane (CAM) assay. Overall, these findings demonstrate that alginate hydrogels can provide sustained and bioactive release of VEGF-C and VEGF-D which could have applications for therapeutic lymphangiogenesis.	[Campbell, Kevin T.; Hadley, Dustin J.; Silva, Eduardo A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Kukis, David L.] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Silva, EA (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	esilva@ucdavis.edu	Silva, Eduardo A./M-2711-2015	Silva, Eduardo A./0000-0003-3173-7622	American Heart Association [15BGIA25730057]; Center for Molecular and Genomic Imaging at UC Davis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086350] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Center for Molecular and Genomic Imaging at UC Davis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant from the American Heart Association (15BGIA25730057) and by pilot funding from the Center for Molecular and Genomic Imaging at UC Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the American Heart Association (15BGIA25730057) and the Center for Molecular and Genomic Imaging at UC Davis for the funding support.	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Anderson EM, 2015, J VASC RES, V52, P62, DOI 10.1159/000382129; Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p; Bronckaers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071104; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Cimpean AM, 2010, CLIN EXP MED, V10, P169, DOI 10.1007/s10238-009-0085-6; Cui Yingjie, 2010, Pathophysiology, V17, P307, DOI 10.1016/j.pathophys.2009.07.006; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028; Henri O, 2016, CIRCULATION, V133, P1484, DOI 10.1161/CIRCULATIONAHA.115.020143; Hwang JH, 2011, BIOMATERIALS, V32, P4415, DOI 10.1016/j.biomaterials.2011.02.051; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]; Kim IG, 2013, J VASC RES, V50, P124, DOI 10.1159/000343699; Kim S, 2016, BIOMATERIALS, V78, P115, DOI 10.1016/j.biomaterials.2015.11.019; Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x; Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r; Li JY, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.71; Lim HY, 2013, CELL METAB, V17, P671, DOI 10.1016/j.cmet.2013.04.002; Ludwig LL, 1997, CARDIOVASC RES, V33, P164, DOI 10.1016/S0008-6363(96)00177-0; Madrigal J.L., 2016, ANN BIOMED ENG; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Martel C, 2013, J CLIN INVEST, V123, P1571, DOI 10.1172/JCI63685; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Randolph GJ, 2014, J CLIN INVEST, V124, P929, DOI 10.1172/JCI71610; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Schulz MMP, 2012, P NATL ACAD SCI USA, V109, pE2665, DOI 10.1073/pnas.1206036109; Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x; Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105; Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052; Singh S, 2012, J BIOMED MATER RES A, V100A, P720, DOI 10.1002/jbm.a.34010; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Williams PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123437; Wong C, 2003, THROMB HAEMOSTASIS, V89, P573, DOI 10.1055/s-0037-1613389; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800	50	30	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181484	10.1371/journal.pone.0181484	http://dx.doi.org/10.1371/journal.pone.0181484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723974	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800054
J	Perdikis, D; Volhard, J; Muller, V; Kaulard, K; Brick, TR; Wallraven, C; Lindenberger, U				Perdikis, Dionysios; Volhard, Jakob; Mueller, Viktor; Kaulard, Kathrin; Brick, Timothy R.; Wallraven, Christian; Lindenberger, Ulman			Brain synchronization during perception of facial emotional expressions with natural and unnatural dynamics	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; PHASE SYNCHRONIZATION; RESPONSES; FACE; RECOGNITION; INFORMATION; HIERARCHY; ALPHA	Research on the perception of facial emotional expressions (FEEs) often uses static images that do not capture the dynamic character of social coordination in natural settings. Recent behavioral and neuroimaging studies suggest that dynamic FEEs (videos or morphs) enhance emotion perception. To identify mechanisms associated with the perception of FEEs with natural dynamics, the present EEG (Electroencephalography) study compared (i) ecologically valid stimuli of angry and happy FEEs with natural dynamics to (ii) FEEs with unnatural dynamics, and to (iii) static FEEs. FEEs with unnatural dynamics showed faces moving in a biologically possible but unpredictable and atypical manner, generally resulting in ambivalent emotional content. Participants were asked to explicitly recognize FEEs. Using whole power (WP) and phase synchrony (Phase Locking Index, PLI), we found that brain responses discriminated between natural and unnatural FEEs (both static and dynamic). Differences were primarily observed in the timing and brain topographies of delta and theta PLI and WP, and in alpha and beta WP. Our results support the view that biologically plausible, albeit atypical, FEEs are processed by the brain by different mechanisms than natural FEEs. We conclude that natural movement dynamics are essential for the perception of FEEs and the associated brain processes.	[Perdikis, Dionysios; Volhard, Jakob; Mueller, Viktor; Brick, Timothy R.; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Kaulard, Kathrin] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany; [Wallraven, Christian] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Max Planck Society; Korea University	Perdikis, D (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany.	perdikis@mpib-berlin.mpg.de	Müller, Viktor/AAX-4429-2021; Brick, Timothy/C-9966-2015	Brick, Timothy/0000-0002-3339-9279; Muller, Viktor/0000-0002-3716-5445; Perdikis, Dionysios/0000-0003-0103-7094	Max Planck Society; Max-Planck Network (Maxnet) for Cognition	Max Planck Society(Max Planck Society); Max-Planck Network (Maxnet) for Cognition	This work was supported by the Max Planck Society and the Max-Planck Network (Maxnet) for Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Arsalidou M, 2011, BRAIN TOPOGR, V24, P149, DOI 10.1007/s10548-011-0171-4; Balconi M, 2006, NEUROSCI LETT, V392, P118, DOI 10.1016/j.neulet.2005.09.004; Brick TR, 2012, FACE MODEL GUI VERSI; Brick TR, STAPLES; Cooper NR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00159; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Cunningham DW, 2009, J VISION, V9, DOI 10.1167/9.13.7; De Winter FL, 2015, NEUROIMAGE, V106, P340, DOI 10.1016/j.neuroimage.2014.11.020; Ekman P., 1976, PICTURES FACIAL AFFE; Enticott PG, 2008, NEUROPSYCHOLOGIA, V46, P2851, DOI 10.1016/j.neuropsychologia.2008.04.022; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Fuchs A, 2008, UNDERST COMPLEX SYST, P327, DOI 10.1007/978-3-540-74479-5_16; Furl N, 2010, CEREB CORTEX, V20, P694, DOI 10.1093/cercor/bhp140; Furl N, 2013, CEREB CORTEX, P1; Furl N., 2014, CEREB CORTEX, V1, P1, DOI DOI 10.1093/CERC0R/BHU083; Furl N, 2012, J NEUROSCI, V32, P15952, DOI 10.1523/JNEUROSCI.1992-12.2012; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gruber WR, 2005, CEREB CORTEX, V15, P371, DOI 10.1093/cercor/bhh139; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kaiser J, 2001, NEUROSCI LETT, V312, P149, DOI 10.1016/S0304-3940(01)02217-0; Kaulard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032321; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Kleinfeld David, 2014, Cold Spring Harb Protoc, V2014, P248, DOI 10.1101/pdb.top081075; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Matthews I, 2004, INT J COMPUT VISION, V60, P135, DOI 10.1023/B:VISI.0000029666.37597.d3; Maturana, 1998, TREE KNOWLEDGE BIOL; Mayes AK, 2009, BRAIN TOPOGR, V22, P145, DOI 10.1007/s10548-009-0106-5; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Moore A, 2012, BEHAV BRAIN RES, V226, P309, DOI 10.1016/j.bbr.2011.07.048; Muller V, 2009, DEVELOPMENTAL SCI, V12, P839, DOI 10.1111/j.1467-7687.2009.00834.x; Park H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059544; Pavlova M, 2004, CEREB CORTEX, V14, P181, DOI 10.1093/cercor/bhg117; Perry A, 2009, BRAIN RES, V1282, P126, DOI 10.1016/j.brainres.2009.05.059; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; Saragih J, 2009, PATTERN RECOGN, V42, P2628, DOI 10.1016/j.patcog.2009.04.014; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001; Sato W, 2007, J NONVERBAL BEHAV, V31, P119, DOI 10.1007/s10919-007-0025-7; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schultz J, 2013, CEREB CORTEX, V23, P1167, DOI 10.1093/cercor/bhs106; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; Trautmann-Lengsfeld SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066997; Tzagarakis C, 2010, J NEUROSCI, V30, P11270, DOI 10.1523/JNEUROSCI.6026-09.2010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Yoshikawa S, 2008, COGN AFFECT BEHAV NE, V8, P25, DOI 10.3758/CABN.8.1.25	63	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181225	10.1371/journal.pone.0181225	http://dx.doi.org/10.1371/journal.pone.0181225			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723957	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800039
J	Pitkanen, M; Kallioniemi, E; Julkunen, P				Pitkanen, Minna; Kallioniemi, Elisa; Julkunen, Petro			Effect of inter-train interval on the induction of repetition suppression of motor-evoked potentials using transcranial magnetic stimulation	PLOS ONE			English	Article							CORTEX EXCITABILITY; HABITUATION; INHIBITION; TMS; RESPONSES	Repetition suppression (RS) is evident as a weakened response to repeated stimuli after the initial response. RS has been demonstrated in motor-evoked potentials (MEPs) induced with transcranial magnetic stimulation (TMS). Here, we investigated the effect of inter-train interval (ITI) on the induction of RS of MEPs with the attempt to optimize the investigative protocols. Trains of TMS pulses, targeted to the primary motor cortex by neuronavigation, were applied at a stimulation intensity of 120% of the resting motor threshold. The stimulus trains included either four or twenty pulses with an inter-stimulus interval (ISI) of 1 s. The ITI was here defined as the interval between the last pulse in a train and the first pulse in the next train; the ITIs used here were 1, 3, 4, 6, 7, 12, and 17 s. RS was observed with all ITIs except with the ITI of 1 s, in which the ITI was equal to ISI. RS was more pronounced with longer ITIs. Shorter ITIs may not allow sufficient time for a return to baseline. RS may reflect a startle-like response to the first pulse of a train followed by habituation. Longer ITIs may allow more recovery time and in turn demonstrate greater RS. Our results indicate that RS can be studied with confidence at relatively short ITIs of 6 s and above.	[Pitkanen, Minna; Kallioniemi, Elisa; Julkunen, Petro] Kuopio Univ Hosp, Dept Clin Neurophysiol, Kuopio, Finland; [Pitkanen, Minna] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo, Finland; [Kallioniemi, Elisa] Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland; [Julkunen, Petro] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; Aalto University; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Pitkanen, M (corresponding author), Kuopio Univ Hosp, Dept Clin Neurophysiol, Kuopio, Finland.; Pitkanen, M (corresponding author), Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo, Finland.	minna.pitk@gmail.com	Julkunen, Petro/AAS-5293-2020; Kallioniemi, Elisa/J-5000-2019	Kallioniemi, Elisa/0000-0001-6706-2837; Julkunen, Petro/0000-0002-0461-1058; Pitkanen, Minna/0000-0003-1716-3909	Finnish Cultural Foundation, Helsinki, Finland; Cancer Society of Finland, Helsinki, Finland; Paivikki and Sakari Sohlberg Foundation, Helsinki, Finland; Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (Kuopio, Finland) [5041726, 5041730, 5041749]	Finnish Cultural Foundation, Helsinki, Finland(Finnish Cultural Foundation); Cancer Society of Finland, Helsinki, Finland; Paivikki and Sakari Sohlberg Foundation, Helsinki, Finland; Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (Kuopio, Finland)	The work was supported by the Finnish Cultural Foundation, Helsinki, Finland, http://skr.fi/en (Received by MP); the Cancer Society of Finland, Helsinki, Finland, https://www.cancersociety.fi/ (Received by EK and PJ); and Paivikki and Sakari Sohlberg Foundation, Helsinki, Finland, http://www.pss-saatio.fi/english.htm (Received by EK). In addition, the authors (EK, PJ) acknowledge the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (projects 5041726, 5041730 and 5041749, Kuopio, Finland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Awiszus F, MOTOR THRESHOLD ASSE; BARKER AT, 1985, LANCET, V1, P1106; Cash RFH, 2017, BRAIN STIMUL, P1; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; FRUHSTOR.H, 1970, ELECTROEN CLIN NEURO, V28, P153, DOI 10.1016/0013-4694(70)90183-5; FRUHSTORFER H, 1971, ELECTROEN CLIN NEURO, V30, P306, DOI 10.1016/0013-4694(71)90113-1; GEYER MA, 1982, PSYCHOPHYSIOLOGY, V19, P1, DOI 10.1111/j.1469-8986.1982.tb02589.x; Giles AC, 2009, NEUROBIOL LEARN MEM, V92, P139, DOI 10.1016/j.nlm.2008.08.004; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hamilton AFD, 2009, HUM BRAIN MAPP, V30, P2898, DOI 10.1002/hbm.20717; Hohlefeld FU, 2011, NEUROREPORT, V22, P141, DOI 10.1097/WNR.0b013e3283436d84; Julkunen P, 2012, BRAIN STIMUL, V5, P526, DOI 10.1016/j.brs.2011.07.006; Kallioniemi E, 2015, NEUROSCIENCE, V310, P504, DOI 10.1016/j.neuroscience.2015.09.056; Kim H, 2017, HUM BRAIN MAPP, V38, P1894, DOI 10.1002/hbm.23492; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lofberg O, 2014, NEUROSCIENCE, V274, P403, DOI 10.1016/j.neuroscience.2014.05.060; Lofberg O, 2013, NEUROSCIENCE, V243, P40, DOI 10.1016/j.neuroscience.2013.03.060; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; Saisanen L, 2008, J CLIN NEUROPHYSIOL, V25, P367, DOI 10.1097/WNP.0b013e31818e7944; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; SCHOENEN J, 1995, EUR J NEUROL, V2, P115, DOI 10.1111/j.1468-1331.1995.tb00103.x; SOININEN HS, 1995, PHYSIOL BEHAV, V57, P927, DOI 10.1016/0031-9384(94)00393-J; Vaalto S, 2011, HUM BRAIN MAPP, V32, P1692, DOI 10.1002/hbm.21137; Volz LJ, 2015, CEREB CORTEX, V25, P2346, DOI 10.1093/cercor/bhu032; Wassermann EM, 1996, ELECTROMYOGR MOTOR C, V101, P412; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	33	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181663	10.1371/journal.pone.0181663	http://dx.doi.org/10.1371/journal.pone.0181663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723977	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800065
J	Zhu, QQ; Yu, SG; Chen, GS; Ke, LL; Pan, DR				Zhu, Qiuqiang; Yu, Shuguang; Chen, Guanshui; Ke, Lanlan; Pan, Daren			Analysis of the differential gene and protein expression profile of the rolled leaf mutant of transgenic rice (Oryza sativa L.)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CELL-DEVELOPMENT; BULLIFORM CELLS; OVEREXPRESSION	The importance of leaf rolling in rice (Oryza sativa L.) has been widely recognized. Although several studies have investigated rice leaf rolling and identified some related genes, knowledge of the molecular mechanism underlying rice leaf rolling, especially outward leaf rolling, is limited. Therefore, in this study, differential proteomics and gene expression profiling were used to analyze rolled leaf mutant of transgenic rice in order to investigate differentially expressed genes and proteins related to rice leaf rolling. To this end, 28 differentially expressed proteins related to rolling leaf traits were isolated and identified. Digital expression profiling detected 10 genes related to rice leaf rolling. Some of the proteins and genes detected are involved in lipid metabolism, which is related to the development of bulliform cells, such as phosphoinositide phospholipase C, Mgll gene, and At4g26790 gene. The "omics"-level techniques were useful for simultaneously isolating several proteins and genes related to rice leaf rolling. In addition, the results of the analysis of differentially expressed proteins and genes were closely consistent with those from a corresponding functional analysis of cellular mechanisms; our study findings might form the basis for further research on the molecular mechanisms underlying rice leaf rolling.	[Zhu, Qiuqiang; Chen, Guanshui; Ke, Lanlan; Pan, Daren] Fujian Agr & Forest Univ, Dept Life Sci, Fuzhou, Fujian, Peoples R China; [Yu, Shuguang] Qingdao Agr Univ, Coll Chem & Pharmaceut Sci, Qingdao, Peoples R China	Fujian Agriculture & Forestry University; Qingdao Agricultural University	Pan, DR (corresponding author), Fujian Agr & Forest Univ, Dept Life Sci, Fuzhou, Fujian, Peoples R China.	qq9884318@163.com	ke, lan/AFP-9825-2022		Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China [2008zx08009-003]	Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China	This work was supported by the Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China (2008zx08009-003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZhangLiu, 2001, Journal of South China Agricultural University, V22, P88; DUNCAN WG, 1971, CROP SCI, V11, P482, DOI 10.2135/cropsci1971.0011183X001100040006x; Fang LK, 2012, PLANT BIOTECHNOL J, V10, P524, DOI 10.1111/j.1467-7652.2012.00679.x; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Li L, 2010, MOL PLANT, V3, P807, DOI 10.1093/mp/ssq022; Luo ZK, 2007, GENOME, V50, P811, DOI 10.1139/G07-064; Shi ZY, 2007, PLANTA, V226, P99, DOI 10.1007/s00425-006-0472-0; Wu RH, 2011, PLANT CELL, V23, P3392, DOI 10.1105/tpc.111.088625; Xiang JJ, 2012, PLANT PHYSIOL, V159, P1488, DOI 10.1104/pp.112.199968; Xu Y, 2014, PLANTA, V239, P803, DOI 10.1007/s00425-013-2009-7; Yan S, 2008, PLANT MOL BIOL, V68, P239, DOI 10.1007/s11103-008-9365-x; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Zhang GH, 2009, PLANT CELL, V21, P719, DOI 10.1105/tpc.108.061457; Zhang JJ, 2015, PLANT BIOLOGY, V17, P437, DOI 10.1111/plb.12255; Zou LP, 2011, PLANT PHYSIOL, V156, P1589, DOI 10.1104/pp.111.176016	15	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181378	10.1371/journal.pone.0181378	http://dx.doi.org/10.1371/journal.pone.0181378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723953	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800047
J	Chen, ZY; Yao, Y				Chen, Zhen-Yan; Yao, Ying			A synergistic negative effect of gestational smoke-exposure and small litter size on rat placental efficiency, vascularisation and angiogenic factors mRNA expression	PLOS ONE			English	Article							FACTOR-RECEPTOR SYSTEM; CIGARETTE-SMOKE; PREGNANCY; VASCULATURE; MOTHERS; MORPHOLOGY; HYPOXIA; RISK; PIGS	Smoking increases the risk of pregnancy complications such as spontaneous abortion and low birth weight (LBW). By cigarette smoke exposure (gestational day, GD3-17), normal-litter-size pregnancy with low birth weight (NP-LBW) and small-litter-size pregnancy with normal birth weight (SP-NBW) in rats were induced. The placental weight in SP-NBW was twice the weight of the normal in contrast with the smaller placenta in NP-LBW. Compared with the normal, placental efficiency (expressed as fetus-to-placenta weight ratio) and placental vascularisation were significantly decreased in smoke exposed placentas with more obvious decrease in SP-NBW. For NP-LBW, decreased placental vascularisation was due to decreased labyrinth vascularisation which was caused by both decreased number density and diameter of fetal capillary. For SP-NBW, decreased placental vascularisation was due to reduced proportion of labyrinth in placenta and decreased labyrinth vascularisation which was caused by decreased fetal capillary number density. Real time RT-PCR analysis showed a tendency for decreased placental mRNA level of vascular endothelial growth factor (VEGF), angiopoietin-1 (Ang1) and tyrosine kinase receptor-2 (Tie2) in NP-LBW(P<0.1), and the tendency became obvious in SP-NBW(P<0.05). A tendency for decreased placental mRNA level of fms-like tyrosine kinase-1(Flt1) and angiopoietin-2 (Ang2) was also observed in SP-LBW(P<0.1). Our data demonstrated the synergistic negative effect of gestational smoke-exposure and small litter size on placental efficiency, placental vascularisation and placental angiogenic growth factor mRNA expression in rat.	[Chen, Zhen-Yan; Yao, Ying] Huazhong Univ Sci & Technol, Dept Nutr, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Yao, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Nutr, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	244454698@qq.com			National Natural Science Foundation of China [81300592]; Scientific Research Foundation of Health Department of Hubei Province [WJ2015MB011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Health Department of Hubei Province	This study was supported by the grants funded by National Natural Science Foundation of China (81300592) and general Program in Scientific Research Foundation of Health Department of Hubei Province (WJ2015MB011).nil_	Akpak YK, 2016, J MATERN FETAL NEONA, V1-6; Benedict MD, 2011, HUM REPROD, V26, P2525, DOI 10.1093/humrep/der226; BURTON GJ, 1989, BRIT J OBSTET GYNAEC, V96, P907, DOI 10.1111/j.1471-0528.1989.tb03344.x; Bush PG, 2000, PLACENTA, V21, P247, DOI 10.1053/plac.1999.0470; Chen ZY, 2013, J HUAZHONG U SCI-MED, V33, P293, DOI 10.1007/s11596-013-1114-y; Detmar J, 2008, AM J PHYSIOL-ENDOC M, V295, pE519, DOI 10.1152/ajpendo.90436.2008; Esposito ER, 2008, TOXICOLOGY, V246, P193, DOI 10.1016/j.tox.2008.01.014; Genbacev O, 2003, REPROD TOXICOL, V17, P509, DOI 10.1016/S0890-6238(03)00094-7; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; JAUNIAUX E, 1992, OBSTET GYNECOL, V79, P645; Jeyabalan A, 2008, AM J HYPERTENS, V21, P943, DOI 10.1038/ajh.2008.219; Kamarainen M, 2009, MOL CELL ENDOCRINOL, V299, P261, DOI 10.1016/j.mce.2008.11.028; Kawashima A, 2014, PLOS ONE, V28; Larsen LG, 2002, AM J OBSTET GYNECOL, V186, P531, DOI 10.1067/mob.2002.120481; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Michaud SE, 2003, FASEB J, V17, P1150, DOI 10.1096/fj.02-0172fje; NAEYE RL, 1978, BRIT J OBSTET GYNAEC, V85, P732, DOI 10.1111/j.1471-0528.1978.tb15593.x; Ness RB, 1999, NEW ENGL J MED, V340, P333, DOI 10.1056/NEJM199902043400501; Pfarrer C, 1999, LANCET, V354, P303, DOI 10.1016/S0140-6736(99)01676-1; Rizzo G, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.041; Shinjo A, 2014, FETAL DIAGN THER, V35, P289, DOI 10.1159/000357704; TACHI N, 1989, B ENVIRON CONTAM TOX, V43, P467, DOI 10.1007/BF01701884; Talbot P, 2011, BIOL RES, V44, P189, DOI /S0716-97602011000200011; TEASDALE F, 1989, BIOL NEONATE, V55, P251; van Oppenraaij RHF, 2012, PLACENTA, V33, P645, DOI 10.1016/j.placenta.2012.05.007; VANDERVELDE WJ, 1983, PLACENTA, V4, P231, DOI 10.1016/S0143-4004(83)80002-2; Vonnahme KA, 2004, BIOL REPROD, V71, P163, DOI 10.1095/biolreprod.103.026344; Vonnahme KA, 2004, J PHYSIOL-LONDON, V554, P194, DOI 10.1113/jphysiol.2003.055061; Vonnahme KA, 2008, ENDOCRINE, V33, P53, DOI 10.1007/s12020-008-9052-3; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Wang N, 2014, PLACENTA, V35, P437, DOI 10.1016/j.placenta.2014.04.006	32	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181348	10.1371/journal.pone.0181348	http://dx.doi.org/10.1371/journal.pone.0181348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719646	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400041
J	Bedubourg, G; Le Strat, Y				Bedubourg, Gabriel; Le Strat, Yann			Evaluation and comparison of statistical methods for early temporal detection of outbreaks: A simulation-based study	PLOS ONE			English	Article							ABERRATION DETECTION METHODS; PUBLIC-HEALTH SURVEILLANCE; SYNDROMIC SURVEILLANCE; ALGORITHM; SYSTEM; MODEL	The objective of this paper is to evaluate a panel of statistical algorithms for temporal outbreak detection. Based on a large dataset of simulated weekly surveillance time series, we performed a systematic assessment of 21 statistical algorithms, 19 implemented in the R package surveillance and two other methods. We estimated false positive rate (FPR), probability of detection (POD), probability of detection during the first week, sensitivity, specificity, negative and positive predictive values and F-1-measure for each detection method. Then, to identify the factors associated with these performance measures, we ran multivariate Poisson regression models adjusted for the characteristics of the simulated time series (trend, seasonality, dispersion, outbreak sizes, etc.). The FPR ranged from 0.7% to 59.9% and the POD from 43.3% to 88.7%. Some methods had a very high specificity, up to 99.4%, but a low sensitivity. Methods with a high sensitivity (up to 79.5%) had a low specificity. All methods had a high negative predictive value, over 94%, while positive predictive values ranged from 6.5% to 68.4%. Multivariate Poisson regression models showed that performance measures were strongly influenced by the characteristics of time series. Past or current outbreak size and duration strongly influenced detection performances.	[Bedubourg, Gabriel] French Armed Forces Ctr Epidemiol & Publ Hlth, CESPA, Marseille, France; [Bedubourg, Gabriel] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France; [Le Strat, Yann] French Natl Publ Hlth Agcy, Sante Publ France, F-94415 St Maurice, France; [Bedubourg, Gabriel] GSBDD Marseille Aubagne, CESPA, 111 Ave Corse,BP 40026, F-13568 Marseille, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institute of Public Health Surveillance	Bedubourg, G (corresponding author), French Armed Forces Ctr Epidemiol & Publ Hlth, CESPA, Marseille, France.; Bedubourg, G (corresponding author), Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France.; Bedubourg, G (corresponding author), GSBDD Marseille Aubagne, CESPA, 111 Ave Corse,BP 40026, F-13568 Marseille, France.	gabrielbedubourg@hotmail.fr		Bedubourg, Gabriel/0000-0002-8182-898X				Barboza P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090536; Buckeridge DL, 2007, J BIOMED INFORM, V40, P370, DOI 10.1016/j.jbi.2006.09.003; Buckeridge David L, 2008, AMIA Annu Symp Proc, P76; Buehler James W, 2004, MMWR Recomm Rep, V53, P1; Burkom Howard S, 2005, MMWR Suppl, V54, P55; Caserio-Schonemann C, 2015, EUROSURVEILLANCE, V20, P35, DOI 10.2807/1560-7917.ES2015.20.19.21126; Centers for Disease Control and Prevention (CDC), 2004, MMWR Suppl, V53, P1; Choi BY, 2010, COMPUTATION STAT, V25, P603, DOI 10.1007/s00180-010-0191-7; Cowling B J, 2013, Hong Kong Med J, V19 Suppl 4, P4; Danan C, 2011, EPIDEMIOL INFECT, V139, P736, DOI 10.1017/S0950268810001469; Enki DG, 2013, EMERG INFECT DIS, V19, P35, DOI 10.3201/eid1901.120493; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Fienberg SE, 2005, STAT MED, V24, P513, DOI 10.1002/sim.2032; Fricker RD, 2008, STAT MED, V27, P3407, DOI 10.1002/sim.3197; Frisen M, 2009, STAT MED, V28, P476, DOI 10.1002/sim.3483; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; Guillou A, 2014, STAT MED, V33, P5015, DOI 10.1002/sim.6275; Hohle M, 2008, COMPUT STAT DATA AN, V52, P4357, DOI 10.1016/j.csda.2008.02.015; Hohle M, 2007, COMPUTATION STAT, V22, P571, DOI 10.1007/s00180-007-0074-8; Hohle M, 2006, POISSON REGRESSION C, P500; Hohle M, 2015, SURVEILLANCE TEMPORA; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Hulth A, 2010, EURO SURVEILLANCE B, V15; Hutwagner L, 2005, EMERG INFECT DIS, V11, P314, DOI 10.3201/eid1102.040587; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; Hutwagner LC, 2005, STAT MED, V24, P543, DOI 10.1002/sim.2034; Jiang Xia, 2009, AMIA Annu Symp Proc, V2009, P281; Kleinman KP, 2006, STAT METHODS MED RES, V15, P445, DOI 10.1177/0962280206071641; Lotze T, 2007, SIMULATING MULTIVARI; Meynard JB, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-29; Noufaily A, 2013, STAT MED, V32, P1206, DOI 10.1002/sim.5595; Rolfhamre P, 2006, EPIDEMIOL INFECT, V134, P863, DOI 10.1017/S095026880500573X; Rossi G, 1999, STAT MED, V18, P2111, DOI 10.1002/(SICI)1097-0258(19990830)18:16<2111::AID-SIM171>3.3.CO;2-H; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Salmon M, 2016, EUROSURVEILLANCE, V21, P47, DOI 10.2807/1560-7917.ES.2016.21.13.30180; Salmon M, 2015, BIOMETRICAL J, V57, P1051, DOI 10.1002/bimj.201400159; Shmueli G, 2010, TECHNOMETRICS, V52, P39, DOI 10.1198/TECH.2010.06134; STROUP DF, 1989, STAT MED, V8, P323, DOI 10.1002/sim.4780080312; STROUP DF, 1993, AM J EPIDEMIOL, V137, P373, DOI 10.1093/oxfordjournals.aje.a116684; Unkel S, 2012, J R STAT SOC A STAT, V175, P49, DOI 10.1111/j.1467-985X.2011.00714.x; Wagner M M, 2001, J Public Health Manag Pract, V7, P51; Wang XL, 2010, J BIOMED INFORM, V43, P97, DOI 10.1016/j.jbi.2009.08.003; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	45	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181227	10.1371/journal.pone.0181227	http://dx.doi.org/10.1371/journal.pone.0181227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715489	Green Submitted, gold, Green Published			2022-12-27	WOS:000443975500038
J	Park, S				Park, SangWook			Index extraction for electromagnetic field evaluation of high power wireless charging system	PLOS ONE			English	Article							ELECTRIC-FIELD; BODY	This paper presents the precise dosimetry for highly resonant wireless power transfer (HRWPT) system using an anatomically realistic human voxel model. The dosimetry for the HRWPT system designed to operate at 13.56 MHz frequency, which one of the ISM band frequency band, is conducted in the various distances between the human model and the system, and in the condition of alignment and misalignment between transmitting and receiving circuits. The specific absorption rates in the human body are computed by the two-step approach; in the first step, the field generated by the HR-WPT system is calculated and in the second step the specific absorption rates are computed with the scattered field finite-difference time-domain method regarding the fields obtained in the first step as the incident fields. The safety compliance for non-uniform field exposure from the HR-WPT system is discussed with the international safety guidelines. Furthermore, the coupling factor concept is employed to relax the maximum allowable transmitting power. Coupling factors derived from the dosimetry results are presented. In this calculation, the external magnetic field from the HR-WPT system can be relaxed by approximately four times using coupling factor in the worst exposure scenario.	[Park, SangWook] Korea Automot Technol Inst, Reliabil & Safety R&D Div, EMI EMC R&D Ctr, Cheonan, South Korea		Park, S (corresponding author), Korea Automot Technol Inst, Reliabil & Safety R&D Div, EMI EMC R&D Ctr, Cheonan, South Korea.	parksw@katech.re.kr			Ministry of Trade, Industry and Energy of Korea [10052912]	Ministry of Trade, Industry and Energy of Korea	This work was supported by a grant Development of Induction/magnetic resonance type 6.6kW, 90% EV Wireless Charger (No. 10052912) from the Ministry of Trade, Industry and Energy of Korea, http://english.motie.go.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, IEC62311; [Anonymous], 2006, C9512005 IEEE, V2005; Choi B, 2004, IEEE T IND ELECTRON, V51, P140, DOI 10.1109/TIE.2003.822039; Elliott GAJ, 2006, IEEE T MAGN, V42, P3389, DOI 10.1109/TMAG.2006.879619; Gabriel C, 1996, REPORT NO 21; GREEN AW, 1994, IEE CONF PUBL, P694; Herbertz J, 1998, HEALTH PHYS, V75, P535; Hui SYR, 2005, IEEE T POWER ELECTR, V20, P620, DOI 10.1109/TPEL.2005.846550; HURLEY WG, 1979, IEEE T MAGN, V15, P1174, DOI 10.1109/TMAG.1979.1145874; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Jang YT, 2003, IEEE T IND ELECTRON, V50, P520, DOI 10.1109/TIE.2003.812472; Kunz K. S., 1993, FINITE DIFFERENCE TI; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Laakso I, 2013, PHYS MED BIOL, V58, P7583, DOI 10.1088/0031-9155/58/21/7583; Nagaoka T, 2004, PHYS MED BIOL, V49, P1, DOI 10.1088/0031-9155/49/1/001; Park SW, 2013, IEEE T MICROW THEORY, V61, P3461, DOI 10.1109/TMTT.2013.2274053; Park SW, 2013, IEEE T MICROW THEORY, V61, P2153, DOI 10.1109/TMTT.2013.2247211; Park SW, 2015, J ELECTROMAGN ENG SC, V15, P129, DOI 10.5515/JKIEES.2015.15.3.129; Schuder J, 1961, I RADIO ENGRS INT CO	19	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180019	10.1371/journal.pone.0180019	http://dx.doi.org/10.1371/journal.pone.0180019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708840	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649800010
J	Pleasants, JM; Zalucki, MP; Oberhauser, KS; Brower, LP; Taylor, OR; Thogmartin, WE				Pleasants, John M.; Zalucki, Myron P.; Oberhauser, Karen S.; Brower, Lincoln P.; Taylor, Orley R.; Thogmartin, Wayne E.			Interpreting surveys to estimate the size of the monarch butterfly population: Pitfalls and prospects	PLOS ONE			English	Article							CYCLE	To assess the change in the size of the eastern North American monarch butterfly summer population, studies have used long-term data sets of counts of adult butterflies or eggs per milkweed stem. Despite the observed decline in the monarch population as measured at overwintering sites in Mexico, these studies found no decline in summer counts in the Midwest, the core of the summer breeding range, leading to a suggestion that the cause of the monarch population decline is not the loss of Midwest agricultural milkweeds but increased mortality during the fall migration. Using these counts to estimate population size, however, does not account for the shift of monarch activity from agricultural fields to non-agricultural sites over the past 20 years, as a result of the loss of agricultural milkweeds due to the nearubiquitous use of glyphosate herbicides. We present the counter-hypotheses that the proportion of the monarch population present in non-agricultural habitats, where counts are made, has increased and that counts reflect both population size and the proportion of the population observed. We use data on the historical change in the proportion of milkweeds, and thus monarch activity, in agricultural fields and non-agricultural habitats to show why using counts can produce misleading conclusions about population size. We then separate out the shifting proportion effect from the counts to estimate the population size and show that these corrected summer monarch counts show a decline over time and are correlated with the size of the overwintering population. In addition, we present evidence against the hypothesis of increased mortality during migration. The milkweed limitation hypothesis for monarch decline remains supported and conservation efforts focusing on adding milkweeds to the landscape in the summer breeding region have a sound scientific basis.	[Pleasants, John M.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Zalucki, Myron P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Oberhauser, Karen S.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Brower, Lincoln P.] Sweet Briar Coll, Sweet Briar, VA 24595 USA; [Taylor, Orley R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Thogmartin, Wayne E.] US Geol Survey, La Crosse, WI USA	Iowa State University; University of Queensland; University of Minnesota System; University of Minnesota Twin Cities; University of Kansas; United States Department of the Interior; United States Geological Survey	Pleasants, JM (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	jpleasan@iastate.edu	Zalucki, Myron P/G-7983-2012; Thogmartin, Wayne/A-4461-2008	Zalucki, Myron P/0000-0001-9603-7577; Thogmartin, Wayne/0000-0002-2384-4279; Pleasants, John/0000-0003-4076-4710				[Anonymous], 2017, N AM BUTTERFLY MONIT; [Anonymous], 2021, LANG ENV STAT COMP; Davis AK, 2015, ANN ENTOMOL SOC AM, V108, P661, DOI 10.1093/aesa/sav070; Dyer LA, 2016, ANN ENTOMOL SOC AM, V109, P172, DOI 10.1093/aesa/sav160; Flockhart DTT, 2017, GLOBAL CHANGE BIOL, V23, P2565, DOI 10.1111/gcb.13589; Flockhart DTT, 2015, J ANIM ECOL, V84, P155, DOI 10.1111/1365-2656.12253; Hartzler RG, 2000, CROP PROT, V19, P363, DOI 10.1016/S0261-2194(00)00024-7; Hartzler RG, 2010, CROP PROT, V29, P1542, DOI 10.1016/j.cropro.2010.07.018; Inamine H, 2016, OIKOS, V125, P1081, DOI 10.1111/oik.03196; Kasten K, 2016, J INSECT CONSERV, V20, P1047, DOI 10.1007/s10841-016-9938-y; Lark TJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/044003; MALCOLM SB, 1993, NAT HIS LOS-SERIES, P253; Nail KR, 2015, ANN ENTOMOL SOC AM, V108, P680, DOI 10.1093/aesa/sav047; Oberhauser K, 2017, ECOL ENTOMOL, V42, P51, DOI 10.1111/een.12351; Pleasants JM., 2015, MONARCHS CHANGING WO, P169; Pleasants J, 2017, INSECT CONSERV DIVER, V10, P42, DOI 10.1111/icad.12198; Pleasants JM, 2016, ANN ENTOMOL SOC AM, V109, P169, DOI 10.1093/aesa/sav115; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Rendon-Salinas E, 2015, FOREST SURFACE OCCUP; Ries L., 2015, MONARCHS CHANGING WO, P268; Ries L, 2015, ANN ENTOMOL SOC AM, V108, P691, DOI 10.1093/aesa/sav055; Saunders SP, 2016, GLOBAL ECOL BIOGEOGR, V25, P1000, DOI 10.1111/geb.12461; Saunders SP, 2017, ECOGRAPHY, V40; Stenoien C., 2016, INSECT SCI; Stenoien C, 2015, ANN ENTOMOL SOC AM, V108, P670, DOI 10.1093/aesa/sav054; Taylor OR., STATUS POPULATION; Thogmartin WE, 2017, PEERJ, V5, DOI 10.7717/peerj.3221; U. S. Department of Agriculture Farm Service Agency, 2014, CONS RES PROGR STAT; U.S. Department of Agriculture (USDA), 2021, PROF STAND DAT; United States Department of Agriculture Economic Research Service, 2012, MAJ LAND US; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Zalucki MP, 2016, AUSTRAL ECOL, V41, P154, DOI 10.1111/aec.12285; ZALUCKI MP, 1982, BEHAVIOUR, V80, P174, DOI 10.1163/156853982X00346; Zalucki MP., 1993, SCI SERIES NATURAL H, V38, P40; ZALUCKI MP, 1985, J LEPID SOC, V38, P209; Zalucki MP, 2010, ECOL ENTOMOL, V35, P84, DOI 10.1111/j.1365-2311.2009.01160.x; Zaya DN, 2017, BIOSCIENCE, V67, P342, DOI 10.1093/biosci/biw186	37	46	46	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181245	10.1371/journal.pone.0181245	http://dx.doi.org/10.1371/journal.pone.0181245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708851	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649800051
J	Reavis, RD; Ebbs, JB; Onunkwo, AK; Sage, LM				Reavis, Rachael D.; Ebbs, Jacob B.; Onunkwo, Adaobi K.; Sage, L. Mariah			A self-affirmation exercise does not improve intentions to vaccinate among parents with negative vaccine attitudes (and may decrease intentions to vaccinate)	PLOS ONE			English	Article							IMMUNIZATION; MESSAGES; CHILDREN; DISEASES; REFUSAL; ONLINE; SAFETY; RISK	Two studies investigated the effectiveness of a self-affirmation exercise on vaccine safety beliefs and intent to vaccinate future children. In Study 1, a sample of 585 parents with at least one child under the age of 18 in the home participated through Amazon's MTurk. Participants were randomly assigned to one of four conditions in a 2 x 2 design. Participants read either correcting information refuting a link between the measles, mumps, and rubella (MMR) vaccine and autism or a control passage about bird feeding. Additionally, participants either completed a self-affirmation exercise where they reflected on their personal values or in a control condition in which they reflected on least-personally-important values that might be important to others. Participants exposed to the correcting information were less likely to believe that vaccines cause serious side effects, but no less likely to believe that the MMR vaccine causes autism. For parents with initially positive vaccine attitudes, there was no effect of condition on intent to vaccinate a future child. For parents with initially negative vaccine attitudes, self-affirmation was ineffective in the presence of correcting information and resulted in less intention to vaccinate in the absence of correcting information. This effect was partially replicated in Study 2 (N = 576), which provided no correcting information but otherwise followed the same procedure as Study 1.	[Reavis, Rachael D.; Ebbs, Jacob B.; Onunkwo, Adaobi K.; Sage, L. Mariah] Earlham Coll, Dept Psychol, Richmond, IN 47374 USA	Earlham College	Reavis, RD (corresponding author), Earlham Coll, Dept Psychol, Richmond, IN 47374 USA.	reavira@earlham.edu						[Anonymous], 2011, BRIT MED J, V342, P64; Baumeister RF, 2007, PERSPECT PSYCHOL SCI, V2, P396, DOI 10.1111/j.1745-6916.2007.00051.x; Bond L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-943; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; California Department of Public Health, SCHOOL IMMUNIZATIONS; Centers for Disease Control, 2011, NATIONAL STATE AND L; Centers for Disease Control, MEASLES CASES AND OU; Centers for Disease Control, 2017 RECOMMENDED IMM; DiBello AM, 2015, ADDICT BEHAV, V41, P87, DOI 10.1016/j.addbeh.2014.09.026; Epton T, 2008, HEALTH PSYCHOL, V27, P746, DOI 10.1037/0278-6133.27.6.746; Federal Drug Administration, BIOTECHNOLOGY QUESTI; Freed GL, 2010, PEDIATRICS, V125, P654, DOI 10.1542/peds.2009-1962; Griffin DW, 2011, PSYCHOL SCI, V22, P572, DOI 10.1177/0956797611405678; Halsey NA, 2015, ANN INTERN MED, V162, P655, DOI 10.7326/M15-0447; Harris PR, 2007, HEALTH PSYCHOL, V26, P437, DOI 10.1037/0278-6133.26.4.437; Harris PR, 2014, HEALTH PSYCHOL, V33, P729, DOI 10.1037/hea0000065; Hobson KA, 2012, WORLD MED HEALTH POL, V4, DOI 10.1515/1948-4682.5; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Leask J, 2017, MMR DECISION AID; Lieu TA, 2015, PEDIATRICS; Maglione MA, 2014, PEDIATRICS, V134, P325, DOI 10.1542/peds.2014-1079; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Ruedl G, 2012, INJURY PREV, V18, P182, DOI 10.1136/injuryprev-2011-040042; Sadaf A, 2013, VACCINE, V31, P4293, DOI 10.1016/j.vaccine.2013.07.013; SCHAFFER SJ, 1995, ARCH PEDIAT ADOL MED, V149, P792, DOI 10.1001/archpedi.1995.02170200082013; Sherman DAK, 2000, PERS SOC PSYCHOL B, V26, P1046, DOI 10.1177/01461672002611003; Sherman DK, 2009, J PERS SOC PSYCHOL, V97, P745, DOI 10.1037/a0015451; Siddiqui M, 2013, HUM VACC IMMUNOTHER, V9, P2643, DOI 10.4161/hv.27243; Smith PJ, 2011, PUBLIC HEALTH REP, V126, P135, DOI 10.1177/00333549111260S215; Steele CM, 1988, ADV EXPT SOCIAL PSYC, P261, DOI DOI 10.1016/S0065-2601(08)60229-4; Taylor LE, 2014, VACCINE, V32, P3623, DOI 10.1016/j.vaccine.2014.04.085; van Koningsbruggen GM, 2009, HEALTH PSYCHOL, V28, P563, DOI 10.1037/a0015610; van Koningsbruggen GM, 2009, PSYCHOL HEALTH, V24, P635, DOI 10.1080/08870440802340156; van Panhuis WG, 2013, NEW ENGL J MED, V369, P2152, DOI 10.1056/NEJMms1215400; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wallace C, 2006, BMJ-BRIT MED J, V332, P146, DOI 10.1136/bmj.38678.681840.68; WHO, 2009, WEEKLY EPIDEMIOLOGIC; Wolfe RM, 2002, BMJ-BRIT MED J, V325, P430, DOI 10.1136/bmj.325.7361.430; Zhou FJ, 2014, PEDIATRICS, V133, P577, DOI 10.1542/peds.2013-0698	39	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							0181368e	10.1371/journal.pone.0181368	http://dx.doi.org/10.1371/journal.pone.0181368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704520	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700129
J	Richards, CD; Warr, CG; Burke, R				Richards, Christopher D.; Warr, Coral G.; Burke, Richard			A role for the Drosophila zinc transporter Zip88E in protecting against dietary zinc toxicity	PLOS ONE			English	Article							MEMBRANE ANDROGEN RECEPTORS; IDENTIFICATION; REVEALS; ZIP9; ABSORPTION; EXPRESSION; DEFICIENCY; PHENOTYPES; MECHANISM; MIDGUT	Zinc absorption in animals is thought to be regulated in a local, cell autonomous manner with intestinal cells responding to dietary zinc content. The Drosophila zinc transporter Zip88E shows strong sequence similarity to Zips 42C. 1, 42C. 2 and 89B as well as mammalian Zips 1, 2 and 3, suggesting that it may act in concert with the apically-localised Drosophila zinc uptake transporters to facilitate dietary zinc absorption by importing ions into the midgut enterocytes. However, the functional characterisation of Zip88E presented here indicates that Zip88E may instead play a role in detecting and responding to zinc toxicity. Larvae homozygous for a null Zip88E allele are viable yet display heightened sensitivity to elevated levels of dietary zinc. This decreased zinc tolerance is accompanied by an overall decrease in Metallothionein B transcription throughout the larval midgut. A Zip88E reporter gene is expressed only in the salivary glands, a handful of enteroendocrine cells at the boundary between the anterior and middle midgut regions, and in two parallel strips of sensory cell projections connecting to the larval ventral ganglion. Zip88E expression solely in this restricted subset of cells is sufficient to rescue the Zip88E mutant phenotype. Together, our data suggest that Zip88E may be functioning in a small subset of cells to detect excessive zinc levels and induce a systemic response to reduce dietary zinc absorption and hence protect against toxicity.	[Richards, Christopher D.; Warr, Coral G.; Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Monash University	Burke, R (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	richard.burke@monash.edu		Warr, Coral/0000-0002-5289-3950; Richards, Christopher/0000-0001-5208-8428; Burke, Richard/0000-0003-0086-0767	National Health and Medical Research Council, Australia [606609]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grant (ID# 606609) funding for RB from the National Health and Medical Research Council, Australia.	Afshar N, 2013, FEBS OPEN BIO, V3, P302, DOI 10.1016/j.fob.2013.07.003; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Berg AH, 2014, ENDOCRINOLOGY, V155, P4237, DOI 10.1210/en.2014-1198; Bulldan A, 2016, CELL SIGNAL, V28, P1075, DOI 10.1016/j.cellsig.2016.04.015; Dechen KS, 2015, INT J BIOCHEM CELL B, V60, P23, DOI 10.1016/j.biocel.2014.12.017; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Kambe T, 2008, AM J PHYSIOL-REG I, V294, pR1474, DOI 10.1152/ajpregu.00130.2008; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lye JC, 2012, J EXP BIOL, V215, P3254, DOI 10.1242/jeb.069260; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Peters JL, 2007, GENESIS, V45, P339, DOI 10.1002/dvg.20297; Qin QH, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-101; Richards CD, 2015, INT J BIOCHEM CELL B, V69, P11, DOI 10.1016/j.biocel.2015.10.004; Shihan M, 2015, CELL SIGNAL, V27, P2077, DOI 10.1016/j.cellsig.2015.07.013; Thomas P, 2017, MOL CELLULAR ENDOCRI; Thomas P, 2014, ENDOCRINOLOGY, V155, P4250, DOI 10.1210/en.2014-1201; Vanderveken M, 2014, ARCH INSECT BIOCHEM, V85, P76, DOI 10.1002/arch.21144; Veenstra JA, 2009, CELL TISSUE RES, V336, P309, DOI 10.1007/s00441-009-0769-y; Wang XX, 2009, FASEB J, V23, P2650, DOI 10.1096/fj.08-126649; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606	24	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181237	10.1371/journal.pone.0181237	http://dx.doi.org/10.1371/journal.pone.0181237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704512	Green Published, gold, Green Accepted			2022-12-27	WOS:000405649700114
J	Kasanke, CP; Leigh, MB				Kasanke, Christopher P.; Leigh, Mary Beth			Factors limiting sulfolane biodegradation in contaminated subarctic aquifer substrate	PLOS ONE			English	Article							NATURAL-GAS PLANT; GROUNDWATER SAMPLES; BACTERIA; SOIL; MINERALIZATION; OXIDATION; SEDIMENTS; CARBON; POPS; IRON	Sulfolane, a water-soluble organosulfur compound, is used industrially worldwide and is associated with one of the largest contaminated groundwater plumes in the state of Alaska. Despite being widely used, little is understood about the degradation of sulfolane in the environment, especially in cold regions. We conducted aerobic and anaerobic microcosm studies to assess the biological and abiotic sulfolane degradation potential of contaminated subarctic aquifer groundwater and sediment from Interior Alaska. We also investigated the impacts of nutrient limitations and hydrocarbon co-contamination on sulfolane degradation. We found that sulfolane underwent biodegradation aerobically but not anaerobically under nitrate, sulfate, or iron-reducing conditions. No abiotic degradation activity was detectable under either oxic or anoxic conditions. Nutrient addition stimulated sulfolane biodegradation in sediment slurries at high sulfolane concentrations (100 mg L-1), but not at low sulfolane concentrations (500 mu g L-1), and nutrient amendments were necessary to stimulate sulfolane biodegradation in incubations containing groundwater only. Hydrocarbon co-contamination retarded aerobic sulfolane biodegradation rates by similar to 30%. Our study is the first to investigate the sulfolane biodegradation potential of subarctic aquifer substrate and identifies several important factors limiting biodegradation rates. We concluded that oxygen is an important factor limiting natural attenuation of this sulfolane plume, and that nutrient amendments are unlikely to accelerate biodegradation within in the plume, although they may biostimulate degradation in ex situ groundwater treatment applications. Future work should be directed at elucidating the identity of indigenous sulfolane-degrading microorganisms and determining their distribution and potential activity in the environment.	[Kasanke, Christopher P.; Leigh, Mary Beth] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Kasanke, CP (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.	cpkasanke@alaska.edu			Alaska Department of Environmental Conservation; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103395]	Alaska Department of Environmental Conservation; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health	This project was funded by the Alaska Department of Environmental Conservation. Additional support was provided in the form of a graduate research fellowship to C.P.K. and a pilot awardto M.B.L. through an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103395. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatonovic V., 2005, SULFOLANE IMPACTED S; Alfreider A, 1997, WATER RES, V31, P832, DOI 10.1016/S0043-1354(96)00311-9; Angermann B, 2013, TECHNICAL MEMORANDUM; [Anonymous], 2017, 2017 REV ONS CLEAN P; ARCADIS U. S. Inc, 2014, 4 QUART 2013 GROUNDW; Augustin JC, 2000, APPL ENVIRON MICROB, V66, P1706, DOI 10.1128/AEM.66.4.1706-1710.2000; Beyer A, 2014, ELSEV INSIGHT, P557, DOI 10.1016/B978-0-12-800021-2.00025-X; Breivik K, 2004, ENVIRON POLLUT, V128, P3, DOI 10.1016/j.envpol.2003.08.031; Chou C., 1982, P 37 IND WAST C PURD, P559; Einsiedl F, 2015, GEOCHIM COSMOCHIM AC, V156, P207, DOI 10.1016/j.gca.2015.01.014; Fedorak PM, 1996, ENVIRON TECHNOL, V17, P1093, DOI 10.1080/09593331708616478; Flynn TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-146; FREDRICKSON AG, 1981, SCIENCE, V213, P972, DOI 10.1126/science.7268409; Gieg LM, 1999, CAN J MICROBIOL, V45, P377, DOI 10.1139/cjm-45-5-377; Gouin T, 2000, ENVIRON SCI TECHNOL, V34, P881, DOI 10.1021/es991011z; Greene EA, 1998, WATER RES, V32, P3680, DOI 10.1016/S0043-1354(98)00139-0; Greene EA, 2001, ENVIRON TECHNOL, V22, P619, DOI 10.1080/09593332208618246; Greene EA, 1998, J MICROBIOL METH, V33, P255, DOI 10.1016/S0167-7012(98)00059-1; Greene EA, 2000, ARCH MICROBIOL, V174, P111, DOI 10.1007/s002030000184; Hamade A., 2014, ALASKA DEP ENV CONSE; Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6; Kaiser E.-A., 1994, BODENK, V157, P271; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Kim CG, 1999, ENVIRON ENG RES, V4, P185; Laidler K J, 1979, Methods Enzymol, V63, P234; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McLeod D.W., 1991, P 46 IND WAST C, P99; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; MOSES CO, 1991, GEOCHIM COSMOCHIM AC, V55, P471, DOI 10.1016/0016-7037(91)90005-P; Passman F., 2003, FUEL FUEL SYSTEM MIC; Petersen D, 2012, PROVISIONAL PEER REV; Renewable Natural Resources Foundation, 2006, RENEW RESOUR J, V24, P1; Soto LM, 1998, J CHROMATOGR A, V824, P45, DOI 10.1016/S0021-9673(98)00583-4; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; The R Foundation for Statistical Computing, 2015, R VERS 3 2 1 WORLD F; Thompson CM, 2013, J APPL TOXICOL, V33, P1395, DOI 10.1002/jat.2799; Tindal M, 2006, CANADIAN ENV QUALITY; Valentin L., 2013, HDB ENV CHEM, P1, DOI DOI 10.1007/698_2012_208; van Breukelen BM, 2004, J CONTAM HYDROL, V73, P181, DOI 10.1016/j.jconhyd.2004.01.001; Waldrop MP, 2004, OECOLOGIA, V138, P275, DOI 10.1007/s00442-003-1419-9	42	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181462	10.1371/journal.pone.0181462	http://dx.doi.org/10.1371/journal.pone.0181462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727811	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500077
J	van Otterdijk, SD; Binder, AM; Szic, KSV; Schwald, J; Michels, KB				van Otterdijk, Sanne D.; Binder, Alexandra M.; Szic, Katarzyna Szarc Vel; Schwald, Julia; Michels, Karin B.			DNA methylation of candidate genes in peripheral blood from patients with type 2 diabetes or the metabolic syndrome	PLOS ONE			English	Article							CAUSES INSULIN-RESISTANCE; EPIGENETIC REGULATION; PANCREATIC-ISLETS; EXPRESSION; CANCER; MUSCLE; HYPERMETHYLATION; SUSCEPTIBILITY; INFLAMMATION; DYSFUNCTION	Introduction The prevalence of type 2 diabetes (T2D) and the metabolic syndrome (MetS) is increasing and several studies suggested an involvement of DNA methylation in the development of these metabolic diseases. This study was designed to investigate if differential DNA methylation in blood can function as a biomarker for T2D and/or MetS. Methods Pyrosequencing analyses were performed for the candidate genes KCNJ11, PPAR., PDK4, KCNQ1, SCD1, PDX1, FTO and PEG3 in peripheral blood leukocytes (PBLs) from 25 patients diagnosed with only T2D, 9 patients diagnosed with T2D and MetS and 11 control subjects without any metabolic disorders. Results No significant differences in gene-specific methylation between patients and controls were observed, although a trend towards significance was observed for PEG3. Differential methylation was observed between the groups in 4 out of the 42 single CpG loci located in the promoters regions of the genes FTO, KCNJ11, PPAR. and PDK4. A trend towards a positive correlation was observed for PEG3 methylation with HDL cholesterol levels. Discussion Altered levels of DNA methylation in PBLs of specific loci might serve as a biomarker for T2D or MetS, although further investigation is required.	[van Otterdijk, Sanne D.; Szic, Katarzyna Szarc Vel; Schwald, Julia; Michels, Karin B.] Univ Med Ctr Freiburg, Inst Prevent & Canc Epidemiol, Freiburg, Germany; [van Otterdijk, Sanne D.; Szic, Katarzyna Szarc Vel] German Canc Consortium DKTK, Freiburg, Germany; [van Otterdijk, Sanne D.; Szic, Katarzyna Szarc Vel] German Canc Res Ctr, Heidelberg, Germany; [Binder, Alexandra M.; Michels, Karin B.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Michels, Karin B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA	University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michels, KB (corresponding author), Univ Med Ctr Freiburg, Inst Prevent & Canc Epidemiol, Freiburg, Germany.; Michels, KB (corresponding author), Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Michels, KB (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA.	k.michels@ucla.edu			German Cancer consortium (DKTK); German Cancer Research Center (DKFZ)	German Cancer consortium (DKTK); German Cancer Research Center (DKFZ)(Helmholtz Association)	SvO and KSvS were supported by the German Cancer consortium (DKTK) and German Cancer Research Center (DKFZ) institutional funding.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Arner P, 2016, DIABETOLOGIA, V59, P2393, DOI 10.1007/s00125-016-4074-5; Bacos K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11089; Bal A, 2012, VIRCHOWS ARCH, V461, P305, DOI 10.1007/s00428-012-1286-z; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Crepin M, 2012, HUM MUTAT, V33, P180, DOI 10.1002/humu.21617; Dave A V, MUTAGENESIS, V30, P411; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Janssen BG, 2014, PLACENTA, V35, P665, DOI 10.1016/j.placenta.2014.06.371; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014; Leclerc D, 2013, CANCER PREV RES, V6, P1171, DOI 10.1158/1940-6207.CAPR-13-0198; Li J, 2016, J DIABETES RES, V2016, DOI DOI 10.1155/2016/5957404; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Liu LM, 2013, DIABETOLOGIA, V56, P2609, DOI 10.1007/s00125-013-3031-9; Liu XQ, 2011, ADV NUTR, V2, P15, DOI 10.3945/an.110.000125; Loke YJ, 2013, TWIN RES HUM GENET, V16, P13, DOI 10.1017/thg.2012.114; Martin-Nunez GM, 2014, MOL NUTR FOOD RES, V58, P1528, DOI 10.1002/mnfr.201400079; Mckay JA, 2011, ACTA PHYSIOL, V202, P103, DOI 10.1111/j.1748-1716.2011.02278.x; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Petersen AK, 2014, HUM MOL GENET, V23, P534, DOI 10.1093/hmg/ddt430; Phillips T., 2008, NAT ED, V1, P116; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Remely M, 2014, GENE, V537, P85, DOI 10.1016/j.gene.2013.11.081; Reyes S, 2009, HUM GENET, V126, P779, DOI 10.1007/s00439-009-0731-9; Ribel-Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051302; Steyn NP, 2004, PUBLIC HEALTH NUTR, V7, P147, DOI 10.1079/PHN2003586; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Toperoff G, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0069-1; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; van Otterdijk SD, 2013, BIOCHEM SOC T, V41, P803, DOI 10.1042/BST20120358; VanderJagt TA, 2015, WORLD J DIABETES, V6, P1113, DOI 10.4239/wjd.v6.i9.1113; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Wheeler JMD, 2000, J MED GENET, V37, P588, DOI 10.1136/jmg.37.8.588; Wren JD, 2005, J BIOMED BIOTECHNOL, P104, DOI 10.1155/JBB.2005.104; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhang S, 2014, PIVOTAL ROLE PYRUVAT, V12, P10; Zhang Y, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-9; Zou L, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/721493	50	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180955	10.1371/journal.pone.0180955	http://dx.doi.org/10.1371/journal.pone.0180955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727822	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500034
J	Yao, X; Liu, SQ				Yao, Xiang; Liu, Shiqing			In vitro study of accuracy of subaxial cervical pedicle screw insertion using calipers based on the gravity line	PLOS ONE			English	Article							VERTEBRAL ARTERY INJURY; SPINE SURGERY; CT-SCAN; PLACEMENT; FIXATION; SYSTEM	Object There is a high probability of iatrogenic perforation of the vertebral pedicle wall during the application of subaxial cervical pedicle screw (CPS). The goal of this study was to evaluate the accuracy of CPS insertion at C3-C7 in vitro using novel calipers based on the gravity line. Methods Nine cadaveric cervical spines underwent computed tomography scanning and preoperative design. A lateral fluoroscopic view was taken to measure the intra-operative sagittal angle by C-arm with hanging cross structured K-wires. By referring to the gravity line, caliper A was used to locate the entry point, while caliper B was employed to guide the screw insertion. Postoperative CT scans were performed to assess the accuracy of the screw placements, according to the Neo classification. Results Overall, 78 (88.6%) of the 88 pedicle screw placements were classified as grade 0 (correct position), 4 (4.5%) were grade 1 (non-critical perforation), 4 (4.5%) were grade 2 (critical perforation), and 2 (2.3%) were grade 3 (critical perforation). Conclusions Using our novel calipers and referring to the gravity line was helpful for locating and guiding individual cervical pedicle screw insertions.	[Yao, Xiang; Liu, Shiqing] Wuhan Univ, Renmin Hosp, Dept Orthoped, Wuhan, Hubei, Peoples R China	Wuhan University	Liu, SQ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Orthoped, Wuhan, Hubei, Peoples R China.	liushiqingwuhan@163.com		Yao, Xiang/0000-0003-0813-4591				Abumi K, 2000, SPINE, V25, P962, DOI 10.1097/00007632-200004150-00011; ABUMI K, 1994, J SPINAL DISORD, V7, P19, DOI 10.1097/00002517-199407010-00003; Abumi K, 2012, SPINE, V37, pE349, DOI 10.1097/BRS.0b013e318239cf1f; Chanplakorn P, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-125; Cong Yu, 2015, Med Sci Monit, V21, P2672, DOI 10.12659/MSM.894074; Gupta R, 2013, SURG RADIOL ANAT, V35, P181, DOI 10.1007/s00276-012-1013-0; Jo DJ, 2012, J KOREAN NEUROSURG S, V52, P459, DOI 10.3340/jkns.2012.52.5.459; Kaneyama S, 2015, SPINE, V40, pE341, DOI 10.1097/BRS.0000000000000772; Kantelhardt SR, 2010, ACTA NEUROCHIR, V152, P655, DOI 10.1007/s00701-009-0447-6; Karaikovic EE, 2000, J SPINAL DISORD, V13, P63, DOI 10.1097/00002517-200002000-00013; Kostrzewski S, 2012, INT J MED ROBOT COMP, V8, P184, DOI 10.1002/rcs.446; Kotani T, 2014, ASIAN SPINE J, V8, P331, DOI 10.4184/asj.2014.8.3.331; Lee DH, 2011, EUR SPINE J, V20, P905, DOI 10.1007/s00586-010-1655-8; Ludwig SC, 1999, CLIN ORTHOP RELAT R, P77; Ludwig SC, 2000, SPINE, V25, P1655, DOI 10.1097/00007632-200007010-00009; Mao GP, 2005, SPINE, V30, P1045, DOI 10.1097/01.brs.0000161011.08086.5b; Morishita K, 2008, MED SCI MONITOR, V14, pCR62; Neo M, 2005, SPINE, V30, P2800, DOI 10.1097/01.brs.0000192297.07709.5d; Neo M, 2008, SPINE, V33, P779, DOI 10.1097/BRS.0b013e31816957a7; Park JH, 2014, SPINE, V39, P280, DOI 10.1097/BRS.0000000000000133; Rahmathulla G, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13516; Rao RD, 2008, J BONE JOINT SURG AM, V90A, P1914, DOI 10.2106/JBJS.G.01166; Reinhold M, 2007, EUR SPINE J, V16, P47, DOI 10.1007/s00586-006-0104-1; Schaefer C, 2011, EUR SPINE J, V20, P977, DOI 10.1007/s00586-011-1775-9; Tian W, 2013, EUR SPINE J, V22, P148, DOI 10.1007/s00586-012-2494-6; Tofuku K, 2012, EUR SPINE J, V21, P353, DOI 10.1007/s00586-011-1969-1; Yoshimoto H, 2009, EUR SPINE J, V18, P1326, DOI 10.1007/s00586-009-1109-3; Yukawa Y, 2009, EUR SPINE J, V18, P1293, DOI 10.1007/s00586-009-1032-7; Zheng XJ, 2010, EUR SPINE J, V19, P105, DOI 10.1007/s00586-009-1213-4	29	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181324	10.1371/journal.pone.0181324	http://dx.doi.org/10.1371/journal.pone.0181324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727778	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500058
J	Cations, M; Withall, A; Horsfall, R; Denham, N; White, F; Trollor, J; Loy, C; Brodaty, H; Sachdev, P; Gonski, P; Demirkol, A; Cumming, RG; Draper, B				Cations, Monica; Withall, Adrienne; Horsfall, Ruth; Denham, Nicole; White, Fiona; Trollor, Julian; Loy, Clement; Brodaty, Henry; Sachdev, Perminder; Gonski, Peter; Demirkol, Apo; Cumming, Robert G.; Draper, Brian			Why aren't people with young onset dementia and their supporters using formal services? Results from the INSPIRED study	PLOS ONE			English	Article							INFORMAL CARE; EXPERIENCES; CAREGIVERS; BURDEN; ALZHEIMERS; NEEDS; DISABILITY; FAMILIES; PARTNER; VERSION	Background/Aims Despite reporting high levels of burden, supporters of people with young onset dementia (YOD) underuse formal community services. Previous quantitative studies in YOD are of limited utility in guiding service design because they did not consider important contextual barriers to service use. The aim of this study was to identify all relevant barriers and describe the service features considered most important to improving uptake by people with YOD and their supporters. Methods Eighty-six people with consensus-confirmed YOD (mean onset age 55.3 years) and/or their primary supporter participated in quantitative interviews, and 50 also participated in one of seven qualitative focus groups. Interview participants reported levels of community service use and reasons for non-use, functional impairment, behavioural and psychological symptoms, supporter burden, social network, and informal care provision. Focus group participants expanded on reasons for non-use and aspects of an ideal service. Results Although at least one community service was recommended to most participants (96.8%), 66.7% chose not to use one or more of these. Few of the clinical or demographic factors included here were related to service use. Qualitative analyses identified that lack of perceived need, availability, and YOD-specific barriers (including ineligibility, unaffordability, lack of security, lack of childcare) were commonly reported. Five aspects of an ideal service were noted: unique, flexibile, affordable, tailored, and promoting meaningful engagement. Conclusion People with YOD and their families report that formal community services do not meet their personal and psychological needs. Researchers can provide ongoing assessment of program feasibility, suitability, and generalisability.	[Cations, Monica; Withall, Adrienne; Horsfall, Ruth; Gonski, Peter; Demirkol, Apo] UNSW Australia, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Cations, Monica; Denham, Nicole; White, Fiona; Brodaty, Henry; Sachdev, Perminder; Draper, Brian] UNSW Australia, Sch Psychiat, Dementia Collaborat Res Ctr Assessment & Better C, Sydney, NSW, Australia; [Trollor, Julian; Brodaty, Henry; Sachdev, Perminder] UNSW Australia, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Trollor, Julian] UNSW Australia, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia; [Loy, Clement] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Brodaty, Henry] Prince Wales Hosp, Acad Dept Old Age Psychiat, Randwick, NSW, Australia; [Sachdev, Perminder] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW, Australia; [Gonski, Peter] South Eastern Sydney Local Hlth Dist, Sutherland Hosp, Div Aged & Extended Care Southcare, Sydney, NSW, Australia; [Demirkol, Apo] South Eastern Sydney Local Hlth Dist, Langton Ctr, Drug & Alcohol Serv, Surry Hills, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Cations, M (corresponding author), UNSW Australia, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.; Cations, M (corresponding author), UNSW Australia, Sch Psychiat, Dementia Collaborat Res Ctr Assessment & Better C, Sydney, NSW, Australia.	m.cations@unsw.edu.au	Cumming, Robert G/R-1548-2016; Withall, Adrienne/AAI-3943-2021; Cations, Monica/L-9663-2018; Demirkol, Apo/AAC-4329-2020; Demirkol, Apo/AAI-9933-2020; Sachdev, Perminder/ABC-1137-2020	Cumming, Robert G/0000-0002-0261-6103; Withall, Adrienne/0000-0001-7079-465X; Cations, Monica/0000-0002-9262-0463; Demirkol, Apo/0000-0002-7937-7948; Sachdev, Perminder/0000-0002-9595-3220; Horsfall, Ruth/0000-0002-6230-6940	National Health and Medical Research Council [1008267]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council (1008267) (https://www.nhmrc.gov.au/) as received by AW and BD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Bakker C, 2013, AM J GERIAT PSYCHIAT, V21, P37, DOI 10.1016/j.jagp.2012.10.004; Beattie AM, 2002, AGING MENT HEALTH, V6, P205, DOI 10.1080/13607860220142396; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Bender D E, 1994, Health Transit Rev, V4, P63; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brodaty H, 2005, INT J GERIATR PSYCH, V20, P537, DOI 10.1002/gps.1322; Brown A., 2010, DEMENTIA-LONDON, V9, P451, DOI DOI 10.1177/1471301210381778; Castleberry A, 2012, NVIVO 10 SOFTWARE P; Craig D, 2016, AUSTRALAS J AGEING, V35, P48, DOI 10.1111/ajag.12264; Draper B, 2016, INT J GERIATR PSYCH, V31, P1217, DOI 10.1002/gps.4430; Ducharme F, 2016, AM J ALZHEIMERS DIS, V31, P48, DOI 10.1177/1533317515578255; Freyne A, 1999, INT J GERIATR PSYCH, V14, P784, DOI 10.1002/(SICI)1099-1166(199909)14:9<784::AID-GPS16>3.0.CO;2-2; Gaugler JE, 2005, GERONTOLOGIST, V45, P177, DOI 10.1093/geront/45.2.177; Gaugler JE, 2003, INT PSYCHOGERIATR, V15, P37, DOI 10.1017/S1041610203008743; Gibson AK, 2014, AM J ALZHEIMERS DIS, V29, P596, DOI 10.1177/1533317514558160; Higginson IJ, 2010, J CLIN EPIDEMIOL, V63, P535, DOI 10.1016/j.jclinepi.2009.06.014; Husband HJ, 1999, PSYCHIAT B, V23, P94; IBM Corp, 2013, IBM VERS WIND SOFTW; Jubb Dennis, 2003, Nurs Times, V99, P34; Kaiser Sam, 2006, Am J Alzheimers Dis Other Demen, V21, P398; Kurz A, 2016, INT PSYCHOGERIATR, V28, P2091, DOI 10.1017/S1041610216001186; Laver K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010767; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lockeridge S, 2013, DEMENTIA-LONDON, V12, P635, DOI 10.1177/1471301212440873; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Luciano JV, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-45; Millenaar JK, 2016, INT J GERIATR PSYCH, V31, P1261, DOI 10.1002/gps.4502; NEWENS AJ, 1995, BRIT J PSYCHIAT, V166, P777, DOI 10.1192/bjp.166.6.777; Pozzebon M, 2016, INT PSYCHOGERIATR, V28, P537, DOI 10.1017/S1041610215002239; Prince M., 2016, WORLD ALZHEIMER REPO; Prorok JC, 2013, CAN MED ASSOC J, V185, pE669, DOI 10.1503/cmaj.121795; Roach P, 2016, J AGING STUD, V36, P26, DOI 10.1016/j.jaging.2015.12.001; Roach P, 2008, REV CLIN GERONTOL, V18, P165, DOI 10.1017/S0959259809002779; Robertson J, 2013, DEMENTIA-LONDON, V12, P666, DOI 10.1177/1471301212473881; Rosness TA, 2011, AGING MENT HEALTH, V15, P299, DOI 10.1080/13607861003713224; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Sousa RM, 2010, INT J METH PSYCH RES, V19, P1, DOI 10.1002/mpr.299; SPERLINGER D, 1994, INT J GERIATR PSYCH, V9, P47, DOI 10.1002/gps.930090110; Sussman T, 2009, HEALTH SOC WORK, V34, P29, DOI 10.1093/hsw/34.1.29; Swaffer K., 2015, REHABILITATION DEMEN; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Wear Helen J., 2008, Dement. neuropsychol., V2, P102, DOI 10.1590/S1980-57642009DN20200005; Westera, 2014, YOUNGER ONSET DEMENT; Williams T., 2001, PSYCHIATR BULL, V25, P384, DOI [https://doi.org/10.1192/pb.25.10.384, DOI 10.1192/PB.25.10.384, 10.1192/pb.25.10.384]; Wimo A, 2010, J NUTR HEALTH AGING, V14, P685, DOI 10.1007/s12603-010-0316-2; Wimo A, 2003, BRAIN AGING, V3, P47	47	58	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180935	10.1371/journal.pone.0180935	http://dx.doi.org/10.1371/journal.pone.0180935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723931	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800032
J	Gallmetzer, I; Haselmair, A; Tomasovych, A; Stachowitsch, M; Zuschin, M				Gallmetzer, Ivo; Haselmair, Alexandra; Tomasovych, Adam; Stachowitsch, Michael; Zuschin, Martin			Responses of molluscan communities to centuries of human impact in the northern Adriatic Sea	PLOS ONE			English	Article							GULF-OF-TRIESTE; AMPHIURA-FILIFORMIS; INTEGRATED APPROACH; SPECIES COMPOSITION; SEDIMENT TRANSPORT; BENTHIC MACROFAUNA; HYPOXIC TOLERANCE; DEATH ASSEMBLAGES; OXYGEN DEFICIENCY; LEVEL CHANGES	In sediment cores spanning similar to 500 years of history in the Gulf of Trieste, down-core changes in molluscan community structure are characterized by marked shifts in species and functional composition. Between the 16th and 19th century, a strong heavy metal contamination of the sediments, most notably by Hg, together with the effects of natural climatic oscillations (increased sedimentation and organic enrichment) drive community changes. Since the early 20th century up to 2013, the combined impacts of cultural eutrophication, frequent hypoxic events and intensifying bottom trawling replace heavy metal contamination and climatic factors as the main drivers. The pollution-tolerant and opportunistic bivalve Corbula gibba and the scavenging gastropod Nassarius pygmaeus significantly increase in abundance during the 20 th century, while species more sensitive to disturbances and hypoxia such as Turritella communis and Kurtiella bidentata become rare or absent. An infaunal life habit and scavenging emerge as the dominant life strategies during the late 20 th century. Down-core shifts in the proportional abundances of molluscan species and functional groups represent a sensitive proxy for past ecological changes and reveal a century-long anthropogenic impact as the main driver behind these processes in the northern Adriatic Sea, offering also a unique perspective for other shallow marine ecosystems worldwide.	[Gallmetzer, Ivo; Haselmair, Alexandra; Zuschin, Martin] Univ Vienna, Dept Palaeontol, Vienna, Austria; [Tomasovych, Adam] Slovak Acad Sci, Geol Inst, Bratislava, Slovakia; [Stachowitsch, Michael] Univ Vienna, Dept Limnol & Biooceanog, Ctr Ecol, Vienna, Austria	University of Vienna; Slovak Academy of Sciences; University of Vienna	Gallmetzer, I (corresponding author), Univ Vienna, Dept Palaeontol, Vienna, Austria.	ivo.gallmetzer@univie.ac.at	Zuschin, Martin/M-9951-2016; Tomasovych, Adam/C-9623-2010	Zuschin, Martin/0000-0002-5235-0198; Tomasovych, Adam/0000-0002-0471-9480	Austrian Science Fund (FWF) [P24901]; Austrian Science Fund (FWF) [P 24901] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF), grant number P24901.; The Austrian Science Fund (FWF) supported this study under grant number P24901.	Acquavita A, 2012, ESTUAR COAST SHELF S, V113, P20, DOI 10.1016/j.ecss.2012.02.012; Albano PG, INVASION SUCCESS MAR; Allen AP, 2013, QUAT GEOCHRONOL, V18, P63, DOI 10.1016/j.quageo.2013.06.003; BARMAWIDJAJA DM, 1995, MAR GEOL, V122, P367, DOI 10.1016/0025-3227(94)00121-Z; Bellan-Santini D., 1985, NATO Conference Series I Ecology, V8, P19; Bevilacqua E., 1996, PORTO MONFALCONE STO; Boening DW, 1999, ENVIRON MONIT ASSESS, V55, P459, DOI 10.1023/A:1005995217901; Boldrin A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004837; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; BRAMBATI A, 1992, OLSEN INT S, P327; Brambati A, 2013, J GEOPHYS RES-OCEANS, V118, P6183; BRYAN GW, 1992, ENVIRON POLLUT, V76, P89, DOI 10.1016/0269-7491(92)90099-V; Car J., 2005, IDRIJSKI RAZGLEDI, V50, P80; Cibic T, 2008, MAR POLLUT BULL, V56, P1650, DOI 10.1016/j.marpolbul.2008.05.009; Cibic T, 2007, ESTUAR COAST SHELF S, V75, P50, DOI 10.1016/j.ecss.2007.01.020; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Comici C, 2007, B GEOFIS TEOR APPL, V48, P435; Covelli S, 2001, APPL GEOCHEM, V16, P541, DOI 10.1016/S0883-2927(00)00042-1; Covelli S, 2006, MAR GEOL, V230, P29, DOI 10.1016/j.margeo.2006.03.013; Covelli S, 2012, ESTUAR COAST SHELF S, V113, P7, DOI 10.1016/j.ecss.2011.12.038; Cozzi S, 2011, CONT SHELF RES, V31, P1881, DOI 10.1016/j.csr.2011.08.010; Danovaro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007006; De Biasi AM, 1999, IMPACT TRAWL FISHING, P61; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Djakovac T, 2015, J MARINE SYST, V141, P179, DOI 10.1016/j.jmarsys.2014.08.001; DUINEVELD GCA, 1986, NETH J SEA RES, V20, P85, DOI 10.1016/0077-7579(86)90064-5; Edgar GJ, 2004, CONSERV BIOL, V18, P1579, DOI 10.1111/j.1523-1739.2004.00191.x; Faber G. L., 1883, FISHERIES ADRIATIC F; FAGANELI J, 1985, MAR POLLUT BULL, V16, P75, DOI 10.1016/0025-326X(85)90127-4; Faivre S, 2013, PALAEOGEOGR PALAEOCL, V369, P163, DOI 10.1016/j.palaeo.2012.10.016; Fonda Umani S., 1989, EPISODI MARE SPORCO; FORTIBUONI T., 2009, THESIS; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; FRANCESCHINI G, 1999, IMPACT TRAWL FISHING, P49; Franzo A, 2016, CONT SHELF RES, V121, P35, DOI 10.1016/j.csr.2015.12.005; Gallmetzer I, 2016, LIMNOL OCEANOGR-METH, V14, P698, DOI 10.1002/lom3.10124; GAMULIN-BRIDA H, 1974, Acta Adriatica, V15, P1; Gelinas M, 2013, J COASTAL RES, V29, P8, DOI 10.2112/JCOASTRES-D-11-00213.1; Giani M, 2012, ESTUAR COAST SHELF S, V115, P1, DOI 10.1016/j.ecss.2012.08.023; Gosar M, 2012, ENV INFLUENCES MERCU; Gosar M, 2015, J GEOCHEM EXPLOR, V149, P97, DOI 10.1016/j.gexplo.2014.11.012; Heath E, 2006, WATER AIR SOIL POLL, V6, P241; Holm P, 2012, GLOB ENVIRON, V5, P66; Holmes SP, 2002, J MAR BIOL ASSOC UK, V82, P971, DOI 10.1017/S0025315402006471; Horvat M, 1999, SCI TOTAL ENVIRON, V238, P43, DOI 10.1016/S0048-9697(99)00123-0; ICRAM, 2005, MUC NELL ADR NEL TIR; JOSEFSON AB, 1992, OLSEN INT S, P21; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Justic Dubravko, 1991, Geological Society Special Publication, V58, P95, DOI 10.1144/GSL.SP.1991.058.01.07; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Karlson K, 2002, OCEANOGR MAR BIOL, V40, P427; Kidwell SM, 2002, GEOLOGY, V30, P803, DOI 10.1130/0091-7613(2002)030<0803:TAMDAP>2.0.CO;2; Kidwell SM, 2015, P NATL ACAD SCI USA, V112, P4922, DOI 10.1073/pnas.1403660112; Kidwell SM, 2013, PALAEONTOLOGY, V56, P487, DOI 10.1111/pala.12042; Kowalewski M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2990; Krisch A, 1900, FISCHEREI ADRIATISCH; Langston William J., 1998, Chapman & Hall Ecotoxicology Series, V7, P219; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; MCGREER ER, 1982, MAR ENVIRON RES, V7, P131, DOI 10.1016/0141-1136(82)90038-1; MCGREER ER, 1979, MAR POLLUT BULL, V10, P259, DOI 10.1016/0025-326X(79)90482-X; Miklavcic V, 1999, MERCURY CONTAMINATED, P259; Mlakar L, 1974, IDRIJSKA RAZGLEDI, V3, P1; MURAKAMI SHIRO, 1963, TRANS ROY SOC NEW ZEALAND, V4, P1; Nerlovic V, 2012, FRESEN ENVIRON BULL, V21, P3600; Nerlovic V, 2011, BIOLOGIA, V66, P1114, DOI 10.2478/s11756-011-0121-3; OCKELMANN KW, 1978, OPHELIA, V17, P1; OGORELEC B, 1991, MAR GEOL, V99, P79, DOI 10.1016/0025-3227(91)90084-H; Oldfield F, 2003, QUATERNARY SCI REV, V22, P319, DOI 10.1016/S0277-3791(02)00088-4; Olsgard Frode, 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P25, DOI 10.1023/A:1009967313147; Orel G., 1987, Bulletin d'Ecologie, V18, P229; Orel G, 1969, Pubbl. Staz. Zool. Napoli, V37, P261; Orel G., 1989, BIOCENOSI BENTONICHE, P59; Orel G, 2005, PROPOSTE PIANO PLURI; Perco F, 2006, FOCE ISONZO LISOLA C; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; Piva A, 2008, HOLOCENE, V18, P153, DOI 10.1177/0959683607085606; Poulos SE, 2002, GEOL SOC SPEC PUBL, V191, P227, DOI 10.1144/GSL.SP.2002.191.01.16; Pozo K, 2009, MAR POLLUT BULL, V58, P773, DOI 10.1016/j.marpolbul.2009.03.003; Prevedelli D, 2001, J MAR BIOL ASSOC UK, V81, P897, DOI 10.1017/S0025315401004817; Ramakritinan CM, 2012, INDIAN J GEO-MAR SCI, V41, P141; Rampazzo F, 2013, ESTUAR COAST SHELF S, V129, P49, DOI 10.1016/j.ecss.2013.06.001; Riedel B, 2014, BIOGEOSCIENCES, V11, P1491, DOI 10.5194/bg-11-1491-2014; Riedel B, 2012, MAR ECOL PROG SER, V458, P39, DOI 10.3354/meps09724; Rinaldi A., 1992, BIOLOGIA MARINA SUPP, V1, P79; ROSENBERG R, 1991, MAR ECOL PROG SER, V79, P127, DOI 10.3354/meps079127; Rueda JL, 2009, J MAR BIOL ASSOC UK, V89, P1319, DOI 10.1017/S0025315409000289; RYGG B, 1985, MAR ECOL PROG SER, V25, P83, DOI 10.3354/meps025083; Sangiorgi F, 2004, ESTUAR COAST SHELF S, V60, P69, DOI 10.1016/j.ecss.2003.12.001; Scarponi D, 2013, GEOLOGY, V41, P239, DOI 10.1130/G33849.1; Singh N, 2009, MAR POLLUT BULL, V58, P559, DOI 10.1016/j.marpolbul.2008.11.014; Smolar-Zvanut N, 2014, HYDROLOG SCI J, V59, P1032, DOI 10.1080/02626667.2013.834339; Solis-Weiss Vivianne, 2007, Annales Series Historia Naturalis, V17, P1; STACHOWITSCH M, 1984, PSZNI MAR ECOL, V5, P243, DOI 10.1111/j.1439-0485.1984.tb00124.x; Stachowitsch Michael, 1991, Geological Society Special Publication, V58, P119, DOI 10.1144/GSL.SP.1991.058.01.09; STEPHENSON RR, 1975, B ENVIRON CONTAM TOX, V14, P304, DOI 10.1007/BF01685641; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thurstan RH, 2013, J NAT CONSERV, V21, P253, DOI 10.1016/j.jnc.2013.01.004; Tillin HM, 2006, MAR ECOL PROG SER, V318, P31, DOI 10.3354/meps318031; Tomasovych A, 2017, GEOLOGY; Tsujimoto A, 2006, MAR MICROPALEONTOL, V60, P258, DOI 10.1016/j.marmicro.2006.06.001; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Vacchi M, 2016, EARTH-SCI REV, V155, P172, DOI 10.1016/j.earscirev.2016.02.002; Vatova A., 1949, Nova Thalassia Venezia, V1, P1; Vidovic J, 2016, BIOGEOSCIENCES, V13, P5965, DOI 10.5194/bg-13-5965-2016; Vistisen B, 1997, MAR BIOL, V128, P241, DOI 10.1007/s002270050088; Wang XH, 2007, CONT SHELF RES, V27, P613, DOI 10.1016/j.csr.2006.10.008; Wang XH, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001303; Ward TJ, 1996, MAR ECOL PROG SER, V135, P123, DOI 10.3354/meps135123; Wittmer JM, 2014, J GEOL, V122, P649, DOI 10.1086/677901; Zuschin M, 1999, LETHAIA, V32, P299; Zuschin Martin, 1994, Beitraege zur Palaeontologie von Oesterreich, V18, P75; [No title captured]	116	26	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180820	10.1371/journal.pone.0180820	http://dx.doi.org/10.1371/journal.pone.0180820			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723935	Green Published, gold			2022-12-27	WOS:000406067800027
J	Ryser, S; Estelles, A; Tenorio, E; Kauvar, LM; Gishizky, ML				Ryser, Stefan; Estelles, Angeles; Tenorio, Edgar; Kauvar, Lawrence M.; Gishizky, Mikhail L.			High affinity anti-TIM-3 and anti-KIR monoclonal antibodies cloned from healthy human individuals	PLOS ONE			English	Article							CANCER-IMMUNOTHERAPY; IMMUNITY; RECEPTORS; INFECTION; DISCOVERY; BLOCKADE	We report here the cloning of native high affinity anti-TIM-3 and anti-KIR IgG monoclonal antibodies (mAbs) from peripheral blood mononuclear cells (PBMC) of healthy human donors. The cells that express these mAbs are rare, present at a frequency of less than one per 10(5) memory B-cells. Using our proprietary multiplexed screening and cloning technology CellSpot(TM) we assessed the presence of memory B-cells reactive to foreign and endogenous disease-associated antigens within the same individual. When comparing the frequencies of antigen-specific memory B-cells analyzed in over 20 screening campaigns, we found a strong correlation of the presence of anti-TIM-3 memory B-cells with memory B-cells expressing mAbs against three disease-associated antigens: (i) bacterial DNABII proteins that are a marker for Gram negative and Gram positive bacterial infections, (ii) hemagglutinin (HA) of influenza virus and (iii) the extracellular domain of anaplastic lymphoma kinase (ALK). One of the native anti-KIR mAbs has similar characteristics as lirilumab, an anti-KIR mAb derived from immunization of humanized transgenic mice that is in ongoing clinical trials. It is interesting to speculate that these native anti-TIM-3 and anti-KIR antibodies may function as natural regulatory antibodies, analogous to the pharmacological use in cancer treatment of engineered antibodies against the same targets. Further characterization studies are needed to define the mechanisms through which these native antibodies may function in healthy and disease conditions.	[Ryser, Stefan; Estelles, Angeles; Tenorio, Edgar; Kauvar, Lawrence M.; Gishizky, Mikhail L.] Trellis Biosci LLC, Menlo Pk, CA 94025 USA		Ryser, S; Gishizky, ML (corresponding author), Trellis Biosci LLC, Menlo Pk, CA 94025 USA.	sryser@trellisbio.com; mgishizky@trellisbio.com			Trellis Bioscience, LLC	Trellis Bioscience, LLC	This research was funded by Trellis Bioscience, LLC. The funder provided support in the form of salaries for authors [SR, AE, ET, LK, MG], but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beerli RR, 2010, MABS-AUSTIN, V2, P365, DOI 10.4161/mabs.12187; Byun DJ, 2017, NAT REV ENDOCRINOL, V13, P195, DOI 10.1038/nrendo.2016.205; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; Ceeraz S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0469-1; Collarini EJ, 2009, J IMMUNOL, V183, P6338, DOI 10.4049/jimmunol.0901373; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Estelles A, 2016, ANTIMICROB AGENTS CH, V60, P2292, DOI 10.1128/AAC.02588-15; Harriman WD, 2009, J IMMUNOL METHODS, V341, P135, DOI 10.1016/j.jim.2008.11.009; Huang YH, 2015, NATURE, V517, P386, DOI 10.1038/nature13848; Hutchins NIA, 2014, TRENDS MOL MED, V20, P224, DOI 10.1016/j.molmed.2014.01.002; Kauvar LM, 2015, ANTIMICROB AGENTS CH, V59, P1563, DOI 10.1128/AAC.04295-14; Lee L, 2016, J CLIN PHARMACOL, V56, DOI 10.1002/jcph.591; McCutcheon KM, 2014, MABS-AUSTIN, V6, P460, DOI 10.4161/mabs.27760; Moretta A, 2006, Antibodies binding to receptors KIR2DL1, -2, -3 but not KIR2DS4 and their therapeutic use (2006) PCT/EP 2005/053122, Patent No. 2005053122; Moretta A, 2006, Antibodies binding to receptors KIR2DL1, -2, -3 but not KIR2DS4 and their therapeutic use (2006) WO/2006/003179, Patent No. 2006003179; Murtaza A, 2016, EUR J CANCER, V69, pS102, DOI 10.1016/S0959-8049(16)32903-3; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Vey N, ASCO 2015; Yang DL, 2016, ANAL BIOCHEM, V508, P78, DOI 10.1016/j.ab.2016.06.024; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	22	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181464	10.1371/journal.pone.0181464	http://dx.doi.org/10.1371/journal.pone.0181464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723950	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800051
J	Wisniewski, MG; Radell, ML; Church, BA; Mercado, E				Wisniewski, Matthew G.; Radell, Milen L.; Church, Barbara A.; Mercado, Eduardo, III			Benefits of fading in perceptual learning are driven by more than dimensional attention	PLOS ONE			English	Article							ARTIFICIAL DIMENSION; CONNECTIONIST MODEL; TEMPORAL DYNAMICS; DISCRIMINATION; SPEECH; CATEGORIZATION; IDENTIFICATION; PLASTICITY; CONTINUUM; CORTEX	Individuals learn to classify percepts effectively when the task is initially easy and then gradually increases in difficulty. Some suggest that this is because easy-to-discriminate events help learners focus attention on discrimination-relevant dimensions. Here, we tested whether such attentional-spotlighting accounts are sufficient to explain easy-to-hard effects in auditory perceptual learning. In two experiments, participants were trained to discriminate periodic, frequency-modulated (FM) tones in two separate frequency ranges (300-600 Hz or 3000-6000 Hz). In one frequency range, sounds gradually increased in similarity as training progressed. In the other, stimulus similarity was constant throughout training. After training, participants showed better performance in their progressively trained frequency range, even though the discrimination-relevant dimension across ranges was the same. Learning theories that posit experience-dependent changes in stimulus representations and/or the strengthening of associations with differential responses, predict the observed specificity of easy-to-hard effects, whereas attentional-spotlighting theories do not. Calibrating the difficulty and temporal sequencing of training experiences to support more incremental representation-based learning can enhance the effectiveness of practice beyond any benefits gained from explicitly highlighting relevant dimensions.	[Wisniewski, Matthew G.] US Air Force, Res Lab, Human Performance Wing 711, Wright Patterson AFB, OH USA; [Radell, Milen L.] Niagara Univ, Dept Psychol, Lewiston, NY USA; [Church, Barbara A.] Georgia State Univ, Language Res Ctr, Dept Psychol, Atlanta, GA 30303 USA; [Mercado, Eduardo, III] SUNY Buffalo, Dept Psychol, Buffalo, NY USA	United States Department of Defense; United States Air Force; University System of Georgia; Georgia State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wisniewski, MG (corresponding author), US Air Force, Res Lab, Human Performance Wing 711, Wright Patterson AFB, OH USA.	mattg.wisniewski@gmail.com		Church, Barbara/0000-0002-1392-9121	NSF [SBE 0542013, SBE 0835976]; National Research Council Associateship Award; U.S. Air Force Research Laboratory; two NSF Science of Learning Centers	NSF(National Science Foundation (NSF)); National Research Council Associateship Award; U.S. Air Force Research Laboratory(United States Department of DefenseUS Air Force Research Laboratory); two NSF Science of Learning Centers	This work was supported in part by NSF Grants SBE 0542013 to the Temporal Dynamics of Learning Center and SBE 0835976 to CELEST, two NSF Science of Learning Centers. This research was performed while M.G.W. held a National Research Council Associateship Award and an Oak Ridge Institute for Science and Education fellowship at the U.S. Air Force Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ali Zakrzewski assisted in data collection. This research was performed while M.G.W. held a National Research Council Associateship Award and an Oak Ridge Institute for Science and Education fellowship at the U.S. Air Force Research Laboratory.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; BAKER RA, 1954, J EXP PSYCHOL, V48, P241, DOI 10.1037/h0059962; Bejjanki VR, 2011, NAT NEUROSCI, V14, P642, DOI 10.1038/nn.2796; Brungart DS, 2001, J ACOUST SOC AM, V110, P425, DOI 10.1121/1.1379730; Carvalho PF, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00505; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; Chandrasekaran B, 2016, ATTEN PERCEPT PSYCHO, V78, P566, DOI 10.3758/s13414-015-0999-x; Chukoskie L, 2013, P NATL ACAD SCI USA, V110, P10438, DOI 10.1073/pnas.1301216110; Church BA, 2013, J EXP PSYCHOL LEARN, V39, P270, DOI 10.1037/a0028647; Church BA, 2010, PSYCHON B REV, V17, P862, DOI 10.3758/PBR.17.6.862; Couperus JW, 2009, ATTEN PERCEPT PSYCHO, V71, P342, DOI 10.3758/APP.71.2.342; DEAL JJ, 1985, J RES MUSIC EDUC, V33, P159, DOI 10.2307/3344803; Sanjuan MD, 2014, LEARN BEHAV, V42, P209, DOI 10.3758/s13420-014-0139-9; Deveau J, 2014, CURR BIOL, V24, pR146, DOI 10.1016/j.cub.2014.01.004; Dinse HR, 2002, PERCEPTUAL LEARNING, P19; Enquist M., 2005, NEURAL NETWORKS ANIM; Faja S, 2008, DEV NEUROPSYCHOL, V33, P1, DOI 10.1080/87565640701729573; Folstein JR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01394; Folstein JR, 2013, CEREB CORTEX, V23, P814, DOI 10.1093/cercor/bhs067; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; GIBSON EJ, 1956, J COMP PHYSIOL PSYCH, V49, P239, DOI 10.1037/h0048274; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; Godde B, 2003, NEUROREPORT, V14, P543, DOI 10.1097/00001756-200303240-00002; GOLDSTONE R, 1994, J EXP PSYCHOL GEN, V123, P178, DOI 10.1037/0096-3445.123.2.178; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Guenther FH, 1999, J ACOUST SOC AM, V106, P2900, DOI 10.1121/1.428112; Hall G., 1991, PERCEPTUAL ASS LEARN; Hammer R, 2008, BRAIN RES, V1225, P102, DOI 10.1016/j.brainres.2008.04.079; Hammer R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00451; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Klemen J, 2011, ATTEN PERCEPT PSYCHO, V73, P2514, DOI 10.3758/s13414-011-0188-5; KRUSCHKE JK, 1992, PSYCHOL REV, V99, P22, DOI 10.1037/0033-295X.99.1.22; LAWRENCE DH, 1952, J COMP PHYSIOL PSYCH, V45, P511, DOI 10.1037/h0057135; Leclercq V, 2012, ATTEN PERCEPT PSYCHO, V74, P648, DOI 10.3758/s13414-012-0270-7; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; Liu EH, 2008, J COMP PSYCHOL, V122, P132, DOI 10.1037/0735-7036.122.2.132; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lu ZL, 2011, NEUROBIOL LEARN MEM, V95, P145, DOI 10.1016/j.nlm.2010.09.010; MACKINTOSH NJ, 1970, CAN J PSYCHOLOGY, V24, P362, DOI 10.1037/h0082872; Macmillan N. A., 1991, DETECTION THEORY USE; McLaren IPL, 2002, ANIM LEARN BEHAV, V30, P177, DOI 10.3758/BF03192828; McLaren IPL, 2002, ANIM LEARN BEH, V26, P211; McQueen JM, 2006, LANG SPEECH, V49, P101, DOI 10.1177/00238309060490010601; Mercado E, 2009, CURR DIR PSYCHOL SCI, V18, P153, DOI 10.1111/j.1467-8721.2009.01627.x; Mercado E, 2001, COGN AFFECT BEHAV NE, V1, P37, DOI 10.3758/CABN.1.1.37; Mercado III E, FRONT INTEG NEUROSCI, V9, P42; Mitchell C, 2014, PSYCHOL BULL, V140, P283, DOI 10.1037/a0032765; Moore DR, 2003, LEARN MEMORY, V10, P83, DOI 10.1101/lm.59703; NORTH AJ, 1959, J COMP PHYSIOL PSYCH, V52, P339, DOI 10.1037/h0045756; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Orduna I, 2012, CLIN NEUROPHYSIOL, V123, P711, DOI 10.1016/j.clinph.2011.08.019; Ortiz JA, 2010, EXP BRAIN RES, V201, P441, DOI 10.1007/s00221-009-2053-5; Pashler H, 2013, J EXP PSYCHOL LEARN, V39, P1162, DOI 10.1037/a0031679; Pavlov I.P., 1927, CONDITIONED REFLEXES; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Riley D.A., 1968, DISCRIMINATION LEARN; Roads B, 2015, PLOS ONE, V11; Sabin AT, 2012, J NEUROSCI, V32, P6542, DOI 10.1523/JNEUROSCI.5732-11.2012; Saksida LM, 1999, J EXP PSYCHOL ANIM B, V25, P308, DOI 10.1037/0097-7403.25.3.308; Saksida LM, 1999, THESIS; Scahill VL, 2004, J EXP PSYCHOL ANIM B, V30, P96, DOI 10.1037/0097-7403.30.2.96; Song JH, 2012, CEREB CORTEX, V22, P1180, DOI 10.1093/cercor/bhr196; Spiering BJ, 2008, PSYCHOL SCI, V19, P1169, DOI 10.1111/j.1467-9280.2008.02219.x; Su YL, 2014, J EXP PSYCHOL HUMAN, V40, P1415, DOI 10.1037/a0036337; Suret M, 2003, Q J EXP PSYCHOL-B, V56, P30, DOI 10.1080/02724990244000142; Suret M, 2002, IEEE IJCNN, P806, DOI 10.1109/IJCNN.2002.1005577; Sutherland NS., 1971, MECH ANIMAL DISCRIMI; Szpiro SFA, 2015, PSYCHOL SCI, V26, P1854, DOI 10.1177/0956797615598976; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; TRABASSO TR, 1963, J EXP PSYCHOL, V65, P398, DOI 10.1037/h0042620; Trappenberg T. P., 2002, FUNDAMENTALS COMPUTA; Tsushima Y, 2009, LEARN BEHAV, V37, P126, DOI 10.3758/LB.37.2.126; Wisniewski M, 2017, EXP BRAIN RES, V235, P1233, DOI 10.1007/s00221-016-4866-3; Wisniewski MG, 2015, NEUROREPORT, V26, P94, DOI 10.1097/WNR.0000000000000306; Wisniewski MG, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00396; Wisniewski MG, 2014, BEHAV PROCESS, V104, P26, DOI 10.1016/j.beproc.2014.01.007; Wisniewski MG, 2014, J ACOUST SOC AM, V135, pEL55, DOI 10.1121/1.4862886; Wisniewski MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041025; Wisniewski MG, 2010, PSYCHON B REV, V17, P809, DOI 10.3758/PBR.17.6.809; Wright BA, 2015, J ACOUST SOC AM, V138, P928, DOI 10.1121/1.4927411; Wright BA, 2010, J NEUROSCI, V30, P12868, DOI 10.1523/JNEUROSCI.0487-10.2010; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262	84	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180959	10.1371/journal.pone.0180959	http://dx.doi.org/10.1371/journal.pone.0180959			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723976	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800033
J	Holman, N; Weinfurter, JT; Harsla, TR; Wiseman, RW; Belli, AJ; Michaels, AJ; Reimann, KA; DeMars, RI; Reynolds, MR				Holman, Nathan; Weinfurter, Jason T.; Harsla, Trevor R.; Wiseman, Roger W.; Belli, Aaron J.; Michaels, Anthony J.; Reimann, Keith A.; DeMars, Robert I.; Reynolds, Matthew R.			Isolation of a monoclonal antibody from a phage display library binding the rhesus macaque MHC class I allomorph Mamu-A1*001	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CYTOTOXIC T-LYMPHOCYTES; ALLELE DISCOVERY; MOLECULE MAMU-A-ASTERISK-01; FULL-LENGTH; LONG-TERM; HLA; EPITOPES; CHIMERISM; CELLS	Monoclonal antibodies that bind to human leukocyte antigen (HLA) are useful tools for HLAtyping, tracking donor-recipient chimerisms after bone marrow transplants, and characterizing specific major histocompatibility complexes (MHC) on cell surfaces. Unfortunately, equivalent reagents are not available for rhesus macaques, which are commonly used animal as models in organ transplant and infectious disease research. To address this deficiency, we isolated an antibody that recognizes the common Indian rhesus macaque MHC class I molecule, Mamu-A1*001. We induced Mamu-A1*001-binding antibodies by alloimmunizing a female Mamu-A1*001-negative rhesus macaque with peripheral blood mononuclear cells (PBMC) from a male Mamu-A1*001-positive donor. A Fab phage display library was constructed with PBMC from the alloimmunized macaque and panned to isolate an antibody that binds to Mamu-A1*001 but not to other common rhesus macaque MHC class I molecules. The isolated antibody distinguishes PBMC from Mamu-A1*001-positive and -negative macaques. Additionally, the Mamu-A1*001-specific antibody binds the cynomolgus macaque MHC class I ortholog Mafa-A1*001: 01 but not variants Mafa-A1*001: 02/03, indicating a high degree of binding specificity. The Mamu-A1*001-specific antibody will be useful for identifying Mamu-A1*001-positive rhesus macaques, for detecting MamuA1*001-positive cells in populations of Mamu-A1*001-negative cells, and for examining disease processes that alter expression of Mamu-A1*001 on cell surfaces. Moreover, the alloimmunization process we describe will be useful for isolating additional MHC allomorphspecific monoclonal antibodies or antibodies against other polymorphic host proteins which are difficult to isolate with traditional technologies.	[Holman, Nathan; Weinfurter, Jason T.; Harsla, Trevor R.; DeMars, Robert I.; Reynolds, Matthew R.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Wiseman, Roger W.; Reynolds, Matthew R.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Belli, Aaron J.; Michaels, Anthony J.; Reimann, Keith A.] Univ Massachusetts, Med Sch, MassBiol, Boston, MA 02125 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Boston	Reynolds, MR (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.; Reynolds, MR (corresponding author), Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA.	mrreynol@wisc.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [HHSN272201600007C, HHSN272201100013C]; Research Facilities Improvement Program [RR15459-01, RR020141-01]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by contracts HHSN272201600007C and HHSN272201100013C from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, and was conducted at a facility constructed with support from the Research Facilities Improvement Program (RR15459-01, RR020141-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 1998, J IMMUNOL, V160, P6062; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Avril Arnaud, 2014, Curr Drug Discov Technol, V11, P20; Barbas C.F., 2004, PHAGE DISPLAY LAB MA; BATTEGAY M, 1995, J VIROL, V69, P2462, DOI 10.1128/JVI.69.4.2462-2470.1995; Budde ML, 2010, IMMUNOGENETICS, V62, P773, DOI 10.1007/s00251-010-0481-9; Cardarelli F, 2005, TRANSPLANT INT, V18, P532, DOI 10.1111/j.1432-2277.2005.00085.x; Choe W, 2016, ANN CLIN LAB SCI, V46, P161; Choo SY, 2007, YONSEI MED J; de Groot NG, 2012, IMMUNOGENETICS, V64, P615, DOI 10.1007/s00251-012-0617-1; DEVITO LD, 1993, HUM IMMUNOL, V37, P165, DOI 10.1016/0198-8859(93)90182-Z; Drabbels JJM, 2011, BLOOD, V118, pE149, DOI 10.1182/blood-2011-06-362053; Dudley DM, 2014, IMMUNOGENETICS, V66, P15, DOI 10.1007/s00251-013-0744-3; Duquesnoy RJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00469; Duquesnoy RJ, 2012, HUM IMMUNOL, V73, P267, DOI 10.1016/j.humimm.2011.11.011; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; El-Awar NR, 2007, TRANSPLANTATION, V84, P532, DOI 10.1097/01.tp.0000278721.97037.1e; Estep RD, 2013, CURR OPIN VIROL, V3, P245, DOI 10.1016/j.coviro.2013.05.016; Glaze ER, 2015, COMPARATIVE MED, V65, P241; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Karl JA, 2017, IMMUNOGENETICS, V69, P211, DOI 10.1007/s00251-017-0969-7; Kasper MR, 2003, J VIROL, V77, P3041, DOI 10.1128/JVI.77.5.3041-3049.2003; Kasuga Kie, 2013, Methods Mol Biol, V1023, P203, DOI 10.1007/978-1-4614-7209-4_14; Kean LS, 2007, AM J TRANSPLANT, V7, P320, DOI 10.1111/j.1600-6143.2006.01622.x; Kean LS, 2012, AM J TRANSPLANT, V12, P812, DOI 10.1111/j.1600-6143.2011.03873.x; Kim BH, 2014, BLOOD, V124; Kling C, 2006, HUM REPROD, V21, P429, DOI 10.1093/humrep/dei316; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; Kuwata T, 2011, AIDS RES HUM RETROV, V27, P487, DOI 10.1089/aid.2010.0191; Kwakkenbos MJ, 2016, IMMUNOL REV, V270, P65, DOI 10.1111/imr.12395; Larsen CP, 2010, AM J TRANSPLANT, V10, P2396, DOI 10.1111/j.1600-6143.2010.03272.x; Lau M, 2004, AM J TRANSPLANT, V4, P1543, DOI 10.1111/j.1600-6143.2004.00529.x; Leith JG, 2003, AIDS RES HUM RETROV, V19, P957, DOI 10.1089/088922203322588305; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; MOWBRAY JF, 1987, LANCET, V2, P679; Mudd PA, 2011, CURR OPIN HIV AIDS, V6, P197, DOI 10.1097/COH.0b013e3283453e16; PAYNE R, 1957, ARCH INTERN MED, V99, P587, DOI 10.1001/archinte.1957.00260040087010; PAYNE R, 1958, J CLIN INVEST, V37, P1756, DOI 10.1172/JCI103768; PISTILLO MP, 1988, HUM IMMUNOL, V21, P265, DOI 10.1016/0198-8859(88)90035-3; Pistillo MP, 1997, HUM IMMUNOL, V57, P19, DOI 10.1016/S0198-8859(97)00176-6; Scanga CA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018564; Schmitz JE, 2013, CURR OPIN HIV AIDS, V8, P273, DOI 10.1097/COH.0b013e328361cf5b; Schumm M, 2007, BONE MARROW TRANSPL, V39, P767, DOI 10.1038/sj.bmt.1705676; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; VANROOD JJ, 1958, NATURE, V181, P1735, DOI 10.1038/1811735a0; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Westbrook CJ, 2015, HUM IMMUNOL, V76, P891, DOI 10.1016/j.humimm.2015.03.022; Wiseman RW, 2013, ILAR J, V54, P196, DOI 10.1093/ilar/ilt036; WOLFEL T, 1989, J EXP MED, V170, P797, DOI 10.1084/jem.170.3.797; Zhang ZQ, 2002, J VIROL, V76, P12845, DOI 10.1128/JVI.76.24.12845-12854.2002	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0179039	10.1371/journal.pone.0179039	http://dx.doi.org/10.1371/journal.pone.0179039			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719653	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400003
J	Skjaker, SA; Hoel, H; Dahl, V; Stavem, K				Skjaker, Stein Arve; Hoel, Henrik; Dahl, Vegard; Stavem, Knut			Factors associated with life-sustaining treatment restriction in a general intensive care unit	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; NOT-RESUSCITATE ORDERS; DECISION-MAKING; SAPS-II; SUPPORT; WITHDRAWAL; MORTALITY; ICU; MULTICENTER; IMPACT	Purpose Few previous studies have investigated associations between clinical variables available after 24 hours in the intensive care unit (ICU), including the Charlson Comorbidity Index (CCI), and decisions to restrict life-sustaining treatment. The aim of this study was to identify factors associated with the life-sustaining treatment restriction and to explore if CCI contributes to explaining decisions to restrict life-sustaining treatment in the ICU at a university hospital in Norway from 2007 to 2009. Methods Patients' Simplified Acute Physiology Score II (SAPS II), age, sex, type of admission, and length of hospital stay prior to being admitted to the unit were recorded. We retrospectively registered the CCI for all patients based on the medical records prior to the index stay. A multivariable logistic regression analysis was used to assess factors associated with treatment restriction during the ICU stay. Results We included 936 patients, comprising 685 (73%) medical, 204 (22%) unscheduled and 47 (5%) scheduled surgical patients. Treatment restriction was experienced by 241 (26%) patients during their ICU stay. The variables that were significantly associated with treatment restriction in multivariable analysis were older age (odds ratio [OR] = 1.48 per 10 years, 95% confidence interval [CI] = 1.28-1.72 per 10 years), higher SAPS II (OR = 1.05, 95% CI = 1.04-1.07) and CCI values relative to the reference of CCI = 0: CCI = 2 (OR = 2.08, 95% CI = 1.20-3.61) and CCI >= 3 (OR = 2.72, 95% CI = 1.65-4.47). Conclusions In multivariable analysis, older age, greater illness severity after 24 h in the ICU and greater comorbidity at hospital admission were independently associated with subsequent life-sustaining treatment restriction. The CCI score contributed additional information independent of the SAPS II illness severity rating.	[Skjaker, Stein Arve] Oslo Univ Hosp, Sect Orthopaed Emergency, Div Orthopaed Surg, Oslo, Norway; [Hoel, Henrik] Sykehuset Innlandet Kongsvinger, Dept Surg, Kongsvinger, Norway; [Dahl, Vegard] Akershus Univ Hosp, Dept Anaesthesiol, Surg Div, Lorenskog, Norway; [Stavem, Knut] Univ Oslo, Inst Clin Med, Oslo, Norway; [Stavem, Knut] Akershus Univ Hosp, Dept Pulm Med, Med Div, Lorenskog, Norway; [Stavem, Knut] Akershus Univ Hosp, Hlth Serv Res Unit, Lorenskog, Norway	University of Oslo; Innlandet Hospital Trust; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Skjaker, SA (corresponding author), Oslo Univ Hosp, Sect Orthopaed Emergency, Div Orthopaed Surg, Oslo, Norway.	steskj@ous-hf.no		Skjaker, Stein Arve/0000-0002-8172-913X				Bertolini G, 2010, INTENS CARE MED, V36, P1495, DOI 10.1007/s00134-010-1910-9; Brandberg C, 2013, ACTA ANAESTH SCAND, V57, P698, DOI 10.1111/aas.12073; Carlet J, 2004, INTENS CARE MED, V30, P770, DOI 10.1007/s00134-004-2241-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YY, 2008, CHEST, V133, P1312, DOI 10.1378/chest.07-1500; Christensen Steffen, 2011, Clin Epidemiol, V3, P203, DOI 10.2147/CLEP.S20247; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Eachempati SR, 2006, J TRAUMA, V60, P193, DOI 10.1097/01.ta.0000197683.89002.62; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Fissell RB, 2005, KIDNEY INT, V68, P1282, DOI 10.1111/j.1523-1755.2005.00525.x; Hakim RB, 1996, ANN INTERN MED, V125, P284, DOI 10.7326/0003-4819-125-4-199608150-00005; Hall RI, 2000, CHEST, V118, P1424, DOI 10.1378/chest.118.5.1424; Hall SF, 2006, J CLIN EPIDEMIOL, V59, P926, DOI 10.1016/j.jclinepi.2006.02.006; Ho KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003226; Hoel H, 2014, ACTA ANAESTH SCAND, V58, P329, DOI 10.1111/aas.12246; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Johnston JA, 2002, MED CARE, V40, P929, DOI 10.1097/00005650-200210000-00010; Keenan SP, 1997, CRIT CARE MED, V25, P1324, DOI 10.1097/00003246-199708000-00019; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Le Gall JR, 2005, CRIT CARE, V9, pR645, DOI 10.1186/cc3821; Le Maguet P, 2014, INTENS CARE MED, V40, P674, DOI 10.1007/s00134-014-3253-4; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lewis JP, 2007, ANAESTH INTENS CARE, V35, P387, DOI 10.1177/0310057X0703500312; Lissauer ME, 2011, J AM COLL SURGEONS, V213, P766, DOI 10.1016/j.jamcollsurg.2011.09.003; Meissner A, 2010, CRIT CARE MED, V38, P1060, DOI 10.1097/CCM.0b013e3181cd1110; Nathens AB, 2008, J TRAUMA, V64, P81, DOI 10.1097/TA.0b013e31815dd4d7; Norwegian Directorate of Health, 2013, DEC MAK PROC LIM LIF; Pang SMC, 2004, J CRIT CARE, V19, P135, DOI 10.1016/j.jcrc.2004.08.001; PITTET D, 1993, INTENS CARE MED, V19, P265, DOI 10.1007/BF01690546; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Reignier J, 2008, CRIT CARE MED, V36, P2076, DOI 10.1097/CCM.0b013e31817c0ea7; Reinikainen M, 2007, ACTA ANAESTH SCAND, V51, P522, DOI 10.1111/j.1399-6576.2007.01274.x; Reynolds S, 2007, SURG CLIN N AM, V87, P919, DOI 10.1016/j.suc.2007.07.013; Sinuff T, 2004, CAN J ANAESTH, V51, P1034, DOI 10.1007/BF03018494; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Turnbull AE, 2014, CRIT CARE, V18, DOI 10.1186/cc13890; WOOD GG, 1995, CAN J ANAESTH, V42, P186, DOI 10.1007/BF03010673; Wunsch H, 2005, INTENS CARE MED, V31, P823, DOI 10.1007/s00134-005-2644-y	40	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181312	10.1371/journal.pone.0181312	http://dx.doi.org/10.1371/journal.pone.0181312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719660	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400037
J	de Villiers, M; Kriticos, DJ; Veldtman, R				de Villiers, Marelize; Kriticos, Darren J.; Veldtman, Ruan			Including irrigation in niche modelling of the invasive wasp Vespula germanica (Fabricius) improves model fit to predict potential for further spread	PLOS ONE			English	Article							YELLOW JACKET WASPS; F HYMENOPTERA; NEW-ZEALAND; EUROPEAN WASP; SOCIAL WASP; VESPIDAE; AUSTRALIA; ABUNDANCE; COLONIES; INSECTS	The European wasp, Vespula germanica (Fabricius) (Hymenoptera: Vespidae), is of Palaearctic origin, being native to Europe, northern Africa and Asia, and introduced into North America, Chile, Argentina, Iceland, Ascension Island, South Africa, Australia and New Zealand. Due to its polyphagous nature and scavenging behaviour, V. germanica threatens agriculture and silviculture, and negatively affects biodiversity, while its aggressive nature and venomous sting pose a health risk to humans. In areas with warmer winters and longer summers, queens and workers can survive the winter months, leading to the build-up of large nests during the following season; thereby increasing the risk posed by this species. To prevent or prepare for such unwanted impacts it is important to know where the wasp may be able to establish, either through natural spread or through introduction as a result of human transport. Distribution data from Argentina and Australia, and seasonal phenology data from Argentina were used to determine the potential distribution of V. germanica using CLIMEX modelling. In contrast to previous models, the influence of irrigation on its distribution was also investigated. Under a natural rainfall scenario, the model showed similarities to previous models. When irrigation is applied, dry stress is alleviated, leading to larger areas modelled climatically suitable compared with previous models, which provided a better fit with the actual distribution of the species. The main areas at risk of invasion by V. germanica include western USA, Mexico, small areas in Central America and in the northwestern region of South America, eastern Brazil, western Russia, north-western China, Japan, the Mediterranean coastal regions of North Africa, and parts of southern and eastern Africa.	[de Villiers, Marelize; Veldtman, Ruan] Stellenbosch Univ, Dept Conservat Ecol & Entomol, Stellenbosch, South Africa; [Kriticos, Darren J.] CSIRO, Canberra, ACT, Australia; [Kriticos, Darren J.] Univ Queensland, St Lucia, Qld, Australia; [Veldtman, Ruan] South African Natl Biodivers Inst, Cape Town, South Africa	Stellenbosch University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; South African National Biodiversity Institute	de Villiers, M (corresponding author), Stellenbosch Univ, Dept Conservat Ecol & Entomol, Stellenbosch, South Africa.	marelizedevilliers@yahoo.co.za	Veldtman, Ruan/I-1131-2019; Kriticos, Darren J/A-4170-2008	Kriticos, Darren J/0000-0003-2599-8105	South African National Biodiversity Institute (SANBI)	South African National Biodiversity Institute (SANBI)	We would like to thank the South African National Biodiversity Institute (SANBI) for funding this project through the Department of Environmental Affairs, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRE RD, 1989, PAN-PAC ENTOMOL, V65, P79; Allsopp MH, 2004, S AFRICAN BEE J, V76, P69; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Austin AD, 2002, REPORT ADELAIDE RES; Bashford Richard, 2001, Australian Entomologist, V28, P1; Beggs J, 2001, BIOL CONSERV, V99, P17, DOI 10.1016/S0006-3207(00)00185-3; BRAVERMAN Y, 1991, MED VET ENTOMOL, V5, P129, DOI 10.1111/j.1365-2915.1991.tb00530.x; Braverman Y, 1998, J ECON ENTOMOL, V91, P486, DOI 10.1093/jee/91.2.486; Chapman RE, 2001, ECOL LETT, V4, P650, DOI 10.1046/j.1461-0248.2001.00253.x; CLAPPERTON BK, 1989, NEW ZEAL J ZOOL, V16, P325, DOI 10.1080/03014223.1989.10422897; Coelho JR, 1996, J COMP PHYSIOL B, V166, P68, DOI 10.1007/BF00264641; CROSLAND MWJ, 1991, NEW ZEAL J ZOOL, V18, P375, DOI 10.1080/03014223.1991.10422843; Davidson S., 1986, ECOSYSTEMS, V50, P14; DONOVAN BJ, 1992, BEE WORLD, V73, P131, DOI 10.1080/0005772X.1992.11099127; DONOVAN BJ, 1992, NEW ZEAL J ZOOL, V19, P61, DOI 10.1080/03014223.1992.10423252; Farji-Brener Alejandro G., 1998, Ecologia Austral, V8, P237; Fox-Wilson G., 1946, P ROYAL ENTOMOLOGICA, V21, P17; GERBER H S, 1990, Journal of the Entomological Society of British Columbia, V87, P73; GOLLER F, 1990, J EXP BIOL, V150, P221; Goodisman MAD, 2001, J HERED, V92, P346, DOI 10.1093/jhered/92.4.346; Harris RJ, 1996, NEW ZEAL J ZOOL, V23, P11, DOI 10.1080/03014223.1996.9518061; Haupt K., 2015, THESIS; HORWOOD MA, 1993, J AUST ENTOMOL SOC, V32, P241; Hurd CR, 2003, BEHAVIOUR, V140, P827, DOI 10.1163/156853903770238337; Kasper ML, 2008, INSECT SOC, V55, P288, DOI 10.1007/s00040-008-1004-7; Kasper ML, 2008, AUST J ENTOMOL, V47, P265, DOI 10.1111/j.1440-6055.2008.00658.x; Kriticos D. J., 2015, CLIMEX VERSION 4 EXP; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132807; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; MADDEN JL, 1981, J AUST ENTOMOL SOC, V20, P59; Masciocchi M, 2013, AUSTRAL ECOL, V38, P162, DOI 10.1111/j.1442-9993.2012.02388.x; Miller P. F., 2005, Fifth International Conference on Urban Pests, Singapore, 11-13 July 2005, P387; MOLLER H, 1989, NEW ZEAL J ZOOL, V16, P289, DOI 10.1080/03014223.1989.10422894; Morse RA, 1976, ENVIRON ENTOMOL, V6, P109; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Richards KT, 1985, AGR PROTECTION BOARD; Sackmann P, 2010, INT J PEST MANAGE, V56, P69, DOI 10.1080/09670870903075022; Sackmann Paula, 2000, New Zealand Entomologist, V23, P55; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; SPRADBER.JP, 1971, J ANIM ECOL, V40, P501, DOI 10.2307/3259; SPRADBERY JP, 1992, AUST J ZOOL, V40, P495, DOI 10.1071/ZO9920495; Spradbery P, 2016, INV SPEC COMP; Sutherst R W, 2007, CLIMEX VERSION 3 USE; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tezcan Serdar, 2005, Turkiye Entomoloji Dergisi, V29, P101; TRIBE GD, 1994, AFR ENTOMOL, V2, P1; Veldtman R, 2012, IOBC WPRS B, V75; Ward D, 2002, AUST J ENTOMOL, V41, P306, DOI 10.1046/j.1440-6055.2002.00308.x; WHITEHEAD V B, 1975, Journal of the Entomological Society of Southern Africa, V38, P39; Wood GM, 2006, J ECON ENTOMOL, V99, P263, DOI 10.1603/0022-0493-99.2.263; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Yonow T, 2017, J PEST SCI, V90, P459, DOI 10.1007/s10340-016-0801-4	52	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181397	10.1371/journal.pone.0181397	http://dx.doi.org/10.1371/journal.pone.0181397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715452	Green Published, Green Submitted, gold			2022-12-27	WOS:000443975500051
J	Fonseca, AM; Quinto, L; Jimenez, A; Gonzalez, R; Bardaji, A; Maculuve, S; Dobano, C; Ruperez, M; Vala, A; Aponte, JJ; Sevene, E; Macete, E; Menendez, C; Mayor, A				Maria Fonseca, Ana; Quinto, Llorenc; Jimenez, Alfons; Gonzalez, Raquel; Bardaji, Azucena; Maculuve, Sonia; Dobano, Carlota; Ruperez, Maria; Vala, Anifa; Aponte, John J.; Sevene, Esperanza; Macete, Eusebio; Menendez, Clara; Mayor, Alfredo			Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; VACCINE CANDIDATE VAR2CSA; INFECTED ERYTHROCYTES; MALARIA TRANSMISSION; PLACENTAL MALARIA; CAMEROONIAN WOMEN; ANTIBODIES; CHILDREN; BINDING; PERSPECTIVES	Background Pregnant women exposed to Plasmodium falciparum generate antibodies against VAR2CSA, the parasite protein that mediates adhesion of infected erythrocytes to the placenta. There is a need of high-throughput tools to determine the fine specificity of these antibodies that can be used to identify immune correlates of protection and exposure. Here we aimed at developing a multiplex-immunoassay to detect antibodies against VAR2CSA antigens. Methods and findings We constructed two multiplex-bead arrays, one composed of 3 VAR2CSA recombinant-domains (DBL3X, DBL5 xi and DBL6 xi) and another composed of 46 new peptides covering VAR2CSA conserved and semi-conserved regions. IgG reactivity was similar in multiplexed and singleplexed determinations (Pearson correlation, protein array: R-2 = 0.99 and peptide array: R-2 = 0.87). IgG recognition of 25 out of 46 peptides and all recombinant-domains was higher in pregnant Mozambican women (n = 106) than in Mozambican men (n = 102) and Spanish individuals (n = 101; p<0.05). Agreement of IgG levels detected in cryopreserved plasma and in elutions from dried blood spots was good after exclusion of inappropriate filter papers. Under heterogeneous levels of exposure to malaria, similar seropositivity cutoffs were obtained using finite mixture models applied to antibodies measured on pregnant Mozambican women and average of antibodies measured on pregnant Spanish women never exposed to malaria. The application of the multiplex-bead array developed here, allowed the assessment of higher IgG levels and seroprevalences against VAR2CSA-derived antigens in women pregnant during 2003-2005 than during 2010-2012, in accordance with the levels of malaria transmission reported for these years in Mozambique. Conclusions The multiplex bead-based immunoassay to detect antibodies against selected 25 VAR2CSA new-peptides and recombinant-domains was successfully implemented. Analysis of field samples showed that responses were specific among pregnant women and dependent on the level of exposure to malaria. This platform provides a high-throughput approach to investigating correlates of protection and identifying serological markers of exposure for malaria in pregnancy.	[Maria Fonseca, Ana; Quinto, Llorenc; Jimenez, Alfons; Gonzalez, Raquel; Bardaji, Azucena; Dobano, Carlota; Ruperez, Maria; Aponte, John J.; Menendez, Clara; Mayor, Alfredo] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Maria Fonseca, Ana] Univ Porto, Grad Program Areas Basic & Appl Biol GABBA, Porto, Portugal; [Jimenez, Alfons] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid, Spain; [Gonzalez, Raquel; Bardaji, Azucena; Maculuve, Sonia; Dobano, Carlota; Ruperez, Maria; Vala, Anifa; Aponte, John J.; Sevene, Esperanza; Macete, Eusebio; Menendez, Clara; Mayor, Alfredo] CISM, Maputo, Mozambique; [Sevene, Esperanza] Eduardo Mondlane Univ, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Universidade do Porto; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Centro de Investigacao em Saude de Manhica; Eduardo Mondlane University	Mayor, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.; Mayor, A (corresponding author), CISM, Maputo, Mozambique.	alfredo.mayor@isglobal.org	Menéndez, Clara/Q-3446-2016; Dobaño, Carlota/N-4119-2014; Alonso, Azucena Bardají/V-5978-2018; Bardají, Azucena/AAE-9145-2019; JIMENEZ, ALFONS/L-2106-2019; Gonzalez, Raquel/J-3604-2017; Mayor, Alfredo/H-7488-2017; Fonseca, Ana Maria/J-4048-2017	Menéndez, Clara/0000-0002-2641-6907; Dobaño, Carlota/0000-0002-6751-4060; Alonso, Azucena Bardají/0000-0002-5135-0540; JIMENEZ, ALFONS/0000-0003-0301-3344; Gonzalez, Raquel/0000-0001-5487-801X; Mayor, Alfredo/0000-0003-3890-2897; Fonseca, Ana Maria/0000-0001-8051-4850; Quinto, Llorenc/0000-0001-9992-6951; Ruperez, Maria/0000-0001-8322-7881	Malaria Eradication Scientific Alliance (MESA); European and Developing Countries Clinical Trials Partnership (EDCTP); Malaria in Pregnancy (MiP) Consortium; Banco de Bilbao; Argentaria Foundation [BBVA 02-0]; Instituto de Salud Carlos III [PS09/01113, PI13/01478]; Fondo Europeo de Desarrollo Regional [FEDER]; AGAUR/Generalitat de Catalunya [2014 SGR 263]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/51696/2011]; CERCA programme/Generalitat de Catalunya; Bill and Melinda Gates Foundation; Vizcaya; Spanish Agency for International Cooperation and Development;  [CES10/021-I3SNS]	Malaria Eradication Scientific Alliance (MESA); European and Developing Countries Clinical Trials Partnership (EDCTP); Malaria in Pregnancy (MiP) Consortium; Banco de Bilbao; Argentaria Foundation; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional [FEDER](European CommissionSpanish Government); AGAUR/Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); CERCA programme/Generalitat de Catalunya; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Vizcaya; Spanish Agency for International Cooperation and Development(Spanish Government); 	Supported by the Malaria Eradication Scientific Alliance (MESA), the European and Developing Countries Clinical Trials Partnership (EDCTP), the Malaria in Pregnancy (MiP) Consortium, and grants from Banco de Bilbao, Vizcaya, Argentaria Foundation (BBVA 02-0), Instituto de Salud Carlos III (grants PS09/01113 and PI13/01478 cofounded by the Fondo Europeo de Desarrollo Regional [FEDER], and CES10/021-I3SNS to AM), AGAUR/Generalitat de Catalunya (2014 SGR 263) and The Fundacao para a Ciencia e Tecnologia (SFRH/BD/51696/2011 to AMF). ISGlobal received support from the CERCA programme/Generalitat de Catalunya. The Centro de Investigacao em Saude da Manhica (CISM) receives core support from the Spanish Agency for International Cooperation and Development. The MiP Consortium and MESA are funded through a grant from the Bill and Melinda Gates Foundation to the Liverpool School of Tropical Medicine and the Barcelona Institute of Global Health, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000397; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Alonso PL, 2002, POPULATION HLTH DEV, P189; Ambrosino E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-317; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; [Anonymous], 1998, REV SCI TECH OFF INT; Ataide R, 2014, TRENDS PARASITOL, V30, P85, DOI 10.1016/j.pt.2013.12.007; Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Babakhanyan A, 2016, AM J TROP MED HYG, V94, P640, DOI 10.4269/ajtmh.15-0521; Babakhanyan A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1023-6; Babakhanyan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088173; Badaut C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011276; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Campo JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025779; Clement F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-384; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fodjo BAY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1585-y; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gangnard S, 2013, J MOL BIOL, V425, P1697, DOI 10.1016/j.jmb.2013.02.014; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Gnidehou S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013105; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001735; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Hoffman SL, 2015, AM J PREV MED, V49, pS319, DOI 10.1016/j.amepre.2015.09.011; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Irion A, 2002, J IMMUNOL METHODS, V259, P111, DOI 10.1016/S0022-1759(01)00500-2; Kerkhof K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0868-z; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mayor A, 2015, NEW ENGL J MED, V373, P1607, DOI 10.1056/NEJMoa1406459; Mayor A, 2013, J INFECT DIS, V207, P1664, DOI 10.1093/infdis/jit083; Mayor A, 2011, INFECT IMMUN, V79, P1654, DOI 10.1128/IAI.01000-10; Mazumdar S, 2010, BIOPROC BIOSYST ENG, V33, P719, DOI 10.1007/s00449-009-0394-x; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073624; Ndam NT, 2015, EMERG INFECT DIS, V21, P813, DOI 10.3201/eid2105.141626; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12; van Eijk AM, 2015, LANCET GLOB HEALTH, V3, pE617, DOI 10.1016/S2214-109X(15)00049-2; WHO, 2006, MAT IMM TET	56	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181150	10.1371/journal.pone.0181150	http://dx.doi.org/10.1371/journal.pone.0181150			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715465	Green Submitted, gold, Green Published			2022-12-27	WOS:000443975500032
J	Liu, BC; Binaykia, A; Chang, PC; Tiwari, MK; Tsao, CC				Liu, Bing-Chun; Binaykia, Arihant; Chang, Pei-Chann; Tiwari, Manoj Kumar; Tsao, Cheng-Chin			Urban air quality forecasting based on multidimensional collaborative Support Vector Regression (SVR): A case study of BeijingTianjin-Shijiazhuang	PLOS ONE			English	Article							PM10 CONCENTRATIONS; NEURAL-NETWORK; MODEL; PREDICTION; POLLUTION	Today, China is facing a very serious issue of Air Pollution due to its dreadful impact on the human health as well as the environment. The urban cities in China are the most affected due to their rapid industrial and economic growth. Therefore, it is of extreme importance to come up with new, better and more reliable forecasting models to accurately predict the air quality. This paper selected Beijing, Tianjin and Shijiazhuang as three cities from the Jingjinji Region for the study to come up with a new model of collaborative forecasting using Support Vector Regression (SVR) for Urban Air Quality Index (AQI) prediction in China. The present study is aimed to improve the forecasting results by minimizing the prediction error of present machine learning algorithms by taking into account multiple city multi-dimensional air quality information and weather conditions as input. The results show that there is a decrease in MAPE in case of multiple city multi-dimensional regression when there is a strong interaction and correlation of the air quality characteristic attributes with AQI. Also, the geographical location is found to play a significant role in Beijing, Tianjin and Shijiazhuang AQI prediction.	[Liu, Bing-Chun] Tianjin Univ Technol, Res Inst Circular Econ, Tianjin, Peoples R China; [Binaykia, Arihant; Tiwari, Manoj Kumar] Indian Inst Technol, Dept Ind & Syst Engn, Kharagpur, W Bengal, India; [Chang, Pei-Chann; Tsao, Cheng-Chin] Yuan Ze Univ, Dept Informat Management, Taoyuan, Taiwan; [Chang, Pei-Chann] Beijing Inst Technol, Zhuhai Coll, Off Acad Affairs, Zhuhai, Peoples R China	Tianjin University of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Yuan Ze University; Beijing Institute of Technology	Chang, PC (corresponding author), Yuan Ze Univ, Dept Informat Management, Taoyuan, Taiwan.; Chang, PC (corresponding author), Beijing Inst Technol, Zhuhai Coll, Off Acad Affairs, Zhuhai, Peoples R China.	iepchang@saturn.yzu.edu.tw	Tiwari, Manoj K./B-3592-2012	Tiwari, M.K/0000-0001-8564-1402	National Natural Science Foundation of China [71503180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors received funding support from the National Natural Science Foundation of China (71503180).	Alhanafy T.E., 2010, J AM SCI, V6, P605; [白鹤鸣 Bai Heming], 2013, [环境科学与技术, Enuivonmental Science and Technology], V36, P186; [陈淳祺 Chen Chunqi], 2013, [环境科学与技术, Enuivonmental Science and Technology], V36, P130; Chen W, 2015, ATMOSPHERE-BASEL, V6, P1243, DOI 10.3390/atmos6081243; Chuang MT, 2011, ATMOS ENVIRON, V45, P6241, DOI 10.1016/j.atmosenv.2011.06.071; Hoi KI, 2008, GLOBAL NEST J, V10, P140; Hu LJ, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8080786; Hu YT, 2010, ATMOS POLLUT RES, V1, P280, DOI 10.5094/APR.2010.035; Kassomenos P, 1999, ATMOS ENVIRON, V33, P1861, DOI 10.1016/S1352-2310(98)00355-0; Konar P, 2011, APPL SOFT COMPUT, V11, P4203, DOI 10.1016/j.asoc.2011.03.014; Kumar A, 2011, ATMOS POLLUT RES, V2, P436, DOI 10.5094/APR.2011.050; Li L, 2014, INT J ENV RES PUB HE, V11, P8909, DOI 10.3390/ijerph110908909; Li M, INTECH, V9, P195; Liu DJ, 2015, INT J ENV RES PUB HE, V12, P7085, DOI 10.3390/ijerph120607085; Liu YH, 2015, ATMOSPHERE-BASEL, V6, P891, DOI 10.3390/atmos6070891; McKeen S, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011697; MULLER KR, ARTIFICIAL NEURAL NE, P999, DOI DOI 10.1016/J.ASOC.2011.03.014; Perez P, 2006, ATMOS ENVIRON, V40, P2845, DOI 10.1016/j.atmosenv.2006.01.010; Plaia A, 2011, REV ENVIRON SCI BIO, V10, P165, DOI 10.1007/s11157-010-9227-2; Queensland Government, 2017, INFL MET AIR QUAL; R Core Team, 2013, R LANG ENV STAT COMP; Rohde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135749; Schwieder M, 2014, REMOTE SENS-BASEL, V6, P3427, DOI 10.3390/rs6043427; Shad R, 2009, COMPUT ENVIRON URBAN, V33, P472, DOI 10.1016/j.compenvurbsys.2009.10.004; Stern R, 2008, ATMOS ENVIRON, V42, P4567, DOI 10.1016/j.atmosenv.2008.01.068; Sun W, 2013, SCI TOTAL ENVIRON, V443, P93, DOI 10.1016/j.scitotenv.2012.10.070; Vapnik V, 1997, ADV NEUR IN, V9, P281; Wang KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075220; XIANG L, 2013, J HUAZHONG U SCI TEC, V41, P63; XIAOFENG XU, 2005, METEOROLOGICAL SCI T, V33, P543, DOI DOI 10.1016/J.ATMOSENV.2011.06.071; ZAHARIM A, 2009, EUR J SCI RES, V27, P308, DOI DOI 10.1016/J.COMPENVURBSYS.2009.10.004	32	79	84	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179763	10.1371/journal.pone.0179763	http://dx.doi.org/10.1371/journal.pone.0179763			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708836	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800007
J	Martino, D; Delorme, C; Pelosin, E; Hartmann, A; Worbe, Y; Avanzino, L				Martino, D.; Delorme, C.; Pelosin, E.; Hartmann, A.; Worbe, Y.; Avanzino, L.			Abnormal lateralization of fine motor actions in Tourette syndrome persists into adulthood	PLOS ONE			English	Article							CORPUS-CALLOSUM; INTERHEMISPHERIC-TRANSFER; TIC SEVERITY; CHILDREN; CONNECTIVITY; DEFICITS; BOYS	Youth with Tourette syndrome (TS) exhibit, compared to healthy, abnormal ability to lateralize digital sequential tasks. It is unknown whether this trait is related to inter-hemispheric connections, and whether it is preserved or lost in patients with TS persisting through adult life. We studied 13 adult TS patients and 15 age-matched healthy volunteers. All participants undertook: 1) a finger opposition task, performed with the right hand (RH) only or with both hands, using a sensor-engineered glove in synchrony with a metronome at 2 Hz; we calculated a lateralization index [(single RH-bimanual RH)/single RH X 100) for percentage of correct movements (%CORR); 2) MRI-based diffusion tensor imaging and probabilistic tractography of inter-hemispheric corpus callosum (CC) connections between supplementary motor areas (SMA) and primary motor cortices (M1). We confirmed a significant increase in the %CORR in RH in the bimanual vs. single task in TS patients (p<0.001), coupled to an abnormal ability to lateralize finger movements (significantly lower lateralization index for %CORR in TS patients, p = 0.04). The % CORR lateralization index correlated positively with tic severity measured with the Yale Global Tic Severity Scale (R = 0.55; p = 0.04). We detected a significantly higher fractional anisotropy (FA) in both the M1-M1 (p = 0.036) and the SMA-SMA (p = 0.018) callosal fibre tracts in TS patients. In healthy subjects, the % CORR lateralization index correlated positively with fractional anisotropy of SMA-SMA fibre tracts (R = 0.63, p = 0.02); this correlation was not significant in TS patients. TS patients exhibited an abnormal ability to lateralize finger movements in sequential tasks, which increased in accuracy when the task was performed bimanually. This abnormality persists throughout different age periods and appears dissociated from the transcallosal connectivity of motor cortical regions. The altered interhemispheric transfer of motor abilities in TS may be the result of compensatory processes linked to self-regulation of motor control.	[Martino, D.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Delorme, C.; Hartmann, A.; Worbe, Y.] UPMC Univ Paris 06, Sorbonne Univ, ICM, UMR S 975,CNRS,UMR 7225, Paris, France; [Delorme, C.; Hartmann, A.; Worbe, Y.] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, 47-83 Blvd Hop, Paris, France; [Delorme, C.; Hartmann, A.; Worbe, Y.] Grp Hosp Pitie Salpetriere, French Natl Reference Ctr Gilles Tourette Syndrom, Paris, France; [Pelosin, E.] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy; [Worbe, Y.] St Antoine Hosp, Dept Neurophysiol, Paris, France; [Avanzino, L.] Univ Genoa, Sect Human Physiol, Genoa, Italy; [Avanzino, L.] Univ Genoa, Ctr Polifunz Sci Motorie, Dept Expt Med, Genoa, Italy	University of Calgary; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; University of Genoa	Avanzino, L (corresponding author), Univ Genoa, Sect Human Physiol, Genoa, Italy.; Avanzino, L (corresponding author), Univ Genoa, Ctr Polifunz Sci Motorie, Dept Expt Med, Genoa, Italy.	lavanzino76@gmail.com	Avanzino, Laura/K-6623-2016; Pelosin, Elisa/AAA-9637-2019; Worbe, Yulia/GYV-3751-2022	AVANZINO, LAURA/0000-0001-6286-1509; Pelosin, Elisa/0000-0002-9880-2241; Worbe, Yulia/0000-0001-5903-9370				American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Avanzino L, 2011, MOVEMENT DISORD, V26, P2114, DOI 10.1002/mds.23839; Baumer T, 2010, MOVEMENT DISORD, V25, P2828, DOI 10.1002/mds.23418; Bloch MH, 2006, J CHILD PSYCHOL PSYC, V47, P551, DOI 10.1111/j.1469-7610.2005.01561.x; Buse J, 2012, DEV MED CHILD NEUROL, V54, P629, DOI 10.1111/j.1469-8749.2012.04273.x; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Ganos C, 2015, NEUROL CLIN, V33, P115, DOI 10.1016/j.ncl.2014.09.008; Gooijers J, 2014, NEUROSCI BIOBEHAV R, V43, P1, DOI 10.1016/j.neubiorev.2014.03.008; Gooijers J, 2013, HUM BRAIN MAPP, V34, P241, DOI 10.1002/hbm.21429; Grados MA, 2009, J PSYCHOSOM RES, V67, P491, DOI 10.1016/j.jpsychores.2009.07.011; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lindenberg R, 2012, HUM BRAIN MAPP, V33, P1040, DOI 10.1002/hbm.21266; Mataix-Cols D, 2015, JAMA PSYCHIAT, V72, P787, DOI 10.1001/jamapsychiatry.2015.0627; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Muetzel RL, 2008, NEUROIMAGE, V39, P1918, DOI 10.1016/j.neuroimage.2007.10.018; Neuner I, 2010, NEUROIMAGE, V51, P1184, DOI 10.1016/j.neuroimage.2010.02.049; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PETERSON BS, 1994, PSYCHIAT RES-NEUROIM, V55, P85, DOI 10.1016/0925-4927(94)90003-5; Plessen KJ, 2007, NEUROPSYCHOLOGIA, V45, P767, DOI 10.1016/j.neuropsychologia.2006.08.006; Plessen KJ, 2006, J CHILD PSYCHOL PSYC, V47, P1013, DOI 10.1111/j.1469-7610.2006.01639.x; Plessen KJ, 2004, AM J PSYCHIAT, V161, P2028, DOI 10.1176/appi.ajp.161.11.2028; Roessner V, 2013, J CHILD PSYCHOL PSYC, V54, P273, DOI 10.1111/j.1469-7610.2012.02584.x; Serbruyns L, 2015, BRAIN STRUCT FUNCT, V220, P273, DOI 10.1007/s00429-013-0654-z; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sisti HM, 2012, LEARN MEMORY, V19, P351, DOI 10.1101/lm.026534.112; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Wolff N, 2016, PSYCHIAT RES-NEUROIM, V247, P1, DOI 10.1016/j.pscychresns.2015.12.003	29	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180812	10.1371/journal.pone.0180812	http://dx.doi.org/10.1371/journal.pone.0180812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708864	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649800023
J	Alonso-Dominguez, JM; Casado, LF; Anguita, E; Gomez-Casares, MT; Buno, I; Ferrer-Marin, F; Arenas, A; Del Orbe, R; Ayala, R; Llamas, P; Salgado, RN; Osorio, S; Sanchez-Godoy, P; Burgaleta, C; Mahillo-Fernandez, I; Garcia-Gutierrez, V; Steegmann, JL; Martinez-Lopez, J				Alonso-Dominguez, Juan M.; Felipe Casado, Luis; Anguita, Eduardo; Teresa Gomez-Casares, Maria; Buno, Ismael; Ferrer-Marin, Francisca; Arenas, Alicia; Del Orbe, Rafael; Ayala, Rosa; Llamas, Pilar; Salgado, Rocio N.; Osorio, Santiago; Sanchez-Godoy, Pedro; Burgaleta, Carmen; Mahillo-Fernandez, Ignacio; Garcia-Gutierrez, Valentin; Luis Steegmann, Juan; Martinez-Lopez, Joaquin			PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase	PLOS ONE			English	Article							EUROPEAN-LEUKEMIANET; HEDGEHOG PATHWAY; EXPRESSION; SURVIVAL; REQUIREMENT; CANCER; CML; STANDARDIZATION; RECOMMENDATIONS; PROGRESSION	Patched homolog 1 gene (PTCH1) expression and the ratio of PTCH1 to Smoothened (SMO) expression have been proposed as prognostic markers of the response of chronic myeloid leukemia (CML) patients to imatinib. We compared these measurements in a realistic cohort of 101 patients with CML in chronic phase (CP) using a simplified qPCR method, and confirmed the prognostic power of each in a competing risk analysis. Gene expression levels were measured in peripheral blood samples at diagnosis. The PTCH1/SMO ratio did not improve PTCH1 prognostic power (area under the receiver operating characteristic curve 0.71 vs. 0.72). In order to reduce the number of genes to be analyzed, PTCH1 was the selected measurement. High and low PTCH1 expression groups had significantly different cumulative incidences of imatinib failure (IF), which was defined as discontinuation of imatinib due to lack of efficacy (5% vs. 25% at 4 years, P = 0.013), probabilities of achieving a major molecular response (81% vs. 53% at first year, P = 0.02), and proportions of early molecular failure (14% vs. 43%, P = 0.015). Every progression to an advanced phase (n = 3) and CML-related death (n = 2) occurred in the low PTCH1 group (P<0.001 for both comparisons). PTCH1 was an independent prognostic factor for the prediction of IF. We also validated previously published thresholds for PTCH1 expression. Therefore, we confirmed that PTCH1 expression can predict the imatinib response in CML patients in CP by applying a more rigorous statistical analysis. Thus, PTCH1 expression is a promising molecular marker for predicting the imatinib response in CML patients in CP.	[Alonso-Dominguez, Juan M.; Llamas, Pilar; Salgado, Rocio N.; Mahillo-Fernandez, Ignacio] UAM, Hosp Univ Fdn Jimenez Diaz, IIS FJD, Madrid, Spain; [Felipe Casado, Luis] Hosp Virgen de la Salud, Toledo, Spain; [Anguita, Eduardo] Hosp Univ Clin San Carlos, Madrid, Spain; [Teresa Gomez-Casares, Maria] Hosp Univ Doctor Negrin, Las Palmas Gran Canaria, Spain; [Buno, Ismael; Osorio, Santiago] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain; [Ferrer-Marin, Francisca] UCAM, CIBERER, Hosp Univ Morales Meseguer, Murcia, Spain; [Arenas, Alicia] Hosp Univ 12 Octubre, Fdn Invest Biomed, Madrid, Spain; [Del Orbe, Rafael] Biocruces Hlth Res Inst, Baracaldo, Bilbao, Spain; [Ayala, Rosa; Martinez-Lopez, Joaquin] Hosp Univ 12 Octubre, Madrid, Spain; [Sanchez-Godoy, Pedro] Hosp Univ Severo Ochoa, Leganes, Madrid, Spain; [Burgaleta, Carmen] Hosp Univ Principe Asturias, Alcala De Henares, Madrid, Spain; [Garcia-Gutierrez, Valentin] Hosp Univ Ramon y Cajal, Madrid, Spain; [Luis Steegmann, Juan] Hosp Univ Princesa, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Complejo Hospitalario de Toledo; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Meseguer General University Hospital Morales; Universidad Catolica de Murcia; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Severo Ochoa University Hospital; Prince of Asturias University Hospital; Hospital Universitario Ramon y Cajal; Hospital de La Princesa	Alonso-Dominguez, JM (corresponding author), UAM, Hosp Univ Fdn Jimenez Diaz, IIS FJD, Madrid, Spain.	juan.adominguez@fjd.es	Anguita, Eduardo/G-6050-2017; CASARES, MARIA TERESA GOMEZ/R-6060-2018; Anguita, Eduardo/AAA-2097-2019; osorio, santiago/AAY-4337-2020; martinez, joaquin/AAN-6939-2020; Blanco, Leire/O-5114-2017; Buno, Ismael/G-4524-2013	Anguita, Eduardo/0000-0003-1386-4943; CASARES, MARIA TERESA GOMEZ/0000-0003-0505-5126; Anguita, Eduardo/0000-0003-1386-4943; martinez, joaquin/0000-0001-7908-0063; Buno, Ismael/0000-0003-4931-9170; Garcia, Valentin/0000-0003-4752-0815; Alonso-Dominguez, Juan Manuel/0000-0001-6233-5912; AYALA DIAZ, ROSA MARIA/0000-0002-2699-8353; Del Orbe Barreto, Rafael Andres/0000-0002-1240-1958; Llamas Sillero, Pilar/0000-0002-8552-3219	Fundacion Cris Contra el Cancer	Fundacion Cris Contra el Cancer	This work was supported by the Fundacion Cris Contra el Cancer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Dominguez JM, 2015, AM J HEMATOL, V90, P20, DOI 10.1002/ajh.23857; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Cross NCP, 2015, ANN HEMATOL, V94, pS219, DOI 10.1007/s00277-015-2315-1; Dc W, 2012, BLOOD, V116, P111; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Garcia-Gutierrez V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173532; Gerrard G, 2014, HAEMATOLOGICA; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grinfeld J, 2013, BRIT J HAEMATOL, V163, P631, DOI 10.1111/bjh.12591; Gromicho M, 2011, LEUKEMIA LYMPHOMA, V52, P1980, DOI 10.3109/10428194.2011.584005; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Hasford J, 1998, JNCI-J NATL CANCER I, V90, P850, DOI 10.1093/jnci/90.11.850; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; Irvine DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25476; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; KAY R, 1984, REV EPIDEMIOL SANTE, V32, P185; Kok CH, 2015, BLOOD, V126, P596; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Jorge CE, 2012, ANN HEMATOL, V91, P1245, DOI 10.1007/s00277-012-1468-4; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; O'Brien SG, 2003, SEMIN HEMATOL, V40, P26, DOI 10.1053/shem.2003.50058; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pfirrmann M, 2015, ANN HEMATOL, V94, pS209, DOI 10.1007/s00277-015-2316-0; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Sadarangani A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0453-9; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Su WX, 2012, EXP HEMATOL, V40, P418, DOI 10.1016/j.exphem.2012.01.003; Tang JY, 2016, LANCET ONCOL, V17, P1720, DOI 10.1016/S1470-2045(16)30566-6; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vardiman JW, 2008, WHO CLASSIFICATION T; Vasconcelos FD, 2016, LEUKEMIA RES, V51, P3, DOI 10.1016/j.leukres.2016.10.005; Yong ASM, 2006, BLOOD, V107, P205, DOI 10.1182/blood-2005-05-2155; Zhang WW, 2009, J CLIN ONCOL, V27, P3642, DOI 10.1200/JCO.2008.19.4076	43	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181366	10.1371/journal.pone.0181366	http://dx.doi.org/10.1371/journal.pone.0181366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704552	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700128
J	Lopes-Ramos, CM; Barros, BP; Koyama, FC; Carpinetti, PA; Pezuk, J; Doimo, NTS; Habr-Gama, A; Perez, RO; Parmigiani, RB				Lopes-Ramos, Camila M.; Barros, Bruna P.; Koyama, Fernanda C.; Carpinetti, Paola A.; Pezuk, Julia; Doimo, Nayara T. S.; Habr-Gama, Angelita; Perez, Rodrigo O.; Parmigiani, Raphael B.			E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; KRAS-VARIANT; MICRORNA; LUNG; POLYMORPHISMS; EXPRESSION; ACTS	Background Genetic studies have largely concentrated on the impact of somatic mutations found in coding regions, and have neglected mutations outside of these. However, 3' untranslated regions (3' UTR) mutations can also disrupt or create miRNA target sites, and trigger oncogene activation or tumor suppressor inactivation. Methods We used next-generation sequencing to widely screen for genetic alterations within predicted miRNA target sites of oncogenes associated with colorectal cancer, and evaluated the functional impact of a new somatic mutation. Target sequencing of 47 genes was performed for 29 primary colorectal tumor samples. For 71 independent samples, Sanger methodology was used to screen for E2F1 mutations in miRNA predicted target sites, and the functional impact of these mutations was evaluated by luciferase reporter assays. Results We identified germline and somatic alterations in E2F1. Of the 100 samples evaluated, 3 had germline alterations at the MIR205-5p target site, while one had a somatic mutation at MIR136-5p target site. E2F1 gene expression was similar between normal and tumor tissues bearing the germline alteration; however, expression was increased 4-fold in tumor tissue that harbored a somatic mutation compared to that in normal tissue. Luciferase reporter assays revealed both germline and somatic alterations increased E2F1 activity relative to wild-type E2F1. Conclusions We demonstrated that somatic mutation within E2F1: MIR136-5p target site impairs miRNAmediated regulation and leads to increased gene activity. We conclude that somatic mutations that disrupt miRNA target sites have the potential to impact gene regulation, highlighting an important mechanism of oncogene activation.	[Lopes-Ramos, Camila M.; Barros, Bruna P.; Koyama, Fernanda C.; Carpinetti, Paola A.; Pezuk, Julia; Doimo, Nayara T. S.; Parmigiani, Raphael B.] Hosp Sirio Libanes, Ctr Oncol Mol, Sao Paulo, Brazil; [Koyama, Fernanda C.; Perez, Rodrigo O.] Ludwig Inst Canc Res, Sao Paulo, Brazil; [Habr-Gama, Angelita; Perez, Rodrigo O.] Angelita & Joaquim Gama Inst, Sao Paulo, Brazil; [Habr-Gama, Angelita; Perez, Rodrigo O.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Parmigiani, Raphael B.] Idengene Med Diagnost LTDA, Sao Paulo, SP, Brazil	Hospital Sirio Libanes; Ludwig Institute for Cancer Research; Universidade de Sao Paulo	Parmigiani, RB (corresponding author), Hosp Sirio Libanes, Ctr Oncol Mol, Sao Paulo, Brazil.; Parmigiani, RB (corresponding author), Idengene Med Diagnost LTDA, Sao Paulo, SP, Brazil.	raphaparmigiani@gmail.com	Pezuk, Julia Alejandra/H-1727-2014; PARMIGIANI, RAPHAEL B/A-7475-2014; Lopes-Ramos, Camila M/K-3240-2014; Carpinetti, Paola A/K-1763-2016; Perez, Rodrigo Oliva/A-2163-2013; Lopes-Ramos, Camila/ABB-6537-2020	Pezuk, Julia Alejandra/0000-0001-5412-6619; PARMIGIANI, RAPHAEL B/0000-0001-8360-3584; Perez, Rodrigo Oliva/0000-0003-1704-2277; Carpinetti, Paola/0000-0001-8728-6344	Sao Paulo Research Foundation (FAPESP) [13/05304-8]; CAPES [PNPD20132180]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	RBP was supported by Sao Paulo Research Foundation (FAPESP) grant 13/05304-8, and CML was supported by CAPES PNPD20132180. The funding agencies had no role in the study design, collection, analysis and interpretation of the data, in writing the article, and in the decision to publish	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharya A, 2013, NUCLEIC ACIDS RES, V41, pD977, DOI 10.1093/nar/gks1138; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Christensen LL, 2013, INT J CANCER, V133, P67, DOI 10.1002/ijc.28010; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Desvignes T, 2015, TRENDS GENET, V31, P613, DOI 10.1016/j.tig.2015.09.002; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Eymin B, 2001, ONCOGENE, V20, P1678, DOI 10.1038/sj.onc.1204242; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Gu YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102602; Iwamoto M, 2004, CANCER BIOL THER, V3, P395, DOI 10.4161/cbt.3.4.733; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu CC, 2014, NUCLEIC ACIDS RES, V42, P9543, DOI 10.1093/nar/gku675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nelson MA, 2006, CANCER BIOL THER, V5, P407, DOI 10.4161/cbt.5.4.2512; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Paranjape T, 2011, LANCET ONCOL, V12, P377, DOI 10.1016/S1470-2045(11)70044-4; Piletic K, 2017, OMICS, V21, P197, DOI 10.1089/omi.2017.0023; Ramsingh G, 2010, BLOOD, V116, P5316, DOI 10.1182/blood-2010-05-285395; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Real S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016163; Salzman DW, 2013, PHARMACOL THERAPEUT, V137, P55, DOI 10.1016/j.pharmthera.2012.08.016; Suzuki T, 1999, INT J CANCER, V81, P535, DOI 10.1002/(SICI)1097-0215(19990517)81:4<535::AID-IJC5>3.0.CO;2-4; Xiao BX, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-172	28	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181153	10.1371/journal.pone.0181153	http://dx.doi.org/10.1371/journal.pone.0181153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704519	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700098
J	Yu, Y; Feng, XY; Vieten, G; Dippel, S; Imvised, T; Gueler, F; Ure, BM; Kuebler, JF; Klemann, C				Yu, Yi; Feng, Xiaoyan; Vieten, Gertrud; Dippel, Stephanie; Imvised, Tawan; Gueler, Faikah; Ure, Benno M.; Kuebler, Jochen F.; Klemann, Christian			Conventional alpha beta (alpha beta) T cells do not contribute to acute intestinal ischemiareperfusion injury in mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE KIDNEY INJURY; ISCHEMIA/REPERFUSION INJURY; RESPONSES; LYMPHOCYTES; COMPLEMENT; INNATE	Purpose Ischemia-reperfusion injury (IRI) is associated with significant patient mortality and morbidity. The complex cascade of IRI is incompletely understood, but inflammation is known to be a key mediator. In addition to the predominant innate immune responses, previous research has also indicated that alpha beta T cells contribute to IRI in various organ models. The aim of this study was to clarify the role alpha beta T cells play in IRI to the gut. Methods Adult wild-type (WT) and alpha beta T cell-deficient mice were subjected to acute intestinal IRI with 30min ischemia followed by 4h reperfusion. The gene expression of pro-inflammatory cytokines was measured by qPCR, and the influx of leukocyte subpopulations in the gut was assessed via flow cytometry and histology. Pro-inflammatory cytokines in the serum were measured, and transaminases were assessed as an indicator of distant organ IRI. Results Intestinal IRI led to an increased expression of pro-inflammatory cytokines in the gut tissue and an influx of leukocytes that predominantly consisted of neutrophils and macrophages. Furthermore, intestinal IRI increased serum IL-6, TNF-alpha, and ALT/AST levels. The alpha beta T cell-deficient mice did not exhibit a more significant increase in pro-inflammatory cytokines in the gut or serum following IR than the WT mice. There was also no difference between WT-and alpha beta T cell-deficient mice in terms of neutrophil infiltration or macrophage activation. Furthermore, the increase in transaminases was equal in both groups indicating that the level of distant organ injury was comparable. Conclusion An increasing body of evidence demonstrates that v T cells play a key role in IRI. In the gut, however, alpha beta T cells are not pivotal in the first hours following acute IRI as deficiency does not impact cytokine production, neutrophil recruitment, macrophage activation, or distant organ injury. Thus, alpha beta T cells may be considered innocent bystanders during the acute phase of intestinal IRI.	[Yu, Yi; Feng, Xiaoyan; Vieten, Gertrud; Dippel, Stephanie; Imvised, Tawan; Ure, Benno M.; Kuebler, Jochen F.; Klemann, Christian] Hannover Med Sch, Ctr Surg, Dept Pediat Surg, Hannover, Germany; [Gueler, Faikah] Hannover Med Sch, Dept Nephrol, Hannover, Germany; [Klemann, Christian] Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Klemann, C (corresponding author), Hannover Med Sch, Ctr Surg, Dept Pediat Surg, Hannover, Germany.; Klemann, C (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany.	Klemann.Christian@mh-hannover.de	Klemann, Christian/AAQ-9301-2020	Klemann, Christian/0000-0002-5639-8690				Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Boros P, 2006, AM J TRANSPLANT, V6, P652, DOI 10.1111/j.1600-6143.2005.01228.x; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chen Y, 2016, J PEDIATR SURG, V51, P1255, DOI 10.1016/j.jpedsurg.2015.12.015; Denecke C, 2014, PROG UROL, V24, pS13, DOI 10.1016/S1166-7087(14)70058-2; Edgerton C, 2009, CLIN IMMUNOL, V130, P313, DOI 10.1016/j.clim.2008.09.019; Fleming SD, 2006, AUTOIMMUN REV, V5, P89, DOI 10.1016/j.autrev.2005.09.006; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; Gueler F, 2004, KIDNEY INT, V66, P523, DOI 10.1111/j.1523-1755.2004.761_11.x; Hochegger K, 2007, AM J PHYSIOL-RENAL, V293, pF741, DOI 10.1152/ajprenal.00486.2006; Hofmann U, 2016, EUR HEART J, V37, P873, DOI 10.1093/eurheartj/ehv639; Huang YF, 2007, CELL IMMUNOL, V248, P4, DOI 10.1016/j.cellimm.2007.03.009; Kalogeris T, 2017, COMPR PHYSIOL, V7, P113, DOI 10.1002/cphy.c160006; Kaminski KA, 2002, INT J CARDIOL, V86, P41, DOI 10.1016/S0167-5273(02)00189-4; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Klemann C, 2016, GASTROENTEROLOGY, V150, P229, DOI 10.1053/j.gastro.2015.09.008; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Lee H, 2010, MOL IMMUNOL, V47, P972, DOI 10.1016/j.molimm.2009.11.022; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P1; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Prinz I, 2013, EUR J IMMUNOL, V43, P1988, DOI 10.1002/eji.201343759; Qiu Y, 2014, J MOL HISTOL, V45, P217, DOI 10.1007/s10735-013-9544-1; Rao JH, 2014, CURR OPIN ORGAN TRAN, V19, P115, DOI 10.1097/MOT.0000000000000064; Rong S, 2014, AM J PHYSIOL-RENAL, V307, pF718, DOI 10.1152/ajprenal.00372.2013; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Shigematsu T, 2002, MICROCIRCULATION, V9, P99, DOI 10.1038/sj.mn.7800126; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Watson MJ, 2012, SURGERY, V152, P843, DOI 10.1016/j.surg.2012.03.001; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Williams TM, 2016, NEPHROLOGY CARLTON; Winterberg T, 2015, EUR J IMMUNOL, V45, P214, DOI 10.1002/eji.201444468; Ysebaert DK, 2000, NEPHROL DIAL TRANSPL, V15, P1562, DOI 10.1093/ndt/15.10.1562; Yu Y, 2015, EUR J PEDIATR SURG, V25, P46, DOI 10.1055/s-0034-1387945; Zhang M, 2007, MOL IMMUNOL, V44, P103, DOI 10.1016/j.molimm.2006.06.022; Zuidema MY, 2010, WORLD J CARDIOL, V2, P325, DOI 10.4330/wjc.v2.i10.325	38	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181326	10.1371/journal.pone.0181326	http://dx.doi.org/10.1371/journal.pone.0181326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704542	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700123
J	Prata, TS; Lopes, FS; Prado, VG; Almeida, I; Matsubara, I; Dorairaj, S; Furlanetto, RL; Vessani, RM; Paranhos, A				Prata, Tiago S.; Lopes, Flavio S.; Prado, Vitor G.; Almeida, Izabela; Matsubara, Igor; Dorairaj, Syril; Furlanetto, Rafael L.; Vessani, Roberto M.; Paranhos, Augusto, Jr.			In vivo analysis of glaucoma-related features within the optic nerve head using enhanced depth imaging optical coherence tomography	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; LAMINA-CRIBROSA; MORPHOLOGY; DAMAGE	Structural differences between optic nerve head (ONH) parameters in glaucomatous and non-glaucomatous eyes has been documented, however the association between such parameters in patients with different disease stages is yet to be elucidated. We investigated the relationship between different laminar and prelaminar ONH structures using enhanced depth imaging spectral-domain optical coherence tomography (EDI OCT) in a population with and without glaucoma. In this observational case-control study, we prospectively enrolled healthy individuals and glaucomatous patients with different disease stages. All participants underwent EDI OCT imaging (Heidelberg Engineering). Following ONH parameters were measured on serial vertical B-scans by two examiners masked to patient's clinical data: lamina cribrosa (LC) and prelaminar neural tissue (PLNT) thicknesses, Bruch's membrane opening (BMO) and cup depth. Associations between cup depth, and laminar and prelaminar parameters were evaluated controlling for possible confounding factors such as axial length and disc size. Sixty-four eyes of 64 patients were included (30 with glaucoma and 34 controls). Eyes with glaucoma had significantly lower mean LC and PLNT thickness, and greater mean cup depth than controls (p<0.01). There was a significant negative association between PLNT thickness and cup depth in glaucomatous eyes (R-2 = 0.158, p = 0.029). In addition, LC thickness correlated significantly with cup depth (R-2 = 0.135, p = 0.045). Eyes with thinner LCs presented deeper cups. Overall, cup depth and BMO had the best and LC thickness had the worst intraobserver and interobserver reproducibility grading. In conclusion, significant associations were seen between cup depth, LC and PLNT thickness. Eyes with deeper cups not only had less neural tissue, but also thinner LCs, independent of disc size and axial length. Best reproducibility was found for prelaminar parameters compared to deeper ONH structures.	[Prata, Tiago S.; Lopes, Flavio S.; Prado, Vitor G.; Almeida, Izabela; Matsubara, Igor; Furlanetto, Rafael L.; Vessani, Roberto M.; Paranhos, Augusto, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Glaucoma Serv, Sao Paulo, Brazil; [Prata, Tiago S.; Lopes, Flavio S.; Almeida, Izabela; Matsubara, Igor] Hosp Med Olhos, Glaucoma Unit, Osasco, Brazil; [Dorairaj, Syril] Mayo Clin, Jacksonville, FL 32224 USA	Universidade Federal de Sao Paulo (UNIFESP); Mayo Clinic	Dorairaj, S (corresponding author), Mayo Clin, Jacksonville, FL 32224 USA.	Dorairaj.syril@mayo.edu	Prata, Tiago/AAV-6676-2020; Vessani, Roberto M/AAQ-3016-2020; Paranhos Jr, Augusto/E-6297-2012	Prata, Tiago/0000-0003-1830-3766; Vessani, Roberto/0000-0003-3742-8601; Paranhos Jr, Augusto/0000-0001-6266-6922; FURLANETTO, RAFAEL/0000-0002-0729-6460				ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P800; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Downs JC, 2009, IEEE ENG MED BIO, P4277, DOI 10.1109/IEMBS.2009.5332755; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; Girard MJA, 2015, INVEST OPHTH VIS SCI, V56, P865, DOI 10.1167/iovs.14-14903; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; HERNANDEZ MR, 1990, AM J OPHTHALMOL, V109, P180, DOI 10.1016/S0002-9394(14)75984-7; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1275, DOI 10.1167/iovs.04-0851; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Kagemann L, 2008, OPHTHAL SURG LAS IM, V39, pS126, DOI 10.3928/15428877-20080715-07; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Lopes FSS, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-72; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Prata Tiago S, 2014, Med Hypothesis Discov Innov Ophthalmol, V3, P91; Prata TS, 2012, CLIN EXP OPHTHALMOL, V40, P682, DOI 10.1111/j.1442-9071.2012.02790.x; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P505; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2159; Ren RJ, 2010, GRAEF ARCH CLIN EXP, V248, P1579, DOI 10.1007/s00417-010-1369-y; Sharpe GP, 2016, OPHTHALMOLOGY, V123, P1949, DOI 10.1016/j.ophtha.2016.06.001; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Strouthidis NG, 2010, INVEST OPHTH VIS SCI, V51, P1464, DOI 10.1167/iovs.09-3984; Tezel G, 2004, BRIT J OPHTHALMOL, V88, P251, DOI 10.1136/bjo.2003.019281; Vilupuru AS, 2007, J OPT SOC AM A, V24, P1417, DOI 10.1364/JOSAA.24.001417; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P7109, DOI 10.1167/iovs.11-7448	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180128	10.1371/journal.pone.0180128	http://dx.doi.org/10.1371/journal.pone.0180128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732047	Green Submitted, Green Published, gold			2022-12-27	WOS:000406643100003
J	Gibbs, A; Carpenter, B; Crankshaw, T; Hannass-Hancock, J; Smit, J; Tomlinson, M; Butler, L				Gibbs, Andrew; Carpenter, Bradley; Crankshaw, Tamaryn; Hannass-Hancock, Jill; Smit, Jennifer; Tomlinson, Mark; Butler, Lisa			Prevalence and factors associated with recent intimate partner violence and relationships between disability and depression in postpartum women in one clinic in eThekwini Municipality, South Africa	PLOS ONE			English	Article							HEALTH; RISK; MULTICOUNTRY; PEOPLE	Intimate partner violence (IPV) experienced by pregnant and post-partum women has negative health effects for women, as well as the foetus, and the new-born child. In this study we sought to assess the prevalence and factors associated with recent IPV amongst post-partum women in one clinic in eThekwini Municipality, South Africa, and explore the relationship between IPV, depression and functional limitations/disabilities. Past 12 month IPV-victimisation was 10.55%. Logistic regression modelled relationships between IPV, functional limitations, depressive symptoms, socio-economic measures, and sexual relationship power. In logistic regression models, overall severity of functional limitations were not associated with IPV-victimisation when treated as a continuous overall score. In this model relationship power (aOR0.22, p = 0.001) and depressive symptoms (aOR1.26, p = 0.001) were significant. When the different functional limitations were separated out in a second model, significant factors were relationship power (aOR0.20, p = 0.001), depressive symptoms (aOR1.20, p = 0.011) and mobility limitations (aOR2.96, p = 0.024). The study emphasises that not all functional limitations are associated with IPV-experience, that depression and disability while overlapping can also be considered different drivers of vulnerability, and that women's experience of IPV is not dependent on pregnancy specific factors, but rather wider social factors that all women experience.	[Gibbs, Andrew] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Gibbs, Andrew; Carpenter, Bradley; Crankshaw, Tamaryn] Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa; [Carpenter, Bradley; Hannass-Hancock, Jill] South African Med Res Council, HIV Prevent Res Unit, Durban, South Africa; [Smit, Jennifer] Univ Witwatersrand, Fac Hlth Sci, Dept Obstet & Gynaecol, MatCH Res Unit, Johannesburg, South Africa; [Tomlinson, Mark] Stellenbosch Univ, Dept Psychol, Stellenbosch, South Africa; [Butler, Lisa] Univ Connecticut, Inst Collaborat Hlth Intervent & Policy, Storrs, CT USA	South African Medical Research Council; University of Kwazulu Natal; South African Medical Research Council; University of Witwatersrand; Stellenbosch University; University of Connecticut	Gibbs, A (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.; Gibbs, A (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa.	Andrew.gibbs@mrc.ac.za	Carpenter, Bradley/F-2554-2015; Hanass-Hancock, Jill/AAV-7141-2021	Carpenter, Bradley/0000-0002-2968-1968; Hanass-Hancock, Jill/0000-0003-3662-8548; Crankshaw, Tamaryn/0000-0001-6974-1593; Gibbs, Andrew/0000-0003-2812-5377	Swedish International Development Agency (Sida); Norwegian Agency for Development Cooperation (Norad), through HEARD, UKZN; AG the South African Medical Research Council; National Research Foundation, South Africa; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA022919] Funding Source: NIH RePORTER	Swedish International Development Agency (Sida); Norwegian Agency for Development Cooperation (Norad), through HEARD, UKZN; AG the South African Medical Research Council(South African Medical Research Council); National Research Foundation, South Africa(National Research Foundation - South Africa); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The original project was funded by the Swedish International Development Agency (Sida), Norwegian Agency for Development Cooperation (Norad), through HEARD, UKZN. Funding for this analysis comes from: AG the South African Medical Research Council. However, the views expressed and information contained within are not necessarily those of or endorsed by Sida or Norad, which can accept no responsibility for such views or information or for any reliance placed on them. MT is a lead investigator with the Centre of Excellence in Human Development, University Witwatersrand, South Africa, and is supported by the National Research Foundation, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MT is a lead investigator with the Centre of Excellence in Human Development, University Witwatersrand, South Africa, and is supported by the National Research Foundation, South Africa. We thank the participants and field staff who collected the data.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Bingham N.H., 2010, REGRESSION LINEAR MO; Brownridge DA, 2006, VIOLENCE AGAINST WOM, V12, P805, DOI 10.1177/1077801206292681; Cholera R, 2014, J AFFECT DISORDERS, V167, P160, DOI [10.1016/j.jad.2014.06.003, 10.1016/]; Christofides NJ, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23719; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; De Beaudrap P, 2017, LANCET HIV, V4, pE161, DOI 10.1016/S2352-3018(16)30209-0; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Dickman B., 2006, DISABILITY SOCIAL CH, P116; Fong S, 2016, INT J GYNECOLOGY OBS; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gender Links, 2011, WAR HOM PREL FIND GA; Gibbs A, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17362; Gielen A C, 2000, Matern Child Health J, V4, P111, DOI 10.1023/A:1009522321240; Groves AK, 2014, RELATIONSHIP FACTORS; Hanass-Hancock J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143936; Health Do, 2014, S AFR NAT ANT HIV PR; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Jewkes R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1325; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kvam MH, 2008, SEX ABUSE-J RES TR, V20, P5, DOI 10.1177/1079063208314817; Machisa M., 2011, WAR HOME GENDER BASE; Machisa MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175240; Pallitto CC, 2013, INT J GYNECOL OBSTET, V120, P3, DOI 10.1016/j.ijgo.2012.07.003; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; Shamu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109447; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Van Der Heijden I, 2014, WHAT WORKS PREVENT V; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Vyas S, 2009, J INT DEV, V21, P577, DOI 10.1002/jid.1500; Wachs TD, 2009, CHILD DEV PERSPECT, V3, P51, DOI 10.1111/j.1750-8606.2008.00077.x; World Health Organization, 2021, VIOL WOM PREV EST 20	36	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181236	10.1371/journal.pone.0181236	http://dx.doi.org/10.1371/journal.pone.0181236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727838	Green Published, gold			2022-12-27	WOS:000406634500048
J	Miki, T; Naito, T; Fujiwara, M; Araki, R; Kiyoi, R; Shiode, Y; Fujiwara, A; Morizane, Y; Shiraga, F				Miki, Takako; Naito, Tomoko; Fujiwara, Miyuki; Araki, Ryoichi; Kiyoi, Rieko; Shiode, Yusuke; Fujiwara, Atsushi; Morizane, Yuki; Shiraga, Fumio			Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomy	PLOS ONE			English	Article							UPPER EYELID SULCUS; TOPICAL ANTIGLAUCOMA MEDICATION; OPEN-ANGLE GLAUCOMA; ORBITAL FAT; INTRAOCULAR-PRESSURE; LID SULCUS; BIMATOPROST; DIFFERENTIATION; LATANOPROST; TRAVOPROST	For primary open angle glaucoma (POAG), laser treatment or surgery is used when the target intraocular pressure (IOP) cannot be achieved by pharmacological agents, such as prostaglandin (PG) analogs; these drugs also have varied effects. We retrospectively reviewed the medical records of 74 POAG patients (74 eyes) whose IOP was inadequately controlled by PG analogs (bimatoprost [13 eyes], latanoprost [34 eyes], tafluprost [11 eyes], and travoprost [16 eyes]) and underwent primary trabeculectomy. The proportion of patients with no recurrent IOP elevation within 24 months post-trabeculectomy was significantly (P < 0.001) lower in the bimatoprost group (31.3%) than in the latanoprost (83.2%), tafluprost (45.5%), or travoprost groups (65.6%). Deepening of the upper eyelid sulcus (DUES) was observed before trabeculectomy in 18 of 74 eyes (24.3%) treated with bimatoprost (9 eyes; 50.0%), latanoprost (3 eyes; 16.7%), tafluprost (1 eye; 5.5%) and travoprost (5 eyes; 27.8%). The proportion of patients with no recurrent IOP elevation up to 24 months post-trabeculectomy was significantly (P < 0.0001) lower in the DUES(+) group (34.7%) than in the DUES(-) group (74.3%). Multivariate stepwise logistic regression analysis, with no recurrent IOP elevation used as dependent variable, and bimatoprost, latanoprost, travoprost, tafluprost, beta-blocker, carbonic anhydrase inhibitor, brimonidine, gender, age, preoperative IOP, mean deviation, duration of PG analog use before surgery, and the number of ophthalmic solutions used as independent variables, identified only bimatoprost as a significant independent factor (P = 0.0368). Thus, the outcome of trabeculectomy varied depending on the PG analog used preoperatively, and bimatoprost use was associated with a high risk of recurrent IOP elevation up to 2 years post-trabeculectomy. This may indicate that the incidence of DUES differed with the PG analog used. Patients with glaucoma who are treated with bimatoprost should be monitored for DUES, and when these patients undergo trabeculectomy, the postoperative course of IOP should be followed carefully.	[Miki, Takako; Naito, Tomoko; Fujiwara, Miyuki; Araki, Ryoichi; Shiode, Yusuke; Fujiwara, Atsushi; Morizane, Yuki; Shiraga, Fumio] Okayama Univ, Dept Ophthalmol, Grad Sch Med, Okayama, Japan; [Kiyoi, Rieko] Japanese Red Cross Okayama Hosp, Okayama, Japan	Okayama University	Miki, T (corresponding author), Okayama Univ, Dept Ophthalmol, Grad Sch Med, Okayama, Japan.	higo_oka@yahoo.co.jp						Aihara M, 2011, JPN J OPHTHALMOL, V55, P600, DOI 10.1007/s10384-011-0075-6; Aihara M, 2010, CLIN OPHTHALMOL, V4, P163; Alm A, 2008, SURV OPHTHALMOL, V53, pS93, DOI 10.1016/j.survophthal.2008.08.004; Ayala M, 2012, J OCUL PHARMACOL TH, V28, P118, DOI 10.1089/jop.2011.0084; Aydin S, 2010, CUTAN OCUL TOXICOL, V29, P212, DOI 10.3109/15569521003796860; BAUDOUIN C, 1994, OPHTHALMOLOGY, V101, P454; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Berke SJ, 2012, REV OPHTHALMOLOGY, V19, P70; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1437, DOI 10.1001/archopht.1994.01090230051020; Choi HY, 2012, J OCUL PHARMACOL TH, V28, P146, DOI 10.1089/jop.2011.0160; Crawley L, 2012, OPHTHALMOL EYE DIS, V4, P43, DOI 10.4137/OED.S4909; Filippopoulos T, 2008, OPHTHAL PLAST RECONS, V24, P302, DOI 10.1097/IOP.0b013e31817d81df; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Ichhpujani P, 2012, J OCUL PHARMACOL TH, V28, P134, DOI 10.1089/jop.2011.0097; Inoue K, 2013, J GLAUCOMA, V22, P626, DOI 10.1097/IJG.0b013e31824d8d7c; Ishida N, 2006, CARDIOVASC DRUG REV, V24, P1, DOI 10.1111/j.1527-3466.2006.00001.x; Kucukevcilioglu M, 2014, CLIN EXP OPHTHALMOL, V42, P126, DOI 10.1111/ceo.12163; Kulkarni Sadhana V, 2008, Patient Prefer Adherence, V2, P303; Lin L, 2014, ANN PHARMACOTHER, V48, P1585, DOI 10.1177/1060028014548569; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; Ogundele AB, 2010, CLIN OPHTHALMOL, V4, P1447, DOI 10.2147/OPTH.S15521; Park J, 2011, JPN J OPHTHALMOL, V55, P22, DOI 10.1007/s10384-010-0904-z; Peplinski LS, 2004, OPTOMETRY VISION SCI, V81, P574, DOI 10.1097/01.opx.0000141791.16683.4a; Sakata R, 2014, EYE, V28, P1446, DOI 10.1038/eye.2014.224; Sakata R, 2013, JPN J OPHTHALMOL, V57, P179, DOI 10.1007/s10384-012-0219-3; Serrero G, 1997, BIOCHEM BIOPH RES CO, V233, P200, DOI 10.1006/bbrc.1997.6433; Sethi HS, 2015, ASTROCYTE, V2, P126; Shah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061638; Singh D, 2009, EYE, V23, P2194, DOI 10.1038/eye.2009.1; Sjoquist B, 2002, SURV OPHTHALMOL, V47, pS6, DOI 10.1016/S0039-6257(02)00302-8; Taketani Y, 2014, INVEST OPHTH VIS SCI, V55, P1269, DOI 10.1167/iovs.13-12589; Tappeiner C, 2008, KLIN MONATSBL AUGENH, V225, P443, DOI 10.1055/s-2008-1027362; Yam JC, 2009, J OCUL PHARMACOL, V53, P176; Yang HK, 2009, JPN J OPHTHALMOL, V53, P176, DOI 10.1007/s10384-008-0623-x; 이중원, 2007, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V48, P332	37	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181550	10.1371/journal.pone.0181550	http://dx.doi.org/10.1371/journal.pone.0181550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727804	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500085
J	Vartanian, V; Tumova, J; Dobrzyn, P; Dobrzyn, A; Nakabeppu, Y; Lloyd, RS; Sampath, H				Vartanian, Vladimir; Tumova, Jana; Dobrzyn, Pawel; Dobrzyn, Agnieszka; Nakabeppu, Yusaku; Lloyd, R. Stephen; Sampath, Harini			8-oxoguanine DNA glycosylase (OGG1) deficiency elicits coordinated changes in lipid and mitochondrial metabolism in muscle	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; ALZHEIMERS-DISEASE BRAIN; BASE EXCISION-REPAIR; SKELETAL-MUSCLE; INSULIN-RESISTANCE; GENE-EXPRESSION; OXIDATIVE DAMAGE; SACCHAROMYCES-CEREVISIAE; SER326CYS POLYMORPHISM; PARKINSONS-DISEASE	Oxidative stress resulting from endogenous and exogenous sources causes damage to cellular components, including genomic and mitochondrial DNA. Oxidative DNA damage is primarily repaired via the base excision repair pathway that is initiated by DNA glycosylases. 8-oxoguanine DNA glycosylase (OGG1) recognizes and cleaves oxidized and ring-fragmented purines, including 8-oxoguanine, the most commonly formed oxidative DNA lesion. Mice lacking the OGG1 gene product are prone to multiple features of the metabolic syndrome, including high-fat diet-induced obesity, hepatic steatosis, and insulin resistance. Here, we report that OGG1-deficient mice also display skeletal muscle pathologies, including increased muscle lipid deposition and alterations in genes regulating lipid uptake and mitochondrial fission in skeletal muscle. In addition, expression of genes of the TCA cycle and of carbohydrate and lipid metabolism are also significantly altered in muscle of OGG1-deficient mice. These tissue changes are accompanied by marked reductions in markers of muscle function in OGG1-deficient animals, including decreased grip strength and treadmill endurance. Collectively, these data indicate a role for skeletal muscle OGG1 in the maintenance of optimal tissue function.	[Vartanian, Vladimir; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Tumova, Jana; Sampath, Harini] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ USA; [Dobrzyn, Pawel; Dobrzyn, Agnieszka] Nencki Inst Expt Biol, Warsaw, Poland; [Nakabeppu, Yusaku] Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Fukuoka, Japan; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Sampath, Harini] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ USA; [Sampath, Harini] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Ctr Digest Hlth, New Brunswick, NJ USA	Oregon Health & Science University; Rutgers State University New Brunswick; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Kyushu University; Oregon Health & Science University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Sampath, H (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ USA.; Nakabeppu, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Fukuoka, Japan.; Sampath, H (corresponding author), Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ USA.; Sampath, H (corresponding author), Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Ctr Digest Hlth, New Brunswick, NJ USA.	yusaku@bioreg.kyushu-u.ac.jp; sampath@ifnh.rutgers.edu	Tumova, Jana/A-2260-2010; Nakabeppu, Yusaku/A-8902-2011; Dobrzyn, Agnieszka/R-4073-2016; Dobrzyn, Pawel/R-4076-2016	Tumova, Jana/0000-0003-1625-4737; Nakabeppu, Yusaku/0000-0002-6739-242X; Dobrzyn, Agnieszka/0000-0002-6331-9460; Lloyd, R. Stephen/0000-0001-7273-372X; Dobrzyn, Pawel/0000-0002-2433-1897	NIH [DK100640, DK075974]; Grants-in-Aid for Scientific Research [17H01391] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by NIH DK100640 to HS and NIH DK075974 to RSL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhassani N, 2016, MECH AGEING DEV; Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Audebert M, 2000, CANCER RES, V60, P4740; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Bess AS, 2012, NUCLEIC ACIDS RES, V40, P7916, DOI 10.1093/nar/gks532; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bordoni A, 1992, Cardiologia, V37, P631; Carcamo JM, 2006, MUTAT RES, V593, P64; Cardozo-Pelaez F, 2005, GENE EXPRESSION, V12, P315, DOI 10.3727/000000005783992007; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Daimon M, 2009, BIOCHEM BIOPH RES CO, V386, P26, DOI 10.1016/j.bbrc.2009.05.119; Dezor M, 2011, FOLIA NEUROPATHOL, V49, P123; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Dorszewska J, 2009, DNA CELL BIOL, V28, P579, DOI 10.1089/dna.2009.0926; Fisher RM, 2005, CURR OPIN LIPIDOL, V16, P173, DOI 10.1097/01.mol.0000162322.39548.b1; Fukae J, 2005, ACTA NEUROPATHOL, V109, P256, DOI 10.1007/s00401-004-0937-9; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Holloway GP, 2008, ACTA PHYSIOL, V194, P293, DOI 10.1111/j.1748-1716.2008.01878.x; Iida T, 2002, ACTA NEUROPATHOL, V103, P20, DOI 10.1007/s004010100418; Itoh K, 2012, TRENDS CELL BIOL; Jeromson S, 2015, MAR DRUGS, V13, P6977, DOI 10.3390/md13116977; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim HJ, 2011, ACTA BIOCH BIOPH SIN, V43, P589, DOI 10.1093/abbs/gmr053; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Klungland A, 2007, DNA REPAIR, V6, P481, DOI 10.1016/j.dnarep.2006.10.012; Kuroki T, 1998, BIOCHEM BIOPH RES CO, V247, P473, DOI 10.1006/bbrc.1998.8814; Le Page F, 2000, P NATL ACAD SCI USA, V97, P8397, DOI 10.1073/pnas.140137297; Li C, 2000, ENDOTEXT; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luiken JJFP, 2001, INT J SPORT NUTR EXE, V11, pS92, DOI 10.1123/ijsnem.11.s1.s92; Luo JX, 2014, FREE RADICAL BIO MED, V73, P430, DOI 10.1016/j.freeradbiomed.2014.03.030; Madani S, 2004, J BIOL CHEM, V279, P1176, DOI 10.1074/jbc.M306252200; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; McAinch AJ, 2003, OBES RES, V11, P1471, DOI 10.1038/oby.2003.197; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MILLER WC, 1984, J APPL PHYSIOL, V56, P78, DOI 10.1152/jappl.1984.56.1.78; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191; Nakabeppu Y, 2014, INT J MOL SCI, V15, P12543, DOI 10.3390/ijms150712543; NEMETH PM, 1992, AM J PHYSIOL, V262, pC282, DOI 10.1152/ajpcell.1992.262.2.C282; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Okasaka T, 2009, J HUM GENET, V54, P739, DOI 10.1038/jhg.2009.108; Osterod M, 2001, CARCINOGENESIS, V22, P1459, DOI 10.1093/carcin/22.9.1459; Pan L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43297; Pan L, 2016, J BIOL CHEM, V291, P25553, DOI 10.1074/jbc.M116.751453; Pastukh V, 2015, AM J PHYSIOL-LUNG C, V309, pL1367, DOI 10.1152/ajplung.00236.2015; Patkova J, 2014, CELL PHYSIOL BIOCHEM, V33, P1439, DOI 10.1159/000358709; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Ritter O, 2015, J MOL MED, V93, P831, DOI 10.1007/s00109-015-1310-2; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Russo MT, 2007, MUTAT RES-FUND MOL M, V614, P69, DOI 10.1016/j.mrfmmm.2006.03.007; Sakumi K, 2003, CANCER RES, V63, P902; Sampath H, 2014, ENVIRON MOL MUTAGEN, V55, P689, DOI 10.1002/em.21886; Sampath H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051697; Sampath H, 2012, FREE RADICAL RES, V46, P460, DOI 10.3109/10715762.2012.655730; Sears B, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0123-1; Seifermann M., 2016, FREE RADIC BIOL MED; Shao C, 2008, FREE RADICAL BIO MED, V45, P813, DOI 10.1016/j.freeradbiomed.2008.06.003; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stiles L, 2012, BEST PRACT RES CL EN, V26, P725, DOI 10.1016/j.beem.2012.05.004; Thameem F, 2010, HUM HERED, V70, P97, DOI 10.1159/000291964; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Torres-Gonzalez M, 2014, AM J PHYSIOL-CELL PH, V306, pC221, DOI 10.1152/ajpcell.00140.2013; Trapp C, 2007, MUTAT RES-FUND MOL M, V625, P155, DOI 10.1016/j.mrfmmm.2007.06.006; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Yan MH, 2012, FREE RADIC BIOL MED; Yuzefovych LV, 2013, ENDOCRINOLOGY, V154, P2640, DOI 10.1210/en.2013-1076; Zhou XL, 2016, CELL SIGNAL, V28, P1163, DOI 10.1016/j.cellsig.2016.05.021	80	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181687	10.1371/journal.pone.0181687	http://dx.doi.org/10.1371/journal.pone.0181687			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727777	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500104
J	Alcaraz-Castano, M; Alcolea-Gonzalez, J; Kehl, M; Albert, RM; Baena-Preysler, J; de Balbin-Behrmann, R; Cuartero, F; Cuenca-Bescos, G; Jimenez-Barredo, F; Lopez-Saez, JA; Pique, R; Rodriguez-Anton, D; Yravedra, J; Weniger, GC				Alcaraz-Castano, Manuel; Alcolea-Gonzalez, Javier; Kehl, Martin; Albert, Rosa-Maria; Baena-Preysler, Javier; de Balbin-Behrmann, Rodrigo; Cuartero, Felipe; Cuenca-Bescos, Gloria; Jimenez-Barredo, Fernando; Lopez-Saez, Jose-Antonio; Pique, Raquel; Rodriguez-Anton, David; Yravedra, Jose; Weniger, Gerd-Christian			A context for the last Neandertals of interior Iberia: Los Casares cave revisited	PLOS ONE			English	Article							UPPER PALEOLITHIC TRANSITION; OLDUVAI GORGE TANZANIA; ISOTOPE MEASUREMENTS; PERCUSSION MARKS; LATE PLEISTOCENE; POLLEN ANALYSIS; MIDDLE; SITE; CHRONOLOGY; HOMINID	Introduction and objectives Although the Iberian Peninsula is a key area for understanding the Middle to Upper Paleolithic transition and the demise of the Neandertals, valuable evidence for these debates remains scarce and problematic in its interior regions. Sparse data supporting a late Neandertal persistence in the Iberian interior have been recently refuted and hence new evidence is needed to build new models on the timing and causes of Neandertal disappearance in inland Iberia and the whole peninsula. In this study we provide new evidence from Los Casares, a cave located in the highlands of the Spanish Meseta, where a Neandertal-associated Middle Paleolithic site was discovered and first excavated in the 1960's. Our main objective is twofold: (1) provide an updated geoarcheological, paleoenvironmental and chronological framework for this site, and (2) discuss obtained results in the context of the time and nature of the last Neandertal presence in Iberia. Methods We conducted new fieldwork in an interior chamber of Los Casares cave named 'Seno A'. Our methods included micromorphology, sedimentology, radiocarbon dating, Uranium/Thorium dating, palinology, microfaunal analysis, anthracology, phytolith analysis, archeo-zoology and lithic technology. Here we present results on site formation processes, paleoenvironment and the chronological setting of the Neandertal occupation at Los Casares cave-Seno A. Results and discussion The sediment sequence reveals a mostly in situ archeological deposit containing evidence of both Neandertal activity and carnivore action in level c, dated to 44,899 +/- 42,175 calendar years ago. This occupation occurred during a warm and humid interval of Marine Isotopic Stage 3, probably correlating with Greenland Interstadial 11, representing one of the latest occurrences of Neandertals in the Iberian interior. However, overlying layer b records a deterioration of local environments, thus providing a plausible explanation for the abandonment of the site, and perhaps for the total disappearance of Neandertals of the highlands of inland Iberia during subsequent Greenland Stadials 11 or 10, or even Heinrich Stadial 4. Since layer b provided very few signs of human activity and no reliable chronometric results, and given the scarce chronostratigrapic evidence recorded so far for this period in interior Iberia, this can only be taken as a working hypothesis to be tested with future research. Meanwhile, 42,000 calendar years ago remains the most plausible date for the abandonment of interior Iberia by Neandertals, possibly due to climate deterioration. Currently, a later survival of this human species in Iberia is limited to the southern coasts.	[Alcaraz-Castano, Manuel; Weniger, Gerd-Christian] Neanderthal Museum, Mettmann, Germany; [Alcaraz-Castano, Manuel; Alcolea-Gonzalez, Javier; de Balbin-Behrmann, Rodrigo] Univ Alcala, Area Prehist, Alcala De Henares, Spain; [Kehl, Martin] Univ Cologne, Inst Geog, Cologne, Germany; [Albert, Rosa-Maria] Univ Barcelona, ERAAUB Dept Hist & Achaeol, Barcelona, Spain; [Albert, Rosa-Maria] ICREA, Barcelona, Spain; [Baena-Preysler, Javier; Cuartero, Felipe] Autonomous Univ Madrid, Dept Prehist & Archeol, Madrid, Spain; [Cuenca-Bescos, Gloria] Univ Zaragoza, Dept Geosci, Aragosaurus IUCA, Zaragoza, Spain; [Jimenez-Barredo, Fernando] CENIEH Natl Res Ctr Human Evolut, Burgos, Spain; [Lopez-Saez, Jose-Antonio] CCHS CSIC, Hist Inst, Archeobiol Res Grp, Madrid, Spain; [Pique, Raquel; Rodriguez-Anton, David] Autonomous Univ Barcelona, Dept Prehist, Barcelona, Spain; [Yravedra, Jose] Univ Complutense Madrid, Dept Prehist, Madrid, Spain	Universidad de Alcala; University of Cologne; University of Barcelona; ICREA; Autonomous University of Madrid; University of Zaragoza; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Historia (IH); Autonomous University of Barcelona; Complutense University of Madrid	Alcaraz-Castano, M (corresponding author), Neanderthal Museum, Mettmann, Germany.; Alcaraz-Castano, M (corresponding author), Univ Alcala, Area Prehist, Alcala De Henares, Spain.	manuel.alcaraz@uah.es	Jimenez, Fernando/W-1462-2019; Alcolea-González, José Javier/ABF-6941-2020; CUARTERO MONTEAGUDO, FELIPE/S-8690-2016; Yravedra, Jose/E-9815-2016; Albert, Rosa Maria/F-2937-2016; David, Rodríguez Antón/ABA-7286-2021; Yravedra, Jose/AAC-2073-2019; Gloria, Cuenca-Bescós/A-3616-2013	Jimenez, Fernando/0000-0002-9794-6489; Alcolea-González, José Javier/0000-0003-0911-5472; CUARTERO MONTEAGUDO, FELIPE/0000-0002-9024-2980; Albert, Rosa Maria/0000-0003-1722-9445; David, Rodríguez Antón/0000-0003-4116-2308; Yravedra, Jose/0000-0002-4323-3379; Gloria, Cuenca-Bescós/0000-0001-5125-9651; Alcaraz-Castano, Manuel/0000-0001-6291-9512; Pique Huerta, Raquel/0000-0002-8253-6874	Marie Curie Intra European Fellowship within the 7th European Community Framework Programme [628179]; German Research Foundation's (DFG) [CRC 806]; Spanish Ministry of Economy, Industry and Competitiveness [HAR2013-48784-C3-3-P, HAR2016-76760-C3-2-P, HAR2013-43701-P, CGL2012-38434-C03-01]; Comunidad de Madrid [2016-T2/HUM-1251]; FP7 Post-Grant Open Access Pilot (OpenAIRE) of the European Commission	Marie Curie Intra European Fellowship within the 7th European Community Framework Programme(European Commission); German Research Foundation's (DFG)(German Research Foundation (DFG)); Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); FP7 Post-Grant Open Access Pilot (OpenAIRE) of the European Commission	This research was funded by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (https://ec.europa.euireseamh/fp7/index_en.cfm), under the project 'Testing population hiatuses in the Late Pleistocene of Central Iberia: a geoarchaeological approach' (Grant number 628179) (MAC, GCW). It was also supported by funding of the German Research Foundation's (DFG) project CRC 806 "Our Way to Europe" (http://www.dfg.de/en/) (GCW, MK), and the Spanish Ministry of Economy, Industry and Competitiveness (http://www.minecogob.es/portal/siteimineco/), project numbers HAR2013-48784-C3-3-P (JBP, FC, MAC), HAR2016-76760-C3-2-P (JBP, FC, MAC), HAR2013-43701-P (JALS) and CGL2012-38434-C03-01 (GCB). MAC currently holds a post-doc fellowship (Ayuda para la Atraccion de Talento lnvestigador 2016-T2/HUM-1251) awarded by the Comunidad de Madrid (http://www.madrimasd.org/madrid-ciencia-tecnologia/). Publication fees were funded by the FP7 Post-Grant Open Access Pilot (OpenAIRE) of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert RM, 1999, J ARCHAEOL SCI, V26, P1249, DOI 10.1006/jasc.1999.0355; Albert RM, 2006, QUATERN INT, V148, P78, DOI 10.1016/j.quaint.2005.11.026; Albert RM, 2001, PHYTOLITHS: APPLICATIONS IN EARTH SCIENCES AND HUMAN HISTORY, P251; Albert RM, 2016, J ARCHAEOL SCI, V68, P98, DOI 10.1016/j.jas.2015.10.014; Alcaraz-Castano M, 2015, 57 ANN M HEID 7 11 A, P14; Alcaraz-Castano M, 2016, P EUR SOC STUD HUM E, P31; Alcaraz-Castano M, VISION GLOBAL CUATER, P42; Alcaraz-Castano M., 2015, ARPI ARQUEOLOGIA PRE, V2, P68; Alcaraz-Castano M, 2015, J ANTHROPOL RES, V71, P565, DOI 10.3998/jar.0521004.0071.406; Alcaraz-Castano M, 2013, TRABAJOS PREHIST, V70, P28, DOI 10.3989/tp.2013.12101; Altuna J, 1973, EXCAVACIONES ARQUEOL, V76, P97; Alvarez-Alonso D, 2017, GEOPH RES ABSTR, V19, P6919; Amick DS, 2014, LITHIC TECHNOL, V39, P64, DOI 10.1179/0197726113Z.00000000025; Andersen KK, 2006, QUATERNARY SCI REV, V25, P3246, DOI 10.1016/j.quascirev.2006.08.002; [Anonymous], [No title captured]; [Anonymous], 1982, BAR BRIT SERIES; Lopez-Saez JA, 2015, PHYTOCOENOLOGIA, V45, P107, DOI 10.1127/0340-269X/2014/0044-0572; Antonio Lopez-Saez Jose, 2013, Lazaroa, V34, P191, DOI 10.5209/rev_LAZA.2013.v34.n1.43599; Lopez-Saez JA, 2010, PHYTOCOENOLOGIA, V40, P57, DOI 10.1127/0340-269X/2010/0040-0430; Arnold L, 2013, OSL DATING MIDDLE PA; Arribas Herrera A., 1999, HUE LLA PASADO FOSIL, P327; Arsuaga JL, 2016, P EUR SOC STUD HUM E, V5, P36; Badal E., 2012, SAGVNTUM EXTRA, V13, P13; Preysler JB, 2015, QUATERN INT, V361, P142, DOI 10.1016/j.quaint.2014.07.007; Balbin-Behrmann R, 1992, ANTHROPOLOGIE, V96, P397; Ball TB, 2016, J ARCHAEOL SCI, V68, P106, DOI 10.1016/j.jas.2015.03.023; Baquedano E., 2016, P EUR SOC STUD HUM E, P41; Bar-Yosef O, 2009, CURR ANTHROPOL, V50, P103, DOI 10.1086/592234; Barandiaran I., 1973, EXCAVACIONES ARQUEOL, V76; Barba R, 2005, J TAPHONOMY, V3, P29; Barboni D, 2009, REV PALAEOBOT PALYNO, V158, P29, DOI 10.1016/j.revpalbo.2009.07.002; Basabe J. M, 1973, EXCAVACIONES ARQUEOL, V76, P117; Beckmann T., 1997, MIKROMORPHOLOGISCHE, V40, P89; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Bradtmoller M, 2012, QUATERN INT, V247, P38, DOI 10.1016/j.quaint.2010.10.015; Brain C. K, 1969, SCI PAPERS NAMIBIAN, V32, P1; Bunn H, 1982, MEAT EATING HUMAN EV; Burnett W.C., 1992, URANIUM SERIES DISEQ, P486; Cabre J, 1936, ACT 16 C INT ANTHR B, VI, P402; Cabre J., 1940, AR ESP ARQ, VXIV, P81; Cabre J., 1934, ARCH ESPAN ART, VX, P225; Caceres I., 2002, TAFONOMA YACIMIENTOS, P659; Cacho C, 2010, MONOGRAFIES SERP, VXXI, P115; Carbonell E., 2014, CAZADORES RECOLECTOR, P608; Carnelli AL, 2004, REV PALAEOBOT PALYNO, V129, P39, DOI 10.1016/j.revpalbo.2003.11.002; Carnelli AL, 2001, ANN BOT-LONDON, V87, P425, DOI 10.1006/anbo.2000.1355; Carrion JS, 2007, J QUATERNARY SCI, V22, P191, DOI 10.1002/jqs.1024; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Cuenca-Bescos G, 2010, QUATERN INT, V212, P129, DOI 10.1016/j.quaint.2009.06.006; Cuenca-Bescos G., 2003, EXTRA, P95; Cuenca-Bescos G, 2014, INTEGR ZOOL, V9, P481, DOI 10.1111/1749-4877.12053; Cuenca-Bescos G, 2009, J ARCHAEOL SCI, V36, P947, DOI 10.1016/j.jas.2008.09.025; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; de la Pena P, 2013, P NATL ACAD SCI USA, V110, pE2086, DOI 10.1073/pnas.1303596110; de la Torre I, 2015, J QUATERNARY SCI, V30, P376, DOI 10.1002/jqs.2791; Desprat S, 2015, J BIOGEOGR, V42, P1998, DOI 10.1111/jbi.12566; Diez C, 2008, CUATERN GEOMORFOL, V22, P135; Domingo R, 2017, QUATERN INT, V435, P129, DOI 10.1016/j.quaint.2015.09.088; Dominguez-Rodrigo M, 1997, J HUM EVOL, V33, P669, DOI 10.1006/jhev.1997.0161; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo Manuel, 2005, Journal of Taphonomy, V3, P121; Esteban I, 2017, ARCHAEOL ANTHROP SCI, V9, P265, DOI 10.1007/s12520-015-0279-7; Fernandez S, 2007, GEOBIOS-LYON, V40, P75, DOI 10.1016/j.geobios.2006.01.004; Finlayson C, 2008, QUATERN INT, V181, P64, DOI 10.1016/j.quaint.2007.11.016; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Galvan B, 2014, J HUM EVOL, V75, P16, DOI 10.1016/j.jhevol.2014.06.002; Gibert L, 2016, J HUM EVOL, V90, P183, DOI 10.1016/j.jhevol.2015.08.002; Goni MFS, 2010, QUATERNARY SCI REV, V29, P2823, DOI 10.1016/j.quascirev.2009.11.014; Grimm E.C., 1993, TILIA PROGRAM ANAL D; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Guillem P., 1995, CUATERNARIO PAIS VAL, P227; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Hodgkins J, 2016, J HUM EVOL, V96, P1, DOI 10.1016/j.jhevol.2016.03.009; Hoffmann DL, 2008, INT J MASS SPECTROM, V275, P75, DOI 10.1016/j.ijms.2008.05.033; Hoffmann DL, 2007, INT J MASS SPECTROM, V264, P97, DOI 10.1016/j.ijms.2007.03.020; Hoffmann DL, 2013, QUATERN INT, V294, P168, DOI 10.1016/j.quaint.2012.05.027; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Inizan ML, 1999, PREHISTORIC PIERRE T, V5; Iturbe G, 1990, RECERQUES MUSEO ALCO, V2, P23; Joris O, 2008, J HUM EVOL, V55, P782, DOI 10.1016/j.jhevol.2008.04.002; Jorda J., 2010, CUATERNARIO ARQUEOLO, P101; Joris O., 2003, TRABAJOS PREHIST, V60, P15, DOI DOI 10.3989/TP.2003.V60.I2.79; Kehl M, 2016, QUAT INT IN PRESS; Kehl M., 2017, GEOPH RES ABSTR, V19, P6402; L6pez Saez J. A., 2003, POLEN, V12, P5; Laplana C, 2013, QUATERNAIRE, V24, P207, DOI 10.4000/quaternaire.6617; Lopez-Garcia JM, 2011, EVOLUION DIVERSIDAD; Lopez-Garcia JM, 2008, J HUM EVOL, V55, P1151, DOI 10.1016/j.jhevol.2008.08.001; Arsuaga JL, 2012, QUATERN INT, V275, P55, DOI 10.1016/j.quaint.2012.04.019; LYMAN RL, 1994, PALAIOS, V9, P288, DOI 10.2307/3515203; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Madella M, 1998, J ARCHAEOL SCI, V25, P801, DOI 10.1006/jasc.1997.0226; Madella M, 2012, QUATERN INT, V275, P76, DOI 10.1016/j.quaint.2011.09.008; Lopez-Garcia JM, 2014, QUATERN INT, V326, P319, DOI 10.1016/j.quaint.2013.09.010; Lopez-Garcia JM, 2010, QUATERNAIRE, V21, P249; Maroto J, 2012, QUATERN INT, V247, P15, DOI 10.1016/j.quaint.2011.07.007; Mingo A, 2014, QUAD PREH ARQ CAST, V32, P21; Moore P.D., 1991, BLACKWELL SCI PUBLI; Moure A., 1983, CURR ANTHROPOL, V19, P155; Navazo M., 2005, MUSEO ALTAMIRA MONOG, V20, P151, DOI DOI 10.3406/BSPF.1995.10058; Navazo M, 2014, QUATERN INT, V331, P267, DOI 10.1016/j.quaint.2014.03.032; Nohemi Sala M. T., 2011, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Geologica, V105, P67; Parsons M. K, 1989, PROCESSES FOSSILIZAT, P22; Perez Ripoll M., 1988, ARCH PREHISTORIA LEV, V18, P83; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Pique R., 2003, RECOGIDA MUESTRAS AR, P11; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Puig, 1894, CAVERNAS SIMAS B COM; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Raposo L, 1998, TRABAJOS PREHIST, V55, P39; Rasmussen SO, 2014, QUATERNARY SCI REV, V106, P14, DOI 10.1016/j.quascirev.2014.09.007; Reille M., 1992, POLLEN SPORES DEUROP; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rethemeyer J, 2013, NUCL INSTRUM METH B, V294, P168, DOI 10.1016/j.nimb.2012.02.012; Romanillo A. Moure, 1997, 2 C ARQ PEN, P67; Ruiz-Bustos A, 1997, CUADERNOS PREHISTORI, V2, P7; Yustos PS, 2015, QUATERNARY SCI REV, V121, P75, DOI 10.1016/j.quascirev.2015.05.005; Schmidt I, 2012, QUATERN INT, V274, P179, DOI 10.1016/j.quaint.2012.01.018; Scholz D., 2008, QUATERNARY SCI J, V57, P52; Sepulchre P, 2007, EARTH PLANET SC LETT, V258, P283, DOI 10.1016/j.epsl.2007.03.041; Sese C, 2011, ESTUD GEOL-MADRID, V67, P471, DOI 10.3989/egeol.40516.203; Silva PG, 2012, ESTUD GEOL-MADRID, V68, P57, DOI 10.3989/egeol.40338.134; Steele TE, 2002, THESIS; Stoops G., 2003, GUIDELINES ANAL DESC; Straus LG, 2005, QUATERN INT, V137, P47, DOI 10.1016/j.quaint.2004.11.019; Straus LG., 1993, PREHISTOIRE EUROPEEN, V3, P11; Svensson A, 2006, QUATERNARY SCI REV, V25, P3258, DOI 10.1016/j.quascirev.2006.08.003; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thompson CEL, 2011, J ARCHAEOL SCI, V38, P784, DOI 10.1016/j.jas.2010.11.001; Tsartsidou G, 2007, J ARCHAEOL SCI, V34, P1262, DOI 10.1016/j.jas.2006.10.017; Twiss P.C., 1992, PHYTOLITH SYSTEMATIC, P113, DOI [10.1007/978-1-4899-1155-1_6, DOI 10.1007/978-1-4899-1155-1_6]; Uzquiano P., 2005, MONOGRAFIAS MUSEO AL, V20, P255; Vaquero M., 2006, NEANDERTHALS MODERN, P419; Vaquero Rodriguez M., 2006, PYRENAE, V37, P107; Vega G., 1993, ORIGEN HOMBRE MODERN, P147; Vega-Toscano LG, HOMME DE NEANDERTAL, V2; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Villaverde V, 1990, PALEOLITHIQUE MOYEN, P177; Walker MJ, 2012, QUATERN INT, V259, P7, DOI 10.1016/j.quaint.2011.03.034; Wood RE, 2014, J HUM EVOL, V69, P91, DOI 10.1016/j.jhevol.2013.12.017; Wood RE, 2013, P NATL ACAD SCI USA, V110, P2781, DOI 10.1073/pnas.1207656110; Yravedra J, 2009, J QUATERNARY SCI, V24, P85, DOI 10.1002/jqs.1164; YRAVEDRA J, 2006, TAFONOMIA APLICADA Z; Yravedra J, 2007, ARQUEOWEB, V9; Zilhao J., 1993, ORIGEN HOMBRE MODERN, P127; Zilhao J., 2006, FARMING, V2006, P95; Zilhao J., 2006, PYRENAE, V37, P7, DOI DOI 10.1039/C4CC09587A; Zilhao J, 2013, CULTURAL PERSPECTIVE, V1, P21; Zilhao J, 2016, QUATERNARY SCI REV, V146, P251, DOI 10.1016/j.quascirev.2016.05.038; Zilhao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008880	153	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180823	10.1371/journal.pone.0180823	http://dx.doi.org/10.1371/journal.pone.0180823			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723924	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800028
J	Paudel, BR; Shrestha, M; Dyer, AG; Li, QJ				Paudel, Babu Ram; Shrestha, Mani; Dyer, Adrian G.; Li, Qing-Jun			Ginger and the beetle: Evidence of primitive pollination system in a Himalayan endemic alpine ginger (Roscoea alpina, Zingiberaceae)	PLOS ONE			English	Article							SELF-POLLINATION; COLOR-VISION; SOUTH-AFRICA; FLOWER COLOR; EVOLUTION; RED; SENSITIVITY; COLEOPTERA; FLY; ANGIOSPERMS	The Himalayan endemic alpine genus Roscoea, like other members of ginger family, exhibits the combination of floral traits that would fit pollination by long distant foragers such as bees, birds or flies. We studied the pollination biology of Roscoea alpina, observed potential floral visitors and determined their foraging behaviour, visitation frequency and pollination efficiency, to seek evidence in support of the pollination syndrome hypothesis. We also measured the floral spectra of R. alpina flowers to evaluate if signals fit with the currently known framework for observed floral visitors. We found that R. alpina have autonomous selfing and pollinator-mediated crossing, but lack apomixis. We observed that a beetle (Mylabris sp.), and a moth (Macroglossum nycteris) visit the flowers of R. alpina for pollen and nectar feeding respectively. Our field observations, the stigmatic pollen count and fruit set data indicated that the visit by the beetle was legitimate, while that of the moth was illegitimate. Emasculated flowers visited by beetles set as many fruits and seeds/fruit as autoselfed and naturally pollinated flowers, while emasculated flowers excluded from beetle visits did not set fruit and seed; indicating that a single visit of a beetle to the flowers of R. alpina can facilitate pollination. We found that flower spectral signal of R. alpina does not fit typical spectra previously reported for beetle or bee-visited flowers. Our results suggest that, to ensure reproductive success in alpine habitat, R. alpina has evolved autonomous selfing as a predominant mode of reproduction, while beetle pollination would promote genetic diversity of this plant species. The visitation of beetles to the flowers of R. alpina, despite floral signal mismatch with the classically associated beetle vision, suggests that a different visual processing may operate in this plant-pollinator interaction at high altitudes.	[Paudel, Babu Ram] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Yunnan, Peoples R China; [Paudel, Babu Ram] Univ Chinese Acad Sci, Beijing, Peoples R China; [Paudel, Babu Ram] Tribhuvan Univ, Dept Bot, Prithvi Narayan Campus, Pokhara, Nepal; [Shrestha, Mani; Dyer, Adrian G.] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia; [Shrestha, Mani] Monash Univ, Fac Informat Technol, Melbourne, Vic, Australia; [Li, Qing-Jun] Yunnan Univ, Lab Ecol & Evolutionary Biol, State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tribhuvan University; Royal Melbourne Institute of Technology (RMIT); Monash University; Yunnan University	Li, QJ (corresponding author), Yunnan Univ, Lab Ecol & Evolutionary Biol, State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China.	Foqingjun.li@ynu.edu.cn	Paudel, Babu Ram/AFN-3769-2022; Shrestha, Mani/P-7045-2015	Garcia, Jair/0000-0001-8456-4759; Paudel, Babu Ram/0000-0002-4556-7794; Shrestha, Mani/0000-0002-6165-8418	National Natural Science Foundation of China [U1202261]; National Basic Research Programme of China (973 Programme) [2007CB411603]; Chinese Academy of Sciences (CAS) 135 Programme [XTBGT01, F01]; Australian Research Council [DP130100015/160100161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Programme of China (973 Programme)(National Basic Research Program of China); Chinese Academy of Sciences (CAS) 135 Programme; Australian Research Council(Australian Research Council)	This study was funded by the "National Natural Science Foundation of China (U1202261), the National Basic Research Programme of China (973 Programme No. 2007CB411603), and the Chinese Academy of Sciences (CAS) 135 Programme (XTBGT01, F01) to QJL". AGD acknowledges Australian Research Council Discovery Projects funding scheme DP130100015/160100161 which assisted in support for Mani Shrestha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SEJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2219; Barth FG., 1985, INSECTS FLOWERS BIOL; BEACH JH, 1982, AM J BOT, V69, P1074, DOI 10.1002/j.1537-2197.1982.tb13352.x; Bernhardt P, 2000, PLANT SYST EVOL, V222, P293, DOI 10.1007/BF00984108; Bingham RA, 1998, NATURE, V391, P238, DOI 10.1038/34564; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Cowley EJ, 2007, THE GENUS ROSCOEA; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; DAFNI A, 1990, ISRAEL J BOT, V39, P81; Dafni A, 2005, PRACTICAL POLLINATIO, P503; Darwin C., 1877, VARIOUS CONTRIVANCES; Department of Hydrology and Meteorology Ministry of Science Technology & Environment Government of Nepal, 2016, CLIM DAT PORT; DIERL W, 1968, KHUMBU HIMAL ERGEBN, V3, P76; Doring TF, 2007, ENTOMOL GEN, V29, P81; Doring TF, 2012, PHYSIOL ENTOMOL, V37, DOI 10.1111/j.1365-3032.2012.00850.x; Dyer AG, 2007, ARTHROPOD-PLANT INTE, V1, P45, DOI 10.1007/s11829-007-9002-7; Dyer Adrian G., 2015, Proceedings of the Royal Society of Victoria, V127, P66, DOI 10.1071/RS15006; Dyer AG, 2012, P ROY SOC B-BIOL SCI, V279, P3606, DOI 10.1098/rspb.2012.0827; ENDRESS PK, 1987, TRENDS ECOL EVOL, V2, P300, DOI 10.1016/0169-5347(87)90082-6; Fan YL, 2012, ANN BOT-LONDON, V110, P969, DOI 10.1093/aob/mcs169; FLETCHER T. BAINBRIGGE, 1931, INDIAN JOUR VET SCI AND ANIMAL HUSBANDRY, V1, P192; Goldblatt P, 2000, ANN MO BOT GARD, V87, P146, DOI 10.2307/2666158; GOTTSBERGER G, 1990, BOT ACTA, V103, P360, DOI 10.1111/j.1438-8677.1990.tb00175.x; KATO M, 1994, NATURE, V368, P195, DOI 10.1038/368195a0; Kato Makoto, 1993, Tropics, V2, P129; Keasar T, 2010, BIOL J LINN SOC, V99, P808, DOI 10.1111/j.1095-8312.2010.01384.x; Kemp DJ, 2015, AM NAT, V185, P705, DOI 10.1086/681021; Kevan P, 1996, TRENDS PLANT SCI, V1, P280; Kress W. John, 2006, Aliso, V22, P621; Kress WJ, 2005, AM J BOT, V92, P167, DOI 10.3732/ajb.92.1.167; LALL AB, 1982, J COMP PHYSIOL, V147, P195, DOI 10.1007/BF00609844; Lall AB, 2010, J COMP PHYSIOL A, V196, P629, DOI 10.1007/s00359-010-0549-x; LARSEN K., 1998, FAMILIES GENERA VASC, V4, P474, DOI DOI 10.1007/978-3-662-03531-3_49; Lebesa LN, 2012, INT J PEST MANAGE, V58, P165, DOI 10.1080/09670874.2012.673032; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; Martinez-Harms J, 2012, J COMP PHYSIOL A, V198, P451, DOI 10.1007/s00359-012-0722-5; Mkenda P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143530; Ne'eman G, 2010, BIOL REV, V85, P435, DOI 10.1111/j.1469-185X.2009.00108.x; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; Paudel BR, 2016, NEW PHYTOL, V211, P1402, DOI 10.1111/nph.13974; Paudel BR, 2015, ECOL EVOL, V5, P5240, DOI 10.1002/ece3.1784; Raven P. H., 1999, BIOL PLANTS, V6th; RAVEN PH, 1972, EVOLUTION, V26, P674, DOI 10.1111/j.1558-5646.1972.tb01975.x; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Sakai S, 1999, AM J BOT, V86, P646, DOI 10.2307/2656573; Sharkey CR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00061-7; Shrestha M, 2016, PLANT BIOLOGY, V18, P842, DOI 10.1111/plb.12456; Shrestha M, 2014, J ECOL, V102, P126, DOI 10.1111/1365-2745.12185; Shrestha Mani, 2013, Commun Integr Biol, V6, pe24000, DOI 10.4161/cib.24000; Shrestha M, 2013, NEW PHYTOL, V198, P301, DOI 10.1111/nph.12135; Steiner KE, 1998, AM J BOT, V85, P1180, DOI 10.2307/2446351; Steiner KE, 1998, PLANT SYST EVOL, V209, P47, DOI 10.1007/BF00991523; Streinzer M, 2009, J EXP BIOL, V212, P1365, DOI 10.1242/jeb.027482; THIEN LB, 1980, BIOTROPICA, V12, P1, DOI 10.2307/2387768; Waddington K.D., 1983, P213; Wang B, 2003, FRONT PLANT SCI, V4, P1; Wang YQ, 2005, INT J PLANT SCI, V166, P753, DOI 10.1086/431803; WCSP, 2015, WORLD CHECKL SEL PLA; YOUNG HJ, 1986, AM J BOT, V73, P931, DOI 10.2307/2444306; Zhang ZQ, 2008, ANN BOT-LONDON, V102, P531, DOI 10.1093/aob/mcn136; Zhao JL, 2016, GONDWANA RES, V32, P232, DOI 10.1016/j.gr.2015.02.004	62	10	13	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180460	10.1371/journal.pone.0180460	http://dx.doi.org/10.1371/journal.pone.0180460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723912	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800014
J	Molina-Lopez, RA; Manosa, S; Torres-Riera, A; Pomarol, M; Darwich, L				Angel Molina-Lopez, Rafael; Manosa, Santi; Torres-Riera, Alex; Pomarol, Manel; Darwich, Laila			Morbidity, outcomes and cost-benefit analysis of wildlife rehabilitation in Catalonia (Spain)	PLOS ONE			English	Article							POSTRELEASE SURVIVAL; MORTALITY; TRADE	Background There are few studies of careful examination of wildlife casualties in Wildlife Rehabilitation Centers. These studies are essential for detecting menaces to wild species and providing objective criteria about cost-benefit of treatments in those centers. The release rate is considered the main outcome indicator, but other parameters such as length of stay at the center and a cost-benefit index expressed as number of released animals per euro and day, could be used as reliable estimators of the rehabilitation costs. Methodology A retrospective study based on 54772 admissions recorded from 1995-2013 in the database of the Wildlife Rehabilitation Center of Torreferrussa (Catalonia, NW Spain) assessed the morbidity, outcomes and cost-benefits of the rehabilitation practices. Results Three hundred and two species were included: 232 birds (n = 48633), 37 mammals (n = 3293), 20 reptiles (n = 2705) and 13 amphibians (n = 141). The most frequent causes of admission were: 39.8% confiscation of protected species (89.4% passerines), 31.8% orphaned young animals (35.3% swifts, 21.7% diurnal raptors and owls) and 17.4% trauma casualties (46.7% raptors and owls). The highest proportion of releases was found in the captivity confiscation category [87.4% passerines (median time of stay: 12 days)], followed by the orphaned category [78% owls (66 days), 76.5% diurnal birds of prey (43 days), 75.6% hedgehogs (49 days), 52.7% swifts (19 days) and 52% bats (55 days)]. For the trauma group, 46.8% of releases were hedgehogs (44 days) and 25.6% owls (103 days). As regards the cost-benefit index, the trauma casualties and infectious diseases had the worse values with 1.3 and 1.4 released animals/euro/day respectively, and were particularly low in raptors, waders, marine birds and chiroptera. On the contrary, captivity (4.6) and misplacement (4.1) had the best index, particulary in amphibian, reptiles and passerines. Conclusions/significance Cost-benefit studies including the release rate, the time of stay at the center and the cost-benefit index should be implemented for improving management efficiency of the Wildlife Rehabilitation Centers.	[Angel Molina-Lopez, Rafael; Pomarol, Manel] Catalan Wildlife Serv, Ctr Fauna Salvatge Torreferrussa, Forestal Catalana, Santa Perpetua, Spain; [Manosa, Santi; Torres-Riera, Alex] Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Inst Recerca Biodiversitat IRBio, Fac Biol, Barcelona, Spain; [Darwich, Laila] UAB, Dept Sanitat & Anat Anim, Fac Vet, Cerdanyola Del Valles, Spain; [Darwich, Laila] IRTA, CReSA, Campus UAB, Cerdanyola Del Valles, Spain	University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA	Molina-Lopez, RA (corresponding author), Catalan Wildlife Serv, Ctr Fauna Salvatge Torreferrussa, Forestal Catalana, Santa Perpetua, Spain.	rafael.molina@gencat.cat	Darwich, Laila/F-5330-2016; Mañosa, Santiago/R-6693-2018	Darwich, Laila/0000-0001-9027-9452; Manosa, Santi/0000-0003-0681-1552; Molina Lopez, Rafael/0000-0002-9043-2346				Baker SE, 2013, BIOSCIENCE, V63, P928, DOI 10.1525/bio.2013.63.12.6; BirdLife International, 2011, EUR C ILL KILL BIRDS; Boughner G, 1995, WILDLIFE REHABILITAT, V13, P139; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Burton DL, 1999, P 4 INT S URB WILDL, P171; Martinez JC, 2014, HYSTRIX, V25, P107, DOI 10.4404/hystrix-25.2-10248; Dubois S, 2003, THESIS; Duerr R, 2007, HAND REARING BIRDS, P3; Estrada J, 2014, PAIS VALENCIA BALEAR; Franco A, 2009, RED ANDALUZA CTR REC; Gosalbez J, 1987, HIST NATURAL DELS PA, V13, P205; Grogan A, 2013, VET REC, V172, P211, DOI 10.1136/vr.101139; Hartup BK, 1996, J WILDLIFE DIS, V32, P109, DOI 10.7589/0090-3558-32.1.109; Kelly Andrew, 2010, Endangered Species Research, V12, P107, DOI 10.3354/esr00299; Kelly TR, 2003, J WILD DIS, V39, P467; Kirkwood James K., 2003, P1; Leighton K, 2008, ANIM WELFARE, V17, P207; Ljubisavljevic K, 2011, NORTH-WEST J ZOOL, V7, P250; Lopez-Jurado L.F, 1979, NATURALIA HISPANICA, V17, P1, DOI [10.5061/dryad.q83bk3jhs, DOI 10.5061/DRYAD.Q83BK3JHS]; Manosa S, 2002, EKV200000637 REGHAB; Martinez Climent Jose Antonio, 2001, Biota (Race), V2, P163; Massey JG, 2005, P INT OIL SPILL C MI P INT OIL SPILL C MI, P463; Memon M, 2009, BIRD POPUL, V9, P76; Miller EA, 2012, MINIMUN STANDARDS WI; Molina-Lopez RA, 2013, PLOS ONE, V17; Molina-Lopez RA, 2015, VET QUART, V35, P9, DOI 10.1080/01652176.2014.985856; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Molony SE, 2007, ANIM WELFARE, V16, P361; Perez I, 2004, BIOL CONSERV, V118, P175, DOI 10.1016/j.biocon.2003.07.019; REDIG PT, 1995, T N AM WILDL NAT RES, P162; Rivera X., 2011, AMFIBIS REPTILS CATA; Schenk AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093517; Serangeli MT, 2012, ANIM WELFARE, V21, P9, DOI 10.7120/096272812799129510; Sharon Silow-Carroll JackA.Meyer., 2007, HOSP PERFORMANCE IMP; Sleeman JM, 2003, J AVIAN MED SURG, V17, P33, DOI 10.1647/1082-6742(2003)017[0033:CWMANP]2.0.CO;2; Sleeman Jonathan M., 2008, P97; Tribe A, 2014, AUSTR WILDL REH C MA; Tribe Andrew, 2000, Human Dimensions of Wildlife, V5, P69; Turkozan Oguz, 2007, APPLIED HERPETOLOGY, V4, P31, DOI 10.1163/157075407779766679; Vogelnest L, 2008, MED AUSTR MAMMALS, P11; Wendell MD, 2002, J WILDLIFE DIS, V38, P101, DOI 10.7589/0090-3558-38.1.101; Wimberger K, 2010, ANIM WELFARE, V19, P501; Zarate V, 2010, REV MED CHILE, V138, P93	43	24	27	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181331	10.1371/journal.pone.0181331	http://dx.doi.org/10.1371/journal.pone.0181331			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719647	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400040
J	Bandyopadhyay, S; Li, J; Traer, E; Tyner, JW; Zhou, A; Oh, ST; Cheng, JX				Bandyopadhyay, Shovik; Li, Junjie; Traer, Elie; Tyner, Jeffrey W.; Zhou, Amy; Oh, Stephen T.; Cheng, Ji-Xin			Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia	PLOS ONE			English	Article							MYELOID-LEUKEMIA; ACYL-COENZYME; CANCER; AVASIMIBE; KINASE; CELLS; PROLIFERATION; VISUALIZATION; METABOLISM; ACTIVATION	Since the advent of tyrosine kinase inhibitors (TKIs) such as imatinib, nilotinib, and dasatinib, chronic myelogenous leukemia (CML) prognosis has improved greatly. However,-3040% of patients develop resistance to imatinib therapy. Although most resistance is caused by mutations in the BCR-ABL kinase domain, 50-85% of these patients develop resistance in the absence of new mutations. In these cases, targeting other pathways may be needed to regain clinical response. Using label-free Raman spectromicroscopy, we evaluated a number of leukemia cell lines and discovered an aberrant accumulation of cholesteryl ester (CE) in CML, which was found to be a result of BCR-ABL kinase activity. CE accumulation in CML was found to be a cancer-specific phenomenon as untransformed cells did not accumulate CE. Blocking cholesterol esterification with avasimibe, a potent inhibitor of acyl-CoA cholesterol acyltransferase 1 (ACAT-1), significantly suppressed CML cell proliferation in Ba/F3 cells with the BCR-ABLT315Imutation and in K562 cells rendered imatinib resistant without mutations in the BCR-ABL kinase domain (K562R cells). Furthermore, the combination of avasimibe and imatinib caused a profound synergistic inhibition of cell proliferation in K562R cells, but not in Ba/F3T3151. This synergistic effect was confirmed in a K562R xenograft mouse model. Analysis of primary cells from a BCR-ABL mutation-independent imatinib resistant patient by mass cytometry suggested that the synergy may be due to downregulation of the MAPK pathway by avasimibe, which sensitized the CML cells to imatinib treatment. Collectively, these data demonstrate a novel strategy for overcoming BCRABL mutation-independent TKI resistance in CML.	[Bandyopadhyay, Shovik] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Li, Junjie; Cheng, Ji-Xin] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Traer, Elie; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Zhou, Amy; Oh, Stephen T.] Washington Univ, Sch Med, Div Hematol, St Louis, MO USA; [Cheng, Ji-Xin] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon Health & Science University; Oregon Health & Science University; Washington University (WUSTL); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cheng, JX (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Oh, ST (corresponding author), Washington Univ, Sch Med, Div Hematol, St Louis, MO USA.; Cheng, JX (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.	stoh@dom.wustl.edu; jcheng@purdue.edu	Li, Junjie/B-1424-2017	Li, Junjie/0000-0003-4542-300X; Cheng, Ji-Xin/0000-0002-5607-6683; Bandyopadhyay, Shovik/0000-0003-3919-3914	Walther Cancer Foundation; NIH [K08HL106576, P01CA101937]; NCI Cancer Center Support Grant [P30CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842, P01CA101937] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL106576] Funding Source: NIH RePORTER	Walther Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by a grant from Walther Cancer Foundation to JXC. This work was supported by NIH grant K08HL106576 to STO. Support for patient sample collection and processing was provided by NIH grant P01CA101937. Technical support was provided by the Alvin J. Site man Cancer Center Tissue Procurement Core Facility, Flow Cytometry Core, and Immunomonitoring Laboratory, which are supported by NCI Cancer Center Support Grant P30CA91842.	Ai J, 2014, THER ADV HEMATOL, V5, P107, DOI 10.1177/2040620714537865; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Chen BC, 2001, BRIT J PHARMACOL, V134, P1055, DOI 10.1038/sj.bjp.0704334; Chen YF, 2011, ACTA PHARM SIN B, V1, P197, DOI 10.1016/j.apsb.2011.10.007; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Johnson KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007439; La Rosee P, 2002, CANCER RES, V62, P7149; Lee SSY, 2015, ACS NANO, V9, P2420, DOI 10.1021/nn504025a; Li J, 2016, ONCOGENE, V35, P6378, DOI 10.1038/onc.2016.168; Li JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06807; Ma LY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009073; Michallet M, 2010, CURR MED RES OPIN, V26, P307, DOI 10.1185/03007990903479299; Mulas MF, 2011, CELL PROLIFERAT, V44, P360, DOI 10.1111/j.1365-2184.2011.00758.x; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Slipchenko MN, 2009, J PHYS CHEM B, V113, P7681, DOI 10.1021/jp902231y; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Thielen N, 2013, EUR J CANCER, V49, P3242, DOI 10.1016/j.ejca.2013.06.018; Traer E, 2014, BLOOD, V123, P1516, DOI 10.1182/blood-2013-07-518381; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019	26	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0179558	10.1371/journal.pone.0179558	http://dx.doi.org/10.1371/journal.pone.0179558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719608	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400006
J	Kim, J; He, HZ; Kim, H				Kim, Joomyeong; He, Hongzhi; Kim, Hana			Inversion of the imprinting control region of the Peg3 domain	PLOS ONE			English	Article							HUMAN-CHROMOSOME 19Q13.4; DNA METHYLATION; GENE; YY1	The imprinting of the mouse Peg3 domain is controlled through a 4-kb genomic region encompassing the bidirectional promoter and 1st exons of Peg3 and Usp29. In the current study, this ICR was inverted to test its orientation dependency for the transcriptional and imprinting control of the Peg3 domain. The inversion resulted in the exchange of promoters and 1st exons between Peg3 and Usp29. Paternal transmission of this inversion caused 10-fold down-regulation of Peg3 and 2-fold up-regulation of Usp29 in neonatal heads, consistent with its original promoter strength in each direction. The paternal transmission also resulted in reduced body size among the animals, which was likely contributed by the dramatic down-regulation of Peg3. Transmission through either allele caused no changes in the DNA methylation and imprinting status of the Peg3 domain except that Zfp264 became bi-allelic through the maternal transmission. Overall, the current study suggests that the orientation of the Peg3-ICR may play no role in its allele-specific DNA methylation, but very critical for the transcriptional regulation of the entire imprinted domain.	[Kim, Joomyeong; He, Hongzhi; Kim, Hana] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Kim, Joomyeong/0000-0001-6577-5526	National Institute of Health [R01-GM066225, R01-GM097074]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institute of Health (R01-GM066225 and R01-GM097074 to J.K.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow DP, 2014, COLD SPRING HARB PER, V6; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Faisal M, 2014, GENE, V533, P434, DOI 10.1016/j.gene.2013.10.006; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; He HZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38136; He HZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158004; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Ivanova E, 2011, J MOL ENDOCRINOL, V47, pR67, DOI 10.1530/JME-11-0065; Kelsey G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0336; Keverne EB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0327; Kim J, 2000, GENOME RES, V10, P1138, DOI 10.1101/gr.10.8.1138; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Perera BPU, 2016, SCI REP-UK, V6, DOI 10.1038/srep24438; Perera BPU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119493; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Renfree MB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0151; Stewart KR, 2016, EPIGENOMICS-UK, V8, P1399, DOI 10.2217/epi-2016-0056; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang CK, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-12	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181591	10.1371/journal.pone.0181591	http://dx.doi.org/10.1371/journal.pone.0181591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719641	gold, Green Published, Green Submitted			2022-12-27	WOS:000406061400058
J	Leiss, H; Salzberger, W; Jacobs, B; Gessl, I; Kozakowski, N; Bluml, S; Puchner, A; Kiss, A; Podesser, BK; Smolen, JS; Stummvoll, GH				Leiss, Harald; Salzberger, Wilhelm; Jacobs, Barbara; Gessl, Irina; Kozakowski, Nicolas; Blueml, Stephan; Puchner, Antonia; Kiss, Attila; Podesser, Bruno K.; Smolen, Josef S.; Stummvoll, Georg H.			MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristaneinduced lupus	PLOS ONE			English	Article							T-CELLS; AUTOIMMUNE INFLAMMATION; BONE HISTOMORPHOMETRY; ERYTHEMATOSUS; INTERFERON; PATHOGENESIS; DISEASE; ARTHRITIS; MECHANISMS; EXPRESSION	Objective We herein examine the role of endogenous miR155 in the development of systemic manifestations in pristane induced lupus. Materials and methods Systemic lupus in miR155-deficient and wild type mice was induced upon injection of pristane and analyzed after 8 months, PBS-injected mice served as controls. Glomerulonephritis and pneumonitis were quantified using the kidney biopsy score and a newly adapted histomorphometric image analysis system; lung tissue was further analyzed by tissue cytometry. Serum levels of anti-dsDNA, anti-histone and anti-chromatin antibodies were measured by ELISA. Frequencies of B cells, activated and regulatory CD4(+) T cells as well as Th1, Th2, Th17 cells were measured by flow cytometry. RT-qPCR was used to measure expression levels of interferon-signature and T-cell subset related as well as miR155-associated genes. Results After induction of lupus, miR155-deficient mice had significant less pulmonary involvement (perivascular inflammatory area in mm2/mm2 lung area 0.00092 +/- 0.00015 vs. 0.0027 +/- 0.00075, p = 0.0347) and renal disease (glomerular activity score 1.95 +/- 0.19 vs 3 +/- 0.26, p = 0.0029) compared to wild types. MiR155-deficient mice had significantly lower serum levels of disease-associated auto-antibodies and decreased frequencies of activated CD4(+)CD25(+) (Foxp3(-)) cells. Upon restimulation, CD4(+) cells showed a less pronounced Th2 and Th17 and a slightly decreased Th1 response in mir155-deficient mice. Pristane-treated wild types showed significantly up-regulated expression of genes related to the INF-signature (MX1, IP10, IRF7, ISG15). Conclusions MiR155-deficient mice had less severe organ involvement, lower serum auto-antibody levels, a less prominent T cell response and lower expressions of genes jointly responsible for disease development. Thus, antagonizing miR155 might be a future approach in treating SLE.	[Leiss, Harald; Salzberger, Wilhelm; Jacobs, Barbara; Gessl, Irina; Blueml, Stephan; Puchner, Antonia; Smolen, Josef S.; Stummvoll, Georg H.] Med Univ Vienna, Dept Rheumatol, Vienna, Austria; [Kozakowski, Nicolas] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Kiss, Attila; Podesser, Bruno K.] Med Univ Vienna, Ctr Biomed Res, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Leiss, H (corresponding author), Med Univ Vienna, Dept Rheumatol, Vienna, Austria.	harald.leiss@meduniwien.ac.at	Kiss, Attila/ABF-3583-2021; Kozakowski, Nicolas/I-1005-2019	Kiss, Attila/0000-0003-4652-1998; Kozakowski, Nicolas/0000-0001-9180-620X; Podesser, Bruno/0000-0002-4641-7202; Bluml, Stephan/0000-0002-2758-4400	Innovative Medicines Initiative (BTCure) [015142]; European Union's Seventh Framework Programme; EFPIA companies	Innovative Medicines Initiative (BTCure); European Union's Seventh Framework Programme; EFPIA companies	This research has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement 015142 (BTCure), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme and EFPIA companies' in kind contribution. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bluml S, 2011, ARTHRITIS RHEUM-US, V63, P1281, DOI 10.1002/art.30281; Bonelli M, 2008, ANN RHEUM DIS, V67, P664, DOI 10.1136/ard.2007.074690; Choi J, 2012, CURR OPIN IMMUNOL, V24, P651, DOI 10.1016/j.coi.2012.10.004; Chowdhary VR, 2007, RHEUMATOLOGY, V46, P1405, DOI 10.1093/rheumatology/kem117; Dahlgren J, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-8; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Hadaschik EN, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0538-0; Han SH, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0886-9; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Hu RZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4131; Huffaker TB, 2012, CELL REP, V2, P1697, DOI 10.1016/j.celrep.2012.10.025; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kong KO, 2009, CLIN EXP IMMUNOL, V156, P134, DOI 10.1111/j.1365-2249.2009.03880.x; Leiss H, 2013, LUPUS, V22, P778, DOI 10.1177/0961203313492869; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Leonard JP, 2012, BLOOD; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma XC, 2013, INT J RHEUM DIS, V16, P115, DOI 10.1111/1756-185X.12083; MCKENZIE WN, 1988, AM J PATHOL, V131, P530; Nacionales DC, 2006, AM J PATHOL, V168, P1227, DOI 10.2353/ajpath.2006.050125; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Redlich K, 2004, AM J PATHOL, V164, P543, DOI 10.1016/S0002-9440(10)63144-6; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ronnblom L, 2006, ARTHRITIS RHEUM-US, V54, P408, DOI 10.1002/art.21571; Scheinecker C, 2001, ARTHRITIS RHEUM, V44, P856, DOI 10.1002/1529-0131(200104)44:4<856::AID-ANR142>3.0.CO;2-A; Scheinecker C, 2010, J AUTOIMMUN, V35, P269, DOI 10.1016/j.jaut.2010.06.018; Schett Georg, 2007, V135, P269; Stummvoll G, 2017, WIEN KLIN W IN PRESS; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505; Thai TH, 2013, P NATL ACAD SCI USA, V110, P20194, DOI 10.1073/pnas.1317632110; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Xin Q, 2015, J IMMUNOL, V194, P5437, DOI 10.4049/jimmunol.1403028; Xu Y, 2014, METHODS MOL BIOL, V1134, P103, DOI 10.1007/978-1-4939-0326-9_9; Zhou SY, 2016, ARTHRITIS RHEUMATOL, V68, P953, DOI 10.1002/art.39485	46	22	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181015	10.1371/journal.pone.0181015	http://dx.doi.org/10.1371/journal.pone.0181015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719617	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400027
J	Mehler, DMA; Reichenbach, A; Klein, J; Diedrichsen, J				Mehler, David Marc Anton; Reichenbach, Alexandra; Klein, Julius; Diedrichsen, Jom			Minimizing endpoint variability through reinforcement learning during reaching movements involving shoulder, elbow and wrist	PLOS ONE			English	Article							MOTOR CONTROL; STROKE; COORDINATION; CEREBELLUM; TASK; ADAPTATION; DYNAMICS; RECOVERY; BEHAVIOR; THERAPY	Reaching movements are comprised of the coordinated action across multiple joints. The human skeleton is redundant for this task because different joint configurations can lead to the same endpoint in space. How do people learn to use combinations of joints that maximize success in goal-directed motor tasks? To answer this question, we used a 3-degreeof-freedom manipulandum to measure shoulder, elbow and wrist joint movements during reaching in a plane. We tested whether a shift in the relative contribution of the wrist and elbow joints to a reaching movement could be learned by an implicit reinforcement regime. Unknown to the participants, we decreased the task success for certain joint configurations (wrist flexion or extension, respectively) by adding random variability to the endpoint feedback. In return, the opposite wrist postures were rewarded in the two experimental groups (flexion and extension group). We found that the joint configuration slowly shifted towards movements that provided more control over the endpoint and hence higher task success. While the overall learning was significant, only the group that was guided to extend the wrist joint more during the movement showed substantial learning. Importantly, all changes in movement pattern occurred independent of conscious awareness of the experimental manipulation. These findings suggest that the motor system is generally sensitive to its output variability and can optimize joint-space solutions that minimize task-relevant output variability. We discuss biomechanical biases (e.g. joint's range of movement) that could impose hurdles to the learning process.	[Mehler, David Marc Anton; Reichenbach, Alexandra; Diedrichsen, Jom] UCL, Inst Cognit Neurosci, London, England; [Mehler, David Marc Anton] Univ Munster, Dept Psychiat & Psychotherapy, Munster, Germany; [Mehler, David Marc Anton] Cardiff Univ, Cardiff Univ Brain Res Imaging Ctr, Sch Psychol, Cardiff, S Glam, Wales; [Reichenbach, Alexandra] Heilbronn Univ, Dept Comp Sci, Heilbronn, Germany; [Klein, Julius] Tecnalia Res & Innovat, Donostia San Sebastian, Spain; [Diedrichsen, Jom] Western Univ, Brain & Mind Inst, London, ON, Canada	University of London; University College London; University of Munster; Cardiff University; Western University (University of Western Ontario)	Diedrichsen, J (corresponding author), UCL, Inst Cognit Neurosci, London, England.; Diedrichsen, J (corresponding author), Western Univ, Brain & Mind Inst, London, ON, Canada.	jdiedric@uwo.ca	Reichenbach, Alexandra/B-1455-2016; Diedrichsen, Jörn/AAQ-2242-2020; Mehler, David/ACO-9611-2022	Reichenbach, Alexandra/0000-0003-4199-3005; Diedrichsen, Jörn/0000-0003-0264-8532; Mehler, David/0000-0001-6587-2617	Biotechnology and Biological Science Research Council (BBSRC) [BB/ J009458/1]; Heinrich Boell Foundation; Deutsche Forschungsgemeinschaft (DFG) [RE 3265/1-1]; Tecnalia Research and Innovation; Heinrich Boll Foundation	Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Heinrich Boell Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Tecnalia Research and Innovation; Heinrich Boll Foundation	This research was funded by the Biotechnology and Biological Science Research Council (BBSRC; BB/ J009458/1; http://www.bbsrc.ac.uk/), a studentship from Heinrich Boell Foundation to D.M.A.M. (https://www.boell.de/en), and a postdoctoral fellowship of the Deutsche Forschungsgemeinschaft (DFG; RE 3265/1-1; http://www.dfg.de/). Tecnalia Research and Innovation provided support in the form of salaries for J.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.; We thank Etienne Burdet and Nick Roach for their contribution to the development of the robotic interface and the Heinrich Boll Foundation for supporting David Mehler with a studentship. We also thank Harry Manley and Oscar Woolnough for helpful comments on an earlier manuscript of this paper.	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; Bernstein NA, 1967, COORDINATION MOVEMEN; Campolo D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002978; Cirstea MC, 2003, EXP BRAIN RES, V151, P289, DOI 10.1007/s00221-003-1438-0; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; Dam G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055352; Dam G, 2009, COGNITIVE SCI, V33, P530, DOI 10.1111/j.1551-6709.2009.01021.x; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Diedrichsen J, 2007, J NEUROSCI, V27, P6291, DOI 10.1523/JNEUROSCI.0061-07.2007; Donchin O, 2012, J NEUROPHYSIOL, V107, P134, DOI 10.1152/jn.00007.2011; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Galloway JC, 2002, EXP BRAIN RES, V142, P163, DOI 10.1007/s002210100882; Ganesh G, 2013, ROBOT AUTON SYST, V61, P362, DOI 10.1016/j.robot.2012.09.024; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Haith AM, 2013, ADV EXP MED BIOL, V782, P1, DOI 10.1007/978-1-4614-5465-6_1; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hasson CJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00459; He K, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005023; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Kitago T, 2013, MOTOR LEARNING PRINC, P110; Kitago T, 2015, J NEUROPHYSIOL, V114, P1885, DOI 10.1152/jn.00336.2015; Klein J, 2014, IEEE T HAPTICS, V7, P229, DOI 10.1109/TOH.2013.59; Klein J, 2012, IEEE T NEUR SYS REH, V20, P268, DOI 10.1109/TNSRE.2012.2195202; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Levin MF, 2009, NEUROREHABILITATION; Manley H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086580; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Ryu J, 1991, JHS, P409; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schweighofer N, 2009, PHYS THER, V89, P1327, DOI 10.2522/ptj.20080402; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shmuelof L, 2012, J NEUROSCI, V32, P14617, DOI 10.1523/JNEUROSCI.2184-12.2012; Sketch SM, 2017, BIORXIV; Sternad D, 2014, ADV EXP MED BIOL, V826, P101, DOI 10.1007/978-1-4939-1338-1_8; Sternad D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002159; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Turner DL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00184; Weiler J, 2015, J NEUROPHYSIOL, V114, P3242, DOI 10.1152/jn.00702.2015; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616; Yarosh CA, 2004, J NEUROPHYSIOL, V92, P3276, DOI 10.1152/jn.00549.2004	50	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180803	10.1371/journal.pone.0180803	http://dx.doi.org/10.1371/journal.pone.0180803			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3RW	28719661	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000406061400018
J	Bao, W; Yue, J; Rao, YL				Bao, Wei; Yue, Jun; Rao, Yulei			A deep learning framework for financial time series using stacked autoencoders and long-short term memory	PLOS ONE			English	Article							NEURAL-NETWORKS; CLASSIFICATION; MARKET; MODEL; PREDICTION; FORECAST; WAVELETS; FEATURES; FUTURES; NETS	The application of deep learning approaches to finance has received a great deal of attention from both investors and researchers. This study presents a novel deep learning framework where wavelet transforms (WT), stacked autoencoders (SAEs) and long-short term memory (LSTM) are combined for stock price forecasting. The SAEs for hierarchically extracted deep features is introduced into stock price forecasting for the first time. The deep learning framework comprises three stages. First, the stock price time series is decomposed by WT to eliminate noise. Second, SAEs is applied to generate deep high-level features for predicting the stock price. Third, high-level denoising features are fed into LSTM to forecast the next day's closing price. Six market indices and their corresponding index futures are chosen to examine the performance of the proposed model. Results show that the proposed model outperforms other similar models in both predictive accuracy and profitability performance.	[Bao, Wei; Rao, Yulei] Cent South Univ, Business Sch, Changsha, Hunan, Peoples R China; [Yue, Jun] Peking Univ, Inst Remote Sensing & Geog Informat Syst, Beijing, Peoples R China	Central South University; Peking University	Yue, J (corresponding author), Peking Univ, Inst Remote Sensing & Geog Informat Syst, Beijing, Peoples R China.	jyue@pku.edu.cn			National Natural Science Foundation of China [71372063, 71673306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (Grant Number: 71372063 and 71673306, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich F, 2002, COMPUT STAT DATA AN, V39, P435, DOI 10.1016/S0167-9473(01)00085-8; Altay E., 2005, J FINANCIAL MANAGEME, V18, P18; Aminghafari M, 2006, COMPUT STAT DATA AN, V50, P2381, DOI 10.1016/j.csda.2004.12.010; [Anonymous], 2010, SSRN ELECT J; Bengio Y, 2013, INT CONF ACOUST SPEE, P8624, DOI 10.1109/ICASSP.2013.6639349; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bengio Yoshua, 2007, P ADV NEUR INF PROC, P153; BLIEMEL F, 1973, J MARKETING RES, V10, P444, DOI 10.2307/3149394; Bodyanskiy Y, 2006, EUR J OPER RES, V175, P1357, DOI 10.1016/j.ejor.2005.02.012; Cavalcante RC, 2016, EXPERT SYST APPL, V55, P194, DOI 10.1016/j.eswa.2016.02.006; Chai S, 2009, INT C NEW TRENDS INF; Chan PMJ, 2016, PLOS ONE, V11; Chan PMJ, 2016, PLOS ONE, V11; Chen AS, 2003, COMPUT OPER RES, V30, P901, DOI 10.1016/S0305-0548(02)00037-0; Chen YS, 2014, IEEE J-STARS, V7, P2094, DOI 10.1109/JSTARS.2014.2329330; Cherkassky V., 1997, NATURE STAT LEARNING; Chu KL, 2016, BEHAV RECOGNITION HU, V13; Das S.P., 2012, INT J COMPUTER APPL, V41, P22, DOI DOI 10.5120/5522-7555; Dghais AAA, 2014, AIP CONF PROC, V1605, P798, DOI 10.1063/1.4887692; Ding X, 2015, INT C ART INT; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gong CC, 2016, PHYSICA A, V444, P63, DOI 10.1016/j.physa.2015.10.028; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Graves A, 2012, SEQUENCE TRANSDUCTIO; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton G.E., 2012, NEURAL NETWORKS TRIC, VVolume 7700, P599, DOI [10.1007/978-3-642-35289-8_32, DOI 10.1007/978-3-642-35289-8_32]; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hsieh TJ, 2011, APPL SOFT COMPUT, V11, P2510, DOI 10.1016/j.asoc.2010.09.007; Huang W, 2005, COMPUT OPER RES, V32, P2513, DOI 10.1016/j.cor.2004.03.016; Hussain AJ, 2008, EXPERT SYST APPL, V35, P1186, DOI 10.1016/j.eswa.2007.08.038; Jean S, 2014, COMPUTER SCI; KAWALLER IG, 1987, J FINANC, V42, P1309, DOI 10.2307/2328529; Kim TY, 2004, NEUROCOMPUTING, V61, P439, DOI 10.1016/j.neucom.2004.04.002; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kuremoto T, 2014, NEUROCOMPUTING, V137, P47, DOI 10.1016/j.neucom.2013.03.047; Le Roux N, 2010, NEURAL COMPUT, V22, P2192, DOI 10.1162/neco.2010.08-09-1081; Leung MKK, 2014, BIOINFORMATICS, V30, P121, DOI 10.1093/bioinformatics/btu277; Liu ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099175; Lu CJ, 2009, DECIS SUPPORT SYST, V47, P115, DOI 10.1016/j.dss.2009.02.001; Ma JS, 2015, J CHEM INF MODEL, V55, P263, DOI 10.1021/ci500747n; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Mesnil G, 2013, INVESTIGATION RECURR; Mikolov T, 2011, STRATEGIES TRAINING; Mikolov T., 2010, INTERSPEECH 2010 C I; Nourani V, 2009, WATER RESOUR MANAG, V23, P2877, DOI 10.1007/s11269-009-9414-5; Palangi H, 2016, IEEE T SIGNAL PROCES, V64, P4504, DOI 10.1109/TSP.2016.2557301; Palangi H, 2016, IEEE-ACM T AUDIO SPE, V24, P694, DOI 10.1109/TASLP.2016.2520371; Parasuraman K, 2005, IEEE INT JOINT C NEU; Pei-Chann Chang, 2004, Journal of the Chinese Institute of Industrial Engineers, V21, P358, DOI 10.1080/10170660409509416; Pizzi MA, 1998, EXAMINATION RELATION; Popoola A, 2006, IEEE INT CONF FUZZY, P1305, DOI 10.1109/FUZZY.2006.1681878; Ramsey JB, 1999, PHILOS T R SOC A, V357, P2593, DOI 10.1098/rsta.1999.0450; Rather AM, 2015, EXPERT SYST APPL, V42, P3234, DOI 10.1016/j.eswa.2014.12.003; REFENES AN, 1994, NEURAL NETWORKS, V7, P375, DOI 10.1016/0893-6080(94)90030-2; ROBINSON AJ, 1994, IEEE T NEURAL NETWOR, V5, P298, DOI 10.1109/72.279192; Sainath TN, DEEP CONVOLUTIONAL N; Salakhutdinov R., 2009, ARTIF INTELL, P1; Shen FR, 2015, NEUROCOMPUTING, V167, P243, DOI 10.1016/j.neucom.2015.04.071; Sircar R., 2002, INTRO WAVELETS OTHER; Sutskever I., 2014, ADV NEURAL INFORM PR, DOI DOI 10.1007/S10107-014-0839-0; Sutskever I, 2008, NEURAL COMPUT, V20, P2629, DOI 10.1162/neco.2008.12-07-661; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tompson JJ., 2014, P ADV NEUR INF PROC, V27, P1799; Wang BH, 2012, NEUROCOMPUTING, V83, P136, DOI 10.1016/j.neucom.2011.12.013; Wei LY, 2012, INT J INNOV COMPUT I, V8, P5559; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yao J, 1999, INT J THEORETICAL AP, V2, P1590; Yin HP, 2015, EXPERT SYST APPL, V42, P3368, DOI 10.1016/j.eswa.2014.11.069; YOON YO, 1993, J OPER RES SOC, V44, P51, DOI 10.2307/2584434; Yoshihara A, 2014, LECT NOTES ARTIF INT, V8862, P759, DOI 10.1007/978-3-319-13560-1_60; Yue J, 2016, REMOTE SENS LETT, V7, P875, DOI 10.1080/2150704X.2016.1193793; Yue J, 2015, REMOTE SENS LETT, V6, P468, DOI 10.1080/2150704X.2015.1047045; Zhang X, 2010, 3 INT C BUS INT FIN; Zhang Y.-Q., 2002, Soft Computing, V6, P406, DOI 10.1007/S00500-002-0193-7; Zhao H, 2010, RES INT BUS FINANC, V24, P103, DOI 10.1016/j.ribaf.2009.09.001	80	378	394	55	381	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180944	10.1371/journal.pone.0180944	http://dx.doi.org/10.1371/journal.pone.0180944			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708865	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649800033
J	Gao, Q; Yu, M				Gao, Qiong; Yu, Mei			Reforestation-induced changes of landscape composition and configuration modulate freshwater supply and flooding risk of tropical watersheds	PLOS ONE			English	Article							LAND-USE CHANGE; PUERTO-RICO; URBAN SPRAWL; FORESTS; REDISTRIBUTION; FRAGMENTATION; GENERATION; MODEL	Impact of changes in land cover and land use on hydrological service of tropical watersheds is one of the focal research tropics in both hydrology and Land Cover Land Use Changes (LCLUC). Land fragmentation is an important feature of LCLUC, however, its impact on hydrological service of tropical watershed is unclear despite a few theoretical frameworks. In this paper, we described a simulation study of eight tropical watersheds in Puerto Rico using the Soil Water Assessment Tool. Annual average stream discharge was derived according to the simulations with the land cover maps in 1977, 1991, and 2000. Annual big stream discharge with risks of flooding and severe soil erosion was computed as the sum of daily discharge greater than 95 th percentile. The impacts of changes in land cover and fragmentation represented by perimeter-to-area ratio of land patches on annual average and big discharges were further analyzed by means of the linear mixed-effects model. Most mountainous watersheds were characterized by reforestation in 1977-1991 but slight deforestation in 1991-2000. Forest perimeter-to-area ratio was significantly correlated with covers of forest (correlation coefficient of -0.97), pasture (0.94), and urban (0.95). Thus forest fragmentation was reduced by reforestation but increased by deforestation. The annual average and big discharges were significantly reduced by forest cover and forest perimeterto-area ratio. The enhanced edge effect by forest fragmentation may have incurred more effective interception of the subsurface flow by forest root system, and promoted forest transpiration, thus reduced stream flows. Land cover change plays more important roles in regulating the big discharges than altering the annual average discharges. Due to the negative correlation between forest cover and fragmentation, the decreased forest fragmentation accompanied with reforestation offsets the impact of reforestation on lessening freshwater supply and flooding risk.	[Gao, Qiong; Yu, Mei] Univ Puerto Rico Rio Piedras, Dept Environm Sci, San Juan, PR 00931 USA	University of Puerto Rico; University of Puerto Rico Rio Piedras	Yu, M (corresponding author), Univ Puerto Rico Rio Piedras, Dept Environm Sci, San Juan, PR 00931 USA.	meiyu@ites.upr.edu			National Aeronautics and Space Administration Land Cover / Land Use Change Program [NNX12AE98G]; Natural Science Foundation LUQ-LTER program (NSF) [DEB-1546686]	National Aeronautics and Space Administration Land Cover / Land Use Change Program; Natural Science Foundation LUQ-LTER program (NSF)	This study was supported by the grants from the National Aeronautics and Space Administration Land Cover / Land Use Change Program (NNX12AE98G), and the Natural Science Foundation LUQ-LTER program (NSF DEB-1546686). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CONTRIBUTION WORKING, P1535; [Anonymous], 2015, SOIL SURV STAFF; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; ARNOLD JG, 1993, J HYDROL, V142, P47, DOI 10.1016/0022-1694(93)90004-S; Arnold JG, 1992, J HYDRAULIC ENG, V121, P171; Bruijnzeel L. A, 1990, HYDROLOGY MOIST TROP; Bunyan M., 2012, American Journal of Plant Sciences, V3, P869, DOI 10.4236/ajps.2012.37104; Calder I. R., 2002, LAND USE WATER RESOU, V2, P1; Campbell JD, 2011, INT J CLIMATOL, V31, P1866, DOI 10.1002/joc.2200; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Cashman A, 2013, WATER SECURITY SERVI; Cotler H, 2006, CATENA, V65, P107, DOI 10.1016/j.catena.2005.11.004; DeFries R, 2004, HYDROL PROCESS, V18, P2183, DOI 10.1002/hyp.5584; Demetriou D, 2012, ENVIRON PLANN B, V39, P609, DOI 10.1068/b37075; Demetrious D., 2014, DEV INTEGRATED PLANN; Farrell D., 2010, DROUGHT EARLY WARNIN; Gao Q, 1997, ENVIRON ECOL STAT, V4, P205; Gao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113140; Gao QO, 1997, LANDSCAPE ECOL, V12, P321, DOI 10.1023/A:1007985624887; Heffernan, 2013, NATURE, DOI 10.1038/nature.2013.12570; Helmer EH, 2002, CARIBB J SCI, V38, P165; International Sustainability Unit, 2015, TROP FOR REV; Kennaway T, 2007, GISCI REMOTE SENS, V44, P356, DOI 10.2747/1548-1603.44.4.356; Laursen L., 2012, NATURE; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Lopez T.D.M., 1998, CARIBB J SCI, V34, P298; Lugo AE, 2004, FOREST ECOL MANAG, V190, P145, DOI 10.1016/j.foreco.2003.09.012; Lugo AE, 2002, LANDSCAPE ECOL, V17, P601, DOI 10.1023/A:1021419815480; LUGO AE, 1981, AMBIO, V10, P318; Martinuzzi S, 2007, LANDSCAPE URBAN PLAN, V79, P288, DOI 10.1016/j.landurbplan.2006.02.014; Mitchell MGE, 2015, TRENDS ECOL EVOL, V30, P190, DOI 10.1016/j.tree.2015.01.011; Mitchell MGE, 2013, ECOSYSTEMS, V16, P894, DOI 10.1007/s10021-013-9647-2; Munoz-Villers LE, 2013, HYDROL EARTH SYST SC, V17, P3543, DOI 10.5194/hess-17-3543-2013; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Pinheiro J, 2001, MIXED EFFECTS MODELS; Qiu JX, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00312.1; R Core Term, 2015, LANG ENV STAT COMP; Recha JW, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI000439.1; Ren Y, 2012, J ENVIRON MANAGE, V113, P447, DOI 10.1016/j.jenvman.2012.09.011; Rowland L, 2015, NATURE, V528, P119, DOI 10.1038/nature15539; Sanderson M., 2012, TREE PHYSIOL, V37, P316; SRINIVASAN R, 1994, WATER RESOUR BULL, V30, P453; Srinivasan R, 1995, HYDROLOGICAL SCI TEC, V11, P160; Wu XB, 2000, J ECOL, V88, P790, DOI 10.1046/j.1365-2745.2000.00491.x; Yu M, 2017, SCI REP, V7; Yu M, 2008, ECOL APPL, V18, P1679, DOI 10.1890/07-0640.1; Ziegler AD, 2004, J HYDROL, V287, P124, DOI 10.1016/j.jhydrol.2003.09.027	47	6	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181315	10.1371/journal.pone.0181315	http://dx.doi.org/10.1371/journal.pone.0181315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708878	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800054
J	Goodman, DM; Ramaswamy, R; Jeuland, M; Srofenyoh, EK; Engmann, CM; Olufolabi, AJ; Owen, MD				Goodman, David M.; Ramaswamy, Rohit; Jeuland, Marc; Srofenyoh, Emmanuel K.; Engmann, Cyril M.; Olufolabi, Adeyemi J.; Owen, Medge D.			The cost effectiveness of a quality improvement program to reduce maternal and fetal mortality in a regional referral hospital in Accra, Ghana	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; ECONOMIC-EVALUATION; HEALTH; CARE; INTERVENTIONS; COUNTRIES; SURVIVAL; OUTCOMES; DEATHS; CONSEQUENCES	Objective To evaluate the cost-effectiveness of a quality improvement intervention aimed at reducing maternal and fetal mortality in Accra, Ghana. Design Quasi-experimental, time-sequence intervention, retrospective cost-effectiveness analysis. Methods Data were collected on the cost and outcomes of a 5-year Kybele-Ghana Health Service Quality Improvement (QI) intervention conducted at Ridge Regional Hospital, a tertiary referral center in Accra, Ghana, focused on systems, personnel, and communication. Maternal deaths prevented were estimated comparing observed rates with counterfactual projections of maternal mortality and case-fatality rates for hypertensive disorders of pregnancy and obstetric hemorrhage. Stillbirths prevented were estimated based on counterfactual estimates of stillbirth rates. Cost-effectiveness was then calculated using estimated disability-adjusted life years averted and subjected to Monte Carlo and one-way sensitivity analyses to test the importance of assumptions inherent in the calculations. Main outcome measure Incremental Cost-effectiveness ratio (ICER), which represents the cost per disability-adjusted life-year (DALY) averted by the intervention compared to a model counterfactual. Results From 2007-2011, 39,234 deliveries were affected by the QI intervention implemented at Ridge Regional Hospital. The total budget for the program was $2,363,100. Based on program estimates, 236 (+/- 5) maternal deaths and 129 (+/- 13) intrapartum stillbirths were averted (14,876 DALYs), implying an ICER of $ 158 ($129-$195) USD. This value is well below the highly cost-effective threshold of $ 1268 USD. Sensitivity analysis considered DALY calculation methods, and yearly prevalence of risk factors and case fatality rates. In each of these analyses, the program remained highly cost-effective with an ICER ranging from $97-$218 Conclusion QI interventions to reduce maternal and fetal mortality in low resource settings can be highly cost effective. Cost-effectiveness analysis is feasible and should regularly be conducted to encourage fiscal responsibility in the pursuit of improved maternal and child health.	[Goodman, David M.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Hubert Yeargan Ctr Global Hlth, Durham, NC 27710 USA; [Ramaswamy, Rohit] Univ N Carolina, Gillings Sch Publ Hlth, Chapel Hill, NC USA; [Jeuland, Marc] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Jeuland, Marc] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Srofenyoh, Emmanuel K.] Ridge Reg Hosp, Ghana Hlth Serv, Accra, Ghana; [Engmann, Cyril M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Engmann, Cyril M.] Seattle Childrens Hosp, Seattle, WA USA; [Olufolabi, Adeyemi J.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Owen, Medge D.] Wake Forest Sch Med, Dept Anesthesiol, Winston Salem, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Ghana Health Service; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Duke University; Wake Forest University	Goodman, DM (corresponding author), Duke Univ, Med Ctr, Dept Obstet & Gynecol, Hubert Yeargan Ctr Global Hlth, Durham, NC 27710 USA.	davidmgoodman@gmail.com		Goodman, David/0000-0002-0180-4911	International Association for the Study of Pain; Lacy Foundation; Obstetric Anaesthetists' Association	International Association for the Study of Pain; Lacy Foundation; Obstetric Anaesthetists' Association	Funding in support of the project was provided by the International Association for the Study of Pain, the Lacy Foundation, and the Obstetric Anaesthetists' Association.	Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Adegoke AA, 2013, MIDWIFERY, V29, pE115, DOI 10.1016/j.midw.2012.11.018; Adu-Bonsaffoh K, 2013, INT J GYNECOL OBSTET, V123, P110, DOI 10.1016/j.ijgo.2013.05.017; Alfonso YN, 2015, HEALTH POLICY PLANN, V30, P88, DOI 10.1093/heapol/czt100; Alkema L, 2015, LANCET; Alkire BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034595; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Broughton E, 2013, INT J HEALTH CARE Q, V26, P250, DOI 10.1108/09526861311311436; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Donnay F, 2000, INT J GYNECOL OBSTET, V70, P89, DOI 10.1016/S0020-7292(00)00236-8; Erim DO, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-786; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Foster S, 2013, FRAMEWORK ESTIMATING; Gomez GB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139048; Gopalan SS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-319; Graham WJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P499; Horton Susan, DIS CONTROL PRIORITI, P338; Hu D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000750; Husereau D, 2013, BJOG-INT J OBSTET GY, V120, P765, DOI 10.1111/1471-0528.12241; Indrani Gupta, 2010, DEMAND SIDE FINANCIN; Jahn A, REFERRAL PREGNANCY C; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Koblinsky M, 2012, J HEALTH POPUL NUTR, V30, P124, DOI 10.3329/jhpn.v30i2.11294; Kruk ME, 2007, BJOG-INT J OBSTET GY, V114, P1253, DOI 10.1111/j.1471-0528.2007.01443.x; Kuznik A, 2015, SEX TRANSM DIS, V42, P369, DOI 10.1097/OLQ.0000000000000291; Lalonde AB, 2003, INT J GYNECOL OBSTET, V80, P204, DOI 10.1016/S0020-7292(02)00389-2; Lawn JE, 2016, LANCET; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; Lee QY, 2012, ACTA OBSTET GYN SCAN, V91, P87, DOI 10.1111/j.1600-0412.2011.01249.x; McCord C, 2003, INT J GYNECOL OBSTET, V81, P83, DOI 10.1016/S0020-7292(03)00072-9; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Phillips J, 2015, BIOETHICS, V29, P413, DOI 10.1111/bioe.12120; Ramaswamy R, 2015, J OBSTET GYNAECOL CA, V37, P905, DOI 10.1016/S1701-2163(16)30029-9; Requejo J, 2010, COUNTDOWN 2015 DECAD; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Srofenyoh E, 2012, INT J GYNECOL OBSTET, V116, P17, DOI 10.1016/j.ijgo.2011.08.010; Srofenyoh EK, 2016, INT J GYNECOL OBSTET, V134, P181, DOI 10.1016/j.ijgo.2015.11.026; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; United States Department of Labor Bureau of Labor Statistics, 2014, OCC EMPL STAT; Vesel L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002326; Yudkowsky Eliezer, H POTTER METHODS RAT	46	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180929	10.1371/journal.pone.0180929	http://dx.doi.org/10.1371/journal.pone.0180929			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708899	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800030
J	Westin, AA; Brekke, M; Molden, E; Skogvoll, E; Spigset, O				Westin, Andreas Austgulen; Brekke, Malin; Molden, Espen; Skogvoll, Eirik; Spigset, Olav			Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition	PLOS ONE			English	Article							PHARMACOKINETIC CHANGES; ANTIDEPRESSANT METABOLISM; PLASMA-CONCENTRATIONS; SERUM CONCENTRATIONS; NORFLUOXETINE; POSTPARTUM; FLUOXETINE; SERTRALINE; CHILDBEARING; ESCITALOPRAM	Background Pregnancy may cause changes in drug disposition. The clinical consequences may be profound and even counterintuitive; in some cases pregnant women may need more than twice their usual drug dose in order to maintain therapeutic drug levels. For antidepressants, evidence on drug disposition in pregnancy is scarce. The aim of this study was to determine the effects of pregnancy on serum levels of selective serotonin reuptake inhibitors (SSRIs) and venlafaxine in a large and naturalistic patient material, in order to provide tentative dose recommendations for pregnant women. Methods Using patient data from two routine therapeutic drug monitoring (TDM) services in Norway with linkage to the national birth registry, dose-adjusted serum drug concentrations of SSRIs and venlafaxine during pregnancy were compared to the women's own baseline (non-pregnant) values, using a linear mixed model. Findings Overall, the TDM databases contained 196,726 serum concentration measurements from 54,393 women. After data linkage and drug selection (SSRIs or venlafaxine only), we identified 367 analyses obtained from a total of 290 pregnancies in 281 women, and 420 baseline observations from the same women. Serum concentrations in the third trimester were significantly lower than baseline for paroxetine (-51%; 95% confidence interval [CI], -66%, -30%; p<0.001), fluvoxamine (-56%; CI, -75%, -23%; p = 0.004) and citalopram (-24%; CI, -38%, -7%; p = 0,007), and higher than baseline for sertraline (+68%; CI, +37%, +106%; p<0.001). For escitalopram, fluoxetine and venlafaxine concentrations did not change significantly. Conclusions For paroxetine and fluvoxamine the pronounced decline in maternal drug serum concentrations in pregnancy may necessitate a dose increase of about 100% during the third trimester in order to maintain stable concentrations. For fluoxetine, venlafaxine, citalopram, escitalopram and sertraline, the present study indicates that dose adjustments are generally not necessary during pregnancy.	[Westin, Andreas Austgulen; Spigset, Olav] St Olavs Univ Hosp, Dept Clin Pharmacol, Trondheim, Norway; [Brekke, Malin; Molden, Espen] Diakonhjemmet Hosp, Ctr Psychopharmacol, Oslo, Norway; [Molden, Espen] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Skogvoll, Eirik] St Olavs Univ Hosp, Dept Anaesthesiol & Intens Care, Trondheim, Norway; [Skogvoll, Eirik] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Spigset, Olav] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Diakonhjemmet Hospital; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Westin, AA (corresponding author), St Olavs Univ Hosp, Dept Clin Pharmacol, Trondheim, Norway.	andreas.westin@stolav.no		Skogvoll, Eirik/0000-0002-6984-0708				Altshuler LL, 1996, J CLIN PSYCHOPHARM, V16, P78, DOI 10.1097/00004714-199602000-00015; Alwan S, 2016, CNS DRUGS, V30, P499, DOI 10.1007/s40263-016-0338-3; Anderson GD, 2005, CLIN PHARMACOKINET, V44, P989, DOI 10.2165/00003088-200544100-00001; Briggs GG, 2015, AM J OBSTET GYNECOL, V213, P810, DOI 10.1016/j.ajog.2015.05.047; Brogtrop J, 2007, PHARM WEEKBLAD, V142, P34; Brunton L., 2011, GOODMAN GILMANS PHAR; Caccia S, 2004, IDRUGS, V7, P143; Costantine MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00065; Deligiannidis KM, 2014, J CLIN PSYCHOPHARM, V34, P244, DOI 10.1097/JCP.0000000000000087; DeVane C Lindsay, 2006, J Psychopharmacol, V20, P54, DOI 10.1177/1359786806066054; Freeman MP, 2008, J CLIN PSYCHOPHARM, V28, P646, DOI 10.1097/JCP.0b013e31818d2048; Gjestad C, 2015, THER DRUG MONIT, V37, P90, DOI 10.1097/FTD.0000000000000101; Heikkinen T, 2003, CLIN PHARMACOL THER, V73, P330, DOI 10.1016/S0009-9236(02)17634-X; Heikkinen T, 2002, CLIN PHARMACOL THER, V72, P184, DOI 10.1067/mcp.2002.126181; Hermann M, 2015, THER DRUG MONIT, V37, P546, DOI 10.1097/FTD.0000000000000169; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Hostetter A, 2000, DEPRESS ANXIETY, V11, P51, DOI 10.1002/(SICI)1520-6394(2000)11:2<51::AID-DA1>3.3.CO;2-I; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Kim J, 2006, BRIT J CLIN PHARMACO, V61, P155, DOI 10.1111/j.1365-2125.2005.02538.x; Klier CM, 2007, J CLIN PSYCHOPHARM, V27, P720, DOI 10.1097/JCP.0b013e31815a57d8; Larsen ER, 2015, ACTA PSYCHIAT SCAND, V132, P1, DOI 10.1111/acps.12479; Matsui D., 2012, OBSTET GYNECOL INT, V2012, DOI DOI 10.1155/2012/796590]; Muzik M, 2016, MATERN CHILD HLTH J, V20, P2268, DOI 10.1007/s10995-016-2038-5; O'Brien L, 2010, FORENSIC SCI INT, V196, P93, DOI 10.1016/j.forsciint.2009.12.034; Obach RS, 2005, DRUG METAB DISPOS, V33, P262, DOI 10.1124/dmd.104.002428; Osborne LM, 2014, ARCH WOMEN MENT HLTH, V17, P239, DOI 10.1007/s00737-014-0421-z; Pariente G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002160; Rao N, 2007, CLIN PHARMACOKINET, V46, P281, DOI 10.2165/00003088-200746040-00002; Reis M, 2009, THER DRUG MONIT, V31, P42, DOI 10.1097/FTD.0b013e31819114ea; Scordo MG, 2005, BASIC CLIN PHARMACOL, V97, P296, DOI 10.1111/j.1742-7843.2005.pto_194.x; Sheffield JS, 2014, CLIN INFECT DIS, V59, pS437, DOI 10.1093/cid/ciu709; Sit D, 2010, J CLIN PSYCHOPHARM, V30, P381, DOI 10.1097/JCP.0b013e3181e7be23; Sit DK, 2008, J CLIN PSYCHIAT, V69, P652, DOI 10.4088/JCP.v69n0419; Spigset Olav, 2008, Tidsskr Nor Laegeforen, V128, P2832; Tang SW, 2008, EXPERT OPIN PHARMACO, V9, P787, DOI 10.1517/14656566.9.5.787 ; Tasnif Y, 2016, CLIN PHARMACOL THER, V100, P53, DOI 10.1002/cpt.382; ter Horst PGJ, 2015, EUR J CLIN PHARMACOL, V71, P1493, DOI 10.1007/s00228-015-1944-6; ter Horst PGJ, 2014, J CLIN PHARM THER, V39, P541, DOI 10.1111/jcpt.12188; Tracy TS, 2005, AM J OBSTET GYNECOL, V192, P633, DOI 10.1016/j.ajog.2004.08.030; van Heeswijk RPG, 2004, CLIN PHARMACOL THER, V76, P588, DOI 10.1016/j.clpt.2004.08.011; Ververs FFT, 2009, CLIN PHARMACOKINET, V48, P677, DOI 10.2165/11318050-000000000-00000; Voinescu PE, 2015, EXPERT REV NEUROTHER, V15, P1171, DOI 10.1586/14737175.2015.1083422; Westin Andreas Austgulen, 2012, Tidsskr Nor Laegeforen, V132, P2382, DOI 10.4045/tidsskr.12.0383; WISNER KL, 1993, AM J PSYCHIAT, V150, P1541; Wisner KL, 1997, PSYCHOPHARMACOL BULL, V33, P243; World Health Organization Collaborating Centre for Drug Statisctics Methodology, 2016, ATC DDD IND	46	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181082	10.1371/journal.pone.0181082	http://dx.doi.org/10.1371/journal.pone.0181082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708853	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800039
J	Wu, Q; Fu, XQ; Jiang, LL; Yang, RS; Cun, JP; Zhou, XF; Zhou, YM; Xiang, YB; Gu, WP; Fan, JH; Li, H; Xu, W				Wu, Qiang; Fu, Xiaoqing; Jiang, Lili; Yang, Rusong; Cun, Jianping; Zhou, Xiaofang; Zhou, Yongming; Xiang, Yibing; Gu, Wenpeng; Fan, Jianhua; Li, Hong; Xu, Wen			Prevalence of enteroviruses in healthy populations and excretion of pathogens in patients with hand, foot, and mouth disease in a highly endemic area of southwest China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PACIFIC REGION; RT-PCR; CHILDREN; CIRCULATION; INFECTION; STRAINS; SAMPLES; RISK; VP1	Etiological carriers and the excretion of the pathogens causing hand, foot, and mouth disease (HFMD) in healthy persons, patients, and asymptomatic persons infected with HFMD as ongoing infection sources may play an important role in perpetuating and spreading epidemics of HFMD. The aims of this study were to determine the carrier status of EV-A71 and CV-A16 in healthy populations, as well as the duration of EV-A71 and CV-A16 shedding in the stools of HFMD patients in an epidemic area of southwest China. A cross-sectional study and a follow-up study were conducted in three HFMD endemic counties of Yunnan Province. Six hundred sixty-seven healthy subjects were recruited to participate in the cross-sectional study, and two stool specimens were collected from each subject. Among the healthy subjects, 90 (13.5%) tested positive for viral isolation, but neither EV-A71 nor CV-A16 was detected in healthy individuals. Of the 150 patients with probable HFMD, 55.3% (83/150) tested positive for viral isolation with presented serotypes such as EV-A71 (51.81%, 43/83), CV-A16 (32.53%, 27/83), other EVs (13.25%, 11/83), and mixed EV-A71 and CV-A16 (2.41%, 2/83). The longest duration of EV-A71 and CV-A16 shedding in stool specimens from patients with HFMD was >46 days after onset. The positive rate of EV-A71 in the stool specimens of confirmed patients dropped to 50% by the end of the third week, and the same occurred with CV-A16 by the end of approximately the seventh week after onset. Although carriers of major causative agents of HFMD in healthy populations are fewer in number, the prolonged shedding of pathogens in patients with HFMD may serve as an important factor in perpetuating and spreading HFMD epidemics.	[Wu, Qiang; Yang, Rusong] Yuxi City Ctr Dis Control & Prevent, Yuxi City, Yunnan, Peoples R China; [Fu, Xiaoqing; Jiang, Lili; Cun, Jianping; Zhou, Xiaofang; Zhou, Yongming; Xiang, Yibing; Gu, Wenpeng; Li, Hong; Xu, Wen] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Fan, Jianhua] Xishuang Banna Autonomous Prefecture Ctr Dis Cont, Jinghong City, Yunnan, Peoples R China		Li, H; Xu, W (corresponding author), Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China.	lihongkmyncn@aliyun.com; yncdcxuwen@sohu.com	Gu, Wenpeng/U-5367-2017		academician workstation in Yunnan [2015IC031]	academician workstation in Yunnan	This work was supported by an academician workstation in Yunnan (No. 2015IC031).	Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chung Pei-Wen, 2001, Journal of Microbiology Immunology and Infection, V34, P167; Cinek O, 2006, J CLIN VIROL, V35, P33, DOI 10.1016/j.jcv.2005.03.007; Deng Ai-ping, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P189; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Guan HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142733; Guo WP, 2015, J CLIN VIROL, V70, P29, DOI 10.1016/j.jcv.2015.06.093; Han J, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-178; He SJ, 2013, INT J INFECT DIS, V17, pE1025, DOI 10.1016/j.ijid.2013.04.003; He Yi-lin, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P1073; Honkanen H, 2013, J CLIN VIROL, V56, P348, DOI 10.1016/j.jcv.2012.11.018; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Jiang WenGuo, 2011, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V6, P857; Li J, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-31; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Pan Hao, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P339; Richardson S, 1998, LANCET, V351, P1844, DOI 10.1016/S0140-6736(97)11257-0; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Shoja ZO, 2007, J CLIN LAB ANAL, V21, P232, DOI 10.1002/jcla.20171; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Teng Shu, 2013, Zhonghua Er Ke Za Zhi, V51, P787; Wang Zhao-guo, 2011, Chinese Journal of Virology, V27, P438; Wen Hong-mei, 2011, Chinese Journal of Virology, V27, P342; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Witso E, 2007, VIRUS RES, V123, P19, DOI 10.1016/j.virusres.2006.07.015; Witso E, 2006, J CLIN MICROBIOL, V44, P4095, DOI 10.1128/JCM.00653-06; Wu WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073920; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-489; Yang Zhi-hong, 2005, Zhonghua Er Ke Za Zhi, V43, P648; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Zeng HR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10550; Zhang XA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-606; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhao Qi, 2015, Bing Du Xue Bao, V31, P554; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923; Zhuang ZC, 2015, VIRUSES-BASEL, V7, P6400, DOI 10.3390/v7122947	44	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181234	10.1371/journal.pone.0181234	http://dx.doi.org/10.1371/journal.pone.0181234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704524	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700113
J	Grigoriev, P; Jasilionis, D; Stumbrys, D; Stankuniene, V; Shkolnikov, VM				Grigoriev, Pavel; Jasilionis, Domantas; Stumbrys, Daumantas; Stankuniene, Vladislava; Shkolnikov, Vladimir M.			Individual- and area-level characteristics associated with alcohol-related mortality among adult Lithuanian males: A multilevel analysis based on census-linked data	PLOS ONE			English	Article							MARITAL-STATUS; PROSPECTIVE COHORT; ALL-CAUSE; RUSSIA; HEALTH; MEN; DEATH; LIFE; INEQUALITIES; CONSUMPTION	Background Although excessive alcohol-related mortality in the post-Soviet countries remains the major public health threat, determinants of this phenomenon are still poorly understood. Aims We assess simultaneously individual-and area-level factors associated with an elevated risk of alcohol-related mortality among Lithuanian males aged 30-64. Methods Our analysis is based on a census-linked dataset containing information on individual-and area-level characteristics and death events which occurred between March 1 st, 2011 and December 31 st, 2013. We limit the analysis to a few causes of death which are directly linked to excessive alcohol consumption: accidental poisonings by alcohol (X45) and liver cirrhosis (K70 and K74). Multilevel Poisson regression models with random intercepts are applied to estimate mortality rate ratios (MRR). Results The selected individual-level characteristics are important predictors of alcohol-related mortality, whereas area-level variables show much less pronounced or insignificant effects. Compared to married men, never married (MRR = 1.9, CI: 1.6-2.2), divorced (MRR = 2.6, CI: 2.3-2.9), and widowed (MRR = 2.4, CI: 1.8-3.1) men are disadvantaged groups. Men who have the lowest level of educational attainment have the highest mortality risk (MRR = 1.7 CI: 1.4-2.1). Being unemployed is associated with a five-fold risk of alcohol-related death (MRR = 5.1, CI: 4.4-5.9), even after adjusting for all other individual variables. Lithuanian males have an advantage over Russian (MRR = 1.3, CI: 1.1-1.6) and Polish (MRR = 1.8, CI: 1.5-2.2) males. After adjusting for all individual characteristics, only two out of seven area-level variables D i.e., the share of ethnic minorities in the population and the election turnout D have statistically significant direct associations. These variables contribute to a higher risk of alcohol-related mortality at the individual level. Conclusions The huge and increasing socio-economic disparities in alcohol-related mortality indicate that recently implemented anti-alcohol measures in Lithuania should be reinforced by specific measures targeting the most disadvantaged population groups and geographical areas.	[Grigoriev, Pavel; Jasilionis, Domantas; Shkolnikov, Vladimir M.] Max Planck Inst Demog Res, Rostock, Germany; [Jasilionis, Domantas; Stumbrys, Daumantas; Stankuniene, Vladislava] Vytautas Magnus Univ, Demog Res Ctr, Kaunas, Lithuania; [Shkolnikov, Vladimir M.] Natl Res Univ Higher Sch Econ, Moscow, Russia	Max Planck Society; Vytautas Magnus University; HSE University (National Research University Higher School of Economics)	Grigoriev, P (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	Grigoriev@demogr.mpg.de		Stumbrys, Daumantas/0000-0002-1324-5758; Jasilionis, Domantas/0000-0001-9959-9292	Research Council of Lithuania [TAP LB-17-027]; Russian Academic Excellence Project [5-100]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Russian Academic Excellence Project(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	The study has been conducted in the framework of the project "Contemporary demographic problems in Belarus and Lithuania: variations, similarities, and ways for transition to sustainable development" (TAP LB-17-027) funded by the Research Council of Lithuania on the basis of the bilateral agreement on the partnership in the areas of science and technology between Lithuania and Belarus http://www.lmt.lt/en/rnd/intergov/lt-by. html. The participation of VMS was partially supported by the Russian Academic Excellence Project 5-100 (http://5top100.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2001, CHALLENGING INEQUITI, P49; Bates D, LME4 LINEAR MIXED EF, P1; Baubiniene A, 1993, MEDICINA, V2, P46; Benosis A, 2014, SVEIK MOKSL, V24, P10, DOI [10.5200/sm-hs.2014.002, DOI 10.5200/SM-HS.2014.002]; Benosis A., 2008, SVEIKATOS MOKSLAI, V1, P1499; Blomgren J, 2004, SOC SCI MED, V58, P2523, DOI 10.1016/j.socscimed.2003.09.027; Brainerd E, 2005, J ECON PERSPECT, V19, P107, DOI 10.1257/0895330053147921; Burneika D., 2013, ETHNICITY STUDIES, V2, P49; Dasgupta P, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-36; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Grabauskas V, 2013, HLTH BEHAV LITHUANIA; Grabauskas V, 2009, MEDICINA-LITHUANIA, V45, P1000, DOI 10.3390/medicina45120128; Grigoriev P, 2015, EUR J PUBLIC HEALTH, P1; Jasilionis D., 2015, LIETUVOS DEMOGRAFINI; Jasilionis D., 2006, SOCIODEMOGRAPHIC MOR; Jasilionis D., 2012, SOCIOECONOMIC DIFFER; Jasilionis D, 2007, POPULATION, V62, P707; Jasilionis D, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2011.133967; Jasilionis D, 2011, EUR J POPUL, V27, P403, DOI 10.1007/s10680-011-9243-0; Jurkynas M., 2012, ELECT STUD, V34, P291; Kunst AE, 1998, REV EPIDEMIOL SANTE, V46, P467; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Mackenbach JP, 2015, SOC SCI MED, V127, P51, DOI 10.1016/j.socscimed.2014.05.021; Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; Martikainen P, 2004, EUR J POPUL, V20, P323, DOI 10.1007/s10680-004-3807-1; MARTIKAINEN PT, 1990, BMJ-BRIT MED J, V301, P407, DOI 10.1136/bmj.301.6749.407; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McKee M, 2001, BRIT MED J, V323, P1051, DOI 10.1136/bmj.323.7320.1051; Mirowsky J, 1998, RES AGING, V20, P415, DOI 10.1177/0164027598204003; Mirowsky J., 2003, ED SOCIAL STATUS HLT; Mirowsky J, 2005, AGEING INT, V30, P27, DOI 10.1007/BF02681006; Paukste E, 2014, ADDICTION, V109, P711, DOI 10.1111/add.12495; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Pridemore WA, 2010, EUR J PUBLIC HEALTH, V20, P569, DOI 10.1093/eurpub/ckq019; Probst C, 2014, INT J EPIDEMIOL, V43, P1314, DOI 10.1093/ije/dyu043; Radisauskas R, 2011, ALCOHOL ALCOHOLISM, V46, P614, DOI 10.1093/alcalc/agr068; Ramonaite A., 2014, POLITOLOGIJA, V1, P3; Rehm J, 2017, ADDICTION, V112, P968, DOI 10.1111/add.13757; Rendall MS, 2011, DEMOGRAPHY, V48, P481, DOI 10.1007/s13524-011-0032-5; Saburova L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-481; Sauliune S., 2008, ALCOHOL ALCOHOLISM, V47, P458; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584; Shkolnikov VM, 2007, SOC SCI MED, V64, P1392, DOI 10.1016/j.socscimed.2006.11.014; Shkolnikov VM, 2004, HYGIEA INT, V4, P29, DOI DOI 10.3384/HYGIEA.1403-8668.044129; SKOG OJ, 1995, ADDICTION, V90, P490, DOI 10.1111/j.1360-0443.1995.tb02182.x; Stelemekas M, 2012, VISUOMENES SVEIKATA, V4, P26; Stickley A, 2007, EUR J PUBLIC HEALTH, P1; Tomkins S, 2007, ADDICTION, V102, P544, DOI 10.1111/j.1360-0443.2006.01693.x; Tomkins S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030274; Vallin J., 1979, READINGS POPUL RES M, V2, P957; Veryga A, 2009, ADDICTION, V104, P1259, DOI 10.1111/j.1360-0443.2009.02654.x; Voss M, 2004, AM J PUBLIC HEALTH, V94, P2155, DOI 10.2105/AJPH.94.12.2155; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; *WHO, EUR HLTH ALL DAT HFA	57	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181622	10.1371/journal.pone.0181622	http://dx.doi.org/10.1371/journal.pone.0181622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC2BU	28732032	gold, Green Published, Green Submitted			2022-12-27	WOS:000406643100050
J	Rose, K; Agius, J; Hall, J; Thompson, P; Eden, JS; Srivastava, M; Tiernan, B; Jenkins, C; Phalen, D				Rose, Karrie; Agius, Jessica; Hall, Jane; Thompson, Paul; Eden, John-Sebastian; Srivastava, Mukesh; Tiernan, Brendan; Jenkins, Cheryl; Phalen, David			Emergent multisystemic Enterococcus infection threatens endangered Christmas Island reptile populations	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; ANTIMICROBIAL RESISTANCE; BIOFILM FORMATION; IDENTIFICATION; EPIDEMIOLOGY; EXTINCTION; VIRULENCE; BACTERIA; WATER; VENOM	Multisystemic infections with a morphologically unusual bacterium were first observed in captive critically endangered Lister's geckos (Lepidodactylus listeri) on Christmas Island in October 2014. Since then the infection was identified in another captive critically endangered lizard species, the blue-tailed skink (Cryptoblepharus egeriae) and two species of invasive geckos; the four clawed gecko (Gehyra mutilata) and Asian house gecko (Hemidactylus frenatus), in a wide geographic range across the east side of the island. The Gram and periodic acid-Schiff positive cocci to diplococci have a propensity to form chains surrounded by a matrix, which ultrastructurally appears to be formed by fibrillar capsular projections. The bacterium was associated with severe and extensive replacement of tissues, but minimal host inflammatory response. Attempts to grow the organism in culture and in embryonated eggs were unsuccessful. Molecular characterisation of the organism placed it as a novel member of the genus Enterococcus. Disease Risk Analyses including this organism should now be factored into conservation management actions and island biosecurity.	[Rose, Karrie; Hall, Jane; Thompson, Paul] Taronga Conservat Soc Australia, Sydney, NSW, Australia; [Rose, Karrie] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Agius, Jessica; Phalen, David] Univ Sydney, Sydney Sch Vet Sci, Fac Vet Sci, Sydney, NSW, Australia; [Eden, John-Sebastian] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Eden, John-Sebastian] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Srivastava, Mukesh; Jenkins, Cheryl] New South Wales Dept Primary Ind, Elizabeth Macarthur Agr Inst, Camden, NSW, Australia; [Tiernan, Brendan] Christmas Isl Natl Pk, Drumsite, CX, Australia	James Cook University; University of Sydney; University of Sydney; University of Sydney; NSW Department of Primary Industries	Rose, K (corresponding author), Taronga Conservat Soc Australia, Sydney, NSW, Australia.; Rose, K (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia.	krose@zoo.nsw.gov.au	Hall, Jane/ABC-6552-2021; Jenkins, Cheryl/N-1937-2015	Hall, Jane/0000-0001-9310-5140; Jenkins, Cheryl/0000-0002-5966-072X; Eden, John-Sebastian/0000-0003-1374-3551; Agius, Jessica/0000-0001-8735-1222	Christmas Island National Park, Parks Australia; Faculty of Veterinary Science, Sydney School of Veterinary Science, University of Sydney; Taronga Conservation Society Australia; National Significant Disease Investigation Scheme of Animal Health Australia; Wildlife Health Australia	Christmas Island National Park, Parks Australia; Faculty of Veterinary Science, Sydney School of Veterinary Science, University of Sydney; Taronga Conservation Society Australia; National Significant Disease Investigation Scheme of Animal Health Australia; Wildlife Health Australia	We acknowledge Christmas Island National Park, Parks Australia and the Faculty of Veterinary Science, Sydney School of Veterinary Science, University of Sydney and Taronga Conservation Society Australia for their financial and logistical support. Further financial support for this project was provided by the National Significant Disease Investigation Scheme of Animal Health Australia and Wildlife Health Australia. We also thank Kim Ho, Melinda Micallef, Dr. Richmond Loh, and Dr. Bernard Hudson for their assistance with attempts to culture the organism described. Drs. David Spratt and Peter Harlow kindly reviewed the manuscript Sharon Candy and Dr. Hannah Bender contributed to image editing, and Dr. Justin Welbergen provided the images of the live gecko in Figure 2.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson ET, 2010, J ZOO WILDLIFE MED, V41, P745, DOI 10.1638/2010-0096.1; Andrew P, 2016, ORYX, P1; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chinnadurai Sathya K, 2009, Vet Clin North Am Exot Anim Pract, V12, P583, DOI 10.1016/j.cvex.2009.06.008; Cogger HG, 2000, TERRESTRIAL REPTILES; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Dahlen Gunnar, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10855; Director of National Parks, 2014, CHRISTM ISL BIOD CON; Distel JW, 2002, J ENDODONT, V28, P689, DOI 10.1097/00004770-200210000-00003; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Gilmore MS, 2013, CURR OPIN MICROBIOL, V16, P10, DOI 10.1016/j.mib.2013.01.006; Goldstein EJC, 2013, J ZOO WILDLIFE MED, V44, P262, DOI 10.1638/2012-0022R.1; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Hall J, 2011, ASSESSMENT REPTILE M, P178; Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13; Hayes JR, 2003, APPL ENVIRON MICROB, V69, P7153, DOI 10.1128/AEM.69.12.7153-7160.2003; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Huebner RA, 2013, PLOS ONE, V8; Innis C, 2010, CHELONIAN CONSERV BI, V9, P205, DOI 10.2744/CCB-0838.1; Innis CJ, 2014, JAVMA-J AM VET MED A, V245, P315, DOI 10.2460/javma.245.3.315; Jacobson ER, 2014, VET J, V201, P257, DOI 10.1016/j.tvjl.2014.05.039; Jakob-Hoff RM., 2014, MANUAL PROCEDURES WI; Cabanes FJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004367; Jay J.M., 2005, MODERN FOOD MICROBIO, V7th; Jho Yeon-Sook, 2011, Lab Anim Res, V27, P213, DOI 10.5625/lar.2011.27.3.213; John VU, 2011, [Frontiers in Biology, 生物学前沿], V6, P357; Johnson J., 2001, P 8 ANN C ASS REPT A, P147; Johnston LM, 2004, APPL ENVIRON MICROB, V70, P3133, DOI 10.1128/AEM.70.5.3133-3137.2004; Jones K, 2016, VET J, V212, P48, DOI 10.1016/j.tvjl.2015.10.041; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; KUMAR A, 1978, A VAN LEEUW J MICROB, V44, P219, DOI 10.1007/BF00643224; Lebreton F, 2017, CELL, V169, P849, DOI 10.1016/j.cell.2017.04.027; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; MCDONALD IJ, 1975, CAN J MICROBIOL, V21, P1198, DOI 10.1139/m75-179; MCNAMARA TS, 1994, J ZOO WILDLIFE MED, V25, P161; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; MUNDT JO, 1963, APPL MICROBIOL, V11, P136, DOI 10.1128/AEM.11.2.136-140.1963; Naser S, 2005, J CLIN MICROBIOL, V43, P2224, DOI 10.1128/JCM.43.5.2224-2230.2005; Naser SM, 2005, MICROBIOL-SGM, V151, P2141, DOI 10.1099/mic.0.27840-0; OBOEGBULEM SI, 1985, INT J ZOONOSES, V12, P228; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; REUTER G, 1992, INT J FOOD MICROBIOL, V17, P101, DOI 10.1016/0168-1605(92)90109-G; Sabia C, 2008, J APPL MICROBIOL, V104, P970, DOI 10.1111/j.1365-2672.2007.03612.x; Schroeter Matthias, 2005, Journal of Herpetological Medicine and Surgery, V15, P53; Schroter M, 2005, J HERPETOL MED SURG, V15, P3; Schumacher J, 2006, J EXOT PET MED, V15, P18, DOI 10.1053/j.jepm.2005.11.004; Singh BR, 2014, J MICROBIOL RES, V4, P78; Singh BR, 2013, INT J MICROBIOL; SLANETZ LW, 1957, J BACTERIOL, V74, P591, DOI 10.1128/JB.74.5.591-595.1957; Smith MJ, 2012, HERPETOL CONSERV BIO, V7, P206; STALEY JT, 1968, J BACTERIOL, V95, P1921, DOI 10.1128/JB.95.5.1921-1942.1968; STEWART JS, 1990, J ZOO WILDLIFE MED, V21, P180; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THEAKSTON RDG, 1990, T ROY SOC TROP MED H, V84, P875, DOI 10.1016/0035-9203(90)90112-R; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zwart P, 1972, 14 INT S ERKR ZOOT W, P265	61	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181240	10.1371/journal.pone.0181240	http://dx.doi.org/10.1371/journal.pone.0181240			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727845	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500049
J	Goodman, JE; Loftus, CT; Liu, XB; Zu, K				Goodman, Julie E.; Loftus, Christine T.; Liu, Xiaobin; Zu, Ke			Impact of respiratory infections, outdoor pollen, and socioeconomic status on associations between air pollutants and pediatric asthma hospital admissions	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; CASE-CROSSOVER ANALYSIS; NEW-YORK-CITY; TIME-SERIES; ENVIRONMENTAL EPIDEMIOLOGY; PARTICULATE MATTER; MEASUREMENT ERROR; NEW-JERSEY; CHILDREN; POLLUTION	Background Epidemiology studies have shown that ambient concentrations of ozone and fine particulate matter (PM2.5) are associated with increased emergency department (ED) visits and hospital admissions (HAs) for asthma. Objective Evaluate the impact of outdoor pollen, respiratory infections, and socioeconomic status (SES) on the associations between ambient ozone and PM2.5 and asthma HAs in New York City. Methods Daily ozone, PM2.5, meteorological factors, pollen, and hospitalization records during 1999 to 2009 were obtained for New York City residents. Daily counts of HAs for asthma and respiratory infections were calculated for all-age and specific age groups, and for high-and low-SES communities. Generalized additive models were used to examine ambient concentrations of ozone and PM2.5 and asthma HAs, potential confounding effects of outdoor pollen and HAs for respiratory infections, and potential effect modification by neighborhood SES. Results Both ozone and PM2.5 were statistically significantly associated with increased asthma HAs in children aged 6-18 years (per 10 ppb increase in ozone: RR = 1.0203, 95% CI: 1.0028-1.0382; per 10 mu g/m(3) increase in PM2.5: RR = 1.0218, 95% CI: 1.0007-1.0434), but not with total asthma HAs, or asthma HAs in other age groups. These associations were stronger for children living in the high-SES areas. Adjustment for respiratory infection HAs at various lags did not result in changes greater than 10% in the risk estimates for either ozone or PM2.5. In contrast, adjustment for outdoor pollen generally attenuated the estimated RRs for both ozone and PM2.5. Conclusions Ambient ozone and PM2.5 are associated with asthma HAs in school-age children, and these associations are not modified by SES. HAs for respiratory infections do not appear to be a confounder for observed ozone- and PM2.5-asthma HAs associations, but pollen may be a weak confounder.	[Goodman, Julie E.; Liu, Xiaobin; Zu, Ke] Gradient, Cambridge, MA 02138 USA; [Loftus, Christine T.] Gradient, Seattle, WA USA; [Loftus, Christine T.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Goodman, JE (corresponding author), Gradient, Cambridge, MA 02138 USA.	jgoodman@gradientcorp.com			Exxonmobil Biomedical Sciences, Inc.	Exxonmobil Biomedical Sciences, Inc.	The work reported in this paper was conducted by the authors during the normal course of their employment, with funding provided by the Exxonmobil Biomedical Sciences, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell ML, 2004, ANNU REV PUBL HEALTH, V25, P247, DOI 10.1146/annurev.publhealth.25.102802.124329; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Canova C, 2013, EUR RESPIR J, V42, P935, DOI 10.1183/09031936.00097412; Dales RE, 2008, INT ARCH ALLERGY IMM, V146, P241, DOI 10.1159/000116360; Darrow LA, 2012, J ALLERGY CLIN IMMUN, V130, P630, DOI 10.1016/j.jaci.2012.06.020; DellaValle CT, 2012, EPIDEMIOLOGY, V23, P55, DOI 10.1097/EDE.0b013e31823b66b8; Dvorin DJ, 2001, ANN ALLERG ASTHMA IM, V87, P394, DOI 10.1016/S1081-1206(10)62921-3; Eggleston PA, 2009, PEDIATRICS, V123, pS160, DOI 10.1542/peds.2008-2233F; Eggo RM, 2016, P NATL ACAD SCI USA, V113, P2194, DOI 10.1073/pnas.1518677113; Evans KA, 2014, ENVIRON RES, V129, P11, DOI 10.1016/j.envres.2013.12.001; Forno E, 2012, AM J RESP CRIT CARE, V185, P1033, DOI 10.1164/rccm.201202-0350ED; Gleason JA, 2014, ENVIRON RES, V132, P421, DOI 10.1016/j.envres.2014.03.035; Goldman GT, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-61; Ito K, 2007, J EXPO SCI ENV EPID, V17, pS45, DOI 10.1038/sj.jes.7500627; Ito K, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0057-0; Jalaludin B, 2008, INT ARCH OCC ENV HEA, V81, P967, DOI 10.1007/s00420-007-0290-0; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Keet CA, 2015, J ALLERGY CLIN IMMUN, V135, P655, DOI 10.1016/j.jaci.2014.11.022; Kloepfer KM, 2010, IMMUNOL ALLERGY CLIN, V30, P553, DOI 10.1016/j.iac.2010.08.002; Lim Hyungryul, 2016, J Prev Med Public Health, V49, P205, DOI 10.3961/jpmph.16.037; Lumley T, 2000, ENVIRONMETRICS, V11, P705, DOI 10.1002/1099-095X(200011/12)11:6<705::AID-ENV444>3.0.CO;2-H; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; O'Lenick CR, 2016, J EPIDEMIOL COMMUNIT; Rabinovitch N, 2004, J ALLERGY CLIN IMMUN, V114, P1131, DOI 10.1016/j.jaci.2004.08.026; Rhomberg LR, 2011, CRIT REV TOXICOL, V41, P651, DOI 10.3109/10408444.2011.563420; Sheffield PE, 2011, ISRN ALLERGY, V2011; Sheffield PE, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0010-2; Strickland MJ, 2014, EPIDEMIOLOGY, V25, P843, DOI 10.1097/EDE.0000000000000170; Strickland MJ, 2010, AM J RESP CRIT CARE, V182, P307, DOI 10.1164/rccm.200908-1201OC; Tolbert PE, 2000, AM J EPIDEMIOL, V151, P798, DOI 10.1093/oxfordjournals.aje.a010280; U.S. Environmental Protection Agency (U.S. EPA), 2013, EPA600R10076F US EPA; US EPA, 2009, EPA600R08139F2 US EP; van der Zee SC, 2000, EUR RESPIR J, V15, P700, DOI 10.1034/j.1399-3003.2000.15d13.x; Villeneuve PJ, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-40; Wilhelm M, 2009, HEALTH PLACE, V15, P25, DOI 10.1016/j.healthplace.2008.02.002; Yap PS, 2013, AM J PUBLIC HEALTH, V103, P695, DOI 10.2105/AJPH.2012.300945; Zheng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117773	37	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180522	10.1371/journal.pone.0180522	http://dx.doi.org/10.1371/journal.pone.0180522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3RW	28719626	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400014
J	Messaritakis, I; Politaki, E; Kotsakis, A; Dermitzaki, EK; Koinis, F; Lagoudaki, E; Koutsopoulos, A; Kallergi, G; Souglakos, J; Georgoulias, V				Messaritakis, Ippokratis; Politaki, Eleni; Kotsakis, Athanasios; Dermitzaki, Eleftheria-Kleio; Koinis, Filippos; Lagoudaki, Eleni; Koutsopoulos, Anastasios; Kallergi, Galatea; Souglakos, John; Georgoulias, Vassilis			Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer	PLOS ONE			English	Article							RNA-POSITIVE CELLS; MESENCHYMAL TRANSITION MARKERS; EARLY BREAST-CANCER; BONE-MARROW; THORACIC RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; PROGNOSTIC RELEVANCE; EXPRESSION; CARCINOMA; CISPLATIN	Background To evaluate the phenotypic heterogeneity of circulating tumor cells (CTCs) based on the expression of proliferative, apoptotic and Epithelial-to-Mesenchymal Transmission (EMT) markers during front-line treatment in patients with small cell lung cancer (SCLC) and to evaluate their clinical relevance. Methods CTCs from 108 chemotherapy-naive patients with SCLC were analyzed by double immunofluorescence staining using anti-Ki67, anti-M30, anti-Vimentin along with anti-CKs antibodies. In 83 patients CTCs were also enumerated using the CellSearch. Results Sequential samples were available from 76 and 48 patients after one-treatment cycle and on disease progression (PD), respectively, for immunofluorescence and from 50 and 36 patients after one-cycle and on PD, respectively, for CellSearch. At baseline, 60.2% of the patients had detectable CTCs by either method. Both proliferative (CK67(+)) and non-proliferative (Ki67(-)), apoptotic (M30(+)) and non-apoptotic (M30(-)) as well as EMT (Vim(+)) CTCs were present in the same patient. Among 22 patients without detectable CTCs by CellSearch, CK+/Ki67(+) and CK+/Vim(+) CTCs could be detected in 6 (27.3%) and 6 (27.3%) patients, respectively. One-chemotherapy cycle reduced both the incidence of detection (p<0.001) and the absolute number (p<0.001) of CTCs; conversely, on PD both the incidence of detection and the number of CTCs were significantly increased (p = 0.002 and p = 0.04, respectively). Multivariate analysis revealed that the increased number of Vim(+) CTCs at baseline and of non-apoptotic CTCs on PD could be emerged as independent prognostic factors associated with decreased OS(p = 0.009 and p = 0.023, respectively). Conclusions CK+/Ki67(+), CK+/M30(+) and CK+/Vim(+) CTCs represent distinct subpopulations of CTCs in patients with SCLC, can be detected even in the absence of detectable CTCs by Cell-Search; CK+/Ki67(+) and CK+/Vim(+) CTCs are associated with unfavorable clinical outcome.	[Messaritakis, Ippokratis; Politaki, Eleni; Kotsakis, Athanasios; Kallergi, Galatea; Souglakos, John; Georgoulias, Vassilis] Univ Crete, Lab Tumor Cell Biol, Med Sch, Iraklion, Greece; [Kotsakis, Athanasios; Dermitzaki, Eleftheria-Kleio; Koinis, Filippos; Souglakos, John; Georgoulias, Vassilis] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece; [Lagoudaki, Eleni; Koutsopoulos, Anastasios] Univ Gen Hosp Heraklion, Dept Pathol, Iraklion, Greece	University of Crete; University Hospital of Heraklion; University Hospital of Heraklion	Georgoulias, V (corresponding author), Univ Crete, Lab Tumor Cell Biol, Med Sch, Iraklion, Greece.; Georgoulias, V (corresponding author), Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece.	georgsec@med.uoc.gr	Messaritakis, Ippokratis/H-6668-2019; Koutsopoulos, Anastasios/AAO-9498-2020	Koutsopoulos, Anastasios/0000-0002-8430-7565; Messaritakis, Ippokratis/0000-0003-1877-500X; kallergi, Galatea/0000-0001-9825-3871	Cretan Association for Biomedical Research (CABR); Hellenic Society of Medical Oncology (HeSMO)	Cretan Association for Biomedical Research (CABR); Hellenic Society of Medical Oncology (HeSMO)	This work was partly supported by research grants from the Cretan Association for Biomedical Research (CABR) and the Hellenic Society of Medical Oncology (HeSMO).	American Cancer Society, 2022, CANC FACTS FIGURES 2; Androulakis N, 2012, BRIT J CANCER, V106, P1917, DOI 10.1038/bjc.2012.202; Ausch C, 2009, J GASTROINTEST SURG, V13, P2020, DOI 10.1007/s11605-009-0992-6; Cabinakova M, 2015, NEOPLASMA, V62, P259, DOI 10.4149/neo_2015_031; Cohen SJ, 2006, CLIN COLORECTAL CANC, V6, P125, DOI 10.3816/CCC.2006.n.029; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Daskalaki A, 2009, BRIT J CANCER, V101, P589, DOI 10.1038/sj.bjc.6605183; Fehm T, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1611; Georgoulias V, 2012, ANN ONCOL, V23, P1744, DOI 10.1093/annonc/mds020; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Grobe A, 2014, CLIN CANCER RES, V20, P425, DOI 10.1158/1078-0432.CCR-13-1101; Hartkopf AD, 2014, BREAST CANCER RES TR, V147, P345, DOI 10.1007/s10549-014-3113-5; Hiltermann TJN, 2012, ANN ONCOL, V23, P2937, DOI 10.1093/annonc/mds138; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Huang CH, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00271; Igawa S, 2014, ONCOL LETT, V7, P1469, DOI 10.3892/ol.2014.1940; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Kallergi G, 2007, MOL MED, V13, P79, DOI 10.2119/2006-00083.Kallergi; Kallergi G, 2013, MOL CANCER THER, V12, P1886, DOI 10.1158/1535-7163.MCT-12-1167; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kallergi G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2452; Kallergi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2149; Kruck S, 2012, ADV UROL, V2012, DOI 10.1155/2012/135281; Larson CJ, 2004, CYTOM PART A, V62A, P46, DOI 10.1002/cyto.a.20073; Lin H, 2011, CRIT REV ONCOL HEMAT, V77, P2, DOI 10.1016/j.critrevonc.2010.04.008; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Naito T, 2012, J THORAC ONCOL, V7, P512, DOI 10.1097/JTO.0b013e31823f125d; Normanno N, 2014, LUNG CANCER, V85, P314, DOI 10.1016/j.lungcan.2014.05.002; Okegawa T, 2009, J UROLOGY, V181, P1091, DOI 10.1016/j.juro.2008.11.015; Papadaki MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-651; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Saloustros E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2897; Shi WL, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0755-9; Spiliotaki M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0485-8; Strati A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-422; Takada M, 2002, J CLIN ONCOL, V20, P3054, DOI 10.1200/JCO.2002.12.071; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Toss A, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.06; Turrisi AT, 1999, NEW ENGL J MED, V340, P265, DOI 10.1056/NEJM199901283400403; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Wimberger P, 2007, GYNECOL ONCOL, V107, P331, DOI 10.1016/j.ygyno.2007.07.073; Xenidis N, 2013, BRIT J CANCER, V108, P549, DOI 10.1038/bjc.2012.597; Xenidis N, 2003, ANN ONCOL, V14, P849, DOI 10.1093/annonc/mdg259; Xenidis N, 2009, J CLIN ONCOL, V27, P2177, DOI 10.1200/JCO.2008.18.0497	45	24	24	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181211	10.1371/journal.pone.0181211	http://dx.doi.org/10.1371/journal.pone.0181211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719656	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400035
J	Moyo, N; Borthwick, NJ; Wee, EG; Capuccil, S; Crook, A; Dorrell, L; Hanke, T				Moyo, Nathifa; Borthwick, Nicola J.; Wee, Edmund G.; Capuccil, Silvia; Crook, Alison; Dorrell, Lucy; Hanke, Tomas			Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens	PLOS ONE			English	Article							HLA CLASS-I; HIGHLY PATHOGENIC SIV; TUMOR-NECROSIS-FACTOR; IMMUNODEFICIENCY-VIRUS; FUNCTIONAL-HETEROGENEITY; VIRAL LOAD; ESCAPE MUTATIONS; INDUCED IMMUNITY; INFECTION; MEMORY	Background Durability of vaccine-elicited immune responses is one of the key determinants for vaccine success. Our aim is to develop a vaccination strategy against the human immunodeficiency virus type 1 (HIV-1), which induces protective and durable CD8(+) T-cell responses. The central theorem of our approach is to focus T cells on highly conserved regions of the HIV-1 proteome and this is achieved through the use of the first-generation conserved vaccine immunogen HIVconsv. This immunogen vectored by plasmid DNA, simian adenovirus and poxvirus MVA was tested in healthy, HIV-1-negative adults in UK and induced high magnitudes of HIVconsv-specific plurifunctional CD8(+) T cells capable of in vitro HIV-1 inhibition. Here, we assessed the durability of these responses. Methods Vaccine recipients in trial HIV-CORE 002 were invited to provide a blood sample at 1 and 2 years after vaccination. Their PBMCs were tested in IFN-gamma ELISPOT, 25-analyte Luminex, CFSE proliferation and intracellular cytokine staining assays, the last enhanced by HLA-peptide dextramer analysis. Results 12/12 (1 year) and 8/8 (2 years) returning subjects had median (range) of 990 (150-2495) and 763 (70-1745) IFN-gamma SFU/10(6) PBMC specific for HIVconsv, respectively, and recognized 5 (1-6) out of 6 peptide pools at 2 years. Over one-half of the HIVconsv-specific cells expressed at least 3 functions IFN-gamma, TNF-alpha and CD 107a, and were capable of proliferation. Among dextramer-reactive cells, naive, transitional, effector and terminally differentiated memory subsets were similarly represented. Conclusions First generation HIVconsv vaccine induced human T cells, which were plurifunctional and persisted for at least 2 years.	[Moyo, Nathifa; Borthwick, Nicola J.; Wee, Edmund G.; Capuccil, Silvia; Crook, Alison; Dorrell, Lucy; Hanke, Tomas] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England; [Capuccil, Silvia] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Dorrell, Lucy] Univ Oxford, Nuffield Dept Med, NDM Res Bldg, Oxford, England; [Dorrell, Lucy] Univ Oxford, Oxford NIHR Biomed Res Ctr, Oxford, England; [Hanke, Tomas] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan	University of Oxford; Jenner Institute; University of Bologna; University of Oxford; University of Oxford; Kumamoto University	Hanke, T (corresponding author), Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England.; Hanke, T (corresponding author), Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan.	tomas.hanke@ndm.ox.ac.uk		Moyo, Nathifa Adaoha/0000-0003-3203-9463; Hanke, Tomas/0000-0002-6076-9546	Medical Research Council (MRC) UK; UK Department for International Development (DFID) under the MRC/DFID [G1001757, MR/N023668/1]; MRC [G0701669, MR/N023668/1] Funding Source: UKRI; Medical Research Council [MR/N023668/1, G0701669] Funding Source: researchfish	Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work is jointly funded by the Medical Research Council (MRC) UK and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreements (G1001757 and MR/N023668/1) to T.H. T.H. and L.D. are the Jenner Institute Investigators. The funders had no role in study design, data collection	Abboud G, 2016, J EXP MED, V213, P2897, DOI 10.1084/jem.20160167; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ahmed T, 2016, VACCINE, V34, P1215, DOI 10.1016/j.vaccine.2015.12.021; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Borthwick N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176418; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Catalina MD, 2002, J IMMUNOL, V168, P4184, DOI 10.4049/jimmunol.168.8.4184; Cramer LA, 2000, J IMMUNOL, V165, P3190, DOI 10.4049/jimmunol.165.6.3190; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Defawe OD, 2012, J IMMUNOL METHODS, V382, P117, DOI 10.1016/j.jim.2012.05.011; Demers KR, 2013, IMMUNOL REV, V254, P190, DOI 10.1111/imr.12069; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; DINARELLO CA, 1986, ANNU REV MED, V37, P173; EPPERSON DE, 1992, J IMMUNOL, V149, P3297; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferguson AL, 2013, IMMUNITY, V38, P606, DOI 10.1016/j.immuni.2012.11.022; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hancock G, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21171; Hancock G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004658; Hanke T, 2014, EXPERT OPIN BIOL TH, V14, P601, DOI 10.1517/14712598.2014.885946; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Hayton EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101591; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; JOHNSON DR, 1990, P NATL ACAD SCI USA, V87, P5183, DOI 10.1073/pnas.87.13.5183; Johnson S, 2015, J VIROL, V89, P7494, DOI 10.1128/JVI.00438-15; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KULL FC, 1988, NAT IMMUN CELL GROW, V7, P254; Lazdins JK, 1997, J EXP MED, V185, P81, DOI 10.1084/jem.185.1.81; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McMichael AJ, 2012, NAT IMMUNOL, V13, P423, DOI 10.1038/ni.2264; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mothe B, HIVCONSV VACCINATION; Mothe B, 2017, C RETR OPP INF SEATT; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Murakoshi H, 2015, J VIROL, V89, P5330, DOI 10.1128/JVI.00020-15; Mutua G, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.61; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Ondondo B, 2016, MOL THER, V24, P832, DOI 10.1038/mt.2016.3; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shankar P, 1999, BLOOD, V94, P3084, DOI 10.1182/blood.V94.9.3084.421k02_3084_3093; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; WALLACH D, 1982, NATURE, V299, P833, DOI 10.1038/299833a0; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379	84	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181382	10.1371/journal.pone.0181382	http://dx.doi.org/10.1371/journal.pone.0181382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719652	gold, Green Published, Green Submitted			2022-12-27	WOS:000406061400044
J	Tadege, B; Shimelis, T				Tadege, Bamlaku; Shimelis, Techalew			Infections with Schistosoma mansoni and geohelminths among school children dwelling along the shore of the Lake Hawassa, southern Ethiopia	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SOIL TRANSMITTED HELMINTHS; TOWN	Background Infections with Schistosoma mansoni and soil-transmitted helminthes (STHs) are major public health problems in Ethiopia. However, information was scarce on the current status of these infections to guide an intervention in the study area. Therefore, this study was conducted to assess the prevalence of infections with S. mansoni and STHs and associated factors among school children in southern Ethiopia. Methods This cross-sectional study investigated children who were attending the Finchawa and Tullo junior elementary schools and were residing along the shore of the lake Hawassa in January and February, 2015. A total of 374 students were selected using systematic random sampling technique. Data on socio-demography and related factors was collected using structured questionnaires. A single stool sample was collected from each child and processed using formol-ether concentration technique and examined microscopically for parasites' ova/larva. Results The prevalence of parasitic infection with one or more than one helminthiasis was found to be 67.9%. Seven different types of helminths were identified and the most prevalent parasites were Ascaris lumbricoides (44.4%), followed by S. mansoni (31%), Trichuris trichiura (11%), and hookworms (7.7%). The rate of infection with STHs was 52.4%. Single, double, triple and quadruple infections were 42.2, 22.5, 2.4, and 0.8%, respectively. Children who practiced open-field defecation (AOR, 3.6; 95% CI 1.6-8.0; p = 0.001) and had not always washed their hands before eating a meal (AOR, 5.0; 95% CI 2.15-11.7; p < 0.001) were more infected with STHs. Moreover, the rate of S. mansoni infection was significantly higher among children who were attending the Finchawa school (AOR, 2.13; 95% CI 1.31-3.46; p = 0.002), aged 11-15 years ( AOR, 1.97; 95% CI 1.22-3.19; p = 0.006), had swum in the lake Hawassa ( AOR, 2.73; 95% CI 1.20-6.17; p = 0.016), and had involved in irrigation-related activities ( AOR, 1.68; 95% CI 1.04-2.71; p = 0.034). Conclusion The study showed high prevalence of STHs and moderate rate of schisotosomiasis. Mass deworming twice a year for STHs and once every two years for S. mansoni, further to strengthening other prevention measures, is critically needed to reduce these infections to inconsequential level.	[Tadege, Bamlaku] Hawassa Univ, Coll Med & Hlth Sci, Sch Med, Microbiol & Parasitol Unit, Hawassa, Ethiopia; [Shimelis, Techalew] Hawassa Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Hawassa, Ethiopia	Hawassa University; Hawassa University	Shimelis, T (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Hawassa, Ethiopia.	techalew03@yahoo.com	Shimelis, Techalew/AFL-2401-2022	Shimelis, Techalew/0000-0003-3531-0482	Hawassa University	Hawassa University	The study was conducted with small grant obtained from Hawassa University.; We would like to thank Hawassa University for financial support of the study. We are so indebted to the Laboratory technicians who analyzed the specimen, and the school directors and health professionals who supported us with data collection. We acknowledge students and their parents/guardians for their willingness and active participation in the study. The Department of Medical Laboratory Science is also much appreciated for allowing us use its laboratory facility.	Abossie A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-166; Alemu A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-189; [Anonymous], 2016, SCHIST CONTR IN SCI; [Anonymous], SCHISTOSOMIASIS CONT; Assefa A, 2013, MOMONA ETHIOP J SCI, V5, P174; Birrie H., 1998, SCHISTOSOMIASIS ETHI, V2, P29; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Dagnew M., 1999, Ethiopian Journal of Health Development, V13, P15; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Debalke S, 2013, ETHIOP J HEALTH SCI, V23, P237, DOI 10.4314/ejhs.v23i3.6; Erko B, 2003, ETHIOPIAN MED J, V41, P333; Federal Ministry of Health, 2010, GUID ENH OUTR STRAT; Hadidjaja P, 1998, AM J TROP MED HYG, V59, P791, DOI 10.4269/ajtmh.1998.59.791; Hotez P, 2007, TRENDS PARASITOL, V23, P511, DOI 10.1016/j.pt.2007.08.015; Hotez PJ, 2010, ADV PARASIT, V72, P31, DOI 10.1016/S0065-308X(10)72002-9; Legesse M, 2004, ETHIOP J HEALTH DEV, V18, P116; Ligabaw W, 2014, J PARASITOL; Lo C., 1988, SCHISTOSOMIASIS ECOL; Mathewos Biniam, 2014, BMC Res Notes, V7, P88, DOI 10.1186/1756-0500-7-88; Mengistu M, 2011, ETHIOP J HEALTH SCI, V21, P111; Rao VG, 2006, PUBLIC HEALTH NUTR, V9, P19, DOI 10.1079/PHN2005761; Samuel F., 2015, AM J HLTH RES, V3, P170, DOI [10.11648/j.ajhr.20150303.21, DOI 10.11648/J.AJHR.20150303.21]; Shamlaye N, 2003, CONTROLLING DISEASE DUE TO HELMINTH INFECTIONS, P239; Steketee RW, 2003, J NUTR, V133, p1661S, DOI 10.1093/jn/133.5.1661S; STEPHENSON LS, 1993, J NUTR, V123, P1036; Sturrock RF., 1998, T R SOC TROP MED HYG, V92, P470; Tadesse Z, 2008, T ROY SOC TROP MED H, V102, P213, DOI 10.1016/j.trstmh.2007.09.005; Terefe A, 2011, ETHIOP J HEALTH DEV, V25, P46; Wale M., 2014, J PARASITOL VECTOR B, V6, P156, DOI [10.5897/JPVB2014.0159, DOI 10.5897/JPVB2014.0159]; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2002, TECHNICAL SERIES REP, V912; WHO, 2012, EL SOIL TRANSM HELM; World Health Organization, 2001, EX BOARD 107 SESS PR; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P157	34	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181547	10.1371/journal.pone.0181547	http://dx.doi.org/10.1371/journal.pone.0181547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719642	gold, Green Submitted, Green Published			2022-12-27	WOS:000406061400054
J	Chang, CH; Chen, SJ; Liu, CY				Chang, Chun-Hung; Chen, Shaw-Ji; Liu, Chieh-Yu			Pediatric sleep apnea and depressive disorders risk: A population-based 15-year retrospective cohort study	PLOS ONE			English	Article							CHILDREN; METAANALYSIS; ASSOCIATION; DISTURBANCES; OVERWEIGHT; CHILDHOOD; BEHAVIOR; OBESITY; DISEASE	Background Studies have shown a higher risk of depressive disorders in children with sleep apnea than in those without sleep apnea. However, the association between sleep apnea and subsequent depressive disorders in the pediatric population remains undetermined. Thus, this study investigated the risk of depressive disorders among pediatric patients with sleep apnea. Methods In this study, the population-based National Health Insurance Research Database of Taiwan was used to identify patients who had first been diagnosed with sleep apnea between 1999 and 2013. Patients with sleep apnea who were younger than 18 years were included in the sleep apnea group. Controls (those without sleep apnea) were matched to patients with sleep apnea at a 1:10 ratio by age, sex, and index year. Patients who had baseline or inherited depressive disorders before the enrollment date were excluded. The two groups were followed up until December 31, 2013. The primary endpoint was the occurrence of one or more depressive disorders. Results At the end of this study, 6,237 children had been enrolled, comprising 567 children with sleep apnea and 5,670 children without sleep apnea. During the mean follow-up period of 5.87 years, a total of 77 children (1.23%) developed one or more depressive disorders; 14 (2.46%) from the sleep apnea group and 63 (1.11%) from the control group. Kaplan-Meier analysis showed that children with sleep apnea had a significantly higher risk of depressive disorders (log-rank test, p = 0.002). After adjusting for covariates, the risk of subsequent depressive disorders among children with sleep apnea was still significantly higher (hazard ratio [HR] = 2.25; 95% confidence interval [CI] = 1.25-4.05; p = 0.006). Moreover, boys with sleep apnea had a significantly higher risk than those without sleep apnea (adjusted HR = 3.77; 95% CI, 1.82-7.54; p < 0.001). Furthermore, in sleep apnea group, children older than 12 years of age had more risk to depression (hazard ratio (HR) = 7.1833, 95% confidence interval (CI), 2.3734 to 21.7411; p = 0.0004). Conclusions This study found a significantly higher subsequent risk of depressive disorders in children with sleep apnea, particularly boys and those older than 12 years of age. The study findings strongly suggest that clinicians should provide psychological evaluation and supportive care for children with sleep apnea, in addition to medical treatment.	[Chang, Chun-Hung] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Chang, Chun-Hung] China Med Univ, Inst Clin Med, Taichung, Taiwan; [Chang, Chun-Hung] Cardinal Tien Jr Coll Healthcare & Management, Dept Nursing, Taipei, Taiwan; [Chen, Shaw-Ji] Mackay Mem Hosp, Dept Psychiat, Taitung Branch, Taitung, Taiwan; [Chen, Shaw-Ji] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Chen, Shaw-Ji] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Biostat Consulting Lab, Dept Midwifery & Women Hlth Care, Taipei, Taiwan; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Dept Speech Language Pathol & Audiol, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Tzu Chi University; National Taipei University of Nursing & Health Science (NTUNHS); National Taipei University of Nursing & Health Science (NTUNHS)	Liu, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Biostat Consulting Lab, Dept Midwifery & Women Hlth Care, Taipei, Taiwan.; Liu, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Speech Language Pathol & Audiol, Taipei, Taiwan.	chiehyu@ntunhs.edu.tw	Chang, Chun-Hung/AAT-1641-2021; Liu, Chieh-Yu/J-3789-2019; Liu, Chieh-Yu/AAR-9654-2021	Liu, Chieh-Yu/0000-0003-3283-028X				Beebe DW, 2010, SLEEP, V33, P1447, DOI 10.1093/sleep/33.11.1447; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Blunden S, 2000, J CLIN EXP NEUROPSYC, V22, P554, DOI 10.1076/1380-3395(200010)22:5;1-9;FT554; Bourke RS, 2011, SLEEP MED, V12, P222, DOI 10.1016/j.sleep.2010.08.011; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974]; Ferini-Strambi L, 2004, Minerva Med, V95, P187; Huang YS, 2007, SLEEP MED, V8, P18, DOI 10.1016/j.sleep.2006.05.016; Kurnatowski P, 2008, J LARYNGOL OTOL, V122, P931, DOI 10.1017/S0022215107001235; Lam RW, 2006, INT CLIN PSYCHOPHARM, V21, pS25, DOI 10.1097/01.yic.0000195658.91524.61; Landau YE, 2012, PEDIATR PULM, V47, P180, DOI 10.1002/ppul.21534; Lin WC, 2012, CURR PSYCHIAT REP, V14, P503, DOI 10.1007/s11920-012-0307-6; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Merikangas AK, 2012, J BEHAV MED, V35, P149, DOI 10.1007/s10865-011-9340-x; Mitchell RB, 2006, INT J PEDIATR OTORHI, V70, P395, DOI 10.1016/j.ijporl.2005.10.020; Nakra N, 2008, PEDIATRICS, V122, pE634, DOI 10.1542/peds.2008-0154; O'Brien LM, 2004, PEDIATRICS, V114, P44, DOI 10.1542/peds.114.1.44; Reeves Gloria M, 2008, Int J Child Health Hum Dev, V1, P103; Rosen CL, 2004, PEDIATRICS, V114, P1640, DOI 10.1542/peds.2004-0103; Schroder Carmen M, 2005, Ann Gen Psychiatry, V4, P13, DOI 10.1186/1744-859X-4-13; Sedky K, 2014, SLEEP MED REV, V18, P349, DOI 10.1016/j.smrv.2013.12.003; Ting H, 2011, SLEEP BREATH, V15, P91, DOI 10.1007/s11325-010-0329-4; Wallace A, 2013, SLEEP, V36, P203, DOI 10.5665/sleep.2374; Wang X, 2013, INT J CARDIOL, V169, P207, DOI 10.1016/j.ijcard.2013.08.088; Yilmaz E, 2013, J CLIN SLEEP MED, V9, P1213, DOI 10.5664/jcsm.3178; Yue WH, 2008, SLEEP, V31, P1535, DOI 10.1093/sleep/31.11.1535	26	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181430	10.1371/journal.pone.0181430	http://dx.doi.org/10.1371/journal.pone.0181430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708880	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800057
J	Panthi, S; Khanal, G; Acharya, KP; Aryal, A; Srivathsa, A				Panthi, Saroj; Khanal, Gopal; Acharya, Krishna Prasad; Aryal, Achyut; Srivathsa, Arjun			Large anthropogenic impacts on a charismatic small carnivore: Insights from distribution surveys of red panda Ailurus fulgens in Nepal	PLOS ONE			English	Article							LANGTANG NATIONAL-PARK; FOOD-HABITS; CONSERVATION; RESERVE; SPACE; AREA; DIVERSITY; LIVESTOCK; ECOLOGY; BAMBOO	Protected areas are key to preserving biodiversity and maintaining ecosystem services. However, their ability to ensure long-term survival of threatened andendangered species varies across countries, regions and landscapes. Distribution surveys can beparticularly important for assessing the value of protected areas, and gauging their efficacy incatering to species-specific requirements. We assessed the conservation value of one such reserve for a charismatic yet globally endangered species, the red panda Ailurus fulgens, in the light of on-going land-use transformation in Nepal. We conducted field surveys forindirect signs of red pandas along forest trails in 25-km(2) sampling grid cells (n = 54) of Dhorpatan Hunting Reserve, and confronted a set of ecological hypotheses to the data using hierarchical occupancy models. We estimated overall occupancy at Psi(SE) = 0.41 (0.007), with relatively high site-level detectability [p = 0.93 (SE = 0.001)]. Our results show that despitebeing a subsistence form of small-scale resource use, extraction of bamboo and livestock grazing negatively affected panda occurrence, albeit at different intensities. The amount of bamboo cover, rather than the overall proportion of forest cover, had greater influence on the panda occurrence. Despite availability of bamboo cover, areas with bamboo extraction and anthropogenic disturbances were less likely to be occupied by pandas. Together, these results suggest that long-term persistence of red pandas in this reserve and elsewhere across the species' range will require preventing commercial extractionof bamboo, coupled with case-specific regulation of anthropogenic exploitation of red panda habitats.	[Panthi, Saroj; Acharya, Krishna Prasad] Minist Forest & Soil Conservat, Dept Forests, Kathmandu, Nepal; [Khanal, Gopal] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Postgrad Programme Wildlife Biol & Conservat, India Program,Wildlife Conservat Soc, Bangalore, Karnataka, India; [Khanal, Gopal] Ctr Ecol Studies, Lalitpur, Nepal; [Aryal, Achyut] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Fac Sci, Sydney, NSW, Australia; [Aryal, Achyut] Toi Ohomai Inst Technol, Dept Forest & Resource Management, Rotorua, New Zealand; [Aryal, Achyut] Federat Univ Australia, Fac Sci & Technol, Gippsland Campus, Churchill, Vic, Australia; [Aryal, Achyut] Massey Univ, Inst Nat & Math Sci, Human Wildlife Interact Res Grp, Auckland, New Zealand; [Srivathsa, Arjun] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [Srivathsa, Arjun] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Sydney; Federation University Australia; Massey University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Panthi, S (corresponding author), Minist Forest & Soil Conservat, Dept Forests, Kathmandu, Nepal.	mountsaroj@gmail.com	Khanal, Gopal/N-7765-2017	Khanal, Gopal/0000-0001-6628-0015; Panthi, Saroj/0000-0002-1502-7711; Srivathsa, Arjun/0000-0003-2935-3857	Dhorpatan Hunting Reserve, Nepal; Rufford Small Grants Foundation, UK	Dhorpatan Hunting Reserve, Nepal; Rufford Small Grants Foundation, UK	We acknowledge the Dhorpatan Hunting Reserve, Nepal for financial, logistic and instrument support and the Rufford Small Grants Foundation, UK for funding support for field data collection.	Acharya KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161717; Appel A, 2013, VERTEBR ZOOL, V63, P111; Aryal A, 2015, HYSTRIX, V26, P85, DOI 10.4404/hystrix-26.2-11210; Aryal Achyut, 2009, Journal of Threatened Taxa, V1, P562; Bhatta Manoj, 2014, Open Journal of Ecology, V4, P989; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Chakraborty R, 2015, MAMMALIA, V79, P25, DOI 10.1515/mammalia-2013-0105; Choudhury A, 2001, ORYX, V35, P250, DOI 10.1046/j.1365-3008.2001.00181.x; Dendup P, 2016, ORYX, P1; DFRS [Department of Forest Research and Survey], 2015, STAT NEP FOR FOR RES; Di Minin E, 2016, TRENDS ECOL EVOL, V31, P99, DOI 10.1016/j.tree.2015.12.006; DNPWC, 2011, ANN REP SHRAW 2067 A; Dorji S, 2012, ORYX, V46, P536, DOI 10.1017/S0030605311000780; Dorji S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026483; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fox J, 1996, CONSERV BIOL, V10, P562, DOI 10.1046/j.1523-1739.1996.10020562.x; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Geldmann J, 2015, BIOL CONSERV, V191, P692, DOI 10.1016/j.biocon.2015.08.029; Glatston A, 2015, AILURUS FULGENS RED; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guillera-Arroita G, 2017, ECOGRAPHY, V40, DOI 10.1111/ecog.02445; Guillera-Arroita G, 2011, METHODS ECOL EVOL, V2, P401, DOI 10.1111/j.2041-210X.2011.00089.x; Hines JE., 2006, PRESENCESOFTWARE EST; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kandel K, 2015, BIOL CONSERV, V181, P150, DOI 10.1016/j.biocon.2014.10.007; Kandel P, 2016, SMALL-SCALE FOR, V15, P481, DOI 10.1007/s11842-016-9335-0; Kanel KR, 2012, STUDY DEMAND SUPPLY; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Lahoz-Monfort JJ, 2010, J APPL ECOL, V47, P1094, DOI 10.1111/j.1365-2664.2010.01854.x; Lama Sonam Tashi, 2015, Journal of Threatened Taxa, V7, P7460, DOI 10.11609/JoTT.o4208.7460-4; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahato N. K., 2005, NEPAL J FORESTRY, V12, P32; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Muzzini E., 2013, URBAN GROWTH SPATIAL; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; Panthi S, 2013, NEPAL OPEN J FOR, V3, P109; Panthi S, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1307-2; Panthi S, 2012, ZOOL STUD, V51, P701; Pradhan S, 2001, BIOL CONSERV, V98, P11, DOI 10.1016/S0006-3207(00)00079-3; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Rayan DM, 2015, BIOL CONSERV, V184, P18, DOI 10.1016/j.biocon.2014.12.024; REID DG, 1991, J ZOOL, V225, P347, DOI 10.1111/j.1469-7998.1991.tb03821.x; Ripple WJ, 2016, TRENDS ECOL EVOL, V31, P495, DOI 10.1016/j.tree.2016.03.011; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sharma HP, 2014, HYSTRIX, V25, P47, DOI 10.4404/hystrix-25.1-9033; Sharma HP, 2014, ORYX, V48, P228, DOI 10.1017/S0030605313001403; Sharma Hari Pd., 2010, Human Dimensions of Wildlife, V15, P299, DOI 10.1080/10871200903582634; Srivathsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106213; Tamang B, 2009, INDIAN J TRADIT KNOW, V8, P89; Thapa A, 2015, INT J CONSERV SCI, V6, P261; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Webb EL, 2011, BIOMASS BIOENERG, V35, P121, DOI 10.1016/j.biombioe.2010.08.023; Wei FW, 1999, J ZOOL, V248, P535, DOI 10.1111/j.1469-7998.1999.tb01053.x; Wei FW, 1999, BIOL CONSERV, V89, P285, DOI 10.1016/S0006-3207(98)00156-6; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; YONZON P, 1991, AMBIO, V20, P285; Yonzon P., 1989, THESIS; YONZON PB, 1991, BIOL CONSERV, V57, P1, DOI 10.1016/0006-3207(91)90104-H; YONZON PB, 1991, CONSERV BIOL, V5, P196, DOI 10.1111/j.1523-1739.1991.tb00124.x; Zhang JD, 2017, BIOL CONSERV, V209, P119, DOI 10.1016/j.biocon.2017.02.014; Zhang ZJ, 2009, ACTA THERIOL, V54, P225, DOI 10.4098/j.at.0001-7051.017.2008	71	20	25	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180978	10.1371/journal.pone.0180978	http://dx.doi.org/10.1371/journal.pone.0180978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708881	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649800036
J	Ghimire, PR; Agho, KE; Renzaho, A; Christou, A; Nisha, MK; Dibley, M; Raynes-Greenow, C				Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore; Renzaho, Andre; Christou, Aliki; Nisha, Monjura Khatun; Dibley, Michael; Raynes-Greenow, Camille			Socio-economic predictors of stillbirths in Nepal (2001-2011)	PLOS ONE			English	Article							RISK-FACTORS; MATERNAL AGE; DELAYED CHILDBEARING; INCOME COUNTRIES; RATES; COMPLICATIONS; DETERMINANTS; BANGLADESH; EDUCATION; DELIVERY	Introduction Stillbirth has a long-lasting impact on parents and families. This study examined socio-economic predictors associated with stillbirth in Nepal for the year 2001, 2006 and 2011. Methods The Nepalese Demographic and Health Survey (NDHS) data for the period (2001-2011) were pooled to estimate socio-economic predictors associated with stillbirths in Nepal using binomial logistic regression while taking clustering and sampling weights into account. Results A total of 18,386 pregnancies of at least 28 weeks gestation were identified. Of these pregnancies, 335 stillbirths were reported. Stillbirth increased significantly among women that lived in the hills ecological zones (aRR 1.38, 95% CI 1.02, 1.87) or in the mountains ecological zones (aRR 1.71, 95% CI 1.10, 2.66). Women with no schooling (aRR 1.72, 95% CI 1.10, 2.69), women with primary education (aRR 1.81, 95% CI 1.11, 2.97); open defecation (aRR 1.48, 95% CI 1.00, 2.18), and those whose major occupation was agriculture (aRR 1.80, 95% CI 1.16, 2.78) are more likely to report higher stillbirth. Conclusions Low levels of education, ecological zones and open defecation were found to be strong predictors of stillbirth. Access to antenatal care services and skilled birth attendants for women in the mountainous and hilly ecological zones of Nepal is needed to further reduce stillbirth and improved services should also focus on women with low levels of education.	[Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Renzaho, Andre] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia; [Christou, Aliki; Nisha, Monjura Khatun; Dibley, Michael; Raynes-Greenow, Camille] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia	Western Sydney University; Western Sydney University; University of Sydney	Ghimire, PR (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	prameshraj@hotmail.com	Agho, Kingsley/AAW-5622-2021; Renzaho, Andre M.N./AAH-7679-2021; Dangal, Ganesh/O-1989-2017; Christou, Aliki/D-1249-2018; Agho, Kingsley/AAE-9971-2020	Agho, Kingsley/0000-0003-4111-3207; Dangal, Ganesh/0000-0002-5834-5525; Christou, Aliki/0000-0001-9525-8255; Ghimire, Pramesh/0000-0002-7902-7294; Ghimire, Pramesh Raj/0000-0003-2816-0463; RENZAHO, ANDRE/0000-0002-6844-0833	National Health and Medical Research Council (of Australia) Career Development Fellowship [1087062]; Australian Research Council Future fellowship [FT110100345]; Australian Postgraduate Award funded through the Australian Commonwealth Government; Early Career Researcher Postgraduate Scholarship, Sydney Medical School	National Health and Medical Research Council (of Australia) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future fellowship(Australian Research Council); Australian Postgraduate Award funded through the Australian Commonwealth Government; Early Career Researcher Postgraduate Scholarship, Sydney Medical School	CRG was supported by National Health and Medical Research Council (of Australia) Career Development Fellowship #1087062, AR is supported by an Australian Research Council Future fellowship FT110100345, AC is supported by an Australian Postgraduate Award funded through the Australian Commonwealth Government, and MKN is supported by Early Career Researcher Postgraduate Scholarship, Sydney Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminu M, 2014, BJOG-INT J OBSTET GY, V121, P141, DOI 10.1111/1471-0528.12995; Ashish KC, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0226-9; Ashish KC, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0567-3; Auger N, 2012, EPIDEMIOLOGY, V23, P247, DOI 10.1097/EDE.0b013e31824587bc; Biggs J, 1973, OBSTET GYNECOLOGICAL, V28, P710; BOOTH RT, 1964, J OBSTET GYN BR COMM, V71, P249; CANO F, 1995, FERTIL STERIL, V64, P584, DOI 10.1016/S0015-0282(16)57797-8; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Cherry N, 2008, B WORLD HEALTH ORGAN, V86, P172, DOI 10.2471/BLT.07.043083; CNATTINGIUS S, 1992, JAMA-J AM MED ASSOC, V268, P886; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Cripe SM, 2007, J TROP PEDIATRICS, V53, P366, DOI 10.1093/tropej/fmm044; de Bernis L, 2016, LANCET, V387, P703, DOI 10.1016/S0140-6736(15)00954-X; Dodds L, 2006, ANN EPIDEMIOL, V16, P607, DOI 10.1016/j.annepidem.2005.11.006; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; FORMAN MR, 1984, JAMA-J AM MED ASSOC, V252, P3135, DOI 10.1001/jama.252.22.3135; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Gonzales GF, 2008, INT J GYNECOL OBSTET, V100, P221, DOI 10.1016/j.ijgo.2007.08.009; Gordon A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-12; Guillot Michel, 2010, Genus, V66, P43; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; KAJANOJA P, 1978, OBSTET GYNECOL, V51, P47; KUMAR R, 1992, Indian Journal of Pediatrics, V59, P455, DOI 10.1007/BF02751561; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lee AC, 2011, INT J GYNECOL OBSTET, V113, P199, DOI 10.1016/j.ijgo.2010.12.015; LEYLAND AH, 1990, NEW ENGL J MED, V323, P413; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Luo ZC, 2006, CAN MED ASSOC J, V174, P1415, DOI 10.1503/cmaj.051096; Manandhar S R, 2010, Kathmandu Univ Med J (KUMJ), V8, P62; McClure EM, 2006, INT J GYNECOL OBSTET, V94, P82, DOI 10.1016/j.ijgo.2006.03.023; McClure EM, 2011, ACTA OBSTET GYN SCAN, V90, P1379, DOI 10.1111/j.1600-0412.2011.01275.x; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health and Population Nepal, 2007, NEP DEM HLTH SURV 20; Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Mullan Z, 2011, LANCET, V377, P1291, DOI 10.1016/S0140-6736(11)60098-6; NAEYE RL, 1983, OBSTET GYNECOL, V61, P210; NAEYE RL, 1979, EARLY HUM DEV, V3, P229, DOI 10.1016/0378-3782(79)90031-8; Nahar S, 2013, PAEDIATR PERINAT EP, V27, P158, DOI 10.1111/ppe.12026; Olsen O, 1999, SCAND J PUBLIC HEALT, V27, P128, DOI 10.1177/14034948990270021301; Padhi BK, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001851; Radestad I, 1996, BRIT MED J, V312, P1505, DOI 10.1136/bmj.312.7045.1505; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Skrondal A., 2004, GEN LATENT VARIABLE; Suleiman BM, 2015, PEDIATRIC REP, V7, DOI 10.4081/pr.2015.5615; Thind A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-29; Turton P, 2009, ARCH WOMEN MENT HLTH, V12, P35, DOI 10.1007/s00737-008-0040-7; UNICEF, 2004, CHILDH THREAT STAT W; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; World Health Organization, 2015, MAT NEWB CHILD AD HL; World Health Organization, 2015, PROGR SAN DRINK WAT; World Health Organization, 2014, EV NEWB ACT PLAN END	54	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181332	10.1371/journal.pone.0181332	http://dx.doi.org/10.1371/journal.pone.0181332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704548	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649700125
J	Silva, JBL; Alves, DM; Bottino-Rojas, V; Pereira, TN; Sorgine, MHF; Caragata, EP; Moreira, LA				Lopes Silva, Jessica Barreto; Alves, Debora Magalhaes; Bottino-Rojas, Vanessa; Pereira, Thiago Nunes; Ferreira Sorgine, Marcos Henrique; Caragata, Eric Pearce; Moreira, Luciano Andrade			Wolbachia and dengue virus infection in the mosquito Aedes fluviatilis (Diptera: Culicidae)	PLOS ONE			English	Article							GLOBAL DISTRIBUTION; ZIKA VIRUS; TRANSMISSION; STRAIN; ESTABLISHMENT; POPULATIONS; ACTIVATION; ALBOPICTUS; BLOCKING; PATHWAY	Dengue represents a serious threat to human health, with billions of people living at risk of the disease. Wolbachia pipientis is a bacterial endosymbiont common to many insect species. Wolbachia transinfections in mosquito disease vectors have great value for disease control given the bacterium's ability to spread into wild mosquito populations, and to interfere with infections of pathogens, such as dengue virus. Aedes fluviatilis is a mosquito with a widespread distribution in Latin America, but its status as a dengue vector has not been clarified. Ae. fluviatilis is also naturally infected by the wFlu Wolbachia strain, which has been demonstrated to enhance infection with the avian malarial parasite Plasmodium gallinaceum. We performed experimental infections of Ae. fluviatilis with DENV-2 and DENV-3 isolates from Brazil via injection or oral feeding to provide insight into its competence for the virus. We also examined the effect of the native Wolbachia infection on the virus using a mosquito line where the wFlu infection had been cleared by antibiotic treatment. Through RT-qPCR, we observed that Ae. fluviatilis could become infected with both viruses via either method of infection, although at a lower rate than Aedes aegypti, the primary dengue vector. We then detected DENV-2 and DENV-3 in the saliva of injected mosquitoes, and observed that injection of DENV-3-infected saliva produced subsequent infections in naive Ae. aegypti. However, across our data we observed no difference in prevalence of infection and viral load between Wolbachia-infected and -uninfected mosquitoes, suggesting that there is no effect of wFlu on dengue virus. Our results highlight that Ae. fluviatilis could potentially serve as a dengue vector under the right circumstances, although further testing is required to determine if this occurs in the field.	[Lopes Silva, Jessica Barreto; Alves, Debora Magalhaes; Pereira, Thiago Nunes; Caragata, Eric Pearce; Moreira, Luciano Andrade] Fiocruz MS, Ctr Pesquisas Rene Rachou, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil; [Bottino-Rojas, Vanessa; Ferreira Sorgine, Marcos Henrique] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Moreira, LA (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.	luciano@cpqrr.fiocruz.br	Bottino-Rojas, Vanessa/AAX-2172-2020	Bottino-Rojas, Vanessa/0000-0001-8019-9942; Moreira, Luciano/0000-0002-9240-3506	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Institutos Nacionais de Ciencia e Tecnologia-Entomologia Molecular (ICNT-EM)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Institutos Nacionais de Ciencia e Tecnologia-Entomologia Molecular (ICNT-EM)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (EPC, LAM); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (EPC, LAM); Institutos Nacionais de Ciencia e Tecnologia-Entomologia Molecular (ICNT-EM) (LAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792; Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677; Auguste AJ, 2010, AM J TROP MED HYG, V83, P1262, DOI 10.4269/ajtmh.2010.10-0280; Augustinos AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028695; Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bordenstein SR, 2009, MOL BIOL EVOL, V26, P231, DOI 10.1093/molbev/msn243; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135; Caragata EP, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3441-4; Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011; Caragata EP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005158; Dutra HL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600175; Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021; Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689; Consoli RA, 1983, MEM I O CRUZ, V78, P37; Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877; Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004; DAVIS Nelson C., 1931, American Journal of Tropical Medicine, V11, P21; de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152; Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965; Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370; Fialho RF, 2000, P ROY SOC B-BIOL SCI, V267, P1469, DOI 10.1098/rspb.2000.1166; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hughes GL, 2014, INSECT MOL BIOL, V23, P141, DOI 10.1111/imb.12066; Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434; Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932; Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525; Olson KE, 2000, INSECT MOL BIOL, V9, P57, DOI 10.1046/j.1365-2583.2000.00162.x; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Sanchez-Vargas I, 2009, PLOS PATHOG, V5; Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005; Tason de Camargo M.V., 1983, Memorias do Instituto Oswaldo Cruz, V78, P83; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Wong ZS, 2015, APPL ENVIRON MICROB, V81, P3001, DOI 10.1128/AEM.03847-14; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; ZCHORIFEIN E, 1995, INSECT MOL BIOL, V4, P173, DOI 10.1111/j.1365-2583.1995.tb00023.x; Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837; Zug R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01201; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	56	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181678	10.1371/journal.pone.0181678	http://dx.doi.org/10.1371/journal.pone.0181678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732048	Green Submitted, gold, Green Published			2022-12-27	WOS:000406643100056
J	Ly, BA; Labonte, R; Bourgeault, IL; Niang, MN				Ly, Birama Apho; Labonte, Ronald; Bourgeault, Ivy Lynn; Niang, Mbayang Ndiaye			The individual and contextual determinants of the use of telemedicine: A descriptive study of the perceptions of Senegal's physicians and telemedicine projects managers	PLOS ONE			English	Article							HEALTH-CARE; TELEHEALTH; IMPLEMENTATION; TECHNOLOGY; ACCEPTANCE; WORKFORCE; BARRIERS; SUPPORT; WORKERS	Telemedicine is considered to be an effective strategy to aid in the recruitment and retention of physicians in underserved areas and, in doing so, improve access to healthcare. Telemedicine's use, however, depends on individual and contextual factors. Using a mixed methods design, we studied these factors in Senegal based on a micro, meso and macro framework. A quantitative questionnaire administered to 165 physicians working in public hospitals and 151 physicians working in district health centres was used to identify individual (micro) factors. This was augmented with qualitative descriptive data involving individual interviews with 30 physicians working in public hospitals, 36 physicians working in district health centres and 10 telemedicine project managers to identify contextual (meso and macro) factors. Physicians were selected using purposeful random sampling; managers through snowball sampling. Quantitative data were analyzed descriptively using SPSS 23 and qualitative data thematically using NVivo 10. At the micro level, we found that 72.1% of the physicians working in public hospitals and 82.1% of the physicians working in district health centres were likely to use telemedicine in their professional activities. At the meso level, we identified several technical, organizational and ethical factors, while at the macro level the study revealed a number of financial, political, legal, socioeconomic and cultural factors. We conclude that better awareness of the interplay between factors can assist health authorities to develop telemedicine in ways that will attract use by physicians, thus improving physicians' recruitment and retention in underserved areas.	[Ly, Birama Apho; Labonte, Ronald; Bourgeault, Ivy Lynn] Univ Ottawa, Populat Hlth Program, Ottawa, ON, Canada; [Ly, Birama Apho] Univ Sci Tech & Technol Bamako, Publ Hlth Teaching & Res Dept, Bamako, Mali; [Labonte, Ronald] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Bourgeault, Ivy Lynn] Univ Ottawa, Telfer Sch Management, Ottawa, ON, Canada; [Niang, Mbayang Ndiaye] Cheikh Anta Diop Univ, Telemed Res & Expertise Interdisciplinary Ctr, Fac Med, Dakar, Senegal	University of Ottawa; University of Science & Technology of Bamako; University of Ottawa; University of Ottawa; University Cheikh Anta Diop Dakar	Ly, BA (corresponding author), Univ Ottawa, Populat Hlth Program, Ottawa, ON, Canada.; Ly, BA (corresponding author), Univ Sci Tech & Technol Bamako, Publ Hlth Teaching & Res Dept, Bamako, Mali.	bly022@uottawa.ca	Labonte, Ronald/G-4229-2011	Bourgeault, Ivy/0000-0002-5113-9243	Faculty of Graduate and Postdoctoral Studies (FGPS) of the University of Ottawa, CIHR [106493]; Faculty of Graduate and Postdoctoral Studies (FGPS) of the University of Ottawa; CIHR [106493]; Telfer School of Management Research Funds (SMRF); Global Health Practicum Grant (GHPG)	Faculty of Graduate and Postdoctoral Studies (FGPS) of the University of Ottawa, CIHR; Faculty of Graduate and Postdoctoral Studies (FGPS) of the University of Ottawa; CIHR(Canadian Institutes of Health Research (CIHR)); Telfer School of Management Research Funds (SMRF); Global Health Practicum Grant (GHPG)	This research was finance by the Faculty of Graduate and Postdoctoral Studies (FGPS) of the University of Ottawa, CIHR through its grant (No 106493) related to the project entitled Source Country perspectives on the migration of highly trained health personnel: causes, consequences and responses, Telfer School of Management Research Funds (SMRF) and Global Health Practicum Grant (GHPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Faculty of Graduate and Postdoctoral Studies (FGPS) of the University of Ottawa for the admission scholarship that they offered to the lead author. We also want to thank CIHR for their financial contribution through their grant (No 106493) related to the project entitled "Source Country perspectives on the migration of highly trained health personnel: causes, consequences and responses". We equally acknowledge Telfer School of Management Research Funds (SMRF) and Global Health Practicum Grant (GHPG) respectively for their financial support. I won't forget the program of population health of the University of Ottawa and the health institutions in Senegal for their technical support. Additionally, I thank Sophie Muluka, Doctor Mahamane Mariko, Marie Claude Lavoie, Touh Diarra and Myuri Manogaran for their technical support. To end, I acknowledge my friends and my family from Mali, Senegal and Canada for their social and technical support.	Aas IHM, 2007, J TELEMED TELECARE, V13, P379, DOI 10.1258/135763307783064340; Abbasi IN, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-24; Al-Qirim N, 2007, INT J MED INFORM, V76, P42, DOI 10.1016/j.ijmedinf.2006.02.001; Brebner EM, 2004, J TELEMED TELECARE, V10, P16, DOI 10.1258/135763304322764130; Brebner JA, 2005, J TELEMED TELECARE, V11, P3, DOI 10.1258/1357633054461778; Broens THF, 2007, J TELEMED TELECARE, V13, P303, DOI 10.1258/135763307781644951; Canadian Council on Social Determinants of Health (CCSDH), 2015, REV FRAM DET HLTH; Chima SC, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-S1-S5; Clemens MA, 2007, NEW DATA AFRICAN HLT; Dunnebeil S, 2012, INT J MED INFORM, V81, P746, DOI 10.1016/j.ijmedinf.2012.02.002; Dunnebeil S, 2010, HEALTHINF 2010: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, P202; Dzenowagis J, 2005, WORLD SUMM INF SOC, P36; El-Mahalli Azza Ali, 2012, Perspect Health Inf Manag, V9, P1; Evans M., 2002, HUMANITARIAN EXCHANG, V20, P5; Gagnon MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-18; Hiratsuka V, 2013, INT J CIRCUMPOL HEAL, V72, P930, DOI 10.3402/ijch.v72i0.21401; Hoerbst A, 2015, Yearb Med Inform, V10, P79, DOI 10.15265/IY-2015-018; Jang-Jaccard J, 2014, TELEMED E-HEALTH, V20, P496, DOI 10.1089/tmj.2013.0189; Jaroslawski S, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-1; Jennett PA, 2004, TELEMED J E-HEALTH, V10, P77, DOI 10.1089/153056204773644616; Jennett PA, 2000, CYBERPSYCHOL BEHAV, V3, P917, DOI 10.1089/109493100452174; Joseph V, 2011, J TELEMED TELECARE, V17, P71, DOI 10.1258/jtt.2010.100315; Kaddu S., 2009, Telehealth in the developing world, P121; Kaddu S., 2008, P134 KEF U GRAZ; Larsen F, 2003, J TELEMED TELECARE, V9, pS17, DOI 10.1258/135763303322196196; Mueller KJ, 2014, HEALTH AFFAIR, V33, P228, DOI 10.1377/hlthaff.2013.1016; Potter AJ, 2014, RURAL REMOTE HEALTH, V14; Pradhan M. R., 2009, Telehealth in the developing world, P182; Schmeida M, 2007, TELEMED J E-HEALTH, V13, P100, DOI 10.1089/tmj.2006.0017; Shiferaw F, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.15638; Simpson J, 2001, J TELEMED TELECARE, V7, P90, DOI 10.1258/1357633011936219; SNIS, 2012, CART SAN SEN MIS JOU; Steele R, 2013, PERS UBIQUIT COMPUT, V17, P533, DOI 10.1007/s00779-012-0506-5; Tanriverdi H, 1999, TELEMED J, V5, P223, DOI 10.1089/107830299311989; Taylor Jo, 2015, Nurs Times, V111, P18; Uscher-Pines L, 2014, TELEMED E-HEALTH, V20, P990, DOI 10.1089/tmj.2014.0015; Watanabe M, 1999, J TELEMED TELECARE, V5, pS11, DOI 10.1258/1357633991933477; Whitehead M, 1991, GEOL FORENINGAN STOC; Williatte- Pellitteri L., 2013, RECHERCHE EUROPEENNE, V2, P17; Wright D, 1999, J TELEMED TELECARE, V5, P107, DOI 10.1258/1357633991932784; Yaya S, 2009, Rev Med Brux, V30, P83; Zailani S, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0111-4; Zurn P, FIDELISATION PERSONN; Zurn P, 2010, B WORLD HEALTH ORGAN, V88, P386, DOI 10.2471/BLT.09.070730	44	12	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181070	10.1371/journal.pone.0181070	http://dx.doi.org/10.1371/journal.pone.0181070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732028	Green Published, gold, Green Submitted			2022-12-27	WOS:000406643100021
J	Passos, LF; Garcia, G; Young, RJ				Passos, Luiza Figueiredo; Garcia, Gerardo; Young, Robert John			Neglecting the call of the wild: Captive frogs like the sound of their own voice	PLOS ONE			English	Article							DART-POISON FROG; MANTELLA-AURANTIACA; AGONISTIC BEHAVIOR; RANA-CLAMITANS; COMMUNICATION; MADAGASCAR; FEMORALIS; SIGNAL; SIZE	Acoustic communication is highly influential in the expression of social behavior by anuran amphibians, transmitting information about the individual's physical condition and motivation. We studied the phonotactic (approach movements) responses of wild and captive male golden mantella frogs to conspecific wild and captive playback calls to determine the impact of captivity on social behaviour mediated by vocalisations. Calls were recorded from one wild and two captive populations. Phonotaxis experiments were then conducted by attracting M. aurantiaca males across a PVC grid on the forest floor or enclosure floor to a speaker. For each playback, the following parameters were recorded to define the accuracy of phonotaxis: (1) number of jumps; (2) jump angles; (3) jump distances; (4) path straightness. During this experiment we observed that wild frogs had a similar behavioural (phonotaxis) response to calls independent of their source while frogs from Chester Zoo had a significantly stronger response to calls of other conspecifics held separately at Chester Zoo. The lack of appropriate phonotaxis response by captive bred frogs to the calls of wild conspecifics could have serious negative conservation implications, if the captive bred individuals were released back to the wild.	[Passos, Luiza Figueiredo; Young, Robert John] Univ Salford Manchester, Sch Environm & Life Sci, Peel Bldg, Salford, Lancs, England; [Passos, Luiza Figueiredo; Garcia, Gerardo] Chester Zoo, Cedar House, Chester, Cheshire, England		Young, RJ (corresponding author), Univ Salford Manchester, Sch Environm & Life Sci, Peel Bldg, Salford, Lancs, England.	r.j.young@salford.ac.uk	Young, Robert/B-7356-2013	Young, Robert/0000-0002-8407-2348	CAPES [6060-13-7]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	LFP was in receipt of a CAPES postgraduate scholarship Proc. 6060-13-7.; The authors are grateful to Chester Zoo, Mitsinjo Association (Devin Edmonds), Madagasikara-Voakajy, the University of Manchester (Dr Richard Preziosi) for the chance of undertaking this project at their facilities and for the logistical support. LFP was in receipt of a CAPES postgraduate scholarship Proc. 6060-13-7.	Audacity Team, AUD R FREE AUD ED RE; Bee MA, 1999, BEHAV ECOL SOCIOBIOL, V45, P177, DOI 10.1007/s002650050551; Bee MA, 2000, BEHAV ECOL, V11, P169, DOI 10.1093/beheco/11.2.169; Bee MA, 2003, BEHAV ECOL SOCIOBIOL, V54, P601, DOI 10.1007/s00265-003-0657-5; Bee MA, 2007, BEHAV ECOL SOCIOBIOL, V61, P955, DOI 10.1007/s00265-006-0324-8; BRENOWITZ EA, 1989, ETHOLOGY, V83, P69; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Caldart VM, 2016, ACTA ETHOL, V19, P151, DOI 10.1007/s10211-016-0235-2; Dietz J. M., 1994, P32; Duellman W. E., 1986, BIOL AMPHIBIANS; Edmonds D, 2015, SALAMANDRA, V51, P315; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; GERHARDT HC, 1980, NATURWISSENSCHAFTEN, V67, P362, DOI 10.1007/BF01106598; Gilligan DM, 2003, CONSERV GENET, V4, P189, DOI 10.1023/A:1023391905158; Johnson K., 2008, AMPHIBIAN ARK SPECIE; Kaiser K, 2011, BEHAVIOUR, V148, P215, DOI 10.1163/000579510X551660; Marshall VT, 2003, ANIM BEHAV, V65, P1223, DOI 10.1006/anbe.2003.2134; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; Mayer M, 2014, ANIM BEHAV, V89, P45, DOI 10.1016/j.anbehav.2013.12.013; McClelland BE, 1996, J EXP BIOL, V199, P1907; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; R Studio Team, 2015, RSTUDIO INT DEV R; RAHBEK C, 1993, BIODIVERS CONSERV, V2, P426, DOI 10.1007/BF00114044; Randrianavelona R, 2010, AFR J HERPETOL, V59, P65, DOI 10.1080/04416651.2010.481761; Ryan M.J., 1988, P637; Sciencedirect S, 2014, ANIM BEHAV, V87, pI; Slade B, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0656; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Ursprung E, 2009, BEHAVIOUR, V146, P153, DOI 10.1163/156853909X410711; Vence M, 2009, IUCN RED LIST THREAT, P1; WELLS KD, 1978, ANIM BEHAV, V26, P1051, DOI 10.1016/0003-3472(78)90094-5	33	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181931	10.1371/journal.pone.0181931	http://dx.doi.org/10.1371/journal.pone.0181931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732034	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000406643100070
J	Yadav, PK; Antonyraj, CB; Ahamed, SIB; Srinivas, S				Yadav, Pradeep K.; Antonyraj, Christian B.; Ahamed, Syed Ibrahim Basheer; Srinivas, Sistla			Understanding Russell's viper venom factor V activator's substrate specificity by surface plasmon resonance and in-silico studies	PLOS ONE			English	Article							BIOSPECIFIC INTERACTION ANALYSIS; COAGULATION-FACTOR-V; SERINE PROTEINASES; ESSENTIAL DYNAMICS; TRYPSIN; INHIBITOR; HEMOSTASIS; CLEAVAGE; COMPLEX; BINDING	Blood coagulation factor V (FV) is activated either by Factor X or thrombin, cleaving at three different sites viz., Site I (Arg709-Ser710), site II (Arg1018-Thr1019), and site III (Arg1545-Ser1546). Russell's viper venom factor V activator (RVV-V) is a thrombin-like serine proteinase that activates FV with selective, single cleavage at site III. A long lasting effort is being pending in understanding the 'selective' binding specificity of the RVV-V towards site III. Here, we present the binding kinetic study of RVV-V with two designed peptides corresponding to the regions from site I (Gln699-Asn713) and site II (1008Lys-Pro1022), respectively, that include 15 amino acids. Our investigation for justifying the binding efficacy and kinetics of peptides includes SPR method, protein-peptide docking, molecular dynamics simulation, and principal component analysis (PCA). Surprisingly, the SPR experiment disclosed that the Peptide II showed a lower binding affinity with K-D of 2.775 mM while the Peptide I showed none. Docking and simulation of both the peptides with RVV-V engaged either rooted or shallow binding for Peptide II and Peptide I respectively. The peptide binding resulted in global conformational changes in the native fold of RVV-V, whereas the similar studies for thrombin failed to make major changes in the native fold. In support, the PCA analysis for RVV-V showed the dislocation of catalytic triad upon binding both the peptides. Hence, RVV-V, a serine protease, is incompetent in cleaving these two sites. This study suggests a transition in RVV-V from the native rigid to the distorted flexible structure and paves a way to design a new peptide substrate/inhibitor.	[Yadav, Pradeep K.; Antonyraj, Christian B.; Ahamed, Syed Ibrahim Basheer] Pondicherry Univ, Ctr Bioinformat, Pondicherry, India; [Srinivas, Sistla] GE Healthcare Life Sci, John F Welch Technol Ctr, EPIP, Bengaluru, India	Pondicherry University; General Electric	Ahamed, SIB (corresponding author), Pondicherry Univ, Ctr Bioinformat, Pondicherry, India.	ibrahim.bic@pondiuni.edu.in	Bharathi, Christian/G-5790-2015; Sistla, Srinivas/H-3335-2019; Yadav, Pradeep Kumar/GZA-4317-2022	Sistla, Srinivas/0000-0003-3693-8597; basheer ahamed, syed ibrahim/0000-0002-5619-5981	SERB [SR/FT/LS-89/2011]	SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	The project was funded by the following agency to Dr. Syed Ibrahim Bahseer Ahamed, and the grant number is mentioned: SERB (SR/FT/LS-89/2011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the Centre for Bioinformatics, Pondicherry University, for providing the computational facilities and BSI expresses its gratitude to SERB (SR/FT/LS-89/2011) for funding the project.	Altis A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2945165; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Blaszczyk M, 2016, METHODS, V93, P72, DOI 10.1016/j.ymeth.2015.07.004; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; de Souza ON, 1999, J BIOMOL STRUCT DYN, V16, P1205, DOI 10.1080/07391102.1999.10508328; Duga S, 2004, INT J BIOCHEM CELL B, V36, P1393, DOI 10.1016/j.biocel.2003.08.002; ESMON C T, 1973, Thrombosis Research, V2, P509, DOI 10.1016/0049-3848(73)90004-2; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; Hanson WM, 2007, J MOL BIOL, V366, P230, DOI 10.1016/j.jmb.2006.11.003; Ibrahim BS, 2005, J MOL BIOL, V348, P1191, DOI 10.1016/j.jmb.2005.03.034; Ibrahim BS, 2004, J BIOMOL STRUCT DYN, V21, P737, DOI 10.1080/07391102.2004.10506964; Ibrahim BS, 2004, BIOCHEM BIOPH RES CO, V313, P8, DOI 10.1016/j.bbrc.2003.11.082; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; KISIEL W, 1979, J BIOL CHEM, V254, P2230; Kurcinski M, 2015, NUCLEIC ACIDS RES, V43, pW419, DOI 10.1093/nar/gkv456; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Maisuradze GG, 2007, PROTEINS, V67, P569, DOI 10.1002/prot.21344; Maroun RC, 2001, HAEMOSTASIS, V31, P247; Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016; Maynard Jennifer A., 2009, Biotechnology Journal, V4, P1542, DOI 10.1002/biot.200900195; Miszkiel A, 2011, J MOL MODEL, V17, P3103, DOI 10.1007/s00894-011-1003-x; Nakayama D, 2011, FEBS LETT, V585, P3020, DOI 10.1016/j.febslet.2011.08.022; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Perchuc AM, 2010, TOXINS HEMOSTASIS BE, P747; Riley BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep35385; SCHIFFMAN S, 1969, BIOCHEMISTRY-US, V8, P1397, DOI 10.1021/bi00832a014; Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Serrano SMT, 2013, TOXICON, V62, P19, DOI 10.1016/j.toxicon.2012.09.003; Silva A, 2013, J VENOM ANIM TOXINS, V19, DOI 10.1186/1678-9199-19-26; Wisner A, 2001, HAEMOSTASIS, V31, P133; Yuan C, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-30; Zelanis A, 2015, J PROTEOMICS, V113, P260, DOI 10.1016/j.jprot.2014.10.002	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181216	10.1371/journal.pone.0181216	http://dx.doi.org/10.1371/journal.pone.0181216			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732041	Green Submitted, gold, Green Published			2022-12-27	WOS:000406643100028
J	Di Biagio, A; Riccardi, N; Signori, A; Maserati, R; Nozza, S; Gori, A; Bonora, S; Borderi, M; Ripamonti, D; Rossi, MC; Orofino, G; Quirino, T; Nunnari, G; Celesia, BM; Martini, S; Sagnelli, C; Mazzola, G; Colletti, P; Bartolozzi, D; Bini, T; Ladisa, N; Castelnuovo, F; Saracino, A; Lo Caputo, S				Di Biagio, Antonio; Riccardi, Niccolo; Signori, Alessio; Maserati, Renato; Nozza, Silvia; Gori, Andrea; Bonora, Stefano; Borderi, Marco; Ripamonti, Diego; Rossi, Maria Cristina; Orofino, Giancarlo; Quirino, Tiziana; Nunnari, Giuseppe; Celesia, Benedetto Maurizio; Martini, Salvatore; Sagnelli, Caterina; Mazzola, Giovanni; Colletti, Pietro; Bartolozzi, Dario; Bini, Teresa; Ladisa, Nicoletta; Castelnuovo, Filippo; Saracino, Annalisa; Lo Caputo, Sergio			PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; AFRICAN WOMEN; KNOWLEDGE; MEN; TENOFOVIR; THERAPY; TRIAL; RISK	Several studies have demonstrated the efficacy of the oral pre-exposure prophylaxis (PrEP) with tenofovir (with or without emtricitabine) on preventing HIV-negative partners of HIV infected patients to become infected through sexual contacts. PrEP is already available in the United States and now is approved by European Medicine Agency. In this setting we would like to gauge physicians' knowledge, acquaintance with and attitude to include PrEP in their clinical practice. A cross sectional survey was conducted among Italian physicians expert on antiretroviral therapy. Out of 146 physicians, 35% of participants declared to be familiar with PrEP but only 46% of them believed that, currently, there are not enough reasons to make it available in Italy. 51% of physicians have already been attracted to prescribe it and 63.4% have been openly asked about PrEP. The main concerns noticed were: the risk of acquire other sexual transmitted diseases (STDs) (70% of physicians feared that PrEP could favor STDs spread), the potential harmful of PrEP if not adequately implemented and, especially the risk of possible side effects if not properly used. Nevertheless, 55.9% of participants believed that Health Authorities face an ethical obligation to make PrEP available as part of the strategies to protect from HIV transmission and half of the respondents asked for further researches to better define the role for PrEP. Attitudes regarding PrEP impact on Italian National Health Organization were also very interesting: 57.5% of participants did not believe that investing in PrEP would be an appropriate use of healthcare resources, while 70.6% affirmed that PrEP's financial coverage should not be funded by the Italian National System of Health (SSN). This survey showed a high awareness of PrEP potential among Italian physicians coupled with a great deal of skepticism about how and if implementing it in clinical practice.	[Di Biagio, Antonio; Riccardi, Niccolo] Osped Policlin San Martino, Dept Internal Med, Infect Dis Clin, Genoa, Italy; [Signori, Alessio] Univ Genoa, Dept Hlth Sci, Biostat, Genoa, Italy; [Maserati, Renato] Fdn IRCCS Policlin San Matteo Pavia, Malattie Infett, Pavia, Italy; [Nozza, Silvia] IRCCS San Raffaele, Dept Infect Dis, Milan, Italy; [Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, Clin Infect Dis, Monza, Italy; [Bonora, Stefano] Univ Turin, Dept Med Sci, Infect Dis Unit, Turin, Italy; [Borderi, Marco] Univ Bologna, St Orsola Hosp, Infect Dis Unit, Bologna, Italy; [Ripamonti, Diego] AO Papa Giovanni XXIII, Infect Dis Unit, Bergamo, Italy; [Rossi, Maria Cristina] Osped Reg Treviso, Infect Dis Unit, Treviso, Italy; [Orofino, Giancarlo] Osped Amedeo Savoia, Infect Dis Unit, Div A, Turin, Italy; [Quirino, Tiziana] Osped Busto Arsizio, Infect Dis Unit, Varese, Italy; [Nunnari, Giuseppe] Univ Messina, Dept Clin & Expt Med, Infect Dis Unit, Messina, Italy; [Celesia, Benedetto Maurizio] Univ Catania, ARNAS Garibaldi, Dept Clin & Mol Biomed, Div Infect Dis, Catania, Italy; [Martini, Salvatore; Sagnelli, Caterina] Univ Naples 2, Dept Clin & Expt Med & Surg F Magrassi & A Lanzar, Naples, Italy; [Mazzola, Giovanni; Colletti, Pietro] Paolo Giaccone Polyclin Univ Hosp, Dept Med Clin & Emerging Dis, Palermo, Italy; [Bartolozzi, Dario] Careggi Univ Hosp, Infect Dis Unit, Florence, Italy; [Bini, Teresa] San Paolo Hosp, Clin Infect Dis, Milan, Italy; [Ladisa, Nicoletta; Saracino, Annalisa; Lo Caputo, Sergio] Univ Bari, Inst Infect Dis, Bari, Italy; [Castelnuovo, Filippo] Spedali Civili Hosp, Infect Dis, Brescia, Italy	University of Genoa; University of Genoa; IRCCS Fondazione San Matteo; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; San Gerardo Hospital; University of Milano-Bicocca; University of Turin; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; ASST Papa Giovanni XXIII; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; Ospedale di Busto Arsizio; University of Messina; University of Catania; Universita della Campania Vanvitelli; University of Palermo; Policlinico Paolo Giaccone; University of Florence; Azienda Ospedaliero Universitaria Careggi; San Paolo-Polo Universitaria Hospital; Universita degli Studi di Bari Aldo Moro; Hospital Spedali Civili Brescia	Riccardi, N (corresponding author), Osped Policlin San Martino, Dept Internal Med, Infect Dis Clin, Genoa, Italy.	niccolo.riccardi@yahoo.it	Gori, Andrea/AAC-6078-2022; Sagnelli, Caterina/AAD-4950-2022; NOZZA, SILVIA/AAC-5445-2022; Signori, Alessio/L-3081-2016; Nunnari, Giuseppe/AAC-1928-2019; Di Biagio, Antonio/J-4901-2019; Riccardi, Niccolò/ABG-7609-2020; celesia, benedetto maurizio/E-4562-2017	Sagnelli, Caterina/0000-0002-6413-7810; Signori, Alessio/0000-0001-6289-9144; Nunnari, Giuseppe/0000-0002-8113-8452; Di Biagio, Antonio/0000-0003-1436-5089; Riccardi, Niccolò/0000-0002-2947-4707; , salvatore/0000-0002-1551-1271; celesia, benedetto maurizio/0000-0002-6919-1955; Lo Caputo, Sergio/0000-0002-4729-7548				[Anonymous], 2017, NOTIZIARIO I SUPER S, V30; [Anonymous], 2014, PREEXP PROPH PREV HI; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, LANCET; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Ouellet E, 2015, CAN J INFECT DIS MED, V26, P23, DOI 10.1155/2015/964512; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Parikh UM, 2016, CURR OPIN HIV AIDS, V11, P49, DOI 10.1097/COH.0000000000000209; Rodger A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-296; Sharma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105283; Spinner CD, 2016, INFECTION, V44, P151, DOI 10.1007/s15010-015-0850-2; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; UNAIDS, 2014, GAP REP; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030; Wilton J, 2015, HIV AIDS-RES PALLIAT, V7, P125, DOI 10.2147/HIV.S50025; World Health Organization, 2014, POL BRIEF CONS GUID	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181433	10.1371/journal.pone.0181433	http://dx.doi.org/10.1371/journal.pone.0181433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727818	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500073
J	McKee, CD; Kosoy, MY; Bai, Y; Osikowicz, LM; Franka, R; Gilbert, AT; Boonmar, S; Rupprecht, CE; Peruski, LF				McKee, Clifton D.; Kosoy, Michael Y.; Bai, Ying; Osikowicz, Lynn M.; Franka, Richard; Gilbert, Amy T.; Boonmar, Sumalee; Rupprecht, Charles E.; Peruski, Leonard F.			Diversity and phylogenetic relationships among Bartonella strains from Thai bats	PLOS ONE			English	Article							FLIES DIPTERA NYCTERIBIIDAE; MOLECULAR CHARACTERIZATION; CTENOCEPHALIDES-FELIS; GENETIC DIVERSITY; RESERVOIR HOSTS; SPP.; IDENTIFICATION; TRANSMISSION; ECTOPARASITES; STREBLIDAE	Bartonellae are phylogenetically diverse, intracellular bacteria commonly found in mammals. Previous studies have demonstrated that bats have a high prevalence and diversity of Bartonella infections globally. Isolates (n = 42) were obtained from five bat species in four provinces of Thailand and analyzed using sequences of the citrate synthase gene (gltA). Sequences clustered into seven distinct genogroups; four of these genogroups displayed similarity with Bartonella spp. sequences from other bats in Southeast Asia, Africa, and Eastern Europe. Thirty of the isolates representing these seven genogroups were further characterized by sequencing four additional loci (ftsZ, nuoG, rpoB, and ITS) to clarify their evolutionary relationships with other Bartonella species and to assess patterns of diversity among strains. Among the seven genogroups, there were differences in the number of sequence variants, ranging from 1-5, and the amount of nucleotide divergence, ranging from 0.035-3.9%. Overall, these seven genogroups meet the criteria for distinction as novel Bartonella species, with sequence divergence among genogroups ranging from 6.4-15.8%. Evidence of intra- and intercontinental phylogenetic relationships and instances of homologous recombination among Bartonella genogroups in related bat species were found in Thai bats.	[McKee, Clifton D.; Kosoy, Michael Y.; Bai, Ying; Osikowicz, Lynn M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA; [McKee, Clifton D.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Franka, Richard; Gilbert, Amy T.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Gilbert, Amy T.] APHIS, Natl Wildlife Res Ctr, USDA, Wildlife Serv, Ft Collins, CO USA; [Boonmar, Sumalee] Rajapruk Univ, Fac Sci & Publ Hlth, Nonthaburi, Thailand; [Rupprecht, Charles E.] LYSSA LLC, Lawrenceville, GA USA; [Peruski, Leonard F.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Colorado State University; Centers for Disease Control & Prevention - USA; United States Department of Agriculture (USDA); Centers for Disease Control & Prevention - USA	McKee, CD (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.; McKee, CD (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	xmm9@cdc.gov	McKee, Clifton/I-4603-2019; Rupprecht, Charles/AAI-1544-2020	McKee, Clifton/0000-0002-6149-0598; Gilbert, Amy T./0000-0002-8256-0081	US Centers for Disease Control and Prevention; US Centers for Disease Control and Prevention, Center for Global Health, Global Disease Detection Technical Support Corps funds; LYSSA LLC	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Centers for Disease Control and Prevention, Center for Global Health, Global Disease Detection Technical Support Corps funds; LYSSA LLC	This study was supported by the US Centers for Disease Control and Prevention, Center for Global Health, Global Disease Detection Technical Support Corps funds to MYK and CER. LYSSA LLC provided support in the form of salary for CER, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Ahamad M, 2013, J MED ENTOMOL, V50, P140, DOI 10.1603/ME11240; Alvarez James D.V., 2015, Check List, V11, P1509; Aroon S., 2015, International Journal of Agricultural Technology, V11, P1781; Arvand M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001346; Azhar Isham, 2015, Check List, V11, P1777; Bai Y, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003478; Bai Y, 2011, EMERG INFECT DIS, V17, P1269, DOI 10.3201/eid1707.101867; Bai Y, 2010, VET MICROBIOL, V146, P314, DOI 10.1016/j.vetmic.2010.05.017; BECK AJ, 1971, J MED ENTOMOL, V8, P147, DOI 10.1093/jmedent/8.2.147; Billeter SA, 2008, MED VET ENTOMOL, V22, P1, DOI 10.1111/j.1365-2915.2008.00713.x; Billeter SA, 2012, PARASITOLOGY, V139, P324, DOI 10.1017/S0031182011002113; Bouhsira E, 2013, COMP IMMUNOL MICROB, V36, P105, DOI 10.1016/j.cimid.2012.10.004; Breitschwerdt EB, 2010, J VET EMERG CRIT CAR, V20, P8, DOI 10.1111/j.1476-4431.2009.00496.x; Brook CE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003532; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Buffet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068956; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Bush SE, 2012, INT J ACAROL, V38, P1, DOI 10.1080/01647954.2011.569509; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaloner GL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001248; Chomel BB, 2010, J APPL MICROBIOL, V109, P743, DOI 10.1111/j.1365-2672.2010.04679.x; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996; Cicuttin GL, 2017, COMP IMMUNOL MICROB, V52, P1, DOI 10.1016/j.cimid.2017.04.004; Colborn JM, 2010, J CLIN MICROBIOL, V48, P4630, DOI 10.1128/JCM.00470-10; Concannon R, 2005, PARASITOLOGY, V131, P489, DOI 10.1017/S0031182005008097; Corpuz-Raros LA, 2015, MUSEUM PUBL NAT HIST, V4, P26; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davoust B, 2016, VECTOR-BORNE ZOONOT, V16, P516, DOI 10.1089/vbz.2015.1918; Dietrich M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152077; Domrow R., 1962, TREUBIA, V26, P1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007; Han HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167915; Loan HK, 2015, VECTOR-BORNE ZOONOT, V15, P40, DOI 10.1089/vbz.2014.1604; Hornok S, 2012, VET MICROBIOL, V159, P541, DOI 10.1016/j.vetmic.2012.04.003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janes JK, 2017, MOL ECOL, V38, P42; Jobling B., 1934, PARASITOLOGY; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Judson SD, 2015, ZOONOSES PUBLIC HLTH, V62, P609, DOI 10.1111/zph.12188; Kading RC, 2013, J GEN VIROL, V94, P2393, DOI 10.1099/vir.0.053983-0; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kernif T, 2014, MOL ECOL, V23, P1204, DOI 10.1111/mec.12663; Klangthong K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140856; Kosoy MY, 2010, BIOL BULL+, V37, P716, DOI 10.1134/S1062359010070071; Kosoy M, 2010, EMERG INFECT DIS, V16, P1875, DOI 10.3201/eid1612.100601; Kosoy MY, 2012, INT C EM INF DIS PRO, P129; La Scola B, 2003, TRENDS MICROBIOL, V11, P318, DOI 10.1016/S0966-842X(03)00143-4; Lei BNR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002738; Leulmi H, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1316-9; Leulmi H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003789; Lilley TM, 2015, VECTOR-BORNE ZOONOT, V15, P706, DOI 10.1089/vbz.2015.1783; Lilley TM, 2017, VECTOR BORNE ZOONOTI, VXX; Lin EY, 2010, EMERG INFECT DIS, V16, P500, DOI 10.3201/eid1603.081673; Lin JW, 2012, VET MICROBIOL, V156, P119, DOI 10.1016/j.vetmic.2011.09.031; Loftis AD, 2005, J MED ENTOMOL, V42, P473, DOI 10.1603/0022-2585(2005)042[0473:DORBAB]2.0.CO;2; MAA T. C., 1962, PACIFIC INSECTS, V4, P417; Maa T.C., 1974, Pacific Insects, V16, P465; Mariana A., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1125; McKee CD, 2016, INFECT GENET EVOL, V44, P382, DOI 10.1016/j.meegid.2016.07.033; Morick D, 2013, APPL ENVIRON MICROB, V79, P1258, DOI 10.1128/AEM.03011-12; Morse SF, 2012, INFECT GENET EVOL, V12, P1717, DOI 10.1016/j.meegid.2012.06.009; NADCHATRAM M, 1980, J MED ENTOMOL, V17, P324, DOI 10.1093/jmedent/17.4.324; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; Anh PH, 2015, EMERG INFECT DIS, V21, P1266, DOI 10.3201/eid2107.141760; Podsiadly E, 2011, VECTOR-BORNE ZOONOT, V11, P985, DOI 10.1089/vbz.2010.0080; Pritchard JK, 2000, GENETICS, V155, P945; Reeves WK, 2007, J VECTOR ECOL, V32, P118, DOI 10.3376/1081-1710(2007)32[118:AOBWTF]2.0.CO;2; Reeves WK, 2005, J VECTOR ECOL, V30, P339; Reeves WK, 2016, J MED ENTOMOL, V53, P1218, DOI 10.1093/jme/tjw078; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stuckey MJ, 2017, EMERG INFECT DIS, V23, P539, DOI 10.3201/eid2303.160934; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THEODOR O, 1973, J MED ENTOMOL, V10, P556, DOI 10.1093/jmedent/10.6.556; Traub R, 1977, P INT C FLEAS, P79; Tsai YL, 2011, COMP IMMUNOL MICROB, V34, P299, DOI 10.1016/j.cimid.2011.04.005; Uchikawa K., 1978, Contributions from the Biological Laboratory Kyoto University, V25, P249; Urushadze L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005428; Vayssier-Taussat M, 2016, EMERG INFECT DIS, V22, P457, DOI 10.3201/eid2203.150269; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Diniz PPVD, 2007, VET RES, V38, P697, DOI 10.1051/vetres:2007023; Wilkinson DA, 2016, APPL ENVIRON MICROB, V82, P1778, DOI 10.1128/AEM.03505-15; WILLIAMS JE, 1976, B WORLD HEALTH ORGAN, V53, P365; WILSON N, 1970, Oriental Insects, V4, P37; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Zade V, 2012, BIOL FORUM, V4, P35; Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P3641, DOI 10.1128/JCM.40.10.3641-3647.2002	93	21	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181696	10.1371/journal.pone.0181696	http://dx.doi.org/10.1371/journal.pone.0181696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727827	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500105
J	Pal, D; Boby, N; Kumar, S; Kaur, G; Ali, SA; Reboud, J; Shrivastava, S; Gupta, PK; Cooper, JM; Chaudhuri, P				Pal, Dheeraj; Boby, Nongthombam; Kumar, Satish; Kaur, Gurpreet; Ali, Syed Atif; Reboud, Julien; Shrivastava, Sameer; Gupta, Praveen K.; Cooper, Jonathan M.; Chaudhuri, Pallab			Visual detection of Brucella in bovine biological samples using DNA-activated gold nanoparticles	PLOS ONE			English	Article							REAL-TIME PCR; ASSAY; AMPLIFICATION; LIVESTOCK; MILK; SPP.	Brucellosis is a bacterial disease, which, although affecting cattle primarily, has been associated with human infections, making its detection an important challenge. The existing gold standard diagnosis relies on the culture of bacteria which is a lengthy and costly process, taking up to 45 days. New technologies based on molecular diagnosis have been proposed, either through dip-stick, immunological assays, which have limited specificity, or using nucleic acid tests, which enable to identify the pathogen, but are impractical for use in the field, where most of the reservoir cases are located. Here we demonstrate a new test based on hybridization assays with metal nanoparticles, which, upon detection of a specific pathogen-derived DNA sequence, yield a visual colour change. We characterise the components used in the assay with a range of analytical techniques and show sensitivities down to 1000 cfu/ml for the detection of Brucella. Finally, we demonstrate that the assay works in a range of bovine samples including semen, milk and urine, opening up the potential for its use in the field, in low-resource settings.	[Pal, Dheeraj; Kaur, Gurpreet; Ali, Syed Atif; Chaudhuri, Pallab] Indian Vet Res Inst, Div Bacteriol & Mycol, Izatnagar, Uttar Pradesh, India; [Boby, Nongthombam; Kumar, Satish; Shrivastava, Sameer; Gupta, Praveen K.] Indian Vet Res Inst, Div Anim Biotechnol, Izatnagar, Uttar Pradesh, India; [Reboud, Julien; Cooper, Jonathan M.] Univ Glasgow, Div Biomed Engn, Sch Engn, Glasgow, Lanark, Scotland	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; University of Glasgow	Chaudhuri, P (corresponding author), Indian Vet Res Inst, Div Bacteriol & Mycol, Izatnagar, Uttar Pradesh, India.; Cooper, JM (corresponding author), Univ Glasgow, Div Biomed Engn, Sch Engn, Glasgow, Lanark, Scotland.	Jon.Cooper@glasgow.ac.uk; pallab.chaudhuri@gmail.com	Cooper, Jonathan/E-9000-2010; Cooper, Jonathan/GLS-9195-2022; Atif Ali, Syed/C-3144-2018; Reboud, Julien/F-1565-2014	Cooper, Jonathan/0000-0002-2358-1050; Cooper, Jonathan/0000-0002-2358-1050; Atif Ali, Syed/0000-0002-8779-547X; Reboud, Julien/0000-0002-6879-8405	Department of Biotechnology, Ministry of Science & Technology, India [BT/IN/Indo-UK/FADH/43/PC/2013]; Biotechnology and Biological Sciences Research Council, UK [BB/L00464X/1]; BBSRC [BB/L00464X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L00464X/1] Funding Source: researchfish	Department of Biotechnology, Ministry of Science & Technology, India; Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Department of Biotechnology, Ministry of Science & Technology, India (PC - BT/IN/Indo-UK/FADH/43/PC/2013) and the Biotechnology and Biological Sciences Research Council, UK (JC - BB/L00464X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk Sascha, 2003, Clin Lab, V49, P577; Amin AS, 2001, VET MICROBIOL, V83, P37, DOI 10.1016/S0378-1135(01)00401-1; Bakthavathsalam P, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-8; Bounaadja L, 2009, VET MICROBIOL, V137, P156, DOI 10.1016/j.vetmic.2008.12.023; Christopher Supriya, 2010, J Lab Physicians, V2, P55, DOI 10.4103/0974-2727.72149; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Dibbern AG, 2015, GENET MOL RES, V14, P227, DOI 10.4238/2015.January.16.6; Fu ZY, 2013, METHODS, V64, P260, DOI 10.1016/j.ymeth.2013.08.003; Godfroid J, 2010, CROAT MED J, V51, P296, DOI 10.3325/cmj.2010.51.296; Hill HD, 2006, NAT PROTOC, V1, P324, DOI 10.1038/nprot.2006.51; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Mayer-Scholl A, 2010, J MICROBIOL METH, V80, P112, DOI 10.1016/j.mimet.2009.10.015; Mohan Hari, 2014, J INNOV BIOL, V1, P163; Pal N, 2016, BIOSENS BIOELECTRON, V77, P270, DOI 10.1016/j.bios.2015.09.037; Romero C, 1999, APPL ENVIRON MICROB, V65, P3735; Sattarahmady N, 2015, BIOCHEM ENG J, V97, P1, DOI 10.1016/j.bej.2015.01.010; Singh BB, 2015, PREV VET MED, V119, P211, DOI 10.1016/j.prevetmed.2015.03.013; Smirnova EA, 2013, ADV INFECT DIS, V3, P177, DOI DOI 10.4236/AID.2013.33026; Soleimani M, 2013, J APPL MICROBIOL, V115, P828, DOI 10.1111/jam.12290; Zhao W, 2008, CHEMBIOCHEM, V9, P2363, DOI 10.1002/cbic.200800282	20	17	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180919	10.1371/journal.pone.0180919	http://dx.doi.org/10.1371/journal.pone.0180919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719613	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000406061400023
J	Martin, F; Palladino, C; Mateus, R; Bolzan, A; Gomes, P; Brito, J; Carvalho, AP; Cardoso, Y; Domingos, C; Clemente, VSL; Taveira, N				Martin, Francisco; Palladino, Claudia; Mateus, Rita; Bolzan, Anna; Gomes, Perpetua; Brito, Jose; Carvalho, Ana Patricia; Cardoso, Yolanda; Domingos, Cristovao; Clemente, Vanda Sofia Loa; Taveira, Nuno			Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spots	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL LOAD ASSAYS; T-CELL CLONE; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; GENETIC DIVERSITY; RECOMBINANT FORMS; TYPE-1; CHILDREN; TRANSMISSION	Background Early diagnosis and treatment reduces HIV-1-related mortality, morbidity and size of viral reservoirs in infants infected perinatally. Commercial molecular tests enable the early diagnosis of infection in infants but the high cost and low sensitivity with dried blood spots (DBS) limit their use in sub-Saharan Africa. Objectives To develop and validate a sensitive and cheap qualitative proviral DNA PCR-based assay for early infant diagnosis (EID) in HIV-1-exposed infants using DBS samples. Study design Chelex-based method was used to extract DNA from DBS samples followed by a nested PCR assay using primers for the HIV-1 integrase gene. Limit of detection (LoD) was determined by Probit regression using limiting dilutions of newly produced recombinant plasmids with the integrase gene of all HIV-1 subtypes and ACH-2 cells. Clinical sensitivity and specificity were evaluated on 100 HIV-1 infected adults; 5 infected infants; 50 healthy volunteers; 139 HIV-1-exposed infants of the Angolan Pediatric HIV Cohort (APEHC) with serology at 18 months of life. Results All subtypes and CRF02_AG were amplified with a LoD of 14 copies. HIV-1 infection in infants was detected at month 1 of life. Sensitivity rate in adults varied with viral load, while diagnostic specificity was 100%. The percentage of HIV-1 MTCT cases between January 2012 and October 2014 was 2.2%. The cost per test was 8-10 USD which is 2- to 4-fold lower in comparison to commercial assays. Conclusions The new PCR assay enables early and accurate EID. The simplicity and low-cost of the assay make it suitable for generalized implementation in Angola and other resource-constrained countries.	[Martin, Francisco; Palladino, Claudia; Mateus, Rita; Taveira, Nuno] Univ Lisbon, Fac Farm, Res Inst Med iMed Ulisboa, Lisbon, Portugal; [Bolzan, Anna; Clemente, Vanda Sofia Loa] Hosp Divina Prov, Luanda, Angola; [Gomes, Perpetua; Carvalho, Ana Patricia] Ctr Hosp Lisboa Ocident, Serv Patol Clin, Lab Microbiol Clin & Biol Mol, EPE, Lisbon, Portugal; [Gomes, Perpetua; Brito, Jose; Taveira, Nuno] Inst Super Ciencias Saude Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz, Caparica, Portugal; [Cardoso, Yolanda] Minist Saude Angola, INSP, Luanda, Angola; [Domingos, Cristovao] Minist Saude Angola, INLS, Luanda, Angola	Universidade de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Instituto Superior de Ciencias da Saude Egas Moniz	Palladino, C; Taveira, N (corresponding author), Univ Lisbon, Fac Farm, Res Inst Med iMed Ulisboa, Lisbon, Portugal.; Taveira, N (corresponding author), Inst Super Ciencias Saude Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz, Caparica, Portugal.	claudiapalladino@ff.ul.pt; ntaveira@ff.ul.pt	Brito, José/AAM-5150-2020; Taveira, Nuno C/A-6252-2014; Palladino, Claudia/E-2523-2014; iMed.ULisboa, EEPHIV/B-4222-2014; Gomes, Perpetua/I-5652-2012	Brito, José/0000-0002-8558-6754; Taveira, Nuno C/0000-0003-0176-5585; Palladino, Claudia/0000-0002-8148-0928; Gomes, Perpetua/0000-0003-3271-8255	Fundacao para a Ciencia e a Tecnologia (FCT) Portugal [PTDC/SAU-EPI/122400/2010]; European Union; Portuguese Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/87488/2012, SFRH/BPD/77448/2011]	Fundacao para a Ciencia e a Tecnologia (FCT) Portugal(Portuguese Foundation for Science and Technology); European Union(European Commission); Portuguese Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology)	Financial support was provided by the Fundacao para a Ciencia e a Tecnologia (FCT) Portugal (PTDC/SAU-EPI/122400/2010), part of the EDCTP2 programme supported by the European Union. Francisco Martin is supported by the Portuguese Fundacao para a Ciencia e Tecnologia (FCT) (grant number SFRH/BD/87488/2012). Claudia Palladino is supported by the Portuguese Fundacao para a Ciencia e Tecnologia (FCT) (grant number SFRH/BPD/77448/2011).	Amendola A, 2002, JAIDS-J ACQ IMM DEF, V31, P488, DOI 10.1097/00126334-200212150-00006; [Anonymous], ABB MOL REALTIME HIV; Antunes R, 2003, J CLIN MICROBIOL, V41, P3361, DOI 10.1128/JCM.41.7.3361-3367.2003; Bartolo I, 2005, AIDS RES HUM RETROV, V21, P306, DOI 10.1089/aid.2005.21.306; Bartolo I, 2016, AIDS RES HUM RETROV, V32, P822, DOI [10.1089/aid.2016.0084, 10.1089/AID.2016.0084]; Bartolo I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113626; Bartolo I, 2009, ANTIMICROB AGENTS CH, V53, P3156, DOI 10.1128/AAC.00110-09; Bartolo I, 2009, INFECT GENET EVOL, V9, P672, DOI 10.1016/j.meegid.2008.05.003; Bitnun A, 2014, CLIN INFECT DIS, V59, P1012, DOI 10.1093/cid/ciu432; Chang J, 2014, J VIROL METHODS, V204, P25, DOI 10.1016/j.jviromet.2014.03.010; Chatterjee A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-553; CLOUSE KA, 1989, J IMMUNOL, V142, P431; DENNY T, 1992, JAMA-J AM MED ASSOC, V267, P1484, DOI 10.1001/jama.267.11.1484; Field N, 2014, LANCET INFECT DIS, V14, P341, DOI 10.1016/S1473-3099(13)70324-4; Fischer A, 2004, J CLIN MICROBIOL, V42, P16, DOI 10.1128/JCM.42.1.16-20.2004; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; GHOSH SK, 1993, J CELL BIOCHEM, P64; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Lussiana C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036381; Marston M, 2011, INT J EPIDEMIOL, V40, P385, DOI 10.1093/ije/dyq255; Nkengasong JN, 1999, AIDS RES HUM RETROV, V15, P495, DOI 10.1089/088922299311015; Penazzato M, 2014, LANCET INFECT DIS, V14, P650, DOI 10.1016/S1473-3099(13)70262-7; Pineda-Pena AC, 2016, INFECT GENET EVOL, V46, P219, DOI 10.1016/j.meegid.2016.08.009; Sciences GHL, 2010, REL EXTR DNA WHATM C; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Swanson P, 2005, J CLIN MICROBIOL, V43, P3860, DOI 10.1128/JCM.43.8.3860-3868.2005; Tetali S, 1996, AIDS RES HUM RETROV, V12, P669, DOI 10.1089/aid.1996.12.669; UNAIDS, 2016, AIDS NUMB 2016 JOINT; UNITAID, 2015, HIV AIDS TECHN LANDS; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2015, HIV ASS LAB PERF OTH; WHO, 2005, SOURC PRIC SEK MED D; [WHO] World Health Organization, 2014, CONS GUID US ANT DRU; World Health Organisation, 2021, CONSOLIDATED GUIDELI	34	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181352	10.1371/journal.pone.0181352	http://dx.doi.org/10.1371/journal.pone.0181352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715460	Green Submitted, gold, Green Published			2022-12-27	WOS:000443975500048
J	Li, Y; Yang, JJ; Zhu, SH; Xu, B; Wang, L				Li, Yang; Yang, Jing-Jing; Zhu, Su-Hui; Xu, Biao; Wang, Lian			Long-term efficacy and safety of carotid artery stenting versus endarterectomy: A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							FOLLOW-UP; STENOSIS; ANGIOPLASTY; OUTCOMES; SOCIETY; STROKE; RISK	Background Many recent trials have investigated the long-term efficacy and safety of endarterectomy versus stenting in treating patients with carotid artery stenosis. We aimed to determine the long-term comparative efficacy and safety of both procedures by pooling this evidence in a meta-analysis. Methods We searched PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials for studies published until May 6, 2016. Randomized controlled trials, which reported outcomes of interest with a median follow-up of at least 4-year, were included. Results Eight trials involving 7005 patients and 41824 patient-years of follow-up were included. In terms of the periprocedural outcomes, stenting was associated with a lower risk of myocardial infarction (OR: 0.51; 95% CI: 0.33 to 0.80; P = 0.003) but a higher risk of death or stroke (the composite endpoint, OR: 1.76; 95% CI: 1.38 to 2.25; P < 0.0001), a result that was primarily driven by minor stroke (OR: 2.19; 95% CI: 1.59 to 3.01; P < 0.0001), less so by periprocedural death (OR: 1.68; 95% CI: 0.82 to 3.44; P = 0.16) and major stroke (OR: 1.41; 95% CI: 0.95 to 2.09; P = 0.09). In terms of the long-term outcomes, stenting was associated with a higher risk of stroke (OR 1.45; 95% CI: 1.22 to 1.73; P < 0.0001) and the composite outcome of death or stroke (OR 1.25; 95% CI: 1.05 to 1.48; P = 0.01). No difference was found in long-term all-cause mortality between stenting and endarterectomy (OR: 1.09; 95% CI: 0.95 to 1.26; P = 0.21) and restenosis (OR: 1.48 (95% CI: 0.93 to 2.35; P = 0.10). No evidence of significant heterogeneity was found in any of the analyses. Conclusions Carotid endarterectomy was found to be superior to stenting for short- and long-term outcomes, although endarterectomy was associated with a higher risk of periprocedural myocardial infarction. Carotid endarterectomy should be offered as the first choice for carotid stenosis at present, however, more evidence is needed because rapid progress in concurrent devices and medical treatments is being made.	[Li, Yang; Zhu, Su-Hui; Xu, Biao; Wang, Lian] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Yang, Jing-Jing] Nanjing Univ Chinese Med, Clin Coll Tradit Chinese & Western Med, Dept Tradit Chinese Med, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University of Chinese Medicine	Xu, B; Wang, L (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	xubiao@medmail.com.cn; wanglian@medmail.com.cn						Abbott AL, 2015, STROKE, V46, P3288, DOI 10.1161/STROKEAHA.115.003390; Albucher JF, 2004, CEREBROVASC DIS, V18, P62, DOI 10.1159/000078751; Arquizan C, 2011, STROKE, V42, P1015, DOI 10.1161/STROKEAHA.110.589309; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bonati LH, 2015, LANCET, V385, P529, DOI 10.1016/S0140-6736(14)61184-3; Bonati LH, 2009, LANCET NEUROL, V8, P908, DOI 10.1016/S1474-4422(09)70227-3; Boulanger M, 2015, STROKE, V46, P2843, DOI 10.1161/STROKEAHA.115.010052; Brooks WH, 2004, NEUROSURGERY, V54, P318, DOI 10.1227/01.NEU.0000103447.30087.D3; Brooks WH, 2001, J AM COLL CARDIOL, V38, P1589, DOI 10.1016/S0735-1097(01)01595-9; Brooks WH, 2014, JACC-CARDIOVASC INTE, V7, P163, DOI 10.1016/j.jcin.2013.09.010; Brott TG, 2016, NEW ENGL J MED, V374, P1021, DOI 10.1056/NEJMoa1505215; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Choi JC, 2015, STROKE, V46, P120, DOI 10.1161/STROKEAHA.114.006209; Coward LJ, 2005, STROKE, V36, P905, DOI 10.1161/01.STR.0000158921.51037.64; Cronenwett JL, 2012, J VASC SURG, V55, P1529, DOI 10.1016/j.jvs.2012.03.016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dumont TM, 2012, J NEUROSURG, V116, P1251, DOI 10.3171/2012.3.JNS111320; Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Ederle J, 2009, LANCET NEUROL, V8, P898, DOI 10.1016/S1474-4422(09)70228-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; HOFFMANN CTA, 2008, CAROTID ARTERY STENT, DOI DOI 10.1227/01.NEU.0000103447.30087.D3; Howard G, 2016, LANCET, V387, P1305, DOI 10.1016/S0140-6736(15)01309-4; Lal BK, 2012, LANCET NEUROL, V11, P755, DOI 10.1016/S1474-4422(12)70159-X; Luebke T, 2016, J CARDIOVASC SURG, V57, P519; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9; Mas JL, 2014, STROKE, V45, P2750, DOI 10.1161/STROKEAHA.114.005671; Meier P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c467; Moore WS, 2016, ANGIOLOGY, V67, P408, DOI 10.1177/0003319715611281; Rosenfield K, 2016, NEW ENGL J MED, V374, P1011, DOI 10.1056/NEJMoa1515706; Rudarakanchana N, 2009, EUR J VASC ENDOVASC, V38, P239, DOI 10.1016/j.ejvs.2009.05.010; Steinbauer MGM, 2008, J VASC SURG, V48, P93, DOI 10.1016/j.jvs.2008.02.049; Vincent S, 2015, CIRC-CARDIOVASC QUAL, V8, pS99, DOI 10.1161/CIRCOUTCOMES.115.001933; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Zhang L, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001060; 2001, LANCET, V357, P1729, DOI DOI 10.1016/S1474-4422(08)70195-9	43	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180804	10.1371/journal.pone.0180804	http://dx.doi.org/10.1371/journal.pone.0180804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708869	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649800022
J	Perrone-Bertolotti, M; Tassin, M; Meunier, F				Perrone-Bertolotti, Marcela; Tassin, Maxime; Meunier, Fanny			Speech-in-speech perception and executive function involvement	PLOS ONE			English	Article							WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; LEXICAL DECISION; EYE-MOVEMENTS; ATTENTION; PRIME; NOISE; TIME; FACILITATION; CAPACITY	This present study investigated the link between speech-in-speech perception capacities and four executive function components: response suppression, inhibitory control, switching and working memory. We constructed a cross-modal semantic priming paradigm using a written target word and a spoken prime word, implemented in one of two concurrent auditory sentences (cocktail party situation). The prime and target were semantically related or unrelated. Participants had to perform a lexical decision task on visual target words and simultaneously listen to only one of two pronounced sentences. The attention of the participant was manipulated: The prime was in the pronounced sentence listened to by the participant or in the ignored one. In addition, we evaluate the executive function abilities of participants (switching cost, inhibitory-control cost and response-suppression cost) and their working memory span. Correlation analyses were performed between the executive and priming measurements. Our results showed a significant interaction effect between attention and semantic priming. We observed a significant priming effect in the attended but not in the ignored condition. Only priming effects obtained in the ignored condition were significantly correlated with some of the executive measurements. However, no correlation between priming effects and working memory capacity was found. Overall, these results confirm, first, the role of attention for semantic priming effect and, second, the implication of executive functions in speech-in-noise understanding capacities.	[Perrone-Bertolotti, Marcela] Univ Grenoble Alpes, CNRS, LPNC, UMR 5105, Grenoble, France; [Tassin, Maxime; Meunier, Fanny] Univ Claude Bernard Lyon 1, CNRS, L2C2, Lyon, France; [Meunier, Fanny] Univ Cote dAzur, CNRS, BCL, Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Meunier, F (corresponding author), Univ Claude Bernard Lyon 1, CNRS, L2C2, Lyon, France.; Meunier, F (corresponding author), Univ Cote dAzur, CNRS, BCL, Nice, France.	fanny.meunier@unice.fr		Perrone-Bertolotti, Marcela/0000-0001-9981-7042	Rhone-Alpes Region, France attributed through the ARC2: Qualite de vie et Vieillissement	Rhone-Alpes Region, France attributed through the ARC2: Qualite de vie et Vieillissement	This work was supported by the Rhone-Alpes Region, France attributed through the "ARC2: Qualite de vie et Vieillissement" attributed to MP-B and Michel Hoen and funding MT's salary.	Akeroyd M, 2008, INT J AUDIOL, V47, pS53, DOI 10.1080/14992020802301142; Andersson U, 2010, MEMORY, V18, P458, DOI 10.1080/09658211003762084; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bialystok E, 2006, J EXP PSYCHOL LEARN, V32, P1341, DOI 10.1037/0278-7393.32.6.1341; Boyle W, 2013, LANG LEARN, V63, P211, DOI 10.1111/lang.12003; Carretti B, 2013, INT J GERIATR PSYCH, V28, P539, DOI 10.1002/gps.3859; Carter MD, 2011, APHASIOLOGY, V25, P761, DOI 10.1080/02687038.2010.539697; Cartwright KB, 2012, EARLY EDUC DEV, V23, P24, DOI 10.1080/10409289.2011.615025; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; DEGROOT AMB, 1984, Q J EXP PSYCHOL-A, V36, P253, DOI 10.1080/14640748408402158; Dekerle M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00878; Dupoux E, 2003, J EXP PSYCHOL HUMAN, V29, P172, DOI 10.1037/0096-1523.29.1.172; Ecker UKH, 2010, J EXP PSYCHOL LEARN, V36, P170, DOI 10.1037/a0017891; Ellis RJ, 2016, EAR HEARING, V37, P73, DOI 10.1097/AUD.0000000000000218; Ferrand L, 2001, ANN PSYCHOL, V101, P683; Fullgrabe C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01268; GREENWALD AG, 1972, J EXP PSYCHOL, V94, P58, DOI 10.1037/h0032760; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Hoedemaker RS, 2014, J EXP PSYCHOL HUMAN, V40, P2179, DOI 10.1037/a0037677; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; HOWARD DV, 1981, J GERONTOL, V36, P707, DOI 10.1093/geronj/36.6.707; Ingvalson EM, 2015, J ACOUST SOC AM, V137, P3477, DOI 10.1121/1.4921601; Keidser G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00597; Kim YSG, 2016, J EXP CHILD PSYCHOL, V141, P101, DOI 10.1016/j.jecp.2015.08.003; Koch I, 2011, J EXP PSYCHOL HUMAN, V37, P1140, DOI 10.1037/a0022189; Koelewijn Thomas, 2012, Int J Otolaryngol, V2012, P865731, DOI 10.1155/2012/865731; Koelewijn T, 2012, EAR HEARING, V33, P291, DOI 10.1097/AUD.0b013e3182310019; Lehto JH, 1996, Q J EXP PSYCHOL-A, V49, P29, DOI 10.1080/027249896392793; Meister H, 2013, AM J AUDIOL, V22, P310, DOI 10.1044/1059-0889(2012/12-0067); Melara RD, 2002, J EXP PSYCHOL HUMAN, V28, P279, DOI 10.1037//0096-1523.28.2.279; Meunier F, 2002, BRAIN LANG, V81, P89, DOI 10.1006/brln.2001.2509; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Milliken B, 1998, PSYCHOL REV, V105, P203, DOI 10.1037/0033-295X.105.2.203; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Monsell S., 1996, UNSOLVED MYSTERIES M, P93; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; NEILL WT, 1977, J EXP PSYCHOL HUMAN, V3, P444, DOI 10.1037/0096-1523.3.3.444; New B, 2001, ANN PSYCHOL, V101, P447; Ng EHN, 2013, INT J AUDIOL, V52, P433, DOI 10.3109/14992027.2013.776181; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; Osborne J. W., 2002, RES EVALUATION, V8; RABBITT PMA, 1968, Q J EXP PSYCHOL, V20, P241, DOI 10.1080/14640746808400158; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reeves C, 2000, J EXP PSYCHOL LEARN, V26, P1638, DOI 10.1037//0278-7393.26.6.1638; Repovs G, 2006, NEUROSCIENCE, V139, P5, DOI 10.1016/j.neuroscience.2005.12.061; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Ronnberg J, 2008, INT J AUDIOL, V47, pS99, DOI 10.1080/14992020802301167; Rudner M, 2011, J AM ACAD AUDIOL, V22, P156, DOI 10.3766/jaaa.22.3.4; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; Schumacher PB, 2012, NEUROSCI LETT, V530, P138, DOI 10.1016/j.neulet.2012.09.057; SHELTON JR, 1992, J EXP PSYCHOL LEARN, V18, P1191, DOI 10.1037/0278-7393.18.6.1191; Silverman MJ, 2007, J MUSIC THER, V44, P415, DOI 10.1093/jmt/44.4.415; Smith SL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01394; Strauss M. E., 2015, J EXPT PSYCHOL GEN; SWINNEY DA, 1979, MEM COGNITION, V7, P159, DOI 10.3758/BF03197534; Tabossi P, 1996, LANG COGNITIVE PROC, V11, P569, DOI 10.1080/016909696386953; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; TREISMAN AM, 1964, AM J PSYCHOL, V77, P533, DOI 10.2307/1420765; Van Zandt T, 2002, STEVENSHANDBOOK EXPT, V4, P461, DOI DOI 10.1002/0471214426.PAS0412; Wechsler D., 2011, MANUEL CHELLE INTELL; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630; Willoughby MT, 2012, CHILD NEUROPSYCHOL, V18, P79, DOI 10.1080/09297049.2011.578572; Wood NL, 1997, MEM COGNITION, V25, P772, DOI 10.3758/BF03211320; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Xiao KC, 2015, CONSCIOUS COGN, V38, P88, DOI 10.1016/j.concog.2015.09.013	70	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180084	10.1371/journal.pone.0180084	http://dx.doi.org/10.1371/journal.pone.0180084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708830	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800012
J	Pu, CL; Li, HT; Zhu, AJ; Chen, YY; Zhao, Y; Zhan, AB				Pu, Chuanliang; Li, Haitao; Zhu, Aijia; Chen, Yiyong; Zhao, Yan; Zhan, Aibin			Phylogeography in Nassarius mud snails: Complex patterns in congeneric species	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; PHYLOGENETIC ANALYSIS; MITOCHONDRIAL; DISPERSAL; MOLLUSK; POLYMORPHISM; DIVERGENCE; GASTROPODA; SOFTWARE; BIVALVE	One major goal for phylogeographical studies is to elucidate respective roles of multiple evolutionary and ecological forces that shape the current distribution patterns. In marine and coastal ecosystems, it has been generated a common realization that species with enormous population size and pelagic larval stages can disperse across broad geographical scales, leading to weak or even no phylogeographical structure across large geographical scales. However, the violation of such realization has been frequently reported, and it remains largely unexplored on mechanisms responsible for various phylogeographical patterns observed in different species at varied geographical scales. Here, we used a speciesrich genus Nassarius to assess and compare phylogeographical patterns in congeneric species, and discuss causes and consequences underlying varied phylogeographical patterns. Interestingly, we observed complex phylogeographical patterns both within single species and across multiple species, and multiple analyses showed varied levels of genetic heterogeneity among sites within and across species. Available evidence suggests that related species with similar biological characteristics may not be necessary to result in consistent phylogeographical patterns. Multiple factors, including larval ecology, interactions between dispersal and natural selection, and human activity-mediated dispersal, can partially explain the complex patterns observed in this study. Deep investigations should be performed on these factors, particularly their respective roles in determining evolutionary/ecological processes to form phylogeographical patterns in species with high dispersal capacities in marine and coastal ecosystems.	[Pu, Chuanliang; Chen, Yiyong; Zhao, Yan; Zhan, Aibin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Pu, Chuanliang; Chen, Yiyong; Zhao, Yan; Zhan, Aibin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Haitao; Zhu, Aijia] State Ocean Adm, South China Sea Environm Monitoring Ctr, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; State Oceanic Administration	Zhan, AB (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.; Zhan, AB (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhanaibin@hotmail.com	Zhan, Aibin/A-7240-2011		100-Talent Program of the Chinese Academy of Sciences; National Natural Science Foundation of China [41606191]	100-Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the 100-Talent Program of the Chinese Academy of Sciences to AZ and the National Natural Science Foundation of China (41606191) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaina N, 2012, MAR BIOL, V159, P1871, DOI 10.1007/s00227-012-1975-9; Armbruster GFJ, 2000, J MOLLUS STUD, V66, P570, DOI 10.1093/mollus/66.4.570; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barber PH, 2006, EVOLUTION, V60, P1825; Barreiro R, 2006, MAR BIOL, V148, P1051, DOI 10.1007/s00227-005-0139-6; CERNOHORSKY W O, 1972, Records of the Auckland Institute and Museum, V9, P125; Cernohorsky W.O., 1984, Bulletin of the Auckland Institute and Museum, P1; Cernohorsky WO, 1984, B AUCKLAND I MUSEUM; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; CRAWFORD DL, 1992, MOL BIOL EVOL, V9, P806; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenberg PB, 2014, ECOL EVOL, V4, P3244, DOI 10.1002/ece3.1181; Fernandez R, 2015, MAR ECOL-EVOL PERSP, V36, P701, DOI 10.1111/maec.12178; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Haasl DM, 2000, J PALEONTOL, V74, P839, DOI 10.1666/0022-3360(2000)074<0839:PRANG>2.0.CO;2; Hasselman DJ, 2014, MOL ECOL, V23, P1137, DOI 10.1111/mec.12674; Huang BX, 2000, MAR BIOL, V136, P207, DOI 10.1007/s002270050678; Hurtado LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011633; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kenchington EL, 2006, MOL ECOL, V15, P1781, DOI 10.1111/j.1365-294X.2006.02915.x; KOEHN RK, 1980, P NATL ACAD SCI-BIOL, V77, P5385, DOI 10.1073/pnas.77.9.5385; Kool H.H., 2007, Miscellanea Malacologica, V2, P87; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kyle CJ, 2000, MAR BIOL, V137, P835, DOI 10.1007/s002270000412; Lee HJE, 2009, MOL ECOL, V18, P2165, DOI 10.1111/j.1365-294X.2009.04169.x; Lee HJ, 2007, MOL ECOL, V16, P3084, DOI 10.1111/j.1365-294X.2007.03364.x; Li HT, 2010, CHIN J OCEANOL LIMN, V28, P565, DOI 10.1007/s00343-010-9031-4; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin YP, 2015, REV AQUACULT, V7, P28, DOI 10.1111/raq.12052; Luttikhuizen PC, 2003, MOL ECOL, V12, P2215, DOI 10.1046/j.1365-294X.2003.01872.x; Miller M.A., 2010, P GAT COMP ENV WORKS; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Paulay G, 2006, INTEGR COMP BIOL, V46, P269, DOI 10.1093/icb/icj027; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ridgway G, 2001, SARSIA, V86, P157, DOI 10.1080/00364827.2001.10420471; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanmartin I, 2003, J BIOGEOGR, V30, P1883, DOI 10.1046/j.0305-0270.2003.00982.x; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2005, ECOL MONOGR, V75, P505, DOI 10.1890/05-0309; Sivasundar A, 2010, MAR BIOL, V157, P1433, DOI 10.1007/s00227-010-1419-3; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Sotka EE, 2006, ECOLOGY, V87, P1094, DOI 10.1890/0012-9658(2006)87[1094:TUOGCT]2.0.CO;2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TALLMARK B, 1980, MAR ECOL PROG SER, V3, P51, DOI 10.3354/meps003051; van Moorsel CHM, 2000, MALACOLOGIA, V42, P203; Veliz D, 2004, J EVOLUTION BIOL, V17, P953, DOI 10.1111/j.1420-9101.2004.00753.x; Wegner KM, 2012, MOL ECOL, V21, P779, DOI 10.1111/j.1365-294X.2011.05401.x; Wilson AB, 1999, CAN J FISH AQUAT SCI, V56, P2248, DOI 10.1139/cjfas-56-12-2248; Zhan AB, 2015, MAR BIOL, V162, P2449, DOI 10.1007/s00227-015-2734-5; Zhan AB, 2012, DIVERS DISTRIB, V18, P1042, DOI 10.1111/j.1472-4642.2012.00894.x; Zhan AB, 2012, ECOL EVOL, V2, P1331, DOI 10.1002/ece3.258; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x; Zhan AB, 2009, MAR BIOTECHNOL, V11, P223, DOI 10.1007/s10126-008-9138-1; Zou SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047276	60	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180728	10.1371/journal.pone.0180728	http://dx.doi.org/10.1371/journal.pone.0180728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704536	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649600046
J	Liu, C; Lu, YJ; Zhang, YF; Li, S; Muller, N				Liu, Cheng; Lu, Yan-Jun; Zhang, Yong-Fang; Li, Sha; Mueller, Norbert			Numerical study on the lubrication performance of compression ring-cylinder liner system with spherical dimples	PLOS ONE			English	Article							HYDRODYNAMIC LUBRICATION; TRIBOLOGICAL PERFORMANCE; MIXED LUBRICATION; PISTON RINGS; SURFACES; CAVITATION; FRICTION; ROUGHNESS; TEXTURES; MODEL	The effects of surface texture on the lubrication performance of a compression ring-cylinder liner system are studied in this paper. By considering the surface roughness of the compression ring and cylinder liner, a mixed lubrication model is presented to investigate the tribological behaviors of a barrel-shaped compression ring-cylinder liner system with spherical dimples on the liner. In order to determine the rupture and reformulation positions of fluid film accurately, the Jacoboson-Floberg-Olsson (JFO) cavitation boundary condition is applied to the mixed lubrication model for ensuring the mass-conservative law. On this basis, the minimum oil film thickness and average friction forces in the compression ring-cylinder liner system are investigated under the engine-like conditions by changing the dimple area density, radius, and depth. The wear load, average friction forces, and power loss of the compression ring-cylinder liner system with and without dimples are also compared for different compression ring face profiles. The results show that the spherical dimples can produce a larger reduction of friction in mixed lubrication region, and reduce power loss significantly in the middle of the strokes. In addition, higher reduction percentages of average friction forces and wear are obtained for smaller crown height or larger axial width.	[Liu, Cheng; Lu, Yan-Jun; Li, Sha] Xian Univ Technol, Sch Mech & Precis Instrument Engn, Xian, Shaanxi, Peoples R China; [Liu, Cheng; Lu, Yan-Jun; Zhang, Yong-Fang; Li, Sha] Xi An Jiao Tong Univ, State Key Lab Strength & Vibrat Mech Struct, Xian, Shaanxi, Peoples R China; [Zhang, Yong-Fang] Xian Univ Technol, Sch Printing Packaging Engn & Digital Media Techn, Xian, Shaanxi, Peoples R China; [Mueller, Norbert] Michigan State Univ, Coll Engn, E Lansing, MI 48824 USA	Xi'an University of Technology; Xi'an Jiaotong University; Xi'an University of Technology; Michigan State University	Lu, YJ (corresponding author), Xian Univ Technol, Sch Mech & Precis Instrument Engn, Xian, Shaanxi, Peoples R China.; Lu, YJ (corresponding author), Xi An Jiao Tong Univ, State Key Lab Strength & Vibrat Mech Struct, Xian, Shaanxi, Peoples R China.	yanjunlu@xaut.edu.cn			National Natural Science Foundation of China [51375380]; Open project of State Key Laboratory for Strength and Vibration of Mechanical Structures of China [SV2016-KF-10]; Shaanxi Provincial Natural Science Foundation [2014JM2-5082]; Scientific Research Program of Shaanxi Provincial Education Department of China [15JS068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open project of State Key Laboratory for Strength and Vibration of Mechanical Structures of China; Shaanxi Provincial Natural Science Foundation; Scientific Research Program of Shaanxi Provincial Education Department of China	This research was funded by the National Natural Science Foundation of China (Grant no. 51375380), Open project of State Key Laboratory for Strength and Vibration of Mechanical Structures of China (Grant no. SV2016-KF-10), Shaanxi Provincial Natural Science Foundation (Grant no. 2014JM2-5082), and Scientific Research Program of Shaanxi Provincial Education Department of China (Grant no. 15JS068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausas RF, 2013, TRIBOL INT, V57, P54, DOI 10.1016/j.triboint.2012.07.003; Becker EP, 2004, TRIBOL INT, V37, P569, DOI 10.1016/j.triboint.2003.12.006; Bertocchi L, 2013, TRIBOL INT, V67, P61, DOI 10.1016/j.triboint.2013.05.018; Biboulet N, 2015, TRIBOL INT, V82, P12, DOI 10.1016/j.triboint.2014.09.024; Checo HM, 2014, TRIBOL INT, V72, P131, DOI 10.1016/j.triboint.2013.12.013; Costa HL, 2007, TRIBOL INT, V40, P1227, DOI 10.1016/j.triboint.2007.01.014; Etsion I, 2005, J TRIBOL-T ASME, V127, P248, DOI 10.1115/1.1828070; Etsion I, 2009, TRIBOL INT, V42, P542, DOI 10.1016/j.triboint.2008.02.015; Gadeschi GB, 2012, J TRIBOL-T ASME, V134, DOI 10.1115/1.4007347; Greenwood I., 1971, P I MECH ENG, V185, P625, DOI [10.1243/PIME_PROC_1970_185_069_02, DOI 10.1243/PIME_PROC_1970_185_069_02]; Gropper D, 2016, TRIBOL INT, V94, P509, DOI 10.1016/j.triboint.2015.10.009; Gu CX, 2016, TRIBOL INT, V103, P516, DOI 10.1016/j.triboint.2016.08.005; Gu CX, 2016, TRIBOL INT, V101, P178, DOI 10.1016/j.triboint.2016.04.024; Gu CX, 2016, TRIBOL INT, V94, P591, DOI 10.1016/j.triboint.2015.10.024; Gu CX, 2016, ASME J TRIBOLOGY, V139; Gulwadi SD, 2000, TRIBOL T, V43, P151, DOI 10.1080/10402000008982325; Johansson S, 2008, TRIBOL INT, V41, P854, DOI 10.1016/j.triboint.2008.02.012; Kligerman Y, 2005, J TRIBOL-T ASME, V127, P632, DOI 10.1115/1.1866171; Kligerman Y, 2015, P I MECH ENG J-J ENG, V229, P336, DOI 10.1177/1350650114545635; Meng XH, 2016, INT J ENGINE RES, V17, P1062, DOI 10.1177/1468087416637952; Mohamad SA, 2015, P I MECH ENG J-J ENG, V229, P989, DOI 10.1177/1350650114556400; Mohamad SA, 2015, ADV MECH ENG, V7, DOI 10.1155/2014/837960; Morris N, 2016, J TRIBOL-T ASME, V138, DOI 10.1115/1.4031780; Morris N, 2013, TRIBOL INT, V59, P248, DOI 10.1016/j.triboint.2012.09.002; Nakano M, 2007, TRIBOL LETT, V28, P131, DOI 10.1007/s11249-007-9257-2; PATIR N, 1978, J LUBRIC TECH-T ASME, V100, P12, DOI 10.1115/1.3453103; Ramesh A, 2013, TRIBOL INT, V57, P170, DOI 10.1016/j.triboint.2012.07.020; Ronen A, 2001, TRIBOL T, V44, P359, DOI 10.1080/10402000108982468; Shahmohamadi H, 2015, TRIBOL INT, V90, P164, DOI 10.1016/j.triboint.2015.04.025; Shen C, 2016, TRIBOL INT, V101, P273, DOI 10.1016/j.triboint.2016.04.009; Smith EH, 2011, TRIBOL INT, V44, P29, DOI 10.1016/j.triboint.2010.09.002; Tomanik E, 2013, TRIBOL INT, V59, P90, DOI 10.1016/j.triboint.2012.01.016; Usman A, 2016, TRIBOL INT, V99, P224, DOI 10.1016/j.triboint.2016.03.030; Wang YS, 2003, J TRIBOL-T ASME, V125, P747, DOI 10.1115/1.1574519; Wu C, 1989, ASME J TRIBOLOGY, V111, P220; Xiong S, 2012, ASME J TRIBOL, V134, P1; Yin BF, 2012, LUBR SCI, V24, P293, DOI 10.1002/ls.1185; Zavos AB, 2015, LUBR SCI, V27, P151, DOI 10.1002/ls.1261; Zhan J, 2014, LASER ENG, V29, P123; Zhang JY, 2012, TRIBOL LETT, V46, P147, DOI 10.1007/s11249-012-9935-6; Zhou YK, 2012, TRIBOL INT, V52, P1, DOI 10.1016/j.triboint.2011.12.017	41	11	11	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181574	10.1371/journal.pone.0181574	http://dx.doi.org/10.1371/journal.pone.0181574			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732042	Green Published, gold, Green Submitted			2022-12-27	WOS:000406643100044
J	Fan, CSD; Zhu, XY; Dosch, HG; von Stutterheim, C; Rupp, A				Fan, Christina Siu-Dschu; Zhu, Xingyu; Dosch, Hans Guenter; von Stutterheim, Christiane; Rupp, Andre			Language related differences of the sustained response evoked by natural speech sounds	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; EVENT-RELATED POTENTIALS; LATERAL HESCHLS GYRUS; BRAIN-STEM; PITCH; ORGANIZATION; PERCEPTION; REPRESENTATION; METAANALYSIS; INFORMATION	In tonal languages, such as Mandarin Chinese, the pitch contour of vowels discriminates lexical meaning, which is not the case in non-tonal languages such as German. Recent data provide evidence that pitch processing is influenced by language experience. However, there are still many open questions concerning the representation of such phonological and language-related differences at the level of the auditory cortex (AC). Using magnetoencephalography (MEG), we recorded transient and sustained auditory evoked fields (AEF) in native Chinese and German speakers to investigate language related phonological and semantic aspects in the processing of acoustic stimuli. AEF were elicited by spoken meaningful and meaningless syllables, by vowels, and by a French horn tone. Speech sounds were recorded from a native speaker and showed frequency-modulations according to the pitch-contours of Mandarin. The sustained field (SF) evoked by natural speech signals was significantly larger for Chinese than for German listeners. In contrast, the SF elicited by a horn tone was not significantly different between groups. Furthermore, the SF of Chinese subjects was larger when evoked by meaningful syllables compared to meaningless ones, but there was no significant difference regarding whether vowels were part of the Chinese phonological system or not. Moreover, the N100m gave subtle but clear evidence that for Chinese listeners other factors than purely physical properties play a role in processing meaningful signals. These findings show that the N100 and the SF generated in Heschl's gyrus are influenced by language experience, which suggests that AC activity related to specific pitch contours of vowels is influenced in a top-down fashion by higher, language related areas. Such interactions are in line with anatomical findings and neuroimaging data, as well as with the dual-stream model of language of Hickok and Poeppel that highlights the close and reciprocal interaction between superior temporal gyrus and sulcus.	[Fan, Christina Siu-Dschu; Dosch, Hans Guenter] Inst Theoret Phys, Heidelberg, Germany; [Fan, Christina Siu-Dschu] Storz Med AG, Tagerwilen, Switzerland; [Zhu, Xingyu; von Stutterheim, Christiane] Heidelberg Univ, Dept Gen & Appl Linguist, Heidelberg, Germany; [Rupp, Andre] Heidelberg Univ, Dept Neurol, Sect Biomagnetism, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Rupp, A (corresponding author), Heidelberg Univ, Dept Neurol, Sect Biomagnetism, Heidelberg, Germany.	andre.rupp@uni-heidelberg.de			Innovationfond FRONTIER of the Excellence Initiative of the University of Heidelberg [ZUK 49/1 TP 1-19]	Innovationfond FRONTIER of the Excellence Initiative of the University of Heidelberg	This study was supported by the grant ZUK 49/1 TP 1-19 of the Innovationfond FRONTIER of the Excellence Initiative of the University of Heidelberg (https.//www.uni.heidelberg.de/ exzellenzinitiative/zukunftskonzept/frontier_de.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author CF is employed by Storz Medical AG, Switzerland. The funder only provided support in the form of salaries for author CF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	ABRAMSON AS, 1978, LANG SPEECH, V21, P319, DOI 10.1177/002383097802100406; Adank P, 2012, NEUROIMAGE, V63, P1601, DOI 10.1016/j.neuroimage.2012.07.027; Andermann M, 2011, NEUROIMAGE, P1; Ash R, 2012, AUDACITY COMPUTER PR; Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; Bidelman GM, 2015, NEUROIMAGE, V120, P191, DOI 10.1016/j.neuroimage.2015.06.087; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; BODDY J, 1986, PSYCHOPHYSIOLOGY, V23, P232, DOI 10.1111/j.1469-8986.1986.tb00624.x; Boersma P., 2010, PRAAT DOING PHONETIC, DOI DOI 10.1007/s10072-018-3598-5; CHAN YYF, 1974, PERCEPTUAL STUDY TON; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Chechik G, 2012, P NATL ACAD SCI USA, V109, P18968, DOI 10.1073/pnas.1111242109; Diesch E, 1996, BRAIN LANG, V53, P143, DOI 10.1006/brln.1996.0042; Garagnani M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.010.2009; Gockel HE, 2011, JARO-J ASSOC RES OTO, V12, P767, DOI 10.1007/s10162-011-0284-1; Goto M., 2003, P 4 INT C MUS INF RE, P229; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Griffiths TD, 2010, CURR BIOL, V20, P1128, DOI 10.1016/j.cub.2010.04.044; Gutschalk A, 2004, NEUROIMAGE, V22, P755, DOI 10.1016/j.neuroimage.2004.01.025; Gutschalk A, 2002, NEUROIMAGE, V15, P207, DOI 10.1006/nimg.2001.0949; Gutschalk A, 2011, NEUROIMAGE, V56, P1578, DOI 10.1016/j.neuroimage.2011.02.026; Gutschalk A, 2010, J NEUROPHYSIOL, V103, P2015, DOI 10.1152/jn.01005.2009; Hackett Troy A, 2015, Handb Clin Neurol, V129, P27, DOI 10.1016/B978-0-444-62630-1.00002-0; Hackett TA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00072; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Helenius P, 2002, J NEUROSCI, V22, P2936, DOI 10.1523/JNEUROSCI.22-07-02936.2002; Hewson-Stoate N, 2006, EUR J NEUROSCI, V24, P2661, DOI 10.1111/j.1460-9568.2006.05096.x; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Jao T, 2009, IEEE ENG MED BIO, P4779, DOI 10.1109/IEMBS.2009.5334211; Kanwal JS, 2011, AUDITORY CORTEX, P343, DOI 10.1007/978-1-4419-0074-6_16; Krishnan A, 2017, BRAIN LANG, V169, P22, DOI 10.1016/j.bandl.2017.01.014; Krishnan A, 2010, J NEUROLINGUIST, V23, P81, DOI 10.1016/j.jneuroling.2009.09.001; Krishnan A, 2009, NEUROREPORT, V20, P408, DOI 10.1097/WNR.0b013e3283263000; Krumbholz K, 2003, CEREB CORTEX, V13, P765, DOI 10.1093/cercor/13.7.765; Kujala A, 2004, COGNITIVE BRAIN RES, V21, P106, DOI 10.1016/j.cogbrainres.2004.05.011; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1982, NEUROPSYCHOLOGIA, V20, P579, DOI 10.1016/0028-3932(82)90031-8; KUTAS M, 1988, ELECTROEN CLIN NEURO, V69, P218, DOI 10.1016/0013-4694(88)90131-9; Lau E, 2009, BRAIN LANG, V111, P161, DOI 10.1016/j.bandl.2009.08.007; Liebenthal E, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00289; MacGregor LJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1715; Makela AM, 2001, NEUROREPORT, V12, P249; Malmierca MS, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00019; Manca AD, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01413; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Meyer M, 2008, Z NEUROPSYCHOL, V19, P101, DOI 10.1024/1016-264X.19.2.101; Nelken I, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00106; Nelken I, 2008, CURR OPIN NEUROBIOL, V18, P413, DOI 10.1016/j.conb.2008.08.014; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; PICTON TW, 1978, ELECTROEN CLIN NEURO, V45, P186, DOI 10.1016/0013-4694(78)90003-2; Plack C.J., 2005, PITCH NEURAL CODING, DOI [10.1007/0-387-28958-5, DOI 10.1007/0-387-28958-5]; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; Schirmer A, 2012, NEUROIMAGE, V63, P137, DOI 10.1016/j.neuroimage.2012.06.025; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schonwiesner M, 2008, EXP BRAIN RES, V187, P97, DOI 10.1007/s00221-008-1286-z; Sieroka N, 2003, NEUROIMAGE, V20, P1697, DOI 10.1016/S1053-8119(03)00445-2; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Stebbings KA, 2014, HEARING RES, V314, P51, DOI 10.1016/j.heares.2014.05.004; Swaminathan J, 2008, NEUROREPORT, V19, P1163, DOI 10.1097/WNR.0b013e3283088d31; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Tremblay KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010283; Turkeltaub PE, 2010, BRAIN LANG, V114, P1, DOI 10.1016/j.bandl.2010.03.008; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Wang X., 2013, CLOUD MANUFACTURING, V2013, P1, DOI DOI 10.1155/2013/569161.ARTICLE; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WOLLBERG Z, 1972, SCIENCE, V175, P212, DOI 10.1126/science.175.4018.212; Yrttiaho S, 2008, J ACOUST SOC AM, V123, P2191, DOI 10.1121/1.2888489	72	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180441	10.1371/journal.pone.0180441	http://dx.doi.org/10.1371/journal.pone.0180441			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727776	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500022
J	Lorenzo, MM; Sanchez-Puig, JM; Blasco, R				Lorenzo, Maria M.; Sanchez-Puig, Juana M.; Blasco, Rafael			Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; INDUCED RESISTANCE; INFLUENZA-VIRUS; MONKEYPOX VIRUS; HIV-1 INFECTION; INHIBITION; GENE; RESCUE; IDENTIFICATION; GLYCOPROTEIN	MxA protein is expressed in response to type I and type III Interferon and constitute an important antiviral factor with broad antiviral activity to diverse RNA viruses. In addition, some studies expand the range of MxA antiviral activity to include particular DNA viruses like Monkeypox virus (MPXV) and African Swine Fever virus (ASFV). However, a broad profile of activity of MxA to large DNA viruses has not been established to date. Here, we investigated if some well characterized DNA viruses belonging to the Poxviridae family are sensitive to human MxA. A cell line inducibly expressing MxA to inhibitory levels showed no anti-Vaccinia virus (VACV) virus activity, indicating either lack of susceptibility of the virus, or the existence of viral factors capable of counteracting MxA inhibition. To determine if VACV resistance to MxA was due to a virus-encoded anti-MxA activity, we performed coinfections of VACV and the MxA-sensitive Vesicular Stomatitis virus (VSV), and show that VACV does not protect VSV from MxA inhibition in trans. Those results were extended to several VACV strains and two CPXV strains, thus confirming that those Orthopoxviruses do not block MxA action. Overall, these results point to a lack of susceptibility of the Poxviridae to MxA antiviral activity.	[Lorenzo, Maria M.; Sanchez-Puig, Juana M.; Blasco, Rafael] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Blasco, R (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain.	blasco@inia.es	Lorenzo, Maria M./ABH-4437-2020; Blasco, Rafael/B-5829-2016; Eyré, Juana Sánchez-Puig/ABF-8080-2020	Sanchez-Puig Eyre, Juana/0000-0002-3966-3499; Lorenzo, Maria M./0000-0001-7588-673X; Blasco, Rafael/0000-0002-8819-5767	Ministerio de Economia y Competitividad, Plan Estatal de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica [RTA2013-00021-00, E-RTA2014-00006]	Ministerio de Economia y Competitividad, Plan Estatal de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica	This work was supported by grants RTA2013-00021-00 and E-RTA2014-00006 from Ministerio de Economia y Competitividad, Plan Estatal de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (http://ww.idi.mineco. gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Americo JL, 2014, VIROLOGY, V449, P120, DOI 10.1016/j.virol.2013.11.017; Americo JL, 2010, J VIROL, V84, P8172, DOI 10.1128/JVI.00621-10; Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Arndt WD, 2015, J VIROL, V89, P10489, DOI 10.1128/JVI.00304-15; Arsenio J, 2008, VIROLOGY, V377, P124, DOI 10.1016/j.virol.2008.04.014; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; BLASCO R, 1993, J VIROL, V67, P3319, DOI 10.1128/JVI.67.6.3319-3325.1993; BLASCO R, 1991, J VIROL, V65, P5910, DOI 10.1128/JVI.65.11.5910-5920.1991; Busnadiego I, 2014, J VIROL, V88, P7738, DOI 10.1128/JVI.00214-14; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cotter CA, 2017, CURR PROTOC MOL BIOL, V117, P1; Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; FRESE M, 1995, J VIROL, V69, P3904, DOI 10.1128/JVI.69.6.3904-3909.1995; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; Fricke T, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0068-x; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Johnston SC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-5; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Lai F, 2008, J VIROL METHODS, V153, P276, DOI 10.1016/j.jviromet.2008.07.001; Landis H, 1998, J VIROL, V72, P1516, DOI 10.1128/JVI.72.2.1516-1522.1998; Maarifi G, 2016, J VIROL, V90, P6598, DOI 10.1128/JVI.00722-16; Moss B, 2015, VIROLOGY, V479, P619, DOI 10.1016/j.virol.2015.02.003; Netherton CL, 2009, J VIROL, V83, P2310, DOI 10.1128/JVI.00781-08; Nurnberger C, 2016, J VIROL, V90, P10682, DOI 10.1128/JVI.01213-16; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; Sanchez-Puig JM, 2005, BIOTECHNIQUES, V39, P665, DOI 10.2144/000112012; Sanchez-Puig JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-10; Sanchez-Puig Juana M, 2012, Methods Mol Biol, V890, P93, DOI 10.1007/978-1-61779-876-4_5; Shors ST, 1998, J INTERF CYTOK RES, V18, P721, DOI 10.1089/jir.1998.18.721; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; STAEHELI P, 1991, J VIROL, V65, P4498, DOI 10.1128/JVI.65.8.4498-4501.1991; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; THACORE HR, 1973, VIROLOGY, V56, P512, DOI 10.1016/0042-6822(73)90054-8; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; WHITAKERDOWLING P, 1983, VIROLOGY, V131, P128, DOI 10.1016/0042-6822(83)90539-1; YOUNGNER JS, 1972, J VIROL, V10, P171, DOI 10.1128/JVI.10.2.171-178.1972	43	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181459	10.1371/journal.pone.0181459	http://dx.doi.org/10.1371/journal.pone.0181459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727764	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500076
J	Miller, LC; Fleming, DS; Li, XD; Bayles, DO; Blecha, F; Sang, YM				Miller, Laura C.; Fleming, Damarius S.; Li, Xiangdong; Bayles, Darrell O.; Blecha, Frank; Sang, Yongming			Comparative analysis of signature genes in PRRSV-infected porcine monocyte-derived cells to different stimuli	PLOS ONE			English	Article							PROTEOGLYCANS; MACROPHAGES; PATHOGENESIS; ACTIVATION; EXPRESSION; AUTOPHAGY; DECORIN; PAMPS; DAMPS	Monocyte-derived DCs (mDCs) are major target cells in porcine reproductive and respiratory syndrome virus (PRRSV) pathogenesis; however, the plasticity of mDCs in response to activation stimuli and PRRSV infection remains unstudied. In this study, we polarized mDCs, and applied genome-wide transcriptomic analysis and predicted protein-protein interaction networks to compare signature genes involved in mDCs activation and response to PRRSV infection. Porcine mDCs were polarized with mediators for 30 hours, then mock-infected, infected with PRRSV strain VR2332, or a highly pathogenic PRRSV strain (rJXwn06), for 5 h. Total RNA was extracted and used to construct sequencing libraries for RNA-Seq. Comparisons were made between each polarized and unpolarized group (i.e. mediator vs. PBS), and between PRRSV-infected and uninfected cells stimulated with the same mediator. Differentially expressed genes (DEG) from the comparisons were used for prediction of interaction networks affected by the viruses and mediators. The results showed that PRRSV infection inhibited M1-prone immune activity, downregulated genes, predicted network interactions related to cellular integrity, and inflammatory signaling in favor of M2 activity. Additionally, the number of DEG and predicted network interactions stimulated in HP-PRRSV infected mDCs was superior to the VR-2332 infected mDCs and conformed with HP-PRRSV pathogenicity.	[Miller, Laura C.; Fleming, Damarius S.] USDA ARS, Virus & Prion Dis Livestock Res Unit, Natl Anim Dis Ctr, 1920 Dayton Ave, Ames, IA 50010 USA; [Li, Xiangdong] Natl Res Ctr Vet Med, Cuiwei Rd, Luoyang, Henan, Peoples R China; [Bayles, Darrell O.] USDA ARS, Infect Bacterial Dis Res Unit, Natl Anim Dis Ctr, 1920 Dayton Ave, Ames, IA USA; [Blecha, Frank; Sang, Yongming] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Sang, Yongming] Tennessee State Univ, Coll Agr Human & Nat Sci, Dept Agr & Environm Sci, 3500 John A Merritt Blvd, Nashville, TN 37203 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Kansas State University; Tennessee State University	Miller, LC (corresponding author), USDA ARS, Virus & Prion Dis Livestock Res Unit, Natl Anim Dis Ctr, 1920 Dayton Ave, Ames, IA 50010 USA.; Sang, YM (corresponding author), Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA.; Sang, YM (corresponding author), Tennessee State Univ, Coll Agr Human & Nat Sci, Dept Agr & Environm Sci, 3500 John A Merritt Blvd, Nashville, TN 37203 USA.	laura.miller@ars.usda.gov; ysang@tnstate.edu	Miller, Laura/B-2268-2017; li, xiangdong/T-6019-2017	Miller, Laura/0000-0002-8946-9416; li, xiangdong/0000-0002-4635-1602	United States Department of Agriculture National Institute of Food and Agriculture Agriculture and Food Research Initiative [2013-67015-21236, 2015-67015-23216]; DOE [DE-AC05-060R23100]; USDA NIFA AFRI [2013-67015-21236, 2015-67015-23216]	United States Department of Agriculture National Institute of Food and Agriculture Agriculture and Food Research Initiative(United States Department of Agriculture (USDA)); DOE(United States Department of Energy (DOE)); USDA NIFA AFRI(United States Department of Agriculture (USDA))	This work was supported by the United States Department of Agriculture National Institute of Food and Agriculture Agriculture and Food Research Initiative 2013-67015-21236, https.//nifa. usda.gov/; United States Department of Agriculture National Institute of Food and Agriculture Agriculture and Food Research Initiative 2015-67015-23216, https://nifa.usda.gov/. Damarius Fleming's appointment to the Agricultural Research Service Research Participation Program was administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the US Department of Energy (DOE) and the US Department of Agriculture. 0 RISE is managed by Oak Ridge Associated Universities under DOE contract no. DE-AC05-060R23100, https://orrise.orau.gov/about-orise/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was mainly supported by the USDA NIFA AFRI 2013-67015-21236, and in part by USDA NIFA AFRI 2015-67015-23216. We would like to thank Barbara Lutjemeier, Qinfang Liu, and Sarah Anderson for their excellent technical support, and Sue Ohlendorf for secretarial assistance in preparation of the manuscript.	Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Chand RJ, 2012, CURR OPIN VIROL, V2, P256, DOI 10.1016/j.coviro.2012.02.002; DAVID JR, 1975, ACTA ENDOCRINOL-COP, V78, P245; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Garcia-Nicolas O, 2014, VIRUS RES, V179, P204, DOI 10.1016/j.virusres.2013.08.009; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Jiang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059229; Koltes JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1635-9; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; LAGER KM, 1995, CAN J VET RES, V59, P187; Liu XD, 2011, J IMMUNOL, V186, P3031, DOI 10.4049/jimmunol.0902687; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Miller LC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-208; Moller ASW, 2005, CYTOKINE, V32, P304, DOI 10.1016/j.cyto.2005.11.008; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; OLDBERG A, 1990, BIOCHEM SOC T, V18, P789, DOI 10.1042/bst0180789; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sang Y, 2015, J CLIN CELL IMMUNOL, V6; Sang YM, 2014, J VIROL, V88, P11395, DOI 10.1128/JVI.01714-14; Sang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087613; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; YANAGISHITA M, 1993, ACTA PATHOL JAPON, V43, P283; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhao JH, 2016, ANTIVIR RES, V132, P268, DOI 10.1016/j.antiviral.2016.07.001	38	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181256	10.1371/journal.pone.0181256	http://dx.doi.org/10.1371/journal.pone.0181256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727780	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500051
J	Pascual, T; Apellaniz-Ruiz, M; Pernaut, C; Cueto-Felgueroso, C; Villalba, P; Alvarez, C; Manso, L; Inglada-Perez, L; Robledo, M; Rodriguez-Antona, C; Ciruelos, E				Pascual, Tomas; Apellaniz-Ruiz, Maria; Pernaut, Cristina; Cueto-Felgueroso, Cecilia; Villalba, Pablo; Alvarez, Carlos; Manso, Luis; Inglada-Perez, Lucia; Robledo, Mercedes; Rodriguez-Antona, Cristina; Ciruelos, Eva			Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PLUS EXEMESTANE; CALCINEURIN-INHIBITORS; MTOR INHIBITORS; THERAPY; RESISTANCE; PATHWAY; TRANSPLANTATION; PROGRESSION; BOLERO-2	Purpose Metastatic breast cancer (MBC) progressing after endocrine therapy frequently activates PI3K/AKT/mTOR pathway. The BOLERO-2 trial showed that everolimus-exemestane achieves increased progression free survival (PFS) compared with exemestane. However, there is great inter-patient variability in toxicity and response to exemestane-everolimus treatment. The objective of this study was to perform an exploratory study analyzing the implication of single nucleotide polymorphisms (SNPs) on outcomes from this treatment through a pharmacogenetic analysis. Patients and methods Blood was collected from 90 postmenopausal women with hormone receptor-positive, HER2-negative MBC treated with exemestane-everolimus following progression after prior treatment with a non-steroidal aromatase inhibitor. Everolimus pharmacokinetics was measured in 37 patients. Twelve SNPs in genes involved in everolimus pharmacokinetics and pharmacodynamics were genotyped and associations assessed with drug plasma levels, clinically relevant toxicities (non-infectious pneumonitis, mucositis, hyperglycemia and hematological toxicities), dose reductions or treatment suspensions due to toxicity, progression free survival (PFS) and overall survival. Results We found that CYP3A4 rs35599367 variant (CYP3A4*22 allele) carriers had higher everolimus blood concentration compared to wild type patients (P = 0.019). ABCB1 rs1045642 was associated with risk of mucositis (P = 0.031), while PIK3R1 rs10515074 and RAPTOR rs9906827 were associated with hyperglycemia and non-infectious pneumonitis (P = 0.016 and 0.024, respectively). Furthermore, RAPTOR rs9906827 was associated with PFS (P = 0.006). Conclusions CYP3A4*22 allele influenced plasma concentration of everolimus and several SNPs in PI3K/AKT/mTOR pathway genes were associated with treatment toxicities and prognosis. These results require replication, but suggest that germline variation could influence everolimus outcomes in MBC.	[Pascual, Tomas; Pernaut, Cristina; Ciruelos, Eva] 12 Octubre Univ Hosp, Dept Med Oncol, Madrid, Spain; [Apellaniz-Ruiz, Maria; Inglada-Perez, Lucia; Robledo, Mercedes; Rodriguez-Antona, Cristina] Spanish Natl Canc Res Ctr CNIO, Hereditary Endocrine Canc Grp, Human Canc Genet Programme, Madrid, Spain; [Cueto-Felgueroso, Cecilia; Villalba, Pablo; Alvarez, Carlos; Manso, Luis] 12 Octubre Univ Hosp, Dept Biochem, Madrid, Spain; [Inglada-Perez, Lucia; Robledo, Mercedes; Rodriguez-Antona, Cristina] CIBERER, Madrid, Spain; [Pascual, Tomas] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain	Hospital Universitario 12 de Octubre; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona	Ciruelos, E (corresponding author), 12 Octubre Univ Hosp, Dept Med Oncol, Madrid, Spain.	eva.ciruelos@gmail.com	Rodriguez-Antona, Cristina/E-1073-2011; Apellaniz-Ruiz, Maria/AAO-9961-2020; Pascual, Tomas/AAH-8993-2019; Robledo, Mercedes/O-2230-2013; Inglada-Perez, Lucia/Z-3020-2019; Apellaniz-Ruiz, Maria/L-7634-2019; manso, luis/AGZ-6467-2022	Rodriguez-Antona, Cristina/0000-0001-8750-7338; Apellaniz-Ruiz, Maria/0000-0002-2137-1439; Pascual, Tomas/0000-0001-8431-3183; Robledo, Mercedes/0000-0001-6256-5902; manso, luis/0000-0002-1683-550X	Mutua Madrilena [2012/0088]; Spanish Ministry of Economy and Competiveness [SAF2012-35779]	Mutua Madrilena; Spanish Ministry of Economy and Competiveness(Spanish Government)	This work was supported by projects from Mutua Madrilena (project number 2012/0088, Principal Investigator: Dr E. Ciruelos) and the Spanish Ministry of Economy and Competiveness (grant number SAF2012-35779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Beck JT, 2014, BREAST CANCER RES TR, V143, P459, DOI 10.1007/s10549-013-2814-5; Beeram M, 2007, ANN ONCOL, V18, P1323, DOI 10.1093/annonc/mdm170; Bellister SA, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.4_suppl.163; Cardoso F, 2016, ANN ONCOL; Chen M, 2010, CARCINOGENESIS, V31, P1387, DOI 10.1093/carcin/bgq110; Chen QR, 2010, J PROTEOME RES, V9, P373, DOI 10.1021/pr900701v; Ciruelos E, 2013, ANTI-CANCER DRUG, V24, P769, DOI 10.1097/CAD.0b013e328363adc5; Dai D, 2001, PHARMACOGENETICS, V11, P597, DOI 10.1097/00008571-200110000-00006; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Gabriella Jerusalem GM, 2014, CANC RES S, V75, P5; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hortobagyi G. N., 2015, J CLIN ONCOL; Hronova K, 2014, EXPERT REV CLIN PHAR, V7, P821, DOI 10.1586/17512433.2014.966811; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Jerusalem G, 2016, ANN ONCOL, V27, P1719, DOI 10.1093/annonc/mdw249; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirchner GI, 2004, CLIN PHARMACOKINET, V43, P83, DOI 10.2165/00003088-200443020-00002; Kniepeiss D, 2011, CLIN TRANSPLANT, V25, P146, DOI 10.1111/j.1399-0012.2009.01198.x; Knops N, 2013, INT J PHARMACEUT, V452, P14, DOI 10.1016/j.ijpharm.2013.05.033; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lemaitre F, 2012, THER DRUG MONIT, V34, P686, DOI 10.1097/FTD.0b013e318273c899; Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093; Margariti N, 2011, BREAST CANCER RES TR, V128, P599, DOI 10.1007/s10549-010-0986-9; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Moes DJAR, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2013.78; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Schoeppler KE, 2014, CLIN TRANSPLANT, V28, P590, DOI 10.1111/ctr.12350; Serra S, 2012, CANCER RES, V72, P5683, DOI 10.1158/0008-5472.CAN-12-2102; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P207, DOI 10.2165/11317550-000000000-00000; Tryfonidis K, 2016, CANCER TREAT REV, V50, P68, DOI 10.1016/j.ctrv.2016.08.008; Vicier C, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3618; Villarreal-Garza C, 2012, ANN ONCOL, V23, P2526, DOI 10.1093/annonc/mds075; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yardley DA, 2013, ADV THER, V30, P870, DOI 10.1007/s12325-013-0060-1	40	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180192	10.1371/journal.pone.0180192	http://dx.doi.org/10.1371/journal.pone.0180192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727815	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500018
J	Campbell, R; Tasevska, N; Jackson, KG; Sagi-Kiss, V; di Paolo, N; Minden, JS; Lister, SJ; Khaw, KT; Kuhnle, GGC				Campbell, Rachel; Tasevska, Natasha; Jackson, Kim G.; Sagi-Kiss, Virag; di Paolo, Nick; Minden, Jennifer S.; Lister, Susan J.; Khaw, Kay-Tee; Kuhnle, Gunter G. C.			Association between urinary biomarkers of total sugars intake and measures of obesity in a cross-sectional study	PLOS ONE			English	Article							SUCROSE INTAKE; FRUCTOSE; DIETARY; CONSUMPTION; HEALTH; INDIVIDUALS; PREVALENCE; NITROGEN; WEIGHT; CANCER	Obesity is an important modifiable risk factor for chronic diseases. While there is increasing focus on the role of dietary sugars, there remains a paucity of data establishing the association between sugar intake and obesity in the general public. The objective of this study was to investigate associations of estimated sugar intake with odds for obesity in a representative sample of English adults. We used data from 434 participants of the 2005 Health Survey of England. Biomarkers for total sugar intake were measured in 24 h urine samples and used to estimate intake. Linear and logistic regression analyses were used to investigate associations between biomarker-based estimated intake and measures of obesity (body mass intake (BMI), waist circumference and waist-to-hip ratio) and obesity risk, respectively. Estimated sugar intake was significantly associated with BMI, waist circumference and waist-to-hip ratio; these associations remained significant after adjustment for estimated protein intake as a marker of non-sugar energy intake. Estimated sugar intake was also associated with increased odds for obesity based on BMI (OR 1.02; 95% CI 1.00-1.04 per 10g), waist-circumference (1.03; 1.01-1.05) and waist-to-hip ratio (1.04; 1.02-1.06); all OR estimates remained significant after adjusting for estimated protein intake. Our results strongly support positive associations between total sugar intake, measures of obesity and likelihood of being obese. It is the first time that such an association has been shown in a nationally-representative sample of the general population using a validated biomarker. This biomarker could be used to monitor the efficacy of public health interventions to reduce sugar intake.	[Campbell, Rachel; Jackson, Kim G.; Sagi-Kiss, Virag; Kuhnle, Gunter G. C.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Tasevska, Natasha; Sagi-Kiss, Virag] Arizona State Univ, Sch Nutr & Hlth Promot, Phoenix, AZ USA; [di Paolo, Nick] NatCen Social Res, London, England; [Minden, Jennifer S.] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Lister, Susan J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Khaw, Kay-Tee; Kuhnle, Gunter G. C.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	University of Reading; Arizona State University; Arizona State University-Downtown Phoenix; University of London; University College London; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Cambridge	Kuhnle, GGC (corresponding author), Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England.; Kuhnle, GGC (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	g.g.kuhnle@reading.ac.uk	Khaw, Kay-Tee/AAZ-3209-2021; Kuhnle, Gunter/AAG-5264-2019; Jackson, Kim/G-7356-2016; Mindell, Jennifer/G-2241-2011	Kuhnle, Gunter/0000-0002-8081-8931; Jackson, Kim/0000-0002-0070-3203; Mindell, Jennifer/0000-0002-7604-6131	World Cancer Research Fund (WCRF); Medical Research Council; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143, MR/N003284/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish; MRC [MR/N003284/1] Funding Source: UKRI	World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was supported by the World Cancer Research Fund (WCRF) and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1462; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Becker E, HLTH SURVEY ENGLAND; BINGHAM S, 1983, CLIN SCI, V64, P629, DOI 10.1042/cs0640629; BINGHAM SA, 1985, AM J CLIN NUTR, V42, P1276, DOI 10.1093/ajcn/42.6.1276; BINGHAM SA, 1995, BRIT J NUTR, V73, P531, DOI 10.1079/BJN19950057; Bingham S, 2007, CANCER EPIDEM BIOMAR, V16, P1651, DOI 10.1158/1055-9965.EPI-06-1050; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; DEANE N, 1955, J CLIN INVEST, V34, P681, DOI 10.1172/JCI103118; Douard Veronique, 2008, Am J Physiol Endocrinol Metab, V295, pE227, DOI 10.1152/ajpendo.90245.2008; England PH, 2015, WHY 5; Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040; Institute of Medicine (US) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, 2006, DIET REF INT ESS GUI, P1; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Joosen AMCP, 2008, INT J OBESITY, V32, P1736, DOI 10.1038/ijo.2008.145; Kawasaki T, 2002, DIABETES CARE, V25, P353, DOI 10.2337/diacare.25.2.353; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Kuhnle GGC, 2015, PUBLIC HEALTH NUTR, V18, P2815, DOI 10.1017/S1368980015000300; Luceri C, 1996, CANCER EPIDEM BIOMAR, V5, P167; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; NAKAMURA H, 1972, CLIN CHIM ACTA, V39, P397, DOI 10.1016/0009-8981(72)90055-1; Poppitt SD, 1998, INT J OBESITY, V22, P303, DOI 10.1038/sj.ijo.0800584; Pryer JA, 1997, INT J EPIDEMIOL, V26, P146, DOI 10.1093/ije/26.1.146; R Core Team, 2021, R LANGUAGE ENV STAT; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; SCHOELLER DA, 1988, J NUTR, V118, P1278, DOI 10.1093/jn/118.11.1278; Scientific Advisory Committee on Nutrition, 2015, CARB HLTH; Tasevska N, 2005, CANCER EPIDEM BIOMAR, V14, P1287, DOI 10.1158/1055-9965.EPI-04-0827; Tasevska N, 2009, EUR J CLIN NUTR, V63, P653, DOI 10.1038/ejcn.2008.21; Tasevska N, 2011, CANCER EPIDEM BIOMAR, V20, P490, DOI 10.1158/1055-9965.EPI-10-0820; Tasevska N, 2015, NUTRIENTS, V7, P5816, DOI 10.3390/nu7075255; Whitton C, 2011, BRIT J NUTR, V106, P1899, DOI 10.1017/S0007114511002340; World Health Organisation, 2015, GUID SUG ADULTS CHIL; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454	36	14	14	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179508	10.1371/journal.pone.0179508	http://dx.doi.org/10.1371/journal.pone.0179508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723954	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000406067800004
J	Nakamoto, K; Aizawa, F; Miyagi, K; Yamashita, T; Mankura, M; Koyama, Y; Kasuya, F; Hirasawa, A; Kurihara, T; Miyata, A; Tokuyama, S				Nakamoto, Kazuo; Aizawa, Fuka; Miyagi, Kei; Yamashita, Takuya; Mankura, Mitsumasa; Koyama, Yutaka; Kasuya, Fumiyo; Hirasawa, Akira; Kurihara, Takashi; Miyata, Atsuro; Tokuyama, Shogo			Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice	PLOS ONE			English	Article							ACID RECEPTOR GPR40; NEUROPATHIC PAIN; FATTY-ACIDS; DESCENDING CONTROL; ACTIVATION; MOUSE; SENSITIZATION; INVOLVEMENT; TRANSITION; NEURONS	We previously showed that activation of G protein-coupled receptor 40/free fatty acid receptor 1 (GPR40/FFAR1) signaling modulates descending inhibition of pain. In this study, we investigated the involvement of fatty acid-GPR40/FFAR1 signaling in the transition from acute to chronic pain. We used GPR40/FFAR1-knockout (GPR40KO) mice and wild-type (WT) mice. A plantar incision was performed, and mechanical allodynia and thermal hyperalgesia were evaluated with a von Frey filament test and plantar test, respectively. Immunohistochemistry was used to localize GPR40/FFAR1, and the levels of free fatty acids in the hypothalamus were analyzed with liquid chromatography-tandem mass spectrometry. The repeated administration of GW1100, a GPR40/FFAR1 antagonist, exacerbated the incisioninduced mechanical allodynia and significantly increased the levels of phosphorylated extracellular signal-regulated kinase in the spinal cord after low-threshold touch stimulation in the mice compared to vehicle-treated mice. The levels of long-chain free fatty acids, such as docosahexaenoic acid, oleic acid, and palmitate, which are GPR40/FFAR1 agonists, were significantly increased in the hypothalamus two days after the surgery compared to levels in the sham group. Furthermore, the incision-induced mechanical allodynia was exacerbated in the GPR40KO mice compared to the WT mice, while the response in the plantar test was not changed. These findings suggested that dysfunction of the GPR40/FFAR1 signaling pathway altered the endogenous pain control system and that this dysfunction might be associated with the development of chronic pain.	[Nakamoto, Kazuo; Aizawa, Fuka; Miyagi, Kei; Tokuyama, Shogo] Kobe Gakuin Univ, Dept Clin Pharm, Sch Pharmaceut Sci, Chuo Ku, Kobe, Hyogo, Japan; [Yamashita, Takuya; Kasuya, Fumiyo] Kobe Gakuin Univ, Biochem Toxicol Lab, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo, Japan; [Mankura, Mitsumasa] Kurashiki Sakuyo Univ, Fac Food Culture, Kurashiki, Okayama, Japan; [Koyama, Yutaka] Osaka Ohtani Univ, Fac Pharm, Lab Pharmacol, Tondabayashi, Osaka, Japan; [Hirasawa, Akira] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto, Japan; [Kurihara, Takashi; Miyata, Atsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pharmacol, Kagoshima, Japan	Kobe Gakuin University; Kobe Gakuin University; Kyoto University; Kagoshima University	Tokuyama, S (corresponding author), Kobe Gakuin Univ, Dept Clin Pharm, Sch Pharmaceut Sci, Chuo Ku, Kobe, Hyogo, Japan.	stoku@pharm.kobegakuin.ac.jp			Takeda Science Foundation; Kobe Gakuin University Joint Research; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [16K15339, 17K08599] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobe Gakuin University Joint Research; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Part of this work was supported by the Takeda Science Foundation, by Grants-in-Aid and Special Coordination Funds from the Kobe Gakuin University Joint Research (A), and a Grant-in-Aid for Scientific Research (C) (15K10566) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Aizawa F, 2016, BIOL PHARM BULL, V39, P1100, DOI 10.1248/bpb.b15-01037; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5744, DOI 10.1111/bph.13348; Boneva NB, 2012, HIPPOCAMPUS, V22, P896, DOI 10.1002/hipo.20951; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Campillo A, 2011, EUR J PHARMACOL, V657, P89, DOI 10.1016/j.ejphar.2011.01.059; Corder G, 2013, SCIENCE, V341, P1394, DOI 10.1126/science.1239403; Gao YJ, 2010, J NEUROCHEM, V115, P505, DOI 10.1111/j.1471-4159.2010.06946.x; Gingrich JA, 2000, CURR OPIN NEUROBIOL, V10, P146, DOI 10.1016/S0959-4388(99)00061-6; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12, DOI 10.1111/j.1476-5381.1957.tb01354.x; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; JENSEN TS, 1985, PAIN, V21, P267, DOI 10.1016/0304-3959(85)90090-9; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Karki P, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0003-8; Katz J, 2009, EXPERT REV NEUROTHER, V9, P723, DOI 10.1586/ERN.09.20; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Li CS, 2014, J NEUROSCI, V34, P13737, DOI 10.1523/JNEUROSCI.2130-14.2014; Ma D, 2008, HIPPOCAMPUS, V18, P326, DOI 10.1002/hipo.20393; Ma D, 2007, NEUROSCI RES, V58, P394, DOI 10.1016/j.neures.2007.05.001; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Mifflin KA, 2014, CAN J ANESTH, V61, P112, DOI 10.1007/s12630-013-0087-4; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Nakamoto K, 2015, BRIT J PHARMACOL, V172, P1250, DOI 10.1111/bph.13003; Nakamoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081563; Nakamoto K, 2012, BRAIN RES, V1432, P74, DOI 10.1016/j.brainres.2011.11.012; Nakamoto K, 2010, BIOL PHARM BULL, V33, P1070, DOI 10.1248/bpb.33.1070; Nishinaka T, 2014, J PHARMACOL SCI, V125, P112, DOI 10.1254/jphs.14001SC; Pereira MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134441; Pogatzki EM, 2003, ANESTHESIOLOGY, V99, P1023, DOI 10.1097/00000542-200310000-00041; Taylor Bradley K, 2014, Curr Top Behav Neurosci, V20, P283, DOI 10.1007/7854_2014_351; Thomas T, 1998, PAIN, V75, P177, DOI 10.1016/S0304-3959(97)00218-2; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07.004; Walwyn WM, 2016, J NEUROSCI, V36, P204, DOI 10.1523/JNEUROSCI.1751-15.2016; Woolf CJ, 2010, J CLIN INVEST, V120, P3742, DOI 10.1172/JCI45178; Yalcin I, 2011, BIOL PSYCHIAT, V70, P946, DOI 10.1016/j.biopsych.2011.07.017; Yamashima T, 2015, PROG LIPID RES, V58, P40, DOI 10.1016/j.plipres.2015.01.002; Zamarbide M, 2014, HIPPOCAMPUS, V24, P733, DOI 10.1002/hipo.22263	39	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180610	10.1371/journal.pone.0180610	http://dx.doi.org/10.1371/journal.pone.0180610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723961	Green Submitted, gold, Green Published			2022-12-27	WOS:000406067800020
J	Bell, KE; Snijders, T; Zulyniak, M; Kumbhare, D; Parise, G; Chabowski, A; Phillips, SM				Bell, Kirsten E.; Snijders, Tim; Zulyniak, Michael; Kumbhare, Dinesh; Parise, Gianni; Chabowski, Adrian; Phillips, Stuart M.			A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; IMPROVES MUSCULAR PERFORMANCE; FAT-FREE MASS; SKELETAL-MUSCLE; CREATINE SUPPLEMENTATION; RESISTANCE EXERCISE; WEIGHT-LOSS; ADULTS; INTERVENTIONS; LEUCINE	Protein and other compounds can exert anabolic effects on skeletal muscle, particularly in conjunction with exercise. The objective of this study was to evaluate the efficacy of twice daily consumption of a protein-based, multi-ingredient nutritional supplement to increase strength and lean mass independent of, and in combination with, exercise in healthy older men. Forty-nine healthy older men (age: 73 +/- 1 years [mean +/- SEM]; BMI: 28.5 +/- 1.5 kg/m(2)) were randomly allocated to 20 weeks of twice daily consumption of either a nutritional supplement (SUPP; n = 25; 30 g whey protein, 2.5 g creatine, 500 IU vitamin D, 400 mg calcium, and 1500 mg n-3 PUFA with 700 mg as eicosapentanoic acid and 445 mg as docosahexanoic acid); or a control (n = 24; CON; 22 g of maltodextrin). The study had two phases. Phase 1 was 6 weeks of SUPP or CON alone. Phase 2 was a 12 week continuation of the SUPP/CON but in combination with exercise: SUPP + EX or CON + EX. Isotonic strength (one repetition maximum [1RM]) and lean body mass (LBM) were the primary outcomes. In Phase 1 only the SUPP group gained strength (Sigma 1RM, SUPP: +14 +/- 4 kg, CON: +3 +/- 2 kg, P < 0.001) and lean mass (LBM, + 1.2 +/- 0.3 kg, CON: -0.1 +/- 0.2 kg, P < 0.001). Although both groups gained strength during Phase 2, upon completion of the study upper body strength was greater in the SUPP group compared to the CON group (Sigma upper body 1RM: 119 +/- 4 vs. 109 +/- 5 kg, P = 0.039). We conclude that twice daily consumption of a multi-ingredient nutritional supplement increased muscle strength and lean mass in older men. Increases in strength were enhanced further with exercise training.	[Bell, Kirsten E.; Snijders, Tim; Parise, Gianni; Phillips, Stuart M.] McMaster Univ, Exercise Metab Res Grp, Dept Kinesiol, Hamilton, ON, Canada; [Snijders, Tim] Maastricht Univ, NUTRIM, Dept Human Biol & Movement Sci, Med Ctr, Maastricht, Netherlands; [Zulyniak, Michael; Kumbhare, Dinesh] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Chabowski, Adrian] Med Univ Bialystok, Dept Physiol, Bialystok, Poland	McMaster University; Maastricht University; McMaster University; Medical University of Bialystok	Phillips, SM (corresponding author), McMaster Univ, Exercise Metab Res Grp, Dept Kinesiol, Hamilton, ON, Canada.	phillis@mcmaster.ca	Snijders, Tim/U-4155-2017; Phillips, Stuart/B-2343-2009; Chabowski, Adrian/T-2225-2018	Snijders, Tim/0000-0002-5874-1245; Phillips, Stuart/0000-0002-1956-4098; Chabowski, Adrian/0000-0002-7407-8156; Zulyniak, Michael/0000-0003-4944-5521; Kumbhare, Dinesh/0000-0003-3889-7557	Labarge Optimal Aging Initiative from McMaster University; Canadian Institutes of Health Research (CIHR) [MOP 123296]; CIHR Canada Graduate Scholarship (CGS-D)	Labarge Optimal Aging Initiative from McMaster University; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canada Graduate Scholarship (CGS-D)	This work was supported by funding from the Labarge Optimal Aging Initiative from McMaster University (to GP) and a Canadian Institutes of Health Research (CIHR) grant (MOP 123296) to SMP. KEB was supported by a CIHR Canada Graduate Scholarship (CGS-D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AF, 2013, EUR J APPL PHYSIOL, V113, P987, DOI 10.1007/s00421-012-2514-6; ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; Bell KE, 2016, J FRALITY AGING, V5, P33, DOI 10.14283/jfa.2016.78; Bell KE, 2015, J GERONTOL A-BIOL, V70, P1024, DOI 10.1093/gerona/glu313; Bermon S, 1998, ACTA PHYSIOL SCAND, V164, P147, DOI 10.1046/j.1365-201X.1998.00427.x; Bradley NS, 1985, J APPL PHYSIOL, V104, P2008; Candow DG, 2008, MED SCI SPORT EXER, V40, P1645, DOI 10.1249/MSS.0b013e318176b310; Cermak NM, 2012, AM J CLIN NUTR, V96, P1454, DOI 10.3945/ajcn.112.037556; Cornelissen Veronique A., 2005, Journal of Hypertension, V23, P251; Curtis E, 2015, J CELL PHYSIOL, V230, P2618, DOI 10.1002/jcp.25001; Da Boit M, 2016, AM J CLIN NUTR; Dawson-Hughes B, 2012, P NUTR SOC, V71, P46, DOI 10.1017/S0029665111003260; de Labra Carmen, 2015, BMC Geriatr, V15, P154, DOI 10.1186/s12877-015-0155-4; Devries MC, 2014, MED SCI SPORT EXER, V46, P1194, DOI 10.1249/MSS.0000000000000220; Dhesi JK, 2004, AGE AGEING, V33, P589, DOI 10.1093/ageing/afh209; Dirks ML, 2016, DIABETES, V65, P2862, DOI 10.2337/db15-1661; Elobeid MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006624; Farsijani S, 2016, AM J CLIN NUTR, V104, P694, DOI 10.3945/ajcn.116.130716; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; Finger D, 2015, SPORTS MED, V45, P245, DOI 10.1007/s40279-014-0269-4; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038; Fuller JC, 2011, JPEN-PARENTER ENTER, V35, P757, DOI 10.1177/0148607111413903; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Gotshalk LA, 2002, MED SCI SPORT EXER, V34, P537, DOI 10.1097/00005768-200203000-00023; Hwang CL, 2016, EXP GERONTOL, V82, P112, DOI 10.1016/j.exger.2016.06.009; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Kikuchi N, 2016, J STRENGTH COND RES, V30, P2318, DOI 10.1519/JSC.0000000000001315; Komar B, 2015, J NUTR HEALTH AGING, V19, P437, DOI 10.1007/s12603-014-0559-4; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; MAHADEVAPPA VG, 1987, J LIPID RES, V28, P1275; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MAYHEW JL, 1995, J SPORT MED PHYS FIT, V35, P108; Moon Anna, 2013, Curr Aging Sci, V6, P251; Murphy CH, 2016, J FRALITY AGING, V5, P49, DOI 10.14283/jfa.2016.80; Naclerio F, 2016, SPORTS MED, V46, P125, DOI 10.1007/s40279-015-0403-y; Nawrocki A, 2004, HORM METAB RES, V36, P601, DOI 10.1055/s-2004-825922; Peterson MD, 2011, MED SCI SPORT EXER, V43, P249, DOI 10.1249/MSS.0b013e3181eb6265; Rantanen Taina, 2002, Aging Clin Exp Res, V14, P10; Rodacki CLN, 2012, AM J CLIN NUTR, V95, P428, DOI 10.3945/ajcn.111.021915; Rondanelli M, 2016, AM J CLIN NUTR, V103, P830, DOI 10.3945/ajcn.115.113357; Sirven N, 2017, AGING CLIN EXP RES; Smith GI, 2015, AM J CLIN NUTR, V102, P115, DOI 10.3945/ajcn.114.105833; Smith GI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001875; Storen O, 2016, MED SCI SPORTS EXERC; Strasser B, 2010, SPORTS MED, V40, P397, DOI 10.2165/11531380-000000000-00000; Thomas DK, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.07.002; Tomlinson PB, 2015, J SCI MED SPORT, V18, P575, DOI 10.1016/j.jsams.2014.07.022; Verdijk LB, 2009, AM J CLIN NUTR, V89, P608, DOI 10.3945/ajcn.2008.26626; Verlaan S, 2017, CLIN NUTR; Verreijen AM, 2015, AM J CLIN NUTR, V101, P279, DOI 10.3945/ajcn.114.090290; Vincent KR, 2002, ARCH INTERN MED, V162, P673, DOI 10.1001/archinte.162.6.673; Wall BT, 2013, AGEING RES REV, V12, P898, DOI 10.1016/j.arr.2013.07.003; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P367, DOI 10.1007/s00198-015-3386-5; Xu ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109141; Zhu K, 2015, J NUTR, V145, P2520, DOI 10.3945/jn.115.218297	57	67	68	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181387	10.1371/journal.pone.0181387	http://dx.doi.org/10.1371/journal.pone.0181387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3RW	28719669	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400045
J	Kang, MJ; Lee, JK; Kang, JW				Kang, Min-Joo; Lee, Jung-Kyung; Kang, Je-Won			Combining random forest with multi-block local binary pattern feature selection for multiclass head pose estimation	PLOS ONE			English	Article							FACE RECOGNITION; CLASSIFICATION	A new head pose estimation technique based on Random Forest (RF) and texture features for facial image analysis using a monocular camera is proposed in this paper, especially about how to efficiently combine the random forest and the features. In the proposed technique a randomized tree with useful attributes is trained to improve estimation accuracy and tolerance of occlusions and illumination. Specifically, a number of features Including Multi-scale Block Local Block Pattern (MB-LBP) are extracted from an Image, and random features such as the MB-LBP scale parameters, a block coordinate, and a layer of an Image pyramid in the feature pool are used for training the tree. The randomized tree aims to maximize the Information gain at each node while random samples traverse the nodes in the tree. To this aim, a split function considering the uniform property of the LBP feature is developed to move sample blocks to the left or the right children nodes. The trees are Independently trained with random Inputs, yet they are grouped to form a random forest so that the results collected from the trees are used for make the final decision. Precisely, we use a Maximum-A-Posteriori criterion in the decision. It Is demonstrated with experimental results that the proposed technique provides significantly enhanced classification performance in the head pose estimation In various conditions of Illumination, poses, expressions, and facial occlusions.	[Kang, Min-Joo; Lee, Jung-Kyung; Kang, Je-Won] Ewha W Univ, Dept Elect Engn, Seoul, South Korea	Ewha Womans University	Kang, JW (corresponding author), Ewha W Univ, Dept Elect Engn, Seoul, South Korea.	jewonk@ewha.ac.kr	Kang, Jewon/AAU-9722-2020		Technology Advancement Research Program (TARP) - Ministry of Land, Infrastructure and Transport of Korean government [16CTAP-C114986-01]	Technology Advancement Research Program (TARP) - Ministry of Land, Infrastructure and Transport of Korean government(Ministry of Land, Infrastructure & Transport (MOLIT), Republic of Korea)	This research was supported by a grant (16CTAP-C114986-01) from Technology Advancement Research Program (TARP) funded by Ministry of Land, Infrastructure and Transport of Korean government.	Ahn B, 2014, REAL TIME HEAD ORIEN; Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Balasubramanian NV, COMPUTER VISION PATT; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen L, WORKSH AN MOD FAC GE; Cheng QA, 2011, IEEE T PATTERN ANAL, V33, P1217, DOI 10.1109/TPAMI.2010.195; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Cuturi LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056862; Drouard V, INT C IM PROC ICIP 2; Fanelli G, COMPUTER VISION PATT; Gottumukkal R, 2004, PATTERN RECOGN LETT, V25, P429, DOI 10.1016/j.patrec.2003.11.005; Gourier N, INT WORKSH VIS OBS D; Guo G, 2008, P 19 INT C PATT REC; Guo GD, 2005, IEEE T SYST MAN CY B, V35, P477, DOI 10.1109/TSMCB.2005.846658; Guyon I, 2010, J MACH LEARN RES, V11, P61; Haj M, CVPR 2012; Han B, 2014, PATTERN RECOGN LETT, V45, P145, DOI 10.1016/j.patrec.2014.03.017; Heisele B, 2003, COMPUT VIS IMAGE UND, V91, P6, DOI 10.1016/S1077-3142(03)00073-0; Huang C, INT C PATT REC 2010; Huang D, 2011, IEEE T SYST MAN CY C, V41, P765, DOI 10.1109/TSMCC.2011.2118750; Jain A, 2014, COMPUTER VISION PATT; Kim H, 2014, HUM-CENT COMPUT INFO, V4, DOI 10.1186/s13673-014-0009-7; Koestinger M, IEEE INT WORKSH BENC; Ksander N, 2015, PLOS ONE; Lee D, IEEE INT C COMP VIS; Lee K, COMPUTER VISION PATT; Li Y, 2010, INT C IM PROC ICIP; Ma B, 2006, P INT C PATT REC; Matsumoto Y, 2000, AUT FACE GESTURES RE; Min S, 2012, COMPUTER VISION PATT; Ming Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124640; Moore S, 2011, COMPUT VIS IMAGE UND, V115, P541, DOI 10.1016/j.cviu.2010.12.001; Murphy-Chutorian E, 2009, IEEE T PATTERN ANAL, V31, P607, DOI 10.1109/TPAMI.2008.106; Niese R, 2013, IEEE INT C SYST MAN; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Peng X, 2015, IEEE INT CONF AUTOMA; Saeed A, 2015, INT C IM PROC ICIP; Sagonas C, 2016, 300 FACES WILD CHALL; Storer M, WORKSH SUBSP METH; Taigman Y, COMPUTER VISION PATT; Taigman Y, CVPR 2012; Tan XY, 2010, IEEE T IMAGE PROCESS, V19, P1635, DOI 10.1109/TIP.2010.2042645; Valenti R, 2012, IEEE T IMAGE PROCESS, V21, P802, DOI 10.1109/TIP.2011.2162740; Valle R, 2016, HEAD POSE ESTIMATION; Vatahska T, 2007, HUMANOIDS; Wang T, SPIE P 2003; Wang Y, 2015, PLOS ONE; Yang J, INT C PATT REC 2012; Zhu XX, 2012, PROC CVPR IEEE, P2879, DOI 10.1109/CVPR.2012.6248014	51	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180792	10.1371/journal.pone.0180792	http://dx.doi.org/10.1371/journal.pone.0180792			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DJ	28715442	Green Published, Green Submitted, gold			2022-12-27	WOS:000413664500001
J	Kim, HS; Kim, JH; Yoon, YC; Choe, BK				Kim, Hyun Su; Kim, Jae-Hun; Yoon, Young Cheol; Choe, Bong Keun			Tumor spatial heterogeneity in myxoid-containing soft tissue using texture analysis of diffusion-weighted MRI	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; FEATURES; CLASSIFICATION; COEFFICIENT; BENIGN; IMAGES	The objective of this study was to examine the tumor spatial heterogeneity in myxoid-containing soft-tissue tumors (STTs) using texture analysis of diffusion-weighted imaging (DWI). A total of 40 patients with myxoid-containing STTs (23 benign and 17 malignant) were included in this study. The region of interest (ROI) was manually drawn on the apparent diffusion coefficient (ADC) map. For texture analysis, the global (mean, standard deviation, skewness, and kurtosis), regional (intensity variability and size-zone variability), and local features (energy, entropy, correlation, contrast, homogeneity, variance, and maximum probability) were extracted from the ADC map. Student's t-test was used to test the difference between group means. Analysis of covariance (ANCOVA) was performed with adjustments for age, sex, and tumor volume. The receiver operating characteristic (ROC) analysis was performed to compare diagnostic performances. Malignant myxoid-containing STTs had significantly higher kurtosis (P = 0.040), energy (P = 0.034), correlation (P<0.001), and homogeneity (P = 0.003), but significantly lower contrast (P<0.001) and variance (P = 0.001) compared with benign myxoid-containing STTs. Contrast showed the highest area under the curve (AUC = 0.923, P<0.001), sensitivity (94.12%), and specificity (86.96%). Our results reveal the potential utility of texture analysis of ADC maps for differentiating benign and malignant myxoid-containing STTs.	[Kim, Hyun Su; Kim, Jae-Hun; Yoon, Young Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, 50 Irwon Dong, Seoul, South Korea; [Choe, Bong Keun] Kyung Hee Univ, Dept Prevent Med, Med Coll, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University	Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, 50 Irwon Dong, Seoul, South Korea.	jaehun.kim78@gmail.com	Yoon, Young Cheol/AAG-4310-2020; Yoon, Young Cheol/AAG-4301-2020; Choe, Bong Keun/AAJ-2060-2020	Yoon, Young Cheol/0000-0002-7822-5344; , Bong Keun/0000-0002-1379-5936; Kim, Jae-Hun/0000-0003-3064-6948; Kim, Hyun Su/0000-0002-0179-9542	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01056845]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01056845).	Baheti AD, 2015, AM J ROENTGENOL, V204, P374, DOI 10.2214/AJR.14.12888; Brynolfsson P, 2014, MED PHYS, V41, DOI 10.1118/1.4894812; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Du J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001028; Einarsdottir H, 2004, EUR RADIOL, V14, P959, DOI 10.1007/s00330-004-2237-0; Genovese E, 2011, RADIOL MED, V116, P644, DOI 10.1007/s11547-011-0666-9; Georgiadis P, 2009, MAGN RESON IMAGING, V27, P120, DOI 10.1016/j.mri.2008.05.017; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hwang IP, 2015, INVEST RADIOL, V50, P798, DOI 10.1097/RLI.0000000000000186; Juntu J, 2010, J MAGN RESON IMAGING, V31, P680, DOI 10.1002/jmri.22095; Kierans AS, 2013, J MAGN RESON IMAGING, V37, P164, DOI 10.1002/jmri.23794; Ko ES, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002453; Lee SY, 2015, EUR RADIOL; Maeda M, 2007, J MAGN RESON IMAGING, V25, P1199, DOI 10.1002/jmri.20931; Mayerhoefer ME, 2008, MAGN RESON IMAGING, V26, P1316, DOI 10.1016/j.mri.2008.02.013; Nagata S, 2008, RADIAT MED, V26, P287, DOI 10.1007/s11604-008-0229-8; Nie K, 2008, ACAD RADIOL, V15, P1513, DOI 10.1016/j.acra.2008.06.005; Pilavaki M, 2004, EUR J RADIOL, V52, P229, DOI 10.1016/j.ejrad.2003.12.001; Subhawong TK, 2014, AM J ROENTGENOL, V203, P560, DOI 10.2214/AJR.13.12165; SUH JS, 1992, RADIOLOGY, V183, P341, DOI 10.1148/radiology.183.2.1561333; Suo S, 2015, J MAGN RESON IMAGING; Thibault G., 2009, PATTERN RECOGNIT INF, V2009, P140; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Tourassi GD, 1999, RADIOLOGY, V213, P317, DOI 10.1148/radiology.213.2.r99nv49317; van Rijswijk CSP, 2002, J MAGN RESON IMAGING, V15, P302, DOI 10.1002/jmri.10061; van Roggen JFG, 1999, HISTOPATHOLOGY, V35, P291; Waugh SA, 2016, EUR RADIOL, V26, P322, DOI 10.1007/s00330-015-3845-6; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147	28	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181339	10.1371/journal.pone.0181339	http://dx.doi.org/10.1371/journal.pone.0181339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708850	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649800056
J	Barbosa, AD; Gofton, AW; Paparini, A; Codello, A; Greay, T; Gillett, A; Warren, K; Irwin, P; Ryan, U				Barbosa, Amanda D.; Gofton, Alexander W.; Paparini, Andrea; Codello, Annachiara; Greay, Telleasha; Gillett, Amber; Warren, Kristin; Irwin, Peter; Ryan, Una			Increased genetic diversity and prevalence of co-infection with Trypanosoma spp. in koalas (Phascolarctos cinereus) and their ticks identified using next-generation sequencing (NGS)	PLOS ONE			English	Article							BRUSH-TAILED BETTONG; 18S RIBOSOMAL-RNA; COPEMANI; TRANSMISSION; GENOTYPES; REVEALS; MAMMALS; DISEASE; DESIGN; PARVUM	Infections with Trypanosoma spp. have been associated with poor health and decreased survival of koalas (Phascolarctos cinereus), particularly in the presence of concurrent pathogens such as Chlamydia and koala retrovirus. The present study describes the application of a next-generation sequencing (NGS)-based assay to characterise the prevalence and genetic diversity of trypanosome communities in koalas and two native species of ticks (Ixodes holocyclus and I. tasmani) removed from koala hosts. Among 168 koalas tested, 32.2% (95% CI: 25.2-39.8%) were positive for at least one Trypanosoma sp. Previously described Trypanosoma spp. from koalas were identified, including T. irwini (32.1%, 95% CI: 25.2-39.8%), T. gilletti (25%, 95% CI: 18.7-32.3%), T. copemani (27.4%, 95% CI: 20.8-34.8%) and T. vegrandis (10.1%, 95% CI: 6.0-15.7%). Trypanosoma noyesi was detected for the first time in koalas, although at a low prevalence (0.6% 95% CI: 0-3.3%), and a novel species (Trypanosoma sp. AB-2017) was identified at a prevalence of 4.8% (95% CI: 2.1-9.2%). Mixed infections with up to five species were present in 27.4% (95% CI: 21-35%) of the koalas, which was significantly higher than the prevalence of single infections 4.8% (95% CI: 2-9%). Overall, a considerably higher proportion (79.7%) of the Trypanosoma sequences isolated from koala blood samples were identified as T. irwini, suggesting this is the dominant species. Co-infections involving T. gilletti, T. irwini, T. copemani, T. vegrandis and Trypanosoma sp. AB-2017 were also detected in ticks, with T. gilletti and T. copemani being the dominant species within the invertebrate hosts. Direct Sanger sequencing of Trypanosoma 18S rRNA gene amplicons was also performed and results revealed that this method was only able to identify the genotypes with greater amount of reads (according to NGS) within koala samples, which highlights the advantages of NGS in detecting mixed infections. The present study provides new insights on the natural genetic diversity of Trypanosoma communities infecting koalas and constitutes a benchmark for future clinical and epidemiological studies required to quantify the contribution of trypanosome infections on koala survival rates.	[Barbosa, Amanda D.; Gofton, Alexander W.; Paparini, Andrea; Codello, Annachiara; Greay, Telleasha; Warren, Kristin; Irwin, Peter; Ryan, Una] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Barbosa, Amanda D.] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Gillett, Amber] Australia Zoo Wildlife Hosp, Beerwah, Qld, Australia; [Gillett, Amber] Univ Queensland, Sch Vet Sci, St Lucia, Qld, Australia	Murdoch University; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); University of Queensland	Barbosa, AD (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.; Barbosa, AD (corresponding author), Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil.	A.DuarteBarbosa@murdoch.edu.au	Gofton, Alexander W/GOJ-8010-2022; Paparini, Andrea/T-8057-2019; Greay, Telleasha/AAZ-4424-2020	Gofton, Alexander W/0000-0002-5039-6117; Greay, Telleasha/0000-0002-0051-2642; Duarte Barbosa, Amanda/0000-0003-3289-1445; Warren, Kristin/0000-0002-9328-2013; Paparini, Andrea/0000-0002-1105-5184; Ryan, Una/0000-0003-2710-9324				Austen JM, 2015, EXP PARASITOL, V153, P105, DOI 10.1016/j.exppara.2015.03.022; Austen JM, 2011, PARASITOLOGY, V138, P866, DOI 10.1017/S0031182011000497; BACKHOUSE TC, 1951, T ROY SOC TROP MED H, V44, P521, DOI 10.1016/0035-9203(51)90032-6; Barbosa A, 2017, VET PARASITOL, V238, P94, DOI 10.1016/j.vetpar.2017.04.007; Barbosa A, 2016, PARASITOL INT, V65, P316, DOI 10.1016/j.parint.2016.03.004; Barbosa AD, 2016, VET PARASITOL, V223, P214, DOI 10.1016/j.vetpar.2016.05.002; Barker SC, 2014, ZOOTAXA, V3816, P1, DOI 10.11646/zootaxa.3816.1.1; Begolo D, 2014, ANTIMICROB AGENTS CH, V58, P6260, DOI 10.1128/AAC.03338-14; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bordbar B, 2014, INFECT GENET EVOL, V25, P81, DOI 10.1016/j.meegid.2014.04.010; Botero A, 2016, PROTIST, V167, P425, DOI 10.1016/j.protis.2016.07.002; Botero Adriana, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P77, DOI 10.1016/j.ijppaw.2013.03.001; Bradley IM, 2016, APPL ENVIRON MICROB, V82, P5878, DOI 10.1128/AEM.01630-16; Bunnik EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r128; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlton JM, 2013, ADV PARASIT, V81, P203, DOI 10.1016/B978-0-12-407826-0.00005-9; Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Cheng WS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2106-z; Cooper C, 2016, ADV PARASIT IN PRESS; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fantin YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054835; Grinberg A, 2013, INFECT GENET EVOL, V15, P18, DOI 10.1016/j.meegid.2012.08.017; Hamilton PB, 2011, TRENDS PARASITOL, V27, P99, DOI 10.1016/j.pt.2010.11.009; Hester J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002569; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leprohon P, 2015, INT J PARASITOL-DRUG, V5, P26, DOI 10.1016/j.ijpddr.2014.09.005; MACKERRAS M. JOSEPHINE, 1959, AUSTRALIAN JOUR ZOOL, V7, P105, DOI 10.1071/ZO9590105; Mackie JT, 2017, AUSTR VET J IN PRESS; Maslov DA, 1996, MOL BIOCHEM PARASIT, V75, P197, DOI 10.1016/0166-6851(95)02526-X; McAlpine C, 2015, BIOL CONSERV, V192, P226, DOI 10.1016/j.biocon.2015.09.020; McInnes LM, 2011, PARASITOLOGY, V138, P873, DOI 10.1017/S0031182011000369; McInnes LM, 2011, PARASITOLOGY, V138, P59, DOI 10.1017/S0031182010000971; McInnes LM, 2009, PARASITOLOGY, V136, P875, DOI 10.1017/S0031182009006313; Paparini A, 2017, PARASITOLOG IN PRESS; Paparini A, 2015, EXP PARASITOL, V151, P21, DOI 10.1016/j.exppara.2015.02.001; Paparini A, 2012, EXP PARASITOL, V131, P404, DOI 10.1016/j.exppara.2012.05.009; Paparini A, 2011, VET PARASITOL, V183, P21, DOI 10.1016/j.vetpar.2011.07.009; Park JW, 2010, J ENVIRON MONITOR, V12, P985, DOI 10.1039/b924160d; Pickering Jane, 1996, Australian Mammalogy, V19, P19; Pollitt LC, 2011, TRENDS PARASITOL, V27, P197, DOI 10.1016/j.pt.2011.01.004; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reifenberg JM, 1997, MED VET ENTOMOL, V11, P246, DOI 10.1111/j.1365-2915.1997.tb00402.x; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Rhodes JR., 2015, S E QUEENSLAND KOALA; Roberts F.H.S., 1970, AUSTR TICKS; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson CK, 2015, TRENDS PARASITOL, V31, P553, DOI 10.1016/j.pt.2015.06.011; Thompson CK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-169; Vermeulen ET, 2016, J MICROBIOL METH, V124, P1, DOI 10.1016/j.mimet.2016.02.018; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Yang RC, 2013, EXP PARASITOL, V135, P142, DOI 10.1016/j.exppara.2013.06.014; Zahedi A, 2017, INT J PARAS IN PRESS	58	25	25	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181279	10.1371/journal.pone.0181279	http://dx.doi.org/10.1371/journal.pone.0181279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704541	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700119
J	Chao, AC; Han, K; Chang, FC; Hsu, HY; Chung, CP; Sheng, WY; Chan, L; Wu, J; Hu, HH				Chao, A-Ching; Han, Ke; Chang, Feng-Chi; Hsu, Hung-Yi; Chung, Chih-Ping; Sheng, Wen-Yung; Chan, Lung; Wu, Jiang; Hu, Han-Hwa			Ultrasound diagnosis of transverse sinus hypoplasia using flow profiles of the internal jugular vein	PLOS ONE			English	Article							VENOUS INSUFFICIENCY; VENOGRAPHY; PATTERNS; SYSTEM; MR	Accurate diagnosis of subtypes of transverse sinus (TS) hypoplasia requires more expensive methods like magnetic resonance (MR) imaging. We hypothesized ultrasound findings of the internal jugular vein (IJV) can be surrogate indicators for diagnosis of TS hypoplasia. MR images were reviewed in 131 subjects to evaluate TS diameter and the location and degree of venous flow stenosis and obstruction. Ultrasound parameters including the crosssectional lumen area (CSA), time-average-mean velocity (TAMV), and flow volume (FV) at each IJV segment were also evaluated. Sixty-nine subjects had TS hypoplasia based on MRV criteria, of which 39 TS hypoplasia were considered a subtype of TS hypoplasia, which is secondary to the downstream venous compression/stenosis or left brachiocephalic vein. In the ultrasound study, the CSA of the IJV ipsilateral to TS hypoplasia was significantly smaller. Further, a contralateral/ipsilateral IJV CSA ratio > 1.55 provided good sensitivity, specificity, and positive predictive value for discriminating TS hypoplasia.	[Chao, A-Ching] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Chao, A-Ching] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Han, Ke; Wu, Jiang] Jilin Univ, Dept Neurol, Hosp 1, Changchun, Jilin, Peoples R China; [Han, Ke; Wu, Jiang] Jilin Univ, Neurosci Ctr, Hosp 1, Changchun, Jilin, Peoples R China; [Chang, Feng-Chi] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chang, Feng-Chi; Chung, Chih-Ping; Sheng, Wen-Yung] Natl Yang Ming Univ, Taipei, Taiwan; [Hsu, Hung-Yi] Tungs Taichung Metro Harbor Hosp, Dept Neurol, Taichung, Taiwan; [Chung, Chih-Ping; Sheng, Wen-Yung] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chan, Lung; Hu, Han-Hwa] Taipei Med Univ, Shaung Ho Hosp, Dept Neurol, Taipei, Taiwan; [Hu, Han-Hwa] Taipei Med Univ, Coll Med, Cerebrovasc Treatment & Res Ctr, Taipei, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Jilin University; Jilin University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University; Taipei Medical University	Han, K (corresponding author), Jilin Univ, Dept Neurol, Hosp 1, Changchun, Jilin, Peoples R China.; Han, K (corresponding author), Jilin Univ, Neurosci Ctr, Hosp 1, Changchun, Jilin, Peoples R China.; Hu, HH (corresponding author), Taipei Med Univ, Shaung Ho Hosp, Dept Neurol, Taipei, Taiwan.; Hu, HH (corresponding author), Taipei Med Univ, Coll Med, Cerebrovasc Treatment & Res Ctr, Taipei, Taiwan.	hanke2580@163.com; hanhwa@hotmail.com	Chan, Lung/AAM-3231-2021; Chan, Lung/AAI-6349-2020	Chan, Lung/0000-0001-5795-4460; Chung, Chih-Ping/0000-0001-9419-9070	Taiwan National Science Council [NSC: 101-2314-B-037-069-MY2]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Taiwan National Science Council (NSC: 101-2314-B-037-069-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva NL, 2008, TERAPEVT ARKH, V80, P50; [Anonymous], 2000, DSM 4 TR DIAGN STAT; Cheng CY, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-94; Chi HY, 2015, J ULTRAS MED, V34, P2043, DOI 10.7863/ultra.14.12065; Chung CP, 2010, ULTRASOUND MED BIOL, V36, P1776, DOI 10.1016/j.ultrasmedbio.2010.07.006; Fofi L, 2012, HEADACHE, V52, P1254, DOI 10.1111/j.1526-4610.2012.02154.x; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048245; Han K., 2015, THESIS; Han K, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002862; Han K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132893; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Kim BS, 2009, NEURORADIOLOGY, V51, P327, DOI 10.1007/s00234-009-0500-4; Krsmanovic Z, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-90; Lin CJ, 2014, AM J NEURORADIOL, V35, P1132, DOI 10.3174/ajnr.A3838; Liu MJ, 2015, J VASC SURG, V61, P1511, DOI 10.1016/j.jvs.2014.02.021; Saiki K, 2013, ANAT SCI INT, V88, P141, DOI 10.1007/s12565-013-0176-z; Tsao YC, 2014, J PSYCHIATR RES, V58, P155, DOI 10.1016/j.jpsychires.2014.07.026; Wilson MH, 2013, ANN NEUROL, V73, P381, DOI 10.1002/ana.23796; Yu WG, 2009, STROKE, V40, P3736, DOI 10.1161/STROKEAHA.109.563080; Zaharchuk G, 2011, AM J NEURORADIOL, V32, P1482, DOI 10.3174/ajnr.A2549; Zamboni P, 2011, INT ANGIOL, V30, P571; ZOUAOUI A, 1988, ACTA ANAT, V133, P318	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181119	10.1371/journal.pone.0181119	http://dx.doi.org/10.1371/journal.pone.0181119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704516	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700093
J	Ferrer-Albero, A; Godoy, EJ; Lozano, M; Martinez-Mateu, L; Atienza, F; Saiz, J; Sebastian, R				Ferrer-Albero, Ana; Godoy, Eduardo J.; Lozano, Miguel; Martinez-Mateu, Laura; Atienza, Felipe; Saiz, Javier; Sebastian, Rafael			Non-invasive localization of atrial ectopic beats by using simulated body surface P-wave integral maps	PLOS ONE			English	Article							CORONARY-SINUS; MODEL; DEPOLARIZATION; ANATOMY; TACHYCARDIA; ACTIVATION; ORIGIN; RHYTHM; ECG	Non-invasive localization of continuous atrial ectopic beats remains a cornerstone for the treatment of atrial arrhythmias. The lack of accurate tools to guide electrophysiologists leads to an increase in the recurrence rate of ablation procedures. Existing approaches are based on the analysis of the P-waves main characteristics and the forward body surface potential maps (BSPMs) or on the inverse estimation of the electric activity of the heart from those BSPMs. These methods have not provided an efficient and systematic tool to localize ectopic triggers. In this work, we propose the use of machine learning techniques to spatially cluster and classify ectopic atrial foci into clearly differentiated atrial regions by using the body surface P-wave integral map (BSPiM) as a biomarker. Our simulated results show that ectopic foci with similar BSPiM naturally cluster into differentiated non-intersected atrial regions and that new patterns could be correctly classified with an accuracy of 97% when considering 2 clusters and 96% for 4 clusters. Our results also suggest that an increase in the number of clusters is feasible at the cost of decreasing accuracy.	[Ferrer-Albero, Ana; Martinez-Mateu, Laura; Saiz, Javier] Univ Politecn Valencia, Ci2B, Valencia, Spain; [Godoy, Eduardo J.; Lozano, Miguel; Sebastian, Rafael] Univ Valencia, Dept Comp Sci, Computat Multiscale Physiol Lab CoMMLab, Valencia, Spain; [Atienza, Felipe] Hosp Gregorio Maranon, Madrid, Spain	Universitat Politecnica de Valencia; University of Valencia; General University Gregorio Maranon Hospital	Ferrer-Albero, A (corresponding author), Univ Politecn Valencia, Ci2B, Valencia, Spain.	anferal0@upvnet.upv.es	Godoy, Eduardo Jorge/AAP-7659-2020; Atienza, Felipe/H-9273-2016; Martinez-Mateu, Laura/AAB-2815-2020; Sebastian, Rafael/E-9386-2011; Saiz, Javier/I-1295-2015	Godoy, Eduardo Jorge/0000-0001-5625-2846; Atienza, Felipe/0000-0002-9596-7649; Martinez-Mateu, Laura/0000-0003-0291-7683; Sebastian, Rafael/0000-0001-6746-5740; Saiz, Javier/0000-0002-9850-0825	Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana [PROMETEU/2016/088]; Ministerio de Economia, Industria y Competitividad of Spain, Agencia Estatal de Investigacion; European Commission (European Regional Development Funds - ERDF -FEDER) [DPI2016-75799-R, TIN2014-59932-JIN]; Ministerio de Economia y Competitividad of Spain, Agencia Estatal de Investigacion	Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Ministerio de Economia, Industria y Competitividad of Spain, Agencia Estatal de Investigacion; European Commission (European Regional Development Funds - ERDF -FEDER); Ministerio de Economia y Competitividad of Spain, Agencia Estatal de Investigacion	This work was partially supported by The "Programa Prometeu" from Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana (www.edu.gva.es/fio/index_es.asp) Award Number: PROMETEU/2016/088 to JS; The "Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion 2013-2016" from the Ministerio de Economia, Industria y Competitividad of Spain, Agencia Estatal de Investigacion (www.mineco.gob.es) and the European Commission (European Regional Development Funds - ERDF -FEDER) (ec.europa.eu/regional_policy/es/funding/erdf/) Award Number: DPI2016-75799-R to JS and The "Programa Estatal de Investigacion, Desarrollo e Innovacion Orientado a los Retos de la Sociedad" from the Ministerio de Economia y Competitividad of Spain, Agencia Estatal de Investigacion (www.mineco.gob.es) and the European Commission (European Regional Development Funds - ERDF -FEDER) (ec.europa.eu/regional_policy/es/funding/erdf/) Award Number: TIN2014-59932-JIN to AFA and RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alday EAP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004026; Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Bishop C.M., 2006, PATTERNS RECOGNITION; Burdumy M, 2012, BIOMED ENG-BIOMED TE, V57, P79, DOI 10.1515/bmt-2011-0059; Cabrera JA, 2008, EUR HEART J, V29, P356, DOI 10.1093/eurheartj/ehm606; Chauvin M, 2000, CIRCULATION, V101, P647, DOI 10.1161/01.CIR.101.6.647; Cibc, 2013, SEG3D VOL IM SEGM VI; Colman MA, 2011, IEEE T BIO-MED ENG, V58, P2952, DOI 10.1109/TBME.2011.2161305; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Cuculich PS, 2010, CIRCULATION, V122, P1364, DOI 10.1161/CIRCULATIONAHA.110.945709; Deng DD, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/891070; Dossel O, 2012, MED BIOL ENG COMPUT, V50, P773, DOI 10.1007/s11517-012-0924-6; Ferrer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141573; Ferrer-Albero A, 2016, COLLECTED WORKS DW W, P1; Gerstenfeld EP, 2000, J ELECTROCARDIOL, V33, P179, DOI 10.1054/jelc.2000.20307; Giacopelli D, 2012, PACE, V35, P819, DOI 10.1111/j.1540-8159.2012.03428.x; Giffard-Roisin S, 2016, IEEE T BIOMED ENG, V9294, P1; Guillem MS, 2009, INT J BIOELECTROMAGN, V11, P22; Harrild D, 2000, ATRIAL MODEL; HARRIS BC, 1968, CIRCULATION, V37, P1000, DOI 10.1161/01.CIR.37.6.1000; Hartigan JA, 1989, CLUSTERING ALGORITHM; Heidenreich EA, 2010, ANN BIOMED ENG, V38, P2331, DOI 10.1007/s10439-010-9997-2; Ho SY, 2012, CIRC-ARRHYTHMIA ELEC, V5, P220, DOI 10.1161/CIRCEP.111.962720; Intini A, 2005, HEART RHYTHM, V2, P1250, DOI 10.1016/j.hrthm.2005.08.019; ISHIHARA H, 1987, JPN CIRC J, V51, P520, DOI 10.1253/jcj.51.520; Jacquemet V, 2015, COMPUT BIOL MED, V65, P192, DOI 10.1016/j.compbiomed.2015.06.007; KAWANO S, 1989, J ELECTROCARDIOL, V22, P27, DOI 10.1016/0022-0736(89)90021-6; KAWANO S, 1983, J ELECTROCARDIOL, V16, P151, DOI 10.1016/S0022-0736(83)80019-3; Keller DUJ, 2010, IEEE T BIO-MED ENG, V57, P1568, DOI 10.1109/TBME.2010.2046485; Kistler PM, 2006, J AM COLL CARDIOL, V48, P1010, DOI 10.1016/j.jacc.2006.03.058; Krueger MW, 2013, IEEE T MED IMAGING, V32, P73, DOI 10.1109/TMI.2012.2201948; Krueger MW, 2011, LECT NOTES COMPUT SC, V6666, P223, DOI 10.1007/978-3-642-21028-0_28; LEON DF, 1970, AM J CARDIOL, V25, P6, DOI 10.1016/0002-9149(70)90808-8; Lim Han S, 2015, Card Electrophysiol Clin, V7, P89, DOI 10.1016/j.ccep.2014.11.004; Lu WJ, 2011, ADV ENG SOFTW, V42, P463, DOI 10.1016/j.advengsoft.2011.03.015; MacLeod R, 1991, ENG MED, V13, P888; Maleckar MM, 2009, AM J PHYSIOL-HEART C, V297, pH1398, DOI 10.1152/ajpheart.00411.2009; Martinez L, 2016, COMPUT CARDIOL 2010, V42, P865; MASSUMI RA, 1969, AM J CARDIOL, V24, P28, DOI 10.1016/0002-9149(69)90047-2; McDowell KS, 2012, J ELECTROCARDIOL, V45, P640, DOI 10.1016/j.jelectrocard.2012.08.005; MIRVIS DM, 1980, CIRCULATION, V62, P167, DOI 10.1161/01.CIR.62.1.167; Niederer SA, 2011, PHILOS T R SOC A, V369, P4331, DOI 10.1098/rsta.2011.0139; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Reich Christian, 2016, Current Directions in Biomedical Engineering, V2, P161, DOI 10.1515/cdbme-2016-0037; Rudy Y., 1999, ANN NONINVAS ELECTRO, V4, P340, DOI DOI 10.1111/J.1542-474X.1999.TB00220.X; Sanchez-Quintana D, 2013, J CARDIOVASC TRANSL, V6, P124, DOI 10.1007/s12265-013-9447-2; Sanchez-Quintana D, 2012, CURR CARDIOL REV, V8, P310, DOI 10.2174/157340312803760721; Saremi F, 2011, RADIOLOGY, V260, P671, DOI 10.1148/radiol.11102278; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Si H, 2005, PROCEEDINGS OF THE 14TH INTERNATIONAL MESHING ROUNDTABLE, P147, DOI 10.1007/3-540-29090-7_9; SippensGroenewegen A, 2004, J ELECTROCARDIOL, V37, P47, DOI 10.1016/j.jelectrocard.2004.08.017; SippensGroenewegen A, 1998, J ELECTROCARDIOL, V31, P85, DOI 10.1016/S1053-0770(98)90298-1; Tobon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050883; Weber FM, 2011, IEEE T BIO-MED ENG, V58, P265, DOI 10.1109/TBME.2010.2090151	55	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181263	10.1371/journal.pone.0181263	http://dx.doi.org/10.1371/journal.pone.0181263			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704537	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649700117
J	Voissiere, A; Jouberton, E; Maubert, E; Degoul, F; Peyrode, C; Chezal, JM; Miot-Noirault, E				Voissiere, Aurelien; Jouberton, Elodie; Maubert, Elise; Degoul, Francoise; Peyrode, Caroline; Chezal, Jean-Michel; Miot-Noirault, Elisabeth			Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing	PLOS ONE			English	Article							HYPOXIA-ACTIVATED PRODRUG; SOFT-TISSUE SARCOMA; TUMOR MICROENVIRONMENT; CARTILAGE TUMORS; CELL-CULTURE; PHASE-II; MODELS; TH-302; SPHEROIDS; SAFETY	It has been suggested that chemoresistance of chondrosarcoma (CHS), the cartilage tumor, is caused by the phenotypic microenvironmental features of the tumor tissue, mainly the chondrogenic extracellular matrix (ECM), and hypoxia. We developed and characterized a multicellular tumor spheroid (MCTS) of human chondrosarcoma HEMC-SS cells to gain insight into tumor cell biology and drug response. At Day 7, HEMC-SS spheroids exhibited a homogeneous distribution of proliferative Ki-67 positive cells, whereas in larger spheroids (Day 14 and Day 20), proliferation was mainly localized in the periphery. In the core of larger spheroids, apoptotic cells were evidenced by TUNEL assay, and hypoxia by pimonidazole staining. Interestingly, VEGF excretion, evidenced by ELISA on culture media, was detectable from Day 14 spheroids, and increased as the spheroids grew in size. HEMC-SS spheroids synthesized a chondrogenic extracellular matrix rich in glycosaminoglycans and type-2 collagen. Finally, we investigated the sensitivity of Day 7 and Day 14 chondrosarcoma MCTS to hypoxia-activated prodrug TH-302 and doxorubicin compared with their 2D counterparts. As expected, TH-302 exhibited higher cytotoxic activity on larger hypoxic spheroids (Day 14) than on non-hypoxic spheroids (Day 7), with multicellular resistance index (MCRI) values of 7.7 and 9.1 respectively. For doxorubicin, the larger-sized spheroids exhibited higher drug resistance (MCRI of 5.0 for Day 7 and 18.3 for Day 14 spheroids), possibly due to impeded drug penetration into the deep layer of spheroids, evidenced by its auto-fluorescence property. We have developed a model of human chondrosarcoma MCTS that combines an ECM rich in glycosaminoglycans with a high hypoxic core associated with VEGF excretion. This model could offer a more predictive in vitro chondrosarcoma system for screening drugs targeting tumor cells and their microenvironment.	[Voissiere, Aurelien; Jouberton, Elodie; Maubert, Elise; Degoul, Francoise; Peyrode, Caroline; Chezal, Jean-Michel; Miot-Noirault, Elisabeth] Univ Clermont Auvergne, INSERM, Imagerie Mol & Strategies Theranost U1240, Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Voissiere, A (corresponding author), Univ Clermont Auvergne, INSERM, Imagerie Mol & Strategies Theranost U1240, Clermont Ferrand, France.	aurelien.voissiere@inserm.fr	Chezal, Jean-Michel/X-8474-2019; DEGOUL, Francoise/L-4856-2015; PEYRODE, Caroline/Y-3794-2019; DEGOUL, Francoise/Q-4745-2019; Miot-Noirault, Elisabeth/Y-2272-2019	DEGOUL, Francoise/0000-0002-0206-3350; DEGOUL, Francoise/0000-0002-0206-3350; Voissiere, Aurelien/0000-0001-7811-3919; PEYRODE, Caroline/0000-0002-0455-7047; CHEZAL, Jean-Michel/0000-0001-7162-8450	Ligue contre le cancer; PRT-k; Translational Cancer Research: INCa-DGOS, D-TECT [R15066CC/RPT15003CCA]	Ligue contre le cancer(Ligue nationale contre le cancer); PRT-k; Translational Cancer Research: INCa-DGOS, D-TECT	This work was supported by Ligue contre le cancer; PRT-k, Translational Cancer Research: INCa-DGOS, D-TECT project reference R15066CC/ RPT15003CCA	Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Benien P, 2014, FUTURE ONCOL, V10, P1311, DOI 10.2217/fon.13.274; Boeuf S, 2010, HISTOPATHOLOGY, V56, P641, DOI 10.1111/j.1365-2559.2010.03528.x; Borad MJ, 2015, J CLIN ONCOL, V33, P1475, DOI 10.1200/JCO.2014.55.7504; Borch RF, 2000, J MED CHEM, V43, P2258, DOI 10.1021/jm0001020; Bovee JVMG, 2010, NAT REV CANCER, V10, P481, DOI 10.1038/nrc2869; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Chatzinikolaidou M, 2016, DRUG DISCOV TODAY, V21, P1553, DOI 10.1016/j.drudis.2016.06.024; Chawla SP, 2014, J CLIN ONCOL, V32, P3299, DOI 10.1200/JCO.2013.54.3660; Chen CB, 2011, ANN SURG ONCOL, V18, P2364, DOI 10.1245/s10434-011-1587-5; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Ganjoo KN, 2011, ONCOLOGY-BASEL, V80, P50, DOI 10.1159/000327739; Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hiscox S, 2011, EXPERT OPIN THER TAR, V15, P609, DOI 10.1517/14728222.2011.561201; Italiano A, 2013, ANN ONCOL, V24, P2916, DOI 10.1093/annonc/mdt374; Italiano A, 2013, ANN ONCOL, V24, P2922, DOI 10.1093/annonc/mdt391; Ivey JW, 2015, CANC LETT; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kamb A, 2005, NAT REV DRUG DISCOV, V4, P161, DOI 10.1038/nrd1635; Katt ME, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00012; Khawar IA, 2015, J CONTROL RELEASE, V201, P78, DOI 10.1016/j.jconrel.2014.12.018; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Liapis V, 2015, CANCER LETT, V357, P160, DOI 10.1016/j.canlet.2014.11.020; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Meng FY, 2012, MOL CANCER THER, V11, P740, DOI 10.1158/1535-7163.MCT-11-0634; Monderer D, 2013, LAB INVEST, V93, P1100, DOI 10.1038/labinvest.2013.101; Onishi Anne C., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/381564; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Schindelin J, NAT METHODS, V9; Terashima J, 2016, CELL BIOL INT; van Oosterwijk JG, 2013, HEMATOL ONCOL CLIN N, V27, P1021, DOI 10.1016/j.hoc.2013.07.012; Weiss GJ, 2011, CLIN CANCER RES, V17, P2997, DOI 10.1158/1078-0432.CCR-10-3425; Westhoff MA, 2009, DRUG RESIST UPDATE, V12, P127, DOI 10.1016/j.drup.2009.08.001; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xu X, 2014, BIOTECHNOL ADV, V32, P1256, DOI 10.1016/j.biotechadv.2014.07.009	39	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							0181340e	10.1371/journal.pone.0181340	http://dx.doi.org/10.1371/journal.pone.0181340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704566	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700126
J	Kanda, K; Sakuma, J; Akimoto, T; Kawakami, Y; Suzuki, K				Kanda, Kazue; Sakuma, Jun; Akimoto, Takayuki; Kawakami, Yasuo; Suzuki, Katsuhiko			Detection of titin fragments in urine in response to exercise-induced muscle damage	PLOS ONE			English	Article							IMMOBILIZED PH GRADIENTS; ECCENTRIC EXERCISE; SKELETAL-MUSCLE; SORENESS; INFLAMMATION; BIOMARKERS; SEQUENCES; DATABASES; PEPTIDES; HUMANS	Many studies have attempted to determine the associations between blood biomarkers and exercise-induced muscle damage. However, poor correlations between the changes in biomarker levels and the magnitude of muscle symptoms have been reported. Recent advances in proteomic tools offer a strategy for the comprehensive analysis of protein expression, which can be used to identify biomarkers. Here, we used a proteomic analysis to identify urinary proteins that appear in response to a calf-raise exercise, including repetitive eccentric muscle contractions, and found that a titin (also known as connectin) N-terminal fragment molecule appears in the urine after eccentric exercise. We measured the titin fragment in urine samples from nine individuals before and after eccentric exercise using a newly-established enzyme-linked immunosorbent assay and found that the titin fragment excretion rate increased 96 h after the exercise (5.1 to 77.6 pg/min, p < 0.01). The changes in the titin fragment excretion rate were correlated strongly with blood markers of muscle damage and with muscle symptoms. These findings suggest that the urinary titin fragment is potentially a noninvasive biomarker of muscle damage.	[Kanda, Kazue; Suzuki, Katsuhiko] Waseda Univ, Inst Nanosci & Nanotechnol, Shinjuku Ku, Tokyo, Japan; [Sakuma, Jun] Musashigaoka Jr Coll, Dept Hlth Sci, Saitama, Japan; [Akimoto, Takayuki] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Regenerat Med Engn,Bunkyo Ku, Tokyo, Japan; [Akimoto, Takayuki; Kawakami, Yasuo; Suzuki, Katsuhiko] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Waseda University; University of Tokyo; Waseda University	Suzuki, K (corresponding author), Waseda Univ, Inst Nanosci & Nanotechnol, Shinjuku Ku, Tokyo, Japan.; Suzuki, K (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	katsu.suzu@waseda.jp	Akimoto, Takayuki/H-6704-2012; Kawakami, Yasuo/AFM-0651-2022; Kawakami, Yasuo/AAH-3075-2022; Suzuki, Katsuhiko/AAI-2197-2019	Akimoto, Takayuki/0000-0002-8874-7779; Kawakami, Yasuo/0000-0003-0588-4039; Kawakami, Yasuo/0000-0003-0588-4039; Suzuki, Katsuhiko/0000-0002-6572-5809	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23240097, 15H0183]; Grants-in-Aid for Scientific Research [16H01870, 15H01833] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant-in Aid for Scientific Research (A) (23240097, 15H0183) and the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RB, 1984, MED SCI SPORT EXER, V16, P529; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Beaton LJ, 2002, CAN J APPL PHYSIOL, V27, P516, DOI 10.1139/h02-028; Bennett S, 2012, ALZ DIS ASSOC DIS, V26, P329, DOI 10.1097/WAD.0b013e318239dcbd; Brancaccio P, 2008, CLIN SPORT MED, V27, P1, DOI 10.1016/j.csm.2007.09.005; Chapman D, 2006, INT J SPORTS MED, V27, P591, DOI 10.1055/s-2005-865920; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Freiburg A, 2000, CIRC RES, V86, P1114; Granzier H, 2007, MUSCLE NERVE, V36, P740, DOI 10.1002/mus.20886; Kanda K, 2014, EXERC IMMUNOL REV, V20, P39; Kanda K, 2013, EXERC IMMUNOL REV, V19, P72; Kruger M, 2011, J BIOL CHEM, V286, P9905, DOI 10.1074/jbc.R110.173260; Labeit S, 2006, J MOL BIOL, V362, P664, DOI 10.1016/j.jmb.2006.07.077; Malm C, 2004, J PHYSIOL-LONDON, V556, P983, DOI 10.1113/jphysiol.2003.056598; Malm C, 2000, J PHYSL, V592, P243; Malm C, 2012, HISTOCHEM CELL BIOL, V138, P89, DOI 10.1007/s00418-012-0946-z; Mann M, 1996, TRENDS BIOCHEM SCI, V21, P494, DOI 10.1016/S0968-0004(96)30042-X; MOKUNO K, 1987, MUSCLE NERVE, V10, P459, DOI 10.1002/mus.880100513; Murphy RM, 2006, J PHYSIOL-LONDON, V576, P595, DOI 10.1113/jphysiol.2006.114090; Nosaka K, 2002, SCAND J MED SCI SPOR, V12, P337, DOI 10.1034/j.1600-0838.2002.10178.x; Ottenheijm CAC, 2010, ADV EXP MED BIOL, V682, P105, DOI 10.1007/978-1-4419-6366-6_6; Peake J, 2005, EXERC IMMUNOL REV, V11, P64; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303; Sanchez JC, 1997, ELECTROPHORESIS, V18, P324, DOI 10.1002/elps.1150180305; Sietsema KE, 2010, BIOMARKERS, V15, P249, DOI 10.3109/13547500903502802; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Wang Chenchen, 2013, Methods Mol Biol, V984, P1, DOI 10.1007/978-1-62703-296-4_1; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016	32	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181623	10.1371/journal.pone.0181623	http://dx.doi.org/10.1371/journal.pone.0181623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727760	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500095
J	Kara-Jose, AC; Melo, LAS; Esporcatte, BLB; Endo, ATNH; Leite, MT; Tavares, IM				Kara-Jose, Andrea C.; Melo, Luiz Alberto S., Jr.; Esporcatte, Bruno L. B.; Endo, Angelica T. N. H.; Leite, Mauro Toledo; Tavares, Ivan Maynart			The disc damage likelihood scale: Diagnostic accuracy and correlations with cup-to-disc ratio, structural tests and standard automated perimetry	PLOS ONE			English	Article							HEIDELBERG RETINA TOMOGRAPH; NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; VISUAL-FIELD; GLAUCOMA DETECTION; THICKNESS; HEAD	Our objective was to compare the diagnostic accuracies of and to determine the correlations between the disc damage likelihood scale (DDLS) and anatomical and functional tests used for glaucoma detection. A total of 54 healthy subjects (54 eyes) and 47 primary open-angle glaucoma patients (47 eyes) were included in this cross-sectional observational study. DDLS scores and cup-to-disc (C/D) ratios were evaluated. Subjects underwent standard automated perimetry (SAP), optic disc and retinal nerve fiber layer (RNFL) imaging with time and spectral-domain optical coherence tomography (TD and SD-OCT), Heidelberg Retina Tomograph (HRT II), and scanning laser polarimetry (GDx-VCC). Areas under the receiver operating characteristic curves (AROCs) for DDLS and diagnostic tests parameters were calculated. DDLS correlations (Spearman's rank) among these parameters were analyzed. Fifty-four eyes were healthy and 47 had glaucoma, including 16 preperimetric glaucoma. DDLS, vertical and horizontal C/D ratios had the largest AROCs (0.92, 0.94 and 0.91, respectively). DDLS diagnostic accuracy was better than the accuracies of HRT II parameters, TD and SD-OCT RNFL thicknesses, and SAP mean deviation (MD) index. There were no significant differences between the accuracies of the DDLS and the C/D ratios, TD-OCT vertical (0.89) and horizontal (0.86) C/D ratios, TD-OCT C/D area ratio (0.89), and GDx-VCC NFI (0.81). DDLS showed significant strong correlations with vertical (r = 0.79) and horizontal (0.74) C/D ratios, and with the parameters vertical C/D ratio and C/D area ratio from HRT II (both 0.77) and TD-OCT (0.75 and 0.72, respectively). DDLS had significant moderate correlations with most of the other structural measurements and SAP MD. The optic disc clinical evaluation with DDLS system and C/D ratio demonstrated excellent accuracy in distinguishing glaucomatous from healthy eyes. DDLS had moderate to strong correlations with most structural and functional parameters. These findings stress the importance of optic disc clinical examination to detect glaucoma in a clinical scenario.	[Kara-Jose, Andrea C.; Melo, Luiz Alberto S., Jr.; Esporcatte, Bruno L. B.; Endo, Angelica T. N. H.; Leite, Mauro Toledo; Tavares, Ivan Maynart] Univ Fed Sao Paulo, Escola Paulista Med, Dept Ophthalmol & Visual Sci, Glaucoma Div, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Kara-Jose, AC (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Ophthalmol & Visual Sci, Glaucoma Div, Sao Paulo, SP, Brazil.	andrea@karajose.med.br	Tavares, Ivan/F-6766-2010; Leite, Mauro Toledo/AAF-5666-2021	Tavares, Ivan/0000-0003-2220-7603; 	CAPES/Ministry of Education of Brazil; CNPq/Ministry of Science and Technology of Brazil	CAPES/Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/Ministry of Science and Technology of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CAPES/Ministry of Education of Brazil (ACKJ, BLBE, IMT) and CNPq/Ministry of Science and Technology of Brazil (IMT).	ARMALY MF, 1967, ARCH OPHTHALMOL-CHIC, V78, P35, DOI 10.1001/archopht.1967.00980030037007; Bachmann F, 2009, KLIN MONATSBL AUGENH, V226, P280, DOI 10.1055/s-0028-1109288; Bayer A, 2002, AM J OPHTHALMOL, V133, P758, DOI 10.1016/S0002-9394(02)01422-8; Chandra Anuradha, 2013, Oman J Ophthalmol, V6, P103, DOI 10.4103/0974-620X.116643; Danesh-Meyer HV, 2006, OPHTHALMOLOGY, V113, P603, DOI 10.1016/j.ophtha.2005.10.055; Danesh-Meyer HV, 2006, BRIT J OPHTHALMOL, V90, P437, DOI 10.1136/bjo.2005.077131; Gonzalez-Garcia AO, 2009, AM J OPHTHALMOL, V147, P1067, DOI 10.1016/j.ajo.2008.12.032; Han JW, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/931738; Henderer JD, 2006, BRIT J OPHTHALMOL, V90, P395, DOI 10.1136/bjo.2005.083360; Henderer JD, 2003, AM J OPHTHALMOL, V135, P44, DOI 10.1016/S0002-9394(02)01833-0; Hornova J, 2008, EUR J OPHTHALMOL, V18, P739, DOI 10.1177/112067210801800513; JONAS JB, 1993, OPHTHALMOLOGY, V100, P63; Jonas JB, 1999, SURV OPHTHALMOL, V43, P293, DOI 10.1016/S0039-6257(98)00049-6; Kitaoka Y, 2015, GRAEFEARCH CLIN EX; Leite MT, 2011, AM J OPHTHALMOL, V151, P85, DOI 10.1016/j.ajo.2010.06.041; Lichter P R, 1976, Trans Am Ophthalmol Soc, V74, P532; Lim CS, 1996, J GLAUCOMA, V5, P241; Lisboa R, 2012, OPHTHALMOLOGY, V119, P2261, DOI 10.1016/j.ophtha.2012.06.009; Majid ASBA, 2010, OPHTHALMOLOGICA, V224, P274, DOI 10.1159/000287350; Mansouri K, 2011, EYE, V25, P269, DOI 10.1038/eye.2010.202; Medeiros FA, 2005, AM J OPHTHALMOL, V139, P44, DOI 10.1016/j.ajo.2004.08.069; Medeiros FA, 2007, BRIT J OPHTHALMOL, V91, P273, DOI 10.1136/bjo.2006.107409; Moreno-Montanes J, 2009, J GLAUCOMA, V18, P528, DOI 10.1097/IJG.0b013e318193c29f; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; Schuman JS, 2003, AM J OPHTHALMOL, V135, P504, DOI 10.1016/S0002-9394(02)02093-7; Sehi M, 2013, AM J OPHTHALMOL, V155, P73, DOI 10.1016/j.ajo.2012.07.005; Sharma P, 2008, SURV OPHTHALMOL, V53, pS17, DOI 10.1016/j.survophthal.2008.08.003; Spaeth GL, 2006, SURV OPHTHALMOL, V51, P293, DOI 10.1016/j.survophthal.2006.04.008; Spaeth George L, 2002, Trans Am Ophthalmol Soc, V100, P181; Spaeth GL, 2014, SURV OPHTHALMOL, V59, P454, DOI 10.1016/j.survophthal.2013.10.004; Tatham AJ, 2015, PROG BRAIN RES, V221, P103, DOI 10.1016/bs.pbr.2015.03.001; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Zangalli C, 2011, SAUDI J OPHTHALMOL, V25, P381, DOI 10.1016/j.sjopt.2011.07.003; Zangwill LM, 2001, ARCH OPHTHALMOL-CHIC, V119, P985, DOI 10.1001/archopht.119.7.985; Zhang CW, 2014, OPHTHALMOLOGY, V121, P2371, DOI 10.1016/j.ophtha.2014.06.047	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181428	10.1371/journal.pone.0181428	http://dx.doi.org/10.1371/journal.pone.0181428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727836	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500071
J	Wang, PY; Bi, SM; Wu, F; Xu, PZ; Shen, XJ; Zhao, QL				Wang, Pingyang; Bi, Simin; Wu, Fan; Xu, Pingzhen; Shen, Xingjia; Zhao, Qiaoling			Differentially expressed genes in the head of the 2nd instar pre-molting larvae of the nm2 mutant of the silkworm, Bombyx mori	PLOS ONE			English	Article							JUVENILE-HORMONE; DROSOPHILA-MELANOGASTER; MANDUCA-SEXTA; POLYTENE CHROMOSOMES; CUTICULAR PROTEIN; NUCLEAR RECEPTORS; CHITIN SYNTHASES; CUTICLE PROTEIN; CORPORA ALLATA; IN-VITRO	Molting is an important physiological process in the larval stage of Bombyx mori and is controlled by various hormones and peptides. The silkworm mutant that exhibits the phenotype of non-molting in the 2nd instar (nm2) is incapable of molting in the 2nd instar and dies after seven or more days. The ecdysone titer in the nm2 mutant is lower than that in the wild-type, and the mutant can be rescued by feeding with 20E and cholesterol. The results of positional cloning indicated that structural alteration of BmCPG10 is responsible for the phenotype of the nm2 mutant. To explore the possible relationship between BmCPG10 and the ecdysone titer as well as the genes affected by BmCPG10, digital gene expression (DGE) profile analysis was conducted in the nm2 mutant, with the wildtype strain C603 serving as the control. The results revealed 1727 differentially expressed genes, among which 651 genes were upregulated and 1076 were downregulated in nm2. BLASTGO analysis showed that these differentially expressed genes were involved in various biological processes, cellular components and molecular functions. KEGG analysis indicated an enrichment of these differentially expressed genes in 240 pathways, including metabolic pathways, pancreatic secretion, protein digestion and absorption, fat digestion and absorption and glycerolipid metabolism. To verify the accuracy of the DGE results, quantitative reverse transcription PCR (qRT-PCR) was performed, focusing on key genes in several related pathways, and the results were highly consistent with the DGE results. Our findings indicated significant differences in cuticular protein genes, ecdysone biosynthesis genes and ecdysone-related nuclear receptors genes, but no significant difference in juvenile hormone and chitin biosynthesis genes was detected. Our research findings lay the foundation for further research on the formation mechanism of the nm2 mutant.	[Wang, Pingyang; Bi, Simin; Xu, Pingzhen; Shen, Xingjia; Zhao, Qiaoling] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China; [Wang, Pingyang; Bi, Simin; Xu, Pingzhen; Shen, Xingjia; Zhao, Qiaoling] Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang, Jiangsu, Peoples R China; [Wu, Fan] Hubei Acad Agr Sci, Ind Crops Inst, Wuhan, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences; Hubei Academy of Agricultural Sciences	Zhao, QL (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China.; Zhao, QL (corresponding author), Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang, Jiangsu, Peoples R China.	qlzhao302@126.com		Wang, Pingyang/0000-0003-3908-6561	National Natural Science Foundation of China [31372378]; Jiangsu University of Science and Technology [YCX16B-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu University of Science and Technology	This work was supported by the funding of the National Natural Science Foundation of China (No. 31372378, Qiaoling Zhao) and the Graduate Student Innovation Program of Jiangsu University of Science and Technology (No. YCX16B-02, Pingyang Wang).; This work was supported by grants from the National Natural Science Foundation of China (No. 31372378).; This work was also supported by the Graduate Student Innovation Program of Jiangsu University of Science and Technology (No. YCX16B-02).	Ali MS, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev019; Asano T, 2013, INSECT BIOCHEM MOLEC, V43, P344, DOI 10.1016/j.ibmb.2013.01.001; ASHBURNER M, 1980, NATURE, V285, P435, DOI 10.1038/285435a0; ASHBURNER M, 1974, DEV BIOL, V39, P141, DOI 10.1016/S0012-1606(74)80016-3; ASHBURNER M, 1973, DEV BIOL, V35, P47, DOI 10.1016/0012-1606(73)90006-7; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Benjamini Y, 2001, ANN STAT, V29, P1165; Bonneton F, 2008, INSECT BIOCHEM MOLEC, V38, P416, DOI 10.1016/j.ibmb.2007.10.006; Busse MS, 2007, EMBO J, V26, P3826, DOI 10.1038/sj.emboj.7601798; CANDY DJ, 1962, J EXP BIOL, V39, P129; CATALAN RE, 1982, COMP BIOCHEM PHYS B, V71, P301, DOI 10.1016/0305-0491(82)90259-0; CAVENER DR, 1992, J MOL BIOL, V223, P811, DOI 10.1016/0022-2836(92)90992-S; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; Christiaens O., 2013, KEY ROLE DIVERSITY E; Cohen E, 2001, PEST MANAG SCI, V57, P946, DOI 10.1002/ps.363; Cruz J, 2008, DEV DYNAM, V237, P3179, DOI 10.1002/dvdy.21728; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Enya S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06586; FUKAMIZO T, 1985, INSECT BIOCHEM, V15, P141, DOI 10.1016/0020-1790(85)90001-0; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Graebin NG, 2016, MOLECULES, V21, DOI 10.3390/molecules21081074; [郭恩恩 GUO EnEn], 2008, [蚕业科学, Acta Sericologica Sinica], V34, P370; Hiruma K, 2001, DEV BIOL, V232, P265, DOI 10.1006/dbio.2001.0165; HIRUMA K, 1995, DEV BIOL, V169, P195, DOI 10.1006/dbio.1995.1137; Ito Y, 2008, ZOOL SCI, V25, P721, DOI 10.2108/zsj.25.721; Jasrapuria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049844; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchal E, 2010, PEPTIDES, V31, P506, DOI 10.1016/j.peptides.2009.08.020; Mauchamp B, 1999, INSECT BIOCHEM MOLEC, V29, P475, DOI 10.1016/S0965-1748(99)00044-2; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mesce KA, 2002, FRONT NEUROENDOCRIN, V23, P179, DOI 10.1006/frne.2002.0228; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Nita M, 2009, COMP BIOCHEM PHYS B, V153, P101, DOI 10.1016/j.cbpb.2009.02.005; Okamoto S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-396; Ote M, 2005, COMP BIOCHEM PHYS B, V141, P314, DOI 10.1016/j.cbpc.2005.04.005; Qiao L, 2014, GENETICS, V196, P1103, DOI 10.1534/genetics.113.158766; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; SHARON N, 1993, SCI AM, V268, P82, DOI 10.1038/scientificamerican0193-82; Soares MPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020513; Steiner B, 1999, J INSECT PHYSIOL, V45, P401, DOI 10.1016/S0022-1910(98)00139-5; Sui YP, 2009, INSECT MOL BIOL, V18, P353, DOI 10.1111/j.1365-2583.2009.00879.x; Teets NM, 2014, J EXP BIOL, V217, P84, DOI 10.1242/jeb.089490; Wu F, 2016, GENE, V586, P170, DOI 10.1016/j.gene.2016.04.021; Wu F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153549; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xu JJ, 2010, J INSECT PHYSIOL, V56, P1471, DOI 10.1016/j.jinsphys.2010.04.004; Yamada M, 2000, DEVELOPMENT, V127, P5083; Zhao Xiao-Fan, 2007, Chinese Bulletin of Entomology, V44, P323; Zhong YS, 2006, INSECT BIOCHEM MOLEC, V36, P99, DOI 10.1016/j.ibmb.2005.07.005	62	2	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180160	10.1371/journal.pone.0180160	http://dx.doi.org/10.1371/journal.pone.0180160			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727825	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500015
J	Gulagi, A; Choudhary, P; Bogdanov, D; Breyer, C				Gulagi, Ashish; Choudhary, Piyush; Bogdanov, Dmitrii; Breyer, Christian			Electricity system based on 100% renewable energy for India and SAARC	PLOS ONE			English	Article							SOLAR PV; GENERATION; COST; BENEFITS; COAL	The developing region of SAARC (South Asian Association for Regional Cooperation) is home to a large number of people living below the poverty line. In future, providing affordable, universally accessible, reliable, low to zero carbon electricity in this region will be the main aim. A cost optimal 100% renewable energy system is simulated for SAARC for the year 2030 on an hourly resolved basis. The region was divided into 16 sub-regions and three different scenarios were set up based on the level of high voltage direct current (HVDC) grid connections. The results obtained for a total system levelised cost of electricity (LCOE) showed a decrease from 71.6 sic/MWh in a decentralized to 67.2 sic/MWh for a centralized grid connected scenario. An additional scenario was simulated to show the benefits of integrating industrial gas production and seawater reverse osmosis desalination demand, and showed the system cost decreased by 5% and total electricity generation decreased by 1%. The results show that a 100% renewable energy system could be a reality in the SAARC region with the cost assumptions used in this research and it may be more cost competitive than nuclear and fossil carbon capture and storage (CCS) alternatives. One of the limitations of this study is the cost of land for installation of renewables which is not included in the LCOE calculations, but regarded as a minor contribution.	[Gulagi, Ashish; Bogdanov, Dmitrii; Breyer, Christian] Lappeenranta Univ Technol, Lappeenranta, Finland; [Choudhary, Piyush] Indian Inst Technol BHU, Varanasi, Uttar Pradesh, India	Lappeenranta University of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT BHU) - Varanasi	Gulagi, A (corresponding author), Lappeenranta Univ Technol, Lappeenranta, Finland.	Ashish.Gulagi@lut.fi	Breyer, Christian/W-2106-2018; Gulagi, Ashish/AAF-5016-2020; Choudhary, Piyush/N-9032-2019; Choudhary, Piyush/G-1114-2017	Breyer, Christian/0000-0002-7380-1816; Gulagi, Ashish/0000-0003-3440-1577; Choudhary, Piyush/0000-0002-1563-4554; Choudhary, Piyush/0000-0002-1563-4554; Bogdanov, Dmitrii/0000-0001-7136-4803	Tekes, the Finnish Funding Agency for Innovation [40101/14]; Fortum Foundation	Tekes, the Finnish Funding Agency for Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Fortum Foundation	The authors gratefully acknowledge the public financing of Tekes, the Finnish Funding Agency for Innovation, for the 'Neo-Carbon Energy' project under the number 40101/14. The first author would like to thank Fortum Foundation for the valuable scholarship.	AAPG, 2015, GLOB HEAT FLOW DAT; Abhyankar N., 2015, ASSESSING TECHNICAL; Agora Energiewende, 2015, CURR FUT COST PHOT L; Agora Energiewende, 2014, COMP COST LOW CARB T, P10; [Anonymous], 2016, EXPLORING POTENTIAL, DOI DOI 10.2172/1321487; [Anonymous], 2012, J SUSTAINABLE ENERGY; [Anonymous], 2015, INDIAS ELECT SECTOR; Barnaby F, 2007, SECURE ENERGY CIVIL; Bertheau P., 2012, 5 INT C INT REN EN D; [BNEF]-Bloomberg New Energy Finance, 2015, DISTR SOL STOR ICEF; Bogdanov D, 2016, ENERG CONVERS MANAGE, V112, P176, DOI 10.1016/j.enconman.2016.01.019; Breyer C., 2011, 26 EU PVSEC; Breyer Ch., 2017, PROG PHOTOVOLT RES A; Breyer C, 2013, PROG PHOTOVOLTAICS, V21, P121, DOI 10.1002/pip.1254; British Petroleum, 2015, BP STAT REV WORLD EN, V54th ed.; Buckley T, 2016, MORE EVIDENCE INDIA; Buckley T, 2016, ANCELLATION ULTRA ME; Buonocore JJ, 2016, NAT CLIM CHANGE, V6, P100, DOI [10.1038/NCLIMATE2771, 10.1038/nclimate2771]; Caldera U, 2016, DESALINATION, V385, P207, DOI 10.1016/j.desal.2016.02.004; [CEA]-Central Electricity Authority, 2016, NAT EL PLAN IN PRESS; [CERC] Central Electricity Regulatory Comission, 2016, DET BENCHM CAP COST; Chakrabarti S., 2013, EN STAT; Chamorro CR, 2014, RENEW ENERG, V66, P1, DOI 10.1016/j.renene.2013.11.065; Chamorro CR, 2014, ENERGY, V65, P250, DOI 10.1016/j.energy.2013.11.078; Coady D., 2015, LARGE ARE GLOBAL ENE; Cochran J., 2013, MARKET EVOLUTION WHO; DBFZ, 2009, REG GLOB RAUML VERT; Denholm P, 2008, ENERG POLICY, V36, P3531, DOI 10.1016/j.enpol.2008.05.035; Dii, 2012, 2050 DES POW PERSP S; Dittmar M, 2012, ENERGY, V37, P35, DOI 10.1016/j.energy.2011.05.040; Duguid B., 2010, ONTARIOS LONG TERM E; Eid C, 2014, ENERG POLICY, V75, P244, DOI 10.1016/j.enpol.2014.09.011; Enerdata, 2014, GLOBAL ENERGY STAT Y; Epstein PR, 2011, ANN NY ACAD SCI, V1219, P73, DOI 10.1111/j.1749-6632.2010.05890.x; Ernst & Young, 2012, REN EN COUNTR ATTR I; European Commission, 2014, INT REN EN EUR STUD, p[7, 54]; European Commission, 2014, ETRI 2014 EN TECHN R; Faiman D., 2009, ENERGY DESERT VERY L; Farfan J, 2017, J CLEAN PROD, V141, P370, DOI 10.1016/j.jclepro.2016.09.068; Gerlach A., 2014, 29 EU PVSEC; German Advisory Council on Global Change (WGBU), 2007, CLIMATE CHANGE SECUR, P23; Gol, 2015, REP IND REN EL ROADM; Goswami D., 2014, CAN INDIA ACHIEVE 10; Gulagi A., 2016, 10 INT REN EN STOR C; Hoffmann W., 2014, EU PVSEC; Huenges E, 2012, GEOTHERMAL ENERGY SY; Hummel P, 2017, UBS EVIDENCE LAB ELE; IASPEI, 2015, INT ASS SEISM PHYS E; IEA, 2012, TECHN ROADM BIOEN HE; IEA, 2012, WORLD EN OUTL 2012; IEA, 2013, WORLD EN OUTL 2013; IEA, 2013, EN BAL NONOECD COUNT; IEA International Energy Agency-IEA, 2014, RES PROS DRIV POL OP; [IMF]-International Monetary Fund, 2014, GETT EN PRIC RIGHT P; International Energy Agency (IEA), 2015, IND EN OUTL; IPCC, 2011, SPEC REP REN EN SOUR; [IPCC]-Intergovernmental Panel on Climate Change, 2014, SPEC REP IMP AD VULN; IRENA, 2015, TECHNICAL REPORT; [ISA]-International Solar Alliance, 2015, WORK PAP INT SOL ALL; King E, 2016, CLIMATECHANGENE 0418; KPMG, 2015, RIS SUN DISR HOR; Krewitt W, 2009, ENERG POLICY, V37, P5764, DOI 10.1016/j.enpol.2009.08.042; Lawson R. L., 2008, 21 CENTURY MARSHALL; Luck M., 2015, AQUEDUCT WATER STRES; [MCG]-Mercom Group Capital, 2014, JAW NEHR NAT SOL MIS; Ministry of Finance, 2015, IND PUBL FIN STAT; [MNRE]-Ministry of New and Renewable Energy, 2014, PHYS PROGR ACH REN E; MoEFCC, 2015, IND INT NATL DET CON; Nykvist B, 2015, NAT CLIM CHANGE, V5, P329, DOI 10.1038/nclimate2564; Papaefthymiou G., 2014, FLEXIBILITY OPTIONS; Pillai GG, 2014, ENERGY, V68, P832, DOI 10.1016/j.energy.2014.02.085; Planning Commission, 2011, FAST SUST MOR INCL G; Plessmann G, 2014, ENRGY PROCED, V46, P22, DOI 10.1016/j.egypro.2014.01.154; Powergrid Corporation of India Ltd, 2013, DES POW IND 2050 INT; Pratap A., 2013, POWERING AHEAD RENEW; [PwC]-PricewaterhouseCoopers and Mytrah, 2015, JOINT REP REN EN TRA; Romero S M., 2015, BRINGING VARIABLE RE; Shearer C, 2017, EARTHS FUTURE, V5, P408, DOI 10.1002/2017EF000542; Shrimali G., REACHING INDIAS RENE; Singer S, 2010, ENERGY REPORT 100 RE; Szabo S, 2017, RENEW SUST ENERG REV, V76, P1291, DOI 10.1016/j.rser.2017.03.117; TERI and WWF, 2011, EN REP IND 100 REN E; Teske S., 2012, TECHNICAL REPORT; Teske S., 2008, TECHNICAL REPORT; Teske S., 2015, TECHNICAL REPORT; [UNFCCC] United Nations Framework Convention on Climate Change, 2015, C PARTIES 21 SESS; United Nations, 2015, GOAL; Urban W., 2009, ABSCHLUSSBERICHT BMB; Vartiainen E., 2015, 31 EU PVSEC; WWF]-World Wildlife Fund-India and [WISE]-World Institute of Sustainable Energy, 2013, EN REP KER 100 REN E	90	63	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180611	10.1371/journal.pone.0180611	http://dx.doi.org/10.1371/journal.pone.0180611			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723937	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800021
J	Runeson, B; Odeberg, J; Pettersson, A; Edbom, T; Adamsson, IJ; Waern, M				Runeson, Bo; Odeberg, Jenny; Pettersson, Agneta; Edbom, Tobias; Adamsson, Ingalill Jildevik; Waern, Margda			Instruments for the assessment of suicide risk: A systematic review evaluating the certainty of the evidence	PLOS ONE			English	Review							DELIBERATE SELF-HARM; EMERGENCY-DEPARTMENT; PREDICTIVE-VALIDITY; ASSESSMENT SCALE; TERM RISK; LONG-TERM; FOLLOW-UP; REPETITION; IDEATION; INTENT	Background Instruments have been developed to facilitate suicide risk assessment. We aimed to evaluate the evidence for these instruments including assessment of risk of bias and diagnostic accuracy for suicide and suicide attempt. Methods PubMed (NLM), PsycInfo, Embase, Cinahl and the Cochrane Library databases were searched until December 2014. We assessed risk of bias with QUADAS-2. The average sensitivity and specificity of each instrument was estimated and the certainty of the evidence was assessed with GRADE. We considered instruments with a sensitivity > 80% and a specificity > 50% to have sufficient diagnostic accuracy. Results Thirty-five relevant studies were identified but 14 were considered to have high risk of bias, leaving 21 studies evaluating altogether 15 risk assessment instruments. We could carry out meta-analyses for five instruments. For the outcome suicide attempt SAD PERSONS Scale had a sensitivity of 15% (95% CI 8-24) and specificity of 97% (96-98), and the Manchester Self-Harm Rule (MSHR) a sensitivity of 97% (97-97) and a specificity of 20% (20-21). ReACT, which is a modification of MSHR, had a similar low specificity, as did the Sodersjukhuset Self Harm Rule. For the outcome suicide, the Beck Hopelessness Scale had a sensitivity of 89% (78-95) and specificity of 42% (40-43). Conclusions Most suicide risk assessment instruments were supported by too few studies to allow for evaluation of accuracy. Among those that could be evaluated, none fulfilled requirements for sufficient diagnostic accuracy.	[Runeson, Bo; Edbom, Tobias] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Runeson, Bo] Stockholm Cty Council, Stockholm Hlth Care Serv, Ctr Psychiat Res, Stockholm, Sweden; [Odeberg, Jenny; Pettersson, Agneta] Swedish Agcy Hlth Technol Assessment & Assessment, Stockholm, Sweden; [Adamsson, Ingalill Jildevik] Ostersund Hosp, Reg Jamtland Harjedalen, Ostersund, Sweden; [Waern, Margda] Univ Goteborg, Dept Psychiat & Neurochem, Gothenburg, Sweden	Karolinska Institutet; Stockholm County Council; University of Gothenburg	Runeson, B (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Runeson, B (corresponding author), Stockholm Cty Council, Stockholm Hlth Care Serv, Ctr Psychiat Res, Stockholm, Sweden.	bo.runeson@ki.se			Swedish Agency for Health Technology Assessment and Assessment of Social Services; Swedish Research Council [521-2013-2699]	Swedish Agency for Health Technology Assessment and Assessment of Social Services; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by and conducted within the framework of the Swedish Agency for Health Technology Assessment and Assessment of Social Services. Margda Waern had financial support by the Swedish Research Council (521-2013-2699)	APA, 2010, PRACT GUID ASS TREAT; Beck AT, 1999, SUICIDE LIFE-THREAT, V29, P1; BECK AT, 1990, AM J PSYCHIAT, V147, P190; Bernert RA, 2014, ACAD PSYCHIATR, V38, P585, DOI 10.1007/s40596-014-0180-1; Bilen K, 2013, EMERG MED J, V30, P650, DOI 10.1136/emermed-2012-201235; Bilen K, 2013, J AFFECT DISORDERS, V149, P253, DOI 10.1016/j.jad.2013.01.037; Bolton JM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4978; Bolton JM, 2015, DEPRESS ANXIETY, V32, P73, DOI 10.1002/da.22320; Carter GL, 2002, SUICIDE LIFE-THREAT, V32, P230, DOI 10.1521/suli.32.3.230.22175; Cassells C, 2005, CRISIS, V26, P53, DOI 10.1027/0227-5910.26.2.53; Claassen CA, 2014, AM J PREV MED, V47, pS181, DOI 10.1016/j.amepre.2014.06.003; Cooper J, 2006, ANN EMERG MED, V48, P459, DOI 10.1016/j.annemergmed.2006.07.944; Ducher JL, 2006, ENCEPHALE, V32, P738; Excellence NIfC, 2011, SELF HARM 8S LONG TE; Fochtmann LJ, 2015, ACAD PSYCHIATR, V39, P490, DOI 10.1007/s40596-015-0349-2; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Gysin-Maillart A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001968; Harriss L, 2005, J AFFECT DISORDERS, V86, P225, DOI 10.1016/j.jad.2005.02.009; Haw C, 2003, SUICIDE LIFE-THREAT, V33, P353, DOI 10.1521/suli.33.4.353.25232; Huth-Bocks AC, 2007, J AM ACAD CHILD PSY, V46, P387, DOI 10.1097/chi.0b013e31802b9535; Ivarsson T, 1998, EUR CHILD ADOLES PSY, V7, P96, DOI 10.1007/s007870050053; Jokinen J, 2010, J CLIN PSYCHIAT, V71, P1025, DOI 10.4088/JCP.09m05944blu; Kapur N, 2015, LANCET PSYCHIAT, V2, P809, DOI 10.1016/S2215-0366(15)00169-8; Keller F, 1993, Crisis, V14, P173; Klonsky ED, 2012, SUICIDE LIFE-THREAT, V42, P1, DOI 10.1111/j.1943-278X.2011.00066.x; Larkin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084282; Larzelere RE, 1996, J AM ACAD CHILD PSY, V35, P166, DOI 10.1097/00004583-199602000-00009; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; Moher David, 2009, Open Med, V3, pe123; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mundt JC, 2013, J CLIN PSYCHIAT, V74, P887, DOI 10.4088/JCP.13m08398; Nicholls TL, 2006, ASSESSMENT, V13, P313, DOI 10.1177/1073191106290559; Nimeus A, 1997, J AFFECT DISORDERS, V42, P137, DOI 10.1016/S0165-0327(96)01404-8; Nimeus A, 2000, EUR PSYCHIAT, V15, P416, DOI 10.1016/S0924-9338(00)00512-5; NIMEUS A., 2002, ARCH SUICIDE RES, V6, P211, DOI DOI 10.1080/13811110214142; Ougrin D, 2013, J ADOLESCENCE, V36, P221, DOI 10.1016/j.adolescence.2012.09.006; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Randall JR, 2013, PSYCHOL ASSESSMENT, V25, P714, DOI 10.1037/a0032391; Randall JR, 2012, CAN J PSYCHIAT, V57, P21, DOI 10.1177/070674371205700105; Reutfors J, 2010, J PSYCHIATR RES, V44, P741, DOI 10.1016/j.jpsychires.2010.02.003; Roaldset JO, 2012, ARCH SUICIDE RES, V16, P287, DOI 10.1080/13811118.2013.722052; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Sanchez-Gistau V, 2013, J CLIN PSYCHIAT, V74, P61, DOI 10.4088/JCP.12m07632; Sapyta J, 2012, J CONSULT CLIN PSYCH, V80, P222, DOI 10.1037/a0026870; Saunders K, 2014, EMERG MED J, V31, P796, DOI 10.1136/emermed-2013-202781; Selaman Z, 2012, J CLIN PSYCHIAT, V73, P1264, DOI [10.4088/JCP.12lr07984, 10.4088/JCP.11m07362]; Sidley GL, 1999, BRIT J CLIN PSYCHOL, V38, P375, DOI 10.1348/014466599162971; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Sjostrom N, 2012, J PSYCHIATR MENT HLT, V19, P62, DOI 10.1111/j.1365-2850.2011.01755.x; Steeg S, 2012, PSYCHOL MED, V42, P2012, DOI 10.1017/S0033291712001389; Stefansson J, 2012, J AFFECT DISORDERS, V136, P167, DOI 10.1016/j.jad.2010.11.016; Thomas LPM, 2014, CRISIS, V35, P161, DOI 10.1027/0227-5910/a000247; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; Vuorilehto M, 2014, EUR PSYCHIAT, V29, P338, DOI 10.1016/j.eurpsy.2013.08.005; Waern M, 2010, EUR PSYCHIAT, V25, P421, DOI 10.1016/j.eurpsy.2010.03.014; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WHO, 2014, PREV SUCIC GLOB IMP; Yeh AWC, 2012, ASIA-PAC PSYCHIAT, V4, P20, DOI 10.1111/j.1758-5872.2011.00165.x	58	110	111	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180292	10.1371/journal.pone.0180292	http://dx.doi.org/10.1371/journal.pone.0180292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723978	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800013
J	Suarez, CG; Singer, BH; Gebremariam, A; Lee, JM; Singer, K				Suarez, Cecilia Gallego; Singer, Benjamin H.; Gebremariam, Achamyeleh; Lee, Joyce M.; Singer, Kanakadurga			The relationship between adiposity and bone density in US children and adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; FAT MASS; MINERAL DENSITY; OBESITY; CHILDHOOD; FEMALES; FATNESS; WOMEN; AGE	Objective In adults, obesity has been associated with several health outcomes including increased bone density. Our objective was to evaluate the association between percent body fat and fat mass with bone mineral density (BMD) in a nationally representative population of children and adolescents. Study design A total of 8,348 participants 8-18 years of age from the National Health and Nutrition Examination Survey (NHANES) 1999-2006 had whole body DXA scans performed. We conducted linear regressions to examine the relationship between percent body fat and fat mass with outcome variables of total body, pelvic and lumbar spine areal BMD (aBMD), controlling for lean body mass and assessing for gender and race/ethnicity interactions. Results We found evidence of gender and race/ethnicity interactions with percent body fat and total fat mass for the different BMD areas. Generally, there were decreases in total body aBMD (p<0.001) and lumbar spine aBMD (p<0.001) with increasing percent body fat and total fat mass, with less consistent patterns for pelvic aBMD. Conclusion Our findings of regional differences in the relationship of adiposity to aBMD in children and adolescents with significant interactions by gender and race/ethnicity emphasizes the need for further investigations to understand the impact of adiposity on bone health outcomes.	[Suarez, Cecilia Gallego; Lee, Joyce M.; Singer, Kanakadurga] Univ Michigan, Med Sch, Div Pediat Endocrinol & Metab, Dept Pediat & Communicable Dis, Ann Arbor, MI USA; [Singer, Benjamin H.] Univ Michigan, Med Sch, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Gebremariam, Achamyeleh; Lee, Joyce M.] Univ Michigan, Med Sch, Child Hlth Evaluat & Res Unit CHEAR, Dept Pediat & Communicable Dis, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Singer, K (corresponding author), Univ Michigan, Med Sch, Div Pediat Endocrinol & Metab, Dept Pediat & Communicable Dis, Ann Arbor, MI USA.	ksinger@umich.edu	Singer, Benjamin/J-6330-2019	Singer, Benjamin/0000-0002-4721-6920; Singer, Kanakadurga/0000-0001-8278-3800	National Institute of Diabetes and Digestive and Kidney Diseases / National Institutes of Health [K08DK101755]; Department of Pediatrics Woodson Biostatistics Major Award; Edith Briskin/SKS Foundation Taubman Emerging Scholars Program from the University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK101755, P30DK092926, P30DK020572] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases / National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Pediatrics Woodson Biostatistics Major Award; Edith Briskin/SKS Foundation Taubman Emerging Scholars Program from the University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Kanakadurga Singer receives support through a National Institute of Diabetes and Digestive and Kidney Diseases / National Institutes of Health Grant (K08DK101755), from the Department of Pediatrics Woodson Biostatistics Major Award and the Edith Briskin/SKS Foundation Taubman Emerging Scholars Program from the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrach LK, 2001, TRENDS ENDOCRIN MET, V12, P22, DOI 10.1016/S1043-2760(00)00336-2; Binkovitz LA, 2007, PEDIATR RADIOL, V37, P21, DOI 10.1007/s00247-006-0153-y; Dugas LR, 2011, OBESITY, V19, P2099, DOI 10.1038/oby.2011.52; Freedman DS, 2008, OBESITY, V16, P1105, DOI 10.1038/oby.2008.30; Freedman DS, 2009, ARCH PEDIAT ADOL MED, V163, P805, DOI 10.1001/archpediatrics.2009.104; Freitas IF, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-37; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; GORAN MI, 1995, INT J OBESITY, V19, P638; Gordon CM, 2014, J CLIN DENSITOM, V17, P219, DOI 10.1016/j.jocd.2014.01.007; Gower BA, 2013, J CLIN DENSITOM, V16, P450, DOI 10.1016/j.jocd.2013.08.010; Gracia-Marco L, 2012, OSTEOPOROSIS INT, V23, P937, DOI 10.1007/s00198-011-1649-3; Johnson CL., 2013, ANAL GUIDELINES 1999; Kohrt WM, 2009, MED SCI SPORT EXER, V41, P2050, DOI 10.1249/MSS.0b013e3181a8c717; Kuperman EF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-377; Lazcano-Ponce E, 2003, OSTEOPOROSIS INT, V14, P539, DOI 10.1007/s00198-002-1363-2; Leonard MB, 2015, BONE, V73, P69, DOI 10.1016/j.bone.2014.12.002; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; Lloyd JT, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0175-2; MCCORMICK DP, 1991, J BONE MINER RES, V6, P507; Mosca LN, 2014, NUTRITION, V30, P847, DOI 10.1016/j.nut.2013.12.003; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patsch JM, 2011, METABOLISM, V60, P243, DOI 10.1016/j.metabol.2009.11.023; Pollock NK, 2007, AM J CLIN NUTR, V86, P1530, DOI 10.1093/ajcn/86.5.1530; Sayers A, 2010, J CLIN ENDOCR METAB, V95, P699, DOI 10.1210/jc.2009-1907; Scheller EL, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00102; Singer K, 2014, OBESITY, V22, P1332, DOI 10.1002/oby.20710; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; Streeter AJ, 2013, PEDIATR OBES, V8, P418, DOI 10.1111/j.2047-6310.2012.00126.x; Taes YEC, 2009, J CLIN ENDOCR METAB, V94, P2325, DOI 10.1210/jc.2008-2501; Van Leeuwen J, 2017, OBES REV; Wang MC, 2005, BONE, V37, P474, DOI 10.1016/j.bone.2005.04.038; Weiler HA, 2000, BONE, V27, P203, DOI 10.1016/S8756-3282(00)00314-8; Wey HE, 2011, J CLIN ENDOCR METAB, V96, P106, DOI 10.1210/jc.2010-0889	34	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181587	10.1371/journal.pone.0181587	http://dx.doi.org/10.1371/journal.pone.0181587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723934	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800060
J	Allevato, M; Bolotin, E; Grossman, M; Mane-Padros, D; Sladek, FM; Martinez, E				Allevato, Michael; Bolotin, Eugene; Grossman, Mark; Mane-Padros, Daniel; Sladek, Frances M.; Martinez, Ernest			Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs	PLOS ONE			English	Article							C-MYC; TRANSCRIPTIONAL CONTROL; MAX; PROTEIN; GENOME; GENE; RECOGNITION; SITES; ACTIVATION; APOPTOSIS	The MYC oncoprotein regulates transcription of a large fraction of the genome as an obligatory heterodimer with the transcription factor MAX. The MYC:MAX heterodimer and MAX: MAX homodimer (hereafter MYC/MAX) bind Enhancer box (E-box) DNA elements (CANNTG) and have the greatest affinity for the canonical MYC E-box (CME) CACGTG. However, MYC:MAX also recognizes E-box variants and was reported to bind DNA in a "non-specific" fashion in vitro and in vivo. Here, in order to identify potential additional non canonical binding sites for MYC/MAX, we employed high throughput in vitro protein-binding microarrays, along with electrophoretic mobility-shift assays and bioinformatic analyses of MYC-bound genomic loci in vivo. We identified all hexameric motifs preferentially bound by MYC/MAX in vitro, which include the low-affinity non-E-box sequence AACGTT, and found that the vast majority (87%) of MYC-bound genomic sites in a human B cell line contain at least one of the top 21 motifs bound by MYC:MAX in vitro. We further show that high MYC/MAX concentrations are needed for specific binding to the low-affinity sequence AACGTT in vitro and that elevated MYC levels in vivo more markedly increase the occupancy of AACGTT sites relative to CME sites, especially at distal intergenic and intragenic loci. Hence, MYC binds diverse DNA motifs with a broad range of affinities in a sequence-specific and dose-dependent manner, suggesting that MYC overexpression has more selective effects on the tumor transcriptome than previously thought.	[Allevato, Michael; Grossman, Mark; Martinez, Ernest] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Bolotin, Eugene; Mane-Padros, Daniel; Sladek, Frances M.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Grossman, Mark] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Martinez, E (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.; Sladek, FM (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	frances.sladek@ucr.edu; ernest.martinez@ucr.edu		Allevato, Michael/0000-0003-1846-7189	NIH [R01CA158540, R01DK094707]; MARC U-STAR training grant from NIH [T34GM062756]; NATIONAL CANCER INSTITUTE [R01CA158540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MARC U-STAR training grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (R01CA158540 to E.M. and R01DK094707 to F.M.S). M.A. was supported by a MARC U-STAR training grant from NIH (T34GM062756).	AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BERBERICH S, 1992, ONCOGENE, V7, P775; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; Cowling Victoria H, 2010, Genes Cancer, V1, P576; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; Farina A, 2004, PROTEIN EXPRES PURIF, V34, P215, DOI 10.1016/j.pep.2003.11.021; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guo JN, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0482-3; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; LINDEMAN GJ, 1995, ONCOGENE, V10, P1013; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Lorenzin F, 2016, ELIFE, V5, DOI 10.7554/eLife.15161; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Perna D, 2012, ONCOGENE, V31, P1695, DOI 10.1038/onc.2011.359; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; SOLOMON DLC, 1993, NUCLEIC ACIDS RES, V21, P5372, DOI 10.1093/nar/21.23.5372; Thomas LR, 2015, MOL CELL, V58, P440, DOI 10.1016/j.molcel.2015.02.028; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tu WB, 2015, BBA-GENE REGUL MECH, V1849, P469, DOI 10.1016/j.bbagrm.2014.06.002; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	40	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180147	10.1371/journal.pone.0180147	http://dx.doi.org/10.1371/journal.pone.0180147			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719624	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400008
J	Kang, D; Jung, J; Lee, D; Kim, H; Won, D				Kang, Dongwoo; Jung, Jaewook; Lee, Donghoon; Kim, Hyoungshick; Won, Dongho			Security analysis and enhanced user authentication in proxy mobile IPv6 networks	PLOS ONE			English	Article							KEY AGREEMENT SCHEME; PROTOCOL	The Proxy Mobile IPv6 (PMIPv6) is a network-based mobility management protocol that allows a Mobile Node(MN) connected to the PMIPv6 domain to move from one network to another without changing the assigned IPv6 address. The user authentication procedure in this protocol is not standardized, but many smartcard based authentication schemes have been proposed. Recently, Alizadeh et al. proposed an authentication scheme for the PMIPv6. However, it could allow an attacker to derive an encryption key that must be securely shared between MN and the Mobile Access Gate(MAG). As a result, outsider adversary can derive MN's identity, password and session key. In this paper, we analyze Alizadeh et al.' s scheme regarding security and propose an enhanced authentication scheme that uses a dynamic identity to satisfy anonymity. Furthermore, we use BAN logic to show that our scheme can successfully generate and communicate with the inter-entity session key.	[Kang, Dongwoo; Jung, Jaewook; Lee, Donghoon; Kim, Hyoungshick; Won, Dongho] Sungkyunkwan Univ, Dept Comp Engn, 2066 Seoburo, Suwon 16419, Gyeonggido, South Korea	Sungkyunkwan University (SKKU)	Won, D (corresponding author), Sungkyunkwan Univ, Dept Comp Engn, 2066 Seoburo, Suwon 16419, Gyeonggido, South Korea.	dhwon@security.re.kr			National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2010-0020210]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2010-0020210) http://www.nrf.re.kr/index.	Alizadeh M, 2015, JURNAL TEKNOLOGI, V72, P27, DOI [http://dx.doi.org/10.11113/jt.v72.3935, DOI 10.11113/JT.V72.3935]; Alizadeh M, 2015, PLOS ONE, V10, P1; Alizadeh M, 2015, J TEKNOL, V72; Amin R., 2016, FUTURE GENER COMP SY, P1; Amin R, 2016, AD HOC NETW, V36, P58, DOI 10.1016/j.adhoc.2015.05.020; Blanchet B., 2015, PROVERIF 1 90 AUTOMA; Burrows JH., 1995, SECURE HASH STANDARD, P17; Chaudhry SA, 2017, WIRELESS PERS COMMUN, V93, P311, DOI 10.1007/s11277-015-3139-y; Chaudhry SA, 2015, SECUR COMMUN NETW, V8, P3782, DOI 10.1002/sec.1299; Chaudhry SA, 2017, PEER PEER NETW APPL, V10, P1, DOI 10.1007/s12083-015-0400-9; Choi Y, 2016, INT J DISTRIB SENS N, DOI [10.1155/2016/8572410, 10.1155/2016/3479247]; Chuang MC, 2013, IEEE SYST J, V7, P102, DOI 10.1109/JSYST.2012.2209276; Dai Wei, 2017, CRYPTO LIB; Farash MS, 2016, AD HOC NETW, V36, P152, DOI 10.1016/j.adhoc.2015.05.014; Giaretta G, 2012, 6612 RFC; Gundavelli S., 2008, 5213 RFC; Heydari M, 2016, WIRELESS PERS COMMUN, V88, P337, DOI 10.1007/s11277-015-3123-6; Jin ATB, 2004, PATTERN RECOGN, V37, P2245, DOI 10.1016/j.patcog.2004.04.011; Johnson D, 2004, 3775 RFC; Jung J, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081299; Jung J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184232; Kempf J, 2007, 4832 RFC; Kocher P, 2011, J CRYPTOGR ENG, V1, P5, DOI 10.1007/s13389-011-0006-y; Kong Ki-Sik, 2008, IEEE WIRELESS COMMUN, V15; Kumari S, 2017, PEER PEER NETW APPL, V10, P92, DOI 10.1007/s12083-015-0409-0; Liao IE, 2006, J COMPUT SYST SCI, V72, P727, DOI 10.1016/j.jcss.2005.10.001; Ma CG, 2014, INT J COMMUN SYST, V27, P2215, DOI 10.1002/dac.2468; Mathuria A. M., 1995, Australian Computer Science Communications, V17, P370; Moon J, 2016, J MED SYST, V40, DOI 10.1007/s10916-015-0422-0; Rogaway P, 2004, LECT NOTES COMPUT SC, V3017, P371; Sutrala AK, 2016, COMPUT METH PROG BIO, V135, P167, DOI 10.1016/j.cmpb.2016.07.028; Tan ZW, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0016-2; Vigano L, 2006, ELECTRON NOTES THEOR, V155, P61, DOI 10.1016/j.entcs.2005.11.052; Wessels J., 2001, CMG FINANCE BV, V19, P1; Yang GM, 2008, J COMPUT SYST SCI, V74, P1160, DOI 10.1016/j.jcss.2008.04.002; You I, 2015, IEEE SYSTEMS J, P1	36	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181031	10.1371/journal.pone.0181031	http://dx.doi.org/10.1371/journal.pone.0181031			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719621	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400029
J	Kim, EK; Cho, JH; Kim, E; Kim, YJ				Kim, Eun-Kyung; Cho, Jae Hee; Kim, EuiJoo; Kim, Yoon Jae			Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; SUSTAINED ERK PHOSPHORYLATION; INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; DEOXYCHOLIC-ACID; CHEMOPREVENTIVE AGENT; ULCERATIVE-COLITIS; CYCLE PROGRESSION; RISK; APOPTOSIS	Introduction The regulation of reactive oxygen species (ROS) exists as a therapeutic target for cancer treatments. Previous studies have shown that ursodeoxycholic acid (UDCA) suppresses the proliferation of colon cancer cells. The aim of this study was to evaluate the effect of UDCA upon the proliferation of colon cancer cells as a direct result of the regulation of ROS. Method Colon cancer cell lines (HT29 and HCT116) were treated with UDCA. The total number of cells and the number of dead cells were determined using cell counters. A fluorescein isothiocyanate-bromodeoxyuridine flow kit was used to analyze cell cycle variations. Upon exposure to UDCA, the protein levels of p27, p21, CDK2, CDK4 and CDK6 were determined using western blotting, and qRT-PCR was used to determine levels of mRNA. We preformed dichlorofluorescindiacetate (DCF-DA) staining to detect alteration of intracellular ROS using fluorescence activated cell sorting (FACS). Colon cancer stem-like cell lines were generated by tumorsphere culture and treated with UDCA for seven days. The total number of tumorspheres was determined using microscopy. Results We found that UDCA reduced the total number of colon cancer cells, but did not increase the number of dead cells. UDCA inhibited the G1/S and G2/M transition phases in colon cancer cells. UDCA induced expression of cell cycle inhibitors such as p27 and p21. However, it was determined that UDCA suppressed levels of CDK2, CDK4, and CDK6. UDCA regulated intracellular ROS generation in colon cancer cells, and induced activation of Erk1/2. Finally, UDCA inhibited formation of colon cancer stem-like cells. Conclusion Our results indicate that UDCA suppresses proliferation through regulation of oxidative stress in colon cancer cells, as well as colon cancer stem-like cells.	[Kim, Eun-Kyung; Cho, Jae Hee; Kim, EuiJoo; Kim, Yoon Jae] Gachon Univ, Div Gastroenterol, Dept Internal Med, Gil Med Ctr, Incheon, South Korea; [Kim, Eun-Kyung] Gachon Univ, Gachon Med Res Inst, Gil Med Ctr, Incheon, South Korea	Gachon University; Gachon University	Kim, YJ (corresponding author), Gachon Univ, Div Gastroenterol, Dept Internal Med, Gil Med Ctr, Incheon, South Korea.	yoonmed@gilhospital.com	Cho, Jae Hee/AAL-8192-2020; Kim, Eui Joo/P-8348-2019; Kim, Yoon Jae/G-6633-2015	Cho, Jae Hee/0000-0003-4174-0091; Kim, Eui Joo/0000-0001-5573-7083; Kim, Yoon Jae/0000-0001-8477-6823	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A1A1A05008202]; Gachon University Gil Medial Cancer [2016-15]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Gachon University Gil Medial Cancer	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2014R1A1A1A05008202) and Gachon University Gil Medial Cancer #2016-15	Akare S, 2006, INT J CANCER, V119, P2958, DOI 10.1002/ijc.22231; Banerjee B, 2016, CANCER PREV RES, V9, P528, DOI 10.1158/1940-6207.CAPR-15-0276; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Cao AL, 2016, BIOL PHARM BULL, V39, P1300, DOI 10.1248/bpb.b16-00094; Cao L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-71; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Collins M, 2016, J CROHNS COLITIS; Dozio E, 2010, EUR J PHARMACOL, V641, P29, DOI 10.1016/j.ejphar.2010.05.009; Goulet AC, 2005, CARCINOGENESIS, V26, P109, DOI 10.1093/carcin/bgh306; Grbavac Z, 1989, Neurologija, V38, P95; Hansen JD, 2013, DIGEST DIS SCI, V58, P3079, DOI 10.1007/s10620-013-2772-0; Huang WK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002980; Huang YQ, 2016, WORLD J HEPATOL, V8, P1419, DOI 10.4254/wjh.v8.i33.1419; Ikegami T, 2008, HEPATOL RES, V38, P123, DOI 10.1111/j.1872-034X.2007.00297.x; Kim HY, 2015, INTEST RES, V13, P233, DOI 10.5217/ir.2015.13.3.233; Kim KY, 2001, J BIOL CHEM, V276, P40591, DOI 10.1074/jbc.M100975200; Kim YH, 2015, INTEST RES, V13, P145, DOI 10.5217/ir.2015.13.2.145; Kohno H, 2007, CLIN CANCER RES, V13, P2519, DOI 10.1158/1078-0432.CCR-06-2727; Kotb MA, 2012, INT J MOL SCI, V13, P8882, DOI 10.3390/ijms13078882; Krishna-Subramanian S, 2012, INT J CANCER, V130, P2771, DOI 10.1002/ijc.26336; Lim SC, 2010, INT J CANCER, V126, P1582, DOI 10.1002/ijc.24853; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Miura T, 2001, J BIOL CHEM, V276, P47371, DOI 10.1074/jbc.M107098200; Pardi DS, 2003, GASTROENTEROLOGY, V124, P889, DOI 10.1053/gast.2003.50156; Patel A, 2016, J CLIN EXP HEPATOL, V6, P311, DOI 10.1016/j.jceh.2016.10.001; Peiro-Jordan R, 2012, EUR J CANCER PREV, V21, P413, DOI 10.1097/CEJ.0b013e32834ef16f; Powell AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-219; Rinaldi S, 2006, INT J CANCER, V118, P2832, DOI 10.1002/ijc.21730; Serfaty L, 2003, HEPATOLOGY, V38, P203, DOI 10.1053/jhep.2003.50311; Shah SA, 2006, INT J CANCER, V118, P532, DOI 10.1002/ijc.21365; Shiraki K, 2005, INT J MOL MED, V16, P729; Singh S, 2013, INFLAMM BOWEL DIS, V19, P1631, DOI 10.1097/MIB.0b013e318286fa61; Sola S, 2003, J BIOL CHEM, V278, P48831, DOI 10.1074/jbc.M300468200; Szary N, 2015, BIOMOLECULES, V5, P3295, DOI 10.3390/biom5043295; Tung BY, 2001, ANN INTERN MED, V134, P89, DOI 10.7326/0003-4819-134-2-200101160-00008; Vogt A, 2001, J BIOL CHEM, V276, P20544, DOI 10.1074/jbc.M100078200; Wali RK, 2002, CANCER EPIDEM BIOMAR, V11, P1653; Wali RK, 2002, CANCER EPIDEM BIOMAR, V11, P1316; Wang ZQ, 2003, J BIOL CHEM, V278, P11138, DOI 10.1074/jbc.M209108200; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Wu WS, 2003, ONCOGENE, V22, P955, DOI 10.1038/sj.onc.1206237; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044	42	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181183	10.1371/journal.pone.0181183	http://dx.doi.org/10.1371/journal.pone.0181183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708871	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649800047
J	Zhu, FJ; Yang, ZY; Zhang, YL; Hu, K; Fang, WH				Zhu, Fengjiao; Yang, Zongying; Zhang, Yiliu; Hu, Kun; Fang, Wenhong			Transcriptome differences between enrofloxacin-resistant and enrofloxacinsusceptible strains of Aeromonas hydrophila	PLOS ONE			English	Article							PLASMID; GENES; INFECTION; SEQUENCE; CARP	Enrofloxacin is the most commonly used antibiotic to control diseases in aquatic animals caused by A. hydrophila. This study conducted de novo transcriptome sequencing and compared the global transcriptomes of enrofloxacin-resistant and enrofloxacin-susceptible strains. We got a total of 4,714 unigenes were assembled. Of these, 4,122 were annotated. A total of 3,280 unigenes were assigned to GO, 3,388 unigenes were classified into Cluster of Orthologous Groups of proteins (COG) using BLAST and BLAST2GO software, and 2,568 were mapped onto pathways using the Kyoto Encyclopedia of Gene and Genomes Pathway database. Furthermore, 218 unigenes were deemed to be DEGs. After enrofloxacin treatment, 135 genes were upregulated and 83 genes were downregulated. The GO terms biological process (126 genes) and metabolic process (136 genes) were the most enriched, and the terms for protein folding, response to stress, and SOS response were also significantly enriched. This study identified enrofloxacin treatment affects multiple biological functions of A. hydrophila. Enrofloxacin resistance in A. hydrophila is closely related to the reduction of intracellular drug accumulation caused by ABC transporters and increased expression of topoisomerase IV.	[Zhu, Fengjiao; Yang, Zongying; Zhang, Yiliu; Hu, Kun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China; [Yang, Zongying] Nanchang Acad Agr Sci, Nanchang, Jiangxi, Peoples R China; [Fang, Wenhong] East China Sea Fisheries Res Inst, Shanghai, Peoples R China	Shanghai Ocean University; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Hu, K (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	khu@shou.edu.cn			Special Fund for Agro-scientific Research in the Public interest [201203085]; 863 Program [2011AA10A216]; Key Project for Developing Agriculture by Science and Technology in Shanghai [2014-3-4]; National Natural Resources Platform; Shanghai University Knowledge Service Platform	Special Fund for Agro-scientific Research in the Public interest; 863 Program(National High Technology Research and Development Program of China); Key Project for Developing Agriculture by Science and Technology in Shanghai; National Natural Resources Platform; Shanghai University Knowledge Service Platform	This research was supported by the Special Fund for Agro-scientific Research in the Public interest (Grant 201203085), the 863 Program (Grant 2011AA10A216), the Key Project for Developing Agriculture by Science and Technology in Shanghai (Grant NO. 2014-3-4), the National Natural Resources Platform, and the Shanghai University Knowledge Service Platform.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Cockerill F. R, 2011, CLIN LAB STANDARDS I, P165; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Czesny S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031803; del Castillo CS, 2013, ANTIMICROB AGENTS CH, V57, P120, DOI 10.1128/AAC.01239-12; Huang L, 2015, GENE, V565, P275, DOI 10.1016/j.gene.2015.04.031; Khushiramani R, 2008, WORLD J MICROB BIOT, V24, P2263, DOI 10.1007/s11274-008-9740-4; Kregiel D., 2014, BIOMED RES INT, V104; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li J, 2012, ENVIRON HEALTH PERSP, V120, P1144, DOI 10.1289/ehp.1104776; Liu B., 2011, PLOS ONE, V6, P1159; Liu L, 2015, FISH SHELLFISH IMMUN, V45, P175, DOI 10.1016/j.fsi.2015.03.043; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Martinez M, 2006, VET J, V172, P10, DOI 10.1016/j.tvjl.2005.07.010; Mu XJ, 2013, FISH SHELLFISH IMMUN, V35, P1566, DOI 10.1016/j.fsi.2013.08.027; Peng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090636; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Plant KP, 2011, DEV COMP IMMUNOL, V35, P1256, DOI 10.1016/j.dci.2011.03.007; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Rodriguez I, 2008, FISH SHELLFISH IMMUN, V25, P239, DOI 10.1016/j.fsi.2008.05.002; Sahoo PK, 2008, FISH SHELLFISH IMMUN, V25, P163, DOI 10.1016/j.fsi.2008.04.003; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Shakir Z, 2012, APPL ENVIRON MICROB, V78, P8137, DOI 10.1128/AEM.02081-12; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van West P, 2010, FEMS MICROBIOL LETT, V310, P127, DOI 10.1111/j.1574-6968.2010.02055.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472	30	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179549	10.1371/journal.pone.0179549	http://dx.doi.org/10.1371/journal.pone.0179549			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708867	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800004
J	Chang, TY; Tsai, WC; Huang, TS; Su, SH; Chang, CY; Ma, HY; Wu, CH; Yang, CY; Lin, CH; Huang, PH; Cheng, CC; Cheng, SM; Wang, HW				Chang, Ting-Yu; Tsai, Wei-Chi; Huang, Tse-Shun; Su, Shu-Han; Chang, Chih-Young; Ma, Hsiu-Yen; Wu, Chun-Hsien; Yang, Chih-Yung; Lin, Chi-Hung; Huang, Po-Hsun; Cheng, Cheng-Chung; Cheng, Shu-Meng; Wang, Hsei-Wei			Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and-146b in cardiovascular disease patients	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; PROGENITOR CELLS; GASTRIC-CANCER; VASCULAR REPAIR; SERUM MICRORNAS; BIOMARKERS; ANGIOGENESIS; EXPRESSION; OUTGROWTH; PATHOGENESIS	Functional impairment of endothelial colony-forming cells (ECFCs), a specific cell lineage of endothelial progenitor cells (EPCs) is highly associated with the severity of coronary artery disease (CAD), the most common type of cardiovascular disease (CVD). Emerging evidence show that circulating microRNAs (miRNAs) in CAD patients' body fluid hold a great potential as biomarkers. However, our knowledge of the role of circulating miRNA in regulating the function of ECFCs and the progression of CAD is still in its infancy. We showed that when ECFCs from healthy volunteers were incubated with conditioned medium or purified exosomes of cultured CAD ECFCs, the secretory factors from CAD ECFCs dysregulated migration and tube formation ability of healthy ECFCs. It is known that exosomes influence the physiology of recipient cells by introducing RNAs including miRNAs. By using small RNA sequencing (smRNA-seq), we deciphered the circulating miRNome in the plasma of healthy individual and CAD patients, and found that the plasma miRNA spectrum from CAD patients was significantly different from that of healthy control. Interestingly, smRNA-seq of both healthy and CAD ECFCs showed that twelve miRNAs that had a higher expression in the plasma of CAD patients also showed higher expression in CAD ECFCs when compared with healthy control. This result suggests that these miRNAs may be involved in the regulation of ECFC functions. For identification of potential mRNA targets of the differentially expressed miRNA in CAD patients, cDNA microarray analysis was performed to identify the angiogenesis-related genes that were down-regulated in CAD ECFCs and Pearson's correlation were used to identify miRNAs that were negatively correlated with the identified angiogenesis- related genes. RT-qPCR analysis of the five miRNAs that negatively correlated with the down-regulated angiogenesis-related genes in plasma and ECFC of CAD patients showed miR-146a-5p and miR-146b-5p up-regulation compared to healthy control. Knockdown of miR-146a-5p or miR-146b-5p in CAD ECFCs enhanced migration and tube formation activity in diseased ECFCs. Contrarily, overexpression of miR-146a-5p or miR146b-5p in healthy ECFC repressed migration and tube formation in ECFCs. TargetScan analysis showed that miR-146a-5p and miR-146b-5p target many of the angiogenesis-elated genes that were down-regulated in CAD ECFCs. Knockdown of miR-146a-5p or miR-146b-5p restores CAV1 and RHOJ levels in CAD ECFCs. Reporter assays confirmed the direct binding and repression of miR-146a-5p and miR-146b-5p to the 3'-UTR of mRNA of RHOJ, a positive regulator of angiogenic potential in endothelial cells. Consistently, RHOJ knockdown inhibited the migration and tube formation ability in ECFCs. Collectively, we discovered the dysregulation of miR-146a-5p/RHOJ and miR-146b-5p/RHOJ axis in the plasma and ECFCs of CAD patients that could be used as biomarkers or therapeutic targets for CAD and other angiogenesis-related diseases.	[Chang, Ting-Yu] Taipei Med Univ, Res Ctr Translat Med, Taipei, Taiwan; [Tsai, Wei-Chi; Wu, Chun-Hsien; Cheng, Cheng-Chung; Cheng, Shu-Meng] Tri Serv Gen Hosp, Div Cardiol, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan; [Tsai, Wei-Chi; Huang, Tse-Shun; Su, Shu-Han; Chang, Chih-Young; Ma, Hsiu-Yen; Wu, Chun-Hsien; Yang, Chih-Yung; Lin, Chi-Hung; Wang, Hsei-Wei] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan; [Huang, Tse-Shun] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA; [Huang, Po-Hsun] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Huang, Po-Hsun] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Huang, Po-Hsun] Inst Clin Med, Taipei, Taiwan	Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; University of California System; University of California San Diego; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Cheng, SM (corresponding author), Tri Serv Gen Hosp, Div Cardiol, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan.	dmscmsc@yahoo.com.tw			Tri-Service General Hospital [TSGH C105-007-S02, TSGH-C106-005-007-S02, TSGH-C106-005-007-S03]; Ministry of Science and Technology [104-2911-1-010-506]; Personal Genomics, Inc.; Quark Biosciences, Inc.; National Health Research Institutes [NHRI-EX104-10254SI]; Taipei City Hospital [10401-62-014]; Ministry of Health and Welfare [MOHW105-TDU-B-212-134-001, MOHW106-TDU-B-212-144001]	Tri-Service General Hospital; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Personal Genomics, Inc.; Quark Biosciences, Inc.; National Health Research Institutes(National Health Research Institutes, Japan); Taipei City Hospital; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	Funding for this study was received from Tri-Service General Hospital (TSGH C105-007-S02, TSGH-C106-005-007-S02, TSGH-C106-005-007-S03), Ministry of Science and Technology (104-2911-1-010-506), Personal Genomics, Inc., Quark Biosciences, Inc., National Health Research Institutes (NHRI-EX104-10254SI), Taipei City Hospital (10401-62-014) and Ministry of Health and Welfare (MOHW105-TDU-B-212-134-001, MOHW106-TDU-B-212-144001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bakogiannis C, 2012, CURR MED CHEM, V19, P2597, DOI 10.2174/092986712800492995; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Cassar A, 2009, MAYO CLIN PROC, V84, P1130, DOI 10.4065/mcp.2009.0391; Cheng WC, 2013, NUCLEIC ACIDS RES, V41, pD285, DOI 10.1093/nar/gks1238; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Di YF, 2015, INT J CLIN EXP MED, V8, P11759; Donahue M, 2013, BIOL CHEM, V394, P1241, DOI 10.1515/hsz-2013-0110; Echavarria R, 2015, CARDIOVASC RES, V106, P465, DOI 10.1093/cvr/cvv120; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gomez-Banoy N, 2016, REV MED CHILE, V144, P355, DOI 10.4067/S0034-98872016000300011; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Han H, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.81; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Iguchi Haruhisa, 2010, Curr Drug Discov Technol, V7, P95; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Jialal I, 2010, ATHEROSCLEROSIS, V211, P297, DOI 10.1016/j.atherosclerosis.2010.01.036; Jin Y, 2015, MOL CELL BIOCHEM, V402, P111, DOI 10.1007/s11010-014-2319-5; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kim C, 2014, CANCER CELL, V25, P102, DOI 10.1016/j.ccr.2013.12.010; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Liu P, 2017, ONCOTARGET, V8, P1993, DOI 10.18632/oncotarget.12888; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu HQ, 2013, J GERIATR CARDIOL, V10, P34, DOI [10.3969/j.issn.1671-5411.2013.01.007, 10.3724/SP.J.1263.2013.01011]; Medina RJ, 2017, STEM CELL TRANSL MED, V6, P1316, DOI 10.1002/sctm.16-0360; Medina RJ, 2013, STEM CELLS, V31, P1657, DOI 10.1002/stem.1414; Medina RJ, 2011, MOL MED, V17, P1045, DOI 10.2119/molmed.2011.00129; Medina RJ, 2010, INVEST OPHTH VIS SCI, V51, P5906, DOI 10.1167/iovs.09-4951; Minami Y, 2009, EUR J CLIN INVEST, V39, P359, DOI 10.1111/j.1365-2362.2009.02110.x; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Pan Qunwen, 2016, Front Physiol, V7, P692, DOI 10.3389/fphys.2016.00692; Poitevin S, 2014, CARDIOVASC RES, V103, P121, DOI 10.1093/cvr/cvu104; Real Carla, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P185, DOI 10.2174/187152908785849071; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Shi TT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6386412; Smythe J, 2008, TISSUE ENG PT C-METH, V14, P59, DOI 10.1089/tec.2007.0251; Su SH, 2017, J VASC RES, V54, P22, DOI 10.1159/000449202; Sun M, 2015, CANCER BIOMARK, V15, P33, DOI 10.3233/CBM-140431; Tagawa S, 2015, INT J VASC MED, V2015, DOI 10.1155/2015/674213; Tasev D, 2016, TISSUE ENG PART B-RE, V22, P371, DOI 10.1089/ten.teb.2016.0050; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Wang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098070; Wang HW, 2014, ARTERIOSCL THROM VAS, V34, P857, DOI 10.1161/ATVBAHA.113.303001; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731; Wang SX, 2016, CARDIOVASC THER, V34, P199, DOI 10.1111/1755-5922.12187; Werner N, 2007, BASIC RES CARDIOL, V102, P565, DOI 10.1007/s00395-007-0680-1; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Wotschofsky Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148746; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yang RQ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027826; Yao QY, 2013, CANCER LETT, V335, P219, DOI 10.1016/j.canlet.2013.02.031; Ye E-A., 2016, MEDIATORS INFLAMM, V2016, P1; Yoon SO, 2016, ONCOTARGET, V7, P2475, DOI 10.18632/oncotarget.6542; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zhang QW, 2011, BIOCHEM BIOPH RES CO, V405, P42, DOI 10.1016/j.bbrc.2010.12.119	62	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181562	10.1371/journal.pone.0181562	http://dx.doi.org/10.1371/journal.pone.0181562			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727754	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500088
J	Jeong, S; Kim, JY; Jeong, SC; Kang, ST; Moon, JK; Kim, N				Jeong, Seongmun; Kim, Jae-Yoon; Jeong, Soon-Chun; Kang, Sung-Taeg; Moon, Jung-Kyung; Kim, Namshin			GenoCore: A simple and fast algorithm for core subset selection from large genotype datasets	PLOS ONE			English	Article							RESOURCES	Selecting core subsets from plant genotype datasets is important for enhancing cost-effectiveness and to shorten the time required for analyses of genome-wide association studies (GWAS), and genomics-assisted breeding of crop species, etc. Recently, a large number of genetic markers (>100,000 single nucleotide polymorphisms) have been identified from high-density single nucleotide polymorphism (SNP) arrays and next-generation sequencing (NGS) data. However, there is no software available for picking out the efficient and consistent core subset from such a huge dataset. It is necessary to develop software that can extract genetically important samples in a population with coherence. We here present a new program, GenoCore, which can find quickly and efficiently the core subset representing the entire population. We introduce simple measures of coverage and diversity scores, which reflect genotype errors and genetic variations, and can help to select a sample rapidly and accurately for crop genotype dataset. Comparison of our method to other core collection software using example datasets are performed to validate the performance according to genetic distance, diversity, coverage, required system resources, and the number of selected samples. GenoCore selects the smallest, most consistent, and most representative core collection from all samples, using less memory with more efficient scores, and shows greater genetic coverage compared to the other software tested. GenoCore was written in R language, and can be accessed online with an example dataset and test results at https://github.com/lovemun/Genocore.	[Jeong, Seongmun; Kim, Jae-Yoon; Kim, Namshin] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Div Strateg Res Grp, Daejeon, South Korea; [Kim, Jae-Yoon; Kim, Namshin] Korea Univ Sci & Technol, KRIBB Sch, Dept Biol Sci, Daejeon, South Korea; [Jeong, Soon-Chun] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongju, Chungbuk, South Korea; [Kang, Sung-Taeg] Dankook Univ, Dept Crop Sci & Biotechnol, Cheonan, Chungnam, South Korea; [Moon, Jung-Kyung] Rural Dev Adm, Natl Inst Crop Sci, Jeonju, Jeonbuk, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Dankook University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science	Kim, N (corresponding author), Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Div Strateg Res Grp, Daejeon, South Korea.; Kim, N (corresponding author), Korea Univ Sci & Technol, KRIBB Sch, Dept Biol Sci, Daejeon, South Korea.; Moon, JK (corresponding author), Rural Dev Adm, Natl Inst Crop Sci, Jeonju, Jeonbuk, South Korea.	moonjk2@korea.kr; deepreds@kribb.re.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X; Moon, Jung-Kyung/0000-0002-5394-617X; Jeong, Soon-Chun/0000-0003-0223-1155; Jeong, Seongmun/0000-0002-0038-461X	National Research Foundation of Korea [NRF-2011-0030049, NRF-2014M3C9A3064552]; Next-Gen Bio-Green21 [PJ011929]; KRIBB initiative program	National Research Foundation of Korea(National Research Foundation of Korea); Next-Gen Bio-Green21; KRIBB initiative program	This work was supported by the National Research Foundation of Korea (NRF-2011-0030049 and NRF-2014M3C9A3064552) (http://www.nrf.re.kr); Next-Gen Bio-Green21 (PJ011929) (http://www.rda.go.kr); and the KRIBB initiative program (http://www.kribb.re.kr) to NK.; This work was supported by grants from the National Research Foundation of Korea (NRF-2011-0030049, NRF-2014M3C9A3064552), Next-Gen Bio-Green21 PJ011929, and the KRIBB initiative program.	Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; De Beukelaer H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-312; Frankel O.H., 1984, CROP GENETIC RESOURC, P249; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Kim KW, 2007, BIOINFORMATICS, V23, P2155, DOI 10.1093/bioinformatics/btm313; Lee YG, 2015, PLANT J, V81, P625, DOI 10.1111/tpj.12755; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Thachuk C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-243; Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219; Wright S, 1978, VARIABILITY NATURAL, V4; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	12	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181420	10.1371/journal.pone.0181420	http://dx.doi.org/10.1371/journal.pone.0181420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727806	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500069
J	Uribe, DJ; Mandell, EK; Watson, A; Martinez, JD; Leighton, JA; Ghosh, S; Rothlin, CV				Uribe, Diana J.; Mandell, Edward K.; Watson, Adam; Martinez, Jesse D.; Leighton, Jonathan A.; Ghosh, Sourav; Rothlin, Carla V.			The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer	PLOS ONE			English	Article							TAM RECEPTORS; EXPRESSION; FAMILY; MER; CABOZANTINIB; TYRO3; NEUROPILIN-1; INHIBITOR; REGULATOR; SURVIVAL	The receptor tyrosine kinases (RTKs) TYRO3, AXL and MERTK (TAM) have well-described oncogenic functions in a number of cancers. Notwithstanding, TAM RTKs are also potent and indispensable inhibitors of inflammation. The combined deletion of Axl and Mertk in mice enhances chronic inflammation and autoimmunity, including increased inflammation in the gut and colitis-associated cancer. On the other hand, deletion of Tyro3 increases the risk of allergic responses. Therefore, the indiscriminate inhibition of these TAM RTKs could result in undesirable immunological diseases. Here we show that AXL, but not MERTK or TYRO3 expression is enhanced in late stage colorectal cancer (CRC) and AXL expression associates with a cell migration gene signature. Silencing AXL or the inhibition of AXL kinase activity significantly inhibits tumor cell migration and invasion. These results indicate that the selective inhibition of AXL alone might confer sufficient therapeutic benefit in CRC, while preserving at least some of the beneficial, anti-inflammatory effects of MERTK and TYRO3 RTKs.	[Uribe, Diana J.; Mandell, Edward K.; Watson, Adam; Martinez, Jesse D.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Leighton, Jonathan A.] Mayo Clin Arizona, Div Gastroenterol, Scottsdale, AZ USA; [Ghosh, Sourav] Yale Univ, Sch Med, Dept Neurol, Pharmacol, New Haven, CT 06510 USA; [Ghosh, Sourav; Rothlin, Carla V.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Rothlin, Carla V.] Yale Univ, Sch Med, Dept Immunobiol, Pharmacol, New Haven, CT 06510 USA; [Uribe, Diana J.] Ventana Med Syst Inc, Tucson, AZ USA	Arizona Center Cancer Care; University of Arizona; Mayo Clinic; Mayo Clinic Phoenix; Yale University; Yale University; Yale University; Roche Holding; Ventana Medical Systems, Inc.	Ghosh, S (corresponding author), Yale Univ, Sch Med, Dept Neurol, Pharmacol, New Haven, CT 06510 USA.; Ghosh, S; Rothlin, CV (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA.; Rothlin, CV (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Pharmacol, New Haven, CT 06510 USA.	sourav.ghosh@yale.edu; carla.rothlin@yale.edu		Watson, Adam/0000-0002-8871-9479; Rothlin, Carla V/0000-0002-5693-5572; Ghosh, Sourav/0000-0001-5990-8708	National Institutes of Health [R01 A1089824, R01 CA212376, R01 CA149258-S]; Crohn's and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (R01 A1089824 to C.V.R., R01 CA212376 to C.V.R. and S.G., and R01 CA149258-S to D.J.U.) and Crohn's and Colitis Foundation (to C.V.R and S.G.). C.V.R. is an HHMI Faculty Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake-Kawano R, 2013, CARCINOGENESIS, V34, P1567, DOI 10.1093/carcin/bgt069; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bosurgi L, 2013, P NATL ACAD SCI USA, V110, P13091, DOI 10.1073/pnas.1302507110; Brandao Luis, 2011, Critical Reviews in Oncogenesis, V16, P47; Chan PY, 2016, SCIENCE, V352, P99, DOI 10.1126/science.aaf1358; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; Chien CW, 2016, ONCOGENE, V35, P5872, DOI 10.1038/onc.2016.120; Choueiri TK, 2015, NEW ENGL J MED, V373, P1814, DOI 10.1056/NEJMoa1510016; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; Dunne PD, 2014, CLIN CANCER RES, V20, P164, DOI 10.1158/1078-0432.CCR-13-1354; Elisei R, 2013, J CLIN ONCOL, V31, P3639, DOI 10.1200/JCO.2012.48.4659; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Grandclement C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020444; Ha SY, 2014, J CLIN PATHOL, V67, P576, DOI 10.1136/jclinpath-2013-202163; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Howlader N., 2016, SEER CANC STAT REV 1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kariolis MS, 2014, NAT CHEM BIOL, V10, P977, DOI [10.1038/NCHEMBIO.1636, 10.1038/nchembio.1636]; Kimani SG, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0142-1; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Linger RM, 2012, ONCOGENE; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martinelli E, 2015, ONCOTARGET, V6, P23281, DOI 10.18632/oncotarget.3962; Maurer CA, 1998, INT J CANCER, V79, P76, DOI 10.1002/(SICI)1097-0215(19980220)79:1<76::AID-IJC15>3.0.CO;2-F; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ochiumi T, 2006, INT J ONCOL, V29, P105; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Rothlin CV, 2014, INFLAMM BOWEL DIS, V20, P1472, DOI 10.1097/MIB.0000000000000050; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Sawabu T, 2007, MOL CARCINOGEN, V46, P155, DOI 10.1002/mc.20211; Sheridan C, 2013, NAT BIOTECHNOL, V31, P775, DOI 10.1038/nbt0913-775a; Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010; Smith MR, 2014, J CLIN ONCOL, V32, P3391, DOI 10.1200/JCO.2013.54.5954; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; von Massenhausen A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010007; Wu CW, 2002, ANTICANCER RES, V22, P1071; Yuen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054211; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zhang SD, 2016, ONCOL LETT, V11, P1223, DOI 10.3892/ol.2015.3999	52	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0179979	10.1371/journal.pone.0179979	http://dx.doi.org/10.1371/journal.pone.0179979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727830	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500011
J	Volpato, N; Kobashigawa, J; Yasuda, CL; Kishimoto, ST; Fernandes, PT; Cendes, F				Volpato, Nathalia; Kobashigawa, Juliana; Yasuda, Clarissa Lin; Kishimoto, Simoni Thiemi; Fernandes, Paula Teixeira; Cendes, Fernando			Level of physical activity and aerobic capacity associate with quality of life in patients with temporal lobe epilepsy	PLOS ONE			English	Article							LEISURE-TIME; MOOD DISORDER; EXERCISE; FITNESS; ADULTS; RATS; POPULATION; HABITS	Epilepsy is more than seizures and includes a high risk of comorbidities and psychological disorders, leading to poor quality of life (QOL). Earlier studies have showed a sedentary lifestyle in people with epilepsy (PWE), which could contribute to poorer health and psychological problems. The purpose of the present study was to compare habits of physical activity (PA), aerobic capacity, and QOL between PWE and healthy controls in order to identify the necessity of intervention of habits and information on physical exercise (PE) and to better understand the importance of PE for PWE. The study included 38 patients with temporal lobe epilepsy and 20 normal controls. Both groups answered the WHOQOL-Bref, which assesses the level of QOL, and IPAQ to evaluate the level of PA. In addition, they were submitted to a treadmill maximal cardiopulmonary effort test to identify physical capacity. The continuous variables were compared between groups by t-test and a general linear model, and the frequencies were compared by Chi-Square test through SPSS software. There was no difference in the level of PA between groups by questionnaire evaluation. However, there were significant differences in overall QOL, physical health, and level of PA in relation to work and physical capacity between groups; controls demonstrated better scores than PWE. Controls presented better physical capacity than PWE by cardiopulmonary effort test. According to intra-group analyses, PWE who were physically active had better QOL than inactive PWE. The study concluded that questionnaires about PE may not be the best instrument of evaluation, as demonstrated by the discrepancy of results compared to the validated objective cardiopulmonary evaluation of level of PA and physical capacity in this study.	[Volpato, Nathalia; Yasuda, Clarissa Lin; Cendes, Fernando] Univ Estadual Campinas, UNICAMP, Neuroimaging Lab, Hosp Clin, Rua Vital Brasil, Campinas, SP, Brazil; [Kobashigawa, Juliana; Kishimoto, Simoni Thiemi; Fernandes, Paula Teixeira] Univ Estadual Campinas, UNICAMP, Phys Educ Coll, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Cendes, F (corresponding author), Univ Estadual Campinas, UNICAMP, Neuroimaging Lab, Hosp Clin, Rua Vital Brasil, Campinas, SP, Brazil.	fcendes@unicamp.br	Fernandes, Paula Teixeira/D-7714-2013; Cendes, Fernando/C-1301-2012; yasuda, clarissa lin/D-4599-2018; yasuda, clarissa l/B-7934-2013	Fernandes, Paula Teixeira/0000-0002-0492-1670; Cendes, Fernando/0000-0001-9336-9568; yasuda, clarissa lin/0000-0001-9084-7173; yasuda, clarissa l/0000-0001-9084-7173	Fapesp [2014/05435-8, 2013/07559-3]	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fapesp:2014/05435-8, www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the FAPESP for its financial support (grants no. 2014/05435-8 and no. 2013/07559-3).	Arida RM, 2007, PROG NEURO-PSYCHOPH, V31, P814, DOI 10.1016/j.pnpbp.2007.01.021; Arida RM, 2009, ARQ NEURO-PSIQUIAT, V67, P1013, DOI 10.1590/S0004-282X2009000600010; Arida RM, 2004, PHYSIOL BEHAV, V83, P165, DOI 10.1016/j.physbeh.2004.08.008; Arida RM, 2003, EPILEPSY BEHAV, V4, P507, DOI 10.1016/S1525-5050(03)00184-7; Baker GA, 1997, EPILEPSIA, V38, P353, DOI 10.1111/j.1528-1157.1997.tb01128.x; Berg AT, 2008, CURR OPIN NEUROL, V21, P173, DOI 10.1097/WCO.0b013e3282f36ccd; BJORHOLT PG, 1990, EPILEPSIA, V31, P83, DOI 10.1111/j.1528-1157.1990.tb05364.x; Camilo F, 2009, ARQ NEURO-PSIQUIAT, V67, P1007, DOI 10.1590/S0004-282X2009000600009; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cendes F, 2014, ACTA NEUROPATHOL, V128, P21, DOI 10.1007/s00401-014-1292-0; Clarke BM, 2006, EPILEPSY BEHAV, V9, P119, DOI 10.1016/j.yebeh.2006.04.008; de Lima C, 2013, EPILEPSY BEHAV, V28, P47, DOI 10.1016/j.yebeh.2013.03.016; DeToledo JC, 2003, EPILEPSY BEHAV, V4, P553, DOI 10.1016/S1525-5050(03)00155-0; Elliott JO, 2008, EPILEPSY BEHAV, V13, P307, DOI 10.1016/j.yebeh.2008.04.003; ERIKSEN HR, 1994, EPILEPSIA, V35, P1256, DOI 10.1111/j.1528-1157.1994.tb01797.x; FLETCHER GF, 1990, CIRCULATION, V82, P2286, DOI 10.1161/01.CIR.82.6.2286; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Gobbo OL, 2005, BEHAV BRAIN RES, V159, P21, DOI 10.1016/j.bbr.2004.09.021; Gordon KE, 2010, EPILEPSIA, V51, P2254, DOI 10.1111/j.1528-1167.2010.02709.x; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; HERMANN BP, 1992, J EPILEPSY, V5, P153, DOI 10.1016/S0896-6974(05)80134-3; Lehrner J, 1999, SEIZURE-EUR J EPILEP, V8, P88, DOI 10.1053/seiz.1999.0272; Lhatoo SD, 2000, EPILEPSIA, V41, P1592; Liou HH, 2005, EPILEPSY RES, V64, P151, DOI 10.1016/j.eplepsyres.2005.03.006; Marques CM, 2007, EPILEPSY BEHAV, V10, P477, DOI 10.1016/j.yebeh.2007.02.002; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; McAuley JW, 2001, EPILEPSY BEHAV, V2, P592, DOI 10.1006/ebeh.2001.0271; MILLINGTON JT, 1985, JAMA-J AM MED ASSOC, V254, P3182, DOI 10.1001/jama.1985.03360220044021; NAKKEN KO, 1990, EPILEPSIA, V31, P88, DOI 10.1111/j.1528-1157.1990.tb05365.x; Ramaratnam S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002029.pub3; ROTH DL, 1994, EPILEPSIA, V35, P1248, DOI 10.1111/j.1528-1157.1994.tb01796.x; Steinhoff BJ, 1996, EPILEPSIA, V37, P1221, DOI 10.1111/j.1528-1157.1996.tb00557.x; Sturm JW, 2002, NEUROLOGY, V59, P1246, DOI 10.1212/WNL.59.8.1246; Wasserman K, 2004, PRINCIPLES EXERCISE, V4th; Werz MA, 2005, EPILEPSY BEHAV, V6, P98, DOI 10.1016/j.yebeh.2004.11.008; World Health Organization, 1995, EXP COMM PHYS STAT U	36	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181505	10.1371/journal.pone.0181505	http://dx.doi.org/10.1371/journal.pone.0181505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723919	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800055
J	Mostert, D; Molina, AB; Daniells, J; Fourie, G; Hermanto, C; Chao, CP; Fabregar, E; Sinohin, VG; Masdek, N; Thangavelu, R; Li, CY; Yi, GY; Mostert, L; Viljoen, A				Mostert, Diane; Molina, Agustin B.; Daniells, Jeff; Fourie, Gerda; Hermanto, Catur; Chao, Chih-Ping; Fabregar, Emily; Sinohin, Vida G.; Masdek, Nik; Thangavelu, Raman; Li, Chunyu; Yi, Ganyun; Mostert, Lizel; Viljoen, Altus			The distribution and host range of the banana Fusarium wilt fungus, Fusarium oxysporum f. sp cubense, in Asia	PLOS ONE			English	Article							VEGETATIVE COMPATIBILITY GROUPS; TROPICAL RACE 4; GENETIC-VARIATION; PANAMA-DISEASE	Fusarium oxysporum formae specialis cubense (Foc) is a soil-borne fungus that causes Fusarium wilt, which is considered to be the most destructive disease of bananas. The fungus is believed to have evolved with its host in the Indo-Malayan region, and from there it was spread to other banana-growing areas with infected planting material. The diversity and distribution of Foc in Asia was investigated. A total of 594 F. oxysporum isolates collected in ten Asian countries were identified by vegetative compatibility groups (VCGs) analysis. To simplify the identification process, the isolates were first divided into DNA lineages using PCR-RFLP analysis. Six lineages and 14 VCGs, representing three Foc races, were identified in this study. The VCG complex 0124/5 was most common in the Indian subcontinent, Vietnam and Cambodia; whereas the VCG complex 01213/16 dominated in the rest of Asia. Sixty-nine F. oxysporum isolates in this study did not match any of the known VCG tester strains. In this study, Foc VCG diversity in Bangladesh, Cambodia and Sri Lanka was determined for the first time and VCGs 01221 and 01222 were first reported from Cambodia and Vietnam. New associations of Foc VCGs and banana cultivars were recorded in all the countries where the fungus was collected. Information obtained in this study could help Asian countries to develop and implement regulatory measures to prevent the incursion of Foc into areas where it does not yet occur. It could also facilitate the deployment of disease resistant banana varieties in infested areas.	[Mostert, Diane; Mostert, Lizel; Viljoen, Altus] Stellenbosch Univ, Dept Plant Pathol, Stellenbosch, South Africa; [Molina, Agustin B.; Sinohin, Vida G.] Biovers Int Asia Pacific, IRRI Campus, Los Banos, Philippines; [Daniells, Jeff] Dept Agr & Fisheries, South Johnstone, Qld, Australia; [Fourie, Gerda] Univ Pretoria, Dept Microbiol & Plant Pathol, FABI, Pretoria, South Africa; [Hermanto, Catur] Indonesian Agcy Agr Res & Dev, Jakarta, Indonesia; [Chao, Chih-Ping] Taiwan Banana Res Inst, Pingtung, Taiwan; [Fabregar, Emily] Lapanday Foods Corp, Davao, Philippines; [Masdek, Nik] Malaysian Agr Res & Dev Inst, Selangor, Malaysia; [Thangavelu, Raman] ICAR Natl Res Ctr Banana, Tiruchirappalli, Tamil Nadu, India; [Li, Chunyu; Yi, Ganyun] Guangdong Acad Agr Sci, Inst Fruit Tree Res, Guangzhou, Guangdong, Peoples R China	Stellenbosch University; University of Pretoria; Indonesian Agency for Agricultural Research & Development; Institute Penyelidikan Dan Kemajuan Pertanian; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre for Banana; Guangdong Academy of Agricultural Sciences	Mostert, D (corresponding author), Stellenbosch Univ, Dept Plant Pathol, Stellenbosch, South Africa.	diane@sun.ac.za	Li, Chunyu/AAB-7399-2020		Lapanday Foods Corporation	Lapanday Foods Corporation	I am herewith declaring that the work included in the research article titled "The distribution and host range of Fusarium oxysporum f. sp. cubense vegetative compatibility groups in Asia" were not funded by the Lapanday Foods Corporation. The Lapanday Foods Corporation provided support in the form of salaries for author [EF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author [EF] has been edited in the 'author contributions' section.	Ammar M. I., 2007, Egyptian Journal of Phytopathology, V35, P81; [Anonymous], 2006, BLACKWELL PUB PROF; Bentley S, 1998, PHYTOPATHOLOGY, V88, P1283, DOI 10.1094/PHYTO.1998.88.12.1283; BENTLEY S, 1995, MYCOL RES, V99, P1378, DOI 10.1016/S0953-7562(09)81225-2; Bentley S, 1996, J PHYTOPATHOL, V144, P207, DOI 10.1111/j.1439-0434.1996.tb01516.x; BOEHM EWA, 1994, MOL PLANT MICROBE IN, V7, P196, DOI 10.1094/MPMI-7-0196; Chen HouBin, 2005, Advancing banana and plantain R&D in Asia and the Pacific, Vol.13. Proceedings of the 3rd BAPNET Steering Committee meeting held in Guangzhou, China, 23-26 November, 2004, P165; CORRELL JC, 1991, PHYTOPATHOLOGY, V81, P1061; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; EDEL V, 1995, PHYTOPATHOLOGY, V85, P579, DOI 10.1094/Phyto-85-579; Espino C, 1999, PANAMA DIS; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Fourie G, 2009, APPL ENVIRON MICROB, V75, P4770, DOI 10.1128/AEM.00370-09; Groenewald S, 2006, MYCOL RES, V110, P297, DOI 10.1016/j.mycres.2005.10.004; Gulino L, 2007, AUSTR BANANAS, V25, P46; Hermanto C, 2011, ACTA HORTIC, V897, P313; Huang BingZhi, 2005, Advancing banana and plantain R&D in Asia and the Pacific, Vol.13. Proceedings of the 3rd BAPNET Steering Committee meeting held in Guangzhou, China, 23-26 November, 2004, P187; Hwang SC, 2004, PLANT DIS, V88, P580, DOI 10.1094/PDIS.2004.88.6.580; Jones D. R., 2000, P1; Kangire A., 2001, BANANA FUSARIUM WILT, P152; Katan T, 1999, PHYTOPARASITICA, V27, P51, DOI 10.1007/BF02980727; Koenig RL, 1997, PHYTOPATHOLOGY, V87, P915, DOI 10.1094/PHYTO.1997.87.9.915; Lescot T., 2015, FRUITROP, V231, P98; LESLIE JF, 1990, FUSARIUM WILT OF BANANA, P37; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; Li CY, 2013, FUNGAL GENOM BI 1126; Lin YH, 2009, EUR J PLANT PATHOL, V123, P353, DOI 10.1007/s10658-008-9372-4; Lodwig EM, 1999, J APPL MICROBIOL, V86, P71, DOI 10.1046/j.1365-2672.1999.00635.x; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Masdek N, 2003, 2 INT S FUS WILT BAN; Molina AB, 2008, PHYTOPATHOLOGY, V98, pS108; Molina AB, 2009, ACTA HORTIC, V828, P109; Molina AB, 2001, P INT WORKSH BAN FUS; Molina AB., 2014, STATUS EPIDEMICS R D; MOORE NY, 1993, AUST J EXP AGR, V33, P797, DOI 10.1071/EA9930797; Nayar NM, 2010, HORTICULTURAL REV, V36, P118; NELSON PE, 1983, FUSARIUM SPECIES AN; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Neill WT, 2011, ACTA HORTIC, V897, P345, DOI 10.17660/ActaHortic.2011.897.47; Pegg K., 1994, IMPROVEMENT TESTING, P70; Ploetz R, 1997, AUSTRALAS PLANT PATH, V26, P239, DOI 10.1071/AP97039; Ploetz R. C., 1992, Plant diseases of international importance. Volume III. Diseases of fruit crops., P270; Ploetz R. C., 2005, Plant Health Progress, P1; Ploetz R. C., 2000, P143; Ploetz RC, 2015, PHYTOPATHOLOGY, V105, P1512, DOI 10.1094/PHYTO-04-15-0101-RVW; Ploetz RC, 2015, CROP PROT, V73, P7, DOI 10.1016/j.cropro.2015.01.007; PLOETZ RC, 1988, PLANT DIS, V72, P325, DOI 10.1094/PD-72-0325; PLOETZ RC, 1990, FUSARIUM WILT OF BANANA, P63; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; PLOETZ RC, 1994, INT J PEST MANAGE, V40, P326, DOI 10.1080/09670879409371908; Ploetz RC, 1997, FRUITS, V51, P387; PUHALLA JE, 1985, CAN J BOT, V63, P179, DOI 10.1139/b85-020; Riska J., 2012, ARPN J AGR BIOL SCI, V4, P244; Rutherford MA, 2001, BANANA FUSARIUM WILT, P86; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Soluri John, 2005, BANANA CULTURES AGR; Somrith A., 2011, Kasetsart Journal, Natural Sciences, V45, P451; Stover R.H., 1962, FUSARIAL WILT PANAMA; STOVER RH, 1990, FUSARIUM WILT OF BANANA, P1; Stover RH, 1987, BANANAS, P486; SU HJ, 1986, PLANT DIS, V70, P814, DOI 10.1094/PD-70-814; SU HJ, 1977, TAIWAN BANANA RES I, V2, P22; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Teunissen HAS, 2002, MOL GENET GENOMICS, V268, P298, DOI 10.1007/s00438-002-0747-5; Thangavelu R, 2012, MOL BIOTECHNOL, V51, P203, DOI 10.1007/s12033-011-9457-8; Thangavelu R, 2003, 2 INT S FUS WILT BAN; Thangavelu R., 2001, BANANA FUSARIUM WILT, P58; Valmayor R., 2000, BANANA CULTIVAR NAME; Viljoen A, 2002, S AFR J SCI, V98, P341; WAITE B. H., 1960, Canadian Journal of Botany, V38, P985, DOI 10.1139/b60-087	70	52	59	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181630	10.1371/journal.pone.0181630	http://dx.doi.org/10.1371/journal.pone.0181630			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719631	Green Published, Green Accepted, gold			2022-12-27	WOS:000406061400060
J	Rahman, M; Sadygov, RG				Rahman, Mahbubur; Sadygov, Rovshan G.			Predicting the protein half-life in tissue from its cellular properties	PLOS ONE			English	Article							EXPRESSION	Protein half-life is an important feature of protein homeostasis (proteostasis). The increasing number of in vivo and in vitro studies using high throughput proteomics provide estimates of the protein half-lives in tissues and cells. However, protein half-lives in cells and tissues are different. Due to the resource requirements for researching tissues, more data is available from cellular studies than tissues. We have designed a multivariate linear model for predicting protein half-life in tissue from its cellular properties. Inputs to the model are cellular half-life, abundance, intrinsically disordered sequences, and transcriptional and translational rates. Before the modeling, we determined substructures in the data using the relative distance from the regression line of the protein half-lives in tissues and cells, identifying three separate clusters. The model was trained on and applied to predict protein half-lives from murine liver, brain and heart tissues. In each tissue type we observed similar prediction patterns of protein half-lives. We found that the model provides the best results when there is a strong correlation between tissue and cell culture protein half-lives. Additionally, we clustered the protein half-lives to determine variations in correlation coefficients between the protein half-lives in the tissue versus in cell culture. The clusters identify strongly and weakly correlated protein half-lives, further improves the overall prediction and identifies sub groupings which exhibit specific characteristics. The model described herein, is generalizable to other data sets and has been implemented in a freely available R code.	[Rahman, Mahbubur; Sadygov, Rovshan G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Rahman, M; Sadygov, RG (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Mol Med, Galveston, TX 77555 USA.	mahrahma@utmb.edu; rovshan.sadygov@utmb.edu			NIGMS of NIH [R01GM112044]; NIGMS of National Institutes of Health (US) [R01GM112044]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112044] Funding Source: NIH RePORTER	NIGMS of NIH; NIGMS of National Institutes of Health (US); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIGMS of NIH under the award R01GM112044.; This work was supported in part by the NIGMS of National Institutes of Health (US) under the award R01GM112044. The fund was received by RGS.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Chiang JH, 2003, IEEE T FUZZY SYST, V11, P518, DOI 10.1109/TFUZZ.2003.814839; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Freedman D.A., 2009, STAT MODELS THEORY P; Fritsch S, 2016, NEURALNET; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guan SH, 2012, ANAL CHEM, V84, P4014, DOI 10.1021/ac203330z; Huang CH, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-015-0246-z; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Lau E, 2016, LARGE DATASET PROTEI, P3; Lau E, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.15; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; McCullagh P, 1989, GEN LINEAR MODELS; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miyagi M, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0378; Murata T, 1996, COMPUT IND ENG, V30, P957, DOI 10.1016/0360-8352(96)00045-9; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Scrucca L, 2013, J STAT SOFTW, V53, P1; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j	23	7	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180428	10.1371/journal.pone.0180428	http://dx.doi.org/10.1371/journal.pone.0180428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719664	gold, Green Submitted, Green Published			2022-12-27	WOS:000406061400013
J	Siqueira, FM; Perez-Wohlfeil, E; Carvalho, FM; Trelles, O; Schrank, IS; Vasconcelos, ATR; Zaha, A				Siqueira, Franciele Maboni; Perez-Wohlfeil, Esteban; Carvalho, Fabiola Marques; Trelles, Oswaldo; Schrank, Irene Silveira; Ribeiro Vasconcelos, Ana Tereza; Zaha, Arnaldo			Microbiome overview in swine lungs	PLOS ONE			English	Article							DISTANCE AIRBORNE TRANSPORT; MYCOPLASMA-HYOPNEUMONIAE; PIGS; PNEUMONIA; TISSUE; DIVERSITY; INFECTION; PATHOGENS; HYORHINIS; DISEASE	Mycoplasma hyopneumoniae is the etiologic agent of swine enzootic pneumonia. However other mycoplasma species and secondary bacteria are found as inhabitants of the swine respiratory tract, which can be also related to disease. In the present study we have performed a total DNA metagenomic analysis from the lungs of pigs kept in a field condition, with suggestive signals of enzootic pneumonia and without any infection signals to evaluate the bacteria variability of the lungs microbiota. Libraries from metagenomic DNA were prepared and sequenced using total DNA shotgun metagenomic pyrosequencing. The metagenomic distribution showed a great abundance of bacteria. The most common microbial families identified from pneumonic swine's lungs were Mycoplasmataceae, Flavobacteriaceae and Pasteurellaceae, whereas in the carrier swine's lungs the most common families were Mycoplasmataceae, Bradyrhizobiaceae and Flavobacteriaceae. Analysis of community composition in both samples confirmed the high prevalence of M. hyopneumoniae. Moreover, the carrier lungs had more diverse family population, which should be related to the lungs normal flora. In summary, we provide a wide view of the bacterial population from lungs with signals of enzootic pneumonia and lungs without signals of enzootic pneumonia in a field situation. These bacteria patterns provide information that may be important for the establishment of disease control measures and to give insights for further studies.	[Siqueira, Franciele Maboni; Schrank, Irene Silveira; Zaha, Arnaldo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Perez-Wohlfeil, Esteban; Trelles, Oswaldo] Univ Malaga, Dept Comp Architecture, Malaga, Spain; [Carvalho, Fabiola Marques; Ribeiro Vasconcelos, Ana Tereza] Lab Bioinformat, Lab Nacl Comp Cient, Rio De Janeiro, Brazil	Universidade Federal do Rio Grande do Sul; Universidad de Malaga; Laboratorio Nacional de Computacao Cientifica (LNCC)	Zaha, A (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.	zaha@cbiot.ufrgs.br	Carvalho, Fabiola M/I-4394-2016; Zaha, Arnaldo/D-3165-2013; Vasconcelos, Ana Tereza R/I-1011-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Siqueira, Franciele M/K-4043-2014	Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Siqueira, Franciele M/0000-0001-7282-6117; Zaha, Arnaldo/0000-0001-6336-474X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CAPES-COFECUB [23038.001507/2013-81]; CAPES-Biologia Computacional [23038.010043/2013-02]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CAPES-COFECUB; CAPES-Biologia Computacional	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CAPES-COFECUB - Grant number: 23038.001507/2013-81 and CAPES-Biologia Computacional - Grant number: 23038.010043/2013-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barfod KK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-303; Charlebois A, 2014, VET MICROBIOL, V168, P348, DOI 10.1016/j.vetmic.2013.11.006; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Dee S, 2009, VET RES, V40, DOI 10.1051/vetres/2009022; FALK K, 1991, ACTA VET SCAND, V32, P67; Fano E, 2007, CAN J VET RES, V71, P195; Neto JCG, 2014, VET MICROBIOL, V174, P163, DOI 10.1016/j.vetmic.2014.08.008; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim HB, 2015, VET MICROBIOL, V177, P242, DOI 10.1016/j.vetmic.2015.03.014; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Lin JH, 2006, VET MICROBIOL, V115, P111, DOI 10.1016/j.vetmic.2006.02.004; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Michiels A, 2015, PREV VET MED, V121, P99, DOI 10.1016/j.prevetmed.2015.06.011; Moorkamp L, 2008, VET J, V175, P273, DOI 10.1016/j.tvjl.2007.01.008; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Palzer A, 2008, VET REC, V162, P267, DOI 10.1136/vr.162.9.267; Perez-Wohlfeil E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3063-x; RUBERG SJ, 1991, BIOMETRICS, V47, P1059, DOI 10.2307/2532658; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Sibila M, 2007, VET MICROBIOL, V121, P352, DOI 10.1016/j.vetmic.2006.12.028; Siqueira FM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-175; Slenker AK, 2012, J CLIN MICROBIOL, V50, P4166, DOI 10.1128/JCM.01761-12; Sorensen V, 2006, DIS SWINE; Stark KDC, 2000, VET J, V159, P37, DOI 10.1053/tvjl.1999.0421; Vangroenweghe F, 2015, J VET DIAGN INVEST, V27, P606, DOI 10.1177/1040638715595062; Vela AI, 2007, INT J SYST EVOL MICR, V57, P1291, DOI 10.1099/ijs.0.64537-0; Vranckx K, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-24; Yamaguti M, 2015, VET REC, V2, DOI 10.1136/vetreco-2014-000093; Young TF, 2000, VET MICROBIOL, V71, P269, DOI 10.1016/S0378-1135(99)00176-5	36	24	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181503	10.1371/journal.pone.0181503	http://dx.doi.org/10.1371/journal.pone.0181503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719637	gold, Green Published, Green Submitted			2022-12-27	WOS:000406061400052
J	Morud, J; Ashouri, A; Larsson, E; Ericson, M; Soderpalm, B				Morud, Julia; Ashouri, Arghavan; Larsson, Erik; Ericson, Mia; Soderpalm, Bo			Transcriptional profiling of the rat nucleus accumbens after modest or high alcohol exposure	PLOS ONE			English	Article							INTERMITTENT ETHANOL EXPOSURE; GENE-EXPRESSION CHANGES; MOTIVATION; ADDICTION; AMYGDALA	Alcohol use disorder is a chronic relapsing brain disorder and a global health issue. Prolonged high alcohol consumption increases the risk for dependence development, a complex state that includes progressive alterations in brain function. The molecular mechanisms behind these changes remain to be fully disclosed, but several genes show altered expression in various regions of the rat brain even after modest alcohol exposure. The present study utilizes whole-transcriptome sequencing (RNA-seq) to investigate expression changes in the brain nucleus accumbens (NAc), an area of particular interest in addictive disorders, of alcohol consuming rats. The impact on gene expression after eight weeks of moderate voluntary alcohol consumption or voluntary consumption combined with forced excessive exposure was explored in two separate experiments. The results point to a lack of strong and consistent expression alterations in the NAc after alcohol exposure, suggesting that transcriptional effects of alcohol are weak or transient, or occur primarily in brain regions other than NAc.	[Morud, Julia; Ericson, Mia; Soderpalm, Bo] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Addict Biol Unit, Gothenburg, Sweden; [Ashouri, Arghavan; Larsson, Erik] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Soderpalm, Bo] Sahlgrens Univ Hosp, Beroendekliniken, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital	Morud, J (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Addict Biol Unit, Gothenburg, Sweden.	julia.morud@neuro.gu.se	Ashouri, Arghavan/C-2607-2019; Larsson Lekholm, Erik/HDM-8032-2022; Ericson, Mia/AAI-9992-2021; Larsson Lekholm, Erik/AHE-0932-2022	Larsson Lekholm, Erik/0000-0003-1400-0119; Larsson Lekholm, Erik/0000-0003-1400-0119; ericson, Mia/0000-0002-7557-7109	Swedish Medical research council [2014-3596, 2014-3887, 2015-02894]; Swedish Brain Foundation; Bror Gadelius Minnesfond; Thurings Stiftelse [2015-00100]; WM Lundgrens Stiftelse [2016-1035]	Swedish Medical research council(Swedish Medical Research Council (SMRC)); Swedish Brain Foundation; Bror Gadelius Minnesfond; Thurings Stiftelse; WM Lundgrens Stiftelse	Financial support was obtained from the Swedish Medical research council (EL, ME, BS. Grant numbers: 2014-3596, 2014-3887, 2015-02894), Swedish Brain Foundation (BS), Bror Gadelius Minnesfond (JM), Thurings Stiftelse (JM: 2015-00100) and WM Lundgrens Stiftelse (JM: 2016-1035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews MM, 2011, BIOL PSYCHIAT, V69, P675, DOI 10.1016/j.biopsych.2010.09.049; Carnicella S, 2014, ALCOHOL, V48, P243, DOI 10.1016/j.alcohol.2014.01.006; Chang GQ, 2010, ALCOHOL CLIN EXP RES, V34, P761, DOI 10.1111/j.1530-0277.2010.01148.x; Farris SP, 2010, INT REV NEUROBIOL, V91, P95, DOI 10.1016/S0074-7742(10)91004-0; Freeman K, 2013, ALCOHOL CLIN EXP RES, V37, pE88, DOI 10.1111/j.1530-0277.2012.01910.x; Gorini G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082656; Guo YQ, 2012, ALCOHOL CLIN EXP RES, V36, P1058, DOI 10.1111/j.1530-0277.2011.01689.x; Hopf FW, 2014, ALCOHOL, V48, P253, DOI 10.1016/j.alcohol.2014.03.001; Jonsson S, 2014, ALCOHOL CLIN EXP RES, V38, P722, DOI 10.1111/acer.12307; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Linsenbardt DN, 2014, ADDICT BIOL, V19, P812, DOI 10.1111/adb.12052; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; McBride WJ, 2010, ALCOHOL, V44, P171, DOI 10.1016/j.alcohol.2009.12.001; Melendez RI, 2012, ADDICT BIOL, V17, P351, DOI 10.1111/j.1369-1600.2011.00357.x; Momeni S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00424; Mulligan MK, 2011, ALCOHOL CLIN EXP RES, V35, P659, DOI 10.1111/j.1530-0277.2010.01384.x; O'Dell LE, 2004, ALCOHOL CLIN EXP RES, V28, P1676, DOI 10.1097/01.ALC.0000145781.11923.4E; Oberlin BG, 2015, PSYCHOPHARMACOLOGY, V232, P2207, DOI 10.1007/s00213-014-3850-5; Osterndorff-Kahanek E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059870; Osterndorff-Kahanek EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121522; Palm S, 2011, ALCOHOL, V45, P607, DOI 10.1016/j.alcohol.2010.11.005; Pickering C, 2015, PHARMACOL BIOCHEM BE, V132, P63, DOI 10.1016/j.pbb.2015.02.021; Ron D, 2013, CURR TOP BEHAV NEURO, V13, P87, DOI 10.1007/7854_2011_161; Soderpalm B, 2013, CURR TOP BEHAV NEURO, V13, P127, DOI 10.1007/7854_2011_170; Sommer WH, 2005, ADDICT BIOL, V10, P71, DOI 10.1080/13556210412331327821; Sommer WH, 2008, BIOL PSYCHIAT, V63, P139, DOI 10.1016/j.biopsych.2007.01.010; Spoelder M, 2015, ALCOHOL CLIN EXP RES, V39, P2427, DOI 10.1111/acer.12891; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Volkow ND, 2007, J NEUROSCI, V27, P12700, DOI 10.1523/JNEUROSCI.3371-07.2007; Volkow ND, 2013, J NEUROSCI, V33, P4527, DOI 10.1523/JNEUROSCI.5261-12.2013; Zahr NM, 2014, PSYCHOPHARMACOLOGY, V231, P429, DOI 10.1007/s00213-013-3253-z	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181084	10.1371/journal.pone.0181084	http://dx.doi.org/10.1371/journal.pone.0181084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715440	Green Submitted, gold, Green Published			2022-12-27	WOS:000443975500025
J	Pan, ML; Chen, LR; Tsao, HM; Chen, KH				Pan, Mei-Lien; Chen, Li-Ru; Tsao, Hsiao-Mei; Chen, Kuo-Hu			Risk of gestational hypertension-preeclampsia in women with preceding endometriosis: A nationwide population-based study	PLOS ONE			English	Article							PREDICTION; DANAZOL; OBESITY; TROPHOBLAST; DIAGNOSIS; CELLS	Objective To investigate the association between preceding endometriosis and gestational hypertension-preeclampsia (GH-PE). Methods In this nationwide population-based longitudinal study, data from 1998-2012 Taiwan National Health Insurance Research Database were used. We used ICD9-CM codes 617.X and 642.X respectively for the diagnoses of endometriosis and GH-PE, which were further confirmed by examining medical records of surgeries, blood pressure and urine protein to ensure the accuracy of the diagnoses. The study excluded women diagnosed with endometriosis at < 15 or > 45 years of age, chronic hypertension, and GH-PE prior to endometriosis. Each pregnant woman with a prior diagnosis of endometriosis was matched to 4 pregnant women without endometriosis by age. Logistic regression analysis was used to calculate odds ratios (ORs) for the risk of GH-PE with adjustment for age, occupation, urbanization, economic status and comorbidities. Results Among 6,300 women with a prior endometriosis diagnosis who were retrieved from a population of 1,000,000 residents, 2,578 (40.92%) had subsequent pregnancies that were eligible for further analysis and were compared with 10,312 pregnant women without previous endometriosis. GH-PE occurred more in women with prior endometriosis as compared to those without endometriosis (3.88% vs. 1.63%, p<0.0001). Further analysis revealed prior endometriosis was associated with GH-PE (adjusted OR = 2.27; 95% CI: 1.76-2.93). For danazol-treated and non-danazol-treated subgroups, the incidences of GH-PE were 3.13% (15/480) and 4.05% (85/2,098), respectively. Although the risk for subsequent GH-PE was lower (adjusted OR = 1.49; 95% CI: 0.86-2.56) after receiving danazol treatment than average (adjusted OR = 2.27; 95% CI:1.76-2.93) for women with preceding endometriosis, the reduction of risk was not statistically remarkable for danazol-treated (adjusted OR = 1.49) vs. non-danazol-treated (adjusted OR = 2.48) subgroups (p heterogeneity = 0.12). Conclusions Preceding endometriosis is an independent and significant risk factor for the occurrence of GH-PE.	[Pan, Mei-Lien; Tsao, Hsiao-Mei] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chen, Li-Ru] Mackay Mem Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Li-Ru] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan; [Chen, Kuo-Hu] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Kuo-Hu] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Academia Sinica - Taiwan; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Tzu Chi University	Chen, KH (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	alexgfctw@yagoo.com.tw			Ministry of Science and Technology, Taiwan; Taipei Tzu-Chi Hospital, Taiwan [TCRDTPE-105-18]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Tzu-Chi Hospital, Taiwan	This work is supported by a grant of the Ministry of Science and Technology, Taiwan (http://www.most.gov.tw/mp.aspx?mp=7) "Multidisciplinary health cloud research program: technology development and application of big health data" for ML Pan, and a grant of Taipei Tzu-Chi Hospital, Taiwan (https://www.tzuchi.com.tw/tzuchi_en/About_TP_Center/Default.htm) (TCRDTPE-105-18) for KH Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu MH, 2010, J ADOLESCENT HEALTH, V46, P77, DOI 10.1016/j.jadohealth.2009.06.006; Arakaki T, 2015, ULTRASOUND OBST GYN, V45, P539, DOI 10.1002/uog.14633; Barton JR, 2008, OBSTET GYNECOL, V112, P359, DOI 10.1097/AOG.0b013e3181801d56; Brosens I, 2013, PLACENTA, V34, P100, DOI 10.1016/j.placenta.2012.11.017; Brosens IA, 2007, HUM REPROD, V22, P1725, DOI 10.1093/humrep/dem072; Cunningham FG, 2010, WILLIAMS OBSTET, p[176, 706 , 964 ]; Farag K, 2004, OBSTET GYNECOL SURV, V59, P464, DOI 10.1097/00006254-200406000-00025; Frederick IO, 2006, EPIDEMIOLOGY, V17, P428, DOI 10.1097/01.ede.0000221028.33245.0b; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Hadfield RM, 2009, HUM REPROD, V24, P2348, DOI 10.1093/humrep/dep123; Hutter S, 2013, J NIPPON MED SCH, V80, P97, DOI 10.1272/jnms.80.97; Jeyabalan A., 2013, NUTR REV S1, V71; Luciano AA, 2006, J MINIM INVAS GYN, V13, P523, DOI 10.1016/j.jmig.2006.06.026; Lynch AM, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.035; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Montagnana M, 2008, FERTIL STERIL, V89, P1282, DOI 10.1016/j.fertnstert.2008.02.151; Murakami K, 2006, FERTIL STERIL, V86, P291, DOI 10.1016/j.fertnstert.2005.12.074; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Pan ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140544; Pauli JM, 2015, OBSTET GYN CLIN N AM, V42, P299, DOI 10.1016/j.ogc.2015.01.007; Prefumo F, 2004, HUM REPROD, V19, P206, DOI 10.1093/humrep/deh037; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Selak V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000068.pub2; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Spradley FT, 2015, BIOMOLECULES, V5, P3142, DOI 10.3390/biom5043142; Stephansson O, 2009, HUM REPROD, V24, P2341, DOI 10.1093/humrep/dep186; Telang MA, 2013, PLACENTA, V34, P2, DOI 10.1016/j.placenta.2012.10.017; Veerbeek JHW, 2015, HYPERTENSION, V65, P600, DOI 10.1161/HYPERTENSIONAHA.114.04850; VIGANO P, 1994, GYNECOL ENDOCRINOL, V8, P13, DOI 10.3109/09513599409028452; Visentin S, 2016, AM J HYPERTENS, V29, P273, DOI 10.1093/ajh/hpv103; Visentin S, 2013, J ULTRAS MED, V32, P279; Wallace AE, 2012, HUM REPROD UPDATE, V18, P458, DOI 10.1093/humupd/dms015; WHO, 2005, MAK EV MOTH CHILD CO; Wolf M, 2001, OBSTET GYNECOL, V98, P757, DOI 10.1016/S0029-7844(01)01551-4; Zavalza-Gomez AB, 2011, ARCH GYNECOL OBSTET, V283, P415, DOI 10.1007/s00404-010-1753-1	36	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181261	10.1371/journal.pone.0181261	http://dx.doi.org/10.1371/journal.pone.0181261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715497	Green Published, gold, Green Submitted			2022-12-27	WOS:000443975500041
J	Goebel, J; Sulke, M; Lazik-Palm, A; Goebel, T; Dechene, A; Bellendorf, A; Mueller, S; Umutlu, L; Theysohn, J				Goebel, Juliane; Sulke, Maximilian; Lazik-Palm, Andrea; Goebel, Thomas; Dechene, Alexander; Bellendorf, Alexander; Mueller, Stefan; Umutlu, Lale; Theysohn, Jens			Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma	PLOS ONE			English	Article							PORTAL-VEIN EMBOLIZATION; ART BRACHYTHERAPY TREATMENT; INTERNAL RADIATION-THERAPY; (90)YTTRIUM MICROSPHERES; Y-90 RADIOEMBOLIZATION; VOLUMETRIC CHANGES; MALIGNANCIES; CIRRHOSIS; CANCER; CELLS	Introduction Radioembolization for the treatment of hepatocellular carcinoma (HCC) induces liver volume changes referred to as "atrophy-hypertrophy complex". The aim of this study was to investigate lobar liver volume changes after unilateral radioembolization and to search for factors associated with hypertrophy of the untreated lobe. Materials and methods Seventy-five patients were retrospectively evaluated. Inclusion criteria were: (1) right-lobar radioembolization for unresectable unilateral HCC, (2) available liver computed tomography scans before, 1, 3, and at least 6 months after radioembolization. Baseline patient characteristics included clinical features, laboratory results, spleen volume, and liver computed tomography. Absolute and relative (referred to the whole liver volume) liver lobe volumes (LLV) as well as relative LLV (rLLV) change per month were evaluated and compared. Results Absolute and relative contralateral LLV continuously increased after radioembolization (p<0.001). Mean relative contralateral LLV increased from 36 +/- 11.6% before radioembolization to 50 +/- 15.3% 6 months after radioembolization. Median contralateral rLLV increase/month (within first 6 months) was 2.5%. Contralateral rLLV increase/month was significantly lower in patients with ascites (p = 0.017) or platelet count <100/nl (p = 0.009). An inverse correlation of contralateral rLVV increase/month with spleen volume (p = 0.017), patient age (p = 0.024), Child Pugh score (p = 0.001), and tumor burden (p = 0.001) was found. Conclusions Significant contralateral hypertrophy and ipsilateral atrophy were common after unilateral radioembolization. Small spleen volume, low patient age, low Child Pugh score, absence of ascites, platelet count >= 100/nl, and low tumor burden were associated with increased contralateral hypertrophy, indicating that younger patients with compensated cirrhosis might benefit most from radioembolization in a "bridge-to-resection" setting.	[Goebel, Juliane; Sulke, Maximilian; Lazik-Palm, Andrea; Umutlu, Lale; Theysohn, Jens] Univ Hosp Essen, Dept Diagnost & Intervent Radiol, Essen, Germany; [Goebel, Thomas] Petrus Hosp, Clin Gastroenterol Hepatol & Diabetol, Wuppertal, Germany; [Bellendorf, Alexander] Univ Hosp Essen, Clin Gastroenterol & Hepatol, Essen, Germany; [Bellendorf, Alexander; Mueller, Stefan] Univ Hosp Essen, Clin Nucl Med, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Goebel, J (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol, Essen, Germany.	Juliane.Goebel@uk-essen.de						Azoulay D, 2000, ANN SURG, V231, P480, DOI 10.1097/00000658-200004000-00005; Berzigotti A, 2015, HEPATOLOGY, V61, P526, DOI 10.1002/hep.27431; Bunchorntavakul C, 2016, J VIRAL HEPATITIS, V23, P408, DOI 10.1111/jvh.12534; Couinaud C, 1957, FOIE ETUDES ANATOMIQ; Dezarn WA, 2011, MED PHYS, V38, P4824, DOI 10.1118/1.3608909; Edeline J, 2013, ANN SURG ONCOL, V20, P2518, DOI 10.1245/s10434-013-2906-9; Gaba RC, 2009, ANN SURG ONCOL, V16, P1587, DOI 10.1245/s10434-009-0454-0; Gulec SA, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-6; Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009; Jakobs TF, 2008, DIGEST DIS SCI, V53, P2556, DOI 10.1007/s10620-007-0148-z; Kim Robin D, 2008, Semin Intervent Radiol, V25, P92, DOI 10.1055/s-2008-1076679; Kopp JL, 2016, NAT CELL BIOL, V18, P238, DOI 10.1038/ncb3309; Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027; Kubota K, 1997, HEPATOLOGY, V26, P1176; Ladurner R, 2009, HPB SURG, V2009; Liu H, 2009, AM J SURG, V197, P686, DOI [10.1016/j.amjsurg.2008.04.006, 10.1016/j.amjsurg.2008.04.022]; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Nadalin S, 2014, Z GASTROENTEROL, V52, P35, DOI 10.1055/s-0033-1356364; Pamecha V, 2009, BRIT J CANCER, V100, P617, DOI 10.1038/sj.bjc.6604872; Salem R, 2006, J VASC INTERV RADIOL, V17, P1571, DOI 10.1097/01.RVI.0000236744.34720.73; Salem R, 2006, J VASC INTERV RADIOL, V17, P1425, DOI 10.1097/01.RVI.0000235779.88652.53; Salem R, 2006, J VASC INTERV RADIOL, V17, P1251, DOI 10.1097/01.RVI.0000233785.75257.9A; Sato K, 2006, CARDIOVASC INTER RAD, V29, P522, DOI 10.1007/s00270-005-0171-4; Swiderska-Syn M, 2014, GUT, V63, P1333, DOI 10.1136/gutjnl-2013-305962; Teo JY, 2014, J DIGEST DIS, V15, P444, DOI 10.1111/1751-2980.12162; Theysohn JM, 2014, CLIN RADIOL, V69, P172, DOI 10.1016/j.crad.2013.09.009; Vouche M, 2013, J HEPATOL, V59, P1029, DOI 10.1016/j.jhep.2013.06.015	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181488	10.1371/journal.pone.0181488	http://dx.doi.org/10.1371/journal.pone.0181488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708902	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649800060
J	Murakami, K; Kobayashi, Y; Uehara, S; Suzuki, T; Koide, M; Yamashita, T; Nakamura, M; Takahashi, N; Kato, H; Udagawa, N; Nakamura, Y				Murakami, Kohei; Kobayashi, Yasuhiro; Uehara, Shunsuke; Suzuki, Takako; Koide, Masanori; Yamashita, Teruhito; Nakamura, Midori; Takahashi, Naoyuki; Kato, Hiroyuki; Udagawa, Nobuyuki; Nakamura, Yukio			A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro	PLOS ONE			English	Article							BONE-FORMATION; SIGNALING PATHWAY; TRABECULAR BONE; KNOCKOUT MICE; CELLS; ARTHRITIS; RECEPTOR; DIFFERENTIATION; CYTOKINES; INTERLEUKIN-6	The Janus kinases (Jaks) are hubs in the signaling process of more than 50 cytokine or hormone receptors. However, the function of Jak in bone metabolism remains to be elucidated. Here, we showed that the inhibition of Jak1 and/or Jak2 in osteoblast-lineage cells led to impaired osteoclastogenesis due to the reduced expression of receptor activator of nuclear factor-.B ligand (RANKL). Murine calvaria-derived osteoblasts induced differentiation of bone marrow cells into osteoclasts in the presence of 1,25-dihydroxyvitamin D-3 (1,25D(3)) and prostaglandin E-2 (PGE(2)) in vitro. However, treatment with the Jak1/2 inhibitor, baricitinib, markedly inhibited osteoclastogenesis in the co-culture. On the other hand, baricitinib did not inhibit RANKL-induced osteoclast differentiation of bone marrow macrophages. These results indicated that baricitinib acted on osteoblasts, but not on bone marrow macrophages. Baricitinib suppressed 1,25D(3) and PGE(2)-induced up-regulation of RANKL in osteoblasts, but not macrophage colony-stimulating factor expression. Moreover, the addition of recombinant RANKL to co-cultures completely rescued baricitinib-induced impairment of osteoclastogenesis. shRNA-mediated knockdown of Jak1 or Jak2 also suppressed RANKL expression in osteoblasts and inhibited osteoclastogenesis. Finally, cytokine array revealed that 1,25D(3) and PGE(2) stimulated secretion of interleukin-6 (IL-6), IL-11, and leukemia inhibitory factor in the co-culture. Hence, Jak1 and Jak2 represent novel therapeutic targets for osteoporosis as well as inflammatory bone diseases including rheumatoid arthritis.	[Murakami, Kohei; Suzuki, Takako; Kato, Hiroyuki; Nakamura, Yukio] Shinshu Univ, Dept Orthoped Surg, Sch Med, Matsumoto, Nagano, Japan; [Murakami, Kohei; Kobayashi, Yasuhiro; Koide, Masanori; Yamashita, Teruhito; Takahashi, Naoyuki] Matsumoto Dent Univ, Inst Oral Sci, Shiojiri, Nagano, Japan; [Murakami, Kohei; Uehara, Shunsuke; Nakamura, Midori; Udagawa, Nobuyuki] Matsumoto Dent Univ, Dept Biochem, Shiojiri, Nagano, Japan	Shinshu University; Matsumoto Dental University; Matsumoto Dental University	Nakamura, Y (corresponding author), Shinshu Univ, Dept Orthoped Surg, Sch Med, Matsumoto, Nagano, Japan.	yxn14@aol.jp	Koide, Masanori/ABE-9670-2020; KOBAYASHI, YASUHIRO/AAU-4931-2021	Koide, Masanori/0000-0002-6511-9999; Kobayashi, Yasuhiro/0000-0002-0903-3226; Murakami, Kohei/0000-0001-5458-410X	joint research	joint research	Eli Lilly provided financial support as joint research. However, Eli Lilly did not have any additional role in the study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Cornish J, 1997, BONE, V21, P243, DOI 10.1016/S8756-3282(97)00144-0; Fridman JS, 2010, J IMMUNOL, V184, P5298, DOI 10.4049/jimmunol.0902819; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Johnson RW, 2015, BONE, V81, P343, DOI 10.1016/j.bone.2015.08.005; Johnson RW, 2014, J BONE MINER RES, V29, P1492, DOI 10.1002/jbmr.2159; LaBranche TP, 2012, ARTHRITIS RHEUM-US, V64, P3531, DOI 10.1002/art.34649; Lee Y, 2011, BIOMOL THER, V19, P141, DOI 10.4062/biomolther.2011.19.2.141; Li C., 2013, J MAT, V2013, P1, DOI DOI 10.5402/2013/629807; Li X, 2002, BONE, V30, P567, DOI 10.1016/S8756-3282(02)00683-X; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; MALAVAL L, 1995, ENDOCRINOLOGY, V136, P1411, DOI 10.1210/en.136.4.1411; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; METCALF D, 1989, P NATL ACAD SCI USA, V86, P5948, DOI 10.1073/pnas.86.15.5948; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Park JS, 2014, J IMMUNOL, V192, P4417, DOI 10.4049/jimmunol.1300514; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Poulton IJ, 2012, J BONE MINER RES, V27, P586, DOI 10.1002/jbmr.1485; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Romas E, 1996, J EXP MED, V183, P2581, DOI 10.1084/jem.183.6.2581; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Sims NA, 2014, ARCH BIOCHEM BIOPHYS, V561, P22, DOI 10.1016/j.abb.2014.05.015; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeda S, 1999, ENDOCRINOLOGY, V140, P1005, DOI 10.1210/en.140.2.1005; Taylor PC, 2017, NEW ENGL J MED, V376, P652, DOI 10.1056/NEJMoa1608345; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; Wong PKK, 2006, ARTHRITIS RHEUM-US, V54, P158, DOI 10.1002/art.21537; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	36	58	63	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181126	10.1371/journal.pone.0181126	http://dx.doi.org/10.1371/journal.pone.0181126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708884	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800043
J	Riau, AK; Liu, YC; Lim, CHL; Lwin, NC; Teo, EP; Yam, GH; Tan, DT; Mehta, JS				Riau, Andri K.; Liu, Yu-Chi; Lim, Chris H. L.; Lwin, Nyein C.; Teo, Ericia P.; Yam, Gary H.; Tan, Donald T.; Mehta, Jodhbir S.			Retreatment strategies following Small Incision Lenticule Extraction (SMILE): In vivo tissue responses	PLOS ONE			English	Article							FEMTOSECOND LASER; PHOTOREFRACTIVE KERATECTOMY; SITU KERATOMILEUSIS; KERATOCYTE APOPTOSIS; CIRCLE PATTERNS; FLAP CREATION; LASIK; ORGANIZATION; ENHANCEMENT; ASTIGMATISM	With any refractive correction, including Small Incision Lenticule Extraction (SMILE), there may be a residual refractive error that requires a retreatment. Here, we investigated the tissue responses following various retreatment procedures in a rabbit model of SMILE. All rabbits underwent a -6.00D correction with SMILE. Two weeks later, they underwent -1.00D enhancement by: (i) VisuMax Circle, followed by excimer ablation (S+C); (ii) secondary SMILE anterior to the primary procedure (S+SE); or (iii) surface ablation (S+P), and were examined for 28 days. S+P induced corneal edema and haze, and more CD11b- (23 +/- 6 cells) and TUNEL-positive (36 +/- 4 cells) cells in the central stromal superficial layers early post-operatively (p<0.001 compared to other procedures). The corneas appeared normal on day 28 after S+P, but had a lower number of keratocytes near the laser ablated plane compared to other procedures. S+SE and S+C did not induce corneal haze and resulted similar level of fibronectin. However, S+C resulted in more inflammatory (10 +/- 2 cells; p = 0.001) and apoptotic cells (25 +/- 2 cells; p<0.001) compared to S+SE (7 +/- 1 inflammatory cells and 21 +/- 3 apoptotic cells) early post-operatively. In conclusion, each SMILE retreatment method resulted in unique tissue responses. S+SE offers advantages, such as minimal inflammation and cell death, as well as maintaining a 'flap-less' surgery, over other procedures. However, depending on the degree of enhancement, the lenticule may become too thin to be extracted and the procedure becomes more difficult to perform than S+C and S+P. S+P can maintain corneal integrity by avoiding flap creation and is technically more simple to perform than the others, but the surgery needs to be supplemented with mitomycin-C in order to reduce inflammation and modulate better wound healing.	[Riau, Andri K.; Liu, Yu-Chi; Lim, Chris H. L.; Lwin, Nyein C.; Teo, Ericia P.; Yam, Gary H.; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Liu, Yu-Chi; Lim, Chris H. L.; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Lim, Chris H. L.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Lim, Chris H. L.] Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore; [Yam, Gary H.; Tan, Donald T.; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; Royal Melbourne Hospital; National University of Singapore; National University of Singapore; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.; Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore.	jodmehta@gmail.com	Yam, Gary Hin-Fai/ABE-1710-2020; Lim, Chris/ABH-2772-2021; Riau, Andri/P-9693-2019; Liu, Yu Chi/AAM-7010-2020; Lim, Chris/ABE-1727-2021	Lim, Chris/0000-0003-2219-3184; Riau, Andri/0000-0002-5105-0484; Liu, Yu Chi/0000-0001-5408-0382; 	National Research Foundation of Singapore [NMRC/TCR/002-SERI/2008]	National Research Foundation of Singapore(National Research Foundation, Singapore)	This study was supported by National Research Foundation of Singapore-Funded Translational and Clinical Research Programme Grant (NMRC/TCR/002-SERI/2008). The funding was received by JSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio JL, 2008, AM J OPHTHALMOL, V145, P55, DOI 10.1016/j.ajo.2007.08.035; Ang M, 2012, INVEST OPHTH VIS SCI, V53, P1414, DOI 10.1167/iovs.11-8808; Blum M, 2013, GRAEF ARCH CLIN EXP, V251, P349, DOI 10.1007/s00417-012-2064-y; Chansue E, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0031-5; Davis EA, 2002, OPHTHALMOLOGY, V109, P2308, DOI 10.1016/S0161-6420(02)01245-9; Donate D, 2015, J REFRACT SURG, V31, P708, DOI 10.3928/1081597X-20150928-04; Durrie DS, 1999, J REFRACT SURG, V15, P150; Febbraro JL, 2000, J CATARACT REFR SURG, V26, P41, DOI 10.1016/S0886-3350(99)00263-1; FUJIKAWA LS, 1984, J CELL BIOL, V98, P128, DOI 10.1083/jcb.98.1.128; Hall RC, 2011, J CATARACT REFR SURG, V37, P544, DOI 10.1016/j.jcrs.2010.10.037; HANNA KD, 1992, ARCH OPHTHALMOL-CHIC, V110, P1286, DOI 10.1001/archopht.1992.01080210104035; Hersh PS, 2003, OPHTHALMOLOGY, V110, P748, DOI 10.1016/S0161-6420(02)01981-4; Hong JW, 2001, INVEST OPHTH VIS SCI, V42, P2795; Ivarsen A, 2014, J REFRACT SURG, V30, P429, DOI 10.3928/1081597X-20140508-02; LATVALA T, 1995, BRIT J OPHTHALMOL, V79, P65, DOI 10.1136/bjo.79.1.65; Li MY, 2014, J REFRACT SURG, V30, P94, DOI 10.3928/1081597X-20140120-04; Meltendorf C, 2007, INVEST OPHTH VIS SCI, V48, P2068, DOI 10.1167/iovs.06-1150; Miyamoto T, 2003, J CATARACT REFR SURG, V29, P153, DOI 10.1016/S0886-3350(02)01450-5; Mohamed-Noriega K, 2014, INVEST OPHTH VIS SCI, V55, P1823, DOI 10.1167/iovs.13-13324; Mohan RR, 2000, INVEST OPHTH VIS SCI, V41, P1327; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Netto MV, 2007, J REFRACT SURG, V23, P667; Netto MV, 2004, OPHTHALMOLOGY, V111, P1362, DOI 10.1016/j.ophtha.2003.11.009; Reinstein DZ, 2014, J REFRACT SURG, V30, P813, DOI 10.3928/1081597X-20141113-07; Ren HW, 1996, INVEST OPHTH VIS SCI, V37, P1017; Riau AK, 2013, J REFRACT SURG, V29, P236, DOI 10.3928/1081597X-20130318-02; Riau AK, 2011, INVEST OPHTH VIS SCI, V52, P6213, DOI 10.1167/iovs.11-7439; Roberts C, 2000, J REFRACT SURG, V16, P407; Roy AS, 2014, J CATARACT REFR SURG, V40, P971, DOI 10.1016/j.jcrs.2013.08.065; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Shen Y, 2014, J REFRACT SURG, V30, P310, DOI 10.3928/1081597X-20140422-01; Tay E, 2012, J CATARACT REFR SURG, V38, P1544, DOI 10.1016/j.jcrs.2012.05.030; Vestergaard A, 2013, ACTA OPHTHALMOL, V91, P355, DOI 10.1111/j.1755-3768.2012.02406.x; Vrana NE, 2007, BIOMATERIALS, V28, P4303, DOI 10.1016/j.biomaterials.2007.06.013; Wilson SE, 1998, INVEST OPHTH VIS SCI, V39, P220; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038	37	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180941	10.1371/journal.pone.0180941	http://dx.doi.org/10.1371/journal.pone.0180941			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708898	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800032
J	Hakkak, R; Korourian, S; Foley, SL; Erickson, BD				Hakkak, Reza; Korourian, Soheila; Foley, Steven L.; Erickson, Bruce D.			Assessment of gut microbiota populations in lean and obese Zucker rats	PLOS ONE			English	Article							AKKERMANSIA-MUCINIPHILA; INTESTINAL MICROBIOTA; FATTY; INFLAMMATION; MUTATION; INSULIN; GROWTH; DNA	Obesity has been on the rise in the US and worldwide for the last several decades. Obesity has been associated with chronic disease development, such as certain types of cancer, type 2 diabetes, cardiovascular disease, and liver diseases. Previously, we reported that obesity promotes DMBA-induced mammary tumor development using the obese Zucker rat model. The intestinal microbiota is composed of a diverse population of obligate and facultative anaerobic microorganisms, and these organisms carry out a broad range of metabolic activities. Obesity has been linked to changes in the intestinal microbiota, but the composition of the bacterial populations in lean and obese Zucker rats not been carefully studied. Therefore, the objective of this study was to determine the effects of obesity on the gut microbiota in this model. Lean and obese female Zucker rats (n = 16) were fed an AIN-93Glike diet for 8 weeks. Rats were weighed twice weekly, and fecal samples were collected at the beginning and end of the experiment. 16S rRNA gene sequencing was used to evaluate the composition of the fecal bacterial populations. At the outset of the study, the lean rats exhibited much lower ratios of the Firmicutes to Bacteroidetes phyla than the obese rats, but after 60 days, this ratio in the lean rats exceeded that of the obese. This shift was associated with reductions in the Bacteroidaceae, S24-7 and Paraprevotellaceae families in the lean rats. Obese rats also showed increased levels of the genus Akkermansia at day 60. PCoA plots of beta diversity showed clustering of the different test groups, indicating clear differences in intestinal microbiota populations associated with both the time point of the study and the lean or obese status in the Zucker rat model for obesity.	[Hakkak, Reza] Univ Arkansas Med Sci, Dept Dietet & Nutr, Little Rock, AR 72205 USA; [Hakkak, Reza] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Hakkak, Reza] Arkansas Childrens Res Inst, Little Rock, AR 72202 USA; [Korourian, Soheila] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Foley, Steven L.; Erickson, Bruce D.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Food & Drug Administration (FDA)	Hakkak, R (corresponding author), Univ Arkansas Med Sci, Dept Dietet & Nutr, Little Rock, AR 72205 USA.; Hakkak, R (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.; Hakkak, R (corresponding author), Arkansas Childrens Res Inst, Little Rock, AR 72202 USA.	HakkakReza@uams.edu		Foley, Steven/0000-0003-3146-4548; Hakkak, Reza/0000-0003-4829-8478	Arkansas Children's Research Institute; Arkansas Biosciences Institute; UAMS Children's University Medical Group	Arkansas Children's Research Institute; Arkansas Biosciences Institute; UAMS Children's University Medical Group	This work was supported by the Arkansas Children's Research Institute and the Arkansas Biosciences Institute and a grant from the UAMS Children's University Medical Group.	Andersson R, 2017, J PHARMACOKINET PHAR, V44, P203, DOI 10.1007/s10928-017-9512-6; BRAY GA, 1989, VITAM HORM, V45, P1; BRAY GA, 1977, FED PROC, V36, P148; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Chua SC, 1996, DIABETES, V45, P1141, DOI 10.2337/diabetes.45.8.1141; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Devaraj S, 2012, EXP DIABETES RES, DOI 10.1155/2012/585018; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Gil-Cardoso K, 2017, BRIT J NUTR, V117, P218, DOI 10.1017/S0007114516004608; Goldszmid RS, 2012, NAT IMMUNOL, V13, P932, DOI 10.1038/ni.2422; Gu CY, 2016, ONCOTARGET, V7, P48941, DOI 10.18632/oncotarget.10597; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hakkak R, 2005, BREAST CANCER RES, V7, pR627, DOI 10.1186/bcr1263; Hakkak R, 2012, GENES NUTR, V7, P549, DOI 10.1007/s12263-012-0294-6; Lees H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100916; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li L, 2016, OBES REV, V17, P510, DOI 10.1111/obr.12407; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Molloy MJ, 2012, SEMIN IMMUNOL, V24, P58, DOI 10.1016/j.smim.2011.11.008; Peng X, 2013, J MICROBIOL METH, V95, P455, DOI 10.1016/j.mimet.2013.07.015; Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916; Ruiz-Hurtado G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00042; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Tagliabue A, 2013, NUTR METAB CARDIOVAS, V23, P160, DOI 10.1016/j.numecd.2012.09.002; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19; World Health Organization, OB OV; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320; ZUCKER LM, 1961, J HERED, V52, P275, DOI 10.1093/oxfordjournals.jhered.a107093; ZUCKER TF, 1963, J NUTR, V80, P6, DOI 10.1093/jn/80.1.6	43	23	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181451	10.1371/journal.pone.0181451	http://dx.doi.org/10.1371/journal.pone.0181451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704522	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700133
J	Carrel, M; Beltran, MA; Morales, VL; Derlon, N; Morgenroth, E; Kaufmann, R; Holzner, M				Carrel, Maxence; Beltran, Mario A.; Morales, Veronica L.; Derlon, Nicolas; Morgenroth, Eberhard; Kaufmann, Rolf; Holzner, Markus			Biofilm imaging in porous media by laboratory X-Ray tomography: Combining a non-destructive contrast agent with propagation-based phase-contrast imaging tools	PLOS ONE			English	Article							BACTERIAL BIOFILMS; GROWTH; IMPACT; FLOW; GROUNDWATER; DETACHMENT; RETRIEVAL; STRATIFICATION; BIODEGRADATION; BIOREMEDIATION	X-ray tomography is a powerful tool giving access to the morphology of biofilms, in 3D porous media, at the mesoscale. Due to the high water content of biofilms, the attenuation coefficient of biofilms and water are very close, hindering the distinction between biofilms and water without the use of contrast agents. Until now, the use of contrast agents such as barium sulfate, silver-coated micro-particles or 1-chloronaphtalene added to the liquid phase allowed imaging the biofilm 3D morphology. However, these contrast agents are not passive and potentially interact with the biofilm when injected into the sample. Here, we use a natural inorganic compound, namely iron sulfate, as a contrast agent progressively bounded in dilute or colloidal form into the EPS matrix during biofilm growth. By combining a very long source-to-detector distance on a X-ray laboratory source with a Lorentzian filter implemented prior to tomographic reconstruction, we substantially increase the contrast between the biofilm and the surrounding liquid, which allows revealing the 3D biofilm morphology. A comparison of this new method with the method proposed by Davit et al (Davit et al., 2011), which uses barium sulfate as a contrast agent to mark the liquid phase was performed. Quantitative evaluations between the methods revealed substantial differences for the volumetric fractions obtained from both methods. Namely, contrast agent D biofilm interactions (e.g. biofilm detachment) occurring during barium sulfate injection caused a reduction of the biofilm volumetric fraction of more than 50% and displacement of biofilm patches elsewhere in the column. Two key advantages of the newly proposed method are that passive addition of iron sulfate maintains the integrity of the biofilm prior to imaging, and that the biofilm itself is marked by the contrast agent, rather than the liquid phase as in other available methods. The iron sulfate method presented can be applied to understand biofilm development and bioclogging mechanisms in porous materials and the obtained biofilm morphology could be an ideal basis for 3D numerical calculations of hydrodynamic conditions to investigate biofilm-flow coupling.	[Carrel, Maxence; Morales, Veronica L.; Derlon, Nicolas; Morgenroth, Eberhard; Holzner, Markus] Swiss Fed Inst Technol, Inst Environm Engn, Stefano Franscini Pl 5, CH-8093 Zurich, Switzerland; [Beltran, Mario A.; Kaufmann, Rolf] Swiss Fed Labs Mat Sci & Technol EMPA, Dubendorf, Switzerland; [Morales, Veronica L.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Derlon, Nicolas; Morgenroth, Eberhard] Swiss Fed Inst Aquat Sci & Technol EAWAG, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Holzner, M (corresponding author), Swiss Fed Inst Technol, Inst Environm Engn, Stefano Franscini Pl 5, CH-8093 Zurich, Switzerland.	holzner@ifu.baug.ethz.ch	Morales, Veronica L/C-7617-2014; Morgenroth, Eberhard/G-1723-2010; Holzner, Markus/A-6215-2008	Morales, Veronica L/0000-0002-9595-6026; Morgenroth, Eberhard/0000-0002-1217-269X; Holzner, Markus/0000-0003-2702-8612; derlon, nicolas/0000-0003-4240-9827	Swiss National Science Foundation (SNF) [144645]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Financial support is acknowledged from the Swiss National Science Foundation (SNF grant number 144645) for M.G. and M.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support is acknowledged from the Swiss National Science Foundation (SNF grant number 144645) for M.C. and M.H. The authors thank Toni Blunschi for manufacturing the tubular reactor, Daniel Braun and Lucien Biolley for providing some of the hardware necessary for this study as well as Michele Griffa for some interesting discussions related to the segmentation. Part of this work has been performed by the use of the Empa Platform for Image Analysis (http://empa.ch/web/s499/software-/-imaging-platform) at Empa's Center for X-ray Analytics. The authors declare that there is no conflict of interest.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Arhatari BD, 2010, J APPL PHYS, V107, DOI 10.1063/1.3298930; Baffin T. J., 2007, NATURE REV MICROBIOL, V5, P76; Baveye P, 1998, CRIT REV ENV SCI TEC, V28, P123, DOI 10.1080/10643389891254197; Beltran MA, 2011, PHYS MED BIOL, V56, P7353, DOI 10.1088/0031-9155/56/23/002; Beltran MA, 2010, OPT EXPRESS, V18, P6423, DOI 10.1364/OE.18.006423; Benner SG, 2002, APPL GEOCHEM, V17, P301, DOI 10.1016/S0883-2927(01)00084-1; Blauert F, 2015, BIOTECHNOL BIOENG, V112, P1893, DOI 10.1002/bit.25590; Blowes DW, 2000, J CONTAM HYDROL, V45, P123, DOI 10.1016/S0169-7722(00)00122-4; Bouwer H, 2002, HYDROGEOL J, V10, P121, DOI 10.1007/s10040-001-0182-4; Burvall A, 2011, OPT EXPRESS, V19, P10359, DOI 10.1364/OE.19.010359; Carrel M., DIGITAL ROCKS DATA R; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; CUNNINGHAM AB, 1991, ENVIRON SCI TECHNOL, V25, P1305, DOI 10.1021/es00019a013; Davit Y, 2011, J MICROSC-OXFORD, V242, P15, DOI 10.1111/j.1365-2818.2010.03432.x; Davit Y, 2010, ADV WATER RESOUR, V33, P1075, DOI 10.1016/j.advwatres.2010.06.013; Derlon N, 2008, WATER RES, V42, P2102, DOI 10.1016/j.watres.2007.11.016; Derlon N, 2012, WATER RES, V46, P3323, DOI 10.1016/j.watres.2012.03.031; Downie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044276; du Roscoat SR, 2014, BIOTECHNOL BIOENG, V111, P1265, DOI 10.1002/bit.25168; Dupin HJ, 2000, ENVIRON SCI TECHNOL, V34, P1513, DOI 10.1021/es990452f; Ebigbo A, 2010, ADV WATER RESOUR, V33, P762, DOI 10.1016/j.advwatres.2010.04.004; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Golfier F, 2009, ADV WATER RESOUR, V32, P463, DOI 10.1016/j.advwatres.2008.11.012; Griebler C, 2009, FRESHWATER BIOL, V54, P649, DOI 10.1111/j.1365-2427.2008.02013.x; Gureyev TE, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2226794; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Holzner M, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.013015; Iltis GC, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009410; In Paganin D., 2006, COHERENT XRAY OPTICS, P411; Ivankovic T, 2016, BIOFOULING, V32, P1235, DOI 10.1080/08927014.2016.1249865; Kapellos GE, 2010, MATH BIOSCI, V225, P83, DOI 10.1016/j.mbs.2010.03.003; Kone T, 2014, WATER RESOUR RES, V50, P9103, DOI 10.1002/2013WR015213; LAPPINSCOTT HM, 1988, APPL ENVIRON MICROB, V54, P1373, DOI 10.1128/AEM.54.6.1373-1382.1988; Leemann A, 2010, CEMENT CONCRETE COMP, V32, P116, DOI 10.1016/j.cemconcomp.2009.11.007; Li L, 2005, GROUND WATER, V43, P582, DOI 10.1111/j.1745-6584.2005.0042.x; Mayo SC, 2003, OPT EXPRESS, V11, P2289, DOI 10.1364/OE.11.002289; Meckenstock RU, 2015, ENVIRON SCI TECHNOL, V49, P7073, DOI 10.1021/acs.est.5b00715; Milferstedt K, 2009, BIOTECHNOL BIOENG, V102, P368, DOI 10.1002/bit.22075; Mitchell AC, 2013, INT J GREENH GAS CON, V15, P86, DOI 10.1016/j.ijggc.2013.02.001; Mohle RB, 2007, BIOTECHNOL BIOENG, V98, P747, DOI 10.1002/bit.21448; Munch B., EMPA BUNDLE IMAGE J; Myers GR, 2008, OPT EXPRESS, V16, P10736, DOI 10.1364/OE.16.010736; Omoregie EO, 2013, APPL ENVIRON MICROB, V79, P4325, DOI 10.1128/AEM.00683-13; Orgogozo L, 2010, ADV WATER RESOUR, V33, P585, DOI 10.1016/j.advwatres.2010.03.004; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Paulsen JE, 1997, WATER SCI TECHNOL, V36, P1, DOI 10.1016/S0273-1223(97)00317-X; Peszynska M, 2016, ADV WATER RESOUR, V95, P288, DOI 10.1016/j.advwatres.2015.07.008; Pintelon TRR, 2009, BIOTECHNOL BIOENG, V103, P767, DOI 10.1002/bit.22303; Plouraboue F, 2004, J MICROSC-OXFORD, V215, P139, DOI 10.1111/j.0022-2720.2004.01362.x; Rochex A, 2009, J IND MICROBIOL BIOT, V36, P467, DOI 10.1007/s10295-009-0543-x; Rusconi R, 2010, J R SOC INTERFACE, V7, P1293, DOI 10.1098/rsif.2010.0096; Sand W, 2003, GEOTHERMICS, V32, P655, DOI 10.1016/S0375-6505(03)00058-0; Seymour JD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198103; Sharp RR, 1999, WATER SCI TECHNOL, V39, P195, DOI 10.2166/wst.1999.0359; Stoodley P, 2005, BIOFOULING, V21, P161, DOI 10.1080/08927010500375524; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; STOODLEY P, 1994, APPL ENVIRON MICROB, V60, P2711, DOI 10.1128/AEM.60.8.2711-2716.1994; TAYLOR SW, 1990, WATER RESOUR RES, V26, P2171, DOI 10.1029/WR026i009p02171; Teixeira S, 2014, INT J PHYTOREMEDIAT, V16, P1228, DOI 10.1080/15226514.2013.821454; Thullner M, 2002, TRANSPORT POROUS MED, V49, P99, DOI 10.1023/A:1016030112089; Vayenas DV, 2002, ADV WATER RESOUR, V25, P203, DOI 10.1016/S0309-1708(01)00023-9; Vogt SJ, 2013, BIOTECHNOL BIOENG, V110, P1366, DOI 10.1002/bit.24803; von der Schulenburg DAG, 2008, BIOTECHNOL BIOENG, V101, P602, DOI 10.1002/bit.21913; von der Schulenburg DAG, 2009, AICHE J, V55, P494, DOI 10.1002/aic.11674; Wagner M, 2010, BIOTECHNOL BIOENG, V107, P844, DOI 10.1002/bit.22864; Wagner M, 2010, BIOTECHNOL BIOENG, V107, P172, DOI 10.1002/bit.22784; Weiner ER, 2013, APPL ENV AQUATIC CHE, P592; Wildenschild D, 2002, J HYDROL, V267, P285, DOI 10.1016/S0022-1694(02)00157-9; Wildenschild D, 2013, ADV WATER RESOUR, V51, P217, DOI 10.1016/j.advwatres.2012.07.018; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Xi CW, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2209962	73	23	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180374	10.1371/journal.pone.0180374	http://dx.doi.org/10.1371/journal.pone.0180374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732010	Green Submitted, Green Published, gold			2022-12-27	WOS:000406643100006
J	Caesar, M; Grandcolas, P; Pellens, R				Caesar, Maram; Grandcolas, Philippe; Pellens, Roseli			Outstanding micro-endemism in New Caledonia: More than one out of ten animal species have a very restricted distribution range	PLOS ONE			English	Article							BIODIVERSITY; CONSERVATION; EXTINCTION; EVOLUTION; RICHNESS; RARITY; ISLAND; CLADE	New Caledonia is a biodiversity hotspot, with an extremely high number of endemic species with narrow distribution ranges that are at high risk of extinction due to open-cast nickel mining, invasive species and seasonal man-induced fires. Mentions of micro-endemism permeate the literature on the biota of this archipelago. However, so far there has been no research comparing distribution range in different animal groups. The aim of this study is to examine the implication of different sampling effort variables in order to distinguish microendemicity from data deficiency, and evaluate the distribution range, frequency, and extent to which micro-endemism is common to several groups of organisms. We compiled a dataset derived from publications in Zoologia Neocaledonica, comprising 1,149 species, of which 86% are endemic to New Caledonia. We found that the sampling effort variables that were best correlated with distribution range were the number of sampling dates and the number of collectors per species. The median value of sampling dates was used to establish a cut-off point for defining adequately sampled species. We showed that, although only 52% of species were sampled adequately enough to determine their distribution range, the number of species with a very narrow distribution range was still high. Among endemics from New Caledonia, 12% (116 species) have ranges <= 5.2km(2) and 3.9% (38 species) have ranges between 23 and 100 km(2). Surprisingly, a similar trend was observed in non-endemic species: 22% occurred in areas <= 5.2 km(2), and 8% in areas 23-100 km(2), suggesting that environmental dissimilarity may play an important role in the distribution of these species. Micro-endemic species were predominant in 18 out of 20 orders. These results will contribute to a re-assessment of the IUCN red list of species in this archipelago, indicating that at least 116 species are probably critically endangered.	[Caesar, Maram; Grandcolas, Philippe; Pellens, Roseli] Sorbonne Univ, CNRS UPMC EPHE, Museum Natl Hist Nat, Inst Systemat Evolut Biodivers, CP 50,45 Rue Buffon, Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Caesar, M (corresponding author), Sorbonne Univ, CNRS UPMC EPHE, Museum Natl Hist Nat, Inst Systemat Evolut Biodivers, CP 50,45 Rue Buffon, Paris, France.	maram.caesar@edu.mnhn.fr		Grandcolas, Philippe/0000-0003-1374-1222	Syrian government (Syrian government-BGF)	Syrian government (Syrian government-BGF)	MC has a Ph.D. grant from the Syrian government (grant from the Syrian government-BGF), http://www.syrie.carnpusfrance.org; http://www.campusfrance.org/fr; http://labex-bcdiv. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was carried out within the framework of the Ph.D. thesis of Maram Caesar at the ED 227 of the Museum National d'Histoire Naturelle and ISYEB. MC has a Ph.D. grant from the Syrian government (Grant from the Syrian government-BGF).	Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bauer Aaron M., 2006, Proceedings of the California Academy of Sciences, V57, P503; BOUCHET P, 1995, BIODIVERS CONSERV, V4, P415, DOI 10.1007/BF00058425; Chazeau J., 1991, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V149, P1; Chazeau J., 1993, Biodiversity Letters, V1, P123, DOI 10.2307/2999756; Christman MC, 2005, J BIOGEOGR, V32, P1441, DOI 10.1111/j.1365-2699.2005.01263.x; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Espeland M, 2010, J BIOGEOGR, V37, P879, DOI 10.1111/j.1365-2699.2009.02263.x; Gaston K. J, 1994, RARITY, V13, P1; Grandcolas P., 2016, 10 FALSE IDEAS NEW C; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Grandcolas Philippe, 2009, Memoires du Museum National d'Histoire Naturelle, V198, P1; Grandcolas Philippe, 2008, P1; Guilbert E, 2014, MEM MUS NAT HIST NAT, V206, P1; Haase M, 1998, HYDROBIOLOGIA, V367, P43, DOI 10.1023/A:1003219931171; Hartley S, 2003, CONSERV BIOL, V17, P1559, DOI 10.1111/j.1523-1739.2003.00015.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Mace G, 2005, MILLENIUM ECOSYSTEM; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Morat P, 1999, B SOC BOT SUD OUEST, V19, P129; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Murienne J, 2008, CLADISTICS, V24, P802, DOI 10.1111/j.1096-0031.2008.00204.x; Murienne J, 2005, CLADISTICS, V21, P2, DOI 10.1111/j.1096-0031.2004.00042.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Najt Judith, 2002, Memoires du Museum National d'Histoire Naturelle, V187, P1; Najt Judith, 1997, Memoires du Museum National d'Histoire Naturelle, V171, P1; Nattier R, 2016, SCI REPORTS IN PRESS; Nattier R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080811; Nattier R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048047; Pascal M, 2008, CONSERV BIOL, V22, P498, DOI 10.1111/j.1523-1739.2008.00889.x; Pellens R, 2016, TOP BIODIV CON, V14, P237, DOI 10.1007/978-3-319-22461-9_12; Pellens R, 2010, ENVIRON SCI ENG TECH, P139; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Schulman L, 2007, BIODIVERS CONSERV, V16, P3011, DOI 10.1007/s10531-007-9158-6; Sharma P, 2009, CLADISTICS, V25, P279, DOI 10.1111/j.1096-0031.2009.00252.x; Tillier S., 1988, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V142, P1; Tillier S, 1993, MEMOIRES MUSEUM NATL, V157, P1; Townsend Peterson A., 1998, Diversity & Distributions, V4, P189, DOI 10.1046/j.1472-4642.1998.00021.x; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wulff AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073371	46	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181437	10.1371/journal.pone.0181437	http://dx.doi.org/10.1371/journal.pone.0181437			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727847	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500075
J	da Silva, VM; Sato, JAP; Araujo, JN; Squina, FM; Muniz, JRC; Riske, KA; Garcia, W				da Silva, Viviam M.; Sato, Juliana A. P.; Araujo, Juscemacia N.; Squina, Fabio M.; Muniz, Joao R. C.; Riske, Karin A.; Garcia, Wanius			Systematic studies of the interactions between a model polyphenol compound and microbial beta-glucosidases	PLOS ONE			English	Article							LIGNOCELLULOSIC BIOMASS; CELLULASE; BINDING; INHIBITION; PRETREATMENT; HYDROLYSIS; BEHAVIOR; LIGNIN; FORCE; ACID	Lignin is a major obstacle for cost-effective conversion of cellulose into fermentable sugars. Non-productive adsorption onto insoluble lignin fragments and interactions with soluble phenols are important inhibition mechanisms of cellulases, including beta-glucosidases. Here, we examined the inhibitory effect of tannic acid (TAN), a model polyphenolic compound, on beta-glucosidases from the bacterium Thermotoga petrophila (TpBGL1 and TpBGL3) and archaeon Pyrococcus furiosus (PfBGL1). The results revealed that the inhibition effects on beta-glucosidases were TAN concentration-dependent. TpBGL1 and TpBGL3 were more tolerant to the presence of TAN when compared with PfBGL1, while TpBGL1 was less inhibited when compared with TpBGL3. In an attempt to better understand the inhibitory effect, the interaction between TAN and beta-glucosidases were analyzed by isothermal titration calorimetry (ITC). Furthermore, the exposed hydrophobic surface areas in beta-glucosidases were analyzed using a fluorescent probe and compared with the results of inhibition and ITC. The binding constants determined by ITC for the interactions between TAN and beta-glucosidases presented the same order of magnitude. However, the number of binding sites and exposed hydrophobic surface areas varied for the beta-glucosidases studied. The binding between TAN and beta-glucosidases were driven by enthalpic effects and with an unfavorable negative change in entropy upon binding. Furthermore, the data suggest that there is a high correlation between exposed hydrophobic surface areas and the number of binding sites on the inhibition of microbial beta-glucosidases by TAN. These studies can be useful for biotechnological applications.	[da Silva, Viviam M.; Sato, Juliana A. P.; Araujo, Juscemacia N.; Garcia, Wanius] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Squina, Fabio M.] Univ Sorocaba UNISO, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil; [Muniz, Joao R. C.] Univ Sao Paulo, IFSC, Sao Carlos, SP, Brazil; [Riske, Karin A.] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sorocaba; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Garcia, W (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil.	wanius.garcia@ufabc.edu.br	Muniz, Joao R/B-7782-2016; Silva, Wanius J. G./L-3948-2016; Riske, Karin A/F-2314-2014; Araujo, Juscemácia/AAQ-7299-2020; Squina, Fabio/J-8130-2012; Araujo, Juscemácia Nascimento/N-2245-2017	Muniz, Joao R/0000-0003-2731-3966; Araujo, Juscemácia/0000-0001-9034-1463; Squina, Fabio/0000-0002-8154-7459; Araujo, Juscemácia Nascimento/0000-0001-9034-1463	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2015/02897-3, 442333/2014-5, 310186/2014-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) via grants number 2015/02897-3 (FAPESP), 442333/2014-5 (CNPq), and 310186/2014-3 (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arouri A, 2007, EUR BIOPHYS J BIOPHY, V36, P647, DOI 10.1007/s00249-007-0140-8; Azqueta A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120785; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Chamani J, 2006, J COLLOID INTERF SCI, V293, P52, DOI 10.1016/j.jcis.2005.06.015; Colussi F, 2015, AMINO ACIDS, V47, P937, DOI 10.1007/s00726-015-1923-3; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Colussi F, 2012, EUR BIOPHYS J BIOPHY, V41, P89, DOI 10.1007/s00249-011-0762-8; COSTAS M, 1994, J CHEM SOC FARADAY T, V90, P1513, DOI 10.1039/ft9949001513; Cota J, 2015, NEW BIOTECHNOL, V32, P13, DOI 10.1016/j.nbt.2014.07.009; da Silva VM, 2016, ENZYME MICROB TECH, V87-88, P1, DOI 10.1016/j.enzmictec.2016.02.007; Garcia W, 2007, BIOCHEMISTRY-US, V46, P11101, DOI 10.1021/bi700702w; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Kado Y, 2011, ACTA CRYSTALLOGR F, V67, P1473, DOI 10.1107/S1744309111035238; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mhlongo SI, 2015, ENZYME MICROB TECH, V81, P16, DOI 10.1016/j.enzmictec.2015.07.005; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Moosavi-Movahedi Z, 2006, PROTEIN J, V25, P193, DOI 10.1007/s10930-006-9002-y; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Oliveira LC, 2015, PLOS ONE, V10; Olsen SN, 2011, ENZYME MICROB TECH, V49, P353, DOI 10.1016/j.enzmictec.2011.06.015; Omidvar Z, 2013, J SOLUTION CHEM, V42, P1005, DOI 10.1007/s10953-013-0009-7; Ozdal T, 2013, FOOD RES INT, V51, P954, DOI 10.1016/j.foodres.2013.02.009; Pinelo M, 2017, BIOFUELS BIOPRO BIOR; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Qin CR, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-65; Ramirez-Coronel MA, 2003, MICROBIOL-SGM, V149, P2941, DOI 10.1099/mic.0.26346-0; Rezende CA, 2011, BIOTECHNOL BIOFUELS, V4, P1, DOI 10.1186/1754-6834-4-54; Segato F, 2014, MICROBIOL MOL BIOL R, V78, P588, DOI 10.1128/MMBR.00019-14; SEMISOTNOV GV, 1987, FEBS LETT, V224, P9, DOI 10.1016/0014-5793(87)80412-X; Silva V.M., 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0092996; Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012; Sorensen A, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030612; Tejirian A, 2011, ENZYME MICROB TECH, V48, P239, DOI 10.1016/j.enzmictec.2010.11.004; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; Ximenes E, 2011, ENZYME MICROB TECH, V48, P54, DOI 10.1016/j.enzmictec.2010.09.006; Ximenes E, 2010, ENZYME MICROB TECH, V46, P170, DOI 10.1016/j.enzmictec.2009.11.001; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h	43	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181629	10.1371/journal.pone.0181629	http://dx.doi.org/10.1371/journal.pone.0181629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727856	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500096
J	Herghelegiu, AM; Moser, A; Prada, GI; Born, S; Wilhelm, M; Stuck, AE				Herghelegiu, Anna Marie; Moser, Andre; Prada, Gabriel Ioan; Born, Stephan; Wilhelm, Matthias; Stuck, Andreas E.			Effects of health risk assessment and counselling on physical activity in older people: A pragmatic randomised trial	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; SEASONAL-VARIATION; APPRAISAL; ADULTS; VALIDITY; PARTICIPATION; INTERVENTIONS; FEASIBILITY; RELIABILITY; PREVENTION	Background Interventions to increase physical activity (PA) among older community-dwelling adults may be enhanced by using multidimensional health risk assessment (HRA) as a basis for PA counselling. Methods The study was conducted among nondisabled but mostly frail persons 65 years of age and older at an ambulatory geriatric clinic in Bucharest, Romania. From May to July 2014, 200 participants were randomly allocated to intervention and control groups. Intervention group participants completed an initial HRA questionnaire and then had monthly counselling sessions with a geriatrician over a period of six months that were aimed at increasing low or maintaining higher PA. Counselling also addressed the older persons' concomitant health risks and problems. The primary outcome was PA at six months (November 2014 to February 2015) evaluated with the International Physical Activity Questionnaire. Results At baseline, PA levels were similar in intervention and control groups (median 1089.0, and 1053.0 MET [metabolic equivalent of task] minutes per week, interquartile ranges 606.0-1401.7, and 544.5-1512.7 MET minutes per week, respectively). Persons in the intervention group had an average of 11.2 concomitant health problems and risks (e.g., pain, depressive mood, hypertension). At six months, PA increased in the intervention group by a median of 180.0 MET minutes per week (95% confidence interval (CI) 43.4-316.6, p = 0.01) to 1248.8 MET minutes per week. In the control group, PA decreased by a median of 346.5 MET minutes per week (95% CI 178.4-514.6, p < 0.001) to 693.0 MET minutes per week due to a seasonal effect, resulting in a difference of 420.0 MET minutes per week (95% CI 212.7-627.3, p < 0.001) between groups. Conclusion The use of HRA to inform individualized PA counselling is a promising method for achieving improvements in PA, and ultimately health and longevity among large groups of community-dwelling older persons.	[Herghelegiu, Anna Marie; Prada, Gabriel Ioan] Natl Inst Gerontol & Geriatr Ana Asian, Bucharest, Romania; [Herghelegiu, Anna Marie; Prada, Gabriel Ioan] Univ Med & Pharm Carol Davila, Geriatr & Gerontol Dept, Bucharest, Romania; [Moser, Andre; Born, Stephan; Stuck, Andreas E.] Univ Hosp, Inselspital, Dept Geriatr, Bern, Switzerland; [Moser, Andre; Born, Stephan; Wilhelm, Matthias; Stuck, Andreas E.] Univ Bern, Bern, Switzerland; [Moser, Andre] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Wilhelm, Matthias] Univ Hosp Bern, Interdisciplinary Ctr Sports Med, Dept Cardiol, Bern, Switzerland	National Institute of Gerontology & Geriatrics "Ana Aslan"; Carol Davila University of Medicine & Pharmacy; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern	Stuck, AE (corresponding author), Univ Hosp, Inselspital, Dept Geriatr, Bern, Switzerland.; Stuck, AE (corresponding author), Univ Bern, Bern, Switzerland.	andreas.stuck@insel.ch	Prada, Gabriel - Ioan/B-8448-2016; Herghelegiu, Anna Marie/I-9520-2016; Wilhelm, Matthias/AAS-9456-2020	Prada, Gabriel - Ioan/0000-0002-4762-9581; Wilhelm, Matthias/0000-0003-4541-3995; Stuck, Andreas/0000-0001-6735-0150; herghelegiu, anna marie/0000-0002-4139-876X; Moser, Andre/0000-0001-7178-6539	Forschungsfonds Geriatrie; Bernische Stiftung fur die Regionalen Spitalzentren, Bern, Switzerland	Forschungsfonds Geriatrie; Bernische Stiftung fur die Regionalen Spitalzentren, Bern, Switzerland	This work was supported by the Forschungsfonds Geriatrie, Bernische Stiftung fur die Regionalen Spitalzentren, Bern, Switzerland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Black SV, 2015, AM J PREV MED, V49, P172, DOI 10.1016/j.amepre.2015.03.009; Breslow L, 1997, AM J HEALTH PROMOT, V11, P337, DOI 10.4278/0890-1171-11.5.337; Chase JAD, 2015, GERONTOLOGIST, V55, P706, DOI 10.1093/geront/gnu090; Christmas C, 2000, J AM GERIATR SOC, V48, P318, DOI 10.1111/j.1532-5415.2000.tb02654.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dapp U, 2011, J GERONTOL A-BIOL, V66, P591, DOI 10.1093/gerona/glr021; European Commission, 2017, EUR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franco MR, 2015, BRIT J SPORT MED, V49, P1268, DOI 10.1136/bjsports-2014-094015; Fries JF, 1998, WESTERN J MED, V169, P201; Greenwood-Hickman MA, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140574; Harari D, 2008, AGE AGEING, V37, P565, DOI 10.1093/ageing/afn150; Harris T, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001783; Hillsdon M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003180.pub.2; Hurtig-Wennlof A, 2010, PUBLIC HEALTH NUTR, V13, P1847, DOI 10.1017/S1368980010000157; Jefferis BJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-382; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P94, DOI DOI 10.1001/JAMA.1963.03060120024016; Kendrick D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009848.pub2; King AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156370; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Merchant AT, 2007, CAN J PUBLIC HEALTH, V98, P203, DOI 10.1007/BF03403713; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; OECD /EU, HLTH GLANC EUR 2016; Oremus M, 2011, HLTH RISK APPRAISAL; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Pears S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1703-8; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Shephard RJ, 2009, EUR J APPL PHYSIOL, V107, P251, DOI 10.1007/s00421-009-1127-1; Silsbury Z, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008430; Stuck AE, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-1; Stuck AE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001889; Tan ZS, 2017, J GERONTOL A-BIOL, V72, P789, DOI 10.1093/gerona/glw130; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; UITENBROEK DG, 1993, MED SCI SPORT EXER, V25, P755; US Department of Health & Human Services, 2008, PHYS ACT GUID AM, DOI DOI 10.4085/1062-6050-44.1.5; van der Vorst A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165127; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181371	10.1371/journal.pone.0181371	http://dx.doi.org/10.1371/journal.pone.0181371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727796	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500064
J	Okely, JA; Shaheen, SO; Weiss, A; Gale, CR				Okely, Judith A.; Shaheen, Seif O.; Weiss, Alexander; Gale, Catharine R.			Wellbeing and chronic lung disease incidence: The Survey of Health, Ageing and Retirement in Europe	PLOS ONE			English	Article							QUALITY-OF-LIFE; OBSTRUCTIVE PULMONARY-DISEASE; POSITIVE AFFECT; SOCIOECONOMIC-STATUS; D SCALE; RISK; DEPRESSION; DETERMINANTS; INFLAMMATION; PREVALENCE	Background Previous studies indicate that psychosocial factors can impact COPD prevalence. However, research into this association has predominantly focused on negative factors such as depression. The aim of this study was to examine whether high subjective wellbeing is associated with a lower risk of developing COPD. Methods The sample consisted of 12,246 participants aged -50 years from the Survey of Health, Ageing and Retirement in Europe. We used Cox proportional hazards regression to examine the relationship between wellbeing (measured using the CASP-12) and incidence of COPD over a follow-up period of 9 years. Results There was a significant association between wellbeing and COPD risk. In age-adjusted analyses, a standard deviation increase in CASP-12 score was associated with a reduced risk of COPD; hazard ratios (95% confidence intervals) for men and women were 0.67 (0.60-0.75) and 0.80 (0.73-0.87) respectively. After additional adjustment for demographic and health behaviour variables, this association remained significant for men but not for women: the fully-adjusted hazard ratios were 0.80 (0.70-0.91) and 0.91 (0.82-1.03) respectively. Conclusions Greater wellbeing is associated with a reduced risk of COPD, particularly in men. Future research is needed to establish whether gender reliably moderates this association.	[Okely, Judith A.; Gale, Catharine R.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Shaheen, Seif O.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England; [Weiss, Alexander] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Gale, Catharine R.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Edinburgh; University of London; Queen Mary University London; University of Edinburgh; University of Southampton	Okely, JA (corresponding author), Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	Judy.Okely@ed.ac.uk	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); MRC [G0400491, MC_U147585819, MC_UU_12011/2, MC_U147585827] Funding Source: UKRI; Medical Research Council [MC_U147585824, 1578662, MC_UU_12011/1, MR/K026992/1, MC_U147585827, MC_UU_12011/2, MC_U147585819, MC_UP_A620_1014, G0400491, U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, NF-SI-0513-10085] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Judith A. Okely and Catharine R. Gale are members of the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (MR/K026992/1). Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcser KH, 2005, SURVEY HLTH AGING RE; [Anonymous], 2015, TAK HER BREATH AW RI; Atlantis E, 2013, CHEST, V144, P766, DOI 10.1378/chest.12-1911; Barr RG, 2009, AM J MED, V122, P348, DOI 10.1016/j.amjmed.2008.09.042; Borsch-Supan A, 2008, START LONGITUD DIMEN; Borsch-Supan A, 2013, INT J EPIDEMIOL; Brett CE, 2012, QUAL LIFE RES, V21, P505, DOI 10.1007/s11136-011-9951-2; Castro-Costa E, 2008, INT J METH PSYCH RES, V17, P12, DOI 10.1002/mpr.236; Cohen S, 2006, CURR DIR PSYCHOL SCI, V15, P122, DOI 10.1111/j.0963-7214.2006.00420.x; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Ellison-Loschmann L, 2007, EUR RESPIR J, V29, P897, DOI 10.1183/09031936.00101606; Friedli L., 2004, SOCIAL PRESCRIBING M; Gale CR, 2015, PSYCHOSOM MED; Garson D., 2015, MISSING VALUES ANAL; GOLD, 2018, GLOBAL STRATEGY DIAG; Grant N, 2009, INT J BEHAV MED, V16, P259, DOI 10.1007/s12529-009-9032-x; Harik-Khan RI, 2002, CHEST, V121, P370, DOI 10.1378/chest.121.2.370; Hobbs FDR, 2002, EUR HEART J, V23, P1867, DOI 10.1053/euhj.2002.3255; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Jenkins A, 2013, LEARNING WELLBEING T; Kahn R., 1981, WORK AND HLTH; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Kubzansky LD, 2006, THORAX, V61, P863, DOI 10.1136/thx.2005.050971; Kubzansky LD, 2002, ANN BEHAV MED, V24, P345, DOI 10.1207/S15324796ABM2404_11; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; MENAGHAN EG, 1984, J HEALTH SOC BEHAV, V25, P406, DOI 10.2307/2136379; Netz Y, 2005, PSYCHOL AGING, V20, P272, DOI 10.1037/0882-7974.20.2.272; Okely JA, 2016, ANN BEHAV MED, P1; Omland O, 2014, SCAND J WORK ENV HEA, V40, P19, DOI 10.5271/sjweh.3400; Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI 10.1016/j.genhosppsych.2008.05.001; Pembroke TPI, 2006, J EPIDEMIOL COMMUN H, V60, P789, DOI 10.1136/jech.2005.042150; Perez-Rojo G., 2017, AGING MENTAL HLTH, P1; Pinquart M, 2000, PSYCHOL AGING, V15, P187, DOI 10.1037//0882-7974.15.2.187; Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P330, DOI 10.1192/bjp.174.4.330; Rippe JM, 1998, OBES RES, V6, P208, DOI 10.1002/j.1550-8528.1998.tb00339.x; Rod NH, 2012, ALLERGY, V67, P1408, DOI 10.1111/j.1398-9995.2012.02882.x.; Rosenberg SR, 2015, SEMIN RESP CRIT CARE, V36, P457, DOI 10.1055/s-0035-1555607; Rovina N, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/413735; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Stafford M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126683; Stellar JE, 2015, EMOTION, V15, P129, DOI 10.1037/emo0000033; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Steptoe A, 2012, PSYCHOSOM MED, V74, P501, DOI 10.1097/PSY.0b013e31824f82c8; Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011; Stocks J, 2013, THER ADV RESPIR DIS, V7, P161, DOI 10.1177/1753465813479428; Varraso R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h286; Ward K, 2011, J EPIDEMIOL COMMUN H, V65, P226, DOI 10.1136/jech.2009.096792; Watson L, 2004, RESP MED, V98, P1207, DOI 10.1016/j.rmed.2004.05.004; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181320	10.1371/journal.pone.0181320	http://dx.doi.org/10.1371/journal.pone.0181320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727748	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500057
J	Schlegel, V; Treuner-Kaueroff, T; Seehofer, D; Berg, T; Becker, S; Ceglarek, U; Thiery, J; Kaiser, T				Schlegel, Valentin; Treuner-Kaueroff, Theresa; Seehofer, Daniel; Berg, Thomas; Becker, Susen; Ceglarek, Uta; Thiery, Joachim; Kaiser, Thorsten			Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease	PLOS ONE			English	Article							LDL RECEPTOR; MODEL; DEGRADATION; CHOLESTEROL; DECREASES; SURVIVAL	Introduction Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a key role in the cholesterol metabolism and is synthesized by the liver. It interacts with the LDL-receptor to promote its degradation. The model of end-stage liver disease (MELD) score is a well-established tool to estimate the risk of mortality in patients with end-stage chronic liver disease. The study aims to assess the associations between PCSK9, hypocholesterinemia, liver synthesis, cholestasis, MELD score and mortality in patients with end-stage liver disease. Methods Serum samples were obtained from 74 patients with severe liver disease. The study participants were aged between 23 and 70 y (mean: 55.8 y; 47 males [63.5%], 27 females [36.5%]). Samples were selected from those with a wide range of MELD scores (7 to 40). Patients that underwent liver transplantation (17 / 74) were censored at the time of transplantation for mortality analysis. Results PCSK9 values ranged from 31.47 ng/mL to 261.64 ng/mL. The median value was 106.39 ng/ml. PCSK9 was negatively correlated with markers of liver function and cholestasis (INR, bilirubin). Over a 90-d follow-up, 15 of 57 (26,3%) patients died within the 90-d follow-up without receiving liver transplantation. Thirteen of 31 (42%) patients with PCSK9 levels below the median died compared to 2/26 (8%) patients with higher PCSK9 levels (p = 0.006). In this cohort, there were no significant correlations between PCSK9, cholesterol, its precursors and several phytosterols. Conclusions Low PCSK9 serum concentrations were associated with higher mortality in patients with end-stage liver disease. The mean PCSK9 levels in the study population were much lower than those found in normal or healthy populations. Further studies are required to acquire a more detailed understanding of the role of PCSK9 in liver-related mortality.	[Schlegel, Valentin; Treuner-Kaueroff, Theresa; Becker, Susen; Ceglarek, Uta; Thiery, Joachim; Kaiser, Thorsten] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Seehofer, Daniel] Univ Hosp Leipzig, Dept Visceral Vasc Thorac & Transplant Surg, Leipzig, Germany; [Berg, Thomas] Univ Hosp Leipzig, Sect Hepatol, Dept Gastroenterol & Rheumatol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Kaiser, T (corresponding author), Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany.	thorsten.kaiser@medizin.uni-leipzig.de	Ceglarek, Uta/GOE-5561-2022; Seehofer, Daniel/X-1933-2019	Berg, Thomas/0000-0003-0003-6241	German Research Foundation (DFG); Leipzig University	German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Becker S, 2015, ANAL BIOANAL CHEM, V407, P5227, DOI 10.1007/s00216-015-8731-1; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Cariou B, 2015, CURR OPIN LIPIDOL, V26, P155, DOI 10.1097/MOL.0000000000000180; Chang JM, 2009, P INT C UBIQ INFORM, P20; Cohen JC, 2006, REV PORT CARDIOL, V25, P769; Ghosh M, 2015, J LIPID RES, V56, P463, DOI 10.1194/jlr.M055780; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Janicko M, 2013, ANN HEPATOL, V12, P413; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Li S, 2015, ONCOTARGET; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Manka P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102351; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Peterson AS, 2008, J LIPID RES, V49, P1595, DOI 10.1194/jlr.CX00001-JLR200; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stein EA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0310-3; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wijers M, 2015, CURR OPIN LIPIDOL, V26, P82, DOI 10.1097/MOL.0000000000000157; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	26	10	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181540	10.1371/journal.pone.0181540	http://dx.doi.org/10.1371/journal.pone.0181540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727814	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500084
J	Mulu, W; Abera, B; Mekonnen, Z; Adem, Y; Yimer, M; Zenebe, Y; Amuamuta, A; Gebeyehu, W				Mulu, Wondemagegn; Abera, Bayeh; Mekonnen, Zewdie; Adem, Yesuf; Yimer, Mulat; Zenebe, Yohannes; Amuamuta, Asmare; Gebeyehu, Wondimu			Haematological and CD4(+) T cells reference ranges in healthy adult populations in Gojjam zones in Amhara region, Ethiopia	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; REFERENCE INTERVALS; REFERENCE VALUES; COUNT	Introduction Establishing national population haematological and immunological reference ranges are essential for clinical management of patients. However, there is scarcity of information on community based haematological reference ranges established from Ethiopian population. Therefore, this study aimed at determining haematological and CD4(+) T cells reference ranges in healthy adults from East and West Gojjam zones, Ethiopia. Methods Community based cross-sectional study was conducted from May 2015 to December 2015 in healthy adult residents of Gojjam zone. A total of 481(246 females and 235 males) healthy adults enrolled in the study. Healthy adults were defined by medical history, physical examination and laboratory screening for HIV, HBV, HCV and intestinal parasitosis. Haematological parameters were measured using haematology analyzer MindrayBC320 (Mindray Biomedical electronic Corporation, China). CD4(+) T cells were enumerated using FACS count (Becton Dickinson). Results The median age of the participants was 25 years. The overall median and 95th percentile of CD4+ T cells count were 869 cells/mm(3) and 396-1598 cells/mm(3), respectively. Females had a significantly higher CD4+ T cell counts compared to males (P = 0.002). The 95th percentile range for red blood cells (RBCs) was 3.93-6.1 x 10(6) cells/mm(3) and for hematocrit (Hct) was 40-58% while for hemoglobin (Hb) was 15.69-17.84g/dl. Males had significantly higher values of RBC and Hct than females (P < 0.001). Females (120-379 x 10(6) cells/mm(3)) had significantly higher platelet counts than males (106-352 x 10(6) cells/mm(3)) (P < 0.001). The overall median of WBC was 6.78 x 10(3)/mm(3) and its 95 th percentile range was 3.5-11.5 x 10(3)/ mm(3). The overall 95 th percentile range of MCV, MCH and MCHC were 89.5-107.5 fl, 28-34pg and 30-33.2g/dl, respectively. The higher mean absolute count of RBCs was found in the youngest age groups (P = 0.03). The mean count of RBCs and Hct were significantly higher in highschool completed and above than other participants ( P < 0.001). The lower and upper limit of platelet counts was significantly higher in highland (118-383x10(6) cells/ mm3) compared to lowland residents (107-352x10(6) cells/ mm3) ( P < 0.001). Moreover, it was significantly higher in residents with better monthly income (124-383x10(6) cells/ mm3) compared to the counters (115-368x10(6) cells/mm(3)) (P = 0.02). Conclusions Some of the haematological and CD4(+) T cells reference ranges of the healthy adults in this study showed variations with the reference ranges used and reported so far in Ethiopia, Africa and Western countries. We recommend further study considering gender, altitude, and residency in other parts of Ethiopia to establish national reference ranges for Ethiopian population.	[Mulu, Wondemagegn; Abera, Bayeh; Adem, Yesuf; Yimer, Mulat; Zenebe, Yohannes] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Microbiol Immunol & Parasitol, Bahir Dar, Ethiopia; [Mekonnen, Zewdie; Amuamuta, Asmare] Bahir Dar Univ, Biotechnol Res Inst, Biomed Res Dept, Bahir Dar, Ethiopia; [Mekonnen, Zewdie; Amuamuta, Asmare] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Biochem, Bahir Dar, Ethiopia; [Gebeyehu, Wondimu] Amhara Reg Hlth Res Lab Ctr, Bahir Dar, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University; Bahir Dar University	Mulu, W (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Microbiol Immunol & Parasitol, Bahir Dar, Ethiopia.	Wondem_32@yahoo.com	/AAD-8608-2020; Limeneh, Asmare Amuamuta/AAB-5229-2021; Abera, Bayeh/AAU-8754-2020; Mulu, Wondemagegn/X-3190-2019	/0000-0001-8016-6817; Limeneh, Asmare Amuamuta/0000-0002-9047-2962; chekol, yohannes zenebe/0000-0003-4522-4481; Mulu, Wondemagegn/0000-0002-5966-9388	Biotechnology Research Institute of Bahir Dar University [2.1/9407/1.11.10]; Biotechnology Research Institute of Bahir Dar University	Biotechnology Research Institute of Bahir Dar University; Biotechnology Research Institute of Bahir Dar University	The research project was funded by Biotechnology Research Institute of Bahir Dar University for the financial support on grant number 2.1/9407/1.11.10. The fund was utilized for purchasing reagents, data collection, analysis and interpretation.; This research was financed by Biotechnology Research Institute of Bahir Dar University. We would like to acknowledge DebreMarkos Referral Hospital for their permission to analyze the haemato immunological parameters in their setting. We also acknowledge the technical support of the staff of DebreMarkos Referral Hospital Laboratory. We also acknowledge Amhara Regional Health Bureau for their permission and support to conduct the study in the region.	Abera B, 2012, ETHIOP J HEALTH DEV, V26, P152; Ambayya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091968; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Federal Ministry of Health (FMOH), 2007, GUID LIN HIV CAR ART; Haileamlak A, 2012, ETHIOP J HEALTH SCI, V22, P39; Ittermann T, 2010, CLIN LAB, V56, P9; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Mine M, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.5; Miri-dashe T, 2014, PLOS ONE; Mugisha Joseph O, 2016, BMC Res Notes, V9, P433, DOI 10.1186/s13104-016-2217-x; Ngowi BJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-1; Osei-Bimpong A, 2012, INT J LAB HEMATOL, V34, P91, DOI 10.1111/j.1751-553X.2011.01365.x; Ramezani A., 2014, IRAN J PATHOL, V9, P50; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Samaneka WP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165821; Segolodi TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093034; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Wintrobe MM, 1999, WINTROBES CLIN HEMAT; Yalew Aregawi, 2016, BMC Res Notes, V9, P483; Yaman A, REFERENCE RANGES LYM; Zeh CE, LAB REFERENCE INTERV; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	22	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181268	10.1371/journal.pone.0181268	http://dx.doi.org/10.1371/journal.pone.0181268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723945	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800042
J	Ershova, AI; Meshkov, AN; Bazhan, SS; Storozhok, MA; Efanov, AY; Medvedeva, IV; Indukaeva, EV; Danilchenko, YV; Kuzmina, OK; Barbarash, OL; Deev, AD; Shalnova, SA; Boytsov, SA				Ershova, Alexandra I.; Meshkov, Alexey N.; Bazhan, Stepan S.; Storozhok, Marina A.; Efanov, Alexey Y.; Medvedeva, Irina V.; Indukaeva, Elena V.; Danilchenko, Yana V.; Kuzmina, Olga K.; Barbarash, Olga L.; Deev, Alexander D.; Shalnova, Svetlana A.; Boytsov, Sergey A.			The prevalence of familial hypercholesterolemia in the West Siberian region of the Russian Federation: A substudy of the ESSE-RF	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; COMMUNITY	Background The prevalence of familial hypercholesterolemia (FH) in Russia has not previously been evaluated. The aim of our study was to investigate the prevalence of FH in the population of the West Siberian region of Russia, and then estimate the frequency of coronary artery disease (CAD) and treatment with cholesterol-lowering medication in FH patients. Methods The sample of our study consisted of participants from the population-based cohort of The Epidemiology of Cardiovascular Risk Factors and Diseases in Regions of the Russian Federation Study (ESSE-RF), conducted in the Tyumen and Kemerovo regions (1,630 and 1,622 people, respectively, aged 25-64). All participants who had LDL-cholesterol higher than 4.9 mmol/l and who had LDL-cholesterol less than or equal to 4.9 mmol/l but had statin therapy were examined and interviewed by experts in FH. Results The prevalence of patients with definite FH was 0.24% (one in 407) (95% confidence interval [CI]: 0.06%-0.42%), with probable FH was 0.68% (one in 148) (95% CI: 0.38%-0.98%), and with definite or probable FH combined was 0.92% (one in 108) (95% CI: 0.58%-1.26%). 40% (95% CI: 20.8%-59.2%) of patients with definite or probable FH had CAD. However, only 23% (95% CI: 6.3%-39.7%) of patients with definite or probable FH were on statins. The odds ratios for CAD and myocardial infarction (MI), adjusted for age, gender, region, smoking, hypertension, and diabetes mellitus, were 3.71 (95% CI: 1.58-8.72) (p = 0.003) and 4.06 (95% CI: 0.89-18.55) (p = 0.070) respectively for individuals with definite or probable FH relative to those who were unlikely to have FH. Conclusions The prevalence of FH in Russia may be significantly higher than previously estimated. There is underdiagnosis and undertreatment of FH in Russia.	[Ershova, Alexandra I.; Meshkov, Alexey N.; Deev, Alexander D.; Shalnova, Svetlana A.; Boytsov, Sergey A.] Natl Res Ctr Prevent Med, Moscow, Russia; [Bazhan, Stepan S.] Inst Internal & Prevent Med, Novosibirsk, Russia; [Storozhok, Marina A.; Efanov, Alexey Y.; Medvedeva, Irina V.] Tyumen State Med Acad, Tyumen, Russia; [Indukaeva, Elena V.; Danilchenko, Yana V.; Kuzmina, Olga K.; Barbarash, Olga L.] Res Inst Complex Issues Cardiovasc Dis, Kemerovo, Russia	National Medical Research Center for Therapy & Preventive Medicine; Tyumen State Medical University; Russian Academy of Medical Sciences; Research Institute for Complex Issues of Cardiovascular Diseases	Ershova, AI (corresponding author), Natl Res Ctr Prevent Med, Moscow, Russia.	alersh@mail.ru	Ershova, Alexandra I/J-8772-2017; Indukaeva, Elena/I-2340-2017; Meshkov, Alexey N/K-1056-2017; Shalnova, Svetlana/D-3824-2016; Boytsov, Sergey A/M-4486-2014; Danilchenko, Yana/H-6780-2017; Efanov, Alexei/N-8887-2016; Boytsov, Sergey/AAK-5354-2021; Storozhok, Marina/AAH-2523-2019; deev, alexander/M-7754-2014; Barbarash, Olga/A-4834-2017	Ershova, Alexandra I/0000-0001-7989-0760; Indukaeva, Elena/0000-0002-6911-6568; Meshkov, Alexey N/0000-0001-5989-6233; Boytsov, Sergey A/0000-0001-6998-8406; Danilchenko, Yana/0000-0001-8308-8308; Boytsov, Sergey/0000-0001-6998-8406; Barbarash, Olga/0000-0002-4642-3610; Efanov, Alexey/0000-0002-3770-3725				[Anonymous], 2014, J CLIN ENDOCRINOL ME, V99, P4758; BASS EB, 1989, J CLIN EPIDEMIOL, V42, P385, DOI 10.1016/0895-4356(89)90126-1; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Boitsov S.A., 2013, PREVENT MED, V6, P25, DOI DOI 10.20333/25000136-2014-4-82-85; De Backer G, 2015, ATHEROSCLEROSIS, V241, P169, DOI 10.1016/j.atherosclerosis.2015.04.809; de Ferranti SD, 2016, CIRCULATION, V133, P1067, DOI 10.1161/CIRCULATIONAHA.115.018791; Goldstein JL, 1995, METABOLIC BASIS INHE, P1215; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Kish L, 1965, SURVEY SAMPLING; Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1; Meshkov AN, 2009, TERAPEVT ARKH, V81, P23; MOORJANI S, 1989, ARTERIOSCLEROSIS, V9, P211, DOI 10.1161/01.ATV.9.2.211; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Shi ZM, 2014, INT J CARDIOL, V174, P834, DOI 10.1016/j.ijcard.2014.04.165; Sjouke B, 2015, EUR HEART J, V36, P560, DOI 10.1093/eurheartj/ehu058; SLACK J, 1969, LANCET, V2, P1380; Steyn K, 1996, HUM GENET, V98, P479, DOI 10.1007/s004390050243; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Watts GF, 2015, INT J CARDIOL, V185, P69, DOI 10.1016/j.ijcard.2015.03.027	20	13	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181148	10.1371/journal.pone.0181148	http://dx.doi.org/10.1371/journal.pone.0181148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719663	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400033
J	Queiroz, FR; Silva, LM; Jeremias, WD; Baba, EH; Caldeira, RL; Coelho, PMZ; Gomes, MD				Queiroz, Fabio Ribeiro; Silva, Luciana Maria; Jeremias, Wander de Jesus; Baba, Elio Hideo; Caldeira, Roberta Lima; Zech Coelho, Paulo Marcos; Gomes, Matheus de Souza			Differential expression of small RNA pathway genes associated with the Biomphalaria glabrata/Schistosoma mansoni interaction	PLOS ONE			English	Article							INTERMEDIATE SNAIL HOST; STEM-CELL MAINTENANCE; SCHISTOSOMA-MANSONI; MICRORNA MATURATION; NUCLEAR EXPORT; AUSTRALORBIS-GLABRATUS; TARGET RECOGNITION; STRUCTURAL BASIS; PIWI PROTEINS; PIRNA PATHWAY	The World Health Organization (WHO) estimates that approximately 240 million people in 78 countries require treatment for schistosomiasis, an endemic disease caused by trematodes of the genus Schistosoma. In Brazil, Schistosoma mansoni is the only species representative of the genus whose passage through an invertebrate host, snails of the genus Biomphalaria, is obligatory before infecting a mammalian host, including humans. The availability of the genome and transcriptome of B. glabrata makes studying the regulation of gene expression, particularly the regulation of miRNA and piRNA processing pathway genes, possible. This might assist in better understanding the biology of B. glabrata as well as its relationship to the parasite S. mansoni. Some aspects of this interaction are still poorly explored, including the participation of non-coding small RNAs, such as miRNAs and piRNAs, with lengths varying from 18 to 30 nucleotides in mature form, which are potent regulators of gene expression. Using bioinformatics tools and quantitative PCR, we characterized and validated the miRNA and piRNA processing pathway genes in B. glabrata. In silico analyses showed that genes involved in miRNA and piRNA pathways were highly conserved in protein domain distribution, catalytic site residue conservation and phylogenetic analysis. Our study showed differential expression of putative Argonaute, Drosha, Piwi, Exportin-5 and Tudor genes at different snail developmental stages and during infection with S. mansoni, suggesting that the machinery is required for miRNA and piRNA processing in B. glabrata at all stages. These data suggested that the silencing pathway mediated by miRNAs and piRNAs can interfere in snail biology throughout the life cycle of the snail, thereby influencing the B. glabrata/S. mansoni interaction. Further studies are needed to confirm the participation of the small RNA processing pathway proteins in the parasite/host relationship, mainly the effective participation of small RNAs in regulating their target genes.	[Queiroz, Fabio Ribeiro; Jeremias, Wander de Jesus; Baba, Elio Hideo; Zech Coelho, Paulo Marcos] Fundacao Oswaldo Cruz, Grp Pesquisa Biol Schistosoma Mansoni & Sua Inter, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Queiroz, Fabio Ribeiro; Silva, Luciana Maria] Fundacao Ezequiel Dias, Serv Biol Celular, Dept Pesquisas & Desenvolvimento, Belo Horizonte, MG, Brazil; [Caldeira, Roberta Lima] Fundacao Oswaldo Cruz, Grp Pesquisa Helmintol & Malacol Med, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Gomes, Matheus de Souza] Univ Fed Uberlandia, Lab Bioinformat & Anal Mol, Inst Genet & Bioquim, Campus Patos Minas, Patos De Minas, MG, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Uberlandia	Silva, LM (corresponding author), Fundacao Ezequiel Dias, Serv Biol Celular, Dept Pesquisas & Desenvolvimento, Belo Horizonte, MG, Brazil.	luciana.silva@funed.mg.gov.br	Silva, Luciana M/I-4353-2014; Coelho, Paulo Marcos Zech/ABE-6169-2021; Silva, Luciana M/R-6340-2018; Caldeira, Roberta/AAZ-3858-2020; de Souza Gomes, Matheus/G-3480-2012	Silva, Luciana M/0000-0002-2038-0405; Coelho, Paulo Marcos Zech/0000-0002-2443-8897; Silva, Luciana M/0000-0002-2038-0405; Caldeira, Roberta/0000-0003-4706-0732; Jeremias, Wander/0000-0001-8204-6712; de Souza Gomes, Matheus/0000-0001-7352-3089	FAPEMIG [APQ-00467-13]; CNPq [479890/2013-7]; CAPES; Rene Rachou Research Center/CPqRR - The Oswaldo Cruz Foundation and Ezequiel Dias Foundation FUNED	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rene Rachou Research Center/CPqRR - The Oswaldo Cruz Foundation and Ezequiel Dias Foundation FUNED	This work was supported by FAPEMIG, through project number APQ-00467-13 and CNPq - project number 479890/2013-7; CAPES, Rene Rachou Research Center/CPqRR - The Oswaldo Cruz Foundation and Ezequiel Dias Foundation FUNED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 2006, MEM I OSWALDO CRUZ, V101, P167, DOI 10.1590/S0074-02762006000900027; Adema CM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15451; de Mattos ACA, 2011, MEM I OSWALDO CRUZ, V106, P424, DOI 10.1590/S0074-02762011000400007; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldeira RL, 2009, ACTA TROP, V111, P1, DOI 10.1016/j.actatropica.2009.02.004; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chen C, 2009, P NATL ACAD SCI USA, V106, P20336, DOI 10.1073/pnas.0911640106; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; clinicaltrials. gov, 2020, RNA; Costa MC, 2012, INT J MOL SCI, V13, P10268, DOI 10.3390/ijms130810268; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Ender C, 2010, J CELL SCI, V123, P1819, DOI 10.1242/jcs.055210; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flor TB, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040538; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gomes MD, 2011, GENOMICS, V98, P96, DOI 10.1016/j.ygeno.2011.05.007; Gomes MS, 2009, PARASITOL INT, V58, P61, DOI 10.1016/j.parint.2008.10.002; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hale BJ, 2014, MOL REPROD DEV, V81, P148, DOI 10.1002/mrd.22272; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hanington PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001591; Hesse M, 2014, METHODS MOL BIOL, V1095, P11, DOI 10.1007/978-1-62703-703-7_2; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Jannot G, 2008, RNA, V14, P829, DOI 10.1261/rna.901908; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2005, MOL CELLS, V19, P1; Knight M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001212; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu HP, 2010, GENE DEV, V24, P1876, DOI 10.1101/gad.1956010; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09999; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maldonado Jose F., 1947, PUERTO RICO JOUR PUBL HEALTH AND TROP MED, V22, P331; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Nam S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109745; Negrao-Correa D, 2012, J Parasitol Res, V2012, P743920, DOI 10.1155/2012/743920; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; PAN CT, 1965, AM J TROP MED HYG, V14, P931, DOI 10.4269/ajtmh.1965.14.931; PAN CT, 1963, ANN NY ACAD SCI, V113, P475, DOI 10.1111/j.1749-6632.1963.tb40684.x; Paraense WL, 2001, MEM I OSWALDO CRUZ, V96, P7, DOI 10.1590/S0074-02762001000900002; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; PIMENTEL D, 1957, ECOLOGY, V38, P576, DOI 10.2307/1943122; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzet M, 2000, PARASITOL TODAY, V16, P536, DOI 10.1016/S0169-4758(00)01787-7; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Simoes MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-47; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; YOSHINO TP, 1983, PARASITE IMMUNOL, V5, P317, DOI 10.1111/j.1365-3024.1983.tb00747.x; Coelho PMZ, 2008, ACTA TROP, V108, P245, DOI 10.1016/j.actatropica.2008.05.028; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang P, 2015, CELL RES, V25, P193, DOI [10.1038/cr.2015.4, 10.1038/cr.2015.14]	99	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181483	10.1371/journal.pone.0181483	http://dx.doi.org/10.1371/journal.pone.0181483			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719649	gold, Green Published, Green Submitted			2022-12-27	WOS:000406061400049
J	Tani, H; Okuda, S; Nakamura, K; Aoki, M; Umemura, T				Tani, Hidenori; Okuda, Sayaka; Nakamura, Kaoru; Aoki, Motohide; Umemura, Tomonari			Short-lived long non-coding RNAs as surrogate indicators for chemical exposure and LINC00152 and MALAT1 modulate their neighboring genes	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GASTRIC-CANCER; HEPATOCELLULAR-CARCINOMA; PROMOTES PROLIFERATION; EXPRESSION; TRANSCRIPTS; PATHWAY; DECAY; IDENTIFICATION; TRANSLATION	Whole transcriptome analyses have revealed a large number of novel long non-coding RNAs (lncRNAs). Although accumulating evidence demonstrates that lncRNAs play important roles in regulating gene expression, the detailed mechanisms of action of most lncRNAs remain unclear. We previously reported that a novel class of lncRNAs with a short half-life (t(1/2) < 4 h) in HeLa cells, termed short-lived non-coding transcripts (SLiTs), are closely associated with physiological and pathological functions. In this study, we focused on 26 SLiTs and nuclear-enriched abundant lncRNA, MALAT1(t(1/2) of 7.6 h in HeLa cells) in neural stem cells (NSCs) derived from human induced pluripotent stem cells, and identified four SLiTs (TUG1, GAS5, FAM222-AS1, and SNHG15) that were affected by the following typical chemical stresses (oxidative stress, heavy metal stress and protein synthesis stress). We also found the expression levels of LINC00152 (t(1/2) of 2.1 h in NSCs), MALAT1 (t(1/2) of 1.8 h in NSCs), and their neighboring genes were elevated proportionally to the chemical doses. Moreover, we confirmed that the overexpression of LINC00152 or MALAT1 upregulated the expressions of their neighboring genes even in the absence of chemical stress. These results reveal that LINC00152 and MALAT1 modulate their neighboring genes, and thus provide a deeper understanding of the functions of lncRNAs.	[Tani, Hidenori; Okuda, Sayaka; Nakamura, Kaoru] Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, 16-1 Onogawa, Tsukuba, Ibaraki, Japan; [Okuda, Sayaka; Aoki, Motohide; Umemura, Tomonari] Tokyo Univ Pharm & Life Sci, Dept Mol Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Pharmacy & Life Sciences	Tani, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, 16-1 Onogawa, Tsukuba, Ibaraki, Japan.	h.tani@aist.go.jp	Tani, Hidenori/F-2042-2010	Tani, Hidenori/0000-0001-6390-4136	JSPS [26810100]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a JSPS Grant-in-Aid for Young Scientists (B), grant number 26810100.; We thank Dr. Yuzuru Ito (AIST) and Dr. Yasuko Onuma (AIST) for their technical help, and Dr. Tetsuro Hirose (Hokkaido University) for providing the plasmid expressing MALAT1. The human iPSC line 201B7 was provided by the RIKEN BRC through the Project for Realization of Regenerative Medicine and the National Bio Resource Project of MEXT, Japan. This work was supported by a JSPS Grant-in-Aid for Young Scientists (B), grant number 26810100.	Abe K, 2012, BIOCHEM BIOPH RES CO, V428, P44, DOI 10.1016/j.bbrc.2012.09.144; Akimitsu N, 2008, J BIOCHEM, V143, P1, DOI 10.1093/jb/mvm204; Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Harigaya Y, 2010, WIRES RNA, V1, P132, DOI 10.1002/wrna.17; Hirose T, 2014, EMBO REP, V15, P489, DOI 10.1002/embr.201338390; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Ji J, 2015, ONCOTARGET, V6, P42813, DOI 10.18632/oncotarget.5970; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Li J, 2015, CELL PHYSIOL BIOCHEM, V37, P687, DOI 10.1159/000430387; Lin R, 2011, FEBS LETT, V585, P671, DOI 10.1016/j.febslet.2011.01.030; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Maekawa S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1358-y; Meola N, 2016, MOL CELL, V64, P520, DOI 10.1016/j.molcel.2016.09.025; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Pang QQ, 2014, TUMOR BIOL, V35, P5441, DOI 10.1007/s13277-014-1709-3; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tani H, 2016, J BIOSCI BIOENG, V122, P329, DOI 10.1016/j.jbiosc.2016.02.007; Tani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106282; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wu MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36045; Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao J, 2015, CELL CYCLE, V14, P3112, DOI 10.1080/15384101.2015.1078034; Zhou JP, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0250-6	36	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181628	10.1371/journal.pone.0181628	http://dx.doi.org/10.1371/journal.pone.0181628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719640	Green Submitted, gold, Green Published			2022-12-27	WOS:000406061400059
J	Ferreira, SJ; Senning, M; Fischer-Stettler, M; Streb, S; Ast, M; Neuhaus, HE; Zeeman, SC; Sonnewald, S; Sonnewald, U				Ferreira, Stephanus J.; Senning, Melanie; Fischer-Stettler, Michaela; Streb, Sebastian; Ast, Michelle; Neuhaus, H. Ekkehard; Zeeman, Samuel C.; Sonnewald, Sophia; Sonnewald, Uwe			Simultaneous silencing of isoamylases ISA1, ISA2 and ISA3 by multi-target RNAi in potato tubers leads to decreased starch content and an early sprouting phenotype	PLOS ONE			English	Article							DEBRANCHING ENZYMES; ARABIDOPSIS LACKING; GRANULE INITIATION; BRANCHING ENZYMES; CHAIN-LENGTH; PROTEIN; GROWTH; AMYLOPECTIN; BREAKDOWN; MUTANTS	Isoamylases hydrolyse (1-6)-alpha-D-glucosidic linkages in starch and are involved in both starch granule formation and starch degradation. In plants, three isoamylase isoforms with distinct functions in starch synthesis (ISA1 and ISA2) and degradation (ISA3) have been described. Here, we created transgenic potato plants with simultaneously decreased expression of all three isoamylases using a chimeric RNAi construct targeting all three isoforms. Constitutive expression of the hairpin RNA using the 35S CaMV promoter resulted in efficient silencing of all three isoforms in leaves, growing tubers, and sprouting tubers. Neither plant growth nor tuber yield was effected in isoamylase- deficient potato lines. Interestingly, starch metabolism was found to be impaired in a tissue- specific manner. While leaf starch content was unaffected, tuber starch was significantly reduced. The reduction in tuber starch content in the transgenic plants was accompanied by a decrease in starch granules size, an increased sucrose content and decreased hexose levels. Despite the effects on granule size, only little changes in chain length composition of soluble and insoluble glucose polymers were detected. The transgenic tubers displayed an early sprouting phenotype that was accompanied by an increased level of sucrose in parenchyma cells below the outgrowing bud. Since high sucrose levels promote sprouting, we propose that the increased number of small starch granules may cause an accelerated turnover of glucan chains and hence a more rapid synthesis of sucrose. This observation links alterations in starch structure/degradation with developmental processes like meristem activation and sprout outgrowth in potato tubers.	[Ferreira, Stephanus J.; Senning, Melanie; Sonnewald, Sophia; Sonnewald, Uwe] Friedrich Alexander Univ Erlangen Nuremberg, Dept Biol, Erlangen, Germany; [Fischer-Stettler, Michaela; Streb, Sebastian; Zeeman, Samuel C.] ETH, Dept Biol, Zurich, Switzerland; [Ast, Michelle; Neuhaus, H. Ekkehard] Tech Univ Kaiserslautern, Dept Biol, Div Plant Physiol, Kaiserslautern, Germany; [Ferreira, Stephanus J.] Westcape Biotech Pty Ltd, Stellenbosch, South Africa	University of Erlangen Nuremberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kaiserslautern	Sonnewald, U (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Dept Biol, Erlangen, Germany.	uwe.sonnewald@fau.de	Sonnewald, Uwe/J-7875-2012	Sonnewald, Uwe/0000-0003-1835-5339; Streb, Sebastian/0000-0002-9095-6596; Zeeman, Samuel/0000-0002-2791-0915	EU-SOL [FOOD-CT-2006-016214]; Deutsche Forschungsgemeinschaft (DFG) within the ERA-CAPS initiative [SO300/20-1, SO1002/3-1]	EU-SOL; Deutsche Forschungsgemeinschaft (DFG) within the ERA-CAPS initiative	The project was funded by EU-SOL (FOOD-CT-2006-016214 (https://www.eu-sol.wur.nl/about.jsp) and by grants from the Deutsche Forschungsgemeinschaft (DFG) within the ERA-CAPS initiative (https://www.eu-sol.wur.nl/about.jsp) to US and SSo (SO300/20-1 and SO1002/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, J BIOTECHNOL, V123, P137, DOI 10.1016/j.jbiotec.2005.11.001; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Carciofi M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-223; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Edwards A, 1999, PLANT J, V17, P251, DOI 10.1046/j.1365-313X.1999.00371.x; Ferreira SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-93; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Hartmann A, 2011, PLANT PHYSIOL, V155, P776, DOI 10.1104/pp.110.168252; Hejazi M, 2008, PLANT J, V55, P323, DOI [10.1111/j.1365-313X.2008.03513.x, 10.1111/j.0960-7412.2008.03513.x]; Hussain H, 2003, PLANT CELL, V15, P133, DOI 10.1105/tpc.006635; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; Lu KJ, 2015, PLANT PHYSIOL, V169, P1638, DOI 10.1104/pp.15.00792; Mason MG, 2014, P NATL ACAD SCI USA, V111, P6092, DOI 10.1073/pnas.1322045111; Miki D, 2005, PLANT PHYSIOL, V138, P1903, DOI 10.1104/pp.105.063933; MULLERROBER B, 1992, EMBO J, V11, P1229, DOI 10.1002/j.1460-2075.1992.tb05167.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister B, 2016, CELL MOL LIFE SCI, V73, P2781, DOI 10.1007/s00018-016-2250-x; Pfister B, 2014, PLANT PHYSIOL, V165, P1457, DOI 10.1104/pp.114.241455; Rahman S, 2003, GENOME, V46, P496, DOI 10.1139/g02-130; Scheidig A, 2002, PLANT J, V30, P581, DOI 10.1046/j.1365-313X.2002.01317.x; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Sonnewald S, 2014, PLANTA, V239, P27, DOI 10.1007/s00425-013-1968-z; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Takashima Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2308, DOI 10.1271/bbb.70215; Tetlow IJ, 2014, IUBMB LIFE, V66, P546, DOI 10.1002/iub.1297; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Van Harsselaar JK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3381-z; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	37	11	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181444	10.1371/journal.pone.0181444	http://dx.doi.org/10.1371/journal.pone.0181444			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708852	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649800058
J	Wagner, FH; Herault, B; Rossi, V; Hilker, T; Maeda, EE; Sanchez, A; Lyapustin, AI; Galvao, LS; Wang, YJ; Aragao, LEOC				Wagner, Fabien Hubert; Herault, Bruno; Rossi, Vivien; Hilker, Thomas; Maeda, Eduardo Eiji; Sanchez, Alber; Lyapustin, Alexei I.; Galvao, Lenio Soares; Wang, Yujie; Aragao, Luiz E. O. C.			Climate drivers of the Amazon forest greening	PLOS ONE			English	Article							TROPICAL DRY FOREST; SEASONAL-VARIATIONS; CANOPY STRUCTURE; WOOD PRODUCTION; RAIN-FOREST; LEAF; PHENOLOGY; DROUGHT; SENSITIVITY; GROWTH	Our limited understanding of the climate controls on tropical forest seasonality is one of the biggest sources of uncertainty in modeling climate change impacts on terrestrial ecosystems. Combining leaf production, litterfall and climate observations from satellite and ground data in the Amazon forest, we show that seasonal variation in leaf production is largely triggered by climate signals, specifically, insolation increase (70.4% of the total area) and precipitation increase (29.6%). Increase of insolation drives leaf growth in the absence of water limitation. For these non-water-limited forests, the simultaneous leaf flush occurs in a sufficient proportion of the trees to be observed from space. While tropical cycles are generally defined in terms of dry or wet season, we show that for a large part of Amazonia the increase in insolation triggers the visible progress of leaf growth, just like during spring in temperate forests. The dependence of leaf growth initiation on climate seasonality may result in a higher sensitivity of these ecosystems to changes in climate than previously thought.	[Wagner, Fabien Hubert; Galvao, Lenio Soares; Aragao, Luiz E. O. C.] Natl Inst Space Res INPE, Remote Sensing Div, BR-12227010 Sao Jose Dos Campos, SP, Brazil; [Herault, Bruno] CIRAD, UMR Ecol Forets Guyane, F-97379 Kourou, France; [Rossi, Vivien] CIRAD, UR B&SEF Biens & Serv Ecosyst Forestiers Tropicau, BP 2572, Yaounde, Cameroon; [Hilker, Thomas] Univ Southampton, Dept Geog & Environm, Southampton SO17 1BJ, Hants, England; [Maeda, Eduardo Eiji] Univ Helsinki, Dept Environm Sci, FI-00014 Helsinki, Finland; [Sanchez, Alber] Natl Inst Space Res INPE, Earth Syst Sci Ctr, BR-12227010 Sao Jose Dos Campos, SP, Brazil; [Lyapustin, Alexei I.; Wang, Yujie] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Aragao, Luiz E. O. C.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4RJ, Devon, England	Instituto Nacional de Pesquisas Espaciais (INPE); AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; University of Southampton; University of Helsinki; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Exeter	Wagner, FH (corresponding author), Natl Inst Space Res INPE, Remote Sensing Div, BR-12227010 Sao Jose Dos Campos, SP, Brazil.	wagner.h.fabien@gmail.com	aragao, luiz eoc/G-8387-2012; Lyapustin, Alexei/H-9924-2014; Sanchez, Alber/AAQ-4055-2021; Hérault, Bruno/B-2765-2011; Wagner, Fabien FW/B-8364-2013; Maeda, Eduardo/E-7327-2011	aragao, luiz eoc/0000-0002-4134-6708; Lyapustin, Alexei/0000-0003-1105-5739; Sanchez, Alber/0000-0001-7966-2880; Hérault, Bruno/0000-0002-6950-7286; Wagner, Fabien FW/0000-0002-9623-1182; Maeda, Eduardo/0000-0001-7932-1824; Galvao, Lenio/0000-0002-8313-0497	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [processo 13/14520-6, processo 15/50484-0, processo 16/17652-9, processo 2016/03397-7]; FAPESP [50533-5]; CNPQ [304425/2013-3]; Academy of Finland [266393]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [PVE 401025/2014-4]; NASA Program "Science from Terra and Aqua"	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Academy of Finland(Academy of Finland); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NASA Program "Science from Terra and Aqua"	This project and F.H.W. have been funded by the Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, processo 13/14520-6, processo 15/50484-0 and processo 16/17652-9). L.E.O.C.A. is thankful for the support of FAPESP (grant 50533-5) and CNPQ (grant 304425/2013-3). E.E.M. was funded by the Academy of Finland (project: 266393). A.S. has been funded by the Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, processo 2016/03397-7). T.H. was supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number PVE 401025/2014-4. The work of Dr. Lyapustin was funded by the NASA Program "Science from Terra and Aqua". The authors declare no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/6/064014; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Bonal D, 2016, ANN FOREST SCI, V73, P27, DOI 10.1007/s13595-015-0522-5; BORCHERT R, 1994, ECOLOGY, V75, P1437, DOI 10.2307/1937467; Borchert R, 2015, NEW PHYTOL, V205, P7, DOI 10.1111/nph.12981; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Brazilian Institute of Geography and Statistics ( IBGE), 2004, MAPA DE VEGETACO DO; Caldararu S, 2014, BIOGEOSCIENCES, V11, P763, DOI 10.5194/bg-11-763-2014; Chavana-Bryant C, 2017, NEW PHYTOL, V214, P1049, DOI 10.1111/nph.13853; Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Elliott S, 2006, GLOBAL ECOL BIOGEOGR, V15, P248, DOI 10.1111/j.1466-822x.2006.00213.x; Feng X, 2013, NAT CLIM CHANGE, V3, P811, DOI [10.1038/nclimate1907, 10.1038/NCLIMATE1907]; Free CM, 2014, FOREST ECOL MANAG, V330, P46, DOI 10.1016/j.foreco.2014.05.057; Galvao LS, 2011, REMOTE SENS ENVIRON, V115, P2350, DOI 10.1016/j.rse.2011.04.035; Girardin CAJ, 2016, GLOBAL BIOGEOCHEM CY, V30, P700, DOI 10.1002/2015GB005270; Grogan J, 2012, BIOTROPICA, V44, P331, DOI 10.1111/j.1744-7429.2011.00825.x; Guan KY, 2015, NAT GEOSCI, V8, P284, DOI 10.1038/NGEO2382; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hilker T, 2014, P NATL ACAD SCI USA, V111, P16041, DOI 10.1073/pnas.1404870111; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete AR, 2008, AGR FOREST METEOROL, V148, P748, DOI 10.1016/j.agrformet.2008.01.012; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Jarvis A, 2008, HOLE FILLED SEAMLESS; Justice CO, 1998, IEEE T GEOSCI REMOTE, V36, P1228, DOI 10.1109/36.701075; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Loeb NG, 2009, J CLIMATE, V22, P748, DOI 10.1175/2008JCLI2637.1; Lopes AP, 2016, REMOTE SENS ENVIRON, V182, P90, DOI 10.1016/j.rse.2016.05.009; Lyapustin AI, 2012, REMOTE SENS ENVIRON, V127, P385, DOI 10.1016/j.rse.2012.09.002; Maeda EE, 2016, INT J APPL EARTH OBS, V52, P42, DOI 10.1016/j.jag.2016.05.005; Marechaux I, 2015, FUNCT ECOL, V29, P1268, DOI 10.1111/1365-2435.12452; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morel H, 2015, DENDROMETER AND LITT, V29, P973; Morel H, 2015, TREES-STRUCT FUNCT, V29, P973, DOI 10.1007/s00468-015-1177-4; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Myneni RB, 2007, P NATL ACAD SCI USA, V104, P4820, DOI 10.1073/pnas.0611338104; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; R. Core Team, 2015, R A LANGUAGE AND ENV; REICH PB, 1984, J ECOL, V72, P61, DOI 10.2307/2260006; Restrepo-Coupe N, 2013, AGR FOREST METEOROL, V182, P128, DOI 10.1016/j.agrformet.2013.04.031; Rivera G, 2002, TREES-STRUCT FUNCT, V16, P445, DOI 10.1007/s00468-002-0185-3; Rowland L, 2014, OECOLOGIA, V174, P295, DOI 10.1007/s00442-013-2766-9; Saleska S.R, 2003, SITZBER HEIDELBER MN, V302, P1554; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Saleska SR, 2016, NATURE, V531, pE4, DOI 10.1038/nature16457; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stahl C, 2010, J TROP ECOL, V26, P393, DOI 10.1017/S0266467410000155; Tang H, 2017, P NATL ACAD SCI USA, V114, P2640, DOI 10.1073/pnas.1616943114; Wagner F, 2013, BIOGEOSCIENCES, V10, P7307, DOI 10.5194/bg-10-7307-2013; Wagner FH, 2016, BIOGEOSCIENCES, V13, P2537, DOI 10.5194/bg-13-2537-2016; WRIGHT SJ, 1994, AM NAT, V143, P192, DOI 10.1086/285600; WRIGHT SJ, 1990, ECOLOGY, V71, P1165, DOI 10.2307/1937384; Wu J, 2016, SCIENCE, V351, P972, DOI 10.1126/science.aad5068; Zhang HC, 2014, ECOL COMPLEX, V20, P240, DOI 10.1016/j.ecocom.2014.01.003; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	59	44	45	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180932	10.1371/journal.pone.0180932	http://dx.doi.org/10.1371/journal.pone.0180932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708897	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649800031
J	Chang, J; de Sousa, A; Sabatier, J; Assane, M; Zhang, GQ; Bila, D; Vaz, P; Alfredo, C; Cossa, L; Bhatt, N; Koumans, EH; Yang, CF; Rivadeneira, E; Jani, I; Houston, JC				Chang, Joy; de Sousa, Amina; Sabatier, Jennifer; Assane, Mariamo; Zhang, Guoqing; Bila, Dulce; Vaz, Paula; Alfredo, Charity; Cossa, Loide; Bhatt, Nilesh; Koumans, Emilia H.; Yang, Chunfu; Rivadeneira, Emilia; Jani, Ilesh; Houston, James C.			Performance characteristics of finger-stick dried blood spots (DBS) on the determination of human immunodeficiency virus (HIV) treatment failure in a pediatric population in Mozambique	PLOS ONE			English	Article							ABBOTT REALTIME HIV-1; RECEIVING ANTIRETROVIRAL THERAPY; RESOURCE-LIMITED SETTINGS; TO-CHILD TRANSMISSION; VIRAL LOAD; VERSION 2.0; DIAGNOSIS; RNA; ASSAY; SPECIMENS	Quantitative plasma viral load (VL) at 1000 copies/mL was recommended as the threshold to confirm antiretroviral therapy (ART) failure by the World Health Organization (WHO). Because of ongoing challenges of using plasma for VL testing in resource-limited settings (RLS), especially for children, this study collected 717 DBS and paired plasma samples from children receiving ART >= 1 year in Mozambique and compared the performance of DBS using Abbott's VL test with a paired plasma sample using Roche's VL test. At a cut-off of 1000 copies/mL, sensitivity of DBS using Abbott DBS VL test was 79.9%, better than 71.0% and 63.9% at 3000 and 5000 copies/mL, respectively. Specificities were 97.6%, 98.8%, 99.3% at 1000, 3000, and 5000 copies/mL, respectively. The Kappa value at 1000 copies/mL, 0.80 (95% CI: 0.73, 0.87), was higher than 0.73 (95% CI: 0.66, 0.80) and 0.66 (95% CI: 0.59, 0.73) at 3000, 5000 copies/mL, respectively, also indicating better agreement. The mean difference between the DBS and plasma VL tests with 95% limits of agreement by Bland-Altman was 0.311 (-0.908, 1.530). Among 73 children with plasma VL between 1000 to 5000 copies/mL, the DBS results were undetectable in 53 at the 1000 copies/mL threshold. While one DBS sample in the Abbott DBS VL test may be an alternative method to confirm ART failure at 1000 copies/mL threshold when a plasma sample is not an option for treatment monitoring, because of sensitivity concerns between 1,000 and 5,000 copies/ml, two DBS samples may be preferred accompanied by careful patient monitoring and repeat testing.	[Chang, Joy; Sabatier, Jennifer; Zhang, Guoqing; Koumans, Emilia H.; Yang, Chunfu; Rivadeneira, Emilia; Houston, James C.] Ctr Dis Control & Prevent, CDC, Atlanta, GA 30333 USA; [de Sousa, Amina; Assane, Mariamo; Cossa, Loide; Bhatt, Nilesh; Jani, Ilesh] Minist Hlth, INS, Maputo, Mozambique; [Bila, Dulce; Vaz, Paula] Fundacao Ariel Glaser SIDA Pediat Ariel, Maputo, Mozambique; [Alfredo, Charity] Ctr Dis Control & Prevent, Maputo, Mozambique	Centers for Disease Control & Prevention - USA	Chang, J (corresponding author), Ctr Dis Control & Prevent, CDC, Atlanta, GA 30333 USA.	ckc7@cdc.gov; vie3@cdc.gov; vie3@cdc.gov	zhang, guoqing/GXG-4800-2022	Jani, Ilesh/0000-0002-6880-6655				Amendola A, 2014, J CLIN MICROBIOL, V52, P2019, DOI 10.1128/JCM.00288-14; [Anonymous], INVENTORABBOTT REALT; [Anonymous], 2016, ABBOTT REALTIME HIV; [Anonymous], 2003, ADHERENCE LONG TERM; [Anonymous], 2010, COBAS AMPLIPREP COBA; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Chohan BH, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-18; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Diallo K, 2014, AIDS RES HUM RETROV, V30, P67, DOI 10.1089/aid.2013.0127; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Garrido C, 2009, J CLIN MICROBIOL, V47, P1031, DOI 10.1128/JCM.02099-08; Kanapathipillai R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086122; Leelawiwat W, 2009, J VIROL METHODS, V155, P109, DOI 10.1016/j.jviromet.2008.09.022; Lilian RR, 2013, PEDIATR INFECT DIS J, V32, P1080, DOI 10.1097/INF.0b013e318290622e; Lilian RR, 2012, J CLIN MICROBIOL, V50, P2373, DOI 10.1128/JCM.00431-12; Lofgren SM, 2009, AIDS, V23, P2459, DOI 10.1097/QAD.0b013e328331f702; Marconi A, 2009, CLIN MICROBIOL INFEC, V15, P93, DOI 10.1111/j.1469-0691.2008.02116.x; Mehta N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005819; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Nguyen S, 2015, J CLIN MICROBIOL, V53, P1129, DOI 10.1128/JCM.02780-14; Nkeze J, 2010, J ANTIVIRALS ANTIRET, V2; Organization WH, PUBL REP WHO PREQ IV; Ouma KN, 2013, J CLIN MICROBIOL, V51, P1208, DOI 10.1128/JCM.03048-12; Paintsil E, 2016, J AIDS CLIN RES, V7; Parry CM, 2014, J CLIN MICROBIOL, V52, P2868, DOI 10.1128/JCM.00544-14; Pirillo MF, 2011, J ANTIMICROB CHEMOTH, V66, P2823, DOI 10.1093/jac/dkr383; Reigadas S, 2009, J VIROL METHODS, V161, P177, DOI 10.1016/j.jviromet.2009.06.002; Rollins NC, 2002, LANCET, V360, P389, DOI 10.1016/S0140-6736(02)09599-5; Rottinghaus EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109060; Rutstein SE, 2014, J CLIN VIROL, V60, P392, DOI 10.1016/j.jcv.2014.05.005; Schmitz ME, 2017, JAIDS-J ACQ IMM DEF, V74, P399, DOI [10.1097/QAI.0000000000001275, 10.1097/qai.0000000000001275]; Sherman GG, 2005, JAIDS-J ACQ IMM DEF, V38, P615, DOI 10.1097/01.qai.0000143604.71857.5d; Taieb F, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw142; van Rensburg EJ, 2011, J CLIN MICROBIOL, V49, P377, DOI 10.1128/JCM.01285-10; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2013, CONS ARV GUID; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2014, TECHN OP CONS IMPL H	38	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181054	10.1371/journal.pone.0181054	http://dx.doi.org/10.1371/journal.pone.0181054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704560	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700084
J	Ramsey, M; Bencsik, M; Newton, MI				Ramsey, Michael; Bencsik, Martin; Newton, Michael I.			Long-term trends in the honeybee 'whooping signal' revealed by automated detection (vol 12, e0181736, 2017)	PLOS ONE			English	Correction													Newton, Michael I/B-8866-2008	Newton, Michael I/0000-0003-4231-1002				Ramsey M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171162	1	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181736	10.1371/journal.pone.0181736	http://dx.doi.org/10.1371/journal.pone.0181736			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704531	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700136
J	Deng, Y; Xie, M; Xie, L; Wang, J; Li, TJ; He, Y; Li, RL; Li, S; Qin, X				Deng, Yan; Xie, Ming; Xie, Li; Wang, Jian; Li, Taijie; He, Yu; Li, Ruolin; Li, Shan; Qin, Xue			RETRACTION: Association between Polymorphism of the Interleukin-13 Gene and Susceptibility to Hepatocellular Carcinoma in the Chinese Population (Retraction of Vol 12, art no E0116682, 2017)	PLOS ONE			English	Retraction																		Deng Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116682	1	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181509	10.1371/journal.pone.0181509	http://dx.doi.org/10.1371/journal.pone.0181509			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704528	Green Published, gold			2022-12-27	WOS:000405649600072
J	Ahmad, T; Munir, A; Bhatti, SH; Aftab, M; Raza, MA				Ahmad, Tanvir; Munir, Assia; Bhatti, Sajjad Haider; Aftab, Muhammad; Raza, Muhammad Ali			Survival analysis of heart failure patients: A case study	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; RISK PREDICTION; TERM MORTALITY; TRIAL; MODEL	This study was focused on survival analysis of heart failure patients who were admitted to Institute of Cardiology and Allied hospital Faisalabad-Pakistan during April-December (2015). All the patients were aged 40 years or above, having left ventricular systolic dysfunction, belonging to NYHA class III and IV. Cox regression was used to model mortality considering age, ejection fraction, serum creatinine, serum sodium, anemia, platelets, creatinine phosphokinase, blood pressure, gender, diabetes and smoking status as potentially contributing for mortality. Kaplan Meier plot was used to study the general pattern of survival which showed high intensity of mortality in the initial days and then a gradual increase up to the end of study. Martingale residuals were used to assess functional form of variables. Results were validated computing calibration slope and discrimination ability of model via bootstrapping. For graphical prediction of survival probability, a nomogram was constructed. Age, renal dysfunction, blood pressure, ejection fraction and anemia were found as significant risk factors for mortality among heart failure patients.	[Ahmad, Tanvir; Munir, Assia; Bhatti, Sajjad Haider; Aftab, Muhammad; Raza, Muhammad Ali] Govt Coll Univ, Dept Stat, Faisalabad, Pakistan	Government College University Faisalabad	Bhatti, SH (corresponding author), Govt Coll Univ, Dept Stat, Faisalabad, Pakistan.	sajjad.haider@gcuf.edu.pk	Ahmad, Tanvir/AAW-4050-2020; Aftab, Muhammad/H-4918-2015; Raza, Ali/AAM-2971-2020; Aftab, Muhammad/O-5160-2019	Aftab, Muhammad/0000-0002-2465-9964; Aftab, Muhammad/0000-0002-2465-9964; , Tanvir/0000-0002-0079-0415; Bhatti, Sajjad Haider/0000-0002-3206-4565				Al-Shifa IH, 2016, CARDIAC DIS PAKISTAN; Barlera S, 2013, CIRC-HEART FAIL, V6, P31, DOI 10.1161/CIRCHEARTFAILURE.112.967828; Cheraghi M, 2010, ARYA ATHEROSCLER, V6, P111; Collett, 2003, MODELLING SURVIVAL D; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fitrianto A., 2013, INT J MATH ANAL, V7, P2645; Gillespie B., 2006, CHECKING ASSUMPTIONS; Gustafsson F, 2004, EUR HEART J, V25, P1711, DOI 10.1016/j.ehj.2004.07.007; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; Otero-Ravina F, 2009, INT J CARDIOL, V136, P56, DOI 10.1016/j.ijcard.2008.04.025; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Pillai HS, 2013, CURR CARDIOL REV, V9, P102, DOI 10.2174/1573403X11309020003; Rahimi K, 2014, JACC-HEART FAIL, V2, P440, DOI 10.1016/j.jchf.2014.04.008; Redondo-Bermejo B, 2007, REV ESP CARDIOL, V60, P1135, DOI 10.1157/13111785; Roman AV, 2005, REV ESP CARDIOL, V58, P1171; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Tavazzi L, 2013, CIRC-HEART FAIL, V6, P473, DOI 10.1161/CIRCHEARTFAILURE.112.000161; Varela-Roman A, 2005, EUR J HEART FAIL, V7, P859, DOI 10.1016/j.ejheart.2005.01.017; WHO, 2016, FACT SHEET ON CVDS; Yang D., 2013, P SAS GLOB FOR 2013	23	47	47	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181001	10.1371/journal.pone.0181001	http://dx.doi.org/10.1371/journal.pone.0181001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727739	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500036
J	Kelsey, TW; McConville, L; Edgar, AB; Ungurianu, AI; Mitchell, RT; Anderson, RA; Wallace, WHB				Kelsey, Thomas W.; McConville, Lauren; Edgar, Angela B.; Ungurianu, Alex I.; Mitchell, Rod T.; Anderson, Richard A.; Wallace, W. Hamish B.			Follicle Stimulating Hormone is an accurate predictor of azoospermia in childhood cancer survivors	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; INHIBIN-B; DIAGNOSTIC-TEST; SERUM MARKER; SPERMATOGENESIS; MEN; QUALITY; CHEMOTHERAPY; METAANALYSIS; CURVE	The accuracy of Follicle Stimulating Hormone as a predictor of azoospermia in adult survivors of childhood cancer is unclear, with conflicting results in the published literature. A systematic review and post hoc analysis of combined data (n = 367) were performed on all published studies containing extractable data on both serum Follicle Stimulating Hormone concentration and semen concentration in survivors of childhood cancer. PubMed and Medline databases were searched up to March 2017 by two blind investigators. Articles were included if they contained both serum FSH concentration and semen concentration, used World Health Organisation certified methods for semen analysis, and the study participants were all childhood cancer survivors. There was no evidence for either publication bias or heterogeneity for the five studies. For the combined data (n = 367) the optimal Follicle Stimulating Hormone threshold was 10.4 IU/L with specificity 81% (95% CI 76%-86%) and sensitivity 83% (95% CI 76%-89%). The AUC was 0.89 (95% CI 0.86-0.93). A range of threshold FSH values for the diagnosis of azoospermia with their associated sensitivities and specificities were calculated. This study provides strong supporting evidence for the use of serum Follicle Stimulating Hormone as a surrogate biomarker for azoospermia in adult males who have been treated for childhood cancer.	[Kelsey, Thomas W.; Ungurianu, Alex I.] Univ St Andrews, Sch Comp Sci, St Andrews, Fife, Scotland; [McConville, Lauren] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Edgar, Angela B.; Wallace, W. Hamish B.] Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh, Midlothian, Scotland; [Mitchell, Rod T.; Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of St Andrews; University of Edinburgh; University of Edinburgh	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh, Midlothian, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458	Wellcome Trust Intermediate Clinical Fellowship [098522]; Engineering and Physical Sciences Research Council [EP/P015638/1]; EPSRC [EP/P015638/1] Funding Source: UKRI; MRC [G1100357] Funding Source: UKRI; Medical Research Council [G1100357] Funding Source: researchfish	Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RTM is supported by a Wellcome Trust Intermediate Clinical Fellowship (grant no: 098522), https://wellcome.ac.uk/what-we-do/directories/intermethate-clinical-fellowships-people-funded. TWK is supported by Engineering and Physical Sciences Research Council grant EP/P015638/1, http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/13015638/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 1997, HUM REPROD, V12, P746, DOI 10.1093/humrep/12.4.746; Anderson RA, 2015, LANCET DIABETES ENDO, V3, P556, DOI 10.1016/S2213-8587(15)00039-X; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Chow EJ, 2016, LANCET ONCOL, V17, P567, DOI 10.1016/S1470-2045(16)00086-3; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Green DM, 2014, LANCET ONCOL, V15, P1215, DOI 10.1016/S1470-2045(14)70408-5; Green DM, 2013, J CLIN ONCOL, V31, P1324, DOI 10.1200/JCO.2012.43.7038; Greenfield DM, 2007, J CLIN ENDOCR METAB, V92, P3476, DOI 10.1210/jc.2006-2744; Greenfield DM, 2010, CANCER-AM CANCER SOC, V116, P1592, DOI 10.1002/cncr.24898; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Higgins J, 2011, COCHRANE COLLAB, V5, P1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HRA, 2013, DOES MY PROJ REQ REV; Iliodromiti S, 2016, DIABETOLOGIA, V59, P692, DOI 10.1007/s00125-015-3855-6; Iliodromiti S, 2013, J CLIN ENDOCR METAB, V98, P3332, DOI 10.1210/jc.2013-1393; Illingworth PJ, 1996, J CLIN ENDOCR METAB, V81, P1321, DOI 10.1210/jc.81.4.1321; Jensen TK, 1997, J CLIN ENDOCR METAB, V82, P4059, DOI 10.1210/jc.82.12.4059; Kelsey TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071465; Lahteenmaki PM, 2008, ACTA PAEDIATR, V97, P935, DOI 10.1111/j.1651-2227.2008.00784.x; Makanji Y, 2014, ENDOCR REV, V35, P747, DOI 10.1210/er.2014-1003; McCullagh DR, 1932, SCIENCE, V76, P19, DOI 10.1126/science.76.1957.19; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Okuma Y, 2006, J ENDOCRINOL, V190, P331, DOI 10.1677/joe.1.06706; R Development Core Team, 2010, R LANG ENV STAT LEAR; Radicioni A, 2013, J ENDOCRINOL INVEST, V36, P739, DOI 10.1007/BF03347112; Rendtorff R, 2012, ANDROLOGIA, V44, P219, DOI 10.1111/j.1439-0272.2011.01167.x; Roberts SC, 2016, HUM REPROD, V31, P1570, DOI 10.1093/humrep/dew114; Romerius P, 2011, INT J ANDROL, V34, P69, DOI 10.1111/j.1365-2605.2010.01058.x; Sedgwick P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4028; Shin T, 2016, INT J CLIN ONCOL, V21, P1167, DOI 10.1007/s10147-016-0998-5; Skinner R, 2017, LANCET ONCOL, V18, pE75, DOI 10.1016/S1470-2045(17)30026-8; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Thomson AB, 2002, LANCET, V360, P361, DOI 10.1016/S0140-6736(02)09606-X; Toulis KA, 2010, HUM REPROD UPDATE, V16, P713, DOI 10.1093/humupd/dmq024; van Beek RD, 2007, HUM REPROD, V22, P3215, DOI 10.1093/humrep/dem313; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WHO, 2010, EX PROC HUM SEM; Wilhelmsson M, 2014, PEDIATR BLOOD CANCER, V61, P1094, DOI 10.1002/pbc.24970	40	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181377	10.1371/journal.pone.0181377	http://dx.doi.org/10.1371/journal.pone.0181377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727831	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500066
J	Yea, JW; Park, JW; Kim, SK; Kim, DY; Kim, JG; Seo, CY; Jeong, WH; Jeong, MY; Oh, SA				Yea, Ji Woon; Park, Jae Won; Kim, Sung Kyu; Kim, Dong Youn; Kim, Jae Gu; Seo, Chan Young; Jeong, Won Hyo; Jeong, Man Youl; Oh, Se An			Feasibility of a 3D-printed anthropomorphic patient-specific head phantom for patient-specific quality assurance of intensity-modulated radiotherapy	PLOS ONE			English	Article								This study evaluated the feasibility of utilizing a 3D-printed anthropomorphic patient-specific head phantom for patient-specific quality assurance (QA) in intensity-modulated radiotherapy (IMRT). Contoured left and right head phantoms were converted from DICOM to STL format. Fused deposition modeling (FDM) was used to construct an anthropomorphic patient-specific head phantom with a 3D printer. An established QA technique and the patient-specific head phantom were used to compare the calculated and measured doses. When the established technique was used to compare the calculated and measured doses, the gamma passing rate for gamma <= 1 was 97.28%, while the gamma failure rate for gamma > 1 was 2.72%. When the 3D-printed patient-specific head phantom was used, the gamma passing patient-specific head phantom was concluded to be highly feasible for patient-specific QA prior to complicated radiotherapy procedures such as IMRT.	[Yea, Ji Woon; Park, Jae Won; Kim, Sung Kyu; Oh, Se An] Yeungnam Univ, Dept Radiat Oncol, Med Ctr, Daegu, South Korea; [Yea, Ji Woon; Park, Jae Won; Kim, Sung Kyu] Yeungnam Univ, Dept Radiat Oncol, Coll Med, Daegu, South Korea; [Kim, Dong Youn; Kim, Jae Gu; Seo, Chan Young; Jeong, Won Hyo; Jeong, Man Youl] Gyeongnam Sci High Sch, Gyeongnam, South Korea	Yeungnam University; Yeungnam University	Oh, SA (corresponding author), Yeungnam Univ, Dept Radiat Oncol, Med Ctr, Daegu, South Korea.	sean.oh5235@gmail.com		Park, Jaewon/0000-0003-1100-5301; Oh, SeAn/0000-0002-8835-2814	Yeungnam University Research Grant - Korea Foundation for the Advancement of Science and Creativity (KOFAC); Ministry of Science, ICT and Future Planning (MSIP)	Yeungnam University Research Grant - Korea Foundation for the Advancement of Science and Creativity (KOFAC); Ministry of Science, ICT and Future Planning (MSIP)	This work was partially supported by the 2015 Yeungnam University Research Grant, funded by the Korea Foundation for the Advancement of Science and Creativity (KOFAC) supported by the Ministry of Science, ICT and Future Planning (MSIP).	Ehler ED, 2014, PHYS MED BIOL, V59, P5763, DOI 10.1088/0031-9155/59/19/5763; Ezzell GA, 2009, MED PHYS, V36, P5359, DOI 10.1118/1.3238104; Ju SG, 2014, INT J RADIAT ONCOL, V88, P453, DOI 10.1016/j.ijrobp.2013.10.024; Khan F.M., 2014, KHANS PHYS RAD THERA, P135; Kim SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110746; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Low DA, 2011, MED PHYS, V38, P1313, DOI 10.1118/1.3514120; Madamesila J, 2016, PHYS MEDICA, V32, P242, DOI 10.1016/j.ejmp.2015.09.013; Oh SA, 2013, J KOREAN PHYS SOC, V63, P2215, DOI 10.3938/jkps.63.2215; Oh S, 2012, J KOREAN PHYS SOC, V60, P1973, DOI 10.3938/jkps.60.1973; OHSEAN, 2014, [PROGRESS in MEDICAL PHYSICS, 의학물리], V25, P218, DOI 10.14316/pmp.2014.25.4.218; OHSEAN, 2013, [PROGRESS in MEDICAL PHYSICS, 의학물리], V24, P145, DOI 10.14316/pmp.2013.24.3.145; OHSEAN, 2012, [PROGRESS in MEDICAL PHYSICS, 의학물리], V23, P48; Park JW, 2016, CANCER RADIOTHER, V20, P205, DOI 10.1016/j.canrad.2015.11.003; Park JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177562; Park So-Yeon, 2016, [PROGRESS in MEDICAL PHYSICS, 의학물리], V27, P180, DOI 10.14316/pmp.2016.27.4.180; Winiecki J, 2009, REP PRACT ONCOL RADI, V14, P162, DOI 10.1016/S1507-1367(10)60031-4; 최우근, 2016, [PROGRESS in MEDICAL PHYSICS, 의학물리], V27, P64	18	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181560	10.1371/journal.pone.0181560	http://dx.doi.org/10.1371/journal.pone.0181560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727787	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500087
J	Njemanze, PC; Kranz, M; Amend, M; Hauser, J; Wehrl, H; Brust, P				Njemanze, Philip C.; Kranz, Mathias; Amend, Mario; Hauser, Jens; Wehrl, Hans; Brust, Peter			Gender differences in cerebral metabolism for color processing in mice: A PET/MRI Study	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; OCULAR DOMINANCE PLASTICITY; RECEPTIVE-FIELD STRUCTURE; PRIMARY VISUAL-CORTEX; BLOOD-FLOW VELOCITY; SEX-DIFFERENCES; BRAIN ACTIVITY; MONOCULAR DEPRIVATION; GENERAL INTELLIGENCE; GLUCOSE-UTILIZATION	Introduction Color processing is a central component of mammalian vision. Gender-related differences of color processing revealed by non-invasive functional transcranial Doppler ultrasound suggested right hemisphere pattern for blue/yellow chromatic opponency by men, and a left hemisphere pattern by women. Materials and Methods The present study measured the accumulation of [F-18] fluorodeoxyglucose ([F-18]FDG) in mouse brain using small animal positron emission tomography and magnetic resonance imaging (PET/MRI) with statistical parametric mapping (SPM) during light stimulation with blue and yellow filters compared to darkness condition. Results PET revealed a reverse pattern relative to dark condition compared to previous human studies: Male mice presented with left visual cortex dominance for blue through the right eye, while female mice presented with right visual cortex dominance for blue through the left eye. We applied statistical parametric mapping (SPM) to examine gender differences in activated architectonic areas within the orbital and medial prefrontal cortex and related cortical and sub-cortical areas that lead to the striatum, medial thalamus and other brain areas. The metabolic connectivity of the orbital and medial prefrontal cortex evoked by blue stimulation spread through a wide range of brain structures implicated in viscerosensory and visceromotor systems in the left intra-hemispheric regions in male, but in the right-to-left inter-hemispheric regions in female mice. Color functional ocular dominance plasticity was noted in the right eye in male mice but in the left eye in female mice. Conclusions This study of color processing in an animal model could be applied in the study of the role of gender differences in brain disease.	[Njemanze, Philip C.] Int Inst Adv Res Training, Neurocybernet Flow Lab, Chidicon Med Ctr, Owerri, Imo State, Nigeria; [Kranz, Mathias; Brust, Peter] Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, Helmholtz Zent Dresden Rossendorf, Leipzig, Germany; [Amend, Mario; Wehrl, Hans] Eberhard Karls Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Tubingen, Germany; [Hauser, Jens] Dept Mech Engn Dresden, Helmholtz Zent Dresden Rossendorf, Dresden, Germany	Eberhard Karls University of Tubingen; Siemens AG; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR)	Brust, P (corresponding author), Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, Helmholtz Zent Dresden Rossendorf, Leipzig, Germany.	p.brust@hzdr.de		Kranz, Mathias/0000-0002-5641-7396	DFG [WE 5795/2-1]; University of Tubingen [2209-0-0]; BMBF [DLR 01GQ1415]; Werner Siemens Foundation; Chidicon Medical Research Foundation	DFG(German Research Foundation (DFG)); University of Tubingen; BMBF(Federal Ministry of Education & Research (BMBF)); Werner Siemens Foundation; Chidicon Medical Research Foundation	M. A. and H.F.W. acknowledge the funding by DFG (WE 5795/2-1), University of Tubingen, fortuene: 2209-0-0, BMBF DLR 01GQ1415 and the Werner Siemens Foundation. P.C.N. was funded by Chidicon Medical Research Foundation.	Armstrong RA, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/908306; Bandi P, 2012, IEEE ENG MED BIO, P5351, DOI 10.1109/EMBC.2012.6347203; BARON M, 1977, ARCH GEN PSYCHIAT, V34, P721; Delpero WT, 2005, AVIAT SPACE ENVIR MD, V76, P127; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; Ducker G., 1964, J BOMBAY NATURAL HIS, V61, P572; Eastman Kodak Company, 1990, KOD PHOT FILT HDB E, P161; Endo S, 1997, IEEE T MED IMAGING, V16, P252, DOI 10.1109/42.585759; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; FRACKOWIAK RSJ, 1994, J ANAT, V184, P211; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Geng Y, 2012, BIOMED OPT EXPRESS, V3, P715, DOI 10.1364/BOE.3.000715; Gerstl F, 2008, NEUROIMAGE, V41, P204, DOI 10.1016/j.neuroimage.2008.02.044; Ghanavati S, 2014, J NEUROSCI METH, V221, P70, DOI 10.1016/j.jneumeth.2013.09.002; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Gordon JA, 1996, J NEUROSCI, V16, P3274; Gouras P., 1991, PERCEPTION COLOR VIS, P179; Gray H., 1984, GRAYS ANATOMY HUMAN, V30; Haak KV, 2014, CORTEX, V56, P14, DOI 10.1016/j.cortex.2012.12.005; HAWRYSHYN CW, 1982, CAN J ZOOL, V60, P2968, DOI 10.1139/z82-378; Helmholtz HV, 1867, HDB PHYSL OPTIK; Hering E., 1878, ZH LEHRE LICHTSINNE, P107; Hering E., 1878, ZH LEHRE LICHTSINNE, P141; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; JACOBS GH, 1985, VISION RES, V25, P141, DOI 10.1016/0042-6989(85)90088-4; Jacobs GH, 1981, COMP COLOR VISION; Jung RE, 2005, NEUROIMAGE, V26, P965, DOI 10.1016/j.neuroimage.2005.02.039; Kitahara Kenji, 2007, Nippon Ganka Gakkai Zasshi, V111, P160; Kollias SS, 2004, EUR J RADIOL, V49, P64, DOI 10.1016/j.ejrad.2003.09.005; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3126, DOI 10.1152/jn.2002.87.6.3126; Lee DS, 2008, EUR J NUCL MED MOL I, V35, P1681, DOI 10.1007/s00259-008-0808-z; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Marshak DW, 2014, VISUAL NEUROSCI, V31, P165, DOI 10.1017/S095252381300031X; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Mata ML, 2005, J NEUROPHYSIOL, V93, P919, DOI 10.1152/jn.00668.2004; Mirrione MM, 2007, NEUROIMAGE, V38, P34, DOI 10.1016/j.neuroimage.2007.06.032; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Neumeyer C., 1991, EVOLUTION EYE VISUAL, V2; NJEMANZE PC, 1992, CORTEX, V28, P69, DOI 10.1016/S0010-9452(13)80166-9; Njemanze PC, 2005, BRAIN LANG, V92, P234, DOI 10.1016/j.bandl.2004.06.104; Njemanze PC, 2004, AVIAT SPACE ENVIR MD, V75, P800; Njemanze PC., 2008, J GRAVIT PHYSL, V15, P49; Njemanze PC, 2007, LATERALITY, V12, P31, DOI 10.1080/13576500600886796; Njemanze Philip C, 2011, Exp Transl Stroke Med, V3, P1, DOI 10.1186/2040-7378-3-1; Njemanze Philip C, 2010, Exp Transl Stroke Med, V2, P21, DOI 10.1186/2040-7378-2-21; NUBOER JFW, 1986, NETH J ZOOL, V36, P344; Onishi A, 2005, ZOOL SCI, V22, P1145, DOI 10.2108/zsj.22.1145; Ortin-Martinez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102392; Pache M, 2003, AGE AGEING, V32, P422, DOI 10.1093/ageing/32.4.422; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Purves D., 2009, VISION, P224; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Siikanen J, 2015, AM J NUCL MED MOLEC, V5, P270; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; STONE J, 1974, J COMP NEUROL, V155, P377, DOI 10.1002/cne.901550402; Takechi H, 1997, NEUROSCI LETT, V230, P17, DOI 10.1016/S0304-3940(97)00461-8; Thie JA, 2004, J NUCL MED, V45, P1431; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; Turner RS., 2014, EYES MIND VISION HEL; Urban A, 2015, NAT METHODS, V12, P873, DOI [10.1038/nmeth.3482, 10.1038/NMETH.3482]; Villien M, 2014, NEUROIMAGE, V100, P192, DOI 10.1016/j.neuroimage.2014.06.025; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Walls GL, 1942, VERTEBRATE EYE ITS A, P810; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wehrl HF, 2014, NEUROIMAGE, V89, P271, DOI 10.1016/j.neuroimage.2013.11.044; Wehrl HF, 2013, NAT MED, V19, P1184, DOI 10.1038/nm.3290; Westheimer G, 2007, PROG RETIN EYE RES, V26, P636, DOI 10.1016/j.preteyeres.2007.07.003; Wichmann FA, 2002, J EXP PSYCHOL LEARN, V28, P509, DOI 10.1037//0278-7393.28.3.509; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092; Woo SK, 2008, NUCL MED BIOL, V35, P143, DOI 10.1016/j.nucmedbio.2007.10.003; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104	86	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179919	10.1371/journal.pone.0179919	http://dx.doi.org/10.1371/journal.pone.0179919			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723938	gold, Green Submitted, Green Published			2022-12-27	WOS:000406067800009
J	Onuma, T; Penwannakul, Y; Fuchimoto, J; Sakai, N				Onuma, Takuya; Penwannakul, Yuwadee; Fuchimoto, Jun; Sakai, Nobuyuki			The effect of order of dwells on the first dwell gaze bias for eventually chosen items	PLOS ONE			English	Article							DECISION-MAKING; EYE-MOVEMENTS; ATTENTION; CHOICE; PREFERENCE; FIXATION; OSCILLATIONS; EXPOSURE; FEATURES; CASCADE	The relationship between choice and eye movement has gained marked interest. The gaze bias effect, i.e., the tendency to look longer at items that are eventually chosen, has been shown to occur in the first dwell (initial cohesion of fixations for an item). In the two-alternative forced-choice (2AFC) paradigm, participants would look at one of the items first (defined as first look; FL), and they would then move and look at another item (second look; SL). This study investigated how the order in which the chosen items were looked at modulates the first dwell gaze bias effect. Participants were asked to assert their preferences and perceptual 2AFC decisions about human faces (Experiment 1) and daily consumer products (Experiment 2), while their eye movements were recorded. The results showed that the first dwell gaze bias was found only when the eventually chosen item was looked at after another one; the chosen item was looked at for longer as compared to the not-chosen item in the SL, but not in the FL. These results indicate that participants actively allocate more time to looking at a subsequently chosen item only after they perceive both items in the SL. Therefore, the selective encoding seems to occur in the early comparison stage of visual decision making, and not in the initial encoding stage. These findings provide insight into the relationship between choice and eye movement.	[Onuma, Takuya; Penwannakul, Yuwadee; Fuchimoto, Jun; Sakai, Nobuyuki] Tohoku Univ, Grad Sch Arts & Letters, Dept Psychol, Sendai, Miyagi, Japan; [Onuma, Takuya] Tohoku Univ, Div Interdisciplinary Adv Res & Educ, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Sakai, N (corresponding author), Tohoku Univ, Grad Sch Arts & Letters, Dept Psychol, Sendai, Miyagi, Japan.	nob_sakai@m.tohoku.ac.jp	Sakai, Nobuyuki/AAE-8840-2019	Sakai, Nobuyuki/0000-0002-4647-8435	JSPS KAKENHI [26350088]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (no. 26350088 to NS, https://www.jsps.go.jp/english/egrants/), and there was no additional external funding received for this study.	Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bialkova S, 2011, FOOD QUAL PREFER, V22, P592, DOI 10.1016/j.foodqual.2011.03.010; Bialkova S, 2010, FOOD QUAL PREFER, V21, P1042, DOI 10.1016/j.foodqual.2010.07.001; Cornelissen PL, 2009, EVOL HUM BEHAV, V30, P417, DOI 10.1016/j.evolhumbehav.2009.04.003; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Glaholt M. G., 2011, J NEUROSCI PSYCHOL E, V4, P125, DOI DOI 10.1037/A0020692; Glaholt MG, 2009, VIS COGN, V17, P1228, DOI 10.1080/13506280802362962; Glaholt MG, 2009, ATTEN PERCEPT PSYCHO, V71, P445, DOI 10.3758/APP.71.3.445; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Lindsen JP, 2011, CONSCIOUS COGN, V20, P1781, DOI 10.1016/j.concog.2011.01.008; Lindsen JP, 2010, NEUROIMAGE, V50, P1626, DOI 10.1016/j.neuroimage.2010.01.079; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Nuthmann A, 2015, ANN NY ACAD SCI, V1339, P82, DOI 10.1111/nyas.12705; Orquin JL, 2013, ACTA PSYCHOL, V144, P190, DOI 10.1016/j.actpsy.2013.06.003; Park J, 2010, P NATL ACAD SCI USA, V104, P18253; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RUSSO JE, 1994, J CONSUM RES, V21, P274, DOI 10.1086/209397; Schotter ER, 2012, VIS COGN, V20, P1110, DOI 10.1080/13506285.2012.735719; Schotter ER, 2010, VIS COGN, V18, P1113, DOI 10.1080/13506281003668900; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Simion C, 2007, PERCEPT PSYCHOPHYS, V69, P591, DOI 10.3758/BF03193916; Simion C, 2006, VISION RES, V46, P3331, DOI 10.1016/j.visres.2006.04.019; Stoll J, 2015, VISION RES, V107, P36, DOI 10.1016/j.visres.2014.11.006; van der Laan LN, 2015, FOOD QUAL PREFER, V39, P46, DOI 10.1016/j.foodqual.2014.06.015; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zhang BY, 2015, FOOD QUAL PREFER, V41, P172, DOI 10.1016/j.foodqual.2014.12.004	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181641	10.1371/journal.pone.0181641	http://dx.doi.org/10.1371/journal.pone.0181641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723947	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800063
J	Alam, U; Jeziorska, M; Petropoulos, LN; Asghar, O; Fadavi, H; Ponirakis, G; Marshall, A; Tavakoli, M; Boulton, AJM; Efron, N; Malik, RA				Alam, Uazman; Jeziorska, Maria; Petropoulos, Loannis N.; Asghar, Omar; Fadavi, Hassan; Ponirakis, Georgios; Marshall, Andrew; Tavakoli, Mitra; Boulton, Andrew J. M.; Efron, Nathan; Malik, Rayaz A.			Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy	PLOS ONE			English	Article							SKIN BIOPSY; CONDUCTION; REGENERATION; SENSATION; SURROGATE; SEVERITY; SYMPTOMS; PANCREAS; DAMAGE; SIGNS	Objectives Corneal confocal microscopy (CCM) is a rapid, non-invasive, reproducible technique that quantifies small nerve fibres. We have compared the diagnostic capability of CCM against a range of established measures of nerve damage in patients with diabetic neuropathy. Methods In this cross sectional study, thirty subjects with Type 1 diabetes without neuropathy (T1DM), thirty one T1DM subjects with neuropathy (DSPN) and twenty seven non-diabetic healthy control subjects underwent detailed assessment of neuropathic symptoms and neurologic deficits, quantitative sensory testing (QST), electrophysiology, skin biopsy and corneal confocal microscopy (CCM). Results Subjects with DSPN were older (C vs T1DM vs DSPN: 41.0 +/- 14.9 vs 38.8 +/- 12.5 vs 53.3 +/- 11.9, P = 0.0002), had a longer duration of diabetes (P<0.0001), lower eGFR (P = 0.006) and higher albumin-creatinine ratio (P = 0.03) with no significant difference for HbA1c, BMI, lipids and blood pressure. Patients with DSPN were representative of subjects with diabetic neuropathy with clinical signs and symptoms of neuropathy and greater neuropathy deficits quantified by QST, electrophysiology, intra-epidermal nerve fibre density and CCM. Corneal nerve fibre density (CNFD) (Spearman's Rho = 0.60 P<0.0001) and IENFD (Spearman's Rho = 0.56 P<0.0001) were comparable when correlated with peroneal nerve conduction velocity. For the diagnosis of diabetic neuropathy the sensitivity for CNFD was 0.77 and specificity was 0.79 with an area under the ROC curve of 0.81. IENFD had a diagnostic sensitivity of 0.61, specificity of 0.80 and area under the ROC curve of 0.73. Conclusions CCM is a valid accurate non-invasive method to identify small nerve fibre pathology and is able to diagnose DPN.	[Alam, Uazman] Univ Liverpool, Inst Ageing & Chron Dis, Diabet & Endocrinol Res, Dept Eye & Vis Sci, Liverpool, Merseyside, England; [Alam, Uazman] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Alam, Uazman; Jeziorska, Maria; Petropoulos, Loannis N.; Asghar, Omar; Fadavi, Hassan; Marshall, Andrew; Tavakoli, Mitra; Boulton, Andrew J. M.; Malik, Rayaz A.] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Inst Human Dev, Manchester, Lancs, England; [Alam, Uazman; Jeziorska, Maria; Petropoulos, Loannis N.; Asghar, Omar; Fadavi, Hassan; Marshall, Andrew; Tavakoli, Mitra; Boulton, Andrew J. M.; Malik, Rayaz A.] Cent Manchester Hosp Fdn Trust, Manchester Royal Infirm, Manchester, Lancs, England; [Ponirakis, Georgios; Malik, Rayaz A.] Weill Cornell Med Qatar, Doha, Qatar; [Tavakoli, Mitra] Univ Exeter, Exeter, Devon, England; [Efron, Nathan] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia	University of Liverpool; Aintree University Hospitals NHS Foundation Trust; University of Manchester; University of Manchester; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Exeter; Queensland University of Technology (QUT)	Malik, RA (corresponding author), Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Inst Human Dev, Manchester, Lancs, England.; Malik, RA (corresponding author), Cent Manchester Hosp Fdn Trust, Manchester Royal Infirm, Manchester, Lancs, England.; Malik, RA (corresponding author), Weill Cornell Med Qatar, Doha, Qatar.	ram2045@qatar-med.cornell.edu	Efron, Nathan/I-9766-2012; Alam, Uazman/I-9173-2019; Ponirakis, Georgios/T-7207-2019; Jeziorska, Maria/P-1731-2015; Marshall, Andrew/AAE-5203-2019; Malik, Rayaz/H-9231-2019; TAVAKOLI, MITRA/N-1402-2016	Efron, Nathan/0000-0002-7037-779X; Alam, Uazman/0000-0002-3190-1122; Ponirakis, Georgios/0000-0002-6936-1248; Jeziorska, Maria/0000-0002-3492-0177; Malik, Rayaz/0000-0002-7188-8903; TAVAKOLI, MITRA/0000-0003-2319-1543	Juvenile Diabetes Research Foundation [8-2008-362]; NIHR/Wellcome Trust Clinical Research Facility (Manchester)	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIHR/Wellcome Trust Clinical Research Facility (Manchester)	This work was funded by the Juvenile Diabetes Research Foundation (Grant No.: 8-2008-362) and the NIHR/Wellcome Trust Clinical Research Facility (Manchester) for their facilitation of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backonja M, 2013, PAIN, V154, P1807, DOI 10.1016/j.pain.2013.05.047; Breiner A, 2014, DIABETES CARE, V37, P1418, DOI 10.2337/dc13-2005; Carrington AL, 2002, DIABETES CARE, V25, P2010, DOI 10.2337/diacare.25.11.2010; Chen X, 2015, DIABETES CARE, V38, P1138, DOI 10.2337/dc14-2422; Chien HF, 2001, ACTA NEUROPATHOL, V102, P455; Dyck PJ, 2007, DIABETES CARE, V30, P2619, DOI 10.2337/dc06-2479; Dyck PJ, 2014, MUSCLE NERVE, V49, P645, DOI 10.1002/mus.23982; Dyck PJ, 2013, DIABETES, V62, P3677, DOI 10.2337/db13-0352; Dyck PJ, 2010, MUSCLE NERVE, V42, P157, DOI 10.1002/mus.21661; Hossain P, 2005, LANCET, V366, P1340, DOI 10.1016/S0140-6736(05)67546-0; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Lauria G, 2007, NAT CLIN PRACT NEURO, V3, P546, DOI 10.1038/ncpneuro0630; Lauria G, 2012, CURR DIABETES REP, V12, P384, DOI 10.1007/s11892-012-0280-9; Loseth S, 2006, EUR J NEUROL, V13, P105, DOI 10.1111/j.1468-1331.2006.01232.x; Malik RA, 2011, DIABETES-METAB RES, V27, P678, DOI 10.1002/dmrr.1222; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; McArthur JC, 1998, ARCH NEUROL-CHICAGO, V55, P1513, DOI 10.1001/archneur.55.12.1513; Mehra S, 2007, DIABETES CARE, V30, P2608, DOI 10.2337/dc07-0870; Nebuchennykh M, 2009, J NEUROL, V256, P1067, DOI 10.1007/s00415-009-5065-y; Petropoulos IN, 2013, DIABETES CARE, V36, P3646, DOI 10.2337/dc13-0193; Petropoulos IN, 2013, CORNEA, V32, pE83, DOI 10.1097/ICO.0b013e3182749419; Pham M, 2011, DIABETES CARE, V34, P721, DOI 10.2337/dc10-1491; Pop-Busui R, 2009, CIRCULATION, V119, P2886, DOI 10.1161/CIRCULATIONAHA.108.837369; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Scherens A, 2009, EUR J PAIN, V13, P711, DOI 10.1016/j.ejpain.2008.07.014; Shun CT, 2004, BRAIN, V127, P1593, DOI 10.1093/brain/awh180; Sivaskandarajah GA, 2013, DIABETES CARE, V36, P2748, DOI 10.2337/dc12-2075; Smith AG, 2006, DIABETES CARE, V29, P1294, DOI 10.2337/dc06-0224; Smith AG, 2001, NEUROLOGY, V57, P1701, DOI 10.1212/WNL.57.9.1701; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tavakoli M, 2011, DIABETIC MED, V28, P1261, DOI 10.1111/j.1464-5491.2011.03372.x; Tavakoli M, 2015, DIABETES CARE, V38, P838, DOI 10.2337/dc14-2311; Tavakoli M, 2013, DIABETES, V62, P254, DOI 10.2337/db12-0574; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Thakkar RS, 2012, AM J ROENTGENOL, V199, P407, DOI 10.2214/AJR.11.7893; Tobin K, 1999, CLIN NEUROPHYSIOL, V110, P1909, DOI 10.1016/S1388-2457(99)00164-9; Umapathi T, 2006, MUSCLE NERVE, V33, P742, DOI 10.1002/mus.20528; Vlckova-Moravcova E, 2008, MUSCLE NERVE, V37, P50, DOI 10.1002/mus.20889	40	93	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180175	10.1371/journal.pone.0180175	http://dx.doi.org/10.1371/journal.pone.0180175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719619	gold, Green Published, Green Submitted			2022-12-27	WOS:000406061400009
J	Ryu, YS; Chandran, SP; Kim, K; Lee, SK				Ryu, Young Shin; Chandran, Sathesh-Prabu; Kim, Kyungchul; Lee, Sung Kuk			Oligo- and dsDNA-mediated genome editing using a tetA dual selection system in Escherichia coli	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; GENE REPLACEMENT; EFFICIENT; SCARLESS; RECOMBINATION; TRANSCRIPTION; SEQUENCE; PATHWAY; DESIGN; CELLS	The ability to precisely and seamlessly modify a target genome is needed for metabolic engineering and synthetic biology techniques aimed at creating potent biosystems. Herein, we report on a promising method in Escherichia coli that relies on the insertion of an optimized tetA dual selection cassette followed by replacement of the same cassette with short, single-stranded DNA (oligos) or long, double-stranded DNA and the isolation of recombinant strains by negative selection using NiCl2. This method could be rapidly and successfully used for genome engineering, including deletions, insertions, replacements, and point mutations, without inactivation of the methyl-directed mismatch repair (MMR) system and plasmid cloning. The method we describe here facilitates positive genome-edited recombinants with selection efficiencies ranging from 57 to 92%. Using our method, we increased lycopene production (3.4-fold) by replacing the ribosome binding site (RBS) of the rate-limiting gene (dxs) in the 1-deoxy-D-xylulose-5-phosphate (DXP) biosynthesis pathway with a strong RBS. Thus, this method could be used to achieve scarless, proficient, and targeted genome editing for engineering E. coli strains.	[Ryu, Young Shin; Chandran, Sathesh-Prabu; Lee, Sung Kuk] UNIST, Sch Energy & Chem Engn, Ulsan, South Korea; [Kim, Kyungchul; Lee, Sung Kuk] UNIST, Sch Life Sci, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST)	Lee, SK (corresponding author), UNIST, Sch Energy & Chem Engn, Ulsan, South Korea.; Lee, SK (corresponding author), UNIST, Sch Life Sci, Ulsan, South Korea.	sklee@unist.ac.kr	Lee, Sung K/E-6525-2010; Lee, Sung K/HGC-6832-2022		National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2058667]; Next-Generation Bio Green 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ011181]	National Research Foundation of Korea (NRF) - Ministry of Education; Next-Generation Bio Green 21 Program (SSAC), Rural Development Administration, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) through grants funded by the Ministry of Education (2013R1A1A2058667) and by a grant from the Next-Generation Bio Green 21 Program (SSAC, PJ011181), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Esvelt KM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.66; GRIFFITH JK, 1982, PLASMID, V8, P86, DOI 10.1016/0147-619X(82)90044-0; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Heermann R, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-14; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Jeong J, 2013, BIOTECHNOL ADV, V31, P804, DOI 10.1016/j.biotechadv.2013.04.003; Kang MJ, 2005, BIOTECHNOL BIOENG, V91, P636, DOI 10.1002/bit.20539; Kim J, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-84; Kim SM, 2015, METAB ENG, V30, P141, DOI 10.1016/j.ymben.2015.05.002; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Li XT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1075; Liang RB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-209; Madyagol M, 2011, FOLIA MICROBIOL, V56, P253, DOI 10.1007/s12223-011-0035-z; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; Mizoguchi H, 2007, BIOSCI BIOTECH BIOCH, V71, P2905, DOI 10.1271/bbb.70274; Muranaka N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp039; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Ng CY, 2015, METAB ENG, V29, P86, DOI 10.1016/j.ymben.2015.03.001; Nomura Y, 2007, BIOSYSTEMS, V90, P115, DOI 10.1016/j.biosystems.2006.07.006; Pines G, 2015, ACS SYNTH BIOL, V4, P1176, DOI 10.1021/acssynbio.5b00009; Podolsky T, 1996, PLASMID, V36, P112, DOI 10.1006/plas.1996.0038; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Ryu YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094266; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Schnappinger D, 1996, ARCH MICROBIOL, V165, P359, DOI 10.1007/s002030050339; Seo SW, 2013, METAB ENG, V15, P67, DOI 10.1016/j.ymben.2012.10.006; Tas H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136963; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Vinuselvi P, 2012, ENZYME MICROB TECH, V50, P1, DOI 10.1016/j.enzmictec.2011.10.001; Vinuselvi P, 2011, BIOFUELS-UK, V2, P153, DOI [10.4155/bfs.11.4, 10.4155/BFS.11.4]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wong QNY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni059; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	47	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181501	10.1371/journal.pone.0181501	http://dx.doi.org/10.1371/journal.pone.0181501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719630	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400051
J	Bhattacharjee, D; Dev, NN; Gupta, S; Sau, S; Sarkar, R; Biswas, A; Banerjee, A; Babu, D; Mehta, D; Bhadra, A				Bhattacharjee, Debottam; Dev, Nikhil N.; Gupta, Shreya; Sau, Shubhra; Sarkar, Rohan; Biswas, Arpita; Banerjee, Arunita; Babu, Daisy; Mehta, Diksha; Bhadra, Anindita			Free-ranging dogs show age related plasticity in their ability to follow human pointing	PLOS ONE			English	Article							CANIS-LUPUS-FAMILIARIS; OBJECT CHOICE TASK; DOMESTIC DOGS; SOCIAL CUES; HIDDEN FOOD; COGNITION; ONTOGENY; WOLVES; GESTURES; OWNER	Differences in pet dogs' and captive wolves' ability to follow human communicative intents have led to the proposition of several hypotheses regarding the possession and development of social cognitive skills in dogs. It is possible that the social cognitive abilities of pet dogs are induced by indirect conditioning through living with humans, and studying free-ranging dogs can provide deeper insights into differentiating between innate abilities and conditioning in dogs. Free-ranging dogs are mostly scavengers, indirectly depending on humans for their sustenance. Humans can act both as food providers and as threats to these dogs, and thus understanding human gestures can be a survival need for the free-ranging dogs. We tested the responsiveness of such dogs in urban areas toward simple human pointing cues using dynamic proximal points. Our experiment showed that pups readily follow proximal pointing and exhibit weaker avoidance to humans, but stop doing so at the later stages of development. While juveniles showed frequent and prolonged gaze alternations, only adults adjusted their behaviour based on the reliability of the human experimenter after being rewarded. Thus free-ranging dogs show a tendency to respond to human pointing gestures, with a certain level of behavioural plasticity that allows learning from ontogenic experience.	[Bhattacharjee, Debottam; Dev, Nikhil N.; Gupta, Shreya; Sau, Shubhra; Sarkar, Rohan; Biswas, Arpita; Banerjee, Arunita; Babu, Daisy; Mehta, Diksha; Bhadra, Anindita] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Nadia, W Bengal, India; [Dev, Nikhil N.] Indian Inst Sci Educ & Res Thiruvannathapuram, Thiruvannathapuram, Kerala, India; [Gupta, Shreya] Indian Inst Sci Educ & Res Bhopal, Bhopal, Madhya Pradesh, India; [Mehta, Diksha] Univ Delhi, Shivaji Coll, Delhi, India	Indian Institute of Science Education & Research (IISER) - Kolkata; Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram; Indian Institute of Science Education & Research (IISER) - Bhopal; University of Delhi	Bhadra, A (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Nadia, W Bengal, India.	abhadra@iiserkol.ac.in	Bhadra, Anindita/H-6899-2019; Bhattacharjee, Debottam/AAN-5412-2020	Bhadra, Anindita/0000-0002-3717-9732; Bhattacharjee, Debottam/0000-0002-4555-7983; Babu, Daisy/0000-0003-4957-1720; Narendradev, Nikhil Dev/0000-0002-5641-3571	INSPIRE fellowship of the Department of Science and Technology, India; IAS; INSA; NASI; DST [SB/WEA-005/2013]; IISER Kolkata PBIP fellowship; DST, IISER Kolkata; IISER Kolkata Summer Research Fellowship	INSPIRE fellowship of the Department of Science and Technology, India; IAS; INSA; NASI; DST(Department of Science & Technology (India)); IISER Kolkata PBIP fellowship; DST, IISER Kolkata; IISER Kolkata Summer Research Fellowship	Debottam Bhattacharjee is supported by the INSPIRE fellowship of the Department of Science and Technology, India. Nikhil Dev N received the Summer Research Fellowship jointly funded by IAS, INSA and NASI, the three science academies of India. Shreya Gupta, Daisy Babu, Arpita Biswas and Diksha Mehta were supported by the IISER Kolkata Summer Research Fellowship during this experiment. Shubhra Sau was supported by a fellowship from the DST funded project SB/WEA-005/2013. Arunita Banerjee received the IISER Kolkata PBIP fellowship. IISER Kolkata provided the infrastructure support, but the project itself was not funded by any specific project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank DST, IISER Kolkata for their support. The authors would also like to thank Dr. Monique Udell, Oregon State University and Dr. Brian Hare, Duke University for their inputs on earlier versions of this manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Albiach-Serrano A, 2012, APPL ANIM BEHAV SCI, V141, P25, DOI 10.1016/j.applanim.2012.07.005; APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bensky MK, 2013, ADV STUD BEHAV, V45, P209, DOI 10.1016/B978-0-12-407186-5.00005-7; Bhadra A, 2015, ETHOL ECOL EVOL, P9370; Bhadra A, 2014, J ETHOL, V32, P15, DOI 10.1007/s10164-013-0388-7; BOITANI L, 1995, ETHOL ECOL EVOL, V7, P49, DOI 10.1080/08927014.1995.9522969; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Clutton-Brock Juliet, 1995, P7; Deldalle S, 2014, J VET BEHAV, V9, P58, DOI 10.1016/j.jveb.2013.11.004; Dorey NR, 2010, ANIM BEHAV, V79, P37, DOI 10.1016/j.anbehav.2009.09.032; Duranton C, 2016, J VET BEHAV, V14, P20, DOI [10.1016/j.jveb.2016.06.011, 10.1016/j.jveb.2016]; FEKADU M, 1982, AM J EPIDEMIOL, V115, P266, DOI 10.1093/oxfordjournals.aje.a113298; FREEDMAN DG, 1961, SCIENCE, V133, P1016, DOI 10.1126/science.133.3457.1016; Gacsi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058475; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Gacsi M, 2009, ANIM COGN, V12, P471, DOI 10.1007/s10071-008-0208-6; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hernadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043267; Horvath Z, 2008, HORM BEHAV, V54, P107, DOI 10.1016/j.yhbeh.2008.02.002; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lord K, 2013, ETHOLOGY, V119, P110, DOI 10.1111/eth.12044; Lord K, 2013, BEHAV PROCESS, V92, P131, DOI 10.1016/j.beproc.2012.10.009; Majumder SS, 2014, ACTA ETHOL, V17, P1, DOI 10.1007/s10211-013-0158-0; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; Marshall-Pescini S, 2013, ANIM COGN, V16, P933, DOI 10.1007/s10071-013-0627-x; Marshall-Pescini S, 2014, THE SOCIAL DOG, P3; Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; MikluEsi A., 2000, ANIM COGN, V3, P159, DOI [DOI 10.1007/S100710000072, 10.1007/s100710000072]; Nawroth C, 2014, ANIM COGN, V17, P701, DOI 10.1007/s10071-013-0702-3; Paul M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170590; Paul M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150580; Paul M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19641; Paul M, 2014, BEHAV PROCESS, V103, P17, DOI 10.1016/j.beproc.2013.10.006; Petter M, 2009, BEHAV PROCESS, V82, P109, DOI 10.1016/j.beproc.2009.07.002; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Reid PJ, 2009, BEHAV PROCESS, V80, P325, DOI 10.1016/j.beproc.2008.11.002; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Sen Majumder S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32014; Serpell JA, 1996, APPL ANIM BEHAV SCI, V47, P49, DOI 10.1016/0168-1591(95)01010-6; Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112; SilleroZubiri C, 1996, J WILDLIFE DIS, V32, P80, DOI 10.7589/0090-3558-32.1.80; Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27; Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Takaoka A, 2015, ANIM COGN, V18, P475, DOI 10.1007/s10071-014-0816-2; Thapar Romila, 1990, HIST INDIA; Udell MAR, 2008, J COMP PSYCHOL, V122, P84, DOI 10.1037/0735-7036.122.1.84; Udell MAR, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0489; Vanak AT, 2009, J MAMMAL, V90, P1058, DOI 10.1644/09-MAMM-A-107.1; Zaine I, 2015, BEHAV PROCESS, V119, P76, DOI 10.1016/j.beproc.2015.07.004	61	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180643	10.1371/journal.pone.0180643	http://dx.doi.org/10.1371/journal.pone.0180643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS8PU	28715475	Green Published, Green Submitted, gold			2022-12-27	WOS:000443975500014
J	Gariepy, G; Elgar, FJ; Sentenac, M; Barrington-Leigh, C				Gariepy, Genevieve; Elgar, Frank J.; Sentenac, Mariane; Barrington-Leigh, Christopher			Early-life family income and subjective well-being in adolescents	PLOS ONE			English	Article							MENTAL-HEALTH; CHILDHOOD POVERTY; BRAIN-DEVELOPMENT; OUTCOMES; INEQUALITIES; CHILDREN; BEHAVIOR	Purpose Subjective well-being (SWB) in youths positively relates to family income, however its association with income during childhood is unclear. Using longitudinal data from the US Panel Study of Income Dynamics (n = 2234 adolescents, age 12-19 years), we examined whether the timing and duration of low family income in childhood was associated with adolescent SWB. Methods We categorized family income during childhood into state-specific quintiles. Adolescent SWB was assessed using a 12-item questionnaire (score range 3-18). We used marginal structural modelling to test for sensitive periods of exposure to low income and tested cumulative effects of income by modelling the number of years spent in the poorest income quintiles. Results A period in early childhood (age 0-2 years) was particularly sensitive to low family income. Adolescent SWB was 1.65 (95% CI 0.40, 2.91) points lower in those who grew up in the poorest income quintiles during early childhood compared with the top quintile. Further, each childhood year spent in the poorest income quintiles was associated with a 0.10 point (95% CI 0.04, 0.16) lower SWB score in adolescence. Conclusions The timing and duration of low family income in childhood both predict individual differences in adolescent SWB. Further studies are needed to clarify the mechanisms of these models and inform public policies.	[Gariepy, Genevieve; Elgar, Frank J.; Sentenac, Mariane; Barrington-Leigh, Christopher] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Elgar, Frank J.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Barrington-Leigh, Christopher] McGill Univ, Dept Econ, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Gariepy, G (corresponding author), McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada.	genevieve.gariepy@mail.mcgill.ca	Elgar, Frank/GSN-3521-2022; Elgar, Frank/ABE-7450-2020; Sentenac, Mariane/AAA-2575-2022	Gariepy, Genevieve/0000-0001-9209-4240; Barrington-Leigh, Christopher/0000-0002-3929-5390	Canadian Institutes for Health Research; Social Sciences and Humanities Research Council of Canada; Canada Research Chairs programme; National Institutes of Health [R01 HD069609]; National Science Foundation [1157698]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069609, R01HD052646] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs programme(Canada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by research grants from the Canadian Institutes for Health Research; the Social Sciences and Humanities Research Council of Canada; and the Canada Research Chairs programme awarded to FJE. The Panel Study of Income Dynamics public use dataset was produced and distributed by the Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI (2015). The collection of data used in this study was partly supported by the National Institutes of Health under grant number R01 HD069609 and the National Science Foundation under award number 1157698.; This work was supported by research grants from the Canadian Institutes for Health Research; the Social Sciences and Humanities Research Council of Canada; and the Canada Research Chairs programme awarded to FJE. The Panel Study of Income Dynamics public use dataset was produced and distributed by the Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI (2015). The collection of data used in this study was partly supported by the National Institutes of Health under grant number R01 HD069609 and the National Science Foundation under award number 1157698. The authors report no conflict of interest.	Akee RKQ, 2010, AM ECON J-APPL ECON, V2, P86, DOI 10.1257/app.2.1.86; [Anonymous], 2015, WORLD HAPP REP 2015; [Anonymous], POV THRESH SIZ FAM N; [Anonymous], 2015, PAN STUD INC DYN; [Anonymous], UNDERSTANDING SOC EA; [Anonymous], 2015, CROSS NAT EQ FIL; Brooks-Gunn J., 1997, CONSEQUENCES GROWING, P1; Centers for Disease Control and Prevention, 2015, CHILD DEV ATL; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; De Neve JE, 2012, P NATL ACAD SCI USA, V109, P19953, DOI 10.1073/pnas.1211437109; Diener E., 2002, HDB POSITIVE PSYCHOL, P63, DOI [10.1093/oxford- hb/9780195187243.013.0017, DOI 10.1093/OXFORD-HB/9780195187243.013.0017]; Duncan GJ, 2017, ANNU REV PSYCHOL, V68, P413, DOI 10.1146/annurev-psych-010416-044224; Elgar FJ, 2010, CAN J PUBLIC HEALTH, V101, pS23; Evans GW, 2012, PSYCHOL SCI, V23, P979, DOI 10.1177/0956797612441218; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Gallagher MW, 2009, J PERS, V77, P1025, DOI 10.1111/j.1467-6494.2009.00573.x; Hair NL, 2015, JAMA PEDIATR, V169, P822, DOI 10.1001/jamapediatrics.2015.1475; Iversen AC, 2008, CHILD INDIC RES, V1, P291, DOI 10.1007/s12187-008-9015-5; Jayawickreme E, 2012, REV GEN PSYCHOL, V16, P327, DOI 10.1037/a0027990; Jewell S, 2015, SOC INDIC RES, V121, P543, DOI 10.1007/s11205-014-0642-6; Kansky J, 2016, APPL PSYCHOL-HLTH WE, V8, P192, DOI 10.1111/aphw.12068; Keyes CL, 2006, SUBJECTIVE WELL BEIN; Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197; Keyes CLM, 2006, AM J ORTHOPSYCHIAT, V76, P395, DOI 10.1037/0002-9432.76.3.395; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; Leventhal T, 2003, AM J PUBLIC HEALTH, V93, P1576, DOI 10.2105/AJPH.93.9.1576; Lindstrom M, 2014, PSYCHIAT RES, V215, P386, DOI 10.1016/j.psychres.2013.11.018; Lipina S. J., 2009, POVERTY BRAIN DEV CH; Luby J, 2013, JAMA PEDIATR, V167, P1135, DOI 10.1001/jamapediatrics.2013.3139; Main G., 2013, GOOD CHILDHOOD REPOR; McLeod JD, 1996, J HEALTH SOC BEHAV, V37, P207, DOI 10.2307/2137292; Mood C, 2016, CHILD INDIC RES, V9, P825, DOI 10.1007/s12187-015-9337-z; Najman JM, 2010, AM J PUBLIC HEALTH, V100, P1719, DOI 10.2105/AJPH.2009.180943; National Institute for Health and Clinical Excellence, 2009, PROM YOUNG PEOPL SOC; Navarro D, 2017, CHILD FAM SOC WORK, V22, P175, DOI 10.1111/cfs.12215; Odgers CL, 2015, AM PSYCHOL, V70, P722, DOI 10.1037/a0039836; Power C, 1997, LANCET, V350, P1584, DOI 10.1016/S0140-6736(97)07474-6; Quon EC, 2014, HEALTH PSYCHOL, V33, P433, DOI 10.1037/a0033716; Rees G, 2011, UNDERSTANDING CHILDR; Reiss F, 2013, SOC SCI MED, V90, P24, DOI 10.1016/j.socscimed.2013.04.026; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Seligman M.E., 2012, FLOURISH VISIONARY N; Singh K, 2015, J ADOLESCENCE, V39, P59, DOI 10.1016/j.adolescence.2014.12.008; Suldo S, 2011, J POSIT PSYCHOL, V6, P17, DOI 10.1080/17439760.2010.536774; Turner H., 2008, ADV LIFE COURSE RES, V13, P1, DOI [DOI 10.1016/S1040-2608(08)00001-4, 10.1016/S1040-2608(08)00001-4]; VanderWeele TJ, 2015, EXPLANATION CAUSAL I	48	13	13	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0179380	10.1371/journal.pone.0179380	http://dx.doi.org/10.1371/journal.pone.0179380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS8PU	28715418	Green Published, Green Submitted, gold			2022-12-27	WOS:000443975500002
J	Papana, A; Kyrtsou, C; Kugiumtzis, D; Diks, C				Papana, Angeliki; Kyrtsou, Catherine; Kugiumtzis, Dimitris; Diks, Cees			Assessment of resampling methods for causality testing: A note on the US inflation behavior	PLOS ONE			English	Article							MUTUAL INFORMATION; TRANSFER ENTROPY; NETWORKS; CONNECTIVITY; INFERENCE; FLOW	Different resampling methods for the null hypothesis of no Granger causality are assessed in the setting of multivariate time series, taking into account that the driving-response coupling is conditioned on the other observed variables. As appropriate test statistic for this setting, the partial transfer entropy (PTE), an information and model-free measure, is used. Two resampling techniques, time-shifted surrogates and the stationary bootstrap, are combined with three independence settings (giving a total of six resampling methods), all approximating the null hypothesis of no Granger causality. In these three settings, the level of dependence is changed, while the conditioning variables remain intact. The empirical null distribution of the PTE, as the surrogate and bootstrapped time series become more independent, is examined along with the size and power of the respective tests. Additionally, we consider a seventh resampling method by contemporaneously resampling the driving and the response time series using the stationary bootstrap. Although this case does not comply with the no causality hypothesis, one can obtain an accurate sampling distribution for the mean of the test statistic since its value is zero under H-0. Results indicate that as the resampling setting gets more independent, the test becomes more conservative. Finally, we conclude with a real application. More specifically, we investigate the causal links among the growth rates for the US CPI, money supply and crude oil. Based on the PTE and the seven resampling methods, we consistently find that changes in crude oil cause inflation conditioning on money supply in the post-1986 period. However this relationship cannot be explained on the basis of traditional cost-push mechanisms.	[Papana, Angeliki; Kyrtsou, Catherine] Univ Macedonia, Dept Econ, Thessaloniki, Greece; [Kyrtsou, Catherine] CAC IXXI ENS Lyon, Lyon, France; [Kyrtsou, Catherine] Univ Paris 10, Paris, France; [Kyrtsou, Catherine] Univ Strasbourg, BETA, Strasbourg, France; [Kugiumtzis, Dimitris] Aristotle Univ Thessaloniki, Dept Elect & Comp Engn, Thessaloniki, Greece; [Diks, Cees] Univ Amsterdam, Amsterdam Sch Econ, Ctr Nonlinear Dynam Econ & Finance CeNDEF, Amsterdam, Netherlands	University of Macedonia; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Paris Nanterre; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Aristotle University of Thessaloniki; University of Amsterdam	Papana, A (corresponding author), Univ Macedonia, Dept Econ, Thessaloniki, Greece.	angeliki.papana@gmail.com	Papana, Angeliki/GRN-7781-2022; Papana, Angeliki/P-2010-2019; Kugiumtzis, Dimitris/N-9295-2015	Papana, Angeliki/0000-0003-4472-8274; 	European Social Fund (ESF); Greek State; University of Amsterdam	European Social Fund (ESF)(European Social Fund (ESF)); Greek State; University of Amsterdam	The research project is implemented within the framework of the Action "Supporting Postdoctoral Researchers" of the Operational Program "Education and Lifelong Learning" (Action's Beneficiary: General Secretariat for Research and Technology), and is co-financed by he European Social Fund (ESF) and the Greek State. The publication fees of this manuscript will be covered by the University of Amsterdam.	Adhikari BM, 2014, NEUROIMAGE, V91, P300, DOI 10.1016/j.neuroimage.2014.01.007; Ahmed MU, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061918; Amigo JM, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0091; Amigo JM, 2012, CHAOS, V22, DOI 10.1063/1.3673238; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Blanchard JO, 2007, NBER WORKING PAPERS, V13368; Brandt PT, 2007, MULTIPLE TIME SERIES, V2, P32; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 2016, FUNDAMENTALS BRAIN N; Diks C, 2002, STUD NONLINEAR DYN E, V6; Diks C, 2001, GLOBAL ANALYSIS OF DYNAMICAL SYSTEMS, P391; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Faes L, 2010, IEEE T BIO-MED ENG, V57, P1897, DOI 10.1109/TBME.2010.2042715; Faes L, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026201; Fieguth P., 2017, OMPLEX SYSTEMS INTRO, P245; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Goebel B, 2005, IEEE ICC, P1102; Hamilton James D., 2007, BROOKINGS PAPERS EC, V1, P215, DOI DOI 10.1353/ECA.0.0047; Hirata Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158572; Hlinka J, 2013, ENTROPY-SWITZ, V15, P2023, DOI 10.3390/e15062023; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kantz H., 2004, NONLINEAR TIME SERIE, V7; Kilian L., 2010, WTO STAFF WORKING PA, V2010-02; Koutlis C, 2016, CHAOS, V26, DOI 10.1063/1.4963175; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kugiumtzis D, 2013, EUR PHYS J-SPEC TOP, V222, P401, DOI 10.1140/epjst/e2013-01849-4; Kugiumtzis D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062918; Kugiumtzis D., 2012, J NONLINEAR SYST APP, V3, P73; Kwon O, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/68003; Marschinski R, 2002, EUR PHYS J B, V30, P275, DOI 10.1140/epjb/e2002-00379-2; MODDEMEIJER R, 1989, SIGNAL PROCESS, V16, P233, DOI 10.1016/0165-1684(89)90132-1; Papana A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036207; Papana A, 2014, 1408 CENDEF U AMST; Papana A, 2014, SPRINGER P MATH STAT, V114, P419; Papana A, 2013, ENTROPY-SWITZ, V15, P2635, DOI 10.3390/e15072635; Papana A, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412502227; Papana A, 2009, INT J BIFURCAT CHAOS, V19, P4197, DOI 10.1142/S0218127409025298; POLITIS DN, 1992, IEEE T SIGNAL PROCES, V40, P1206, DOI 10.1109/78.134482; Porta A, 2016, P IEEE, V104, P282, DOI 10.1109/JPROC.2015.2476824; Porta A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132851; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Razak FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099462; Runge J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.258701; Schelter B, 2006, J NEUROSCI METH, V152, P210, DOI 10.1016/j.jneumeth.2005.09.001; Schmidt C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153105; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schutze Henry, 2012, Artificial Neural Networks and Machine Learning - ICANN 2012. 22nd International Conference on Artificial Neural Networks, P540, DOI 10.1007/978-3-642-33266-1_67; Silverman B.W., 1986, DENSITY ESTIMATION S; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; Summers P. M., 2005, ECON REV, V90, P5; Sun XQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03711; Takahashi DY, 2007, J APPL STAT, V34, P1259, DOI 10.1080/02664760701593065; Thiel M, 2006, EUROPHYS LETT, V75, P535, DOI 10.1209/epl/i2006-10147-0; Vakorin VA, 2009, J NEUROSCI METH, V184, P152, DOI 10.1016/j.jneumeth.2009.07.014; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Vlachos I, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016207; Wibral M, 2014, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-54474-3; Winterhalder M, 2005, SIGNAL PROCESS, V85, P2137, DOI 10.1016/j.sigpro.2005.07.011; Yang F, 2014, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-319-05380-6; Yu GH, 2001, STOCH ENV RES RISK A, V15, P462, DOI 10.1007/s004770100083	62	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180852	10.1371/journal.pone.0180852	http://dx.doi.org/10.1371/journal.pone.0180852			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708870	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800025
J	Renard, M; Muino-Mosquera, L; Manalo, EC; Tufa, S; Carlson, EJ; Keene, DR; De Backer, J; Sakai, LY				Renard, Marjolijn; Muino-Mosquera, Laura; Manalo, Elise C.; Tufa, Sara; Carlson, Eric J.; Keene, Douglas R.; De Backer, Julie; Sakai, Lynn Y.			Sex, pregnancy and aortic disease in Marfan syndrome	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; TGFBR2 MUTATIONS; IN-VIVO; ANEURYSM; FIBRILLIN-1; WOMEN; COMPLICATIONS; MICE; ESTROGEN; GROWTH	Background Sex-related differences as well as the adverse effect of pregnancy on aortic disease outcome are well-established phenomena in humans with Marfan syndrome (MFS). The underlying mechanisms of these observations are largely unknown. Objectives In an initial (pilot) step we aimed to confirm the differences between male and female MFS patients as well as between females with and without previous pregnancy. We then sought to evaluate whether these findings are recapitulated in a pre-clinical model and performed in-depth cardiovascular phenotyping of mutant male and both nulliparous and multiparous female Marfan mice. The effect of 17 beta-estradiol on fibrillin-1 protein synthesis was compared in vitro using human aortic smooth muscle cells and fibroblasts. Results Our small retrospective study of aortic dimensions in a cohort of 10 men and 20 women with MFS (10 pregnant and 10 non-pregnant) confirmed that aortic root growth was significantly increased in the pregnant group compared to the non-pregnant group (0.64mm/year vs. 0.12mm/year, p = 0.018). Male MFS patients had significantly larger aortic root diameters compared to the non-pregnant and pregnant females at baseline and follow-up (p = 0.002 and p = 0.007, respectively), but no significant increase in aortic root growth was observed compared to the females after follow-up (p = 0.559 and p = 0.352). In the GT-8/+ MFS mouse model, multiparous female Marfan mice showed increased aortic diameters when compared to nulliparous females. Aortic dilatation in multiparous females was comparable to Marfan male mice. Moreover, increased aortic diameters were associated with more severe fragmentation of the elastic lamellae. In addition, 17 beta-estradiol was found to promote fibrillin-1 production by human aortic smooth muscle cells. Conclusions Pregnancy-related changes influence aortic disease severity in otherwise protected female MFS mice and patients. There may be a role for estrogen in the female sex protective effect.	[Renard, Marjolijn; Muino-Mosquera, Laura; De Backer, Julie] Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium; [Manalo, Elise C.; Carlson, Eric J.; Sakai, Lynn Y.] Shriners Hosp Children, Dept Mol & Med Genet & Biochem & Mol Biol, Portland, OR 97201 USA; [Tufa, Sara; Keene, Douglas R.] Shriners Hosp Children, Microimaging Ctr, Portland, OR 97201 USA	Ghent University	Renard, M (corresponding author), Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium.	marjolijn.renard@ugent.be	De Backer, Julie/B-2897-2014; Muino Mosquera, Laura/ABD-5010-2020	De Backer, Julie/0000-0001-8878-1507; Muino Mosquera, Laura/0000-0002-3094-7807; Manalo, Elise/0000-0003-2752-5280; Tufa, Sara/0000-0002-6447-8041; Renard, Marjolijn/0000-0003-1105-8948	Flemishg overnment; Ghent University [BOF15/ MET-V/011]; NIH [P01AR049698]; Shriners Hospitals for Children; Special Research Fund from the Ghent University [BOFB/13474/01]	Flemishg overnment(European Commission); Ghent University(Ghent University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; Special Research Fund from the Ghent University	This study was supported by a Methusalem grant from the Flemishg overnment and the Ghent University to A. DePaepe (BOF15/ MET-V/011; www.ugent.be) and by grants from the NIH (P01AR049698; www.nig.gov) and from the Shriners Hospitals for Children (to LYS and DRK; http://www.shrinershospitalsforchildren.org). MR is a postdoctoral fellow and JDB is a senior clinical investigator of the Research Foundation - Flanders www.fwo.be). LMM is supported by a Special Research Fund from the Ghent University (BOFB/ 13474/01; www.ugent.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailawadi G, 2004, ARTERIOSCL THROM VAS, V24, P2116, DOI 10.1161/01.ATV.0000143386.26399.84; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; Campens L, 2015, PEDIATR RES, V78, P256, DOI 10.1038/pr.2015.110; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau NL, 2010, J BIOL CHEM, V285, P24943, DOI 10.1074/jbc.M110.130021; Cho BS, 2010, SURGERY, V147, P258, DOI 10.1016/j.surg.2009.06.047; Cook JR, 2014, J CLIN INVEST, V124, P1329, DOI 10.1172/JCI71059; Das BB, 2006, PEDIATR CARDIOL, V27, P256, DOI 10.1007/s00246-005-1139-5; De Backer JF, 2006, INT J CARDIOL, V112, P353, DOI 10.1016/j.ijcard.2005.10.010; Detaint D, 2010, EUR HEART J, V31, P2223, DOI 10.1093/eurheartj/ehq258; Dietz H. C., 1996, AM J MED GENET, V26, P10; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Donnelly RT, 2012, J AM COLL CARDIOL, V60, P224, DOI 10.1016/j.jacc.2012.03.051; EASTERLING TR, 1991, OBSTET GYNECOL, V78, P1073; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; FINKBOHNER R, 1995, CIRCULATION, V91, P728, DOI 10.1161/01.CIR.91.3.728; Franken R, 2016, EUR HEART J, V37, P3285, DOI 10.1093/eurheartj/ehv739; HUNTER S, 1992, BRIT HEART J, V68, P540; Johnston WF, 2015, J VASC SURG, V61, P1565, DOI 10.1016/j.jvs.2014.01.032; Jondeau G, 2016, CIRC-CARDIOVASC GENE, V9, P548, DOI 10.1161/CIRCGENETICS.116.001485; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kissin EY, 2002, ARTHRITIS RHEUM, V46, P3000, DOI 10.1002/art.10621; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Lind J, 2001, EUR J OBSTET GYN R B, V98, P28, DOI 10.1016/S0301-2115(01)00314-1; Lipscomb KJ, 1997, BRIT J OBSTET GYNAEC, V104, P201, DOI 10.1111/j.1471-0528.1997.tb11045.x; Marshall LM, 2013, CIRC RES, V113, P1159, DOI 10.1161/CIRCRESAHA.113.301498; Martin-McNulty B, 2003, ARTERIOSCL THROM VAS, V23, P1627, DOI 10.1161/01.ATV.0000085842.20866.6A; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; Meijboom LJ, 2006, INT J CARDIOL, V110, P53, DOI 10.1016/j.ijcard.2005.07.017; Meijboom LJ, 2005, EUR HEART J, V26, P914, DOI 10.1093/eurheartj/ehi103; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Natoli AK, 2005, HYPERTENSION, V46, P1129, DOI 10.1161/01.HYP.0000187016.06549.96; Omnes S, 2013, INT J GYNECOL OBSTET, V122, P219, DOI 10.1016/j.ijgo.2013.04.013; Pacini L, 2009, INT J CARDIOL, V136, P156, DOI 10.1016/j.ijcard.2008.04.035; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; PYERITZ RE, 1981, AM J MED, V71, P784, DOI 10.1016/0002-9343(81)90365-X; Rahman J, 2003, J REPROD MED, V48, P723; ROBSON SC, 1987, BRIT MED J, V294, P1065, DOI 10.1136/bmj.294.6579.1065; Roman MJ., 2016, J AM HEART ASSOC, V5, P8, DOI DOI 10.1161/JAHA.116.004052; ROSSITER JP, 1995, AM J OBSTET GYNECOL, V173, P1599, DOI 10.1016/0002-9378(95)90655-X; Rybczynski M, 2007, CLIN CARDIOL, V30, P19, DOI 10.1002/clc.3; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SAVOLAINEN A, 1994, EUR HEART J, V15, P625, DOI 10.1093/oxfordjournals.eurheartj.a060558; Schmit BM, 2015, AM J PHYSIOL-HEART C, V308, pH115, DOI 10.1152/ajpheart.00521.2014; Schoenhoff FS, 2013, CIRCULATION, V127, P1569, DOI 10.1161/CIRCULATIONAHA.113.001457; Sinha I, 2006, ANN NY ACAD SCI, V1085, P367, DOI 10.1196/annals.1383.027; Tran-Fadulu V, 2009, J MED GENET, V46, P607, DOI 10.1136/jmg.2008.062844; Wu XF, 2009, AM J SURG, V197, P49, DOI 10.1016/j.amjsurg.2007.11.022; Zhang X, 2012, CIRC RES, V110, pE73, DOI 10.1161/CIRCRESAHA.111.253880	51	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181166	10.1371/journal.pone.0181166	http://dx.doi.org/10.1371/journal.pone.0181166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708846	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649800044
J	Chan, HS; de Blois, E; Morgenstern, A; Bruchertseifer, F; de Jong, M; Breeman, W; Konijnenberg, M				Chan, Ho Sze; de Blois, Erik; Morgenstern, Alfred; Bruchertseifer, Frank; de Jong, Marion; Breeman, Wouter; Konijnenberg, Mark			In Vitro comparison of Bi-213- and Lu-177-radiation for peptide receptor radionuclide therapy	PLOS ONE			English	Article							ALPHA-PARTICLE EMITTERS; SOMATOSTATIN RECEPTORS; DOSIMETRY; RADIOTHERAPY; RADIATION; SOFTWARE; ANTIBODY; TUMORS; CELLS; MODEL	Background Absorbed doses for alpha-emitters are different from those for beta-emitters, as the high linear energy transfer (LET) nature of alpha-particles results in a very dense energy deposition over a relatively short path length near the point of emission. This highly localized and therefore high energy deposition can lead to enhanced cell-killing effects at absorbed doses that are non-lethal in low-LET type of exposure. Affinities of DOTA-DPhe(1) - Tyr(3) -octreotate (DOTATATE), In-115-DOTATATE, Lu-175-DOTATATE and Bi-209-DOTATATE were determined in the K562-SST2 cell line. Two other cell lines were used for radiation response assessment; BON and CA20948, with a low and high expression of somatostatin receptors, respectively. Cellular uptake kinetics of In-111-DOTATATE were determined in CA20948 cells. CA20948 and BON were irradiated with Cs-137, Lu-177-DTPA, Lu-177-DOTATATE, Bi-213-DTPA and Bi-213-DOTATATE. Absorbed doses were calculated using the MIRDcell dosimetry method for the specific binding and a Monte Carlo model of a cylindrical 6-well plate geometry for the exposure by the radioactive incubation medium. Absorbed doses were compared to conventional irradiation of cells with Cs-137 and the relative biological effect (RBE) at 10% survival was calculated. Results IC50 of (labelled) DOTATATE was in the nM range. Absorbed doses up to 7 Gy were obtained by 5.2 MBq Bi-213-DOTATATE, in majority the dose was caused by alpha-particle radiation. Cellular internalization determined with In-111-DOTATATE showed a linear relation with incubation time. Cell survival after exposure of Bi-213-DTPA and Bi-213-DOTATATE to BON or CA20948 cells showed a linear-exponential relation with the absorbed dose, confirming the high LET character of Bi-213. The survival of CA20948 after exposure to Lu-177-DOTATATE and the reference Cs-137 irradiation showed the typical curvature of the linear-quadratic model. 10% Cell survival of CA20948 was reached at 3 Gy with Bi-213-DOTATATE, a factor 6 lower than the 18 Gy found for Lu-177-DOTATATE and also below the 5 Gy after Cs-137 external exposure. Conclusion Bi-213-DTPA and Bi-213-DOTATATE lead to a factor 6 advantage in cell killing compared to Lu-177-DOTATATE. The RBE at 10% survival by (213) Bi-ligand compared to Cs-137 was 2.0 whereas the RBE for Lu-177-DOTATATE was 0.3 in the CA20948 in vitro model.	[Chan, Ho Sze; de Blois, Erik; de Jong, Marion; Breeman, Wouter; Konijnenberg, Mark] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [Morgenstern, Alfred; Bruchertseifer, Frank] European Commiss, Joint Res Ctr, Inst Transuranium Elements ITU, Karlsruhe, Germany	Erasmus University Rotterdam; Erasmus MC; European Commission Joint Research Centre; EC JRC Institute for Transuranium Elements (ITU)	Chan, HS (corresponding author), Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands.	h.s.chan1982@gmail.com			Dinse Stiftung	Dinse Stiftung	This research was supported by the Dinse Stiftung. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard B, 2004, CANCER BIOTHER RADIO, V19, P173, DOI 10.1089/108497804323071940; Bolch WE, 2009, J NUCL MED, V50, P477, DOI 10.2967/jnumed.108.056036; Chan HS, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0162-2; Chan HS, 2016, EJNMMI RADIOPHARMACY, V1; Cremonesi M, 2006, J NUCL MED, V47, P1467; de Blois E, 2012, CURR TOP MED CHEM, V12, P2668; de Blois E, 2011, APPL RADIAT ISOTOPES, V69, P308, DOI 10.1016/j.apradiso.2010.11.015; Eckerman KF, 2008, MIRD RADIONUCLIDE DA; Eigqvist J, 2014, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00324; Enger SA, 2008, PHYS MED BIOL, V53, P1909, DOI 10.1088/0031-9155/53/7/007; Eriksson D, 2010, TUMOR BIOL, V31, P363, DOI 10.1007/s13277-010-0042-8; Ferone D, 1999, ENDOCRINOLOGY, V140, P373, DOI 10.1210/en.140.1.373; Graf F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088239; Hobbs RF, 2014, RADIAT RES, V181, P90, DOI 10.1667/RR13483.1; Huang CY, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/153212; JONAS S, 1995, LANGENBECK ARCH CHIR, V380, P90; Kascakova S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104448; Kratochwil C, 2014, EUR J NUCL MED MOL I, V41, P2106, DOI 10.1007/s00259-014-2857-9; Lewis JS, 1999, CLIN CANCER RES, V5, P3608; Morgenstern A, 2012, CURR RADIOPHARM, V5, P221, DOI 10.2174/1874471011205030221; Nayak TK, 2007, NUCL MED BIOL, V34, P185, DOI 10.1016/j.nucmedbio.2006.11.006; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Norenberg JP, 2006, CLIN CANCER RES, V12, P897, DOI 10.1158/1078-0432.CCR-05-1264; Pasternack JB, 2014, J NUCL MED, V55, P2012, DOI 10.2967/jnumed.114.141580; REUBI JC, 1985, LIFE SCI, V36, P1829, DOI 10.1016/0024-3205(85)90155-9; Roeske JC, 1997, J NUCL MED, V38, P1923; Sgouros G, 2010, J NUCL MED, V51, P311, DOI 10.2967/jnumed.108.058651; Song H, 2013, MOL CANCER THER, V12, P2043, DOI 10.1158/1535-7163.MCT-13-0108; Vaziri B, 2014, J NUCL MED, V55, P1557, DOI 10.2967/jnumed.113.131037; Verwijnen S, 2004, CANCER BIOTHER RADIO, V19, P285, DOI 10.1089/1084978041425098	30	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181473	10.1371/journal.pone.0181473	http://dx.doi.org/10.1371/journal.pone.0181473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732021	gold, Green Published, Green Submitted			2022-12-27	WOS:000406643100038
J	Commisso, M; Bianconi, M; Di Carlo, F; Poletti, S; Bulgarini, A; Munari, F; Negri, S; Stocchero, M; Ceoldo, S; Avesani, L; Assfalg, M; Zoccatelli, G; Guzzo, F				Commisso, Mauro; Bianconi, Martino; Di Carlo, Flavia; Poletti, Stefania; Bulgarini, Alessandra; Munari, Francesca; Negri, Stefano; Stocchero, Matteo; Ceoldo, Stefania; Avesani, Linda; Assfalg, Michael; Zoccatelli, Gianni; Guzzo, Flavia			Multi-approach metabolomics analysis and artificial simplified phytocomplexes reveal cultivar-dependent synergy between polyphenols and ascorbic acid in fruits of the sweet cherry (Prunus avium L.)	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; CIRCULATING CONCENTRATIONS; CHEMICAL-CONSTITUENTS; POSTHARVEST STORAGE; PHENOLIC-COMPOUNDS; HUMAN HEALTH; CONSUMPTION; ANTHOCYANINS; PERFORMANCE; MECHANISMS	Fruits of the sweet cherry (Prunus avium L.) accumulate a range of antioxidants that can help to prevent cardiovascular disease, inflammation and cancer. We tested the in vitro antioxidant activity of 18 sweet cherry cultivars collected from 12 farms in the protected geographical indication region of Marostica (Vicenza, Italy) during two growing seasons. Multiple targeted and untargeted metabolomics approaches (NMR, LC-MS, HPLC-DAD, HPLC-UV) as well as artificial simplified phytocomplexes representing the cultivars Sandra Tardiva, Sandra and Grace Star were then used to determine whether the total antioxidant activity reflected the additive effects of each compound or resulted from synergistic interactions. We found that the composition of each cultivar depended more on genetic variability than environmental factors. Furthermore, phenolic compounds were the principal source of antioxidant activity and experiments with artificial simplified phytocomplexes indicated strong synergy between the anthocyanins and quercetins/ascorbic acid specifically in the cultivar Sandra Tardiva. Our data therefore indicate that the total antioxidant activity of sweet cherry fruits may originate from cultivar-dependent interactions among different classes of metabolite.	[Commisso, Mauro; Bianconi, Martino; Poletti, Stefania; Bulgarini, Alessandra; Munari, Francesca; Negri, Stefano; Ceoldo, Stefania; Avesani, Linda; Assfalg, Michael; Zoccatelli, Gianni; Guzzo, Flavia] Univ Verona, Dept Biotechnol, Verona, Italy; [Di Carlo, Flavia] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Palermo, Italy; [Stocchero, Matteo] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy	University of Verona; University of Palermo; University of Padua	Guzzo, F (corresponding author), Univ Verona, Dept Biotechnol, Verona, Italy.	flavia.guzzo@univr.it	Commisso, Mauro/M-5616-2016	Commisso, Mauro/0000-0001-6474-8577; Munari, Francesca/0000-0002-8217-1481	Regione Veneto; Veneto Agricoltura within the project "Caratterizzazione qualitativa dei principali prodotti ortofrutticoli veneti e del loro ambiente di produzione" [DGR 2860]	Regione Veneto(Regione Veneto); Veneto Agricoltura within the project "Caratterizzazione qualitativa dei principali prodotti ortofrutticoli veneti e del loro ambiente di produzione"	This work was supported by Regione Veneto and Veneto Agricoltura within the project "Caratterizzazione qualitativa dei principali prodotti ortofrutticoli veneti e del loro ambiente di produzione", DGR 2860 30/12/2013. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Apak R, 2016, J AGR FOOD CHEM, V64, P997, DOI 10.1021/acs.jafc.5b04739; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Ballistreri G, 2013, FOOD CHEM, V140, P630, DOI 10.1016/j.foodchem.2012.11.024; Bastos C, 2015, FOOD CHEM, V173, P1045, DOI 10.1016/j.foodchem.2014.10.145; Benzie IFF, 1999, J AGR FOOD CHEM, V47, P633, DOI 10.1021/jf9807768; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Chaovanalikit A, 2004, J FOOD SCI, V69; Chockchaisawasdee S, 2016, TRENDS FOOD SCI TECH, V55, P72, DOI 10.1016/j.tifs.2016.07.002; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Crupi P, 2014, J MASS SPECTROM, V49, P1025, DOI 10.1002/jms.3423; Dever MC, 1996, HORTSCIENCE, V31, P150, DOI 10.21273/HORTSCI.31.1.150; Diaz-Mula H, 2010, FOOD SCI TECHNOL INT; Faniadis D, 2010, SCI HORTIC-AMSTERDAM, V125, P301, DOI 10.1016/j.scienta.2010.04.013; Farhadfar S., 2016, International Journal of Agriculture and Forestry, V6, P20; Ferretti G, 2010, MOLECULES, V15, P6993, DOI 10.3390/molecules15106993; Galgano E, 2002, ITALIAN J FOOD SCI, V14; Gallo V, 2015, ANAL CHEM, V87, P6709, DOI 10.1021/acs.analchem.5b00919; Garcia-Montiel F, 2010, SPAN J AGRIC RES, V8, P1118; Goncalves B, 2004, J SCI FOOD AGR, V84, P1013, DOI 10.1002/jsfa.1752; Goncalves B, 2004, J AGR FOOD CHEM, V52, P523, DOI 10.1021/jf030595s; Goncalves B, 2007, FOOD CHEM, V103, P976, DOI 10.1016/j.foodchem.2006.08.039; Gonzalez-Gomez D, 2010, J FOOD COMPOS ANAL, V23, P533, DOI 10.1016/j.jfca.2009.02.008; Habib M, 2015, CRIT REV FO IN PRESS; Hajimehdipoor H, 2014, RES J PHARMACOGN, V1, P35; Hayaloglu AA, 2016, J FOOD SCI, V81, pC7, DOI 10.1111/1750-3841.13175; Hayaloglu AA, 2015, J FOOD SCI, V80, pC564, DOI 10.1111/1750-3841.12781; Herrera E, 2009, NUTR REV, V67, pS140, DOI 10.1111/j.1753-4887.2009.00177.x; Hidalgo M, 2010, FOOD CHEM, V121, P691, DOI 10.1016/j.foodchem.2009.12.097; Iacopini P, 2008, J FOOD COMPOS ANAL, V21, P589, DOI 10.1016/j.jfca.2008.03.011; Jacob RA, 2003, J NUTR, V133, P1826, DOI 10.1093/jn/133.6.1826; Kappel F, 2002, HORTSCIENCE, V37, P139, DOI 10.21273/HORTSCI.37.1.139; Kappel F, 2006, CAN J PLANT SCI, V86, P1197, DOI 10.4141/P05-244; Karlidag H, 2009, BIOTECHNOL BIOTEC EQ, V23, P1325, DOI 10.1080/13102818.2009.10817663; Kelebek H, 2011, INT J FOOD SCI TECH, V46, P2530, DOI 10.1111/j.1365-2621.2011.02777.x; Kelley DS, 2013, J NUTR, V143, P340, DOI 10.3945/jn.112.171371; Kelley DS, 2006, J NUTR, V136, P981, DOI 10.1093/jn/136.4.981; Kim DO, 2005, J AGR FOOD CHEM, V53, P9921, DOI 10.1021/jf0518599; Kurin E, 2012, MOLECULES, V17, P14336, DOI 10.3390/molecules171214336; Liu Y, 2011, J FOOD SCI, V76, pC633, DOI 10.1111/j.1750-3841.2011.02150.x; Liu ZH, 2016, J FOOD SCI, V81, pC1091, DOI 10.1111/1750-3841.13292; Lopez-Alarcon C, 2013, ANAL CHIM ACTA, V763, P1, DOI 10.1016/j.aca.2012.11.051; Marquardt KC, 2013, POLYPHENOLS PUBLIC H; McCune LM, 2011, CRIT REV FOOD SCI, V51, P1, DOI 10.1080/10408390903001719; Milinovic B, 2016, J APPL BOT FOOD QUAL, P89; Mozetic B, 2006, FOOD CHEM, V97, P302, DOI 10.1016/j.foodchem.2005.04.018; Nagy-Gasztonyi M, 2010, CHROMATOGRAPHIA, V71, pS99, DOI 10.1365/s10337-010-1590-1; Olmstead JW, 2007, J AM SOC HORTIC SCI, V132, P697, DOI 10.21273/JASHS.132.5.697; Perez-Sanchez R, 2008, SPAN J AGRIC RES, V6, P42, DOI 10.5424/sjar/2008061-293; Prvulovic D., 2011, WORLD ACAD SCI ENG T, V59, P1149; Schuster M, 2012, SCI HORTIC-AMSTERDAM, V148, P59, DOI 10.1016/j.scienta.2012.09.012; Seeram NP, 2003, NUTR CANCER, V46, P101, DOI 10.1207/S15327914NC4601_13; Serrano M, 2005, J AGR FOOD CHEM, V53, P2741, DOI 10.1021/jf0479160; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087221; Wang X., 2014, FRUIT VEGETABLE CONS; Zhang YQ, 2012, ARTHRITIS RHEUM-US, V64, P4004, DOI 10.1002/art.34677	57	31	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180889	10.1371/journal.pone.0180889	http://dx.doi.org/10.1371/journal.pone.0180889			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732012	Green Published, Green Submitted, gold			2022-12-27	WOS:000406643100013
J	Kalimuthu, S; Oh, JM; Gangadaran, P; Zhu, LY; Lee, HW; Jeon, YH; Jeong, SY; Lee, SW; Lee, J; Ahn, BC				Kalimuthu, Senthilkumar; Oh, Ji Min; Gangadaran, Prakash; Zhu, Liya; Lee, Ho Won; Jeon, Yong Hyun; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol			Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer	PLOS ONE			English	Article							BREAST-CANCER; TRANSGENE EXPRESSION; RESPONSIVE PROMOTERS; MAMMALIAN-CELLS; TIGHT CONTROL; THERAPY; MICE; MELANOMA; VECTORS; MODEL	Anaplastic thyroid cancer (ATC) is the most aggressive malignancy of the thyroid, during which undifferentiated tumors arise from the thyroid follicular epithelium. ATC has a very poor prognosis due to its aggressive behavior and poor response to conventional therapies. Gene-directed enzyme/prodrug therapy using genetically engineered mesenchymal stromal cells (MSC) is a promising therapeutic strategy. The doxycycline (DOX)-controlled Tet inducible system is the most widely utilized regulatory system and could be a useful tool for therapeutic gene-based therapies. For example, use a synthetic "tetracycline-on" switch system to control the expression of the therapeutic gene thymidine kinase, which converts prodrugs to active drugs. The aim of this study was to develop therapeutic MSCs, harboring an inducible suicide gene, and to validate therapeutic gene expression using optical molecular imaging of ATC. We designed the Tet-On system using a retroviral vector expressing herpes simplex virus thymidine kinase (HSV1-sr39TK) with dual reporters (eGFP-Fluc2). Mouse bone marrow-derived mesenchymal stromal cells (BM-MSC) were transduced using this system with (MSC-Tet-TK/Fluc2) or without (MSC-TK/Fluc) the Tet-On system. Transduced cells were screened and characterized. Engineered MSCs were co-cultured with ATC (CAL62/Rluc) cells in the presence of the prodrug ganciclovir (GCV) and stimulated with DOX. The efficiency of cell killing monitored by assessing Rluc (CAL62/Rluc) and Fluc (MSC-Tet-TK/Fluc and MSC-TK/Fluc) activities using IVIS imaging. Fluc activity increased in MSC-Tet-TK/Fluc cells in a dose dependent manner following DOX treatment (R2 = 0.95), whereas no signal was observed in untreated cells. eGFP could also be visualized after induction with DOX, and the HSV1-TK protein could be detected by western blotting. In MSC-TK/Fluc cells, the Fluc activity increased with increasing cell number (R2 = 0.98), and eGFP could be visualized by fluorescence microscopy. The Fluc activity and cell viability of MSC-Tet-TK/Fluc and MSC-TK/Fluc cells decreased significantly following GCV treatment. A bystander effect of the therapeutic cells confirmed in co-cultures of CAL62 cells, an anaplastic thyroid cancer cell line, with either MSC-Tet-TK/Fluc cells or MSC-TK/Fluc cells. The Rluc activity in MSC-Tet-TK/Fluc co-cultures, derived from the CAL62/Rluc cells, decreased significantly with GCV treatment of DOX treated cultures, whereas no significant changes were observed in untreated cultures. In addition, the Fluc activity of MSC-Tet-TK/Fluc cells also decreased significantly with DOX treatment whereas no signal was present in untreated cultures. A bystander effect also be demonstrated in co-cultures with MSC-TK/Fluc cells and CAL62/Rluc; both the Rluc activity and the Fluc activity were significantly decreased following GCV treatment. We have successfully developed a Tet-On system of gene-directed enzyme/prodrug delivery using MSCs. We confirmed the therapeutic bystander effect in CAL62/Rluc cells with respect to MSC-Tet-TK/Fluc and MSC-TK/Fluc cells after GCV treatment with and without DOX. Our results confirm the therapeutic efficiency of a suicide gene, with or without the Tet-On system, for ATC therapy. In addition, our findings provide an innovative therapeutic approach for using the Tet-On system to eradicate tumors by simple, repeated administration of MSC-Tet-TK/Fluc cells with DOX and GCV.	[Kalimuthu, Senthilkumar; Oh, Ji Min; Gangadaran, Prakash; Zhu, Liya; Lee, Ho Won; Jeon, Yong Hyun; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med Hosp, Dept Nucl Med, Daegu, South Korea	Kyungpook National University	Ahn, BC (corresponding author), Kyungpook Natl Univ, Sch Med Hosp, Dept Nucl Med, Daegu, South Korea.	abc2000@knu.ac.kr	Jeon, Yong hyun/N-6910-2019; Lee, Jaetae/AAR-3317-2021; Lee, Jaetae/ABF-3980-2020; Gangadaran, Prakash/AAV-3102-2021	Jeon, Yong hyun/0000-0003-3161-7698; Gangadaran, Prakash/0000-0002-0658-4604; Ahn, Byeong-Cheol/0000-0001-7700-3929	National Nuclear R&D Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012M2A2A7014020]; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI16C1501]; Medical Cluster R&D Support Project of Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF); Ministry of Health & Welfare, Republic of Korea [HT13C0002, H115C0001]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF- 2015M2A2A7A01045177]; basic science research program through the NRF - ministry of education [NRF-2016R1D1A1A02936968]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES027306, F31ES027304] Funding Source: NIH RePORTER	National Nuclear R&D Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Medical Cluster R&D Support Project of Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea (NRF) grant - Korean government (MSIP); basic science research program through the NRF - ministry of education(National Research Foundation of Korea); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Nuclear R&D Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (No. 2012M2A2A7014020), a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI16C1501), a grant from the Medical Cluster R&D Support Project of Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF) funded by the Ministry of Health & Welfare, Republic of Korea (HT13C0002), and a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (H115C0001). This work was also supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. NRF- 2015M2A2A7A01045177). Also this research was supported by basic science research program through the NRF funded by the ministry of education (NRF-2016R1D1A1A02936968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Amano S, 2009, INT J ONCOL, V35, P1265, DOI 10.3892/ijo_00000443; Amer MH, 2014, MOL CELL THER, V2, P1; Barese CN, 2012, MOL THER, V20, P1932, DOI 10.1038/mt.2012.166; Bonini C, 2007, MOL THER, V15, P1248, DOI 10.1038/sj.mt.6300190; Cavarretta IT, 2010, MOL THER, V18, P223, DOI 10.1038/mt.2009.237; de Melo SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128922; Dwyer RM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt25; Fillat C., 2003, Current Gene Therapy, V3, P13, DOI 10.2174/1566523033347426; Gebremedhin S, 2014, EUR J PHARM SCI, V60, P72, DOI 10.1016/j.ejps.2014.03.003; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022; Han Y, 2010, GENE THER, V17, P616, DOI 10.1038/gt.2010.6; Hoyng SA, 2014, GENE THER, V21, P549, DOI 10.1038/gt.2014.22; Josiah DT, 2010, MOL THER, V18, P377, DOI 10.1038/mt.2009.265; Kim JE, 2015, NUCL MED MOLEC IMAG, V49, P3, DOI 10.1007/s13139-014-0309-x; Kim KB, 2004, CANCER-AM CANCER SOC, V101, P596, DOI 10.1002/cncr.20403; Kis Z, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1000; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Koponen JK, 2003, GENE THER, V10, P459, DOI 10.1038/sj.gt.3301889; Kucerova L, 2008, J GENE MED, V10, P1071, DOI 10.1002/jgm.1239; Kucerova L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-129; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Leng L, 2014, BIOMATERIALS, V35, P5162, DOI 10.1016/j.biomaterials.2014.03.014; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Mader EK, 2009, CLIN CANCER RES, V15, P7246, DOI 10.1158/1078-0432.CCR-09-1292; Matuskova M, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0149-2; Mizuguchi H, 2003, HUM GENE THER, V14, P1265, DOI 10.1089/104303403767740803; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Nouri FS, 2015, J CONTROL RELEASE, V200, P179, DOI 10.1016/j.jconrel.2015.01.003; Patel Kepal N, 2006, Cancer Control, V13, P119; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Rodenhuis S, 2003, NEW ENGL J MED, V349, P7, DOI 10.1056/NEJMoa022794; Schmeisser F, 2002, HUM GENE THER, V13, P2113, DOI 10.1089/104303402320987815; Sekar TV, 2014, THERANOSTICS, V4, P460, DOI 10.7150/thno.8077; Smallridge RC, 2012, THYROID, V22, P1104, DOI 10.1089/thy.2012.0302; Strachan T, 1999, GENE THERAPY OTHER M; Su H, 2004, MOL IMAGING BIOL, V6, P139, DOI 10.1016/j.mibio.2004.02.001; Torsvik A, 2013, CANCER TREAT REV, V39, P180, DOI 10.1016/j.ctrv.2012.03.005; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vilalta M, 2009, GENE THER, V16, P547, DOI 10.1038/gt.2008.176; Wang LN, 2013, CURR PHARM BIOTECHNO, V14, P683; Weichselbaum RR, 1997, LANCET, V349, pS10, DOI 10.1016/S0140-6736(97)90013-1; Yong RL, 2009, CANCER RES, V69, P8932, DOI 10.1158/0008-5472.CAN-08-3873; Zeng ZJ, 2006, CANCER GENE THER, V13, P290, DOI 10.1038/sj.cgt.7700889; Zhang TY, 2015, J CONTROL RELEASE, V209, P260, DOI 10.1016/j.jconrel.2015.05.007; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	49	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181318	10.1371/journal.pone.0181318	http://dx.doi.org/10.1371/journal.pone.0181318			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727740	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500056
J	Matzaraki, V; Gresnigt, MS; Jaeger, M; Ricano-Ponce, I; Johnson, MD; Oosting, M; Franke, L; Withoff, S; Perfect, JR; Joosten, LAB; Kullberg, BJ; van de Veerdonk, FL; Jonkers, I; Li, Y; Wijmenga, C; Netea, MG; Kumar, V				Matzaraki, Vasiliki; Gresnigt, Mark S.; Jaeger, Martin; Ricano-Ponce, Isis; Johnson, Melissa D.; Oosting, Marije; Franke, Lude; Withoff, Sebo; Perfect, John R.; Joosten, Leo A. B.; Kullberg, Bart Jan; van de Veerdonk, Frank L.; Jonkers, Iris; Li, Yang; Wijmenga, Cisca; Netea, Mihai G.; Kumar, Vinod			An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HOST-DEFENSE; ALBICANS; INFLAMMATION; RECOGNITION; ASSOCIATION; INDUCTION; CYTOKINES; RESPONSES; SEPSIS	Candidaemia is a bloodstream infection caused by Candida species that primarily affects specific groups of at-risk patients. Because only small candidaemia patient cohorts are available, classical genome wide association cannot be used to identify Candida susceptibility genes. Therefore, we have applied an integrative genomics approach to identify novel susceptibility genes and pathways for candidaemia. Candida-induced transcriptome changes in human primary leukocytes were assessed by RNA sequencing. Genetic susceptibility to candidaemia was assessed using the Illumina immunochip platform for genotyping of a cohort of 217 patients. We then integrated genetics data with gene-expression profiles, Candidainduced cytokine production capacity, and circulating concentrations of cytokines. Based on the intersection of transcriptome pathways and genomic data, we prioritized 31 candidate genes for candidaemia susceptibility. This group of genes was enriched with genes involved in inflammation, innate immunity, complement, and hemostasis. We then validated the role of MAP3K8 in cytokine regulation in response to Candida stimulation. Here, we present a new framework for the identification of susceptibility genes for infectious diseases that uses an unbiased, hypothesis-free, systems genetics approach. By applying this approach to candidaemia, we identified novel susceptibility genes and pathways for candidaemia, and future studies should assess their potential as therapeutic targets.	[Matzaraki, Vasiliki; Ricano-Ponce, Isis; Franke, Lude; Withoff, Sebo; Jonkers, Iris; Li, Yang; Wijmenga, Cisca; Kumar, Vinod] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Gresnigt, Mark S.; Jaeger, Martin; Oosting, Marije; Joosten, Leo A. B.; Kullberg, Bart Jan; van de Veerdonk, Frank L.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Gresnigt, Mark S.; Jaeger, Martin; Oosting, Marije; Joosten, Leo A. B.; Kullberg, Bart Jan; van de Veerdonk, Frank L.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Johnson, Melissa D.; Perfect, John R.] Duke Univ, Med Ctr, Durham, NC USA; [Wijmenga, Cisca] Univ Oslo, Dept Immunol, KG Jebsen Coeliac Dis Res Ctr, Oslo, Norway; [Netea, Mihai G.] Craiova Univ Med & Pharm, Human Genom Lab, Craiova, Romania	University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; Duke University; University of Oslo; University of Medicine & Pharmacy of Craiova	Kumar, V (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	v.kumar@umcg.nl	Matzaraki, Vasiliki/V-7081-2018; van de Veerdonk, Frank L/C-7256-2008; Gresnigt, Mark/H-3530-2015; Johnson, Melissa D/AAT-2078-2020; Ricaño-Ponce, Isis/ABC-5454-2020; Matzaraki, Vasiliki/AAK-7880-2020; Joosten, Leo AB/H-3138-2015; Jaeger, Martin/H-3359-2015; Wijmenga, Cisca/AAE-7719-2019; Kullberg, BJ/C-8520-2013; Kumar, Vinod/ABC-4866-2020; Netea, Mihai/N-5155-2014; Li, Yang/HGT-8446-2022; Matzaraki, Vasiliki/GZB-0509-2022; Oosting, Marije/H-7437-2015	Matzaraki, Vasiliki/0000-0002-5852-6801; van de Veerdonk, Frank L/0000-0002-1121-4894; Gresnigt, Mark/0000-0002-9514-4634; Johnson, Melissa D/0000-0002-6606-9460; Ricaño-Ponce, Isis/0000-0002-7530-9526; Matzaraki, Vasiliki/0000-0002-5852-6801; Joosten, Leo AB/0000-0001-6166-9830; Jaeger, Martin/0000-0001-6994-493X; Wijmenga, Cisca/0000-0002-5635-1614; Kullberg, BJ/0000-0002-6813-8167; Kumar, Vinod/0000-0002-2775-6049; Li, Yang/0000-0003-4022-7341; Matzaraki, Vasiliki/0000-0002-5852-6801; 	ERC [FP/ERC] [2012-310372, 2012-322698]; Spinoza prize grant [NWO SPI 92-266]; European Union Seventh Framework Programme grant (EU FP7) TANDEM project [HEALTH-F3-2012-305279]; NWO VENI grant [863.13.011]; Graduate School of Medical Sciences, University of Groningen, the Netherlands	ERC [FP/ERC]; Spinoza prize grant; European Union Seventh Framework Programme grant (EU FP7) TANDEM project; NWO VENI grant; Graduate School of Medical Sciences, University of Groningen, the Netherlands	This work was supported by an ERC Consolidator Grant [FP/2007-2013/ERC grant 2012-310372 to M.G.N.], an ERC Advanced grant [FP/2007-2013/ERC grant 2012-322698 to C.W.], a Spinoza prize grant [NWO SPI 92-266 to C.W.], a European Union Seventh Framework Programme grant (EU FP7) TANDEM project [HEALTH-F3-2012-305279 to C.W. and V.K.] and an NWO VENI grant [863.13.011 to Y.L.]. V.M. is supported by a PhD scholarship from Graduate School of Medical Sciences, University of Groningen, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2005, CRIT CARE CLIN, V21, P417, DOI 10.1016/j.ccc.2005.04.004; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bonder MJ, 2017, NAT GENET, V49, P131, DOI 10.1038/ng.3721; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Davenport EE, 2016, LANCET RESP MED, V4, P259, DOI 10.1016/S2213-2600(16)00046-1; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Esmon CT, 2011, J THROMB HAEMOST, V9, P182, DOI 10.1111/j.1538-7836.2011.04323.x; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; George D, 2009, CURR TOP MED CHEM, V9, P611, DOI 10.2174/156802609789007345; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Griese M, 2007, EUR RESPIR J, V29, P240, DOI 10.1183/09031936.00047306; Hu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102767; Jaeger M, 2015, EUR J CLIN MICROBIOL, V34, P963, DOI 10.1007/s10096-014-2309-2; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kaner Z, 2015, J INFECT DIS, V211, P1489, DOI 10.1093/infdis/jiu620; Khakpour S, 2015, INNATE IMMUN-LONDON, V21, P827, DOI 10.1177/1753425915606525; Kidane YH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-224; Krueger KE, 2004, MICROBIOL-SGM, V150, P229, DOI 10.1099/mic.0.26792-0; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Kumar V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5675; Kuriakose T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005038; LEHRER RI, 1969, J BACTERIOL, V98, P996, DOI 10.1128/JB.98.3.996-1004.1969; Li Y, 2016, NAT MED, V22, P952, DOI 10.1038/nm.4139; Lowman DW, 2014, J BIOL CHEM, V289, P3432, DOI 10.1074/jbc.M113.529131; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897; Newport MJ, 2011, BRIEF FUNCT GENOMICS, V10, P98, DOI 10.1093/bfgp/elq037; Obel N, 2010, AM J EPIDEMIOL, V171, P1007, DOI 10.1093/aje/kwq037; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Plantinga TS, 2012, J INFECT DIS, V205, P934, DOI 10.1093/infdis/jir867; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Speth C, 2014, THROMB HAEMOSTASIS, V112, P632, DOI 10.1160/TH14-01-0074; Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI; Tong HV, 2012, IMMUNOGENETICS, V64, P261, DOI 10.1007/s00251-011-0584-y; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van de Veerdonk FL, 2012, CLIN MICROBIOL INFEC, V18, P112, DOI 10.1111/j.1469-0691.2011.03676.x; van der Graaf CAA, 2005, INFECT IMMUN, V73, P7458, DOI 10.1128/IAI.73.11.7458-7464.2005; Vani J, 2010, NEW ENGL J MED, V363, P1676, DOI 10.1056/NEJMc1007642; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Warenda AJ, 2003, INFECT IMMUN, V71, P4045, DOI 10.1128/IAI.71.7.4045-4051.2003; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wisplinghoff H, 2006, CLIN MICROBIOL INFEC, V12, P170, DOI 10.1111/j.1469-0691.2005.01318.x; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xiao NM, 2009, J IMMUNOL, V183, P7975, DOI 10.4049/jimmunol.0902718; Yanagisawa H, 2003, CELL DEATH DIFFER, V10, P798, DOI 10.1038/sj.cdd.4401246; Zipfel PF, 2012, EUR J IMMUNOL, V42, P822, DOI 10.1002/eji.201242466	52	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180824	10.1371/journal.pone.0180824	http://dx.doi.org/10.1371/journal.pone.0180824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727728	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500030
J	Tanibe, T; Hashimoto, T; Karasawa, K				Tanibe, Tetsushi; Hashimoto, Takaaki; Karasawa, Kaori			We perceive a mind in a robot when we help it	PLOS ONE			English	Article							PERCEPTION; ATTRIBUTION; AGENTS	People sometimes perceive a mind in inorganic entities like robots. Psychological research has shown that mind perception correlates with moral judgments and that immoral behaviors ( i.e., intentional harm) facilitate mind perception toward otherwise mindless victims. We conducted a vignette experiment ( N = 129; M-age = 21.8 +/- 6.0 years) concerning human-robot interactions and extended previous research's results in two ways. First, mind perception toward the robot was facilitated when it received a benevolent behavior, although only when participants took the perspective of an actor. Second, imagining a benevolent interaction led to more positive attitudes toward the robot, and this effect was mediated by mind perception. These results help predict what people's reactions in future human-robot interactions would be like, and have implications for how to design future social rules about the treatment of robots.	[Tanibe, Tetsushi; Hashimoto, Takaaki; Karasawa, Kaori] Univ Tokyo, Dept Social Psychol, Tokyo, Japan	University of Tokyo	Tanibe, T (corresponding author), Univ Tokyo, Dept Social Psychol, Tokyo, Japan.	tanibe@l.u-tokyo.ac.jp		Tanibe, Tetsushi/0000-0001-5611-5550	JSPS KAKENHI [JP16H03726, JP16H03093]; Grants-in-Aid for Scientific Research [15K13112] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers JP16H03726, JP16H03093. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by JSPS KAKENHI Grant Numbers JP16H03726, JP16H03093.	European Parliament, ROB LEG AFF COMM CAL; Eyssel F, 2012, BRIT J SOC PSYCHOL, V51, P724, DOI 10.1111/j.2044-8309.2011.02082.x; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Gray K., 2012, SOCIAL PSYCHOL MORAL, P109, DOI [10.1037/13091-006, DOI 10.1037/13091-006]; Gray K, 2012, PSYCHOL INQ, V23, P101, DOI 10.1080/1047840X.2012.651387; Gray K, 2011, P NATL ACAD SCI USA, V108, P477, DOI 10.1073/pnas.1015493108; Gray K, 2009, J PERS SOC PSYCHOL, V96, P505, DOI 10.1037/a0013748; Hare RD, 1999, PSYCHIAT QUART, V70, P181, DOI 10.1023/A:1022094925150; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Morewedge CK, 2009, J EXP PSYCHOL GEN, V138, P535, DOI 10.1037/a0016796; Osumi T, 2008, JAPANESE J PERSONALI, V16, P117; Pronin E, 2007, J PERS SOC PSYCHOL, V92, P585, DOI 10.1037/0022-3514.92.4.585; Shimizu H., 2016, J MEDIA INFORM COMMU, V1, P59; Stone P, 100 YEAR STUD ART IN; Takahashi H, 2014, CORTEX, V58, P289, DOI 10.1016/j.cortex.2014.03.011; TAYLOR SE, 1991, PSYCHOL BULL, V110, P67, DOI 10.1037/0033-2909.110.1.67; Ward AF, 2013, PSYCHOL SCI, V24, P1437, DOI 10.1177/0956797612472343	17	19	19	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180952	10.1371/journal.pone.0180952	http://dx.doi.org/10.1371/journal.pone.0180952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727735	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500033
J	Benoit, L; Moro, MR; Falissard, B; Henckes, N				Benoit, Laelia; Moro, Marie Rose; Falissard, Bruno; Henckes, Nicolas			Psychosis risk research versus daily prognosis uncertainties: A qualitative study of French youth psychiatrists' attitudes toward predictive practices	PLOS ONE			English	Article							ULTRA-HIGH RISK; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; YOUNG-PEOPLE; DSM-V; SCHIZOPHRENIA; BRAIN; PREVENTION; SYMPTOMS; INTERVENTIONS	Background Over the last twenty years, predicting psychosis has become a priority of both research and policies. Those approaches include the use of the At Risk Mental State category (ARMS) and of standardized predictive tools. In comparison to most developed countries, early interventions programs are only little developed in France. However, cases of young patients presenting unclear symptoms that might be a beginning psychosis or might as well reflect some adolescent unease are commonplace in psychiatry. Yet little is known about the routine practices of youth psychiatrists regarding psychosis risk management. Do they anticipate mental disorders? Method The Grounded Theory is an agreed-upon qualitative method in social science field that links subjective experiences (individual narratives) to social processes (professional norms and mental health policies). 12 French youth psychiatrists were interviewed about psychosis early management and their daily prognosis practices with teenagers. Results If all participants were aware of early intervention programs, most of them did not make use of standardized scales. Psychiatrists' reluctance toward a psychosis risk standardized assessment was shaped by three difficulties: first the gap between theoretical knowledge and practice; second their impossibility to make reliable prognoses; and third, the many uncertainties surrounding medical judgment, adolescence and the nature of psychosis. Nevertheless, they provided their young patients with multiple months follow up without disclosing any risk category. Conclusion Anticipating a psychosis onset remains a highly uncertain task for psychiatrists. In France, psychiatrists' inconspicuous risk management might be supported by the universal costs coverage that is not conditional on a diagnosis disclosure.	[Benoit, Laelia; Moro, Marie Rose] Cochin Hosp, Dept Psychiat, Paris, France; [Benoit, Laelia; Moro, Marie Rose; Falissard, Bruno] Univ Paris 05, CESP, INSERM U1018, Univ Paris Saclay,Univ Paris Sud,UVSQ, Paris, France; [Henckes, Nicolas] CNRS, CERMES3, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Benoit, L (corresponding author), Cochin Hosp, Dept Psychiat, Paris, France.; Benoit, L (corresponding author), Univ Paris 05, CESP, INSERM U1018, Univ Paris Saclay,Univ Paris Sud,UVSQ, Paris, France.	laelia@benoit.nom.fr		Henckes, Nicolas/0000-0002-1324-6590	Paris City, through the project "Psychosis risk and misfortune anticipation in contemporary psychiatry, a sociological approach"; PSYFRING on psychiatry fringes, an after war history and sociology of early psychosis in France and Germany	Paris City, through the project "Psychosis risk and misfortune anticipation in contemporary psychiatry, a sociological approach"; PSYFRING on psychiatry fringes, an after war history and sociology of early psychosis in France and Germany	This work is part of a project that explores the development of institutions promoting predictive psychiatry addressed for a young public in France, Germany, and Switzerland. It received funding from Paris City, through the project "Psychosis risk and misfortune anticipation in contemporary psychiatry, a sociological approach" and from the national research funding (A.N.R.) "PSYFRING on psychiatry fringes, an after war history and sociology of early psychosis in France and Germany".	Addington J, 2011, AM J PSYCHIAT, V168, P800, DOI 10.1176/appi.ajp.2011.10081191; American Psychiatric Association, 2013, DSM 5 DIAGN STAT MAN, V5th; [Anonymous], 2008, INTERPRETATIVE PHENO; [Anonymous], 1960, CIRC 15 MARS 1960 RE; Armando M, 2010, SCHIZOPHR RES, V119, P258, DOI 10.1016/j.schres.2010.03.001; Arnett JJ, 1999, AM PSYCHOL; BECKER HS, 1960, AM J SOCIOL, V66, P32, DOI 10.1086/222820; Benoit L, TRANSCULT PSYCHIAT; Benoit Laelia, 2016, ADOLESCENT FRAGILE P; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Cabut S., 2015, MONDE; Caplan G., 1964, PRINCIPLES PREVENTIV; Carey B., 2015, NY TIMES; CARPENTER WT, 1973, ARCH GEN PSYCHIAT, V28, P847; Charmaz K., 2001, HDB ETHNOGRAPHY, P160, DOI DOI 10.4135/9781848608337; Christakis NA., 2001, DEATH FORETOLD PROPH; Corbin J, 2014, BASICS QUALITATIVE R; Corcoran CM, 2010, SCHIZOPHR RES, V120, P16, DOI 10.1016/j.schres.2010.03.018; Cornblatt BA, 2016, JAMA PSYCHIAT, V73, P105, DOI 10.1001/jamapsychiatry.2015.2454; Correll CU, 2010, J CHILD PSYCHOL PSYC, V51, P390, DOI 10.1111/j.1469-7610.2010.02235.x; DAVIS F, 1960, AM J SOCIOL, V66, P41, DOI 10.1086/222821; Dennis EL, 2013, NEUROIMAGE, V64, P671, DOI 10.1016/j.neuroimage.2012.09.004; Falissard B, 2016, EUR CHILD ADOLES PSY, V25, P1041, DOI 10.1007/s00787-016-0906-6; Fisher M, 2014, SCHIZOPHR B; Fisher M, 2010, SCHIZOPHRENIA BULL, V36, P869, DOI 10.1093/schbul/sbn170; Fossey E, 2002, AUST NZ J PSYCHIAT, V36, P717, DOI 10.1046/j.1440-1614.2002.01100.x; FOWLER RC, 1972, ARCH GEN PSYCHIAT, V26, P182; Fox R.C., 2000, HDB SOCIAL STUDIES H; Fox RC., 1957, STUDENT PHYS INTRO S, P96; Freidson E., 1970, PROFESSION MED STUDY; FREUD A, 1958, PSYCHOANAL STUD CHIL, V13, P255, DOI 10.1080/00797308.1958.11823182; Fusar-Poli P, 2016, Psychiatry J, V2016, P7146341, DOI 10.1155/2016/7146341; Fusar-Poli P, 2016, JAMA PSYCHIAT, V73, P113, DOI 10.1001/jamapsychiatry.2015.2324; Fusar-Poli P, 2015, BRIT J PSYCHIAT, V207, P198, DOI 10.1192/bjp.bp.114.157115; Gaebel W, 2015, PSYCHIAT CLIN NEUROS, V69, P661, DOI 10.1111/pcn.12322; Glaser B.G., 1968, DISCOV GROUNDED THEO; GLASER BG, 1964, AM SOCIOL REV, V29, P669, DOI 10.2307/2091417; Grube M, 2006, PSYCHOPATHOLOGY, V39, P209, DOI 10.1159/000093921; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P921, DOI 10.1093/schbul/sbm045; Hall WD, 2016, LANCET PSYCHIAT, V3, P265, DOI 10.1016/S2215-0366(16)00013-4; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Hefferon K, 2011, PSYCHOLOGIST, V24, P756; Hosman C., 2004, PREV MENT DIS EFF IN; Jablensky A, 1997, SCHIZOPHR RES, V28, P111, DOI 10.1016/S0920-9964(97)85354-6; Kaplan RM, 2008, AUSTRALAS PSYCHIATRY, V16, P305, DOI 10.1080/10398560802302176; Kestemberg E., 1962, PSYCHIAT ENFANT, V5, P441; Kraepelin Emil, 1883, COMPENDIUM PSYCHIATR; LANTERIL.G, 1972, ANN ECON SOC CIVIL, V27, P548, DOI 10.3406/ahess.1972.422522; Larkin M., 2006, QUAL RES PSYCHOL, V3, P102, DOI [10.1191/1478088706qp062oa, DOI 10.1191/1478088706QP062OA]; Lasalvia A, 2015, SCHIZOPHR RES, V162, P276, DOI 10.1016/j.schres.2015.01.031; Les comptes de la Securite Sociale, 2014, ETAT LIEUX LOFFRE SO, P116; LIGHT D, 1979, J HEALTH SOC BEHAV, V20, P310, DOI 10.2307/2955407; Lin A, 2011, SCHIZOPHR RES, V132, P1, DOI 10.1016/j.schres.2011.06.014; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; McGlashan TH, 2006, AM J PSYCHIAT, V163, P790, DOI 10.1176/appi.ajp.163.5.790; McGorry Patrick, 2013, Br J Psychiatry Suppl, V54, ps30, DOI 10.1192/bjp.bp.112.119214; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; Mills KL, 2014, SOC COGN AFFECT NEUR, V9, P123, DOI 10.1093/scan/nss113; Montgomery Hunter K, 1991, DOCTORS STORIES NARR; Morrison AP, 2007, SCHIZOPHRENIA BULL, V33, P682, DOI 10.1093/schbul/sbl042; Nelson B, 2010, AUST NZ J PSYCHIAT, V44, P625, DOI 10.3109/00048671003620210; Oppetit A, 2016, EARLY INTERV PSYCHIA; Phillips LJ, 2007, SCHIZOPHR RES, V96, P25, DOI 10.1016/j.schres.2007.05.018; Piaget J., 1967, PSYCHOL INTELLIGENCE, V5; Rapado-Castro M, 2015, SCHIZOPHR RES, V165, P15, DOI 10.1016/j.schres.2015.03.022; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Rosier F, 2015, MONDE; Rumke H C, 1990, Hist Psychiatry, V1, P331, DOI 10.1177/0957154X9000100304; Sadock BJ., 2017, KAPLAN SADOCKS COMPR; Simpkin AL, 2016, NEW ENGL J MED, V375, P1713, DOI 10.1056/NEJMp1606402; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; Strauss A., 1990, BASICS QUALITATIVE R; STRAUSS JS, 1972, ARCH GEN PSYCHIAT, V27, P739; Varga S, 2013, PHENOMENOL COGN SCI, V12, P131, DOI 10.1007/s11097-010-9173-z; Whitley R, 2009, ACAD PSYCHIATR, V33, P252, DOI 10.1176/appi.ap.33.3.252; World Health Organization. Regional office for Europe, 2008, POL PRACT MENT HLTH, P192; Yang LH, 2010, SCHIZOPHR RES, V120, P42, DOI 10.1016/j.schres.2010.03.012; Yung AR, 2008, SCHIZOPHR RES, V105, P10, DOI 10.1016/j.schres.2008.07.012; Yung AR, 2011, J CLIN PSYCHIAT, V72, P430, DOI 10.4088/JCP.08m04979ora; Yung AR, 2010, SCHIZOPHR RES, V120, P7, DOI 10.1016/j.schres.2010.03.017; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353; Yung AR, 1998, BRIT J PSYCHIAT, V172, P14, DOI 10.1192/S0007125000297602; Zinn JO, 2008, HEALTH RISK SOC, V10, P439, DOI 10.1080/13698570802380891; Zipursky RB, 2013, SCHIZOPHRENIA BULL, V39, P1363, DOI 10.1093/schbul/sbs135	84	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179849	10.1371/journal.pone.0179849	http://dx.doi.org/10.1371/journal.pone.0179849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723956	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800008
J	Duarte, S; Cassio, F; Pascoal, C; Barlocher, F				Duarte, Sofia; Cassio, Fernanda; Pascoal, Claudia; Barlocher, Felix			Taxa-area relationship of aquatic fungi on deciduous leaves	PLOS ONE			English	Article							DECOMPOSER COMMUNITIES; SPECIES ACCUMULATION; LITTER DECOMPOSITION; ISLAND SIZE; DIVERSITY; MICROBES; COLONIZATION; EVOLUTIONARY; DISPERSAL; PATTERNS	One of the fundamental patterns in macroecology is the increase in the number of observed taxa with size of sampled area. For microbes, the shape of this relationship remains less clear. The current study assessed the diversity of aquatic fungi, by the traditional approach based on conidial morphology (captures reproducing aquatic hyphomycetes) and next generation sequencing (NGS; captures other fungi as well), on graded sizes of alder leaves (0.6 to 13.6 cm(2)). Leaves were submerged in two streams in geographically distant locations: the Oliveira Stream in Portugal and the Boss Brook in Canada. Decay rates of alder leaves and fungal sporulation rates did not differ between streams. Fungal biomass was higher in Boss Brook than in Oliveira Stream, and in both streams almost 100% of the reads belonged to active fungal taxa. In general, larger leaf areas tended to harbour more fungi, but these findings were not consistent between techniques. Morphospecies-based diversity increased with leaf area in Boss Brook, but not in Oliveira Stream; metabarcoding data showed an opposite trend. The higher resolution of metabarcoding resulted in steeper taxa-accumulation curves than morphospecies-based assessments (fungal conidia morphology). Fungal communities assessed by metabarcoding were spatially structured by leaf area in both streams. Metabarcoding promises greater resolution to assess biodiversity patterns in aquatic fungi and may be more accurate for assessing taxa-area relationships and local to global diversity ratios.	[Duarte, Sofia; Cassio, Fernanda; Pascoal, Claudia] Univ Minho, Ctr Mol & Environm Biol CBMA, Dept Biol, Braga, Portugal; [Cassio, Fernanda; Pascoal, Claudia] Univ Minho, Inst Sci & Innovat Biosustainabil IB S, Braga, Portugal; [Barlocher, Felix] Mt Allison Univ, Dept Biol, New Brunswick, NJ USA	Universidade do Minho; Universidade do Minho	Duarte, S (corresponding author), Univ Minho, Ctr Mol & Environm Biol CBMA, Dept Biol, Braga, Portugal.	sduarte@bio.uminho.pt	Duarte, Sofia/H-3323-2013; Baerlocher, Felix/C-1307-2011; Duarte, Sofia/ABD-8278-2021; Pascoal, Claudia/C-4072-2009; Cassio, Fernanda/A-6653-2011	Duarte, Sofia/0000-0002-0181-0676; Baerlocher, Felix/0000-0003-2404-625X; Duarte, Sofia/0000-0002-0181-0676; Pascoal, Claudia/0000-0002-2018-4201; Cassio, Fernanda/0000-0003-3924-3280	Portuguese Foundation for Science and Technology (FCT) [UID/BIA/04050/2013 (POCI-01-0145-FEDER-007569)]; ERDF through the COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT [PTDC/AAC-AMB/117068/2010, SFRH/BPD/47574/2008, SFRH/BPD/109842/2015]; European Regional Development Funds through the Operational Competitiveness Program (FEDER-COMPETE); NSERC Discovery grant program; Fundação para a Ciência e a Tecnologia [PTDC/AAC-AMB/117068/2010] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); ERDF through the COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Funds through the Operational Competitiveness Program (FEDER-COMPETE); NSERC Discovery grant program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fundação para a Ciência e a Tecnologia	This work was supported by the strategic programme UID/BIA/04050/2013 (POCI-01-0145-FEDER-007569), funded by national funds through the Portuguese Foundation for Science and Technology (FCT) I.P. (http://www.fct.pt/) and by the ERDF through the COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) and by the project PTDC/AAC-AMB/117068/2010, funded by national funds through FCT I.P. and the European Regional Development Funds through the Operational Competitiveness Program (FEDER-COMPETE). Support from FCT to SD (SFRH/BPD/47574/2008 and SFRH/BPD/109842/2015) and from NSERC Discovery grant program (http://www.nserc-crsng.gc.ca/index_eng.asp) to FB is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], ISME J; Arkin, 2019, SCIENCE, DOI [10.1126/science.364.6438.320, 10.1126/science.abe9728]; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Azovsky AI, 2002, ECOGRAPHY, V25, P273, DOI 10.1034/j.1600-0587.2002.250303.x; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Barlocher F, 2016, FUNGAL ECOL, V19, P14, DOI 10.1016/j.funeco.2015.05.005; Barlocher F, 2009, MYCOSCIENCE, V50, P3, DOI 10.1007/s10267-008-0449-x; Baerlocher Felix, 2011, Czech Mycology, V63, P113; Barlocher F, 2010, J N AM BENTHOL SOC, V29, P1027, DOI 10.1899/09-081.1; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; BARLOCHER F, 1980, OECOLOGIA, V47, P303, DOI 10.1007/BF00398521; BARLOCHER F, 1983, OIKOS, V41, P205, DOI 10.2307/3544265; BARLOCHER F, 1981, T BRIT MYCOL SOC, V76, P479; BARLOCHER F, 2005, FUNGAL COMMUNITY ITS, P39, DOI DOI 10.1201/9781420027891.CH3; Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardoso P, 2009, DIVERS DISTRIB, V15, P1081, DOI 10.1111/j.1472-4642.2009.00607.x; Charcosset JY, 1999, MYCOL RES, V103, P736, DOI 10.1017/S0953756298007606; Dengler J, 2009, J BIOGEOGR, V36, P728, DOI 10.1111/j.1365-2699.2008.02038.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Duarte S, 2015, FUNGAL DIVERS, V70, P127, DOI 10.1007/s13225-014-0300-y; Duarte S, 2017, LIMNETICA IN PRESS; Duarte S, 2016, FUNGAL ECOL, V19, P169, DOI 10.1016/j.funeco.2015.06.002; Duarte S, 2009, APPL ENVIRON MICROB, V75, P6211, DOI 10.1128/AEM.00971-09; Dunck B, 2015, ENVIRON POLLUT, V202, P32, DOI 10.1016/j.envpol.2015.03.014; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fenchel T, 1997, OIKOS, V80, P220, DOI 10.2307/3546589; Fernandes I, 2015, FUNGAL ECOL, V18, P130, DOI 10.1016/j.funeco.2015.08.005; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gessner Mark O., 2005, P189, DOI 10.1007/1-4020-3466-0_25; Gray JS, 2004, GLOBAL ECOL BIOGEOGR, V13, P567, DOI 10.1111/j.1466-822X.2004.00138.x; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Grimmett IJ, 2013, FUNGAL ECOL, V6, P493, DOI 10.1016/j.funeco.2013.08.002; Grimmett IJ, 2012, FRESHW SCI, V31, P1088, DOI 10.1899/12-034.1; Gulis Vladislav, 2005, P153, DOI 10.1007/1-4020-3466-0_21; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Lima-Fernandes E, 2015, FRESHW SCI, V34, P31, DOI 10.1086/679223; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Matthews TJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P607, DOI 10.1111/geb.12439; Meiser A, 2014, NEW PHYTOL, V201, P623, DOI 10.1111/nph.12532; Motulsky Harvey J., 2004, P1; Nikolcheva LG, 2005, ENVIRON MICROBIOL, V7, P270, DOI 10.1111/j.1462-2920.2004.00709.x; Nikolcheva LG, 2003, APPL ENVIRON MICROB, V69, P2548, DOI 10.1128/AEM.69.5.2548-2554.2003; Noguez AM, 2005, GLOBAL ECOL BIOGEOGR, V14, P241, DOI 10.1111/j.1466-822x.2005.00156.x; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SANDERS PF, 1979, T BRIT MYCOL SOC, V73, P103, DOI 10.1016/S0007-1536(79)80079-0; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Steinbauer MJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1203, DOI 10.1111/j.1466-8238.2012.00772.x; Suberkropp K, 1998, MICROORGANISMS ORGAN; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; van der Gast CJ, 2005, ENVIRON MICROBIOL, V7, P1220, DOI 10.1111/j.1462-2920.2005.00802.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Woodcock S, 2006, ECOL LETT, V9, P805, DOI 10.1111/j.1461-0248.2006.00929.x; WOODEGGENSCHWILER S, 1983, T BRIT MYCOL SOC, V81, P371, DOI 10.1016/S0007-1536(83)80089-8; Wurzbacher Christian, 2015, F1000Res, V4, P1378, DOI 10.12688/f1000research.7359.1; Zar J.H., 1996, BIOSTAT ANAL	66	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181545	10.1371/journal.pone.0181545	http://dx.doi.org/10.1371/journal.pone.0181545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719634	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400053
J	te Beest, DE; de Bruin, E; Imholz, S; Koopmans, M; van Boven, M				te Beest, Dennis E.; de Bruin, Erwin; Imholz, Sandra; Koopmans, Marion; van Boven, Michiel			Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2)	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; MEMORY B-CELLS; VIRUS HEMAGGLUTININ; PROTEIN MICROARRAY; VACCINE; INFECTION; RESPONSES; EPITOPE; TRANSMISSION; RECOGNITION	Epidemics of influenza A vary greatly in size and age distribution of cases, and this variation is attributed to varying levels of pre-existing immunity. Recent studies have shown that anti-body-mediated immune responses are more cross-reactive than previously believed, and shape patterns of humoral immunity to influenza A viruses over long periods. Here we quantify antibody responses to the hemagglutinin subunit 1 (HA1) across a range of subtypes using protein microarray analysis of cross-sectional serological surveys carried out in the Netherlands before and after the A/2009 (H1N1) pandemic. We find significant associations of responses, both within and between subtypes. Interestingly, substantial overall reactivity is observed to HA1 of avian H7N7 and H9N2 viruses. Seroprevalence of H7N7 correlates with antibody titers to A/1968 (H3N2), and is highest in persons born between 1954 and 1969. Seroprevalence of H9N2 is high across all ages, and correlates strongly with A/1957 (H2N2). This correlation is most pronounced in A/2009 (H1N1) infected persons born after 1968 who have never encountered A/1957 (H2N2)-like viruses. We conclude that heterosubtypic antibody cross-reactivity, both between human subtypes and between human and nonhuman subtypes, is common in the human population.	[te Beest, Dennis E.; de Bruin, Erwin; Koopmans, Marion; van Boven, Michiel] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [te Beest, Dennis E.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [de Bruin, Erwin; Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Imholz, Sandra] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment	van Boven, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	michiel.van.boven@rivm.nl	Koopmans, Marion/Y-9170-2019	Koopmans, Marion/0000-0002-5204-2312; te Beest, Dennis E./0000-0001-5265-9008	National Institute for Public Health and the Environment project [S/210096]	National Institute for Public Health and the Environment project	This work was supported by the National Institute for Public Health and the Environment project S/210096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas DC, 2013, J MED VIROL, V85, P899, DOI 10.1002/jmv.23535; Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Birrell PJ, 2011, P NATL ACAD SCI USA, V108, P18238, DOI 10.1073/pnas.1103002108; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Boni MF, 2013, J INFECT DIS, V208, P554, DOI 10.1093/infdis/jit224; Chiu C, 2015, CURR TOP MICROBIOL, V386, P381, DOI 10.1007/82_2014_425; Chiu C, 2013, ANN NY ACAD SCI, V1283, P13, DOI 10.1111/nyas.12012; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dunand CJH, 2015, J CLIN INVEST, V125, P1255, DOI 10.1172/JCI74374; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Friesen RHE, 2014, P NATL ACAD SCI USA, V111, P445, DOI 10.1073/pnas.1319058110; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Huijskens EGW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054890; Iba Y, 2014, J VIROL, V88, P7130, DOI 10.1128/JVI.00420-14; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; Krammer F, 2015, CURR TOP MICROBIOL, V386, P301, DOI 10.1007/82_2014_408; Krammer F, 2013, CURR OPIN VIROL, V3, P521, DOI 10.1016/j.coviro.2013.07.007; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Kucharski AJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002082; Kucharski AJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002741; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224; Lee PS, 2015, CURR TOP MICROBIOL, V386, P323, DOI 10.1007/82_2014_413; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; Miller MS, 2014, CELL, V157, P294, DOI 10.1016/j.cell.2014.03.023; Miller MS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006637; Nachbagauer R, 2017, NAT IMMUNOL, V18, P464, DOI 10.1038/ni.3684; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Steens A, 2011, AM J EPIDEMIOL, V174, P1307, DOI 10.1093/aje/kwr245; Tan GS, 2014, J VIROL, V88, P13580, DOI 10.1128/JVI.02289-14; te Beest D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113021; te Beest DE, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1244; te Beest DE, 2013, AM J EPIDEMIOL, V178, P1469, DOI 10.1093/aje/kwt132; Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI 10.1111/irv.12074; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang W, 2015, P NATL ACAD SCI USA, V112, P2723, DOI 10.1073/pnas.1415012112	48	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181093	10.1371/journal.pone.0181093	http://dx.doi.org/10.1371/journal.pone.0181093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715468	Green Published, Green Submitted, gold			2022-12-27	WOS:000443975500027
J	von Niederhausern, B; Schandelmaier, S; Bonde, MM; Brunner, N; Hemkens, LG; Rutquist, M; Bhatnagar, N; Guyatt, GH; Pauli-Magnus, C; Briel, M				von Niederhausern, Belinda; Schandelmaier, Stefan; Bonde, Marie Mi; Brunner, Nicole; Hemkens, Lars G.; Rutquist, Marielle; Bhatnagar, Neera; Guyatt, Gordon H.; Pauli-Magnus, Christiane; Briel, Matthias			Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research quality	PLOS ONE			English	Article							INCREASING VALUE; REDUCING WASTE; HEALTH-CARE; EXPLANATION; TRIALS; STATEMENT; REVIEWS; ISSUES	Objective To systematically survey existing definitions, concepts, and criteria of clinical research quality, both developed by stakeholder groups as well as in the medical literature. This study serves as a first step in the development of a comprehensive framework for the quality of clinical research. Study design and setting We systematically and in duplicate searched definitions, concepts and criteria of clinical research quality on websites of stakeholders in clinical research until no further insights emerged and in MEDLINE up to February 2015. Stakeholders included governmental bodies, regulatory agencies, the pharmaceutical industry, academic and commercial contract research organizations, initiatives, research ethics committees, patient organizations and funding agencies from 13 countries. Data synthesis involved descriptive and qualitative analyses following the Framework Method on definitions, concepts, and criteria of clinical research quality. Descriptive codes were applied and grouped into clusters to identify common and stakeholder-specific quality themes. Results Stakeholder concepts on how to assure quality throughout study conduct or articles on quality assessment tools were common, generally with no a priori definition of the term quality itself. We identified a total of 20 explicit definitions of clinical research quality including varying quality dimensions and focusing on different stages in the clinical research process. Encountered quality dimensions include ethical conduct, patient safety/rights/priorities, internal validity, precision of results, generalizability or external validity, scientific and societal relevance, transparency and accessibility of information, research infrastructure and sustainability. None of the definitions appeared to be comprehensive either in terms of quality dimensions, research stages, or stakeholder perspectives. Conclusion Clinical research quality is often discussed but rarely defined. A framework defining clinical research quality across stakeholders' individual perspectives is desirable to facilitate discussion, assessment, and improvement of quality at all stages of clinical research.	[von Niederhausern, Belinda; Bonde, Marie Mi; Brunner, Nicole; Rutquist, Marielle; Pauli-Magnus, Christiane] Univ Hosp Basel, Dept Clin Res, Clin Trial Unit, Basel, Switzerland; [Schandelmaier, Stefan; Hemkens, Lars G.; Briel, Matthias] Univ Hosp Basel, Basel Inst Clin Epidemiol & Biostat, Dept Clin Res, Basel, Switzerland; [Schandelmaier, Stefan; Bhatnagar, Neera; Guyatt, Gordon H.; Briel, Matthias] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada	University of Basel; University of Basel; McMaster University	von Niederhausern, B (corresponding author), Univ Hosp Basel, Dept Clin Res, Clin Trial Unit, Basel, Switzerland.	belinda.vonniederhausern@usb.ch	Schandelmaier, Stefan/GLV-3722-2022; Hemkens, Lars G./AAB-2653-2020; Briel, Matthias/AAT-9284-2021	Schandelmaier, Stefan/0000-0002-8429-0337; Hemkens, Lars G./0000-0002-3444-1432; Briel, Matthias/0000-0002-2070-5230				Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bhatt Arun, 2011, Perspect Clin Res, V2, P124, DOI 10.4103/2229-3485.86880; Cabral AP, 2014, PROCD SOC BEHV, V116, P1528, DOI 10.1016/j.sbspro.2014.01.429; Castermans AG, 2015, EVALUATING DUTCH LEG, P447; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Coulter A, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S2; Dawn AG, 2003, AM J MED QUAL, V18, P265, DOI 10.1177/106286060301800607; Donabedian A., 1980, EXPLORATIONS QUALITY; Donabedian A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI [10.1001/JAMA.1988.03410120089033, DOI 10.1001/JAMA.1988.03410120089033]; Dugas M, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-016-0399-8; Franck Linda S, 2004, Int J Health Care Qual Assur Inc Leadersh Health Serv, V17, P239, DOI 10.1108/09526860410549344; Frank L, 2015, QUAL LIFE RES, V24, P1033, DOI 10.1007/s11136-014-0893-3; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Grimes DA, 2005, LANCET, V366, P172, DOI 10.1016/S0140-6736(05)66875-4; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ioannidis JPA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002049; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jenkinson C, 2002, INT J QUAL HEALTH C, V14, P353, DOI 10.1093/intqhc/14.5.353; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kasenda B, 2014, JAMA-J AM MED ASSOC, V311, P1045, DOI 10.1001/jama.2014.1361; Kellow A, 2012, EUR POLIT SCI, V11, P567, DOI 10.1057/eps.2011.70; Krestin GP, 2008, RADIOLOGY, V249, P418, DOI 10.1148/radiol.2491080832; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; McMahon AD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000131; Moher D, 1996, INT J TECHNOL ASSESS, V12, P195, DOI 10.1017/S0266462300009570; Njie VPS, 2001, J PROF NURS, V17, P233, DOI 10.1053/jpnu.2001.26308; Patrick WJ, 1996, RES HIGH EDUC, V37, P23, DOI 10.1007/BF01680040; Rajan A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-274; Salman RA, 2014, LANCET, V383, P176, DOI 10.1016/S0140-6736(13)62297-7; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Stewart PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1732; Switula D, 2006, SCI ENG ETHICS, V12, P147, DOI 10.1007/s11948-006-0015-x; Urden Linda D, 2002, Lippincotts Case Manag, V7, P194, DOI 10.1097/00129234-200209000-00006; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Verhagen AP, 2001, J CLIN EPIDEMIOL, V54, P651, DOI 10.1016/S0895-4356(00)00360-7; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WOOLF SH, 1992, ARCH INTERN MED, V152, P946, DOI 10.1001/archinte.152.5.946	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180635	10.1371/journal.pone.0180635	http://dx.doi.org/10.1371/journal.pone.0180635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS8PU	28715491	Green Submitted, Green Published, gold			2022-12-27	WOS:000443975500013
J	Kolek, V; Grygarkova, I; Koubkova, L; Skrickova, J; Svecova, J; Sixtova, D; Bartos, J; Tichopad, A				Kolek, Vitezslav; Grygarkova, Ivona; Koubkova, Leona; Skrickova, Jana; Svecova, Jirina; Sixtova, Dimka; Bartos, Jiri; Tichopad, Ales			Carboplatin with intravenous and subsequent oral administration of vinorelbine in resected non-small-cell-lung cancer in real-world set-up	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIALS; ADJUVANT CHEMOTHERAPY; PLUS CISPLATIN; PHASE-II; METAANALYSIS; IMPACT; NSCLC	Objectives Adjuvant cisplatin-based chemotherapy is recommended for routine use in patients with Stage IIA, IIB or IIIA non-small cell lung cancer (NSCLC) after complete resection. Results obtained for Stage IB were not conclusive. While vinorelbine plus cisplatin is the preferred choice after resection, combining vinorelbine with carboplatin promises improved compliance and delivery of drugs due to lower toxicity. We evaluated the impact of this option on treatment compliance and survival under real-world conditions. Material and methods A prospective, single-arm, multicenter, non-interventional study evaluated the tolerability, dose intensity and survival resulting from adjuvant use of intravenous carboplatin (AUC 5 on day 1) with vinorelbine administered both intravenously (25 mg/m(2) on day 1) and orally (60 mg/m(2) on day 8) within four cycles of 21 days each. A total of 74 patients with a median age of 64 years were observed. Results The mean number of accomplished cycles was 3.78, and 62 patients (83.7%) completed all four planned cycles. Relative dose intensity for carboplatin was 88.9%, for intravenous vinorelbine 93.1%, and for oral vinorelbine 83.2%. Median follow-up was 4.73 years. Median disease-specific survival (DSS) was 7.63 years, median overall survival (OS) was 5.90 years, median disease-free survival (DFS0) was 4.43 years, and five-year survival was 56.2%. TNM stage of disease significantly affected DSS and OS. Favorable survival was observed in females, nonsmokers, patients aged over 65 years, patient with prior lobectomy, patients with tumor of squamous histology, and those who finished the planned therapy, but the differences were non-significant. Conclusion Adjuvant carboplatin with vinorelbine switched from intravenous to oral administration was shown to be a favorable regimen with regard to tolerability and safety. Compliance to therapy was high, and survival parameters were promising, showing that applied regimen can be another potential option for adjuvant chemotherapy in patients with NSCLC.	[Kolek, Vitezslav; Grygarkova, Ivona] Univ Hosp, Dept Resp Med, Olomouc, Czech Republic; [Koubkova, Leona] Univ Hosp, Dept Pneumol, Prague, Czech Republic; [Skrickova, Jana] Univ Hosp Brno, Dept Resp Dis & TB, Brno, Czech Republic; [Svecova, Jirina] Hosp Tabor, Dept Oncol, Tabor, Czech Republic; [Sixtova, Dimka] Mem Thomayer Hosp, Dept Resp Dis, Prague, Czech Republic; [Bartos, Jiri] Reg Hosp Liberec, Dept Oncol, Liberec, Czech Republic; [Tichopad, Ales] Kantar Hlth Sro, Prague, Czech Republic	University Hospital Olomouc; General University Hospital Prague; University Hospital Brno; Thomayer Hospital	Tichopad, A (corresponding author), Kantar Hlth Sro, Prague, Czech Republic.	tichopada@gmail.com			Ministry of Health of the Czech Republic [NV16-32318A, NT 13569]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	The study was funded by a grant provided by the Ministry of Health of the Czech Republic, reference number: NV16-32318A, NT 13569 to Professor Kolek from Palacky University of Olomouc. Kantar Health had no role in study design, data collection and analysis or decision to publish the manuscript. Kantar Health has just contributed to preparation of the manuscript and provided financial support in the form of author's salary [AT]. The Ministry of Health of the Czech Republic did not intervene in the study design or its conduct, except for assessment of its compliance and registration. The specific roles of all authors are articulated in the 'author contributions' section.	Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Arriagada R, 2010, J CLIN ONCOL, V28, P35, DOI 10.1200/JCO.2009.23.2272; Cortes AA, 2015, TRANSL LUNG CANCER R, V4, P191, DOI 10.3978/j.issn.2218-6751.2014.06.01; Bria E, 2009, LUNG CANCER, V63, P50, DOI 10.1016/j.lungcan.2008.05.002; Burdett S, 2014, LANCET, V383, P1561, DOI 10.1016/S0140-6736(13)62159-5; Catania C, 2005, BREAST CANCER RES TR, V92, P265, DOI 10.1007/s10549-005-3376-y; Coello Michael C, 2004, Clin Lung Cancer, V5, P214; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gu F, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7014; Hotta K, 2004, J CLIN ONCOL, V22, P3852, DOI 10.1200/JCO.2004.02.109; HRYNIUK WM, 1990, J CLIN ONCOL, V8, P1935, DOI 10.1200/JCO.1990.8.12.1935; Jassem J, 2001, ANN ONCOL, V12, P1375, DOI 10.1023/A:1012539225493; Jensen LH, 2008, LUNG CANCER, V62, P85, DOI 10.1016/j.lungcan.2008.02.009; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Non-Small Cell Lung Cancer Collaborative Group, 1995, BMJ-BRIT MED J, V311, P899, DOI DOI 10.1136/BMJ.311.7010.899; O'Brien MER, 2004, ANN ONCOL, V15, P921, DOI 10.1093/annonc/mdh233; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Scagliotti GV, 2003, JNCI-J NATL CANCER I, V95, P1453, DOI 10.1093/jnci/djg059; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P414, DOI 10.1016/j.jtcvs.2004.04.027; Shepherd FA, 2015, J CLIN ONCOL, V33; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sorensen SF, 2015, LUNG CANCER, V88, P167, DOI 10.1016/j.lungcan.2015.02.010; Speicher PJ, 2015, J NATL COMPR CANC NE, V13, P755, DOI 10.6004/jnccn.2015.0090; Stinchcombe TE, 2008, J THORAC ONCOL, V3, P145, DOI 10.1097/JTO.0b013e318160c5f1; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Sun H, 2009, CHIN J LUNG CANC, V12, P975; Wakelee HA, 2011, J THORAC ONCOL, V6, pS464; Waller D, 2004, EUR J CARDIO-THORAC, V26, P173, DOI 10.1016/j.ejcts.2004.03.041; Williams CD, 2014, CANCER-AM CANCER SOC, V120, P1939, DOI 10.1002/cncr.28679; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Wisnivesky JP, 2011, BMJ-BRIT MED J, V343, P247; Younis T, 2008, J THORAC ONCOL, V3, P1272, DOI 10.1097/JTO.0b013e318189f562	33	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181803	10.1371/journal.pone.0181803	http://dx.doi.org/10.1371/journal.pone.0181803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732018	gold, Green Published, Green Submitted			2022-12-27	WOS:000406643100063
J	Bogaerts, S; Carvalho, CD; Scheys, L; Desloovere, K; D'hooge, J; Maes, F; Suetens, P; Peers, K				Bogaerts, Stijn; Carvalho, Catarina De Brito; Scheys, Lennart; Desloovere, Kaat; D'hooge, Jan; Maes, Frederik; Suetens, Paul; Peers, Koen			Evaluation of tissue displacement and regional strain in the Achilles tendon using quantitative high-frequency ultrasound	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; IMAGE REGISTRATION; PATELLAR TENDON; TENDINOPATHY; PATTERNS; DEFORMATION	The Achilles tendon has a unique structure-function relationship thanks to its innate hierarchical architecture in combination with the rotational anatomy of the sub-tendons from the triceps surae muscles. Previous research has provided valuable insight in global Achilles tendon mechanics, but limitations with the technique used remain. Furthermore, given the global approach evaluating muscle-tendon junction to insertion, regional differences in tendon mechanical properties might be overlooked. However, recent advancements in the field of ultrasound imaging in combination with speckle tracking have made an intratendinous evaluation possible. This study uses high-frequency ultrasound to allow for quantification of regional tendon deformation. Also, an interactive application was developed to improve clinical applicability. A dynamic ultrasound of both Achilles tendons of ten asymptomatic subjects was taken. The displacement and regional strain in the superficial, middle and deep layer were evaluated during passive elongation and isometric contraction. Building on previous research, results showed that the Achilles tendon displaces non-uniformly with a higher displacement found in the deep layer of the tendon. Adding to this, a non-uniform regional strain behavior was found in the Achilles tendon during passive elongation, with the highest strain in the superficial layer. Further exploration of tendon mechanics will improve the knowledge on etiology of tendinopathy and provide options to optimize existing therapeutic loading programs.	[Bogaerts, Stijn; Peers, Koen] KULeuven, Dept Dev & Regenerat, Leuven, Belgium; [Bogaerts, Stijn; Peers, Koen] Univ Hosp Leuven, Dept Phys Med & Rehabil, Leuven, Belgium; [Carvalho, Catarina De Brito; Maes, Frederik; Suetens, Paul] KULeuven, MIRC, ESAT PSI, Leuven, Belgium; [Carvalho, Catarina De Brito; Maes, Frederik; Suetens, Paul] KULeuven, MIRC, UZ Leuven, Leuven, Belgium; [Carvalho, Catarina De Brito; Desloovere, Kaat; Maes, Frederik; Suetens, Paul] Univ Hosp Leuven, Leuven, Belgium; [Scheys, Lennart] KULeuven, IORT, Dept Dev & Regenerat, Leuven, Belgium; [Scheys, Lennart] Univ Hosp Leuven, Div Orthoped, Leuven, Belgium; [Desloovere, Kaat] KULeuven, Dept Rehabil Sci, Clin Mot Anal Lab, Leuven, Belgium; [D'hooge, Jan] Univ Hosp Leuven, Dept Cardiovasc Sci, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Bogaerts, S (corresponding author), KULeuven, Dept Dev & Regenerat, Leuven, Belgium.; Bogaerts, S (corresponding author), Univ Hosp Leuven, Dept Phys Med & Rehabil, Leuven, Belgium.	stijn_bogaerts@hotmail.com	Scheys, Lennart/K-6511-2019; Desloovere, Kaat/F-3240-2014; Maes, Frederik/I-7572-2013; Carvalho, Catarina/AAA-9158-2019; Scheys, Lennart/A-3584-2019	Scheys, Lennart/0000-0002-1727-533X; Desloovere, Kaat/0000-0002-8507-5276; Maes, Frederik/0000-0003-0027-1479; Carvalho, Catarina/0000-0002-6408-6339; Scheys, Lennart/0000-0002-1727-533X; Bogaerts, Stijn/0000-0001-5708-2439; D'hooge, Jan/0000-0002-2346-142X				Almekinders LC, 2002, KNEE SURG SPORT TR A, V10, P2, DOI 10.1007/s001670100224; [Anonymous], 2016, J BIOMECH, V49, P3122, DOI 10.1016/j.jbiomech.2016.06.028; Arndt A, 2012, KNEE SURG SPORT TR A, V20, P1868, DOI 10.1007/s00167-011-1801-9; Arnoczky SP, 2002, J ORTHOPAED RES, V20, P29, DOI 10.1016/S0736-0266(01)00080-8; Arnoczky SP, 2007, INT J EXP PATHOL, V88, P217, DOI 10.1111/j.1365-2613.2007.00548.x; Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Bey MJ, 2002, J ORTHOPAED RES, V20, P869, DOI 10.1016/S0736-0266(01)00177-2; Bogaerts S, 2016, J BIOMECH, V49, P1411, DOI 10.1016/j.jbiomech.2016.02.057; Bojsen-Moller J, 2015, EXERC SPORT SCI REV, V43, P190, DOI 10.1249/JES.0000000000000062; BURCKHARDT CB, 1978, IEEE T SON ULTRASON, V25, P1, DOI 10.1109/T-SU.1978.30978; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Chang YJ, 2015, J PHYSIOL-LONDON, V593, P3373, DOI 10.1113/JP270220; Child S, 2010, AM J SPORT MED, V38, P1885, DOI 10.1177/0363546510366234; Chimenti RL, 2016, J ORTHOP RES; Chimenti RL, 2016, J BIOMECH, V49, P39, DOI 10.1016/j.jbiomech.2015.11.008; Couppe A C, 2015, J ORTHOP SPORT PHYS, V45, P1; Farris DJ, 2013, J EXP BIOL, V216, P594, DOI 10.1242/jeb.077131; Finni T, 2012, SCAND J MED SCI SPOR, V2015, P26; Froberg A, 2016, ACTA RADIOL, V57, P1223, DOI 10.1177/0284185115626471; Handsfield GG, 2017, J BIOMECH, V51, P17, DOI 10.1016/j.jbiomech.2016.11.062; Haraldsson BT, 2008, MATRIX BIOL, V27, P86, DOI 10.1016/j.matbio.2007.09.001; Haraldsson BT, 2005, J APPL PHYSIOL, V98, P1006, DOI 10.1152/japplphysiol.00482.2004; Heyde B, 2013, ULTRASOUND MED BIOL, V39, P1688, DOI 10.1016/j.ultrasmedbio.2013.02.463; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kulig K, 2016, ULTRASOUND MED BIOL, V42, P664, DOI 10.1016/j.ultrasmedbio.2015.11.013; Lavagnino M, 2008, AM J SPORT MED, V36, P2110, DOI 10.1177/0363546508322496; Lersch C, 2012, CLIN BIOMECH, V27, P955, DOI 10.1016/j.clinbiomech.2012.07.001; Lyman J, 2004, AM J SPORT MED, V32, P457, DOI 10.1177/0095399703258621; Maganaris CN, 2008, DISABIL REHABIL, V30, P1542, DOI 10.1080/09638280701785494; Magnusson SP, 2010, NAT REV RHEUMATOL, V6, P262, DOI 10.1038/nrrheum.2010.43; Pearson SJ, 2014, SPORTS MED, V44, P1101, DOI 10.1007/s40279-014-0201-y; Pekala PA, 2017, SCAND J MED SCI SPOR, V27, P1705, DOI 10.1111/sms.12835; Podilchuk C, 2012, IEEE SIG PROC MED; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Screen HRC, 2004, STRAIN, V40, P157, DOI 10.1111/j.1475-1305.2004.00164.x; Seynnes OR, 2015, J APPL PHYSIOL, V118, P133, DOI 10.1152/japplphysiol.00849.2014; Shamonin DP, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00050; Silbernagel KG, 2015, J ORTHOP SPORT PHYS, V45, P876, DOI 10.2519/jospt.2015.5885; Slagmolen P, 2011, J ORTHOP RES, V29, P1931; Slane LC, 2017, EUR RADIOL, V27, P474, DOI 10.1007/s00330-016-4409-0; Slane LC, 2015, MED ENG PHYS, V37, P712, DOI 10.1016/j.medengphy.2015.04.004; Slane LC, 2014, J BIOMECH, V47, P2831, DOI 10.1016/j.jbiomech.2014.07.032; Slane LC, 2014, THESIS; Svensson RB, 2017, ACTA BIOMATER, V50, P293, DOI 10.1016/j.actbio.2017.01.006; Svensson RB, 2016, J APPL PHYSIOL, V121, DOI 10.1152/japplphysiol.00328.2016; Szaro P, 2009, ANN ANAT, V191, P586, DOI 10.1016/j.aanat.2009.07.006; Thorpe CT, 2015, SCAND J MED SCI SPOR, V25, pe381, DOI 10.1111/sms.12333; Thorpe CT, 2015, J MECH BEHAV BIOMED, V52, P85, DOI 10.1016/j.jmbbm.2015.04.009; Wood LK, 2016, J ORTHOP RES, V34, P346, DOI 10.1002/jor.22824	51	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181364	10.1371/journal.pone.0181364	http://dx.doi.org/10.1371/journal.pone.0181364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727745	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500063
J	Carillion, A; Feldman, S; Na, N; Biais, M; Carpentier, W; Birenbaum, A; Cagnard, N; Loyer, X; Bonnefont-Rousselot, D; Hatem, S; Riou, B; Amour, J				Carillion, Aude; Feldman, Sarah; Na, Na; Biais, Matthieu; Carpentier, Wassila; Birenbaum, Aurelie; Cagnard, Nicolas; Loyer, Xavier; Bonnefont-Rousselot, Dominique; Hatem, Stephane; Riou, Bruno; Amour, Julien			Atorvastatin reduces beta-Adrenergic dysfunction in rats with diabetic cardiomyopathy	PLOS ONE			English	Article							CONTRACTILE RESPONSE; STATIN THERAPY; MYOCARDIAL-INFARCTION; VENTRICULAR MYOCYTES; NONCARDIAC SURGERY; CARDIAC MYOCYTES; PROTEIN MRP4; NITRIC-OXIDE; STIMULATION; MORTALITY	Background In the diabetic heart the beta-adrenergic response is altered partly by down-regulation of the beta 1-adrenoceptor, reducing its positive inotropic effect and up-regulation of the beta 3-adrenoceptor, increasing its negative inotropic effect. Statins have clinical benefits on morbidity and mortality in diabetic patients which are attributed to their "pleiotropic" effects. The objective of our study was to investigate the role of statin treatment on beta-adrenergic dysfunction in diabetic rat cardiomyocytes. Methods beta-adrenergic responses were investigated in vivo (echocardiography) and ex vivo (left ventricular papillary muscles) in healthy and streptozotocin-induced diabetic rats, who were pre-treated or not by oral atorvastatin over 15 days (50 mg.kg(-1).day(-1)). Micro-array analysis and immunoblotting were performed in left ventricular homogenates. Data are presented as mean percentage of baseline +/- SD. Results Atorvastatin restored the impaired positive inotropic effect of beta-adrenergic stimulation in diabetic hearts compared with healthy hearts both in vivo and ex vivo but did not suppress the diastolic dysfunction of diabetes. Atorvastatin changed the RNA expression of 9 genes in the beta-adrenergic pathway and corrected the protein expression of beta 1-adrenoceptor and beta 1/beta 3-adrenoceptor ratio, and multidrug resistance protein 4 (MRP4). Nitric oxide synthase (NOS) inhibition abolished the beneficial effects of atorvastatin on the beta-adrenoceptor response. Conclusions Atorvastatin restored the positive inotropic effect of the beta-adrenoceptor stimulation in diabetic cardiomyopathy. This effect is mediated by multiple modifications in expression of proteins in the beta-adrenergic signaling pathway, particularly through the NOS pathway.	[Carillion, Aude; Feldman, Sarah; Na, Na; Biais, Matthieu; Birenbaum, Aurelie; Riou, Bruno; Amour, Julien] UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMR 1166,IHU ICAN, Paris, France; [Carillion, Aude; Feldman, Sarah; Birenbaum, Aurelie; Amour, Julien] Hop La Pitie Salpetriere, APHP, Dept Anesthesiol & Crit Care Med, Paris, France; [Na, Na; Riou, Bruno] Hop La Pitie Salpetriere, APHP, Dept Emergency Med & Surg, Paris, France; [Biais, Matthieu] Univ Bordeaux Segalen, Hop Pellegrin, Dept Anesthesiol & Crit Care, Bordeaux, France; [Carpentier, Wassila] UPMC Univ Paris 06, Sorbonne Univ, Postgenom Platform, Paris, France; [Cagnard, Nicolas] Univ Paris 05, Sorbonne Univ, Bioinformat Platform, Paris, France; [Loyer, Xavier] Univ Paris 05, Sorbonne Univ, Hop Europeen Georges Pompidou, APHP,UMRS,INSERM,U970,Cardiovasc Res Ctr, Paris, France; [Bonnefont-Rousselot, Dominique] Paris Descartes Univ, La Pitie Salpetriere Charles Foix Univ Hosp, AP HP,Fac Pharm,Sorbonne Paris Cite, Dept Metab Biochem,CNRS,UMR8258,INSERM,U1022, Paris, France; [Hatem, Stephane] UPMC Univ Paris 06, Sorbonne Univ, Hop Pitie Salpetriere, APHP,UMR 1166,INSERM,IHU ICAN, Paris, France; [Carillion, Aude; Feldman, Sarah; Na, Na; Carpentier, Wassila; Birenbaum, Aurelie; Bonnefont-Rousselot, Dominique; Riou, Bruno; Amour, Julien] Hop La Pitie Salpetriere, 47-83 Blvd Hop, Paris, France; [Biais, Matthieu] Hop Pellegrin, Pl Amelie Rabba Leon, Bordeaux, France; [Cagnard, Nicolas] Hop Necker Enfants Malad, 149 Rue Sevres, Paris, France; [Loyer, Xavier] Hop Europeen Georges Pompidou, 20 Rue Leblanc, Paris, France; [Hatem, Stephane] INSERM, UMR 1166, 91 Blvd Hop, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Amour, J (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMR 1166,IHU ICAN, Paris, France.; Amour, J (corresponding author), Hop La Pitie Salpetriere, APHP, Dept Anesthesiol & Crit Care Med, Paris, France.; Amour, J (corresponding author), Hop La Pitie Salpetriere, 47-83 Blvd Hop, Paris, France.	julien.amour@aphp.fr	LOYER, Xavier/AAR-2492-2020; LOYER, Xavier/O-7281-2017; FELDMAN, SARAH/F-8423-2013; Rousselot, Bonnefont/U-7434-2019; Cagnard, Nicolas/K-2754-2014	LOYER, Xavier/0000-0003-4294-3608; LOYER, Xavier/0000-0003-4294-3608; FELDMAN, SARAH/0000-0002-1671-9365; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202; Cagnard, Nicolas/0000-0002-9051-1896; Feldman, Sarah/0000-0001-8264-5184	Fondation pour la Recherche Medicale (Paris, France) [DEA200961244]; (European Society of Anaesthesiology (ESA)) from European Society of Anaesthesiology	Fondation pour la Recherche Medicale (Paris, France)(Fondation pour la Recherche Medicale); (European Society of Anaesthesiology (ESA)) from European Society of Anaesthesiology	Support was provided solely from institutional and/or departmental sources. Dr. Aude Carillion was the recipient of a research grant (FRM grant number DEA200961244) from the Fondation pour la Recherche Medicale (Paris, France). Pr Julien Amour was the recipient of research grant (European Society of Anaesthesiology (ESA) Research grant 2009) from European Society of Anaesthesiology.	Amour J, 2008, ANESTH ANALG, V107, P1130, DOI 10.1213/ane.0b013e3181806903; Amour J, 2008, ANESTHESIOLOGY, V108, P524, DOI 10.1097/ALN.0b013e3181649369; Amour J, 2007, ANESTHESIOLOGY, V107, P452, DOI 10.1097/01.anes.0000278909.40408.24; Beloeil H, 2005, BRIT J ANAESTH, V95, P782, DOI 10.1093/bja/aei259; Blanco-Rivero J, 2011, BRIT J PHARMACOL, V162, P271, DOI 10.1111/j.1476-5381.2010.01030.x; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Carillion A, 2015, ANESTHESIOLOGY, V122, P334, DOI 10.1097/ALN.0000000000000526; Chen Y, 2007, CIRC J, V71, P144, DOI 10.1253/circj.71.144; Dai QM, 2011, CHINESE MED J-PEKING, V124, P89, DOI 10.3760/cma.j.issn.0366-6999.2011.01.017; Datar R, 2010, BRIT J PHARMACOL, V160, P1765, DOI 10.1111/j.1476-5381.2010.00817.x; Dernellis J, 2006, HEART, V92, P1645, DOI 10.1136/hrt.2005.085530; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; Hammill BG, 2008, ANESTHESIOLOGY, V108, P559, DOI 10.1097/ALN.0b013e31816725ef; Ito M, 2004, CIRCULATION, V110, P412, DOI 10.1161/01.CIR.0000136088.18960.E6; Jiang C, 2015, CRIT CARE MED, V43, pE241, DOI 10.1097/CCM.0000000000000999; Kang L, 2007, PHARMACOLOGY, V80, P120, DOI 10.1159/000103251; Koh GCKW, 2012, CRIT CARE MED, V40, P1835, DOI 10.1097/CCM.0b013e31824e1696; Kojda G, 1996, CIRC RES, V78, P91, DOI 10.1161/01.RES.78.1.91; Martin JH, 2010, INT J CARDIOL, V143, P353, DOI 10.1016/j.ijcard.2009.03.098; McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285; Mohan P, 1996, CIRCULATION, V93, P1223, DOI 10.1161/01.CIR.93.6.1223; Muhlhauser U, 2006, FASEB J, V20, P785, DOI 10.1096/fj.05-5067fje; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Papazian L, 2013, JAMA-J AM MED ASSOC, V310, P1692, DOI 10.1001/jama.2013.280031; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Pugh SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106905; ROTH DA, 1995, J MOL CELL CARDIOL, V27, P2315, DOI 10.1016/S0022-2828(95)91875-2; Sassi Y, 2012, FASEB J, V26, P1009, DOI 10.1096/fj.11-194027; Van Linthout S, 2007, DIABETOLOGIA, V50, P1977, DOI 10.1007/s00125-007-0719-8; Xie F, 2011, ACTA PHARMACOL SIN, V32, P321, DOI 10.1038/aps.2010.221; Zaitone SA, 2012, EUR J PHARMACOL, V691, P134, DOI 10.1016/j.ejphar.2012.06.022; Zheng X, 2006, HEART VESSELS, V21, P116, DOI 10.1007/s00380-005-0868-y	32	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180103	10.1371/journal.pone.0180103	http://dx.doi.org/10.1371/journal.pone.0180103			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727746	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500013
J	Steiner, N; Hajek, R; Sevcikova, S; Borjan, B; Johrer, K; Gobel, G; Untergasser, G; Gunsilius, E				Steiner, Normann; Hajek, Roman; Sevcikova, Sabina; Borjan, Bojana; Joehrer, Karin; Goebel, Georg; Untergasser, Gerold; Gunsilius, Eberhard			High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; POTENTIAL ROLE; FLT3 LIGAND; ANGIOGENESIS; ANGIOPOIETIN-2; ENDOSTATIN; TIE2; OSTEOCLASTOGENESIS	Introduction Multiple myeloma (MM) is still incurable due to resistance against various therapies. Thus, the identification of biomarkers predicting progression is urgently needed. Here, we evaluated four biomarkers in bone marrow and peripheral blood of MM patients for their prognostic significance. Materials & methods Bone marrow- and peripheral blood plasma levels of FLT3-L, soluble TIE2, endostatin, and osteoactivin were determined in patients with monoclonal gammopathy of undetermined significance (MGUS, n = 14/n = 4), patients with newly diagnosed MM (NDMM, n = 42/n = 31) and patients with relapsed/refractory MM (RRMM, n = 27/n = 16) by sandwich ELISA. Results Median FLT3-L expression increased from MGUS (58.77 pg/ml in bone marrow; 80.40 pg/ml in peripheral blood) to NDMM (63.15 pg/ml in bone marrow; 85.05 pg/ml in peripheral blood) and was maximal in RRMM (122 pg/ml in bone marrow; 160.47 pg/ml in peripheral blood; NDMM vs. RRMM p<0.001). A cut-off value of FLT3-L >92 pg/ml in bone marrow and >121 pg/ml in peripheral blood was associated with relapse or refractoriness in MM patients. FLT3-L was found to be a high predictive marker for discrimination between NDMM and RRMM as well in bone marrow as in peripheral blood (AUC 0.75 in bone marrow; vs 0.84 in peripheral blood). Conclusion High levels of FLT3-L in bone marrow and peripheral blood of MM patients identify patients with progressive disease and are associated with relapse or refractoriness in MM patients. FLT3-L could be useful as a marker to identify RRMM patients and should be evaluated as target for future therapies.	[Steiner, Normann; Untergasser, Gerold; Gunsilius, Eberhard] Innsbruck Med Univ, Dept Internal Med Hematol & Med Oncol 5, Anichstr 35, Innsbruck, Austria; [Steiner, Normann; Borjan, Bojana; Gunsilius, Eberhard] Innsbruck Med Univ, Lab Tumor Biol & Angiogenesis, Innrain 66, Innsbruck, Austria; [Hajek, Roman] Univ Ostrava, Fac Med, Ostrava, Czech Republic; [Hajek, Roman] Univ Hosp Ostrava, Dept Hematol Oncol, Ostrava, Czech Republic; [Sevcikova, Sabina] Masaryk Univ, Fac Med, Dept Pathol Physiol, Babak Myeloma Grp, Brno, Czech Republic; [Sevcikova, Sabina] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic; [Borjan, Bojana; Joehrer, Karin; Untergasser, Gerold] Tyrolean Canc Res Inst, Innrain 66, Innsbruck, Austria; [Goebel, Georg] Innsbruck Med Univ, Dept Med Stat Informat & Hlth Econ, Schopfstr 41, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; University of Ostrava; University Hospital Ostrava; Masaryk University Brno; University Hospital Brno; Medical University of Innsbruck	Steiner, N (corresponding author), Innsbruck Med Univ, Dept Internal Med Hematol & Med Oncol 5, Anichstr 35, Innsbruck, Austria.; Steiner, N (corresponding author), Innsbruck Med Univ, Lab Tumor Biol & Angiogenesis, Innrain 66, Innsbruck, Austria.	normann.steiner@i-med.ac.at	Sevcikova, Sabina/AAB-4267-2021; Jöhrer, Karin/H-9143-2019; Gunsilius, Eberhard/AAI-9333-2021; Hajek, Roman/I-6639-2017	Jöhrer, Karin/0000-0002-6400-6175; Gunsilius, Eberhard/0000-0003-1327-2921; Hajek, Roman/0000-0001-6955-6267				Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Antonysamy MA, 2000, CYTOKINE, V12, P87, DOI 10.1006/cyto.1999.0540; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Babarovic E, 2016, PATHOL RES PRACT, V212, P509, DOI 10.1016/j.prp.2015.11.021; Belloni D, 2015, EXP CELL RES, V330, P1, DOI 10.1016/j.yexcr.2014.10.017; Buza-Vidas N, 2007, BLOOD, V110, P424, DOI 10.1182/blood-2006-09-047480; Campochiaro PA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0816-5; Ergun S, 2001, ANGIOGENESIS, V4, P193, DOI DOI 10.1023/A:1014027218980; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Ferrarini M, 2011, CURR MED CHEM, V18, P5185, DOI 10.2174/092986711798184316; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Fowler JA, 2012, CANCER RES, V72, P2183, DOI 10.1158/0008-5472.CAN-11-2067; Gentile M, 2013, EXPERT OPIN BIOL TH, V13, pS1, DOI 10.1517/14712598.2013.799132; Greystoke A, 2011, BRIT J CANCER, V104, P719, DOI 10.1038/sj.bjc.6606082; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hu XF, 2013, J CELL BIOCHEM, V114, P2729, DOI 10.1002/jcb.24621; Jones N, 2001, NAT REV MOL CELL BIO, V2, P257, DOI 10.1038/35067005; Kokonozaki M, 2015, LEUKEMIA RES, V39, P1467, DOI 10.1016/j.leukres.2015.10.009; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Martin V, 2008, HISTOL HISTOPATHOL, V23, P773, DOI 10.14670/HH-23.773; McClanahan T, 1996, BLOOD, V88, P3371, DOI 10.1182/blood.V88.9.3371.bloodjournal8893371; Moreau Philippe, 2015, Am Soc Clin Oncol Educ Book, pe504, DOI 10.14694/EdBook_AM.2015.35.e504; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pappa CA, 2014, J CANCER RES CLIN, V140, P1801, DOI 10.1007/s00432-014-1731-2; Pappa CA, 2013, CANCER INVEST, V31, P385, DOI 10.3109/07357907.2013.800093; Pour L, 2010, NEOPLASMA, V57, P29, DOI 10.4149/neo_2010_01_029; Pour L, 2010, ANN HEMATOL, V89, P385, DOI 10.1007/s00277-009-0834-3; Rajkumar SV, 2002, CLIN CANCER RES, V8, P2210; Ribatti D, 2006, ONCOGENE, V25, P4257, DOI 10.1038/sj.onc.1209456; Ribatti Domenico, 2016, Cancer Treat Res, V169, P51; Ribatti D, 2012, CURR CANCER DRUG TAR, V12, P768, DOI 10.2174/156800912802429346; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Silvestris F, 2011, ADV EXP MED BIOL, V714, P113, DOI 10.1007/978-94-007-0782-5_5; Solanilla A, 2000, LEUKEMIA, V14, P153, DOI 10.1038/sj.leu.2401635; Sondag GR, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.78; Urbanska-Rys H, 2003, MEDIAT INFLAMM, V12, P229, DOI 10.1080/09629350310001599675; Vacca A, 2006, LEUKEMIA, V20, P193, DOI 10.1038/sj.leu.2404067; Vacca A, 2003, HAEMATOLOGICA, V88, P176; VACCA A, 1994, BRIT J HAEMATOL, V87, P503, DOI 10.1111/j.1365-2141.1994.tb08304.x; Wen W, 1999, CANCER RES, V59, P6052; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	44	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181487	10.1371/journal.pone.0181487	http://dx.doi.org/10.1371/journal.pone.0181487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727816	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500078
J	Zhao, HZ; Liu, FX; Li, LY				Zhao, Hui-zhen; Liu, Fu-xian; Li, Long-yue			Improving deep convolutional neural networks with mixed maxout units	PLOS ONE			English	Article								Motivated by insights from the maxout-units-based deep Convolutional Neural Network (CNN) that "non-maximal features are unable to deliver" and "feature mapping subspace pooling is insufficient," we present a novel mixed variant of the recently introduced maxout unit called a mixout unit. Specifically, we do so by calculating the exponential probabilities of feature mappings gained by applying different convolutional transformations over the same input and then calculating the expected values according to their exponential probabilities. Moreover, we introduce the Bernoulli distribution to balance the maximum values with the expected values of the feature mappings subspace. Finally, we design a simple model to verify the pooling ability of mixout units and a Mixout-units-based Network-in-Network (NiN) model to analyze the feature learning ability of the mixout models. We argue that our proposed units improve the pooling ability and that mixout models can achieve better feature learning and classification performance.	[Zhao, Hui-zhen; Liu, Fu-xian; Li, Long-yue] Air Force Engn Univ, Air & Missile Def Coll, Xian, Shaanxi, Peoples R China	Air Force Engineering University	Zhao, HZ (corresponding author), Air Force Engn Univ, Air & Missile Def Coll, Xian, Shaanxi, Peoples R China.	margeryzhao@outlook.com	Li, Longyue/P-1802-2018	Li, Longyue/0000-0001-5234-2625	National Natural Science Foundation of China [61601499, 61272011]; Air Force Engineering University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Air Force Engineering University	This work was supported by the National Natural Science Foundation of China (61601499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China under Grant No.61601499, No 61272011 and two grants from Air Force Engineering University. All the funds above can cover the costs to publish in open access. The authors would like to thank all of the team members of D605 Laboratory.	Chang J.R., 2015, COMPUTER SCI; Goodfellow IJ, ARXIV13024389, P1319; He K., 2016, CVPR, P770; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Jin XJ, 2016, AAAI CONF ARTIF INTE, P1737; Krizhevsky A, 2009, THESIS U TORONTO TOR; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Li J, 2013, 38 IEEE INT C AC SPE; Liao Z, 2016, APPL COMP VIS WACV 2; Lin M, 2014, PUBLIC HEALTH NUTR, V17, P2029, DOI [10.1017/S1368980013002176, 10.1109/PLASMA.2013.6634954]; Maas A.L., 2013, INT C MACHINE LEARNI, V30, P3, DOI DOI 10.1016/0010-0277(84)90022-2; Nair V., 2010, P 27 INT C INT C MAC, P807; Netzer Y., 2011, READING DIGITS NATUR, DOI DOI 10.2118/18761-MS; Springenberg J. T., 2013, ARXIV13126116; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tompson J, 2015, P IEEE C COMP VIS PA; Wan L., 2013, INT C MACHINE LEARNI, VVolume 28, P1058; Wang S., 2013, P 30 INT C MACH LEAR, P118; Weinberger K.Q., 2013, ADV NEURAL INFORM PR, P3084; Xu B., 2015, ARXIV150500853, V1505, P853; Yu D, 2014, INT C ROUGH SETS KNO; Zeiler M.D., 2013, ARXIV13013557	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180049	10.1371/journal.pone.0180049	http://dx.doi.org/10.1371/journal.pone.0180049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727737	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500012
J	Zhao, R; Catalano, P; DeGruttola, VG; Michor, F				Zhao, Rui; Catalano, Paul; DeGruttola, Victor G.; Michor, Franziska			Estimating mono- and bi-phasic regression parameters using a mixture piecewise linear Bayesian hierarchical model	PLOS ONE			English	Article							MIXED-EFFECTS MODELS; DYNAMICS; THERAPY; SELECTION; VARIABLES; KINETICS; CRITERIA; CELLS	The dynamics of tumor burden, secreted proteins or other biomarkers over time, is often used to evaluate the effectiveness of therapy and to predict outcomes for patients. Many methods have been proposed to investigate longitudinal trends to better characterize patients and to understand disease progression. However, most approaches assume a homogeneous patient population and a uniform response trajectory over time and across patients. Here, we present a mixture piecewise linear Bayesian hierarchical model, which takes into account both population heterogeneity and nonlinear relationships between biomarkers and time. Simulation results show that our method was able to classify subjects according to their patterns of treatment response with greater than 80% accuracy in the three scenarios tested. We then applied our model to a large randomized controlled phase III clinical trial of multiple myeloma patients. Analysis results suggest that the longitudinal tumor burden trajectories in multiple myeloma patients are heterogeneous and nonlinear, even among patients assigned to the same treatment cohort. In addition, between cohorts, there are distinct differences in terms of the regression parameters and the distributions among categories in the mixture. Those results imply that longitudinal data from clinical trials may harbor unobserved subgroups and nonlinear relationships; accounting for both may be important for analyzing longitudinal data.	[Zhao, Rui; Catalano, Paul; DeGruttola, Victor G.; Michor, Franziska] Harvard Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Zhao, Rui; Catalano, Paul; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Zhao, R (corresponding author), Harvard Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.; Zhao, R (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA.	rzhao@hsph.harvard.edu			Dana-Farber Cancer Institute Physical Sciences Oncology Center [U54CA143798]; NIH [R37 51164]; NATIONAL CANCER INSTITUTE [U54CA193461] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Physical Sciences Oncology Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Dana-Farber Cancer Institute Physical Sciences Oncology Center (U54CA143798) and NIH grant R37 51164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; [Anonymous], 2014, R LANG ENV STAT COMP; Arnaout RA, 2000, P ROY SOC B-BIOL SCI, V267, P1347, DOI 10.1098/rspb.2000.1149; Basseville M, 1993, DETECTION ABRUPT CHA, V104; BELIN TR, 1995, STAT MED, V14, P747, DOI 10.1002/sim.4780140805; BESAG J, 1995, STAT SCI, V10, P3, DOI 10.1214/ss/1177010123; Carlin B. P., 1995, J ROYAL STAT SOC B, V57, P473; CARLIN BP, 1992, APPL STAT-J ROY ST C, V41, P389; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Chen J., 2011, PARAMETRIC STAT CHAN; Cudeck R, 2002, PSYCHOL METHODS, V7, P41, DOI 10.1037/1082-989X.7.1.41; Fitzmaurice G. M., 2012, APPL LONGITUDINAL AN, V998; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Hammer SM, 2002, JAMA-J AM MED ASSOC, V288, P169, DOI 10.1001/jama.288.2.169; HANNAN EJ, 1979, J ROY STAT SOC B MET, V41, P190; Harring JR, 2006, MULTIVAR BEHAV RES, V41, P579, DOI 10.1207/s15327906mbr4104_7; Held L, 2004, J COMPUTATIONAL GRAP, V13; HINKLEY DV, 1969, BIOMETRIKA, V56, P635, DOI 10.1093/biomet/56.3.635; Jessica M, 2012, J BIOMETRICS BIOSTAT; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Leisch F., 2004, FLEXMIX GEN FRAMEWOR; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; Lu X, 2014, STAT MED; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; MORRELL CH, 1995, J AM STAT ASSOC, V90, P45, DOI 10.2307/2291128; Naumova EN, 2001, INT J EPIDEMIOL, V30, P1332, DOI 10.1093/ije/30.6.1332; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; NISHII R, 1984, ANN STAT, V12, P758, DOI 10.1214/aos/1176346522; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Pauler DK, 2000, BIOMETRICS, V56, P464, DOI 10.1111/j.0006-341X.2000.00464.x; Perelson AS, 1997, EXPERT REV MOL MED; Pinheiro J, 2001, MIXED EFFECTS MODELS; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; SHIBATA R, 1976, BIOMETRIKA, V63, P117; Stein AM, 2011, CLIN CANCER RES, V17, P6812, DOI 10.1158/1078-0432.CCR-11-0396; Tsiang M, 1999, HEPATOLOGY, V29, P1863, DOI 10.1002/hep.510290626; van den Hout A, 2011, STAT MED, V30, P599, DOI 10.1002/sim.4127; Verbeke G, 1996, J AM STAT ASSOC, V91, P217, DOI 10.2307/2291398; Verbeke G, 2009, SPRINGER SER STAT, P1; Xu W, 2001, J Biopharm Stat, V11, P253, DOI 10.1081/BIP-120008848	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180756	10.1371/journal.pone.0180756	http://dx.doi.org/10.1371/journal.pone.0180756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723910	gold, Green Published			2022-12-27	WOS:000406067800023
J	Klyczek, KK; Bonilla, JA; Jacobs-Sere, D; Adair, TL; Afram, P; Allen, KG; Archambault, ML; Aziz, RM; Bagnasco, FG; Ball, SL; Barrette, NA; Benjamin, RC; Blasi, CJ; Borst, K; Braun, MA; Broomell, H; Browns, CB; Brynell, ZS; Bue, AB; Burke, SO; Casazza, W; Cautele, JA; Chen, K; Chimalakonda, NS; Chudoff, D; Connor, JA; Cross, TS; Curtis, KN; Dahlke, JA; Deaton, BM; Degroote, SJ; DeNigris, DM; DeRuff, KC; Dolan, M; Dunbar, D; Egan, MS; Evans, DR; Fahnestock, AK; Farooq, A; Finn, G; Fratus, CR; Gaffney, BL; Garlena, RA; Garrigan, KE; Gibbon, BC; Goedde, MA; Bustamante, CAG; Harrison, M; Hartwell, MC; Heckman, EL; Huang, J; Hughes, LE; Hyduchak, KM; Jacob, AE; Kaku, M; Karstens, AW; Kenna, MA; Khetarpal, S; King, RA; Kobokovich, AL; Kolev, H; Konde, SA; Kriese, E; Lamey, ME; Lantz, CN; Lapin, JS; Lawson, TO; Lee, IY; Lee, SM; Lee-Soety, JY; Lehmann, EM; London, SC; Lopez, AJ; Lynch, KC; Mageeney, CM; Martynyuk, T; Mathew, KJ; Mavrich, TN; McDaniel, CM; McDonald, H; McManus, CJ; Medrano, JE; Melee, FE; Menninger, JE; Miller, SN; Minick, JE; Nabua, CT; Napoli, CK; Nkangabwa, M; Oates, EA; Ott, CT; Pellerino, SK; Pinamont, WJ; Pirnie, RT; Pizzorno, MC; Plautz, EJ; Pope, WH; Pruett, KM; Rickstrew, G; Rimple, PA; Rinehart, CA; Robinson, KM; Rose, VA; Russell, DA; Schick, AM; Schlossman, J; Schneider, VM; Sells, CA; Sieker, JW; Silvan, MP; Silvi, MM; Simons, SE; Staples, AK; Steed, IL; Stowe, EL; Stueven, NA; Swartz, PT; Sweet, EA; Sweetman, AT; Tender, C; Terry, K; Thomas, C; Thomas, DS; Thompson, AR; Vanderveen, L; Varma, R; Vaught, HL; Vo, QD; Vonberg, ZT; Ware, VC; Warrad, YM; Wathen, KE; Weinstein, JL; Wyper, JF; Yankauskas, JR; Zhang, C; Hatfull, GF				Klyczek, Karen K.; Bonilla, J. Alfred; Jacobs-Sere, Deborah; Adair, Tamarah L.; Afram, Patricia; Allen, Katherine G.; Archambault, Megan L.; Aziz, Rahat M.; Bagnasco, Filippa G.; Ball, Sarah L.; Barrette, Natalie A.; Benjamin, Robert C.; Blasi, Christopher J.; Borst, Katherine; Braun, Mary A.; Broomell, Haley; Browns, Conner B.; Brynell, Zachary S.; Bue, Ashley B.; Burke, Sydney O.; Casazza, William; Cautele, Julia A.; Chen, Kevin; Chimalakonda, Nitish S.; Chudoff, Dylan; Connor, Jade A.; Cross, Trevor S.; Curtis, Kyra N.; Dahlke, Jessica A.; Deaton, Bethany M.; Degroote, Sarah J.; DeNigris, Danielle M.; DeRuff, Katherine C.; Dolan, Milan; Dunbar, David; Egan, Marisa S.; Evans, Daniel R.; Fahnestock, Abby K.; Farooq, Amal; Finn, Garrett; Fratus, Christopher R.; Gaffney, Bobby L.; Garlena, Rebecca A.; Garrigan, Kelly E.; Gibbon, Bryan C.; Goedde, Michael A.; Bustamante, Carlos A. Guerrero; Harrison, Melinda; Hartwell, Megan C.; Heckman, Emily L.; Huang, Jennifer; Hughes, Lee E.; Hyduchak, Kathryn M.; Jacob, Aswathi E.; Kaku, Machika; Karstens, Allen W.; Kenna, Margaret A.; Khetarpal, Susheel; King, Rodney A.; Kobokovich, Amanda L.; Kolev, Hannah; Konde, Sai A.; Kriese, Elizabeth; Lamey, Morgan E.; Lantz, Carter N.; Lapin, Jonathan S.; Lawson, Temiloluwa O.; Lee, In Young; Lee, Scott M.; Lee-Soety, Julia Y.; Lehmann, Emily M.; London, Shawn C.; Lopez, A. Javier; Lynch, Kelly C.; Mageeney, Catherine M.; Martynyuk, Tetyana; Mathew, Kevin J.; Mavrich, Travis N.; McDaniel, Christopher M.; McDonald, Hannah; McManus, C. Joel; Medrano, Jessica E.; Melee, Francis E.; Menninger, Jennifer E.; Miller, Sierra N.; Minick, Josephine E.; Nabua, Courtney T.; Napoli, Caroline K.; Nkangabwa, Martha; Oates, Elizabeth A.; Ott, Cassandra T.; Pellerino, Sarah K.; Pinamont, William J.; Pirnie, Ross T.; Pizzorno, Marie C.; Plautz, Emilee J.; Pope, Welkin H.; Pruett, Katelyn M.; Rickstrew, Gabbi; Rimple, Patrick A.; Rinehart, Claire A.; Robinson, Kayla M.; Rose, Victoria A.; Russell, Daniel A.; Schick, Amelia M.; Schlossman, Julia; Schneider, Victoria M.; Sells, Chloe A.; Sieker, Jeremy W.; Silvan, Morgan P.; Silvi, Marissa M.; Simons, Stephanie E.; Staples, Amanda K.; Steed, Isabelle L.; Stowe, Emily L.; Stueven, Noah A.; Swartz, Porter T.; Sweet, Emma A.; Sweetman, Abigail T.; Tender, Corrina; Terry, Katrina; Thomas, Chrystal; Thomas, Daniel S.; Thompson, Allison R.; Vanderveen, Lorianna; Varma, Rohan; Vaught, Hannah L.; Vo, Quynh D.; Vonberg, Zachary T.; Ware, Vassie C.; Warrad, Yasmene M.; Wathen, Kaitlyn E.; Weinstein, Jonathan L.; Wyper, Jacqueline F.; Yankauskas, Jakob R.; Zhang, Christine; Hatfull, Graham F.			Tales of diversity: Genomic and morphological characteristics of forty-six Arthrobacter phages	PLOS ONE			English	Article							BACTERIOPHAGES; SOIL; ACTINOMYCETE; EVOLUTION; HOST	The vast bacteriophage population harbors an immense reservoir of genetic information. Almost 2000 phage genomes have been sequenced from phages infecting hosts in the phylum Actinobacteria, and analysis of these genomes reveals substantial diversity, pervasive mosaicism, and novel mechanisms for phage replication and lysogeny. Here, we describe the isolation and genomic characterization of 46 phages from environmental samples at various geographic locations in the U.S. infecting a single Arthrobacter sp. strain. These phages include representatives of all three virion morphologies, and Jasmine is the first sequenced podovirus of an actinobacterial host. The phages also span considerable sequence diversity, and can be grouped into 10 clusters according to their nucleotide diversity, and two singletons each with no close relatives. However, the clusters/singletons appear to be genomically well separated from each other, and relatively few genes are shared between clusters. Genome size varies from among the smallest of siphoviral phages (15,319 bp) to over 70 kbp, and G+C contents range from 45-68%, compared to 63.4% for the host genome. Although temperate phages are common among other actinobacterial hosts, these Arthrobacter phages are primarily lytic, and only the singleton Galaxy is likely temperate.	[Klyczek, Karen K.; Bonilla, J. Alfred; Archambault, Megan L.; Bue, Ashley B.; Dahlke, Jessica A.; Degroote, Sarah J.; Finn, Garrett; Kriese, Elizabeth; Lawson, Temiloluwa O.; Lehmann, Emily M.; Pellerino, Sarah K.; Plautz, Emilee J.; Steed, Isabelle L.; Stueven, Noah A.; Swartz, Porter T.; Sweet, Emma A.; Vaught, Hannah L.; Vonberg, Zachary T.] Univ Wisconsin, Biol Dept, River Falls, WI 54022 USA; [Jacobs-Sere, Deborah; Garlena, Rebecca A.; Bustamante, Carlos A. Guerrero; Lapin, Jonathan S.; Lee, In Young; Mavrich, Travis N.; Ott, Cassandra T.; Pope, Welkin H.; Rimple, Patrick A.; Russell, Daniel A.; Schneider, Victoria M.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Adair, Tamarah L.; Bagnasco, Filippa G.; Brynell, Zachary S.; Burke, Sydney O.; Chimalakonda, Nitish S.; Connor, Jade A.; Curtis, Kyra N.; Deaton, Bethany M.; Fahnestock, Abby K.; Fratus, Christopher R.; Gibbon, Bryan C.; Karstens, Allen W.; Konde, Sai A.; Lantz, Carter N.; Lee, Scott M.; Miller, Sierra N.; Minick, Josephine E.; Pruett, Katelyn M.; Rose, Victoria A.; Schick, Amelia M.; Sells, Chloe A.; Sieker, Jeremy W.; Thomas, Daniel S.; Warrad, Yasmene M.; Wyper, Jacqueline F.] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Afram, Patricia; Broomell, Haley; Chudoff, Dylan; Cross, Trevor S.; Dunbar, David; Harrison, Melinda; Terry, Katrina] Cabrini Univ, Dept Sci, Radnor, PA USA; [Allen, Katherine G.; Browns, Conner B.; Dolan, Milan; Gaffney, Bobby L.; Goedde, Michael A.; King, Rodney A.; Lynch, Kelly C.; McDaniel, Christopher M.; Oates, Elizabeth A.; Rinehart, Claire A.; Staples, Amanda K.; Thompson, Allison R.; Wathen, Kaitlyn E.] Western Kentucky Univ, Biol Dept, Bowling Green, KY 42101 USA; [Aziz, Rahat M.; Benjamin, Robert C.; Farooq, Amal; Hughes, Lee E.; Mathew, Kevin J.; Robinson, Kayla M.; Silvan, Morgan P.; Simons, Stephanie E.; Vo, Quynh D.] Univ North Texas, Dept Biol Sci, Denton, TX USA; [Ball, Sarah L.] Ohio State Univ, Ctr Life Sci Educ, Columbus, OH 43210 USA; [Barrette, Natalie A.; Cautele, Julia A.; DeNigris, Danielle M.; Egan, Marisa S.; Garrigan, Kelly E.; Hartwell, Megan C.; Hyduchak, Kathryn M.; Jacob, Aswathi E.; Lamey, Morgan E.; Lee-Soety, Julia Y.; London, Shawn C.; Martynyuk, Tetyana; Melee, Francis E.; Menninger, Jennifer E.; Nabua, Courtney T.; Napoli, Caroline K.; Sweetman, Abigail T.; Weinstein, Jonathan L.] St Josephs Univ, Biol Dept, Philadelphia, PA 19131 USA; [Blasi, Christopher J.; DeRuff, Katherine C.; Kobokovich, Amanda L.; Medrano, Jessica E.; Pinamont, William J.; Pirnie, Ross T.; Pizzorno, Marie C.; Silvi, Marissa M.; Stowe, Emily L.; Yankauskas, Jakob R.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Borst, Katherine; Braun, Mary A.; Casazza, William; Chen, Kevin; Evans, Daniel R.; Huang, Jennifer; Kaku, Machika; Khetarpal, Susheel; Kolev, Hannah; Lopez, A. Javier; McDonald, Hannah; McManus, C. Joel; Nkangabwa, Martha; Rickstrew, Gabbi; Schlossman, Julia; Tender, Corrina; Thomas, Chrystal; Vanderveen, Lorianna; Varma, Rohan; Zhang, Christine] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Heckman, Emily L.; Kenna, Margaret A.; Mageeney, Catherine M.; Ware, Vassie C.] Lehigh Univ, Biol Sci, Bethlehem, PA 18015 USA	University of Wisconsin System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor University; Western Kentucky University; University of North Texas System; University of North Texas Denton; University System of Ohio; Ohio State University; Saint Joseph's University; Bucknell University; Carnegie Mellon University; Lehigh University	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu	Evans, Daniel/AAM-3103-2020	Thomas, Chrystal/0000-0001-7926-8293; DeRuff, Katherine/0000-0001-6011-4323; Lee, In Young/0000-0001-8406-1801; Evans, Daniel/0000-0002-3553-9263; Guerrero, Carlos/0000-0002-7256-5188; Barrett, Natalie/0000-0001-6732-418X; Egan, Marisa/0000-0001-6191-5552; Klyczek, Karen/0000-0001-7882-0429; Miller, Sierra/0000-0002-9490-9041; Cross, Trevor/0000-0002-6102-2532; Pizzorno, Marie/0000-0003-3502-6289; Sells, Chloe/0000-0002-9895-0949; Mavrich, Travis/0000-0001-9252-5020; Kaku, Machika/0000-0002-9921-0678	National Institutes of Health [GM116884, P20GM103436]; Howard Hughes Medical Institute [54308198]; National Science Foundation [1247842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116884, P20GM103436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM116884 to GFH, Howard Hughes Medical Institute 54308198 to GFH, National Science Foundation 1247842 to TNM, and National Institutes of Health P20GM103436 to RAK and CAR.	ACHBERGER EC, 1978, J BACTERIOL, V135, P595, DOI 10.1128/JB.135.2.595-602.1978; Bebeacua C, 2013, J VIROL, V87, P12302, DOI 10.1128/JVI.02033-13; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Broussard GW, 2013, MOL CELL, V49, P237, DOI 10.1016/j.molcel.2012.11.012; BROWN DR, 1978, APPL ENVIRON MICROB, V35, P185, DOI 10.1128/AEM.35.1.185-191.1978; Camargo FAO, 2004, BIOL TRACE ELEM RES, V97, P183, DOI 10.1385/BTER:97:2:183; CASIDA LE, 1974, APPL MICROBIOL, V28, P951, DOI 10.1128/AEM.28.6.951-959.1974; Cresawn SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118725; Dyson ZA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134512; EINCK KH, 1973, J VIROL, V12, P1031, DOI 10.1128/JVI.12.5.1031-1033.1973; Gao BL, 2012, MICROBIOL MOL BIOL R, V76, P66, DOI 10.1128/MMBR.05011-11; Gregory AC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3286-x; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hendrix R., 2006, BACTERIOPHAGES; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Jordan TC, 2014, MBIO, V5, DOI 10.1128/mBio.01051-13; Kaliniene L, 2017, J VIROL, V91, DOI [10.1128/JVI.00023-17, 10.1128/jvi.00023-17]; Khairnar Krishna, 2014, Biotechnol Res Int, V2014, P151952, DOI 10.1155/2014/151952; Kloepper TH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-22; Knowles B, 2016, NATURE, V531, P466, DOI 10.1038/nature17193; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Liu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13754; Marinelli LJ, 2012, MBIO, V3, DOI 10.1128/mBio.00279-12; Monnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015489; O'Loughlin EJ, 1999, BIODEGRADATION, V10, P93, DOI 10.1023/A:1008309026751; OSTLE AG, 1979, APPL ENVIRON MICROB, V38, P59, DOI 10.1128/AEM.38.1.59-65.1979; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Payne KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034052; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Petrovski S, 2013, ARCH VIROL, V158, P601, DOI 10.1007/s00705-012-1530-5; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P1389, DOI 10.1128/AEM.01938-10; Pope WH, 2015, ELIFE, V4, DOI 10.7554/eLife.06416; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Salifu SP, 2013, ENV MICROBIOL REP, V5, P170, DOI 10.1111/1758-2229.12028; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sarkis GJ, 1998, METH MOL B, V101, P145, DOI 10.1385/0-89603-471-2:145; Simoliunas E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111230; Smith MCM, 2013, J BACTERIOL, V195, P4924, DOI 10.1128/JB.00618-13; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Summer EJ, 2011, APPL ENVIRON MICROB, V77, P669, DOI 10.1128/AEM.01952-10; TO CM, 1966, J ULTRA MOL STRUCT R, V14, P441, DOI 10.1016/S0022-5320(66)80074-6; Veesler D, 2014, STRUCTURE, V22, P230, DOI 10.1016/j.str.2013.11.007; Verma M, 2013, RES MICROBIOL, V164, P718, DOI 10.1016/j.resmic.2013.04.002; WARD CM, 1973, J BACTERIOL, V114, P378, DOI 10.1128/JB.114.1.378-389.1973; Westerberg K, 2000, INT J SYST EVOL MICR, V50, P2083, DOI 10.1099/00207713-50-6-2083	52	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180517	10.1371/journal.pone.0180517	http://dx.doi.org/10.1371/journal.pone.0180517			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715480	Green Submitted, gold, Green Published			2022-12-27	WOS:000443975500010
J	vanEngelsdorp, D; Traynor, KS; Andree, M; Lichtenberg, EM; Chen, YP; Saegerman, C; Cox-Foster, DL				vanEngelsdorp, Dennis; Traynor, Kirsten S.; Andree, Michael; Lichtenberg, Elinor M.; Chen, Yanping; Saegerman, Claude; Cox-Foster, Diana L.			Colony Collapse Disorder (CCD) and bee age impact honey bee pathophysiology	PLOS ONE			English	Article							MALPIGHIAN TUBULES; APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; NATIONAL-SURVEY; LOSSES; HYMENOPTERA; SENSITIVITY; HOMEOSTASIS; MICROFLORA; NODULATION	Honey bee (Apis mellifera) colonies continue to experience high annual losses that remain poorly explained. Numerous interacting factors have been linked to colony declines. Understanding the pathways linking pathophysiology with symptoms is an important step in understanding the mechanisms of disease. In this study we examined the specific pathologies associated with honey bees collected from colonies suffering from Colony Collapse Disorder (CCD) and compared these with bees collected from apparently healthy colonies. We identified a set of pathological physical characteristics that occurred at different rates in CCD diagnosed colonies prior to their collapse: rectum distension, Malpighian tubule iridescence, fecal matter consistency, rectal enteroliths (hard concretions), and venom sac color. The multiple differences in rectum symptomology in bees from CCD apiaries and colonies suggest effected bees had trouble regulating water. To ensure that pathologies we found associated with CCD were indeed pathologies and not due to normal changes in physical appearances that occur as an adult bee ages (CCD colonies are assumed to be composed mostly of young bees), we documented the changes in bees of different ages taken from healthy colonies. We found that young bees had much greater incidences of white nodules than older cohorts. Prevalent in newly-emerged bees, these white nodules or cellular encapsulations indicate an active immune response. Comparing the two sets of characteristics, we determined a subset of pathologies that reliably predict CCD status rather than bee age (fecal matter consistency, rectal distension size, rectal enteroliths and Malpighian tubule iridescence) and that may serve as biomarkers for colony health. In addition, these pathologies suggest that CCD bees are experiencing disrupted excretory physiology. Our identification of these symptoms is an important first step in understanding the physiological pathways that underlie CCD and factors impacting bee health.	[vanEngelsdorp, Dennis; Traynor, Kirsten S.; Lichtenberg, Elinor M.] Univ Maryland, Dept Entomol, Plant Sci Bldg, College Pk, MD 20742 USA; [Andree, Michael] Univ Calif Cooperat Extens, Cooperat Extens Butte Cty, Oroville, CA USA; [Lichtenberg, Elinor M.] Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA; [Chen, Yanping] USDA ARS, Bee Res Lab, Beltsville, MD USA; [Saegerman, Claude] Univ Liege, Fac Vet Med, Fundamental & Appl Res Anim & Hlth FARAH Ctr, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, Sart Tilman Par Liege, Belgium; [Cox-Foster, Diana L.] USDA ARS PWA, Pollinating Insect Biol, Mgmt Syst Res Unit, Logan, UT USA; [Cox-Foster, Diana L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	University System of Maryland; University of Maryland College Park; University of California System; University of Arizona; United States Department of Agriculture (USDA); University of Liege; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	vanEngelsdorp, D (corresponding author), Univ Maryland, Dept Entomol, Plant Sci Bldg, College Pk, MD 20742 USA.	dvane@umd.edu	Traynor, Kirsten/GWC-1553-2022; Lichtenberg, Elinor M./I-4126-2012; vanEngelsdorp, Dennis/E-7934-2010; Lichtenberg, Elinor M./AAG-6251-2020	Saegerman, Claude/0000-0001-9087-7436; Traynor, Kirsten/0000-0002-0848-4607; Lichtenberg, Elinor/0000-0002-2729-4534	Pennsylvania Department of Agriculture; US National Honey Board; Pennsylvania State University, Department of Entomology	Pennsylvania Department of Agriculture; US National Honey Board; Pennsylvania State University, Department of Entomology	The following provided funding for this study: Pennsylvania Department of Agriculture (DVE, DCF), US National Honey Board (DVE, DCF), and the Pennsylvania State University, Department of Entomology (DCF, DVE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila JR, 2007, J EXP BIOL, V210, P956, DOI 10.1242/jeb.001586; Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; [Anonymous], 2014, R LANG ENV STAT COMP; Barron AB, 2015, CURR OPIN INSECT SCI, V10, P45, DOI 10.1016/j.cois.2015.04.004; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bedick JC, 2001, COMP BIOCHEM PHYS C, V130, P107, DOI 10.1016/S1532-0456(01)00226-5; Beyenbach KW, 2003, J EXP BIOL, V206, P3845, DOI 10.1242/jeb.00639; Breiman L., 1984, CLASSIFICATION REGRE; CALDERONE NW, 1988, BEHAV ECOL SOCIOBIOL, V22, P17, DOI 10.1007/BF00395694; Carreck NL, 2015, J APICULT RES, V52, P1; Christensen R., 2013, R PACKAGE VERSION 20, P08; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dade H.A., 1994, ANATOMY DISSECTION H; Dow J. A. T., 1987, ADV INSECT PHYSIOL, V19, P187, DOI [DOI 10.1016/S0065-2806(08)60102-2, 10.1016/S0065-2806(08)60102-2]; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Engel P, 2015, MBIO, V6, DOI 10.1128/mBio.00193-15; Erickson E, 1997, J INVERTEBR PATHOL, V70, P27, DOI 10.1006/jipa.1997.4663; Evans JM, 2005, J EXP BIOL, V208, P3771, DOI 10.1242/jeb.01829; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; FYG W, 1964, ANNU REV ENTOMOL, V9, P207, DOI 10.1146/annurev.en.09.010164.001231; Fyg W, 1960, Z BIENENFORSCH, V5, P93; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Graham JM, 1992, HIVE HONEY BEE, Vxxv; Gramigni E, 2011, X-RAY SPECTROM, V40, P186, DOI 10.1002/xrs.1308; Gurvits GE, 2014, WORLD J GASTROENTERO, V20, P17819, DOI 10.3748/wjg.v20.i47.17819; Hertig M., 1923, Journal of Parasitology Urbana, V9, P109; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; Hothorn T, 2015, SIMULTANEOUS INFEREN; Isidori AM, 2014, EUR UROL, V65, P99, DOI 10.1016/j.eururo.2013.08.048; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kacaniova M, 2004, FOLIA MICROBIOL, V49, P169, DOI 10.1007/BF02931394; KUMMEL G, 1974, CYTOBIOLOGIE, V9, P432; Lacey Lawrence A., 1997, P1, DOI 10.1016/B978-012432555-5/50004-X; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; LIU TP, 1985, J INVERTEBR PATHOL, V46, P125, DOI 10.1016/0022-2011(85)90140-5; Lothmar R, 1946, FLAGELLATEN BAKTERIE, P49; Maiolino P., 2014, VET MED ANIM SCI, V2, P4, DOI [10.7243/2054-3425-2-4, DOI 10.7243/2054-3425-2-4]; MARTIGNONI ME, 1964, ANNU REV ENTOMOL, V9, P179, DOI 10.1146/annurev.en.09.010164.001143; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Miller J, 2013, J UROLOGY, V190, P1648, DOI 10.1016/j.juro.2013.03.010; Nation J, 2005, ENCY ENTOMOLOGY, P65; Nicolson SW, 2009, J EXP BIOL, V212, P429, DOI 10.1242/jeb.022343; Page RE, 1995, ANIM BEHAV, V50, P1617, DOI 10.1016/0003-3472(95)80015-8; PAGE RE, 1991, ADV INSECT PHYSIOL, V23, P117, DOI 10.1016/S0065-2806(08)60093-4; Peng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10565; Pennsylvania State University College of Agricultural Sciences Mid-Atlantic Apiculture Research and Extension Consortium United_ States_ Department_ of_ Agriculture, 2011, FIELD GUIDE HONEY BE; Pettis JS, 2010, APIDOLOGIE, V41, P256, DOI 10.1051/apido/2010013; Porter RS, 2011, TRANSBOUND EMERG DIS, V58, P197, DOI 10.1111/j.1865-1682.2010.01196.x; Rada V, 1997, APIDOLOGIE, V28, P357, DOI 10.1051/apido:19970603; Rennich K., 2012, 2011 2012 NATL HONEY; Ritter W., 2006, HONEY BEE DIS PESTS; Saegerman C, 2015, TRANSBOUND EMERG DIS, V62, P46, DOI 10.1111/tbed.12070; Saegerman C, 2011, REV SCI TECH OIE, V30, P555; Saegerman C, 2014, CLIN SENTINEL SURVEI; Sammataro D, 2015, J APICULT RES, V52, P1; Sammataro D, 2006, INT J ACAROL, V32, P339, DOI 10.1080/01647950608684479; Santos DE, 2015, PROTOPLASMA, V252, P619, DOI 10.1007/s00709-014-0707-z; Satyavathi VV, 2014, CELL SIGNAL, V26, P1753, DOI 10.1016/j.cellsig.2014.02.024; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; Seeley TD, 1995, WISDOM HIVE SOCIAL P, VXIV; Seitz N, 2016, J APICULT RES, P1; Shimanuki H., 2000, DIAGNOSIS HONEY BEE; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Snow JW, 2016, J INVERTEBR PATHOL, V135, P10, DOI 10.1016/j.jip.2016.01.007; SOHAL RS, 1976, TISSUE CELL, V8, P447, DOI 10.1016/0040-8166(76)90005-7; Spivak M., 2006, HONEY BEE DIS PESTS; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; The National Bee Unit, 2015, COMM PESTS DIS DIS A, P20; Trappmann W., 1923, Archiv fuer Bienenkunde, V5, P190; Tursi A, 2015, ALIMENT PHARM THER, V42, P664, DOI 10.1111/apt.13322; VanEngelsdorp D, 2007, FALL DWINDLE DIS INV; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vanengelsdorp D, 2009, J INVERTEBR PATHOL, V101, P147, DOI 10.1016/j.jip.2009.03.008; WEIL ERNEST, 1935, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V30, P438, DOI 10.1007/BF00410842; White G. F., 1919, Bulletin United States Department of Agriculture, V780; World Organization for Animal Health (OIE), 2016, NOS HON BEES MAN DIA; Zanella G, 2013, TRANSBOUND EMERG DIS, V60, P231, DOI 10.1111/j.1865-1682.2012.01334.x	88	42	45	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0179535	10.1371/journal.pone.0179535	http://dx.doi.org/10.1371/journal.pone.0179535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715431	Green Published, gold, Green Submitted			2022-12-27	WOS:000443975500003
J	Jamei, M; Nisnevich, A; Wetchler, E; Sudat, S; Liu, E				Jamei, Mehdi; Nisnevich, Aleksandr; Wetchler, Everett; Sudat, Sylvia; Liu, Eric			Predicting all-cause risk of 30-day hospital readmission using artificial neural networks	PLOS ONE			English	Article							HEART-FAILURE; MODELS	Avoidable hospital readmissions not only contribute to the high costs of healthcare in the US, but also have an impact on the quality of care for patients. Large scale adoption of Electronic Health Records (EHR) has created the opportunity to proactively identify patients with high risk of hospital readmission, and apply effective interventions to mitigate that risk. To that end, in the past, numerous machine-learning models have been employed to predict the risk of 30-day hospital readmission. However, the need for an accurate and real-time predictive model, suitable for hospital setting applications still exists. Here, using data from more than 300,000 hospital stays in California from Sutter Health's EHR system, we built and tested an artificial neural network (NN) model based on Google's TensorFlow library. Through comparison with other traditional and non-traditional models, we demonstrated that neural networks are great candidates to capture the complexity and interdependency of various data fields in EHRs. LACE, the current industry standard, showed a precision (PPV) of 0.20 in identifying high-risk patients in our database. In contrast, our NN model yielded a PPV of 0.24, which is a 20% improvement over LACE. Additionally, we discussed the predictive power of Social Determinants of Health (SDoH) data, and presented a simple cost analysis to assist hospitalists in implementing helpful and cost-effective post-discharge interventions.	[Jamei, Mehdi; Nisnevich, Aleksandr; Wetchler, Everett; Liu, Eric] Bayes Impact, Technol 501 c3 Nonprofit, San Francisco, CA 94103 USA; [Sudat, Sylvia] Sutter Hlth, Res Dev & Disseminat, Walnut Creek, CA USA		Jamei, M (corresponding author), Bayes Impact, Technol 501 c3 Nonprofit, San Francisco, CA 94103 USA.	mehdi@bayesimpact.org; keuters@sutterhealth.org		Upadhyaya, Kirtan/0000-0002-0708-0141; Jamei, Mehdi/0000-0003-0658-9621	Robert Wood Johnson Foundation;  [33676]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); 	Robert Wood Johnson Foundation (www.rwjf.org) funded this study through a grant. Eric Liu was awarded grant #33676. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi  M., 2016, ARXIV160304467; Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; [Anonymous], 2015, SOCIAL EXPLORER TABL; Bayati M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109264; Chollet F., 2015, KERAS DEEP LEARNING; Commission MPA, 2007, REP C PROM GREAT EFF; Futoma J, 2015, J BIOMED INFORM, V56, P229, DOI 10.1016/j.jbi.2015.05.016; Gerhardt G, 2012, MED MED RES REV, V2013, P3; Goodman D, 2013, REVOLVING DOOR REPOR; Hao SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140271; He DN, 2014, J AM MED INFORM ASSN, V21, P272, DOI 10.1136/amiajnl-2013-002151; Ho TK, 1995, P 3 INT C DOC AN REC; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; McIlvennan CK, 2015, CIRCULATION, V131, P1796, DOI 10.1161/CIRCULATIONAHA.114.010270; McKinney W., 2010, P 9 PYTH SCI C, DOI DOI 10.25080/MAJORA-92BF1922-00A; Meyer PA, 2013, MMWR-MORBID MORTAL W, V62, P3; Navathe A., 2016, AC HLTH ANN RES M BO; QGIS A., 2015, FREE OP SOURC GEOGR; Rockville M., 2015, HOSP GUIDE REDUCING; Shams I, 2015, HEALTH CARE MANAG SC, V18, P19, DOI 10.1007/s10729-014-9278-y; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117	22	61	62	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181173	10.1371/journal.pone.0181173	http://dx.doi.org/10.1371/journal.pone.0181173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708848	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800045
J	Zhang, YX; Yu, CS; Lin, JZ; Liu, J; Liu, B; Wang, J; Huang, AB; Li, HY; Zhao, T				Zhang, Yongxing; Yu, Chunsheng; Lin, Jianzhong; Liu, Jun; Liu, Bin; Wang, Jian; Huang, Aobo; Li, Hongyu; Zhao, Tao			OsMPH1 regulates plant height and improves grain yield in rice	PLOS ONE			English	Article							SECONDARY WALL BIOSYNTHESIS; 2ND GREEN-REVOLUTION; MYB TRANSCRIPTION FACTORS; KINASE GENE FAMILY; CELL-SURFACE; ARABIDOPSIS; EXPRESSION; NAC; DNA	Plant height is a major trait affecting yield potential in rice. Using a large-scale hybrid transcription factor approach, we identified the novel MYB-like transcription factor OsMPH1 (MYB-like gene of Plant Height 1), which is involved in the regulation of plant height in rice. Overexpression of OsMPH1 leads to increases of plant height and grain yield in rice, while knockdown of OsMPH1 leads to the opposite phenotypes. Microscopy of longitudinal stem sections indicated that a change in internode cell length resulted in the change in plant height. RNA sequencing (RNA-seq) analysis of transgenic rice lines showed that multiple genes related to cell elongation and cell wall synthesis, which are associated with plant height and yield phenotypes, exhibited an altered expression profile. These results imply that OsMPH1 might be involved in specific recognition and signal transduction processes related to plant height and yield formation, providing further insights into the mechanisms underlying the regulation of plant height and providing a candidate gene for the efficient improvement of rice yield.	[Zhang, Yongxing; Yu, Chunsheng; Liu, Jun; Liu, Bin; Huang, Aobo; Li, Hongyu; Zhao, Tao] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Lin, Jianzhong] Hunan Univ, Coll Biol, Hunan Prov Key Lab Plant Funct Genom & Dev Regula, Changsha, Hunan, Peoples R China; [Wang, Jian] Ningxia Acad Agr & Forestry Sci, Crop Res Inst, Ningxia, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Hunan University	Li, HY; Zhao, T (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	lihongyu@caas.cn; zhaotao02@caas.cn		Zhao, Tao/0000-0002-5641-8161	Ministry of Agriculture Transgenic Research Grant [2010ZX08010-002]; National Natural Science Foundation of China [3157101834]; CAAS Innovation Program	Ministry of Agriculture Transgenic Research Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAAS Innovation Program	This study design, data collection and analysis, decision to publish, or preparation of the manuscripThis work is supported in part by Ministry of Agriculture Transgenic Research Grant 2010ZX08010-002 awarded to the Institute of Crop Science Chinese Academy of Agricultural Sciences and by the National Natural Science Foundation of China (3157101834 to T.Z) and the CAAS Innovation Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassan-Wang H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00189; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang DB, 2015, PLANT CELL, V27, P1681, DOI 10.1105/tpc.15.00015; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kim WC, 2013, PLANT J, V73, P26, DOI 10.1111/j.1365-313x.2012.05124.x; Ko JH, 2012, MOL PLANT, V5, P961, DOI 10.1093/mp/sss076; Ko JH, 2009, PLANT J, V60, P649, DOI 10.1111/j.1365-313X.2009.03989.x; Lally D, 2001, PLANT CELL, V13, P1317, DOI 10.1105/tpc.13.6.1317; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; Meng YY, 2013, PLANT CELL, V25, P4405, DOI 10.1105/tpc.113.116590; Mooney BP, 2009, BIOCHEM J, V418, P219, DOI 10.1042/BJ20081769; Palme K, 2014, J GENET GENOMICS, V41, P315, DOI 10.1016/j.jgg.2014.05.003; Steffen A, 1994, PLANT J, V5, P421; de Oliveira LFV, 2014, PLANT SCI, V229, P181, DOI 10.1016/j.plantsci.2014.09.007; Verica JA, 2002, PLANT PHYSIOL, V129, P455, DOI 10.1104/pp.011028; Wollenweber B, 2005, CURR OPIN PLANT BIOL, V8, P337, DOI 10.1016/j.pbi.2005.03.001; Xu TD, 2014, SCIENCE, V343, P1025, DOI 10.1126/science.1245125; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Ye YF, 2015, PLANT MOL BIOL, V89, P385, DOI 10.1007/s11103-015-0376-0; Zhao T, 2015, SCI CHINA LIFE SCI, V58, P1160, DOI 10.1007/s11427-015-4937-x; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325	26	23	26	16	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180825	10.1371/journal.pone.0180825	http://dx.doi.org/10.1371/journal.pone.0180825			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708834	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800024
J	Wang, HL; Zhang, J; Sun, QL; Lian, C; Sun, L				Wang, Hai-liang; Zhang, Jian; Sun, Qing-lei; Lian, Chao; Sun, Li			A comparative study revealed first insights into the diversity and metabolisms of the microbial communities in the sediments of Pacmanus and Desmos hydrothermal fields	PLOS ONE			English	Article							BACK-ARC BASIN; COMPLETE GENOME SEQUENCE; EASTERN MANUS BASIN; DEEP-SEA SEDIMENTS; PHYLOGENETIC DIVERSITY; VENT FIELD; EPSILON-PROTEOBACTERIA; SULFUR OXIDATION; IHEYA NORTH; GEN. NOV.	Currently, little is known about the microbial diversity in the sediments of Pacmanus and Desmos hydrothermal fields in Manus Basin. In this study, Illumina-based sequencing of 16S rRNA gene amplicons and metagenomic analysis were conducted to investigate the microbial populations and metabolic profiles in the sediments from four different regions in Pacmanus and Desmos hydrothermal fields. It was found that Gammaproteobacteria and Thaumarchaeota were the most abundant bacterial and archaeal populations, respectively. The autotrophic prokaryotes in the four communities probably fixed CO2 via four major pathways, i.e. Calvin-Benson-Bassham cycle, reductive acetyl-CoA cycle, rTCA cycle, and 3-hydroxypropionate/ 4-hydroxybutyrate cycle. Ammonia- oxidizing Thaumarchaeota, nitrifiers, denitrifiers, and sulfur oxidizers belonging to the subgroups of Proteobacteria (e.g., alpha, beta, gamma, and epsilon), Nitrospira, and Nitrospina, and sulfate-reducing Desulfobacterales likely played critical roles in nitrogen and sulfur cycling, in which ammonia, sulfur compounds, and hydrogen could be utilized as potential energy sources. These findings revealed new insights into the operational mechanism of the microbial communities associated with Pacmanus and Desmos hydrothermal fields.	[Wang, Hai-liang; Zhang, Jian; Sun, Qing-lei; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Hai-liang; Zhang, Jian; Sun, Qing-lei; Sun, Li] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Wang, Hai-liang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lian, Chao] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Geol & Environm, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.; Sun, L (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	lsun@qdio.ac.cn			Strategic Biological Resources Service Network Plan of Chinese Academy of Sciences [ZSSD-005]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11030401]; Scientific & Technological Innovation Projects - Qingdao National Laboratory for Marine Science and Technology [2016ASKJ14, 2016ASKJ05]; Taishan Scholar Program of Shandong Province	Strategic Biological Resources Service Network Plan of Chinese Academy of Sciences; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Scientific & Technological Innovation Projects - Qingdao National Laboratory for Marine Science and Technology; Taishan Scholar Program of Shandong Province	This work was supported by the grants from the Strategic Biological Resources Service Network Plan of Chinese Academy of Sciences (ZSSD-005), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA11030401), the Scientific & Technological Innovation Projects supported by Qingdao National Laboratory for Marine Science and Technology (No. 2016ASKJ14 and No. 2016ASKJ05), and the Taishan Scholar Program of Shandong Province. We thank there search vessel KEXUE of the Chinese Academy of Sciences for collecting samples and WPOS sample center for providing samples	Anantharaman K, 2016, ISME J, V10, P225, DOI 10.1038/ismej.2015.81; Anantharaman K, 2013, P NATL ACAD SCI USA, V110, P330, DOI 10.1073/pnas.1215340110; Binns R.A., 2007, PAP NEW GUIN P OC DR, P1, DOI DOI 10.2973/ODP.PROC.SR.193.201.2007; Bock E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P457, DOI 10.1007/0-387-30742-7_16; Bothe H, 2000, FEMS MICROBIOL REV, V24, P673, DOI 10.1111/j.1574-6976.2000.tb00566.x; Burow LC, 2014, GEOBIOLOGY, V12, P221, DOI 10.1111/gbi.12080; Cao HL, 2014, MBIO, V5, DOI 10.1128/mBio.00980-13; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerqueira T, 2015, MAR GENOM, V24, P343, DOI 10.1016/j.margen.2015.09.001; Cheng TW, 2014, MICROBES ENVIRON, V29, P377, DOI 10.1264/jsme2.ME14086; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Feng WW, 2011, INT BIODETER BIODEGR, V65, P1081, DOI 10.1016/j.ibiod.2011.05.009; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GAMO T, 1993, DEEP-SEA RES PT I, V40, P2335, DOI 10.1016/0967-0637(93)90108-F; Gamo T, 1997, GEOLOGY, V25, P139, DOI 10.1130/0091-7613(1997)025<0139:AASRHF>2.3.CO;2; Gena K, 2001, RESOUR GEOL, V51, P31, DOI 10.1111/j.1751-3928.2001.tb00079.x; Gena KR, 2006, RESOUR GEOL, V56, P183, DOI 10.1111/j.1751-3928.2006.tb00278.x; Guo JH, 2016, ENVIRON MICROBIOL, V18, P2979, DOI 10.1111/1462-2920.13132; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Huber JA, 2010, FEMS MICROBIOL ECOL, V73, P538, DOI 10.1111/j.1574-6941.2010.00910.x; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Hug LA, 2016, ENVIRON MICROBIOL, V18, P159, DOI 10.1111/1462-2920.12930; Inagaki F, 2004, INT J SYST EVOL MICR, V54, P1477, DOI 10.1099/ijs.0.03042-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Khelifi N, 2014, ISME J, V8, P2153, DOI 10.1038/ismej.2014.58; Kimura H, 2003, APPL ENVIRON MICROB, V69, P644, DOI 10.1128/AEM.69.1.644-648.2003; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kouridaki I, 2010, INT MICROBIOL, V13, P143, DOI 10.2436/20.1501.01.119; Lee CS, 2006, SCI TOTAL ENVIRON, V356, P45, DOI 10.1016/j.scitotenv.2005.03.024; Lenk S, 2012, ISME J, V6, P2178, DOI 10.1038/ismej.2012.66; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maugeri TL, 2013, ATTI ACCAD PELORIT, V91, DOI 10.1478/AAPP.912A1; McDermott JM, 2015, GEOCHIM COSMOCHIM AC, V160, P169, DOI 10.1016/j.gca.2015.02.016; Mino S, 2014, INT J SYST EVOL MICR, V64, P3195, DOI 10.1099/ijs.0.065094-0; Monecke T, 2007, J VOLCANOL GEOTH RES, V160, P23, DOI 10.1016/j.jvolgeores.2006.08.007; Moss R, 2001, CAN MINERAL, V39, P957, DOI 10.2113/gscanmin.39.4.957; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Nakagawa T, 2004, FEMS MICROBIOL LETT, V232, P145, DOI 10.1016/S0378-1097(04)00044-8; Nercessian O, 2005, ENVIRON MICROBIOL, V7, P698, DOI 10.1111/j.1462-2920.2005.00744.x; Nilsen RK, 1996, INT J SYST BACTERIOL, V46, P397, DOI 10.1099/00207713-46-2-397; Ontiveros-Valencia A, 2013, FEMS MICROBIOL ECOL, V85, P158, DOI 10.1111/1574-6941.12107; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Plewniak F, 2013, MOL ECOL, V22, P4870, DOI 10.1111/mec.12432; Plugge CM, 2012, STAND GENOMIC SCI, V7, P91, DOI 10.4056/sigs.2996379; Reed AJ, 2009, DEEP-SEA RES PT II, V56, P1665, DOI 10.1016/j.dsr2.2009.05.012; Reeves EP, 2011, GEOCHIM COSMOCHIM AC, V75, P1088, DOI 10.1016/j.gca.2010.11.008; Ruff SE, 2015, P NATL ACAD SCI USA, V112, P4015, DOI 10.1073/pnas.1421865112; Schauer R, 2011, ENVIRON MICROBIOL, V13, P2633, DOI 10.1111/j.1462-2920.2011.02530.x; Seitz KW, 2016, ISME J, V10, P1696, DOI 10.1038/ismej.2015.233; Sikorski J, 2010, STAND GENOMIC SCI, V3, P194, DOI 10.4056/sigs.1173118; Sun QL, 2015, WORLD J MICROB BIOT, V31, P2025, DOI 10.1007/s11274-015-1953-8; Takai K, 2001, APPL ENVIRON MICROB, V67, P3618, DOI 10.1128/AEM.67.8.3618-3629.2001; Takai K, 2009, ENVIRON MICROBIOL, V11, P1983, DOI 10.1111/j.1462-2920.2009.01921.x; Taketani RG, 2010, J MICROBIOL, V48, P7, DOI 10.1007/s12275-009-0147-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka N, 2011, INT J SYST EVOL MICR, V61, P412, DOI 10.1099/ijs.0.020263-0; Taubner Ruth-Sophie, 2015, Life-Basel, V5, P1652, DOI 10.3390/life5041652; Thal J, 2014, MAR GEOL, V355, P98, DOI 10.1016/j.margeo.2014.05.011; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trubitsyn IV, 2013, MICROBIOLOGY+, V82, P15, DOI 10.1134/S0026261713010153; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wang L, 2015, J BASIC MICROB, V55, P1308, DOI 10.1002/jobm.201400811; Wang XY, 2014, APPL MICROBIOL BIOT, V98, P1883, DOI 10.1007/s00253-013-5174-5; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Winkel M, 2014, ENVIRON MICROBIOL, V16, P1612, DOI 10.1111/1462-2920.12316; Wu YH, 2014, ACTA OCEANOL SIN, V33, P94, DOI 10.1007/s13131-014-0544-0; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144; Yamamoto M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00192; Yanagawa K, 2014, APPL ENVIRON MICROB, V80, P6126, DOI 10.1128/AEM.01741-14; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhang J, 2015, MICROBIOL RES, V177, P43, DOI 10.1016/j.micres.2015.05.006; Zhou JZ, 2011, NAT REV MICROBIOL, V9, P452, DOI 10.1038/nrmicro2575; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	87	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181048	10.1371/journal.pone.0181048	http://dx.doi.org/10.1371/journal.pone.0181048			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704556	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600055
J	Liu, XD; Sun, L; Chen, JG; Jin, YY; Liu, Q; Xia, ZN; Wang, L; Li, JJ				Liu, Xudong; Sun, Lin; Chen, Jugang; Jin, Yingying; Liu, Qing; Xia, Zhongnan; Wang, Liang; Li, Jingjie			Effects of local cardiac denervation on cardiac innervation and ventricular arrhythmia after chronic myocardial infarction	PLOS ONE			English	Article							SUDDEN-DEATH; SYMPATHETIC DENERVATION; STELLATE GANGLION; HEART-FAILURE; CANINE MODEL; STIMULATION; PREVENTION; INHIBITION; METOPROLOL; ISCHEMIA	Background Modulation of the autonomic nervous system (ANS) has already been demonstrated to display antiarrhythmic effects in patients and animals with MI. In this study, we investigated whether local cardiac denervation has any beneficial effects on ventricular electrical stability and cardiac function in the chronic phase of MI. Methods Twenty-one anesthetized dogs were randomly assigned into the sham-operated, MI and MI-ablation groups, respectively. Four weeks after local cardiac denervation, LSG stimulation was used to induce VPCs and VAs. The ventricular fibrillation threshold (VFT) and the incidence of inducible VPCs were measured with electrophysiological protocol. Cardiac innervation was determined with immunohistochemical staining of growth associated protein-43 (GAP43) and tyrosine hydroxylase (TH). The global cardiac and regional ventricular function was evaluated with doppler echocardiography in this study. Results Four weeks after operation, the incidence of inducible VPC and VF in MI-ablation group were significantly reduced compared to the MI dogs (p<0.05). Moreover, local cardiac denervation significantly improved VFT in the infarcted border zone (p<0.05). The densities of GAP43 and TH-positive nerve fibers in the infarcted border zone in the MI-ablation group were lower than those in the MI group (p<0.05). However, the local cardiac denervation did not significantly improve cardiac function in the chronic phase of MI, determined by the left ventricle diameter (LV), left atrial diameter (LA), ejection fraction (EF). Conclusions Summarily, in the chronic phase of MI, local cardiac denervation reduces the ventricular electrical instability, and attenuates spatial heterogeneity of sympathetic nerve reconstruction. Our study suggests that this methodology might decrease malignant ventricular arrhythmia in chronic MI, and has a great potential for clinical application.	[Liu, Xudong; Sun, Lin; Jin, Yingying; Liu, Qing; Xia, Zhongnan; Wang, Liang; Li, Jingjie] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Chen, Jugang] Xingxiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Xinxiang City, Henan, Peoples R China	Harbin Medical University; Xinxiang Medical University	Li, JJ (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China.	lijingjie1968@126.com		Li, Jing-jie/0000-0001-6569-9578	Scientific Research Projects of Heilongjiang Province [201403, 201607]	Scientific Research Projects of Heilongjiang Province	This work was supported by Scientific Research Projects of Heilongjiang Province, Award Number 201403 (Recipient: Jingjie Li); and Scientific Research Projects of Heilongjiang Province, Award Number: 201607 (Recipient: Jingjie Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTZ M, 1995, J CARDIOVASC PHARM, V26, P627, DOI 10.1097/00005344-199510000-00019; Bangalore S, 2007, J AM COLL CARDIOL, V50, P563, DOI 10.1016/j.jacc.2007.04.060; BARBER MJ, 1983, CIRCULATION, V67, P787, DOI 10.1161/01.CIR.67.4.787; BISTENI A, 1953, CIRCULATION, V7, P523, DOI 10.1161/01.CIR.7.4.523; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Chen JG, 2015, INT J CARDIOL, V184, P667, DOI 10.1016/j.ijcard.2015.03.057; COETZEE WA, 1987, CIRC RES, V61, P157, DOI 10.1161/01.RES.61.2.157; Grimaldi R, 2012, HEART RHYTHM, V9, P1884, DOI 10.1016/j.hrthm.2012.08.007; Han S, 2012, J AM COLL CARDIOL, V59, P954, DOI 10.1016/j.jacc.2011.11.030; He B, 2013, INT J CARDIOL, V168, P86, DOI 10.1016/j.ijcard.2012.09.067; Issa ZF, 2005, CIRCULATION, V111, P3217, DOI 10.1161/CIRCULATIONAHA.104.507897; Linz D, 2013, HEART RHYTHM, V10, P1525, DOI 10.1016/j.hrthm.2013.07.015; Manousiouthakis E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4918; OLSSON G, 1985, J AM COLL CARDIOL, V5, P1428, DOI 10.1016/S0735-1097(85)80360-0; Pouliopoulos J, 2009, PACE, V32, P851, DOI 10.1111/j.1540-8159.2009.02399.x; Samaan A, 1935, J PHYSIOL-LONDON, V83, P332, DOI 10.1113/jphysiol.1935.sp003232; STEINBECK G, 1992, NEW ENGL J MED, V327, P987, DOI 10.1056/NEJM199210013271404; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Ukena C, 2012, CLIN RES CARDIOL, V101, P63, DOI 10.1007/s00392-011-0365-5; VANOLI E, 1991, CIRC RES, V68, P1471, DOI 10.1161/01.RES.68.5.1471; Vaseghi M, 2014, HEART RHYTHM, V11, P360, DOI 10.1016/j.hrthm.2013.11.028; Yan SH, 2008, CLIN INVEST MED, V31, pE198; Zhou S, 2008, HEART RHYTHM, V5, P131, DOI 10.1016/j.hrthm.2007.09.007; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	25	7	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181322	10.1371/journal.pone.0181322	http://dx.doi.org/10.1371/journal.pone.0181322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732009	Green Published, Green Submitted, gold			2022-12-27	WOS:000406643100031
J	Oh, TK; Jeon, JH; Lee, JM; Kim, MS; Kim, JH; Cho, H; Kim, SE; Eom, W				Oh, Tak Kyu; Jeon, Jae Hyun; Lee, Jong Mog; Kim, Moon Soo; Kim, Jee Hee; Cho, Hyeyeon; Kim, Seong-eun; Eom, Woosik			Investigation of opioid use and long-term oncologic outcomes for non-small cell lung cancer patients treated with surgery	PLOS ONE			English	Article							POSTOPERATIVE COMPLICATIONS; ANESTHETIC TECHNIQUE; RECURRENCE; PROGRESSION; RESECTION; RECEPTOR; IMPACT	Opioids are commonly used for postoperative pain control in cancer patients. In addition to pain control, an association between opioid use and long-term oncologic outcomes, such as recurrence or overall survival, has been postulated. The aim of this study was to determine whether postoperative opioid use in patients with non-small cell lung cancer is associated with long-term oncologic outcomes, including recurrence and death. Data obtained from 1009 medical records of patients who underwent curative resection at the National Cancer Center, Korea between January 2006 and December 2010 were retrospectively analyzed. Seven-day opioid use was divided into four quartiles to analyze probability of recurrence and death. Multivariate regression analyses of recurrence and death was conducted, including the calculation of odds ratios. A total of 871 patients were analyzed. When opioid dosage was examined by quartiles, the probability of death and recurrence increased gradually with increasing opioid use. However, in the multivariate regression analysis, the amount of opioid usage did not affect the risk of recurrence or death of lung cancer (P = 0.520 for recurrence; P = 0.659 for death). Opioid use was correlated with outcome when stratified by lung cancer stage (P = 0.004 for recurrence; P = 0.049 for death); however, the odds ratios only slightly increased (1.001 for stage IA-IIIA) for both outcomes. In non-small cell lung cancer patients, the amount of opioid usage does not affect the risk of recurrence and death of lung cancer. There was an association with stage (IA-IIIA), but the effect was negligible. A well-designed prospective study is needed.	[Oh, Tak Kyu] Seoul Natl Univ, Dept Anesthesiol & Pain Med, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea; [Jeon, Jae Hyun; Lee, Jong Mog; Kim, Moon Soo] Natl Canc Ctr, Dept Thorac Surg, 323 Ilsan Ro, Goyang Si, Gyeonggi Do, South Korea; [Kim, Jee Hee; Cho, Hyeyeon; Eom, Woosik] Natl Canc Ctr, Dept Anesthesiol & Pain Med, 323 Ilsan Ro, Goyang Si, Gyeonggi Do, South Korea; [Kim, Seong-eun] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, Gyeonggi Do, South Korea	Seoul National University (SNU); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Seoul National University (SNU)	Eom, W (corresponding author), Natl Canc Ctr, Dept Anesthesiol & Pain Med, 323 Ilsan Ro, Goyang Si, Gyeonggi Do, South Korea.	uchic@ncc.re.kr	Lee, Jeong Min/V-3429-2019	Lee, Jeong Min/0000-0003-0561-8777; eom, woosik/0000-0003-1524-0325				Benzon H, 2008, RAJS PRACTICAL MANAG; Bharati SJ, 2016, J CANCER RES THER, V12, P464, DOI 10.4103/0973-1482.148670; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Cata JP, 2011, EUR J PAIN S, V5, P345, DOI DOI 10.1016/J.EUJPS.2011.08.017; Cata JP, 2014, CANCER MED-US, V3, P900, DOI 10.1002/cam4.236; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Hesker Pamela Rose, 2013, Front Biosci (Schol Ed), V5, P575; JACOX A, 1994, AM FAM PHYSICIAN, V49, P1853; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Law WL, 2007, ANN SURG ONCOL, V14, P2559, DOI 10.1245/s10434-007-9434-4; Lennon FE, 2012, ANESTHESIOLOGY, V116, P940, DOI 10.1097/ALN.0b013e31824b9512; Lerut T, 2009, ANN SURG, V250, P798, DOI 10.1097/SLA.0b013e3181bdd5a8; Maher DP, 2014, BRIT J ANAESTH, V113, P88, DOI 10.1093/bja/aeu192; Mathew B, 2011, ANESTH ANALG, V112, P558, DOI 10.1213/ANE.0b013e31820568af; O'Bryant Cindy L, 2008, J Pain Palliat Care Pharmacother, V22, P282, DOI 10.1080/15360280802537241; Patanwala AE, 2007, ANN PHARMACOTHER, V41, P255, DOI 10.1345/aph.1H421; Pearson FG, 1999, CHEST, V116, p500S, DOI 10.1378/chest.116.suppl_3.500S; SJOSTROM S, 1987, ANESTHESIOLOGY, V67, P877; Taylor MD, 2012, ANN THORAC SURG, V93, P1813, DOI 10.1016/j.athoracsur.2012.03.031; Zylla D, 2014, BR J ANAESTH	21	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181672	10.1371/journal.pone.0181672	http://dx.doi.org/10.1371/journal.pone.0181672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732026	Green Published, gold, Green Submitted			2022-12-27	WOS:000406643100054
J	Amara, VR; Surapaneni, SK; Tikoo, K				Amara, Venkateswara Rao; Surapaneni, Sunil Kumar; Tikoo, Kulbhushan			Dysregulation of microRNAs and reninangiotensin system in high salt diet-induced cardiac dysfunction in uninephrectomized rats	PLOS ONE			English	Article							ANGIOTENSIN-II; CALCIUM-CHANNELS; BLOOD-PRESSURE; FOLLOW-UP; HYPERTENSION; HYPERTROPHY; HEART; ACTIVATION; MECHANISMS; IMPAIRMENT	Uninephrectomy is not associated with major adverse events in cardiovascular and renal functions of live kidney donors. The effect of high salt diet on the quality of life of live kidney donors is largely unknown. Hence in this study, we aimed to determine the effect of high salt diet on the alterations of renin-angiotensin system and microRNAs leading to CV and renal dysfunction in uninephrectomized rats. In order to mimic clinical scenario, uninephrectomized male Sprague Dawley rats were fed initially with normal pellet diet for 12 weeks and then for 20 weeks with high salt (10% w/w NaCl) diet. At the end of the study, biochemical, functional, histological and molecular parameters were measured. High salt diet feeding resulted in renal dysfunction & fibrosis, decreased baroreflex sensitivity, increased in vivo cardiovascular reactivity to angiotensin II owing to upregulation of angiotensin II type 1 receptors and L-type calcium channels leading to cardiovascular dysfunction in uninephrectomized rats (UNX+ HSD) worse than that of normal (binephric) rats fed with high salt diet (HSD). Protein expression of functional and hypertrophic protein markers revealed decreased SERCA, p-AMPK and increased p-AKT. Interestingly, levels of miR-25, miR-451 and miR-155 increased and miR-99 decreased in heart of uninephrectomized rats fed with high salt. However, circulating miR-25 and miR-451 levels decreased and miR-99b increased in these animals. Our study points out that since tissue and circulating levels of miRNAs are not similar, caution must be exercised during the usage of miRs as diagnostic or prognostic biomarkers. To our knowledge, we are the first to show that epigenetic alterations result in cardiac dysfunction in uninephrectomized rats fed with high salt diet.	[Amara, Venkateswara Rao; Surapaneni, Sunil Kumar; Tikoo, Kulbhushan] NIPER, Dept Pharmacol & Toxicol, Lab Epigenet & Dis, Sas Nagar, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Tikoo, K (corresponding author), NIPER, Dept Pharmacol & Toxicol, Lab Epigenet & Dis, Sas Nagar, Punjab, India.	tikoo.k@gmail.com	Amara, Venkateswara Rao/AGJ-6417-2022; Amara, Venkateswara Rao/U-1081-2019; Amara, Venkateswara Rao/AGP-0388-2022		National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar; National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar, India	National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar; National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar, India	National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wholeheartedly thank National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar, India for supporting this research work. We are grateful to Umashanker Navik for his selfless help in histological data collection and analysis. We owe a lot to Pinakin Arun Karpe, Yogesh Kumar Bulani, Krishna Prahlad Maremanda, Sandeep Kumar and Sabbir Khan for their technical advice.	Arsenijevic D, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00195; Arun KHS, 2005, CARDIOVASC RES, V65, P374, DOI 10.1016/j.cardiores.2004.10.010; Belke DD, 2004, CURR HYPERTENS REP, V6, P424, DOI 10.1007/s11906-004-0035-3; Bernardi S, 2012, NEPHROL DIAL TRANSPL, V27, P1793, DOI 10.1093/ndt/gfr600; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bhat S, 2010, INDIAN J UROL, V26, P167, DOI 10.4103/0970-1591.65381; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Carlstrom M, 2007, HYPERTENSION, V49, P1342, DOI 10.1161/HYPERTENSIONAHA.107.087213; Crestani S, 2014, VASC PHARMACOL, V60, P67, DOI 10.1016/j.vph.2013.12.001; Delanaye P, 2012, NEPHROL DIAL TRANSPL, V27, P41, DOI 10.1093/ndt/gfr669; Do KH, 2009, EXP MOL MED, V41, P569, DOI 10.3858/emm.2009.41.8.062; Drenjancevic-Peric I, 2011, KIDNEY BLOOD PRESS R, V34, P1, DOI 10.1159/000320387; Gai ZB, 2014, BBA-MOL BASIS DIS, V1842, P1870, DOI 10.1016/j.bbadis.2014.07.001; Gao F, 2014, PPAR RES, V2014, DOI 10.1155/2014/491963; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gossmann J, 2005, AM J TRANSPLANT, V5, P2417, DOI 10.1111/j.1600-6143.2005.01037.x; Gupta Sushil, 2013, Indian J Endocrinol Metab, V17, P806, DOI 10.4103/2230-8210.117212; HALL JE, 1986, J HYPERTENS, V4, pS57; Holte K, 2002, BRIT J ANAESTH, V89, P622, DOI 10.1093/bja/aef220; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Joly E, 2005, CLIN EXP PHARMACOL P, V32, P241, DOI 10.1111/j.1440-1681.2005.04181.x; Juric D, 2007, AM J PHYSIOL-HEART C, V292, pH2138, DOI 10.1152/ajpheart.00852.2006; Kanaide H, 2003, CIRC RES, V93, P1015, DOI 10.1161/01.RES.0000105920.33926.60; Kanellis J, 2010, NEPHROLOGY, V15, pS72, DOI 10.1111/j.1440-1797.2009.01212.x; Karpe PA, 2012, J HYPERTENS, V30, P132, DOI 10.1097/HJH.0b013e32834d9efe; Katori M, 2006, J PHARMACOL SCI, V100, P370, DOI 10.1254/jphs.CRJ06003X; Khaliq F, 2013, CARDIOVASC TOXICOL, V13, P68, DOI 10.1007/s12012-012-9187-6; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kuwabara Y, 2015, CIRC RES, V116, P279, DOI 10.1161/CIRCRESAHA.116.304707; Landsberg L, 2013, OBESITY, V21, P8, DOI 10.1002/oby.20181; Lang HM, 2015, BRIT J PHARMACOL, V172, P5548, DOI 10.1111/bph.12987; Lehnart SE, 1998, ANN NY ACAD SCI, V853, P220, DOI 10.1111/j.1749-6632.1998.tb08270.x; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Luke Robert G, 2007, Trans Am Clin Climatol Assoc, V118, P1; Pacurari M, 2014, INT J INFLAMM, V2014, DOI 10.1155/2014/689360; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Radhika G, 2007, J Assoc Physicians India, V55, P405; Ramcharan T, 2002, AM J TRANSPLANT, V2, P959, DOI 10.1034/j.1600-6143.2002.21013.x; Rao AD, 2016, DIABETES, V65, P209, DOI 10.2337/db15-0871; Romaine SPR, 2015, HEART, V101, P921, DOI 10.1136/heartjnl-2013-305402; Sakai N, 2008, J HYPERTENS, V26, P780, DOI 10.1097/HJH.0b013e3282f3e9e6; Schefold JC, 2016, NAT REV NEPHROL, V12, P610, DOI 10.1038/nrneph.2016.113; Schroder F, 1998, CIRCULATION, V98, P969, DOI 10.1161/01.CIR.98.10.969; Seok HY, 2014, CIRC RES, V114, P1585, DOI 10.1161/CIRCRESAHA.114.303784; Taylor TA, 2003, HYPERTENSION, V41, P657, DOI 10.1161/01.HYP.0000048193.85814.78; Ufnal M, 2011, BRIT J NUTR, V106, P292, DOI 10.1017/S0007114511000110; United States Renal Data System, 2016, EXPL TRIAL EV SAF IM; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang F, 2014, FRONT MED-PRC, V8, P404, DOI 10.1007/s11684-014-0379-2; Wang HX, 2013, MICRO NANO LETT, V8, P11, DOI 10.1049/mnl.2012.0776; WCRFI Alliance TN, 2014, LINK FOOD NUTR DIET; Wende AR, 2015, MOL CELL BIOL, V35, P831, DOI 10.1128/MCB.01109-14; Williams JM, 2004, HYPERTENSION, V44, P770, DOI 10.1161/01.HYP.0000144073.42537.06; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794	56	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180490	10.1371/journal.pone.0180490	http://dx.doi.org/10.1371/journal.pone.0180490			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727756	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500023
J	Ellis-Soto, D; Blake, S; Soultan, A; Guezou, A; Cabrera, F; Lotters, S				Ellis-Soto, Diego; Blake, Stephen; Soultan, Alaaeldin; Guezou, Anne; Cabrera, Fredy; Loetters, Stefan			Plant species dispersed by Galapagos tortoises surf the wave of habitat suitability under anthropogenic climate change	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; SEED DISPERSAL; DISTRIBUTIONS; VEGETATION; INVASIONS; IMPACT; CONSEQUENCES; ECOSYSTEMS; ISLANDS; MODELS	Native biodiversity on the Galapagos Archipelago is severely threatened by invasive alien species. On Santa Cruz Island, the abundance of introduced plant species is low in the arid lowlands of the Galapagos National Park, but increases with elevation into unprotected humid highlands. Two common alien plant species, guava (Psidium guajava) and passion fruit (Passiflora edulis) occur at higher elevations yet their seeds are dispersed into the lowlands by migrating Galapagos tortoises (Chelonoidis spp.). Tortoises transport large quantities of seeds over long distances into environments in which they have little or no chance of germination and survival under current climate conditions. However, climate change is projected to modify environmental conditions on Galapagos with unknown consequences for the distribution of native and introduced biodiversity. We quantified seed dispersal of guava and passion fruit in tortoise dung piles and the distribution of adult plants along two elevation gradients on Santa Cruz to assess current levels of 'wasted' seed dispersal. We computed species distribution models for both taxa under current and predicted future climate conditions. Assuming that tortoise migratory behaviour continues, current levels of "wasted" seed dispersal in lowlands were projected to decline dramatically in the future for guava but not for passion fruit. Tortoises will facilitate rapid range expansion for guava into lowland areas within the Galapagos National Park where this species is currently absent. Coupled with putative reduction in arid habitat for native species caused by climate change, tortoise driven guava invasion will pose a serious threat to local plant communities.	[Ellis-Soto, Diego; Blake, Stephen; Soultan, Alaaeldin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Ellis-Soto, Diego; Soultan, Alaaeldin] Univ Konstanz, Dept Biol, Constance, Germany; [Ellis-Soto, Diego; Loetters, Stefan] Trier Univ, Biogeog, Trier, Germany; [Blake, Stephen] Univ Missouri, Whitney R Harris World Ecol Ctr, St Louis, MO 63121 USA; [Blake, Stephen] St Louis Zoo, WildCare Inst, St Louis, MO USA; [Blake, Stephen] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Blake, Stephen] SUNY Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Blake, Stephen; Guezou, Anne; Cabrera, Fredy] Charles Darwin Fdn, Santa Cruz, Galapagos, Ecuador	Max Planck Society; University of Konstanz; Universitat Trier; University of Missouri System; University of Missouri Saint Louis; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Ellis-Soto, D (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.; Ellis-Soto, D (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.; Ellis-Soto, D (corresponding author), Trier Univ, Biogeog, Trier, Germany.	dellis@orn.mpg.de	Soultan, Alaaeldin/AGW-5311-2022	Soultan, Alaaeldin/0000-0002-3976-2657	National Science Foundation [1258062]; National Geographic Society Committee for Research and Exploration; Swiss Friends of Galapagos; Galapagos Conservation Trust; Max Planck Institute for Ornithology; Direct For Biological Sciences [1258062] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Geographic Society Committee for Research and Exploration(National Geographic Society); Swiss Friends of Galapagos; Galapagos Conservation Trust; Max Planck Institute for Ornithology(Max Planck Society); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors (SB) received funding from the National Science Foundation Grant No. 1258062 https://www.nsf.gov/awardsearch/ showAward?AWD_ID=1258062), the National Geographic Society Committee for Research and Exploration, the Swiss Friends of Galapagos, the Galapagos Conservation Trust, and the Max Planck Institute for Ornithology.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], CAN WE INFER ISLAND; [Anonymous], BIOMOD2 ENSEMBLE PLA; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Auffret AG, 2014, DIVERS DISTRIB, V20, P1450, DOI 10.1111/ddi.12251; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bensted-Smith, 2002, BIODIVERSITY VISION; Bertelsmeier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075438; Blake S, 2015, BIOTROPICA, V47, P246, DOI 10.1111/btp.12195; Blake S, 2013, J ANIM ECOL, V82, P310, DOI 10.1111/1365-2656.12020; Blake S, 2012, J BIOGEOGR, V39, P1961, DOI 10.1111/j.1365-2699.2011.02672.x; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Buddenhagen C, 2006, ORNITOL NEOTROP, V17, P73; BUSBY J R, 1991, Plant Protection Quarterly, V6, P8; Caccone A, 2002, EVOLUTION, V56, P2052; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Cain ML, 2003, ECOLOGY, V84, P1943, DOI 10.1890/01-0614; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Clarke L, 2007, SCENARIOS GREENHOUSE, V6; Colinvaux PA, KEY ENV GALAPAGOS; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dullinger S, 2004, J ECOL, V92, P241, DOI 10.1111/j.0022-0477.2004.00872.x; Dulloo ME, 2002, INT FOREST REV, V4, P277, DOI 10.1505/ifor.4.4.277.40525; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P94, DOI 10.1016/j.cbpa.2010.09.007; Fryxell JM, 2013, ECOLOGY, V94, P1274, DOI 10.1890/12-0668.1; Gardener MR, 2010, RESTOR ECOL, V18, P20, DOI 10.1111/j.1526-100X.2009.00614.x; Goodland T. C. R., 1998, CONTROL MANAGEMENT I; Guezou A, 2014, C DARWIN FDN GALAPAG, P180; Heleno R, 2011, INTEGR ZOOL, V6, P110, DOI 10.1111/j.1749-4877.2011.00236.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Hijmans RJ, 2012, SPECIES DISTRIBUTION; Hosmer DW, 1997, STAT MED, V16, P965; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jaramillo Diaz P, 2014, C DARWIN FDN GALAPAG; Kluzek E, 2010, TECHNICAL DESCRIPTIO; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Lambertini M, 2011, SCIENCE, V333, P404, DOI 10.1126/science.333.6041.404-b; Leon MG, 2012, INFORME GALAPAGOS, P44; MACE GM, 1983, AM NAT, V121, P120, DOI 10.1086/284043; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meyer JY, 1996, J BIOGEOGR, V23, P775, DOI 10.1111/j.1365-2699.1996.tb00038.x; Middleton AD, 2013, ECOLOGY, V94, P1245, DOI 10.1890/11-2298.1; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Orwa C, 2009, AGROFORESTRY TREE DA; Cordeiro JLP, 2016, PEERJ, V4, DOI 10.7717/peerj.2456; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Poulakakis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138779; Poulakakis N, 2012, MOL ECOL, V21, P160, DOI 10.1111/j.1365-294X.2011.05370.x; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Reaser JK, 2007, ENVIRON CONSERV, V34, P98, DOI 10.1017/S0376892907003815; Rojas- Sandoval J, 2016, COMPENDIUM; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sheppard CS, 2014, GLOBAL CHANGE BIOL, V20, P2800, DOI 10.1111/gcb.12531; Snell HM, 1996, J BIOGEOGR, V23, P619, DOI 10.1111/j.1365-2699.1996.tb00022.x; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Trueman M, 2014, BIOL CONSERV, V172, P37, DOI 10.1016/j.biocon.2014.02.005; Trueman Mandy, 2010, Galapagos Research, V67, P26; Trueman M, 2010, BIOL INVASIONS, V12, P3949, DOI 10.1007/s10530-010-9822-8; Tye A, 2006, BIOL INVASIONS, V8, P201, DOI 10.1007/s10530-004-3574-2; Tye A., 2001, Weed risk assessment, P153; Venables WN., 2002, MODERN APPL STAT S 4; Vitousek PM, 1996, AM SCI, V84, P468; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Watson J, 2010, ORYX, V44, P79, DOI 10.1017/S0030605309990226; Weber E., 2003, INVASIVE PLANT SPECI; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiggins IL, 1971, FLORA GALAPAGOS ISLA; Yackulic CB, J ANIM ECOL; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	83	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181333	10.1371/journal.pone.0181333	http://dx.doi.org/10.1371/journal.pone.0181333			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727747	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500059
J	Connor, DO; Danckert, L; Hoppe, S; Bier, FF; von Nickisch-Rosenegk, M				Connor, Daniel O.; Danckert, Lena; Hoppe, Sebastian; Bier, Frank F.; von Nickisch-Rosenegk, Markus			Epitope determination of immunogenic proteins of Neisseria gonorrhoeae	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MODEL QUALITY; I-TASSER; RECOGNITION; PEPTIDE; IDENTIFICATION; LOCALIZATION; FLEXIBILITY; SPECIFICITY; PREVALENCE	Neisseria gonorrhoeae is the causative organism of gonorrhoea, a sexually transmitted disease that globally accounts for an estimated 80 to 100 million new infections per year. Increasing resistances to all common antibiotics used for N. gonorrhoeae treatment pose the risk of an untreatable disease. Further knowledge of ways of infection and host immune response are needed to understand the pathogen-host interaction and to discover new treatment alternatives against this disease. Therefore, detailed information about immunogenic proteins and their properties like epitope sites could advance further research in this area. In this work, we investigated immunogenic proteins of N. gonorrhoeae for linear epitopes by microarrays. Dominant linear epitopes were identified for eleven of the nineteen investigated proteins with three polyclonal rabbit antibodies from different immunisations. Identified linear epitopes were further examined for non-specific binding with antibodies to Escherichia coli and the closely related pathogen Neisseria meningitidis. On top of that, amino acids crucial for the antibody epitope binding were detected by microarray based alanine scans.	[Connor, Daniel O.; Danckert, Lena; Hoppe, Sebastian; von Nickisch-Rosenegk, Markus] Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc, Dept Mol & Cellular Bioanalyt, Potsdam, Germany; [Bier, Frank F.] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Bier, Frank F.] Fraunhofer Inst Cell Therapy & Immunol, Dept Automat, Branch Bioanalyt & Bioproc, Potsdam, Germany	Fraunhofer Gesellschaft; University of Potsdam; Fraunhofer Gesellschaft	Connor, DO (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc, Dept Mol & Cellular Bioanalyt, Potsdam, Germany.	Daniel.Connor@izi-bb.fraunhofer.de	Bier, Frank/AAN-2532-2020	Bier, Frank/0000-0003-0375-9832	German Federal Ministry of Education and Research [03I52201A]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grant 03I52201A of the German Federal Ministry of Education and Research (www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Bennett JE, 2015, MANDELL DOUGLAS BENN; Bignell C, 2013, INT J STD AIDS, V24, P85, DOI 10.1177/0956462412472837; CDC, 2014, REP STDS US; CDC, 2015, GONOCOCCAL INFECT 20; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Connor DO, 2016, PLOS ONE, P11; Cordeiro AT, 2007, J MOL BIOL, V372, P1215, DOI 10.1016/j.jmb.2007.07.021; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Gaseitsiwe S, 2010, CLIN VACCINE IMMUNOL, V17, P168, DOI 10.1128/CVI.00208-09; HANDSFIELD HH, 1974, NEW ENGL J MED, V290, P117, DOI 10.1056/NEJM197401172900301; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Hoppe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110703; Hoppe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065837; HORSFALL AC, 1991, IMMUNOL TODAY, V12, P211, DOI 10.1016/0167-5699(91)90029-S; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Jw T, 1994, SEX TRANSM DIS, V22, P310; KAWULA TH, 1987, MOL MICROBIOL, V1, P179, DOI 10.1111/j.1365-2958.1987.tb00510.x; Kim DH, 2014, ACTA CRYSTALLOGR D, V70, P3273, DOI 10.1107/S1399004714023931; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kovach AR, 2014, RNA, V20, P1548, DOI 10.1261/rna.044032.113; Nisemblat S, 2015, P NATL ACAD SCI USA, V112, P6044, DOI 10.1073/pnas.1411718112; Pariser H, 1976, Cutis, V17, P723; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shigematsu H, 2000, HEPATOLOGY, V32, P901, DOI 10.1053/jhep.2000.18714; Song KY, 2013, J GEN VIROL, V94, P1510, DOI 10.1099/vir.0.052084-0; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Tanaka M, 2000, J CLIN MICROBIOL, V38, P521, DOI 10.1128/JCM.38.2.521-525.2000; Tapsall JW, 2009, CURR OPIN INFECT DIS, V22, P87, DOI 10.1097/QCO.0b013e328320a836; Unemo M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0009-2015; VIRJI M, 1989, J GEN MICROBIOL, V135, P1895; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; Wang J, 2003, J MOL BIOL, V327, P843, DOI 10.1016/S0022-2836(03)00184-0; Wang JJ, 2014, J BIOL CHEM, V289, P15215, DOI 10.1074/jbc.M113.544080; Wang LF, 2004, CURR DRUG TARGETS, V5, P1, DOI 10.2174/1389450043490668; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; World Health Organization, 2015, SEX TRANSM INF STIS; Yang HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152186; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	47	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180962	10.1371/journal.pone.0180962	http://dx.doi.org/10.1371/journal.pone.0180962			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723967	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800034
J	Tien, SH; Crabtree, JN; Gray, HL; Peterson, EJ				Tien, Shelly H.; Crabtree, Juliet N.; Gray, Heather L.; Peterson, Erik J.			Immunologic response to vaccine challenge in pregnant PTPN22 R620W carriers and non-carriers	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; INFLUENZA VACCINE; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; VIRUS ILLNESS; T-CELLS; WOMEN; IMMUNIZATION; MONOVALENT; PROFILES	Objectives Influenza infection is a significant cause of respiratory morbidity among pregnant women. Seasonal influenza vaccination engages innate immune receptors to promote protective immunity. A coding polymorphism (R620W) in PTPN22 imparts elevated risk for human infection and autoimmune disease, predisposes to diminished innate immune responses, and associates with reduced immunization responses. We sought to quantify the effects of PTPN22-R620W on humoral and cell-mediated immune responses to the inactivated influenza vaccine among healthy pregnant women. Study Design Immune responses were measured in healthy pregnant R620W carrier (n = 17) and non-carrier (n = 33) women receiving the 2013 quadrivalent inactivated influenza vaccine (Fluzone). Hemagglutination inhibition assays were performed to quantify neutralizing antibodies; functional influenza-reactive CD4 T cells were quantified by flow cytometry, and influenza-specific CD8 T cells were enumerated with MHC Class I tetramers. Antibody seroconversion data were evaluated by Chi-square analysis, and the Mann-Whitney or Wilcoxon signed-rank tests were applied to T cell response data. Results PTPN22 R620W carrier (n = 17) and non-carrier (n = 33) groups did not differ in age, parity, BMI, gestational age at time of vaccine, or history of prior influenza vaccination. After Fluzone exposure, 51.5% of non-carriers met criteria for antibody seroconversion to H1N1 influenza, compared with 23.5% of R620W carriers (p = 0.06). Influenza-reactive CD4 T cells showed modest increase at days 9-15 after vaccination in both R620W carriers and non-carriers (p = 0.02 and p = 0.04, respectively). However, there was no difference inoverall response between the two groups (p = 0.6). The vaccine did not result in significant induction of influenza-specific CD8 T cells in either group. Conclusions There was no significant difference among healthy pregnant R620W carriers and non-carriers in H1N1 antibody seroconversion rates after influenza vaccination. Studies of larger cohorts will be needed to define the effect of PTPN22 risk allele carriage on antibody and T cell responses to influenza vaccination during pregnancy.	[Tien, Shelly H.; Gray, Heather L.] Univ Minnesota, Dept Obstet Gynecol & Womens Hlth, Div Maternal Fetal Med, Minneapolis, MN 55455 USA; [Crabtree, Juliet N.; Peterson, Erik J.] Univ Minnesota, Dept Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Crabtree, Juliet N.; Peterson, Erik J.] Univ Minnesota, Dept Med, Div Rheumat & Autoimmune Dis, Minneapolis, MN 55455 USA; [Tien, Shelly H.] Northshore Univ Hlth Syst, Ctr Maternal & Fetal Hlth, Evanston, IL 60201 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; NorthShore University Health System	Tien, SH (corresponding author), Univ Minnesota, Dept Obstet Gynecol & Womens Hlth, Div Maternal Fetal Med, Minneapolis, MN 55455 USA.; Tien, SH (corresponding author), Northshore Univ Hlth Syst, Ctr Maternal & Fetal Hlth, Evanston, IL 60201 USA.	shtien@gmail.com		Crabtree, Juliet/0000-0003-4921-0087	National Center for Advancing Translational Sciences of National Institutes of Health [UL1TR000114]; University of Minnesota Center for Health Equity from National Institute on Minority Health and Health Disparities [1P6OMD003433]; Department of Obstetrics, Gynecology, and Women's Health, Division of Maternal-Fetal Medicine fellowship research stipend; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of National Institutes of Health; University of Minnesota Center for Health Equity from National Institute on Minority Health and Health Disparities; Department of Obstetrics, Gynecology, and Women's Health, Division of Maternal-Fetal Medicine fellowship research stipend; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. http://www. ctsi.umn.edu/about-ctsa-award. The University of Minnesota Center for Health Equity, 1P6OMD003433 from the National Institute on Minority Health and Health Disparities. http://www.umnche.umn.edu/. The Department of Obstetrics, Gynecology, and Women's Health, Division of Maternal-Fetal Medicine fellowship research stipend. http://www.obgyn.umn.edu/educational-opportunities/maternal-fetel-medicinefellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg AF, 2015, VACCINE, V33, P500, DOI 10.1016/j.vaccine.2014.11.054; Andrews NJ, 2011, VACCINE, V29, P7913, DOI 10.1016/j.vaccine.2011.08.076; [Anonymous], 2014, Obstet Gynecol, V124, P648, DOI 10.1097/01.AOG.0000453599.11566.11; [Anonymous], COMPELLING NEED GAME; [Anonymous], 2013, MMWR RECOMM REP; [Anonymous], PLOS ONE; Arimura Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000966; Berger CT, 2015, HUM VACC IMMUNOTHER, V11, P391, DOI 10.1080/21645515.2015.1008930; Bottini N, 2014, ANNU REV IMMUNOL, V32, P83, DOI 10.1146/annurev-immunol-032713-120249; BUGAWAN TL, 1994, TISSUE ANTIGENS, V44, P137, DOI 10.1111/j.1399-0039.1994.tb02371.x; Chapman SJ, 2006, NAT GENET, V38, P499, DOI 10.1038/ng0506-499; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Couch R B, 2003, Dev Biol (Basel), V115, P25; Crabtree JN, 2016, J INFECT DIS, V214, P248, DOI 10.1093/infdis/jiw126; Dolfi DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077164; Dolfi DV, 2013, J LEUKOCYTE BIOL, V93, P825, DOI 10.1189/jlb.0912438; Faucette AN, 2015, HUM REPROD UPDATE, V21, P119, DOI 10.1093/humupd/dmu041; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Heer AK, 2007, J IMMUNOL, P178; Hegewald MJ, 2011, CLIN CHEST MED, V32, P1, DOI 10.1016/j.ccm.2010.11.001; Jackson LA, 2011, J INFECT DIS, V204, P854, DOI 10.1093/infdis/jir440; Jamieson DJ, 2012, AM J OBSTET GYNECOL, V207, pS17, DOI 10.1016/j.ajog.2012.06.070; Jegaskanda S, 2013, J VIROL, V87, P13706, DOI 10.1128/JVI.01666-13; Kay AW, 2014, P NATL ACAD SCI USA, V111, P14506, DOI 10.1073/pnas.1416569111; Kourtis AP, 2014, NEW ENGL J MED, P371; Krnic EK, 2008, SCAND J IMMUNOL, V67, P86, DOI 10.1111/j.1365-3083.2007.02042.x; Lobermann M, 2012, AUTOIMMUN REV, V11, P212, DOI 10.1016/j.autrev.2011.05.015; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mahnke YD, 2011, VACCINE, V29, P8606, DOI 10.1016/j.vaccine.2011.09.019; Nasr R, 2012, CURR OPIN RHEUMATOL, V24, P609, DOI 10.1097/BOR.0b013e3283585731; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Schlaudecker EP, 2012, J INFECT DIS, V206, P1670, DOI 10.1093/infdis/jis592; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Thompson MG, 2014, CLIN INFECT DIS, V58, P449, DOI 10.1093/cid/cit750; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Tsatsaris V, 2011, ANN INTERN MED, V155, P733, DOI 10.7326/0003-4819-155-11-201112060-00005; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	47	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181338	10.1371/journal.pone.0181338	http://dx.doi.org/10.1371/journal.pone.0181338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723925	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800044
J	Imohl, M; Fitzner, C; Perniciaro, S; van der Linden, M				Imoehl, Matthias; Fitzner, Christina; Perniciaro, Stephanie; van der Linden, Mark			Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014	PLOS ONE			English	Article							INFECTIONS; PROFILE; EUROPE	A nationwide laboratory-based surveillance study of invasive S. pyogenes infections was conducted in Germany. Invasive isolates (n = 719) were obtained between 2009 and 2014. Most isolates were obtained from blood (92.1%). The proportions of isolates from cerebrospinal fluid, pleural fluid, synovial fluid and peritoneal fluid were 3.9%, 1.8%, 1.7% and 0.6%, respectively. The most common emm types were emm 1 (31.8%), emm 28 (15.4%) and emm 89 (14.5%). The most common superantigen genes (speA, speC, speG, speH, speI, speJ, speK, speL, speM, ssa) identified from S. pyogenes were speG (92.1%), speJ (50.9%), and speC (42.0%). Significant associations of superantigen genes with underlying conditions or risks were observed in speG, speH, speJ, and speK. Significant associations between emm types or superantigen genes with clinical complications were observed in emm type 3 and in superantigen gene speA 1-3. Most frequent clinical manifestations included sepsis 59.4%, STSS 6.3%, meningitis 5.4%, and necrotizing fasciitis 5.0% (significantly associated with emm1).	[Imoehl, Matthias; Perniciaro, Stephanie; van der Linden, Mark] Univ Hosp RWTH, Inst Med Microbiol, Aachen, Germany; [Imoehl, Matthias; Perniciaro, Stephanie; van der Linden, Mark] Univ Hosp RWTH, Natl Reference Ctr Streptococci, Aachen, Germany; [Fitzner, Christina] Univ Hosp RWTH, Dept Med Stat, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Imohl, M (corresponding author), Univ Hosp RWTH, Inst Med Microbiol, Aachen, Germany.; Imohl, M (corresponding author), Univ Hosp RWTH, Natl Reference Ctr Streptococci, Aachen, Germany.	mimoehl@ukaachen.de	Imöhl, Matthias/P-5014-2014; van der Linden, Mark/B-9305-2009; Perniciaro, Stephanie R/J-3669-2017; Fitzner, Christina/H-6431-2013	Imöhl, Matthias/0000-0002-8372-0251; van der Linden, Mark/0000-0002-6574-4313; Perniciaro, Stephanie R/0000-0002-3146-2182; 				BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Commons RJ, 2014, TRENDS MOL MED, V20, P48, DOI 10.1016/j.molmed.2013.10.004; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Ekelund K, 2005, J CLIN MICROBIOL, V43, P1789, DOI 10.1128/JCM.43.4.1789-1796.2005; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Friaes A, 2013, INT J MED MICROBIOL, V303, P505, DOI 10.1016/j.ijmm.2013.07.004; Ikebe T, 2007, EPIDEMIOL INFECT, V135, P1227, DOI 10.1017/S0950268807007984; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Lamagni T L, 2005, Euro Surveill, V10, P179; Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08; Lintges M, 2007, INT J MED MICROBIOL, V297, P471, DOI 10.1016/j.ijmm.2007.03.015; Lintges M, 2010, J INFECT DIS, V202, P20, DOI 10.1086/653082; Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Martin J, 2011, EURO SURVEILL, V16; Meehan M, 2013, EUROSURVEILLANCE, P18; O'Grady KAF, 2007, MED J AUSTRALIA, V186, P565, DOI 10.5694/j.1326-5377.2007.tb01054.x; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; PODBIELSKI A, 1991, MED MICROBIOL IMMUN, V180, P213; Schmitz FJ, 2003, J INFECT DIS, V188, P1578, DOI 10.1086/379230; Siljander T, 2010, EUR J CLIN MICROBIOL, V29, P1229, DOI 10.1007/s10096-010-0989-9; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Vikerfors A, 2009, SCAND J INFECT DIS, V41, P823, DOI 10.3109/00365540903179749; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vlaminckx BJM, 2003, J CLIN MICROBIOL, V41, P4941, DOI 10.1128/JCM.41.11.4941-4949.2003; Wahl RU, 2007, CLIN MICROBIOL INFEC, V13, P1173, DOI 10.1111/j.1469-0691.2007.01821.x; Zakikhany K, 2011, EUROSURVEILLANCE, P16	30	24	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180757	10.1371/journal.pone.0180757	http://dx.doi.org/10.1371/journal.pone.0180757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719668	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400016
J	Moreno, X; Albala, C; Lera, L; Sanchez, H; Fuentes-Garcia, A; Dangour, AD				Moreno, Ximena; Albala, Cecilia; Lera, Lydia; Sanchez, Hugo; Fuentes-Garcia, Alejandra; Dangour, Alan D.			The role of gender in the association between self-rated health and mortality among older adults in Santiago, Chile: A cohort study	PLOS ONE			English	Article							BODY-MASS INDEX; FOLLOW-UP; SOCIOECONOMIC INEQUALITIES; 5-YEAR MORTALITY; LIFE EXPECTANCY; PREDICTORS; WOMEN; RISK; MEN; DISABILITY	Background Previous studies on the role of gender in the association between self-rated health and mortality have shown contrasting results. This study was aimed to determine the importance of gender in the association between self-rated health and mortality among older people in Santiago, Chile. Methods A 10 year follow-up of 1066 people aged 60 or more, from the Chilean cohort of the Study of Health, Ageing and Well-Being. Self-rated health was assessed in face to face interviews through a single general question, along with socio-demographic and health status information. Cox proportional hazards and flexible parametric models for survival analyses were employed. Results By the end of follow-up, 30.7% of women and 39.4% of men died. Adjusted hazard ratio of poor self-rated health, compared to good self-rated health, was 1.92(95% CI 1.29-2.86). In models stratified by gender, an increased risk of mortality was observed among women who rated their health as poor (HR = 2.21, 95% CI 1.43-3.40), but not among men (HR = 1.04, 95% CI 0.58-1.86). Age was associated with mortality in both groups; for men, functional limitation and underweight were also risk factors and obesity was a protective factor. Conclusions Compared to older women who rated their health as good, older women who rated their health as poor had a 2 fold increased risk of mortality over the subsequent 10 years. These findings stress the importance of considering a gender perspective into health programmes, including those focused on older people, in order to address the different elements that increase, on the long run, the risk of dying among older women and men.	[Moreno, Ximena; Albala, Cecilia; Lera, Lydia; Sanchez, Hugo] Univ Chile, Inst Nutr & Food Technol, ElLibano 5524, Santiago, Chile; [Fuentes-Garcia, Alejandra] Univ Chile, Publ Hlth Sch, Fac Med, Ave Independencia 939, Santiago, Chile; [Dangour, Alan D.] London Sch Hyg & Trop Med, Dept Populat Hlth, Fac Epidemiol & Populat Hlth, London, England	Universidad de Chile; Universidad de Chile; University of London; London School of Hygiene & Tropical Medicine	Albala, C (corresponding author), Univ Chile, Inst Nutr & Food Technol, ElLibano 5524, Santiago, Chile.	calbala@uchile.cl	Fuentes-García, Alejandra/N-7507-2018; Lera, Lydia/A-8508-2015; Albala, Cecilia/A-7260-2015	Fuentes-García, Alejandra/0000-0003-3094-1330; Lera, Lydia/0000-0001-7470-2433; Dangour, Alan/0000-0001-6908-1273; Moreno, Ximena/0000-0002-0586-4364	Chilean National Fund for Scientific and Technological Development [Fondecyt 1080589, 1130947]	Chilean National Fund for Scientific and Technological Development	This study was supported by the Chilean National Fund for Scientific and Technological Development (projects Fondecyt 1080589 and 1130947) http://www.conicyt.cl/fondecyt/. This funding institution played no role in the design, execution, analysis and interpretation of the data, nor writing of the study.	Aguilera X, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001676; Albala C, 2005, REV PANAM SALUD PUBL, V17, P307, DOI 10.1590/S1020-49892005000500003; Albala C, 2004, GERONTOLOGIST, V44, P550; ALBALA C, 2010, ESTUDIO NACL DEPENDE; Albala C, 2011, REV MED CHILE, V139, P1276, DOI [10.4067/S0034-98872011001000005, /S0034-98872011001000005]; Bath PA, 2003, GERONTOLOGIST, V43, P387, DOI 10.1093/geront/43.3.387; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Benyamini Y, 2003, GERONTOLOGIST, V43, P396, DOI 10.1093/geront/43.3.396; Cesari M, 2016, J AM MED DIR ASSOC, V17, P188, DOI 10.1016/j.jamda.2015.12.016; Chang SH, 2012, MATURITAS, V72, P175, DOI 10.1016/j.maturitas.2012.04.004; Cheng FW, 2016, OBESITY, V24, P2232, DOI 10.1002/oby.21612; DeCaria JE, 2012, INT J OBESITY, V36, P1141, DOI 10.1038/ijo.2012.29; Deeg DJH, 2005, DISABIL REHABIL, V27, P253, DOI 10.1080/09638280400006507; Deeg DJH, 2003, GERONTOLOGIST, V43, P376, DOI 10.1093/geront/43.3.376; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Franks P, 1996, HEALTH SERV RES, V31, P347; Fuentes-Garcia A, 2013, GAC SANIT, V27, P226, DOI 10.1016/j.gaceta.2012.11.005; Ganguli M, 2002, ARCH GEN PSYCHIAT, V59, P1046, DOI 10.1001/archpsyc.59.11.1046; Hansen H, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-39; Hays JC, 1996, J CLIN EPIDEMIOL, V49, P969, DOI 10.1016/0895-4356(96)00138-2; Helmer C, 1999, J GERONTOL B-PSYCHOL, V54, pS84, DOI 10.1093/geronb/54B.2.S84; IDLER EL, 1991, J GERONTOL, V46, pS55, DOI 10.1093/geronj/46.2.S55; Idler EL, 2003, GERONTOLOGIST, V43, P372, DOI 10.1093/geront/43.3.372; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Koch E, 2007, REV MED CHILE, V135, P1370, DOI /S0034-98872007001100002; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Lima-Costa MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144456; Lima-Costa MF, 2012, AM J EPIDEMIOL, V175, P228, DOI 10.1093/aje/kwr290; Lucicesare A, 2010, AGING CLIN EXP RES, V22, P255, DOI [10.1007/BF03324805, 10.3275/6625]; Lyyra TM, 2009, ARCH GERONTOL GERIAT, V48, P14, DOI 10.1016/j.archger.2007.09.004; Manderbacka K, 2003, SOC SCI MED, V56, P1447, DOI 10.1016/S0277-9536(02)00141-7; MCCALLUM J, 1994, AM J PUBLIC HEALTH, V84, P1100, DOI 10.2105/AJPH.84.7.1100; Moreno X, 2014, GAC SANIT, V28, P246, DOI 10.1016/j.gaceta.2013.07.006; Murata C, 2006, ARCH GERONTOL GERIAT, V43, P369, DOI 10.1016/j.archger.2006.01.002; Naseer M, 2016, EUR J CLIN NUTR, V70, P399, DOI 10.1038/ejcn.2015.196; Okamoto K, 2007, ARCH GERONTOL GERIAT, V45, P335, DOI 10.1016/j.archger.2007.02.002; Palloni A, 2007, J CROSS-CULT GERONTO, V22, P263, DOI 10.1007/s10823-006-9001-7; Price GM, 2006, AM J CLIN NUTR, V84, P449; Quiroga LP, 2004, REV MED CHILE, V132, P467; RUIGOMEZ A, 1995, AGE AGEING, V24, P113, DOI 10.1093/ageing/24.2.113; Sanchez RH, 2004, REV MED CHILE, V132, P453; Santiago LM, 2010, ARCH GERONTOL GERIAT, V51, pE88, DOI 10.1016/j.archger.2010.01.004; Sargent-Cox KA, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-18; Scott WK, 1997, J CLIN EPIDEMIOL, V50, P291, DOI 10.1016/S0895-4356(96)00365-4; Simons LA, 1996, AUST NZ J MED, V26, P40, DOI 10.1111/j.1445-5994.1996.tb02905.x; Spiers N, 2003, GERONTOLOGIST, V43, P406, DOI 10.1093/geront/43.3.406; van Doorn C, 1998, J GERONTOL B-PSYCHOL, V53, pS28, DOI 10.1093/geronb/53B.1.S28; Veronese N, 2015, OBES REV, V16, P1001, DOI 10.1111/obr.12309; Campos ACV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1666-9; Vogelsang EM, 2014, J GERONTOL B-PSYCHOL, V69, P612, DOI 10.1093/geronb/gbu013; Vuorisalmi M, 2005, J CLIN EPIDEMIOL, V58, P680, DOI 10.1016/j.jclinepi.2004.11.025; Wagner DC, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130241; World Bank, 2015, STATISTICS; Yu ESH, 1998, AM J EPIDEMIOL, V147, P880, DOI 10.1093/oxfordjournals.aje.a009542	54	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181317	10.1371/journal.pone.0181317	http://dx.doi.org/10.1371/journal.pone.0181317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3RW	28719627	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000406061400038
J	Steinborn, C; Klemd, AM; Sanchez-Campillo, AS; Rieger, S; Scheffen, M; Sauer, B; Garcia-Kaufer, M; Urech, K; Follo, M; Ucker, A; Kienle, GS; Huber, R; Grundemann, C				Steinborn, Carmen; Klemd, Amy Marisa; Sanchez-Campillo, Ann-Sophie; Rieger, Sophie; Scheffen, Marieke; Sauer, Barbara; Garcia-Kaeufer, Manuel; Urech, Konrad; Follo, Marie; Uecker, Annekathrin; Kienle, Gunver Sophia; Huber, Roman; Gruendemann, Carsten			Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN DENDRITIC CELLS; PANCREATIC-CANCER; MISTLETOE; MATURATION; ACTIVATION; THERAPY; LECTINS; STIMULATION; INHIBITION	Tumor cells have the capacity to secrete immunosuppressive substances in order to diminish dendritic cell (DC) activity and thereby escape from immune responses. The impact of mistletoe (Viscum album) extracts (VAE), which are frequently used as an additive anti-cancer therapy to stimulate the immune response, is still unknown. Using a human cellular system, the impact of two different VAE (VAEA + VAEI) on the maturation of human dendritic cells and on T cell function has been investigated using flow cytometry, automated fluorescence microscopy and cytokine bead array assays. Furthermore, we examined whether VAEI was able to counteract tumor-induced immunosuppression within this cellular system using a renal cancer cell model. The role of mistletoe lectin (ML) was analyzed using ML-specific antibodies and ML-depleted VAEI. VAEI and VAEA augmented the maturation of dendritic cells. VAEI abrogated tumor-induced immunosuppression of dendritic cells and both processes were partially mediated by ML since ML-depleted VAEI and ML-specific antibodies almost neutralized the rehabilitative effects of VAEI on DC maturation. Using these settings, co-culture experiments with purified CD4(+) T cells had no influence on T cell proliferation and activation but did have an impact on IFN-Upsilon secretion. The study provides a potential mode-of-action of VAE as an additive cancer therapy based on immunomodulatory effects. However, the impact on the in vivo situation has to be evaluated in further studies.	[Steinborn, Carmen; Klemd, Amy Marisa; Sanchez-Campillo, Ann-Sophie; Rieger, Sophie; Scheffen, Marieke; Sauer, Barbara; Garcia-Kaeufer, Manuel; Uecker, Annekathrin; Kienle, Gunver Sophia; Huber, Roman; Gruendemann, Carsten] Univ Freiburg, Ctr Complementary Med, Inst Infect Prevent & Hosp Epidemiol, Fac Med, Freiburg, Germany; [Urech, Konrad] Verein Krebsforsch, Arlesheim, Switzerland; [Follo, Marie] Univ Freiburg, Lighthouse Core Facil, Dept Med 1, Med Ctr,Fac Med, Freiburg, Germany	University of Freiburg; University of Freiburg	Grundemann, C (corresponding author), Univ Freiburg, Ctr Complementary Med, Inst Infect Prevent & Hosp Epidemiol, Fac Med, Freiburg, Germany.	carsten.gruendemann@uniklinik-freiburg.de	Garcia-Käufer, Manuel/AAF-8340-2020	Follo, Marie/0000-0002-3090-7442	Software AG foundation; DAMUSDONATA e.V.; Iscador AG; ABNOBA GmbH; Verein zur Forderung der Naturheilkunde am Universitatsklinikum Freiburg e.V.	Software AG foundation; DAMUSDONATA e.V.; Iscador AG; ABNOBA GmbH; Verein zur Forderung der Naturheilkunde am Universitatsklinikum Freiburg e.V.	CG and CS have been financed by the Software AG foundation and DAMUSDONATA e.V.. The study was kindly financially supported by the Iscador AG, ABNOBA GmbH and the Verein zur Forderung der Naturheilkunde am Universitatsklinikum Freiburg e.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bantel H, 1999, CANCER RES, V59, P2083; Chen X, 2017, ONCOTARGET, P5; Elluru SR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-161; Frantz M, 2000, ARZNEIMITTEL-FORSCH, V50, P471; FRANZ H, 1986, ONCOLOGY, V43, P23, DOI 10.1159/000226417; Fricke I, 2006, IMMUNOL INVEST, V35, P459, DOI 10.1080/08820130600803429; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Horneber MA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003297.pub2; Huber R, 2005, EUR J MED RES, V10, P411; Huber Roman, 2006, J Soc Integr Oncol, V4, P3; Huber R, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-116; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; JAGGY C, 1995, ARZNEIMITTEL-FORSCH, V45-2, P905; Kelter G, 2007, ANTICANCER RES, V27, P223; Kienle GS, 2010, INTEGR CANCER THER, V9, P142, DOI 10.1177/1534735410369673; Lechmann M, 2002, INT ARCH ALLERGY IMM, V129, P113, DOI 10.1159/000065883; Oosterhoff D, 2012, ONCOIMMUNOLOGY, V1, P649, DOI 10.4161/onci.20365; Podlech O, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/501796; Rostock M, 2005, ANTICANCER RES, V25, P1969; Saha C, 2016, MOLECULES, V21, DOI 10.3390/molecules21070912; Schad F, 2014, INTEGR CANCER THER, V13, P332, DOI 10.1177/1534735413513637; Seifert G, 2008, CANCER LETT, V264, P218, DOI 10.1016/j.canlet.2008.01.036; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Sombroek CC, 2002, J IMMUNOL, V168, P4333, DOI 10.4049/jimmunol.168.9.4333; Stein GM, 2002, ANTICANCER RES, V22, P4215; STIRPE F, 1992, BIO-TECHNOL, V10, P405, DOI 10.1038/nbt0492-405; Takahashi A, 2004, CANCER IMMUNOL IMMUN, V53, P543, DOI 10.1007/s00262-003-0466-8; Troger W, 2013, EUR J CANCER, V49, P3788, DOI 10.1016/j.ejca.2013.06.043; Troy AJ, 1998, CLIN CANCER RES, V4, P585; Urech K, 2006, ARZNEIMITTEL-FORSCH, V56, P428; Valentiner U, 2002, TOXICOLOGY, V171, P187, DOI 10.1016/S0300-483X(01)00581-9; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Webster R, 2014, NAT REV DRUG DISCOV, V13, P883, DOI 10.1038/nrd4476	35	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181553	10.1371/journal.pone.0181553	http://dx.doi.org/10.1371/journal.pone.0181553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719632	gold, Green Published			2022-12-27	WOS:000406061400055
J	Bonjack-Shterengartz, M; Avnir, D				Bonjack-Shterengartz, Maayan; Avnir, David			The enigma of the near-symmetry of proteins: Domain swapping	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SH3 DOMAIN; STEFIN-B; DIMER; EVOLUTION; MECHANISM; BINDING; OLIGOMERIZATION; RESOLUTION; REVEALS	The majority of proteins form oligomers which have rotational symmetry. Literature has suggested many functional advantages that the symmetric packing offers. Yet, despite these advantages, the vast majority of protein oligomers are only nearly symmetric. A key question in the field of proteins structure is therefore, if symmetry is so advantageous, why do oligomers settle for aggregates that do not maximize that structural property? The answer to that question is apparently multi-parametric, and involves distortions at the interaction zones of the monomer units of the oligomer in order to minimize the free energy, the dynamics of the protein, the effects of surroundings parameters, and the mechanism of oligomerization. The study of this problem is in its infancy: Only the first parameter has been explored so far. Here we focus on the last parameter-the mechanism of formation. To test this effect we have selected to focus on the domain swapping mechanism of oligomerization, by which oligomers form in a mechanism that swaps identical portions of monomeric units, resulting in an interwoven oligomer. We are using continuous symmetry measures to analyze in detail the oligomer formed by this mechanism, and found, that without exception, in all analyzed cases, perfect symmetry is given away, and we are able to identify that the main burden of distortion lies in the hinge regions that connect the swapped portions. We show that the continuous symmetry analysis method clearly identifies the hinge region of swapped domain proteins-considered to be a non-trivial task. We corroborate our conclusion about the central role of the hinge region in affecting the symmetry of the oligomers, by a special probability analysis developed particularly for that purpose.	[Avnir, David] Hebrew Univ Jerusalem, Inst Chem, Jerusalem, Israel; Hebrew Univ Jerusalem, Lise Meitner Minerva Ctr Computat Quantum Chem, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Avnir, D (corresponding author), Hebrew Univ Jerusalem, Inst Chem, Jerusalem, Israel.	david.avnir@mail.huji.ac.il	Avnir, David/AAK-4189-2021		Israel Science Foundation Grant [411/15]	Israel Science Foundation Grant(Israel Science Foundation)	The study was supported by the Israel Science Foundation Grant (grant #411/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Barrientos LG, 2002, STRUCTURE, V10, P673, DOI 10.1016/S0969-2126(02)00758-X; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Berchanski A, 2005, PROTEINS, V60, P202, DOI 10.1002/prot.20558; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; Bonjack-Shterengartz M, 2015, PROTEINS, V83, P722, DOI 10.1002/prot.24706; Bourne Y, 2000, STRUCT FOLD DES, V8, P841, DOI 10.1016/S0969-2126(00)00175-1; BOURNE Y, 1995, P NATL ACAD SCI USA, V92, P10232, DOI 10.1073/pnas.92.22.10232; Camara-Artigas A, 2016, ARCH BIOCHEM BIOPHYS, V602, P116, DOI 10.1016/j.abb.2016.02.024; Canals A, 2001, STRUCTURE, V9, P967, DOI 10.1016/S0969-2126(01)00659-1; Chagot B, 2005, PROTEINS, V59, P380, DOI 10.1002/prot.20425; Chu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013361; Czjzek M, 2007, J MOL BIOL, V365, P1176, DOI 10.1016/j.jmb.2006.10.063; D'Alessio G, 1999, PROG BIOPHYS MOL BIO, V72, P271, DOI 10.1016/S0079-6107(99)00009-7; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Dryzun C, 2009, PHYS CHEM CHEM PHYS, V11, P9653, DOI 10.1039/b911179d; Fridmann-Sirkis Y, 2006, TRAFFIC, V7, P182, DOI 10.1111/j.1600-0854.2005.00374.x; Fushinobu S, 2003, BIOCHEMISTRY-US, V42, P11707, DOI 10.1021/bi034220b; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; GREEN SM, 1995, NAT STRUCT BIOL, V2, P746, DOI 10.1038/nsb0995-746; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Huang YQ, 2012, PROTEINS, V80, P1610, DOI 10.1002/prot.24055; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Kojic-Prodic B, 2010, SYMMETRY-BASEL, V2, P884, DOI 10.3390/sym2020884; Kokalj SJ, 2007, J MOL BIOL, V366, P1569, DOI 10.1016/j.jmb.2006.12.025; Levy Y, 2005, P NATL ACAD SCI USA, V102, P2373, DOI 10.1073/pnas.0409572102; Lin YW, 2015, ANGEW CHEM INT EDIT, V54, P511, DOI 10.1002/anie.201409267; Linhananta A, 2002, PROTEIN SCI, V11, P1695, DOI 10.1110/ps.0205002; Lipinski PFJ, 2014, RSC ADV, V4, P47047, DOI 10.1039/c4ra08434a; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu SJ, 2015, INT J PRECIS ENG MAN, V16, P2731, DOI 10.1007/s12541-015-0349-x; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2002, PROTEIN SCI, V11, P371, DOI 10.1110/ps.36602; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; MAZZARELLA L, 1993, ACTA CRYSTALLOGR D, V49, P389, DOI 10.1107/S0907444993003403; Mezey PG, 2014, ACCOUNTS CHEM RES, V47, P2821, DOI 10.1021/ar5001154; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; Morimoto K, 2006, J MOL BIOL, V360, P117, DOI 10.1016/j.jmb.2006.04.067; Mura C, 2003, J MOL BIOL, V326, P1559, DOI 10.1016/S0022-2836(03)00056-1; Murray AJ, 1998, NAT STRUCT BIOL, V5, P778, DOI 10.1038/1816; MURRAY AJ, 1995, P NATL ACAD SCI USA, V92, P7337, DOI 10.1073/pnas.92.16.7337; NALINI V, 1994, J MOL BIOL, V236, P1250, DOI 10.1016/0022-2836(94)90025-6; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; Ohlendorf DH, 1998, J MOL BIOL, V280, P129, DOI 10.1006/jmbi.1998.1849; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Pinsky M, 1998, INORG CHEM, V37, P5575, DOI 10.1021/ic9804925; Pinsky M, 2008, J COMPUT CHEM, V29, P2712, DOI 10.1002/jcc.20990; Raaijmakers H, 2001, J MOL BIOL, V308, P311, DOI 10.1006/jmbi.2001.4592; Radaev S, 2003, STRUCTURE, V11, P1527, DOI 10.1016/j.str.2003.11.001; Ridderstrom M, 1998, J BIOL CHEM, V273, P21623, DOI 10.1074/jbc.273.34.21623; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Salomon Y, 1999, J MATH CHEM, V25, P295, DOI 10.1023/A:1019144702913; Schiering N, 2000, BIOCHEMISTRY-US, V39, P13376, DOI 10.1021/bi0012336; Shameer K, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar042; Shingate P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039305; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Stehr M, 2004, PROTEINS, V55, P613, DOI 10.1002/prot.20126; Taylor WR, 2001, REP PROG PHYS, V64, P517, DOI 10.1088/0034-4885/64/4/203; Taylor WR, 2004, SERIES IN BIOPHYSICS; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Venkatakrishnan AJ, 2010, BIOCHEM SOC T, V38, P879, DOI 10.1042/BST0380879; Xu D, 1998, PROTEIN SCI, V7, P533; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200; ZABRODSKY H, 1992, J AM CHEM SOC, V114, P7843, DOI 10.1021/ja00046a033; Zerovnik E, 1997, EUR J BIOCHEM, V245, P364, DOI 10.1111/j.1432-1033.1997.t01-1-00364.x; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	77	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180030	10.1371/journal.pone.0180030	http://dx.doi.org/10.1371/journal.pone.0180030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708874	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649800011
J	Powell, AC; Mirhadi, AJ; Loy, BA; Happe, LE; Long, JW; Kren, EM; Gupta, AK				Powell, Adam C.; Mirhadi, Amin J.; Loy, Bryan A.; Happe, Laura E.; Long, James W.; Kren, Erin M.; Gupta, Amit K.			Presentation at computed tomography (CT) scan of the thorax and first year diagnostic and treatment utilization among patients diagnosed with lung cancer	PLOS ONE			English	Article								Background As Medicare expands the use of computed tomography (CT) for diagnosing lung cancer, there is increased opportunity to diagnose lung cancer in asymptomatic patients. This descriptive study characterizes the disease-specific diagnostic and treatment services that patients with a positive diagnosis following CT received, stratified by presentation at CT. Methods Patients who were diagnosed with lung cancer following CT in 2013, had no history of lung cancer, survived at least 1 year, were aged 55-80 years, and had Medicare Advantage insurance were included. Patients were grouped based upon presentation at CT: morbidities unrelated to lung cancer, classic lung cancer symptoms, and cancer syndromes. Patients with none of these factors were categorized into a no diagnoses/symptoms group. The type and intensity of services used in the year following the CT was reported for each group. Results 1,261 patients were included. Early treatment services were most common in the group with morbidities unrelated to lung cancer (13.7%) and least common in the cancer syndromes group (6.6%). Advanced treatment services were used by 47.3% of the cancer syndromes group versus 23.5% of the no diagnoses/symptoms group. Conclusions The intensity of disease-specific diagnostic and treatment services varied by presentation at CT. Patients with no symptoms or morbidities at the time of CT less frequently received advanced interventions. Learning about the utilization patterns of others with a similar presentation at CT may help patients with positive lung cancer diagnoses engage in shared decision making and in norming their experiences against those of other similarly-situated patients.	[Powell, Adam C.; Mirhadi, Amin J.; Kren, Erin M.; Gupta, Amit K.] HealthHelp, Houston, TX 77060 USA; [Loy, Bryan A.; Happe, Laura E.; Long, James W.] Humana Inc, Louisville, KY USA	Humana Inc.	Powell, AC (corresponding author), HealthHelp, Houston, TX 77060 USA.	powellad@healthhelp.com		Powell, Adam/0000-0001-6519-3120	Health Help and Humana Inc.	Health Help and Humana Inc.	The authors received no specific funding for this work. This study was completed by Humana, Inc. and Health Help, and authors worked on it as a part of their duties for their respective organization. Health Help and Humana Inc. provided support in the form of paid employment or consulting fees for all the authors. (Humana: BL, LH, and JL. Health Help: AP, AM, EK, and AG.). The specific roles of these authors are articulated in the 'author contributions' section. This research represents the findings of a quality improvement project conducted by the funding organizations, which were both actively involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. URL of Health Help :www.healthhelp.com; URL of Humana: www.humana.com.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Centers for Medicare & Medicaid Services, 2010, BEN POL OP GUID REG; Centers for Medicare & Medicaid Services (CMS), 2015, DECISION MEMO SCREEN; Coyle N, 2006, J PAIN SYMPTOM MANAG, V32, P266, DOI 10.1016/j.jpainsymman.2006.04.003; Dismuke CE, 2005, MED CARE, V43, P713, DOI 10.1097/01.mlr.0000167175.72130.a7; Gould MK, 2014, NEW ENGL J MED, V371, P1813, DOI 10.1056/NEJMcp1404071; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Medicare.gov, 2017, MED ADV PLANS COV AL; MURRAY N, 1993, J CLIN ONCOL, V11, P336, DOI 10.1200/JCO.1993.11.2.336; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Powell A, 2012, M&SOM-MANUF SERV OP, V14, P512, DOI 10.1287/msom.1120.0384; Powell RC., 2014, DEATH IS NOT THEORET; Quest Diagnostics, 2017, LUNG CANC MUT PAN; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; U.S. Food and Drug Administration, 2016, HEM ONC CANC APPR SA; U. S. Preventive Services Task Force (USPSTF) Recommendations, 2013, US PREVENTIVE SERVIC; United States Securities and Exchange Commission, 2016, FORM 10 K YEAR END D; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181319	10.1371/journal.pone.0181319	http://dx.doi.org/10.1371/journal.pone.0181319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708876	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800055
J	Singh, M; Khan, MMA; Uddin, M; Naeem, M; Qureshi, MI				Singh, Minu; Khan, M. Masroor A.; Uddin, Moin; Naeem, M.; Qureshi, M. Irfan			Proliferating effect of radiolytically depolymerized carrageenan on physiological attributes, plant water relation parameters, essential oil production and active constituents of Cymbopogon flexuosus Steud. under drought stress	PLOS ONE			English	Article							IRRADIATED SODIUM ALGINATE; NITRATE REDUCTASE; SALICYLIC-ACID; ANTIOXIDANT ACTIVITY; BIOCHEMICAL-CHANGES; OSMOTIC-STRESS; RICE SEEDLINGS; GROWTH; TOLERANCE; MODULATION	Carrageenan has been proved as potent growth promoting substance in its depolymerized form. However, relatively little is known about its role in counteracting the adverse effects of drought stress on plants. In a pot experiment, lemongrass (Cymbopogon flexuosus Steud.), grown under different water stress regimes [(100% field capacity (FC), 80% FC and 60% FC)], was sprayed with 40, 80 and 120 mg L-1 of gamma irradiated carrageenan (ICA). Foliar application of ICA mitigated the harmful effects of drought stress to various extents and improved the biochemical characteristics, quality attributes and active constituents (citral and geraniol) of lemongrass significantly. Among the applied treatments, ICA-80 mg L(-)1 proved the best in alleviating detrimental effects of drought. However, drought stress (80 and 60% FC), irrespective of the growth stages, had an adverse impact on most of the studied attributes. Generally, 60% FC proved more deleterious than 80% FC. At 80% FC, application of ICA-80 mg L-1 elevated the essential oil (EO) content by 18.9 and 25%, citral content by 7.33 and 8.19% and geraniol content by 9.2 and 8.9% at 90 and 120 days after planting (DAP), respectively, as compared to the deionized-water (DW) spray treatment (80% FC+DW). Whereas, at 60% FC, foliar application of 80 mg L-1 ICA significantly augmented the EO content by 15.4 and 17.8% and active constituents viz. citral and geraniol, by 5.01 and 5.62% and by 6.06 and 5.61% at 90 and 120 DAP, respectively, as compared to the control (water-spray treatment).	[Singh, Minu; Khan, M. Masroor A.; Uddin, Moin; Naeem, M.] Aligarh Muslim Univ, Dept Bot, Plant Physiol Sect, Aligarh, Uttar Pradesh, India; [Singh, Minu; Qureshi, M. Irfan] Jamia Millia Islamia, Dept Biotechnol, Prote & Bioinformat Lab, New Delhi, India	Aligarh Muslim University; Jamia Millia Islamia	Singh, M (corresponding author), Aligarh Muslim Univ, Dept Bot, Plant Physiol Sect, Aligarh, Uttar Pradesh, India.; Singh, M (corresponding author), Jamia Millia Islamia, Dept Biotechnol, Prote & Bioinformat Lab, New Delhi, India.	minusingh5@gmail.com	Qureshi, M Irfan/CAF-0824-2022; Naeem, M/ABE-5239-2020	Qureshi, M Irfan/0000-0001-9625-0036; Naeem, M/0000-0002-2487-1228; A Khan, M Masroor/0000-0002-4530-9082	University Grant Commission, New Delhi, India; Post Doctoral Fellowship [F.15/17/12]	University Grant Commission, New Delhi, India(University Grants Commission, India); Post Doctoral Fellowship	Financial support by the University Grant Commission, New Delhi, India for the award of Women Scientist, Post Doctoral Fellowship (Project No. F.15/17/12) is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad LV, 2009, CARBOHYD POLYM, V78, P100, DOI 10.1016/j.carbpol.2009.04.009; Abad LV, 2016, RADIAT PHYS CHEM, V118, P75, DOI 10.1016/j.radphyschem.2015.03.001; Abad LV, 2014, NUCL INSTRUM METH B, V336, P167, DOI 10.1016/j.nimb.2014.07.005; Abad LV, 2004, INT J BIOL MACROMOL, V34, P81, DOI 10.1016/j.ijbiomac.2004.03.012; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Aftab T, 2013, IND CROP PROD, V50, P874, DOI 10.1016/j.indcrop.2013.08.026; AHMADIMIRABAD A, 2014, ELECTRON J BIOL, V10, P79; Ali A, 2014, CARBOHYD POLYM, V112, P134, DOI 10.1016/j.carbpol.2014.05.070; Anjum SA, 2011, AFR J AGR RES, V6, P2026; [Anonymous], 1992, J ESSEN OIL RES, DOI DOI 10.1080/10412905.1992.9698013; [Anonymous], 1972, ESSENTIAL OILS HIST; Bandurska H, 2001, ACTA PHYSIOL PLANT, V23, P483, DOI 10.1007/s11738-001-0059-0; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bi F, 2011, J SAUDI CHEM SOC, V15, P269, DOI 10.1016/j.jscs.2010.10.003; Birhanu K., 2010, African Journal of Food, Agriculture, Nutrition and Development, V10, P2139; Campbell Wilbur H., 2002, Physiology and Molecular Biology of Plants, V8, P31; Castro J, 2012, J PLANT GROWTH REGUL, V31, P173, DOI 10.1007/s00344-011-9229-5; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; CHARLES DJ, 1990, PHYTOCHEMISTRY, V29, P2837, DOI 10.1016/0031-9422(90)87087-B; Dalal VK, 2012, PLANT CELL ENVIRON, V35, P1685, DOI 10.1111/j.1365-3040.2012.02520.x; Dash S, 2001, J PLANT PHYSIOL, V158, P1153, DOI 10.1078/0176-1617-00243; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; DWIVEDI RS, 1974, PLANT SOIL, V40, P445, DOI 10.1007/BF00011531; Farahani HA, 2009, J MED PLANTS RES, V3, P329; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Farooqi A. H. A., 2000, Journal of Plant Biology, V27, P277; FERRARIO S, 1995, PLANTA, V196, P288, DOI 10.1007/BF00201387; Gonzalez A, 2013, J PLANT GROWTH REGUL, V32, P443, DOI 10.1007/s00344-012-9309-1; Grzesiak MT, 2006, PHOTOSYNTHETICA, V44, P561, DOI 10.1007/s11099-006-0072-z; Harpaz-Saad S, 2007, PLANT CELL, V19, P1007, DOI 10.1105/tpc.107.050633; Hashmi N, 2012, CARBOHYD POLYM, V90, P407, DOI 10.1016/j.carbpol.2012.05.058; Hayat S, 2008, J PLANT INTERACT, V3, P297, DOI 10.1080/17429140802320797; Hien NQ, 2000, RADIAT PHYS CHEM, V59, P97, DOI 10.1016/S0969-806X(99)00522-8; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; Hristova, 2003, BULG J PLANT PHYSL, V133, P152; Hura T, 2007, ANN BOT-LONDON, V100, P767, DOI 10.1093/aob/mcm162; Hussein M. M., 2012, Agricultural Sciences, V3, P241, DOI 10.4236/as.2012.32028; Idrees M, 2012, IND CROP PROD, V40, P62, DOI 10.1016/j.indcrop.2012.02.024; Idrees M, 2010, J PLANT INTERACT, V5, P293, DOI 10.1080/17429145.2010.508566; JAWORSKI EG, 1971, BIOCHEM BIOPH RES CO, V43, P1274, DOI 10.1016/S0006-291X(71)80010-4; Jones HG, 1998, J EXP BOT, V49, P387, DOI 10.1093/jexbot/49.suppl_1.387; Kalaji M.H., 2010, CHLOROPHYLL FLUORESC, P116; Khalid K. A., 2006, International Agrophysics, V20, P289; Khanna-Chopra R, 2007, ENVIRON EXP BOT, V60, P276, DOI 10.1016/j.envexpbot.2006.11.004; Kume T, 2002, RADIAT PHYS CHEM, V63, P625, DOI 10.1016/S0969-806X(01)00558-8; Kusvuran S., 2012, African Journal of Agricultural Research, V7, P775; Lejay L, 1997, PLANT PHYSIOL, V115, P623, DOI 10.1104/pp.115.2.623; Lichtenthaler H.K., 2001, CURR PROTOC FOOD ANA, V1, pF4.3.1, DOI [10.1002/0471142913.faf0403s01, DOI 10.1002/0471142913.FAF0403S01]; Luan L. Q., 2006, RADIOISOTOPES TOKYO, V55, P23; Ma LJ, 2010, PLANT GROWTH REGUL, V62, P71, DOI 10.1007/s10725-010-9489-2; Maningas JAC, 2016, PNRI NEWSLETTER, V12, P5; Marcinska I, 2013, INT J MOL SCI, V14, P13171, DOI 10.3390/ijms140713171; Matysik J, 2002, CURR SCI INDIA, V82, P525; Moinuddin, 2007, J PLANT NUTR, V30, P517, DOI 10.1080/01904160701209196; Moinuddin, 2004, CROP SCI, V44, P449; Naeem M, 2017, J ESSENT OIL RES, V29, P179, DOI 10.1080/10412905.2016.1213188; Naeem M, ADV BOT; Ozturk A, 2004, J AGRON CROP SCI, V190, P93, DOI 10.1046/j.1439-037X.2003.00080.x; PAPAGEORGIOU GC, 1995, PHOTOSYNTH RES, V44, P243, DOI 10.1007/BF00048597; Pereira GJG, 2002, PLANT SOIL, V239, P123, DOI 10.1023/A:1014951524286; Potin P, 1999, CURR OPIN MICROBIOL, V2, P276, DOI 10.1016/S1369-5274(99)80048-4; Qazi Fariduddin, 2014, Journal of Stress Physiology & Biochemistry, V10, P181; Relleve L, 2005, POLYM DEGRAD STABIL, V87, P403, DOI 10.1016/j.polymdegradstab.2004.09.003; Sabharwal S, 2004, IAEATECDOC1422; Sangwan, 2006, PHYSIOL MOL BIOL PLA, V11, P153; SANGWAN RS, 1993, J PLANT PHYSIOL, V142, P618, DOI 10.1016/S0176-1617(11)80408-6; Sara K., 2012, Journal of Stress Physiology & Biochemistry, V8, P160; Sarfaraz A, 2011, J MED PLANTS RES, V5, P15; Scandalios JO, 1997, COLD SPRING HARBOR M, V34, P343, DOI DOI 10.1101/087969502.34.343; SINGH AK, 1995, PHOTOSYNTHETICA, V31, P489; Singh B, 2003, PLANT GROWTH REGUL, V39, P137, DOI 10.1023/A:1022556103536; SINGHSANGWAN N, 1994, NEW PHYTOL, V128, P173, DOI 10.1111/j.1469-8137.1994.tb04000.x; Siriwardhana N, 2003, FOOD SCI TECHNOL INT, V9, P339, DOI 10.1177/1082013203039014; Srivalli B, 2003, PHYSIOL PLANTARUM, V119, P503, DOI 10.1046/j.1399-3054.2003.00125.x; SUMITHRA K, 2004, J PLANT BIOL, V31, P201; Taiz L., 2015, PLANT PHYSL DEV; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; Tiwari A, 2005, PHOTOSYNTHETICA, V43, P1, DOI 10.1007/s11099-005-1011-0; Tsiapali E, 2001, FREE RADICAL BIO MED, V30, P393, DOI 10.1016/S0891-5849(00)00485-8	80	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180129	10.1371/journal.pone.0180129	http://dx.doi.org/10.1371/journal.pone.0180129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708833	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800013
J	Blanc-Durand, P; Van Der Gucht, A; Guedj, E; Abulizi, M; Aoun-Sebaiti, M; Lerman, L; Verger, A; Authier, FJ; Itti, E				Blanc-Durand, Paul; Van Der Gucht, Axel; Guedj, Eric; Abulizi, Mukedaisi; Aoun-Sebaiti, Mehdi; Lerman, Lionel; Verger, Antoine; Authier, Francois-Jerome; Itti, Emmanuel			Cerebral F-18-FDG PET in macrophagic myofasciitis: An individual SVM-based approach	PLOS ONE			English	Article							ALUMINUM-HYDROXIDE; FIBROMYALGIA; ABNORMALITIES; DIAGNOSIS	Introduction Macrophagic myofasciitis (MMF) is an emerging condition with highly specific myopathological alterations. A peculiar spatial pattern of a cerebral glucose hypometabolism involving occipito-temporal cortex and cerebellum have been reported in patients with MMF; however, the full pattern is not systematically present in routine interpretation of scans, and with varying degrees of severity depending on the cognitive profile of patients. Aim was to generate and evaluate a support vector machine (SVM) procedure to classify patients between healthy or MMF (18) F-FDG brain profiles. Methods F-18-FDG PET brain images of 119 patients with MMF and 64 healthy subjects were retrospectively analyzed. The whole-population was divided into two groups; a training set (100 MMF, 44 healthy subjects) and a testing set (19 MMF, 20 healthy subjects). Dimensionality reduction was performed using a t-map from statistical parametric mapping (SPM) and a SVM with a linear kernel was trained on the training set. To evaluate the performance of the SVM classifier, values of sensitivity (Se), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV) and accuracy (Acc) were calculated. Results The SPM12 analysis on the training set exhibited the already reported hypometabolism pattern involving occipito-temporal and fronto-parietal cortices, limbic system and cerebellum. The SVM procedure, based on the t-test mask generated from the training set, correctly classified MMF patients of the testing set with following Se, Sp, PPV, NPV and Acc: 89%, 85%, 85%, 89%, and 87%. Conclusion We developed an original and individual approach including a SVM to classify patients between healthy or MMF metabolic brain profiles using (18) F-FDG-PET. Machine learning algorithms are promising for computer-aided diagnosis but will need further validation in prospective cohorts.	[Blanc-Durand, Paul; Van Der Gucht, Axel; Abulizi, Mukedaisi; Lerman, Lionel; Itti, Emmanuel] Paris Est Univ, H Mondor Hosp, AP HP, Dept Nucl Med, Creteil, France; [Guedj, Eric] La Timone Hosp, AP HM, Dept Nucl Med, Marseille, France; [Guedj, Eric] Aix Marseille Univ, INT, CNRS UMR 7289, Marseille, France; [Guedj, Eric] Aix Marseille Univ, CERIMED, Marseille, France; [Aoun-Sebaiti, Mehdi; Authier, Francois-Jerome] INSERM U955, Team 10, Creteil, France; [Aoun-Sebaiti, Mehdi] Paris Est Univ, H Mondor Hosp, AP HP, Dept Neurol, Creteil, France; [Verger, Antoine] CHU Nancy, Nucl Med & Nancyclotep Expt Imaging Platform, Nancy, France; [Authier, Francois-Jerome] Paris Est Univ, H Mondor Hosp, AP HP, Dept Pathol, Creteil, France; [Authier, Francois-Jerome] H Mondor Hosp, AP HP, Reference Ctr Neuromuscular Disorders, Creteil, France; [Itti, Emmanuel] INSERM U955, GRC Amyloid Res Inst, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Van Der Gucht, A (corresponding author), Paris Est Univ, H Mondor Hosp, AP HP, Dept Nucl Med, Creteil, France.	axel.vandergucht@gmail.com	Guedj, Eric/AAK-1589-2020; Verger, Antoine/AAA-2066-2022; Guedj, Eric/AAF-8682-2019	AUTHIER, Francois Jerome/0000-0002-0182-2052; Itti, Emmanuel/0000-0003-1578-4058	Region Ile-de-France; Association Francaise contre les Myopathies though Translamuscle program; A*MIDEX project - ''Investissements d'Avenir'' French Government program [ANR-11-IDEX-0001-02]; patients association E3M through "Partenariats institutions-citoyens pour la recherche et l'innovation" (PICRI programs)	Region Ile-de-France(Region Ile-de-France); Association Francaise contre les Myopathies though Translamuscle program; A*MIDEX project - ''Investissements d'Avenir'' French Government program(French National Research Agency (ANR)); patients association E3M through "Partenariats institutions-citoyens pour la recherche et l'innovation" (PICRI programs)	This work was supported by grants from Region Ile-de-France and patients association E3M through "Partenariats institutions-citoyens pour la recherche et l'innovation" (PICRI programs 2010 and 2014), and from the Association Francaise contre les Myopathies though Translamuscle program. This work has been carried out thanks to the support of the A*MIDEX project (no ANR-11-IDEX-0001-02) funded by the ''Investissements dAvenir'' French Government program, managed by the French National Research Agency (ANR).	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Authier FJ, 2003, ARTHRITIS RHEUM-US, V48, P569, DOI 10.1002/art.10740; Bao Y, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1353-6; Blanc-Durand P, 2017, J NUCL MED; Couette M, 2009, J INORG BIOCHEM, V103, P1571, DOI 10.1016/j.jinorgbio.2009.08.005; Gherardi RK, 1998, LANCET, V352, P347, DOI 10.1016/S0140-6736(98)02326-5; Gherardi RK, 2001, BRAIN, V124, P1821, DOI 10.1093/brain/124.9.1821; Guedj E, 2008, J NUCL MED, V49, P1798, DOI 10.2967/jnumed.108.053264; Kuncheva LI, 2010, IEEE T MED IMAGING, V29, P531, DOI 10.1109/TMI.2009.2037756; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu JK, 2017, J MED SYST, V41, DOI 10.1007/s10916-016-0669-0; Long ZQ, 2016, NEUROSCIENCE, V331, P169, DOI 10.1016/j.neuroscience.2016.06.025; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Passeri E, 2011, J INORG BIOCHEM, V105, P1457, DOI 10.1016/j.jinorgbio.2011.08.006; Pouliakis A, 2016, BIOMED ENG COMPUT BI, V7, P1, DOI 10.4137/BECB.S31601; Rigolet M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00230; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Van der Gucht A, 2017, J NUCL MED, V58, P492, DOI 10.2967/jnumed.114.151878; Van Der Gucht A, 2016, NUCL MED MOLEC IMAG, V50, P80, DOI 10.1007/s13139-015-0371-z; Van Der Gucht A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128353; Van Weehaeghe D, 2016, J NUCL MED, V57, P1238, DOI 10.2967/jnumed.115.166272; Vapnik V., 1998, STAT LEARNING THEORY; Wik G, 2003, NEUROREPORT, V14, P619, DOI 10.1097/00001756-200303240-00019; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Xu R, 2014, ANN NUCL MED, V28, P926, DOI 10.1007/s12149-014-0895-9; Yoshida H, 2001, IEEE T MED IMAGING, V20, P1261, DOI 10.1109/42.974921; Yunus MB, 2004, ARTHRIT RHEUM-ARTHR, V51, P513, DOI 10.1002/art.20544	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181152	10.1371/journal.pone.0181152	http://dx.doi.org/10.1371/journal.pone.0181152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704562	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649700097
J	Abubakar, B; Zawawi, N; Omar, AR; Ismail, M				Abubakar, Bilyaminu; Zawawi, Norhasnida; Omar, Abdul Rahman; Ismail, Maznah			Predisposition to insulin resistance and obesity due to staple consumption of rice: Amylose content versus germination status	PLOS ONE			English	Article							BROWN RICE; RISK-FACTORS; STARCH DIGESTIBILITY; AMYLOPECTIN STARCH; GLYCEMIC INDEX; WHITE RICE; METABOLISM; GLUCOSE; MEN	Type 2 diabetes is a metabolic disorder with established, well-defined precursors. Obesity and insulin resistance are amongst most important factors in predisposition to diabetes. Rice is a staple for about half the global population and its consumption has been strongly linked with diabetogenesis. We assert that tackling the prevalence of predisposing factors by modifying certain rice cultivars could reduce the global burden of obesity and insulin resistance, and by extension type 2 diabetes. Several rice cultivars with various properties were fed to nulliparous rats (five weeks old at the start of the experiment) for 90 days. They were then returned to a diet of standard pellets and mated with males raised on a standard diet. The resulting pups and dams were investigated for obesity and insulin resistance markers. We found that germination did more to reduce predisposition to obesity and insulin resistance than high amylose content. The combined reducing effect of germination and high amylose content on predisposition to obesity and insulin resistance was greater than the sum of their independent effects. Polished (white) rice with a low amylose content predisposed dams on a high-fat diet to markers of insulin resistance and obesity and this predisposition was inherited (in biochemical terms) by their F1 offspring. Overall, the results suggest that harnessing the beneficial properties of germination and amylose in rice would reduce the burden of obesity and insulin resistance, which are known to be key risk factors for development of type 2 diabetes.	[Abubakar, Bilyaminu; Ismail, Maznah] Univ Putra Malaysia, Inst Biosci, Lab Mol Biomed, Serdang, Selangor, Malaysia; [Abubakar, Bilyaminu] Usmanu Danfodiyo Univ, Dept Pharmacol & Toxicol, Sokoto, Nigeria; [Zawawi, Norhasnida] Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Sci, Serdang, Selangor, Malaysia; [Omar, Abdul Rahman] Univ Putra Malaysia, Fac Vet Med, Dept Anim Sci, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Abubakar, B; Ismail, M (corresponding author), Univ Putra Malaysia, Inst Biosci, Lab Mol Biomed, Serdang, Selangor, Malaysia.; Abubakar, B (corresponding author), Usmanu Danfodiyo Univ, Dept Pharmacol & Toxicol, Sokoto, Nigeria.	abu3163abu@yahoo.co.uk; myhome.e@gmail.com	Zawawi, Norhasnida/AAI-6421-2021; Abubakar, Bilyaminu/AAC-5821-2019	Zawawi, Norhasnida/0000-0001-7459-5025; 	Padi Beras Nasional Berhad (BERNAS); Universiti Putra Malaysia (UPM); Bernas Sdn. Bhd	Padi Beras Nasional Berhad (BERNAS); Universiti Putra Malaysia (UPM); Bernas Sdn. Bhd	The authors wish to express their gratitude towards Padi Beras Nasional Berhad (BERNAS) and Universiti Putra Malaysia (UPM) for sponsoring this research (vote no. 63536).; The authors wish to acknowledge Dr Asfaliza Ramli of the Malaysian Agricultural Research and Development Institute for providing the samples, and Bernas Sdn. Bhd. for providing funds for the conduct of this research.	Batres-Marquez SP, 2009, J AM DIET ASSOC, V109, P1719, DOI 10.1016/j.jada.2009.07.010; BEHALL KM, 1989, AM J CLIN NUTR, V49, P337, DOI 10.1093/ajcn/49.2.337; Coll JL, 2015, OBESITY FACTS, V8, P220, DOI 10.1159/000435826; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Denardin CC, 2012, CIENC RURAL, V42, P381, DOI 10.1590/S0103-84782012005000002; Frei M, 2003, FOOD CHEM, V83, P395, DOI 10.1016/S0308-8146(03)00101-8; Graus-Nunes F, 2015, NUTRITION, V31, P380, DOI 10.1016/j.nut.2014.08.002; Hall KD, 2015, CELL METAB, V22, P427, DOI 10.1016/j.cmet.2015.07.021; Ho JN, 2012, BIOSCI BIOTECH BIOCH, V76, P1068, DOI 10.1271/bbb.110666; Hu EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1454; Imam MU, 2013, NUTRIENTS, V5, P468, DOI 10.3390/nu5020468; Imam MU, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/816501; Imam MU, 2012, INT J MOL SCI, V13, P12952, DOI 10.3390/ijms131012952; International Diabetic Federation, 2015, DIAB FACTS FIG; International Standard Organisation, RIC DET AM CONT; Kabir M, 1998, J NUTR, V128, P35, DOI 10.1093/jn/128.1.35; Lanas F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163727; Lim SM, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1116-y; Martin-Timon I, 2014, WORLD J DIABETES, V5, P444, DOI 10.4239/wjd.v5.i4.444; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Nanri A, 2010, AM J CLIN NUTR, V92, P1468, DOI 10.3945/ajcn.2010.29512; Ooi DJ, 2012, MOLECULES, V17, P11139, DOI 10.3390/molecules170911139; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109; Wang SJ, 2013, FOOD FUNCT, V4, P1564, DOI 10.1039/c3fo60258c; WHO, 2016, GLOB REP PSOR; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Wu YL, 2014, INT J MED SCI, V11, P1185, DOI 10.7150/ijms.10001	28	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181309	10.1371/journal.pone.0181309	http://dx.doi.org/10.1371/journal.pone.0181309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727791	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000406634500054
J	Chang, YW; Chen, JY; Lu, MX; Gao, Y; Tian, ZH; Gong, WR; Dong, CS; Du, YZ				Chang, Ya-Wen; Chen, Jing-Yun; Lu, Ming-Xing; Gao, Yuan; Tian, Zi-Hua; Gong, Wei-Rong; Dong, Chang-Sheng; Du, Yu-Zhou			Cloning and expression of genes encoding heat shock proteins in Liriomyza trifolii and comparison with two congener leafminer species	PLOS ONE			English	Article							SATIVAE DIPTERA; COLD-HARDINESS; LEAF-MINER; TOLERANCE; AGROMYZIDAE; EVOLUTIONARY; ADAPTATION; PATTERNS; HSP70; FLY	The polyphagous agromyzid fly, Liriomyza trifolii, is a significant and important insect pest of ornamental and vegetable crops worldwide. The adaptation of insects to different environments is facilitated by heat shock proteins (HSPs), which play an important role in acclimation to thermal stress. In this study, we cloned and characterized five HSP-encoding genes of L. trifolii (Lthsp20, Lthsp40, Lthsp60, Lthsp70, and Lthsp90) and monitored their expression under different thermal stresses using real-time quantitative PCR. Pupae of L. trifolii were exposed to 19 different temperatures ranging from -20 to 45 degrees C. The results revealed that Lthsp20, Lthsp40, Lthsp70 and Lthsp90 were significantly upregulated in response to both heat and cold stress, while Lthsp60 was induced only by heat temperatures. The temperatures of the onset (T-on) and maximal (T-max) expression of the five Lthsps were also determined and compared with published T-on and T-max values of homologous genes in L. sativae and L. huidobrensis. Although L. trifolii occurs primarily in southern China, it has cold tolerance comparable with the other two Liriomyza species. Based on the heat shock proteins expression patterns, L. trifolii has the capacity to tolerate extreme temperatures and the potential to disseminate to northern regions of China.	[Chang, Ya-Wen; Chen, Jing-Yun; Lu, Ming-Xing; Du, Yu-Zhou] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China; [Chang, Ya-Wen; Chen, Jing-Yun; Lu, Ming-Xing; Du, Yu-Zhou] Yangzhou Univ, Inst Appl Entomol, Yangzhou, Jiangsu, Peoples R China; [Chen, Jing-Yun; Gao, Yuan] Suzhou Entry Exit Inspect & Quarantine Bur, Lab Prevent & Control Alien Pests, Suzhou, Peoples R China; [Lu, Ming-Xing; Du, Yu-Zhou] Yangzhou Univ, Joint Int Res Lab Agr & Agri Prod Safety, Yangzhou, Jiangsu, Peoples R China; [Tian, Zi-Hua; Gong, Wei-Rong] Plant Protect & Quarantine Stn Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Dong, Chang-Sheng] Agr Technol Extens Serv Ctr Guangling Dist, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University	Du, YZ (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.; Du, YZ (corresponding author), Yangzhou Univ, Inst Appl Entomol, Yangzhou, Jiangsu, Peoples R China.; Du, YZ (corresponding author), Yangzhou Univ, Joint Int Res Lab Agr & Agri Prod Safety, Yangzhou, Jiangsu, Peoples R China.	yzdu@yzu.edu.cn		Du, Yu-Zhou/0000-0002-4452-7125	Priority Academic Program Development of Jiangsu Higher Education Institutions; National Science and Technology [2012BAD19B06]; Jiangsu Science Technology [BE2014410]; Science and Technology Program of Yangzhou [YZ2014171]; Basic Research Program of Agricultural application of Suzhou [SNG201602]	Priority Academic Program Development of Jiangsu Higher Education Institutions; National Science and Technology; Jiangsu Science Technology; Science and Technology Program of Yangzhou; Basic Research Program of Agricultural application of Suzhou	This research was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the National Science and Technology Support Program [2012BAD19B06 (YZD)] (http://jsycw.ec.is.edu.cn/), the Jiangsu Science & Technology Support Program [BE2014410 (YZD)] (http://www.jstd.gov.cn/), the Science and Technology Program of Yangzhou [YZ2014171 (YZD)] (http://kjj.yangzhou.gov.cn/), and the Basic Research Program of Agricultural application of Suzhou [SNG201602 (JYC)] (http://szkj.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank Dr. Tom for editing the manuscript prior to submission. We express our deep gratitude to the Testing Center of Yangzhou University. This research was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the National Science and Technology Support Program (2012BAD19B06), the Jiangsu Science & Technology Support Program (BE2014410), the Science and Technology Program of Yangzhou (YZ2014171), and the Basic Research Program of Agricultural application of Suzhou (SNG201602).	Abe Y, 2001, APPL ENTOMOL ZOOL, V36, P277, DOI 10.1303/aez.2001.277; Abe Y, 2008, BIOL INVASIONS, V10, P951, DOI 10.1007/s10530-007-9173-2; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Chang Ya-Wen, 2016, Chinese Journal of Applied Entomology, V53, P884, DOI 10.7679/j.issn.2095-1353.2016.110; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chen B, 2005, APPL ENTOMOL ZOOL, V40, P437, DOI 10.1303/aez.2005.437; Chen B, 2005, OECOLOGIA, V144, P187, DOI 10.1007/s00442-005-0051-2; Chen B, 2005, PROG NAT SCI-MATER, V15, P289; Chen B, 2004, ENVIRON ENTOMOL, V33, P155, DOI 10.1603/0046-225X-33.2.155; Chen B, 2002, CRYOLETTERS, V23, P173; Chen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020308; Chen SJ, 2000, JIANGSU AGR SCI, V2, P44; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gao YL, 2017, PEST MANAG SCI; Gao YL, 2017, ANNU REV ENTOMOL, V62, P165, DOI 10.1146/annurev-ento-031616-035425; Gao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092625; Gao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036622; GEHRING WJ, 1995, P NATL ACAD SCI USA, V92, P2994, DOI 10.1073/pnas.92.7.2994; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Huang LH, 2008, CELL RES, V18, P1074, DOI 10.1038/cr.2008.283; Huang LH, 2007, J INSECT PHYSIOL, V53, P1199, DOI 10.1016/j.jinsphys.2007.06.011; Huang LH, 2007, INSECT MOL BIOL, V16, P491, DOI 10.1111/j.1365-2583.2007.00744.x; Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004; [吉青战 Ji Qingzhan], 2013, [植物保护, Plant Protection], V39, P110; JOHNSON MW, 1983, J ECON ENTOMOL, V76, P1061, DOI 10.1093/jee/76.5.1061; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Kelly SA, 2012, COMPR PHYSIOL, V2, P1417, DOI 10.1002/cphy.c110008; Klok CJ, 2003, FUNCT ECOL, V17, P858, DOI 10.1111/j.1365-2435.2003.00794.x; [雷仲仁 Lei Zhongren], 2007, [植物保护, Plant Protection], V33, P100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MX, 2016, J THERM BIOL, V57, P110, DOI 10.1016/j.jtherbio.2016.03.005; Lu MX, 2014, ANN ENTOMOL SOC AM, V107, P667, DOI 10.1603/AN13092; Lu MX, 2014, CELL STRESS CHAPERON, V19, P91, DOI 10.1007/s12192-013-0437-8; Lu ZC, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.124; Luo Jin-Cang, 2002, Entomological Knowledge, V39, P136; Matsuda K, 2014, CROP PROT, V55, P50, DOI 10.1016/j.cropro.2013.10.011; PARRELLA MP, 1985, ANN ENTOMOL SOC AM, V78, P90, DOI 10.1093/aesa/78.1.90; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Reitz SR, 1999, AGR ECOSYST ENVIRON, V73, P185, DOI 10.1016/S0167-8809(99)00016-X; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Reitz SR, 2002, ENTOMOL EXP APPL, V102, P101, DOI 10.1023/A:1015861716270; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Sinclair BJ, 2003, J INSECT PHYSIOL, V49, P1049, DOI 10.1016/j.jinsphys.2003.08.002; Sinclair BJ, 2015, J THERM BIOL, V53, P180, DOI 10.1016/j.jtherbio.2015.11.003; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Spencer K.A., 1973, SERIES ENTOMOLOGICA, V9, P19; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Sun M, 2014, INT J MOL SCI, V15, P23196, DOI 10.3390/ijms151223196; Tang XT, 2015, J ASIA-PAC ENTOMOL, V18, P529, DOI 10.1016/j.aspen.2015.07.005; TAYLOR F, 1981, AM NAT, V117, P1, DOI 10.1086/283683; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomanek L, 2002, J EXP BIOL, V205, P677; TSUGEKI R, 1992, EUR J BIOCHEM, V209, P453, DOI 10.1111/j.1432-1033.1992.tb17309.x; Wang HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098761; Wang Kai-ge, 2013, Scientia Agricultura Sinica, V46, P4842; Wang XH, 2014, ANNU REV ENTOMOL, V59, P225, DOI 10.1146/annurev-ento-011613-162019; Wang Z. G., 2007, PLANT QUARANTINE, V21, P19; Wen JZ, 1998, CHINA PLANT PROT, V24, P18; Weng Jinzeng, 1996, Entomotaxonomia, V18, P311; Worland MR, 2001, FUNCT ECOL, V15, P515, DOI 10.1046/j.0269-8463.2001.00547.x; Xiao Ting, 2012, Southwest China Journal of Agricultural Sciences, V25, P1289; [肖婷 Xiao Ting], 2011, [环境昆虫学报, Journal of Environmental Entomology], V33, P8; Yang F, 2013, GENE, V529, P1, DOI 10.1016/j.gene.2013.08.010; [杨飞 Yang Fei], 2010, [植物保护, Plant Protection], V36, P108; Zhao YX, 2000, J APPL ENTOMOL, V124, P185, DOI 10.1046/j.1439-0418.2000.00463.x; Zheng Dan, 2010, Acta Phytophylacica Sinica, V37, P159	72	17	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181355	10.1371/journal.pone.0181355	http://dx.doi.org/10.1371/journal.pone.0181355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727798	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500061
J	Chen, W; Zhou, FJ; Hall, BJ; Tucker, JD; Latkin, C; Renzaho, AMN; Ling, L				Chen, Wen; Zhou, Fangjing; Hall, Brian J.; Tucker, Joseph D.; Latkin, Carl; Renzaho, Andre M. N.; Ling, Li			Is there a relationship between geographic distance and uptake of HIV testing services? A representative population-based study of Chinese adults in Guangzhou, China	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; COST-EFFECTIVENESS; MIGRANTS; COMMUNITY; COUNTRIES; PATTERNS; FRANCE; ACCESS; TIME; AREA	Achieving high coverage of HIV testing services is critical in many health systems, especially where HIV testing services remain centralized and inconvenient for many. As a result, planning the optimal spatial distribution of HIV testing sites is increasingly important. We aimed to assess the relationship between geographic distance and uptake of HIV testing services among the general population in Guangzhou, China. Utilizing spatial epidemiological methods and stratified household random sampling, we studied 666 adults aged 18-59. Computer-assisted interviews assessed self-reported HIV testing history. Spatial scan statistic assessed the clustering of participants who have ever been tested for HIV, and two-level logistic regression models assessed the association between uptake of HIV testing and the mean driving distance from the participant's residence to all HIV testing sites in the research sites. The percentage of participants who have ever been tested for HIV was 25.2% (168/666, 95% CI: 21.9%, 28.5%), and the majority (82.7%) of participants tested for HIV in Centres for Disease Control and Prevention, public hospitals or STIs clinics. None reported using self-testing. Spatial clustering analyses found a hotspot included 48 participants who have ever been tested for HIV and 25.8 expected cases (Rate Ratio = 1.86, P = 0.002). Adjusted two-level logistic regression found an inverse relationship between geographic distance (kilometers) and ever being tested for HIV (aOR = 0.90, 95% CI: 0.84, 0.96). Married or cohabiting participants (aOR = 2.14, 95% CI: 1.09, 4.20) and those with greater social support (aOR = 1.04, 95% CI: 1.01, 1.07) were more likely to be tested for HIV. Our findings underscore the importance of considering the geographical distribution of HIV testing sites to increase testing. In addition, expanding HIV testing coverage by introducing non-facility based HIV testing services and self-testing might be useful to achieve the goal that 90% of people living with HIV knowing their HIV status by the year 2020.	[Chen, Wen; Ling, Li] Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China; [Chen, Wen; Zhou, Fangjing; Hall, Brian J.; Tucker, Joseph D.; Ling, Li] Sun Yat Sen Univ, Ctr Migrant Hlth Policy, Guangzhou, Guangdong, Peoples R China; [Chen, Wen; Renzaho, Andre M. N.] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia; [Zhou, Fangjing] Ctr TB Control Guangdong Prov, Dept Prevent & Treatment, Guangzhou, Guangdong, Peoples R China; [Hall, Brian J.] Univ Macau, Dept Psychol, Fac Social Sci, Global & Community Mental Hlth Res Grp, Macau, Peoples R China; [Hall, Brian J.; Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Tucker, Joseph D.] UNC Project China, Guangzhou, Guangdong, Peoples R China; [Tucker, Joseph D.] Univ North Carolina Chapel Hill, UNC Global Hlth & Infect Dis, Chapel Hill, NC USA; [Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Sun Yat Sen University; Sun Yat Sen University; Western Sydney University; University of Macau; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Chen, W; Ling, L (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China.; Chen, W; Ling, L (corresponding author), Sun Yat Sen Univ, Ctr Migrant Hlth Policy, Guangzhou, Guangdong, Peoples R China.; Chen, W (corresponding author), Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia.	chenwen200485@163.com; lingli@mail.sysu.edu.cn	Hall, Brian J./B-7694-2016; Renzaho, Andre M.N./AAH-7679-2021	Hall, Brian J./0000-0001-9358-2377; RENZAHO, ANDRE/0000-0002-6844-0833	Fogarty Global Health Fellows Program Consortium of the University of North Carolina, John Hopkins Bloomberg School of Public Health, Morehouse and Tulane [5R25TW009340-02, 1R25TW009340-01]; University of Macau [SRG2014-00001-FSS, MYRG2015-00124-FSS, MYRG2015-00109-FSS]; NIH (NIAID) [1R01A1114310, 1D43TW009532]; Australian Research Council's Future Fellowship [FT110100345]; China Medical Board [12-111]; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114310, P30AI050410] Funding Source: NIH RePORTER	Fogarty Global Health Fellows Program Consortium of the University of North Carolina, John Hopkins Bloomberg School of Public Health, Morehouse and Tulane; University of Macau; NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Australian Research Council's Future Fellowship(Australian Research Council); China Medical Board; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by Fogarty Global Health Fellows Program Consortium comprised of the University of North Carolina, John Hopkins Bloomberg School of Public Health, Morehouse and Tulane http://globalhealth.unc.edu/ujmt-fogarty-global-health-fellowship/ (5R25TW009340-02, 1R25TW009340-01). Professor Hall received additional support from grants SRG2014-00001-FSS, MYRG2015-00124-FSS and MYRG2015-00109-FSS awarded by the University of Macauhttp://www.umac.mo/research/aboutus.html. Professor Tucker received support from the NIH https.//www.nih.gov/ (NIAID 1R01A1114310, 1D43TW009532). Professor Renzaho is funded by an Australian Research Council's Future Fellowship http.//www.arc.gov.au/ (FT110100345). Professor Ling is funded by the China Medical Boardhttp://www.chinamedicalboard.org/ (12-111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers ML, 2014, AM J TROP MED HYG, V90, P224, DOI 10.4269/ajtmh.13-0181; ACTON JP, 1975, J POLIT ECON, V83, P595, DOI 10.1086/260342; [Anonymous], 2014, GLOB UPD HLTH SECT R; Arcury TA, 2005, HEALTH SERV RES, V40, P135, DOI 10.1111/j.1475-6773.2005.00346.x; Babor TF., 2001, AUDIT ALCOHOL USE DI; Bing L, 2003, CHINESE MENTAL HLTH, V17, P1; Blondell SJ, 2015, AIDS BEHAV, V19, P2012, DOI 10.1007/s10461-015-1095-x; Bolsewicz K, 2015, AIDS CARE, V27, P570, DOI 10.1080/09540121.2014.986050; Buskin Susan E, 2002, J Public Health Manag Pract, V8, P38; Cai R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079320; Chen W, 2016, SEX TRANSM INFECT, V92, P316, DOI 10.1136/sextrans-2015-052268; *CHIN MIN HLTH, 2003, JOINT ASS HIV AIDS P; Cook PA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-78; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Han L, 2014, JAIDS-J ACQ IMM DEF, V67, P216, DOI 10.1097/QAI.0000000000000278; He X, 2015, GUANGZHOU DAILY; Hoi CK, 2015, J PAC RIM PSYCHOL, V9, P120, DOI 10.1017/prp.2015.12; Huang W, 2014, PREV SCI, V15, P329, DOI 10.1007/s11121-013-0423-5; Huntington S, 2011, HIV MED, V12, P361, DOI 10.1111/j.1468-1293.2010.00891.x; Jacobsen MM, 2016, CURR HIV-AIDS REP, V13, P64, DOI 10.1007/s11904-016-0303-2; Jarvis M, 2015, CURR PHARM TEACH LEA, V7, P137, DOI 10.1016/j.cpil.2014.09.002; Joint United Nations Programme on HIV/AIDS, 2014, AMB TREATM TARG WRIT; Juan S, 2017, CHINA DAILY; Kulldorff M, 2002, INT J EPIDEMIOL, V31, P495, DOI 10.1093/ije/31.2.495; Lapostolle A, 2011, AIDS CARE, V23, P1117, DOI 10.1080/09540121.2011.554522; Leibowitz AA, 2007, MED CARE RES REV, V64, P568, DOI 10.1177/1077558707304634; Li G, 2014, GUANGZHOU DAILY; Lucas A, 2013, AIDS, V27, P795, DOI 10.1097/QAD.0b013e32835c54f9; MCGUIRK MA, 1984, INQUIRY-J HEALTH CAR, V21, P84; National AIDS Control Council of Kenya, 2014, KEN AIDS RESP PROGR; National AIDS Control Organization, 2008, NAT BEH SURV SURV BS; National Center for HIV/ AIDS Viral Hepatitis STD and TB Prevention, 2016, CDC FACT SHEET HIV T; National Health and Family Planning Commission of the People's Republic of China, 2015, 2015 CHIN AIDS RESP; Ojikutu B, 2013, AIDS PATIENT CARE ST, V27, P45, DOI 10.1089/apc.2012.0312; Organization WH, 2015, PREV HIV AD AG 15 49; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Renzi C, 2001, PREV MED, V32, P40, DOI 10.1006/pmed.2000.0778; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Shisana O., 2014, AFRICAN NATL HIV P; States CfDCaPiU, 2015, TRENDS PREV SEX BEH; Thornton AC, 2012, HIV MED, V13, P416, DOI 10.1111/j.1468-1293.2012.00992.x; Tucker JD, 2012, SEX TRANSM INFECT, V88, P116, DOI 10.1136/sextrans-2011-050135; Wang P, 2014, YANGCHENG EVENING NE; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; WHO, 2015, CONSOLIDATED GUIDELI; WHO, 2016, GUID HIV SELF TEST P; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; Wu Di, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P1095; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Wu ZY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001874; Xiao S, 1999, MENTAL HEALTH SCALE; Xiao S.Y., 1987, CHIN MENT HLTH J, V4, P183; Zou X, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-490	54	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180801	10.1371/journal.pone.0180801	http://dx.doi.org/10.1371/journal.pone.0180801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727786	gold, Green Published			2022-12-27	WOS:000406634500029
J	Larifla, L; Armand, C; Bangou, J; Blanchet-Deverly, A; Numeric, P; Fonteau, C; Michel, CT; Ferdinand, S; Bourrhis, V; Velayoudom-Cephise, FL				Larifla, Laurent; Armand, Christophe; Bangou, Jacqueline; Blanchet-Deverly, Anne; Numeric, Patrick; Fonteau, Christiane; Michel, Carl-Thony; Ferdinand, Severine; Bourrhis, Veronique; Velayoudom-Cephise, Fritz-Line			Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans	PLOS ONE			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; HEART-DISEASE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; ADULT-POPULATION; RISK-FACTORS; E GENOTYPES; SMOKING; FREQUENCY; MEN	Objectives Apolipoprotein E gene (APOE) polymorphism is associated with the lipid profile and cardiovascular disease. However, these relationships vary between ethnic groups. We evaluated, for the first time in an Afro-Caribbean population, the distribution of APOE polymorphisms and their associations with coronary artery disease (CAD), the lipid profile and other cardio-metabolic risk factors. Methods We studied 712 Afro-Caribbean subjects including 220 with documented CAD and 492 healthy subjects. TaqMan assays were performed to genotype rs7412 and rs429358, the two variants that determine the APOE alleles epsilon 2, epsilon 3 and epsilon 4. The association between APOE genotype and the lipid profile was analysed by comparing epsilon 2 carriers, epsilon 3 homozygotes and epsilon 4 carriers. Results The frequencies of epsilon 2, epsilon 3 and epsilon 4 in the overall sample were 8%, 70% and 22%, respectively. CAD was not associated with APOE polymorphism. The total cholesterol level was higher in epsilon 4 carriers compared with epsilon 2 carriers: 5.07 vs 4.59 mmol/L (P = 0.016). The LDL-cholesterol level was lower in APOE epsilon 2 carriers compared with epsilon 3 homozygotes and epsilon 4 carriers: 2.65 vs 3.03 and 3.17 mmol/L, respectively (p = 0.002). The total cholesterol/HDL-cholesterol and LDL-cholesterol/HDL-cholesterol ratios were similar in the three allelic groups. APOE polymorphism was not associated with diabetes, hypertension, waist circumference or body mass index. Conclusions Our results indicate that APOE gene polymorphism is associated with the lipid profile but not with CAD in Afro-Caribbean people. This lack of association with CAD may be explained by the low atherogenic profile observed in epsilon 4 carriers, which may warrant further investigation.	[Larifla, Laurent; Armand, Christophe; Bangou, Jacqueline; Blanchet-Deverly, Anne; Velayoudom-Cephise, Fritz-Line] Univ Antilles, ECM LAMIA EA 4540, Res Grp Clin Epidemiol & Med, Pointe a Pitre, Guadeloupe, France; [Larifla, Laurent; Michel, Carl-Thony] Univ Hosp Guadeloupe, Dept Cardiol, Pointe a Pitre, Guadeloupe, France; [Armand, Christophe; Ferdinand, Severine] Univ Hosp Guadeloupe, Dept Med Informat & Publ Hlth, Pointe a Pitre, Guadeloupe, France; [Bangou, Jacqueline] Univ Hosp Guadeloupe, Biochem Unit, Pointe a Pitre, Guadeloupe, France; [Numeric, Patrick] Univ Hosp Martinique, Dept Internal Med Unit, Fort De France, France; [Fonteau, Christiane] Univ Hosp Martinique, Biochem Unit, Fort De France, France; [Bourrhis, Veronique] Univ Hosp Guadeloupe, Dept Med, Pointe a Pitre, Guadeloupe, France; [Velayoudom-Cephise, Fritz-Line] Univ Hosp Guadeloupe, Dept Endocrinol & Diabetol, Pointe a Pitre, Guadeloupe, France	Universite des Antilles; CHU Guadeloupe; CHU Guadeloupe; CHU Guadeloupe; CHU Martinique; CHU Martinique; CHU Guadeloupe; CHU Guadeloupe	Larifla, L (corresponding author), Univ Antilles, ECM LAMIA EA 4540, Res Grp Clin Epidemiol & Med, Pointe a Pitre, Guadeloupe, France.; Larifla, L (corresponding author), Univ Hosp Guadeloupe, Dept Cardiol, Pointe a Pitre, Guadeloupe, France.	laurent.larifla@chu-guadeloupe.fr		FERDINAND, Severine/0000-0001-8258-5089; Larifla, Laurent/0000-0002-1447-7753	"Programme Hospitalier pour la Recherche Clinique (PHRC)", France	"Programme Hospitalier pour la Recherche Clinique (PHRC)", France	This study was supported by grants from the "Programme Hospitalier pour la Recherche Clinique (PHRC)", France.	Anuurad E, 2006, J LIPID RES, V47, P2475, DOI 10.1194/jlr.M600288-JLR200; Atadzhanov Masharip, 2014, BMC Res Notes, V7, P194, DOI 10.1186/1756-0500-7-194; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Chang MH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-62; Chaturvedi N, 2003, HEART, V89, P681, DOI 10.1136/heart.89.6.681; CHATURVEDI N, 1994, DIABETOLOGIA, V37, P765, DOI 10.1007/s001250050177; Chaudhary R, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-36; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Foucan L, 2001, EUR J EPIDEMIOL, V17, P1089, DOI 10.1023/A:1021213729434; Foucan L, 2000, DIABETES METAB, V26, P473; Grammer TB, 2013, EUR HEART J, V34, P1298, DOI 10.1093/eurheartj/eht001; Gustavsson J, 2012, ATHEROSCLEROSIS, V220, P486, DOI 10.1016/j.atherosclerosis.2011.10.011; Hagberg JM, 2000, PHYSIOL GENOMICS, V4, P101, DOI 10.1152/physiolgenomics.2000.4.2.101; Holmes MV, 2014, ATHEROSCLEROSIS, V237, P5, DOI 10.1016/j.atherosclerosis.2014.07.038; Inamo J, 2011, J HYPERTENS, V29, P1494, DOI 10.1097/HJH.0b013e328348fd95; Isles CG, 2000, QJM-INT J MED, V93, P567, DOI 10.1093/qjmed/93.9.567; KINOSIAN B, 1995, J INVEST MED, V43, P443; Kolovou GD, 2007, AGEING RES REV, V6, P94, DOI 10.1016/j.arr.2006.11.001; Kypreos KE, 2009, FEBS J, V276, P5720, DOI 10.1111/j.1742-4658.2009.07301.x; Lahoz C, 2001, ATHEROSCLEROSIS, V154, P529, DOI 10.1016/S0021-9150(00)00570-0; Lee MJ, 2013, CLIN CHIM ACTA, V416, P31, DOI 10.1016/j.cca.2012.10.054; Loktionov A, 1999, ATHEROSCLEROSIS, V145, P125, DOI 10.1016/S0021-9150(99)00022-2; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Masemola ML, 2007, SCAND J PUBLIC HEALT, V35, P60, DOI 10.1080/14034950701355635; Nam BH, 2006, AM J CARDIOL, V97, P372, DOI 10.1016/j.amjcard.2005.08.055; Novotny D, 2014, CLIN BIOCHEM, V47, P1015, DOI 10.1016/j.clinbiochem.2014.03.015; Ordovas JM, 1999, CURR OPIN LIPIDOL, V10, P15, DOI 10.1097/00041433-199902000-00004; Rubin J, 2002, CURR OPIN LIPIDOL, V13, P25, DOI 10.1097/00041433-200202000-00005; SANDHOLZER C, 1995, HUM GENET, V95, P46; Stoumpos S, 2013, J HUM HYPERTENS, V27, P245, DOI 10.1038/jhh.2012.37; Talmud PJ, 2005, ANN HUM GENET, V69, P613, DOI 10.1111/j.1529-8817.2005.00205.x; Talmud PJ, 2004, ATHEROSCLEROSIS, V177, P105, DOI 10.1016/j.atherosclerosis.2004.06.008; Tan CE, 2003, ATHEROSCLEROSIS, V170, P253, DOI 10.1016/S0021-9150(03)00232-6; Tao MH, 2011, METABOLISM, V60, P1488, DOI 10.1016/j.metabol.2011.03.004; Ward H, 2009, ARCH INTERN MED, V169, P1424, DOI 10.1001/archinternmed.2009.234; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Willis F, 2003, J NATL MED ASSOC, V95, P71	37	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181620	10.1371/journal.pone.0181620	http://dx.doi.org/10.1371/journal.pone.0181620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727855	Green Submitted, gold, Green Published			2022-12-27	WOS:000406634500093
J	Mizutaka, S; Yakubo, K				Mizutaka, Shogo; Yakubo, Kousuke			Structural instability of large-scale functional networks	PLOS ONE			English	Article								We study how large functional networks can grow stably under possible cascading overload failures and evaluated the maximum stable network size above which even a small-scale failure would cause a fatal breakdown of the network. Employing a model of cascading failures induced by temporally fluctuating loads, the maximum stable size nmax has been calculated as a function of the load reduction parameter rthat characterizes how quickly the total load is reduced during the cascade. If we reduce the total load sufficiently fast ( r >= r(c)), the network can grow infinitely. Otherwise, nmax is finite and increases with r. For a fixed r(< r(c)), nmax for a scale-free network is larger than that for an exponential network with the same average degree. We also discuss how one detects and avoids the crisis of a fatal breakdown of the network from the relation between the sizes of the initial network and the largest component after an ordinarily occurring cascading failure.	[Mizutaka, Shogo] Inst Stat Math, Sch Stat Thinking, Tachikawa, Tokyo, Japan; [Yakubo, Kousuke] Hokkaido Univ, Dept Appl Phys, Sapporo, Hokkaido, Japan	Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Hokkaido University	Mizutaka, S (corresponding author), Inst Stat Math, Sch Stat Thinking, Tachikawa, Tokyo, Japan.	mizutaka@ism.ac.jp	Mizutaka, Shogo/GSD-2376-2022		Japan Society for the Promotion of Science [16K05466]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (No. 16K05466) from the Japan Society for the Promotion of Science.	Abramowitz M., 1964, HDB MATH FUNCTIONS F; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Crucitti P, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.045104; de Menezes MA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028701; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Gao J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.092002; GARDNER MR, 1970, NATURE, V228, P784, DOI 10.1038/228784a0; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goltsev AV, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051105; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Holme P, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036119; Kishore V, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.188701; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Meade JE, 2010, ALTERNATIVE SYSTEMS; Meloni S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.208701; Mizutaka S, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012814; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Ostilli M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061149; PORTER RH, 1983, BELL J ECON, V14, P301, DOI 10.2307/3003634; Shimada T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04082; Shiraki Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036101; Stauffer D., 1991, INTRO PERCOLATION TH; Tan SY, 2016, EPL-EUROPHYS LETT, V114, DOI 10.1209/0295-5075/114/58002; Tanizawa T, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046109; Watanabe A, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.114003; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhou D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.066103	33	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181247	10.1371/journal.pone.0181247	http://dx.doi.org/10.1371/journal.pone.0181247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727823	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500050
J	Persoon, S; Chinapaw, MJM; Buffart, LM; Liu, RDK; Wijermans, P; Koene, HR; Minnema, MC; Lugtenburg, PJ; Marijt, EWA; Brug, J; Nollet, F; Kersten, MJ				Persoon, Saskia; ChinAPaw, Mai J. M.; Buffart, Laurien M.; Liu, Roberto D. K.; Wijermans, Pierre; Koene, Harry R.; Minnema, Monique C.; Lugtenburg, Pieternella J.; Marijt, Erik W. A.; Brug, Johannes; Nollet, Frans; Kersten, Marie Jose			Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CANCER SURVIVORS; PHYSICAL-EXERCISE; HOSPITAL ANXIETY; RESISTANCE; STRENGTH; FATIGUE; FITNESS; INTERVENTION; DETERMINANTS	Background This single blind, multicenter randomized controlled trial aimed to evaluate the effectiveness of a supervised high intensity exercise program on physical fitness and fatigue in patients with multiple myeloma or lymphoma recently treated with autologous stem cell transplantation. Methods 109 patients were randomly assigned to the 18-week exercise intervention or the usual care control group. The primary outcomes included physical fitness (VO2-peak andWpeak determined using a cardiopulmonary exercise test; grip strength and the 30s chair stand test) and fatigue (Multidimensional Fatigue Inventory) and were assessed prior to randomization and after completion of the intervention or at similar time points for the control group. Multivariable multilevel linear regression analyses were performed to assess intervention effects. Results Patients in the intervention group attended 86% of the prescribed exercise sessions. Of the patients in the control group, 47% reported >= 10 physiotherapy sessions, which most likely included supervised exercise, suggesting a high rate of contamination. Median improvements in physical fitness ranged between 16 and 25% in the intervention group and between 12 and 19% in the control group. Fatigue decreased in both groups. There were no significant differences between the intervention and control group. Conclusion We found no significant beneficial effects of the supervised high intensity exercise program on physical fitness and fatigue when compared to usual care. We hypothesized that the lack of significant intervention effects may relate to suboptimal timing of intervention delivery, contamination in the control group and/or suboptimal compliance to the prescribed exercise intervention.	[Persoon, Saskia; Nollet, Frans] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, Amsterdam, Netherlands; [ChinAPaw, Mai J. M.] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [ChinAPaw, Mai J. M.; Buffart, Laurien M.; Brug, Johannes] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Buffart, Laurien M.; Brug, Johannes] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Liu, Roberto D. K.; Kersten, Marie Jose] Univ Amsterdam, Acad Med Ctr, Dept Hematol, Amsterdam, Netherlands; [Wijermans, Pierre] Haga Teaching Hosp, Dept Hematol, The Hague, Netherlands; [Koene, Harry R.] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands; [Minnema, Monique C.] UMC Utrecht, Dept Hematol, Utrecht, Netherlands; [Lugtenburg, Pieternella J.] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands; [Marijt, Erik W. A.] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Haga Hospital; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kersten, MJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Hematol, Amsterdam, Netherlands.	m.j.kersten@amc.uva.nl	Buffart, Laurien/ABA-8889-2020; Paw, Mai Chin A/N-1665-2019; Brug, Johannes/A-8242-2018	Buffart, Laurien/0000-0002-8095-436X; Paw, Mai Chin A/0000-0001-6259-2441; Brug, Johannes/0000-0002-1904-7349	Alpe d'HuZes/KWF Fund; Dutch Cancer Society [ALPE 2009-4620]	Alpe d'HuZes/KWF Fund; Dutch Cancer Society(KWF Kankerbestrijding)	This study was supported by the Alpe d'HuZes/KWF Fund. The research grant was provided by the Dutch Cancer Society (Grant number: ALPE 2009-4620), http://www.kwf.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; [Anonymous], 2009, ACSMS GUIDELINES EXE; Braamse AMJ, 2014, BONE MARROW TRANSPL, V49, P292, DOI 10.1038/bmt.2013.155; Campbell KL, 2012, BRIT J SPORT MED, V46, P909, DOI [10.1136/bjsm.2010.082719, 10.1136/bjsports-2010-082719]; Chinapaw MJM, 2012, INT J BEHAV MED, V19, P143, DOI 10.1007/s12529-011-9158-5; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Cocks K, 2007, EUR J CANCER, V43, P1670, DOI 10.1016/j.ejca.2007.04.022; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Cramp F, 2012, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD006145.PUB3; De Backer IC, 2008, BRIT J CANCER, V99, P30, DOI 10.1038/sj.bjc.6604433; De Backer IC, 2007, ACTA ONCOL, V46, P1143, DOI 10.1080/02841860701418838; De Backer IC, 2007, ARCH PHYS MED REHAB, V88, P610, DOI 10.1016/j.apmr.2007.02.013; Fess EE, 1992, CLIN ASSESSMENT RECO, V2nd; Hacker ED, 2017, BIOL BLOOD MARROW TR, V23, P659, DOI 10.1016/j.bbmt.2016.12.637; Hacker ED, 2014, EUR J ONCOL NURS, V18, P175, DOI 10.1016/j.ejon.2013.10.013; Hacker ED, 2011, CANCER NURS, V34, P238, DOI 10.1097/NCC.0b013e3181fb3686; Hayes SC, 2004, BRIT J SPORT MED, V38, P304, DOI 10.1136/bjsm.2002.003632; Hayward V, 2014, ADV FITNESS ASSESSME; Hulscher MEJL, 2003, QUAL SAF HEALTH CARE, V12, P40, DOI 10.1136/qhc.12.1.40; Jones LW, 2011, ONCOLOGIST, V16, P112, DOI 10.1634/theoncologist.2010-0197; Kampshoff CS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0513-2; Knols RH, 2011, BONE MARROW TRANSPL, V46, P1245, DOI 10.1038/bmt.2010.288; Kuehl R, 2016, SUPPORT CARE CANCER, V24, P4327, DOI 10.1007/s00520-016-3271-6; Mosher CE, 2009, PSYCHO-ONCOLOGY, V18, P113, DOI 10.1002/pon.1399; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; Padilha CS, 2017, J CANCER SURVIV, V11, P339, DOI 10.1007/s11764-016-0592-x; Persoon S, 2013, CANCER TREAT REV, V39, P682, DOI 10.1016/j.ctrv.2013.01.001; Persoon S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-671; Pidala J, 2010, BRIT J HAEMATOL, V148, P373, DOI 10.1111/j.1365-2141.2009.07992.x; POSNER JD, 1995, ARCH PHYS MED REHAB, V76, P373, DOI 10.1016/S0003-9993(95)80664-4; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P129, DOI 10.1123/japa.7.2.129; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Strasser B, 2013, MED SCI SPORT EXER, V45, P2080, DOI 10.1249/MSS.0b013e31829a3b63; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; van Haren IEPM, 2013, PHYS THER, V93, P514, DOI 10.2522/ptj.20120181; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Winters-Stone KM, 2014, BRIT J SPORT MED, V48, P987, DOI 10.1136/bjsports-2012-091732; Wolin KY, 2010, LEUKEMIA, V24, P1113, DOI 10.1038/leu.2010.54; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181313	10.1371/journal.pone.0181313	http://dx.doi.org/10.1371/journal.pone.0181313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727771	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500055
J	Pirie-Shepherd, SR; Painter, C; Whalen, P; Vizcarra, P; Roy, M; Qian, J; Franks, T; Coskran, T; Golas, J; Deng, SB; Zhong, WY; Tucker, E; Marrinucci, D; Gerber, HP; Powell, EL				Pirie-Shepherd, Steven R.; Painter, Cory; Whalen, Pamela; Vizcarra, Pamela; Roy, Marc; Qian, Jesse; Franks, Tania; Coskran, Tim; Golas, Jon; Deng, Shibing; Zhong, Wenyan; Tucker, Eric; Marrinucci, Dena; Gerber, Hans-Peter; Powell, Eric L.			Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients	PLOS ONE			English	Article							BREAST-CANCER; ANTIGEN; CELLS; ANTIBODY; HER2	The fetal oncogene 5T4 is a cell surface protein, with overexpression observed in a variety of cancers as compared to normal adult tissue. The ability to select patients with tumors that express high levels of 5T4 may enrich a clinical trial cohort with patients most likely to respond to 5T4 targeted therapy. To that end, we developed assays to measure 5T4 in both tumors and in circulating tumor cells (CTCs). We identified the presence of 5T4 in both adenocarcinoma and squamous cell carcinoma of lung, in all clinical stages and grades of disease. CTCs were identified in peripheral blood from the majority of patients with NSCLC, and 5T4 was detectable in most samples. Although 5T4 was present in both CTCs and tumors in most patients, there was no concordance between relative amount in either sample type. Clinical response rates of patients treated with the therapies directed against 5T4 in early stage clinical trials, as determined by these assays, may provide important insights into the biology of 5T4 in tumors and the mechanisms of action of 5T4-targeting therapy.	[Pirie-Shepherd, Steven R.; Painter, Cory; Whalen, Pamela; Vizcarra, Pamela; Deng, Shibing; Powell, Eric L.] Pfizer Inc, WRD, EORCD, La Jolla, CA USA; [Roy, Marc; Qian, Jesse; Franks, Tania; Coskran, Tim] Pfizer Inc, WRD, IPL, Groton, CT 06340 USA; [Golas, Jon; Zhong, Wenyan; Gerber, Hans-Peter] Pfizer Inc, WRD, OTTD, Pearl River, NY USA; [Tucker, Eric; Marrinucci, Dena] Epic Sci, San Diego, CA USA; [Marrinucci, Dena] Truvian Sci, San Diego, CA USA; [Gerber, Hans-Peter] Harpoon Therapeut Inc, Brisbane, CA USA	Pfizer; Pfizer; Pfizer	Pirie-Shepherd, SR (corresponding author), Pfizer Inc, WRD, EORCD, La Jolla, CA USA.	steven.pirie-shepherd@pfizer.com			Pfizer Inc.	Pfizer Inc.(Pfizer)	This work was funded by Pfizer Inc. We can state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Damelin M, 2011, CANCER RES, V71, P4236, DOI 10.1158/0008-5472.CAN-10-3919; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Liu Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-202; Marrinucci D, 2009, ARCH PATHOL LAB MED, V133, P1468, DOI 10.1043/1543-2165-133.9.1468; Munzone E, 2010, CLIN BREAST CANCER, V10, P392, DOI 10.3816/CBC.2010.n.052; Naganuma H, 2002, ANTICANCER RES, V22, P1033; Nieva J, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016004; O'Flaherty JD, 2012, LUNG CANCER, V76, P19, DOI 10.1016/j.lungcan.2011.10.018; Perez EA, 2011, ONCOLOGIST, V16, P20, DOI 10.1634/theoncologist.2011-S1-20; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; Sapra P, 2013, MOL CANCER THER, V12, P38, DOI 10.1158/1535-7163.MCT-12-0603; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SOUTHALL PJ, 1990, BRIT J CANCER, V61, P89, DOI 10.1038/bjc.1990.20; Steinestel K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-17; Turner N, 2014, CANCERS, V6, P684, DOI 10.3390/cancers6020684; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wendel M, 2012, PHYS BIOL, V9, DOI [10.1088/1478-3967/9/1/016005, 10.1088/1478-3975/9/1/016005]; WRIGLEY E, 1995, INT J GYNECOL CANCER, V5, P269, DOI 10.1046/j.1525-1438.1995.05040269.x; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	20	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0179561	10.1371/journal.pone.0179561	http://dx.doi.org/10.1371/journal.pone.0179561			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727782	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500005
J	Schubert, LF; Kruger, S; Moritz, GB; Schubert, V				Schubert, Lea F.; Krueger, Stephanie; Moritz, Gerald B.; Schubert, Veit			Male reproductive system and spermatogenesis of Limodromus assimilis (Paykull 1790)	PLOS ONE			English	Article							SPERM-BUNDLES; COLEOPTERA CARABIDAE; ACCESSORY-GLANDS; ULTRASTRUCTURE; MORPHOLOGY; SPERMATOZOON; DIVERSITY; EVOLUTION; ORGANS	Based on advanced light and electron microscopy, we describe the male reproductive system and sperm development of Limodromus assimilis. The genital tract consists of pairs of uni-follicular testes, spermatic ducts with diverticula regions, seminal vesicles, accessory glands, an unpaired ejaculatory duct and an aedeagus containing an internal sac equipped with sclerotic scales. Based on their morphology, we draw conclusions about their functions. After spermatogenesis within the follicle, the spermatozoa become released from the sperm cysts. The single spermatozoa move into the diverticula of the vasa deferentia I. Here, they become attached to central rods (spermatostyles), forming secondary conjugates (spermiozeugmata). The coordinated flagella movement of the conjugates possibly improves sperm velocity. Using super-resolution microscopy, we identified highly condensed reticulate chromatin in the lancet-shaped spermatozoa heads and the mitochondrial derivates of the flagella, likely formed by genomic and mitochondrial DNA, respectively. The results show, for the first time, sperm bundle formation in a Platynini species mainly corresponding to that found in Pterostichini species.	[Schubert, Lea F.; Krueger, Stephanie; Moritz, Gerald B.] Martin Luther Univ Halle Wittenberg, Halle, Germany; [Schubert, Veit] Leibniz Inst Plant Genet & Crop Plant Res IPK, Seeland, Germany	Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Schubert, V (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Seeland, Germany.	schubertv@ipk-gatersleben.de		Schubert, Veit/0000-0002-3072-0485; Kruger, Stephanie/0000-0002-7159-8316				ANDERSON JM, 1950, BIOL BULL, V99, P49, DOI 10.2307/1538751; Ballowitz E, 1916, BIOL ZBL, V36, P209; BAWA SR, 1975, EXPERIENTIA, V31, P684, DOI 10.1007/BF01944627; Bock C, 1987, BEITR ELEKTRONENMIKR, V20, P209; BRELAND O P, 1970, Entomological News, V81, P101; Cadeddu B., 2008, STRATEGIE MONITORAGG; Carcupino M, 2002, PROCEEDING OF 9TH INTERNATIONAL SYMPOSIUM ON SPERMATOLOGY, P31; CHEN PS, 1984, ANNU REV ENTOMOL, V29, P233, DOI 10.1146/annurev.en.29.010184.001313; Dallai R, 2014, ARTHROPOD STRUCT DEV, V43, P257, DOI 10.1016/j.asd.2014.04.002; DELOOF A, 1972, Z ZELLFORSCH MIK ANA, V130, P545; Dettner K, 2010, LEHRBUCH ENTOMOLOGIE; Dias G, 2015, MICRON, V73, P21, DOI 10.1016/j.micron.2015.03.003; Ferenz H.-J., 1986, P147; Ferraguti M, 2006, TISSUE CELL, V38, P1, DOI 10.1016/j.tice.2005.05.001; FREUDE H., 1976, KAFER MITTELEUROPAS, V2; Fritzsch D, 2013, THESIS, P23; Gilbert O., 1956, N WALES, V7, P22; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gilson G., 1884, CELLULE, VI, P84; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; HAPP GM, 1992, ANNU REV ENTOMOL, V37, P303, DOI 10.1146/annurev.en.37.010192.001511; Hayashi F, 1998, FUNCT ECOL, V12, P347, DOI 10.1046/j.1365-2435.1998.00205.x; Hayashi F, 1997, INT J INSECT MORPHOL, V26, P63, DOI 10.1016/S0020-7322(96)00023-2; HECHT NB, 1995, DEV GENET, V16, P95, DOI 10.1002/dvg.1020160202; Higginson DM, 2011, BIOL REV, V86, P249, DOI 10.1111/j.1469-185X.2010.00147.x; Hodgson AN, 2013, INVERTEBR REPROD DEV, V57, P120, DOI 10.1080/07924259.2012.695295; ISHIKAWA R, 1973, Bulletin of the National Science Museum (Tokyo), V16, P191; Jamieson B.G., 1987, ULTRASTRUCTURE PHYLO; Kaulenas MS, 1992, INSECT ACCESSORY REP, p[3, 123]; Koch D., 1986, P267; Kruger S, 2014, INVERTEBR REPROD DEV, V58, P75, DOI 10.1080/07924259.2013.822835; Lawrence J.F., 1991, P543; Loser S, 1973, VERHANDLUNGEN DTSCH, V66, P83; MACKIE JB, 1974, CELL TISSUE RES, V148, P505; Opitz W, 2003, COLEOPTS BULL, V57, P167, DOI 10.1649/0010-065X(2003)057[0167:SSPIOO]2.0.CO;2; Paoli F, 2014, TISSUE CELL, V46, P274, DOI 10.1016/j.tice.2014.06.003; PHILLIPS DM, 1970, J CELL BIOL, V44, P243, DOI 10.1083/jcb.44.2.243; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; PRATT SA, 1968, J MORPHOL, V126, P31, DOI 10.1002/jmor.1051260104; Romeis B, 2010, MIKROSKOPISCHE TECHN, P214; Sasakawa K, 2008, ENTOMOL SCI, V11, P415, DOI 10.1111/j.1479-8298.2008.00289.x; Sasakawa K, 2007, NATURWISSENSCHAFTEN, V94, P384, DOI 10.1007/s00114-006-0200-4; SHARP D, 1912, T ROYAL ENTOMOLOGICA, V60, P477, DOI DOI 10.1111/J.1365-2311.1912.TB03107.X; Skinner BM, 2017, CHROMOSOMA, V126, P195, DOI 10.1007/s00412-016-0614-5; Snodgrass RE, 1993, PRINCIPLES INSECT MO, DOI DOI 10.7591/J.CTV1NHM1J; SPICER S. S., 1960, TECH BULL REG MED TECHNOL, V30, P53; Takami Y, 2002, ZOOL SCI, V19, P1067, DOI 10.2108/zsj.19.1067; Takami Y, 2007, NATURWISSENSCHAFTEN, V94, P543, DOI 10.1007/s00114-007-0225-3; Temkin MH, 2004, BIOL BULL-US, V206, P35, DOI 10.2307/1543196; Viscuso R, 1998, TISSUE CELL, V30, P453, DOI 10.1016/S0040-8166(98)80059-1; Weisshart K.D., 2016, BIOPROTOC, V6, pe1725, DOI [10.21769/BioProtoc.1725, DOI 10.21769/BIOPROTOC.1725, DOI 10.21769/BioProtoc.1725]; WERNER G, 1965, Z ZELLFORSCH MIK ANA, V66, P255, DOI 10.1007/BF00344339; Will KW, 2005, J MORPHOL, V264, P75, DOI 10.1002/jmor.10319; WITZ BW, 1990, INVERTEBR REPROD DEV, V18, P197, DOI 10.1080/07924259.1990.9672144; Wolfer M., 2010, THESIS, P31; Wu YF, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew116	56	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180492	10.1371/journal.pone.0180492	http://dx.doi.org/10.1371/journal.pone.0180492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723911	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800016
J	Jesus, TF; Moreno, JM; Repolho, T; Athanasiadis, A; Rosa, R; Almeida-Val, VMF; Coelho, MM				Jesus, Tiago F.; Moreno, Joao M.; Repolho, Tiago; Athanasiadis, Alekos; Rosa, Rui; Almeida-Val, Vera M. F.; Coelho, Maria M.			Protein analysis and gene expression indicate differential vulnerability of Iberian fish species under a climate change scenario	PLOS ONE			English	Article							GUANYLATE-BINDING PROTEIN-1; FRESH-WATER; TEMPERATURE; ACIDIFICATION; EVOLUTIONARY; RESPONSES; IMPACTS; BIODIVERSITY; TORGALENSIS; PHYSIOLOGY	Current knowledge on the biological responses of freshwater fish under projected scenarios of climate change remains limited. Here, we examine differences in the protein configuration of two endemic Iberian freshwater fish species, Squalius carolitertii and the critically endangered S. torgalensis that inhabit in the Atlantic-type northern and in the Mediterranean-type southwestern regions, respectively. We performed protein structure modeling of fourteen genes linked to protein folding, energy metabolism, circadian rhythms and immune responses. Structural differences in proteins between the two species were found for HSC70, FKBP52, HIF1 alpha and GPB1. For S. torgalensis, besides structural differences, we found higher thermostability for two proteins (HSP90 and GBP1), which can be advantageous in a warmer environment. Additionally, we investigated how these species might respond to projected scenarios of 3 degrees climate change warming, acidification (Delta pH = -0.4), and their combined effects. Significant changes in gene expression were observed in response to all treatments, particularly under the combined warming and acidification. While S. carolitertii presented changes in gene expression for multiple proteins related to folding (hsp90aa1, hsc70, fkbp4 and stip1), only one such gene was altered in S. torgalensis (stip1). However, S. torgalensis showed a greater capacity for energy production under both the acidification and combined scenarios by increasing cs gene expression and maintaining ldha gene expression in muscle. Overall, these findings suggest that S. torgalensis is better prepared to cope with projected climate change. Worryingly, under the simulated scenarios, disturbances to circadian rhythm and immune system genes (cry1aa, per1a and gbp1) raise concerns for the persistence of both species, highlighting the need to consider multi-stressor effects when evaluating climate change impacts upon fish. This work also highlights that assessments of the potential of endangered freshwater species to cope with environmental change are crucial to help decision-makers adopt future conservation strategies.	[Jesus, Tiago F.; Moreno, Joao M.; Coelho, Maria M.] Univ Lisbon, Ctr Ecol Evolucao & Alteracaes Ambientais, Fac Ciencias, Lisbon, Portugal; [Repolho, Tiago; Rosa, Rui] Univ Lisbon, Lab Maritimo Guia, MARE Ctr Ciencias Mar & Ambiente, Fac Ciencias, Ave Nossa Senhora Cabo, Cascais, Portugal; [Athanasiadis, Alekos] Inst Gulbenkian Ciencias, Rua Quinta Grande, Oeiras, Portugal; [Almeida-Val, Vera M. F.] INPA, Lab Ecofisiol & Evolucao Mol, Manaus, AM, Brazil	Universidade de Lisboa; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Institute Nacional de Pesquisas da Amazonia	Jesus, TF (corresponding author), Univ Lisbon, Ctr Ecol Evolucao & Alteracaes Ambientais, Fac Ciencias, Lisbon, Portugal.	tfjesus@fc.ul.pt	Moreno, João M/M-1651-2017; Athanasiadis, Alekos/F-2038-2011; Rosa, Rui/A-4580-2009; Coelho, Maria M/B-8672-2009; Repolho, Tiago/C-8975-2009; de Jesus, Tiago Filipe Salgueiro/J-1765-2019; Almeida-Val, Vera/J-5818-2014	Moreno, João M/0000-0002-2004-7442; Athanasiadis, Alekos/0000-0003-1526-0000; Rosa, Rui/0000-0003-2801-5178; Coelho, Maria M/0000-0003-3288-1693; Repolho, Tiago/0000-0002-1048-8009; de Jesus, Tiago Filipe Salgueiro/0000-0001-8054-4136; Almeida-Val, Vera/0000-0001-7038-5266	Fundacao para a Ciencia e Tecnologia [SFRH/BD/73801/2010]; FCT fellowship [SFRH/BD/73801/2010]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT fellowship(Portuguese Foundation for Science and Technology)	The experimental procedures of this study were financially supported by the PhD fellowship SFRH/BD/73801/2010 from Fundacao para a Ciencia e Tecnologia (http://www.fct.pt).; We thank Isa Matos, Miguel Machado, Miguel Santos and Joana Pinho for their help in fieldwork. We thank two anonymous reviewers, Vitor Sousa and Margarida Matos for their helpful comments and suggestions on the manuscript. We also acknowledge ICNF (Instituto da Conservacao da Natureza e Florestas) for issuing the fishing licenses. This work was supported by the FCT fellowship SFRH/BD/73801/2010 to Tiago F. Jesus.	Almeida-Val VMF, 2015, MOL ECOL RESOUR, V15, P1256, DOI 10.1111/1755-0998.12439; Alvarez P, 2015, MOL ECOL RESOUR, V15, P1510, DOI 10.1111/1755-0998.12454; Amaral IPG, 2012, AM J PHYSIOL-REG I, V302, pR193, DOI 10.1152/ajpregu.00367.2011; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aurelio M, 2013, MAR BIOL, V160, P2663, DOI 10.1007/s00227-013-2259-8; Behrens MD, 2007, CAN J FISH AQUAT SCI, V64, P867, DOI 10.1139/F07-063; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Bignami S, 2013, P NATL ACAD SCI USA, V110, P7366, DOI 10.1073/pnas.1301365110; Boersma M, 2016, ECOL LETT, V19, P45, DOI 10.1111/ele.12541; Buxbaum E., 2007, PROTEIN STRUCTURE FU, P15; Campos DF, 2017, HYDROBIOLOGIA, V789, P133, DOI 10.1007/s10750-016-2649-2; Carvalho SB, 2010, GLOBAL CHANGE BIOL, V16, P3257, DOI 10.1111/j.1365-2486.2010.02212.x; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; Coelho MM, 1998, J FISH BIOL, V52, P937, DOI 10.1006/jfbi.1998.0642; Cornish -Bowden A., 2013, FUNDAMENTALS ENZYME; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Doadrio I., 1988, Senckenbergiana Biologica, V68, P301; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Field C.B., 2014, CLIMATE CHANGE 2014, P1132; Fussel H-M, 2012, EEA REPORT; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hartmann DL, 2013, WORKING GROUP CONTRI; Henriques R, 2010, CONSERV GENET, V11, P1859, DOI 10.1007/s10592-010-0078-8; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Idda ML, 2012, PROG BRAIN RES, V199, P41, DOI 10.1016/B978-0-444-59427-3.00003-4; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Jesus TF, 2013, GENET MOL BIOL, V36, P61, DOI 10.1590/S1415-47572013000100009; Jesus TF, 2016, J THERM BIOL, V55, P54, DOI 10.1016/j.jtherbio.2015.11.009; Cisneros BEJ, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P229; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Lake PS, 2000, BIOSCIENCE, V50, P1099, DOI 10.1641/0006-3568(2000)050[1099:GCATBO]2.0.CO;2; Leduc AOHC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0447; LIAW SH, 1995, PROTEIN SCI, V4, P2358, DOI 10.1002/pro.5560041114; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lu Yin-ping, 2007, Virologica Sinica, V22, P193, DOI 10.1007/s12250-007-0021-4; Magalhaes MF, 2003, J FISH BIOL, V63, P300, DOI 10.1046/j.1095-8649.2003.00148.x; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McCairns RJS, 2016, EVOL APPL, V9, P531, DOI 10.1111/eva.12363; Mesquita N, 2007, J FISH BIOL, V71, P45, DOI 10.1111/j.1095-8649.2007.01518.x; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Munoz NJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1082; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Ou M, 2015, NAT CLIM CHANGE, V5, P950, DOI 10.1038/NCLIMATE2694; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pimentel MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134082; Pimentel MS, 2014, J EXP BIOL, V217, P2062, DOI 10.1242/jeb.092635; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Prado-Lima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152366; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Rosa R, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2840-z; Rosa R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1738; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Scammell JG, 2003, GENOMICS, V81, P640, DOI 10.1016/S0888-7543(03)00090-9; Schunter C, 2016, NAT CLIM CHANGE, V6, P1014, DOI 10.1038/NCLIMATE3087; Semenza GL, 1997, KIDNEY INT, V51, P553, DOI 10.1038/ki.1997.77; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Somero GN, 2011, AM J PHYSIOL-REG I, V301, pR1, DOI 10.1152/ajpregu.00719.2010; Sorensen JG, 2009, J THERM BIOL, V34, P49, DOI 10.1016/j.jtherbio.2008.10.004; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Trifonov EN, 2003, CURR OPIN STRUC BIOL, V13, P110, DOI 10.1016/S0959-440X(03)00005-8; Veilleux HD, 2015, NAT CLIM CHANGE, V5, P1074, DOI [10.1038/nclimate2724, 10.1038/NCLIMATE2724]; Vinagre C, 2013, REG ENVIRON CHANGE, V13, P853, DOI 10.1007/s10113-012-0376-4; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1	78	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181325	10.1371/journal.pone.0181325	http://dx.doi.org/10.1371/journal.pone.0181325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719655	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400039
J	Luciano, CS; Newell, SJ				Luciano, Carl S.; Newell, Sandra J.			Effects of prey, pitcher age, and microbes on acid phosphatase activity in fluid from pitchers of Sarracenia purpurea (Sarraceniaceae)	PLOS ONE			English	Article							BACTERIAL DIVERSITY; CARNIVOROUS PLANTS; WONDERFUL PLANTS; NEPENTHES; STOICHIOMETRY; EXPRESSION; MUTUALISM; COMMUNITY; DISTINCT; ENZYMES	Carnivory in pitcher plants generally involves digestion of prey, by the plant itself, by symbionts, or both. While symbionts appear to be important in the digestion of prey in Sarracenia purpurea, the importance of pitcher-derived enzymes is less well documented. Our goal was to reduce microbial numbers in pitcher fluid in order to measure the acid phosphatase activity attributable to the pitchers themselves. Preliminary experiments indicated that various antibiotics were minimally effective at reducing microbial populations and that antibioticresistant microbes were easily cultured from pitcher fluid. Consequently, we measured the abundance of culturable microbes in every sample taken for the measurement of acid phosphatase activity. Pitchers fed with one sterilized ant had higher levels of acid phosphatase activity than unfed pitchers. Older pitchers were more responsive to feeding than young pitchers. Pitchers with high levels of microbes (on Day 5) had higher acid phosphatase activity than pitchers with low levels of microbes. However, fed pitchers were not more likely to have higher microbe levels and microbe levels were not related to pitcher age. When fluid samples from inside the pitcher were compared to appropriate controls incubated outside the pitcher, acid phosphatase activity was higher inside the pitcher. Results from the feeding experiments are consistent with a primary role of microbes in the digestion of prey in pitchers of S. purpurea. However, the relationship between pitcher age and enzyme activity is not a function of microbes in the pitcher fluid and may depend on enzymes produced by the plant. Our methods would not detect microbes embedded on the inner surface of the pitcher; and if they survived the alcohol rinse and antibiotics, we cannot rule out microbes as the source of the relationship between pitcher age and acid phosphatase activity.	[Luciano, Carl S.; Newell, Sandra J.] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA	Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania	Luciano, CS (corresponding author), Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA.	luciano@iup.edu			IUP Senate; IUP School of Graduate Studies	IUP Senate; IUP School of Graduate Studies	The authors CSL and SJN received funding from the IUP Senate (http://www.iup.edu/senate/committees/research/) and the IUP School of Graduate Studies (http://www.iup.edu/graduatestudies/) to support this work but no specific grant numbers were associated with the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec L, 1997, BOT REV, V63, P273, DOI 10.1007/BF02857953; Adamec L, 2011, CELL ORIG LIFE EXTRE, V16, P457; ADAMS RM, 1977, AM J BOT, V64, P265, DOI 10.2307/2441969; Adlassnig W, 2011, ANN BOT-LONDON, V107, P181, DOI 10.1093/aob/mcq238; Anderson B, 2003, OIKOS, V102, P221, DOI 10.1034/j.1600-0706.2003.12478.x; Buch F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118853; Buch F, 2013, ANN BOT-LONDON, V111, P375, DOI 10.1093/aob/mcs287; Buckley HL, 2003, ECOL LETT, V6, P825, DOI 10.1046/j.1461-0248.2003.00504.x; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; CHAPIN CT, 1995, CAN J BOT, V73, P728, DOI 10.1139/b95-079; Chase MW, 2009, BOT J LINN SOC, V161, P329, DOI 10.1111/j.1095-8339.2009.01014.x; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; Deubel A, 2005, SOIL BIOL, V3, P177; Ellison AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039291; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Fukushima K, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0059; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; Givnish TJ, 2015, P NATL ACAD SCI USA, V112, P10, DOI 10.1073/pnas.1422278112; Gray SM, 2006, HYDROBIOLOGIA, V573, P173, DOI 10.1007/s10750-006-0265-2; Gray SM, 2012, AQUAT ECOL, V46, P487, DOI 10.1007/s10452-012-9417-9; Harvey E, 1996, OECOLOGIA, V108, P562, DOI 10.1007/BF00333734; HEARD SB, 1994, ECOLOGY, V75, P1647, DOI 10.2307/1939625; Hepburn JS, 1927, T WAGNER FREE I SCI, V11, P75; HEPBURN JS, 1927, T WAGNER FREE I SCI, V11, P49; HIGASHI S, 1993, J PLANT RES, V106, P47, DOI 10.1007/BF02344372; Hoekman D, 2011, OECOLOGIA, V165, P1073, DOI 10.1007/s00442-010-1802-2; JAFFE K, 1992, NEW PHYTOL, V122, P733; JENTSCH J, 1972, FEBS LETT, V21, P273, DOI 10.1016/0014-5793(72)80181-9; Joel D.M., 1986, P219; Kneitel JM, 2007, J ANIM ECOL, V76, P651, DOI 10.1111/j.1365-2656.2007.01250.x; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; Koopman MM, 2011, MICROB ECOL, V61, P750, DOI 10.1007/s00248-011-9832-9; Koopman MM, 2010, APPL ENVIRON MICROB, V76, P1851, DOI 10.1128/AEM.02440-09; Krieger JR, 2012, FEMS MICROBIOL ECOL, V79, P555, DOI 10.1111/j.1574-6941.2011.01240.x; Krol E, 2012, ANN BOT-LONDON, V109, P47, DOI 10.1093/aob/mcr249; Miller TE, 2002, COMMUNITY ECOL, V3, P109, DOI 10.1556/ComEc.3.2002.1.13; Mouquet N, 2008, FUNCT ECOL, V22, P728, DOI 10.1111/j.1365-2435.2008.01421.x; Peeples CR, 2013, EC SOC AM 98 ANN M A; Peterson CN, 2008, ENVIRON MICROBIOL, V10, P2257, DOI 10.1111/j.1462-2920.2008.01648.x; Plachno BJ, 2006, PLANT BIOLOGY, V8, P813, DOI 10.1055/s-2006-924177; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Robinson W.J., 1908, TORREYA, V8, P181; Rottloff S, 2011, J EXP BOT, V62, P4639, DOI 10.1093/jxb/err173; Schnell D.E., 2002, CARNIVOROUS PLANTS U; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Stauffer RE, 1987, P ROCHESTER ACAD SCI, V15, P181; Strojsova A, 2003, EUR J PHYCOL, V38, P295, DOI 10.1080/09670260310001612628; TOKES ZA, 1974, PLANTA, V119, P39, DOI 10.1007/BF00390820; Tran MPT., 2015, THESIS; Trzcinski MK, 2003, ECOL ENTOMOL, V28, P482, DOI 10.1046/j.1365-2311.2003.00530.x; Wakefield AE, 2005, ECOLOGY, V86, P1737, DOI 10.1890/04-1673	51	11	11	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181252	10.1371/journal.pone.0181252	http://dx.doi.org/10.1371/journal.pone.0181252			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719666	gold, Green Published, Green Submitted			2022-12-27	WOS:000406061400036
J	Dou, LL; Jia, XY; Wei, HL; Fan, SL; Wang, HT; Guo, YN; Duan, S; Pang, CY; Yu, SX				Dou, Lingling; Jia, Xiaoyun; Wei, Hengling; Fan, Shuli; Wang, Hantao; Guo, Yaning; Duan, Shan; Pang, Chaoyou; Yu, Shuxun			Global analysis of DNA methylation in young (J1) and senescent (J2) Gossypium hirsutum L. cotyledons by MeDIP-Seq	PLOS ONE			English	Article							PLANT SENESCENCE; LEAF SENESCENCE; CPG-ISLANDS; GENOME; GENE; TRANSCRIPTOME; EXPRESSION; RNA; DEMETHYLATION; PATTERNS	DNA methylation is an important epigenetic modification regulating gene expression, genomic imprinting, transposon silencing and chromatin structure in plants and plays an important role in leaf senescence. However, the DNA methylation pattern during Gossypium hirsutum L. cotyledon senescence is poorly understood. In this study, global DNA methylation patterns were compared between two cotyledon development stages, young (J1) and senescence (J2), using methylated DNA immunoprecipitation (MeDIP-Seq). Methylated cytosine occurred mostly in repeat elements, especially LTR/Gypsy in both J1 and J2. When comparing J1 against J2, there were 1222 down-methylated genes and 623 up-methylated genes. Methylated genes were significantly enriched in carbohydrate metabolism, biosynthesis of other secondary metabolites and amino acid metabolism pathways. The global DNA methylation level decreased from J1 to J2, especially in gene promoters, transcriptional termination regions and regions around CpG islands. We further investigated the expression patterns of 9 DNA methyltransferase-associated genes and 2 DNA demethyl-transferase-associated genes from young to senescent cotyledons, which were down-regulated during cotyledon development. In this paper, we first reported that senescent cotton cotyledons exhibited lower DNA methylation levels, primarily due to decreased DNA methyltransferase activity and which also play important role in regulating secondary metabolite process.	[Dou, Lingling; Jia, Xiaoyun; Wei, Hengling; Fan, Shuli; Wang, Hantao; Guo, Yaning; Duan, Shan; Pang, Chaoyou; Yu, Shuxun] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Dou, Lingling] Weinan Inst Agr Sci, Weinan, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Pang, CY; Yu, SX (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	chypang@163.com; ysx195311@163.com	Wang, Han/GPW-9809-2022		earmarked fund for China Agriculture Research System [CARS-18]	earmarked fund for China Agriculture Research System	We appreciate and thank the earmarked fund for China Agriculture Research System (CARS-18) for the financial support.; We appreciate and thank the earmarked fund for China Agriculture Research System (CARS-18) for the financial support.	Ay N, 2014, J EXP BOT, V65, P3875, DOI 10.1093/jxb/eru132; Baurens FC, 2004, TREE PHYSIOL, V24, P401, DOI 10.1093/treephys/24.4.401; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Diaz-Mendoza M, 2016, GENET MOL BIOL, V39, P329, DOI 10.1590/1678-4685-GMB-2016-0015; Dou LL, 2014, MOL GENET GENOMICS, V289, P1103, DOI 10.1007/s00438-014-0872-y; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fraga MF, 2002, TREE PHYSIOL, V22, P813, DOI 10.1093/treephys/22.11.813; Gim JA, 2015, MOL CELLS, V38, P210, DOI 10.14348/molcells.2015.2138; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Henderson IR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001182; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Jin X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060547; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-300; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lin M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0433-5; Lin MH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/798631; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mankessi F, 2011, PHYSIOL PLANTARUM, V143, P178, DOI 10.1111/j.1399-3054.2011.01491.x; Michalak M, 2015, ANN BOT-LONDON, V116, P369, DOI 10.1093/aob/mcv104; Min L, 2014, PLANT PHYSIOL, V164, P1293, DOI 10.1104/pp.113.232314; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Osabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086049; Ouyang B, 2012, PLANT MOL BIOL, V79, P315, DOI 10.1007/s11103-012-9914-1; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Permar V, 2014, PHYSIOL MOL PLANT P, V88, P77, DOI 10.1016/j.pmpp.2014.09.004; Reed K, 2010, ANAL BIOCHEM, V397, P96, DOI 10.1016/j.ab.2009.10.021; Schippers JHM, 2015, CURR OPIN PLANT BIOL, V27, P77, DOI 10.1016/j.pbi.2015.06.018; Seymour DK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004785; Shah ST, 2014, PLANT CELL TISS ORG, V117, P167, DOI 10.1007/s11240-014-0430-7; Shakeel A, 2012, J ANIM PLANT SCI, V22, P722; Shi J, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00803; Song QX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005724; Su JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-12; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Teixeira FK, 2010, HEREDITY, V105, P14, DOI 10.1038/hdy.2010.52; Wang K, 2016, SCI CHINA LIFE SCI, V59, P112, DOI 10.1007/s11427-015-4928-y; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Watson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105338; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yan HX, 2015, RICE, V8, P1, DOI 10.1186/s12284-015-0047-4; Yang HX, 2015, PLANT J, V81, P268, DOI 10.1111/tpj.12726; Yuan JL, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-4; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036126; Zhu MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep07693	53	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0179141	10.1371/journal.pone.0179141	http://dx.doi.org/10.1371/journal.pone.0179141			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM3TT	28715427	Green Published, gold, Green Submitted			2022-12-27	WOS:000414932400001
J	von der Beck, D; Seeger, W; Herold, S; Gunther, A; Loh, B				von der Beck, Daniel; Seeger, Werner; Herold, Susanne; Guenther, Andreas; Loeh, Benjamin			Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient data	PLOS ONE			English	Article							A H1N1 VIRUS; INFECTION; A(H1N1); PREGNANCY; ILLNESS; DEATH; 1ST	Rationale From June of 2009 to August of 2010 the influenza subtype H1N1pdm09 caused a worldwide pandemic. The impact on populations and health care systems around the globe evolved differently. Substantial data come from the German national surveillance network in an outpatient and private practice setting, while information on hospitalized patients in Germany is rather limited. Methods Data from the Federal Statistics Office comprising health insurance claims of the entire nationwide inpatient sample from 2005 to 2012 were used to identify patients who were hospitalized for laboratory-confirmed influenza and to analyse demographical aspects, comorbidities, hospitalization duration, outcomes and ventilator use during the pandemic and seasonal waves of influenza. Measurements and main results A number of 34,493 admissions for laboratory-confirmed influenza occurred during waves between 2005 and 2012. During the pandemic seasonal waves, the number of hospitalizations vastly surpassed the level that was seen in any of the seasonal waves. A major demographic shift was seen with respect to patient age, as younger patients (< 60 years old) were more frequently hospitalized. Mean length of stay was shorter (149 vs. 193 hours), mean time on ventilation tended to be shorter (261 vs. 305 hours) in young children (< 4 years old) and longer (393 vs. 339 hours) in the elderly (> 60 years old). Time to ventilation was shorter in non-fatal cases (328 vs. 349 hours) and longer in fatal cases (419 vs. 358 hours). Logistic regression was used to show the impact of comorbidities and co-diagnoses on mortality and the need for ventilation, as well as differences between pandemic and seasonal influenza. Conclusions Inpatient data suggest differences in patient populations during pandemic and seasonal influenza. Younger patients were more frequently hospitalized. Differences with respect to the presence of certain comorbidities and co-diagnoses, length of stay, time to ventilation and ventilation time could be identified.	[von der Beck, Daniel; Seeger, Werner; Herold, Susanne; Guenther, Andreas; Loeh, Benjamin] Univ Giessen, Giessen, Germany; [von der Beck, Daniel; Seeger, Werner; Herold, Susanne; Guenther, Andreas; Loeh, Benjamin] German Ctr Lung Res DZL, Marburg Lung Ctr UGMLC, Giessen, Germany; [Guenther, Andreas; Loeh, Benjamin] Agaples Lung Clin Waldhof Elgershausen, Greifensstein, Germany	Justus Liebig University Giessen	von der Beck, D (corresponding author), Univ Giessen, Giessen, Germany.; von der Beck, D (corresponding author), German Ctr Lung Res DZL, Marburg Lung Ctr UGMLC, Giessen, Germany.	daniel.vdbeck@outlook.de		Herold, Susanne/0000-0001-6343-0911; Seeger, Werner/0000-0003-1946-0894				Adlhoch C, 2012, INFLUENZA OTHER RESP, V6, pe162, DOI 10.1111/j.1750-2659.2012.00404.x; Balanzat AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033670; Becker A, 2007, MDK AUTWANDSPAUSCHAL, V76, P508; Buda S, 2010, BUNDESGESUNDHEITSBLA, V53, P1223, DOI 10.1007/s00103-010-1158-0; Buda S, 2010, BERICHT EPIDEMIOLOGI; Chen CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024440; Chowell G, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/914196; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; CULLEN G, 2009, EURO SURVEILL, V14; Denholm JT, 2010, MED J AUSTRALIA, V192, P84, DOI 10.5694/j.1326-5377.2010.tb03424.x; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Hansen C, 2012, J INFECT DIS, V206, P1260, DOI 10.1093/infdis/jis488; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Louie JK, 2010, NEW ENGL J MED, V65, P227, DOI DOI 10.1097/01.0GX.0000371713.49382.2F; Pebody RG, 2010, EUROSURVEILLANCE, V15; Poggensee G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-155; Reed C, 2014, CLIN INFECT DIS, V59, P166, DOI 10.1093/cid/ciu285; Santa-Olalla Peralta P, 2010, EUROSURVEILLANCE, V15; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; VAILLANT L, 2009, EURO SURVEILL, V14; van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI DOI 10.1111/IRV.12074; Widgren K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013939; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Organization, 2015, MAN EST DIS BURD ASS; World Health Organization, 2009, WHO GUID DOC; Yang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125447; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	34	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180920	10.1371/journal.pone.0180920	http://dx.doi.org/10.1371/journal.pone.0180920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708896	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800029
J	Wu, X; Li, F				Wu, Xu; Li, Feng			A multi-domain trust management model for supporting RFID applications of IoT	PLOS ONE			English	Article								The use of RFID technology in complex and distributed environments often leads to a multidomain RFID system, in which trust establishment among entities from heterogeneous domains without past interaction or prior agreed policy, is a challenge. The current trust management mechanisms in the literature do not meet the specific requirements in multidomain RFID systems. Therefore, this paper analyzes the special challenges on trust management in multi-domain RFID systems, and identifies the implications and the requirements of the challenges on the solutions to the trust management of multi-domain RFID systems. A multi-domain trust management model is proposed, which provides a hierarchical trust management framework include a diversity of trust evaluation and establishment approaches. The simulation results and analysis show that the proposed method has excellent ability to deal with the trust relationships, better security, and higher accuracy rate.	[Wu, Xu] Guangxi Univ, Sch Comp Elect & Informat, Nanning, Peoples R China; [Wu, Xu] Xian Univ Posts & Telecommun, Sch Comp Sci, Xian, Peoples R China; [Li, Feng] Indiana Univ Purdue Univ, Sch Engn & Technol, Indianapolis, IN 46202 USA	Guangxi University; Xi'an University of Posts & Telecommunications; Indiana University System; Indiana University-Purdue University Indianapolis	Wu, X (corresponding author), Guangxi Univ, Sch Comp Elect & Informat, Nanning, Peoples R China.; Wu, X (corresponding author), Xian Univ Posts & Telecommun, Sch Comp Sci, Xian, Peoples R China.	xrdz2006@163.com			National Natural Science Foundation of China [71501156]; China Postdoctoral Science Foundation [2014M560796]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The work in this paper has been supported by National Natural Science Foundation of China (Program No.71501156) and China Postdoctoral Science Foundation (Program No.2014M560796).http://www.nsfc.gov.cn/, http://jj.china postdoctor.org.cn/V1/Program3/ Default.aspx	Alghamdi S, 2013, 8 INT C INT SENS SEN; Alshehri MD, 2015, LECT NOTES COMPUT SC, V9492, P596, DOI 10.1007/978-3-319-26561-2_70; Ben Saied Y, 2013, COMPUT SECUR, V39, P351, DOI 10.1016/j.cose.2013.09.001; Braun M, 2010, IFIP INTERNATIONAL W; CAI SY, 2012, 27 INF SEC PRIV C; Carolina VLM, 2015, INT J DISTRIB SENS N, V11, P1; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Falk R, 2008, IEEE RFID C; Feng, 2015, INT J DISTRIB SENS N, V2015, P1, DOI DOI 10.1155/2015/678926; Feng R., 2013, INT J DISTRIB SENS N, V2013, P1; Gil D, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16071069; Guo J, 2015, IEEE INT C SERV COMP; Ishmanov F, 2015, SENSORS-BASEL, V15, P7040, DOI 10.3390/s150307040; Jan TM, 2015, 20 EUR S COMP SEC; Kumar A, 2016, INT J NETWORK SECURI, V18, P1; Kumar A, 2015, ETRI J, V37, P186, DOI 10.4218/etrij.15.0114.0177; [刘文懋 Liu Wenmao], 2012, [计算机学报, Chinese Journal of Computers], V35, P846; Manmeet MC, 2009, 6 INT C MOB ADH SENS; Parade R, 2017, IEEE COMMUN MAG, V55, P56, DOI 10.1109/MCOM.2017.1600701CM; Qi SY, 2014, 22 INT C NETW PROT I; Ray BR, 2014, COMPUT NETW, V67, P89, DOI 10.1016/j.comnet.2014.03.023; Xiang Qiu, 2010, Journal of Networks, V5, P1025, DOI 10.4304/jnw.5.9.1025-1032; Zahariadis T, 2009, 16 INT C SYST SIGN I; Zhang YJ, 2017, ANN OPER RES, V255, P117, DOI [10.1007/s10479-016-2232-2, 10.1007/978-3-319-24160-9]; Zouka HAE, 2015, INT J ELECT COMPUTER, V9, P1152	25	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181124	10.1371/journal.pone.0181124	http://dx.doi.org/10.1371/journal.pone.0181124			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708855	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800042
J	An, XP; Song, YX; Hou, JX; Zhang, Y; Chen, KW; Ma, HD; Zhao, XY; Li, G; Gao, KX; Wang, S; Cao, BY; Bai, YY				An, Xiaopeng; Song, Yuxuan; Hou, Jinxing; Zhang, Yue; Chen, Kaiwen; Ma, Haidong; Zhao, Xinyan; Li, Guang; Gao, Kexin; Wang, Shan; Cao, Binyun; Bai, Yueyu			Chi-miR-4110 promotes granulosa cell apoptosis by targeting Sma- and Mad-related protein 2 (Smad2) in the caprine ovary	PLOS ONE			English	Article							EXPRESSION; MICRORNA; PROLIFERATION; LOCALIZATION; ATRESIA; GROWTH	Follicular atresia mainly results from the apoptosis of granulosa cells (GCs). Whilst our previous investigations examined the role of chi-miR-4110 in regulating ovarian function, the present study detected the role of chi-miR-4110 in GC development. We transfected caprine GCs cultured in vitro with chi-miR-4110 mimics. Results revealed that chi-miR-4110 decreased mRNA and protein levels of Smad2 by targeting its 3'-untranslated region (3'UTR). FoxC1 and Sp1 mRNA and protein levels markedly increased, whereas those of bHLHe22 significantly decreased (P< 0.01 or 0.05) in GCs transfected with the chi-miR-4110 mimics. Further studies revealed a significantly higher number of apoptotic cells in GCs transfected with the chi-miR-4110 mimics (P< 0.05) than in GCs transfected with mimics negative control. GCs transfected with the chi-miR-4110 mimics exhibited significantly increased mRNA and protein levels of the pro-apoptotic gene Bax (P< 0.01) and significantly decreased expression levels of the anti-apoptotic gene BCL-2 (P< 0.01). Smad2 interference (Si-1282) results were consistent with those of the chi-miR-4110 mimics. Previous reports and our results showed that chi-miR-4110 increases Sp1 expression by repressing Smad2. The increase in Sp1 induces p53-upregulated modulator of apoptosis, which increases the relative abundance of Bax and causes caprine GC apoptosis. Our findings may provide relevant data for the investigation of miRNA-mediated regulation of ovarian functions.	[An, Xiaopeng; Song, Yuxuan; Zhang, Yue; Chen, Kaiwen; Ma, Haidong; Li, Guang; Gao, Kexin; Wang, Shan; Cao, Binyun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Hou, Jinxing] Yangling Vocat & Tech Coll, Anim Engn Branch, Yangling, Shaanxi, Peoples R China; [Zhao, Xinyan] Northwest A&F Univ, Northwest A&F Univ Hosp, Yangling, Shaanxi, Peoples R China; [Bai, Yueyu] Anim Hlth Supervis Inst Henan Prov, Zhengzhou, Henan, Peoples R China	Northwest A&F University - China; Yangling Vocational & Technical College; Northwest A&F University - China	Cao, BY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Bai, YY (corresponding author), Anim Hlth Supervis Inst Henan Prov, Zhengzhou, Henan, Peoples R China.	caobinyun@126.com; baiyueyu_56@163.com		Zhang, Yue/0000-0003-3568-0395	National Natural Science Foundation of China [31601925]; China Postdoctoral Science Foundation [2016T90954, 2014M552498]; Nature Science Foundation of Shaanxi Provincial [2015JM3087]; Shaanxi Science and Technology Innovation Project Plan [2015KTCQ03-08]; PhD Research Funding of Northwest AF University [2013BSJJ003]; Basic Research Funds of Northwest AF University [2452015029]; Shaanxi Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Nature Science Foundation of Shaanxi Provincial; Shaanxi Science and Technology Innovation Project Plan; PhD Research Funding of Northwest AF University; Basic Research Funds of Northwest AF University; Shaanxi Postdoctoral Science Foundation	This study was supported by the National Natural Science Foundation of China (31601925), China Postdoctoral Science Foundation (2016T90954 and 2014M552498), Nature Science Foundation of Shaanxi Provincial (2015JM3087), Shaanxi Science and Technology Innovation Project Plan (2015KTCQ03-08), PhD Research Funding of Northwest A&F University (2013BSJJ003), Basic Research Funds of Northwest A&F University (2452015029), and Shaanxi Postdoctoral Science Foundation.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; An XP, 2016, THERIOGENOLOGY, V85, P769, DOI 10.1016/j.theriogenology.2015.09.056; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bradford AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135163; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cheng JC, 2014, PLOS ONE, V10; Christenson L. K., 2010, Animal Reproduction, V7, P129; Fenwick MA, 2013, ENDOCRINOLOGY, V154, P3423, DOI 10.1210/en.2012-2251; Gebremedhn S, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137539; Gebremedhn S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125912; Grossman H, 2015, FASEB J, V29, P3206, DOI 10.1096/fj.14-269449; Hopkins A, 2016, J CELL BIOCHEM, V117, P1707, DOI 10.1002/jcb.25464; Iwamune M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108997; Jiang LL, 2015, J CLIN ENDOCR METAB, V100, pE729, DOI 10.1210/jc.2014-3827; Kaivo-Oja N, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-21; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Li JX, 2016, REPROD SCI, V23, P386, DOI 10.1177/1933719115602768; Liu JY, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.122788; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21602; Maalouf SW, 2016, CELL TISSUE RES, V363, P7, DOI 10.1007/s00441-015-2307-4; Maeda A, 2007, J REPROD DEVELOP, V53, P481, DOI 10.1262/jrd.18149; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Peng JY, 2016, DOMEST ANIM ENDOCRIN, V57, P108, DOI 10.1016/j.domaniend.2016.05.006; Peng JY, 2015, MOL CELL ENDOCRINOL, V412, P104, DOI 10.1016/j.mce.2015.06.001; Perdas E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060909; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Stouffer RL, 2007, FRONT BIOSCI, V12, P297, DOI 10.2741/2065; Tian X, 2010, GENE EXPR PATTERNS, V10, P105, DOI 10.1016/j.gep.2010.02.003; Toms D, 2015, MOL CELL ENDOCRINOL, V399, P95, DOI 10.1016/j.mce.2014.07.022; Troppmann B, 2014, MOL CELL ENDOCRINOL, V390, P65, DOI 10.1016/j.mce.2014.04.003; Xing N, 2014, ACTA HISTOCHEM, V116, P1301, DOI 10.1016/j.acthis.2014.07.014; Yin MM, 2014, J BIOL CHEM, V289, P18239, DOI 10.1074/jbc.M113.546044; Zhao L, 2011, ACTA HISTOCHEM, V113, P771, DOI 10.1016/j.acthis.2010.11.005; Zhou JL, 2015, MOL CELL ENDOCRINOL, V409, P103, DOI 10.1016/j.mce.2015.03.012	41	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181162	10.1371/journal.pone.0181162	http://dx.doi.org/10.1371/journal.pone.0181162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704526	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700100
J	Wang, C; Zhang, LG; Su, WP; Ying, ZX; He, JT; Zhang, LL; Zhong, X; Wang, T				Wang, Chao; Zhang, Ligen; Su, Weipeng; Ying, Zhixiong; He, Jintian; Zhang, Lili; Zhong, Xiang; Wang, Tian			Zinc oxide nanoparticles as a substitute for zinc oxide or colistin sulfate: Effects on growth, serum enzymes, zinc deposition, intestinal morphology and epithelial barrier in weaned piglets	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; ZNO NANOPARTICLES; ANTIBACTERIAL ACTIVITY; PIGS; PERFORMANCE; EXPRESSION; APOPTOSIS; ALTERNATIVES; PERMEABILITY; PROMOTERS	The objective of this study was to evaluate effects of zinc oxide nanoparticles (nano-ZnOs) as a substitute for colistin sulfate (CS) and/or zinc oxide (ZnO) on growth performance, serum enzymes, zinc deposition, intestinal morphology and epithelial barrier in weaned piglets. A total of 216 crossbred Duroc(x)(Landrace xYorkshire) piglets weaned at 23 days were randomly assigned into 3 groups, which were fed with basal diets supplemented with 20 mg/kg CS (CS group), 20mg/kg CS+ 3000 mg/kg ZnO (CS+ ZnO group), and 1200 mg/kg nanoZnOs (nano-ZnO group) for 14 days. Results indicated that compared to CS group, supplementation of 1200 mg/kg nano-ZnOs (about 30 nm) significantly increased final body weight and average daily gain, and 3000 mg/kg ZnO plus colistin sulfate significantly increased average daily gain and decreased diarrhea rate in weaned piglets. There was no significant difference in growth performance and diarrhea rate between nano-ZnO and CS+ ZnO groups. Supplementation of nano-ZnOs did not affect serum enzymes (glutamic oxalacetic transaminase, glutamic-pyruvic transaminase, and lactate dehydrogenase), but significantly increased plasma and tissue zinc concentrations (liver, tibia), improved intestinal morphology (increased duodenal and ileal villus length, crypt depth, and villus surface), enhanced mRNA expression of ZO-1 in ileal mucosa, and significantly decreased diamine oxidase activity in plasma, total aerobic bacterial population in MLN as compared to CS group. Effects of nano-ZnOs on serum enzymes, intestinal morphology, and mRNA expressions of tight junction were similar to those of high dietary ZnO plus colistin sulfate, while nano-ZnOs significantly reduced zinc concentrations of liver, tibia, and feces, and decreased total aerobic bacterial population in MLN as compared to CS+ ZnO group. These results suggested that nano-ZnOs (1200 mg/kg) might be used as a substitute for colistin sulfate and high dietary ZnO in weaned piglets.	[Wang, Chao; Zhang, Ligen; Su, Weipeng; Ying, Zhixiong; He, Jintian; Zhang, Lili; Zhong, Xiang; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, T (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	tianwangnjau@163.com			Fundamental Research Funds for the Central Universities [6J0518]; Priority Academic Program Development of Jiangsu Higher Education Institutions II (PAPD II)	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions II (PAPD II)	This study was supported by the Fundamental Research Funds for the Central Universities (Grant No. 6J0518) and by A Project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions II (PAPD II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneesh PM, 2007, PROC SPIE, V6639, DOI 10.1117/12.730364; Antoine TE, 2016, J IMMUNOL, V196, P4566, DOI 10.4049/jimmunol.1502373; Berube DM, 2008, J NANOPART RES, V10, P23, DOI 10.1007/s11051-008-9362-7; Boyen F, 2010, VET MICROBIOL, V144, P359, DOI 10.1016/j.vetmic.2010.01.010; Carlson MS, 2004, J ANIM SCI, V82, P1359; Carlson MS, 1999, J ANIM SCI, V77, P1199; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Croteau MN, 2011, NANOTOXICOLOGY, V5, P79, DOI 10.3109/17435390.2010.501914; Demirbas A, 1999, FOOD CHEM, V67, P27, DOI 10.1016/S0308-8146(99)00103-X; Dong L, 2014, J HISTOCHEM CYTOCHEM, V62, P510, DOI 10.1369/0022155414532655; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Gajjar Priyanka, 2009, J Biol Eng, V3, P9, DOI 10.1186/1754-1611-3-9; GAUTREAUX MD, 1994, INFECT IMMUN, V62, P2132, DOI 10.1128/IAI.62.5.2132-2134.1994; GHISHAN FK, 1984, J PEDIATR GASTR NUTR, V3, P608, DOI 10.1097/00005176-198409000-00022; HAHN JD, 1993, J ANIM SCI, V71, P3020, DOI 10.2527/1993.71113020x; Heuer OE, 2006, CLIN INFECT DIS, V43, P911, DOI 10.1086/507534; Hu CH, 2013, ANIM FEED SCI TECH, V181, P65, DOI 10.1016/j.anifeedsci.2013.02.003; Hu CH, 2012, BIOL TRACE ELEM RES, V149, P190, DOI 10.1007/s12011-012-9422-9; Jin X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106991; Jondreville C, 2003, LIVEST PROD SCI, V84, P147, DOI 10.1016/j.livprodsci.2003.09.011; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; Liu Y, 2009, J APPL MICROBIOL, V107, P1193, DOI 10.1111/j.1365-2672.2009.04303.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma HB, 2013, ENVIRON POLLUT, V172, P76, DOI 10.1016/j.envpol.2012.08.011; Muralisankar T, 2014, BIOL TRACE ELEM RES, V160, P56, DOI 10.1007/s12011-014-0026-4; National Research Council, 2012, NUTR REQ SWIN, V11th ed., DOI [10.17226/13298, DOI 10.17226/13298]; Noah TK, 2013, ANNU REV PHYSIOL, V75, P263, DOI 10.1146/annurev-physiol-030212-183741; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Pluske JR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-1; Pluske JR, 1997, LIVEST PROD SCI, V51, P215, DOI 10.1016/S0301-6226(97)00057-2; Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324; Sabir Sidra, 2014, ScientificWorldJournal, V2014, P925494, DOI 10.1155/2014/925494; Sanna V, 2014, INT J NANOMED, V9, P467, DOI 10.2147/IJN.S36654; Sharma V, 2012, MUTAT RES-GEN TOX EN, V745, P84, DOI 10.1016/j.mrgentox.2011.12.009; Sirelkhatim A, 2015, NANO-MICRO LETT, V7, P219, DOI 10.1007/s40820-015-0040-x; Smith MG, 2010, VET MICROBIOL, V145, P299, DOI 10.1016/j.vetmic.2010.04.004; Talebian N, 2013, J PHOTOCH PHOTOBIO B, V120, P66, DOI 10.1016/j.jphotobiol.2013.01.004; Tossou MCB, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2912418; Verstegen MWA, 2002, ANIM BIOTECHNOL, V13, P113, DOI 10.1081/ABIO-120005774; Vondruskova H, 2010, VET MED-CZECH, V55, P199, DOI 10.17221/2998-VETMED; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P1181, DOI 10.1166/jbn.2013.1652; Wang B, 2006, TOXICOL LETT, V161, P115, DOI 10.1016/j.toxlet.2005.08.007; Wang B, 2008, J NANOPART RES, V10, P263, DOI 10.1007/s11051-007-9245-3; Wang CB, 2019, BRIT J NEUROSURG, V33, P675, DOI 10.1080/02688697.2017.1396286; Wang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164434; Wang MQ, 2012, BIOL TRACE ELEM RES, V149, P197, DOI 10.1007/s12011-012-9428-3; Wang Y, 2010, BIOL TRACE ELEM RES, V133, P325, DOI 10.1007/s12011-009-8437-3; Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033; Zhao CY, 2014, BIOL TRACE ELEM RES, V160, P361, DOI 10.1007/s12011-014-0052-2; Zhou YP, 2004, CLIN NUTR, P55, DOI 10.1016/j.clnu.2004.07.012	56	40	44	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181136	10.1371/journal.pone.0181136	http://dx.doi.org/10.1371/journal.pone.0181136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704517	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700095
J	Wie, JH; Park, IY; Namkung, J; Seo, HW; Jeong, MJ; Kwon, JY				Wie, Jeong Ha; Park, In Yang; Namkung, Jeong; Seo, Hae Won; Jeong, Min Jin; Kwon, Ji Young			Is it appropriate for Korean women to adopt the 2009 Institute of Medicine recommendations for gestational weight gain?	PLOS ONE			English	Article							BODY-MASS INDEX; PREGNANCY OUTCOMES; RISK; OVERWEIGHT; OBESITY; IMPACT	Background The 2009 Institute of Medicine (IOM) guidelines for gestational weight gain (GWG) are intended for use among women in the United States. Little data are available on whether the 2009 IOM recommendations can be applied to Asian women. This study aimed to evaluate whether the recommendations are related to adverse pregnancy outcomes in Korean pregnant women. Methods and findings A retrospective cohort study was conducted for all singleton-pregnant women at a university hospital in Korea. After classifying the enrolled women into four Korean pre-pregnancy body mass index (BMI) categories, the risk of adverse pregnancy outcomes were analyzed for women who gained inadequate or excessive GWG based on 2009 IOM recommendations. Of 7,843 pregnancies, 64.0% of women had normal pre-pregnancy BMI and 42.7% achieved optimal GWG. Across all BMI categories, adverse pregnancies outcomes such as small for gestational age (SGA), large for gestational age (LGA), preterm birth, preeclampsia, and cesarean due to dystocia were significantly associated with GWG (all P <= 0.001). Women with normal BMI who gained inadequate weight were more likely to develop SGA and preterm birth and less likely to develop LGA (adjusted odds ratio (aOR) 2.21, 1.33, and 0.54, respectively). Whereas, women with normal BMI who gained excessive weight were more likely to develop LGA, preterm birth, preeclampsia, and cesarean section due to dystocia (aOR 2.10, 1.33, 1.37, and 1.37, respectively) and less likely to develop SGA (aOR 0.60). Conclusions It is tolerable for Korean women to follow recommended GWG from the 2009 IOM guidelines to decrease adverse pregnancy outcomes. This will be helpful for antenatal care on GWG not only for Korean pregnant women, but also other Asian women who have lower BMI criteria than Caucasian women.	[Wie, Jeong Ha; Park, In Yang; Namkung, Jeong; Seo, Hae Won; Jeong, Min Jin; Kwon, Ji Young] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Catholic University of Korea	Kwon, JY (corresponding author), Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jiyoungk@catholic.ac.kr		Wie, Jeong Ha/0000-0001-7897-5148				Anderson JE, 2012, PRIMARY CARE, V39, P135, DOI 10.1016/j.pop.2011.12.002; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bauer CMC, 2016, J PERINATOL, V36, P278, DOI 10.1038/jp.2015.202; Bogaerts A, 2015, OBSTET GYNECOL, V125, P566, DOI 10.1097/AOG.0000000000000677; Challis JRG, 2004, AM J OBSTET GYNECOL, V191, P1059, DOI 10.1016/j.ajog.2004.06.071; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Enomoto K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157081; Fouelifack Florent Ymele, 2015, BMC Res Notes, V8, P806, DOI 10.1186/s13104-015-1765-9; Hannaford KE, 2017, AM J PERINAT, V34, P147, DOI 10.1055/s-0036-1584583; Headen I, 2017, OBES REV, V18, P350, DOI 10.1111/obr.12486; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Jeffs E, 2014, NEW ZEAL MED J, V127, P17; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; Leeman L, 2008, AM FAM PHYSICIAN, V78, P93; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Liu YY, 2012, ARCH GYNECOL OBSTET, V286, P905, DOI 10.1007/s00404-012-2403-6; Mandujano A, 2012, J MATERN-FETAL NEO M, V25, P1395, DOI 10.3109/14767058.2011.636099; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Sharples H, 2012, NEW ZEAL MED J, V125, P60; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Tanaka T, 2014, J OBSTET GYNAECOL RE, V40, P1296, DOI 10.1111/jog.12353; Triunfo S, 2015, J ENDOCRINOL INVEST, V38, P31, DOI 10.1007/s40618-014-0168-4; Truong YN, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.027; Vesco KK, 2009, OBSTET GYNECOL, V114, P1069, DOI 10.1097/AOG.0b013e3181baeacf; Waldenstrom U, 2014, OBSTET GYNECOL, V123, P104, DOI 10.1097/AOG.0000000000000062; Wong W, 2000, J AM DIET ASSOC, V100, P791, DOI 10.1016/S0002-8223(00)00230-3; 이정주, 2007, Clinical and Experimental Pediatrics, V50, P732	29	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181164	10.1371/journal.pone.0181164	http://dx.doi.org/10.1371/journal.pone.0181164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704550	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700101
J	Kuhnen, VV; Romero, GQ; Linhares, AX; Vizentin-Bugoni, J; Porto, EAC; Setz, EZF				Kuhnen, Vanessa Villanova; Romero, Gustavo Quevedo; Linhares, Aricio Xavier; Vizentin-Bugoni, Jeferson; Correa Porto, Erica Aline; Freire Setz, Eleonore Zulnara			Diet overlap and spatial segregation between two neotropical marsupials revealed by multiple analytical approaches	PLOS ONE			English	Article							OPOSSUM DIDELPHIS-AURITA; STABLE-ISOTOPE ANALYSIS; ATLANTIC FOREST; FOOD-HABITS; METACHIRUS-NUDICAUDATUS; SOUTHEASTERN BRAZIL; SOUTHERN BRAZIL; SMALL MAMMALS; RESOURCE USE; NICHE	Species co-existence depends on how organisms utilize their environment and resources. When two sympatric species are similar in some ecological requirements, their coexistence may arise from differences in resource use over time and/ or space. Interactions among coexisting marsupials remain poorly understood, especially in the Neotropics. Here we combine spatial niche measurements, individual-resource networks, and isotopic niche approaches, to investigate the ecological strategies used by the Neotropical marsupials Didelphis aurita and Metachirus nudicaudatus to co-occur in an area of Serra do Mar State Park (southeast of Brazil). Both individual-resource networks and isotopic niche approaches indicate similar patterns of omnivory for both species. Isotopic analysis showed the species' trophic niche to be similar, with 52% of overlap, and no differences between proportional contributions of each resource to their diets. Moreover, individual-resource network analysis found no evidence of diet nestedness or segregation. The trophic niche overlap observed was associated with spatial segregation between species. Despite using the same area over the year, D. aurita and M. nudicaudatus exhibited spatial segregation among seasons. These results illustrate that the detection of spatial segregation is scale-dependent and must be carefully considered. In conclusion, our findings provide a new perspective on the ecology of these two Neotropical marsupials by illustrating how the association of distinct but complementary methods can be applied to reach a more complete understanding of resource partitioning and species coexistence.	[Kuhnen, Vanessa Villanova; Vizentin-Bugoni, Jeferson] Univ Estadual Campinas, Inst Biol, Posgrad Ecol, Campinas, SP, Brazil; [Romero, Gustavo Quevedo; Linhares, Aricio Xavier; Freire Setz, Eleonore Zulnara] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil; [Correa Porto, Erica Aline] Univ Estadual Campinas, Inst Biol, Grad Ciencias Biol, Campinas, SP, Brazil; [Kuhnen, Vanessa Villanova] Inst Pesca, Lab Piscicultura Marinha Nucleo Pesquisa & Desenv, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Kuhnen, VV (corresponding author), Univ Estadual Campinas, Inst Biol, Posgrad Ecol, Campinas, SP, Brazil.; Kuhnen, VV (corresponding author), Inst Pesca, Lab Piscicultura Marinha Nucleo Pesquisa & Desenv, Sao Paulo, Brazil.	vanessavk3@gmail.com	Vizentin-Bugoni, Jeferson/J-9342-2016; Romero, Gustavo Q/N-1896-2019; Kuhnen, Vanessa Villanova/F-8360-2016; Romero, Gustavo Q/H-8974-2012; Setz, Eleonore Z F/C-1050-2012	Vizentin-Bugoni, Jeferson/0000-0002-6343-3650; Romero, Gustavo Q/0000-0003-3736-4759; Kuhnen, Vanessa Villanova/0000-0001-7087-1395; Romero, Gustavo Q/0000-0003-3736-4759; Setz, Eleonore Z F/0000-0001-7638-7086	Conselho Nacionalde Desenvolvimento Cientifico e Tecnologico (CNPq) [142137/20120]; Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior (CAPES); Fundac Eaode Amparo Pesquisado Estadode Sao Paulo (FAPESP)	Conselho Nacionalde Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundac Eaode Amparo Pesquisado Estadode Sao Paulo (FAPESP)	V.V. Kuhnen PhD scholarship was funded by Conselho Nacionalde Desenvolvimento Cientifico e Tecnologico (CNPq, 142137/20120). J. Vizentin-Bugoni PhD scholarship was funded by Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior (CAPES). Isotopic analyses were funded by Fundac Eaode Amparo Pesquisado Estadode Sao Paulo (FAPESP) project coordinated by GQ Romero. GQ Romero received a CNPq-Brazil research grant. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Alves LF, 2010, FOREST ECOL MANAG, V260, P679, DOI 10.1016/j.foreco.2010.05.023; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Araujo MS, 2010, OIKOS, V119, P81, DOI 10.1111/j.1600-0706.2009.17624.x; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Astua de Moraes D., 2000, Hystrix, V11, P115; Astua Diego, 2006, Boletim do Museu de Biologia Mello Leitao Nova Serie, V19, P31; Baldi R, 2004, J WILDLIFE MANAGE, V68, P924, DOI 10.2193/0022-541X(2004)068[0924:HPFCBG]2.0.CO;2; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Benadi G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0117; Breviglieri CPB, 2016, FOLIA ZOOL, V65, P243, DOI 10.25225/fozo.v65.i3.a11.2016; Bowen WD, 2013, MAR MAMMAL SCI, V29, P719, DOI 10.1111/j.1748-7692.2012.00604.x; Browning NE, 2014, J EXP MAR BIOL ECOL, V457, P15, DOI 10.1016/j.jembe.2014.03.016; Burns JM, 1998, POLAR BIOL, V19, P272, DOI 10.1007/s003000050245; Caceres NC, 2004, MAMM BIOL, V69, P430, DOI 10.1078/1616-5047-00165; Caceres NC, 2001, STUD NEOTROP FAUNA E, V36, P85, DOI 10.1076/snfe.36.2.85.2138; Caceres Nilton C., 2013, Open Ecology Journal, V6, P10; Cantor M, 2013, OIKOS, V122, P1085, DOI 10.1111/j.1600-0706.2012.00070.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Ceotto Paula, 2009, Mastozool. neotrop., V16, P49; CIIAGRO (Centro Integrado de Informacoes Agrometeorologicas), 2015, CIIAGRO DAT BAS; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Correa SB, 2014, ECOLOGY, V95, P210, DOI 10.1890/13-0393.1; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Cunha AA, 2002, J ZOOL, V258, P419, DOI 10.1017/S0952836902001565; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; DICKMAN CR, 1988, J MAMMAL, V69, P108, DOI 10.2307/1381753; DIETZ J M, 1984, Smithsonian Contributions to Zoology, P1; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dormann CF, 2014, METHODS ECOL EVOL, V5, P90, DOI 10.1111/2041-210X.12139; Eisenlohr PV, 2013, BIODIVERS CONSERV, V22, P2767, DOI 10.1007/s10531-013-0553-x; Freitas Simone R., 1997, Revista Brasileira de Biologia, V57, P93; Gause G. F., 1934, STRUGGLE EXISTENCE; Gonzalez AMM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1212, DOI 10.1111/geb.12355; Graipel ME, 2003, MAMMALIA, V67, P551, DOI 10.1515/mamm-2003-0409; Grelle CEV, 2003, STUD NEOTROP FAUNA E, V38, P81, DOI 10.1076/snfe.38.2.81.15926; Harris DB, 2007, ECOLOGY, V88, P2330, DOI 10.1890/06-1701.1; Helder-Jose H., 2012, MARSUPIAIS BRASIL BI, P185; HELDERJOSE, 1995, ACTA ANAT, V153, P31; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Jansa SA, 2014, EVOLUTION, V68, P684, DOI 10.1111/evo.12290; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kronfeld-Schor N, 1999, OECOLOGIA, V121, P123, DOI 10.1007/s004420050913; Kuhnen VV, 2017, BIOTROPICA IN PRESS; Kuhnen VV, 2016, B SOC BRAS MASTOZOOL, V75, P1; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lessa LG, 2014, STUD NEOTROP FAUNA E, V49, P75, DOI 10.1080/01650521.2014.924805; Lessa LG, 2010, MAMM BIOL, V75, P10, DOI 10.1016/j.mambio.2008.11.002; Logan Kenneth A., 2010, P105; Macandza VA, 2012, OIKOS, V121, P891, DOI 10.1111/j.1600-0706.2012.20250.x; MACDONALD SM, 1980, ACTA THERIOL, V25, P245, DOI 10.4098/AT.arch.80-19; Maitz WE, 2001, OECOLOGIA, V128, P526, DOI 10.1007/s004420100689; Svendsen GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126182; Melo GL, 2012, MARSUPIAIS BRASIL BI, P385; Mohd-Azlan J, 2014, BIOTROPICA, V46, P331, DOI 10.1111/btp.12108; Moura MC, 2009, AUSTRAL ECOL, V34, P481, DOI 10.1111/j.1442-9993.2009.01948.x; MUNHOZ COG, 1967, ACTA ANAT, V68, P258; Nakano S, 1999, J ANIM ECOL, V68, P1079, DOI 10.1046/j.1365-2656.1999.00355.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Paglia A.P., 2012, OCCASIONAL PAPERS CO, V6, P1, DOI DOI 10.1646/0006-3606(2000)032[; Parnell A. C., 2013, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Passamani Marcelo, 2000, Boletim do Museu de Biologia Mello Leitao, V11-12, P215; Pires MM, 2011, J ANIM ECOL, V80, P896, DOI 10.1111/j.1365-2656.2011.01818.x; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Reid REB, 2013, J MAMMAL, V94, P1248, DOI 10.1644/13-MAMM-A-104.1; Remonti L, 2012, POPUL ECOL, V54, P521, DOI 10.1007/s10144-012-0326-5; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Righetti J, 2000, AUST J ZOOL, V48, P561, DOI 10.1071/ZO00023; Rossi RV, 2012, MARSUPIAIS BRASIL BI, P385; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Santori RT, 1995, MAMMALIA, V59, P511, DOI 10.1515/mamm.1995.59.4.511; Santori RT, 2012, MARSUPIAIS BRASIL BI, P383; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; THOMSON J. A., 1962, VICTORIAN NAT, V78, P306; TYNDALEBISCOE CH, 1976, J MAMMAL, V57, P249, DOI 10.2307/1379686; Veloso H.P., 1991, CLASSIFICACAO VEGETA; Vieira EM, 2006, PREDATORS POUCHES BI, P271; Vilar de Carvalho Fabio Martins, 1999, Zoociencias, V1, P91	86	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181188	10.1371/journal.pone.0181188	http://dx.doi.org/10.1371/journal.pone.0181188			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704561	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649600065
J	Zheng, BQ; Zou, LH; Li, K; Wan, X; Wang, Y				Zheng, Bao-Qiang; Zou, Long-Hai; Li, Kui; Wan, Xiao; Wang, Yan			Photosynthetic, morphological, and reproductive variations in Cypripedium tibeticum in relation to different light regimes in a subalpine forest	PLOS ONE			English	Article							UV-B RADIATION; LEAF TRAITS; GROWTH; IRRADIANCE; PLASTICITY; FLAVUM; PAPHIOPEDILUM; UNDERSTOREY; POPULATIONS; PERFORMANCE	Cypripedium tibeticum, a subalpine orchid species, inhabits various habitats of subalpine forests, mainly including the forest edge (FE), forest gap (FG), and understory (UST), which have significantly different light intensities (FE > FG > UST). However, the ecological and physiological influences caused by different light regimes in this species are still poorly understood. In the present study, photosynthetic, morphological, and reproductive characteristics were comprehensively studied in plants of C. tibeticum grown in three types of habitats. The photosynthetic capacities, such as the net photosynthetic rate, light-saturated photosynthesis (P-max), and dry mass per unit leaf area (LMA), were higher in FE and FG than in UST according to light availability. Compared with FG, the populations in FE and UST suffer from excessively strong and inadequate radiation, respectively, which was further corroborated by the low Fv/Fm in FE and high apparent quantum yield (AQY) in FG. The leaves of the orchids had various proportions of constituents, such as the leaf area, thickness and (or) epidermal hair, to reduce damage from high radiation (including ultraviolet-b radiation) in FE and capture more light in FG and UST. Although the flower rate (FR) was positively correlated to both P-max and the daily mean PAR, fruit-set only occurred in the populations in FG. The failures in FE and UST might be ascribed to changes in the floral functional structure and low biomass accumulation, respectively. Moreover, analysis of the demographic statistics showed that FG was an advantageous habitat for the orchid. Thus, C. tibeticum reacted to photosynthetic and morphological changes to adapt to different subalpine forest habitats, and neither full (under FE) nor low (UST) illumination was favorable for population expansion. These findings could serve as a guide for the protection and reintroduction of C. tibeticum and emphasize the importance of specific habitats for Cypripedium spp.	[Wang, Yan] State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF	Wang, Y (corresponding author), State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	chwy8915@sina.com			Basic Research Fund of RIF [RIF2014-05]	Basic Research Fund of RIF	This work was supported by the Basic Research Fund of RIF (grant No. RIF2014-05) to Bao-Qiang Zheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroniya SS, 2013, ACTA PHYSIOL PLANT, V35, P1521, DOI 10.1007/s11738-012-1193-6; Cai ZQ, 2011, IND CROP PROD, V34, P1235, DOI 10.1016/j.indcrop.2011.03.021; Chang W, 2011, PHYSIOL PLANTARUM, V141, P30, DOI 10.1111/j.1399-3054.2010.01418.x; Chen JW, 2011, PHYSIOL PLANTARUM, V141, P84, DOI 10.1111/j.1399-3054.2010.01414.x; Chen SC, 1997, FLORAE REIPUBLICAE P, P20; Costa R, 2008, GENETIC DIVERSITY UN; Cribb P, 1997, GENUS CYPRIPEDIUM; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Evans JR, 1999, NEW PHYTOL, V143, P93, DOI 10.1046/j.1469-8137.1999.00440.x; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Gaafar ARZ, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0109-4; Gratani L., 2014, ADV IN BOT, V2014, DOI [10.1155/2014/208747, DOI 10.1155/2014/208747]; Greenberg BM, 1997, PLANTS ENV STUDIES; Gregoriou K, 2007, PHOTOSYNTHETICA, V45, P172, DOI 10.1007/s11099-007-0029-x; Guan ZJ, 2011, J PLANT RES, V124, P289, DOI 10.1007/s10265-010-0372-z; Jin LI, 2011, FOR RESOUR MANAG, V40, P30; Jonson G., 2007, HDB PLANT SCI, V2, P1206; Kull T, 1999, J ECOL, V87, P913, DOI 10.1046/j.1365-2745.1999.00407.x; Kull T, 1998, BOT J LINN SOC, V126, P27, DOI 10.1111/j.1095-8339.1998.tb02513.x; Li P, 2006, PLANT SYST EVOL, V262, P53, DOI 10.1007/s00606-006-0456-3; Li ZR, 2008, J PLANT RES, V121, P559, DOI 10.1007/s10265-008-0186-4; MADRONICH S, 1995, AMBIO, V24, P143; MARLER TE, 1994, J AM SOC HORTIC SCI, V119, P711, DOI 10.21273/JASHS.119.4.711; Muraoka H, 2003, OECOLOGIA, V135, P500, DOI 10.1007/s00442-003-1227-2; [李鹏 Peng Li], 2009, [生物多样性, Biodiversity Science], V17, P406; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; RANKOU H, 2014, IUCN RED LIST THREAT; Richardson AD, 2002, AM J BOT, V89, P88, DOI 10.3732/ajb.89.1.88; Rocas G, 2001, BOT J LINN SOC, V136, P231, DOI 10.1111/j.1095-8339.2001.tb00568.x; Rozema J, 1997, TRENDS ECOL EVOL, V12, P22, DOI 10.1016/S0169-5347(96)10062-8; SALLEO S, 1990, ANN BOT-LONDON, V65, P259, DOI 10.1093/oxfordjournals.aob.a087932; Shi S, 1999, ACTA PHYTOECOL SIN, P64; TERAMURA AH, 1994, PHOTOSYNTH RES, V39, P463, DOI 10.1007/BF00014599; Urban O, 2006, PHOTOSYNTHETICA, V44, P215, DOI 10.1007/s11099-006-0009-6; Valladares F, 2002, TREES-STRUCT FUNCT, V16, P395, DOI 10.1007/s00468.002.0184.4; van Steenis W., 2021, IUCN RED LIST THREAT, pe.T149165436A149165446, DOI [10.2305/IUCN.UK.2021-3.RLTS.T149165436A149165446.en, DOI 10.2305/IUCN.UK.2021-1.RLTS.T49254712A49256721]; Vats SK, 2002, PHOTOSYNTHETICA, V40, P625, DOI 10.1023/A:1024372623650; VOGELMANN TC, 1993, PLANT CELL ENVIRON, V16, P65, DOI 10.1111/j.1365-3040.1993.tb00845.x; Xiong FSS, 2002, GLOBAL CHANGE BIOL, V8, P1146, DOI 10.1046/j.1365-2486.2002.00539.x; Xu D, 2005, HDB PHOTOSYNTH, V2, P287; Xu D-Q, 2012, SCI PHOTOSYNTHESIS; Yang SJ, 2014, J EUR CERAM SOC, V34, P3329; Ye ZP, 2007, PHOTOSYNTHETICA, V45, P637, DOI 10.1007/s11099-007-0110-5; YOUNG DR, 1983, ECOLOGY, V64, P681, DOI 10.2307/1937189; Yuan L, 2010, MYCORRHIZA, V20, P559, DOI 10.1007/s00572-010-0307-5; Zhang JinFeng, 2012, Journal of West China Forestry Science, V41, P34; Zhang SB, 2008, ACTA PHYSIOL PLANT, V30, P381, DOI 10.1007/s11738-008-0135-9; Zhang SB, 2006, PHOTOSYNTHETICA, V44, P425, DOI 10.1007/s11099-006-0046-1; Zhang SB, 2005, ANN BOT-LONDON, V96, P43, DOI 10.1093/aob/mci146; Zhang SB, 2007, J PLANT PHYSIOL, V164, P611, DOI 10.1016/j.jplph.2006.02.012; Zunzunegui M, 2011, PLANT ECOL, V212, P127, DOI 10.1007/s11258-010-9809-7	52	4	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181274	10.1371/journal.pone.0181274	http://dx.doi.org/10.1371/journal.pone.0181274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704518	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649600070
J	Benitez, AD; Martins, FDC; Mareze, M; Santos, NJR; Ferreira, FP; Martins, CM; Garcia, JL; Mitsuka-Bregano, R; Freire, RL; Biondo, AW; Navarro, IT				Benitez, Aline do Nascimento; Cardoso Martins, Felippe Danyel; Mareze, Marcelle; Rodrigues Santos, Nelson Jesse; Ferreira, Fernanda Pinto; Martins, Camila Marinelli; Garcia, Joao Luis; Mitsuka-Bregano, Regina; Freire, Roberta Lemos; Biondo, Alexander Welker; Navarro, Italmar Teodorico			Spatial and simultaneous representative seroprevalence of anti-Toxoplasma gondii antibodies in owners and their domiciled dogs in a major city of southern Brazil	PLOS ONE			English	Article							RISK-FACTORS; PREGNANT-WOMEN; URBAN AREA; WATERBORNE TOXOPLASMOSIS; ONE HEALTH; PET DOGS; INFECTION; TRANSMISSION; PREVALENCE; STATE	Toxoplasmosis, caused by Toxoplasma gondii, has traditionally been considered an important water and foodborne protozoonosis with important public health considerations. Although felids play a well-established role as definitive hosts, canine epidemiological involvement in the parasite's life cycle remains questionable and controversial. The increasing closeness of the human-dog bond, particularly seen in urban settings, has been recognized as a historically unprecedented worldwide movement. Sharing daily lives in the same households, dogs may be exposed to similar associated risks of T. gondii infection as their owners. Thus, epidemiological assessment of the intra-domiciled environment, especially among socio-economically different human populations, may provide novel information regarding the actual role of dogs in animal and human toxoplasmosis. Despite spatial approaches being recently used for other water and foodborne diseases, no study has been conducted on the simultaneous spatial seroprevalence of both human and animal IgG antiT. gondii antibodies in urban areas of major cities. Accordingly, the aim of the present study was to assess the seroprevalence and associated variables of Toxoplasma infection in owners and their domiciled dogs in Londrina, southern Brazil. Human and canine seroprevalence rates and variables associated with seroprevalence were investigated through representative random sampling among 564 households, which included 597 owners and 729 dogs. Overall, statistically significant differences between the seroprevalence of human and dog anti-T. gondii antibodies were found by Immunofluorescence Antibody Testing in 248/597 (41.54%) owners and 119/729 (16.32%) dogs. Through multiple analysis, significant concomitant variables for seropositivity of household individuals (people and dogs) were determined, including public sewer service, yard cleaning frequency, and having a dirty yard. Although no statistically significant multiple logistic model was observed among owners, univariate analysis detected associations with monthly income, soil contact, and occupation. Among dogs, the absence of other dogs and the absence of a dirty yard were concomitant significantly protective associated factors. Age differences between seropositive and seronegative individuals was significant only for human beings, with the median age of negative individuals significantly higher than positive individuals. Although no spatial clusters were identified for humans or residences, a significant cluster was identified for dogs. In conclusion, characteristics of urban toxoplasmosis may include significantly higher owner seroprevalence than their owned dogs, with canine seroprevalence directly associated with having more dogs and a dirty backyard, and spatial differences in both human and dog exposures. Although not a good indicator for human foodborne diseases, dogs may be a reliable sentinel for environmental infection. Moreover, such a holistic approach may provide crucial information for more focused prevention and monitoring programs, particularly in households with multiple pets and trash-filled backyards.	[Benitez, Aline do Nascimento; Cardoso Martins, Felippe Danyel; Mareze, Marcelle; Rodrigues Santos, Nelson Jesse; Ferreira, Fernanda Pinto] Univ Estadual Londrina, Lab Zoonoses & Publ Hlth, Londrina, Parana, Brazil; [Martins, Camila Marinelli] Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, SP, Brazil; [Garcia, Joao Luis; Mitsuka-Bregano, Regina; Freire, Roberta Lemos; Navarro, Italmar Teodorico] Univ Estadual Londrina, Dept Vet Prevent Med, Londrina, Parana, Brazil; [Biondo, Alexander Welker] Univ Fed Parana, Dept Vet Med, Curitiba, Parana, Brazil	Universidade Estadual de Londrina; Universidade de Sao Paulo; Universidade Estadual de Londrina; Universidade Federal do Parana	Navarro, IT (corresponding author), Univ Estadual Londrina, Dept Vet Prevent Med, Londrina, Parana, Brazil.	italmar@uel.br	Garcia, João Luis/X-4279-2019; BIONDO, ALEXANDER WELKER W/E-8823-2018; BIONDO, ALEXANDER WELKER/AAU-8955-2021; Luis, João/AAE-9252-2019; Martins, Felippe Danyel Cardoso/T-5710-2019; Benitez, Aline N/M-1677-2017; Bregano, Regina Mitsuka/AAX-3103-2020; Santos, Nelson JR/H-7989-2018; Garcia, Joao Luis/Y-8864-2019; Martins, felippe danyel cardoso/E-8522-2019	Garcia, João Luis/0000-0003-1826-7582; BIONDO, ALEXANDER WELKER W/0000-0002-4182-5821; BIONDO, ALEXANDER WELKER/0000-0002-4182-5821; Benitez, Aline N/0000-0002-0770-9552; Santos, Nelson JR/0000-0003-4811-312X; Garcia, Joao Luis/0000-0002-5736-7511; Martins, felippe danyel cardoso/0000-0002-9162-1536	CAPES/CNPq	CAPES/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CAPES/CNPq have provided only funding for Dr. Benitez costs, which included fellowship and travel grants for meeting presentations. No funding was granted for publication.	Afonso Eve, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P278, DOI 10.1016/j.ijppaw.2013.09.006; AndreAleixo M, 2015, SEMIN-CIENC AGRAR, V36, P1451, DOI 10.5433/1679-0359.2015v36n3p1451; Alvarado-Esquivel C, 2009, J PARASITOL, V95, P271, DOI 10.1645/GE-1829.1; Alvarado-Esquivel C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-13; Alvarado-Esquivel C, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-235; Ayres M., 2003, BIOESTAT 3 0 APLICAC; Baddeley A, 2015, SPATIAL POINT PATTER, P799; Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; Benitez AD, 2012, SEMIN-CIENC AGRAR, V33, P3201, DOI 10.5433/1679-0359.2012v33Supl2p3201; Cabezon O, 2010, PARASITOL RES, V107, P1505, DOI 10.1007/s00436-010-2015-7; CamargO M. E., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P117; Cano-Terriza D, 2016, PARASITOL INT, V65, P363, DOI 10.1016/j.parint.2016.05.001; Canon-Franco WA, 2004, VET RES COMMUN, V28, P113, DOI 10.1023/B:VERC.0000012114.71235.73; Casartelli-Alves L, 2015, GEOSPATIAL HEALTH, V10, P20, DOI 10.4081/gh.2015.311; CDC, 2006, PRINC EP PUBL HLTH P; Condoleo R, 2016, GEOSPATIAL HEALTH, V11, P206, DOI 10.4081/0.2016.432; Coryell W, 2016, ARCH SUICIDE RES, V20, P605, DOI 10.1080/13811118.2016.1158677; Dard C, 2016, TRENDS PARASITOL, V32, P492, DOI 10.1016/j.pt.2016.04.001; de B Bittencourt LHF, 2012, REV BRAS GINECOL OBS, V34, P63; de Barros LD, 2014, REV BRAS PARASITOL V, V23, P443, DOI [10.1590/S1984-29612014073, 10.1590/s1984-29612014073]; Dean AG, 1990, EPIINFO WORD PROCESS; Del Grande C, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6010003; Duan G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-118; DUBEY JP, 1985, J AM VET MED ASSOC, V186, P969; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Engroff P, 2014, CIENC SAUDE COLETIVA, V19, P3385, DOI 10.1590/1413-81232014198.12402013; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; Etheredge GD, 2004, REV PANAM SALUD PUBL, V16, P176, DOI 10.1590/S1020-49892004000900004; FAO OIE WHO UN System Influenza Coordination UNICEF World Bank Group, 2008, CONTR ON WORLD ON HL; Ferguson W, 2011, IRISH J MED SCI, V180, P807, DOI 10.1007/s11845-011-0723-3; Ferreira AIC, 2014, EPIDEMIOL INFECT, V142, P142, DOI 10.1017/S0950268813000526; Dias RCF, 2011, REV INST MED TROP SP, V53, P185, DOI 10.1590/S0036-46652011000400002; Francisco Fabio de Moraes, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P167; Frank D, 2008, CAN VET J, V49, P1063; Frenkel JK, 1995, AM J TROP MED HYG, V53, P226; Guimaraes AM, 2009, REV BRAS PARASITOL V, V18, P49, DOI 10.4322/rbpv.018e1009; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Heidenreich NB, 2013, ASTA-ADV STAT ANAL, V97, P403, DOI 10.1007/s10182-013-0216-y; IBGE, 2014, SAL IMPR IBGE DIV ES; Jones J L, 2001, Infect Dis Obstet Gynecol, V9, P23, DOI 10.1155/S1064744901000059; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M., 2020, SATSCAN SOFTWARE SPA; Lindsay DS, 1997, VET PARASITOL, V73, P27, DOI 10.1016/S0304-4017(97)00048-4; Magalhaes FJR, 2017, PARASITOL INT, V66, P43, DOI 10.1016/j.parint.2016.11.014; Mangot Ajish G, 2016, J Parasit Dis, V40, P1636, DOI 10.1007/s12639-015-0684-y; Meireles LR, 2004, TROP MED INT HEALTH, V9, P876, DOI 10.1111/j.1365-3156.2004.01280.x; Menezes JA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/621854; NRC, 1991, AN SENT ENV HLTH HAZ; Paredes H, 2010, CAD SAUDE PUBLICA, V26, P1013, DOI 10.1590/S0102-311X2010000500023; Paul M, 2010, TRENDS PARASITOL, V26, P153, DOI 10.1016/j.pt.2010.01.008; Pereira KS, 2010, ADV FOOD NUTR RES, V60, P1, DOI 10.1016/S1043-4526(10)60001-0; Pereira-Chioccola VL, 2009, FUTURE MICROBIOL, V4, P1363, DOI [10.2217/fmb.09.89, 10.2217/FMB.09.89]; Raimundo JM, 2015, REV BRAS PARASITOL V, V24, P475, DOI 10.1590/S1984-29612015068; Rengifo-Herrera C, 2017, PARASITE, V24, DOI 10.1051/parasite/2017009; Rosso F, 2008, AM J TROP MED HYG, V78, P504, DOI 10.4269/ajtmh.2008.78.504; Ruffolo BB, 2016, REV INST MED TROP SP, V58, DOI [10.1590/s1678-9946201658028, 10.1590/S1678-9946201658028]; Lopes-Mori FMR, 2013, BRAZ J INFECT DIS, V17, P405, DOI 10.1016/j.bjid.2012.12.003; Samudio M, 2015, REV CHIL INFECTOL, V32, P658, DOI 10.4067/S0716-10182015000700007; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sousa IC, 2016, VET PARASITOL, V223, P159, DOI 10.1016/j.vetpar.2016.04.041; Sroka S, 2010, AM J TROP MED HYG, V83, P528, DOI 10.4269/ajtmh.2010.10-0082; Sugden K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148435; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Torgerson PR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001920; VanWormer E, 2013, COMP IMMUNOL MICROB, V36, P217, DOI 10.1016/j.cimid.2012.10.006; Varandas N. P., 2001, Semina: Ciencias Agrarias (Londrina), V22, P105; Vieira FP, 2015, MEM I OSWALDO CRUZ, V110, P929, DOI 10.1590/0074-02760150262; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Wei HX, 2016, COMP PARASITOL, V83, P11, DOI 10.1654/1525-2647-83.1.11; WHO, 2010, CONTR LEISHM; Wilking H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22551; Woldehanna S, 2015, SOC SCI MED, V129, P87, DOI 10.1016/j.socscimed.2014.10.059; Yan C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1432-6; ZHOU XN, 2007, PARASITE VECTOR, V2, P10	74	19	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180906	10.1371/journal.pone.0180906	http://dx.doi.org/10.1371/journal.pone.0180906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732033	gold, Green Published, Green Submitted			2022-12-27	WOS:000406643100014
J	Tan, WG; Zubkova, I; Kachko, A; Wells, F; Adler, H; Sutter, G; Major, ME				Tan, Wendy G.; Zubkova, Iryna; Kachko, Alla; Wells, Frances; Adler, Heiko; Sutter, Gerd; Major, Marian E.			Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens	PLOS ONE			English	Article							IMMUNE-RESPONSES; VIRAL CLEARANCE; INFECTION; HCV; PERSISTENCE; DIFFERENTIATION; RESTORATION; VACCINATION; CHIMPANZEES; EXPRESSION	T-cell based vaccines have been considered as attractive candidates for prevention of hepatitis C virus (HCV) infections. In this study we compared the magnitude and phenotypic characteristics of CD8+ T-cells induced by three commonly used viral vectors, Adenovirus-5 (Ad5), Vaccinia virus (VV) and Modified Vaccinia Ankara (MVA) expressing the HCV NS3/4A protein. C57/BL6 mice were primed with DNA expressing NS3/4A and boosted with each of the viral vectors in individual groups of mice. We then tracked the vaccine-induced CD8+ T-cell responses using pentamer binding and cytokine production analysis. Overall, our data indicate that the memory cells induced by Ad5 were inferior to those induced by VV or MVA. We found that Ad5 boosting resulted in rapid expansion and significantly higher frequencies of NS3-specific T-cells compared to VV and MVA boosting. However, the functional profiles, assessed through analysis of the memory cell marker CD127 and the antiapoptotic molecule Bcl-2 in the blood, spleen, and liver; and measurements of interferongamma, tumor necrosis factor-alpha, and interleukin-2 production indicated significantly lower frequencies of long-lived memory T-cells following Ad5 boosting compared to VV and MVA. This same set of analyses suggested that the memory cells induced following boosting with MVA were superior to those induced by both Ad5 and VV. This superiority of the MVA-induced CD8+ T-cells was confirmed following surrogate challenge of mice with a recombinant mouse herpes virus expressing the HCV NS3 protein. Higher levels of NS3-specific CD8+ T-cells displaying the functional markers CD69, Ki67 and Granzyme B were found in the spleens of mice boosted with MVA compared to VV and Ad5, both alone and in combination. These data suggest that MVA may be a more successful viral vector for induction of effective CD8+ T-cell responses against hepatitis C virus.	[Tan, Wendy G.; Zubkova, Iryna; Kachko, Alla; Wells, Frances; Major, Marian E.] US FDA, Lab Hepatitis Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Adler, Heiko] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Lung Repair & Regenerat, Comprehens Pneumol Ctr, Munich, Germany; [Adler, Heiko] German Ctr Lung Res DZL, Munich, Germany; [Sutter, Gerd] LMU Univ Munich, Inst Infect Dis & Zoonoses, Munich, Germany	US Food & Drug Administration (FDA); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Major, ME (corresponding author), US FDA, Lab Hepatitis Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	marian.major@fda.hhs.gov		Sutter, Gerd/0000-0001-6143-082X; Major, Marian/0000-0003-0874-359X	Food and Drug Administration intramural funds [Z01 BK 04010-11 LHV]; Oak Ridge Institute for Science and Education (ORISE fellowship); FDA Commissioner's Fellowship	Food and Drug Administration intramural funds; Oak Ridge Institute for Science and Education (ORISE fellowship); FDA Commissioner's Fellowship	Financial support for this work was provided by the Food and Drug Administration intramural funds [Program Number Z01 BK 04010-11 LHV to M.E.M, the Oak Ridge Institute for Science and Education (ORISE fellowship) to AK, and FDA Commissioner's Fellowship to WT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem MS, 2010, J VIROL, V84, P10429, DOI 10.1128/JVI.01094-10; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Cox MA, 2011, TRENDS IMMUNOL, V32, P180, DOI 10.1016/j.it.2011.01.004; Dahari H, 2010, GASTROENTEROLOGY, V139, P965, DOI 10.1053/j.gastro.2010.05.077; Day CL, 2002, J VIROL, V76, P12584, DOI 10.1128/JVI.76.24.12584-12595.2002; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Dunkle A, 2013, J IMMUNOL, V190, P940, DOI 10.4049/jimmunol.1103481; El-Gogo S, 2008, J GENE MED, V10, P177, DOI 10.1002/jgm.1144; El-Gogo S, 2007, VACCINE, V25, P3934, DOI 10.1016/j.vaccine.2007.02.054; Feinstone SM, 2012, CLIN INFECT DIS, V55, pS25, DOI 10.1093/cid/cis362; Frey SE, 2010, VACCINE, V28, P6367, DOI 10.1016/j.vaccine.2010.06.084; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hovav AH, 2007, J VIROL, V81, P12793, DOI 10.1128/JVI.01519-07; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Lauer GM, 2004, GASTROENTEROLOGY, V127, P924, DOI 10.1053/j.gastro.2004.06.015; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Missale G, 2012, GUT, V61, P1076, DOI 10.1136/gutjnl-2011-300515; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Puig M, 2006, HEPATOLOGY, V44, P736, DOI 10.1002/hep.21319; Shiffman ML, 2014, CURR OPIN GASTROEN, V30, P217, DOI 10.1097/MOG.0000000000000062; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Spada E, 2004, GUT, V53, P1673, DOI 10.1136/gut.2003.037788; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Volz A, 2017, ADV VIRUS RES, V97, P187, DOI 10.1016/bs.aivir.2016.07.001; Zubkova I, 2009, VACCINE, V27, P2594, DOI 10.1016/j.vaccine.2009.02.045; Zubkova I, 2014, HEPATOLOGY, V59, P803, DOI 10.1002/hep.26747; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181578	10.1371/journal.pone.0181578	http://dx.doi.org/10.1371/journal.pone.0181578			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732046	Green Published, gold, Green Submitted			2022-12-27	WOS:000406643100046
J	Adler, PH; Hamada, N; do Nascimento, JMC; Grillet, ME				Adler, Peter H.; Hamada, Neusa; Cavalcante do Nascimento, Jeane Marcelle; Grillet, Maria Eugenia			River-specific macrogenomic diversity in Simulium guianense s. l. (Diptera: Simuliidae), a complex of tropical American vectors associated with human onchocerciasis	PLOS ONE			English	Article							BLACK FLIES DIPTERA; POPULATION; BIODIVERSITY; IDENTIFICATION; EPIDEMIOLOGY; ECOREGIONS; VERECUNDUM; HABITAT; LARVAL; FOCUS	Simulium guianense Wise is a Latin American vector complex of black flies associated with transmission of the causal agent of human onchocerciasis (river blindness). An analysis of the chromosomal banding patterns of 607 larvae of S. guianense s. l. revealed a high level of variation involving 83 macrogenomic rearrangements across 25 populations in Brazil, French Guiana, and Venezuela. The 25 populations were assigned to 13 cytoforms (A1, A2, B1-B4, C, D, E1-E4, and F), some of which are probably valid species. Based on geographical proximity, a member of the B group of cytoforms probably represents the name-bearing type specimen of S. guianense and the primary vector in the last-remaining onchocerciasis foci in the Western Hemisphere. Cytoform B3 in Amapa A State is implicated as an anthropophilic simuliid in an area currently and historically free of onchocerciasis. Distributions of cytoforms are associated with geography, elevation, and drainage basin, and are largely congruent with ecoregions. Despite extraordinarily large larval populations of S. guianense s. l. in big rivers and consequent production of female flies for dispersal, the cytoforms maintain their chromosomal distinction within individual rivers, suggesting a high degree of fidelity to the specialized breeding habitats-rocky shoals-of the natal rivers.	[Adler, Peter H.] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA; [Hamada, Neusa; Cavalcante do Nascimento, Jeane Marcelle] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Curso Posgrad Entomol, Manaus, Amazonas, Brazil; [Grillet, Maria Eugenia] Univ Cent Venezuela, Inst Zool & Ecol Trop, Fac Ciencias, Lab Biol Vectores & Parasitos, Caracas, Venezuela	Clemson University; Institute Nacional de Pesquisas da Amazonia; University of Central Venezuela	Adler, PH (corresponding author), Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA.	padler@clemson.edu	Grillet, Maria Eugenia/AAR-6116-2021; Nascimento, Jeane Marcelle/AAT-3193-2020; Hamada, Neusa/E-3383-2013	Nascimento, Jeane Marcelle/0000-0002-5428-7495; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [475663/2012-8]; Ministerio da Ciencia, Tecnologia, Inovacoes e Comunicacoes (MCTIC)/Instituto Nacional de Pesquisas da Amazonia (INPA); Ministerio da Ciencia, Tecnologia, Inovacoes e Cornunicacoes (MCTIC)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Secretaria de Ciencia, Tecnologia e Inovacao do Amazonas/Fundacao de Amparo a Pesquisa do Estado do Amazonas (SECTI-AM/FAPEAM)-Edital [015/2014 PAPAC]; Council for Sciences and Humanities Development (CDCH-UCV) [PG 03-00-5739]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia, Tecnologia, Inovacoes e Comunicacoes (MCTIC)/Instituto Nacional de Pesquisas da Amazonia (INPA); Ministerio da Ciencia, Tecnologia, Inovacoes e Cornunicacoes (MCTIC)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Secretaria de Ciencia, Tecnologia e Inovacao do Amazonas/Fundacao de Amparo a Pesquisa do Estado do Amazonas (SECTI-AM/FAPEAM)-Edital; Council for Sciences and Humanities Development (CDCH-UCV)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) processo n. 475663/2012-8 to NH and JMCN (URL: www.cripg.br); Ministerio da Ciencia, Tecnologia, Inovacoes e Comunicacoes (MCTIC)/Instituto Nacional de Pesquisas da Amazonia (INPA) to NH (URL: http://portal.inpa.gov.br/); Ministerio da Ciencia, Tecnologia, Inovacoes e Cornunicacoes (MCTIC)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to NH (URL: www.cripq.br); Secretaria de Ciencia, Tecnologia e Inovacao do Amazonas/Fundacao de Amparo a Pesquisa do Estado do Amazonas (SECTI-AM/FAPEAM)-Edital 015/2014 PAPAC to NH (URL: http://www.fapeam.am.gov.br/); and Council for Sciences and Humanities Development (CDCH-UCV, PG 03-00-5739) to MEG (URL: http./Avww.ucv.ve/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Adler P. H., 2017, WORLD BLACKFLIES DIP; Adler P. H., 1988, BLACK FLIES ECOLOGY, P63; Adler PH, 2017, ACTA TROP, V173, P171, DOI 10.1016/j.actatropica.2017.06.017; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158272; Adler PH, 2011, CAN ENTOMOL, V143, P612, DOI 10.4039/n11-035; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Adler PH, 2016, NOVA ACTA LEOPOLDINA, V411, P23; Adler PH, PLOS ONE, V673; Adler PH, 2017, INSECT BIODIVERSITY, V1, P713; Adler PH, 2004, BLACK FLIES SIMULIID; Amorim DS, 2012, BIOGEOGRAFIA NEOTROP; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P501; Arteaga LT, 1999, J MED ENTOMOL, V36, P133, DOI 10.1093/jmedent/36.2.133; Basanez MG, 2009, ADV PARASIT, V68, P263, DOI 10.1016/S0065-308X(08)00611-8; BASANEZ MG, 1988, ANN TROP MED PARASIT, V82, P597, DOI 10.1080/00034983.1988.11812296; Botto C., 2013, REF MODULE EARTH SYS; Botto C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1313-z; Charalambous M, 1996, MED VET ENTOMOL, V10, P111, DOI 10.1111/j.1365-2915.1996.tb00716.x; CONN J, 1989, CAN J ZOOL, V67, P1217, DOI 10.1139/z89-176; Coscaron S., 2007, AQUATIC BIODIVERSITY, V3; Crainey JL, 2014, ACTA TROP, V131, P47, DOI 10.1016/j.actatropica.2013.10.019; dos Santos-Neto CR, 2015, FLA ENTOMOL, V98, P446, DOI 10.1653/024.098.0209; FEOW, 2015, FRESHW EC WORLD; Goloboff PA, 2001, CLADISTICS, V17, pS26, DOI 10.1111/j.1096-0031.2001.tb00102.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Gomes Silvana Angelica Gama, 2002, Entomologia y Vectores, V9, P443; Grillet ME, 2001, J MED ENTOMOL, V38, P520, DOI 10.1603/0022-2585-38.4.520; Hamada N, 2010, ZOOTAXA, P22; Hamada Neusa, 2001, Entomotropica, V16, P29; Hernandez-Triana LM., 2011, THESIS; Hernandez-Triana LM, 2015, ZOOTAXA, V3936, P93, DOI 10.11646/zootaxa.3936.1.5; Hernandez-Triana LM, 2012, ZOOTAXA, P43; HIRAI H, 1994, GENOME, V37, P36, DOI 10.1139/g94-006; Mattos AA, 2007, THESIS; McCreadie JW, 2006, ECOGRAPHY, V29, P603, DOI 10.1111/j.0906-7590.2006.04541.x; McCreadie JW, 1998, OECOLOGIA, V114, P79, DOI 10.1007/s004420050423; MCCREADIE JW, 1993, CAN J ZOOL, V71, P358, DOI 10.1139/z93-050; Meredith S. E. O., 1988, BLACK FLIES ECOLOGY, P53; Ministe A rio do Meio Ambiente, 2006, CAD MEIO AMB; Negrel P, 2000, J HYDROL, V237, P212, DOI 10.1016/S0022-1694(00)00308-5; Nixon K.C., 2002, WINCLADA VERSION 1 0; Pomara LY, 2014, J BIOGEOGR, V41, P784, DOI 10.1111/jbi.12247; Post RJ, 2007, TROP MED INT HEALTH, V12, P1342, DOI 10.1111/j.1365-3156.2007.01921.x; Pramual P, 2005, MOL ECOL, V14, P3989, DOI 10.1111/j.1365-294X.2005.02639.x; Pramual P, 2015, J ASIA-PAC ENTOMOL, V18, P33, DOI 10.1016/j.aspen.2014.11.002; Pramual P, 2011, GENOME, V54, P1, DOI 10.1139/G10-100; Prendini L, 2000, CLADISTICS, V16, P1, DOI 10.1111/j.1096-0031.2000.tb00348.x; PROCUNIER WS, 1986, PARASITOL TODAY, V2, P307, DOI 10.1016/0169-4758(86)90125-0; PROCUNIER WS, 1989, GENOME, V32, P559, DOI 10.1139/g89-483; ROTHFELS K, 1978, CAN J ZOOL, V56, P1110, DOI 10.1139/z78-155; ROTHFELS K, 1981, CAN J ZOOL, V59, P1857, DOI 10.1139/z81-255; ROTHFELS KH, 1979, ANNU REV ENTOMOL, V24, P507, DOI 10.1146/annurev.en.24.010179.002451; Shelley A.J., 1997, Bulletin of the Natural History Museum Entomology Series, V66, P1; Shelley AJ, 2001, MED VET ENTOMOL, V15, P28, DOI 10.1046/j.1365-2915.2001.00275.x; SHELLEY AJ, 2010, AQUATIC BIODIVERSITY, V6; Tangkawanit U, 2009, ZOOL J LINN SOC-LOND, V155, P289, DOI 10.1111/j.1096-3642.2008.00433.x; Villamizar N, 2011, B MALARIOL SALUD AMB, V51, P97; WHO (World Health Organization), 2017, ONCH	60	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181679	10.1371/journal.pone.0181679	http://dx.doi.org/10.1371/journal.pone.0181679			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727841	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500102
J	Jara-Samaniego, J; Perez-Murcia, MD; Bustamante, MA; Paredes, C; Perez-Espinosa, A; Gavilanes-Teran, I; Lopez, M; Marhuenda-Egea, FC; Brito, H; Moral, R				Jara-Samaniego, J.; Perez-Murcia, M. D.; Bustamante, M. A.; Paredes, C.; Perez-Espinosa, A.; Gavilanes-Teran, I.; Lopez, M.; Marhuenda-Egea, F. C.; Brito, H.; Moral, R.			Development of organic fertilizers from food market waste and urban gardening by composting in Ecuador	PLOS ONE			English	Article							DISTILLERY WASTES; GREEN WASTE; NITROGEN; CARBON; BIOTRANSFORMATION; EVOLUTION; MATTER; SOIL; AGROINDUSTRIAL; VERMICOMPOST	Currently, the management of urban waste streams in developing countries is not optimized yet, and in many cases these wastes are disposed untreated in open dumps. This fact causes serious environmental and health problems due to the presence of contaminants and pathogens. Frequently, the use of specific low-cost strategies reduces the total amount of wastes. These strategies are mainly associated to the identification, separate collection and composting of specific organic waste streams, such as vegetable and fruit refuses from food markets and urban gardening activities. Concretely, in the Chimborazo Region (Ecuador), more than 80% of municipal solid waste is dumped into environment due to the lack of an efficient waste management strategy. Therefore, the aim of this study was to develop a demonstration project at field scale in this region to evaluate the feasibility of implanting the composting technology not only for the management of the organic waste fluxes from food market and gardening activities to be scaled-up in other developing regions, but also to obtain an end-product with a commercial value as organic fertilizer. Three co-composting mixtures were prepared using market wastes mixed with pruning of trees and ornamental palms as bulking agents. Two piles were created using different proportions of market waste and prunings of trees and ornamental palms: pile 1 (50: 33: 17) with a C/N ratio 25; pile 2: (60: 30: 10) with C/N ratio 24 and pile 3 (75: 0: 25) with C/N ratio 33), prepared with market waste and prunings of ornamental palm. Throughout the process, the temperature of the mixtures was monitored and organic matter evolution was determined using thermogravimetric and chemical techniques. Additionally, physico-chemical, chemical and agronomic parameters were determined to evaluate compost quality. The results obtained indicated that all the piles showed a suitable development of the composting process, with a significant organic matter decomposition, reached in a shorter period of time in pile 3. At the end of the process, all the composts showed absence of phytotoxicity and suitable agronomic properties for their use as organic fertilizers. This reflects the viability of the proposed alternative to be scaled-up in developing areas, not only to manage and recycle urban waste fluxes, but also to obtain organic fertilizers, including added value in economic terms related to nutrient contents.	[Jara-Samaniego, J.; Brito, H.] Escuela Super Politecn Chimborazo, Fac Ciencias, Riobamba, Chimborazo, Ecuador; [Perez-Murcia, M. D.; Bustamante, M. A.; Paredes, C.; Perez-Espinosa, A.; Moral, R.] Miguel Hernandez Univ, Dept Agrochem & Environm, Alicante, Spain; [Gavilanes-Teran, I.] Escuela Super Politecn Chimborazo, Fac Salud Publ, Riobamba, Chimborazo, Ecuador; [Lopez, M.] Univ Politecn Cataluna, Dept Agrifood Engn & Biotechnol, Castelldefels, Spain; [Marhuenda-Egea, F. C.] Alicante Univ, Dept Biochem & Agrochem, Alicante, Spain	Universidad Miguel Hernandez de Elche; Universitat Politecnica de Catalunya; Universitat d'Alacant	Bustamante, MA (corresponding author), Miguel Hernandez Univ, Dept Agrochem & Environm, Alicante, Spain.	marian.bustamante@umh.es	Bustamante, Maria Angeles/ABF-3793-2020; Marhuenda-Egea, Frutos C/B-3412-2018; murcia, perez MD/O-9753-2014; Gavilanes, Irene/G-1280-2018; Gavilanes Terán, Irene/AAE-4736-2022; Moral, Raul/C-7473-2009; López, Marga/AAU-5531-2020; Bustamante, Maria Angeles/H-9171-2013; Perez Espinosa, Aurelia/ABC-4951-2021; Paredes, Concepcion/C-9325-2012	Bustamante, Maria Angeles/0000-0001-9931-1711; Marhuenda-Egea, Frutos C/0000-0002-0402-9770; murcia, perez MD/0000-0003-0722-9599; Gavilanes, Irene/0000-0001-5576-2908; Gavilanes Terán, Irene/0000-0001-5576-2908; Moral, Raul/0000-0002-4881-480X; López, Marga/0000-0001-5913-6445; Bustamante, Maria Angeles/0000-0001-9931-1711; Perez Espinosa, Aurelia/0000-0003-2881-3073; Paredes, Concepcion/0000-0002-9735-5099; Marhuenda-Egea, Frutos/0000-0002-7457-1805	National Secretary of Higher Education, Science, Technology and Innovation SENESCYT of Ecuador; project of the Spanish Ministry of Economy and Competitiveness - EU through the Social Funds [AGL2013-41612-R]; Spanish Ministry of Economy and Competitiveness [AGL2013-41612-R]	National Secretary of Higher Education, Science, Technology and Innovation SENESCYT of Ecuador; project of the Spanish Ministry of Economy and Competitiveness - EU through the Social Funds; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by a PhD scholarship to JJS of the National Secretary of Higher Education, Science, Technology and Innovation SENESCYT of Ecuador and it was also developed in the framework of the project of the Spanish Ministry of Economy and Competitiveness co-funded by the EU through the Social Funds (ref. AGL2013-41612-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the National Secretary of Higher Education, Science, Technology and Innovation SENESCYT of Ecuador, since this work is a part of the doctoral research project on the issue of waste management in the province of Chimborazo-Ecuador, also developed in the framework of the project reference AGL2013-41612-R of the Spanish Ministry of Economy and Competitiveness. The authors also wish to thank the Polytechnic School of Chimborazo (Ecuador) and the Applied Research in Agrochemistry and Environment group (GIAAMA) of the Miguel Hernandez University (Spain), for their invaluable technical and scientific contribution.	Alburquerque JA, 2006, CHEMOSPHERE, V64, P470, DOI 10.1016/j.chemosphere.2005.10.055; Ali M, 2012, BIODEGRADATION, V23, P231, DOI 10.1007/s10532-011-9502-0; [Anonymous], THESIS; Bernache G., 1995, ECOLOGIA SOC GUADALA; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bernal MP, 1996, BIOL FERT SOILS, V22, P141, DOI 10.1007/BF00384446; Boldrin A, 2010, WASTE MANAGE, V30, P551, DOI 10.1016/j.wasman.2009.11.031; Brewer LJ, 2003, COMPOST SCI UTIL, V11, P96; Brinton W.F, 2000, COMPOST QUALITY STAN; Buenrostro O, 1999, REV INT CONTAM AMBIE, V15, P27; Bustamante MA, 2008, CHEMOSPHERE, V72, P551, DOI 10.1016/j.chemosphere.2008.03.030; Bustamante MA, 2008, RESOUR CONSERV RECY, V52, P792, DOI 10.1016/j.resconrec.2007.11.005; Bustamante MA, 2007, BIORESOURCE TECHNOL, V98, P3269, DOI 10.1016/j.biortech.2006.07.013; Bustamante MA, 2010, BIORESOURCE TECHNOL, V101, P4068, DOI 10.1016/j.biortech.2010.01.085; Bustamante MA, 2009, BIORESOURCE TECHNOL, V100, P4766, DOI 10.1016/j.biortech.2009.04.033; Caceres R, 2015, BIORESOURCE TECHNOL, V179, P398, DOI 10.1016/j.biortech.2014.12.051; EC, 2014, JRC SCI POL REP; EC, OFFICIAL J EUROPEA L, V325, P28; El Fels L, 2014, INT BIODETER BIODEGR, V87, P128, DOI 10.1016/j.ibiod.2013.09.024; Epstein E., 1997, SCI COMPOSTING TECHN, P83; Farrell M, 2009, BIORESOURCE TECHNOL, V100, P4301, DOI 10.1016/j.biortech.2009.04.029; Gavilanes-Teran I, 2016, WASTE MANAGE, V48, P127, DOI 10.1016/j.wasman.2015.11.026; Gregorich EG, 2015, SOIL BIOL BIOCHEM, V91, P182, DOI 10.1016/j.soilbio.2015.08.032; Guendez R, 2005, FOOD CHEM, V89, P1, DOI 10.1016/j.foodchem.2004.02.010; Huerta-Pujol O, 2011, RESOUR CONSERV RECY, V55, P1095, DOI 10.1016/j.resconrec.2011.06.008; Iglesias-Jimenez E., 1992, AGR ECOSYST ENVIRON, V38, P331, DOI DOI 10.1016/0167-8809(92)90154-4; Jara-Samaniego J, 2017, J CLEAN PROD, V141, P1349, DOI 10.1016/j.jclepro.2016.09.178; Jara-Samaniego J, 2015, COMMUN SOIL SCI PLAN, V46, P157, DOI 10.1080/00103624.2014.988587; Gonzalez-Fernandez JJ, 2015, J ENVIRON MANAGE, V147, P132, DOI 10.1016/j.jenvman.2014.09.016; Jurado MM, 2014, J ENVIRON MANAGE, V133, P355, DOI 10.1016/j.jenvman.2013.12.020; Lim SL, 2016, J CLEAN PROD, V111, P262, DOI 10.1016/j.jclepro.2015.08.083; Lim SL, 2015, ECOL ENG, V84, P515, DOI 10.1016/j.ecoleng.2015.09.050; Lim SL, 2015, J SCI FOOD AGR, V95, P1143, DOI 10.1002/jsfa.6849; Lopez M, 2010, RESOUR CONSERV RECY, V54, P222, DOI 10.1016/j.resconrec.2009.08.003; Mathava K, 2010, WASTE MANAGE, V30, P602; Paredes C, 2000, BIOL FERT SOILS, V32, P222, DOI 10.1007/s003740000239; Paredes C, 2001, BIODEGRADATION, V12, P225, DOI 10.1023/A:1017374421565; RICHARDSON GM, 1995, HUM ECOL, V23, P455, DOI 10.1007/BF01190132; Smidt E, 2005, BIODEGRADATION, V16, P67, DOI 10.1007/s10531-004-0430-8; TAM NFY, 1994, RESOUR CONSERV RECY, V11, P261, DOI 10.1016/0921-3449(94)90094-9; Tchobanoglaus G, 1993, INTEGRATED SOLID WAS, P421; Torres-Climent A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138925; US Composting Council, 2001, FIELD GUID COMP US 2; USEPA, 1998, EPA530R97003; Varma VS, 2015, INT J ENVIRON SCI TE, V12, P2015, DOI 10.1007/s13762-014-0582-3; Varma V. Sudharsan, 2014, Environmental Engineering Research, V19, P67, DOI 10.4491/eer.2014.19.1.067; VIEL M, 1987, BIOL WASTE, V20, P167, DOI 10.1016/0269-7483(87)90152-2; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088279; Wu TY, 2014, CHEM ENGINEER TRANS, V39, P1579, DOI 10.3303/CET1439264; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078121; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; ZUCCONI F, 1981, BIOCYCLE, V22, P54	52	26	26	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181621	10.1371/journal.pone.0181621	http://dx.doi.org/10.1371/journal.pone.0181621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727757	Green Published, gold			2022-12-27	WOS:000406634500094
J	Nakamura, T; Matsumine, A; Matsubara, T; Asanuma, K; Yada, Y; Hagi, T; Sudo, A				Nakamura, Tomoki; Matsumine, Akihiko; Matsubara, Takao; Asanuma, Kunihiro; Yada, Yuki; Hagi, Tomohito; Sudo, Akihiro			Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CLINICOPATHOLOGICAL ANALYSIS; LYMPHOCYTE RATIO; MYXOFIBROSARCOMA; SURVIVAL; NEUTROPHIL; EMPHASIS; LEVEL; MRI	Objective The aim of this study was to determine whether the tumor infiltrative growth pattern on magnetic resonance imaging (MRI) was associated with blood inflammatory markers (C-reactive protein; CRP and Neutrophil-lymphocyte ratio; NLR) and survival in patients with high-grade soft-tissue sarcoma (STS). Methods The cohort for this retrospective study included 81 patients with a mean age of 63 years. The tumor depth was superficial or deep in 15 and 66 patients, respectively. The mean CRP and NLR were 1.31 mg/dL and 2.81, respectively. The assessment of a peripheral growth pattern which divided into three patterns on MRI was based on the largest midsection of the tumor. Results On MRI scans, diffuse-type, focal-type, and pushing-type growth patterns were observed in 18, 33, and 30 patients, respectively. Superficial high-grade STS were prone to show a focal-type pattern on MRI. There were no correlations between growth pattern type and clinicopathological factors such as age, sex, tumor size, and histological grade. However, the incidence of infiltrative growth was significantly higher in patients with elevated CRP (p = 0.0002). In multivariate analysis, growth pattern and CRP were independent prognostic factors for disease-specific survival, metastasis-free survival. Growth pattern was also related to local tumor control. Conclusions There were significant associations between the tumor growth pattern and CRP levels in patients with high-grade soft-tissue sarcoma. An infiltrative growth pattern and elevated CRP may be associated with inferior disease-specific and metastasis-free survival rates in these patients. Therefore, careful post-treatment follow-up should be conducted in such patients.	[Nakamura, Tomoki; Matsumine, Akihiko; Matsubara, Takao; Asanuma, Kunihiro; Yada, Yuki; Hagi, Tomohito; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan	Mie University	Nakamura, T (corresponding author), Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan.	tomoki66@clin.medic.mie-u.ac.jp						CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fernebro Josefin, 2006, Sarcoma, V2006, P1, DOI 10.1155/SRCM/2006/21251; Huang HY, 2004, HUM PATHOL, V35, P612, DOI 10.1016/j.humpath.2004.01.016; Idowu OK, 2012, BIOMARKERS, V17, P539, DOI 10.3109/1354750X.2012.699554; Iwata S, 2014, J SURG ONCOL, V110, P707, DOI 10.1002/jso.23708; Kikuta K, 2015, SKELETAL RADIOL, V44, P55, DOI 10.1007/s00256-014-1992-5; Lefkowitz RA, 2013, SKELETAL RADIOL, V42, P809, DOI 10.1007/s00256-012-1563-6; Manoso MW, 2006, CLIN ORTHOP RELAT R, P89, DOI 10.1097/01.blo.0000229292.98850.14; Mentzel T, 1996, AM J SURG PATHOL, V20, P391, DOI 10.1097/00000478-199604000-00001; Nakamura T, 2015, BONE JOINT J, V97B, P847, DOI [10.1302/0301-620X.97B6.35098, 10.1302/0301-620X.97B.35098]; Nakamura T, 2015, ONCOL LETT, V10, P841, DOI 10.3892/ol.2015.3289; Nakamura T, 2013, J SURG ONCOL, V108, P481, DOI 10.1002/jso.23424; Nakamura T, 2013, EUR J CANCER, V49, P377, DOI 10.1016/j.ejca.2012.09.004; Nakamura T, 2012, CANCER-AM CANCER SOC, V118, P1055, DOI 10.1002/cncr.26353; Pisters PWT, 1996, J CLIN ONCOL, V14, P1679, DOI 10.1200/JCO.1996.14.5.1679; Szkandera J, 2013, BRIT J CANCER, V109, P2316, DOI 10.1038/bjc.2013.595; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Yoo HJ, 2014, EUR RADIOL, V24, P1749, DOI 10.1007/s00330-014-3181-2	19	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181787	10.1371/journal.pone.0181787	http://dx.doi.org/10.1371/journal.pone.0181787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727824	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500110
J	Pannakal, ST; Jager, S; Duranton, A; Tewari, A; Saha, S; Radhakrishnan, A; Roy, N; Kuntz, JF; Fermas, S; James, D; Mellor, J; Misra, N; Breton, L				Pannakal, Steve Thomas; Jager, Sibylle; Duranton, Albert; Tewari, Amit; Saha, Subarna; Radhakrishnan, Aneesha; Roy, Nita; Kuntz, Jean Francois; Fermas, Soraya; James, Darryl; Mellor, Jane; Misra, Namita; Breton, Lionel			Longevity effect of a polysaccharide from Chlorophytum borivilianum on Caenorhabditis elegans and Saccharomyces cerevisiae	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; CHRONOLOGICAL LIFE-SPAN; HUMAN SKIN; OXIDATIVE STRESS; CD44; AGE; SECRETION; GENETICS	The traditional Indian medicine, Ayurveda, provides insights and practical solutions towards a healthy life style. Rasayana is a branch of Ayurveda known for preserving and promoting health, enhancing the quality of life and delaying the aging process. In the traditional knowledge, the Rasayana herb, Chlorophytum borivilianum (C. borivilanum) is regarded as a general health promoting tonic that delays aging and increases lifespan, cognitive function and physical strength. Aging is a complex and multifactorial physiological phenomenon that manifests itself over a wide range of biological systems, tissues, and functions. Longevity is an obvious marker of physiological aging. Simple model systems such as the single-cell budding yeast Saccharomyces cerevisiae (S. cerevisiae) and the nematode, Caenorhabditis elegans (C. elegans) are widely used to study the aging process and longevity. Here, we show that a polysaccharide fraction obtained from C. borivilianum increases the lifespan of S. cerevisiae and C. elegans, using an automated screening platform (Chronoscreen TM). Chemical analysis of this extract revealed a low molecular weight polysaccharide of 1000 Da, predominantly comprising Glu1 -> 6Glu linkage. This polysaccharide showed significant dose-dependent extension of the median lifespan of S. cerevisiae by up to 41% and of the median lifespan of C. elegans by up to 10%. Taking cue from these results and the traditionally described benefits of Rasayanas on skin rejuvenation, we tested in vitro the polysaccharide for potential skin benefits. In a keratinocyte culture, we observed that this polysaccharide increased cell proliferation significantly, and induced synthesis of hyaluronic acid (HA), a well-known extracellular matrix component. Furthermore, when added to culture medium of human reconstructed epidermis, we observed an enhanced production of epidermal markers, e.g. CD44 and HA that are otherwise diminished in aged skin. Together, these results suggest that in addition to lifespan extension of S. cerevisiae and C. elegans, a polysaccharide from the Rasayana herb, C. borivilianum may have beneficial effects on skin aging parameters.	[Pannakal, Steve Thomas; Tewari, Amit; Saha, Subarna; Roy, Nita; James, Darryl; Misra, Namita] LOreal Res & Innovat, Bangalore, Karnataka, India; [Jager, Sibylle; Duranton, Albert; Kuntz, Jean Francois; Fermas, Soraya; Breton, Lionel] LOreal Res & Innovat, Aulnay Sous Bois, France; [Radhakrishnan, Aneesha] Inst Bioinformat, Int Tech Pk, Bangalore, Karnataka, India; [Mellor, Jane] Univ Oxford, Dept Biochem, Oxford, England; [Mellor, Jane] Sibelius Ltd, Oxford, England	L'Oreal Group; L'Oreal Group; University of Oxford	Pannakal, ST; Misra, N (corresponding author), LOreal Res & Innovat, Bangalore, Karnataka, India.	spannakal@rd.loreal.com; nmisra@rd.loreal.com		Mellor, Jane/0000-0002-5196-3734; Jager, Sibylle/0000-0001-8102-7149; Duranton, Albert/0000-0002-4057-7176				Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; Baaten Bas Jg, 2010, Commun Integr Biol, V3, P508, DOI 10.4161/cib.3.6.13495; Balasubramani SP, 2011, CHIN J INTEGR MED, V17, P88, DOI 10.1007/s11655-011-0659-5; Bhullar KS, 2015, BBA-MOL BASIS DIS, V1852, P1209, DOI 10.1016/j.bbadis.2015.01.012; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Bourguignon LYW, 2014, AM J PATHOL, V184, P1912, DOI 10.1016/j.ajpath.2014.03.010; BRENNER S, 1974, GENETICS, V77, P71; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; Daubenmier JJ, 2007, ANN BEHAV MED; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ELIAS PM, 1991, J CONTROL RELEASE, V15, P199, DOI 10.1016/0168-3659(91)90111-P; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; GARROZZO D, 1995, RAPID COMMUN MASS SP, V9, P937, DOI 10.1002/rcm.1290091014; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Guo LQ, 2007, FOOD CHEM, V100, P643, DOI 10.1016/j.foodchem.2005.09.087; Hsu AL, 2009, NEUROBIOL AGING, V30, P1498, DOI 10.1016/j.neurobiolaging.2007.12.007; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Ido Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115341; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Khanam Z, 2013, J ETHNOPHARMACOL, V150, P421, DOI 10.1016/j.jep.2013.08.064; Kim MS, 2005, INT J ONCOL, V27, P839; Kumar R, 2013, ANN NEUROSCI, V20, P13, DOI 10.5214/ans.0972.7531.200106; Larsen BS, 1996, J AM SOC MASS SPECTR, V7, P287, DOI 10.1016/1044-0305(95)00706-7; Laurent M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009346; Li WJ, 2012, J AGR FOOD CHEM, V60, P1413, DOI 10.1021/jf204748a; Lorencini M, 2014, AGEING RES REV, V15, P100, DOI 10.1016/j.arr.2014.03.002; Makrantonaki E, 2007, ANN NY ACAD SCI, V1119, P40, DOI 10.1196/annals.1404.027; Mechref Y, 2003, ANAL CHEM, V75, P4895, DOI 10.1021/ac0341968; Murakami S, 2005, NEUROBIOL AGING, V26, P899, DOI 10.1016/j.neurobiolaging.2004.08.007; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Oh JH, 2011, EXP DERMATOL, V20, P455, DOI 10.1111/j.1600-0625.2011.01258.x; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Olshansky SJ, 2007, ANN NY ACAD SCI, V1114, P11, DOI 10.1196/annals.1396.050; Papakonstantinou E, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.21923; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Priess J. R., 1997, C ELEGANS 2; Raja R, 2016, ONCOTARGET, V7, P61229, DOI 10.18632/oncotarget.11310; Rizzarelli P, 2006, RAPID COMMUN MASS SP, V20, P1683, DOI 10.1002/rcm.2483; Robert C, 2003, PATHOL BIOL, V51, P586, DOI 10.1016/j.patbio.2003.09.009; Ronkart SN, 2006, TALANTA, V70, P1006, DOI 10.1016/j.talanta.2006.02.024; Scherfer C, 2013, AGING-US, V5, P276, DOI 10.18632/aging.100549; Singh R, 2008, BIOGERONTOLOGY, V9, P369, DOI 10.1007/s10522-008-9185-z; Subramaniam V, 2007, EXP MOL PATHOL, V83, P341, DOI 10.1016/j.yexmp.2007.08.007; Tatar M, 2009, J GERONTOL A-BIOL, V64, P161, DOI 10.1093/gerona/gln067; THURINGER JM, 1959, J INVEST DERMATOL, V33, P35, DOI 10.1038/jid.1959.119; Udapa MH, 2004, COMPREHENSIVE KAAYAC; VARANI J, 1994, J CLIN INVEST, V94, P1747, DOI 10.1172/JCI117522; Varley H, 1980, PRACTICAL CLIN CHEM, VI, P491; WEST MD, 1994, ARCH DERMATOL, V130, P87, DOI 10.1001/archderm.130.1.87; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Zhang YS, 2015, PHARMACOGN MAG, V11, P449, DOI [10.4103/0973-1296.1604471, 10.4103/0973-1296.160447]; 2006, ULTRAFLEX 3 USER MAN	59	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e179813	10.1371/journal.pone.0179813	http://dx.doi.org/10.1371/journal.pone.0179813			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727758	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500010
J	Adane, M; Mengistie, B; Medhin, G; Kloos, H; Mulat, W				Adane, Metadel; Mengistie, Bezatu; Medhin, Girmay; Kloos, Helmut; Mulat, Worku			Piped water supply interruptions and acute diarrhea among under-five children in Addis Ababa slums, Ethiopia: A matched case-control study	PLOS ONE			English	Article							GLOBAL ENTERIC MULTICENTER; HOUSEHOLD DRINKING-WATER; DEVELOPING-COUNTRIES; MICROBIOLOGICAL CONTAMINATION; FECAL CONTAMINATION; REDUCE DIARRHEA; QUALITY; STORAGE; HOME; SANITATION	Background The problem of intermittent piped water supplies that exists in low-and middle-income countries is particularly severe in the slums of sub-Saharan Africa. However, little is known about whether there is deterioration of the microbiological quality of the intermittent piped water supply at a household level and whether it is a factor in reducing or increasing the occurrence of acute diarrhea among under-five children in slums of Addis Ababa. This study aimed to determine the association of intermittent piped water supplies and point-of-use (POU) contamination of household stored water by Escherichia coli (E. coli) with acute diarrhea among under-five children in slums of Addis Ababa. Methods A community-based matched case-control study was conducted from November to December, 2014. Cases were defined as under-five children with acute diarrhea during the two weeks before the survey. Controls were matched by age and neighborhood with cases by individual matching. Data were collected using a pre-tested structured questionnaire and E. coli analysis of water from piped water supplies and household stored water. A five-tube method of Most Probable Number (MPN)/100 ml standard procedure was used for E. coli analysis. Multivariable conditional logistic regression with 95% confidence interval (CI) was used for data analysis by controlling potential confounding effects of selected socio-demographic characteristics. Main findings During the two weeks before the survey, 87.9% of case households and 51.0% of control households had an intermittent piped water supply for an average of 4.3 days and 3.9 days, respectively. POU contamination of household stored water by E. coli was found in 83.3% of the case households, and 52.1% of the control households. In a fully adjusted model, a periodically intermittent piped water supply (adjusted matched odds ratio (adjusted mOR) = 4.8; 95% CI: 1.3-17.8), POU water contamination in household stored water by E. coli (adjusted mOR = 3.3; 95% CI: 1.1-10.1), water retrieved from water storage containers using handleless vessels (adjusted mOR = 16.3; 95% CI: 4.4-60.1), and water retrieved by interchangeably using vessels both with and without handle (adjusted mOR = 5.4; 95% CI: 1.1-29.1) were independently associated with acute diarrhea. Conclusion We conclude that provision of continuously available piped water supplies and education of caregivers about proper water retrieval methods of household stored water can effectively reduce POU contamination of water at the household level and thereby reduce acute diarrhea among under-five children in slums of Addis Ababa. Promotion of household water treatment is also highly encouraged until the City's water authority is able to deliver continuously available piped water supplies.	[Adane, Metadel] Addis Ababa Univ, EIWR, Addis Ababa, Ethiopia; [Mengistie, Bezatu] Haramaya Univ, Coll Hlth & Med Sci, Haramaya, Ethiopia; [Medhin, Girmay] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Kloos, Helmut] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Mulat, Worku] Univ Connecticut, Dept Civil & Environm Engn, Storrs, CT USA	Addis Ababa University; Haramaya University; Addis Ababa University; University of California System; University of California San Francisco; University of Connecticut	Adane, M (corresponding author), Addis Ababa Univ, EIWR, Addis Ababa, Ethiopia.	metadel.adane2@gmail.com	Adane, Metadel/AFQ-9478-2022	Adane, Metadel/0000-0002-7039-4768; Medhin, Girmay/0000-0003-2146-4261	Ethiopian Institute of Water Resources of Addis Ababa University; Wollo University; Addis Ababa Water and Sewerage Authority	Ethiopian Institute of Water Resources of Addis Ababa University; Wollo University; Addis Ababa Water and Sewerage Authority	Ethiopian Institute of Water Resources of Addis Ababa University and Wollo University funded this research project. Addis Ababa Water and Sewerage Authority also supported the research by making available free of charge all the necessary reagents and chemicals for bacteriological analysis of water. The funders had no role in study design, data collection and analysis, decision to publish, interpretation of the data or preparation of the manuscript for publication.; We would like to thank the Addis Ababa Water and Sewerage Authority for their support by allowing us the use of their bacteriological laboratory for two months. We are also very grateful to the caregivers of the studied children for their dedication and commitment to providing information. We also strongly acknowledge the support of Shirley Lewis, Linda A. Willis and Adrienne Cruise for our project. Lisa Penttila and Linda M. Weller are highly acknowledged for the language editing of the manuscript.	Adane M, 2017, J HEALTH POPUL NUTR, V36, P1, DOI 10.1186/s41043-017-0085-1; Alam MJ, 2007, BRAC U J, V4, P103; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Bain RES, 2012, B WORLD HEALTH ORGAN, V90, P228, DOI 10.2471/BLT.11.094284; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Baker KK, 2013, AM J TROP MED HYG, V89, P214, DOI 10.4269/ajtmh.12-0256; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Baum R, 2014, AM J TROP MED HYG, V90, P121, DOI 10.4269/ajtmh.13-0380; Breurec S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004283; Brick T, 2004, INT J HYG ENVIR HEAL, V207, P473, DOI 10.1078/1438-4639-00318; Brocklehurst C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001894; City Government of Addis Ababa Addis Ababa Water and Sewerage Authority (AAWSA), 2011, BUS PLAN 2011 2020 F; Clasen TF, 2006, INT J ENVIRON HEAL R, V16, P231, DOI 10.1080/09603120600641474; Clasen T, 2007, BMJ-BRIT MED J, V334, P782, DOI 10.1136/bmj.39118.489931.BE; Copeland CC, 2009, J WATER HEALTH, V7, P324, DOI 10.2166/wh.2009.081; Council for International Organizations of Medical Sciences, 2002, Bull Med Ethics, P17; Ercumen A, 2017, TROP MED INT HEALTH, V22, P2, DOI 10.1111/tmi.12803; Ercumen A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001892; Ercumen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121907; Erickson JJ, 2017, WATER RES, V114, P338, DOI 10.1016/j.watres.2017.02.009; Fadel ME, 2014, ENVIRON MONIT ASSESS, V186, P665, DOI DOI 10.1007/S10661-013-3406-X; Farthing M, 2012, ACUTE DIARRHEA ADULT, P1; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Gruber JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107429; HACH, 2003, WAT WAST QUAL PROC; Herbst S, 2008, INT J ENVIRON HEAL R, V18, P305, DOI 10.1080/09603120701834507; Jalan J, 2003, J ECONOMETRICS, V112, P153, DOI 10.1016/S0304-4076(02)00158-6; Jeandron A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001893; Johnson K.M., 2010, ECOL ENVIRON CONSERV, V16, P277; Kirkwood BR, 2003, ESSENTIAL MED STAT; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kumpel E, 2016, ENVIRON SCI TECHNOL, V50, P542, DOI 10.1021/acs.est.5b03973; Luby SP, 2004, AM J TROP MED HYG, V71, P420, DOI 10.4269/ajtmh.2004.71.420; Luby SP, 2015, AM J TROP MED HYG, V93, P904, DOI 10.4269/ajtmh.15-0274; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; McNamee R, 2003, OCCUP ENVIRON MED, V60, P227, DOI 10.1136/oem.60.3.227; MIETTINEN OS, 1969, BIOMETRICS, V25, P339, DOI 10.2307/2528794; MINTZ ED, 1995, JAMA-J AM MED ASSOC, V273, P948, DOI 10.1001/jama.273.12.948; MoH, 2011, NAT DRINK WAT QUAL M; Oswald WE, 2007, AM J TROP MED HYG, V77, P699, DOI 10.4269/ajtmh.2007.77.699; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P2391, DOI 10.1021/es203177v; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P144; Subbaraman R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-173; Tadesse D, 2010, RAPID ASSESSMENT DRI; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Trevett AF, 2004, INT J ENVIRON HEAL R, V14, P273, DOI 10.1080/09603120410001725612; Trevett Andrew Francis, 2005, Journal of Water and Health, V3, P259; Tumwine JK, 2002, TROP MED INT HEALTH, V7, P750, DOI 10.1046/j.1365-3156.2002.00927.x; UN-HABITAT, 2010, ETH CAS COND HOUS IN; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; Vedachalam S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176272; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wang X, 2010, AM J TROP MED HYG, V83, P582, DOI 10.4269/ajtmh.2010.10-0215; WHO, 2011, GUID DRINK WAT QUAL; WHO UNICEF, 2015, PR3GR SAN DR2N5 WAT; WHO/UNICEF, 2014, PROGR DRINK WAT SAN; WHO(WorldHealthOrganization), 1997, GUID DRINK WAT QUAL; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; World Health Organization, 2000, GLOB WAT SUPPL SAN A; World Health Organization, 2005, TREATM DIARRH MAN PH; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	62	47	47	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181516	10.1371/journal.pone.0181516	http://dx.doi.org/10.1371/journal.pone.0181516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723927	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800056
J	Falk, BG; Snow, RW; Reed, RN				Falk, Bryan G.; Snow, Ray W.; Reed, Robert N.			A validation of 11 body-condition indices in a giant snake species that exhibits positive allometry	PLOS ONE			English	Article							ESTIMATING FITNESS; SIZE; MASS; REPRODUCTION; RESIDUALS; NORMALITY; VARIABLES; PYTHONS; ENERGY; ERRORS	Body condition is a gauge of the energy stores of an animal, and though it has important implications for fitness, survival, competition, and disease, it is difficult to measure directly. Instead, body condition is frequently estimated as a body condition index (BCI) using length and mass measurements. A desirable BCI should accurately reflect true body condition and be unbiased with respect to size (i.e., mean BCI estimates should not change across different length or mass ranges), and choosing the most-appropriate BCI is not straightforward. We evaluated 11 different BCIs in 248 Burmese pythons (Python bivittatus), organisms that, like other snakes, exhibit simple body plans well characterized by length and mass. We found that the length-mass relationship in Burmese pythons is positively allometric, where mass increases rapidly with respect to length, and this allowed us to explore the effects of allometry on BCI verification. We employed three alternative measures of 'true' body condition: percent fat, scaled fat, and residual fat. The latter two measures mostly accommodated allometry in true body condition, but percent fat did not. Our inferences of the best-performing BCIs depended heavily on our measure of true body condition, with most BCIs falling into one of two groups. The first group contained most BCIs based on ratios, and these were associated with percent fat and body length (i.e., were biased). The second group contained the scaled mass index and most of the BCIs based on linear regressions, and these were associated with both scaled and residual fat but not body length (i.e., were unbiased). Our results show that potential differences in measures of true body condition should be explored in BCI verification studies, particularly in organisms undergoing allometric growth. Furthermore, the caveats of each BCI and similarities to other BCIs are important to consider when determining which BCI is appropriate for any particular taxon.	[Falk, Bryan G.; Reed, Robert N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Snow, Ray W.] Natl Pk Serv, Everglades Natl Pk, Homestead, FL USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior	Falk, BG (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA.	bfalk@usgs.gov			Everglades National Park; USGS Greater Everglades Priority Ecosystem Science Program; USGS Invasive Species Science Program	Everglades National Park; USGS Greater Everglades Priority Ecosystem Science Program; USGS Invasive Species Science Program	Research for this project was funded by Everglades National Park, the USGS Greater Everglades Priority Ecosystem Science Program (http://access.usgs.gov/about.html), and the USGS Invasive Species Science Program (https://www2.usgs.goviecosystems/invasive_species/). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet X., 1995, P237; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; Brown GP, 2005, CAN J ZOOL, V83, P1134, DOI 10.1139/Z05-115; Burton NHK, 2006, J APPL ECOL, V43, P464, DOI 10.1111/j.1365-2664.2006.01156.x; CALE W G JR, 1972, Herpetologica, V28, P51; Chang W., 2014, EXTRAFONT TOOLS USIN; Cox RM, 2015, FUNCT ECOL, V29, P404, DOI 10.1111/1365-2435.12346; DAGOSTIN.RB, 1970, BIOMETRIKA, V57, P679, DOI 10.1093/biomet/57.3.679; Dawson RD, 2000, AUK, V117, P373, DOI 10.1642/0004-8038(2000)117[0373:EOHPOC]2.0.CO;2; Falk BG, 2015, PEERJ, V3, DOI 10.7717/peerj.1445; Feldman A, 2013, BIOL J LINN SOC, V108, P161, DOI 10.1111/j.1095-8312.2012.02001.x; Fox J., 2018, R COMPANION APPL REG, VThird; GARROW JS, 1985, INT J OBESITY, V9, P147; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Guinet C, 1998, CAN J ZOOL, V76, P1418, DOI 10.1139/cjz-76-8-1418; Hayes Jack P., 2001, P8, DOI 10.1017/CBO9780511551741.003; Jacobson Elliott R., 2007, P571; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; JELLIFFE DB, 1979, AM J CLIN NUTR, V32, P2519, DOI 10.1093/ajcn/32.12.2519; Kelly CD, 2014, ECOL EVOL, V4, P4476, DOI 10.1002/ece3.1257; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Komsta L., 2015, MOMENTS MOMENTS CUMU; Kotiaho JS, 1999, OIKOS, V87, P399, DOI 10.2307/3546755; Labocha MK, 2014, OIKOS, V123, P111, DOI 10.1111/j.1600-0706.2013.00755.x; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; Legendre P., 2014, LMODEL2 MODEL 2 REGR; Lleonart J, 2000, J THEOR BIOL, V205, P85, DOI 10.1006/jtbi.2000.2043; Madsen T, 2000, AUSTRAL ECOL, V25, P670, DOI 10.1046/j.1442-9993.2000.01067.x; Madsen T, 1996, HERPETOLOGICA, V52, P146; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Moller AP, 1998, OIKOS, V83, P301, DOI 10.2307/3546841; Nash RDM, 2006, FISHERIES, V31, P236; Naulleau G, 1996, OECOLOGIA, V107, P301, DOI 10.1007/BF00328446; Neff BD, 2004, ENVIRON BIOL FISH, V71, P297, DOI 10.1007/s10641-004-1263-8; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; PLUMMER MV, 1983, COPEIA, P741, DOI 10.2307/1444340; R Core Team, 2021, R LANGUAGE ENV STAT; RAMSEY JB, 1969, J ROY STAT SOC B, V31, P350; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; Reichert MS, 2011, ANIM BEHAV, V82, P1357, DOI 10.1016/j.anbehav.2011.09.019; REIST JD, 1985, CAN J ZOOL, V63, P1429, DOI 10.1139/z85-213; Reynolds D. Scott, 2001, P39, DOI 10.1017/CBO9780511551741.004; RICKER W E, 1975, P382; Schamber JL, 2009, J AVIAN BIOL, V40, P49, DOI 10.1111/j.1600-048X.2008.04462.x; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Secor SM, 2008, J EXP BIOL, V211, P3767, DOI 10.1242/jeb.023754; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Steen DA, 2013, J ZOOL, V289, P86, DOI 10.1111/j.1469-7998.2012.00965.x; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Sutton SG, 2000, T AM FISH SOC, V129, P527, DOI 10.1577/1548-8659(2000)129&lt;0527:RAFWBW&gt;2.0.CO;2; TEIXEIRA A, 1989, ANIM PROD, V49, P275, DOI 10.1017/S0003356100032402; VANMIEROP LHS, 1978, COPEIA, P615; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Weatherhead PJ, 1996, CAN J ZOOL, V74, P1617, DOI 10.1139/z96-179; Wei T., 2011, CORRPLOT VISUALIZATI; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilder SM, 2016, FUNCT ECOL, V30, P108, DOI 10.1111/1365-2435.12460; Wilke CO, 2016, COWPLOT STREAMLINED; Wuertz D, 2014, FBASICS RMETRICS D M; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/	64	19	21	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180791	10.1371/journal.pone.0180791	http://dx.doi.org/10.1371/journal.pone.0180791			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723960	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800026
J	Tarcha, EJ; Olsen, CM; Probst, P; Peckham, D; Munoz-Elias, EJ; Kruger, JG; Iadonato, SP				Tarcha, Eric J.; Olsen, Chelsea M.; Probst, Peter; Peckham, David; Munoz-Elias, Ernesto J.; Kruger, James G.; Iadonato, Shawn P.			Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial	PLOS ONE			English	Article							MEMORY T-CELLS; AUTOIMMUNE-DISEASES; POTASSIUM CHANNELS; UNITED-STATES; K+ CHANNEL; LYMPHOCYTES; 4-AMINOPYRIDINE; EXPRESSION; THERAPY; NEURONS	Background Dalazatide is a specific inhibitor of the Kv1.3 potassium channel. The expression and function of Kv1.3 channels are required for the function of chronically activated memory T cells, which have been shown to be key mediators of autoimmune diseases, including psoriasis. Objective The primary objective was to evaluate the safety of repeat doses of dalazatide in adult patients with mild-to-moderate plaque psoriasis. Secondary objectives were to evaluate clinical proof of concept and the effects of dalazatide on mediators of inflammation in the blood and on chronically activated memory T cell populations. Methods Patients (n = 24) were randomized 5:5:2 to receive dalazatide at 30 mcg/dose, 60 mcg/dose, or placebo twice weekly by subcutaneous injection (9 doses total). Safety was assessed on the basis of physical and neurological examination and laboratory testing. Clinical assessments included body-surface area affected, Psoriasis Area and Severity Index (PASI), and investigator and patient questionnaires. Results The most common adverse events were temporary mild (Grade 1) hypoesthesia (n = 20; 75% placebo, 85% dalazatide) and paresthesia (n = 15; 25% placebo, 70% dalazatide) involving the hands, feet, or perioral area. Nine of 10 patients in the 60 mcg/dose group had a reduction in their PASI score between baseline and Day 32, and the mean reduction in PASI score was significant in this group (P < 0.01). Dalazatide treatment reduced the plasma levels of multiple inflammation markers and reduced the expression of T cell activation markers on peripheral blood memory T cells. Limitations The study was small and drug treatment was for a short duration (4 weeks). Conclusion This study indicates that dalazatide is generally well tolerated and can improve psoriatic skin lesions by modulating T cell surface and activation marker expression and inhibiting mediators of inflammation in the blood. Larger studies of longer duration are warranted.	[Tarcha, Eric J.; Olsen, Chelsea M.; Probst, Peter; Peckham, David; Munoz-Elias, Ernesto J.; Iadonato, Shawn P.] Kineta Inc, Seattle, WA 98109 USA; [Kruger, James G.] Rockefeller Univ, Lab Investigative Dermatol, 1230 York Ave, New York, NY 10021 USA; [Olsen, Chelsea M.] KPI Therapeutics Inc, Seattle, WA USA; [Munoz-Elias, Ernesto J.] Johnson & Johnson, Dept Immunodermatol Janssen Res & Dev, San Diego, CA USA	Rockefeller University; Johnson & Johnson; Johnson & Johnson USA	Olsen, CM (corresponding author), Kineta Inc, Seattle, WA 98109 USA.; Olsen, CM (corresponding author), KPI Therapeutics Inc, Seattle, WA USA.	colsen@kpitherapeutics.com			Kv1.3 Therapeutics LLC, Seattle WA; Kineta Inc	Kv1.3 Therapeutics LLC, Seattle WA; Kineta Inc	The study was funded by Kv1.3 Therapeutics LLC (formerly Kineta One LLC), Seattle WA. Co-authors Eric J. Tarcha (EJT), Chelsea M. Olsen (CMO), Peter Probst (PP), David Peckham (DP), Ernesto J. Munoz -Elias (EJM), and Shawn P. ladonato (SPI) were employed by Kineta Inc during the course of the study. Kineta Inc provided support in the form of salaries for authors EJT, CMO, PP, DP, EJM, and SPI and was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Almutawa F, 2013, AM J CLIN DERMATOL, V14, P87, DOI 10.1007/s40257-013-0015-y; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Armstrong AW, 2013, JAMA DERMATOL, V149, P1180, DOI 10.1001/jamadermatol.2013.5264; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; BERGER SG, 1989, NEUROPHARMACOLOGY, V28, P191, DOI 10.1016/0028-3908(89)90056-7; Busard C, 2014, JAMA DERMATOL, V150, P1213, DOI 10.1001/jamadermatol.2014.1111; Campa M, 2016, DERMATOLOGY THER, V6, P1, DOI 10.1007/s13555-015-0092-3; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Chaarani J, 2010, EXPERT OPIN DRUG MET, V6, P355, DOI 10.1517/17425251003641967; Chandy KG, 2017, CURR OPIN CHEM BIOL, V38, P97, DOI 10.1016/j.cbpa.2017.02.015; Chandy KG., 2006, VOLTAGE GATED ION CH, P214, DOI DOI 10.1002/3527608141.CH7B; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Chiang EY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14644; Clark RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010641; Devarajan P, 2013, IMMUNOL RES, V57, P12, DOI 10.1007/s12026-013-8448-1; Dunn L K, 2010, Skin Therapy Lett, V15, P1; Ehling P, 2015, PFLUG ARCH EUR J PHY, V467, P959, DOI 10.1007/s00424-014-1664-2; Elias EJ, 2012, J PHARMACOL EXP THER, V342, P642; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Ferran M, 2013, EXP DERMATOL, V22, P439, DOI 10.1111/exd.12154; Gocke AR, 2012, J IMMUNOL, V188, P5877, DOI 10.4049/jimmunol.1103095; Haut SR, 2012, EXPERT OPIN DRUG SAF, V11, P651, DOI 10.1517/14740338.2012.697896; Hsiao CF, 2009, J NEUROPHYSIOL, V101, P1407, DOI 10.1152/jn.91053.2008; Hu L, 2007, J IMMUNOL, V179, P4563, DOI 10.4049/jimmunol.179.7.4563; Jensen HB, 2014, THER ADV NEUROL DISO, V7, P97, DOI 10.1177/1756285613512712; Kopp T, 2015, NATURE, V521, P222, DOI 10.1038/nature14175; Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Mason AR, 2013, COCHRANE DB SYST REV, V3; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Menter A, 2009, J AM ACAD DERMATOL, V61, P451, DOI 10.1016/j.jaad.2009.03.027; Miyadera H, 2015, J HUM GENET, V60, P697, DOI 10.1038/jhg.2015.100; Monteleone G, 2011, CLIN SCI, V120, P1, DOI 10.1042/CS20100163; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Rachakonda TD, 2014, J AM ACAD DERMATOL, V70, P512, DOI 10.1016/j.jaad.2013.11.013; SCHULZ BS, 1993, J IMMUNOL, V151, P4399; Semble AL, 2014, AM J CLIN DERMATOL, V15, P37, DOI 10.1007/s40257-013-0053-5; Spuls PI, 2010, J INVEST DERMATOL, V130, P933, DOI 10.1038/jid.2009.391; Witt KA, 2001, PEPTIDES, V22, P2329, DOI 10.1016/S0196-9781(01)00537-X; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zhao YP, 2015, TOXINS, V7, P1749, DOI 10.3390/toxins7051749	45	77	78	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180762	10.1371/journal.pone.0180762	http://dx.doi.org/10.1371/journal.pone.0180762			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723914	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800024
J	Xi, L; Belyaev, A; Spurgeon, S; Wang, XH; Gong, HB; Aboukhalil, R; Fekete, R				Xi, Larry; Belyaev, Alexander; Spurgeon, Sandra; Wang, Xiaohui; Gong, Haibiao; Aboukhalil, Robert; Fekete, Richard			New library construction method for single-cell genomes	PLOS ONE			English	Article							COPY-NUMBER VARIATIONS; CANCER; AMPLIFICATION; EVOLUTION; PCR	A central challenge in sequencing single-cell genomes is the accurate determination of point mutations, phasing of these mutations, and identifying copy number variations with few assumptions. Ideally, this is accomplished under as low sequencing coverage as possible. Here we report our attempt to meet these goals with a novel library construction and library amplification methodology. In our approach, single-cell genomic DNA is first fragmented with saturated transposition to make a primary library that uniformly covers the whole genome by short fragments. The library is then amplified by a carefully optimized PCR protocol in a uniform and synchronized fashion for next-generation sequencing. Each step of the protocol can be quantitatively characterized. Our shallow sequencing data show that the library is tightly distributed and is useful for the determination of copy number variations.	[Xi, Larry; Belyaev, Alexander; Spurgeon, Sandra; Wang, Xiaohui; Gong, Haibiao; Aboukhalil, Robert; Fekete, Richard] Fluidigm Corp, San Francisco, CA 94080 USA; [Xi, Larry] Digenomix Corp, San Francisco, CA USA		Xi, L (corresponding author), Fluidigm Corp, San Francisco, CA 94080 USA.	lxi@digenomix.net			Fluidigm	Fluidigm	Fluidigm provided financial support in the form of authors' salaries and research materials for the authors, LX, AB, SS, XW, HG, RA, and RF. Fluidigm did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Arneson N, 2008, CSH PROTOC; Babayan A., 2016, ONCOTARGET; Baslan T, 2014, CURR OPIN GENET DEV, V26, P59, DOI 10.1016/j.gde.2014.06.004; Bronner I.F., 2014, CURR PROTOC HUM GENE, V80, P2, DOI DOI 10.1002/0471142905.HG1802S80; Chen CY, 2017, SCIENCE, V356, P189, DOI 10.1126/science.aak9787; Dai ZM, 2007, J BIOTECHNOL, V128, P435, DOI 10.1016/j.jbiotec.2006.10.018; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Garvin T, 2015, NAT METHODS, V12, P1058, DOI [10.1038/NMETH.3578, 10.1038/nmeth.3578]; Green B, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-3; Gundry M, 2012, NUCLEIC ACIDS RES, V40, P2032, DOI 10.1093/nar/gkr949; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Linnarsson S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0960-x; Mamaeva SE, 1998, INT REV CYTOL, V178, P1; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; MUTTER GL, 1991, NUCLEIC ACIDS RES, V19, P4203, DOI 10.1093/nar/19.15.4203; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin NE, 2015, GENOME RES, V25, P1499, DOI 10.1101/gr.191098.115; Navin NE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8319; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rubin H, 2001, Dev Biol (Basel), V106, P61; Szulwach KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135007; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; Zahn H, 2017, NAT METHODS, V14, P167, DOI [10.1038/NMETH.4140, 10.1038/nmeth.4140]; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	34	14	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181163	10.1371/journal.pone.0181163	http://dx.doi.org/10.1371/journal.pone.0181163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723968	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800037
J	Li, CJ; Shi, X; Mohamad, OA; Gaol, J; Xu, XW; Xie, YJ				Li, Congjuan; Shi, Xiang; Mohamad, Osama Abdalla; Gaol, Jie; Xu, Xinwen; Xie, Yijun			Moderate irrigation intervals facilitate establishment of two desert shrubs in the Taklimakan Desert Highway Shelterbelt in China	PLOS ONE			English	Article							SALINE WATER; HALOXYLON-AMMODENDRON; CARBON ASSIMILATION; PRECIPITATION; CLIMATE; CLASSIFICATION; RESPONSES; STRATEGY; DROUGHT	Background Water influences various physiological and ecological processes of plants in different ecosystems, especially in desert ecosystems. The purpose of this study is to investigate the response of physiological and morphological acclimation of two shrubs Haloxylon ammo-dendron and Calligonum mongolicunl to variations in irrigation intervals. Methodology/Principal findings The irrigation frequency was set as 1-, 2-, 4-, 8- and 12-week intervals respectively from March to October during 2012-2014 to investigate the response of physiological and morphological acclimation of two desert shrubs Haloxylon ammo-dendron and Calligonum mongolicunl to variations in the irrigation system. The irrigation interval significantly affected the individual-scale carbon acquisition and biomass allocation pattern of both species. Under good water conditions (1- and 2-week intervals), carbon assimilation was significantly higher than other treatments; while, under water shortage conditions (8- and 12-week intervals), there was much defoliation; and under moderate irrigation intervals (4 weeks), the assimilative organs grew gently with almost no defoliation occurring. Conclusion/Significance Both studied species maintained similar ecophysiologically adaptive strategies, while C. mongolicunl was more sensitive to drought stress because of its shallow root system and preferential belowground allocation of resources. A moderate irrigation interval of 4 weeks was a suitable pattern for both plants since it not only saved water but also met the water demands of the plants.	[Li, Congjuan; Gaol, Jie; Xu, Xinwen] Chinese Acad Sci, Dept Natl Engn Technol Res Ctr Desert Oasis Ecol, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China; [Shi, Xiang] Shihezi Univ, Dept Agr Coll, Shihezi, Xinjiang, Peoples R China; [Mohamad, Osama Abdalla] Chinese Acad Sci, Dept Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China; [Xie, Yijun] Urumqi Forestry Bur, Dept Midong Municipal Bur Pk, Urumqi, Xinjiang, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Shihezi University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Shi, X (corresponding author), Shihezi Univ, Dept Agr Coll, Shihezi, Xinjiang, Peoples R China.	2000wwww@163.com	Li, Congjuan/ABH-8523-2020; Abdalla Abdelshafy Mohamad, Osama/GGS-3886-2022	Abdalla Abdelshafy Mohamad, Osama/0000-0002-2234-8273	Youth Innovation Promotion Association of CAS [2017476]; Xinjiang Youth Science and Technology Innovation Leader Project [QN2016BS0162]; National Natural Science Foundation of China [31300449, 31660061, 31200417, 41301038]; Western Light Project of CAS [XBBS201205]; Urumqi Science and Technology Support [G151310005]	Youth Innovation Promotion Association of CAS; Xinjiang Youth Science and Technology Innovation Leader Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Western Light Project of CAS; Urumqi Science and Technology Support	This study was supported by grants from the Youth Innovation Promotion Association of CAS (2017476), Xinjiang Youth Science and Technology Innovation Leader Project (QN2016BS0162), the National Natural Science Foundation of China (31300449, 31660061, 31200417, 41301038), the Western Light Project of CAS (XBBS201205), and Urumqi Science and Technology Support (G151310005).	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; [李向义 Li Xiangyi], 2004, [生态学报, Acta Ecologica Sinica], V24, P1164; Beltran JM, 1999, AGR WATER MANAGE, V40, P183, DOI 10.1016/S0378-3774(98)00120-6; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; COHEN Y, 1983, J EXP BOT, V34, P451, DOI 10.1093/jxb/34.4.451; Dai Y, 2015, PLANT SOIL, V389, P73, DOI 10.1007/s11104-014-2342-z; Dai Yue, 2014, Chinese Journal of Plant Ecology, V38, P1214, DOI 10.3724/SP.J.1258.2014.00117; Day P. R., 1965, METHODS SOIL ANAL 2, V9, P548; DONOVAN LA, 1994, FUNCT ECOL, V8, P289, DOI 10.2307/2389821; Feikema PM, 2010, PLANT SOIL, V332, P429, DOI 10.1007/s11104-010-0309-2; GIBSON AC, 1996, STRUCTURE FUNCTION R, P45; Griffith C, 2004, AM J BOT, V91, P837, DOI 10.3732/ajb.91.6.837; Horton JL, 2001, TREE PHYSIOL, V21, P233, DOI 10.1093/treephys/21.4.233; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Lei JQ, 2008, CHINESE SCI BULL, V53, P1, DOI 10.1007/s11434-008-6023-2; Li BW, 2008, CHINESE SCI BULL, V53, P31, DOI 10.1007/s11434-008-6003-6; Li C.J., 2012, 2 INT C REM SENS ENV, P2522, DOI [10.1109/rsete.2012.6260734, DOI 10.1109/RSETE.2012.6260734]; Li CJ, 2015, SOIL TILL RES, V146, P99, DOI 10.1016/j.still.2014.03.013; Li CJ, 2011, ECOL RES, V26, P385, DOI 10.1007/s11284-010-0793-0; Li XY, 2002, ACTA PHYTOECOLOGIC S, V27, P516; Li Y, 2005, PLANT CELL ENVIRON, V28, P492, DOI 10.1111/j.1365-3040.2005.01291.x; Lombardini L, 2006, DRYLAND ECOHYDROLOGY, P47, DOI 10.1007/1-4020-4260-4_4; Pyankov VI, 1999, PLANT CELL PHYSIOL, V40, P125, DOI 10.1093/oxfordjournals.pcp.a029519; Reynolds JF, 1999, ECOL MONOGR, V69, P69, DOI 10.1890/0012-9615(1999)069[0069:IODODS]2.0.CO;2; Schwinning S, 2001, J ECOL, V89, P464, DOI 10.1046/j.1365-2745.2001.00576.x; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; SMITH SD, 1997, PHYSL ECOLOGY N AM D, P27; Su PeiXi, 2005, Acta Phytoecologica Sinica, V29, P1; [苏培垒 SU PeiXi], 2006, [生态学报, Acta Ecologica Sinica], V26, P75; Su PX, 2004, SCI CHINA SER D, V47, P39, DOI 10.1360/04zd0005; Tedeschi A, 2005, AGR WATER MANAGE, V77, P308, DOI 10.1016/j.agwat.2004.09.036; Verma AK, 2012, AGR WATER MANAGE, V115, P186, DOI 10.1016/j.agwat.2012.09.005; Wang HF, 2008, CHINESE SCI BULL, V53, P41, DOI 10.1007/s11434-008-6004-5; Wang RS, 2011, AGR WATER MANAGE, V100, P58, DOI 10.1016/j.agwat.2011.08.005; Weltzin JF, 2000, ECOLOGY, V81, P1902, DOI 10.1890/0012-9658(2000)081[1902:IOPRFS]2.0.CO;2; Xu GQ, 2008, FUNCT PLANT BIOL, V35, P1234, DOI 10.1071/FP08175; Xu GQ, 2016, J PLANT PHYSIOL, V194, P35, DOI 10.1016/j.jplph.2016.02.014; Xu GQ, 2014, J ARID LAND, V6, P581, DOI 10.1007/s40333-014-0029-1; Xu H, 2007, PLANT CELL ENVIRON, V30, P399, DOI 10.1111/j.1365-3040.2006.001626.x; Xu H, 2006, PLANT SOIL, V285, P5, DOI 10.1007/s11104-005-5108-9; Xu Hao, 2010, Chinese Journal of Plant Ecology, V34, P375, DOI 10.3773/j.issn.1005-264x.2010.04.003; Yang Xiao-Lin, 2008, Zhiwu Shengtai Xuebao, V32, P1268, DOI 10.3773/j.issn.1005-264x.2008.06.007; [杨小林 Yang Xiaolin], 2015, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V29, P145; Zhang JG, 2008, CHINESE SCI BULL, V53, P63, DOI 10.1007/s11434-008-6006-3; Zou T, 2010, ECOL RES, V25, P185, DOI 10.1007/s11284-009-0642-1	45	10	11	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180875	10.1371/journal.pone.0180875	http://dx.doi.org/10.1371/journal.pone.0180875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719623	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400022
J	Martincic-Ipsic, S; Mocibob, E; Perc, M				Martincic-Ipsic, Sanda; Mocibob, Edvin; Perc, Matjaz			Link prediction on Twitter	PLOS ONE			English	Article							NETWORKS; BEHAVIOR; LANGUAGE	With over 300 million active users, Twitter is among the largest online news and social networking services in existence today. Open access to information on Twitter makes it a valuable source of data for research on social interactions, sentiment analysis, content diffusion, link prediction, and the dynamics behind human collective behaviour in general. Here we use Twitter data to construct co-occurrence language networks based on hashtags and based on all the words in tweets, and we use these networks to study link prediction by means of different methods and evaluation metrics. In addition to using five known methods, we propose two effective weighted similarity measures, and we compare the obtained outcomes in dependence on the selected semantic context of topics on Twitter. We find that hashtag networks yield to a large degree equal results as all-word networks, thus supporting the claim that hashtags alone robustly capture the semantic context of tweets, and as such are useful and suitable for studying the content and categorization. We also introduce ranking diagrams as an efficient tool for the comparison of the performance of different link prediction algorithms across multiple datasets. Our research indicates that successful link prediction algorithms work well in correctly foretelling highly probable links even if the information about a network structure is incomplete, and they do so even if the semantic context is rationalized to hashtags.	[Martincic-Ipsic, Sanda; Mocibob, Edvin] Univ Rijeka, Dept Informat, Rijeka, Croatia; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, Maribor, Slovenia; [Perc, Matjaz] Univ Maribor, Ctr Appl Math & Theoret Phys, Maribor, Slovenia	University of Rijeka; University of Maribor; University of Maribor	Perc, M (corresponding author), Univ Maribor, Fac Nat Sci & Math, Maribor, Slovenia.; Perc, M (corresponding author), Univ Maribor, Ctr Appl Math & Theoret Phys, Maribor, Slovenia.	matjaz.perc@uni-mb.si	Perc, Matjaz/A-5148-2009; Martincic, Sanda/N-7971-2018	Perc, Matjaz/0000-0002-3087-541X; Martincic, Sanda/0000-0002-1900-5333	University of Rijeka under the LangNet project [13.13.2.2.07]; Javna Agencija za Raziskovalno Dejavnost RS [J1-7009, P5-0027]	University of Rijeka under the LangNet project; Javna Agencija za Raziskovalno Dejavnost RS(Slovenian Research Agency - Slovenia)	This work was supported by the University of Rijeka under the LangNet project (Grant number 13.13.2.2.07), and by Javna Agencija za Raziskovalno Dejavnost RS (Grant numbers J1-7009 and P5-0027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Al Hasan M, 2011, SOCIAL NETWORK DATA ANALYTICS, P243; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; Aparicio S, 2015, ENTROPY-SWITZ, V17, P5848, DOI 10.3390/e17085848; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Beliga S, 2016, INT J SEMANT WEB INF, V12, P1, DOI 10.4018/IJSWIS.2016070101; Beliga S, 2015, J INF ORGAN SCI, V39, P1; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134641; Bliss CA, 2014, J COMPUT SCI-NETH, V5, P750, DOI 10.1016/j.jocs.2014.01.003; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cha M., 2010, ICWSM, V10, P30, DOI DOI 10.1145/2897659.2897663; Chatterjee A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01049; Cong J, 2014, PHYS LIFE REV, V11, P598, DOI 10.1016/j.plrev.2014.04.004; Conover M. D., 2011, 5 INT AAAI C WEBL SO, DOI DOI 10.1021/JA202932E; Curiskis SA, 2015, AUSTR DAT MIN C, P39; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; de Sa HR, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P2281, DOI 10.1109/IJCNN.2011.6033513; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Go A., 2009, CS224N PROJECT REPOR, V1; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hagberg DA, P 7 PYTH SCI C PAS C, V2008, P11; He YL, 2015, EXPERT SYST APPL, V42, P21, DOI 10.1016/j.eswa.2014.07.018; Hong L., 2011, WWW, P57, DOI DOI 10.1145/1963192.1963222; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lehman HC, 1947, SOC FORCES, V25, P281, DOI 10.2307/3005665; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lu LY, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/18001; Margan Domagoj, 2014, COMPLEX NETWORKS, P275, DOI DOI 10.1007/978-3-319-05401-8_; Martincic-Ipsic S, 2016, COMM COM INF SC, V639, P536, DOI 10.1007/978-3-319-46254-7_43; Martincic-Ipsic S, 2016, PHYSICA A, V457, P117, DOI 10.1016/j.physa.2016.03.082; Martinez-Camara E, 2014, NAT LANG ENG, V20, P1, DOI 10.1017/S1351324912000332; Masucci AP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026102; Mathioudakis M., 2010, P 2010 ACM SIGMOD IN, P1155, DOI DOI 10.1145/1807167.1807306; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; miltrovic M, 2004, SCI REP, V4, P6174; Mitrovic M, 2010, EUR PHYS J B, V77, P597, DOI 10.1140/epjb/e2010-00279-x; Mitrovic M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/P02005; Murata T, 2001, P IEEE WIC ACM INT C, P85; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Perc M, 2017, PHYS REP, V687, P1, DOI 10.1016/j.physrep.2017.05.004; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Rowe M., 2012, P 11 INT C SEM WEB 1, P476, DOI DOI 10.1007/978-3-642-35176-1_30; Sharma Shikhar, 2016, Comput Soc Netw, V3, P7, DOI 10.1186/s40649-016-0034-y; Song SY, 2014, LECT NOTES ARTIF INT, V8862, P26, DOI 10.1007/978-3-319-13560-1_3; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; Valverde-Rebaza J, 2013, SOC NETW ANAL MIN, V3, P1063, DOI 10.1007/s13278-013-0142-8; Vicient C, 2015, EXPERT SYST APPL, V42, P6472, DOI 10.1016/j.eswa.2015.04.014; Wang Xiaolong, 2011, P 20 ACM INT C INF K, P1031, DOI [10.1145/2063576.2063726, DOI 10.1145/2063576.2063726]; Wang Z, 2016, PHYS REP, V664, P1, DOI 10.1016/j.physrep.2016.10.006; Yang Y, 2015, KNOWL INF SYST, V45, P751, DOI 10.1007/s10115-014-0789-0; Zhao J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12261; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	63	48	48	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181079	10.1371/journal.pone.0181079	http://dx.doi.org/10.1371/journal.pone.0181079			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719651	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400031
J	Xu, MJ; Kitaura, Y; Ishikawa, T; Kadota, Y; Terai, C; Shindo, D; Morioka, T; Ota, M; Morishita, Y; Ishihara, K; Shimomura, Y				Xu, Minjun; Kitaura, Yasuyuki; Ishikawa, Takuya; Kadota, Yoshihiro; Terai, Chihaya; Shindo, Daichi; Morioka, Takashi; Ota, Miki; Morishita, Yukako; Ishihara, Kengo; Shimomura, Yoshiharu			Endurance performance and energy metabolism during exercise in mice with a muscle-specific defect in the control of branched-chain amino acid catabolism	PLOS ONE			English	Article							KETOACID DEHYDROGENASE KINASE; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; SWIMMING POOL; ACTIVATION; COMPLEX; PROTEIN; SUPPLEMENTATION; EXPRESSION; CAPACITY	It is known that the catabolism of branched-chain amino acids (BCAAs) in skeletal muscle is suppressed under normal and sedentary conditions but is promoted by exercise. BCAA catabolism in muscle tissues is regulated by the branched-chain a-keto acid (BCKA) dehydrogenase complex, which is inactivated by phosphorylation by BCKA dehydrogenase kinase (BDK). In the present study, we used muscle-specific BDK deficient mice (BDK-mKO mice) to examine the effect of uncontrolled BCAA catabolism on endurance exercise performance and skeletal muscle energy metabolism. Untrained control and BDK-mKO mice showed the same performance; however, the endurance performance enhanced by 2 weeks of running training was somewhat, but significantly less in BDK-mKO mice than in control mice. Skeletal muscle of BDK-mKO mice had low levels of glycogen. Metabolome analysis showed that BCAA catabolism was greatly enhanced in the muscle of BDK-mKO mice and produced branched-chain acyl-carnitine, which induced perturbation of energy metabolism in the muscle. These results suggest that the tight regulation of BCAA catabolism in muscles is important for homeostasis of muscle energy metabolism and, at least in part, for adaptation to exercise training.	[Xu, Minjun; Kitaura, Yasuyuki; Ishikawa, Takuya; Kadota, Yoshihiro; Terai, Chihaya; Shindo, Daichi; Morioka, Takashi; Ota, Miki; Morishita, Yukako; Shimomura, Yoshiharu] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Ishihara, Kengo] Ryukoku Univ, Fac Agr, Fushimi Ku, Kyoto, Japan	Nagoya University; Ryukoku University	Shimomura, Y (corresponding author), Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan.	shimo@agr.nagoya-u.ac.jp	Ishihara, Kengo/J-7913-2019	Ishihara, Kengo/0000-0001-9374-5033	JSPS KAKENHI [26292068, 17H03817, 25504005, 22650152]; Uehara Memorial Foundation; Food Science Institute Foundation; Grants-in-Aid for Scientific Research [17H03817] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Food Science Institute Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (No. 26292068 and 17H03817 from Grant-in-Aid for Scientific Research (B) (to YS), No. 25504005 from Grant-in-Aid for Scientific Research (C) (to YKitaura), No. 22650152 from Grant-in-Aid for Challenging Exploratory Research (to YS)), The Uehara Memorial Foundation (to YKitaura), and The Food Science Institute Foundation (YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antweiler RC, 2008, ENVIRON SCI TECHNOL, V42, P3732, DOI 10.1021/es071301c; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Ishihara K, 2009, J NUTR SCI VITAMINOL, V55, P301, DOI 10.3177/jnsv.55.301; Ishikawa T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39825; Joshi M, 2007, BIOCHEM BIOPH RES CO, V356, P38, DOI 10.1016/j.bbrc.2007.02.108; Kephart WC, 2016, AMINO ACIDS, V48, P779, DOI 10.1007/s00726-015-2125-8; Kobayashi R, 1999, J NUTR SCI VITAMINOL, V45, P303, DOI 10.3177/jnsv.45.303; Kobayashi R, 2002, ARCH BIOCHEM BIOPHYS, V407, P231, DOI 10.1016/S0003-9861(02)00472-1; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; POPOV KM, 1992, J BIOL CHEM, V267, P13127; Schadewaldt P, 2000, METHOD ENZYMOL, V324, P23; SHIMOMURA Y, 1995, J NUTR, V125, pS1762; SHIMOMURA Y, 1990, J APPL PHYSIOL, V68, P161, DOI 10.1152/jappl.1990.68.1.161; Shimomura Y, 2006, J NUTR, V136, p250S, DOI 10.1093/jn/136.1.250S; SHIMOMURA Y, 1990, ARCH BIOCHEM BIOPHYS, V283, P293, DOI 10.1016/0003-9861(90)90645-F; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Uchida MC, 2008, REV BRAS MED ESPORTE, V14, P42, DOI 10.1590/S1517-86922008000100008; Wagenmakers AJM, 1998, EXERCISE SPORT SCI R, V26, P287; WAGENMAKERS AJM, 1989, EUR J APPL PHYSIOL, V59, P159, DOI 10.1007/BF02386181; Watson P, 2004, EUR J APPL PHYSIOL, V93, P306, DOI 10.1007/s00421-004-1206-2; Wharton DC., 1967, METHOD ENZYMOL, P245; Xu M, 2001, BIOCHEM BIOPH RES CO, V287, P752, DOI 10.1006/bbrc.2001.5647	32	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180989	10.1371/journal.pone.0180989	http://dx.doi.org/10.1371/journal.pone.0180989			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719620	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400026
J	Barr, KA; Reinitz, J				Barr, Kenneth A.; Reinitz, John			A sequence level model of an intact locus predicts the location and function of nonadditive enhancers	PLOS ONE			English	Article							SEGMENTATION GENE-EXPRESSION; TRANSCRIPTION FACTOR-BINDING; CIS-REGULATORY MODULES; MULTIPLE ENHANCERS; SHADOW ENHANCERS; COMMON SET; DROSOPHILA; STRIPE; ELEMENTS; PATTERNS	Metazoan gene expression is controlled through the action of long stretches of noncoding DNA that contain enhancers-shorter sequences responsible for controlling a single aspect of a gene's expression pattern. Models built on thermodynamics have shown how enhancers interpret protein concentration in order to determine specific levels of gene expression, but the emergent regulatory logic of a complete regulatory locus shows qualitative and quantitative differences from isolated enhancers. Such differences may arise from steric competition limiting the quantity of DNA that can simultaneously influence the transcription machinery. We incorporated this competition into a mechanistic model of gene regulation, generated efficient algorithms for this computation, and applied it to the regulation of Drosophila even-skipped (eve). This model finds the location of enhancers and identifies which factors control the boundaries of eve expression. This model predicts a new enhancer that, when assayed in vivo, drives expression in a non-eve pattern. Incorporation of chromatin accessibility eliminates this inconsistency.	[Barr, Kenneth A.; Reinitz, John] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Barr, KA (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA.	barr@uchicago.edu		Barr, Kenneth/0000-0002-0769-7053	National Institute of Health [R01 OD010936]; University of Chicago; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010936] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago(University of Chicago); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health R01 OD010936 (KB JR) and the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartman CR, 2016, MOL CELL, V62, P237, DOI 10.1016/j.molcel.2016.03.007; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Bertolino E, 2016, DEV BIOL, V413, P128, DOI 10.1016/j.ydbio.2016.02.030; Bothma JP, 2015, ELIFE, V4, DOI 10.7554/eLife.07956; Bothma JP, 2014, P NATL ACAD SCI USA, V111, P10598, DOI 10.1073/pnas.1410022111; Cannavo E, 2016, CURR BIOL, V26, P38, DOI 10.1016/j.cub.2015.11.034; Chu KW, 1999, J COMPUT PHYS, V148, P646, DOI 10.1006/jcph.1998.6134; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunipace L, 2011, DEVELOPMENT, V138, P4075, DOI 10.1242/dev.069146; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; FRASCH M, 1987, GENE DEV, V1, P981, DOI 10.1101/gad.1.9.981; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Gibson D., 2009, PROTOCOL EXCHANGE; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; GRAY S, 1994, GENE DEV, V8, P1829, DOI 10.1101/gad.8.15.1829; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; He X, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000935; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Janssens H, 2005, DEV GENES EVOL, V215, P374, DOI 10.1007/s00427-005-0484-y; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Jiang P, 2015, DEV BIOL, V123, p106 ; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kazemian M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000456; Kim AR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003243; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Kozlov Konstantin, 2002, In Silico Biology, V2, P125; Kozlov KN, 2009, FLY, V3, P151, DOI 10.4161/fly.8599; Lam J., 1988, EFFICIENT SIMULATED, P8816; Lam J., 1988, EFFICIENT SIMULATED; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Martinez C, 2014, MOL BIOL EVOL, V31, P903, DOI 10.1093/molbev/msu042; Martinez CA, 2013, METHODS, V62, P91, DOI 10.1016/j.ymeth.2013.05.014; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McKay DJ, 2013, DEV CELL, V27, P306, DOI 10.1016/j.devcel.2013.10.009; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Noyes MB, 2008, NUCLEIC ACIDS RES, P1; Ogawa N, 2012, METHODS MOL BIOL, V786, P51, DOI 10.1007/978-1-61779-292-2_3; Pagans S, 2002, NUCLEIC ACIDS RES, V30, P4406, DOI 10.1093/nar/gkf570; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; REINITZ J, 1995, MECH DEVELOP, V49, P133, DOI 10.1016/0925-4773(94)00310-J; Reinitz John, 2003, ComPlexUs, V1, P54, DOI 10.1159/000070462; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Russell SRH, 1996, DEVELOPMENT, V122, P3669; Sackerson C, 1999, DEV BIOL, V211, P39, DOI 10.1006/dbio.1999.9301; Samee MA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003467; Samee MA, 2013, METHODS, V62, P79, DOI 10.1016/j.ymeth.2013.03.005; Satija R, 2012, GENOME RES, V22, P656, DOI 10.1101/gr.130682.111; Schulz KN, 2015, GENOME RES, V25, P1715, DOI 10.1101/gr.192682.115; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; SMALL S, 1993, DEVELOPMENT, V119, P767; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; Staller MV, 2015, P NATL ACAD SCI USA, V112, P785, DOI 10.1073/pnas.1413877112; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Struffi P, 2011, DEVELOPMENT, V138, P4291, DOI 10.1242/dev.065987; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Surkova S, 2008, FLY, V2, P58, DOI 10.4161/fly.6060; Teif VB, 2013, METHODS, V62, P26, DOI 10.1016/j.ymeth.2013.03.011; Tsurumi A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002086; Vernimmen D, 2015, TRENDS GENET, V31, P696, DOI 10.1016/j.tig.2015.10.004; Yu D, 2008, CURR BIOL, V18, P868, DOI 10.1016/j.cub.2008.05.050	79	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180861	10.1371/journal.pone.0180861	http://dx.doi.org/10.1371/journal.pone.0180861			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715438	gold, Green Submitted, Green Published			2022-12-27	WOS:000443975500019
J	Ogunola, OF; Hawkins, LK; Mylroie, E; Kolomiets, MV; Borrego, E; Tang, JD; Williams, WP; Warburton, ML				Ogunola, Oluwaseun F.; Hawkins, Leigh K.; Mylroie, Erik; Kolomiets, Michael, V; Borrego, Eli; Tang, Juliet D.; Williams, W. Paul; Warburton, Marilyn L.			Characterization of the maize lipoxygenase gene family in relation to aflatoxin accumulation resistance	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; FUSARIUM-VERTICILLIOIDES; CONTRIBUTING RESISTANCE; ASPERGILLUS-FLAVUS; JASMONIC ACID; DEFENSE; IDENTIFICATION; EXPRESSION; DISRUPTION; INFECTION	Maize (Zea mays L.) is a globally important staple food crop prone to contamination by aflatoxin, a carcinogenic secondary metabolite produced by the fungus Aspergillus flavus. An efficient approach to reduce accumulation of aflatoxin is the development of germplasm resistant to colonization and toxin production by A. flavus. Lipoxygenases (LOXs) are a group of non-heme iron containing dioxygenase enzymes that catalyze oxygenation of polyunsaturated fatty acids (PUFAs). LOX derived oxylipins play critical roles in plant defense against pathogens including A. flavus. The objectives of this study were to summarize sequence diversity and expression patterns for all LOX genes in the maize genome, and map their effect on aflatoxin accumulation via linkage and association mapping. In total, 13 LOX genes were identified, characterized, and mapped. The sequence of one gene, ZmLOX10, is reported from 5 inbred lines. Genes ZmLOX1/2, 5, 8, 9, 10 and 12 (GRMZM2G156861, or V4 numbers ZM00001D042541 and Zm00001D042540, GRMZM2G102760, GRMZM2G104843, GRMZM2G017616, GRMZM2G015419, and GRMZM2G106748, respectively) fell under previously published QTL in one or more mapping populations and are linked to a measurable reduction of aflatoxin in maize grains. Association mapping results found 28 of the 726 SNPs tested were associated with reduced aflatoxin levels at p <= 9.71 x 10(-4) according to association statistics. These fell within or near nine of the ZmLOX genes. This work confirms the importance of some lipoxygenases for resistance to aflatoxin accumulation and may be used to direct future genetic selection in maize.	[Ogunola, Oluwaseun F.] Mississippi State Univ, Dept Plant & Soil Sci, Starkville, MS USA; [Hawkins, Leigh K.; Mylroie, Erik; Williams, W. Paul; Warburton, Marilyn L.] USDA ARS, Corn Host Plant Resistance Res Unit, Starkville, MS 39759 USA; [Kolomiets, Michael, V; Borrego, Eli] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Tang, Juliet D.] USDA FS, Forest Prod Lab, Durabil & Wood Protect, Starkville, MS USA	Mississippi State University; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Forest Service	Warburton, ML (corresponding author), USDA ARS, Corn Host Plant Resistance Res Unit, Starkville, MS 39759 USA.	marilyn.warburton@ars.usda.gov	Borrego, Eli/G-9867-2011; Warburton, Marilyn/J-2250-2017	Borrego, Eli/0000-0002-3538-3203; Warburton, Marilyn/0000-0002-9542-9912	United States Department of Agriculture; United States Agency for International Development joint Feed the Future program, project "Genetic resistance to Aspergillus flavus and aflatoxin in maize" [58-0210-3-012]	United States Department of Agriculture(United States Department of Agriculture (USDA)); United States Agency for International Development joint Feed the Future program, project "Genetic resistance to Aspergillus flavus and aflatoxin in maize"(United States Agency for International Development (USAID))	This work was supported entirely by the United States Department of Agriculture and the United States Agency for International Development joint Feed the Future program, project "Genetic resistance to Aspergillus flavus and aflatoxin in maize", agreement 58-0210-3-012. There was no additional external funding received for this study.	Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Anders S, 2014, BIOINFORMATICS, V25; Andorf CM, 2016, NUCLEIC ACIDS RES, V44, pD1195, DOI 10.1093/nar/gkv1007; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Blount WP, 1961, TURKEYS, V52, P55; Borrego EJ, 2012, BIOCOMMUNICATION FUN, P249; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brooks TD, 2005, CROP SCI, V45, P171; Castegnaro M, 1998, REV MED VET-TOULOUSE, V149, P671; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Christensen SA, 2014, MOL PLANT MICROBE IN, V27, P1263, DOI 10.1094/MPMI-06-13-0184-R; Christensen SA, 2013, PLANT J, V74, P59, DOI 10.1111/tpj.12101; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; De La Fuente GN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053973; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Finn RD, 2013, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, DOI 10.1093/NAR/GKH121]; Gao XQ, 2008, MOL PLANT MICROBE IN, V21, P98, DOI 10.1094/MPMI-21-1-0098; Gao XQ, 2007, MOL PLANT MICROBE IN, V20, P922, DOI 10.1094/MPMI-20-8-0922; Gao XQ, 2009, TOXIN REV, V28, P79, DOI 10.1080/15569540802420584; Goldblatt L., 2012, AFLATOXIN SCI BACKGR; Isakeit T, 2007, J PHYTOPATHOL, V155, P758, DOI 10.1111/j.1439-0434.2007.01301.x; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Kim ES, 2003, PLANT MOL BIOL, V52, P1203, DOI 10.1023/B:PLAN.0000004331.94803.b0; Lawrence Carolyn J, 2008, Int J Plant Genomics, V2008, P496957, DOI 10.1155/2008/496957; MARSH SF, 1984, PHYTOPATHOLOGY, V74, P1284, DOI 10.1094/Phyto-74-1284; Maschietto V, 2015, J PLANT PHYSIOL, V188, P9, DOI 10.1016/j.jplph.2015.09.003; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Monaco MK, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.09.0025; Moreno OJ, 1999, PLANT BREEDING, V118, P1, DOI 10.1046/j.1439-0523.1999.118001001.x; Nemchenko A, 2006, J EXP BOT, V57, P3767, DOI 10.1093/jxb/erl137; Park Yoon Joo, 2011, THESIS; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Stelpflug SC, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.04.0025; Tang JD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1874-9; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2013, NUCLEIC ACIDS RES, V41, pD1159, DOI 10.1093/nar/gks1109; Warburton ML, 2015, CROP SCI, V55, P1857, DOI 10.2135/cropsci2014.06.0424; Warburton ML, 2013, CROP SCI, V53, P2374, DOI 10.2135/cropsci2012.10.0616; Warburton ML, 2011, MOL BREEDING, V27, P491, DOI 10.1007/s11032-010-9446-9; Warburton ML, 2009, CROP SCI, V49, P1403, DOI 10.2135/cropsci2008.12.0696; Warburton ML, 2014, ADV BOT, V2014, P10, DOI [10.1155/2014/352831, DOI 10.1155/2014/352831]; Wessler S, 2009, MAIZE TRANSPOSABLE E; Willcox MC, 2013, MOL BREEDING, V32, P15, DOI 10.1007/s11032-012-9821-9; Williams WP, 2015, WORLD MYCOTOXIN J, V8, P193, DOI 10.3920/WMJ2014.1751; Yan YX, 2012, PLANT CELL, V24, P1420, DOI 10.1105/tpc.111.094151	49	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181265	10.1371/journal.pone.0181265	http://dx.doi.org/10.1371/journal.pone.0181265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715485	Green Submitted, Green Published, gold			2022-12-27	WOS:000443975500042
J	Kim, JH; Kim, HJ; Lee, DH				Kim, Jun-Ho; Kim, Hyun-Jung; Lee, Dae-Hee			Leg length change after opening wedge and closing wedge high tibial osteotomy: A meta-analysis	PLOS ONE			English	Article							LIMB-LENGTH; DISCREPANCY; INEQUALITY; ROTATION; GAIT	Background Theoretical considerations suggest that leg length increases after opening wedge high tibial osteotomy ( HTO) and decreases after closing wedge HTO; however, in vivo studies have yielded conflicting results. This meta-analysis therefore assessed changes in leg length after opening wedge and closing wedge HTO. Methods All studies comparing pre-and postoperative leg length in patients who underwent opening and/or closing wedge HTO were included. Two reviewers independently recorded data from each study in terms of sample size as well as preoperative and postoperative leg length of open wedge and/or closed wedge HTO groups. Results Four studies were included in the meta-analysis. Although pooled results showed leg length changes from before to after surgery were-6.93 mm ( 95% confidence interval [CI]:-17.53 to 3.67 mm; P = 0.20) in opening wedge HTO and 1.97 mm ( 95% CI:-7.13 to 11.07 mm; P = 0.67) in closing wedge HTO, respectively, these values were statistically not significant. However, the difference in the pooled mean leg length change from before to after surgery between opening wedge and closing wedge HTO was 8 mm, a difference that was significant ( 95% CI: 6.53 to 9.46 mm; P<0.001). Conclusion The change in leg length was not statistically significant for either opening or closing wedge HTO. However, leg length change from before to after surgery was 8 mm greater for opening wedge HTO than for closing wedge HTO.	[Kim, Jun-Ho; Lee, Dae-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea; [Kim, Hyun-Jung] Korea Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine)	Lee, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea.	eoak22@empal.com	lee, dae hee/I-9390-2017	Lee, Dae-Hee/0000-0003-3147-8763				Amis AA, 2013, KNEE SURG SPORT TR A, V21, P197, DOI 10.1007/s00167-012-2122-3; ANDRIACCHI TP, 1994, ORTHOP CLIN N AM, V25, P395; Asada S, 2012, KNEE SURG SPORT TR A, V20, P571, DOI 10.1007/s00167-011-1610-1; Bae DK, 2013, KNEE SURG SPORT TR A, V21, P120, DOI 10.1007/s00167-012-1898-5; Bin SI, 2016, ARTHROSCOPY; Defrin R, 2005, ARCH PHYS MED REHAB, V86, P2075, DOI 10.1016/j.apmr.2005.06.012; Halder A, 2012, J BONE JOINT SURG AM, V94A, P1023, DOI 10.2106/JBJS.K.00927; Harvey WF, 2010, ANN INTERN MED, V152, P287, DOI 10.7326/0003-4819-152-5-201003020-00006; Hinterwimmer S, 2016, INT ORTHOP, V40, P1849, DOI 10.1007/s00264-015-3100-4; Jang KM, 2016, J ARTHROPLASTY, V31, P59, DOI 10.1016/j.arth.2015.08.010; Kaufman KR, 1996, J PEDIATR ORTHOPED, V16, P144, DOI 10.1097/01241398-199603000-00002; Kendoff D, 2008, KNEE SURG SPORT TR A, V16, P904, DOI 10.1007/s00167-008-0567-1; Kim JI, 2016, AM J SPORTS MED; Kim Kug Jin, 2015, Knee Surg Relat Res, V27, P181, DOI 10.5792/ksrr.2015.27.3.181; Kyung HS, 2015, CLIN ORTHOP SURG, V7, P185, DOI 10.4055/cios.2015.7.2.185; Magnussen RA, 2011, AM J SPORT MED, V39, P1900, DOI 10.1177/0363546511410025; Nerhus TK, 2015, KNEE SURG SPORTS TRA; Nha KW, 2016, AM J SPORTS MED; Resende RA, 2016, GAIT POSTURE, V46, P147, DOI 10.1016/j.gaitpost.2016.03.012; Swaminathan V, 2014, GAIT POSTURE, V40, P561, DOI 10.1016/j.gaitpost.2014.06.020; Wells G., 2013, NEWCASTLE OTTAWA SCA	21	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181328	10.1371/journal.pone.0181328	http://dx.doi.org/10.1371/journal.pone.0181328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704523	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700124
J	Lim, YC; Li, J; Ni, YY; Liang, Q; Zhang, JJ; Yeo, GSH; Lyu, JX; Jin, SN; Ding, CM				Lim, Yen Ching; Li, Jie; Ni, Yiyun; Liang, Qi; Zhang, Junjiao; Yeo, George S. H.; Lyu, Jianxin; Jin, Shengnan; Ding, Chunming			A complex association between DNA methylation and gene expression in human placenta at first and third trimesters	PLOS ONE			English	Article							IMPRINTED GENES; GROWTH; METHYLOME; PATTERNS; CHILDREN	The human placenta is a maternal-fetal organ essential for normal fetal development and maternal health. During pregnancy, the placenta undergoes many structural and functional changes in response to fetal needs and environmental exposures. Previous studies have demonstrated widespread epigenetic and gene expression changes from early to late pregnancy. However, on the global level, how DNA methylation changes impact on gene expression in human placenta is not yet well understood. We performed DNA methylome analysis by reduced representation bisulfite sequencing (RRBS)and gene expression analysis by RNA-Seq for both first and third trimester human placenta tissues. From first to third trimester, 199 promoters (corresponding to 189 genes) and 2,297 gene bodies were differentially methylated, with a clear dominance of hypermethylation (96.8% and 93.0% for promoters and gene bodies, respectively). A total of 2,447 genes were differentially expressed, of which 77.2% were down-regulated. Gene ontology analysis using differentially expressed genes were enriched for cell cycle and immune response functions. The correlation between DNA methylation and gene expression was non-linear and complex, depending on the genomic context (promoter or gene body) and gene expression levels. A wide range of DNA methylation and gene expression changes were observed at different gestational ages. The non-linear association between DNA methylation and gene expression indicates that epigenetic regulation of placenta development is more complex than previously envisioned.	[Lim, Yen Ching; Li, Jie; Ni, Yiyun; Liang, Qi; Zhang, Junjiao; Lyu, Jianxin; Jin, Shengnan; Ding, Chunming] Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ China, Wenzhou, Zhejiang, Peoples R China; [Yeo, George S. H.] KK Womens & Childrens Hosp, Singapore, Singapore	Ministry of Education, China; Wenzhou Medical University; KK Women's & Children's Hospital	Lyu, JX; Jin, SN; Ding, CM (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ China, Wenzhou, Zhejiang, Peoples R China.	ljxwzmc@aliyun.com; snjin1997@qq.com; cmding@gmail.com	Jin, Shengnan/I-6264-2012; Ding, Chunming/B-2593-2008	Jin, Shengnan/0000-0003-0467-6502; Ding, Chunming/0000-0002-2063-5594	National Health and Family Planning Commission of Zhejiang Province; Wenzhou Medical University Startup fund	National Health and Family Planning Commission of Zhejiang Province; Wenzhou Medical University Startup fund	This work is supported by National Health and Family Planning Commission of Zhejiang Province (CD) and the Wenzhou Medical University Startup fund (CD and SJ). The funder provided support in the form of salaries for authors [JL, SJ, CD, YCL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barbaux S, 2012, EPIGENETICS-US, V7, P1079, DOI 10.4161/epi.21495; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Buckberry S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051210; Chu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107318; Comas M, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.044; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; Das R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-685; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fattal-Valevski A, 2009, J CHILD NEUROL, V24, P846, DOI 10.1177/0883073808331082; Fernandez-Funez P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000507; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Hamada H, 2016, AM J HUM GENET, V99, P1045, DOI 10.1016/j.ajhg.2016.08.021; HECHER K, 1995, CIRCULATION, V91, P129, DOI 10.1161/01.CIR.91.1.129; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jin SN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003515; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; John R, 2012, REPROD BIOMED ONLINE, V25, P5, DOI 10.1016/j.rbmo.2012.03.018; Lambertini L, 2012, PLACENTA, V33, P480, DOI 10.1016/j.placenta.2012.03.001; Lambertini L, 2011, REPROD SCI, V18, P1111, DOI 10.1177/1933719111404611; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee YK, 2014, BIOL PROCED ONLINE, V16, DOI 10.1186/1480-9222-16-1; Lim YC, 2016, MOL METAB, V5, P1033, DOI 10.1016/j.molmet.2016.08.006; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Magalhaes HR, 2013, BRAZ J MED BIOL RES, V46, P916, DOI 10.1590/1414-431X20133035; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; Moore GE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0074; Novakovic B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-529; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Roifman M, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0238-x; Sitras V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033294; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Spence D, 2012, PUBLIC HEALTH, V126, P561, DOI 10.1016/j.puhe.2012.03.010; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Teeninga N, 2008, NEPHROL DIAL TRANSPL, V23, P1615, DOI 10.1093/ndt/gfm829; Tycko B, 2006, CYTOGENET GENOME RES, V113, P271, DOI 10.1159/000090842; Uuskula L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049248; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Yeung KR, 2016, AM J PHYSIOL-HEART C, V310, pH1295, DOI 10.1152/ajpheart.00958.2015; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011	46	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181155	10.1371/journal.pone.0181155	http://dx.doi.org/10.1371/journal.pone.0181155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704530	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700099
J	Dave, E; Ozbek, U; Gupta, V; Genden, E; Miles, B; Teng, M; Posner, M; Misiukiewicz, K; Bakst, RL				Dave, Eesha; Ozbek, Umut; Gupta, Vishal; Genden, Eric; Miles, Brett; Teng, Marita; Posner, Marshall; Misiukiewicz, Krzysztof; Bakst, Richard L.			The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer	PLOS ONE			English	Article								Introduction Despite the human papillomavirus conferring a better prognosis in the primary treatment setting, the prognostic impact of viral status after treatment failure in oropharyngeal squamous cell carcinoma patients is poorly understood. Methods We retrospectively identified 33 oropharyngeal squamous cell carcinoma (OPC) patients with local and/or distant disease recurrence post-treatment, and looked at metastatic patterns, time to failure and survival patterns by HPV status. Results Median overall survival following local failure was not significantly different by HPV status (17 months for HPV+ vs. 14 months for HPV-, p = 0.23). However, following distant failures, HPV+ patients lived significantly longer than HPV- patients (median 42 months vs. 11 months, p = 0.004). HPV- patients were more likely to have locoregional failures as compared to HPV+ patients (p = 0.005), but the difference in distant failure between both groups was not significant (p = 0.09). HPV+ patients were more likely to develop metastases to sites other than the lung and bones. Conclusion HPV positivity predicts a favorable prognosis with the potential for long-term survival following distant, not locoregional, failures. These results have important implications for the aggressiveness of treatment and type of surveillance imaging performed.	[Dave, Eesha] Icahn Sch Med, Dept Med Educ, New York, NY USA; [Ozbek, Umut] Mt Sinai Hosp, Dept Populat Sci & Policy, New York, NY 10029 USA; [Gupta, Vishal; Bakst, Richard L.] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA; [Genden, Eric; Miles, Brett; Teng, Marita] Icahn Sch Med Mt Sinai, Dept Otolaryngol Head & Neck Surg, New York, NY 10029 USA; [Posner, Marshall; Misiukiewicz, Krzysztof] Icahn Sch Med Mt Sinai, Dept Hematol Oncol, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bakst, RL (corresponding author), Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA.	richard.bakst@mountsinai.org			NATIONAL CANCER INSTITUTE [P30CA196521] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA196521] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Argiris A, ANN ONCOLOGY OFFICIA; Dang RP, ANTICANCER RES; Fakhry C, J NATL CANC I; Goodman MT, EUROPEAN J CANC; Huang SH, 2013, ORAL ONCOL, V49, P79, DOI 10.1016/j.oraloncology.2012.07.015; Kano S, INT J CLIN ONCOLOGY, P817; Mouw KW, CLIN CANC RES OFFICI, P1117; NCCN Clinical Practice Guidelines in Oncology, 2013, NCCN CLIN PRACT GUID, P2; OSullivan B, RADIOTHERAPY ONCOLOG; Posner MR, ANN ONCOLOGY OFFICIA; Trosman SJ, JAMA OTOLARYNGOLOGY, P2168; Wang MB, OTOLARYNGOLOGY HEAD	13	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181108	10.1371/journal.pone.0181108	http://dx.doi.org/10.1371/journal.pone.0181108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732044	gold, Green Published, Green Submitted			2022-12-27	WOS:000406643100023
J	Feng, D; Wang, YW; Lu, TG; Zhang, ZG; Han, X				Feng, Dan; Wang, Yanwei; Lu, Tiegang; Zhang, Zhiguo; Han, Xiao			Proteomics analysis reveals a dynamic diurnal pattern of photosynthesis-related pathways in maize leaves	PLOS ONE			English	Article							KEY PATHWAYS; ACID; ARABIDOPSIS; DEHYDROGENASE; TRANSCRIPTOME; CARBOXYLASE; MECHANISM; DROUGHT; GROWTH	Plant leaves exhibit differentiated patterns of photosynthesis rates under diurnal light regulation. Maize leaves show a single-peak pattern without photoinhibition at midday when the light intensity is maximized. This mechanism contributes to highly efficient photosynthesis in maize leaves. To understand the molecular basis of this process, an isobaric tag for relative and absolute quantitation (iTRAQ)-based proteomics analysis was performed to reveal the dynamic pattern of proteins related to photosynthetic reactions. Steady, single-peak and double-peak protein expression patterns were discovered in maize leaves, and antenna proteins in these leaves displayed a steady pattern. In contrast, the photosystem, carbon fixation and citrate pathways were highly controlled by diurnal light intensity. Most enzymes in the limiting steps of these pathways were major sites of regulation. Thus, maize leaves optimize photosynthesis and carbon fixation outside of light harvesting to adapt to the changes in diurnal light intensity at the protein level.	[Feng, Dan; Wang, Yanwei; Lu, Tiegang; Zhang, Zhiguo; Han, Xiao] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zhang, ZG; Han, X (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	lutiegang@caas.cn; hanxiao@caas.cn	han, xiao/CAI-6839-2022; han, xiao/CAG-0473-2022	han, xiao/0000-0002-4557-1304; 	National Key Basic Research Program of China [2015CB150103]; National Nature Science Foundation [31471166]; collaborative project of the Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences [CMS-XTCX2016002]; Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences	National Key Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); collaborative project of the Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences; Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences	This work was support by National Key Basic Research Program of China (project number. 2015CB150103), National Nature Science Foundation (project number: 31471166), the collaborative project of the Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences (CMS-XTCX2016002) and Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences to TG Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD B, 1953, J BIOL CHEM, V204, P939; Bagard M, 2015, ENVIRON POLLUT, V206, P411, DOI 10.1016/j.envpol.2015.07.046; Belcher S, 2015, BBA-BIOENERGETICS, V1847, P1004, DOI 10.1016/j.bbabio.2015.02.014; BOWES G, 1971, BIOCHEM BIOPH RES CO, V45, P716, DOI 10.1016/0006-291X(71)90475-X; Cao PJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-17; Chan AyeNyein, 2015, American Journal of Plant Sciences, V6, P2209, DOI 10.4236/ajps.2015.613223; Chikov VI, 2016, RUSS J PLANT PHYSL+, V63, P620, DOI 10.1134/S1021443716050034; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Ding ZS, 2015, PHOTOSYNTHETICA, V53, P481, DOI 10.1007/s11099-015-0126-1; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Facella P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002798; Filichkin SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016907; Fries M, 2003, BIOCHEMISTRY-US, V42, P6996, DOI 10.1021/bi027397z; Ghimire B, 2015, J MAIZE RES DEV, V1, P134, DOI 10.3126/jmrd.v1i1.14251; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; HATHAWAY JA, 1963, J BIOL CHEM, V238, P2875; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Ifuku K, 2014, PLANT PHYSIOL BIOCH, V81, P108, DOI 10.1016/j.plaphy.2014.01.001; Joriczyk M, 2011, PLOS ONE, V6, P366; KAUFMAN S, 1955, J BIOL CHEM, V216, P153; Khan S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-126; Kim YO, 1999, J BIOL CHEM, V274, P36866, DOI 10.1074/jbc.274.52.36866; Knuesting J, 2015, PLANT PHYSIOL, V167, P1643, DOI 10.1104/pp.15.00049; Ludwig M, 2013, PHOTOSYNTH RES, V117, P147, DOI 10.1007/s11120-013-9853-y; MAZELIS M, 1957, PLANT PHYSIOL, V32, P591, DOI 10.1104/pp.32.6.591; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Murchie EH, 2009, NEW PHYTOL, V181, P532, DOI 10.1111/j.1469-8137.2008.02705.x; Neiff N, 2016, HIGH TEMPERATURES FL; OCHOA S, 1954, ADV ENZYMOL REL S BI, V15, P183; Ono K, 2015, PLANT PROD SCI, V6, P281; Perduns R, 2015, PLANT PHYSIOL, V168, P1378, DOI 10.1104/pp.15.00934; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Sachanowicz K, 2012, PURIFICATION PROPERT, P437; Samira M, 2015, AFRICAN CROP SCI J, V628, P1; Schoning JC, 2005, FEBS LETT, V579, P3246, DOI 10.1016/j.febslet.2005.03.028; Sheen J, 1999, ANNU REV PLANT PHYS, V50, P187, DOI 10.1146/annurev.arplant.50.1.187; Sugiyama N, 2001, PLANT J, V26, P607, DOI 10.1046/j.1365-313x.2001.01063.x; Tang N, 2015, RES J BIOTECHNOL, V10, P89; Tovar-Mendez A, 2000, PLANT PHYSIOL, V123, P149, DOI 10.1104/pp.123.1.149; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; VANROOYEN JPG, 1994, J INHERIT METAB DIS, V17, P738, DOI 10.1007/BF00712017; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; WALKER DA, 1960, BIOCHEM J, V74, P216, DOI 10.1042/bj0740216; WISHNICK M, 1969, J BIOL CHEM, V244, P5761; Yakir E, 2007, FEBS J, V274, P335, DOI 10.1111/j.1742-4658.2006.05616.x; Yan Xiao-hong, 2013, Shengtaixue Zazhi, V32, P604; Zhang Y, 2015, JMATERCHEMA, V3; Zhao Wen-Sai, 2016, Chinese Journal of Plant Ecology, V40, P594, DOI 10.17521/cjpe.2015.0345; Zhu YN, 2012, J SHENYANG AGR U	50	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180670	10.1371/journal.pone.0180670	http://dx.doi.org/10.1371/journal.pone.0180670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732011	Green Published, gold, Green Submitted			2022-12-27	WOS:000406643100009
J	Goos, C; Dejung, M; Janzen, CJ; Butter, F; Kramer, S				Goos, Carina; Dejung, Mario; Janzen, Christian J.; Butter, Falk; Kramer, Susanne			The nuclear proteome of Trypanosoma brucei	PLOS ONE			English	Article							BLOOD-STREAM FORM; LIFE-CYCLE STAGES; FUNCTIONAL-CHARACTERIZATION; IDENTIFICATION; REVEALS; COMPLEX; EXOSOME; ROLES; SILAC; INTERFACE	Trypanosoma brucei is a protozoan flagellate that is transmitted by tsetse flies into the mammalian bloodstream. The parasite has a huge impact on human health both directly by causing African sleeping sickness and indirectly, by infecting domestic cattle. The biology of trypanosomes involves some highly unusual, nuclear-localised processes. These include polycistronic transcription without classical promoters initiated from regions defined by histone variants, trans-splicing of all transcripts to the exon of a spliced leader RNA, transcription of some very abundant proteins by RNA polymerase I and antigenic variation, a switch in expression of the cell surface protein variants that allows the parasite to resist the immune system of its mammalian host. Here, we provide the nuclear proteome of procyclic Trypanosoma brucei, the stage that resides within the tsetse fly midgut. We have performed quantitative label-free mass spectrometry to score 764 significantly nuclear enriched proteins in comparison to whole cell lysates. A comparison with proteomes of several experimentally characterised nuclear and non-nuclear structures and pathways confirmed the high quality of the dataset: the proteome contains about 80% of all nuclear proteins and less than 2% false positives. Using motif enrichment, we found the amino acid sequence KRxR present in a large number of nuclear proteins. KRxR is a sub-motif of a classical eukaryotic monopartite nuclear localisation signal and could be responsible for nuclear localization of proteins in Kinetoplastida species. As a proof of principle, we have confirmed the nuclear localisation of six proteins with previously unknown localisation by expressing eYFP fusion proteins. While proteome data of several T. brucei organelles have been published, our nuclear proteome closes an important gap in knowledge to study trypanosome biology, in particular nuclearrelated processes.	[Goos, Carina; Janzen, Christian J.; Kramer, Susanne] Univ Wurzburg, Bioctr, Dept Cell & Dev Biol, Wurzburg, Germany; [Dejung, Mario; Butter, Falk] Inst Mol Biol, Ackermannweg 4, Mainz, Germany	University of Wurzburg; Institute of Molecular Biology (IMB)	Kramer, S (corresponding author), Univ Wurzburg, Bioctr, Dept Cell & Dev Biol, Wurzburg, Germany.; Butter, F (corresponding author), Inst Mol Biol, Ackermannweg 4, Mainz, Germany.	f.butter@imb.de; susanne.kramer@uni-wuerzburg.de		Butter, Falk/0000-0002-7197-7279	DFG [Kr4017/1-2]	DFG(German Research Foundation (DFG))	This work was supported by DFG, www.dfg.de Kr4017/1-2 (SK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bessat M, 2009, MOL MICROBIOL, V71, P1371, DOI 10.1111/j.1365-2958.2009.06611.x; Bluhm A, 2016, PROTEOMICS, V16, P427, DOI 10.1002/pmic.201500217; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; Cassola A, 2010, RNA BIOL, V7, P339, DOI 10.4161/rna.7.3.12087; Clayton C, 2010, ADV EXP MED BIOL, V702, P39, DOI 10.1007/978-1-4419-7841-7_4; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cristodero M, 2007, NUCLEIC ACIDS RES, V35, P7023, DOI 10.1093/nar/gkm736; D'Archivio S, 2016, J CELL BIOL, V36; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Dean S, 2016, P NATL ACAD SCI USA, V113, pE5135, DOI 10.1073/pnas.1604258113; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; DeGrasse Jeffrey A., 2008, V463, P77, DOI 10.1007/978-1-59745-406-3_6; Dejung M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005439; DuBois KN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001287; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Fadda A, 2013, RNA, V19, P937, DOI 10.1261/rna.038430.113; Gassen A, 2012, NUCLEIC ACIDS RES, V40, P10302, DOI 10.1093/nar/gks801; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Kramer S, 2016, MOL BIOCHEM PARASIT, V205, P1, DOI 10.1016/j.molbiopara.2016.02.009; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Lueong S, 2016, MOL MICROBIOL, V100, P457, DOI 10.1111/mmi.13328; Marchetti MA, 2000, J CELL SCI, V113, P899; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Obado SO, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002365; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Peikert CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15272; Preusser C, 2012, INT J MED MICROBIOL, V302, P221, DOI 10.1016/j.ijmm.2012.07.004; Rout MP, 2001, J BIOL CHEM, V276, P38261; Santos Junior dos A de CM, 2015, PLOS ONE, V10; Shimogawa MM, 2015, MOL CELL PROTEOMICS, V14, P1977, DOI 10.1074/mcp.M114.045146; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; Subota I, 2014, MOL CELLULAR PROTEOM; Tarun SZ, 2008, RNA, V14, P347, DOI 10.1261/rna.763308; Tkacz ID, 2008, MOL BIOCHEM PARASIT, V160, P22, DOI 10.1016/j.molbiopara.2008.03.003; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Zikova A, 2008, MOL CELL PROTEOMICS, V7, P1286, DOI 10.1074/mcp.M700490-MCP200	51	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181884	10.1371/journal.pone.0181884	http://dx.doi.org/10.1371/journal.pone.0181884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727848	Green Submitted, gold, Green Published			2022-12-27	WOS:000406634500111
J	Jakovac, CC; Dutrieux, LP; Siti, L; Pena-Claros, M; Bongers, F				Jakovac, Catarina Conte; Dutrieux, Loic Paul; Siti, Latifah; Pena-Claros, Marielos; Bongers, Frans			Spatial and temporal dynamics of shifting cultivation in the middle-Amazonas river: Expansion and intensification	PLOS ONE			English	Article							FOREST-AGRICULTURE FRONTIERS; LAND-USE; SWIDDEN AGRICULTURE; DEFORESTATION; ACCESSIBILITY; RESOURCES; LANDSCAPE; DRIVERS; IMPACT; CARBON	Shifting cultivation is the main land-use system transforming landscapes in riverine Amazonia. Increased concentration of the human population around villages and increasing market integration during the last decades may be causing agricultural intensification. Studies have shown that agricultural intensification, i.e. higher number of swidden-fallow cycles and shorter fallow periods, reduces crop productivity of swiddens and the regrowth capacity of fallows, undermining the resilience of the shifting cultivation system as a whole. We investigated the temporal and spatial dynamics of shifting cultivation in Brazilian Amazonia to test the hypotheses that (i) agriculture has become more intensive over time, and (ii) patterns of land-use intensity are related to land accessibility and human population density. We applied a breakpoint-detection algorithm to Landsat time-series spanning three decades (1984-2015) and retrieved the temporal dynamics of shifting cultivation fields, which go through alternating phases of crop production (swidden) and secondary forest regrowth (fallow). We found that fallow-period length has decreased from 6.4 to 5.1 years on average, and that expansion over old-growth forest has slowed down over time. Shorter fallow periods and higher frequency of slash and burn cycles are practiced closer to residences and around larger villages. Our results indicate that shifting cultivation in riverine Amazonia has gone through a process of agricultural intensification in the past three decades. The resulting landscape is predominantly covered by young secondary forests (<= 12 yrs old), and 20% of it have gone through intensive use. Reversing this trend and avoiding the negative consequences of agricultural intensification requires land use planning that accounts for the constraints of land use in riverine areas.	[Jakovac, Catarina Conte] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Jakovac, Catarina Conte; Pena-Claros, Marielos; Bongers, Frans] Wageningen Univ & Res, Forest Ecol & Forest Management Grp, Wageningen, Netherlands; [Dutrieux, Loic Paul; Siti, Latifah] Wageningen Univ & Res, Lab Geoinformat Sci & Remote Sensing, Wageningen, Netherlands	Institute Nacional de Pesquisas da Amazonia; Wageningen University & Research; Wageningen University & Research	Jakovac, CC (corresponding author), Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil.; Jakovac, CC (corresponding author), Wageningen Univ & Res, Forest Ecol & Forest Management Grp, Wageningen, Netherlands.	catacj@gmail.com	Jakovac, Catarina/P-7599-2018	Jakovac, Catarina/0000-0002-8130-852X; Dutrieux, Loic/0000-0002-5058-2526; Pena-Claros, Marielos/0000-0001-9134-6733	Wageningen University [11/00220]; NUFFIC [NFP 3246/11]; Comissao Nacional de Etica em Pesquisa-CONEP [20361713.7.0000.0006]; Direct For Biological Sciences [1147429] Funding Source: National Science Foundation	Wageningen University(European Commission); NUFFIC; Comissao Nacional de Etica em Pesquisa-CONEP; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was financially supported by Wageningen University (Sandwich grant 11/00220; NL; http.//www.wur.nl/en/Education-Programmes/PhD-Programme/Funding-your-PhD. htm) and by NUFFIC (NFP 3246/11; NL; https//www.epnuffic.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the farmers who authorized and contributed to this research. We also thank Luke Parry for contributing information on the location and size of villages of the study area, and Patrick Jansen for assistance with statistical analysis. This research is in accordance with the Brazilian regulation on ethics in research, under project number 20361713.7.0000.0006, approved by the Comissao Nacional de Etica em Pesquisa-CONEP and Comite de Etica em Pesquisa from the Instituto Nacional de Pesquisas da Amazonia (Br).	Adams C, 2009, AMAZON PEASANT SOCIETIES IN A CHANGING ENVIRONMENT, P1, DOI 10.1007/978-1-4020-9283-1; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; Asner GP, 2001, INT J REMOTE SENS, V22, P3855, DOI 10.1080/01431160010006926; Barber CP, 2014, BIOL CONSERV, V177, P203, DOI 10.1016/j.biocon.2014.07.004; BOSERUP E., 1965, The conditions of agricultural growth. The economics of agrarian change under population pressure.; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brondizio E, 2009, AMAZON PEASANT SOCIETIES IN A CHANGING ENVIRONMENT, P181, DOI 10.1007/978-1-4020-9283-1_9; Castella JC, 2005, APPL GEOGR, V25, P308, DOI 10.1016/j.apgeog.2005.07.003; Coomes OT, 2000, ECOL ECON, V32, P109, DOI 10.1016/S0921-8009(99)00066-X; Coppin P, 2004, INT J REMOTE SENS, V25, P1565, DOI 10.1080/0143116031000101675; Core-Team R-D, 2013, R LANG ENV STAT COMP; Dalle SP, 2006, ECOL SOC, V11; Dalle SP, 2011, ECOL APPL, V21, P1557, DOI 10.1890/10-0700.1; DeVries B, 2015, REMOTE SENS ENVIRON, V161, P107, DOI 10.1016/j.rse.2015.02.012; Dutrieux LP, 2016, INT J APPL EARTH OBS, V47, P112, DOI 10.1016/j.jag.2015.11.018; Dutrieux LP, 2015, ISPRS J PHOTOGRAMM, V107, P112, DOI 10.1016/j.isprsjprs.2015.03.015; Eloy L, 2015, B LAT AM RES, V34, P1, DOI 10.1111/blar.12268; Emperaire L, 2015, B LAT AM RES, V34, P70, DOI 10.1111/blar.12176; Emperaire L, 2012, CAH AGRIC, V21, P25, DOI 10.1684/agr.2012.0537; ESRI, 2012, ARCGIS DESKT 10 1; Fox J, 2009, HUM ECOL, V37, P305, DOI 10.1007/s10745-009-9240-7; Grau HR, 2003, BIOSCIENCE, V53, P1159, DOI 10.1641/0006-3568(2003)053[1159:TECOSA]2.0.CO;2; IBGE, 2013, PRODES; Jakovac CC, 2016, AGR ECOSYST ENVIRON, V218, P116, DOI 10.1016/j.agee.2015.11.013; Jakovac CC, 2015, J ECOL, V103, P67, DOI 10.1111/1365-2745.12298; Johnson CM, 2001, FOREST ECOL MANAG, V147, P245, DOI 10.1016/S0378-1127(00)00466-7; Kauffman JB, 2009, ECOL APPL, V19, P1211, DOI 10.1890/08-1696.1; Kawa NC, 2013, CURR ANTHROPOL, V54, P764, DOI 10.1086/673528; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Latifah SH, 2015, THESIS; Lawrence D, 1998, LANDSCAPE ECOL, V13, P135, DOI 10.1023/A:1007985915187; Lawrence D, 2007, P NATL ACAD SCI USA, V104, P20696, DOI 10.1073/pnas.0705005104; Li P, 2014, REMOTE SENS-BASEL, V6, P1654, DOI 10.3390/rs6021654; MORAN EF, 1993, HUM ECOL, V21, P1, DOI 10.1007/BF00890069; Padoch C, 2007, GEOGR TIDSSKR-DEN, V107, P29, DOI 10.1080/00167223.2007.10801373; Padoch C, 2008, ECOL SOC, V13; Parry L, 2010, POPUL ENVIRON, V32, P137, DOI 10.1007/s11111-010-0127-8; Parry L, 2010, CONSERV LETT, V3, P251, DOI 10.1111/j.1755-263X.2010.00106.x; Pereira H.S., 1994, REV U AMAZONAS CA, V3, P1; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Salonen M, 2012, APPL GEOGR, V32, P501, DOI 10.1016/j.apgeog.2011.06.017; Siren AH, 2007, HUM ECOL, V35, P669, DOI 10.1007/s10745-006-9089-y; Soler LD, 2009, APPL GEOGR, V29, P182, DOI 10.1016/j.apgeog.2008.09.005; Therneau T.M., 2000, MODELING SURVIVAL DA; Turner BL, 1996, P NATL ACAD SCI USA, V93, P14984, DOI 10.1073/pnas.93.25.14984; van Breugel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082433; van Vliet N, 2013, SOC NATUR RESOUR, V26, P1454, DOI 10.1080/08941920.2013.820813; van Vliet N, 2012, GLOBAL ENVIRON CHANG, V22, P418, DOI 10.1016/j.gloenvcha.2011.10.009; Vance C, 2002, AGR ECON-BLACKWELL, V27, P317, DOI 10.1111/j.1574-0862.2002.tb00123.x; Vogt ND, 2015, SOC NAT RES, P1, DOI DOI 10.1080/08941920.2015.1014603; Vosti SA, 2002, AGR INTENSIFICATION; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6; Zuur A, 2009, MIXED EFFECTS MODELS	54	43	43	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181092	10.1371/journal.pone.0181092	http://dx.doi.org/10.1371/journal.pone.0181092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727828	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500039
J	Vicenzino, B; Britt, H; Pollack, AJ; Hall, M; Bennell, KL; Hunter, DJ				Vicenzino, Bill; Britt, Helena; Pollack, Allan J.; Hall, Michelle; Bennell, Kim L.; Hunter, David J.			No abatement of steroid injections for tennis elbow in Australian General Practice: A 15-year observational study with random general practitioner sampling	PLOS ONE			English	Article							LATERAL EPICONDYLALGIA; CORTICOSTEROID INJECTIONS; MUSCULOSKELETAL DISORDERS; CONTROLLED-TRIAL; UPPER-LIMB; PHYSIOTHERAPY; MANAGEMENT; TENDINOPATHY; POPULATION; PREVALENCE	Objective Evaluate general practitioner (GP) management of tennis elbow (TE) in Australia. Methods Data about the management of TE by GPs from 2000 to 2015 were extracted from the Bettering the Evaluation of Care of Health program database. Patient and GP characteristics and encounter management data were classified by the International Classification of Primary Care, version 2, and reported using descriptive statistics with point estimates and 95% confidence intervals. Results TE was managed by GPs 242,000 times per year on average. Patients were mainly female (52.3%), aged between 35 and 64 years (mean: 49.3 yrs), had higher relative risks of concomitant disorders (e.g. carpal tunnel syndrome and other tendonitis) and their TE was 10 times more likely to be work related than problems managed for patients who did not have TE. Use of diagnostic tests was low, implying a clinical examination based diagnosis of TE. Management was by procedural treatments (36 per 100 TE problems), advice, education or counselling (25 per 100), and referral to other health care providers (14 per 100, mainly to physiotherapy). The rate of local injection did not change over the 15 years and was performed at similar rates as physiotherapy referral. Conclusion The high risk of comorbidities and work relatedness and no abatement in the reasonably high rate of local injections (which is contrary to the evidence from clinical trials) provides support for the development and dissemination of TE clinical guidelines for GPs.	[Vicenzino, Bill] Univ Queensland, Sch Hlth & Rehabil Sci Physiotherapy, Brisbane, Qld, Australia; [Britt, Helena; Pollack, Allan J.] Univ Sydney, Family Med Res Ctr, Sydney, NSW, Australia; [Hall, Michelle; Bennell, Kim L.] Univ Melbourne, Dept Physiotherapy, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Hunter, David J.] Kolling Inst, Inst Bone & Joint Res, Sydney, NSW, Australia; [Hunter, David J.] Univ Sydney, Sydney, NSW, Australia	University of Queensland; University of Sydney; University of Melbourne; University of Sydney; Kolling Institute of Medical Research; University of Sydney	Vicenzino, B (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci Physiotherapy, Brisbane, Qld, Australia.	b.vicenzino@uq.edu.au	Vicenzino, Bill/A-8492-2011; Hall, Michelle MH/P-2178-2016	Vicenzino, Bill/0000-0003-0253-5933; Hall, Michelle MH/0000-0003-2024-4945	Australian Government Department of Health; AstraZeneca Pty Ltd (Australia); Sequirus Australia) Pty Ltd; Sanofi-Aventis Australia Pty Ltd; AbbVie Pty Ltd; Merck, Sharp and Dohme (Australia) Pty Ltd; Pfizer Australia; National Prescribing Service Ltd; GlaxoSmithKline Australia Pty Ltd; Bayer Australia Ltd; Janssen-Cilag Pty Ltd; Abbott Australasia Pty Ltd; Wyeth Australia Pty Ltd; Roche Products Pty Ltd; National Health Medical Research Council (NHMRC) Principal Research Fellowship [APP1058440]; NHMRC practitioner Fellowship [APP1079777]; NHMRC program [1091302]	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); AstraZeneca Pty Ltd (Australia)(AstraZeneca); Sequirus Australia) Pty Ltd; Sanofi-Aventis Australia Pty Ltd(Sanofi-Aventis); AbbVie Pty Ltd(AbbVie); Merck, Sharp and Dohme (Australia) Pty Ltd(Merck & Company); Pfizer Australia(PfizerPfizer Australia); National Prescribing Service Ltd; GlaxoSmithKline Australia Pty Ltd; Bayer Australia Ltd; Janssen-Cilag Pty Ltd(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott Australasia Pty Ltd(Abbott Laboratories); Wyeth Australia Pty Ltd; Roche Products Pty Ltd; National Health Medical Research Council (NHMRC) Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC program(National Health and Medical Research Council (NHMRC) of Australia)	BEACH supporting organisations 2000-2016 include: Australian Government Department of Health (1998-2004,2007-2016); AstraZeneca Pty Ltd (Australia) (1998-2016); Sequirus Australia) Pty Ltd (2010-2016); Sanofi-Aventis Australia Pty Ltd (2006-2012,2015-16); AbbVie Pty Ltd (2014-2015); Merck, Sharp and Dohme (Australia) Pty Ltd (2002-2013); Pfizer Australia (2003-2013); National Prescribing Service Ltd (2005-2009,2012-2013); GlaxoSmithKline Australia Pty Ltd (2010-2012); Bayer Australia Ltd (2010-2011); Janssen-Cilag Pty Ltd (2000-2010); Abbott Australasia Pty Ltd (2006-2010); Wyeth Australia Pty Ltd (2008-2010); Roche Products Pty Ltd (1998-2006). KLB is supported by a National Health Medical Research Council (NHMRC) Principal Research Fellowship (APP1058440). DJH has a NHMRC practitioner Fellowship (APP1079777). MH is supported by a NHMRC program grant (#1091302). The funders had no role in any part of the study or in any decision about the publication.	Alizadehkhaiyat O, 2007, J ELECTROMYOGR KINES, V17, P428, DOI 10.1016/j.jelekin.2006.04.007; [Anonymous], 2012, BRUKNER KHANS CLIN S; Bisset L, 2006, BMJ-BRIT MED J, V333, P939, DOI 10.1136/bmj.38961.584653.AE; Bisset LM, 2015, J PHYSIOTHER, V61, P174, DOI 10.1016/j.jphys.2015.07.015; Brand CA, 2014, ARTHRIT CARE RES, V66, P551, DOI 10.1002/acr.22197; Britt H., 2014, DECADE AUSTR GEN PRA; Britt H., 2016, GEN PRACTICE ACTIVIT; Britt H, 2015, AUST FAM PHYSICIAN, V44, P411; Coombes BK, 2015, J ORTHOP SPORT PHYS, V45, P938, DOI 10.2519/jospt.2015.5841; Coombes BK, 2013, JAMA-J AM MED ASSOC, V309, P461, DOI 10.1001/jama.2013.129; Coombes BK, 2012, BRIT J SPORT MED, V46, P449, DOI 10.1136/bjsm.2011.083949; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; Descatha A, 2015, JOINT BONE SPINE, V82, P5, DOI 10.1016/j.jbspin.2014.10.013; Family Medicine Research Centre TUoS, 2016, ICPC 2 PLUS BEACH CO; Family Medicine Research Centre TUoS, CAPS COD ATL PHARM S; Franceschi F, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/670262; Gruchow H W, 1979, Am J Sports Med, V7, P234; Harrison CM, 2011, MED J AUSTRALIA, V195, P192, DOI 10.5694/j.1326-5377.2011.tb03278.x; Jacobson JA, 2014, J ULTRAS MED, V33, P1041, DOI 10.7863/ultra.33.6.1041; Krzywinski M, 2013, NAT METHODS, V10, P921, DOI 10.1038/nmeth.2659; KURPPA K, 1991, SCAND J WORK ENV HEA, V17, P32, DOI 10.5271/sjweh.1737; Linaker CH, 1999, BEST PRACT RES CL RH, V13, P197, DOI 10.1053/berh.1999.0016; Malhi GS, 2015, AUST NZ J PSYCHIAT, V49, P1087, DOI 10.1177/0004867415617657; National Heart Foundation of Australia, 2012, RED RISK HEART DIS E; Ranger TA, 2015, BR J SPORTS MED; Scott A, 2015, BRIT J SPORT MED, V49, P984, DOI 10.1136/bjsports-2014-093989; Shiri R, 2006, AM J EPIDEMIOL, V164, P1065, DOI 10.1093/aje/kwj325; Smidt N, 2002, LANCET, V359, P657, DOI 10.1016/S0140-6736(02)07811-X; Smidt N, 2006, BMJ-BRIT MED J, V333, P927, DOI 10.1136/bmj.39017.396389.BE; Smidt N, 2006, J RHEUMATOL, V33, P2053; VERHAAR JAN, 1994, INT ORTHOP, V18, P263; Vicenzino B, 2003, MANUAL THER, V8, P66, DOI 10.1016/S1356-689X(02)00157-1; Walker-Bone K, 2004, ARTHRIT RHEUM-ARTHR, V51, P642, DOI 10.1002/art.20535; World Health Organization, 2004, ICD 10 INT STAT CLAS, DOI 10/2016/en#/II; World Organization of National Colleges A Committee AAoGPFPC, 1998, ICPC 2 INT CLASS PRI	35	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181631	10.1371/journal.pone.0181631	http://dx.doi.org/10.1371/journal.pone.0181631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727755	Green Published, gold			2022-12-27	WOS:000406634500097
J	Xiao, SL; Li, YG; Wong, TW; Hui, DSC				Xiao, Shenglan; Li, Yuguo; Wong, Tze-Wai; Hui, David S. C.			Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS; SUPER-SPREADERS; AIR-FLOW; INFLUENZA; INFECTION; VIRUS; CONTAMINATION; PREVENTION; PATIENT	The epidemic of severe acute respiratory syndrome (SARS) had a significant effect on global society in the early 2000s and the potential of its resurgence exists. Studies on the modes of transmission of SARS are limited though a number of outbreak studies have revealed the possible airborne route. To develop more specific and effective control strategies, we conducted a detailed mechanism-based investigation that explored the role of fomite transmission in the well-known Ward 8A outbreak. We considered three hypothetical transmission routes, i.e., the long-range airborne, fomite and combined routes, in 1,744 scenarios with combinations of some important parameters. A multi-agent model was used to predict the infection risk distributions of the three hypothetical routes. Model selection was carried out for different scenarios to compare the distributions of infection risk with that of the reported attack rates and select the hypotheses with the best fitness. Our results reveal that under the assumed conditions, the SARS coronavirus was most possible to have spread via the combined long-range airborne and fomite routes, and that the fomite route played a non-negligible role in the transmission.	[Xiao, Shenglan; Li, Yuguo] Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China; [Wong, Tze-Wai] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Hui, David S. C.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Xiao, SL (corresponding author), Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.	u3002980@hku.hk	Li, Yuguo/A-9469-2010; Shenglan, Xiao/M-9801-2019; Hui, David Shu-Cheong/O-2754-2015	Li, Yuguo/0000-0002-2281-4529; Shenglan, Xiao/0000-0002-6265-9199; Hui, David Shu-Cheong/0000-0003-4382-2445	Research Grants Council (RGC) General Research Fund (GRF) of the Hong Kong SAR Government [17205014]; Research Grants Council (RGC) Theme-based Research Scheme (TRS) of the Hong Kong SAR Government [T11-705/14-N]	Research Grants Council (RGC) General Research Fund (GRF) of the Hong Kong SAR Government; Research Grants Council (RGC) Theme-based Research Scheme (TRS) of the Hong Kong SAR Government	The study was supported by an Research Grants Council (RGC) General Research Fund (GRF) grant (No. 17205014) and an Research Grants Council (RGC) Theme-based Research Scheme (TRS) grant (No. T11-705/14-N) of the Hong Kong SAR Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Chen C, 2011, J R SOC INTERFACE, V8, P699, DOI 10.1098/rsif.2010.0486; Chen YC, 2004, EMERG INFECT DIS, V10, P782, DOI 10.3201/eid1005.030579; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Cheng VCC, 2013, ANTIVIR RES, V100, P407, DOI 10.1016/j.antiviral.2013.08.016; DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005; Dowell SF, 2004, CLIN INFECT DIS, V39, P652, DOI 10.1086/422652; Draper NR, 1966, APPL REGRESSION ANAL, V3; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Gao X., 2011, THESIS; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gryphon Scientific, 2015, SUPPL INF DOS RESP P; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; Legislative Council Select Committee, 2003, OUTBR PRINC WAL HOSP; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Y, 2005, INDOOR AIR, V15, P96, DOI 10.1111/j.1600-0668.2004.00318.x; Li Y, 2005, INDOOR AIR, V15, P83, DOI 10.1111/j.1600-0668.2004.00317.x; Li YG, 2000, BUILD ENVIRON, V35, P191, DOI 10.1016/S0360-1323(99)00011-6; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Nicas M, 2009, RISK ANAL, V29, P1292, DOI 10.1111/j.1539-6924.2009.01253.x; Otter JA, 2016, J HOSP INFECT, V92, P235, DOI 10.1016/j.jhin.2015.08.027; Peckham R., 2016, HAS SARS GONE STRANG; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Samuel H., 2014, DAILY TELEGRAPH; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Shirato K, 2012, J GEN VIROL, V93, P1908, DOI 10.1099/vir.0.043117-0; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; Teleman MD, 2004, EPIDEMIOL INFECT, V132, P797, DOI [10.1017/S0950268804002766, 10.1017/s0950268804002766]; WHO, 2004, SUMM PROB SARS CAS O; Wolff MH, 2005, BIRK ADV INFECT DIS, P201; Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013; Wong RSM, 2004, EMERG INFECT DIS, V10, P339, DOI 10.3201/eid1002.030645; Wong TW, 2004, EMERG INFECT DIS, V10, P269, DOI 10.3201/eid1002.030452; World Health Organisation, CHIN LAT SARS OUTBR; World Health Organization, 2016, SIT UPD SARS; World Health Organization, 2003, AL VER PUBL HLTH MAN; World Health Organization, 2003, SEV AC RESP SYNDR SA; World Health Organization, SEV AC RESP SYNDR SA; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867	45	65	68	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181558	10.1371/journal.pone.0181558	http://dx.doi.org/10.1371/journal.pone.0181558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727803	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500086
J	Chen, XG; Lu, XK; Shu, N; Wang, DL; Wang, S; Wang, JJ; Guo, LX; Guo, XN; Fan, WL; Lin, ZX; Ye, WW				Chen, Xiugui; Lu, Xuke; Shu, Na; Wang, Delong; Wang, Shuai; Wang, Junjuan; Guo, Lixue; Guo, Xiaoning; Fan, Weili; Lin, Zhongxu; Ye, Wuwei			GhSOS1, a plasma membrane Na+/H+ antiporter gene from upland cotton, enhances salt tolerance in transgenic Arabidopsis thaliana	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM; ION HOMEOSTASIS; PROTEIN-KINASE; SOS1; TRANSPORT; CONSERVATION; EXPRESSION; HALOPHYTE	Upland cotton (Gossypium hirsutum L.), an important source of natural fiber, can tolerate relatively high salinity and drought stresses. In the present study, a plasma membrane Na+/H+ antiporter gene, GhSOS1, was cloned from a salt-tolerant genotype of G. hirsutum, Zhong 9807. The expression level of GhSOS1 in cotton roots was significantly upregulated in the presence of high concentrations of NaCl (200 mM), while its transcript abundance was increased when exposed to low temperature and drought stresses. Localization analysis using onion epidermal cells showed that the GhSOS1 protein was localized to the plasma membrane. The overexpression of GhSOS1 in Arabidopsis enhanced tolerance to salt stress, as indicated by a lower MDA content and decreased Na+/K+ ratio in transgenic plants. Moreover, the transcript levels of stress-related genes were significantly higher in GhSOS1 overexpression lines than in wild-type plants under salt treatment. Hence, GhSOS1 may be a potential target gene for enhancing salt tolerance in transgenic plants.	[Chen, Xiugui; Lu, Xuke; Shu, Na; Wang, Delong; Wang, Shuai; Wang, Junjuan; Guo, Lixue; Guo, Xiaoning; Fan, Weili; Ye, Wuwei] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Chen, Xiugui; Lin, Zhongxu] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Huazhong Agricultural University	Ye, WW (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	yew158@163.com			National key research and development program [2016YFD0101400]; National Key Program of Research and Development in China [2016YFD0101400]	National key research and development program; National Key Program of Research and Development in China	This work was supported by grants from National key research and development program (2016YFD0101400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from National Key Program of Research and Development in China (2016YFD0101400).	An J, 2014, MOL BIOL REP, V41, P4155, DOI 10.1007/s11033-014-3287-2; Ashraf M, 2000, FIELD CROP RES, V66, P115, DOI 10.1016/S0378-4290(00)00064-2; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Chung JS, 2008, PLANT J, V53, P554, DOI 10.1111/j.1365-313X.2007.03364.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Fraile-Escanciano A, 2010, NEW PHYTOL, V188, P750, DOI 10.1111/j.1469-8137.2010.03405.x; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Iqbal K, 2011, INT J AGRIC BIOL, V13, P61; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Jain M, 2001, PLANT CELL REP, V20, P463, DOI 10.1007/s002990100353; Kant S, 2006, PLANT CELL ENVIRON, V29, P1220, DOI 10.1111/j.1365-3040.2006.01502.x; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li Q, 2014, MOL BIOL REP, V41, P5097, DOI 10.1007/s11033-014-3375-3; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Maathuis FJM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00467; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Oh DH, 2009, PLANT PHYSIOL, V151, P210, DOI 10.1104/pp.109.137802; Olias R, 2009, PLANT CELL ENVIRON, V32, P904, DOI 10.1111/j.1365-3040.2009.01971.x; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Rus A, 2001, P NATL ACAD SCI USA, V98, P14150, DOI 10.1073/pnas.241501798; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Song A, 2012, PLANT BIOLOGY, V14, P706, DOI 10.1111/j.1438-8677.2011.00560.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Wu YX, 2007, PLANT MOL BIOL, V65, P1, DOI 10.1007/s11103-007-9170-y; Xu HX, 2008, ARCH BIOCHEM BIOPHYS, V473, P8, DOI 10.1016/j.abb.2008.02.018; Yadav NS, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-188; Zhou L, 2015, PLANT PHYSIOL BIOCH, V96, P311, DOI 10.1016/j.plaphy.2015.08.016; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	38	37	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181450	10.1371/journal.pone.0181450	http://dx.doi.org/10.1371/journal.pone.0181450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723926	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800050
J	Dean, CL; Eggleston, BA; Gibney, KD; Aligbe, E; Blackwell, M; Kwakye, LD				Dean, Cassandra L.; Eggleston, Brady A.; Gibney, Kyla David; Aligbe, Enimielen; Blackwell, Marissa; Kwakye, Leslie Dowell			Auditory and visual distractors disrupt multisensory temporal acuity in the crossmodal temporal order judgment task	PLOS ONE			English	Article							AUDIOVISUAL SPEECH-PERCEPTION; SUPERIOR COLLICULUS NEURONS; AUTISM SPECTRUM DISORDERS; SPATIAL ATTENTION; PRIOR ENTRY; SENSORY MODALITIES; DEVELOPMENTAL DYSLEXIA; PSYCHOMETRIC FUNCTION; SELECTIVE ATTENTION; TIME-WINDOW	The ability to synthesize information across multiple senses is known as multisensory integration and is essential to our understanding of the world around us. Sensory stimuli that occur close in time are likely to be integrated, and the accuracy of this integration is dependent on our ability to precisely discriminate the relative timing of unisensory stimuli (crossmodal temporal acuity). Previous research has shown that multisensory integration is modulated by both bottom-up stimulus features, such as the temporal structure of unisensory stimuli, and top-down processes such as attention. However, it is currently uncertain how attention alters crossmodal temporal acuity. The present study investigated whether increasing attentional load would decrease crossmodal temporal acuity by utilizing a dual-task paradigm. In this study, participants were asked to judge the temporal order of a flash and beep presented at various temporal offsets (crossmodal temporal order judgment (CTOJ) task) while also directing their attention to a secondary distractor task in which they detected a target stimulus within a stream visual or auditory distractors. We found decreased performance on the CTOJ task as well as increases in both the positive and negative just noticeable difference with increasing load for both the auditory and visual distractor tasks. This strongly suggests that attention promotes greater crossmodal temporal acuity and that reducing the attentional capacity to process multisensory stimuli results in detriments to multisensory temporal processing. Our study is the first to demonstrate changes in multisensory temporal processing with decreased attentional capacity using a dual task paradigm and has strong implications for developmental disorders such as autism spectrum disorders and developmental dyslexia which are associated with alterations in both multisensory temporal processing and attention.	[Dean, Cassandra L.; Eggleston, Brady A.; Gibney, Kyla David; Aligbe, Enimielen; Blackwell, Marissa; Kwakye, Leslie Dowell] Oberlin Coll, Dept Neurosci, Oberlin, OH 44074 USA	Oberlin College	Kwakye, LD (corresponding author), Oberlin Coll, Dept Neurosci, Oberlin, OH 44074 USA.	LKwakye@oberlin.edu		Gibney, Kyla/0000-0003-4319-9200	Oberlin College Research Fellowship; Oberlin College Office of Foundation, Government, and Corporate Grants	Oberlin College Research Fellowship; Oberlin College Office of Foundation, Government, and Corporate Grants	We would like to thank the Oberlin College Research Fellowship and the Oberlin College Office of Foundation, Government, and Corporate Grants for their support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the contributions of Susan Russ to some of the data collection and analysis for this study. We would also like to thank the Oberlin College Research Fellowship and the Oberlin College Office of Foundation, Government, and Corporate Grants for their support of this study.	Alain C, 2003, J COGNITIVE NEUROSCI, V15, P1063, DOI 10.1162/089892903770007443; Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Alsius A, 2007, EXP BRAIN RES, V183, P399, DOI 10.1007/s00221-007-1110-1; Alsius A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00727; Asanowicz D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00452; Barrett DJK, 2012, EXP BRAIN RES, V222, P11, DOI 10.1007/s00221-012-3191-8; Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Bonato M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136719; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; Colonius H, 2004, J COGNITIVE NEUROSCI, V16, P1000, DOI 10.1162/0898929041502733; Diederich A, 2015, PSYCHOL REV, V122, P232, DOI 10.1037/a0038696; Donohue SE, 2015, FRONT INTEGR NEUROSC, V9, DOI [10.3389/fnint.2015.00032, 10.3389/fnint.2015.0003]; Donohue SE, 2011, J NEUROSCI, V31, P7982, DOI 10.1523/JNEUROSCI.5298-10.2011; Driver J, 1998, TRENDS COGN SCI, V2, P254, DOI 10.1016/S1364-6613(98)01188-7; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Foss-Feig JH, 2010, EXP BRAIN RES, V203, P381, DOI 10.1007/s00221-010-2240-4; Gibney KD, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00001; Greenaway R, 2005, PSYCHOL SCI, V16, P987, DOI 10.1111/j.1467-9280.2005.01648.x; Hairston WD, 2005, EXP BRAIN RES, V166, P474, DOI 10.1007/s00221-005-2387-6; Hillock AR, 2011, NEUROPSYCHOLOGIA, V49, P461, DOI 10.1016/j.neuropsychologia.2010.11.041; Hillock-Dunn A., 2016, NEUROPSYCHOLOGIA; Holmes NP, 2007, CORTEX, V43, P469, DOI 10.1016/S0010-9452(08)70471-4; Jacoby O, 2012, NEUROIMAGE, V61, P1050, DOI 10.1016/j.neuroimage.2012.03.040; Klemen J, 2009, EUR J NEUROSCI, V29, P2426, DOI 10.1111/j.1460-9568.2009.06774.x; Kostaki M, 2016, VISION RES, V127, P165, DOI 10.1016/j.visres.2016.08.004; Krause MB, 2015, DYSLEXIA, V21, P285, DOI 10.1002/dys.1505; Kwakye LD, 2011, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00129; Lavie N, 2003, PSYCHOL SCI, V14, P510, DOI 10.1111/1467-9280.03453; Marchant JL, 2012, HUM BRAIN MAPP, V33, P1212, DOI 10.1002/hbm.21278; Mazza V, 2007, NEUROPSYCHOLOGIA, V45, P514, DOI 10.1016/j.neuropsychologia.2006.02.010; Megevand P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071608; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Molholm S, 2007, EUR J NEUROSCI, V26, P499, DOI 10.1111/j.1460-9568.2007.05668.x; Molloy K, 2015, J NEUROSCI, V35, P16046, DOI 10.1523/JNEUROSCI.2931-15.2015; Mozolic JL, 2008, EXP BRAIN RES, V184, P39, DOI 10.1007/s00221-007-1080-3; Murata A, 2017, APPL ERGON, V60, P58, DOI 10.1016/j.apergo.2016.11.002; Noel JP, 2016, NEUROPSYCHOLOGIA, V82, P84, DOI 10.1016/j.neuropsychologia.2016.01.005; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Parks NA, 2011, J COGNITIVE NEUROSCI, V23, P1113, DOI 10.1162/jocn.2010.21460; Pierno AC, 2005, APPL ERGON, V36, P335, DOI 10.1016/j.apergo.2004.11.002; Powers AR, 2012, J NEUROSCI, V32, P6263, DOI 10.1523/JNEUROSCI.6138-11.2012; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; Rees G, 2001, NEUROPSYCHOLOGIA, V39, P937, DOI 10.1016/S0028-3932(01)00016-1; Santangelo V, 2008, CONSCIOUS COGN, V17, P989, DOI 10.1016/j.concog.2008.02.006; Santangelo V, 2008, PSYCHON B REV, V15, P398, DOI 10.3758/PBR.15.2.398; Santangelo V, 2007, J EXP PSYCHOL HUMAN, V33, P1311, DOI 10.1037/0096-1523.33.6.1311; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Senkowski D, 2007, NEUROPSYCHOLOGIA, V45, P561, DOI 10.1016/j.neuropsychologia.2006.01.013; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Spence C, 2009, HEARING RES, V258, P134, DOI 10.1016/j.heares.2009.04.015; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Stevenson RA, 2014, BRAIN TOPOGR, V27, P707, DOI 10.1007/s10548-014-0365-7; Stevenson RA, 2014, J NEUROSCI, V34, P691, DOI 10.1523/JNEUROSCI.3615-13.2014; Stevenson RA, 2013, EXP BRAIN RES, V227, P249, DOI 10.1007/s00221-013-3507-3; Stevenson RA, 2013, EXP BRAIN RES, V225, P479, DOI 10.1007/s00221-012-3387-y; Stevenson RA, 2010, NEUROIMAGE, V49, P3308, DOI 10.1016/j.neuroimage.2009.12.001; Stolte M, 2014, J VISION, V14, DOI 10.1167/14.3.9; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Talsma D, 2009, EXP BRAIN RES, V198, P313, DOI 10.1007/s00221-009-1858-6; Tang XY, 2016, NEUROSCI BIOBEHAV R, V61, P208, DOI 10.1016/j.neubiorev.2015.11.002; Treutwein B, 1999, PERCEPT PSYCHOPHYS, V61, P87, DOI 10.3758/BF03211951; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05098; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; Vatakis A, 2006, NEUROSCI LETT, V408, P5, DOI 10.1016/j.neulet.2006.06.017; Venezia JH, 2016, ATTEN PERCEPT PSYCHO, V78, P583, DOI 10.3758/s13414-015-1026-y; Vibell J, 2007, J COGNITIVE NEUROSCI, V19, P109, DOI 10.1162/jocn.2007.19.1.109; Vroomen J, 2001, PERCEPT PSYCHOPHYS, V63, P651, DOI 10.3758/BF03194427; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; Wahn B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01084; Wallace MT, 2014, NEUROPSYCHOLOGIA, V64, P105, DOI 10.1016/j.neuropsychologia.2014.08.005; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Woynaroski TG, 2013, J AUTISM DEV DISORD, V43, P2891, DOI 10.1007/s10803-013-1836-5; Yates MJ, 2011, ATTEN PERCEPT PSYCHO, V73, P1586, DOI 10.3758/s13414-011-0117-7; Zampini M, 2005, NEUROSCI LETT, V381, P217, DOI 10.1016/j.neulet.2005.01.085; Zampini M, 2007, NEUROSCI LETT, V414, P75, DOI 10.1016/j.neulet.2006.12.006; Zimmer U, 2010, NEUROIMAGE, V52, P606, DOI 10.1016/j.neuroimage.2010.04.245	85	8	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179564	10.1371/journal.pone.0179564	http://dx.doi.org/10.1371/journal.pone.0179564			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723907	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800006
J	Schmidt, P; Nash, DJ; Coulson, S; Goden, MB; Awcock, GJ				Schmidt, Patrick; Nash, David J.; Coulson, Sheila; Goeden, Matthias B.; Awcock, Graeme J.			Heat treatment as a universal technical solution for silcrete use? A comparison between silcrete from the Western Cape (South Africa) and the Kalahari (Botswana)	PLOS ONE			English	Article							MIDDLE STONE-AGE; CALCRETE INTERGRADE DURICRUSTS; LENGTH-FAST CHALCEDONY; TSODILO HILLS; TRANSFORMATIONS; ARTIFACTS; BEHAVIOR; WATER; CAVE; TECHNOLOGY	Heat treatment was one of the first transformative technologies in the southern African Middle Stone Age (MSA), with many studies in the Cape coastal zone of South Africa identifying it as an essential step in the preparation of silcrete prior to its use in stone tool manufacture. To date, however, no studies have investigated whether heat treatment is necessary for all silcrete types, and how geographically widespread heat treatment was in the subcontinent. The aim of this study is to investigate experimentally whether heat treatment continued further north into the Kalahari Desert of Botswana and northernmost South Africa, the closest area with major silcrete outcrops to the Cape. For this we analyse the thermal transformations of silcrete from both regions, proposing a comprehensive model of the chemical, crystallographic and 'water'-related processes taking place upon heat treatment. For the first time, we also explore the mobility of minor and trace elements during heat treatment and introduce a previously undescribed mechanism-steam leaching-causing depletion of a limited number of elements. The results of this comparative study reveal the Cape and Kalahari silcrete to respond fundamentally differently to heat treatment. While the former can be significantly improved by heat, the latter is deteriorated in terms of knapping quality. These findings have important implications for our understanding of the role of fire as a technical solution in MSA stone tool knapping, and for the extension of its use in southern Africa. Silcrete heat treatment-at least in the form we understand it today-may have been a strictly regional phenomenon, confined to a narrow zone along the west and south coast of the Cape. On the basis of our findings, silcrete heat treatment should not be added as a new trait on the list of behaviours that characterise the MSA of the southern African subcontinent.	[Schmidt, Patrick; Goeden, Matthias B.] Eberhard Karls Univ Tubingen, Dept Prehist & Quaternary Ecol, Tubingen, Germany; [Schmidt, Patrick] Eberhard Karls Univ Tubingen, Dept Geosci, Appl Mineral, Tubingen, Germany; [Nash, David J.] Univ Brighton, Sch Environm & Technol, Brighton, E Sussex, England; [Nash, David J.; Awcock, Graeme J.] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Coulson, Sheila] Univ Oslo, Inst Archaeol Conservat & Hist, Dept Archaeol, Oslo, Norway	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Brighton; University of Witwatersrand; University of Oslo	Schmidt, P (corresponding author), Eberhard Karls Univ Tubingen, Dept Prehist & Quaternary Ecol, Tubingen, Germany.; Schmidt, P (corresponding author), Eberhard Karls Univ Tubingen, Dept Geosci, Appl Mineral, Tubingen, Germany.	patrick.schmidt@uni-tuebingen.de	Schmidt, Patrick/D-3925-2016	Schmidt, Patrick/0000-0002-8727-6127; Nash, David/0000-0002-7641-5857	Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen; British Academy and Leverhulme Trust [SG142023]; Deutsche Forschungsgemeinschaft (DFG) [SCHM 3275/2-1, CO 226/25-1, MI 1748/2-1, NI 299/25-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen; British Academy and Leverhulme Trust; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. We thank the British Academy and Leverhulme Trust (small research grant number SG142023) for funding the project 'Heat treatment of silcrete raw materials: the implications of temperature-induced transformations for archaeological provenancing studies'. Financial support for PS was provided by the Deutsche Forschungsgemeinschaft (DFG) (grant numbers SCHM 3275/2-1 and CO 226/25-1, MI 1748/2-1, NI 299/25-1).	[Anonymous], 1976, ATLAS INFRARED SPECT; [Anonymous], 2007, R X RAY DIFFRACTION; Brooks A.S., 1977, BOTSW NOTES REC, V9, P21; Brooks A.S., 1978, BOTSW NOTES REC, V10, P1; Brown K, 2010, ABSTRACTS PALEOANTHR; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Burnham CW., 1969, GEOL SOC AM SPEC PAP, V132, p96p; Coulson S., 2011, PALEOANTHROPOLOGY, V2011, P18, DOI DOI 10.4207/PA.2011.ART42; Delagnes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163874; GRAETSCH H, 1985, PHYS CHEM MINER, V12, P300, DOI 10.1007/BF00310343; HELGREN DM, 1983, J ARCHAEOL SCI, V10, P181, DOI 10.1016/0305-4403(83)90051-1; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Inizan ML, 1976, QUATERNARIA, V19, P1; KRONENBERG AK, 1994, REV MINERAL, V29, P123; Milot J, 2016, ARCHAEOMETRY; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Nash D.J., 2007, GEOCHEMICAL SEDIMENT, P95; Nash DJ, 2016, J HUM EVOL, V96, P113, DOI 10.1016/j.jhevol.2016.05.004; Nash DJ, 2013, J HUM EVOL, V64, P280, DOI 10.1016/j.jhevol.2013.01.010; Nash DJ, 2004, EARTH SURF PROC LAND, V29, P1559, DOI 10.1002/esp.1138; NASH DJ, 1994, PALAEOGEOGR PALAEOCL, V112, P279, DOI 10.1016/0031-0182(94)90077-9; NASH DJ, 1994, EARTH SURF PROCESSES, V19, P299, DOI 10.1002/esp.3290190403; Nash DJ, 1998, J AFR EARTH SCI, V27, P11, DOI 10.1016/S0899-5362(98)00043-8; PELTO CR, 1956, AM J SCI, V254, P32, DOI 10.2475/ajs.254.1.32; Porraz G, 2016, SOUTH AFR HUMANIT, V29, P203; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Ritchie RO, 1999, INT J FRACTURE, V100, P55, DOI 10.1023/A:1018655917051; Scherrer P., 1918, NACHRICHTEN GESELLSC, V2, P96; Schmidt P, 2016, J ARCHAEOLOGICAL SCI; Schmidt P, 2017, PHYS CHEM MINER, V44, P21, DOI 10.1007/s00269-016-0833-6; Schmidt P, 2016, ARCHAEOL ANTHROP SCI, V8, P839, DOI 10.1007/s12520-015-0259-y; Schmidt P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149243; Schmidt P, 2015, J HUM EVOL, V85, P22, DOI 10.1016/j.jhevol.2015.05.001; Schmidt P, 2014, ARCHAEOL ANTHROP SCI, V6, P107, DOI 10.1007/s12520-013-0162-3; Schmidt P, 2013, J ARCHAEOL SCI, V40, P3519, DOI 10.1016/j.jas.2012.10.016; Schmidt P, 2013, PHYS CHEM MINER, V40, P331, DOI 10.1007/s00269-013-0574-8; Schmidt P, 2012, PHYS CHEM MINER, V39, P455, DOI 10.1007/s00269-012-0499-7; Schmidt P, 2012, J ARCHAEOL SCI, V39, P135, DOI 10.1016/j.jas.2011.09.012; Schmidt P, 2011, SPECTROCHIM ACTA A, V81, P552, DOI 10.1016/j.saa.2011.06.050; Scholze H., 1960, FORTSCHR MINERAL, V38, P122; SCHWERTMANN U, 1993, SSSA SPEC PUBL, V31, P51; Shaw PA, 1998, EARTH SURF PROC LAND, V23, P705, DOI 10.1002/(SICI)1096-9837(199808)23:8<705::AID-ESP875>3.0.CO;2-7; Staurset S, 2014, J HUM EVOL, V75, P153, DOI 10.1016/j.jhevol.2014.04.006; Summerfield M. A., 1983, Chemical sediments and geomorphology: Precipitates and residua in the near-surface environment, P59; Summerfield M.A., 1982, CATENA, V1, P37; Summerfield M.A., 1983, SPECIAL PUBLICATION, V11, P167, DOI [10.1144/GSL.SP.1983.011.01.17, DOI 10.1144/GSL.SP.1983.011.01.17]; SUMMERFIELD MA, 1983, J SEDIMENT PETROL, V53, P895; Summerfield MA, 1981, S AFRICA S AFRICA SC; Thiry M, 2016, J ARCHAEOLOGICAL SCI; Troscianko J, 2015, METHODS ECOL EVOL, V6, P1320, DOI 10.1111/2041-210X.12439; Wadley L, 2014, J HUM EVOL, V70, P49, DOI 10.1016/j.jhevol.2013.11.003; Wadley L, 2013, CAMB ARCHAEOL J, V23, P163, DOI 10.1017/S0959774313000309; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6; Wurz S, 2013, CURR ANTHROPOL, V54, pS305, DOI 10.1086/673283	55	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181586	10.1371/journal.pone.0181586	http://dx.doi.org/10.1371/journal.pone.0181586			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723941	Green Published, gold			2022-12-27	WOS:000406067800059
J	Alanagreh, L; Pegg, C; Harikumar, A; Buchheim, M				Alanagreh, Lo'ai; Pegg, Caitlin; Harikumar, Amritha; Buchheim, Mark			Assessing intragenomic variation of the internal transcribed spacer two: Adapting the Illumina metagenomics protocol	PLOS ONE			English	Article							HAEMATOCOCCUS CHLOROPHYCEAE; CONCERTED EVOLUTION; FUNGAL COMMUNITIES; PROFILE DISTANCES; GENE CONVERSION; RIBOSOMAL DNA; RDNA REGION; ITS2 RDNA; PHYLOGENY; DIVERSITY	Primary and secondary structural data from the internal transcribed spacer two (ITS2) have been used extensively for diversity studies of many different eukaryotic organisms, including the green algae. Ease of amplification is due, at least in part, to the fact that ITS2 is part of the tandemly-repeated rRNA array. The potential confounding influence of intragenomic variability has yet to be addressed except in a few organisms. Moreover, few of the assessments of intragenomic variation have taken advantage of the deep sequencing capacity of sequence-by-synthesis protocols. We present results from our adaptation of the 16S Meta-genomics Sequencing Library Preparation/Illumina protocol for deep sequencing of the ITS2 genes in selected isolates of the green algal genus, Haematococcus. Deep sequencing yielded from just under 20,000 to more than 500,000 merged reads, outpacing results from recent pyrosequencing efforts. Furthermore, a conservative evaluation of these data revealed a range of three to six ITS2 sequence haplotypes (defined as unique sets of nucleotide polymorphisms) across the taxon sampling. The frequency of the dominant haplotype ranged from 0.35 to 0.98. In all but two cases, the haplotype with the greatest frequency corresponded to a sequence obtained by the Sanger method using PCR templates. Our data also show that results from the sequencing-by-synthesis approach are reproducible. In addition to advancing our understanding of ribosomal RNA variation, the results of this investigation will allow us to begin testing hypotheses regarding the maintenance of homogeneity across multi-copy genes.	[Alanagreh, Lo'ai; Pegg, Caitlin; Harikumar, Amritha; Buchheim, Mark] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA; [Pegg, Caitlin] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Harikumar, Amritha] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA	University of Tulsa; Northwestern University; Feinberg School of Medicine; California State University System; San Diego State University	Buchheim, M (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	mark-buchheim@utulsa.edu		Harikumar, Amritha/0000-0002-6681-7756; Alanagreh, loai/0000-0001-5759-4581	Office of Research at the University of Tulsa; Mervin Bovaird Institute for Molecular Biology and Biotechnology at the University of Tulsa; Oklahoma Center for the Advancement of Science and Technology [PS 16-02]	Office of Research at the University of Tulsa; Mervin Bovaird Institute for Molecular Biology and Biotechnology at the University of Tulsa; Oklahoma Center for the Advancement of Science and Technology	This project was supported by grants from the Office of Research at the University of Tulsa (to MB, LS and CP), the Mervin Bovaird Institute for Molecular Biology and Biotechnology at the University of Tulsa (to MB), and the Oklahoma Center for the Advancement of Science and Technology (PS 16-02 to MB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Allewaert CC, 2015, PHYCOLOGIA, V54, P583, DOI 10.2216/15-55.1; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Ankenbrand MJ, 2015, MOL BIOL EVOL, V32, P3030, DOI 10.1093/molbev/msv174; [Anonymous], PAUP; Arif C, 2014, MOL ECOL, V23, P4418, DOI 10.1111/mec.12869; Arnheim N., 1983, P38; Bao Y, 2010, MOL PHYLOGENET EVOL, V55, P136, DOI 10.1016/j.ympev.2009.10.023; Bart A, 2008, J CLIN MICROBIOL, V46, P3270, DOI 10.1128/JCM.00680-08; Batovska J, 2017, G3-GENES GENOM GENET, V7, P19, DOI 10.1534/g3.116.036145; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Behnke A, 2004, J PHYCOL, V40, P193, DOI 10.1046/j.1529-8817.2004.03037.x; Boyanton BL, 2008, ARCH PATHOL LAB MED, V132, P667, DOI 10.1043/1543-2165(2008)132[667:DPIOPC]2.0.CO;2; Buchheim M, 2005, J PHYCOL, V41, P1039, DOI 10.1111/j.1529-8817.2005.00129.x; Buchheim MA, 2013, EUR J PHYCOL, V48, P318, DOI 10.1080/09670262.2013.830344; Buchheim MA, 2012, ANN BOT-LONDON, V109, P109, DOI 10.1093/aob/mcr275; Buchheim MA, 2010, J PHYCOL, V46, P1038, DOI 10.1111/j.1529-8817.2010.00886.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Friedrich J, 2005, BIOINFORMATICS, V21, P2108, DOI 10.1093/bioinformatics/bti289; Harder CB, 2013, FUNGAL BIOL-UK, V117, P764, DOI 10.1016/j.funbio.2013.09.004; Harpke D, 2006, MOL PHYLOGENET EVOL, V41, P579, DOI 10.1016/j.ympev.2006.05.036; Harris DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/oxfordjournals.molbev.a026308; Harris E.H, 2009, INTRO CHLAMYDOMONAS; HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647; Karlep L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066601; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Maddison W.P., MESQUITE MODULAR SYS; Mark K, 2016, GENOME, V59, P685, DOI 10.1139/gen-2015-0189; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; NAGYLAKI T, 1984, P NATL ACAD SCI-BIOL, V81, P3796, DOI 10.1073/pnas.81.12.3796; Pegg C, 2015, PHYCOLOGIA, V54, P385, DOI 10.2216/15-015.1; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; Pocock M. A., 1960, Transactions of the Royal Society of South Africa, V36, P5; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Rahmann S, 2006, ADV DATA MINING TECH, P104; Richardson R. T, 2015, APPL PLANT SCI, V3; Rybalka N, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-39; SCHLOTTERER C, 1994, CURR BIOL, V4, P777, DOI 10.1016/S0960-9822(00)00175-5; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Simon UK, 2008, MOL BIOL EVOL, V25, P2251, DOI 10.1093/molbev/msn188; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Triki A, 1997, PHYCOLOGIA, V36, P190, DOI 10.2216/i0031-8884-36-3-190.1; Vaz ABM, 2017, PHYTOTAXA, V295, P1, DOI 10.11646/phytotaxa.295.1.1; Vetrovsky T, 2013, BIOL FERT SOILS, V49, P1027, DOI 10.1007/s00374-013-0801-y; Waud M, 2014, MOL ECOL RESOUR, V14, P679, DOI 10.1111/1755-0998.12229; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wolf M, 2008, BIOINFORMATICS, V24, P2401, DOI 10.1093/bioinformatics/btn453; Wolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066726; Xiao LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117971; Xiao LQ, 2010, MOL PHYLOGENET EVOL, V55, P168, DOI 10.1016/j.ympev.2009.11.020; Zheng XY, 2008, MOL PHYLOGENET EVOL, V48, P892, DOI 10.1016/j.ympev.2008.05.039; Zimmer EA, 1980, P NATL ACAD SCI USA, V77, P2518	58	12	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181491	10.1371/journal.pone.0181491	http://dx.doi.org/10.1371/journal.pone.0181491			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719667	Green Submitted, gold, Green Published			2022-12-27	WOS:000406061400050
J	Bard, F; Chia, J				Bard, Frederic; Chia, Joanne			Comment on "The GaINAc-T Activation Pathway (GALA) is not a general mechanism for regulating mucin-type O-glycosylation"	PLOS ONE			English	Editorial Material							GALNAC; FAMILY		[Bard, Frederic] Inst Mol & Cell Biol, Proteos, Singapore, Singapore; Natl Univ Singapore, Dept Biochem, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Bard, F (corresponding author), Inst Mol & Cell Biol, Proteos, Singapore, Singapore.	fbard@imcb.a-star.edu.sg						Bard F, 2016, TRENDS CELL BIOL, V26, P379, DOI 10.1016/j.tcb.2015.12.004; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Chia J, 2014, ELIFE, V3, DOI 10.7554/eLife.01828; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Ryu H, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156458; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051	8	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180005	10.1371/journal.pone.0180005	http://dx.doi.org/10.1371/journal.pone.0180005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719645	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400007
J	Matoba, R; Morizane, Y; Shiode, Y; Hirano, M; Doi, S; Toshima, S; Araki, R; Hosogi, M; Yonezawa, T; Shiraga, F				Matoba, Ryo; Morizane, Yuki; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Araki, Ryoichi; Hosogi, Mika; Yonezawa, Tomoko; Shiraga, Fumio			Suppressive effect of AMP-activated protein kinase on the epithelial-mesenchymal transition in retinal pigment epithelial cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PROLIFERATIVE VITREORETINOPATHY; TGF-BETA; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; MATRIX METALLOPROTEINASES; THERAPEUTIC TARGET; RPE CELLS; INHIBITION; EXPRESSION; CYTOKINES	The epithelial-mesenchymal transition (EMT) in retinal pigment epithelial (RPE) cells plays a central role in the development of proliferative vitreoretinopathy (PVR). The purpose of this study was to investigate the effect of AMP-activated protein kinase (AMPK), a key regulator of energy homeostasis, on the EMT in RPE cells. In this study, EMT-associated formation of cellular aggregates was induced by co-stimulation of cultured ARPE-19 cells with tumor necrosis factor (TNF)-alpha (10 ng/ml) and transforming growth factor (TGF)-beta(2) (5 ng/ml). 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR), a potent activator of AMPK, significantly suppressed TNF-alpha and TGF-beta(2)-induced cellular aggregate formation (p < 0.01). Dipyridamole almost completely reversed the suppressive effect of AICAR, whereas 5'-amino-5'-deoxyadenosine restored aggregate formation by approximately 50%. AICAR suppressed the downregulation of E-cadherin and the upregulation of fibronectin and alpha-smooth muscle actin by TNF-alpha and TGF-beta(2). The levels of matrix metalloproteinase (MMP)-2, MMP-9, interleukin-6, and vascular endothelial growth factor were significantly decreased by AICAR. Activation of the mitogen-activated protein kinase and mammalian target of rapamycin pathways, but not the Smad pathway, was inhibited by AICAR. These findings indicate that AICAR suppresses the EMT in RPE cells at least partially via activation of AMPK. AMPK is a potential target molecule for the prevention and treatment of PVR, so AICAR may be a promising candidate for PVR therapy.	[Matoba, Ryo; Morizane, Yuki; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Araki, Ryoichi; Hosogi, Mika; Shiraga, Fumio] Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Yonezawa, Tomoko] Okayama Univ, Dept Mol Biol & Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University; Okayama University	Morizane, Y (corresponding author), Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	moriza-y@okayama-u.ac.jp		YONEZAWA, Tomoko/0000-0002-3380-8298; Matoba, Ryo/0000-0003-0440-1103				Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chan CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056819, 10.1371/journal.pone.0068504]; Chen YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044937; Eichler W, 2002, INVEST OPHTH VIS SCI, V43, P2767; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; He SK, 2010, INVEST OPHTH VIS SCI, V51, P543, DOI 10.1167/iovs.09-3475; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; HUNT RC, 1993, INVEST OPHTH VIS SCI, V34, P3179; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; KAUFFMANN DJH, 1994, INVEST OPHTH VIS SCI, V35, P900; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Kon CH, 1998, INVEST OPHTH VIS SCI, V39, P1524; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LEAVER PK, 1995, BRIT J OPHTHALMOL, V79, P871, DOI 10.1136/bjo.79.10.871; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lin H, 2015, MOL PHARMACOL, V88, P1062, DOI 10.1124/mol.115.099549; Liou G, 2002, MOL VIS, V8, P494; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Moysidis SN, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/815937; NEWSOME DA, 1981, ARCH OPHTHALMOL-CHIC, V99, P873, DOI 10.1001/archopht.1981.03930010873017; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Pennock S, 2013, AM J PATHOL, V182, P1659, DOI 10.1016/j.ajpath.2013.01.052; Qin SF, 2008, INVEST OPHTH VIS SCI, V49, P1274, DOI 10.1167/iovs.07-1109; Qiu SL, 2015, J PATHOL, V237, P330, DOI 10.1002/path.4579; Qu C, 2014, MOL CELL BIOCHEM, V386, P63, DOI 10.1007/s11010-013-1845-x; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Saika S, 2005, LAB INVEST, V85, P838, DOI 10.1038/labinvest.3700294; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Shibata T, 2013, J PHARMACOL SCI, V122, P93, DOI 10.1254/jphs.12270FP; Symeonidis C, 2007, GRAEF ARCH CLIN EXP, V245, P560, DOI 10.1007/s00417-006-0386-3; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Wang Q, 2012, INVEST OPHTH VIS SCI, V53, P2395, DOI 10.1167/iovs.11-8982; Xiao W, 2014, J CELL MOL MED, V18, P646, DOI 10.1111/jcmm.12212; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Yang S, 2015, DISCOV MED, V20, P207; Zhao ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095884	44	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181481	10.1371/journal.pone.0181481	http://dx.doi.org/10.1371/journal.pone.0181481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719670	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400048
J	Huang, CN; Wang, CJ; Lee, YJ; Peng, CH				Huang, Chien-Ning; Wang, Chau-Jong; Lee, Yi-Ju; Peng, Chiung-Huei			Active subfractions of Abelmoschus esculentus substantially prevent free fatty acid-induced beta cell apoptosis via inhibiting dipeptidyl peptidase-4	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SIGNALING PATHWAY; PROTEIN-KINASE; HIGH GLUCOSE; AMPK; SURVIVAL; PROLIFERATION; LIPOTOXICITY; LIPOGENESIS; ACTIVATION	Lipotoxicity plays an important role in exacerbating type 2 diabetes mellitus (T2DM) and leads to apoptosis of beta cells. Recently dipeptidyl peptidase-4 (DPP-4) inhibitors have emerged as a useful tool in the treatment of T2DM. DPP-4 degrades type 1 glucagon-like peptide (GLP-1), and GLP-1 receptor (GLP-1R) signaling has been shown to protect beta cells by modulating AMPK/mTOR, PI3K, and Bax. The anti-hyperglycemic effect of Abelmoschus esculentus (AE) is well known, however its mucilage makes it difficult to further examine this effect. In our recent report, a sequence of extraction steps was used to obtain a series of subfractions from AE, each with its own composition and property. Among them F1 (rich in quercetin glucosides and pentacyclic triterpene ester) and F2 (containing large amounts of carbohydrates and polysaccharides) were found to be especially effective in attenuating DPP-4 signaling, and to have the potential to counter diabetic nephropathy. Hence, the aim of the present study was to investigate whether AE subfractions can prevent the palmitate-induced apoptosis of beta cells, and the putative signals involved. We demonstrated that AE, and especially 1 mu g/mL of F2, decreased palmitate-induced apoptosis analyzed by flow cytometry. The result of western blot revealed that palmitate-induced decrease in GLP-1R and increase in DPP-4 were restored by F1 and F2. The DPP-4 inhibitor linagliptin decreased the expression of caspase 3, suggesting that DPP-4 is critically involved in apoptotic signaling. Analysis of enzyme activity revealed that palmitate increased the activity of DPP4 nearly 2 folds, while F2 especially inhibited the activation. In addition, AMPK/mTOR, PI3K and mitochondrial pathways were regulated by AE, and this attenuated the palmitate-induced signaling cascades. In conclusion, AE is useful to prevent the exacerbation of beta cell apoptosis, and it could potentially be used as adjuvant or nutraceutical therapy for diabetes.	[Huang, Chien-Ning] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Huang, Chien-Ning] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wang, Chau-Jong] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Lee, Yi-Ju] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Peng, Chiung-Huei] Hungkuang Univ, Div Basic Med Sci, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Hungkuang University	Peng, CH (corresponding author), Hungkuang Univ, Div Basic Med Sci, Taichung, Taiwan.	a222907@sunrise.hk.edu.tw		Peng, Chiung-Huei/0000-0003-1833-5522	Ministry of Science and Techonology, Taiwan [MOST 105-2320-B-241 -004 -MY2]	Ministry of Science and Techonology, Taiwan	This work was supported by the grant MOST 105-2320-B-241 -004 -MY2 of Ministry of Science and Techonology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiu N, 1995, ILLUSTRATED MED PLAN, VI.; Choi YJ, 2005, J NUTR, V135, P707, DOI 10.1093/jn/135.4.707; Council NR, 2006, LOST CROPS AFR; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Hocher B, 2012, KIDNEY BLOOD PRESS R, V36, P65, DOI 10.1159/000339028; Hwang HJ, 2014, MOL CELL ENDOCRINOL, V392, P1, DOI 10.1016/j.mce.2014.04.017; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Lin CL, 2008, MOL NUTR FOOD RES, V52, P930, DOI 10.1002/mnfr.200700437; Liu JH, 2012, TOXICOL IN VITRO, V26, P1093, DOI 10.1016/j.tiv.2012.07.004; Miao XY, 2013, PEPTIDES, V39, P71, DOI 10.1016/j.peptides.2012.10.006; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Peng CH, 2016, FOOD FUNCT, V7, P728, DOI [10.1039/C5FO01214G, 10.1039/c5fo01214g]; Peterszegi G, 2003, BIOMED PHARMACOTHER, V57, P187, DOI 10.1016/S0753-3322(03)00031-3; Puljak L, 2008, EXP CELL RES, V314, P2100, DOI 10.1016/j.yexcr.2008.03.002; Shirakawa J, 2011, J BIOL CHEM, V286, P25467, DOI 10.1074/jbc.M110.217216; Tseng HL, 2012, TOXICOL APPL PHARM, V264, P104, DOI 10.1016/j.taap.2012.07.022; Wang XM, 2015, CELL PHYSIOL BIOCHEM, V37, P1914, DOI 10.1159/000438552; Wang X, 2007, BIOCHEM BIOPH RES CO, V352, P463, DOI 10.1016/j.bbrc.2006.11.032; Wei Q, 2012, PEPTIDES, V37, P18, DOI 10.1016/j.peptides.2012.06.018; Wu YJ, 2015, METABOLISM, V64, P226, DOI 10.1016/j.metabol.2014.08.006; Yang MY, 2010, J AGR FOOD CHEM, V58, P850, DOI 10.1021/jf903209w; Yang TY, 2016, TOXICOL APPL PHARM, V294, P54, DOI 10.1016/j.taap.2016.01.013; Yao RQ, 2012, NEUROCHEM RES, V37, P2777, DOI 10.1007/s11064-012-0871-5	24	23	26	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180285	10.1371/journal.pone.0180285	http://dx.doi.org/10.1371/journal.pone.0180285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715446	gold, Green Published, Green Submitted			2022-12-27	WOS:000443975500005
J	Seliger, C; Meier, CR; Becker, C; Jick, SS; Proescholdt, M; Bogdahn, U; Hau, P; Leitzmann, MF				Seliger, Corinna; Meier, Christoph R.; Becker, Claudia; Jick, Susan S.; Proescholdt, Martin; Bogdahn, Ulrich; Hau, Peter; Leitzmann, Michael F.			Diabetes, use of metformin, and the risk of meningioma	PLOS ONE			English	Article							BRAIN-TUMORS; GLIOMA; ASSOCIATION; THERAPY; HISTORY; CANCER; WOMEN	Background Metformin is a commonly used oral antidiabetic agent that has been associated with decreased cancer risk. However, data regarding the association between metformin use and the risk of meningioma are unavailable. Methods We conducted a matched case-control analysis using data from the U. K.-based Clinical Practice Research Datalink (CPRD) to analyse diabetes status, duration of diabetes, glycemic control, and use of metformin, sulfonylureas, and insulin in relation to the risk of meningioma. We conducted conditional logistic regression analyses to determine relative risks, estimated as odds ratios (ORs) with 95% confidence intervals (CIs) and adjusted for body mass index, smoking, history of arterial hypertension, myocardial infarction, and use of estrogens (among women). Results We identified 2,027 meningioma cases and 20,269 controls. For diabetes there was the suggestion of an inverse association with meningioma (OR = 0.89; 95% CI = 0.74 - 1.07), which was driven by an inverse relation among women (OR = 0.78; 95% CI = 0.62 - 0.98), in whom we also noted a suggestive inverse association with duration of diabetes (p-value for trend = 0.071). For metformin there was a suggestive positive relation, particularly after matching on duration of diabetes and HbA1c level (OR = 1.64; 95% CI = 0.89 - 3.04). Sulfonylureas showed no clear association (OR = 0.91; 95% CI = 0.46 - 1.80). For insulin there was the suggestion of an inverse relation, in particular when comparing a high vs. low number of prescriptions (OR = 0.58; 95% CI = 0.18 - 1.83). Conclusion Further studies are needed to solidify a possible inverse association between diabetes and meningioma risk and to clarify the role of antidiabetics in this context.	[Seliger, Corinna; Bogdahn, Ulrich; Hau, Peter] Regensburg Univ Hosp, Dept Neurol, Regensburg, Germany; [Seliger, Corinna; Bogdahn, Ulrich; Hau, Peter] Regensburg Univ Hosp, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany; [Meier, Christoph R.; Becker, Claudia] Univ Basel, Div Clin Pharm & Epidemiol, Dept Pharmaceut Sci, Basel Pharmacoepidemiol Unit, Basel, Switzerland; [Meier, Christoph R.; Jick, Susan S.] Boston Univ, Sch Publ Hlth, Boston Collaborat Drug Surveillance Program, Boston, MA USA; [Meier, Christoph R.] Univ Hosp Basel, Hosp Pharm, Basel, Switzerland; [Proescholdt, Martin] Regensburg Univ Hosp, Dept Neurosurg, Regensburg, Germany; [Leitzmann, Michael F.] Univ Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Basel; Boston University; University of Basel; University of Regensburg; University of Regensburg	Seliger, C (corresponding author), Regensburg Univ Hosp, Dept Neurol, Regensburg, Germany.; Seliger, C (corresponding author), Regensburg Univ Hosp, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany.	corinna.seliger@klinik.uni-regensburg.de	Seliger, Corinna/GSE-3989-2022	Jick, Susan/0000-0002-2215-1067; Hau, Peter/0000-0003-3894-5053	German Research Foundation [KFO262-P10]	German Research Foundation(German Research Foundation (DFG))	This work was founded by the German Research Foundation (KFO262-P10 to C.S. and M. F.L.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson VS, 2008, BRIT J CANCER, V99, P185, DOI 10.1038/sj.bjc.6604445; Benson VS, 2015, INT J CANCER, V136, P2369, DOI 10.1002/ijc.29274; Bernardo BM, 2016, BRIT J CANCER, V115, P108, DOI 10.1038/bjc.2016.157; Birsoy K, 2012, NAT MED, V18, P1022, DOI 10.1038/nm.2870; Brenner AV, 2002, INT J CANCER, V99, P252, DOI 10.1002/ijc.10320; Claus EB, 2013, J NEUROSURG, V118, P649, DOI 10.3171/2012.9.JNS12811; Edlinger M, 2012, J HYPERTENS, V30, P290, DOI 10.1097/HJH.0b013e32834e9176; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Inskip PD, 1995, EPIDEMIOL REV, V17, P382; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Labuzek K, 2010, PHARMACOL REP, V62, P956; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Niedermaier T, 2015, NEUROLOGY, V85, P1342, DOI 10.1212/WNL.0000000000002020; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Pachow D, 2013, CLIN CANCER RES, V19, P1180, DOI 10.1158/1078-0432.CCR-12-1904; Saraf S, 2011, ONCOLOGIST, V16, P1604, DOI 10.1634/theoncologist.2011-0193; SCHEEN AJ, 1993, DIABETES METAB, V19, P547; Schlehofer B, 1999, INT J CANCER, V82, P155, DOI 10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P; Schneider B, 2005, CANCER DETECT PREV, V29, P440, DOI 10.1016/j.cdp.2005.07.002; Schwartzbaum J, 2005, CANCER EPIDEM BIOMAR, V14, P643, DOI 10.1158/1055-9965.EPI-04-0119; Seliger C, 2016, ONCOTARGET; Stamataki KE, 1996, CLIN ENDOCRINOL, V45, P615, DOI 10.1046/j.1365-2265.1996.00795.x; Surace EI, 2004, ANN NEUROL, V56, P295, DOI 10.1002/ana.20201; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Wilisch-Neumann A, 2014, J CANCER RES CLIN, V140, P1343, DOI 10.1007/s00432-014-1683-6; Zahra M, 2016, HORMONE AND METABOLI	29	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181089	10.1371/journal.pone.0181089	http://dx.doi.org/10.1371/journal.pone.0181089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708856	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800041
J	Mathews, JA; Kasahara, DI; Cho, Y; Bell, LN; Gunst, PR; Karoly, ED; Shore, SA				Mathews, Joel Andrew; Kasahara, David Itiro; Cho, Youngji; Bell, Lauren Nicole; Gunst, Philip Ross; Karoly, Edward D.; Shore, Stephanie Ann			Effect of acute ozone exposure on the lung metabolomes of obese and lean mice	PLOS ONE			English	Article							AIRWAY HYPERRESPONSIVENESS; PULMONARY RESPONSES; OXIDATIVE STRESS; ACID-METABOLISM; GUT MICROBIOME; NITRIC-OXIDE; TIME-SERIES; INFLAMMATION; MORTALITY; POLLUTION	Pulmonary responses to the air pollutant, ozone, are increased in obesity. Both obesity and ozone cause changes in systemic metabolism. Consequently, we examined the impact of ozone on the lung metabolomes of obese and lean mice. Lean wildtype and obese db/db mice were exposed to acute ozone ( 2 ppm for 3 h) or air. 24 hours later, the lungs were excised, flushed with PBS to remove blood and analyzed via liquid-chromatography or gaschromatography coupled to mass spectrometry for metabolites. Both obesity and ozone caused changes in the lung metabolome. Of 321 compounds identified, 101 were significantly impacted by obesity in air-exposed mice. These included biochemicals related to carbohydrate and lipid metabolism, which were each increased in lungs of obese versus lean mice. These metabolite changes may be of functional importance given the signaling capacity of these moieties. Ozone differentially affected the lung metabolome in obese versus lean mice. For example, almost all phosphocholine-containing lysolipids were significantly reduced in lean mice, but this effect was attenuated in obese mice. Glutathione metabolism was also differentially affected by ozone in obese and lean mice. Finally, the lung metabolome indicated a role for the microbiome in the effects of both obesity and ozone: all measured bacterial/mammalian co-metabolites were significantly affected by obesity and/or ozone. Thus, metabolic derangements in obesity appear to impact the response to ozone.	[Mathews, Joel Andrew; Kasahara, David Itiro; Cho, Youngji; Shore, Stephanie Ann] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Bell, Lauren Nicole; Gunst, Philip Ross; Karoly, Edward D.] Metabolon Inc, Res Triangle Pk, NC USA	Harvard University; Harvard T.H. Chan School of Public Health; Metabolon	Mathews, JA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	joel.mathews@gmail.com			National Institutes of Health [ES013307, F32ES02256, HL007118, ES024032, ES000002]; Metabolon; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES022556, R01ES013307, R21ES024032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Metabolon; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health grants ES013307, F32ES02256, HL007118, ES024032, and ES000002. Metabolon provided support in the form of salaries for authors (LB, PRG and EK), but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Ahn WG, 2017, INFLAMMATION, V40, P537, DOI 10.1007/s10753-016-0500-6; Alexeeff SE, 2007, CHEST, V132, P1890, DOI 10.1378/chest.07-1126; [Anonymous], 2017, R LANG ENV STAT COMP; Baffi CW, 2016, CHEST; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Bennett WD, 2007, INHAL TOXICOL, V19, P1147, DOI 10.1080/08958370701665475; BISWAS SK, 2008, MOL ASPECTS MED; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Chalfant M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090530; Cho Y, 2014, AM J RESP CRIT CARE, V189; Davenport AP, 2013, PHARMACOL REV, V65, P967, DOI 10.1124/pr.112.007179; Dinan T. G., 2016, NEUROPSYCHOPHARMACOL; Dong GH, 2013, INT J OBESITY, V37, P94, DOI 10.1038/ijo.2012.125; El Aidy S, 2013, ISME J, V7, P743, DOI 10.1038/ismej.2012.142; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fabisiak JP, 2011, MOL NUTR FOOD RES, V55, P1423, DOI 10.1002/mnfr.201100291; Fessler M.B., 2016, AM J RESP CELL MOL B; Foster WM, 2000, J APPL PHYSIOL, V89, P1804, DOI 10.1152/jappl.2000.89.5.1804; Fujita T, 1999, CLIN CHIM ACTA, V287, P145, DOI 10.1016/S0009-8981(99)00129-1; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; Giesbertz P, 2015, DIABETOLOGIA, V58, P2133, DOI 10.1007/s00125-015-3656-y; Gleason JA, 2015, J ASTHMA, V52, P815, DOI 10.3109/02770903.2015.1033726; Hashmi H, 2016, AM J RESP CRIT CARE, V193; Holguin Fernando, 2013, Ann Am Thorac Soc, V10 Suppl, pS150, DOI 10.1513/AnnalsATS.201305-116AW; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Ji M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024006; Johnson CH, 2012, ANNU REV PHARMACOL, V52, P37, DOI 10.1146/annurev-pharmtox-010611-134748; Johnston RA, 2008, J APPL PHYSIOL, V104, P1727, DOI 10.1152/japplphysiol.00075.2008; Johnston RA, 2010, J APPL PHYSIOL, V108, P1812, DOI 10.1152/japplphysiol.00784.2009; Jz H, 2015, METABOLOMICS LOS ANG, V5; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30111; Komakula S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-32; Lang JE, 2008, AM J PHYSIOL-LUNG C, V294, pL1013, DOI 10.1152/ajplung.00122.2007; Laskin DL, 2001, ADV EXP MED BIOL, V500, P183; Lees HJ, 2013, J PROTEOME RES; Leikauf GD, 2012, AM J RESP CELL MOL, V47, P234, DOI 10.1165/rcmb.2012-0026OC; Lichtenstein JHR, 2016, AM J RESP CELL MOL, V55, P521, DOI 10.1165/rcmb.2015-0291OC; Marcobal A, 2013, ISME J; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P5296, DOI 10.1073/pnas.86.14.5296; Mathews JA, 2017, ENVIRON HEALTH PERSP, V125, P246, DOI 10.1289/EHP272; Miller DB, 2016, TOXICOL SCI, V150, P312, DOI 10.1093/toxsci/kfv331; Miller DB, 2015, TOXICOL APPL PHARM, V286, P65, DOI 10.1016/j.taap.2015.03.025; Milner JJ, 2015, J IMMUNOL, V194, P4846, DOI 10.4049/jimmunol.1402295; Morgan SA, 2013, ENDOCRINOLOGY, V154, P2374, DOI 10.1210/en.2012-2214; NAWABI MD, 1990, J CLIN INVEST, V85, P256, DOI 10.1172/JCI114421; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Oh DY, 2011, CURR OPIN CLIN NUTR, V14, P322, DOI 10.1097/MCO.0b013e3283479230; Quinn KD, 2017, ALLERGY; Rice MB, 2013, AM J RESP CRIT CARE, V188, P1351, DOI 10.1164/rccm.201308-1414OC; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Shin AC, 2014, CELL METAB, V20, P898, DOI 10.1016/j.cmet.2014.09.003; Shore SA, 2003, J APPL PHYSIOL, V95, P938, DOI 10.1152/japplphysiol.00336.2003; Shore SA, 2016, AM J RESP CELL MOL B; Shore SA, 2011, INHAL TOXICOL, V23, P878, DOI 10.3109/08958378.2011.622316; Shore SA, 2010, J APPL PHYSIOL, V108, P735, DOI 10.1152/japplphysiol.00749.2009; Soroosh P, 2014, P NATL ACAD SCI USA, V111, P12163, DOI 10.1073/pnas.1322807111; Stanek LW, 2011, TOXICOL SCI, V120, pS8, DOI 10.1093/toxsci/kfq367; Thompson KC, 2013, LANGMUIR, V29, P4594, DOI 10.1021/la304312y; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turner MC, 2016, AM J RESP CRIT CARE, V193, P1134, DOI 10.1164/rccm.201508-1633OC; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang XF, 2017, SCI TOTAL ENVIRON, V592, P41, DOI 10.1016/j.scitotenv.2017.03.064; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiegman CH, 2014, CLIN SCI, V126, P425, DOI 10.1042/CS20130039; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Williams AS, 2013, ENVIRON HEALTH PERSP, V121, P551, DOI 10.1289/ehp.1205880; Won EY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075998; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yun KU, 2013, FOOD CHEM TOXICOL, V53, P180, DOI 10.1016/j.fct.2012.11.046	75	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							0181017	10.1371/journal.pone.0181017	http://dx.doi.org/10.1371/journal.pone.0181017			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704544	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700074
J	Hughes, MG; Tucker, WW; Reddy, S; Brier, ME; Koch, D; McClain, CJ; Jonsson, CB; Matoba, N; Chung, D				Hughes, Michael G.; Tucker, William W.; Reddy, Sreelatha; Brier, Michael E.; Koch, David; McClain, Craig J.; Jonsson, Colleen B.; Matoba, Nobuyuki; Chung, Donghoon			Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition	PLOS ONE			English	Article							B TYPE-I; VIRUS-INFECTION; TRANSMISSION; RECEPTOR; KINETICS; CD81	To better understand the dynamics of early hepatitis C virus (HCV) infection, we determined how rapidly non-cirrhotic HCV-uninfected liver allografts clear HCV from the circulation of cirrhotic HCV-infected patients at the time of transplantation but before administration of immunosuppression. Specifically, we characterized serum HCV kinetics during the first 90 min of reperfusion for 19 chronically HCV-infected patients transplanted with an HCV-uninfected liver by measuring serum viral load immediately prior to reperfusion (t = 0) and then every 15 min for a total of 90 min (t = 90). Immunosuppression was withheld until all samples were taken to better model primary infection. During this period, rates of viral clearance varied more than 20-fold with a median rate constant of 0.0357 1/min, range 0.0089 - 0.2169; half-life (minutes) median 19.4, range 3.2 - 77.8. The majority of viral clearance occurred within the first 60 min. The amount of blood transfused during this 90-min period (a potential confounding variable of this human liver transplant model of primary infection) accounted for 53% and 59% of k (r = 0.53, p = 0.05) and half-life (r = 0.59, p = 0.03) variability, respectively. No other clinical variables tested (age, allograft weight, and degree of reperfusion injury as assessed by peak postoperative ALT or AST) accounted for the remaining variability (p> 0.05). Conclusion: In a human liver transplant model of primary infection, HCV rapidly clears the bloodstream. With approximately 90% of clearance occurring in the first 90 minutes of reperfusion, studies of HCV entry inhibition could utilize rate of clearance during this early period as an outcome measure.	[Hughes, Michael G.; Tucker, William W.; Reddy, Sreelatha] Univ Louisville, Dept Surg, Louisville, KY 40292 USA; [Brier, Michael E.; McClain, Craig J.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Koch, David] Med Univ South Carolina, Dept Med, Charleston, SC USA; [McClain, Craig J.; Matoba, Nobuyuki] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [McClain, Craig J.] Robley Rex Louisville Veteran Affairs Med Ctr, Louisville, KY USA; [Jonsson, Colleen B.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Chung, Donghoon] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; Medical University of South Carolina; University of Louisville; University of Tennessee System; University of Tennessee Knoxville; University of Louisville	Hughes, MG (corresponding author), Univ Louisville, Dept Surg, Louisville, KY 40292 USA.	mike.hughes@louisville.edu	Jonsson, Colleen/GPC-4424-2022; Jonsson, Colleen/X-2360-2019; Brier, Michael/B-9805-2013	Jonsson, Colleen/0000-0002-2640-7672; Brier, Michael/0000-0002-5952-9561; Matoba, Nobuyuki/0000-0001-7231-3004	American Society of Transplant Surgeons; American Association for the Study of Liver Diseases; ASTS Roche Surgical Scientist Scholarship; ASTS Team Donate Life Junior Faculty Award; AASLD Career Development Award in Liver in Transplantation; NIH through an institutional KL2 at the Medical University of South Carolina; American Society of Transplant Surgeons Team Donate Life Junior Faculty Award; American Association for the Study of Liver Diseases Career Development Award in Liver Transplantation; National Institutes of Health [KL2 1KL2RR029880-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR029880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA023681] Funding Source: NIH RePORTER	American Society of Transplant Surgeons; American Association for the Study of Liver Diseases; ASTS Roche Surgical Scientist Scholarship; ASTS Team Donate Life Junior Faculty Award; AASLD Career Development Award in Liver in Transplantation; NIH through an institutional KL2 at the Medical University of South Carolina; American Society of Transplant Surgeons Team Donate Life Junior Faculty Award; American Association for the Study of Liver Diseases Career Development Award in Liver Transplantation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The American Society of Transplant Surgeons and American Association for the Study of Liver Diseases have funded this work, as the ASTS Roche Surgical Scientist Scholarship (MGH), the ASTS Team Donate Life Junior Faculty Award (MGH) and the AASLD Career Development Award in Liver in Transplantation (MGH). Additionally, the NIH through an institutional KL2 at the Medical University of South Carolina (MGH) helped fund this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was received from the following sources: American Society of Transplant Surgeons Team Donate Life Junior Faculty Award (MGH); American Association for the Study of Liver Diseases Career Development Award in Liver Transplantation (MGH); and National Institutes of Health KL2 1KL2RR029880-01 (MGH). We would like to extend a special thanks to Marion McClain and Margaret Abby for review and editing of the manuscript. Members of the University of Louisville Center for Predictive Medicine Virology Discussion Group also made significant contributions to the design and analysis of results.	ALTER MJ, 1994, NEW ENGL J MED, V330, P784, DOI 10.1056/NEJM199403173301111; Charlton M, 1998, HEPATOLOGY, V28, P823, DOI 10.1002/hep.510280333; Dahari H, 2005, J HEPATOL, V42, P491, DOI 10.1016/j.jhep.2004.12.017; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Eyre Nicholas S, 2009, Hepatology, V49, P1770, DOI 10.1002/hep.22935; Felmlee DJ, 2016, LANCET INFECT DIS, V16, P735, DOI 10.1016/S1473-3099(16)00120-1; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; GORDON SC, 1993, HEPATOLOGY, V18, P1338, DOI 10.1002/hep.1840180609; Graziadei IW, 2012, LIVER TRANSPLANT, V18, P671, DOI 10.1002/lt.23402; GRETCH DR, 1995, HEPATOLOGY, V22, P1; Hughes MG, 2005, AM J TRANSPLANT, V5, P2504, DOI 10.1111/j.1600-6143.2005.01060.x; Hughes MG, 2004, LIVER TRANSPLANT, V10, P208, DOI 10.1002/lt.20060; Hughes MG, 2009, LIVER TRANSPLANT, V15, P1395, DOI 10.1002/lt.21866; Liu RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066872; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Mensa L, 2011, HEPATOLOGY, V53, P1436, DOI 10.1002/hep.24110; OHTO H, 1994, NEW ENGL J MED, V330, P744, DOI 10.1056/NEJM199403173301103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Powers KA, 2006, LIVER TRANSPLANT, V12, P207, DOI 10.1002/lt.20572; Rowe IA, 2016, LIVER TRANSPLANT, V22, P287, DOI 10.1002/lt.24349; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Uprichard SL, 2015, GUT, V64, P690, DOI 10.1136/gutjnl-2014-308396; Wiesmann F, 2015, MED MICROBIOL IMMUN, V204, P515, DOI 10.1007/s00430-014-0364-z; Xiao F, 2015, GUT, V64, P483, DOI 10.1136/gutjnl-2013-306155	24	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180719	10.1371/journal.pone.0180719	http://dx.doi.org/10.1371/journal.pone.0180719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732019	gold, Green Submitted, Green Published			2022-12-27	WOS:000406643100011
J	Wang, J; Huo, BB; Liu, WT; Li, DL; Liao, L				Wang, Jun; Huo, Beibei; Liu, Wanting; Li, Daili; Liao, Ling			Abnormal meiosis in an intersectional allotriploid of Populus L. and segregation of ploidy levels in 2X x 3Xprogeny	PLOS ONE			English	Article							EMBRYO SAC DEVELOPMENT; GENETIC DIVERSITY; TRIPLOID POPULUS; MECHANISMS; ANEUPLOIDY; DOSAGE; EVOLUTION; BALANCE; MICROSPOROGENESIS; HYBRIDIZATION	Triploid plants are usually highly aborted owing to unbalanced meiotic chromosome segregation, but limited viable gametes can participate in the transition to different ploidy levels. In this study, numerous meiotic abnormalities were found with high frequency in an intersectional allotriploid poplar (Populus alba x P. berolinensis 'Yinzhong'), including univalents, precocious chromosome migration, lagging chromosomes, chromosome bridges, micronuclei, and precocious cytokinesis, indicating high genetic imbalance in this allotriploid. Some micronuclei trigger mini-spindle formation in metaphase II and participate in cytokinesis to form polyads with microcytes. Unbalanced chromosome segregation and chromosome elimination resulted in the formation of microspores with aneuploid chromosome sets. Fusion of sister nuclei occurs in microsporocytes with precocious cytokinesis, which could form second meiotic division restitution (SDR)-type gametes. However, SDR-type gametes likely contain incomplete chromosome sets due to unbalanced segregation of homologous chromosomes during the first meiotic division in triploids. Misorientation of spindles during the second meiotic division, such as fused and tripolar spindles with low frequency, could result in the formation of first meiotic division restitution (FDR)-type unreduced gametes, which most likely contain three complete chromosome sets. Although 'Yinzhong' yields 88.7% stainable pollen grains with wide diameter variation from 23.9 to 61.3 mu m, the pollen viability is poor (2.78% +/- 0.38). A cross of 'Yinzhong' pollen with a diploid female clone produced progeny with extensive segregation of ploidy levels, including 29 diploids, 18 triploids, 4 tetraploids, and 48 aneuploids, suggesting the formation of viable aneuploidy and unreduced pollen in 'Yinzhong'. Individuals with different chromosome compositions are potential to analyze chromosomal function and to integrate the chromosomal dosage variation into breeding programs of Populus.	[Wang, Jun; Huo, Beibei; Liu, Wanting] Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China; [Wang, Jun; Huo, Beibei; Liu, Wanting] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Wang, Jun; Li, Daili] Beijing Forestry Univ, MOE, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China; [Wang, Jun; Huo, Beibei; Liu, Wanting; Li, Daili; Liao, Ling] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Li, Daili] Beijing Huang Fa Nursery, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Wang, J (corresponding author), Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China.; Wang, J (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.; Wang, J (corresponding author), Beijing Forestry Univ, MOE, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China.; Wang, J (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.	wangjun@bjfu.edu.cn	Wang, Jun/Y-9104-2018	Wang, Jun/0000-0003-0679-1125	National Natural Science Foundation of China [31470662]; 12th National Key Technology RD Program [2015BAD09B02]; Program for New Century Excellent Talents in University [NCET-13-0672]; Beijing Nova program [Z141105001814007]; Beijing Municipal Education Commission [CEFF-PXM2017_014207_000043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th National Key Technology RD Program; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Nova program(Beijing Municipal Science & Technology Commission); Beijing Municipal Education Commission(Beijing Municipal Commission of Education)	This work was supported by the National Natural Science Foundation of China (31470662), the 12th National Key Technology R&D Program (2015BAD09B02), Program for New Century Excellent Talents in University (NCET-13-0672), the Beijing Nova program (Z141105001814007), and the program from the Beijing Municipal Education Commission (CEFF-PXM2017_014207_000043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister G., 1980, ALLG FORESTZ, V35, P697; BEDNARA J, 1986, PROTOPLASMA, V130, P145, DOI 10.1007/BF01276596; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; BRETAGNOLLE F, 1995, NEW PHYTOL, V129, P1, DOI 10.1111/j.1469-8137.1995.tb03005.x; Brown RC, 1996, SEX PLANT REPROD, V9, P145, DOI 10.1007/BF02221394; [陈成彬 Chen Chengban], 2004, [武汉植物学研究, Journal of Wuhan Botanical Research], V22, P565; Chester M, 2012, P NATL ACAD SCI USA, V109, P1176, DOI 10.1073/pnas.1112041109; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; De Storme N, 2014, CURR PLANT BIOL, V1, P10, DOI 10.1016/j.cpb.2014.09.002; De Storme N, 2013, NEW PHYTOL, V198, P670, DOI 10.1111/nph.12184; Del Bosco SF, 1999, HEREDITY, V83, P373, DOI 10.1038/sj.hdy.6885770; Dong CB, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0799-9; DWEIKAT IM, 1988, THEOR APPL GENET, V76, P555, DOI 10.1007/BF00260907; Einspahr D. W., 1984, Iowa State Journal of Research, V58, P401; EZURA H, 1994, PLANT CELL TISS ORG, V38, P61, DOI 10.1007/BF00034445; Farco GE, 2014, PLANT SYST EVOL, V300, P1843, DOI 10.1007/s00606-014-1011-2; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gale MD., 1987, WHEAT BREEDING ITS S, P173, DOI DOI 10.1007/978-94-009-3131-2_7; Henry IM, 2009, HEREDITY, V103, P458, DOI 10.1038/hdy.2009.81; Henry IM, 2005, GENETICS, V170, P1979, DOI 10.1534/genetics.104.037788; Henry IM, 2006, PLANT J, V48, P307, DOI 10.1111/j.1365-313X.2006.02871.x; Henry IM, 2015, PLANT CELL, V27, P2370, DOI 10.1105/tpc.15.00349; Henry IM, 2010, GENETICS, V186, P1231, DOI 10.1534/genetics.110.121079; [Hu Baoquan 胡宝全], 2012, [南开大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Nankaiensis], V45, P58; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Husband BC, 2004, BIOL J LINN SOC, V82, P537, DOI 10.1111/j.1095-8312.2004.00339.x; ISING G, 1966, HEREDITAS-GENETISK A, V56, P27; JACKSON RC, 1976, ANNU REV ECOL SYST, V7, P209, DOI 10.1146/annurev.es.07.110176.001233; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Johnsson H, 1940, HEREDITAS, V26, P321; Jorgensen MH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-346; Kang XiangYang, 2000, Journal of Beijing Forestry University, V22, P8; Kang XiangYang, 2002, Journal of Beijing Forestry University, V24, P67; Kohler C, 2010, TRENDS GENET, V26, P142, DOI 10.1016/j.tig.2009.12.006; Law CN., 1987, WHEAT BREEDING ITS S, P71, DOI [10.1007/978-94-009-3131-2_4, DOI 10.1007/978-94-009-3131-2_4]; Li DW, 2014, TREE GENET GENOMES, V10, P1451, DOI 10.1007/s11295-014-0773-6; Liehr T, 2006, CYTOGENET GENOME RES, V114, P240, DOI 10.1159/000094207; Lin HB, 1988, J BEIJING FORESTRY U, V10, P97; Liu YH, 1979, J NE FORESTRY I, V2, P1; LUPTON FGH, 1987, WHEAT BREEDING ITS S; Mashkina O. S., 1989, Lesovedenie, P19; Mason AS, 2015, TRENDS GENET, V31, P5, DOI 10.1016/j.tig.2014.09.011; NIJS TPMD, 1977, EUPHYTICA, V26, P585, DOI 10.1007/BF00021684; Ogilvie CM, 2005, J HISTOCHEM CYTOCHEM, V53, P285, DOI 10.1369/jhc.4B6409.2005; Osuji J. O., 1997, Tropicultura, V15, P37; Rae Anne M., 2007, V7, P1; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Rao JingYun, 2012, Acta Horticulturae Sinica, V39, P1447; Rauch A, 2004, J MED GENET, V41, P916, DOI 10.1136/jmg.2004.022855; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Schatlowski N, 2012, J EXP BOT, V63, P6059, DOI 10.1093/jxb/ers288; SEITZ F. W., 1954, Zeitschrift fur Forstgenetik und Forstpflanzenzuchtung, V3, P1; [史全良 Shi Quanliang], 2006, [分子植物育种, Molecular Plant Breeding], V4, P255; Stanton BJ, 2010, PLANT GENET GENOMICS, V8, P309, DOI 10.1007/978-1-4419-1541-2_14; Tel-Zur N, 2005, J HERED, V96, P124, DOI 10.1093/jhered/esi012; Tian J, 2015, EUPHYTICA, V206, P433, DOI 10.1007/s10681-015-1507-z; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Wang J, 2012, SILVAE GENET, V61, P85, DOI 10.1515/sg-2012-0011; Wang J, 2010, SILVAE GENET, V59, P40, DOI 10.1515/sg-2010-0005; Wang J, 2009, SILVAE GENET, V58, P220, DOI 10.1515/sg-2009-0028; Wang J, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0880-z; Wang J, 2013, SILVA FENN, V47, DOI 10.14214/sf.932; Wang J, 2012, ANN FOREST SCI, V69, P59, DOI 10.1007/s13595-011-0152-5; Wang J, 2010, TREE GENET GENOMES, V6, P281, DOI 10.1007/s11295-009-0248-3; Weisgerber H., 1980, ALLG, V26, P665; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Zhang Chun Hua, 2009, Horticulture Environment and Biotechnology, V50, P203; Zhang L., 2010, J NUCL AGR SCI, V24, P1158; Zhang S, 2004, SILVAE GENET, V53, P69, DOI 10.1515/sg-2004-0013; Zhang SG, 2005, ACTA PHYTOTAXON SIN, V43, P539, DOI 10.1360/aps040008; Zhang ZH, 2010, EUPHYTICA, V173, P151, DOI 10.1007/s10681-009-0051-0; Zhou L.J., 1992, PROTECT SCI TECHNOL, V1, P23; Zhu ZhiTi, 1998, Scientia Silvae Sinicae, V34, P22	74	13	15	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e018176 7	10.1371/journal.pone.0181767	http://dx.doi.org/10.1371/journal.pone.0181767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732039	Green Published, gold, Green Submitted			2022-12-27	WOS:000406643100061
J	Zhang, WL; Wang, WN; Chai, W; Luo, XM; Li, JN; Shi, J; Bi, LQ; Niu, LZ				Zhang, Wenlong; Wang, Wanning; Chai, Wei; Luo, Xiaomei; Li, Jiannan; Shi, Jian; Bi, Liqi; Niu, Lizhi			Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; CANCER PATIENTS; EARLY-STAGE; LIVER; CARCINOMA; HARMS	Background and aim Irreversible electroporation (IRE) was confirmed to control several solid tumors effectively in vivo. Our preclinical study aimed to assess the feasibility and safety of IRE in the breast of rabbit. Methods Thirty New Zealand white rabbits were randomly divided into 3 groups of 10 rabbits (control group, IRE group A, and B). Two mono-electrode needles were inserted into the breast tissue by percutaneous puncture. Electrocardiogram and vital signs were monitored before, during, and after ablation. Histopathology, immunohistochemistry, and transmission electron microscopy were examined at 0 hours, 12 hours, 24 hours, 4 days, 7 days, 14 days, and 28 days after ablation. Results All the rabbits survived the procedure with no significant adverse effects. Intra-operative ventricular arrhythmias occurred in 1 rabbit from IRE group B and was immediately relieved after ablation. Reversible subcutaneous hemorrhage was observed in 8 rabbits from IRE group A and 7 rabbits from IRE group B. No skin was burnt, however, pectoralis major muscle injuries were found in all rabbits. Histopathological and ultrastructural examination revealed the coexistence of cell necrosis and apoptosis. HE, TUNEL, and Masson staining revealed breast tissue injury and the recovery of damage by fibrous tissue and granulation tissue. Notably, the structures of mammary gland lobules and interstitial components of the breasts were well preserved. Conclusions Our study suggests that IRE destroys breast cancer while effectively preserving the skin, the structure of mammary gland lobules, and interstitial components. IRE may be a promising technique to locally control breast cancer and to maintain the esthetic of the breast.	[Zhang, Wenlong] Jilin Univ, China Japan Union Hosp, Dept Hematol & Oncol, Changchun, Jilin, Peoples R China; [Wang, Wanning] Jilin Univ, Hosp 1, Dept Nephrol, Changchun, Jilin, Peoples R China; [Chai, Wei] Jilin Univ, Hosp 1, Dept Gynecol & Obstet, Changchun, Jilin, Peoples R China; [Luo, Xiaomei] Jinan Univ, Sch Med, Guangzhou, Guangdong, Peoples R China; [Li, Jiannan; Shi, Jian] Jilin Univ, Hosp 2, Dept Gen Surg, Changchun, Jilin, Peoples R China; [Bi, Liqi] Jilin Univ, China Japan Union Hosp, Dept Rheumatol & Immunol, Changchun, Jilin, Peoples R China; [Niu, Lizhi] Jinan Univ, Fuda Canc Hosp, Sch Med, Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China	Jilin University; Jilin University; Jilin University; Jinan University; Jilin University; Jilin University; Jinan University	Bi, LQ (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Rheumatol & Immunol, Changchun, Jilin, Peoples R China.; Niu, LZ (corresponding author), Jinan Univ, Fuda Canc Hosp, Sch Med, Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China.	liqibi2016@sina.com; fudaclab@163.com	li, jn/ABH-3120-2021	Li, Jiannan/0000-0001-9744-7666				Akinwande O, 2015, J ONCOL, V2015, DOI 10.1155/2015/680319; Angarita FA, 2015, EJSO-EUR J SURG ONC, V41, P625, DOI 10.1016/j.ejso.2015.01.028; Chen XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16233; Cheng RG, 2015, J VASC INTERV RADIOL, V26, P1184, DOI 10.1016/j.jvir.2015.05.014; Deodhar A, 2011, AM J ROENTGENOL, V196, pW330, DOI 10.2214/AJR.10.4490; Dunki-Jacobs EM, 2014, BRIT J SURG, V101, P1113, DOI 10.1002/bjs.9536; Garcia-Saenz JA, 2015, CLIN TRANSL ONCOL, V17, P939, DOI 10.1007/s12094-015-1427-3; Guo Y, 2010, CANCER RES, V70, P1555, DOI 10.1158/0008-5472.CAN-09-3067; Izzo F, 2001, CANCER, V92, P2036, DOI 10.1002/1097-0142(20011015)92:8<2036::AID-CNCR1542>3.0.CO;2-W; Kerlikowske K, 2016, JAMA INTERN MED, V176, P562, DOI 10.1001/jamainternmed.2016.0225; Klassen Anne F, 2009, BMC Womens Health, V9, P11, DOI 10.1186/1472-6874-9-11; Lee EW, 2012, J VASC INTERV RADIOL, V23, P833, DOI 10.1016/j.jvir.2012.02.017; Long G, 2014, TECHNOL CANCER RES T, V13, P561, DOI 10.7785/tcrtexpress.2013.600253; Manenti G, 2013, BREAST CARE, V8, P356, DOI 10.1159/000355707; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Martin RCG, 2013, ANN SURG ONCOL, V20, pS443, DOI 10.1245/s10434-012-2736-1; Memon Zahid Ali, 2015, Asian Pac J Cancer Prev, V16, P7485; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; Neal RE, 2010, BREAST CANCER RES TR, V123, P295, DOI 10.1007/s10549-010-0803-5; Neal RE, 2009, ANN BIOMED ENG, V37, P2615, DOI 10.1007/s10439-009-9796-9; Niessen C, 2015, CLIN HEMORHEOL MICRO, V61, P135, DOI 10.3233/CH-151985; Noguchi M, 2012, EJSO-EUR J SURG ONC, V38, P1036, DOI 10.1016/j.ejso.2012.08.006; Ohtani S, 2011, BREAST, V20, P431, DOI 10.1016/j.breast.2011.04.007; Oura Shoji, 2007, Breast Cancer, V14, P48, DOI 10.2325/jbcs.14.48; Peek MCL, 2015, BRIT J SURG, V102, P873, DOI 10.1002/bjs.9793; Philips P, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.1; Sawyer DB, 2013, NEW ENGL J MED, V368, P1154, DOI 10.1056/NEJMcibr1214975; Schassburger KU, 2014, BREAST, V23, P152, DOI 10.1016/j.breast.2013.12.007; Scheffer HJ, 2014, EUR RADIOL, V24, P2467, DOI 10.1007/s00330-014-3259-x; Sherwell-Cabello S, 2015, CIR CIR, V83, P199, DOI 10.1016/j.circir.2015.05.015; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sierink JC, 2014, BREAST, V23, P793, DOI 10.1016/j.breast.2014.08.006; Song ZQ, 2014, INT J CLIN EXP MED, V7, P2386; Sugimoto K, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0828-7; SUROWIEC AJ, 1988, IEEE T BIO-MED ENG, V35, P257, DOI 10.1109/10.1374; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Ting F, 2016, PROSTATE CANCER P D, V19, P46, DOI 10.1038/pcan.2015.47; van Gemert MJC, 2015, PROSTATE, V75, P332, DOI 10.1002/pros.22913; Wiksell H, 2010, BREAST, V19, P219, DOI 10.1016/j.breast.2010.01.016; Witherby S, 2016, SEMIN RADIAT ONCOL, V26, P59, DOI 10.1016/j.semradonc.2015.09.005; Zhang ZL, 2014, NANOMEDICINE-UK, V9, P1181, DOI [10.2217/nnm.13.72, 10.2217/NNM.13.72]; Zhao Z, 2010, EJSO-EUR J SURG ONC, V36, P1149, DOI 10.1016/j.ejso.2010.09.012; Zhou W, 2012, J CANCER RES THER, V8, P80, DOI 10.4103/0973-1482.95179	43	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181555	10.1371/journal.pone.0181555	http://dx.doi.org/10.1371/journal.pone.0181555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732031	Green Submitted, Green Published, gold			2022-12-27	WOS:000406643100043
J	Alicke, M; Boakye-Appiah, JK; Abdul-Jalil, I; Henze, A; van der Giet, M; Schulze, MB; Schweigert, FJ; Mockenhaupt, FP; Bedu-Addo, G; Danquah, I				Alicke, Marie; Boakye-Appiah, Justice K.; Abdul-Jalil, Inusah; Henze, Andrea; van der Giet, Markus; Schulze, Matthias B.; Schweigert, Florian J.; Mockenhaupt, Frank P.; Bedu-Addo, George; Danquah, Ina			eAdolescent health in rural Ghana: A crosssectional study on the co-occurrence of infectious diseases, malnutrition and cardiometabolic risk factors	PLOS ONE			English	Article							VITAMIN-A; ADOLESCENTS; OBESITY; PREVALENCE; CHILDREN; MALARIA; TRANSITION; OVERWEIGHT; HOUSEHOLD; BURDEN	In sub-Saharan Africa, infectious diseases and malnutrition constitute the main health problems in children, while adolescents and adults are increasingly facing cardio-metabolic conditions. Among adolescents as the largest population group in this region, we investigated the co-occurrence of infectious diseases, malnutrition and cardio-metabolic risk factors (CRFs), and evaluated demographic, socio-economic and medical risk factors for these entities. In a cross-sectional study among 188 adolescents in rural Ghana, malarial infection, common infectious diseases and Body Mass Index were assessed. We measured ferritin, C-reactive protein, retinol, fasting glucose and blood pressure. Socio-demographic data were documented. We analyzed the proportions (95% confidence interval, CI) and the cooccurrence of infectious diseases (malaria, other common diseases), malnutrition (underweight, stunting, iron deficiency, vitamin A deficiency [VAD]), and CRFs (overweight, obesity, impaired fasting glucose, hypertension). In logistic regression, odds ratios (OR) and 95% CIs were calculated for the associations with socio-demographic factors. In this Ghanaian population (age range, 14.4-15.5 years; males, 50%), the proportions were for infectious diseases 45% (95% CI: 38-52%), for malnutrition 50% (43-57%) and for CRFs 16% (11- 21%). Infectious diseases and malnutrition frequently co-existed (28%; 21-34%). Specifically, VAD increased the odds of non-malarial infectious diseases 3-fold (95% CI: 1.03, 10.19). Overlap of CRFs with infectious diseases (6%; 2-9%) or with malnutrition (7%; 3-11%) was also present. Male gender and low socio-economic status increased the odds of infectious diseases and malnutrition, respectively. Malarial infection, chronic malnutrition and VAD remain the predominant health problems among these Ghanaian adolescents. Investigating the relationships with evolving CRFs is warranted.	[Alicke, Marie; Mockenhaupt, Frank P.] Charite, Inst Trop Med & Int Hlth, Berlin, Germany; [Boakye-Appiah, Justice K.; Abdul-Jalil, Inusah; Bedu-Addo, George] Kwame Nkrumah Univ Sci & Technol, Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Henze, Andrea; Schweigert, Florian J.] Univ Potsdam, Inst Nutr Sci, Dept Physiol & Pathophysiol Nutr, Potsdam, Germany; [van der Giet, Markus] Charite, Dept Nephrol 4, Berlin, Germany; [Schulze, Matthias B.; Danquah, Ina] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Danquah, Ina] Charite, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Kwame Nkrumah University Science & Technology; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Danquah, I (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany.; Danquah, I (corresponding author), Charite, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.	ina.danquah@dife.de	Mockenhaupt, Frank P/U-9824-2017; Schulze, Matthias B/AAH-6906-2021; Henze, Andrea/A-9176-2019	Mockenhaupt, Frank P/0000-0002-8117-5421; Schulze, Matthias B/0000-0002-0830-5277; Henze, Andrea/0000-0002-5708-2989; van der Giet, Markus/0000-0003-3590-5451				Abizari AR, 2014, BRIT J NUTR, V112, P1019, DOI 10.1017/S0007114514001585; Afrifa-Anane E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1546-3; Agbre-Yace ML, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0261-7; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; [Anonymous], 2009, WHO GLOBAL DATABASE; Babio N, 2014, PUBLIC HEALTH NUTR, V17, P1403, DOI 10.1017/S1368980013001274; Danquah I, 2015, AM J CLIN NUTR, V102, P207, DOI 10.3945/ajcn.114.101345; Defo BK, 2014, GLOBAL HEALTH ACTION, V7, P17, DOI 10.3402/gha.v7.22443; Dop MC, 2012, FOOD NUTR BULL, V33, pS221, DOI 10.1177/15648265120333S211; Duah FD, 2013, SAGE OPEN, P1; Duda RB, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-44; Egbi G., 2012, AFRIC J FOOD AGR NUT, V12; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; Ferreira ED, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0870-5; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Frank LK, 2013, TROP MED INT HEALTH, V18, P141, DOI 10.1111/tmi.12024; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Genuth S, 2003, DIABETES CARE, V26, P3160; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; Ghana Statistical Service Ghana Health Service ICF Macro, 2009, GHAN DEM HLTH SURV; Hervish A., 2012, STATUS REPORT ADOLES; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jones AD, 2016, J NUTR, V146, P1257, DOI 10.3945/jn.115.226654; Kurtis JD, 2001, INFECT IMMUN, V69, P123, DOI 10.1128/IAI.69.1.123-128.2001; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Manyanga T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-887; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Muthuri SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092846; Oluwayemi IO, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/417859; Oni T, 2015, INT HEALTH, V7, P390, DOI 10.1093/inthealth/ihv040; Organization WH, 2016, GLOBAL STATUS REPORT; Peltzer K, 2011, INT J ENV RES PUB HE, V8, P3859, DOI 10.3390/ijerph8103859; Peltzer K, 2011, INT J BEHAV MED, V17, P271, DOI 10.1007/s12529-009-9073-1; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199; Schweigert FJ, 2003, HUM REPROD, V18, P1259, DOI 10.1093/humrep/deg249; Senbanjo IO, 2011, J HEALTH POPUL NUTR, V29, P364, DOI 10.3329/jhpn.v29i4.8452; Sifft KC, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1606-x; Smallman-Raynor M, 1999, HEALTH PLACE, V5, P209, DOI 10.1016/S1353-8292(99)00010-6; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; U.S. Department of Health and Human Services National Institute of Health National Heart Lung and Blood Institute, 2005, 4 US DEP HLTH HUM SE; World Health Organization, 2004, SER FERR CONC ASS IR; Zeba AN, 2012, PUBLIC HEALTH NUTR, V15, P2210, DOI 10.1017/S1368980012000729	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180436	10.1371/journal.pone.0180436	http://dx.doi.org/10.1371/journal.pone.0180436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727775	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000406634500021
J	Anaker, A; von Koch, L; Sjostrand, C; Bernhardt, J; Elf, M				Anaker, Anna; von Koch, Lena; Sjostrand, Christina; Bernhardt, Julie; Elf, Marie			A comparative study of patients' activities and interactions in a stroke unit before and after reconstruction-The significance of the built environment	PLOS ONE			English	Article							ENRICHED ENVIRONMENT; PHYSICAL-ACTIVITY; REHABILITATION; CARE; ROOMS; EMERGENCY	Early mobilization and rehabilitation, multidisciplinary stroke expertise and comprehensive therapies are fundamental in a stroke unit. To achieve effective and safe stroke care, the physical environment in modern stroke units should facilitate the delivery of evidence-based care. Therefore, the purpose of this study was to explore patients' activities and interactions in a stroke unit before the reconstruction of the physical environment, while in a temporary location and after reconstruction. This case study examined a stroke unit as an integrated whole. The data were collected using a behavioral mapping technique at three different time points: in the original unit, in the temporary unit and in the new unit. A total of 59 patients were included. The analysis included field notes from observations of the physical environment and examples from planning and design documents. The findings indicated that in the new unit, the patients spent more time in their rooms, were less active, and had fewer interactions with staff and family than the patients in the original unit. The reconstruction involved a change from a primarily multi-bed room design to single-room accommodations. In the new unit, the patients' lounge was located in a far corner of the unit with a smaller entrance than the patients' lounge in the old unit, which was located at the end of a corridor with a noticeable entrance. Changes in the design of the stroke unit may have influenced the patients' activities and interactions. This study raises the question of how the physical environment should be designed in the future to facilitate the delivery of health care and improve outcomes for stroke patients. This research is based on a case study, and although the results should be interpreted with caution, we strongly recommend that environmental considerations be included in future stroke guidelines.	[Anaker, Anna; von Koch, Lena; Elf, Marie] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Anaker, Anna; Elf, Marie] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [von Koch, Lena; Sjostrand, Christina] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Sjostrand, Christina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Bernhardt, Julie] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Elf, Marie] Chalmers Univ Technol, Sch Architecture, Gothenburg, Sweden	Karolinska Institutet; Dalarna University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Florey Institute of Neuroscience & Mental Health; Chalmers University of Technology	Anaker, A (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.; Anaker, A (corresponding author), Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden.	anna.anaker@ki.se	von Koch, Lena/P-2310-2018; Bernhardt, Julie/F-9538-2015	von Koch, Lena/0000-0002-8560-3016; Bernhardt, Julie/0000-0002-2787-8484	Swedish Research Council Formas; Swedish Stroke Association; Doctoral School in Health Care Sciences at Karolinska Institutet	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Stroke Association; Doctoral School in Health Care Sciences at Karolinska Institutet	Financial support was provided through the Swedish Research Council Formas, the Swedish Stroke Association and the Doctoral School in Health Care Sciences at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided through the Swedish Research Council Formas, the Swedish Stroke Association and the Doctoral School in Health Care Sciences at Karolinska Institutet. We would like to thank Christina Nylen and Olivia Ortlund, who both worked as research assistants in the study, and Jan Chamberlain for support with data processing.	Astrand A, 2016, J STROKE CEREBROVASC, V25, P938, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.046; Barlas D, 2001, ANN EMERG MED, V38, P135, DOI 10.1067/mem.2001.115441; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Chaudhury H, 2005, ENVIRON BEHAV, V37, P760, DOI 10.1177/0013916504272658; De Wit L, 2005, STROKE, V36, P1977, DOI 10.1161/01.STR.0000177871.59003.e3; Devlin AS, 2016, HERD-HEALTH ENV RES, V9, P190, DOI 10.1177/1937586715607052; Elf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161942; Elf M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0782-7; Hagerman I, 2005, INT J CARDIOL, V98, P267, DOI 10.1016/j.ijcard.2003.11.006; Hamilton D.K., 2003, HEALTHCARE DESIGN, V3, P18; Hendrich AL, 2004, AM J CRIT CARE, V13, P35, DOI 10.4037/ajcc2004.13.1.35; Hokstad A, 2015, J STROKE CEREBROVASC, V24, P1333, DOI 10.1016/j.jstrokecerebrovasdis.2015.02.009; Janssen H, 2014, DISABIL REHABIL, V36, P255, DOI 10.3109/09638288.2013.788218; Keysor JJ, 2006, ARCH PHYS MED REHAB, V87, P1566, DOI 10.1016/j.apmr.2006.08.347; Kramer SF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/460482; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lincoln N B, 1989, Int Disabil Stud, V11, P149; Maben J, 2015, ONE SIZE FITS ALL MI; Malenbaum S, 2008, PAIN, V134, P241, DOI 10.1016/j.pain.2007.12.002; McDonald S., 2005, QUAL RES, V5, P455, DOI 10.1177/1468794105056923; Persson E, 2015, SCAND J CARING SCI, V29, P340, DOI 10.1111/scs.12168; Rapoport A., 1990, MEANING BUILT ENV NO; RIKS Stroke, 2014, STROK TIA; Ringelstein EB, 2013, STROKE, V44, P828, DOI 10.1161/STROKEAHA.112.670430; Sadler BL, 2011, HASTINGS CENT REP, V41, P13; Salonen H, 2013, INTELL BUILD INT, V5, P26, DOI 10.1080/17508975.2013.764839; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; Singh I, 2016, GERONTOLOGY GEARIATR, V2; Spradley J. P., 2016, PARTICIPANT OBSERVAT; Steinke C, 2009, HERD, V3, P63; Steinke C, 2015, HERD-HEALTH ENV RES, V8, P31, DOI 10.1177/1937586714565611; SUTC, 2013, COCHRANE DATABASE SY; Teasell R. W., 2015, TOP STROKE REHABIL; Tinson D J, 1989, Int Disabil Stud, V11, P45; Ulrich RS, 2010, HERD-HEALTH ENV RES, V4, P95, DOI 10.1177/193758671000400107; Ulrich RS, 2008, HERD-HEALTH ENV RES, V1, P61, DOI 10.1177/193758670800100306; West T, 2011, STROKE RES TREATMENT; White JH, 2014, DISABIL REHABIL, V36, P1783, DOI 10.3109/09638288.2013.872200; World Health Organization (WHO), 2015, INT CLASS FUNCT DIS, V1st; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed., DOI [10.33524/cjar.v14i1.73, DOI 10.33524/CJAR.V14I1.73]	41	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0177477	10.1371/journal.pone.0177477	http://dx.doi.org/10.1371/journal.pone.0177477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727727	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500001
J	Gladstone, BP; Cona, A; Shamsrizi, P; Vilken, T; Kern, WV; Malek, N; Tacconelli, E				Gladstone, Beryl Primrose; Cona, Andrea; Shamsrizi, Parichehr; Vilken, Tuba; Kern, Winfred V.; Malek, Nisar; Tacconelli, Evelina			Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-THERAPY; INFECTIONS; VANCOMYCIN; HOSPITALS; MRSA; METAANALYSIS; USAGE	Surveillance data are considered essential to appropriate empiric antibiotic therapy and stewardship. The objective of this study was to determine if a change in the rates of antibiotic resistance impacts antibiotic use in European hospitals. Glycopeptides use was selected to study the correlation between resistance rates and antibiotic use because of the restricted spectrum against resistant gram positive bacteria. PubMed, ECDC databases and national/regional surveillance systems were searched to identify glycopeptides' consumption in defined daily dose per 1000 inhabitant-days (DID) and rate of methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant coagulase negative staphylococci (MRCoNS), and vancomycin-resistant enterococci (VRE) in bloodstream infections (BSIs) in European countries between 1997 and 2015. Time trends were studied and associations between DID and BSI resistance rates were tested using multi-level mixed effect models. To account for the gap in the publication and dissemination of the yearly resistance data, a 2-year lag in the resistance rates was applied. Data on glycopeptides' DID and resistance rates of target microorganisms in blood cultures were identified among 31 countries over a 19-year period. Glycopeptides use significantly increased (p < 0.0001) while rates of MRSA BSIs decreased in majority of the countries (p < 0.0001) and MRCoNS and VRE BSIs remained stable. Variation in glycopeptides' DID was not associated with variation in BSIs due to MRSA (p = 0.136) and VRE (p = 0.613). After adjusting for MRCoNS and VRE resistance rates, among 21 countries, 11 (52%) had a concordant and 10 (48%) a discordant trend in yearly glycopeptides A DID and MRSA BSI rates. No correlation was found between resistance rates and DID data even among 8 countries with more than 5% decrease in MRSA rates over time. (RC -0.009, p = 0.059). Resistance rate of MRSA, MRCoNS, and VRE BSIs does not impact DID of glycopeptides in European hospitals. This finding is key to redefining the role and structure of antimicrobial surveillance and stewardship programmes.	[Gladstone, Beryl Primrose; Cona, Andrea; Shamsrizi, Parichehr; Vilken, Tuba; Malek, Nisar; Tacconelli, Evelina] Tubingen Univ Hosp, DZIF Partner, Dept Internal Med 1, Infect Dis, Tubingen, Germany; [Cona, Andrea] Univ Milan, San Paolo Hosp, Infect Dis & Trop Med, Milan, Italy; [Kern, Winfred V.] Univ Hosp & Med Ctr, Dept Med, Infect Dis, Freiburg, Germany; [Kern, Winfred V.] Albert Ludwigs Univ, Fac Med, Freiburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; German Center for Infection Research; San Paolo-Polo Universitaria Hospital; University of Milan; University of Freiburg; University of Freiburg	Tacconelli, E (corresponding author), Tubingen Univ Hosp, DZIF Partner, Dept Internal Med 1, Infect Dis, Tubingen, Germany.	Evelina.Tacconelli@med.uni-tuebingen.de	Tacconelli, Evelina/AAC-8200-2019	Shamsrizi, Dr. Parichehr/0000-0002-0376-0967	Innovative Medicines Initiative Joint Undertaking [115737 (COMBACTE-MAGNET), 115618 (DRIVE-AB)]; European Union Seventh Framework Programme; EFPIA	Innovative Medicines Initiative Joint Undertaking; European Union Seventh Framework Programme(European Commission); EFPIA	This research project receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement numbers 115737 (COMBACTE-MAGNET) and 115618 (DRIVE-AB), resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118; Berrington A, 2010, J ANTIMICROB CHEMOTH, V65, P163, DOI 10.1093/jac/dkp399; Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-25; Coulter S, 2015, INT J ANTIMICROB AG, V46, P140, DOI 10.1016/j.ijantimicag.2015.04.007; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; ECDC/EMEA, 2009, BACT CHALL TIM REACT; ESPAUR, 2014, ENGL SURV PROGR ANT; European Centre for Disease Control, DAT TOOLS; Floret N, 2001, PHARM WORLD SCI, V23, P93, DOI 10.1023/A:1011269131048; Grau S, 2015, J ANTIMICROB CHEMOTH, V70, P1193, DOI 10.1093/jac/dku487; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Kern W V, 2015, Dtsch Med Wochenschr, V140, pe237, DOI 10.1055/s-0041-105938; Kirst HA, 1998, ANTIMICROB AGENTS CH, V42, P1303, DOI 10.1128/AAC.42.5.1303; Kumana CR, 2001, BRIT J CLIN PHARMACO, V52, P427, DOI 10.1046/j.0306-5251.2001.01455.x; Marquet Kristel, 2015, Crit Care, V19, P63, DOI 10.1186/s13054-015-0795-y; Meyer E, 2010, INFECTION, V38, P19, DOI 10.1007/s15010-009-9115-2; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; National Institute for Health and Care Excellence, 2015, ANT STEW SYST PROC E; O'Neill J, TACKLING DRUG RESIST; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; Raman G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1123-5; Schweizer ML, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-28; Shigemura K, 2013, J ANTIBIOT, V66, P273, DOI 10.1038/ja.2013.14; StataCorp, 2015, STAT STAT SOFTW REL; Surveillance of antimicrobial consumption in Europe, 2012, SURV ANT CONS EUR TA; Tacconelli E, 2009, CURR OPIN INFECT DIS, V22, P352, DOI 10.1097/QCO.0b013e32832d52e0; Trautner BW, 2015, JAMA INTERN MED, V175, P1120, DOI 10.1001/jamainternmed.2015.1878; Trilla Antoni, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 3, P1; Van Gastel E, 2010, J ANTIMICROB CHEMOTH, V65, P576, DOI 10.1093/jac/dkp470	29	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181358	10.1371/journal.pone.0181358	http://dx.doi.org/10.1371/journal.pone.0181358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727741	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500062
J	He, LY; Yin, F; Zhong, ZQ; Ding, ZH				He, Lingyun; Yin, Fang; Zhong, Zhangqi; Ding, Zhihua			The impact of local government investment on the carbon emissions reduction effect: An empirical analysis of panel data from 30 provinces and municipalities in China	PLOS ONE			English	Article							ENERGY-CONSUMPTION; CO2 EMISSIONS; DIOXIDE EMISSIONS; ECONOMIC-GROWTH; TECHNOLOGICAL-INNOVATION; PRICES; SYSTEM; TRADE	Among studies of the factors that influence carbon emissions and related regulations, economic aggregates, industrial structures, energy structures, population levels, and energy prices have been extensively explored, whereas studies from the perspective of fiscal leverage, particularly of local government investment (LGI), are rare. Of the limited number of studies on the effect of LGI on carbon emissions, most focus on its direct effect. Few studies consider regulatory effects, and there is a lack of emphasis on local areas. Using a cointegration test, a panel data model and clustering analysis based on Chinese data between 2000 and 2013, this study measures the direct role of LGI in carbon dioxide (CO2) emissions reduction. First, overall, within the sample time period, a 1% increase in LGI inhibits carbon emissions by 0.8906% and 0.5851% through its influence on the industrial structure and energy efficiency, respectively, with the industrial structure path playing a greater role than the efficiency path. Second, carbon emissions to some extent exhibit inertia. The previous year's carbon emissions impact the following year's carbon emissions by 0.5375%. Thus, if a reduction in carbon emissions in the previous year has a positive effect, then the carbon emissions reduction effect generated by LGI in the following year will be magnified. Third, LGI can effectively reduce carbon emissions, but there are significant regional differences in its impact. For example, in some provinces, such as Sichuan and Anhui, economic growth has not been decoupled from carbon emissions. Fourth, the carbon emissions reduction effect in the 30 provinces and municipalities sampled in this study can be classified into five categories - strong, relatively strong, medium, relatively weak and weak - based on the degree of local governments' regulation of carbon emissions. The carbon emissions reduction effect of LGI is significant in the western and central regions of China but not in the eastern and northeast regions. This study helps overcome the limitations of previous studies on the regulatory effects of LGI on carbon emissions, and the constructed model may more closely reflect actual economic conditions. Moreover, the current study can benefit countries similar to China that aim to objectively identify the impacts of their LGI on carbon emissions, and such countries can use it as a reference in the formulation of investment policies based on their economic and industrial characteristics.	[He, Lingyun; Yin, Fang; Ding, Zhihua] China Univ Min & Technol, Sch Management, Xuzhou, Peoples R China; [Zhong, Zhangqi] Zhejiang Univ Finance & Econ, Sch Econ, Hangzhou, Zhejiang, Peoples R China	China University of Mining & Technology; Zhejiang University of Finance & Economics	Yin, F (corresponding author), China Univ Min & Technol, Sch Management, Xuzhou, Peoples R China.	yindf_11@126.com			National Natural Science Foundation of China [71203219]; key project of National Social Sciences Program Fund of China [15ZDB163]; Ministry of education of Humanities and Social Science project of China [16YJAZH015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of National Social Sciences Program Fund of China; Ministry of education of Humanities and Social Science project of China	The authors are grateful for the financial support provided by the National Natural Science Foundation of China under grant no. 71203219, the key project of National Social Sciences Program Fund of China under grant no. 15ZDB163, and the Ministry of education of Humanities and Social Science project of China under grant no. 16YJAZH015.	Adom PK, 2012, ENERGY, V47, P314, DOI 10.1016/j.energy.2012.09.025; Al-Mulali U, 2015, NAT HAZARDS, V79, P621, DOI 10.1007/s11069-015-1865-9; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Baek JH, 2009, J EAST ASIAN ECON IN, V13, P87, DOI 10.11644/KIEP.JEAI.2009.13.2.202; Ben Jebli M, 2016, ECOL INDIC, V60, P824, DOI 10.1016/j.ecolind.2015.08.031; Ben Jebli M, 2015, ENVIRON SCI POLLUT R, V22, P16022, DOI 10.1007/s11356-015-4792-0; Chen X.P., 2012, EMPIRICAL METHODS OR; Dogan E, 2016, ENVIRON SCI POLLUT R, P1; Dogan E, 2017, CURR ISSUES TOUR, V20, P1701, DOI 10.1080/13683500.2015.1119103; Dogan E, 2016, RENEW SUST ENERG REV, V60, P1074, DOI 10.1016/j.rser.2016.02.006; Dogan E, 2016, RENEW ENERG, V94, P429, DOI 10.1016/j.renene.2016.03.078; Dogan E, 2016, ENVIRON SCI POLLUT R, V23, P1203, DOI 10.1007/s11356-015-5323-8; Drezner JA, 1999, THESIS, P60; Du LM, 2012, CHINA ECON REV, V23, P371, DOI 10.1016/j.chieco.2012.02.004; Ertugrul HM, 2016, ECOL INDIC, V67, P543, DOI 10.1016/j.ecolind.2016.03.027; Fei Q, 2014, ENRGY PROCED, V61, P1142, DOI 10.1016/j.egypro.2014.11.1041; Framstad NC, 2013, RESOUR ENERGY ECON, V41, P1; Fu F, 2014, ENERG CONVERS MANAGE, V85, P573, DOI 10.1016/j.enconman.2014.05.046; Glomm G, 2008, J POLICY MODEL, V30, P19, DOI 10.1016/j.jpolmod.2007.09.001; [何凌云 He Lingyun], 2016, [资源科学, Resources Science], V38, P1383; Hubler M, 2012, ENERG POLICY, V50, P315, DOI 10.1016/j.enpol.2012.07.025; Jorgenson AndrewK., 2007, INT J COMP SOCIOL, V48, P29, DOI DOI 10.1177/0020715207072158; Kais S, 2016, RENEW SUST ENERG REV, V59, P1101, DOI 10.1016/j.rser.2016.01.054; Kaya Y., 1989, COMMUNICATION; Lee KH, 2015, INT J PROD ECON, V167, P1, DOI 10.1016/j.ijpe.2015.05.018; Lee S, 2016, RESOUR CONSERV RECY, V107, P220, DOI 10.1016/j.resconrec.2016.01.003; Li K, 2015, RENEW SUST ENERG REV, V42, P952, DOI 10.1016/j.rser.2014.10.083; Liu LC, 2007, ENERG POLICY, V35, P5892, DOI 10.1016/j.enpol.2007.07.010; Lu CY, 2010, ENERGY, V35, P4319, DOI 10.1016/j.energy.2009.04.007; Mahesh A, 2013, RENEW SUST ENERG REV, V26, P414, DOI 10.1016/j.rser.2013.05.069; Mao GZ, 2013, ENERGY STRATEG REV, V2, P199, DOI 10.1016/j.esr.2013.07.004; Martinsen D, 2007, ENERG POLICY, V35, P4504, DOI 10.1016/j.enpol.2007.03.003; Mi ZF, 2015, J CLEAN PROD, V103, P455, DOI 10.1016/j.jclepro.2014.06.011; Ministry of Finance of the People's Republic of China, 2001, CHIN FIN YB 2001 201; National Bureau of Statistics of People's Republic of China, 2001, CHIN STAT YB 2001 20; National Bureau of Statistics of People's Republic of China, 2002, CHIN EN STAT YB 2002; National Bureau of Statistics of People's Republic of China, 2013, CHIN EN STAT YB 2013; Peng Y., 2010, PUBLIC FINANCE RES, V12, P30; Peng Y., 2013, COMP EC SOCIAL SYSTE, V3, P92; Purohit I, 2007, INT J ENERGY SECT MA, V1, P141, DOI 10.1108/17506220710761564; Shafiei S, 2014, ENERG POLICY, V66, P547, DOI 10.1016/j.enpol.2013.10.064; Shen L, 2014, RES EC MANAGEMENT, V1, P56; Shi D., 2003, EC THEORY BUS MANAG, V8, P30, DOI 10.3969/j.issn.1000-596X.2003.08.006; Song ZJ, 2013, ENTERPRISE EC, V10, P171; Sun JW, 1998, ENERG ECON, V20, P85, DOI 10.1016/S0140-9883(97)00012-1; Wang J., 2014, EC MANAG, V36, P13; Wang K-I, 2012, MANAG REV, V24, P40; Wang SH, 2016, RESOURCES SCI, V36, P2500; Zhang D. J., 2016, TRANSPORT RES D-TR E, P1; Zhang HX, 2011, J INNER MONGOLIA FIN, V3, P22; Zhang LF, 2011, J ARID LAND RESOURCE, V5, P1; Zhang M, 2009, ECOLOGICAL EC, V68, P2111; Zhang N, 2016, ENERGY, V99, P10, DOI 10.1016/j.energy.2016.01.012; Zhang TT, 2012, STAT DECISION, V9, P161; Zhang WG, 2015, ECOLOGICAL EC, V31, P14; Zhang WG, 2010, CHINA IND EC, V8, P23; Zhao P., 2013, FINANCE EC, V18, P75; [郑蕾 Zheng Lei], 2015, [资源科学, Resources Science], V37, P2330; Zhou GL, 2012, EC PROBLEMS, V1, P24; Zhou J, 2012, SHANGHAI J EC, V1, P24; Zhou XY, 2013, ENERG POLICY, V57, P43, DOI 10.1016/j.enpol.2012.07.017	61	9	9	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180946	10.1371/journal.pone.0180946	http://dx.doi.org/10.1371/journal.pone.0180946			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727783	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500032
J	Howard, B; Scott, JT; Blubaugh, M; Roepke, B; Scheckel, C; Vassar, M				Howard, Benjamin; Scott, Jared T.; Blubaugh, Mark; Roepke, Brie; Scheckel, Caleb; Vassar, Matt			Systematic review: Outcome reporting bias is a problem in high impact factor neurology journals	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; MEDICINE JOURNALS; REGISTRATION; EDITORS	Background Selective outcome reporting is a significant methodological concern. Comparisons between the outcomes reported in clinical trial registrations and those later published allow investigators to understand the extent of selection bias among trialists. We examined the possibility of selective outcome reporting in randomized controlled trials (RCTs) published in neurology journals. Methods We searched PubMed for randomized controlled trials from Jan 1, 2010 - Dec 31, 2015 published in the top 3 impact factor neurology journals. These articles were screened according to specific inclusion criteria. Each author individually extracted data from trials following a standardized protocol. A second author verified each extracted element and discrepancies were resolved. Consistency between registered and published outcomes was evaluated and correlations between discrepancies and funding, journal, and temporal trends were examined. Results 180 trials were included for analysis. 10 (6%) primary outcomes were demoted, 38 (21%) primary outcomes were omitted from the publication, and 61 (34%) unregistered primary outcomes were added to the published report. There were 18 (10%) cases of secondary outcomes being upgraded to primary outcomes in the publication, and there were 53 (29%) changes in timing of assessment. Of 82 (46%) major discrepancies with reported p-values, 54 (66.0%) favored publication of statistically significant results. Conclusion Across trials, we found 180 major discrepancies. 66% of major discrepancies with a reported p-value (n = 82) favored statistically significant results. These results suggest a need within neurology to provide more consistent and timely registration of outcomes.	[Howard, Benjamin; Scott, Jared T.] Oklahoma State Univ, Ctr Hlth Sci, Coll Osteopath Med, Tulsa, OK 74074 USA; [Blubaugh, Mark; Roepke, Brie] Oklahoma State Univ, Med Ctr, Emergency Med, Tulsa, OK USA; [Scheckel, Caleb] Mayo Clin, Internal Med, Scottsdale, AZ USA; [Vassar, Matt] Oklahoma State Univ, Ctr Hlth Sci, Dept Inst Res, Tulsa, OK USA	Oklahoma State University System; Oklahoma State University Center for Health Sciences; Oklahoma State University System; Oklahoma State University Center for Health Sciences; Mayo Clinic; Mayo Clinic Phoenix; Oklahoma State University System; Oklahoma State University Center for Health Sciences	Howard, B; Scott, JT (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Coll Osteopath Med, Tulsa, OK 74074 USA.	Benjamin.Howard@okstate.edu; jared.t.scott@okstate.edu	Vassar, Matt/AAD-5385-2020	Vassar, Ben Matthew/0000-0003-2859-6152				Altman DG, 2013, BMJ, V347, P1669; [Anonymous], 2016, STANDARDS SYSTEMATIC; [Anonymous], 2016, ANN NEUROLOGY; [Anonymous], 2016, NIH OUTREACH TOOLKIT; [Anonymous], 2014, COCHRANE HDB SYSTEMA; [Anonymous], 2016, TRACKING SWITCHED OU; [Anonymous], 2016, TRENDS CHARTS MAPS; Chan A-W, 2005, BMJ-BRIT MED J, P330; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Dal-Re R, 2015, EUR J CLIN INVEST, V45, P895, DOI 10.1111/eci.12484; Dal-Re R, 2014, EUR J CLIN PHARMACOL, V70, P491, DOI 10.1007/s00228-013-1635-0; De Angelis C, 2005, STROKE, V36, P924, DOI 10.1161/01.STR.0000162239.47724.c2; De Oliveira GS, 2015, ANESTH ANALG, V121, P1030, DOI 10.1213/ANE.0000000000000824; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Hardt JLS, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-407; Jones CW, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0520-3; Jones CW, 2012, ANN EMERG MED, V60, P458, DOI 10.1016/j.annemergmed.2012.02.005; Li TJ, 2015, ANN INTERN MED, V162, P287, DOI 10.7326/M14-1603; Mathieu S, 2013, PLOS ONE, V10, P8, DOI DOI 10.1371/J0URNAL.P0NE.0059910; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; NANKERVIS H, 2012, J INVEST DERMATOL, V132, P2727, DOI DOI 10.1038/jid.2012.231; Rasmussen N, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-116; Rayhill ML, 2015, NEUROLOGY, V85, P1789, DOI 10.1212/WNL.0000000000002127; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; van Lent M, 2015, J CLIN EPIDEMIOL, V68, P1059, DOI 10.1016/j.jclinepi.2014.11.019	25	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180986	10.1371/journal.pone.0180986	http://dx.doi.org/10.1371/journal.pone.0180986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727834	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500035
J	Hull-Sanders, H; Pepper, E; Davis, K; Trotter, RT				Hull-Sanders, Helen; Pepper, Eugene; Davis, Kevin; Trotter, Robert Talbot, III			Description of an establishment event by the invasive Asian longhorned beetle (Anoplophora glabripennis) in a suburban landscape in the northeastern United States	PLOS ONE			English	Article							COLEOPTERA-CERAMBYCIDAE; MARK-RECAPTURE; DISPERSAL; ECOLOGY; INFESTATION; POPULATIONS; WELENSII; STANDS; DEHESA	The establishment of non-native species is commonly described as occurring in three phases: arrival, establishment, and dispersal. Both arrival and dispersal by the Asian longhorned beetle (Anoplophora glabripennis Motschulsky), a xylophagous Cerambycid native to China and the Korean peninsula, has been documented for multiple locations in both North America and Europe, however the transitional phase, establishment, is not well understood for this species due to the need to rapidly remove populations to prevent dispersal and assist eradication, and the evident variation in the behavior of populations. Here we describe the dynamics of an establishment event for the Asian longhorned beetle in a small, isolated population within the regulated quarantine zone near Worcester, Massachusetts, USA. These data were collected during an opportunity afforded by logistical limits on the Cooperative Asian Longhorned Beetle Eradication Program administered by state, federal, and local government partners. Seventy-one infested red maple (Acer rubrum) trees and 456 interspersed un-infested trees were surveyed in an isolated, recently established population within a similar to 0.29 ha stand in a suburban wetland conservation area in which nearly 90% of the trees were host species, and nearly 80% were Acer rubrum. Tree-ring analyses show that within this establishing population, Asian longhorned beetles initially infested one or two A. rubrum, before moving through the stand to infest additional A. rubrum based not on distance or direction, but on tree size, with infestation biased towards trees with larger trunk diameters. Survey data from the larger landscape suggest this population may have generated long-distance dispersers (similar to 1400 m), and that these dispersal events occurred before the originally infested host trees were fully exploited by the beetle. The distribution and intensity of damage documented in this population suggest dispersal here may have been spatially more rapid and diffuse than in other documented infestations. Dispersal at these larger spatial scales also implies that when beetles move beyond the closed canopy of the stand, the direction of dispersal may be linked to prevailing winds.	[Hull-Sanders, Helen] USDA, Ctr Plant Hlth Sci & Technol, Anim & Plant Hlth Inspect Serv, Plant Protect & Quarantine,Otis Lab, Washington, DC 20250 USA; [Pepper, Eugene; Davis, Kevin] USDA, Anim & Plant Hlth Inspect Serv, Asian Longhorned Beetle Cooperat Eradicat Program, 151 West Boylston Dr, Worcester, MA USA; [Trotter, Robert Talbot, III] US Forest Serv, USDA, Northern Res Stn, Hamden, CT USA; [Hull-Sanders, Helen] US EPA, USEPA Headquarters, William Jefferson Clintom Bldg,1200 Penn Ave NW, Washington, DC 20460 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Forest Service; United States Environmental Protection Agency	Hull-Sanders, H (corresponding author), USDA, Ctr Plant Hlth Sci & Technol, Anim & Plant Hlth Inspect Serv, Plant Protect & Quarantine,Otis Lab, Washington, DC 20250 USA.; Hull-Sanders, H (corresponding author), US EPA, USEPA Headquarters, William Jefferson Clintom Bldg,1200 Penn Ave NW, Washington, DC 20460 USA.	hhullsanders@gmail.com			USDA Animal Plant Health Inspection Service; USDA Forest Service; USDA PPQ-Otis Laboratory, Buzzards Bay, Massachusetts; USDA PPQ Asian Longhorned Beetle Eradication Program, Worcester, Massachusetts	USDA Animal Plant Health Inspection Service; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); USDA PPQ-Otis Laboratory, Buzzards Bay, Massachusetts; USDA PPQ Asian Longhorned Beetle Eradication Program, Worcester, Massachusetts	This work supported by the USDA Animal Plant Health Inspection Service and the USDA Forest Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the USDA PPQ-Otis Laboratory, Buzzards Bay, Massachusetts and USDA PPQ Asian Longhorned Beetle Eradication Program, Worcester, Massachusetts for all their cooperation and support on this project. We would also like to acknowledge the contributions of Christopher Perry, J. Chris Fagan, and David Mikus for their invaluable technical help in the field and processing of wood samples. Any reference to commercial software is made for the convenience of the reader, and does not constitute an endorsement of any software or company.	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; [Anonymous], 2013, MATLAB STAT TOOLB RE; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Bancroft JS, 2005, ENTOMOL EXP APPL, V116, P83, DOI 10.1111/j.1570-7458.2005.00320.x; Bartell SM, 2004, RISK ANAL, V24, P833, DOI 10.1111/j.0272-4332.2004.00482.x; Dodds Kevin J., 2014, Insects, V5, P105, DOI 10.3390/insects5010105; Dodds KJ, 2011, CAN J FOREST RES, V41, P1729, DOI [10.1139/X11-097, 10.1139/x11-097]; Drag L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021345; Environmental Systems Research Institute (ESRI), 2006, ARCPAD VERS 10 SOFTW; ESRI, 2011, ARCGIS DESKT REL 10; Favaro R, 2015, ENTOMOL EXP APPL, V155, P95, DOI 10.1111/eea.12292; Fritts H. C., 1976, TREE RINGS CLIMATE; (GAO) Government Accountability Office, 2006, GAO06353 COMM RES HO; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Hsiao K. J., 1982, Crop Protection, V1, P359, DOI 10.1016/0261-2194(82)90011-4; Hu JF, 2009, AGR FOREST ENTOMOL, V11, P359, DOI 10.1111/j.1461-9563.2009.00443.x; Li Guo-hong, 2010, Forest Research, V23, P678; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Lingafelter S.W., 2002, REVISION GENUS ANOPL; Lopez-Pantoja G, 2008, CENT EUR J BIOL, V3, P431, DOI 10.2478/s11535-008-0044-3; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Nowak DJ, 2001, J ECON ENTOMOL, V94, P116, DOI 10.1603/0022-0493-94.1.116; Parker BL, 2012, NAPR0512 USDA; Peng J., 1992, ICONOGRAPHY FOREST I; R Foundation for Statistical Computing V. Austria. . R Development Core Team, 2008, R LANG ENV STAT COMP; Sawyer A., 2009, EXPECTED DISPERSAL A; SHIBATA E, 1986, RES POPUL ECOL, V28, P253, DOI 10.1007/BF02515453; Smith Michael T., 2009, American Entomologist, V55, P21; Smith MT, 2004, ENVIRON ENTOMOL, V33, P435, DOI 10.1603/0046-225X-33.2.435; Smith MT, 2002, ENVIRON ENTOMOL, V31, P76, DOI 10.1603/0046-225X-31.1.76; Smith MT, 2001, ENVIRON ENTOMOL, V30, P1036, DOI 10.1603/0046-225X-30.6.1036; Straw NA, 2016, AGR FOREST ENTOMOL, V18, P280, DOI 10.1111/afe.12160; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Torres-Vila LM, 2013, ENTOMOL EXP APPL, V149, P273, DOI 10.1111/eea.12133; Trotter RT, 2015, BIOL INVASIONS, V17, P3359, DOI 10.1007/s10530-015-0961-9; Turgeon JJ, 2015, COLEOPTS BULL, V69, P674, DOI 10.1649/0010-065X-69.4.674; United States Army, 1956, 2126 FM US ARM DEP A; Wang B., 2005, GEN TECHNICAL REPORT, P89; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Williams DW, 2004, ENVIRON ENTOMOL, V33, P540, DOI 10.1603/0046-225X-33.3.540; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wu Weiwen, 1998, Acta Entomologica Sinica, V41, P284; Xiao G.R., 1992, FOREST INSECTS CHINA, V2nd eds; Yan J., 1992, FOREST INSECTS CHINA, P455	44	11	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181655	10.1371/journal.pone.0181655	http://dx.doi.org/10.1371/journal.pone.0181655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727772	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500100
J	Singh, SP; Swanson, M				Singh, Shane P.; Swanson, Meili			How issue frames shape beliefs about the importance of climate change policy across ideological and partisan groups	PLOS ONE			English	Article							PUBLIC-OPINION; SUPPORT; MITIGATION; POLARIZATION; INFORMATION; ENVIRONMENT; COMPASSION; ATTITUDES; DISTANCE; LIMITS	We use an experiment to examine whether the way in which climate change is framed affects individuals' beliefs about its importance as a policy issue. We employ frames that emphasize national security, human rights, and environmental importance about the consequences of climate change. We find no evidence that issue frames have an overall effect on opinions about the importance of climate change policy. We do find some evidence that the effect of issue frames varies across ideological and partisan groups. Most notably, issue frames can lead Republicans and those on the political right to view climate change policy as less important. We conclude by discussing our findings relative to extant literature and considering the implications of our findings for those who seek to address the issue of climate change.	[Singh, Shane P.] Univ Georgia, Dept Int Affairs, Athens, GA 30602 USA; [Swanson, Meili] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); Sandia National Laboratories	Singh, SP (corresponding author), Univ Georgia, Dept Int Affairs, Athens, GA 30602 USA.	singh@uga.edu		Singh, Shane/0000-0003-3263-5281				Aklin M, 2013, GLOBAL ENVIRON CHANG, V23, P1225, DOI 10.1016/j.gloenvcha.2013.03.007; Armitage CJ, 2000, PERS SOC PSYCHOL B, V26, P1421, DOI 10.1177/0146167200263009; Aschemann-Witzel J, 2015, FOOD QUAL PREFER, V42, P90, DOI 10.1016/j.foodqual.2015.01.008; Bechtel MM, 2015, POLIT SCI RES METH, V3, P683, DOI 10.1017/psrm.2014.39; Berinsky AJ, 2006, J POLIT, V68, P640, DOI 10.1111/j.1468-2508.2006.00451.x; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bernauer T, 2016, NAT CLIM CHANGE, V6, P680, DOI [10.1038/nclimate2948, 10.1038/NCLIMATE2948]; Bolsen T, 2014, PUBLIC OPIN QUART, V78, P1, DOI 10.1093/poq/nft044; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; De Mesquita BB, 2005, INT STUD QUART, V49, P439, DOI 10.1111/j.1468-2478.2005.00372.x; Druckman JN, 2001, J POLIT, V63, P1041, DOI 10.1111/0022-3816.00100; Gallup, CLIM CHANG NOT TOP W; Gauchat G., 2012, AM SOCIOL REV, V77, P167, DOI [10.1177/0003122412438225, DOI 10.1177/0003122412438225]; Gill J, 1999, POLIT RES QUART, V52, P647, DOI 10.1177/106591299905200309; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Gross K, 2004, POLIT PSYCHOL, V25, P1, DOI 10.1111/j.1467-9221.2004.00354.x; Hamilton LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138208; Hart PS, 2012, COMMUN RES, V39, P701, DOI 10.1177/0093650211416646; Hochschild J, 2015, BRIT J POLIT SCI, V45, P467, DOI 10.1017/S000712341400043X; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; Huff C, 2015, RES POLITICS, V2, DOI 10.1177/2053168015604648; Jacoby WG, 2000, AM J POLIT SCI, V44, P750, DOI 10.2307/2669279; Kahan DM, 2015, ANN AM ACAD POLIT SS, V658, P192, DOI 10.1177/0002716214559002; Kamradt-Scott A, 2012, GLOB PUBLIC HEALTH, V7, pS95, DOI 10.1080/17441692.2012.725752; Kellstedt PM, 2008, RISK ANAL, V28, P113, DOI 10.1111/j.1539-6924.2008.01010.x; Keohane RO, 2015, PS-POLIT SCI POLIT, V48, P19, DOI 10.1017/S1049096514001541; Kolsto SD, 2006, INT J SCI EDUC, V28, P1689, DOI 10.1080/09500690600560878; KROSNICK JA, 1990, AM POLIT SCI REV, V84, P497, DOI 10.2307/1963531; Lahav G, 2012, POLIT BEHAV, V34, P477, DOI 10.1007/s11109-011-9171-z; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Liberman N, 2007, J EXP SOC PSYCHOL, V43, P143, DOI 10.1016/j.jesp.2005.12.009; Lu H, 2016, J ENVIRON PSYCHOL, V45, P192, DOI 10.1016/j.jenvp.2016.01.007; Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Molden D. C., 2005, CAMBRIDGE HDB THINKI, P295, DOI DOI 10.13140/2.1.5188.6883; Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6; National Public Radio, NEARL 200 NAT AD CLI; Nisbet MC, 2009, ENVIRONMENT, V51, P12, DOI 10.3200/ENVT.51.2.12-23; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; Petrovic N, 2014, CLIMATIC CHANGE, V126, P245, DOI 10.1007/s10584-014-1192-2; Pfattheicher S, 2016, ENVIRON BEHAV, V48, P929, DOI 10.1177/0013916515574549; Rathzel N, 2009, GLOBAL ENVIRON CHANG, V19, P326, DOI 10.1016/j.gloenvcha.2009.05.001; Riffkin R., UNEMPLOYMENT RISES T; Schuldt JP, 2011, PUBLIC OPIN QUART, V75, P115, DOI 10.1093/poq/nfq073; Severson AW, 2015, SOC SCI QUART, V96, P1277, DOI 10.1111/ssqu.12159; Soroka StuartN., 2010, DEGREES DEMOCRACY PO; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; STIMSON JA, 1995, AM POLIT SCI REV, V89, P543, DOI 10.2307/2082973; Stokes B., 2013, AM FOREIGN POLICY PR; Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x; The White House, 2015, NAT SEC STRAT; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; United States Department of Defense, 2015, NAT SEC IMPL CLIM RE; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; Warner K., 2011, EHR, V76, P789; Wiest SL, 2015, GLOBAL ENVIRON CHANG, V31, P187, DOI 10.1016/j.gloenvcha.2014.12.006; Yang FY, 2003, INT J SCI EDUC, V25, P221, DOI 10.1080/09500690210126739; Yarnal B., 2003, LOCAL ENVIRON, V8, P457, DOI [10.1080/13549830306668, DOI 10.1080/13549830306668]	58	15	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181401	10.1371/journal.pone.0181401	http://dx.doi.org/10.1371/journal.pone.0181401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727842	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500067
J	Abernathy, J; Brezas, A; Snekvik, KR; Hardy, RW; Overturf, K				Abernathy, Jason; Brezas, Andreas; Snekvik, Kevin R.; Hardy, Ronald W.; Overturf, Ken			Integrative functional analyses using rainbow trout selected for tolerance to plant diets reveal nutrigenomic signatures for soy utilization without the concurrence of enteritis	PLOS ONE			English	Article							SALMON SALMO-SALAR; ONCORHYNCHUS-MYKISS WALBAUM; FISH-MEAL REPLACEMENT; ATLANTIC SALMON; SOYBEAN-MEAL; GENE-EXPRESSION; GROWTH-PERFORMANCE; DISTAL INTESTINE; PROTEIN-SOURCES; GRADED-LEVELS	Finding suitable alternative protein sources for diets of carnivorous fish species remains a major concern for sustainable aquaculture. Through genetic selection, we created a strain of rainbow trout that outperforms parental lines in utilizing an all-plant protein diet and does not develop enteritis in the distal intestine, as is typical with salmonids on long-term plant protein-based feeds. By incorporating this strain into functional analyses, we set out to determine which genes are critical to plant protein utilization in the absence of gut inflammation. After a 12-week feeding trial with our selected strain and a control trout strain fed either a fishmeal-based diet or an all-plant protein diet, high-throughput RNA sequencing was completed on both liver and muscle tissues. Differential gene expression analyses, weighted correlation network analyses and further functional characterization were performed. A strain-by-diet design revealed differential expression ranging from a few dozen to over one thousand genes among the various comparisons and tissues. Major gene ontology groups identified between comparisons included those encompassing central, intermediary and foreign molecule metabolism, associated biosynthetic pathways as well as immunity. A systems approach indicated that genes involved in purine metabolism were highly perturbed. Systems analysis among the tissues tested further suggests the interplay between selection for growth, dietary utilization and protein tolerance may also have implications for nonspecific immunity. By combining data from differential gene expression and co-expression networks using selected trout, along with ontology and pathway analyses, a set of 63 candidate genes for plant diet tolerance was found. Risk loci in human inflammatory bowel diseases were also found in our datasets, indicating rainbow trout selected for plant-diet tolerance may have added utility as a potential biomedical model.	[Abernathy, Jason; Overturf, Ken] USDA ARS, Hagerman Fish Culture Expt Stn, Hagerman, ID 83332 USA; [Brezas, Andreas; Hardy, Ronald W.] Univ Idaho, Aquaculture Res Inst, Hagerman, ID USA; [Snekvik, Kevin R.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Abernathy, Jason] USDA ARS, Harry K Dupree Stuttgart Natl Aquaculture Res Ctr, Stuttgart, AR USA	United States Department of Agriculture (USDA); Idaho; University of Idaho; Washington State University; United States Department of Agriculture (USDA)	Abernathy, J; Overturf, K (corresponding author), USDA ARS, Hagerman Fish Culture Expt Stn, Hagerman, ID 83332 USA.	Jason.Abernathy@ars.usda.gov; Ken.Overturf@ars.usda.gov	Hardy, Ronald/AAK-4878-2021	Hardy, Ronald/0000-0002-4521-864X; Abernathy, Jason/0000-0001-6084-8239	Soy Aquaculture Alliance [UI/2013T01, U1/2013T02]; USDA Agricultural Research Service [2050-21310-005-00D]	Soy Aquaculture Alliance; USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by grants to RWH and KO from the Soy Aquaculture Alliance (awards #UI/2013T01 and #U1/2013T02) and by the USDA Agricultural Research Service under the Trout Grains Project (project #2050-21310-005-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy J, 2016, ANIM BIOTECHNOL, V27, P60, DOI 10.1080/10495398.2015.1086365; Alami-Durante H, 2010, AQUACULTURE, V303, P50, DOI 10.1016/j.aquaculture.2010.03.012; Andersen O, 2006, FEBS J, V273, P2839, DOI 10.1111/j.1742-4658.2006.05288.x; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Bakke-McKellep AM, 2007, BRIT J NUTR, V97, P699, DOI 10.1017/S0007114507381397; Bizuayehu TT, 2014, GENOME BIOL EVOL, V6, P1911, DOI 10.1093/gbe/evu151; Burr GS, 2012, AQUACULTURE, V334, P110, DOI 10.1016/j.aquaculture.2011.12.044; Caruso G., 2015, FISH AQUAC J, V6, pe123, DOI DOI 10.4172/2150-3508.1000E123; CHELLAPPA S, 1995, J FISH BIOL, V47, P775, DOI 10.1111/j.1095-8649.1995.tb06002.x; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Cronstein BN, 1999, OSTEOARTHR CARTILAGE, V7, P361, DOI 10.1053/joca.1998.0236; Davies SJ, 1997, AQUAC RES, V28, P65, DOI 10.1111/j.1365-2109.1997.tb01316.x; Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808; Ding Y, 2016, FISH SHELLFISH IMMUN; Dupont-Nivet M, 2009, AQUACULTURE, V295, P15, DOI 10.1016/j.aquaculture.2009.06.031; Fonseca-Camarillo G, 2011, INFLAMM BOWEL DIS, V17, pE135, DOI 10.1002/ibd.21816; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Glencross BD, 2007, AQUACULT NUTR, V13, P17, DOI 10.1111/j.1365-2095.2007.00450.x; Gomez-Requeni P, 2004, AQUACULTURE, V232, P493, DOI 10.1016/S0044-8486(03)00532-5; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hasler R, 2011, EUR J CELL BIOL, V90, P603, DOI 10.1016/j.ejcb.2010.11.010; Han QF, 2015, J IMMUNOL, V195, P5440, DOI 10.4049/jimmunol.1500892; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; Heath A.G., 1995, WATER POLLUTION FISH; Hixson S. M., 2014, Journal of Aquaculture Research and Development, V5, P234; Jenke AC, 2012, CURR OPIN GASTROEN, V28, P577, DOI 10.1097/MOG.0b013e328357336b; Jonas E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00049; Kaneko K, 2008, NUCLEOS NUCLEOT NUCL, V27, P628, DOI 10.1080/15257770802138681; Kim YS, 2005, FREE RADICAL BIO MED, V38, P85, DOI 10.1016/j.freeradbiomed.2004.09.031; Krogdahl A, 2000, AQUACULT NUTR, V6, P77; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; Lee KJ, 2015, AQUAC RES, V46, P1590, DOI 10.1111/are.12313; Lilleeng E, 2007, AQUACULTURE, V267, P269, DOI 10.1016/j.aquaculture.2007.01.048; Lilleeng E, 2007, COMP BIOCHEM PHYS A, V147, P25, DOI 10.1016/j.cbpa.2006.10.043; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Martin SAM, 2003, BBA-PROTEINS PROTEOM, V1651, P17, DOI 10.1016/S1570-9639(03)00231-0; Mirza AH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0162-2; Montes CL, 2007, J LEUKOCYTE BIOL, V82, P1027, DOI 10.1189/jlb.0407214; Morais S, 2012, BMC GENOMICS, V13, P1; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Murdoch BM, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00182; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Overturf K, 2013, AQUAC RES, V44, P604, DOI 10.1111/j.1365-2109.2011.03065.x; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Refstie S, 2000, AQUACULTURE, V190, P49, DOI 10.1016/S0044-8486(00)00382-3; Renna M, 2006, INT J BIOCHEM CELL B, V38, P2040, DOI 10.1016/j.biocel.2006.05.016; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Sahlmann C, 2013, FISH SHELLFISH IMMUN, V34, P599, DOI 10.1016/j.fsi.2012.11.031; Salem M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121778; Santigosa E, 2008, AQUACULTURE, V282, P68, DOI 10.1016/j.aquaculture.2008.06.007; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Sasaki MM, 2016, INFLAMM BOWEL DIS, V22, P20, DOI 10.1097/MIB.0000000000000610; Sealey WM, 2013, J WORLD AQUACULT SOC, V44, P655, DOI 10.1111/jwas.12074; Skugor S, 2011, AQUACULT NUTR, V17, P505, DOI 10.1111/j.1365-2095.2010.00832.x; Tacchi L, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-363; Tacchi L, 2011, FISH SHELLFISH IMMUN, V31, P704, DOI 10.1016/j.fsi.2011.02.023; Ulloa PE, 2015, MAR BIOTECHNOL, V17, P353, DOI 10.1007/s10126-015-9624-1; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Venold FF, 2012, AQUACULTURE, V364, P281, DOI 10.1016/j.aquaculture.2012.08.035; Vilhelmsson OT, 2004, BRIT J NUTR, V92, P71, DOI 10.1079/BJN20041176; Wu BJ, 2011, IMMUNOGENETICS, V63, P835, DOI 10.1007/s00251-011-0554-4; Ye JHQ, 2009, WORLD J GASTROENTERO, V15, P4491, DOI 10.3748/wjg.15.4491; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yendrek Craig R, 2012, BMC Res Notes, V5, P506, DOI 10.1186/1756-0500-5-506; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020	77	15	15	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180972	10.1371/journal.pone.0180972	http://dx.doi.org/10.1371/journal.pone.0180972			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723948	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800035
J	Alvarado, D; Ligon, GF; Lillquist, JS; Seibel, SB; Wallweber, G; Neumeister, VM; Rimm, DL; McMahon, G; LaVallee, TM				Alvarado, Diego; Ligon, Gwenda F.; Lillquist, Jay S.; Seibel, Scott B.; Wallweber, Gerald; Neumeister, Veronique M.; Rimm, David L.; McMahon, Gerald; LaVallee, Theresa M.			ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODY; BREAST-CANCER; UP-REGULATION; PHASE-II; CETUXIMAB; HER3; HEAD; NECK; INHIBITION	Head and neck squamous cell carcinoma (HNSCC) accounts for 3-5% of all tumor types and remains an unmet medical need with only two targeted therapies approved to date. ErbB3 (HER3), the kinase-impaired member of the EGFR/ErbB family, has been implicated as a disease driver in a number of solid tumors, including a subset of HNSCC. Here we show that the molecular components required for ErbB3 activation, including its ligand neuregulin-1 (NRG1), are highly prevalent in HNSCC and that HER2, but not EGFR, is the major activating ErbB3 kinase partner. We demonstrate that cetuximab treatment primarily inhibits the ERK signaling pathway and KTN3379, an anti-ErbB3 monoclonal antibody, inhibits the AKT signaling pathway, and that dual ErbB receptor inhibition results in enhanced antitumor activity in HNSCC models. Surprisingly, we found that while NRG1 is required for ErbB3 activation, it was not sufficient to fully predict for KTN3379 activity. An evaluation of HNSCC patient samples demonstrated that NRG1 expression was significantly associated with expression of the EGFR ligands amphiregulin (AREG) and transforming growth factor a (TGF alpha). Furthermore, NRG1-positive HNSCC cell lines that secreted high levels of AREG and TGFa or contained high levels of EGFR homodimers (H11D) demonstrated a better response to KTN3379. Although ErbB3 and EGFR activation are uncoupled at the receptor level, their respective signaling pathways are linked through co-expression of their respective ligands. We propose that NRG1 expression and EGFR activation signatures may enrich for improved efficacy of anti-ErbB3 therapeutic mAb approaches when combined with EGFR-targeting therapies in HNSCC.	[Alvarado, Diego; Ligon, Gwenda F.; Lillquist, Jay S.; Seibel, Scott B.; McMahon, Gerald; LaVallee, Theresa M.] Kolltan Pharmaceut, New Haven, CT 06511 USA; [Wallweber, Gerald] Lab Corp Amer Holdings, Monogram Biosci, San Francisco, CA USA; [Neumeister, Veronique M.; Rimm, David L.] Yale Univ, Yale Pathol Tissue Serv, New Haven, CT USA; [Alvarado, Diego; Ligon, Gwenda F.; Lillquist, Jay S.; LaVallee, Theresa M.] Celldex Therapeut Inc, New Haven, CT 06511 USA; [McMahon, Gerald] Harpoon Therapeut, San Francisco, CA USA	Yale University	Alvarado, D (corresponding author), Kolltan Pharmaceut, New Haven, CT 06511 USA.; Alvarado, D (corresponding author), Celldex Therapeut Inc, New Haven, CT 06511 USA.	dalvarado@celldex.com	Garzon-Alvarado, Diego/AAD-6607-2019	Rimm, David/0000-0001-5820-4397; Alvarado, Diego/0000-0002-5878-1730	Kolltan Pharmaceuticals; Monogram Biosciences	Kolltan Pharmaceuticals; Monogram Biosciences	Kolltan Pharmaceuticals provided support in the form of salaries for authors DA, GFL, JSL, SBS, GM and TML but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. GW, VMN and DLR were contracted by Kolltan Pharmaceuticals to carry out specific assays described in the manuscript. Monogram Biosciences provided support in the form of salaries for author GW. The specific roles of these authors are articulated in the 'author contributions' section.	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Awasthi S, 2014, J CELL PHYSIOL, V229, P1831, DOI 10.1002/jcp.24637; Baselga J, 2014, J CLIN ONCOL, V32, P3753, DOI 10.1200/JCO.2013.54.5384; Bordeaux JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036559; Brand TM, 2011, CANCER BIOL THER, V11, P777, DOI 10.4161/cbt.11.9.15050; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Capparelli C, 2015, J BIOL CHEM, V290, P24267, DOI 10.1074/jbc.M115.657270; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chen RC, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.18_suppl.LBA10033; Cheng H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-326; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Gianni L, 2010, J CLIN ONCOL, V28, P1131, DOI 10.1200/JCO.2009.24.1661; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Hughes B, 2014, ONCOLOGIST, V19, P175, DOI 10.1634/theoncologist.2013-0026; Janjigian YY, 2014, CANCER DISCOV, V4, P1036, DOI 10.1158/2159-8290.CD-14-0326; Jiang N, 2014, MOL CANCER THER, V13, P1826, DOI 10.1158/1535-7163.MCT-13-1093; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee S, 2015, P NATL ACAD SCI USA, V112, P13225, DOI 10.1073/pnas.1518361112; Lipton A, 2013, BREAST CANCER RES TR, V141, P43, DOI 10.1007/s10549-013-2665-0; Liu JF, 2016, J CLIN ONCOL, V34, P4345, DOI 10.1200/JCO.2016.67.1891; Ma J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-105; MacBeath G, 2014, ANN ONCOL, V25, piv58; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; Mandic R, 2006, FEBS LETT, V580, P4793, DOI 10.1016/j.febslet.2006.07.064; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Pollock NI, 2015, CLIN CANCER RES, V21, P4597, DOI 10.1158/1078-0432.CCR-14-3338; Qian GQ, 2015, CANCER-AM CANCER SOC, V121, P3600, DOI 10.1002/cncr.29549; Rubinson DA, 2014, INVEST NEW DRUG, V32, P113, DOI 10.1007/s10637-013-9956-5; Sacco AG, 2015, J CLIN ONCOL, V33, P3305, DOI 10.1200/JCO.2015.62.0963; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Shames DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056765; Shames DS, 2012, ASCO M, V30, P5575; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Von Pawel J, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8045; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Xiao Z, 2016, MOL CANCER THER, V15, P689, DOI 10.1158/1535-7163.MCT-15-0555; Yoshida T, 2008, INT J CANCER, V122, P1530, DOI 10.1002/ijc.23253; Zhang L, 2014, MOL CANCER THER, V13, P1345, DOI 10.1158/1535-7163.MCT-13-1033	50	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181356	10.1371/journal.pone.0181356	http://dx.doi.org/10.1371/journal.pone.0181356			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723928	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800045
J	Mollazade, M; Tabarin, T; Nicovich, PR; Soeriyadi, A; Nieves, DJ; Gooding, JJ; Gaus, K				Mollazade, Mahdie; Tabarin, Thibault; Nicovich, Philip R.; Soeriyadi, Alexander; Nieves, Daniel J.; Gooding, J. Justin; Gaus, Katharina			Can single molecule localization microscopy be used to map closely spaced RGD nanodomains?	PLOS ONE			English	Article							STEM-CELL ADHESION; SUPERRESOLUTION MICROSCOPY; FLUORESCENT-PROBES; INTEGRIN LIGANDS; FOCAL ADHESIONS; SURFACE; NANOLITHOGRAPHY; MORPHOLOGY; INTERFACES; DYNAMICS	Cells sense and respond to nanoscale variations in the distribution of ligands to adhesion receptors. This makes single molecule localization microscopy (SMLM) an attractive tool to map the distribution of ligands on nanopatterned surfaces. We explore the use of SMLM spatial cluster analysis to detect nanodomains of the cell adhesion-stimulating tripeptide arginine-glycine-aspartic acid (RGD). These domains were formed by the phase separation of block copolymers with controllable spacing on the scale of tens of nanometers. We first determined the topology of the block copolymer with atomic force microscopy (AFM) and then imaged the localization of individual RGD peptides with direct stochastic optical reconstruction microscopy (dSTORM). To compare the data, we analyzed the dSTORM data with DBSCAN (density-based spatial clustering application with noise). The ligand distribution and polymer topology are not necessary identical since peptides may attach to the polymer outside the nanodomains and/or coupling and detection of peptides within the nanodomains is incomplete. We therefore performed simulations to explore the extent to which nanodomains could be mapped with dSTORM. We found that successful detection of nanodomains by dSTORM was influenced by the inter-domain spacing and the localization precision of individual fluorophores, and less by non-specific absorption of ligands to the substratum. For example, under our imaging conditions, DBSCAN identification of nanodomains spaced further than 50 nm apart was largely independent of background localisations, while nanodomains spaced closer than 50 nm required a localization precision of similar to 11 nm to correctly estimate the modal nearest neighbor distance (NDD) between nanodomains. We therefore conclude that SMLM is a promising technique to directly map the distribution and nanoscale organization of ligands and would benefit from an improved localization precision.	[Mollazade, Mahdie; Tabarin, Thibault; Nicovich, Philip R.; Nieves, Daniel J.; Gaus, Katharina] Univ New South Wales, EMBL Australia Node Single Mol Sci, Sch Med Sci, Sydney, NSW, Australia; [Mollazade, Mahdie; Tabarin, Thibault; Nicovich, Philip R.; Nieves, Daniel J.; Gaus, Katharina] Univ New South Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia; [Soeriyadi, Alexander; Gooding, J. Justin] Univ New South Wales, Sch Chem, Australian Ctr NanoMed, Sydney, NSW, Australia; [Soeriyadi, Alexander; Gooding, J. Justin] Univ New South Wales, ARC Ctr Excellence Convergent Bionano Sci & Techn, Sydney, NSW, Australia; [Nicovich, Philip R.] Allen Inst Brain Sci, Seattle, WA USA	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Allen Institute for Brain Science	Gaus, K (corresponding author), Univ New South Wales, EMBL Australia Node Single Mol Sci, Sch Med Sci, Sydney, NSW, Australia.; Gaus, K (corresponding author), Univ New South Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia.	k.gaus@unsw.edu.au	tabarin, thibault P/M-7212-2018; Nieves, Daniel/I-5906-2014	Gooding, John Justin/0000-0002-5398-0597; Gaus, Katharina/0000-0002-8009-9658; Nieves, Daniel/0000-0002-0873-4418; Soeriyadi, Alexander/0000-0003-2876-2384; Mollazade, Mahdie/0000-0001-8648-5413; Nicovich, Philip/0000-0002-8517-4469	Australian Research Council [LP140100967, DP130100269]; ARC Centre of Excellence in Advanced Molecular Imaging [CE140100011]; National Health and Medical Research Council of Australia [1059278, 1037320]; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology [CE140100036]; ARC Laureate Fellowship [FL150100060]	Australian Research Council(Australian Research Council); ARC Centre of Excellence in Advanced Molecular Imaging(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); ARC Laureate Fellowship(Australian Research Council)	This work was supported by the Australian Research Council; grant numbers LP140100967 (to KG and PRN) and DP130100269 (to KG). KG also acknowledges funding from the ARC Centre of Excellence in Advanced Molecular Imaging (CE140100011) and National Health and Medical Research Council of Australia (1059278, 1037320). JJB acknowledges funding from the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology (CE140100036) and the ARC Laureate Fellowship (FL150100060) program. The authors declare no competing interests.	Andronov L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24084; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d; Baddeley D, 2010, MICROSC MICROANAL, V16, P64, DOI 10.1017/S143192760999122X; Bang J, 2009, ADV MATER, V21, P4769, DOI 10.1002/adma.200803302; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bifano TG, 2016, P SPIE; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bretschneider S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218103; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Chao J, 2009, OPT EXPRESS, V17, P24377, DOI 10.1364/OE.17.024377; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Clerget E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063722; Deeg JA, 2011, NANO LETT, V11, P1469, DOI 10.1021/nl104079r; Ester M, 1996, COMPR CHEMOM, V2, P635, DOI DOI 10.1016/8978-044452701-1.00067-3; George PA, 2009, BIOMATERIALS, V30, P4732, DOI 10.1016/j.biomaterials.2009.05.039; George PA, 2009, EUR POLYM J, V45, P1065, DOI 10.1016/j.eurpolymj.2008.11.039; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314; Glass R, 2003, ADV FUNCT MATER, V13, P569, DOI 10.1002/adfm.200304331; Gooding JJ, 2016, ANGEW CHEM INT EDIT, V55, P11354, DOI 10.1002/anie.201600495; Gramlich MW, 2014, OPT EXPRESS, V22, P8438, DOI 10.1364/OE.22.008438; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Hennig S, 2015, ACS NANO, V9, P8122, DOI 10.1021/acsnano.5b02220; Henriques R, 2011, BIOPOLYMERS, V95, P322, DOI 10.1002/bip.21586; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Kimura T, 2012, LANGMUIR, V28, P12901, DOI 10.1021/la302695q; Klein T, 2014, HISTOCHEM CELL BIOL, V141, P561, DOI 10.1007/s00418-014-1184-3; Le Saux G, 2011, BIOPHYS J, V101, P764, DOI 10.1016/j.bpj.2011.06.064; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Lei Y, 2011, CHEM SOC REV, V40, P1247, DOI 10.1039/b924854b; Levet F, 2015, NAT METHODS, V12, P1065, DOI [10.1038/NMETH.3579, 10.1038/nmeth.3579]; Lew MD, 2011, P NATL ACAD SCI USA, V108, pE1102, DOI 10.1073/pnas.1114444108; Li H, 2014, BIOMATER SCI-UK, V2, P1693, DOI 10.1039/c4bm00109e; Li HQ, 2014, BIOMACROMOLECULES, V15, P43, DOI 10.1021/bm4012562; Lin ZQ, 2002, ADV MATER, V14, P1373, DOI 10.1002/1521-4095(20021002)14:19<1373::AID-ADMA1373>3.0.CO;2-F; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; Maheshwari G, 2000, J CELL SCI, V113, P1677; MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Pertsinidis A, 2013, P NATL ACAD SCI USA, V110, pE2812, DOI 10.1073/pnas.1310654110; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Rubin-Delanchy P, 2015, NAT METHODS, V12, P1072, DOI [10.1038/nmeth.3612, 10.1038/NMETH.3612]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Smith JR, 2011, T I MET FINISH, V89, P18, DOI 10.1179/174591910X12922367327388; Tehrani KF, 2015, PROC SPIE, V9335, DOI 10.1117/12.2077269; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Zamir E, 2001, J CELL SCI, V114, P3583	57	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180871	10.1371/journal.pone.0180871	http://dx.doi.org/10.1371/journal.pone.0180871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723958	Green Published, gold			2022-12-27	WOS:000406067800029
J	Virtanen, S; Kalliala, I; Nieminen, P; Salonen, A				Virtanen, Seppo; Kalliala, Ilkka; Nieminen, Pekka; Salonen, Anne			Comparative analysis of vaginal microbiota sampling using 16S rRNA gene analysis	PLOS ONE			English	Article							BACTERIAL; DIVERSITY; ASSOCIATION; WOMEN	Background Molecular methods such as next-generation sequencing are actively being employed to characterize the vaginal microbiota in health and disease. Previous studies have focused on characterizing the biological variation in the microbiota, and less is known about how factors related to sampling contribute to the results. Our aim was to investigate the impact of a sampling device and anatomical sampling site on the quantitative and qualitative outcomes relevant for vaginal microbiota research. We sampled 10 Finnish women representing diverse clinical characteristics with flocked swabs, the Evalyn (R) self-sampling device, sterile plastic spatulas and a cervical brush that were used to collect samples from fornix, vaginal wall and cervix. Samples were compared on DNA and protein yield, bacterial load, and microbiota diversity and species composition based on Illumina MiSeq sequencing of the 16S rRNA gene. We quantified the relative contributions of sampling variables versus intrinsic variables in the overall microbiota variation, and evaluated the microbiota profiles using several commonly employed metrics such as alpha and beta diversity as well as abundance of major bacterial genera and species. Results The total DNA yield was strongly dependent on the sampling device and to a lesser extent on the anatomical site of sampling. The sampling strategy did not affect the protein yield or the bacterial load. All tested sampling methods produced highly comparable microbiota profiles based on MiSeq sequencing. The sampling method explained only 2% (p-value = 0.89) of the overall microbiota variation, markedly surpassed by intrinsic factors such as clinical status (microscopy for bacterial vaginosis 53%, p = 0.0001), bleeding (19%, p = 0.0001), and the variation between subjects (11%, p-value 0.0001). Conclusions The results indicate that different sampling strategies yield comparable vaginal microbiota composition and diversity. Hence, past and future vaginal microbiota studies employing different sampling strategies should be comparable in the absence of other technical confounders. The Evalyn (R) self-sampling device performed equally well compared to samples taken by a clinician, and hence offers a good-quality microbiota sample without the need for a gynecological examination. The amount of collected sample as well as the DNA and protein yield varied across the sampling techniques, which may have practical implications for study design.	[Virtanen, Seppo; Kalliala, Ilkka; Nieminen, Pekka] Univ Helsinki, Obstet & Gynecol, Helsinki, Finland; [Virtanen, Seppo; Kalliala, Ilkka; Nieminen, Pekka] Helsinki Univ Hosp, Helsinki, Finland; [Kalliala, Ilkka] Imperial Coll London, Inst Reprod & Dev Biol, Dept Surg & Canc, London, England; [Salonen, Anne] Univ Helsinki, Dept Bacteriol & Immunol, Immunobiol Res Programme, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Imperial College London; University of Helsinki	Salonen, A (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Immunobiol Res Programme, Helsinki, Finland.	anne.salonen@helsinki.fi	Nieminen, Pekka/W-8570-2019; Kalliala, Ilkka/ABC-9253-2021; Salonen, Anne/AAW-1858-2020	Kalliala, Ilkka/0000-0002-7664-0587; Salonen, Anne/0000-0002-6960-7447	Helsinki University Central Hospital [TYH2014310/1179003]	Helsinki University Central Hospital	This work was supported by Pekka Nieminen, Helsinki University Central Hospital, Special State Funding (TYH2014310/1179003) and Seppo Virtanen, Doctoral School in Health Sciences, University of Helsinki and Helsinki Central Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; [Anonymous], 2021, LANG ENV STAT COMP; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Bai GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036934; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brotman RM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-471; Brotman RM, 2014, MENOPAUSE, V21, P450, DOI 10.1097/GME.0b013e3182a4690b; Dezzutti CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023136; Drell T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054379; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Fettweis JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S17; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gill C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163148; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Hyman RW, 2012, J ASSIST REPROD GEN, V29, P105, DOI 10.1007/s10815-011-9694-6; Karjalainen L, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2246-9; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Korpela K, 2016, MICROBIOTA ANAL R EA, DOI [10.5281/zenodo.50310, DOI 10.5281/ZENODO.50310]; Korpela K, 2016, MARE BACKGROUND READ; Kyrgiou M, 2016, TRANSL RES; Lee JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063514; Ling ZX, 2011, MICROB ECOL, V61, P704, DOI 10.1007/s00248-011-9813-z; Lopes dos Santos Santiago G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028180; Lunny C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132776; Mitra A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16865; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oksanen J, 2022, R PACKAGE VERSION; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Ramiro-Garcia Javier, 2016, F1000Res, V5, P1791, DOI 10.12688/f1000research.9227.2; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Skaug H., GEN LINEAR MIXED MOD; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Venables WN., 2002, MODERN APPL STAT S 4; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	49	33	36	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181477	10.1371/journal.pone.0181477	http://dx.doi.org/10.1371/journal.pone.0181477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723942	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800053
J	Yi, D; Seo, EH; Han, JY; Sohn, BK; Byun, MS; Lee, JH; Choe, YM; Ahn, S; Woo, JI; Jun, J; Lee, DY				Yi, Dahyun; Seo, Eun Hyun; Han, Ji Young; Sohn, Bo Kyung; Byun, Min Soo; Lee, Jun Ho; Choe, Young Min; Ahn, Suzy; Woo, Jong Inn; Jun, Jongho; Lee, Dong Young			Development of the Korean Adult Reading Test (KART) to estimate premorbid intelligence in dementia patients	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL ASSESSMENT BATTERY; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CERAD; VALIDATION; VERSION	We aimed to develop a word-reading test for Korean-speaking adults using irregularly pronounced words that would be useful for estimation of premorbid intelligence. A linguist who specialized in Korean phonology selected 94 words that have irregular relationship between orthography and phonology. Sixty cognitively normal elderly (CN) and 31 patients with Alzheimer's disease (AD) were asked to read out loud the words and were administered the Wechsler Adult Intelligence Scale, 4th edition, Korean version (K-WAIS-IV). Among the 94 words, 50 words that did not show a significant difference between the CN and the AD group were selected and constituted the KART. Using the 30 CN calculation group (CNc), a linear regression equation was obtained in which the observed full-scale IQ (FSIQ) was regressed on the reading errors of the KART, where education was included as an additional variable. When the regressed equation computed from the CNc was applied to 30 CN individuals of the validation group (CNv), the predicted FSIQ adequately fit the observed FSIQ (R-2 = 0.63). In addition, independent sample t-test showed that the KART-predicted IQs were not significantly different between the CNv and AD groups, whereas the performance of the AD group was significantly worse in the observed IQs. In addition, an extended validation of the KART was performed with a separate sample consisted of 84 CN, 56 elderly with mild cognitive impairment (MCI), and 43 AD patients who were administered comprehensive neuropsychological assessments in addition to the KART. When the equation obtained from the CNc was applied to the extended validation sample, the KART-predicted IQs of the AD, MCI and the CN groups did not significantly differ, whereas their current global cognition scores significantly differed between the groups. In conclusion, the results support the validity of KART-predicted IQ as an index of premorbid IQ in individuals with AD.	[Yi, Dahyun; Han, Ji Young; Byun, Min Soo; Lee, Jun Ho; Woo, Jong Inn; Lee, Dong Young] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul, South Korea; [Seo, Eun Hyun] Chosun Univ, Coll Med, Premed Sci, Gwangju, South Korea; [Sohn, Bo Kyung] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Neuropsychiat, Seoul, South Korea; [Choe, Young Min] Ulsan Univ Hosp, Dept Neuropsychiat, Ulsan, South Korea; [Ahn, Suzy] NYU, Dept Linguist, New York, NY USA; [Jun, Jongho] Seoul Natl Univ, Dept Linguist, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Chosun University; Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Ulsan University Hospital; New York University; Seoul National University (SNU)	Lee, DY (corresponding author), Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul, South Korea.	selfpsy@snu.ac.kr	Byun, Min Soo/GLS-1324-2022		Ministry of Science, ICT, and Future Planning, Republic of Korea [NRF-2014M3C7A1046042]	Ministry of Science, ICT, and Future Planning, Republic of Korea	This study was supported by a grant from the Ministry of Science, ICT, and Future Planning, Republic of Korea (grant number NRF-2014M3C7A1046042).	Association A. P., 2000, DIAGN CRIT DSM 4 TR; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; CUMMINGS JL, 1988, NEUROLOGY, V38, P680, DOI 10.1212/WNL.38.5.680; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; HART S, 1986, BRIT J CLIN PSYCHOL, V25, P119, DOI 10.1111/j.2044-8260.1986.tb00680.x; Hong SY, 2015, J HUMAN STUDIES, V36, P3; Lee DY, 2004, J INT NEUROPSYCH SOC, V10, P72, DOI 10.1017/s1355617704101094; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A, Vxiv; Mackinnon A, 2005, ENCEPHALE, V31, P31; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; NEBES RD, 1984, J ABNORM PSYCHOL, V93, P321, DOI 10.1037/0021-843X.93.3.321; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; OCARROLL RE, 1987, BRIT J CLIN PSYCHOL, V26, P315, DOI 10.1111/j.2044-8260.1987.tb01367.x; OCARROLL RE, 1986, BRIT J CLIN PSYCHOL, V25, P157, DOI 10.1111/j.2044-8260.1986.tb00690.x; Park C., 2011, INFLUENCE L1 PHONOLO; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Seo EH, 2010, AM J GERIAT PSYCHIAT, V18, P801, DOI 10.1097/JGP.0b013e3181cab764; SHARPE K, 1991, BRIT J CLIN PSYCHOL, V30, P381, DOI 10.1111/j.2044-8260.1991.tb00962.x; Sanjurjo NS, 2015, APPL NEUROPSYCH-ADUL, V22, P252, DOI 10.1080/23279095.2014.918543; Teng EL, 2005, ALZ DIS ASSOC DIS, V19, P267, DOI 10.1097/01.wad.0000190805.13126.8e; Whang ST, 2011, KOREAN WECHLSER ADUL	27	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181523	10.1371/journal.pone.0181523	http://dx.doi.org/10.1371/journal.pone.0181523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723964	Green Submitted, Green Published, gold			2022-12-27	WOS:000406067800058
J	Vanobberghen, F; Letang, E; Gamell, A; Mnzava, DK; Faini, D; Luwanda, LB; Mapesi, H; Mwamelo, K; Sikalengo, G; Tanner, M; Hatz, C; Furrer, H; Battegay, M; Glass, TR				Vanobberghen, Fiona; Letang, Emilio; Gamell, Anna; Mnzava, Dorcas K.; Faini, Diana; Luwanda, Lameck B.; Mapesi, Herry; Mwamelo, Kim; Sikalengo, George; Tanner, Marcel; Hatz, Christoph; Furrer, Hansjakob; Battegay, Manuel; Glass, Tracy R.		KIULARCO Study Grp	A decade of HIV care in rural Tanzania: Trends in clinical outcomes and impact of clinic optimisation in an open, prospective cohort	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; RESOURCE-LIMITED SETTINGS; ANTIRETROVIRAL TREATMENT PROGRAMS; SUB-SAHARAN AFRICA; FOLLOW-UP; INFECTED PATIENTS; CASE DEFINITIONS; KAPOSI-SARCOMA; THERAPY; MORTALITY	Objectives Our objectives were to describe trends in enrolment and clinical outcomes in the open, prospective Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) in the Morogoro region of southern Tanzania, and identify strengths and areas for improvement in the care of HIV-positive individuals in rural Tanzania. Methods We included adults (>= 15 years) and children (<15 years) enrolled in the cohort in 2005-014. The cohort underwent significant changes from autumn 2012 to optimise care. We evaluated mortality and loss to follow-up (LTFU) using competing risks methods, ART usage, opportunistic infections (OI), co-infections and laboratory abnormalities. Results Overall, 7010 adults and 680 children were enrolled; enrolment peaked in 2008 but has increased steadily since 2011. Among adults (65% female; median age 37 [interquartile range 31-45] years), the proportion referred from hospital wards quadrupled in 2013-14 versus earlier years. 653 (9%) adults died and 2648 (38%) were LTFU; the five-year cumulative probabilities of death and LTFU were 10.3% and 44.0%, respectively. Among children, 69 (10%) died and 225 (33%) were LTFU. The corresponding five-year probabilities were 12.1% and 39.6%. Adult ART use (regardless of eligibility) increased from 5% in 2005 to 89% in 2014 (similarly among children), with 9% on second-line therapy in 2014 (17% of children). OI diagnoses increased over time; tuberculosis prevalence at enrolment quadrupled from 6% in 2011 to 26% in 2014. The proportion of newly-enrolled participants assessed for laboratory abnormalities peaked at nearly 100% in 2014 (from a minimum of 24%), yet abnormality prevalences remained fairly constant. Conclusions In this cohort, ART usage improved dramatically and is approaching targets of 90%. Improved screening led to increases in detection of OIs and laboratory abnormalities, suggesting that a large number of these co-morbidities previously went undetected and untreated. Further work will address the high LTFU rates and implications for mortality estimates, and the management and outcomes of co-morbidities.	[Vanobberghen, Fiona; Letang, Emilio; Gamell, Anna; Tanner, Marcel; Hatz, Christoph; Glass, Tracy R.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Vanobberghen, Fiona; Letang, Emilio; Gamell, Anna; Tanner, Marcel; Hatz, Christoph; Battegay, Manuel; Glass, Tracy R.] Univ Basel, Basel, Switzerland; [Letang, Emilio; Gamell, Anna; Mnzava, Dorcas K.; Faini, Diana; Luwanda, Lameck B.; Mapesi, Herry; Mwamelo, Kim; Sikalengo, George] Ifakara Hlth Inst, Ifakara, Tanzania; [Letang, Emilio] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Furrer, Hansjakob] Bern Univ Hosp, Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, Bern, Switzerland; [Battegay, Manuel] Univ Hosp Basel, Dept Infect Dis & Hosp Epidemiol, Dept Clin Res, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Ifakara Health Institute; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Bern; University Hospital of Bern; University of Bern; University of Basel	Glass, TR (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.; Glass, TR (corresponding author), Univ Basel, Basel, Switzerland.	tracy.glass@unibas.ch	Glass, Tracy R/D-5046-2017; Furrer, Hansjakob/G-6768-2013	Glass, Tracy R/0000-0001-7075-9803; Furrer, Hansjakob/0000-0002-1375-3146; Mapesi, Herry/0000-0001-7753-464X	Swiss Tropical & Public Health Institute and development funds from the Canton of Basel-Stadt, Switzerland; Government of the Canton of Basel, Switzerland; Swiss Tropical & Public Health Institute; Ifakara Health Institute; Government of Tanzania; United States Agency for International Development through TUNAJALI-Deloitte	Swiss Tropical & Public Health Institute and development funds from the Canton of Basel-Stadt, Switzerland; Government of the Canton of Basel, Switzerland; Swiss Tropical & Public Health Institute; Ifakara Health Institute; Government of Tanzania; United States Agency for International Development through TUNAJALI-Deloitte(United States Agency for International Development (USAID))	This work was supported by the Swiss Tropical & Public Health Institute and development funds from the Canton of Basel-Stadt, Switzerland. The Kilombero and Ulanga Antiretroviral Cohort and the Chronic Diseases Clinic Ifakara receive financial support from the Government of the Canton of Basel, Switzerland, the Swiss Tropical & Public Health Institute, the Ifakara Health Institute, the Government of Tanzania, and the United States Agency for International Development through TUNAJALI-Deloitte. Cryptococcal antigen lateral flow assays are donated by IMMY, Norman, Oklahoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerson E, 2016, JAIDS-J ACQ IMM DEF, V71, P295, DOI 10.1097/QAI.0000000000000862; Bekolo Cavin Epie, 2013, BMC Res Notes, V6, P512, DOI 10.1186/1756-0500-6-512; Brinkhof MWG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014149; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chi BH, 2010, AM J EPIDEMIOL, V171, P924, DOI 10.1093/aje/kwq008; Colebunders R, 2005, AIDS REV, V7, P148; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Delpierre C, 2008, EUR J PUBLIC HEALTH, V18, P345, DOI 10.1093/eurpub/ckm117; Dong BJ, 2012, AIDS, V26, P833, DOI 10.1097/QAD.0b013e328351a521; Faini D, 2016, C RETR OPP INFL; Faini D, 2015, MYCOSES, V58, P70, DOI 10.1111/myc.12390; Franzeck FC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-90; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Gamell A, 2016, JAIDS-J ACQ IMM DEF, V73, pE67, DOI 10.1097/QAI.0000000000001178; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; Haddow LJ, 2010, LANCET INFECT DIS, V10, P791, DOI 10.1016/S1473-3099(10)70170-5; Haraka F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123275; Jafari A, 2014, EUR J CLIN PHARMACOL, V70, P1029, DOI 10.1007/s00228-014-1712-z; Jamisse L, 2007, JAIDS-J ACQ IMM DEF, V44, P371, DOI 10.1097/QAI.0b013e318032bbee; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Letang E, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv046; Letang E, 2012, CLIN INFECT DIS, V55, P157, DOI 10.1093/cid/cis308; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Ministry of Health and Social Welfare; National AIDS Control Program, 2013, NAT AIDS CONTR PROGR; Montlahuc C, 2013, JAIDS-J ACQ IMM DEF, V64, P197, DOI 10.1097/QAI.0b013e31829cfbfa; Mossdorf E, 2010, TROP MED INT HEALTH, V15, P567, DOI 10.1111/j.1365-3156.2010.02490.x; Mutyaba I, 2015, JAIDS-J ACQ IMM DEF, V69, P481, DOI 10.1097/QAI.0000000000000620; Mwita J, 2012, East Afr J Public Health, V9, P10; Parkes-Ratanshi Rosalind, 2015, J Int Assoc Provid AIDS Care, V14, P455, DOI 10.1177/2325957414557264; Pintilie M, 2006, COMPETING RISKS PRAC; Ramirez-Mena A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw162; Ruhl CE, 2012, HEPATOLOGY, V55, P447, DOI 10.1002/hep.24725; Shiels MS, 2017, CURR OPIN HIV AIDS, V12, P6, DOI 10.1097/COH.0000000000000327; Tanzania Ministry of Health and Social Welfare National Tuberculosis and Leprosy Programme, 2013, MAN MAN TUB LEPR; Tanzania National AIDS Control Program, 2015, NAT GUID MAN HIV AID; Tanzania National AIDS Control Program, 2012, NAT GUID MAN HIV AID; UNAIDS, 2013, GLOBAL REPORT UNAIDS; UNAIDS, 2014, 90 90 90 AMB TREATM; Wandeler G, 2013, AIDS, V27, P2225, DOI 10.1097/QAD.0b013e328362d887; Wasserman S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1809-3; Waters L, 2011, EXPERT REV ANTI-INFE, V9, P877, DOI [10.1586/eri.11.106, 10.1586/ERI.11.106]; WHO, 2016, CONGUID UANT DRU; WHO, 2013, GLOB UPD HIV TREATM; World Health Organization, 2011, SER FERR CONC ASS IR; Zhou JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-5	47	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180983	10.1371/journal.pone.0180983	http://dx.doi.org/10.1371/journal.pone.0180983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719610	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400025
J	Balazsfi, DG; Zelena, D; Farkas, L; Demeter, K; Barna, I; Cserep, C; Takacs, VT; Nyiri, G; Goloncser, F; Sperlagh, B; Freund, TF; Haller, J				Balazsfi, Diana G.; Zelena, Dora; Farkas, Livia; Demeter, Komel; Barna, Istvan; Cserep, Csaba; Takacs, Virag T.; Nyiri, Gabor; Goloncser, Flora; Sperlagh, Beata; Freund, Tamas F.; Haller, Jozsef			Median raphe region stimulation alone generates remote, but not recent fear memory traces	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; CONDITIONED FEAR; HIPPOCAMPAL; NUCLEUS; RAT; ACTIVATION; EXPRESSION; RECEPTORS; BEHAVIOR; NEURONS	The median raphe region (MRR) is believed to control the fear circuitry indirectly, by influencing the encoding and retrieval of fear memories by amygdala, hippocampus and prefrontal cortex. Here we show that in addition to this established role, MRR stimulation may alone elicit the emergence of remote but not recent fear memories. We substituted electric shocks with optic stimulation of MRR in C57BL/6N male mice in an optogenetic conditioning paradigm and found that stimulations produced agitation, but not fear, during the conditioning trial. Contextual fear, reflected by freezing was not present the next day, but appeared after a 7 days incubation. The optogenetic silencing of MRR during electric shocks ameliorated conditioned fear also seven, but not one day after conditioning. The optogenetic stimulation patterns (50Hz theta burst and 20Hz) used in our tests elicited serotonin release in vitro and lead to activation primarily in the periaqueductal gray examined by c-Fos immunohistochemistry. Earlier studies demonstrated that fear can be induced acutely by stimulation of several subcortical centers, which, however, do not generate persistent fear memories. Here we show that the MRR also elicits fear, but this develops slowly over time, likely by plastic changes induced by the area and its connections. These findings assign a specific role to the MRR in fear learning. Particularly, we suggest that this area is responsible for the durable sensitization of fear circuits towards aversive contexts, and by this, it contributes to the persistence of fear memories. This suggests the existence a bottom-up control of fear circuits by the MRR, which complements the top-down control exerted by the medial prefrontal cortex.	[Balazsfi, Diana G.; Zelena, Dora; Farkas, Livia; Demeter, Komel; Barna, Istvan; Haller, Jozsef] Inst Expt Med, Dept Behav Neurobiol, Budapest, Hungary; [Balazsfi, Diana G.] Semmelweis Univ, Janos Szentagothai Sch Neurosci, Budapest, Hungary; [Cserep, Csaba; Takacs, Virag T.; Nyiri, Gabor; Freund, Tamas F.] Inst Expt Med, Dept Cellular & Network Neurobiol, Budapest, Hungary; [Goloncser, Flora; Sperlagh, Beata] Inst Expt Med, Dept Pharmacol, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Semmelweis University; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Balazsfi, DG (corresponding author), Inst Expt Med, Dept Behav Neurobiol, Budapest, Hungary.; Balazsfi, DG (corresponding author), Semmelweis Univ, Janos Szentagothai Sch Neurosci, Budapest, Hungary.	balazsfi.diana@koki.mta.hu	Zelena, Dóra/AAO-5418-2020; Demeter, Kornel/GRF-0289-2022	Demeter, Kornel/0000-0002-5497-6493; Haller, Jozsef/0000-0003-4315-3026	European Research Council Advanced Research grant (SERRACO) [ERC-2011-ADG-294313]; NKFIH [112907, 120311]	European Research Council Advanced Research grant (SERRACO); NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary)	This study was supported by European Research Council Advanced Research grant ERC-2011-ADG-294313 (SERRACO) to Tamas Freund (https://erc.europa.eu/projects-figures/erc-funded-projects/results?search_api_views_fulltext=SERRACO), NKFIH 120311 to Dora Zelena (www.otka.hu); NKFIH 112907 to Jozsef Haller (www.otka.hu).	Adhikari A, 2015, NATURE, V527, P179, DOI 10.1038/nature15698; Aliczki M, 2015, COMPREHENSIVE GUIDE; Amo R, 2014, NEURON, V84, P1034, DOI 10.1016/j.neuron.2014.10.035; Asan E, 2013, HISTOCHEM CELL BIOL, V139, P785, DOI 10.1007/s00418-013-1081-1; Avanzi V, 1998, BRAIN RES, V790, P178, DOI 10.1016/S0006-8993(97)01538-2; BANDLER R, 1991, NATO ADV SCI I A-LIF, V213, P175; Berg BA, 2014, EUR J NEUROSCI, V40, P3096, DOI 10.1111/ejn.12676; Bittencourt AS, 2004, NEUROSCIENCE, V125, P71, DOI 10.1016/j.neuroscience.2004.01.026; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Haller J, 2014, PSYCHOPHARMACOLOGY, V231, P593, DOI 10.1007/s00213-013-3273-8; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hayes DJ, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00049; Horvath G, 2014, NEUROBIOL DIS, V70, P162, DOI 10.1016/j.nbd.2014.06.011; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kocsis B, 2006, P NATL ACAD SCI USA, V103, P1059, DOI 10.1073/pnas.0508360103; Liu Y, 2015, NEUROSCIENCE, V298, P436, DOI 10.1016/j.neuroscience.2015.04.032; Paxinos G., 2001, THE MOUSE BRAIN IN S, V2; PECK BK, 1991, BRAIN RES, V568, P244, DOI 10.1016/0006-8993(91)91404-O; Poulos AM, 2016, LEARN MEMORY, V23, P379, DOI 10.1101/lm.041400.115; Sale A, 2014, PHYSIOL REV, V94, P189, DOI 10.1152/physrev.00036.2012; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Schenberg LC, 2005, NEUROSCI BIOBEHAV R, V29, P1279, DOI 10.1016/j.neubiorev.2005.05.006; Silva RCB, 2004, BEHAV BRAIN RES, V151, P93, DOI 10.1016/j.bbr.2003.08.015; Stanton PK, 1996, HIPPOCAMPUS, V6, P35, DOI 10.1002/(SICI)1098-1063(1996)6:1<35::AID-HIPO7>3.0.CO;2-6; Suvrathan A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0151; Szonyi A, 2016, BRAIN STRUCT FUNCT, V221, P735, DOI 10.1007/s00429-014-0935-1; Takase LF, 2004, BEHAV BRAIN RES, V153, P233, DOI 10.1016/j.bbr.2003.12.020; Tulogdi A, 2012, BRAIN RES BULL, V88, P359, DOI 10.1016/j.brainresbull.2012.04.001; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Wang DV, 2015, NAT NEUROSCI, V18, P728, DOI 10.1038/nn.3998; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zelena D, 2016, PSYCHOPHARMACOLOGY, V233, P2065, DOI 10.1007/s00213-016-4255-4	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181264	10.1371/journal.pone.0181264	http://dx.doi.org/10.1371/journal.pone.0181264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708877	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000405649800053
J	Couderc, E; Morel, F; Levillain, P; Buffiere-Morgado, A; Camus, M; Paquier, C; Bodet, C; Jegou, JF; Pohin, M; Favot, L; Garcia, M; Huguier, V; Mcheik, J; Lacombe, C; Yssel, H; Guillet, G; Bernard, FX; Lecron, JC				Couderc, Elodie; Morel, Franck; Levillain, Pierre; Buffiere-Morgado, Amandine; Camus, Magalie; Paquier, Camille; Bodet, Charles; Jegou, Jean-Francois; Pohin, Mathilde; Favot, Laure; Garcia, Martine; Huguier, Vincent; Mcheik, Jiad; Lacombe, Corinne; Yssel, Hans; Guillet, Gerard; Bernard, Francois-Xavier; Lecron, Jean-Claude			Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; SKIN INFLAMMATION; KAPPA-B; RHEUMATOID-ARTHRITIS; ONCOSTATIN-M; EXPRESSION; BINDING; CD36; DIFFERENTIATION; SECRETION	Background Acute-serum Amyloid A (A-SAA), one of the major acute-phase proteins, is mainly produced in the liver but extra-hepatic synthesis involving the skin has been reported. Its expression is regulated by the transcription factors NF-kappa B, C/EBP beta, STAT3 activated by proinflammatory cytokines. Objectives We investigated A-SAA synthesis by resting and cytokine-activated Normal Human Epidermal Keratinocytes (NHEK), and their inflammatory response to A-SAA stimulation. A-SAA expression was also studied in mouse skin and liver in a model mimicking psoriasis and in the skin and sera of psoriatic and atopic dermatitis (AD) patients. Methods NHEK were stimulated by A-SAA or the cytokines IL-1 alpha, IL-17A, IL-22, OSM, TNF-alpha alone or in combination, previously reported to reproduce features of psoriasis. Murine skins were treated by imiquimod cream. Human skins and sera were obtained from patients with psoriasis and AD. A-SAA mRNA was quantified by RT qPCR. A-SAA proteins were dosed by ELISA or immunonephelemetry assay. Results IL-1 alpha, TNF-alpha and mainly IL-17A induced A-SAA expression by NHEK. A-SAA induced its own production and the synthesis of hBD2 and CCL20, both ligands for CCR6, a chemokine receptor involved in the trafficking of Th17 lymphocytes. A-SAA expression was increased in skins and livers from imiquimod-treated mice and in patient skins with psoriasis, but not significantly in those with AD. Correlations between A-SAA and psoriasis severity and duration were observed. Conclusion Keratinocytes could contribute to psoriasis pathogenesis via A-SAA production, maintaining a cutaneous inflammatory environment, activating innate immunity and Th17 lymphocyte recruitment.	[Couderc, Elodie; Morel, Franck; Buffiere-Morgado, Amandine; Camus, Magalie; Paquier, Camille; Bodet, Charles; Jegou, Jean-Francois; Pohin, Mathilde; Favot, Laure; Garcia, Martine; Huguier, Vincent; Mcheik, Jiad; Guillet, Gerard; Lecron, Jean-Claude] Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines, UPRES EA4331, Pole Biol Sante,TSA, Poitiers, France; [Couderc, Elodie; Buffiere-Morgado, Amandine; Camus, Magalie; Paquier, Camille; Huguier, Vincent; Mcheik, Jiad; Guillet, Gerard] CHU Poitiers, Serv Dermatol, Poitiers, France; [Levillain, Pierre; Huguier, Vincent; Mcheik, Jiad; Lacombe, Corinne] CHU Poitiers, Serv Anatomopathol, Poitiers, France; [Huguier, Vincent; Mcheik, Jiad] CHU Poitiers, Serv Chirurg Plast, Poitiers, France; [Mcheik, Jiad] CHU Poitiers, Serv Chirurg Pediat, Poitiers, France; [Lacombe, Corinne; Lecron, Jean-Claude] CHU Poitiers, Serv Immunol & Inflammat, Poitiers, France; [Yssel, Hans] Hop La Pitie Salpetriere, Ctr Immunol & Malad Infect, INSERM, U1135, Paris, France; [Bernard, Francois-Xavier] Lab BIOalternat, Gencay, France	Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Lecron, JC (corresponding author), Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines, UPRES EA4331, Pole Biol Sante,TSA, Poitiers, France.; Lecron, JC (corresponding author), CHU Poitiers, Serv Immunol & Inflammat, Poitiers, France.	Jean-Claude.Lecron@univ-poitiers.fr	Morel, Franck/AAI-4274-2021; Yssel, Hans/C-6406-2009; Yssel, Hans/AFV-2907-2022; Laforge, Laure Favot/AGW-2729-2022; Bodet, Charles/Z-4585-2019	Morel, Franck/0000-0003-3812-9304; Yssel, Hans/0000-0001-7454-1836; Yssel, Hans/0000-0001-7454-1836; Bodet, Charles/0000-0002-8016-0324; Jegou, Jean-Francois/0000-0002-9703-5976; POHIN, Mathilde/0000-0003-2809-9498; LECRON, Jean-Claude/0000-0003-3990-5213				Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Armstrong AW, 2011, BRIT J DERMATOL, V165, P1162, DOI 10.1111/j.1365-2133.2011.10526.x; Balci DD, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2008.02936.x; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Bergis M, 2003, ANN DERMATOL VENER, V130, P1039; Beygi S, 2014, J EUR ACAD DERMATOL, V28, P700, DOI 10.1111/jdv.12257; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Dogan S, 2010, BRIT J DERMATOL, V163, P895, DOI 10.1111/j.1365-2133.2010.09907.x; Dzhndoian Z T, 2011, Georgian Med News, P48; Fujimoto E, 2010, J INVEST DERMATOL, V130, P405, DOI 10.1038/jid.2009.269; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ghannam S, 2011, J IMMUNOL, V186, P1411, DOI 10.4049/jimmunol.1000597; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Hari-Dass R, 2005, J BIOL CHEM, V280, P18562, DOI 10.1074/jbc.M500490200; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; Jung SY, 2007, YONSEI MED J, V48, P218, DOI 10.3349/ymj.2007.48.2.218; KISILEVSKY R, 1992, LAB INVEST, V66, P778; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lee HY, 2013, BIOCHEM BIOPH RES CO, V433, P255, DOI 10.1016/j.bbrc.2013.03.002; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Morizane S, 2017, J INVEST DERMATOL, V137, P757, DOI 10.1016/j.jid.2016.10.016; Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; Okamoto H, 2008, J RHEUMATOL, V35, P752; Ortiz A, 2012, INT J DERMATOL, V51, P250, DOI 10.1111/j.1365-4632.2011.05205.x; Panzer R, 2014, EXP DERMATOL, V23, P364, DOI 10.1111/exd.12383; Patel U, 2011, BRIT J DERMATOL, V164, P670, DOI 10.1111/j.1365-2133.2010.10124.x; Rabeony H, 2015, EUR J IMMUNOL, V45, P2847, DOI 10.1002/eji.201445215; Rabeony H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101937; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Steel DM, 1996, SCAND J IMMUNOL, V44, P493, DOI 10.1046/j.1365-3083.1996.d01-341.x; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Upragarin N, 2005, HISTOL HISTOPATHOL, V20, P1295, DOI 10.14670/HH-20.1295; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yu N, 2015, CLIN EXP IMMUNOL, V179, P344, DOI 10.1111/cei.12458; Yu N, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12320	51	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181486	10.1371/journal.pone.0181486	http://dx.doi.org/10.1371/journal.pone.0181486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708859	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649800059
J	Micewicz, ED; Kim, K; Iwamoto, KS; Ratikan, JA; Cheng, GH; Boxx, GM; Damoiseaux, RD; Whitelegge, JP; Ruchala, P; Nguyen, C; Purbey, P; Loos, J; Deng, G; Jung, ME; Sayre, JW; Norris, AJ; Schaue, D; McBride, WH				Micewicz, Ewa D.; Kim, Kwanghee; Iwamoto, Keisuke S.; Ratikan, Josephine A.; Cheng, Genhong; Boxx, Gayle M.; Damoiseaux, Robert D.; Whitelegge, Julian P.; Ruchala, Piotr; Nguyen, Christine; Purbey, Prabhat; Loos, Joseph; Deng, Gang; Jung, Michael E.; Sayre, James W.; Norris, Andrew J.; Schaue, Dorthe; McBride, William H.			4-(Nitrophenylsulfonyl) piperazines mitigate radiation damage to multiple tissues	PLOS ONE			English	Article							P53-DEPENDENT APOPTOSIS; MEDICAL COUNTERMEASURES; IONIZING-RADIATION; LOCAL IRRADIATION; SUPPRESSOR-CELLS; COX-2 INHIBITOR; PROTECTS MICE; GROWTH-FACTOR; LUNG-CANCER; STEM-CELLS	Our ability to use ionizing radiation as an energy source, as a therapeutic agent, and, unfortunately, as a weapon, has evolved tremendously over the past 120 years, yet our tool box to handle the consequences of accidental and unwanted radiation exposure remains very limited. We have identified a novel group of small molecule compounds with a 4-nitrophenylsulfonamide (NPS) backbone in common that dramatically decrease mortality from the hematopoietic acute radiation syndrome (hARS). The group emerged from an in vitro high throughput screen (HTS) for inhibitors of radiation-induced apoptosis. The lead compound also mitigates against death after local abdominal irradiation and after local thoracic irradiation (LTI) in models of subacute radiation pneumonitis and late radiation fibrosis. Mitigation of hARS is through activation of radiation-induced CD11b(+)Ly6G(+)Ly6C(+) immature myeloid cells. This is consistent with the notion that myeloerythroid-restricted progenitors protect against WBI-induced lethality and extends the possible involvement of the myeloid lineage in radiation effects. The lead compound was active if given to mice before or after WBI and had some anti-tumor action, suggesting that these compounds may find broader applications to cancer radiation therapy.	[Micewicz, Ewa D.; Kim, Kwanghee; Iwamoto, Keisuke S.; Ratikan, Josephine A.; Nguyen, Christine; Schaue, Dorthe; McBride, William H.] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA; [Cheng, Genhong; Boxx, Gayle M.; Purbey, Prabhat] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Damoiseaux, Robert D.] Univ Calif Los Angeles, Mol Screening Shared Resource, Los Angeles, CA USA; [Whitelegge, Julian P.; Ruchala, Piotr] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Los Angeles, CA USA; [Loos, Joseph; Deng, Gang; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Sayre, James W.] Univ Calif Los Angeles, Sch Publ Hlth Biostat & Radiol, Los Angeles, CA USA; [Norris, Andrew J.] BCN Biosci LLC, Pasadena, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Schaue, D (corresponding author), Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA.	dschaue@mednet.ucla.edu	Damoiseaux, Robert/F-1086-2011; Damoiseaux, Robert/S-6712-2019	Damoiseaux, Robert/0000-0002-7611-7534; Damoiseaux, Robert/0000-0002-7611-7534; RUCHALA, PIOTR/0000-0002-5574-2779	NIH/NIAID [U19 A1067769]; UCLA Center for Medical Countermeasures Against Radiation; BCN Biosciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCLA Center for Medical Countermeasures Against Radiation; BCN Biosciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH/NIAID Award U19 A1067769 (to Dr. William H. McBride), UCLA Center for Medical Countermeasures Against Radiation. We hereby declare that BCN Biosciences provided support in the form of salaries for author AJN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. E. Angelis for editorial assistance with the manuscript. This work was supported by NIH/NIAID Award U19 AI067769, UCLA Center for Medical Countermeasures Against Radiation.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Berredjem M., 2010, X-RAY STRUCT ANAL ON, V26, P13, DOI [https://doi.org/10.2116/xraystruct.26.13, DOI 10.2116/XRAYSTRUCT.26.13]; Bisht KS, 2003, INT J RADIAT BIOL, V79, P879, DOI 10.1080/09553000310001621400; Boettcher S, 2012, J IMMUNOL, V188, P5824, DOI 10.4049/jimmunol.1103253; Bond FP, 1965, MAMMALIAN RAD LETHAL; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Casey-Sawicki K, 2014, HEALTH PHYS, V106, P704, DOI 10.1097/HP.0000000000000095; CRONKITE EP, 1955, ANN NY ACAD SCI, V59, P815, DOI 10.1111/j.1749-6632.1955.tb45985.x; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Frantz MC, 2013, ORG BIOMOL CHEM, V11, P4147, DOI 10.1039/c3ob40489g; Girvan RC, 2011, VACCINE, V29, P545, DOI 10.1016/j.vaccine.2010.10.040; Himburg HA, 2014, J CLIN INVEST, V124, P4753, DOI 10.1172/JCI76838; Hochst B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119662; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Katoch O, 2012, J ENVIRON PATHOL TOX, V31, P357, DOI 10.1615/JEnvironPatholToxicolOncol.2013005833; Kim J, 2005, CANCER RES, V65, P8242, DOI 10.1158/0008-5472.CAN-05-0942; Kim K, 2011, INT J RADIAT BIOL, V87, P839, DOI 10.3109/09553002.2011.560994; Kim K, 2009, CLIN CANCER RES, V15, P7238, DOI 10.1158/1078-0432.CCR-09-1964; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Kuipers GK, 2007, INT J RADIAT BIOL, V83, P677, DOI 10.1080/09553000701558985; Liu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04833; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; MASON KA, 1989, RADIAT RES, V117, P480, DOI 10.2307/3577353; MCBRIDE WH, 1992, CANCER RES, V52, P3931; Medhora M, 2014, RADIAT RES, V182, P545, DOI 10.1667/RR13425.1; Monma H, 2013, MOL CANCER THER, V12, P341, DOI 10.1158/1535-7163.MCT-12-0954; Morita A, 2014, BIOCHEM BIOPH RES CO, V450, P1498, DOI 10.1016/j.bbrc.2014.07.037; Moulder JE, 2014, HEALTH PHYS, V107, P164, DOI 10.1097/HP.0000000000000082; Mukherjee D, 2014, J PATHOL, V232, P289, DOI 10.1002/path.4299; Mukherjee D, 2013, INT J RADIAT BIOL, V89, P139, DOI 10.3109/09553002.2013.741280; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Patil R, 2015, CHEM BIOL, V22, P206, DOI 10.1016/j.chembiol.2014.12.009; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; Pyo H, 2001, CLIN CANCER RES, V7, P2998; Riehl TE, 2004, AM J PHYSIOL-GASTR L, V286, pG166, DOI 10.1152/ajpgi.00537.2002; Saha D, 2003, AM J CLIN ONCOL-CANC, V26, pS70, DOI 10.1097/01.COC.0000074161.92815.93; Saha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024072; Sekihara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078772; Shakhov AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033044; Shen ZH, 1997, J IMMUNOL, V158, P2723; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Turinetto V, 2010, DNA REPAIR, V9, P1200, DOI 10.1016/j.dnarep.2010.09.003; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wang XW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08566; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981; Yang WC, 2013, J MOL CELL BIOL, V5, P207, DOI 10.1093/jmcb/mjt009; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	49	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181577	10.1371/journal.pone.0181577	http://dx.doi.org/10.1371/journal.pone.0181577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732024	Green Published, gold			2022-12-27	WOS:000406643100045
J	Passos, LF; Garcia, G; Young, RJ				Passos, Luiza Figueiredo; Garcia, Gerardo; Young, Robert John			The tonic immobility test: Do wild and captive golden mantella frogs (Mantella aurantiaca) have the same response?	PLOS ONE			English	Article							BODY CONDITION INDEX; GENETIC ADAPTATION; CONSERVATION; STRESS; AMPHIBIANS; PREDATORS; HEALTH; POPULATIONS; MADAGASCAR; RADIATION	Adaptations to captivity that reduce fitness are one of many reasons, which explain the low success rate of reintroductions. One way of testing this hypothesis is to compare an important behavioural response in captive and wild members of the same species. Thanatosis, is an anti-predator strategy that reduces the risk of death from predation, which is a common behavioral response in frogs. The study subjects for this investigation were captive and wild populations of Mantella aurantiaca. Thanatosis reaction was measured using the Tonic Immobility (TI) test, a method that consists of placing a frog on its back, restraining it in this position for a short period of time and then releasing it and measuring how much time was spent feigning death. To understand the pattern of reaction time, morphometric data were also collected as body condition can affect the duration of thanatosis. The significantly different TI times found in this study, one captive population with shorter responses, were principally an effect of body condition rather than being a result of rearing environment. However, this does not mean that we can always dismiss the importance of rearing environment in terms of behavioural skills expressed.	[Passos, Luiza Figueiredo; Young, Robert John] Univ Salford Manchester, Sch Environm & Life Sci, Peel Bldg, Salford, Lancs, England; [Passos, Luiza Figueiredo; Garcia, Gerardo] Chester Zoo, Cedar House, Chester, Cheshire, England		Young, RJ (corresponding author), Univ Salford Manchester, Sch Environm & Life Sci, Peel Bldg, Salford, Lancs, England.	r.j.young@salford.ac.uk	Young, Robert/B-7356-2013	Young, Robert/0000-0002-8407-2348	CAPES postgraduate scholarship [6060-13-7]	CAPES postgraduate scholarship	LFP was in receipt of a CAPES postgraduate scholarship Proc. 6060-13-7. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Chester Zoo, Mitsinjo Association (Devin Edmonds), Madagasikara-Voakajy and Ambatovy for the chance to develop this project at their facilities and for logistical support. LFP was in receipt of a CAPES postgraduate scholarship Proc. 6060-13-7.	Alberts AC, 2007, APPL ANIM BEHAV SCI, V102, P380, DOI 10.1016/j.applanim.2006.05.037; Antwis RE, 2009, COMP BIOCHEM PHYS A, V154, P184, DOI 10.1016/j.cbpa.2009.06.008; Balmford A, 1996, CONSERV BIOL, V10, P719, DOI 10.1046/j.1523-1739.1996.10030719.x; Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Broom D.M., 2019, STRESS ANIMAL WELFAR, V2nd ed., P99; Burghardt GM, 2013, APPL ANIM BEHAV SCI, V147, P286, DOI 10.1016/j.applanim.2013.04.013; CHROUSOS GP, 1997, GROWTH GENET HORM, V13, P1; DABROWSKA B, 1982, BEHAV PROCESS, V7, P179, DOI 10.1016/0376-6357(82)90026-2; Edmonds D, 2015, SALAMANDRA, V51, P315; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Fureix C, 2015, APPL ANIM BEHAV SCI, V171, P8, DOI 10.1016/j.applanim.2015.08.036; Germano JM, 2009, CONSERV BIOL, V23, P7, DOI 10.1111/j.1523-1739.2008.01123.x; Gilligan DM, 2003, CONSERV GENET, V4, P189, DOI 10.1023/A:1023391905158; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; Hing S, 2016, WILDLIFE RES, V43, P51, DOI 10.1071/WR15183; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; JOHNSON JA, 1975, AM MIDL NAT, V93, P139, DOI 10.2307/2424112; Johnson K., 2008, AMPHIBIAN ARK SPECIE; Jovanovic O, 2009, ZOOTAXA, P21, DOI 10.11646/zootaxa.2124.1.2; Konkle ATM, 2003, BRAIN RES, V992, P227, DOI 10.1016/j.brainres.2003.08.047; Kraaijeveld-Smit FJL, 2006, J APPL ECOL, V43, P360, DOI 10.1111/j.1365-2664.2006.01137.x; Labocha MK, 2014, OIKOS, V123, P111, DOI 10.1111/j.1600-0706.2013.00755.x; Livingston S, 2014, ZOO BIOL, V33, P565, DOI 10.1002/zoo.21177; MacCracken JG, 2012, J HERPETOL, V46, P346, DOI 10.1670/10-292; Machado Leonardo L., 2007, South American Journal of Herpetology, V2, P136, DOI 10.2994/1808-9798(2007)2[136:DBOTLT]2.0.CO;2; Michaels CJ, 2015, J ANIM PHYSIOL AN N, V99, P391, DOI 10.1111/jpn.12203; Miyatake T, 2009, P R SOC B, V276, P2763, DOI 10.1098/rspb.2009.0558; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Narayan EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073564; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V165, P304, DOI 10.1016/j.cbpa.2013.03.033; NASH RF, 1970, PSYCHON SCI, V21, P155; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; R Studio Team, 2016, RSTUDIO INT DEV ENV; Randrianavelona R, 2010, AFR J HERPETOL, V59, P65, DOI 10.1080/04416651.2010.481761; Reading R.P., 2013, ZOO BIOL, V9999, P1; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Schulte-Hostedde AI, 2015, EVOL APPL, V8, P413, DOI 10.1111/eva.12258; Schumann K, 2014, J APPL ANIM WELF SCI, V17, P111, DOI 10.1080/10888705.2014.884407; Suzuki K, 2013, BEHAV PROCESS, V100, P58, DOI 10.1016/j.beproc.2013.08.004; Tapley B, 2015, ZOO BIOL, V34, P46, DOI 10.1002/zoo.21170; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Toledo LF, 2010, J NAT HIST, V44, P1979, DOI 10.1080/00222931003624804; TSIGOS C, 1995, HDB STRESS MED, P61; Vences M., 2004, IUCN 2009 IUCN RED L, V1; Young R. J., 2003, ENV ENRICHMENT CAPTI, P150	47	8	8	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181972	10.1371/journal.pone.0181972	http://dx.doi.org/10.1371/journal.pone.0181972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732029	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000406643100073
J	Asbury, K; Moran, N; Plomin, R				Asbury, Kathryn; Moran, Nicola; Plomin, Robert			Do MZ twins have discordant experiences of friendship? A qualitative hypothesisgenerating MZ twin differences study	PLOS ONE			English	Article							ENVIRONMENTAL-INFLUENCES; NONSHARED ENVIRONMENT; PEER AFFILIATION; CHILDREN; FAMILY; VICTIMIZATION; ADOLESCENCE; DEPENDENCE; BEHAVIOR; OUTCOMES	Using a qualitative monozygotic (MZ) twin differences design we explored whether adolescent MZ twins report discordant peer relationships and, if so, whether they perceive them as causes, consequences or correlates of discordant behaviour. We gathered free-response questionnaire data from 497 families and conducted in-depth telephone interviews with 97 of them. Within this dataset n = 112 families (23% of the sample) described discordant peer relationships. Six categories of discordance were identified (peer victimisation, peer rejection, fewer friends, different friends, different attitudes to friendship and dependence on cotwin). Participants described peer relationship discordance arising as a result of chance occurrences, enhanced vulnerability in one twin or discordant behaviour. Consequences of discordant peer relationships were seen as discordance in self-confidence, future plans, social isolation, mental health and interests. In all cases the twin with worse peer experiences was seen as having a worse outcome. Specific hypotheses are presented.	[Asbury, Kathryn] Univ York, Dept Educ, Psychol Educ Res Ctr, York, N Yorkshire, England; [Moran, Nicola] Univ York, Dept Social Policy & Social Work, York, N Yorkshire, England; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London, England	University of York - UK; University of York - UK; University of London; King's College London	Asbury, K (corresponding author), Univ York, Dept Educ, Psychol Educ Res Ctr, York, N Yorkshire, England.	kathryn.asbury@york.ac.uk		Plomin, Robert/0000-0002-0756-3629; Asbury, Kathryn/0000-0003-0011-457X	Nuffield Foundation [EDU/40881]; MRC [G0901245, MR/M021475/1, G19/2, G0500079] Funding Source: UKRI; Medical Research Council [G0901245, G19/2, G0500079, MR/M021475/1] Funding Source: researchfish	Nuffield Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by a grant awarded to RP and KA by the Nuffield Foundation (EDU/40881), http://www.nuffieldfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbury K, 2003, CHILD DEV, V74, P933, DOI 10.1111/1467-8624.00577; Asbury Kathryn, 2016, AERA OPEN, V2; Bouchard TJ, 2004, CURR DIR PSYCHOL SCI, V13, P148, DOI 10.1111/j.0963-7214.2004.00295.x; Brendgen M, 2017, PSYCHOL MED, V47, P460, DOI 10.1017/S003329171600252X; Brendgen M, 2014, J PEDIATR PSYCHOL, V39, P96, DOI 10.1093/jpepsy/jst078; Bukowski W. M., 2007, HDB SOCIALIZATION TH, P355; Bullock BM, 2006, J ABNORM CHILD PSYCH, V34, P29, DOI 10.1007/s10802-005-9004-9; Burt SA, 2009, DEV PSYCHOL, V45, P1752, DOI 10.1037/a0016687; Button TMM, 2007, J ABNORM PSYCHOL, V116, P554, DOI 10.1037/0021-843X.116.3.554; Button TMM, 2009, DRUG ALCOHOL DEPEN, V100, P1, DOI 10.1016/j.drugalcdep.2008.08.014; Collins WA, 2000, AM PSYCHOL, V55, P218, DOI 10.1037/0003-066X.55.2.218; Dick DM, 2007, ALCOHOL CLIN EXP RES, V31, P2012, DOI 10.1111/j.1530-0277.2007.00523.x; Harris Judith Rich, 1998, NURTURE ASSUMPTION W; Haworth CMA, 2013, TWIN RES HUM GENET, V16, P117, DOI 10.1017/thg.2012.91; Hicks BM, 2010, ALCOHOL CLIN EXP RES, V34, P819, DOI 10.1111/j.1530-0277.2010.01154.x; Iervolino AC, 2002, CHILD DEV, V73, P162, DOI 10.1111/1467-8624.00398; Kendler KS, 2007, PSYCHOL MED, V38; Koch H.L., 1966, TWINS TWIN RELATIONS; Kretschmer T, 2010, J FAM PSYCHOL, V24, P411, DOI 10.1037/a0020060; Larson RW, 1996, DEV PSYCHOL, V32, P744, DOI 10.1037/0012-1649.32.4.744; Leve LD, 2003, MARRIAGE FAM REV, V33, P225; Loehlin JC, 1997, J PERS SOC PSYCHOL, V72, P1197, DOI 10.1037/0022-3514.72.5.1197; MANKE B, 1995, SOC DEV, V4, P238, DOI 10.1111/j.1467-9507.1995.tb00064.x; Marion D, 2013, J YOUTH ADOLESCENCE, V42, P1299, DOI 10.1007/s10964-013-9969-6; Oliver BR, 2007, TWIN RES HUM GENET, V10, P96, DOI 10.1375/twin.10.1.96; Plomin R, 2005, ANN AM ACAD POLIT SS, V600, P86, DOI 10.1177/0002716205277184; PLOMIN R, 1987, BEHAV BRAIN SCI, V10, P1, DOI 10.1017/S0140525X00055941; Plomin R, 2001, CAN J PSYCHIAT, V46, P225, DOI 10.1177/070674370104600302; Plomin R, 2011, INT J EPIDEMIOL, V40, P563, DOI 10.1093/ije/dyq148; Plomin R, 2011, INT J EPIDEMIOL, V40, P582, DOI 10.1093/ije/dyq144; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/136905200320565391; Ritchie J, 1994, ANAL QUALITATIVE DAT, P173, DOI DOI 10.4324/9780203413081; Rose Richard J., 2002, PATHS SUCCESSFUL DEV, P106; SCARR S, 1983, CHILD DEV, V54, P424, DOI 10.2307/1129703; Silberg JL, 2016, PSYCHOL MED, V46, P1875, DOI 10.1017/S0033291716000362; Thorpe K, 2006, TWIN RES HUM GENET, V9, P155, DOI 10.1375/183242706776402984; Thorpe K, 2003, TWIN RES, V6, P532, DOI 10.1375/136905203322686545; Turkheimer E, 2000, PSYCHOL BULL, V126, P78, DOI 10.1037/0033-2909.126.1.78; Vandell DL, 2000, DEV PSYCHOL, V36, P699, DOI 10.1037//0012-1649.36.6.699; Vitaro F, 2016, INT J BEHAV DEV, V40, P234, DOI 10.1177/0165025415618277	41	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180521	10.1371/journal.pone.0180521	http://dx.doi.org/10.1371/journal.pone.0180521			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727730	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500024
J	Bakshi, N; Sinha, CB; Ross, D; Khemani, K; Loewenstein, G; Krishnamurti, L				Bakshi, Nitya; Sinha, Cynthia B.; Ross, Diana; Khemani, Kirshma; Loewenstein, George; Krishnamurti, Lakshmanan			Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease	PLOS ONE			English	Article							SHARED DECISION-MAKING; STROKE PREVENTION TRIAL; QUALITY-OF-LIFE; HEALTH-CARE; ANEMIA; TRANSPLANTATION; HYDROXYUREA; PATIENT; IMPACT; ATTITUDES	Sickle cell disease (SCD) is an inherited blood disorder that primarily affects African-American and other ethnic minority populations. There are three available disease-modifying therapies for sickle cell disease: hydroxyurea (HU), bone marrow transplantation (BMT), and chronic blood transfusion (CBT). Since these treatments vary in their therapeutic intent, efficacy in preventing progression of the disease, short and long-term adverse effects, costs and patient burden, the decision-making process regarding these therapies is complicated for both the patient and healthcare provider. While previous research has focused on the patient perspective of treatment-related decision making, there is a paucity of research investigating the physician perspective of treatment-related decision making. We conducted a qualitative study with physicians who were experts in the field of SCD. Interviews focused on physician perceptions of patient decisional needs as well as physicians' approach to decision making regarding disease-modifying therapies in SCD. Thirty-six physician interviews were analyzed, with a focus on their perspectives regarding available treatment options and on how they approach decision making with patients. We identified two narrative approaches. The Collaborative approach (CA) was characterized by emphasizing the need to discuss all possible treatment options to ensure that the patient and/or family was equipped to make an informed decision. The Proponent approach (PA) was characterized by strongly advocating a pre-determined treatment plan and providing patients/families with information, with the objective of convincing them to accept the treatment. An interplay of patient-related and disease-related factors, decision type and physician-related factors, as well as institutional frameworks, influenced physician perspectives on treatment options and decision making regarding these therapies. These findings point to the potential value of developing systems to foster patient engagement as a way of facilitating shared decision making.	[Bakshi, Nitya; Ross, Diana; Krishnamurti, Lakshmanan] Childrens Hosp Pittsburgh, Div Pediat Hematol Oncol, Pittsburgh, PA 15213 USA; [Bakshi, Nitya; Ross, Diana; Krishnamurti, Lakshmanan] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Bakshi, Nitya; Krishnamurti, Lakshmanan] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders, Atlanta, GA 30329 USA; [Bakshi, Nitya; Sinha, Cynthia B.; Ross, Diana; Khemani, Kirshma; Krishnamurti, Lakshmanan] Emory Univ, Dept Pediat, Div Pediat Hematol Oncol BMT, Atlanta, GA 30322 USA; [Loewenstein, George] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Bakshi, Nitya; Krishnamurti, Lakshmanan] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30329 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Healthcare of Atlanta (CHOA); Emory University; Carnegie Mellon University; Children's Healthcare of Atlanta (CHOA)	Krishnamurti, L (corresponding author), Childrens Hosp Pittsburgh, Div Pediat Hematol Oncol, Pittsburgh, PA 15213 USA.; Krishnamurti, L (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.; Krishnamurti, L (corresponding author), Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders, Atlanta, GA 30329 USA.; Krishnamurti, L (corresponding author), Emory Univ, Dept Pediat, Div Pediat Hematol Oncol BMT, Atlanta, GA 30322 USA.; Krishnamurti, L (corresponding author), Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30329 USA.	lkrishn@emory.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Krishnamurti, Lakshmanan/0000-0003-3242-0037	Patient Centered Outcomes Research Institute (PCORI)	Patient Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI)	This study was funded by the Patient Centered Outcomes Research Institute (PCORI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2000, J CHILD NEUROL, V15, P344, DOI 10.1177/088307380001500511; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Corbin JM, 2015, BASICS QUALITATIVE R, Vxviii; Crowe M, 2015, AUST NZ J PSYCHIAT, V49, P616, DOI 10.1177/0004867415582053; Drake RE, 2009, PSYCHIAT SERV, V60, P1007, DOI 10.1176/appi.ps.60.8.1007; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Foley KA, 2006, MED CARE, V44, P421, DOI 10.1097/01.mlr.0000208017.18278.1a; Haywood C, 2014, J GEN INTERN MED, V29, P1657, DOI 10.1007/s11606-014-2986-7; Haywood C, 2010, J GEN INTERN MED, V25, P543, DOI 10.1007/s11606-009-1247-7; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Kim SP, 2001, CANCER INVEST, V19, P684, DOI 10.1081/CNV-100106143; Kon AA, 2010, JAMA-J AM MED ASSOC, V304, P903, DOI 10.1001/jama.2010.1208; Legare F, 2006, CAN FAM PHYSICIAN, V52, P476; Lipstein EA, 2015, MED DECIS MAKING, V35, P703, DOI 10.1177/0272989X15581805; Matlock DD, 2011, PACE, V34, P1634, DOI 10.1111/j.1540-8159.2011.03237.x; McCavit TL, 2012, PEDIATR REV, V33, P195, DOI 10.1542/pir.33-5-195; Miller ST, 2001, J PEDIATR-US, V139, P785, DOI 10.1067/mpd.2001.119593; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Muller-Engelmann M, 2011, PATIENT EDUC COUNS, V82, P240, DOI 10.1016/j.pec.2010.04.028; Panepinto JA, 2012, PEDIATR BLOOD CANCER, V59, P377, DOI 10.1002/pbc.24176; Panepinto J, 2009, QUAL LIFE RES, V18, P5, DOI 10.1007/s11136-008-9412-8; Peek ME, 2010, SOC SCI MED, V71, P13, DOI 10.1016/j.socscimed.2010.03.018; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Pollard S, 2015, PATIENT EDUC COUNS, V98, P1046, DOI 10.1016/j.pec.2015.05.004; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Walters MC, 2015, CURR OPIN HEMATOL, V22, P227, DOI 10.1097/MOH.0000000000000136; Walters MC, 2010, BIOL BLOOD MARROW TR, V16, P263, DOI 10.1016/j.bbmt.2009.10.005; Walters MC, 2004, PEDIATR TRANSPLANT, V8, P33, DOI 10.1111/j.1398-2265.2004.00188.x; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Wennberg J E, 1984, Health Manage Q, P6, DOI 10.1377/hlthaff.3.2.6	33	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e178413	10.1371/journal.pone.0178413	http://dx.doi.org/10.1371/journal.pone.0178413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727801	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500003
J	Cai, GJ; Zhang, XY; Weng, WJ; Shi, GW; Xue, SL; Zhang, BF				Cai, Gaojun; Zhang, Xinyong; Weng, Weijin; Shi, Ganwei; Xue, Sheliang; Zhang, Bifeng			Associations between PPARG polymorphisms and the risk of essential hypertension	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; SYNTHASE-4A/B GENE POLYMORPHISMS; PRO12ALA POLYMORPHISM; PPAR-GAMMA-2 GENE; BLOOD-PRESSURE; HAN CHINESE; PROLIFERATOR; RS1801282; VARIANT	Background Peroxisome proliferator-activated receptor gamma (PPARG) plays an important role in the pathogenesis and maintenance of essential hypertension (EH). It has been suggested that polymorphisms of PPARG are associated with the risk of EH. However, findings to date remain controversial. To elucidate the associations between the PPARG Pro12Ala and C161T polymorphisms and EH risk, a meta-analysis was carried out. Methods A comprehensive literature search of PubMed, Embase, CNKI (Chinese National Knowledge Infrastructure), VIP and Wanfang databases was conducted. The pooled odds ratios (ORs) and 95% confidence interval (CI) were calculated to estimate the size of the effect using the random-effects model. At the same time, the pooled standardized mean difference (SMD) with 95% CI was used for the meta-analysis of the PPARG Pro12Ala polymorphism and blood pressure. Results Finally, Fifteen papers (seventeen studies) including 4,151 cases and 4,997 controls to evaluate the association of the PPARGPro12Ala polymorphism and EH risk, were included in this study. Overall, the results suggested that Ala allele was associated with the decreased EH risk (for allelic model, OR = 0.757, 95% CI: 0.624-0.918, P = 0.005; for dominant model, OR = 0.771, 95% CI: 0.627-0.946, P = 0.013). The subgroup analysis stratified by ethnicity showed that the significant association between the PPARG Pro12Ala polymorphism and EH was only detected in the Asian subgroup. There was no difference in blood pressure values between Ala carriers and non-carriers. For the C161T polymorphism, only 5 studies comprising 1,118 cases and 1,357 controls met the inclusion criteria. The overall results showed that the PPARG C161T polymorphism was not associated with the risk of EH. But in the subgroup analysis, we found that the PPARG C161T polymorphism significantly associated with the risk of EH in the Asian subgroup (for allelic model, OR = 0.719, 95% CI: 0.537-0.963, P = 0.027; for dominant model, OR = 0.653, 95% CI: 0.439-0.972, P = 0.036). Conclusion Our meta-analysis suggested that the PPARG polymorphisms might be associated with the risk of EH.	[Cai, Gaojun; Weng, Weijin; Shi, Ganwei; Xue, Sheliang] Jiangsu Univ, Wujin Hosp, Dept Cardiol, Changzhou, Jiangsu, Peoples R China; [Zhang, Xinyong] Xuzhou Med Univ, Affiliated Huaian Hosp, Huaian Peoples Hosp 2, Dept Neurol, Huaian, Jiangsu, Peoples R China; [Zhang, Bifeng] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	Jiangsu University; Xuzhou Medical University; McMaster University	Cai, GJ (corresponding author), Jiangsu Univ, Wujin Hosp, Dept Cardiol, Changzhou, Jiangsu, Peoples R China.	cgj982@126.com			Jiangsu Youth Medical Talents Project [QNRC2016310]; Changzhou SciTech Program [CJ20160004]; Science and technology project of Wujin [WS201603]	Jiangsu Youth Medical Talents Project; Changzhou SciTech Program; Science and technology project of Wujin	Our manuscript was supported by Jiangsu Youth Medical Talents Project (QNRC2016310), the Changzhou Sci&Tech Program (Grant No.CJ20160004) and the Science and technology project of Wujin (WS201603).	Afzal Naeema, 2016, J Ayub Med Coll Abbottabad, V28, P130; [Anonymous], 2013, 64 INT ASTR C; Azhar S, 2010, FUTUR CARDIOL, V6, P657, DOI [10.2217/FCA.10.86, 10.2217/fca.10.86]; Bener A, 2013, APPL CLIN GENET, V6, P103, DOI 10.2147/TACG.S49875; Butt H, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0183-z; Cai GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102058; Chen J, 2014, J PRACTICAL MED, V30, P2922; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dong HR, 2012, INT J LAB MED, V33, P2698; Gao L, 2010, GENET MOL RES, V9, P1312, DOI 10.4238/vol9-3gmr833; Gouni-Berthold I, 2005, J HYPERTENS, V23, P301, DOI 10.1097/00004872-200502000-00012; Grygiel-Gorniak B, 2015, J CLIN HYPERTENS, V17, P549, DOI 10.1111/jch.12537; Horiki M, 2004, DIABETES RES CLIN PR, V66, pS63, DOI 10.1016/j.diabres.2003.09.023; Kanauchi M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008404; Kim K, 2007, J NUTR SCI VITAMINOL, V53, P239, DOI 10.3177/jnsv.53.239; Li HB, 2016, TOXICOL APPL PHARM, V305, P93, DOI 10.1016/j.taap.2016.06.014; Lin Yao, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P597; Lu ZC, 2008, EXP GERONTOL, V43, P1108, DOI 10.1016/j.exger.2008.08.046; Lv YB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158880; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Neve BP, 2000, BIOCHEM PHARMACOL, V60, P1245, DOI 10.1016/S0006-2952(00)00430-5; Newhouse SJ, 2005, HUM MOL GENET, V14, P1805, DOI 10.1093/hmg/ddi187; Pan HJ, 2007, CHINESE J BIRTH HLTH, V15, P19; Qu FZ, 2008, CHINA MED, V3, P171; Rocha RM, 2015, ARCH ENDOCRIN METAB, V59, P297, DOI 10.1590/2359-3997000000086; Rodriguez-Esparragon FJ, 2003, J HYPERTENS, V21, P1649, DOI 10.1097/01.hjh.0000084719.53355.20; [沈丹 Shen Dan], 2005, [中国老年学杂志, Chinese Journal of Gerontology], V25, P235; Stefanski A, 2006, J HUM HYPERTENS, V20, P684, DOI 10.1038/sj.jhh.1002040; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Usuda D, 2014, WORLD J CARDIOL, V6, P744, DOI 10.4330/wjc.v6.i8.744; Wang G, 2015, IRAN J BASIC MED SCI, V18, P1228; Wang YJ, 2012, GENE, V502, P159, DOI 10.1016/j.gene.2012.04.035; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Ye HD, 2015, GENET MOL RES, V14, P6350, DOI 10.4238/2015.June.11.10; Yin RX, 2008, AM J MED, V121, P811, DOI 10.1016/j.amjmed.2008.04.026; Yu Y, 2015, HYPERTENSION, V66, P403, DOI 10.1161/HYPERTENSIONAHA.115.05726; Zhang AP, 2015, J CLIN INTERN MED, V22, P694; Zhang Y, 2014, J CHINESE PRACTICAL, V28, P134	38	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181644	10.1371/journal.pone.0181644	http://dx.doi.org/10.1371/journal.pone.0181644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727849	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500099
J	Haggblom, A; Santacatterina, M; Neogi, U; Gisslen, M; Hejdeman, B; Flamholc, L; Sonnerborg, A				Haggblom, Amanda; Santacatterina, Michele; Neogi, Ujjwal; Gisslen, Magnus; Hejdeman, Bo; Flamholc, Leo; Sonnerborg, Anders			Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients	PLOS ONE			English	Article							DRUG-RESISTANCE; VIRAL LOAD; VIROLOGICAL RESPONSE; DISEASE PROGRESSION; REGRESSION; MORTALITY; OUTCOMES; TYPE-1; WEB	Background Switch from first line antiretroviral therapy (ART) to second-line ART is common in clinical practice. However, there is limited knowledge of to which extent different reason for therapy switch are associated with differences in long-term consequences and sustainability of the second line ART. Material and methods Data from 869 patients with 14601 clinical visits between 1999-2014 were derived from the national cohort database. Reason for therapy switch and viral load (VL) levels at first-line ART failure were compared with regard to outcome of second line ART. Using the Laplace regression model we analyzed the median, 10th, 20th, 30th and 40th percentile of time to viral failure (VF). Results Most patients (n = 495; 57.0%) switched from first-line to second-line ART without VF. Patients switching due to detectable VL with (n = 124; 14.2%) or without drug resistance mutations (DRM) (n = 250; 28.8%) experienced VF to their second line regimen sooner (median time, years: 3.43 (95% CI 2.90-3.96) and 3.20 (95% 2.65-3.75), respectively) compared with those who switched without VF (4.53 years). Furthermore level of VL at first-line ART failure had a significant impact on failure of second-line ART starting after 2.5 years of second-line ART. Conclusions In the context of life-long therapy, a median time on second line ART of 4.53 years for these patients is short. To prolong time on second-line ART, further studies are needed on the reasons for therapy changes. Additionally patients with a high VL at first-line VF should be more frequently monitored the period after the therapy switch.	[Haggblom, Amanda; Sonnerborg, Anders] Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Santacatterina, Michele] Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden; [Neogi, Ujjwal; Sonnerborg, Anders] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Gisslen, Magnus] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden; [Hejdeman, Bo] South Gen Hosp, Dept Infect Dis Venhalsan, Stockholm, Sweden; [Flamholc, Leo] Malmo Univ Hosp, Dept Infect Dis, Malmo, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Lund University; Skane University Hospital	Haggblom, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden.	Amanda.haggblom@ki.se	Neogi, Ujjwal/E-4274-2012; Santacatterina, Michele/AAL-5050-2020; Neogi, Ujjwal/ABF-1172-2021; Sönnerborg, Anders/W-2011-2019; Gisslen, Magnus/D-7454-2015	Santacatterina, Michele/0000-0003-0599-3876; Neogi, Ujjwal/0000-0002-0844-3338; Sönnerborg, Anders/0000-0001-8928-3374; Gisslen, Magnus/0000-0002-2357-1020	Physician Against AIDS Research Fund [FOa2013-0014]	Physician Against AIDS Research Fund	This work was supported by Physician Against AIDS Research Fund, Grant number: FOa2013-0014, http://www.aidsfond.se/ansokanomforskningsanslag-24944283.	Bontell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059337; Bottai M, 2010, BIOMETRICAL J, V52, P487, DOI 10.1002/bimj.200900310; Charpentier C, 2004, J VIROL, V78, P4234, DOI 10.1128/JVI.78.8.4234-4247.2004; Cozzi-Lepri A, 2008, AIDS, V22, P2187, DOI 10.1097/QAD.0b013e328310e04f; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Kozal MJ, 2011, ANTIVIR THER, V16, P925, DOI 10.3851/IMP1851; Lepri AC, 2001, AIDS, V15, P47, DOI 10.1097/00002030-200101050-00008; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lohse N, 2006, CLIN INFECT DIS, V42, P136, DOI 10.1086/498515; Lohse N, 2007, ANTIVIR THER, V12, P909; Lucas GM, 2004, AIDS, V18, P1539, DOI 10.1097/01.aids.0000131339.68666.1a; Lucas GM, 2005, J ANTIMICROB CHEMOTH, V55, P413, DOI 10.1093/jac/dki042; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Napravnik S, 2013, AIDS RES HUM RETROV, V29, P574, DOI [10.1089/aid.2012.0210, 10.1089/AID.2012.0210]; Neogi U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099390; Ormaasen V, 2004, HIV MED, V5, P400, DOI 10.1111/j.1468-1293.2004.00244.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Ramadhani HO, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu079; ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135; Santoro MM, 2013, ANTIVIR THER, V18, P867, DOI 10.3851/IMP2531; Taiwo B, EFFICACY NUCLOSIDE S; van Leth F, EFFECT BASELINE CD4; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Zaccarelli M, 2005, AIDS, V19, P1081, DOI 10.1097/01.aids.0000174455.01369.ad	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180140	10.1371/journal.pone.0180140	http://dx.doi.org/10.1371/journal.pone.0180140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727795	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500014
J	Potocnik, N; Perse, M; Cerar, A; Injac, R; Finderle, Z				Potocnik, Nejka; Perse, Martina; Cerar, Anton; Injac, Rade; Finderle, Zarko			Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; INDUCED CARDIOTOXICITY; NERVOUS-SYSTEM; CARDIOVASCULAR VARIABILITY; MYOCARDIAL DAMAGE; FAILURE SECONDARY; VAGAL MODULATION; DOWN-REGULATION; RATS; C-60(OH)(24)	The very effective anticancer drug doxorubicin (DOX) is known to have cardiotoxic side effects, which could be accompanied by autonomic modulation. Autonomic disbalance might even be an initiating mechanism underlying DOX-induced cardiotoxicity and can be studied noninvasively by the analysis of heart rate variability (HRV). A number of strategies have been assessed to predict chemotherapy-induced cardiac dysfunction while HRV, a potential detecting tool, has not yet been tested. Thus, we aimed to determine the effect of DOX treatment on HRV in a rat model of colorectal cancer. While pretreatment with fullerenol (Frl) acts protectively on DOX-induced cardiotoxicity, we aimed to test the effect of Frl pretreatment on DOX-induced HRV alterations. After the induction of colorectal cancer, adult male Wistar rats were treated with saline (n = 7), DOX (1.5 mg/kg per week, n = 7) or DOX after pretreatment with Frl (25 mg/kg per week, n = 7) for three weeks (cumulative DOX dose 4.5 mg/kg). One week after treatment rats were anaesthetized, standard ECG was measured and HRV was analyzed in time and frequency domain. During autopsy the intestines and hearts were gathered for biochemical analysis and histopathological examination. DOX treatment significantly decreased parasympathetically mediated high-frequency component (p<0.05) and increased the low-frequency component of HRV (p<0.05), resulting in an increased LF/HF ratio (p<0.05) in cancerous rats. When pretreated with Frl, DOX-induced HRV alterations were prevented: the high-frequency component of HRV increased (p<0.01), the low-frequency decreased (p<0.01), LF/HF ratio decreased consequently (p<0.01) compared to DOX only treatment. In all DOX-treated animals, disbalance of oxidative status in heart tissue and early myocardial lesions were found and were significantly reduced in rats receiving Frl pretreatment. Autonomic modulation accompanied the development of DOX-induced cardiotoxicity in rat model of colorectal cancer and was prevented by Frl pretreatment. Our results demonstrated the positive prognostic power of HRV for the early detection of DOX-induced cardiotoxicity.	[Potocnik, Nejka; Finderle, Zarko] Univ Ljubljana, Fac Med, Inst Physiol, Ljubljana, Slovenia; [Perse, Martina; Cerar, Anton] Univ Ljubljana, Fac Med, Med Expt Ctr, Inst Pathol, Ljubljana, Slovenia; [Injac, Rade] Univ Ljubljana, Dept Pharmaceut Biol, Fac Pharm, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; University of Ljubljana	Potocnik, N (corresponding author), Univ Ljubljana, Fac Med, Inst Physiol, Ljubljana, Slovenia.	nejka.potocnik@mf.uni-lj.si	Perse, Martina/AAS-2898-2020		Slovenian Research Agency, Slovenia [P4-0127]	Slovenian Research Agency, Slovenia(Slovenian Research Agency - Slovenia)	This work was supported by a grant from the Slovenian Research Agency, Slovenia, Grant no. P4-0127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0198-3; Apaijai N, 2013, BRIT J PHARMACOL, V169, P1048, DOI 10.1111/bph.12176; Arab C, 2016, PSYCHONEUROENDOCRINO, V68, P57, DOI 10.1016/j.psyneuen.2016.02.018; Bertinchant JP, 2003, CLIN CHIM ACTA, V329, P39, DOI 10.1016/S0009-8981(03)00013-5; Bianucci E, 2012, BIOMETALS, V25, P23, DOI 10.1007/s10534-011-9480-z; BINKLEY PF, 1991, J AM COLL CARDIOL, V18, P464, DOI 10.1016/0735-1097(91)90602-6; Camm AJ, 1996, CIRCULATION, V93, P1043; Carnevali L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00118; Carnevali L, 2014, PHYSIOL BEHAV, V128, P16, DOI 10.1016/j.physbeh.2014.01.033; CARRE F, 1994, EUR HEART J, V15, P58, DOI 10.1093/eurheartj/15.suppl_D.58; Cekici L, 2009, BRIT J CLIN PHARMACO, V67, P394, DOI 10.1111/j.1365-2125.2009.03377.x; CERUTTI C, 1991, AM J PHYSIOL, V261, pH1292, DOI 10.1152/ajpheart.1991.261.4.H1292; Chaswal M, 2011, CAN J PHYSIOL PHARM, V89, P865, DOI [10.1139/Y11-084, 10.1139/y11-084]; Chattipakorn N, 2007, INT J CARDIOL, V120, P289, DOI 10.1016/j.ijcard.2006.11.221; Chen X, 2007, CARDIOVASC DRUG THER, V21, P367, DOI 10.1007/s10557-007-6052-0; Chung WB, 2016, KOREAN J INTERN MED, V31, P625, DOI 10.3904/kjim.2016.017; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; De Angelis K, 2012, AM J PHYSIOL-REG I, V302, pR950, DOI 10.1152/ajpregu.00450.2011; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Fadillioglu E, 2004, J APPL TOXICOL, V24, P47, DOI 10.1002/jat.945; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Hasan W, 2013, ORGANOGENESIS, V9, P176, DOI 10.4161/org.24892; Hellstrom HR, 2007, MED HYPOTHESES, V68, P415, DOI 10.1016/j.mehy.2006.05.031; HRUSHESKY WJM, 1991, CIRCULATION, V84, P697, DOI 10.1161/01.CIR.84.2.697; Injac Rade, 2013, Methods Mol Biol, V1028, P75, DOI 10.1007/978-1-62703-475-3_5; Injac R, 2009, PHARMACOL REP, V61, P335, DOI 10.1016/S1734-1140(09)70041-6; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Kalay N, 2006, J AM COLL CARDIOL, V48, P2258, DOI 10.1016/j.jacc.2006.07.052; Kang YJ, 1999, P SOC EXP BIOL MED, V222, P263, DOI 10.1046/j.1525-1373.1999.d01-143.x; Kazmi SZH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157557; Kelishomi RB, 2008, TOXICOLOGY, V243, P96, DOI 10.1016/j.tox.2007.09.026; Kenk M, 2010, J NUCL CARDIOL, V17, P254, DOI 10.1007/s12350-009-9190-x; Kishi T, 2012, J CARDIOL, V59, P117, DOI 10.1016/j.jjcc.2011.12.006; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kur'yanova EV, 2014, B EXP BIOL MED+, V157, P311, DOI 10.1007/s10517-014-2553-6; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lee MS, 2014, INT J CARDIOL, V176, P166, DOI 10.1016/j.ijcard.2014.07.012; Lichota A, 2016, MED PR, V67, P817, DOI 10.13075/mp.5893.00466; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Loncar-Turukalo T, 2015, PHYSIOL MEAS, V36, P727, DOI 10.1088/0967-3334/36/4/727; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; MASKENS AP, 1976, CANCER RES, V36, P1585; Menna P, 2010, CHEM RES TOXICOL, V23, P6, DOI 10.1021/tx9003424; Merlet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064711; MINCHIN RF, 1988, CANCER, V61, P1320, DOI 10.1002/1097-0142(19880401)61:7<1320::AID-CNCR2820610708>3.0.CO;2-J; Molinaro M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/138148; Mong MC, 2013, J FOOD SCI, V78, pH1621, DOI 10.1111/1750-3841.12257; Ong DS, 2014, EXPERT REV CARDIOVAS, V12, P487, DOI 10.1586/14779072.2014.893824; PANINA G, 1995, AM HEART J, V129, P748, DOI 10.1016/0002-8703(95)90325-9; Papaioannou VE, 2013, CURR CARDIOL REV, V9, P82, DOI 10.2174/1573403X11309010010; Parati G, 2006, J APPL PHYSIOL, V101, P676, DOI 10.1152/japplphysiol.00446.2006; PARLOW J, 1995, HYPERTENSION, V25, P1058, DOI 10.1161/01.HYP.25.5.1058; Pecoraro M, 2016, TOXICOL APPL PHARM, V293, P44, DOI 10.1016/j.taap.2016.01.006; Perse M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/473964; Ribeiro ALP, 2007, INT J CARDIOL, V117, P59, DOI 10.1016/j.ijcard.2006.04.053; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; PORTER TR, 1990, J CLIN INVEST, V85, P1362, DOI 10.1172/JCI114580; Ramirez-Villegas JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017060; Roca-Alonso L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.89; Rowan WH, 2007, CARDIOVASC TOXICOL, V7, P28, DOI 10.1007/s12012-007-0004-6; Schumann A, 2002, STAT MED, V21, P2225, DOI 10.1002/sim.979; Sebastian S, 2013, AM J PHYSIOL-REG I, V305, pR435, DOI 10.1152/ajpregu.00037.2013; Srdjenovic B, 2010, TOXICOL MECH METHOD, V20, P298, DOI 10.3109/15376516.2010.485622; Svorc P Jr, 2013, Prague Med Rep, V114, P72; Szabo BM, 1997, AM J CARDIOL, V79, P978, DOI 10.1016/S0002-9149(97)00026-X; Sztajzel J, 2004, SWISS MED WKLY, V134, P514; TONG J, 1991, AM J PHYSIOL, V260, pH909, DOI 10.1152/ajpheart.1991.260.3.H909; Torres VM, 2010, PHARMACOL REP, V62, P707, DOI 10.1016/S1734-1140(10)70328-5; Ueno M, 2006, J PHARMACOL SCI, V101, P151, DOI 10.1254/jphs.FP0050980; Vapa I, 2012, EUR J DRUG METAB PH, V37, P301, DOI 10.1007/s13318-012-0092-y; VIQUERAT CE, 1985, AM J MED, V78, P455, DOI 10.1016/0002-9343(85)90338-9; Wallace KB, 1997, FUND APPL TOXICOL, V38, P23, DOI 10.1006/faat.1997.2320; Wang HB, 2016, CELL PHYSIOL BIOCHEM, V40, P1163, DOI 10.1159/000453170; Wulsin LR, 2015, J CLIN ENDOCR METAB, V100, P2443, DOI 10.1210/jc.2015-1748; Xu XL, 2006, AUTON NEUROSCI-BASIC, V130, P6, DOI 10.1016/j.autneu.2006.04.005; Yagmurca M, 2003, PHARMACOL RES, V48, P377, DOI 10.1016/S1043-6618(03)00185-3; Yu AF, 2016, HEART, V102, P425, DOI 10.1136/heartjnl-2015-307894; Zhao Y, 2014, FREE RADICAL BIO MED, V72, P55, DOI 10.1016/j.freeradbiomed.2014.03.001; Zila I, 2015, PHYSIOL RES, V64, pS669, DOI 10.33549/physiolres.933226	80	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181632	10.1371/journal.pone.0181632	http://dx.doi.org/10.1371/journal.pone.0181632			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727839	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500098
J	Shen, YQ; Huang, GY; McCormick, BP; Song, T; Xu, XF				Shen, Youqing; Huang, Guoyuan; McCormick, Bryan P.; Song, Tao; Xu, Xiangfeng			Effects of high-intensity interval versus mild-intensity endurance training on metabolic phenotype and corticosterone response in rats fed a high-fat or control diet	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ANXIETY-LIKE BEHAVIORS; REDUCES LIVER FAT; INTERMITTENT EXERCISE; SKELETAL-MUSCLE; INDUCED OBESITY; LOW-VOLUME; STRESS; MODEL; HYPERINSULINEMIA	The aim of the present study was to compare the effects of high-intensity interval training (HI) to mild-intensity endurance training (ME), combined with a high-fat diet (HFD) or control diet (CD) on metabolic phenotype and corticosterone levels in rats. Fifty-three rats were randomized to 6 groups according to diet and training regimen as follows: CD and sedentary (CS, n = 11), CD and ME (CME, n = 8), CD and HI (CHI, n = 8), HFD and sedentary (HS, n = 10), HFD and ME (HME, n = 8), and HFD and HI (HHI, n = 8). All exercise groups were trained for 10 weeks and had matched running distances. Dietary intake, body composition, blood metabolites, and corticosterone levels were measured. Histological lipid droplets were observed in the livers. The HFD led to hyperglycemia, hyperlipidemia and higher body fat (all, P < 0.01, eta(2) > 0.06), as well as higher corticosterone levels (P < 0.01, eta(2) = 0.09) compared with the CD groups. Exercise training improved fat weight, glucose, and lipid profiles, and reduced corticosterone levels (P < 0.01, eta(2) = 0.123). Furthermore, body and fat weight, serum glucose and triglycerides, lipid content in the liver, and corticosterone levels (P < 0.05) were lower with HI training compared to ME training. Reductions in HFD-induced body weight gain, blood glucose and lipid profiles, and corticosterone levels, as well as improvements in QUICKI were better with HHI compared to HME. Correlation analyses revealed that corticosterone levels were significantly associated with phenotype variables (P < 0.01). Corticosterone level was inversely correlated with QUICKI (r = -0.38, P < 0.01). Altogether, these results indicate that HFD may elicit an exacerbated basal serum corticosterone level and thus producing a metabolic imbalance. Compared with ME training, HI training contributes to greater improvements in metabolic and corticosterone responses, leading to a greater reduction in susceptibility to HFD-induced disorders.	[Shen, Youqing] Hubei Univ Educ, Sch Phys Educ, Wuhan, Hubei, Peoples R China; [Huang, Guoyuan] Univ Southern Indiana, Pott Coll Sci Engn & Educ, Evansville, IN USA; [Shen, Youqing; McCormick, Bryan P.] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA; [Song, Tao] Jianghan Univ, Sch Phys Educ, Wuhan, Hubei, Peoples R China; [Xu, Xiangfeng] Wuhan Sports Univ, Sch Phys Educ, Wuhan, Hubei, Peoples R China	Hubei University Education; Indiana University System; Indiana University Bloomington; Jianghan University; Wuhan Sports University	Xu, XF (corresponding author), Wuhan Sports Univ, Sch Phys Educ, Wuhan, Hubei, Peoples R China.	future0104@126.com			Department of Scientific Research, Hubei Province [B2016220]; China Scholarship Council [201508420205]; Wuhan Institutes of Biomedical Science and Jianghan University	Department of Scientific Research, Hubei Province; China Scholarship Council(China Scholarship Council); Wuhan Institutes of Biomedical Science and Jianghan University	This project was partly funded by a Grant (#B2016220) from the Department of Scientific Research, Hubei Province. We also thank the China Scholarship Council (201508420205) for funding Youqing Shen's academic scholarship at the Indiana University-Bloomington, which was a requirement for her research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; These experiments were supported by Wuhan Institutes of Biomedical Science and Jianghan University. The authors thank Dr. Kai Yue and Qiu Pang for assisting with experimental trials. We are also grateful to Accdon for English language assistance during the revision of this manuscript. The authors have no conflicts to declare.	Alvarez C, 2016, INT J SPORTS MED, V37, P723, DOI 10.1055/s-0042-104935; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Auvinen HE, 2011, HORM METAB RES, V43, P899, DOI 10.1055/s-0031-1291305; Ayroldi E, 2014, FASEB J, V28, P5055, DOI 10.1096/fj.14-254755; Beaudry JL, 2015, J APPL PHYSIOL, V118, P1331, DOI 10.1152/japplphysiol.00467.2014; Beaudry JL, 2013, ENDOCRINOLOGY, V154, P3197, DOI 10.1210/en.2012-2114; BEDFORD TG, 1979, J APPL PHYSIOL, V47, P1278, DOI 10.1152/jappl.1979.47.6.1278; Campeau S, 2010, J NEUROENDOCRINOL, V22, P872, DOI 10.1111/j.1365-2826.2010.02007.x; Cassidy S, 2016, DIABETOLOGIA, V59, P56, DOI 10.1007/s00125-015-3741-2; Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010; Dutheil S, 2016, NEUROPSYCHOPHARMACOL, V41, P1874, DOI 10.1038/npp.2015.357; Ebada ME, 2016, BEHAV BRAIN RES, V311, P228, DOI 10.1016/j.bbr.2016.05.051; Field BCT, 2014, BRIT MED BULL, V109, P73, DOI 10.1093/bmb/ldu001; Galitzky J, 2013, CELL METAB, V18, P3, DOI 10.1016/j.cmet.2013.06.008; Gergerlioglu HS, 2016, LIFE SCI, V148, P279, DOI 10.1016/j.lfs.2016.02.011; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Glastras SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162131; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Hallsworth K, 2015, CLIN SCI, V129, P1097, DOI 10.1042/CS20150308; Hare BD, 2014, NEUROPSYCHOPHARMACOL, V39, P1262, DOI 10.1038/npp.2013.329; Hicks JA, 2016, BEHAV BRAIN RES, V310, P1, DOI 10.1016/j.bbr.2016.04.051; Higgins JA, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-49; Jacks DE, 2002, J STRENGTH COND RES, V16, P286, DOI 10.1519/00124278-200205000-00018; Jankord R, 2008, APPL PHYSIOL NUTR ME, V33, P461, DOI 10.1139/H08-022; Jones AB, 2016, BEHAV BRAIN RES, V311, P279, DOI 10.1016/j.bbr.2016.05.058; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Lee SH, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010401; Legendre A, 2006, AM J PHYSIOL-REG I, V291, pR1288, DOI 10.1152/ajpregu.00234.2006; Li CT, 2015, BEHAV BRAIN RES, V288, P39, DOI 10.1016/j.bbr.2015.04.007; Manolopoulos Konstantinos, 2015, Lancet, V385 Suppl 1, pS63, DOI 10.1016/S0140-6736(15)60378-6; Martins C, 2016, INT J SPORT NUTR EXE, V26, P197, DOI 10.1123/ijsnem.2015-0078; Miller DB, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.33184; Morris RT, 2008, J APPL PHYSIOL, V104, P708, DOI 10.1152/japplphysiol.01034.2007; Motta VF, 2016, J SPORT MED PHYS FIT, V56, P655; Muniyappa R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1023, DOI 10.1152/ajpendo.00397.2009; Patterson ZR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00130; Pimenta M, 2015, LIFE SCI, V139, P75, DOI 10.1016/j.lfs.2015.08.004; Rose AJ, 2010, J STEROID BIOCHEM, V122, P10, DOI 10.1016/j.jsbmb.2010.02.010; Sene-Fiorese M, 2008, OBESITY, V16, P2217, DOI 10.1038/oby.2008.339; Shen YQ, 2015, OBESITY, V23, P1000, DOI 10.1002/oby.21056; Shin AC, 2010, INT J OBESITY, V34, P1218, DOI 10.1038/ijo.2010.34; Shpilberg Y, 2012, DIS MODEL MECH, V5, P671, DOI 10.1242/dmm.008912; Sivanathan S, 2015, BEHAV BRAIN RES, V286, P265, DOI 10.1016/j.bbr.2015.02.036; Smith-Ryan AE, 2016, J SPORT SCI, V34, P2038, DOI 10.1080/02640414.2016.1149609; Suzuki M, 2011, INT J SPORT NUTR EXE, V21, P222, DOI 10.1123/ijsnem.21.3.222; Thompson W. R., 2009, ACSMS GUIDELINES EXE; Touati S, 2011, MED SCI SPORT EXER, V43, P398, DOI 10.1249/MSS.0b013e3181eeb12d; Vicennati V, 2009, OBESITY, V17, P1678, DOI 10.1038/oby.2009.76; Wang Deng, 2015, Zhong Yao Cai, V38, P1919	50	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181684	10.1371/journal.pone.0181684	http://dx.doi.org/10.1371/journal.pone.0181684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727846	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500103
J	Zhou, AT; Wang, K; Fan, LP; Tao, B				Zhou, Aitao; Wang, Kai; Fan, Lingpeng; Tao, Bo			Propagation characteristics of pulverized coal and gas two-phase flow during an outburst	PLOS ONE			English	Article							SHOCK-WAVES; MINE; STABILIZATION; TECHNOLOGY; DRAINAGE; MODEL; SEAM	Coal and gas outbursts are dynamic failures that can involve the ejection of thousands tons of pulverized coal, as well as considerable volumes of gas, into a limited working space within a short period. The two-phase flow of gas and pulverized coal that occurs during an outburst can lead to fatalities and destroy underground equipment. This article examines the interaction mechanism between pulverized coal and gas flow. Based on the role of gas expansion energy in the development stage of outbursts, a numerical simulation method is proposed for investigating the propagation characteristics of the two-phase flow. This simulation method was verified by a shock tube experiment involving pulverized coal and gas flow. The experimental and simulated results both demonstrate that the instantaneous ejection of pulverized coal and gas flow can form outburst shock waves. These are attenuated along the propagation direction, and the volume fraction of pulverized coal in the two-phase flow has significant influence on attenuation of the outburst shock wave. As a whole, pulverized coal flow has a negative impact on gas flow, which makes a great loss of large amounts of initial energy, blocking the propagation of gas flow. According to comparison of numerical results for different roadway types, the attenuation effect of T-type roadways is best. In the propagation of shock wave, reflection and diffraction of shock wave interact through the complex roadway types.	[Zhou, Aitao; Wang, Kai; Fan, Lingpeng; Tao, Bo] China Univ Min & Technol Beijing, Beijing Key Lab Precise Min Intergrown Energy & R, Beijing, Peoples R China; [Zhou, Aitao; Wang, Kai; Fan, Lingpeng; Tao, Bo] China Univ Min & Technol Beijing, Sch Resource & Safety Engn, Beijing, Peoples R China	China University of Mining & Technology; China University of Mining & Technology	Wang, K (corresponding author), China Univ Min & Technol Beijing, Beijing Key Lab Precise Min Intergrown Energy & R, Beijing, Peoples R China.; Wang, K (corresponding author), China Univ Min & Technol Beijing, Sch Resource & Safety Engn, Beijing, Peoples R China.	kaiwang@cumtb.edu.cn			State Key Research Development Program of China [2016YFC0801402]; National Natural Science Foundation of China [51474219]	State Key Research Development Program of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by the State Key Research Development Program of China (grant no. 2016YFC0801402), National Natural Science Foundation of China (grant no. 51474219). Thank you again for your consideration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FH, 2013, COMPUT GEOTECH, V54, P222, DOI 10.1016/j.compgeo.2013.07.013; [程五一 Cheng Wuyi], 2004, [煤炭学报, Journal of China Coal Society], V29, P57; Guo HJ, 2016, J NAT GAS SCI ENG, V33, P867, DOI 10.1016/j.jngse.2016.06.033; Jiang J.J., 2015, PLOS ONE, V10; Jiang JY, 2015, J NAT GAS SCI ENG, V24, P412, DOI 10.1016/j.jngse.2015.04.001; Otuonye F, 1994, GEOTECH GEOL ENG, V12, P15; Peng SJ, 2012, SAFETY SCI, V50, P816, DOI 10.1016/j.ssci.2011.08.027; Sobczyk J, 2014, FUEL, V115, P288, DOI 10.1016/j.fuel.2013.07.016; Tang J, 2016, J NAT GAS SCI ENG, V34, P412, DOI 10.1016/j.jngse.2016.07.010; Wang K, 2012, SAFETY SCI, V50, P835, DOI 10.1016/j.ssci.2011.08.024; Yang W, 2012, TUNN UNDERGR SP TECH, V31, P139, DOI 10.1016/j.tust.2012.04.015; Yuan L, 2016, J ROCK MECH GEOTECH, V8, P559, DOI 10.1016/j.jrmge.2016.01.005; Zhao W, 2017, POWDER TECHNOL, V305, P39, DOI 10.1016/j.powtec.2016.09.047; Zhou AT, 2017, J LOSS PREVENT PROC, V47, P104, DOI 10.1016/j.jlp.2017.02.014; Zhou A, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6564-2; Zhou AT, 2016, J NAT GAS SCI ENG, V35, P720, DOI 10.1016/j.jngse.2016.09.021; Zhou AT, 2015, INT J MIN SCI TECHNO, V25, P106, DOI 10.1016/j.ijmst.2014.12.009; Zhou AT, 2014, INT J MIN SCI TECHNO, V24, P23, DOI 10.1016/j.ijmst.2013.12.005; Zhou HX, 2014, J NAT GAS SCI ENG, V20, P357, DOI 10.1016/j.jngse.2014.07.023	19	7	7	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180672	10.1371/journal.pone.0180672	http://dx.doi.org/10.1371/journal.pone.0180672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727738	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500027
J	Ben El Haj, R; Salmi, A; Regragui, W; Moussa, A; Bouslam, N; Tiber, H; Benomar, A; Yahyaoui, M; Bouhouche, A				Ben El Haj, Rafiqua; Salmi, Ayyoub; Regragui, Wafa; Moussa, Ahmed; Bouslam, Naima; Tiber, Houyam; Benomar, Ali; Yahyaoui, Mohamed; Bouhouche, Ahmed			Evidence for prehistoric origins of the G2019S mutation in the North African Berber population	PLOS ONE			English	Article							PARKINSONS-DISEASE PATIENTS; Y-CHROMOSOME; LRRK2 G2019S; PATERNAL LINEAGES; GENE; PHYLOGEOGRAPHY; IDENTIFICATION; HAPLOGROUPS; FOOTPRINTS; COUNTRIES	The most common cause of the monogenic form of Parkinson's disease known so far is the G2019S mutation of the leucine-rich repeat kinase 2 (LRRK2) gene. Its frequency varies greatly among ethnic groups and geographic regions ranging from less than 0.1% in Asia to 40% in North Africa. This mutation has three distinct haplotypes; haplotype 1 being the oldest and most common. Recent studies have dated haplotype 1 of the G2019S mutation to about 4000 years ago, but it remains controversial whether the mutation has a Near-Eastern or Moroccan-Berber ancestral origin. To decipher this evolutionary history, we genotyped 10 microsatellite markers spanning a region of 11.27 Mb in a total of 57 unrelated Moroccan PD patients carrying the G2019S mutation for which the Berber or Arab origin was established over 3 generations based on spoken language. We estimated the age of the most recent common ancestor for the 36 Arab-speaking and the 15 Berber-speaking G2019S carriers using the likelihood-based method with a mutation rate of 10(-4). Data analysis suggests that the shortest haplotype originated in a patient of Berber ethnicity. The common founder was estimated to have lived 159 generations ago (95% CI 116-224) for Arab patients, and 200 generations ago (95% CI 123-348) for Berber patients. Then, 29 native North African males carrying the mutation were assessed for specific uniparental markers by sequencing the Y-chromosome (E-M81, E-M78, and M-267) and mitochondrial DNA (mtDNA) hypervariable regions (HV1 and HV2) to examine paternal and maternal contributions, respectively. Results showed that the autochthonous genetic component reached 76% for mtDNA (Eurasian and north African haplogroups) and 59% for the Y-chromosome (E-M81 and E-M78), suggesting that the G2019S mutation may have arisen in an autochthonous DNA pool. Therefore, we conclude that LRRK2 G2019S mutation most likely originated in a Berber founder who lived at least 5000 years ago (95% CI 3075-8700).	[Ben El Haj, Rafiqua; Regragui, Wafa; Tiber, Houyam; Benomar, Ali; Yahyaoui, Mohamed; Bouhouche, Ahmed] Mohammed V Univ, Med Sch & Pharm, Genom Ctr Human Pathol, Res Team Neurol & Neurogenet, Rabat, Morocco; [Salmi, Ayyoub; Moussa, Ahmed] Abdelmalek Essaadi Univ, Natl Sch Appl Sci, Lab Informat & Commun Technol, Tanger, Morocco; [Regragui, Wafa; Bouslam, Naima; Tiber, Houyam; Benomar, Ali; Yahyaoui, Mohamed; Bouhouche, Ahmed] IBN Sina Univ, Specialties Hosp, Hosp Ctr, Dept Neurol & Neurogenet, Rabat, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Abdelmalek Essaadi University of Tetouan; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Bouhouche, A (corresponding author), Mohammed V Univ, Med Sch & Pharm, Genom Ctr Human Pathol, Res Team Neurol & Neurogenet, Rabat, Morocco.; Bouhouche, A (corresponding author), IBN Sina Univ, Specialties Hosp, Hosp Ctr, Dept Neurol & Neurogenet, Rabat, Morocco.	a.bouhouche@um5s.net.ma	Moussa, Ahmed/AAI-1351-2020	Moussa, Ahmed/0000-0003-1628-8179; Salmi, Ayyoub/0000-0003-1332-8534; Bouhouche, Ahmed/0000-0001-5279-8649	"Centre National de Recherche Scientifique et Technique" (CNRST) of "Ministere de l'Enseignement Superieur, de la Recherche Scientifique et de la Formation des Cadres" (MESRSFC); Mohammed V University in Rabat, Morocco [UM5R]	"Centre National de Recherche Scientifique et Technique" (CNRST) of "Ministere de l'Enseignement Superieur, de la Recherche Scientifique et de la Formation des Cadres" (MESRSFC); Mohammed V University in Rabat, Morocco	This work was supported by the "Centre National de Recherche Scientifique et Technique" (CNRST) of "Ministere de l'Enseignement Superieur, de la Recherche Scientifique et de la Formation des Cadres" (MESRSFC) and the Mohammed V University in Rabat (UM5R), Morocco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboukhalid R, 2013, INT J LEGAL MED, V127, P757, DOI 10.1007/s00414-012-0813-4; Abu-Amero KK, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-59; Al-Mubarak BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135950; Al-Zahery N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-288; Alamri Y, 2015, EUR NEUROL, V74, P222, DOI 10.1159/000442283; Allouche-Benayoun J, 1989, JUIFS ALGERIE MEMOIR; Ayoun R, 1982, JIFS ALGERIE DEUX MI, P27; Bar-Shira A, 2009, NEUROGENETICS, V10, P355, DOI 10.1007/s10048-009-0186-0; Bekada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056775; Ben-Sasson HH, 1976, HIST JEWISH PEOPLE; Benamer HTS, 2010, EUR NEUROL, V63, P321, DOI 10.1159/000279653; Bokbot Y, 2008, ETUDES ANTIQUITES AF, V1, P21; Bonifati Vincenzo, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS23, DOI 10.1016/S1353-8020(13)70009-9; Bouhouche A, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/2412486; Campbell CL, 2012, P NATL ACAD SCI USA, V109, P13865, DOI 10.1073/pnas.1204840109; Capelli C, 2009, EUR J HUM GENET, V17, P848, DOI 10.1038/ejhg.2008.258; Change N, 2008, GENET TEST, V12, P333, DOI 10.1089/gte.2007.0098; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Coudray C, 2009, ANN HUM GENET, V73, P196, DOI 10.1111/j.1469-1809.2008.00493.x; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Dieterlen F, 2010, INT J MOD ANTHROP, V3, P81; DONNELLY P, 1986, ADV APPL PROBAB, V18, P1, DOI 10.2307/1427237; El-Desoky E. S., 2015, British Journal of Medicine and Medical Research, V5, P404, DOI 10.9734/BJMMR/2015/10458; Fadhlaoui-Zid K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080293; Falk R, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00462; Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Hashad DI, 2011, GENET TEST MOL BIOMA, V15, P861, DOI 10.1089/gtmb.2011.0016; Healy D G, 2008, Pract Neurol, V8, P381, DOI 10.1136/jnnp.2008.162420; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Huang QY, 2002, AM J HUM GENET, V70, P625, DOI 10.1086/338997; Ibn Khaldoun, 1978, HIST BERBERES DYNAST; Kefi R, 2005, ANTHROPOL-INT J HUM, V43, P1; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lesage S, 2005, AM J HUM GENET, V77, P330, DOI 10.1086/432422; Lesage S, 2010, HUM MOL GENET, V19, P1998, DOI 10.1093/hmg/ddq081; Levin BC, 1999, GENOMICS, V55, P135, DOI 10.1006/geno.1998.5513; Li JQ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-47; Lucotte G., 2012, INT J MOD ANTHR, V1, P11, DOI [10.4314/ijma.v1i5.1, DOI 10.4314/IJMA.V1I5.1]; Nebel A, 2002, AM J HUM GENET, V70, P1594, DOI 10.1086/340669; Nebot D, 2004, TRIBUS OUBLIEES ISRA; Nebot D., LA KAHENA; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Pirkevi C, 2009, NEUROGENETICS, V10, P271, DOI 10.1007/s10048-009-0173-5; Reguig A, 2014, HUM BIOL, V86, P105, DOI 10.3378/027.086.0204; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Schulte C, 2011, APPL CLIN GENET, V4, P67, DOI 10.2147/TACG.S11639; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Sierra M, 2011, MOVEMENT DISORD, V26, P2343, DOI 10.1002/mds.23965; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tomiyama H, 2006, MOVEMENT DISORD, V21, P1102, DOI 10.1002/mds.20886; Triki-Fendri S, 2016, AM J HUM BIOL, V28, P203, DOI 10.1002/ajhb.22773; Triki-Fendri S, 2015, AM J PHYS ANTHROPOL, V157, P242, DOI 10.1002/ajpa.22705; Turchi C, 2009, FORENSIC SCI INT-GEN, V3, P166, DOI 10.1016/j.fsigen.2009.01.014; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Warren L, 2008, PARKINSONISM RELAT D, V14, P77, DOI 10.1016/j.parkreldis.2007.02.001; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Zabetian CP, 2006, NEUROLOGY, V67, P697, DOI 10.1212/01.wnl.0000227732.37801.d4; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012	61	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181335	10.1371/journal.pone.0181335	http://dx.doi.org/10.1371/journal.pone.0181335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723952	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800043
J	Tanos, T; Saibene, AM; Pipolo, C; Battaglia, P; Felisati, G; Rubio, A				Tanos, Tamara; Saibene, Alberto Maria; Pipolo, Carlotta; Battaglia, Paolo; Felisati, Giovanni; Rubio, Alicia			Isolation of putative stem cells present in human adult olfactory mucosa	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; HORIZONTAL BASAL-CELLS; MEMBRANE GLYCOPROTEIN; SELF-RENEWAL; IN-VITRO; EPITHELIUM; REGENERATION; EXPRESSION; BRAIN; NICHE	The olfactory mucosa (OM) has the unique characteristic of performing an almost continuous and lifelong neurogenesis in response to external injuries, due to the presence of olfactory stem cells that guarantee the maintenance of the olfactory function. The easy accessibility of the OM in humans makes these stem cells feasible candidates for the development of regenerative therapies. In this report we present a detailed characterization of a patient-derived OM, together with a description of cell cultures obtained from the OM. In addition, we present a method for the enrichment and isolation of OM stem cells that might be used for future translational studies dealing with neuronal plasticity, neuro-regeneration or disease modeling.	[Tanos, Tamara; Rubio, Alicia] Ist Europeo Oncol, Milan, Italy; [Saibene, Alberto Maria; Pipolo, Carlotta; Felisati, Giovanni] Univ Milan, Otolaryngol Unit, ASST Santi Paolo & Carlo, Dept Hlth Sci, Milan, Italy; [Battaglia, Paolo] Univ Insubria, Otolaryngol Unit, Varese, Italy; [Tanos, Tamara] InSphero AG, Wagistr 27, Zurich, Switzerland; [Rubio, Alicia] Ist Sci San Raffaele, Stem Cells & Neurogenesis Res Unit, Div Neurosci, Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Milan; University of Insubria; InSphero AG; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Rubio, A (corresponding author), Ist Europeo Oncol, Milan, Italy.; Felisati, G (corresponding author), Univ Milan, Otolaryngol Unit, ASST Santi Paolo & Carlo, Dept Hlth Sci, Milan, Italy.; Rubio, A (corresponding author), Ist Sci San Raffaele, Stem Cells & Neurogenesis Res Unit, Div Neurosci, Milan, Italy.	giovanni.felisati@unimi.it; rubiogarrido.alicia@hsr.it	felisati, giovanni/AAW-2724-2021; rubio, alicia/I-7487-2018; Battaglia, Paolo/AAT-7742-2020; Pipolo, Carlotta/AAA-3425-2022; Saibene, Alberto Maria/H-7702-2019	felisati, giovanni/0000-0001-6763-4305; rubio, alicia/0000-0003-0897-4806; Saibene, Alberto Maria/0000-0003-1457-6871; Tanos, Tamara/0000-0002-3217-3104; PIPOLO, GIORGIA CARLOTTA/0000-0001-6628-2117	"Instituto de Salud Carlos III"	"Instituto de Salud Carlos III"(Instituto de Salud Carlos III)	The authors received no specific funding for this work. A.R. had a postdoctoral fellowship Sara Borrell from the "Instituto de Salud Carlos III."	Borgmann-Winter K, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.141; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; COSTANZO RM, 1985, BRAIN RES, V361, P258, DOI 10.1016/0006-8993(85)91297-1; COSTANZO RM, 1984, BRAIN RES, V307, P295, DOI 10.1016/0006-8993(84)90483-9; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; Fjorback AW, 2009, J MOL NEUROSCI, V37, P191, DOI 10.1007/s12031-008-9092-4; Fletcher RB, 2011, NEURON, V72, P748, DOI 10.1016/j.neuron.2011.09.009; Fuchsova B, 2015, NEUROSCIENCE, V299, P1, DOI 10.1016/j.neuroscience.2015.04.057; Garcia-Escudero V, 2015, J CELL MOL MED, V19, P1284, DOI 10.1111/jcmm.12488; Garcia-Escudero V, 2012, NEUROSCI LETT, V509, P27, DOI 10.1016/j.neulet.2011.12.037; Guo Z, 2010, J COMP NEUROL, V518, P4395, DOI 10.1002/cne.22463; HAAN EA, 1982, P NATL ACAD SCI-BIOL, V79, P7585, DOI 10.1073/pnas.79.23.7585; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Holbrook EH, 2011, LARYNGOSCOPE, V121, P1687, DOI 10.1002/lary.21856; Hruska M, 2012, MOL CELL NEUROSCI, V50, P35, DOI 10.1016/j.mcn.2012.03.004; Iwai N, 2008, STEM CELLS, V26, P1298, DOI 10.1634/stemcells.2007-0891; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Krolewski RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051737; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Lindsay SL, 2016, NEUROCHEMISTRY INT; Lindsay SL, 2013, GLIA, V61, P368, DOI 10.1002/glia.22440; Mackay-Sim A, 2010, ARCH ITAL BIOL, V148, P47; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MORRISON EE, 1990, J COMP NEUROL, V297, P1, DOI 10.1002/cne.902970102; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; Murrell W, 2008, STEM CELLS, V26, P2183, DOI 10.1634/stemcells.2008-0074; Murrell W, 2009, SPINE J, V9, P585, DOI 10.1016/j.spinee.2009.02.011; NAKASHIMA T, 1984, ARCH OTOLARYNGOL, V110, P641; PAIK SI, 1992, ARCH OTOLARYNGOL, V118, P731; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Qin FX, 2015, SCI REP-UK, V5, DOI 10.1038/srep14430; Salgado AJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00249; Sensenbrenner M, 1997, J MOL MED-JMM, V75, P653, DOI 10.1007/s001090050149; Tome M, 2009, STEM CELLS, V27, P2196, DOI 10.1002/stem.130; Tosoni D, 2015, J CELL BIOL, V211, P845, DOI 10.1083/jcb.201505037; VINORES SA, 1984, CANCER RES, V44, P2595; Whitlock KE, 2004, BRAIN BEHAV EVOLUT, V64, P126, DOI 10.1159/000079742; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Xu Y, 2010, NEUROSCI BULL, V26, P474, DOI 10.1007/s12264-010-0730-9; YAMAGISHI M, 1989, ANN OTO RHINOL LARYN, V98, P384, DOI 10.1177/000348948909800514; Yee KK, 2010, AM J RHINOL ALLERGY, V24, P110, DOI 10.2500/ajra.2010.24.3435	43	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181151	10.1371/journal.pone.0181151	http://dx.doi.org/10.1371/journal.pone.0181151			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719644	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400034
J	Welsch, N; Lyon, LA				Welsch, Nicole; Lyon, L. Andrew			Oligo(ethylene glycol)-sidechain microgels prepared in absence of cross-linking agent: Polymerization, characterization and variation of particle deformability	PLOS ONE			English	Article							FREE-RADICAL POLYMERIZATION; N-ISOPROPYLACRYLAMIDE; POLY(ETHYLENE GLYCOL); MECHANICAL-PROPERTIES; RESPONSIVE MICROGELS; PORE SENSOR; POLYMERS; NANOPARTICLES; BIOMATERIALS; SUSPENSIONS	We present a systematic study of self-cross-linked microgels formed by precipitation polymerization of oligo ethylene glycol methacrylates. The cross-linking density of these microgels and, thus, the network flexibility can be easily tuned through the modulation of the reaction temperature during polymerization. Microgels prepared in absence of any difunctional monomer, i.e. cross-linker, show enhanced deformability and particle spreading on solid surfaces as compared to microgels cross-linked with varying amounts of poly(ethylene glycol diacrylate) (PEG-DA) in addition to self-crosslinking. Particles prepared at low reaction temperatures exhibit the highest degree of spreading due to the lightly cross-linked and flexible polymer network. Moreover, AFM force spectroscopy studies suggest that cross-linker-free microgels constitute of a more homogeneous polymer network than PEG-DA cross-linked particles and have elastic moduli at the particle apex that are similar to 5 times smaller than the moduli of 5 mol-% PEG-DA cross-linked microgels. Resistive pulse sensing experiments demonstrate that microgels prepared at 75 and 80 degrees C without PEG-DA are able to deform significantly to pass through nanopores that are smaller than the microgel size. Additionally, we found that polymer network flexibility of microgels is a useful tool to control the formation of particle dewetting patterns. This offers a promising new avenue for build-up of 2D self-assembled particle structures with patterned chemical and mechanical properties.	[Welsch, Nicole; Lyon, L. Andrew] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Lyon, L. Andrew] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Lyon, L. Andrew] Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Chapman University System; Chapman University	Lyon, LA (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; Lyon, LA (corresponding author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.; Lyon, LA (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA.	lyon@chapman.edu	Lyon, Andrew/A-4082-2009	Lyon, Andrew/0000-0001-7828-7345	German Research Foundation (DFG) [WE 5485/1-1]; National Institute of Health [R01HL130918]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130918] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work received support from the National Institute of Health (R01HL130918); URL: https://www.nih.gov/ and the German Research Foundation (DFG, WE 5485/1-1); URL:http://www. dfg.de/.; Viscometry experiments were performed in the laboratories of A. Fernandez-Nieves, to whom we are extremely grateful for his assistance. We thank Dr. Molla Islam for helpful discussions regarding this work. Financial support from the German Research Foundation (DFG, WE 5485/1-1) and the National Institute of Health (R01HL130918) is gratefully acknowledged.	Bachman H, 2015, SOFT MATTER, V11, P2018, DOI 10.1039/c5sm00047e; Bakaic E, 2015, RSC ADV, V5, P35469, DOI 10.1039/c4ra13581d; Balaceanu A, 2011, MACROMOLECULES, V44, P2161, DOI 10.1021/ma200103y; Barth J, 2010, MACROMOLECULES, V43, P4023, DOI 10.1021/ma1006039; BATCHELOR GK, 1977, J FLUID MECH, V83, P97, DOI 10.1017/S0022112077001062; Brown AC, 2014, NAT MATER, V13, P1108, DOI [10.1038/nmat4066, 10.1038/NMAT4066]; Burmistrova A, 2011, COLLOID POLYM SCI, V289, P613, DOI 10.1007/s00396-011-2383-2; Carlsson L, 2010, SOFT MATTER, V6, P3619, DOI 10.1039/c0sm00009d; Chua GBH, 2012, MACROMOLECULES, V45, P1362, DOI 10.1021/ma202700y; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Dong HC, 2010, MACROMOLECULES, V43, P4623, DOI 10.1021/ma100570s; Gao J, 2003, LANGMUIR, V19, P5217, DOI 10.1021/la034207s; Gao J, 2003, LANGMUIR, V19, P5212, DOI 10.1021/la0269762; Gaulding JC, 2013, POLYM CHEM-UK, V4, P4890, DOI 10.1039/c3py00173c; Gawlitza K, 2014, POLYMER, V55, P6717, DOI 10.1016/j.polymer.2014.10.069; Gawlitza K, 2012, Z PHYS CHEM, V226, P749, DOI 10.1524/zpch.2012.0271; Geoghegan M, 2003, PROG POLYM SCI, V28, P261, DOI 10.1016/S0079-6700(02)00080-1; Gu LM, 2001, MACROMOL RAPID COMM, V22, P212, DOI 10.1002/1521-3927(200102)22:3<212::AID-MARC212>3.0.CO;2-B; Guan Y, 2011, SOFT MATTER, V7, P6375, DOI 10.1039/c0sm01541e; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hashmi SM, 2009, SOFT MATTER, V5, P3682, DOI 10.1039/b906051k; Higgins MJ, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2162455; Hu ZB, 2010, SOFT MATTER, V6, P2115, DOI 10.1039/b921150k; Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956; Junkers T, 2008, J POLYM SCI POL CHEM, V46, P7585, DOI 10.1002/pola.23071; Kozak D, 2012, CHEM LETT, V41, P1134, DOI 10.1246/cl.2012.1134; Kozak D, 2012, ACS NANO, V6, P6990, DOI 10.1021/nn3020322; Lapeyre V, 2006, BIOMACROMOLECULES, V7, P3356, DOI 10.1021/bm060588n; Lee TY, 2004, POLYMER, V45, P6155, DOI 10.1016/j.polymer.2004.06.060; Liu RX, 2012, SOFT MATTER, V8, P10932, DOI 10.1039/c2sm26522b; Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706; Lutz JF, 2007, MACROMOLECULES, V40, P8540, DOI 10.1021/ma7021474; Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n; Lyon LA, 2012, ANNU REV PHYS CHEM, V63, P25, DOI 10.1146/annurev-physchem-032511-143735; Martin CP, 2004, NANO LETT, V4, P2389, DOI 10.1021/nl048536w; MCPHEE W, 1993, J COLLOID INTERF SCI, V156, P24, DOI 10.1006/jcis.1993.1075; Merkel TJ, 2011, P NATL ACAD SCI USA, V108, P586, DOI 10.1073/pnas.1010013108; Moad G, 2008, ACCOUNTS CHEM RES, V41, P1133, DOI 10.1021/ar800075n; Nayak S, 2005, ANGEW CHEM INT EDIT, V44, P7686, DOI 10.1002/anie.200501321; Qiao ZY, 2010, MACROMOLECULES, V43, P6485, DOI 10.1021/ma101090g; Saunders BR, 2009, ADV COLLOID INTERFAC, V147-48, P251, DOI 10.1016/j.cis.2008.08.008; Saxena S, 2014, ACCOUNTS CHEM RES, V47, P2426, DOI 10.1021/ar500131v; Saxena S, 2014, SOFT MATTER, V10, P1356, DOI 10.1039/c3sm52518j; SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R; Schmidt S, 2010, ADV FUNCT MATER, V20, P3235, DOI 10.1002/adfm.201000730; Senff H, 2000, COLLOID POLYM SCI, V278, P830, DOI 10.1007/s003960000329; Smith MH, 2012, ACCOUNTS CHEM RES, V45, P985, DOI 10.1021/ar200216f; Smith MH, 2011, J PHYS CHEM B, V115, P3761, DOI 10.1021/jp111634k; South AB, 2010, CHEM MATER, V22, P3300, DOI 10.1021/cm100702p; South AB, 2009, ACS APPL MATER INTER, V1, P2747, DOI 10.1021/am9005435; Stieger M, 2004, J CHEM PHYS, V120, P6197, DOI 10.1063/1.1665752; Tsutsui M, 2012, ACS NANO, V6, P3499, DOI 10.1021/nn300530b; Vancoillie G, 2014, PROG POLYM SCI, V39, P1074, DOI 10.1016/j.progpolymsci.2014.02.005; Virtanen OLJ, 2016, SOFT MATTER, V12, P3919, DOI 10.1039/c6sm00140h; Vogel R, 2011, ANAL CHEM, V83, P3499, DOI 10.1021/ac200195n; Voudouris P, 2013, SOFT MATTER, V9, P7158, DOI 10.1039/c3sm50917f; Wang W, 2010, CHEM ENG TECHNOL, V33, P1745, DOI 10.1002/ceat.201000234; Wang Y, 2013, BIOMACROMOLECULES, V14, P3034, DOI 10.1021/bm401131w; Webster R, 2009, MILESTONES DRUG THER, P127, DOI 10.1007/978-3-7643-8679-5_8; Welsch N, 2009, J PHYS CHEM B, V113, P16039, DOI 10.1021/jp907508w; Wiedemair J, 2007, LANGMUIR, V23, P130, DOI 10.1021/la061288u; Wu WT, 2010, ACS NANO, V4, P4831, DOI 10.1021/nn1008319; WU X, 1994, COLLOID POLYM SCI, V272, P467, DOI 10.1007/BF00659460; Xu YH, 2008, J CHROMATOGR A, V1191, P40, DOI 10.1016/j.chroma.2008.01.051; Yao ZL, 2013, SOFT MATTER, V9, P5319, DOI 10.1039/c3sm50374g	65	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181369	10.1371/journal.pone.0181369	http://dx.doi.org/10.1371/journal.pone.0181369			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719648	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400042
J	Xie, DL; Zheng, MM; Zheng, Y; Gao, H; Zhang, J; Zhang, T; Guo, JC; Yang, XF; Zhong, XP; Lou, YL				Xie, Dan-Li; Zheng, Meng-Meng; Zheng, Yi; Gao, Hui; Zhang, Jie; Zhang, Ting; Guo, Jian-Chun; Yang, X. Frank; Zhong, Xiao-Ping; Lou, Yong-Liang			Vibrio vulnificus induces mTOR activation and inflammatory responses in macrophages	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; SCLEROSIS COMPLEX 1; KAPPA-B PATHWAY; PATHOGEN RECOGNITION; MAMMALIAN TARGET; INNATE IMMUNITY; MARINE VIBRIO; DISEASE; INFECTION; LIVER	Vibrio vulnificus (V. vulnificus), a Gram-negative marine bacterium, can cause life-threatening primary septicemia, especially in patients with liver diseases. How V. vulnificus affects the liver and how it acts on macrophages are not well understood. In this report, we demonstrated that V. vulnificus infection causes a strong inflammatory response, marked expansion of liver-resident macrophages, and liver damage in mice. We demonstrated further that V. vulnificus activates mTOR in macrophages and inhibition of mTOR differentially regulates V. vulnificus induced inflammatory responses, suggesting the possibility of targeting mTOR as a strategy to modulate V. vulnificus induced inflammatory responses.	[Xie, Dan-Li; Zheng, Meng-Meng; Zheng, Yi; Gao, Hui; Guo, Jian-Chun; Zhong, Xiao-Ping; Lou, Yong-Liang] Wenzhou Med Univ, Dept Microbiol & Immunol, Sch Lab Med, Wenzhou, Zhejiang, Peoples R China; [Xie, Dan-Li; Zheng, Yi; Zhong, Xiao-Ping; Lou, Yong-Liang] China Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zhang, Jie] Sichuan Prov Peoples Hosp, Dept Clin Lab Med, Chengdu, Sichuan, Peoples R China; [Zhang, Ting] Fudan Univ, Dept Lab Med, Jinshan Hosp, Shanghai, Peoples R China; [Yang, X. Frank] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA	Wenzhou Medical University; Sichuan Provincial People's Hospital; Fudan University; Indiana University System; Indiana University Bloomington; Duke University	Zhong, XP; Lou, YL (corresponding author), Wenzhou Med Univ, Dept Microbiol & Immunol, Sch Lab Med, Wenzhou, Zhejiang, Peoples R China.; Zhong, XP; Lou, YL (corresponding author), China Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China.; Zhong, XP (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA.	xiaoping.zhong@duke.edu; lyl@wmu.edu.cn			National Natural Science Foundation Grant [31400763]; Zhejiang Provincial Natural Science Foundation [LY13H190007]; Zhejiang Provincial Medical Science Foundation [2015KYB238]; Zhejiang Provincial Top Key Discipline of Clinical Medicine (Laboratory Medicine); National Institute of Allergy and Infectious Diseases [R01 (AI101206)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101206] Funding Source: NIH RePORTER	National Natural Science Foundation Grant(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Medical Science Foundation; Zhejiang Provincial Top Key Discipline of Clinical Medicine (Laboratory Medicine); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by Chinese National Natural Science Foundation Grant (31400763 to DLX, https://urldefense.proofpoint.com/v2/url?u=http-3A www.nsfc.gov.cn-&d=DwIFAw&c=imBPVzF250nBgGmVOIcsiEgHoG1i6 YHLR0Sj_gZ4adc&r=S_JYpfDmLaCC5h9z1VA JNIjLauCLn5g6DAXa1EehYb0&m=XIUXuJN_RGRbtSLmM33ECqPzzDZGaLjTSBWV1zNYk&s=Ofe0f_WYMDZFIQCqNwlc9XPFZHx2ZqWbfK-vMyYrbDag&e=), Zhejiang Provincial Natural Science Foundation Grant (LY13H190007 to DLX, https://urldefense.proofpoint.com/v2/url?u=http-3A_www.zinsf.gov.cn_&d=DwIFAw&c= imBPVzF250nBgGmV0IcsiEgHoG1i6YHLR0Sj_ gZ4adc&r=S_JYpfDmLaCC5h9z1VAJNljLauCLn5 g6DAXa1EehYb0&m=,X1UXuJN_RGJRbtSLmM3 3ECqPzzZvZGaLjTSBWV1zNYk&s=K2ZgERc PVNiUyndwY4LhAspigWjqM5RyMwy_scnu 4bU&e=), Zhejiang Provincial Medical Science Foundation Grant (2015KYB238 to YZ, https://urldefense.proofpoint.com/v2/url?=http-3A_kj.zjwst.gov.cn_&d=DwIFAw&c=imBPVzF250nBgGmVOIcsIEgHoG1i6yHLR0Sj_gZ4adc&r=S_jypfDmLaCEgHoG1i6YHLROSi_gZ4adc&r=S_JYpfDmLaCC5h9z1VAJNILauCLn5g6DAXa1EehYn0&m=XIUXuJN_RGJBbtSLmM33ECqPzzZvZGaLjTSBWV1zNYk&s=WB6AuX6_w2TICh2hnlf24l30E1HSGfAGSdWd7RhEH1k&e=) and Open Fund of Zhejiang Provincial Top Key Discipline of Clinical Medicine (Laboratory Medicine,toXFY,https://urldefense.proofpoint.com/v2/ur1?u=http-3A_www.wmu.edu.cn_view.php-3Fid-3077e70089-2D5da6-2D11e5-2D11e5-2Dbc3f-2Ddd6031fe976&d=,DwlFAw&c=imBPVzF250nBgGMVOlcsiEgHoG!,v&c=imBPV7F250nE3gGmVOIcsiEgHoG1i6YHLR0Si_gZ4adc&r=G_JYpfDmLaCC5b9z1VAJ NljLauCLn5g6DAXal EehYb08,m,X1UXuJ RGJRbtSLmM33ECqpzzZvZGaLjTSBWV1zNYk&s= 6-arDcNi5NqGgPiXmJmMElAc45P0zwrK9BLP7u FI-DY&e=,), and The National Institute of Allergy and Infectious Diseases-R01 (AI101206 to XPZ, https://urldefense.proofpoint.com/v2/url?u-https-3A_projectreporter.nih.gov_project-5Finfo-5Fdetails.cfm=3Faid=3D9062374=26icde=3D34992657&d=DwlFAw&c=imBPVzF250nBgGmVOIcsiEgH0G1I6YHLR0Sj_gZ4adc&r=S_JYPfDmLaCC5h9z1VAJNIjLauCLn5g6DAXa1EehYb0&m=XIUXuJN_RGJRbtSLmM33ECqPzzaZvZGaLjTSBWV1zNYk&s=r9ZA99LrG01jRVyy7Sk6UwMXa7gVQa0zENQuubK4QGE&e=). Thefunders did not play a role in experimental design.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ali S, 2004, CELL BIOCHEM FUNCT, V22, P67, DOI 10.1002/cbf.1082; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BLAKE PA, 1979, NEW ENGL J MED, V300, P1, DOI 10.1056/NEJM197901043000101; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chapman NM, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00686; Deng WH, 2017, J IMMUNOL, V198, P492, DOI 10.4049/jimmunol.1501845; ELLINGTON EP, 1982, NEW ENGL J MED, V307, P1642; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Gorentla BK, 2011, BLOOD, V117, P4022, DOI 10.1182/blood-2010-08-300731; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gulig PA, 2005, J MICROBIOL, V43, P118; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jeong HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002581; Jiang Q, 2011, CANCER RES, V71, P4074, DOI 10.1158/0008-5472.CAN-10-3968; Kashimoto T, 2003, INFECT IMMUN, V71, P533, DOI 10.1128/IAI.71.1.533-535.2003; Kim K, 2015, INFECT IMMUN, V83, P1150, DOI 10.1128/IAI.02878-14; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee BC, 2010, INT J MOL MED, V25, P581, DOI 10.3892/ijmm_00000380; Lee SJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.19; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Lee SJ, 2015, J IMMUNOL, V195, P2282, DOI 10.4049/jimmunol.1500951; Liu XF, 2015, INFLAMMATION, V38, P1864, DOI 10.1007/s10753-015-0166-5; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Nazir Salik, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-214772; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Brien TF, 2012, ARCH IMMUNOL THER EX, V60, P173, DOI 10.1007/s00005-012-0171-4; Pan HJ, 2013, J IMMUNOL, V191, P699, DOI 10.4049/jimmunol.1201443; Pan HJ, 2012, J IMMUNOL, V188, P3658, DOI 10.4049/jimmunol.1102187; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Wang YY, 2013, P NATL ACAD SCI USA, V110, pE4894, DOI 10.1073/pnas.1308905110; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wu JH, 2014, J IMMUNOL, V192, P2643, DOI 10.4049/jimmunol.1302076; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	44	9	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181454	10.1371/journal.pone.0181454	http://dx.doi.org/10.1371/journal.pone.0181454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719654	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400047
J	Beamish, JA; Chen, E; Putnam, AJ				Beamish, Jeffrey A.; Chen, Evan; Putnam, Andrew J.			Engineered extracellular matrices with controlled mechanics modulate renal proximal tubular cell epithelialization	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; POLY(ETHYLENE GLYCOL) HYDROGELS; FOCAL ADHESION; DIACRYLATE HYDROGELS; MC3T3-E1 CELLS; PROLIFERATION; STIFFNESS; RIGIDITY; FIBROSIS; GROWTH	Acute kidney injury (AKI) is common and associated with significant morbidity and mortality. Recovery from many forms of AKI involves the proliferation of renal proximal tubular epithelial cells (RPTECs), but the influence of the microenvironment in which this recovery occurs remains poorly understood. Here we report the development of a poly(ethylene glycol) (PEG) hydrogel platform to study the influence of substrate mechanical properties on the proliferation of human RPTECs as a model for recovery from AKI. PEG diacrylate based hydrogels were generated with orthogonal control of mechanics and cell-substrate interactions. Using this platform, we found that increased substrate stiffness promotes RPTEC spreading and proliferation. RPTECs showed similar degrees of apoptosis and Yes-associated protein (YAP) nuclear localization regardless of stiffness, suggesting these were not key mediators of the effect. However, focal adhesion formation, cytoskeletal organization, focal adhesion kinase (FAK) activation, and extracellular signal-regulated kinase (ERK) activation were all enhanced with increasing substrate stiffness. Inhibition of ERK activation substantially attenuated the effect of stiffness on proliferation. In long-term culture, hydrogel stiffness promoted the formation of more complete epithelial monolayers with tight junctions, cell polarity, and an organized basement membrane. These data suggest that increased stiffness potentially may have beneficial consequences for the renal tubular epithelium during recovery from AKI.	[Beamish, Jeffrey A.] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Chen, Evan; Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Beamish, JA (corresponding author), Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA.; Putnam, AJ (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	jebeamish@med.umich.edu; putnam@umich.edu	Putnam, Andrew J./E-8643-2010	Putnam, Andrew J./0000-0002-1262-4377	University of Michigan O'Brien Kidney Center [DK-P30-081943]; NIH/NHLBI [R01-HL085339]; NIH [T32-DK007378]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK081943, T32DK007378] Funding Source: NIH RePORTER	University of Michigan O'Brien Kidney Center; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for this work was provided in part by the University of Michigan O'Brien Kidney Center (DK-P30-081943) and the NIH/NHLBI (R01-HL085339 to AJP). JAB was also supported by NIH T32-DK007378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderliesten M, 2007, AM J PATHOL, V171, P452, DOI 10.2353/ajpath.2007.060805; Anvari A, 2015, ABDOM IMAGING, V40, P709, DOI 10.1007/s00261-015-0383-2; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002; Beamish JA, 2010, J BIOMED MATER RES A, V92A, P441, DOI 10.1002/jbm.a.32353; Berger K, 2014, P NATL ACAD SCI USA, V111, P1533, DOI 10.1073/pnas.1316177111; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Brito PL, 1998, KIDNEY INT, V53, P754, DOI 10.1046/j.1523-1755.1998.00809.x; Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Chen WC, 2015, AM J PATHOL, V185, P2468, DOI 10.1016/j.ajpath.2015.05.019; Chen WC, 2014, AM J PHYSIOL-RENAL, V307, pF695, DOI 10.1152/ajprenal.00684.2013; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2010, CURR OPIN NEPHROL HY, V19, P266, DOI 10.1097/MNH.0b013e3283375538; Cuchiara MP, 2010, BIOMATERIALS, V31, P5491, DOI 10.1016/j.biomaterials.2010.03.031; Cummings BS, 2001, MEASUREMENT CELL DEA, DOI [10.1002/0471141755.ph1208s56, DOI 10.1002/0471141755.PH1208S56]; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kohn JC, 2016, J BIOMECH, V49, P1447, DOI 10.1016/j.jbiomech.2016.03.016; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Lin L, 2014, ACTA BIOMATER, V10, P5106, DOI 10.1016/j.actbio.2014.08.025; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Mih JD, 2012, J CELL SCI, V125, P5974, DOI 10.1242/jcs.108886; Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196; Morikawa H, 2011, J GASTROENTEROL, V46, P350, DOI 10.1007/s00535-010-0301-x; Orlacchio A, 2014, ULTRASOUND MED BIOL, V40, P2564, DOI 10.1016/j.ultrasmedbio.2014.06.002; Oxburgh L, 2017, J AM SOC NEPHROL, V28, P1370, DOI 10.1681/ASN.2016101077; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Qin Y, 2011, AM J PATHOL, V179, P2766, DOI 10.1016/j.ajpath.2011.08.025; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Samir AE, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0120-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh RK, 2013, BIOMATERIALS, V34, P9331, DOI 10.1016/j.biomaterials.2013.08.016; Wang YH, 2007, J BIOL CHEM, V282, P752, DOI 10.1074/jbc.M604801200; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; West MB, 2010, ARCH BIOCHEM BIOPHYS, V504, P177, DOI 10.1016/j.abb.2010.08.019; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044	56	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181085	10.1371/journal.pone.0181085	http://dx.doi.org/10.1371/journal.pone.0181085			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715434	Green Submitted, Green Published, gold			2022-12-27	WOS:000443975500026
J	Casillas-Espinosa, PM; Powell, KL; Zhu, MF; Campbell, CR; Maia, JM; Ren, Z; Jones, NC; O'Brien, TJ; Petrovski, S				Casillas-Espinosa, Pablo M.; Powell, Kim L.; Zhu, Mingfu; Campbell, C. Ryan; Maia, Jessica M.; Ren, Zhong; Jones, Nigel C.; O'Brien, Terence J.; Petrovski, Slave			Evaluating whole genome sequence data from the Genetic Absence Epilepsy Rat from Strasbourg and its related non-epileptic strain	PLOS ONE			English	Article							GENERALIZED EPILEPSY; SEIZURE EXPRESSION; MODEL; EPILEPTOGENESIS; MECHANISMS; PHENOTYPES; DISORDERS; CHILDREN; BEHAVIOR; STRESS	Objective The Genetic Absence Epilepsy Rats from Strasbourg (GAERS) are an inbreed Wistar rat strain widely used as a model of genetic generalised epilepsy with absence seizures. As in humans, the genetic architecture that results in genetic generalized epilepsy in GAERS is poorly understood. Here we present the strain-specific variants found among the epileptic GAERS and their related Non-Epileptic Control (NEC) strain. The GAERS and NEC represent a powerful opportunity to identify neurobiological factors that are associated with the genetic generalised epilepsy phenotype. Methods We performed whole genome sequencing on adult epileptic GAERS and adult NEC rats, a strain derived from the same original Wistar colony. We also generated whole genome sequencing on four double-crossed (GAERS with NEC) F-2 selected for high-seizing (n = 2) and non-seizing (n = 2) phenotypes. Results Specific to the GAERS genome, we identified 1.12 million single nucleotide variants, 296.5K short insertion-deletions, and 354 putative copy number variants that result in complete or partial loss/duplication of 41 genes. Of the GAERS-specific variants that met high quality criteria, 25 are annotated as stop codon gain/loss, 56 as putative essential splice sites, and 56 indels are predicted to result in a frameshift. Subsequent screening against the two F-2 progeny sequenced for having the highest and two F-2 progeny for having the lowest seizure burden identified only the selected Cacna1h GAERS-private protein-coding variant as exclusively co-segregating with the two high-seizing F-2 rats. Significance This study highlights an approach for using whole genome sequencing to narrow down to a manageable candidate list of genetic variants in a complex genetic epilepsy animal model, and suggests utility of this sequencing design to investigate other spontaneously occurring animal models of human disease.	[Casillas-Espinosa, Pablo M.; Powell, Kim L.; Jones, Nigel C.; O'Brien, Terence J.; Petrovski, Slave] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Zhu, Mingfu; Campbell, C. Ryan] Duke Univ, Sch Med, Durham, NC USA; [Maia, Jessica M.] BD Technol, Durham, NC USA; [Ren, Zhong; Petrovski, Slave] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10027 USA	Royal Melbourne Hospital; University of Melbourne; Duke University; Columbia University	Petrovski, S (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.; Petrovski, S (corresponding author), Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10027 USA.	slavep@unimelb.edu.au	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	O'Brien, Terence/0000-0002-7198-8621; Powell, Kim/0000-0002-9007-4614; Jones, Nigel/0000-0002-1080-8439	Melbourne Research Scholarship; NHMRC Project	Melbourne Research Scholarship; NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia)	Pablo M. Casillas-Espinosa was funded by a Melbourne Research Scholarship. Work for this project was supported in part by a NH&MRC Project Grant to Terence OBrien and Kim Powell and a R.D Wright Career Development Fellowship (1126877) to SP. The current affiliation of JMM, BD technologies, provides support in the form of salaries for JMM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arion D, 2006, NEUROBIOL DIS, V22, P374, DOI 10.1016/j.nbd.2005.12.012; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Danober L, 1998, PROG NEUROBIOL, V55, P27, DOI 10.1016/S0301-0082(97)00091-9; Depaulis A, 2016, J NEUROSCI METH, V260, P159, DOI 10.1016/j.jneumeth.2015.05.022; Dezsi G, 2013, EPILEPSIA, V54, P635, DOI 10.1111/epi.12118; DOOSE H, 1994, EUR J PEDIATR, V153, P372, DOI 10.1007/s004310050157; DOOSE H, 1973, EPILEPSIA, V14, P57, DOI 10.1111/j.1528-1157.1973.tb03942.x; Dwinell MR, 2009, NUCLEIC ACIDS RES, V37, pD744, DOI 10.1093/nar/gkn842; Edwards HE, 2002, EXP NEUROL, V175, P182, DOI 10.1006/exnr.2002.7874; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gardiner M, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.1528-1167.2005.00310.x; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goltvanitsa GA, 2012, ZH NEVROL PSIKHIATR, V112, P25; Hermsen R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1594-1; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Kaminski RM, 2011, NEUROPHARMACOLOGY, V61, P133, DOI 10.1016/j.neuropharm.2011.03.019; Koe AS, 2014, PSYCHONEUROENDOCRINO, V42, P124, DOI 10.1016/j.psyneuen.2014.01.009; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Leu C, 2012, EPILEPSIA, V53, P308, DOI 10.1111/j.1528-1167.2011.03379.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu LG, 2006, J PHARMACOL EXP THER, V319, P790, DOI 10.1124/jpet.106.104968; LOISEAU P, 1995, EPILEPSIA, V36, P1182, DOI 10.1111/j.1528-1157.1995.tb01060.x; Maggio N, 2012, EXP NEUROL, V234, P200, DOI 10.1016/j.expneurol.2011.12.035; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; MARESCAUX M, 1984, REV NEUROL-FRANCE, V140, P63; MICHELETTI G, 1987, EUR J PHARMACOL, V135, P397, DOI 10.1016/0014-2999(87)90690-X; MICHELETTI G, 1985, ARZNEIMITTELFORSCH, V35, P483; Ott D, 2003, EPILEPSIA, V44, P591, DOI 10.1046/j.1528-1157.2003.25002.x; Ott D, 2001, J AM ACAD CHILD PSY, V40, P907, DOI 10.1097/00004583-200108000-00012; Ottman R, 1997, EPIDEMIOL REV, V19, P120, DOI 10.1093/oxfordjournals.epirev.a017934; PORTER RJ, 1993, EPILEPSIA, V34, pS42; Powell KL, 2014, EPILEPSIA, V55, P1959, DOI 10.1111/epi.12840; Powell KL, 2009, J NEUROSCI, V29, P371, DOI 10.1523/JNEUROSCI.5295-08.2009; Racine RJ, 1999, EPILEPSY RES, V35, P183, DOI 10.1016/S0920-1211(99)00013-3; Rudolf G, 2004, EPILEPSIA, V45, P301, DOI 10.1111/j.0013-9580.2004.50303.x; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; Zheng T, 2009, EPILEPSIA, V50, P83, DOI 10.1111/j.1528-1167.2008.01759.x; Zhu MF, 2012, AM J HUM GENET, V91, P408, DOI 10.1016/j.ajhg.2012.07.004	43	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179924	10.1371/journal.pone.0179924	http://dx.doi.org/10.1371/journal.pone.0179924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708842	Green Published, gold			2022-12-27	WOS:000405649800009
J	Swainston, N; Batista-Navarro, R; Carbonell, P; Dobson, PD; Dunstan, M; Jervis, AJ; Vinaixa, M; Williams, AR; Ananiadou, S; Faulon, JL; Mendes, P; Kell, DB; Scrutton, NS; Breitling, R				Swainston, Neil; Batista-Navarro, Riza; Carbonell, Pablo; Dobson, Paul D.; Dunstan, Mark; Jervis, Adrian J.; Vinaixa, Maria; Williams, Alan R.; Ananiadou, Sophia; Faulon, Jean-Loup; Mendes, Pedro; Kell, Douglas B.; Scrutton, Nigel S.; Breitling, Rainer			biochem4j: Integrated and extensible biochemical knowledge through graph databases	PLOS ONE			English	Article							RESOURCE; ANNOTATION; WORKFLOWS; PATHWAYS; SERVICES; TAVERNA; MODEL; SBML	Biologists and biochemists have at their disposal a number of excellent, publicly available data resources such as UniProt, KEGG, and NCBI Taxonomy, which catalogue biological entities. Despite the usefulness of these resources, they remain fundamentally unconnected. While links may appear between entries across these databases, users are typically only able to follow such links by manual browsing or through specialised workflows. Although many of the resources provide web-service interfaces for computational access, performing federated queries across databases remains a non-trivial but essential activity in interdisciplinary systems and synthetic biology programmes. What is needed are integrated repositories to catalogue both biological entities and-crucially-the relationships between them. Such a resource should be extensible, such that newly discovered relationships-for example, those between novel, synthetic enzymes and non-natural products-can be added over time. With the introduction of graph databases, the barrier to the rapid generation, extension and querying of such a resource has been lowered considerably. With a particular focus on metabolic engineering as an illustrative application domain, biochem4j, freely available at http://biochem4j. org, is introduced to provide an integrated, queryable database that warehouses chemical, reaction, enzyme and taxonomic data from a range of reliable resources. The biochem4j framework establishes a starting point for the flexible integration and exploitation of an ever-wider range of biological data sources, from public databases to laboratory-specific experimental datasets, for the benefit of systems biologists, biosystems engineers and the wider community of molecular biologists and biological chemists.	[Swainston, Neil; Carbonell, Pablo; Dunstan, Mark; Jervis, Adrian J.; Vinaixa, Maria; Faulon, Jean-Loup; Kell, Douglas B.; Scrutton, Nigel S.; Breitling, Rainer] Univ Manchester, Manchester Inst Biotechnol, Manchester Ctr Synthet Biol Fine & Specialty Chem, Manchester, Lancs, England; [Batista-Navarro, Riza; Dobson, Paul D.; Williams, Alan R.; Ananiadou, Sophia] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Faulon, Jean-Loup] Univ Evry, Inst Syst & Synthet Biol, Evry, France; [Faulon, Jean-Loup; Kell, Douglas B.; Scrutton, Nigel S.; Breitling, Rainer] Univ Manchester, Sch Chem, Manchester, Lancs, England; [Mendes, Pedro] UConn Hlth, Ctr Quantitat Med, 263 Farmington Ave, Farmington, CT USA	University of Manchester; University of Manchester; UDICE-French Research Universities; Universite Paris Saclay; University of Manchester	Swainston, N (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester Ctr Synthet Biol Fine & Specialty Chem, Manchester, Lancs, England.	neil.swainston@manchester.ac.uk	Vinaixa, Maria/AAB-1176-2020; Batista-Navarro, Riza/ABD-6210-2021; Vinaixa, Maria/L-7236-2014; Carbonell, Pablo/A-3572-2011; Kell, Douglas/E-8318-2011	Vinaixa, Maria/0000-0001-9804-0171; Vinaixa, Maria/0000-0001-9804-0171; Carbonell, Pablo/0000-0002-0993-5625; Batista-Navarro, Riza/0000-0001-6693-7531; Dunstan, Mark/0000-0002-9416-5505; Kell, Douglas/0000-0001-5838-7963; Mendes, Pedro/0000-0001-6507-9168; Swainston, Neil/0000-0001-7020-1236; Breitling, Rainer/0000-0001-7173-0922; Faulon, Jean-Loup/0000-0003-4274-2953	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M017702/1]; BBSRC [BB/K019783/1, BB/M006891/1]; BBSRC [BB/M017702/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M006891/1, BB/M017702/1, BB/K019783/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	NS, PC, MD, AJJ, MV, ARW, J-LF, PM, DBK, NSS and RB acknowledge the funding from the Biotechnology and Biological Sciences Research Council (BBSRC; http://www.bbsrc.ac.uk) under grant BB/M017702/1, Centre for synthetic biology of fine and speciality chemicals (SYNBIOCHEM). NS, DBK and PM thank the BBSRC for funding under grant BB/K019783/1, Continued development of ChEBI towards better usability for the systems biology and metabolic modelling community. NS, RBN, PD, SA, DBK and PM thank the BBSRC for funding under grant BB/M006891/1, Enriching Metabolic PATHwaY models with evidence from the literature (EMPATHY).	Abouelhoda M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-77; Afendi FM, 2012, PLANT CELL PHYSIOL, V53, DOI 10.1093/pcp/pcr165; Alocci D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144578; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aziz RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048053; Balaur I, 2017, BIOINFORMATICS, V33, P1096, DOI 10.1093/bioinformatics/btw731; Brown M, 2009, ANALYST, V134, P1322, DOI 10.1039/b901179j; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Chang A, 2015, NUCLEIC ACIDS RES, V43, pD439, DOI 10.1093/nar/gku1068; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Currin A, 2015, CHEM SOC REV, V44, P1172, DOI 10.1039/c4cs00351a; Ellis LBM, 2006, NUCLEIC ACIDS RES, V34, pD517, DOI 10.1093/nar/gkj076; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Feher T, 2014, BIOTECHNOL J, V9, P1446, DOI 10.1002/biot.201400055; Garavelli JS, 2004, PROTEOMICS, V4, P1527, DOI 10.1002/pmic.200300777; Hastings J, 2016, NUCLEIC ACIDS RES, V44, pD1214, DOI 10.1093/nar/gkv1031; Have CT, 2013, BIOINFORMATICS, V29, P3107, DOI 10.1093/bioinformatics/btt549; Heller SR, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0068-4; Henkel R, 2015, DATABASE-OXFORD, V8, P2015; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Juty N, 2012, NUCLEIC ACIDS RES, V40, pD580, DOI 10.1093/nar/gkr1097; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Krause F, 2011, METHOD ENZYMOL, V500, P371, DOI 10.1016/B978-0-12-385118-5.00019-0; McDonald AG, 2009, NUCLEIC ACIDS RES, V37, pD593, DOI 10.1093/nar/gkn582; Moretti S, 2016, NUCLEIC ACIDS RES, V44, pD523, DOI 10.1093/nar/gkv1117; Morgat A, 2015, NUCLEIC ACIDS RES, V43, pD459, DOI 10.1093/nar/gku961; Morgat A, 2012, NUCLEIC ACIDS RES, V40, pD761, DOI 10.1093/nar/gkr1023; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Robinson I., 2015, GRAPH DATABASES, V2nd; Rose PW, 2016, NUCL ACIDS RES; Smallbone K, 2013, FEBS LETT, V587, P2832, DOI 10.1016/j.febslet.2013.06.043; Swainston N, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1051-4; Swainston N, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0123-9; Swainston N, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-186; Swainston N, 2009, BIOINFORMATICS, V25, P2292, DOI 10.1093/bioinformatics/btp392; Tomasulo Patricia, 2002, Med Ref Serv Q, V21, P53, DOI 10.1300/J115v21n01_04; Toure V, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1394-x; Waagmeester A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004989; Warr WA, 2012, J COMPUT AID MOL DES, V26, P801, DOI 10.1007/s10822-012-9577-7; Webb E.C, 1992, ENZYME NOMENCLATURE; Williams A, 2014, J COMPUT AID MOL DES, V28, P1023, DOI 10.1007/s10822-014-9784-5; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wittig U, 2012, NUCLEIC ACIDS RES, V40, pD790, DOI 10.1093/nar/gkr1046; Wolstencroft K, 2013, NUCLEIC ACIDS RES, V41, pW557, DOI 10.1093/nar/gkt328	47	20	20	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179130	10.1371/journal.pone.0179130	http://dx.doi.org/10.1371/journal.pone.0179130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708831	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800002
J	Liu, PL; Liu, WL; Chang, JM; Chen, YH; Liu, YP; Kuo, HF; Hsieh, CC; Ding, YS; Chen, WW; Chong, IW				Liu, Po-Len; Liu, Wei-Lun; Chang, Jia-Ming; Chen, Yung-Hsiang; Liu, Yu-Peng; Kuo, Hsuan-Fu; Hsieh, Chong-Chao; Ding, Yu-Sian; Chen, Wei-Wei; Chong, Inn-Wen			MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1	PLOS ONE			English	Article							TUMOR-CELL INVASIVENESS; GROUP BOX PROTEIN-1; ACTIN CYTOSKELETON; GASTRIC-CANCER; EXPRESSION; PROGRESSION; MIR-200C; METASTASIS; RESISTANCE; ZEB2	MicroRNAs (miRs) play critical roles in cancer development, proliferation, epithelial-mesenchymal transition (EMT), invasion, and migration through regulating the expression of onco-genes and tumour suppressor genes. Previous studies have indicated that miR-200c acts as a tumour suppressor in various cancers by downregulating high-mobility group box 1 (HMGB1) and thereby suppressing EMT and metastasis. In addition, miR-200c was reported to be downregulated and correlated with poor outcomes in non-small cell lung cancer (NSCLC). However, its functional role in HMGB1 regulation in NSCLC is still unclear. This study aimed to clarify whether miR-200c acts as a tumour suppressor in NSCLC by downregulating HMGB1, which is associated with EMT, invasion, cytoskeleton rearrangement, and migration in vitro and in vivo. In order to demonstrate HMGB1 downregulation by miR-200c, the NSCLC cell line A549 was transfected with miR-200c mimic or inhibitor. The mimic significantly reduced HMGB1 expression and suppressed EMT, invasion, and migration, while the inhibitor generated the opposite effects. Additionally, using xenograft mouse models, we confirmed that HMGB1 overexpression increased tumour EMT. In summary, our results demonstrated that miR-200c could suppress EMT, invasion, and migration of NSCLC cells by downregulating HMGB1.	[Liu, Po-Len; Chong, Inn-Wen] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan; [Liu, Wei-Lun] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Liu, Wei-Lun] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [Chang, Jia-Ming; Ding, Yu-Sian; Chen, Wei-Wei] Natl Res Project Biopharmaceut, Preclin Anim Pharmacol Testing Ctr, New Taipei, Taiwan; [Chang, Jia-Ming; Ding, Yu-Sian; Chen, Wei-Wei] Dev Ctr Biotechnol, Inst Drug Evaluat Platform, Dept Pharmacol, New Taipei, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan; [Chen, Yung-Hsiang] Asia Univ, Coll Med & Hlth Sci, Dept Psychol, Taichung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Dept Genome Med, Kaohsiung, Taiwan; [Kuo, Hsuan-Fu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsieh, Chong-Chao] Kaohsiung Med Univ Hosp, Dept Surg, Div Cardiovasc Surg, Kaohsiung, Taiwan; [Chong, Inn-Wen] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Chi Mei Hospital; Fu Jen Catholic University; China Medical University Taiwan; Asia University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chong, IW (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan.; Chong, IW (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.	chong@kmu.edu.tw	Chen, Yung-Hsiang/K-6766-2015; Chang, Jia-Ming/P-4010-2019; Kuo, Hsuan-Fu/GVS-2875-2022	Chen, Yung-Hsiang/0000-0002-8756-5113; 	Taiwan Ministry of Science and Technology [MOST 104-2314-6-037-087, MOST 104-2314-6-037-071-MY2, MOST 101-2314-B-037-065-MY2, MOST 102-2314-B-037-067, MOST 103-2314-6-037-051]; Chi Mei Medical Center, Liouying [CLEHR10423]; Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation [103CM-KMU-08]; Core Service Platform Project for Animal Pharmacology, National Research Program, Ministry of Science and Technology, Taiwan	Taiwan Ministry of Science and Technology; Chi Mei Medical Center, Liouying; Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation; Core Service Platform Project for Animal Pharmacology, National Research Program, Ministry of Science and Technology, Taiwan	This study was supported in part by grants from the Taiwan Ministry of Science and Technology (MOST 104-2314-6-037-087, MOST 104-2314-6-037-071-MY2, MOST 101-2314-B-037-065-MY2, MOST 102-2314-B-037-067, and MOST 103-2314-6-037-051), the Chi Mei Medical Center, Liouying (CLEHR10423), and the Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation (103CM-KMU-08). The animal study was supported by grants from the Core Service Platform Project for Animal Pharmacology, National Research Program, Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the anonymous reviewers for their constructive helpful comments that contributed to improving the final version of the paper. We would also like to thank the Editor for his generous comments and support during the review process. The animal study was supported by grants from the Core Service Platform Project for Animal Pharmacology, National Research Program, Ministry of Science and Technology, Taiwan. We thank the Center for Research Resources and Development of Kaohsiung Medical University for confocal microscopy support.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Ananthula S, 2016, ONCOTARGET, V7, P20869, DOI 10.18632/oncotarget.8029; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Bryant JL, 2012, BRIT J CANCER, V106, P148, DOI 10.1038/bjc.2011.465; Chang BP, 2014, J HUAZHONG U SCI-MED, V34, P201, DOI 10.1007/s11596-014-1259-3; Chang YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10979; Chen Y., 2016, SCI REP, P6; Chevalier SA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003917; Chung HW, 2015, INT J CANCER, V137, P1598, DOI 10.1002/ijc.29539; Feng AL, 2016, ONCOTARGET, V7, P20507, DOI 10.18632/oncotarget.7050; Feng B, 2012, BIOMED PHARMACOTHER, V66, P397, DOI 10.1016/j.biopha.2012.06.002; Gonzalez-Arriaga P, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-378; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; Hashida S, 2015, CANCER SCI, V106, P1377, DOI 10.1111/cas.12749; He J, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0378-z; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Jiao AH, 2016, MOL MED REP, V13, P3349, DOI 10.3892/mmr.2016.4901; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Khurana S, 2011, CELL ADHES MIGR, V5, P409, DOI 10.4161/cam.5.5.17644; Kumar S, 2015, CURR DRUG TARGETS, V16, P1381, DOI 10.2174/1389450116666150325231419; Kuo HF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156059; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li Y, 2014, NEOPLASMA, V61, P579, DOI 10.4149/neo_2014_070; Liu PL, 2005, AM J PHYSIOL-LUNG C, V289, pL739, DOI 10.1152/ajplung.00099.2005; Liu PL, 2010, AM J RESP CELL MOL, V43, P530, DOI 10.1165/rcmb.2009-0269OC; Liu PL, 2010, MOL CARCINOGEN, V49, P874, DOI 10.1002/mc.20663; Liu ZK, 2016, ONCOTARGET, V7, P36909, DOI 10.18632/oncotarget.9377; Lu Y., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1155/2014/162517; Lynch J, 2010, AM J NEPHROL, V32, P590, DOI 10.1159/000320485; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mitselou A, 2016, ANTICANCER RES, V36, P2271; Mutlu M, 2016, J MOL MED, V94, P629, DOI 10.1007/s00109-016-1420-5; Osugi J, 2016, J CANCER RES THER, V12, P945, DOI 10.4103/0973-1482.176168; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Perdigao-Henriques R, 2016, ONCOGENE, V35, P158, DOI 10.1038/onc.2015.69; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; SALGADO J, 1993, BIOCHIM BIOPHYS ACTA, V1145, P284, DOI 10.1016/0005-2736(93)90301-F; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Shan WL, 2016, GENE, V593, P265, DOI 10.1016/j.gene.2016.07.038; Sohun M, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.05.36; Tsai JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144462; Wang XB, 2015, INT J MOL SCI, V16, P22527, DOI 10.3390/ijms160922527; Wu TY, 2016, ONCOTARGET, V7, P50417, DOI 10.18632/oncotarget.10413; Xu YF, 2015, WORLD J GASTROENTERO, V21, P3256, DOI 10.3748/wjg.v21.i11.3256; Zhang JY, 2016, MOL CLIN ONCOL, V4, P933, DOI 10.3892/mco.2016.842; Zhao HG, 2015, INT J CLIN EXP PATHO, V8, P15582; Zhou XL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0428-3; Zhu LY, 2015, CANCER LETT, V357, P527, DOI 10.1016/j.canlet.2014.12.012	50	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180844	10.1371/journal.pone.0180844	http://dx.doi.org/10.1371/journal.pone.0180844			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727734	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500031
J	Postnikov, AV; Uvarov, IV; Lokhanin, MV; Svetovoy, VB				Postnikov, Alexander V.; Uvarov, Ilia V.; Lokhanin, Mikhail V.; Svetovoy, Vitaly B.			Electrically controlled cloud of bulk nanobubbles in water solutions	PLOS ONE			English	Article							HYDROGEN NANOBUBBLES; GENERATION; COMBUSTION; BUBBLES	Using different experimental techniques we visualize a cloud of gas in water that is produced electrochemically by the alternating polarity process. Liquid enriched with gas does not contain bubbles strongly scattering visible light but its refractive index changes significantly near the electrodes. The change of the refractive index is a collective effect of bulk nanobubbles with a diameter smaller than 200 nm. Any alternative explanation fails to explain the magnitude of the effect. Spatial structure of the cloud is investigated with the optical lever method. Its dynamics is visualised observing optical distortion of the electrode images or using differential interference contrast method. The cloud covers concentric electrodes, in a steady state it is roughly hemispherical with a size two times larger than the size of the electrode structure. When the electrical pulses are switched off the cloud disappears in less than one second. The total concentration of gases can reach very high value estimated as 3.5 x 10(20) cm(-3) that corresponds to an effective supersaturation of 500 and 150 for hydrogen and oxygen, respectively.	[Postnikov, Alexander V.; Uvarov, Ilia V.; Svetovoy, Vitaly B.] Russian Acad Sci, Inst Phys & Technol, Yaroslavl Branch, Yaroslavl, Russia; [Lokhanin, Mikhail V.] PG Demidov Yaroslavl State Univ, Dept Phys, Yaroslavl, Russia; [Svetovoy, Vitaly B.] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands	Russian Academy of Sciences; Yaroslavl State University; University of Groningen	Svetovoy, VB (corresponding author), Russian Acad Sci, Inst Phys & Technol, Yaroslavl Branch, Yaroslavl, Russia.; Svetovoy, VB (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands.	v.b.svetovoy@rug.nl	Svetovoy, Vitaly/F-8654-2011; Uvarov, Ilia V/B-6394-2015; Institute, Zernike/W-7033-2019	Svetovoy, Vitaly/0000-0002-9649-5663; Uvarov, Ilia V/0000-0002-6882-0625; 	Russian Science Foundation [15-19-20003]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation, grant 15-19-20003, VBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, CHEMOSPHERE, V84, P1175, DOI 10.1016/j.chemosphere.2011.05.054; Alheshibri M, 2016, LANGMUIR, V32, P11086, DOI 10.1021/acs.langmuir.6b02489; ASPNES DE, 1982, THIN SOLID FILMS, V89, P249, DOI 10.1016/0040-6090(82)90590-9; Azevedo A, 2016, MINER ENG, V94, P29, DOI 10.1016/j.mineng.2016.05.001; Bunkin NF, 2012, J CHEM PHYS, V137; Kikuchi K, 2001, J ELECTROANAL CHEM, V506, P22, DOI 10.1016/S0022-0728(01)00517-4; Kikuchi K, 2007, J ELECTROANAL CHEM, V600, P303, DOI 10.1016/j.jelechem.2006.10.005; Kikuchi K, 2006, ELECTROCHIM ACTA, V52, P904, DOI 10.1016/j.electacta.2006.06.026; Kikuchi K, 2006, J COLLOID INTERF SCI, V298, P914, DOI 10.1016/j.jcis.2006.01.010; Kikuchi K, 2009, J COLLOID INTERF SCI, V329, P306, DOI 10.1016/j.jcis.2008.10.009; Li P, 2009, CHEMOSPHERE, V77, P1157, DOI 10.1016/j.chemosphere.2009.07.062; Liu GM, 2008, J PHYS CHEM C, V112, P16748, DOI 10.1021/jp805143c; Liu GM, 2009, ACS APPL MATER INTER, V1, P481, DOI 10.1021/am800150p; Lohse D, 2015, REV MOD PHYS, V87, P981, DOI 10.1103/RevModPhys.87.981; Mishchuk N, 2006, J COLLOID INTERF SCI, V301, P168, DOI 10.1016/j.jcis.2006.04.071; Modi KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103606; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051869; Murphy D B, 2001, FUNDAMENTALS LIGHT M; Ohgaki K, 2010, CHEM ENG SCI, V65, P1296, DOI 10.1016/j.ces.2009.10.003; Pan G, 2016, LANGMUIR, V32, P11133, DOI 10.1021/acs.langmuir.6b01483; Postnikov AV, 2016, SCI REP-UK, V6, DOI 10.1038/srep39381; Postnikov AV, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4944780; Prokaznikov A, 2017, ENERGIES, V10, DOI 10.3390/en10020178; Seddon JRT, 2012, CHEMPHYSCHEM, V13, P2179, DOI 10.1002/cphc.201100900; Svetovoy V, 2016, ENERGIES, V9, DOI 10.3390/en9020094; Svetovoy VB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04296; Svetovoy VB, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.035302; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Tasaki T, 2009, IND ENG CHEM RES, V48, P4237, DOI 10.1021/ie801279b; Thormaehlen I, 1985, J PHYS CHEM REF DATA, V14; Urrejola S, 2010, J CHEM ENG DATA, V55, P2924, DOI 10.1021/je9010129; Ushikubo FY, 2010, COLLOID SURFACE A, V361, P31, DOI 10.1016/j.colsurfa.2010.03.005; Van Gils S, 2004, SURF COAT TECH, V185, P303, DOI 10.1016/j.surfcoat.2004.01.021; Vogt H, 2005, ELECTROCHIM ACTA, V50, P2073, DOI 10.1016/j.electacta.2004.09.025; Wang YL, 2010, SOFT MATTER, V6, P29, DOI 10.1039/b917017k; Wang YL, 2009, LANGMUIR, V25, P9328, DOI 10.1021/la901186a; Wu ZH, 2008, J COLLOID INTERF SCI, V328, P10, DOI 10.1016/j.jcis.2008.08.064; Yurchenko SO, 2016, LANGMUIR, V32, P11245, DOI 10.1021/acs.langmuir.6b01644; Zhu J, 2016, LANGMUIR, V32, P11203, DOI 10.1021/acs.langmuir.6b01004	39	18	19	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181727	10.1371/journal.pone.0181727	http://dx.doi.org/10.1371/journal.pone.0181727			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727812	Green Published, gold			2022-12-27	WOS:000406634500108
J	Takada, K; Okamoto, T; Tominaga, M; Teraishi, K; Akamine, T; Takamori, S; Katsura, M; Toyokawa, G; Shoji, F; Okamoto, M; Oda, Y; Hoshino, T; Maehara, Y				Takada, Kazuki; Okamoto, Tatsuro; Tominaga, Masaki; Teraishi, Koji; Akamine, Takaki; Takamori, Shinkichi; Katsura, Masakazu; Toyokawa, Gouji; Shoji, Fumihiro; Okamoto, Masaki; Oda, Yoshinao; Hoshino, Tomoaki; Maehara, Yoshihiko			Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression	PLOS ONE			English	Article							INTERLEUKIN-1 FAMILY; CANCER-IMMUNOTHERAPY; PROTEIN EXPRESSION; DOCETAXEL; CELLS; NIVOLUMAB; INSIGHTS	Interleukin (IL)-38, a novel member of the IL-1 cytokine family, is homologous to IL-1 receptor antagonist (IL-1Ra) and IL-36Ra, and has been reported to act as an antagonist. IL-38 expression is found in tonsil, placenta, and spleen, and recent studies suggest an association between IL-38 and autoimmune diseases. However, whether IL-38 plays a role in carcinogenesis or cancer growth is unclear. In the present study, we identified increases in IL-38 expression by immunohistochemistry in multiple types of cancer cells. In the examination of 417 surgically resected primary lung adenocarcinomas, Fisher's exact tests showed significant associations between high IL-38 expression and high tumor grades, an advanced T status, advanced N status, advanced stage, and the presence of pleural and vessel invasions. Survival analyses by the Kaplan-Meier method showed that patients with high expression of IL-38 had significantly shorter disease-free survival and shorter overall survival after surgery than patients with low expression of IL-38 (log-rank test: P = 0.0021 and P = 0.0035, respectively). Moreover, programmed cell death-ligand 1 (PD-L1)-positive cases showed higher expression of IL-38 than PD-L1-negative cases (Wilcoxon rank-sum test: P < 0.0001). In conclusion, IL-38 was expressed in tumor cells of various cancers, and IL-38 expression was associated with poor survival of lung adenocarcinoma patients. IL-38 may affect host immunity or the tumor microenvironment, and contribute to the progression of lung adenocarcinoma.	[Takada, Kazuki; Okamoto, Tatsuro; Teraishi, Koji; Akamine, Takaki; Takamori, Shinkichi; Katsura, Masakazu; Toyokawa, Gouji; Shoji, Fumihiro; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan; [Takada, Kazuki; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka, Japan; [Tominaga, Masaki; Okamoto, Masaki; Hoshino, Tomoaki] Kurume Univ, Div Respirol Neurol & Rheumatol, Dept Internal Med, Sch Med, Kurume, Fukuoka, Japan	Kyushu University; Kyushu University; Kurume University	Okamoto, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan.	tatsuro@surg2.med.kyushu-u.ac.jp		Okamoto, Tatsuro/0000-0002-3568-1876; Katsura, Masakazu/0000-0001-8059-1768				Akdis M, 2016, J ALLERGY CLIN IMMUN; [Anonymous], [No title captured]; Barton BE, 1997, CLIN IMMUNOL IMMUNOP, V85, P16, DOI 10.1006/clin.1997.4420; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Boutet MA, 2015, CLIN EXPT IMMUNOLOGY; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; CHU M, 2016, MOLECULES, V21; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gatalica Z, 2014, CANCER EPIDEM BIOMAR, V23, P2965, DOI 10.1158/1055-9965.EPI-14-0654; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Hahn M, 2016, CURRENT OPINION RHEU; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Huang WL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-309; Keermann M, 2015, J DERMATOL SCI; Kohno M, 2014, CLIN CANCER RES, V20, P3613, DOI 10.1158/1078-0432.CCR-13-2683; Lin HS, 2001, J BIOL CHEM, V276, P20597, DOI 10.1074/jbc.M010095200; Lv ZL, 2016, MOL MED REP, V13, P1404, DOI 10.3892/mmr.2015.4667; Palomo J, 2015, CYTOKINE; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Reck M, 2016, NEW ENGLAND J MED; Rudloff I, 2015, ARTHRITIS RHEUMATOL, V67, P3219, DOI 10.1002/art.39328; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Solahaye-Kahnamouii S, 2014, IRAN J CANCER PREV, V7, P197; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Takada K, 2016, J THORAC ONCOL, V11, P1879, DOI 10.1016/j.jtho.2016.06.006; Takada K, 2016, ANTICANCER RES, V36, P3409; Takenaka Shin-Ichi, 2015, Biochem Biophys Rep, V4, P386, DOI 10.1016/j.bbrep.2015.10.015; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Toyokawa G, 2016, ANTICANCER RES, V36, P4329; Tsurutani N, 2016, J IMMUNOL, V196, P124, DOI 10.4049/jimmunol.1501217; van de Veerdonk FL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00167; Vigne S, 2012, BLOOD, V120, P3478, DOI 10.1182/blood-2012-06-439026; Wang M, 2016, CELL MOL BIOL, V62, P31, DOI 10.14715/cmb/2016.62.4.6; Weinstein AM, 2015, ADV CANCER RES, V128, P197, DOI 10.1016/bs.acr.2015.04.003; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yuan XL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/807976; Zhang L, 2014, INFLAMMATION, V37, P1213, DOI 10.1007/s10753-014-9848-7	42	28	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181598	10.1371/journal.pone.0181598	http://dx.doi.org/10.1371/journal.pone.0181598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727766	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500092
J	Tortosa, C; Cabrera-Marante, O; Serrano, M; Martinez-Flores, JA; Perez, D; Lora, D; Morillas, L; Paz-Artal, E; Morales, JM; Pleguezuelo, D; Serrano, A				Tortosa, Carlos; Cabrera-Marante, Oscar; Serrano, Manuel; Martinez-Flores, Jose A.; Perez, Dolores; Lora, David; Morillas, Luis; Paz-Artal, Estela; Morales, Jose M.; Pleguezuelo, Daniel; Serrano, Antonio			Incidence of thromboembolic events in asymptomatic carriers of IgA anti beta 2 glycoprotein-I antibodies	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; 14TH INTERNATIONAL-CONGRESS; ANTI-BETA-2 GLYCOPROTEIN I; ANTIPHOSPHOLIPID SYNDROME; RISK-FACTORS; CLINICAL-SIGNIFICANCE; THROMBOTIC RECURRENCES; PIEDMONT COHORT; ANTICARDIOLIPIN; DIAGNOSIS	Background The antiphospholipid syndrome (APS) is defined by simultaneous presence of vascular clinical events and antiphospholipid antibodies (aPL). The aPL considered as diagnostics are lupus anticoagulant and antibodies anticardiolipin (aCL) and anti-beta 2 glycoprotein-I (aB2GP1). During recent years, IgA aB2GP1 antibodies have been associated with thrombotic events both in patients positive, and mainly negative for other aPL, however its value as a pro-thrombotic risk-factor in asymptomatic patients has not been well defined. Objective To test the role of IgA anti B2GP1 as a risk factor for the development of APS-events (thrombosis or pregnancy morbidity) in asymptomatic population with a 5-year follow-up. Methods 244 patients isolated positive for anti-beta2-glycoprotein I IgA (Group-1 study) and 221 negative patients (Group-2 control) were studied. All the patients were negative for IgG and IgM aCL. Results During the follow-up, 45 patients (9.7%) had APS-events, 38 positive for IgA-aB2GP1 and 7 negative (15.6% vs 3.2%, p<0.001). The incidence rate of APS-events was 3.1% per year in IgA-aB2GP1 positive patients and 0.6% per year in the control group. Arterial thrombosis were the most frequent APS-events (N = 25, 55%) and were mainly observed in Group-1 patients (21 vs 4, p = 0.001). Multivariate analysis were shown as independent risk-factors for the development of APS-events, age, sex (men) and presence of IgA-aB2GP1 (odds ratio 5.25, 95% CI 2.24 to 12.32). Conclusion The presence of IgA-aB2GP1 in people with no history of APS-events is the main independent risk factor for the development of these types of events, mainly arterial thrombosis.	[Tortosa, Carlos; Cabrera-Marante, Oscar; Serrano, Manuel; Martinez-Flores, Jose A.; Perez, Dolores; Paz-Artal, Estela; Morales, Jose M.; Pleguezuelo, Daniel; Serrano, Antonio] Hosp Univ 12 Octubre, Inst Invest, Dept Immunol, Madrid, Spain; [Lora, David] Hosp Univ 12 Octubre, Inst Invest, Dept Epidemiol, Madrid, Spain; [Morillas, Luis] Hosp Univ 12 Octubre, Inst Invest, Dept Rheumatol, Madrid, Spain	Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre	Serrano, A (corresponding author), Hosp Univ 12 Octubre, Inst Invest, Dept Immunol, Madrid, Spain.	aserrano@h12o.es		Serrano, Antonio/0000-0003-1993-640X	Fondo de Investigaciones Sanitarias; EU FEDER funds [PI14-00360]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); EU FEDER funds(European Commission)	This work was supported by grants from Fondo de Investigaciones Sanitarias and cofunded by EU FEDER funds (Grant: PI14-00360).	Amengual O, 2015, LUPUS, V24, P1135, DOI 10.1177/0961203315578765; Andreoli L, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0343-1; ANNESI I, 1989, STAT MED, V8, P1515, DOI 10.1002/sim.4780081211; Arnaud L, 2015, AUTOIMMUN REV, V14, P192, DOI 10.1016/j.autrev.2014.10.019; Artenjak A, 2012, AUTOIMMUN REV, V11, P873, DOI 10.1016/j.autrev.2012.03.002; Audrain MAP, 2002, RHEUMATOLOGY, V41, P550, DOI 10.1093/rheumatology/41.5.550; Barbhaiya M, 2011, CURR RHEUMATOL REP, V13, P59, DOI 10.1007/s11926-010-0149-3; Bazzan M, 2016, LUPUS, V25, P479, DOI 10.1177/0961203315617538; Bazzan M, 2013, AUTOIMMUN REV, V12, P826, DOI 10.1016/j.autrev.2012.11.007; Bertolaccini ML, 2014, AUTOIMMUN REV, V13, P917, DOI 10.1016/j.autrev.2014.05.001; Brusch A, 2016, ANTIBODIES, V5, DOI 10.3390/antib5020016; Cervera R, 2015, ANN RHEUM DIS, V74, P1011, DOI 10.1136/annrheumdis-2013-204838; Cervera R, 2012, AUTOIMMUN REV, V11, P581, DOI 10.1016/j.autrev.2011.10.017; Cervera R, 2009, J AUTOIMMUN, V32, P240, DOI 10.1016/j.jaut.2009.02.008; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Despierres L, 2014, RHEUMATOLOGY, V53, P1215, DOI 10.1093/rheumatology/keu003; Douketis JD, 2016, INTERN EMERG MED; Erkan D, 2002, RHEUMATOLOGY, V41, P924, DOI 10.1093/rheumatology/41.8.924; Forastiero R, 2005, J THROMB HAEMOST, V3, P1231, DOI 10.1111/j.1538-7836.2005.01295.x; Garcia D, 2013, BLOOD, V122, P817, DOI 10.1182/blood-2013-04-496257; Gerosa M, 2016, CURR OPIN RHEUMATOL, V28, P51, DOI 10.1097/BOR.0000000000000240; Hood DB, 2015, EUR J RHEUMATOL, V2, P135, DOI 10.5152/eurjrheum.2015.0012; Hughes GRV, 2014, LUPUS, V23, P400, DOI 10.1177/0961203314522341; Keswani SC, 2002, J ROY SOC MED, V95, P336, DOI 10.1258/jrsm.95.7.336; Lakos G, 1999, CLIN EXP IMMUNOL, V117, P574; Lakos G, 2012, ARTHRITIS RHEUM-US, V64, P1, DOI 10.1002/art.33349; Martinez-Flores JA, 2016, J ATHEROSCLER THROMB, V23, P1242, DOI 10.5551/jat.34488; Martinez-Flores JA, 2013, ANAL CHEM, V85, P12093, DOI 10.1021/ac403194t; Mehrani T, 2011, J RHEUMATOL, V38, P64, DOI 10.3899/jrheum.100568; Meijide H, 2013, AUTOIMMUN REV, V12, P421, DOI 10.1016/j.autrev.2012.08.002; Metjian Ara, 2009, Hematology Am Soc Hematol Educ Program, P247, DOI 10.1182/asheducation-2009.1.247; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Morales JM, 2016, TRANSPLANTATION; Morales JM, 2015, J AM SOC NEPHROL, V26, P735, DOI 10.1681/ASN.2014030228; Murthy V, 2013, ARTHRITIS RHEUM-US, V65, P3186, DOI 10.1002/art.38131; Mustonen P, 2014, LUPUS, V23, P1468, DOI 10.1177/0961203314545410; Pengo V, 2011, BLOOD, V118, P4714, DOI 10.1182/blood-2011-03-340232; Perez D, 2016, INT J LAB HEMATOL, V38, P560, DOI 10.1111/ijlh.12543; Pericleous C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156407; Pierangeli SS, 2005, CLIN CHIM ACTA, V357, P17, DOI 10.1016/j.cccn.2005.02.002; Previtali E, 2011, BLOOD TRANSFUS-ITALY, V9, P120, DOI 10.2450/2010.0066-10; Rodriguez-Garcia V, 2015, RHEUMATOLOGY, V54, P2042, DOI 10.1093/rheumatology/kev226; Ruffatti A, 2011, ANN RHEUM DIS, V70, P1083, DOI 10.1136/ard.2010.142042; Ruiz-Garcia R, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/704395; Samarkos M, 2006, CLIN RHEUMATOL, V25, P199, DOI 10.1007/s10067-005-1156-z; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Serrano A, 2012, KIDNEY INT, V81, P1239, DOI 10.1038/ki.2011.477; Tebo AE, 2016, CLIN CHIM ACTA, V460, P107, DOI 10.1016/j.cca.2016.06.025; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Yamada H, 1999, ARTHRITIS RHEUM, V42, P2727, DOI 10.1002/1529-0131(199912)42:12<2727::AID-ANR33>3.0.CO;2-Q	50	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e178889	10.1371/journal.pone.0178889	http://dx.doi.org/10.1371/journal.pone.0178889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727732	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500004
J	Zhang, C; Wang, DD; Yang, CH; Kong, N; Shi, Z; Zhao, P; Nan, YY; Nie, TK; Wang, RQ; Ma, HL; Chen, Q				Zhang, Chao; Wang, Dongdong; Yang, Chenghui; Kong, Nana; Shi, Zheng; Zhao, Peng; Nan, Yunyou; Nie, Tengkun; Wang, Ruoqiu; Ma, Haoli; Chen, Qin			Genome-wide identification of the potato WRKY transcription factor family	PLOS ONE			English	Article							EXPRESSION ANALYSIS; GENE FAMILY; STRESS-RESPONSE; DNA-BINDING; EVOLUTION; SUPERFAMILY; RESISTANCE; TOLERANCE; WHEAT; PATHWAY	WRKY transcription factors play pivotal roles in regulation of stress responses. This study identified 79 WRKY genes in potato (Solanum tuberosum). Based on multiple sequence alignment and phylogenetic relationships, WRKY genes were classified into three major groups. The majority of WRKY genes belonged to Group II (52 StWRKYs), Group III had 14 and Group I consisted of 13. The phylogenetic tree further classified Group II into five subgroups. All StWRKY genes except StWRKY79 were mapped on potato chromosomes, with eight tandem duplication gene pairs and seven segmental duplication gene pairs found from StWRKY family genes. The expression analysis of 22 StWRKYs showed their differential expression levels under various stress conditions. Cis-element prediction showed that a large number of elements related to drought, heat and salicylic acid were present in the promotor regions of StWRKY genes. The expression analysis indicated that seven StWRKYs seemed to respond to stress (heat, drought and salinity) and salicylic acid treatment. These genes are candidates for abiotic stress signaling for further research.	[Zhang, Chao; Wang, Dongdong; Yang, Chenghui; Kong, Nana; Shi, Zheng; Zhao, Peng; Nan, Yunyou; Nie, Tengkun; Wang, Ruoqiu; Ma, Haoli; Chen, Qin] Northwest A&F Univ, Dept Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Ma, HL; Chen, Q (corresponding author), Northwest A&F Univ, Dept Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	mahaoli@nwsuaf.edu.cn; chenpeter2289@nwsuaf.edu.cn			Northwest Agriculture and Forestry University [Z111021202]	Northwest Agriculture and Forestry University	This work was financially supported by the Research funding for special professor of Northwest Agriculture and Forestry University (grant Nos. Z111021202).; We thank the Northwest Agriculture Forestry University and State Key Laboratory of Crop Stress Biology for Arid Areas. This work was financially supported by the Research funding for special professor of Northwest Agriculture and Forestry University (grant Nos. Z111021202).	Banerjee Aditya, 2015, ScientificWorldJournal, V2015, P807560, DOI 10.1155/2015/807560; Brand LH, 2013, NUCLEIC ACIDS RES, V41, P9764, DOI 10.1093/nar/gkt732; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Diao WP, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.01727, 10.3389/fpls.2016.00211]; Ding MQ, 2015, MOL GENET GENOMICS, V290, P151, DOI 10.1007/s00438-014-0904-7; Dou LL, 2014, MOL GENET GENOMICS, V289, P1103, DOI 10.1007/s00438-014-0872-y; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Evers D, 2012, PLANT MOL BIOL, V78, P503, DOI 10.1007/s11103-012-9879-0; Fan XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126148; Gallou A, 2012, FUNCT INTEGR GENOMIC, V12, P183, DOI 10.1007/s10142-011-0241-4; Goel R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00299; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; Huang SX, 2012, MOL GENET GENOMICS, V287, P495, DOI 10.1007/s00438-012-0696-6; Huang Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3123-2; Jiang YZ, 2014, J EXP BOT, V65, P6629, DOI 10.1093/jxb/eru381; Kopecki Z, 2007, J PATHOL, V211, P351, DOI 10.1002/path.2113; Koralewski TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018055; Kumar K, 2016, DNA RES, V23, P225, DOI 10.1093/dnares/dsw010; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23101; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Liu XF, 2016, PROTOPLASMA, V253, P1265, DOI 10.1007/s00709-015-0885-3; Ma HL, 2016, PLANT PHYSIOL BIOCH, V107, P164, DOI 10.1016/j.plaphy.2016.06.007; Ma JH, 2014, CYTOGENET GENOME RES, V144, P243, DOI 10.1159/000370172; Massa AN, PLANT GENOME; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Okay S, 2014, MOL GENET GENOMICS, V289, P765, DOI 10.1007/s00438-014-0849-x; Pan LJ, 2014, MOL BIOL REP, V41, P1215, DOI 10.1007/s11033-013-2966-8; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Qiu YP, 2004, CHINESE SCI BULL, V49, P2159, DOI 10.1360/982004-183; Rinerson CI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0456-y; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Sanchez-Rojo S, 2013, SALICYLIC ACID, P315; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Satapathy L, 2014, MOL GENET GENOMICS, V289, P1289, DOI 10.1007/s00438-014-0890-9; Shahzad Raheel, 2016, Plant Omics, V9, P149, DOI 10.21475/poj.160902.p7649x; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00534; Song Y, 2010, RICE SCI, V17, P60, DOI 10.1016/S1672-6308(08)60105-5; Tripathi P, 2014, PLANTA, V239, P255, DOI 10.1007/s00425-013-1985-y; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055587; Wang LN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-103; Wang QS, 2011, GENETICA, V139, P973, DOI 10.1007/s10709-011-9599-4; Wang YY, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0076-3; Wei W, 2016, PLANT PHYSIOL BIOCH, V105, P129, DOI 10.1016/j.plaphy.2016.04.014; Wen F, 2014, DNA RES, V21, P327, DOI 10.1093/dnares/dst060; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Xie Z, 2007, PLANT MOL BIOL, V64, P293, DOI 10.1007/s11103-007-9152-0; Yin GJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-148; Yogendra KN, 2015, J EXP BOT, V66, P7377, DOI 10.1093/jxb/erv434; Yogendra KN, 2016, PLANT SCI; Yu FF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-144; Yu YC, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2647-x; Zhang YZ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017023; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhou HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154312; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zou Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148243	60	46	51	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181573	10.1371/journal.pone.0181573	http://dx.doi.org/10.1371/journal.pone.0181573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727761	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500089
J	Dargham, SR; Ahmed, L; Kilpatrick, ES; Atkin, SL				Dargham, Soha R.; Ahmed, Lina; Kilpatrick, Eric S.; Atkin, Stephen L.			The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population	PLOS ONE			English	Article							BLOOD-PRESSURE VARIABILITY; DIAGNOSTIC-CRITERIA; RISK-FACTORS; WOMEN; FEATURES; PCOS	Objective The prevalence of polycystic ovary syndrome (PCOS) in the Qatari population is unknown and hence the estimated impact on the local population cannot be determined. The purpose of this study was to estimate the prevalence and metabolic features of PCOS among Qatari women. Design Cross sectional analysis. Patients 3,017 Qatari subjects volunteered to be phenotyped and genotyped for the Qatar Biobank from which all women between the ages of 18-40 years were identified (750). Measurements 720 women had testosterone and sex hormone binding globulin (SHBG) measurements. PCOS was diagnosed according the National Institute of Health (NIH) Guidelines of a raised androgen level (free androgen index >4.5 or a raised total testosterone) and menstrual irregularity after the exclusion of other conditions. Results All results are reported as mean value of PCOS versus control. 87 of 720 women fulfilled the NIH guidelines (12.1%) for PCOS specifically using a free androgen index greater than 4.5 or a total testosterone greater than 2.7nmol/l and menstrual irregularity. Subjects were heavier with a more metabolic profile of a greater systolic and diastolic blood pressure, higher levels of C reactive protein, insulin (p<0.01) and HbA1c (P<0.02), and decreased HDL levels (p<0.01). Pulse wave velocity as a marker of arterial stiffness was also increased (p<0.05) Conclusions By NIH guidelines the prevalence of PCOS in this Qatari cohort was 12.1% that would likely reflect 20% by Rotterdam criteria, with a markedly more metabolic phenotype than Qatari controls.	[Dargham, Soha R.] Weill Cornell Med, Infect Dis Epidemiol Grp, Doha, Qatar; [Ahmed, Lina; Atkin, Stephen L.] Weill Cornell Med, Res Fac, Doha, Qatar; [Kilpatrick, Eric S.] Sidra Med & Res Ctr, Dept Pathol, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Sidra Medical & Research Center	Atkin, SL (corresponding author), Weill Cornell Med, Res Fac, Doha, Qatar.	sla2002@qatar-med.cornell.edu	Atkin, stephen/ABE-7047-2020; Atkin, Stephen/D-7400-2014	Atkin, Stephen/0000-0002-5887-7257; Dargham, Soha/0000-0003-2695-6564; Hasabelgawi, Lina/0000-0001-9512-8231	Qatar Foundation; Qatar Biobank	Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Qatar Biobank(Qatar Foundation (QF))	This work was supported by the Qatar Foundation and the Qatar Biobank. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful for the support for this work from the Qatar Biobank and the Qatar Foundation.	Al-Ruhaily AD, 2008, ANN SAUDI MED, V28, P28; Boardman H, 2017, J HYPERTENS, V35, P513, DOI 10.1097/HJH.0000000000001192; Bozdag G, 2016, HUM REPROD, V31, P2841, DOI 10.1093/humrep/dew218; Casarini L, 2014, J CLIN ENDOCR METAB, V99, pE2412, DOI 10.1210/jc.2014-2703; Dumesic DA, 2016, J CLIN ENDOCR METAB, V101, P4178, DOI 10.1210/jc.2016-2586; Dunaif A, 2016, J CLIN ENDOCR METAB, V101, P759, DOI 10.1210/jc.2015-3780; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Glintborg D, 2010, CLIN ENDOCRINOL, V73, P732, DOI 10.1111/j.1365-2265.2010.03873.x; Kahal H, 2013, CLIN ENDOCRINOL, V79, P252, DOI 10.1111/cen.12137; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Rosenfield RL, 2016, ENDOCR REV; Sathyapalan T, 2011, EUROPEAN J ENDOCRINO; Sharif E, 2017, INT J WOMENS HEALTH, V9, P1, DOI 10.2147/IJWH.S120027; Teede HJ, 2013, OBESITY, V21, P1526, DOI 10.1002/oby.20213; van Wissen S, 2002, ATHEROSCLEROSIS, V165, P361, DOI 10.1016/S0021-9150(02)00280-0; Vishram JKK, 2015, J HYPERTENS, V33, P2422, DOI 10.1097/HJH.0000000000000739; Wijeyaratne CN, 2002, CLIN ENDOCRINOL, V57, P343, DOI 10.1046/j.1365-2265.2002.01603.x; World Health Organization, 2008, WAIST CIRCUMFERENCE; Yildiz BO, 2012, HUM REPROD, V27, P3067, DOI 10.1093/humrep/des232	21	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181467	10.1371/journal.pone.0181467	http://dx.doi.org/10.1371/journal.pone.0181467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723965	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800052
J	Marioni, J; Bresoli-Obach, R; Agut, M; Comini, LR; Cabrera, JL; Paraje, MG; Nonell, S; Montoya, SC				Marioni, Juliana; Bresoli-Obach, Roger; Agut, Montserrat; Comini, Laura R.; Cabrera, Jose L.; Paraje, Maria G.; Nonell, Santi; Nunez Montoya, Susana C.			On the mechanism of Candida tropicalis biofilm reduction by the combined action of naturally-occurring anthraquinones and blue light	PLOS ONE			English	Article							SINGLET OXYGEN; PHOTODYNAMIC THERAPY; ESCHERICHIA-COLI; INACTIVATION; HYPERICIN	The photoprocesses involved in the photo-induced Candida tropicalis biofilm reduction by two natural anthraquinones (AQs), rubiadin (1) and rubiadin-1-methyl ether (2), were examined. Production of singlet oxygen (O-1(2)) and of superoxide radical anion (O-2(center dot-)) was studied. Although it was not possible to detect the triplet state absorption of any AQs in biofilms, observation of O-1(2) phosphorescence incubated with deuterated Phosphate Buffer Solution, indicated that this species is actually formed in biofilms. 2 was accumulated in the biofilm to a greater extent than 1 and produced measurable amounts of O-2(center dot-) after 3h incubation in biofilms. The effect of reactive oxygen species scavengers on the photo-induced biofilm reduction showed that Tiron (a specific O-2(center dot-) scavenger) is most effective than sodium azide (a specific O-1(2) quencher). This suggests that O-2(center dot-) formed by electron transfer quenching of the AQs excited states, is the main photosensitizing mechanism involved in the photoinduced antibiofilm activity, whereas O-1(2) participation seems of lesser importance.	[Marioni, Juliana; Comini, Laura R.; Cabrera, Jose L.; Paraje, Maria G.; Nunez Montoya, Susana C.] Univ Nacl Cordoba, CONICET, IMBIV, Cordoba, Argentina; [Marioni, Juliana; Comini, Laura R.; Cabrera, Jose L.; Nunez Montoya, Susana C.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Ciencias Farmaceut, Cordoba, Argentina; [Bresoli-Obach, Roger; Agut, Montserrat; Nonell, Santi] Univ Ramon Llull, Inst Quim Sarria, Barcelona, Spain; [Paraje, Maria G.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Catedra Microbiol, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Universitat Ramon Llull; Institut Quimic de Sarria; National University of Cordoba	Montoya, SC (corresponding author), Univ Nacl Cordoba, CONICET, IMBIV, Cordoba, Argentina.; Montoya, SC (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Ciencias Farmaceut, Cordoba, Argentina.; Nonell, S (corresponding author), Univ Ramon Llull, Inst Quim Sarria, Barcelona, Spain.	santi.nonell@iqs.url.edu; sununez@fcq.unc.edu.ar	Comini, Laura Raquel/AAP-3720-2021; Agut, Montserrat/L-5905-2013; Obach, Roger Bresoli/ABG-5022-2020	Agut, Montserrat/0000-0001-9173-9684; MARIONI, JULIANA/0000-0002-4404-0800; Bresoli-Obach, Roger/0000-0002-7819-7750	Fondo para investigacion Cientifica y Tecnologica [2204]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [GI 4316/2013]; Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba, Categoria [203/14]; Ministerio de Economia y Competitividad [CTQ2013-48767-C3-1-R]; European Social Funds; SUR del DEC de la Generalitat de Catalunya [2016 FI_B1 00021]	Fondo para investigacion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba, Categoria; Ministerio de Economia y Competitividad(Spanish Government); European Social Funds(European Social Fund (ESF)); SUR del DEC de la Generalitat de Catalunya	This study was funded by Fondo para investigacion Cientifica y Tecnologica. Plan Argentina Innovadora 2020, tipo A, PICT 2014 no 2204, http://www.agencia.mincyt.gob.ar/frontend/ agencia/fondo/foncyt JLC; Consejo Nacional de Investigaciones Cientificas y Tecnicas, PIP 2013-2015, s/ res. GI 4316/2013, http://www.conicet. gov.ar/ JLC; Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba, Categoria A, s/ res. no 203/14, http:http://www.unc.edu.ar/investigacion/finarciamiento/subsidios-e-incentivos SCNM; Ministerio de Economia y Competitividad, CTQ2013-48767-C3-1-R, http://ww.mineco.gob.es/portal/site/mineco/idi SN.; J. Marioni is a research fellow of CONICET. L.R. Comini, M.G. Paraje, J.L. Cabrera and S.C. Nunez Montoya are members of the Research Career of CONICET. R.B.-O. thanks the European Social Funds and the SUR del DEC de la Generalitat de Catalunya for his predoctoral fellowship (2016 FI_B1 00021).	Allevato MA., 2006, ACT TERAP DERMATOL, V29, P302; Peralta MA, 2015, PHYTOMEDICINE, V22, P975, DOI 10.1016/j.phymed.2015.07.003; Villegas NA, 2015, TOXICOL IN VITRO, V29, P1692, DOI 10.1016/j.tiv.2015.06.025; Bacigalupo NM., 1993, FLORA PROVINCIA JUJU, P375; Berry D, 2015, P NATL ACAD SCI USA, V112, pE194, DOI 10.1073/pnas.1420406112; Bizerra FC, 2008, FEMS YEAST RES, V8, P442, DOI 10.1111/j.1567-1364.2007.00347.x; BORS W, 1979, BIOCHIM BIOPHYS ACTA, V582, P537, DOI 10.1016/0304-4165(79)90145-4; Calzavara-Pinton P, 2012, PHOTOCHEM PHOTOBIOL, V88, P512, DOI 10.1111/j.1751-1097.2012.01107.x; Cieplik F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00405; Clinical and Laboratory Standards Institute (CLSI), 2002, M27A2 CLSI; Comini LR, 2007, J PHOTOCH PHOTOBIO A, V188, P185, DOI 10.1016/j.jphotochem.2006.12.011; Davids LM, 2008, J PHOTOCH PHOTOBIO B, V91, P67, DOI 10.1016/j.jphotobiol.2008.01.011; Dijkstra AT, 2001, J EUR ACAD DERMATOL, V15, P550, DOI 10.1046/j.1468-3083.2001.00333.x; Eisfeld A, 2006, CHEM PHYS, V324, P376, DOI 10.1016/j.chemphys.2005.11.015; Goldani LZ, 2003, J INFECTION, V46, P155, DOI 10.1053/jinf.2002.1067; Gonzalez F Pereira, 2011, FUNGAL BIOL, V116, P1; Gouloumis A, 2006, J AM CHEM SOC, V128, P12674, DOI 10.1021/ja055344+; Jimenez-Banzo A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1003, DOI 10.1039/b804333g; Kahler C P, 2000, Blood Cells Mol Dis, V26, P626, DOI 10.1006/bcmd.2000.0340; Khan MSA, 2010, COMBATING FUNGAL INFECTIONS: PROBLEMS AND REMEDY, P21, DOI 10.1007/978-3-642-12173-9_2; Konigheim BS, 2012, LAT AM J PHARM, V31, P51; Lopez-Chicon P, 2012, PHOTOCH PHOTOBIO SCI, V11, P1099, DOI 10.1039/c2pp25105a; Marioni J, 2016, PHARM BIOL, V54, P2791, DOI 10.1080/13880209.2016.1183683; Marioni J, 2016, PHYTOMEDICINE, V23, P1321, DOI 10.1016/j.phymed.2016.07.008; Marti C, 1996, J PHOTOCH PHOTOBIO A, V97, P11, DOI 10.1016/1010-6030(96)04321-3; Montoya SC, 2006, ACTA FARM BONAER, V25, P252; Montoya SCN, 2005, J PHOTOCH PHOTOBIO B, V78, P77, DOI 10.1016/j.jphotobiol.2004.09.009; Montoya SCN, 2003, PHYTOMEDICINE, V10, P569, DOI 10.1078/094471103322331854; Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683; Montoya SCN, 2006, J NAT PROD, V69, P801, DOI 10.1021/np050181o; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Paz-Cristobal MP, 2014, MYCOSES, V57, P35, DOI 10.1111/myc.12099; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Price M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1177, DOI 10.1111/j.1751-1097.2009.00555.x; Ragas X, 2010, FREE RADICAL BIO MED, V49, P770, DOI 10.1016/j.freeradbiomed.2010.05.027; Rajendran M, 2016, PHOTODIAGN PHOTODYN, V13, P175, DOI 10.1016/j.pdpdt.2015.07.177; Ramage Gordon, 2012, Int J Microbiol, V2012, P528521, DOI 10.1155/2012/528521; SCHMIDT R, 1994, J PHOTOCH PHOTOBIO A, V79, P11, DOI 10.1016/1010-6030(93)03746-4; Shida T., 1988, PHYS SCI DATA, V34; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Snyder JW, 2006, PHYS CHEM CHEM PHYS, V8, P4280, DOI 10.1039/b609070m; Zhang YS, 2016, VIRULENCE, V7, P536, DOI 10.1080/21505594.2016.1155015	42	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181517	10.1371/journal.pone.0181517	http://dx.doi.org/10.1371/journal.pone.0181517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723923	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800057
J	Park, H; Lee, D; Chey, J				Park, Heyeon; Lee, Daeyeol; Chey, Jeanyung			Stress enhances model-free reinforcement learning only after negative outcome	PLOS ONE			English	Article							DECISION-MAKING; PREFRONTAL CORTEX; SOCIAL STRESS; HPA AXIS; HUMANS; HIPPOCAMPUS; STRATEGIES; PREDICTION; DOPAMINE; MEMORIES	Previous studies found that stress shifts behavioral control by promoting habits while decreasing goal-directed behaviors during reward-based decision-making. It is, however, unclear how stress disrupts the relative contribution of the two systems controlling rewardseeking behavior, i.e. model-free (or habit) and model-based (or goal-directed). Here, we investigated whether stress biases the contribution of model-free and model-based reinforcement learning processes differently depending on the valence of outcome, and whether stress alters the learning rate, i.e., how quickly information from the new environment is incorporated into choices. Participants were randomly assigned to either a stress or a control condition, and performed a two-stage Markov decision-making task in which the reward probabilities underwent periodic reversals without notice. We found that stress increased the contribution of model-free reinforcement learning only after negative outcome. Furthermore, stress decreased the learning rate. The results suggest that stress diminishes one's ability to make adaptive choices in multiple aspects of reinforcement learning. This finding has implications for understanding how stress facilitates maladaptive habits, such as addictive behavior, and other dysfunctional behaviors associated with stress in clinical and educational contexts.	[Park, Heyeon; Chey, Jeanyung] Seoul Natl Univ, Dept Psychol, Seoul, South Korea; [Lee, Daeyeol] Yale Sch Med, Dept Psychiat, Dept Neurosci, New Haven, CT USA; [Lee, Daeyeol] Yale Univ, Dept Psychol, New Haven, CT USA; [Park, Heyeon] Seoul Natl Univ, Bundang Hosp, Dept Publ Hlth Med Serv, Seongnam, South Korea	Seoul National University (SNU); Yale University; Yale University; Seoul National University (SNU)	Chey, J (corresponding author), Seoul Natl Univ, Dept Psychol, Seoul, South Korea.	jychey@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0005029]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (No. 2011-0005029). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akam T, 2015, BIORXIV, DOI DOI 10.1101/021428; Akam T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004648; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Cavanagh JF, 2011, SOC COGN AFFECT NEUR, V6, P311, DOI 10.1093/scan/nsq041; Cohen S., 1988, SOC PSYCH HLTH CLAR; Costa VD, 2015, J NEUROSCI, V35, P2407, DOI 10.1523/JNEUROSCI.1989-14.2015; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Doll BB, 2012, CURRENT OPINION NEUR; Ferragud A, 2010, BEHAV BRAIN RES, V210, P134, DOI 10.1016/j.bbr.2010.02.013; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Ito M, 2009, J NEUROSCI, V29, P9861, DOI 10.1523/JNEUROSCI.6157-08.2009; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lee D, 2013, NEURON, V78, P233, DOI 10.1016/j.neuron.2013.04.008; Lighthall NR, 2013, PSYCHOL AGING, V28, P35, DOI 10.1037/a0029823; Mendelson JH, 2005, NEUROPSYCHOPHARMACOL, V30, P1751, DOI 10.1038/sj.npp.1300753; Otto AR, 2013, P NATL ACAD SCI USA, V110, P20941, DOI 10.1073/pnas.1312011110; Penner MR, 2012, PROG NEUROBIOL, V96, P96, DOI 10.1016/j.pneurobio.2011.08.010; Porcelli AJ, 2009, PSYCHOL SCI, V20, P278, DOI 10.1111/j.1467-9280.2009.02288.x; Radenbach C, 2015, PSYCHONEUROENDOCRINO, V53, P268, DOI 10.1016/j.psyneuen.2014.12.017; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Sang W Lee, 2014, NEURON, V81, P687; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P495, DOI 10.1016/j.nlm.2008.07.015; Schwabe L, 2007, LEARN MEMORY, V14, P109, DOI 10.1101/lm.435807; Schwabe L, 2010, J COGNITIVE NEUROSCI, V22, P1362, DOI 10.1162/jocn.2009.21278; Schwabe L, 2009, J NEUROSCI, V29, P7191, DOI 10.1523/JNEUROSCI.0979-09.2009; Simon D.A., 2011, ADV NEURAL INFORM PR, V24, P127; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Worbe Y, 2016, MOL PSYCHIATR, V21, P624, DOI 10.1038/mp.2015.46	37	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180588	10.1371/journal.pone.0180588	http://dx.doi.org/10.1371/journal.pone.0180588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723943	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800019
J	Yu, MY; Lee, SW; Baek, SH; Na, KY; Chae, DW; Chin, HJ; Kim, S				Yu, Mi-yeon; Lee, Sung Woo; Baek, Seon Ha; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun; Kim, Sejoong			Hypoalbuminemia at admission predicts the development of acute kidney injury in hospitalized patients: A retrospective cohort study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; NITRIC-OXIDE; SERUM-ALBUMIN; RISK-FACTOR; SURVIVAL; RESUSCITATION; METAANALYSIS; OUTCOMES; SURGERY	Background Development of acute kidney injury (AKI) is common and is associated with poor outcomes. We aimed to determine whether hypoalbuminemia (HA) at admission could be a risk factor for the development of AKI and mortality in hospitalized patients. Methods We enrolled patients who were admitted to Seoul National University Bundang Hospital from January 2013 to December 2013. HA at admission was defined as a serum albumin level < 3.4 mg/dL measured within two days after admission. AKI was defined as an increase in the serum creatinine level by >= 0.3 mg/dL or >= 1.5 times of the baseline value during the hospital stay. Results A total of 19,472 patients were enrolled and divided into HA and normoalbuminemia (NA) groups at admission. The incidence of AKI was 10.7% (340/3179) in the HA group and 4.1% (662/16293) in the NA group (adjusted odds ratio [OR], 1.243; 95% confidence interval [CI], 1.069 +/- 1.445; P = 0.005). The hazard ratios for the 30-day, 90-day, and 1-year mortality were 1.873 (95% CI, 1.383 +/- 2.537; P < 0.001), 1.710 (95% CI, 1.410 +/- 2.072; P < 0.001), and 1.372 (95% CI, 1.214 +/- 1.551; P < 0.001), compared to the NA group. In patients with AKI, albumin replacement improved renal recovery (OR, 2.605; 95% CI, 1.450 +/- 4.681; P = 0.001). The mortality rate was not different according to albumin replacement. Conclusions HA is associated with the development of AKI and high mortality in hospitalized patients. Replacement of albumin after the development of AKI may contribute to renal recovery. Further clinical trials are warranted.	[Yu, Mi-yeon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Sung Woo] Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea; [Baek, Seon Ha] Hallym Univ, Dept Internal Med, Dongtan Sacred Heart Hosp, Gyeonggi Do, South Korea; [Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun; Kim, Sejoong] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Eulji University; Hallym University; Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.	sejoong2@snu.ac.kr	Yu, Mi-Yeon/ABB-7937-2021; Kim, Sejoong/J-5356-2015	Kim, Sejoong/0000-0002-7238-9962	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C2221]; National Research Foundation of Korea [2017R1A2B4005251]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by the a grand of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C2221), and a grant No. 2017R1A2B4005251 from the National Research Foundation of Korea.	Asher V, 2012, MED ONCOL, V29, P2005, DOI 10.1007/s12032-011-0019-5; Baek SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156444; Berbel MN, 2011, REV ASSOC MED BRAS, V57, P600, DOI 10.1590/S0104-42302011000500022; Brown JR, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4278579; BURLESON RL, 1978, ARCH SURG-CHICAGO, V113, P688; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Chawla LS, 2005, KIDNEY INT, V68, P2274, DOI 10.1111/j.1523-1755.2005.00686.x; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; CONTRERAS AM, 1994, REV INVEST CLIN, V46, P37; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P207, DOI 10.1177/0148607191015002207; Duly EB, 2003, J CLIN PATHOL, V56, P780, DOI 10.1136/jcp.56.10.780; Frenette AJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0602-1; GERKENS JF, 1990, EUR J PHARMACOL, V177, P119, DOI 10.1016/0014-2999(90)90261-4; Hollenberg SM, 1997, AM J PHYSIOL-REG I, V272, pR969, DOI 10.1152/ajpregu.1997.272.3.R969; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Igleslas J, 1999, AM J PHYSIOL-RENAL, V277, pF711, DOI 10.1152/ajprenal.1999.277.5.F711; Jellinge ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105983; Kellum JA, 2017, AM J RESP CRIT CARE, V195, P784, DOI 10.1164/rccm.201604-0799OC; Kellum JA, 2016, AM J RESP CRIT CARE, V193, P281, DOI 10.1164/rccm.201505-0995OC; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Lee EH, 2016, ANESTHESIOLOGY, V124, P1001, DOI 10.1097/ALN.0000000000001051; Lee EH, 2012, INTENS CARE MED, V38, P1478, DOI 10.1007/s00134-012-2599-8; Lee SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162990; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; Lopes JA, 2013, CLIN KIDNEY J, V6, P8, DOI 10.1093/ckj/sfs160; Lyons O, 2010, EUR J INTERN MED, V21, P17, DOI 10.1016/j.ejim.2009.10.010; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; POCKAJ BA, 1994, J IMMUNOTHER, V15, P22, DOI 10.1097/00002371-199401000-00003; Pulimood TB, 2000, CRIT CARE, V4, P151, DOI 10.1186/cc688; ROTHMAN KJ, 1974, AM J EPIDEMIOL, V99, P385, DOI 10.1093/oxfordjournals.aje.a121626; Sang BH, 2015, CRIT CARE MED, V43, P2552, DOI 10.1097/CCM.0000000000001279; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Sung J, 2004, AM SURGEON, V70, P1099; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Tsai HS, 2014, ACTA CARDIOL SIN, V30, P93; Wiedermann CJ, 2010, INTENS CARE MED, V36, P1657, DOI 10.1007/s00134-010-1928-z; Wilkes MM, 2001, ANN INTERN MED, V135, P149, DOI 10.7326/0003-4819-135-3-200108070-00007; Zamlauski-Tucker M, 1988, Ren Physiol, V10, P352	42	28	30	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180750	10.1371/journal.pone.0180750	http://dx.doi.org/10.1371/journal.pone.0180750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723973	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800022
J	Paiva, JS; Dias, D; Cunha, JPS				Paiva, Joana S.; Dias, Duarte; Cunha, Joao P. S.			Beat-ID: Towards a computationally low-cost single heartbeat biometric identity check system based on electrocardiogram wave morphology	PLOS ONE			English	Article							QT INTERVAL; ECG; RECOGNITION; CLASSIFICATION; IDENTIFICATION; SIGNAL; TIME; VERIFICATION; COMPLEX; AUTHENTICATION	In recent years, safer and more reliable biometric methods have been developed. Apart from the need for enhanced security, the media and entertainment sectors have also been applying biometrics in the emerging market of user-adaptable objects/systems to make these systems more user-friendly. However, the complexity of some state-of-the-art biometric systems (e.g., iris recognition) or their high false rejection rate (e.g., fingerprint recognition) is neither compatible with the simple hardware architecture required by reduced-size devices nor the new trend of implementing smart objects within the dynamic market of the Internet of Things (IoT). It was recently shown that an individual can be recognized by extracting features from their electrocardiogram (ECG). However, most current ECG-based biometric algorithms are computationally demanding and/or rely on relatively large (several seconds) ECG samples, which are incompatible with the aforementioned application fields. Here, we present a computationally low-cost method (patent pending), including simple mathematical operations, for identifying a person using only three ECG morphology-based characteristics from a single heartbeat. The algorithm was trained/tested using ECG signals of different duration from the Physionet database on more than 60 different training/test datasets. The proposed method achieved maximal averaged accuracy of 97.450% in distinguishing each subject from a ten-subject set and false acceptance and rejection rates (FAR and FRR) of 5.710 +/- 1.900% and 3.440 +/- 1.980%, respectively, placing Beat-ID in a very competitive position in terms of the FRR/FAR among state-of-the-art methods. Furthermore, the proposed method can identify a person using an average of 1.020 heartbeats. It therefore has FRR/FAR behavior similar to obtaining a fingerprint, yet it is simpler and requires less expensive hardware. This method targets low-computational/energy-cost scenarios, such as tiny wearable devices (e.g., a smart object that automatically adapts its configuration to the user). A hardware proof-of concept implementation is presented as an annex to this paper.	[Paiva, Joana S.; Dias, Duarte; Cunha, Joao P. S.] NESC Technol & Sci, Biomed Res & Nnovat BRAIN, C BER, Oporto, Portugal; [Paiva, Joana S.] Univ Porto, Fac Sci, Phys & Astron Dept, Oporto, Portugal; [Cunha, Joao P. S.] Univ Porto, Fac Engn, Oporto, Portugal	Universidade do Porto; Universidade do Porto	Cunha, JPS (corresponding author), NESC Technol & Sci, Biomed Res & Nnovat BRAIN, C BER, Oporto, Portugal.; Cunha, JPS (corresponding author), Univ Porto, Fac Engn, Oporto, Portugal.	jcunha@ieee.org	Paiva, Joana S./AAD-7356-2021; Cunha, João Paulo/AAL-1526-2021; Cunha, Joao Paulo/F-9039-2010	S. Paiva, Joana/0000-0003-0413-587X; Cunha, Joao Paulo/0000-0003-4131-9045; Dias, Duarte/0000-0002-8119-258X	National Funds through the FCT (Portuguese Foundation for Science and Technology) within the project VR2Market [CMUP-ERI/FIA/0031/2013]; National Funds through the FCT (Portuguese Foundation for Science and Technology) within the FCT grant [PD/BD/135023/2017]; North Portugal Regional Operational Program (NORTE) under the PORTUGAL Partnership Agreement; North Portugal Regional Operational Program (NORTE) through the European Regional Development Fund (ERDF); National Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) within the project VR2Market [CMUP-ERI/FIA/0031/2013]; National Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) within the FCT PhD grant [PD/BD/135023/2017]	National Funds through the FCT (Portuguese Foundation for Science and Technology) within the project VR2Market; National Funds through the FCT (Portuguese Foundation for Science and Technology) within the FCT grant; North Portugal Regional Operational Program (NORTE) under the PORTUGAL Partnership Agreement; North Portugal Regional Operational Program (NORTE) through the European Regional Development Fund (ERDF); National Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) within the project VR2Market; National Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) within the FCT PhD grant	This work is financed by National Funds through the FCT (Portuguese Foundation for Science and Technology) within the project VR2Market CMUP-ERI/FIA/0031/2013 and within the FCT grant PD/BD/135023/2017. It is also partly developed under the project NanoSTIMA, funded by the North Portugal Regional Operational Program (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, and through the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is financed by National Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) within the project VR2Market CMUP-ERI/FIA/0031/2013 and within the FCT PhD grant PD/BD/135023/2017. It is also partly developed under the project NanoSTIMA, funded by the North Portugal Regional Operational Program (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, and through the European Regional Development Fund (ERDF). The authors would also like to thank Paulo Azevedo and Pedro Pinto da Silva.	Afifi S., 2015, P PAC RIM S IM VID T, P235; Agrafioti F, 2014, SYSTEM METHOD ENABLI; Agrafioti F, 2009, SIGNAL IMAGE VIDEO P, V3, P329, DOI 10.1007/s11760-008-0073-4; Akhbari M, 2013, INT CONF ACOUST SPEE, P1257, DOI 10.1109/ICASSP.2013.6637852; Andrassy Gabor, 2009, Orvosi Hetilap, V150, P447, DOI 10.1556/OH.2009.28537; [Anonymous], 2004, STAT PATTERN RECOGNI; [Anonymous], ADV METHODS TOOLS EC, DOI DOI 10.1186/1475-925X-6-18; [Anonymous], 2012, INT J COMPUTER ELECT, DOI DOI 10.7763/IJCEE.2012.V4.522; Araujo T, 2015, ADV INTELL SYST, V318, P301, DOI 10.1007/978-3-319-12610-4_19; Ashok J., 2010, INT J COMPUTER SCI E, V2, P2402; Baier J, 2012, SYSTEM METHODOLOGY P; Basil T, 2014, EUR SIGNAL PR CONF, P1542; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Benyon D., 2005, DESIGNING INTERACTIV; Berini D, 2016, MULTIBIOMETRIC ENROL; Bhatia R., 2013, INT J ADV RES COMPUT, V3; Bhide A, 2016, INT J MEDICAL SCI PU, V5; Biel L, 2001, IEEE T INSTRUM MEAS, V50, P808, DOI 10.1109/19.930458; Bishop CM, 2006, PATTERN RECOGNITION, V1; Blount M, 2007, IBM SYST J, V46, P95, DOI 10.1147/sj.461.0095; Boumbarov O, 2009, INT WORKSH INT DATA, P446, DOI 10.1109/IDAACS.2009.5342942; Bousseljot R., 1995, BIOMED TECH, V40, P317, DOI DOI 10.1515/BMTE.1995.40.S1.317; Brumback C, 2014, BIOMETRIC SENSING DE; Carvalho J, 2015, PR INT CONF INF WAR, P66; Cetingul HE, 2006, SIGNAL PROCESS, V86, P3549, DOI 10.1016/j.sigpro.2006.02.045; CHAITMAN BR, 1979, CIRCULATION, V59, P560, DOI 10.1161/01.CIR.59.3.560; Chen CH, 2006, LECT NOTES COMPUT SC, V3832, P571; Chun SY, 2016, 2016 39TH INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS AND SIGNAL PROCESSING (TSP), P656, DOI 10.1109/TSP.2016.7760964; Cogill S, 2016, BIOINFORMATICS, V32, P3611, DOI 10.1093/bioinformatics/btw498; Coyle D., 2014, CONTROL PANEL; Cunha J.P.S., 2010, 4 INT ICST C PERVASI, V6, P1; Cunha Joao Paulo Silva, 2012, Stud Health Technol Inform, V177, P185; Cunha JPS, 2016, BIOMETRIC METHOD DEV; Da Silva H.P., 2013, BIOM THEOR APPL SYST, P1, DOI [10.1109/BTAS.2013.6712689, DOI 10.1109/BTAS.2013.6712689]; Das R., 2014, BIOMETRIC TECHNOLOGY; De Luca A., 2012, P SIGCHI C HUM FACT, P987, DOI DOI 10.1145/2207676.2208544; de Sa J. P. M., 2001, PATTERN RECOGN; Deepthi A, 2015, COMPUSOFT, V4, P1890; Derawi M. O., 2010, Proceedings of the 2010 Sixth International Conference on Intelligent Information Hiding and Multimedia Signal Processing (IIHMSP 2010), P306, DOI 10.1109/IIHMSP.2010.83; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Fatemian S.Z., 2009, 16 INT C DIG SIGN PR, P1, DOI DOI 10.1109/ICDSP.2009.5201143; FROELICHER VF, 1976, CHEST, V70, P611, DOI 10.1378/chest.70.5.611; Fyke S, 2012, SHAPE ADAPTABLE SURF; Fyke S, 2011, USING SHAPE CHANGING; Gamassi M, 2005, IEEE T INSTRUM MEAS, V54, P1489, DOI 10.1109/TIM.2005.851087; Gao ZK, 2017, PHYSICA A, V476, P43, DOI 10.1016/j.physa.2017.02.038; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gargiulo F, 2015, COMPUT METH PROG BIO, V121, P127, DOI 10.1016/j.cmpb.2015.05.012; Ghorai S, 2017, COMPUT COMMUN, P325; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; HAMILTON PS, 1986, IEEE T BIO-MED ENG, V33, P1157, DOI 10.1109/TBME.1986.325695; Hassan M, 2015, ASIAN J APPL SCI, V3; Hejazi M, 2015, APPL ARTIF INTELL, V29, P660, DOI 10.1080/08839514.2015.1051887; Hjelm J, 2014, COMMUNICATION APPARA; HOLMES J, 1991, PERFORMANCE EVALUATI; Huerta-Franco MR, 2015, J PHYS CONF SER, V582, DOI 10.1088/1742-6596/582/1/012040; Irvine J. M., 2009, EURASIP J ADV SIG PR, V2009, P1, DOI DOI 10.1155/2009/243215; Israel SA, 2005, PATTERN RECOGN, V38, P133, DOI 10.1016/j.patcog.2004.05.014; Jadhav M, 2015, INT J ADV RES ELECT, V4; Jain AK, 2004, IEEE T CIRC SYST VID, V14, P4, DOI 10.1109/TCSVT.2003.818349; Jain AK, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0254; Jallad AHM, 2014, NASA ESA CONF, P256, DOI 10.1109/AHS.2014.6880185; Jarad M, 2014, INT CONF COMP SCI, P189, DOI 10.1109/CSIT.2014.6805999; Jeon T, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-160; Kakadiaris IA, 2007, IEEE T PATTERN ANAL, V29, P640, DOI 10.1109/TPAMI.2007.1017; Kandgaonkar T. V., 2015, IBMRDS J MANAGEMENT, V4, p88?103; Kang SJ, 2016, IEEE SIGNAL PROC LET, V23, P805, DOI 10.1109/LSP.2016.2531996; Karmakar C, 2014, COMPUT CARDIOL CONF, V41, P1009; Karthikeyan P., 2012, INT J ELECT ENG INF, V4, P306, DOI DOI 10.15676/IJEEI.2012.4.2.9; Kaur G, 2015, INT J EMERGING RES M, V4, P202; Kennedy AP, 2015, DRUG ALCOHOL DEPEN, V151, P159, DOI 10.1016/j.drugalcdep.2015.03.024; Kephart J., 2013, BIOMETRIC EXIT TRACK; Kohler BU, 2002, IEEE ENG MED BIOL, V21, P42, DOI 10.1109/51.993193; Korurek M, 2010, EXPERT SYST APPL, V37, P7563, DOI 10.1016/j.eswa.2010.04.087; Kreiseler, 1995, BIOMED TECH, V40, P319, DOI DOI 10.1515/bmte.1995.40.s1.319; Kyoso M, 2001, P ANN INT IEEE EMBS, V23, P3721, DOI 10.1109/IEMBS.2001.1019645; Lajevardi SM, 2013, IEEE T IMAGE PROCESS, V22, P3625, DOI 10.1109/TIP.2013.2266257; Lange D, 2014, ELECTROBIOMETRIC AUT; Lange D., 2006, ETHOD APPARATUS ELEC; Lange D, 2014, MULTIELECROBIOMETRIC; Lenkarski L, 2011, BASE FRAME GAME USIN; Li HQ, 2016, CIRC SYST SIGNAL PR, V35, P1187, DOI 10.1007/s00034-015-0108-3; Li X, 2004, NUCLEIC ACIDS RES, V32, P2685, DOI 10.1093/nar/gkh563; Liu Y, 2015, PAC AS C INF SYST; Liu Y, 2006, PATTERN RECOGN, V39, P1333, DOI 10.1016/j.patcog.2005.10.006; Loong J. L. C., 2010, WORLD ACAD SCI ENG T, V68, P759; Lourenco A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/720971; Ma L, 2003, IEEE T PATTERN ANAL, V25, P1519, DOI 10.1109/TPAMI.2003.1251145; Maglaveras N, 1998, INT J MED INFORM, V52, P191, DOI 10.1016/S1386-5056(98)00138-5; Mammadova N, 2013, SCI WORLD J, DOI 10.1155/2013/603897; Mansfield T., 2001, BIOMETRIC AUTHENTICA; Meng WZ, 2015, IEEE COMMUN SURV TUT, V17, P1268, DOI 10.1109/COMST.2014.2386915; Munich ME, 2003, IEEE T PATTERN ANAL, V25, P200, DOI 10.1109/TPAMI.2003.1177152; Nacke L, 2009, P DIGRA; Negin M, 2000, COMPUTER, V33, P70, DOI 10.1109/2.820042; Odinaka I, 2012, IEEE T INF FOREN SEC, V7, P1812, DOI 10.1109/TIFS.2012.2215324; Paiva JS, 2016, IEEE ENG MED BIO, P3378, DOI 10.1109/EMBC.2016.7591452; Pal A, 2015, PROCEDIA COMPUT SCI, V48, P746, DOI 10.1016/j.procs.2015.04.211; Palaniappan R, 2006, PATTERN RECOGN LETT, V27, P726, DOI 10.1016/j.patrec.2005.10.020; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Patrick AS., 2008, FINGERPRINT CONCERNS; Paulet MV, 2015, 2015 9TH INTERNATIONAL SYMPOSIUM ON ADVANCED TOPICS IN ELECTRICAL ENGINEERING (ATEE), P281, DOI 10.1109/ATEE.2015.7133780; Pei L, 2012, SENSORS-BASEL, V12, P6155, DOI 10.3390/s120506155; Peralta D, 2015, INFORM SCIENCES, V315, P67, DOI 10.1016/j.ins.2015.04.013; Phan DQ, 2015, J PEDIATR-US, V166, P960, DOI 10.1016/j.jpeds.2014.12.037; Phua K, 2008, PATTERN RECOGN, V41, P906, DOI 10.1016/j.patcog.2007.07.018; Plataniotis Konstantinos N., 2006, 2006 BIOMETRICS S SP, P1; Prabhakar S, 2002, PATTERN RECOGN, V35, P861, DOI 10.1016/S0031-3203(01)00103-0; Rani P, 2006, PATTERN ANAL APPL, V9, P58, DOI 10.1007/s10044-006-0025-y; Rani R, 2015, INT J COMPUT SCI NET, V15, P1; Ribaric S, 2005, IEEE T PATTERN ANAL, V27, P1698, DOI 10.1109/TPAMI.2005.209; Riester M, 2012, CLIN CANCER RES, V18, P1323, DOI 10.1158/1078-0432.CCR-11-2271; Sagi-Dolev A., 2001, INTERACTIVE INTERFAC; Sakr GE, 2016, 2016 IEEE INTERNATIONAL MULTIDISCIPLINARY CONFERENCE ON ENGINEERING TECHNOLOGY (IMCET), P207, DOI 10.1109/IMCET.2016.7777453; Shen TW, 2002, P ANN INT IEEE EMBS, P62; Silva H, 2013, DEVICE METHOD CONTIN; Silva H, 2011, CLIN DATA PRIVACY CU; Simon BP, 1997, COMPUT BIOMED RES, V30, P257, DOI 10.1006/cbmr.1997.1446; Singh Y. N., 2012, J INFORM SECURITY, V3, P39; Singh YN, 2008, 2008 IEEE SECOND INTERNATIONAL CONFERENCE ON BIOMETRICS: THEORY, APPLICATIONS AND SYSTEMS (BTAS), P72; Sriram J. C., 2009, P 2009 INT C MULT IN, P297, DOI DOI 10.1145/1647314.1647378; Subban Ravi, 2013, Lecture Notes on Software Engineering, V1, P209, DOI 10.7763/LNSE.2013.V1.47; Sufi F, 2010, HANDBOOK OF INFORMATION AND COMMUNICATION SECURITY, P309, DOI 10.1007/978-3-642-04117-4_17; Supriya G, 2015, IJAR, V1, P1067; Vaidya M., 2015, INT J INNOVATIONS EN, V5, P235; Voss A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118308; Wang L, 2007, IET COMPUT VIS, V1, P113, DOI 10.1049/iet-cvi:20070009; Wang YJ, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/148658; Wayman J, 2005, INTRO BIOMETRIC AUTH; Weising G., 2011, BIOMETRIC INTERFACE; Wildes RP, 1997, P IEEE, V85, P1348, DOI 10.1109/5.628669; Woodard DL, 2005, COMPUT VIS IMAGE UND, V100, P357, DOI 10.1016/j.cviu.2005.06.003; Wuebbeler G, 2004, WORKING GROUP 8 42 P, V8; Wubbeler G, 2007, PATTERN RECOGN LETT, V28, P1172, DOI 10.1016/j.patrec.2007.01.014; Yang Ming, 2013, Comput Math Methods Med, V2013, P971272, DOI 10.1155/2013/971272; Ye C, 2011, P 4 INT S APPL SCI B; Ye C, 2012, IEEE T BIO-MED ENG, V59, P2930, DOI 10.1109/TBME.2012.2213253; Zhang L, 2000, CIRCULATION, V102, P2849; Ziauddin S, 2008, IEEE IMAGE PROC, P277, DOI 10.1109/ICIP.2008.4711745	141	21	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180942	10.1371/journal.pone.0180942	http://dx.doi.org/10.1371/journal.pone.0180942			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719614	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400024
J	Sevrin, T; Alexandre-Gouabau, MC; Darmaun, D; Palvadeau, A; Andre, A; Nguyen, P; Ouguerram, K; Boquien, CY				Sevrin, Thomas; Alexandre-Gouabau, Marie-Cecile; Darmaun, Dominique; Palvadeau, Antoine; Andre, Agnes; Nguyen, Patrick; Ouguerram, Khadija; Boquien, Clair-Yves			Use of water turnover method to measure mother's milk flow in a rat model: Application to dams receiving a low protein diet during gestation and lactation	PLOS ONE			English	Article							TOTAL-BODY WATER; DEUTERIUM-OXIDE; RESTRICTION; GROWTH; METABOLISM; INSULIN; YIELD; O-18; LIFE; H-2	Assessment of milk production is of utmost relevance for pediatricians and scientists interested in early life nutrition. The weight-suckle-weight (WSW) method, which consists of weighing babies before and after they suckle their mother, uses the difference in body weight as an estimate of milk intake. However, this is prone to many sources of error. In the current study, we used for the first time the water turnover method and compartmental analysis with deuterated water (D2O) as a non-toxic tracer to quantify in vivo milk production in a rat model. We assessed the effect of a nutritional intervention presumed to affect milk production, a maternal dietary protein restriction during gestation and lactation, which results in the birth of pups with intrauterine growth restriction. The specific aim of this study was to determine milk production with the body water turnover method in rat dams receiving during gestation and lactation, either a control diet (NP) or an iso-caloric low-protein diet (LP). In NP dams, mass of dam's total body water, output flow constant from dam to litter (K21) and median milk flow, calculated between days 11 to 14 after pup birth, were 282.1 g, 0.0122 h(-1) and 3.30 g/h for NP dams, respectively. Maternal dietary protein restriction (-59%) during perinatal period led to a 34% reduction in milk flow (NP versus LP). With the WSW method, milk flow varied from 1.96 g/h to 2.37 g/h between days 11 to 14 for NP dams. The main advantage of the D(2)0 method compared to the WSW method stems from its higher precision, as attested by the narrowest range of measured values of milk flow ([2.90; 3.75] and [0.98; 6.85] g/h, respectively) for NP group. This method could be suitable for testing the effectiveness of candidate galactologue molecules presumed to enhance milk production in the lactating rat model.	[Sevrin, Thomas; Alexandre-Gouabau, Marie-Cecile; Darmaun, Dominique; Palvadeau, Antoine; Ouguerram, Khadija; Boquien, Clair-Yves] Univ Nantes, UMR PhAN, INRA, CRNH Ouest, Nantes, France; [Darmaun, Dominique] CHU Hotel Dieu, Nantes Hosp, CRNH Ouest, IMAD,DHU2020, Nantes, France; [Andre, Agnes; Nguyen, Patrick] Nantes Atlantic Natl Coll Vet Med, ONIRIS, UNE, Nantes, France	INRAE; Nantes Universite; Nantes Universite; CHU de Nantes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Boquien, CY (corresponding author), Univ Nantes, UMR PhAN, INRA, CRNH Ouest, Nantes, France.	clair-yves.boquien@univ-nantes.fr	Darmaun, Dominique/X-8453-2018; Boquien, Clair-Yves/AAP-5275-2020	Darmaun, Dominique/0000-0002-0366-3227; Boquien, Clair-Yves/0000-0001-6944-5372; Alexandre-Gouabau, Marie-Cecile/0000-0002-9966-9593; Sevrin, Thomas/0000-0003-2596-6998	AlimH Department of INRA (AlimH - ANSSD 2015); AlimH Department of INRA (AlimH-ANSSD 2015)	AlimH Department of INRA (AlimH - ANSSD 2015); AlimH Department of INRA (AlimH-ANSSD 2015)	The study was supported, in part, by a grant from the AlimH Department of INRA (AlimH - ANSSD 2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported, in part, by a grant from the AlimH Department of INRA (AlimH-ANSSD 2015). The authors would like to thank specifically Guillaume POUPEAU and Thomas MOYON (PhAN, INRA, Nantes, France) for animal care and for statistical analysis supervision, respectively. The authors also acknowledge Prof. Jean-Francois HUNEAU (Agro-ParisTech) for his invaluable advice in setting up the deuterated water dilution method.	Agnoux AM, 2015, J NUTR BIOCHEM, V26, P784, DOI 10.1016/j.jnutbio.2015.02.012; Agnoux AM, 2014, AM J PHYSIOL-REG I, V307, pR184, DOI 10.1152/ajpregu.00015.2014; Bautista CJ, 2008, PEDIATR RES, V63, P358, DOI 10.1203/01.pdr.0000304938.78998.21; Berman ESF, 2015, EUR J CLIN NUTR, V69, P1091, DOI 10.1038/ejcn.2015.10; BUTTE NF, 1988, AM J CLIN NUTR, V47, P815, DOI 10.1093/ajcn/47.5.815; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Fanca-Berthon P, 2009, PEDIATR RES, V66, P47, DOI 10.1203/PDR.0b013e3181a2047e; Ferrier L, 2002, J NUTR, V132, p1725S, DOI 10.1093/jn/132.6.1725S; FOY JM, 1960, J PHYSIOL-LONDON, V154, P169, DOI 10.1113/jphysiol.1960.sp006571; Haisma H, 2003, BREAST MILK ENERGY I; Hauck YL, 2011, MATERN CHILD HLTH J, V15, P260, DOI 10.1007/s10995-009-0554-2; Houdebine L- M, 2007, BIOL LACTATION; KANTO U, 1980, J NUTR, V110, P1840, DOI 10.1093/jn/110.9.1840; KLAVER J, 1981, J ANIM SCI, V52, P1091, DOI 10.2527/jas1981.5251091x; Maugeais C, 1998, CLIN CHEM LAB MED, V36, P739, DOI 10.1515/CCLM.1998.131; Morag M, 1975, Lab Anim, V9, P43, DOI 10.1258/002367775780994844; Moretto VL, 2011, ISRN OBSTET GYNECOL, V2011, DOI [10.5402/2011/876502, DOI 10.5402/2011/876502]; Salanave B., 2014, Bulletin Epidemiologique Hebdomadaire, P450; SAMPSON DA, 1984, J PEDIATR GASTR NUTR, V3, P613, DOI 10.1097/00005176-198409000-00023; Savenije OEM, 2006, ARCH DIS CHILD-FETAL, V91, P330, DOI 10.1136/adc.2005.091876; SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686; Siret V, 2008, ARCH PEDIATRIE, V15, P1167, DOI 10.1016/j.arcped.2008.04.014; Theil PK, 2002, ACTA AGR SCAND A-AN, V52, P221, DOI 10.1080/090647002762381104; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896	26	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180550	10.1371/journal.pone.0180550	http://dx.doi.org/10.1371/journal.pone.0180550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715436	Green Published, gold, Green Submitted			2022-12-27	WOS:000443975500011
J	Ateia, M; Koch, C; Jelavic, S; Hirt, A; Quinson, J; Yoshimura, C; Johnson, M				Ateia, Mohamed; Koch, Christian; Jelavic, Stanislav; Hirt, Ann; Quinson, Jonathan; Yoshimura, Chihiro; Johnson, Matthew			Green and facile approach for enhancing the inherent magnetic properties of carbon nanotubes for water treatment applications	PLOS ONE			English	Article							ACTIVATED CARBON; AQUEOUS-SOLUTION; ARSENIC REMOVAL; ONE-POT; ADSORPTION; CATALYST; NANOPARTICLES; PURIFICATION; PARTICLES; GRAPHENE	Current methods for preparing magnetic composites with carbon nanotubes (MCNT) commonly include extensive use of treatment with strong acids and result in massive losses of carbon nanotubes (CNTs). In this study we explore the potential of taking advantage of the inherent magnetic properties associated with the metal (alloy or oxide) incorporated in CNTs during their production. The as-received CNTs are refined by applying a permanent magnet to a suspension of CNTs to separate the high-magnetic fraction; the low-magnetic fraction is discarded with the solvent. The collected MCNTs were characterized by a suite of 10 diffraction and spectroscopic techniques. A key discovery is that metallic nano-clusters of Fe and/or Ni located in the interior cavities of the nanotubes give MCNTs their ferromagnetic character. After refinement using our method, the MCNTs show saturation magnetizations up to 10 times that of the as-received materials. In addition, we demonstrate the ability of these MCNTs to repeatedly remove atrazine from water in a cycle of dispersion into a water sample, adsorption of the atrazine onto the MCNTs, collection by magnetic attraction and regeneration by ethanol. The resulting MCNTs show high adsorption capacities (>40 mg-atrazine/g), high magnetic response, and straightforward regeneration. The method presented here is simpler, faster, and substantially reduces chemical waste relative to current techniques and the resulting MCNTs are promising adsorbents for organic/chemical contaminants in environmental waters.	[Ateia, Mohamed; Yoshimura, Chihiro] Tokyo Inst Technol, Dept Civil & Environm Engn, Tokyo, Japan; [Koch, Christian; Johnson, Matthew] Univ Copenhagen, Dept Chem, Univ Pk 5, Copenhagen O, Denmark; [Jelavic, Stanislav; Quinson, Jonathan] Univ Copenhagen, Dept Chem, Nanosci Ctr, Univ Pk 5, Copenhagen O, Denmark; [Hirt, Ann] ETH, Inst Geophys, Sonneggstr 5, Zurich, Switzerland	Tokyo Institute of Technology; University of Copenhagen; University of Copenhagen; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ateia, M (corresponding author), Tokyo Inst Technol, Dept Civil & Environm Engn, Tokyo, Japan.	mohamedateia1@gmail.com	Johnson, Matthew Stanley/AAS-7100-2021; Quinson, Jonathan/AAG-8243-2021; Ateia, Mohamed/AAF-8299-2020; Ateia, Mohamed/S-3512-2017; Quinson, Jonathan/I-8780-2016; Hirt, Ann M/M-5540-2016; Koch, Christian Bender/C-7070-2013	Johnson, Matthew Stanley/0000-0002-3645-3955; Quinson, Jonathan/0000-0002-9374-9330; Ateia, Mohamed/0000-0002-3524-5513; Ateia, Mohamed/0000-0002-3524-5513; Quinson, Jonathan/0000-0002-9374-9330; Hirt, Ann M/0000-0002-2193-0472; Koch, Christian Bender/0000-0002-7496-297X	Program for Leading Graduate School "Academy for Co creative Education of Environment and Energy Science," MEXT, Japan, Tokyo Institute of Technology; JSPS Core-to-Core Program	Program for Leading Graduate School "Academy for Co creative Education of Environment and Energy Science," MEXT, Japan, Tokyo Institute of Technology; JSPS Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Program for Leading Graduate School "Academy for Co creative Education of Environment and Energy Science," MEXT, Japan, Tokyo Institute of Technology and the JSPS Core-to-Core Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Khabouri S, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0971-7; Alig I, 2012, POLYMER, V53, P4, DOI 10.1016/j.polymer.2011.10.063; Antunes EF, 2011, APPL SURF SCI, V257, P8038, DOI 10.1016/j.apsusc.2011.04.090; Ateia M, 2017, INT J ENVIRON SCI TE, V14, P867, DOI 10.1007/s13762-016-1214-x; Ateia M, 2017, ENV SCI TECHNOLOGY; Bhattacharjee K, 2013, COLLOID POLYM SCI, V291, P2589, DOI 10.1007/s00396-013-3002-1; Bilgili MS, 2006, J HAZARD MATER, V137, P157, DOI 10.1016/j.jhazmat.2006.01.005; Chen B, 2014, J COLLOID INTERF SCI, V434, P9, DOI 10.1016/j.jcis.2014.07.046; Choi JH, 2007, NANO LETT, V7, P861, DOI 10.1021/nl062306v; Dong XL, 1998, J MATER SCI, V33, P1915, DOI 10.1023/A:1004369708540; Edwards ER, 2011, APPL SURF SCI, V258, P641, DOI 10.1016/j.apsusc.2011.07.032; Engel M, 2016, WATER RES, V106, P146, DOI 10.1016/j.watres.2016.09.051; Feng JT, 2008, MATER SCI ENG B-ADV, V150, P208, DOI 10.1016/j.mseb.2008.05.017; Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013; Gao C, 2006, J PHYS CHEM B, V110, P7213, DOI 10.1021/jp0602474; Ghosh S, 2014, J PHYS CHEM C, V118, P4489, DOI 10.1021/jp411941k; Hartmann NB, 2015, J TOXICOL ENV HEAL B, V18, P299, DOI 10.1080/10937404.2015.1074969; Ho YS, 2002, WATER AIR SOIL POLL, V141, P1, DOI 10.1023/A:1021304828010; Hosseini SJ, 2011, FRESEN ENVIRON BULL, V20, P219; Hu WC, 2016, MATERIALS, V9, DOI 10.3390/ma9110939; John AR, 2014, CHEM ENG J, V243, P436, DOI 10.1016/j.cej.2013.12.087; Jordanova D, 2016, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2015.00090; Koh B, 2014, LANGMUIR, V30, P10899, DOI 10.1021/la5014279; Kolodiazhnyi T, 2008, SMALL, V4, P1476, DOI 10.1002/smll.200800125; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Liu RJ, 2016, J ALLOY COMPD, V657, P138, DOI 10.1016/j.jallcom.2015.10.099; Lottermoser W, 2006, J PHYS CHEM B, V110, P9768, DOI 10.1021/jp061803x; Ma J, 2008, CHEM MATER, V20, P2895, DOI 10.1021/cm8001699; Ma J, 2013, J MATER CHEM A, V1, P4662, DOI 10.1039/c3ta10329c; Mahmood A, 2014, FOOD CHEM TOXICOLOGY; Masotti A, 2013, INT J MOL SCI, V14, P24619, DOI 10.3390/ijms141224619; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Nakanishi R, 2017, MATERIALS, V10, DOI 10.3390/ma10010007; Pacakova B, 2015, J MATER SCI, V50, P2544, DOI 10.1007/s10853-014-8813-z; Pardasani D, 2011, TALANTA, V86, P248, DOI 10.1016/j.talanta.2011.08.067; Pastrana-Martinez LM, 2010, WATER RES, V44, P879, DOI 10.1016/j.watres.2009.09.053; Pike C, 1999, J APPL PHYS, V85, P6668, DOI 10.1063/1.370177; Pike CR, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.104424; Pumera M, 2007, LANGMUIR, V23, P6453, DOI 10.1021/la070088v; Qu S, 2008, J HAZARD MATER, V160, P643, DOI 10.1016/j.jhazmat.2008.03.037; Rambabu N, 2012, CHEM ENG TECHNOL, V35, P272, DOI 10.1002/ceat.201100376; Ruskov T, 2004, J APPL PHYS, V96, P7514, DOI 10.1063/1.1811781; Salam MA, 2012, SYNTHETIC MET, V161, P2651, DOI 10.1016/j.synthmet.2011.09.038; Scrimshire A, 2015, CROAT CHEM ACTA, V88, DOI 10.5562/cca2782; Shan Y, 2010, APPL SURF SCI, V257, P362, DOI 10.1016/j.apsusc.2010.06.078; Smith SWJ, 1912, P PHYS SOC LOND, V24, P62; Sui ZY, 2012, J MATER CHEM, V22, P8767, DOI 10.1039/c2jm00055e; Sun ZY, 2005, J MATER CHEM, V15, P4497, DOI 10.1039/b509968d; Tang WW, 2012, CHEM ENG J, V211, P470, DOI 10.1016/j.cej.2012.09.102; Uzun I, 2004, J COLLOID INTERF SCI, V274, P398, DOI 10.1016/j.jcis.2004.02.022; Vejpravova J, 2016, ANALYST, V141, P2639, DOI 10.1039/c6an00248j; Wang Q, 2011, CHEM ENG J, V174, P126, DOI 10.1016/j.cej.2011.08.059; Weissker U, 2010, MATERIALS, V3, P4387, DOI 10.3390/ma3084387; Winklhofer M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2176598; Xiao D., 2012, J NANOPART RES, V14, P1; Yan XM, 2008, J COLLOID INTERF SCI, V321, P30, DOI 10.1016/j.jcis.2008.01.047; Yang D, 2009, CHEM COMMUN, P4447, DOI 10.1039/b908012k; Zhang M, 2016, CATAL COMMUN, V78, P26, DOI 10.1016/j.catcom.2016.02.004; Zhao X, 2009, J MATER CHEM, V19, P8755, DOI 10.1039/b909779a; Zhao YR, 2015, RSC ADV, V5, P70309, DOI 10.1039/c5ra13183a; Zhong W, 2012, IND ENG CHEM RES, V51, P12017, DOI 10.1021/ie300891h; Zhou LX, 2014, CHEM ENG J, V257, P10, DOI 10.1016/j.cej.2014.07.060	62	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180636	10.1371/journal.pone.0180636	http://dx.doi.org/10.1371/journal.pone.0180636			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708835	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800017
J	Li, SY; Liu, B; Peng, ML; Chen, M; Yin, WW; Tang, H; Luo, YX; Hu, P; Ren, H				Li, Shiying; Liu, Bin; Peng, Mingli; Chen, Min; Yin, Wenwei; Tang, Hui; Luo, Yuxuan; Hu, Peng; Ren, Hong			Diagnostic accuracy of Xpert MTB/RIF for tuberculosis detection in different regions with different endemic burden: A systematic review and meta-analysis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; RESISTANT TUBERCULOSIS; ASSAY; CHILDREN; SMEAR	Purpose To estimate the diagnostic accuracy of Xpert MTB/RIF, a systematic review and meta-analysis were carried out. Methods Up to June 20, 2015, multiple databases were screened for relevant studies. Results Accordingly, 106 studies included 52,410 samples were selected. Diagnostic accuracy of Xpert MTB/RIF for TB detection was validated against either culture or a composite reference standard (CRS). Additionally, selected studies were further subgrouped in four groups based on sample's type, subject's age, status of HIV co-infection and smear-positivity. The overall pooled sensitivity and specificity of Xpert MTB/RIF was 0.85 (95% confidence interval [CI] 0.82 -0.88) and 0.98 (95% CI 0.96-0.98), respectively, compared to culture; while it was 0.59 (95% CI 0.44-0.72) and 0.99 (95% CI 0.97-1.00) compared to CRS. The overall sensitivity was lower in countries with high TB prevalence than countries with middle/low prevalence (0.84, 95% CI: 0.80-0.88 versus 0.89, 95% CI: 0.84-0.93). Furthermore, Xpert MTB/RIF has higher sensitivity in patients with positive smears (0.99, 95% CI 0.97-0.99), in patients with pulmonary TB samples (0.87, 95% CI 0.83-0.90), in adults (0.82, 95% CI 0.76-0.86) and in HIV-positive patients (0.81, 95% CI 0.73-0.87). Conclusions Taken together, Xpert MTB/RIF is a quick and accurate diagnostic assay for TB which will significantly help the physicians to make their clinical decisions.	[Li, Shiying; Liu, Bin; Peng, Mingli; Chen, Min; Yin, Wenwei; Tang, Hui; Luo, Yuxuan; Hu, Peng; Ren, Hong] Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Inst Viral Hepatitis,Minist Educ,Key Lab Mol Biol, Chongqing, Peoples R China	Chongqing Medical University	Hu, P; Ren, H (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Inst Viral Hepatitis,Minist Educ,Key Lab Mol Biol, Chongqing, Peoples R China.	hp_cq@163.com; renhong0531@vip.sina.com		Hu, Peng/0000-0001-8481-0841; Luo, Yuxuan/0000-0001-9932-6577				[Anonymous], 2011, POLICY STATEMENT AUT; Barrera L, 2008, WHO GUIDELINES APPRO; Chaisson RE, 2012, NEW ENGL J MED, V366, P2223, DOI 10.1056/NEJMe1204478; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P4357, DOI 10.1128/JCM.43.9.4357-4362.2005; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; Detjen AK, 2015, LANCET RESP MED, V3, P451, DOI 10.1016/S2213-2600(15)00095-8; Lawn SD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0432-2; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Leeflang MMG, 2014, CLIN MICROBIOL INFEC, V20, P105, DOI 10.1111/1469-0691.12474; Macaskill P, 2010, COCHRANE HDB SYSTEMA, V1st; Marais BJ, 2006, PEDIATRICS, V118, pE1350, DOI 10.1542/peds.2006-0519; Mbonze NB, 2016, INT J TUBERC LUNG D, V20, P240, DOI 10.5588/ijtld.15.0177; Naaktgeboren CA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5605; Penz E, 2015, INT J TUBERC LUNG D, V19, P278, DOI 10.5588/ijtld.14.0262; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; WHO, 2010, POL FRAM IMPL NEW TU; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	22	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180725	10.1371/journal.pone.0180725	http://dx.doi.org/10.1371/journal.pone.0180725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708844	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800020
J	Wright, B; Hackney, L; Hughes, E; Barry, M; Glaser, D; Prior, V; Allgar, V; Marshall, D; Barrow, J; Kirby, N; Garside, M; Kaushal, P; Perry, A; McMillan, D				Wright, Barry; Hackney, Lisa; Hughes, Ellen; Barry, Melissa; Glaser, Danya; Prior, Vivien; Allgar, Victoria; Marshall, David; Barrow, Jamie; Kirby, Natalie; Garside, Megan; Kaushal, Pulkit; Perry, Amanda; McMillan, Dean			Decreasing rates of disorganised attachment in infants and young children, who are at risk of developing, or who already have disorganised attachment. A systematic review and meta-analysis of early parenting interventions	PLOS ONE			English	Article							MATERNAL SENSITIVITY; MALTREATED CHILDREN; INSECURE ATTACHMENT; MOTHERS; SECURITY; DEPRESSION; EFFICACY; BEHAVIOR; PSYCHOTHERAPY; DISORDERS	Background Disorganised attachment patterns in infants have been linked to later psychopathology. Services have variable practices for identifying and providing interventions for families of children with disorganised attachment patterns, which is the attachment pattern leading to most future psychopathology. Several recent government reports have highlighted the need for better parenting interventions in at risk groups. Objectives The objective of this review and meta-analysis was to evaluate the clinical effectiveness of available parenting interventions for families of children at high risk of developing, or already showing, a disorganised pattern of attachment. Methods Population: Studies were included if they involved parents or caregivers of young children with a mean age under 13 years who had a disorganised classification of attachment or were identified as at high risk of developing such problems. Included interventions were aimed at parents or caregivers (e.g. foster carers) seeking to improve attachment. Comparators included an alternative intervention, an attention control, treatment as usual or no intervention. The primary outcome was a disorganised pattern in childhood measured using a validated attachment instrument. Studies that did not use a true Randomised Controlled Trial (RCT) design were excluded from the review. Both published and unpublished papers were included, there were no restrictions on years since publication and foreign language papers were included where translation services could be accessed within necessary timescales. Results A comprehensive search of relevant databases yielded 15,298 papers. This paper reports a systematic review as part of an NIHR HTA study identifying studies pre-2012, updated to include all papers to October 2016. Two independent reviewers undertook two stage screening and data extraction of the included studies at all stages. A Cochrane quality assessment was carried out to assess the risk of bias. In total, fourteen studies were included in the review. In a meta-analysis of these fourteen studies the interventions saw less disorganised attachment at outcome compared to the control (OR = 0.50, ( 0.32, 0.77), p = 0.008). The majority of the interventions targeted maternal sensitivity. We carried out exploratory analyses to examine factors that may influence treatment outcome but these should be treated with caution given that we were limited by small numbers of studies. Conclusions Parenting interventions that target parental sensitivity show promise in reducing disorganised attachment. This is limited by few high quality studies and the fact that most studies are with mothers. More high quality randomised controlled trials are required to elucidate this further.	[Wright, Barry; Allgar, Victoria; Kirby, Natalie] Univ York, Hull York Med Sch, York, N Yorkshire, England; [Wright, Barry; Hackney, Lisa; Hughes, Ellen; Barry, Melissa; Marshall, David; Barrow, Jamie; Kirby, Natalie; Garside, Megan] Leeds & York Partnership NHS Fdn Trust, Leeds, W Yorkshire, England; [Glaser, Danya] Great Ormond St Hosp Sick Children, London, England; [Glaser, Danya] UCL, London, England; [Prior, Vivien] UCL, Inst Child Hlth, London, England; [Kaushal, Pulkit] Tees Esk & Wear Valley NHS Fdn Trust, York, N Yorkshire, England; [Perry, Amanda; McMillan, Dean] Univ York, Dept Hlth Sci, York, N Yorkshire, England	University of Hull; University of York - UK; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; University of York - UK	Wright, B (corresponding author), Univ York, Hull York Med Sch, York, N Yorkshire, England.; Wright, B (corresponding author), Leeds & York Partnership NHS Fdn Trust, Leeds, W Yorkshire, England.	barry.wright1@nhs.net	Marshall, David/AAA-6602-2019	Marshall, David/0000-0001-5969-9539; perry, amanda/0000-0002-0279-1884; Wright, Barry/0000-0002-8692-6001; Allgar, Victoria/0000-0002-5228-2623; Garside, Megan/0000-0001-5250-2326	National Institute for Health Research, HTA [10/45/04]; National Institute for Health Research [10/45/04, ACF-2015-03-003] Funding Source: researchfish	National Institute for Health Research, HTA; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research, HTA (project number 10/45/04).	Ainsworth M.D.S., 1978, PATTERNS ATTACHMENT, DOI DOI 10.4324/9780203758045; [Anonymous], 1993, PREVENTION MENTAL HL; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Bakermans-Kranenburg MJ, 2005, INFANT MENT HEALTH J, V26, P191, DOI 10.1002/imhj.20046; Becker-Weidman A., 2011, DYADIC DEV PSYCHOTHE; Bernard K, 2012, CHILD DEV, V83, P623, DOI 10.1111/j.1467-8624.2011.01712.x; Booth P. B, 2009, THERAPLAY HELPING PA; Borenstein M., 2009, INTRO METAANALYSIS, P45, DOI DOI 10.1002/9780470743386.CH7; Boris NW, 2004, J AM ACAD CHILD PSY, V43, P568, DOI 10.1097/00004583-200405000-00010; Carlson EA, 1998, CHILD DEV, V69, P1107, DOI 10.1111/j.1467-8624.1998.tb06163.x; Carlson EA, 2009, DEV PSYCHOPATHOL, V21, P1311, DOI 10.1017/S0954579409990174; Cassidy J., 1992, ATTACHMENT ORG 2 4 Y; Cassidy J, 2011, DEV PSYCHOPATHOL, V23, P131, DOI 10.1017/S0954579410000696; Challacombe F. L., 2017, PSYCHOL MED, P1; Cicchetti D, 1999, Attach Hum Dev, V1, P34, DOI 10.1080/14616739900134021; Cicchetti D, 2006, DEV PSYCHOPATHOL, V18, P623, DOI 10.1017/S0954579406060329; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen NJ, 1999, INF MENTAL HLTH J, V20, P429, DOI 10.1002/(SICI)1097-0355(199924)20:4<429::AID-IMHJ5>3.0.CO;2-Q; Cooper P., 1997, IMPACT PSYCHOL TREAT; Cooper PJ, 2015, PRIM HEALTH CARE RES, V16, P383, DOI 10.1017/S1463423614000401; Cooper PJ, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b974; Fearon RP, 2010, CHILD DEV, V81, P435, DOI 10.1111/j.1467-8624.2009.01405.x; Fonagy P, 2016, INFANT MENT HEALTH J, V37, P97, DOI 10.1002/imhj.21553; Futh A, 2008, J AM ACAD CHILD PSY, V47, P709, DOI 10.1097/CHI.0b013e31816bff65; Gelfand DM, 1996, J CLIN CHILD PSYCHOL, V25, P406, DOI 10.1207/s15374424jccp2504_6; Gradisar M, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1486; Green J, 2002, J CHILD PSYCHOL PSYC, V43, P835, DOI 10.1111/1469-7610.00102; Greenberg M.T., 1999, HDB ATTACHMENT THEOR, P469; Groh AM, 2014, ATTACH HUM DEV, V16, P103, DOI 10.1080/14616734.2014.883636; Groh AM, 2012, CHILD DEV, V83, P591, DOI 10.1111/j.1467-8624.2011.01711.x; Heinicke CM, 1999, INF MENTAL HLTH J, V20, P349, DOI 10.1002/(SICI)1097-0355(199924)20:4<349::AID-IMHJ1>3.0.CO;2-X; Heinicke CM, 2000, INF MENTAL HLTH J, V21, P133; Heinicke CM, 2001, INF MENTAL HLTH J, V22, P431, DOI 10.1002/imhj.1010; Jaffari-Bimmel N, 2006, DEV PSYCHOL, V42, P1143, DOI 10.1037/0012-1649.42.6.1143; Juffer F, 2005, J CHILD PSYCHOL PSYC, V46, P263, DOI 10.1111/j.1469-7610.2004.00353.x; Leschied A. W., 2005, CHILD FAMILY SOCIAL, V10, P281, DOI DOI 10.1111/J.1365-2206.2005.00365.X; Lyons-Ruth K, 1999, MONOGR SOC RES CHILD, V64, P67, DOI 10.1111/1540-5834.00034; Lyons-Ruth K., 2008, HDB ATTACHMENT THEOR, P666; LYONSRUTH K, 1990, CHILD DEV, V61, P85, DOI 10.2307/1131049; LyonsRuth K, 1996, J CONSULT CLIN PSYCH, V64, P64, DOI 10.1037/0022-006X.64.1.64; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Main M, 1990, ATTACHMENT PRESCHOOL, P121; Moran G, 2005, INFANT MENT HEALTH J, V26, P231, DOI 10.1002/imhj.20045; Moss E, 2011, DEV PSYCHOPATHOL, V23, P195, DOI 10.1017/S0954579410000738; O'Connor TG, 1999, INFANT MENT HEALTH J, V20, P10, DOI 10.1002/(SICI)1097-0355(199921)20:1<10::AID-IMHJ2>3.3.CO;2-J; Sajaniemi N, 2001, EUR CHILD ADOLES PSY, V10, P122, DOI 10.1007/s007870170035; Sroufe L.A., 2005, POWER LONGITUDINAL A, P48; Stronach EP, 2013, DEV PSYCHOPATHOL, V25, P919, DOI 10.1017/S0954579413000278; Tereno S., 2016, SECURITE LATTACHEMEN; Toth SL, 2006, J CONSULT CLIN PSYCH, V74, P1006, DOI 10.1037/0022-006X.74.6.1006; VAN IJZENDOORN MH, 1995, J CHILD PSYCHOL PSYC, V36, P225; van Ijzendoorn MH, 1999, DEV PSYCHOPATHOL, V11, P225, DOI 10.1017/S0954579499002035; VANDENBOOM DC, 1994, CHILD DEV, V65, P1457, DOI 10.2307/1131511; vandenBoom DC, 1995, CHILD DEV, V66, P1798, DOI 10.2307/1131911; WAVE Trust, 2013, CONC AG 2 AG OPP; Wright B, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19520; Zeanah CH, 2011, J CHILD PSYCHOL PSYC, V52, P819, DOI 10.1111/j.1469-7610.2011.02399.x	57	18	18	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180858	10.1371/journal.pone.0180858	http://dx.doi.org/10.1371/journal.pone.0180858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708838	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000405649800026
J	Amissah, NA; van Dam, L; Ablordey, A; Ampomah, OW; Prah, I; Tetteh, CS; van der Werf, TS; Friedrich, AW; Rossen, JW; van Dijl, JM; Stienstra, Y				Amissah, Nana Ama; van Dam, Lieke; Ablordey, Anthony; Ampomah, Opoku-Ware; Prah, Isaac; Tetteh, Caitlin S.; van der Werf, Tjip S.; Friedrich, Alexander W.; Rossen, John W.; van Dijl, Jan Maarten; Stienstra, Ymkje			Epidemiology of Staphylococcus aureus in a burn unit of a tertiary care center in Ghana	PLOS ONE			English	Article							HAND HYGIENE PRACTICES; METHICILLIN-RESISTANT; ANTIBIOTIC CONSUMPTION; TRANSMISSION; COLONIZATION; PROBABILITY; ACQUISITION; PREVALENCE; RESOURCES; MORTALITY	Background In developing countries, hospitalized burn victims are at high risk of nosocomial infections caused by Staphylococcus aureus. Risk factors include poor infection control practices, prolonged hospitalisation and limited capacity for laboratory microbiological analyses. These problems are compounded by widespread use of antibiotics that drives the spread of multidrug resistant bacteria. Methods During the study period (November 2014-June 2015), nasal and invasive S. aureus isolates were collected consecutively from patients and healthcare workers (HCWs) within the burn unit of the Reconstructive Plastic Surgery and Burn Center of Korle Bu Teaching Hospital in Ghana. Antibiotic prescription, antibiotic susceptibility and bacterial typing were used to assess antibiotic pressure, antibiotic resistance, and possible transmission events among patients and HCWs. Results Eighty S. aureus isolates were obtained from 37 of the 62 included burn patients and 13 of the 29 HCWs. At admission, 50% of patients carried or were infected with S. aureus including methicillin resistant S. aureus (MRSA). Antibiotic use per 100 days of hospitalization was high (91.2 days), indicating high selective pressure for resistant pathogens. MRSA isolates obtained from 11 patients and one HCW belonged to the same spa-type t928 and multi-locus sequence type 250, implying possible transmission events. A mortality rate of 24% was recorded over the time of admission in the burn unit. Conclusion This study revealed a high potential for MRSA outbreaks and emergence of resistant pathogens amongst burn patients due to lack of patient screening and extended empirical use of antibiotics. Our observations underscore the need to implement a system of antibiotic stewardship and infection prevention where microbiological diagnostics results are made available to physicians for timely and appropriate patient treatment.	[Amissah, Nana Ama; van der Werf, Tjip S.; Stienstra, Ymkje] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands; [Amissah, Nana Ama; Ablordey, Anthony; Prah, Isaac; Tetteh, Caitlin S.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Bacteriol, Legon, Ghana; [van Dam, Lieke; Friedrich, Alexander W.; Rossen, John W.; van Dijl, Jan Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Ampomah, Opoku-Ware] Korle Bu Teaching Hosp, Reconstruct Plast Surg & Burn Ctr, Korle Bu, Ghana	University of Groningen; University of Ghana; University of Groningen	Amissah, NA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands.; Amissah, NA (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Bacteriol, Legon, Ghana.	namissah@noguchi.ug.edu.gh	Rossen, John W/G-7564-2011; Friedrich, Alex/ABG-9823-2020; Ablordey, Anthony/AAY-4016-2021	Rossen, John W/0000-0002-7167-8623; van der Werf, Tjip/0000-0002-4824-1642; Amissah, Nana Ama/0000-0003-1373-8330; Ablordey, Anthony/0000-0002-4486-0286	Graduate School for Medical Sciences of the University of Groningen NAA	Graduate School for Medical Sciences of the University of Groningen NAA	This work was supported by the Fellowship from the Graduate School for Medical Sciences of the University of Groningen NAA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbenorku P, 2010, BURNS, V36, P1309, DOI 10.1016/j.burns.2010.03.017; Agbenorku P, 2011, BURNS, V37, P1259, DOI 10.1016/j.burns.2011.04.014; Ahuja RB, 2004, BRIT MED J, V329, P447, DOI 10.1136/bmj.329.7463.447; Amissah NA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003421; Asare A, 2009, J INFECT DEV COUNTR, V3, P352; Atiyeh B, 2009, Ann Burns Fire Disasters, V22, P189; Bahemia IA, 2015, BURNS, V41, P1536, DOI 10.1016/j.burns.2015.05.007; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; COURTRIGHT P, 1993, J EPIDEMIOL COMMUN H, V47, P19, DOI 10.1136/jech.47.1.19; Dokter J, 2016, BURNS, V42, P421, DOI 10.1016/j.burns.2015.08.006; Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096119; Egyir B, 2013, J GLOB ANTIMICROB RE, V1, P189, DOI 10.1016/j.jgar.2013.05.006; Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089716; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; FORJUOH SN, 1995, BURNS, V21, P24, DOI 10.1016/0305-4179(95)90776-V; Fournier A, 2016, BURNS, V42, P564, DOI 10.1016/j.burns.2015.10.030; Gupta S, 2014, INT J SURG, V12, P1070, DOI 10.1016/j.ijsu.2014.08.353; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hassen AF, 2014, BURNS, V40, P1040, DOI 10.1016/j.burns.2013.10.020; Hodges SC, 2007, ANAESTHESIA, V62, P4, DOI 10.1111/j.1365-2044.2006.04907.x; Jeschke MG, 2016, BURNS, V42, P276, DOI 10.1016/j.burns.2015.12.008; Khashaba HA, 2012, ANN BURNS FIRE DISAS, V25, P178; Khosravi AD, 2012, BURNS, V38, P247, DOI 10.1016/j.burns.2011.08.002; Kpeli G., 2016, New Microbes and New Infections, V13, P92, DOI 10.1016/j.nmni.2016.07.001; Kraft R, 2012, LANCET, V379, P1013, DOI 10.1016/S0140-6736(11)61345-7; Kypraios T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-29; Lancashire JF, 2013, PATHOLOGY, V45, P492, DOI 10.1097/PAT.0b013e3283632667; Leseva M, 2013, Ann Burns Fire Disasters, V26, P5; Mann EA, 2012, SHOCK, V37, P4, DOI 10.1097/SHK.0b013e318237d6bf; Merrer J, 2000, INFECT CONT HOSP EP, V21, P718, DOI 10.1086/501721; Meshulam-Derazon S, 2006, PLAST RECONSTR SURG, V118, P116, DOI 10.1097/01.prs.0000221111.89812.ad; Mir MA, 2017, INT WOUND J, V14, P194, DOI 10.1111/iwj.12588; Murray CK, 2009, BURNS, V35, P1112, DOI 10.1016/j.burns.2009.02.013; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; Nthumba PM, 2016, BURNS, V42, P258, DOI 10.1016/j.burns.2015.04.006; Oncul O, 2014, BURNS, V40, P835, DOI 10.1016/j.burns.2013.11.003; Owusu-Ofori A, 2010, INFECT CONT HOSP EP, V31, P802, DOI 10.1086/654005; Patel M, 2013, J HOSP INFECT, V84, P319, DOI 10.1016/j.jhin.2013.04.013; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; References World Health Organization, 2008, A WHO PLAN FOR BURN; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Scholten-Jaegers SMHJ, 2017, J BURN CARE RES, V38, pE432, DOI 10.1097/BCR.0000000000000448; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Tagoe D N A, 2011, Ghana Med J, V45, P22; Vandendriessche S, 2017, EUR J CLIN MICROBIOL; Yawson AE, 2013, J INFECT DEV COUNTR, V7, P338, DOI 10.3855/jidc.2422	50	14	16	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181072	10.1371/journal.pone.0181072	http://dx.doi.org/10.1371/journal.pone.0181072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704546	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700088
J	Das, G; Patra, JK; Lee, SY; Kim, C; Park, JG; Baek, KH				Das, Gitishree; Patra, Jayanta Kumar; Lee, Sun-Young; Kim, Changgeon; Park, Jae Gyu; Baek, Kwang-Hyun			Analysis of metabolomic profile of fermented Orostachys japonicus A. Berger by capillary electrophoresis time of flight mass spectrometry	PLOS ONE			English	Article							LACTOBACILLUS-PLANTARUM STRAINS; ACID; NICOTINAMIDE; PATHWAY; GROWTH; IDENTIFICATION; HISTAMINE; FOODS; TOOL; NAD	Microbial cell performance in food biotechnological processes has become an important concern for improving human health worldwide. Lactobacillus plantarum, which is widely distributed in nature, is a lactic acid bacterium with many industrial applications for fermented foods or functional foods (e.g., probiotics). In the present study, using capillary electrophoresis time of flight mass spectrometry, the metabolomic profile of dried Orostachys japonicus A. Berger, a perennial medicinal herb with L. plantarum was compared with that of O. japonicus fermented with L. plantarum to elucidate the metabolomic changes induced by the fermentation process. The levels of several metabolites were changed by the fermentation process, indicating their involvement in microbial performance. For example, glycolysis, the pentose phosphate pathway, the TCA cycle, the urea cycle-related metabolism, nucleotide metabolism, and lipid and amino acid metabolism were altered significantly by the fermentation process. Although the fermented metabolites were not tested using in vivo studies to increase human health benefits, our findings provide an insight into the alteration of metabolites induced by fermentation, and indicated that the metabolomic analysis for the process should be accompanied by fermenting strains and conditions.	[Das, Gitishree; Patra, Jayanta Kumar] Dongguk Univ Seoul, Res Inst Biotechnol & Med Converged Sci, Gyeonggi Do, South Korea; [Lee, Sun-Young] Chung Ang Univ, Dept Food Sci & Technol, Anseong, Gyeonggi Do, South Korea; [Kim, Changgeon; Park, Jae Gyu] Pohang Technopk Fdn, Pohang Ctr Evaluat Biomat POCEB, Pohang, Gyeongbuk, South Korea; [Baek, Kwang-Hyun] Yeungnam Univ, Dept Biotechnol, Gyongsan, Gyeongbuk, South Korea	Dongguk University; Chung Ang University; Yeungnam University	Park, JG (corresponding author), Pohang Technopk Fdn, Pohang Ctr Evaluat Biomat POCEB, Pohang, Gyeongbuk, South Korea.; Baek, KH (corresponding author), Yeungnam Univ, Dept Biotechnol, Gyongsan, Gyeongbuk, South Korea.	jaepark@pohangtp.org; khbaek@ynu.ac.kr	PATRA, JAYANTA KUMAR/AEM-6689-2022	PATRA, JAYANTA KUMAR/0000-0003-4118-4355; BAEK, KWANG-HYUN/0000-0002-6719-9187	industrial infrastructure program for fundamental technologies [N0000885]; Ministry of Trade, Industry & Energy (MOTIE, Korea)	industrial infrastructure program for fundamental technologies; Ministry of Trade, Industry & Energy (MOTIE, Korea)	This research was conducted under the industrial infrastructure program for fundamental technologies (N0000885), which was funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumourad I. M. K., 2013, Journal of Applied Sciences Research, V9, P572; Akdis CA, 2003, J ALLERGY CLIN IMMUN, V112, P15, DOI 10.1067/mai.2003.1585; Arasu MV, 2013, J APPL MICROBIOL, V115, P1172, DOI 10.1111/jam.12319; Benavente CA, 2009, CURR PHARM DESIGN, V15, P29, DOI 10.2174/138161209787185760; Bron PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038720; Brown M, 2009, ANALYST, V134, P1322, DOI 10.1039/b901179j; Bull MJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07202; Dhanasekaran AR, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0462-y; Di Cagno R, 2013, FOOD MICROBIOL, V33, P1, DOI 10.1016/j.fm.2012.09.003; Dickinson JR, 1998, J BIOL CHEM, V273, P25751, DOI 10.1074/jbc.273.40.25751; Elli M, 2000, J APPL MICROBIOL, V88, P695, DOI 10.1046/j.1365-2672.2000.01013.x; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Ganzle MG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00340; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Huang CC, 2014, ASIAN J COMPLEMENT A, V2, P12; Huang PX, 2015, ONCOTARGET, V6, P10812, DOI 10.18632/oncotarget.3580; Jutel M, 2009, CLIN EXP ALLERGY, V39, P1786, DOI 10.1111/j.1365-2222.2009.03374.x; Kandler O., 1986, BERGEYS MANUAL SYSTE, P1208; Karthikeyan K, 2002, INT J DERMATOL, V41, P476, DOI 10.1046/j.1365-4362.2002.01551.x; KILARA A, 1978, J DAIRY SCI, V61, P1793, DOI 10.3168/jds.S0022-0302(78)83805-3; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Lee Won Sup, 2015, Asian Pac J Cancer Prev, V16, P465; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; McKinlay JB, 2007, APPL MICROBIOL BIOT, V76, P727, DOI 10.1007/s00253-007-1057-y; MOLIN G, 1993, J APPL BACTERIOL, V74, P314, DOI 10.1111/j.1365-2672.1993.tb03031.x; Mozzi F, 2013, FOOD RES INT, V54, P1152, DOI 10.1016/j.foodres.2012.11.010; Murray MF, 2003, CLIN INFECT DIS, V36, P453, DOI 10.1086/367544; Murray MF, 1999, MED HYPOTHESES, V53, P375, DOI 10.1054/mehy.1999.0908; Okano K, 2009, APPL ENVIRON MICROB, V75, P5175, DOI 10.1128/AEM.00573-09; Park HJ, 2015, J ETHNOPHARMACOL, V170, P210, DOI 10.1016/j.jep.2015.04.012; Plumed-Ferrer C, 2008, APPL ENVIRON MICROB, V74, P5349, DOI 10.1128/AEM.00324-08; Romeo T, 2005, ECOSAL PLUS, P1; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Schachter M, 2005, CARDIOVASC DRUG THER, V19, P415, DOI 10.1007/s10557-005-5685-0; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Siragusa S, 2014, J PROTEOMICS, V96, P366, DOI 10.1016/j.jprot.2013.11.003; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soudijn W, 2007, MED RES REV, V27, P417, DOI 10.1002/med.20102; Surjana D, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/157591; Tomaszewska E, 2012, J PHYSIOL PHARMACOL, V63, P547; Tsuji A, 2013, ENZYME MICROB TECH, V53, P97, DOI 10.1016/j.enzmictec.2013.04.008; Wolfe AJ, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0014-2014; [No title captured]	50	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181280	10.1371/journal.pone.0181280	http://dx.doi.org/10.1371/journal.pone.0181280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704842	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700120
J	Sliwicka, E; Cison, T; Kasprzak, Z; Nowak, A; Pilaczynska-Szczesniak, L				Sliwicka, Ewa; Cison, Tomasz; Kasprzak, Zbigniew; Nowak, Alicja; Pilaczynska-Szczesniak, Lucja			Serum irisin and myostatin levels after 2 weeks of high-altitude climbing	PLOS ONE			English	Article							BODY-COMPOSITION CHANGES; SKELETAL-MUSCLE ATROPHY; VITAMIN-D-RECEPTOR; OXIDATIVE STRESS; CYTOKINE RESPONSE; WEIGHT-LOSS; EXERCISE; HYPOXIA; HUMANS; DIFFERENTIATION	Exposure to high-altitude hypoxia causes physiological and metabolic adaptive changes by disturbing homeostasis. Hypoxia-related changes in skeletal muscle affect the closely interconnected energy and regeneration processes. The balance between protein synthesis and degradation in the skeletal muscle is regulated by several molecules such as myostatin, cytokines, vitamin D, and irisin. This study investigates changes in irisin and myostatin levels in male climbers after a 2-week high-altitude expedition, and their association with 25 (OH) D and indices of inflammatory processes. The study was performed in 8 men aged between 23 and 31 years, who participated in a 2-week climbing expedition in the Alps. The measurements of body composition and serum concentrations of irisin, myostatin, 25(OH) D, interleukin-6, myoglobin, high-sensitivity C-reactive protein, osteoprotegerin, and high-sensitivity soluble receptor activator of NF-kappa B ligand (sRANKL) were performed before and after expedition. A 2-week exposure to hypobaric hypoxia caused significant decrease in body mass, body mass index (BMI), free fat mass and irisin, 25-Hydroxyvitamin D levels. On the other hand, significant increase in the levels of myoglobin, high-sensitivity C-reactive protein, interleukin-6, and osteoprotegerin were noted. The observed correlations of irisin with 25(OH) D levels, as well as myostatin levels with inflammatory markers and the OPG/RANKL ratio indicate that these myokines may be involved in the energy-related processes and skeletal muscle regeneration in response to 2-week exposure to hypobaric hypoxia.	[Sliwicka, Ewa; Kasprzak, Zbigniew; Nowak, Alicja; Pilaczynska-Szczesniak, Lucja] Poznan Univ Phys Educ, Dept Hyg, Poznan, Poland; [Cison, Tomasz] State Higher Vocat Sch, Dept Biomed Sci, Nowy Sacz, Poland		Sliwicka, E (corresponding author), Poznan Univ Phys Educ, Dept Hyg, Poznan, Poland.	sliwicka@awf.poznan.pl	Kasprzak, Zbigniew/AAT-9016-2021; Śliwicka, Ewa/ABB-7085-2021	Pilaczynska-Szczesniak, Lucja/0000-0002-3683-9428; Sliwicka, Ewa/0000-0002-5475-3011				Bhat M, 2015, J STEROID BIOCHEM, V152, P171, DOI 10.1016/j.jsbmb.2015.05.012; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chaillou T, 2013, ACTA PHYSIOL, V209, P272, DOI 10.1111/apha.12110; Chang J. S., 2017, GERIATR GERONTOL INT; Chaudhary P, 2012, MOL CELL BIOCHEM, V364, P101, DOI 10.1007/s11010-011-1210-x; Dosek A, 2007, RESP PHYSIOL NEUROBI, V158, P128, DOI 10.1016/j.resp.2007.03.013; Dufresne SS, 2015, AM J PATHOL, V185, P920, DOI 10.1016/j.ajpath.2015.01.006; Eleganczyk-Kot H, 2011, J HUM KINET, V27, P45; Feng X., 2013, DISCRETE DYN NAT SOC, V2013, P1, DOI DOI 10.1155/2013/160123; FULCO CS, 1992, J APPL PHYSIOL, V72, P2181, DOI 10.1152/jappl.1992.72.6.2181; Garcia LA, 2011, ENDOCRINOLOGY, V152, P2976, DOI 10.1210/en.2011-0159; Girgis CM, 2014, ENDOCRINOLOGY, V155, P347, DOI 10.1210/en.2013-1205; Hagobian TA, 2006, MED SCI SPORT EXER, V38, P276, DOI 10.1249/01.mss.0000188577.63910.51; Hamad N, 2006, EUR J GASTROEN HEPAT, V18, P5, DOI 10.1097/00042737-200601000-00002; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Himadri P, 2010, HIGH ALT MED BIOL, V11, P231, DOI 10.1089/ham.2009.1057; Hirose L, 2004, EXERC IMMUNOL REV, V10, P75; Hjorth M, 2015, ACTA PHYSL OXF; HOPPELER H, 1990, INT J SPORTS MED, V11, pS3, DOI 10.1055/s-2007-1024846; Horscroft JA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-19; Howald H, 2003, EUR J APPL PHYSIOL, V90, P360, DOI 10.1007/s00421-003-0872-9; Huh JY, 2014, INT J OBESITY, V38, P1538, DOI 10.1038/ijo.2014.42; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Imray C, 2010, PROG CARDIOVASC DIS, V52, P467, DOI 10.1016/j.pcad.2010.02.003; Jacobs RA, 2013, EXP PHYSIOL, V98, P245, DOI 10.1113/expphysiol.2012.066092; Kanamaru F, 2004, IMMUNOL LETT, V94, P239, DOI 10.1016/j.imlet.2004.05.010; Kasprzak Z, 2015, HIGH ALT MED BIOL, V16, P230, DOI 10.1089/ham.2015.0008; Kermanac'h NS, 2002, EUR CYTOKINE NETW, V13, P144; Kirk S, 2000, J CELL PHYSIOL, V184, P356, DOI 10.1002/1097-4652(200009)184:3<356::AID-JCP10>3.0.CO;2-R; Lee MJ, 2015, ATHEROSCLEROSIS, V242, P476, DOI 10.1016/j.atherosclerosis.2015.08.002; MACDOUGALL JD, 1991, ACTA PHYSIOL SCAND, V142, P421, DOI 10.1111/j.1748-1716.1991.tb09176.x; Magalhaes J, 1985, J APPL PHYSIOL, V99, P1247, DOI DOI 10.1152/JAPPLPHYSI01.01324.2004; Martin DS, 2010, EXP PHYSIOL, V95, P463, DOI 10.1113/expphysiol.2009.047589; Mazzeo RS, 2008, SPORTS MED, V38, P1, DOI 10.2165/00007256-200838010-00001; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Ostrowski K, 2000, EUR J APPL PHYSIOL, V83, P512, DOI 10.1007/s004210000312; Peake JM, 2005, MED SCI SPORT EXER, V37, P737, DOI 10.1249/01.MSS.0000161804.05399.3B; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Philippou A, 2009, CLIN CHEM LAB MED, V47, P777, DOI 10.1515/CCLM.2009.163; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; Savkur RS, 2005, MOL PHARMACOL, V68, P511, DOI 10.1124/mol.105.012708.; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Shimamura M, 2014, P NATL ACAD SCI USA, V111, P8191, DOI 10.1073/pnas.1400544111; SILLAU AH, 1977, PFLUG ARCH EUR J PHY, V370, P227, DOI 10.1007/BF00585531; Sinha A, 2013, J CLIN ENDOCR METAB, V98, pE509, DOI 10.1210/jc.2012-3592; Stratos I, 2013, AM J PATHOL, V182, P895, DOI 10.1016/j.ajpath.2012.11.006; Vaughan RA, 2015, J PHYSIOL BIOCHEM, V71, P679, DOI 10.1007/s13105-015-0433-9; Zaccagni L, 2014, HIGH ALT MED BIOL, V15, P176, DOI 10.1089/ham.2013.1133; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	50	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181259	10.1371/journal.pone.0181259	http://dx.doi.org/10.1371/journal.pone.0181259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732027	Green Submitted, Green Published, gold			2022-12-27	WOS:000406643100029
J	D'Souza, WN; Douangpanya, J; Mu, SR; Jaeckel, P; Zhang, M; Maxwell, JR; Rottman, JB; Labitzke, K; Willee, A; Beckmann, H; Wang, YC; Li, Y; Schwandner, R; Johnston, JA; Towne, JE; Hsu, HL				D'Souza, Warren N.; Douangpanya, Jason; Mu, Sharon; Jaeckel, Peter; Zhang, Ming; Maxwell, Joseph R.; Rottman, James B.; Labitzke, Katja; Willee, Angela; Beckmann, Holger; Wang, Yingcai; Li, Yang; Schwandner, Ralf; Johnston, James A.; Towne, Jennifer E.; Hsu, Hailing			Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PROTEIN-COUPLED RECEPTOR; DEXTRAN SULFATE COLITIS; NF-KAPPA-B; METABOLITE BUTYRATE; MONONUCLEAR-CELLS; EPITHELIAL-CELLS; GUT INFLAMMATION; CROHNS-DISEASE; UP-REGULATION	Inflammatory bowel disease (IBD) is associated with a loss of intestinal barrier function and dysregulated immune responses. It has been shown that short chain fatty acids (SCFAs) are protective in IBD and that GPR43 mediates the protective effects of SCFAs. In this study, we investigated the effects of SCFAs in comparison to highly specific GPR43 agonists on human intestinal epithelial and immune cells. Our results confirm that SCFAs are enhancers of barrier function in intestinal epithelial cells. Additionally, SCFAs also displayed potent immunoregulatory properties based upon the ability to inhibit LPS-induced cytokine production in PBMC, and human T cell proliferation and cytokine production. Unexpectedly, and in contrast to the current belief, specific GPR43 agonists failed to exhibit similar barrier enhancing and anti-inflammatory properties. These findings demonstrate that SCFA possess broad protective functions in IBD and agonizing GPR43 alone is unlikely to be beneficial in patients.	[D'Souza, Warren N.; Mu, Sharon; Zhang, Ming; Willee, Angela; Johnston, James A.; Hsu, Hailing] Amgen Inc, Thousand Oaks, CA 91320 USA; [Douangpanya, Jason; Maxwell, Joseph R.; Towne, Jennifer E.] Amgen Inc, Seattle, WA USA; [Jaeckel, Peter; Labitzke, Katja; Beckmann, Holger; Schwandner, Ralf] Amgen Inc, Regensburg, Germany; [Rottman, James B.] Amgen Inc, Cambridge, MA USA; [Wang, Yingcai; Li, Yang] Amgen Inc, San Francisco, CA USA	Amgen; Amgen; Amgen; Amgen Research Munich GmbH; Amgen; Amgen	D'Souza, WN (corresponding author), Amgen Inc, Thousand Oaks, CA 91320 USA.	wdsouza@amgen.com			Amgen	Amgen(Amgen)	Amgen provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aoyama M, 2010, NUTRITION, V26, P653, DOI 10.1016/j.nut.2009.07.006; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Boismenu R, 2000, J LEUKOCYTE BIOL, V67, P267, DOI 10.1002/jlb.67.3.267; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Butzner JD, 1996, GUT, V38, P568, DOI 10.1136/gut.38.4.568; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; EFTIMIADI C, 1987, J INFECTION, V14, P43, DOI 10.1016/S0163-4453(87)90808-5; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Mariadason JM, 1997, AM J PHYSIOL-GASTR L, V272, pG705, DOI 10.1152/ajpgi.1997.272.4.G705; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Masui R, 2013, INFLAMM BOWEL DIS, V19, P2848, DOI 10.1097/01.MIB.0000435444.14860.ea; Mishiro T, 2013, LAB INVEST, V93, P834, DOI 10.1038/labinvest.2013.70; Nancy S, 2002, DIGEST DIS SCI, V47, P921, DOI 10.1023/A:1014781109498; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Okamoto T, 2000, J GASTROENTEROL, V35, P341, DOI 10.1007/s005350050358; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Saemann MD, 2000, FASEB J, V14, P2380; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Schultsz C, 1999, GASTROENTEROLOGY, V117, P1089, DOI 10.1016/S0016-5085(99)70393-8; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Soldavini J, 2013, DIGEST DIS SCI, V58, P2756, DOI 10.1007/s10620-013-2744-4; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Usami M, 2008, NUTR RES, V28, P321, DOI 10.1016/j.nutres.2008.02.012; Venkatraman A, 2000, SCAND J GASTROENTERO, V35, P1053; Venkatraman A, 2003, AM J PHYSIOL-GASTR L, V285, pG177, DOI 10.1152/ajpgi.00307.2002; Vieira ELM, 2012, J NUTR BIOCHEM, V23, P430, DOI 10.1016/j.jnutbio.2011.01.007; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Wilson AJ, 1997, GASTROENTEROLOGY, V113, P487, DOI 10.1053/gast.1997.v113.pm9247468	50	69	74	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180190	10.1371/journal.pone.0180190	http://dx.doi.org/10.1371/journal.pone.0180190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727837	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500017
J	Sanchez, P; Everett, B; Salamonson, Y; Ajwani, S; Bhole, S; Bishop, J; Lintern, K; Nolan, S; Rajaratnam, R; Redfern, J; Sheehan, M; Skarligos, F; Spencer, L; Srinivas, R; George, A				Sanchez, Paula; Everett, Bronwyn; Salamonson, Yenna; Ajwani, Shilpi; Bhole, Sameer; Bishop, Joshua; Lintern, Karen; Nolan, Samantha; Rajaratnam, Rohan; Redfern, Julie; Sheehan, Maria; Skarligos, Fiona; Spencer, Lissa; Srinivas, Ravi; George, Ajesh			Oral health and cardiovascular care: Perceptions of people with cardiovascular disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; PERIODONTAL-DISEASE; MYOCARDIAL-INFARCTION; CONSENSUS REPORT; PREGNANT-WOMEN; RISK; MIDWIVES; PROGRAM; METAANALYSIS	Main objective The aim of this study was to explore the perception of patients with cardiovascular disease towards oral health and the potential for cardiac care clinicians to promote oral health. Method A needs assessment was undertaken with twelve patients with cardiovascular disease attending cardiac rehabilitation between 2015 and 2016, in three metropolitan hospitals in Sydney, Australia. These patients participated in face-to-face semi-structured interviews. Data was analysed using thematic analysis. Results Results suggested that while oral health was considered relevant there was high prevalence of poor oral health among participants, especially those from socioeconomic disadvantaged background. Awareness regarding the importance of oral health care its impact on cardiovascular outcomes was poor among participants. Oral health issues were rarely discussed in the cardiac setting. Main barriers deterring participants from seeking oral health care included lack of awareness, high cost of dental care and difficulties in accessing the public dental service. Findings also revealed that participants were interested in receiving further information about oral health and suggested various mediums for information delivery. The concept of cardiac care clinicians, especially nurses providing education, assessment and referrals to ongoing dental care was well received by participants who felt the post-acute period was the most appropriate time to receive oral health care advice. The issues of oral health training for non-dental clinicians and how to address existing barriers were highlighted by participants. Relevance to clinical practice The lack of oral health education being provided to patients with cardiovascular disease offers an opportunity to improve care and potentially, outcomes. In view of the evidence linking poor oral health with cardiovascular disease, cardiac care clinicians, especially nurses, should be appropriately trained to promote oral health in their practice. Affordable and accessible dental care services for people with cardiovascular disease should be considered and offered by health services in Australia.	[Sanchez, Paula; Everett, Bronwyn; Salamonson, Yenna; Srinivas, Ravi; George, Ajesh] Western Sydney Univ, Sch Nursing & Midwifery, Sydney, NSW, Australia; [Sanchez, Paula; Everett, Bronwyn; Salamonson, Yenna; Lintern, Karen; Rajaratnam, Rohan; Sheehan, Maria; Srinivas, Ravi; George, Ajesh] South Western Sydney Local Hlth Dist, Sydney, NSW, Australia; [Sanchez, Paula; Srinivas, Ravi; George, Ajesh] Collaborat Oral Hlth Outcomes Res Translat & Eval, Liverpool, Australia; [Sanchez, Paula; Everett, Bronwyn; Salamonson, Yenna; Srinivas, Ravi; George, Ajesh] Ingham Inst Appl Med Res, Liverpool, Australia; [Everett, Bronwyn; Salamonson, Yenna] Ctr Appl Nursing Res, Liverpool, Australia; [Ajwani, Shilpi; Bhole, Sameer; Bishop, Joshua; Nolan, Samantha; Skarligos, Fiona; Spencer, Lissa] Sydney Local Hlth Dist, Sydney, NSW, Australia; [Ajwani, Shilpi; Bhole, Sameer] Sydney Dent Hosp, Oral Hlth Serv, Sydney, NSW, Australia; [Ajwani, Shilpi; Bhole, Sameer; George, Ajesh] Univ Sydney, Fac Dent, Sydney, NSW, Australia; [Rajaratnam, Rohan] Western Sydney Univ, Sch Med, Sydney, NSW, Australia; [Rajaratnam, Rohan] Univ New South Wales, Sydney, NSW, Australia; [Redfern, Julie] George Inst Global Hlth, Sydney, NSW, Australia; [Redfern, Julie] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia	Western Sydney University; Ingham Institute for Applied Medical Research; University of Sydney; Western Sydney University; University of New South Wales Sydney; George Institute for Global Health; University of Sydney; University of Sydney	Sanchez, P (corresponding author), Western Sydney Univ, Sch Nursing & Midwifery, Sydney, NSW, Australia.; Sanchez, P (corresponding author), South Western Sydney Local Hlth Dist, Sydney, NSW, Australia.; Sanchez, P (corresponding author), Collaborat Oral Hlth Outcomes Res Translat & Eval, Liverpool, Australia.; Sanchez, P (corresponding author), Ingham Inst Appl Med Res, Liverpool, Australia.	paula.sanchez@sswahs.nsw.gov.au	Salamonson, Yenna/AAX-4499-2020; Sanchez, Paula/ABG-8563-2021; Redfern, Julie/AAM-8617-2020; George, Ajesh/AAW-7813-2020; Everett, Bronwyn Lee/AAT-1308-2021	Redfern, Julie/0000-0001-8707-5563; George, Ajesh/0000-0002-6795-2546; Everett, Bronwyn/0000-0003-1733-7462; Rajaratnam, Rohan/0000-0002-7643-0221; Bhole, Sameer/0000-0002-3111-6335	Australian Postgraduate Award PhD scholarship through Western Sydney University; NHMRC Career Development Fellowship - National Heart Foundation Future Fellowship [1061793, G160523]	Australian Postgraduate Award PhD scholarship through Western Sydney University; NHMRC Career Development Fellowship - National Heart Foundation Future Fellowship	This study was supported by an Australian Postgraduate Award PhD scholarship through Western Sydney University. JR is funded by a NHMRC Career Development Fellowship (1061793) co-funded with a National Heart Foundation Future Fellowship (G160523).	American Heart Association, 2015, WHAT IS CARD DIS; Andersen R, 1995, REVISITING BEHAV MOD; [Anonymous], 2015, NAT REV IMMUNOL, DOI [DOI 10.1902/jop.2009.097001, DOI 10.1038/nri3785]; Australian Commission on Safety and Quality in Health Care, 2013, CONS HLTH SYST HLTH; Australian Dental Association, 2016, DENT PRACT SURV 2013; Australian Education Network, 2016, AUSTR U GUID; [Australian Government. Healthy Mouths Council CoAGCH], 2015, HLTH LIV AUSTR NAT O, P1; Australian Institute of Health and Welfare, 2016, COST DENT CAR; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bartova J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/636893; Beukers NGFM, 2017, J EPIDEMIOL COMMUN H, V71, P37, DOI 10.1136/jech-2015-206745; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Bouchard P, 2010, EUR HEART J SUPPL, V12, pB13, DOI 10.1093/eurheartj/suq001; Bowyer V, 2011, BRIT DENT J, V211, DOI 10.1038/sj.bdj.2011.769; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Campbell PC, 2015, AWARENESS METHOD ORA; Caula AL, 2014, J CLIN PERIODONTOL, V41, P875, DOI 10.1111/jcpe.12290; Chalmers JM, 2005, SPEC CARE DENT, V25, P227, DOI 10.1111/j.1754-4505.2005.tb01654.x; CHOICE Australia, 2013, MOUTH DENT FEES; Chrisopoulos S, 2016, ORAL HLTH DENT CARE; Clemmens DA, 2008, MCN-AM J MATERN-CHIL, V33, P10, DOI 10.1097/01.NMC.0000305650.56000.e8; D'Aiuto F, 2013, J CLIN PERIODONTOL, V40, pS85, DOI [10.1902/jop.2013.134007, 10.1111/jcpe.12061]; Demmer RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077441; Dhadse Prasad, 2010, J Indian Soc Periodontol, V14, P148, DOI 10.4103/0972-124X.75908; Dolce MC, 2014, J PROF NURS, V30, P63, DOI 10.1016/j.profnurs.2013.06.002; Dorn JM, 2010, J PERIODONTOL, V81, P502, DOI 10.1902/jop.2009.090499; Eke P. I., 2015, J PERIODONTOL, V86, P611, DOI DOI 10.1902/J0P.2015.140520; Flores MF, 2014, J PERIODONTOL, V85, P545, DOI 10.1902/jop.2013.130255; Frenkel H, 2002, COMMUNITY DENT ORAL, V30, P91, DOI 10.1034/j.1600-0528.2002.300202.x; Furr LA, 2004, J ADV NURS, V48, P454, DOI 10.1111/j.1365-2648.2004.03228.x; Fusch PI, 2015, QUAL REP, V20, P1408; Genco R. J., 2010, PERIODONTAL DIS OVER; George A, 2013, 10 WORLD C PREV DENT; George A, 2016, WOMEN BIRTH, V29, P208, DOI 10.1016/j.wombi.2015.10.004; George A, 2015, HEALTH CARE WOMEN IN, V36, P1160, DOI 10.1080/07399332.2014.959170; George A, 2012, J CLIN NURS, V21, P1087, DOI 10.1111/j.1365-2702.2011.03870.x; George A, 2010, J CLIN NURS, V19, P3324, DOI 10.1111/j.1365-2702.2010.03426.x; Ghapanchi J, 2016, BR J MED MED RES, V11, P1; Gomes IS, 2011, J PERIODONTOL, V82, P969, DOI 10.1902/jop.2010.100511; Government of South Australia, 2011, STAT CARD CLIN NETW; Griffiths J, 2002, JDOH, V3, P30; Heart Foundation, 2014, DIR NSW ACT CARD HLT; Heilbrunn-Lang AY, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0536-x; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Ioannidou E, 2006, J PERIODONTOL, V77, P1635, DOI 10.1902/jop.2006.050443; Johnson NA, 2010, AUST J ADV NURS, V27, P31; Joshy G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012386; Kandelman D, 2012, PERIODONTOL 2000, V60, P98, DOI 10.1111/j.1600-0757.2011.00427.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Khader YS, 2004, J PERIODONTOL, V75, P1046, DOI 10.1902/jop.2004.75.8.1046; Kinane D, 2008, J CLIN PERIODONTOL, V35, P333, DOI 10.1111/j.1600-051X.2008.01278.x; Kuramoto C, 2011, GERIATR GERONTOL INT, V11, P460, DOI 10.1111/j.1447-0594.2011.00709.x; Lam OLT, 2011, INT J CARDIOL, V151, P261, DOI 10.1016/j.ijcard.2010.11.014; Leng WD, 2015, INT J CARDIOL, V201, P469, DOI 10.1016/j.ijcard.2015.07.087; Li CJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009197.pub2; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Loos BG, 2016, ORAL INFECT GEN HLTH, P19; Maher L, 2012, HEALTH PROMOT J AUST, V23, P171, DOI 10.1071/HE12171; Montebugnoli L, 2002, J AM DENT ASSOC, V133, P468, DOI 10.14219/jada.archive.2002.0205; Moura Foz A, 2010, Minerva Stomatol, V59, P271; National Health Service England, 2014, IMPR DENT CAR OR HLT; Niwa H, 2000, ORAL SURG ORAL MED O, V89, P35, DOI 10.1016/S1079-2104(00)80011-6; Petersen PE, 2012, PERIODONTOL 2000, V60, P15, DOI 10.1111/j.1600-0757.2011.00425.x; Petersen PE, 2009, COMMUNITY DENT ORAL, V37, P1, DOI 10.1111/j.1600-0528.2008.00448.x; QRS International Pty Ltd, 2015, NVIVO QUAL DAT AN SO; Rasouli-Ghahroudi AA, 2016, ARYA ATHEROSCLER, V12, P1; Sanchez P, 2017, J CARDIOVASC NURS, V32, pE10, DOI 10.1097/JCN.0000000000000388; Schwarz E, 2006, COMMUNITY DENT ORAL, V34, P225, DOI 10.1111/j.1600-0528.2006.00301.x; SLHD Sydney Cardiothoracic Surgeons, 2016, HEART VAL SURG BOOKL; Song M, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-65; Stevens J, 2007, JOGNN-J OBST GYN NEO, V36, P581, DOI [10.1111/j.1552-6909.2007.00189.x, 10.1111/J.1552-6909.2007.00189.x]; Teeuw WJ, 2014, J CLIN PERIODONTOL, V41, P70, DOI 10.1111/jcpe.12171; Teles R, 2011, ORAL DIS, V17, P450, DOI 10.1111/j.1601-0825.2010.01784.x; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Vieira CLZ, 2009, ORAL DIS, V15, P538, DOI 10.1111/j.1601-0825.2009.01589.x; Virdee P, 2006, BRIT DENT J, V201, P132, DOI 10.1038/sj.bdj.4813891; World Health Organization, 2016, INT STAT CLASS DIS R, V10th	78	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181189	10.1371/journal.pone.0181189	http://dx.doi.org/10.1371/journal.pone.0181189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727751	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500044
J	Pita, S; Panzera, F; Mora, P; Vela, J; Cuadrado, A; Sanchez, A; Palomeque, T; Lorite, P				Pita, Sebastian; Panzera, Francisco; Mora, Pablo; Vela, Jesus; Cuadrado, Angeles; Sanchez, Antonio; Palomeque, Teresa; Lorite, Pedro			Comparative repeatome analysis on Triatoma infestans Andean and Non-Andean lineages, main vector of Chagas disease	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; REPETITIVE DNA; SATELLITE DNA; SEX-CHROMOSOMES; SOUTH-AMERICA; SEQUENCES; EVOLUTIONARY; ORGANIZATION; HETEROPTERA; VARIABILITY	Triatoma infestans is the most important Chagas disease vector in South America. Two main evolutionary lineages, named Andean and non-Andean, have been recognized by geographical distribution, phenetic and genetic characteristics. One of the main differences is the genomic size, varying over 30% in their haploid DNA content. Here we realize a genome wide analysis to compare the repetitive genome fraction (repeatome) between both lineages in order to identify the main repetitive DNA changes occurred during T. infestans differentiation process. RepeatExplorer analysis using Illumina reads showed that both lineages exhibit the same amount of non-repeat sequences, and that satellite DNA is by far the major component of repetitive DNA and the main responsible for the genome size differentiation between both lineages. We characterize 42 satellite DNA families, which are virtually all present in both lineages but with different amount in each lineage. Furthermore, chromosomal location of satellite DNA by fluorescence in situ hybridization showed that genomic variations in T. infestans are mainly due to satellite DNA families located on the heterochromatic regions. The results also show that many satDNA families are located on the euchromatic regions of the chromosomes.	[Pita, Sebastian; Panzera, Francisco] Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay; [Mora, Pablo; Vela, Jesus; Sanchez, Antonio; Palomeque, Teresa; Lorite, Pedro] Univ Jaen, Area Genet, Dept Biol Expt, Jaen, Spain; [Cuadrado, Angeles] Univ Alcala de Henares, Dept Cell Biol & Genet, Madrid, Spain	Universidad de la Republica, Uruguay; Universidad de Jaen; Universidad de Alcala	Pita, S (corresponding author), Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay.	spita@fcien.edu.uy	Mora, Pablo/S-5300-2016; Panzera, Francisco/M-9884-2015; Palomeque, Teresa/H-6365-2015; Pita, Sebastián/Z-6090-2019; Cuadrado, Angeles/H-3470-2015; Sanchez, Antonio/N-4174-2015; Martínez, Pedro Lorite/K-6806-2012; Mora-Ruiz, Pablo/U-7587-2019; Vela, Jesus/A-7534-2017	Mora, Pablo/0000-0001-7967-3379; Panzera, Francisco/0000-0001-5148-957X; Palomeque, Teresa/0000-0002-7144-4931; Pita, Sebastián/0000-0002-4102-5808; Cuadrado, Angeles/0000-0003-0089-5249; Sanchez, Antonio/0000-0002-6715-8158; Martínez, Pedro Lorite/0000-0002-9692-5870; Mora-Ruiz, Pablo/0000-0001-7967-3379; Vela, Jesus/0000-0003-2699-3031	"Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar, Uruguay); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); "Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia" - Program of Academic Mobility of AUIP (Ibero-American University Postgraduate Association); Spanish Junta de Andalucia, through the program "Ayudas a Grupos de Investigacion" [610220]; University of Jaen through the program "Ayudas para la realizacion de tesis doctoral en regimen de cotutela"	"Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar, Uruguay); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); "Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia" - Program of Academic Mobility of AUIP (Ibero-American University Postgraduate Association); Spanish Junta de Andalucia, through the program "Ayudas a Grupos de Investigacion"; University of Jaen through the program "Ayudas para la realizacion de tesis doctoral en regimen de cotutela"	This work was funded by the project grant from the "Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar, Uruguay), Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay), Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay) and by the "Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia", sponsor of Program of Academic Mobility of AUIP (Ibero-American University Postgraduate Association) for SP and FP. This work was also supported by the Spanish Junta de Andalucia, through the program "Ayudas a Grupos de Investigacion," Group 610220, assigned to PL and TP. This paper is included in the Ph.D. Thesis of Sebastian Pita (Udelar-University of Jaen), partially funded by a grant from the University of Jaen through the program "Ayudas para la realizacion de tesis doctoral en regimen de cotutela."	Altemose N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003628; Bardella VB, 2014, INFECT GENET EVOL, V23, P106, DOI 10.1016/j.meegid.2014.01.035; Bargues MD, 2006, INFECT GENET EVOL, V6, P46, DOI 10.1016/j.meegid.2005.01.006; Biscotti MA, 2015, CHROMOSOME RES, V23, P415, DOI 10.1007/s10577-015-9499-z; Calderon-Fernandez GM, 2012, MED VET ENTOMOL, V26, P201, DOI 10.1111/j.1365-2915.2011.00978.x; Depickere S, 2012, MEM I OSWALDO CRUZ, V107, P1042, DOI 10.1590/S0074-02762012000800013; Fernandez-Medina RD, 2016, INSECT BIOCHEM MOLEC, V69, P14, DOI 10.1016/j.ibmb.2015.09.003; FRY K, 1977, CELL, V12, P1069, DOI 10.1016/0092-8674(77)90170-2; Heckmann S, 2013, PLANT J, V73, P555, DOI 10.1111/tpj.12054; Hernandez L, 2008, ACTA TROP, V106, P60, DOI 10.1016/j.actatropica.2008.01.006; Hughes SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000233; JONES KW, 1981, HUM GENET, V58, P46; Kumar RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2872; Maumus F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094101; Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112; Mestrovic N, 1998, MOL BIOL EVOL, V15, P1062, DOI 10.1093/oxfordjournals.molbev.a026005; MIKLOS GLG, 1989, CHROMOSOMA, V98, P194, DOI 10.1007/BF00329683; Monteiro FA, 1999, MEM I OSWALDO CRUZ, V94, P229, DOI 10.1590/S0074-02761999000700037; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Palomeque T, 2005, CHROMOSOME RES, V13, P795, DOI 10.1007/s10577-005-1013-6; Panzera F, 2004, EMERG INFECT DIS, V10, P438, DOI 10.3201/eid1003.020812; Panzera F, 2010, CYTOGENET GENOME RES, V128, P77, DOI 10.1159/000298824; Panzera F, 2007, AM J TROP MED HYG, V76, P516, DOI 10.4269/ajtmh.2007.76.516; Panzera F, 2014, INFECT GENET EVOL, V27, P105, DOI 10.1016/j.meegid.2014.07.006; Pavlek M, 2015, DNA RES, V22, P387, DOI 10.1093/dnares/dsv021; Pita S, 2017, J MED ENTOMOL, V54, P44, DOI 10.1093/jme/tjw146; Pita S, 2016, COMP CYTOGENET, V10, P427, DOI 10.3897/CompCytogen.v10i3.9960; Pita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114298; Ribeiro T, 2016, CHROMOSOMA, P1; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rovatsos M, 2015, CYTOGENET GENOME RES, V147, P48, DOI 10.1159/000441646; Ruiz-Ruano FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28333; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; Sharakhov IV, 2015, CURR OPIN INSECT SCI, V10, P110, DOI 10.1016/j.cois.2015.05.003; SINGH L, 1982, CELL, V28, P205, DOI 10.1016/0092-8674(82)90338-5; Subramanian S, 2003, BIOINFORMATICS, V19, P681, DOI 10.1093/bioinformatics/btg067; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xue J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0521-0	40	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181635	10.1371/journal.pone.0181635	http://dx.doi.org/10.1371/journal.pone.0181635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723933	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800062
J	Richardson, S; Seekaew, P; Koblin, B; Vazquez, T; Nandi, V; Tieu, HV				Richardson, Sharise; Seekaew, Pich; Koblin, Beryl; Vazquez, Tasha; Nandi, Vijay; Tieu, Hong-Van			Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City	PLOS ONE			English	Article							TRANSGENDER WOMEN; TRIALS; WILLINGNESS; RISK; MEN; SEX; ENROLLMENT; INFECTION	Background Black men who have sex with men (MSM), and Transwomen (TW) shoulder disproportionate burden of HIV. However, they are unrepresented in HIV vaccine trials. We investigated the perceptions of that factors associated with HIV vaccine trials participation among Black MSM and TW in New York. Methods Self-administered online questionnaires were administered to 18-29 years of NYC residents who identified as Black MSM and TW, assessing demographics, awareness and willingness to participate in HIV vaccine trials, barriers and facilitators associated with willingness, and sexual behaviors. Frequency summation was performed to determine barriers and facilitators, and logistic regression analysis was performed to determine factors association with expressed willingness. Results Black MSM and TW who reported engaging in risk behaviors had a 61% lower likelihood of participating in HIV vaccine trials when compared to those who did not report engaging in any risk behavior. Facilitators associated with trial participation were: cash compensation, confidentiality regarding participation, public transportation vouchers, gift cards, and food or grocery vouchers as potential facilitators for trial participation. Conversely, fear of side effects from the vaccine, concerns about testing positive on routine HIV testing due to an HIV vaccine, limited knowledge of research trials, and fear of being judged as HIV-positive were perceived as barriers. Conclusions These findings provided insights into the considerations and perceptions of Black MSM and TW towards HIV vaccine trials. However, further studies are needed to delineate the complex mechanisms underlying the decision-making process and establish approaches to increase study participation in this population.	[Richardson, Sharise] Univ Miami, Sch Med, Miami, FL 33146 USA; [Seekaew, Pich] Thai Red Cross AIDS Res Ctr, Dept Prevent, Bangkok, Thailand; [Koblin, Beryl; Vazquez, Tasha; Nandi, Vijay; Tieu, Hong-Van] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA; [Koblin, Beryl; Vazquez, Tasha; Nandi, Vijay; Tieu, Hong-Van] New York Blood Ctr, New York, NY 10021 USA	University of Miami; Thai Red Cross Society; New York Blood Center; New York Blood Center	Seekaew, P (corresponding author), Thai Red Cross AIDS Res Ctr, Dept Prevent, Bangkok, Thailand.	pich@trcarc.org	Seekaew, Pich/GPJ-9576-2022		National Institutes of Mental Health (NIMH); National Institute of Allergy and Infectious Diseases (NIAID) U.S. Public Health Service, HVTN Research and Mentorship Program (RAMP) [UM1 A1068614]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069470, UM1AI068614] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases (NIAID) U.S. Public Health Service, HVTN Research and Mentorship Program (RAMP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Mental Health (NIMH) and the National Institute of Allergy and Infectious Diseases (NIAID) U.S. Public Health Service Grant UM1 A1068614 [LOC: HIV Vaccine Trials Network (HVTN)] as part of the HVTN Research and Mentorship Program (RAMP) Scholar Program (SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Castillo-Mancilla JR, 2014, HIV CLIN TRIALS, V15, P14, DOI 10.1310/hct1501-14; Centers for Disease Control and Prevention, 2016, HIV SURV REP 2016, V17, P4; Chu Z, 2013, BIOMED RES INT; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dhalla S, 2011, VACCINE, V29, P5850, DOI 10.1016/j.vaccine.2011.06.055; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Jenkins RA, 2000, SEX TRANSM INFECT, V76, P386, DOI 10.1136/sti.76.5.386; Khurana S, 2006, JAIDS-J ACQ IMM DEF, V43, P304, DOI 10.1097/01.qai.0000242465.50947.5f; Mbunda T, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.22853; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Newman PA, 2004, JAIDS-J ACQ IMM DEF, V37, P1393, DOI 10.1097/01.qai.0000127064.84325.ad; Newman PA, 2008, VACCINE, V26, P1091, DOI 10.1016/j.vaccine.2007.12.016; Newman PA, 2014, VACCINE, V32, P5854, DOI 10.1016/j.vaccine.2014.08.043; Newman PA, 2009, HEALTH SERV RES, V44, P2167, DOI 10.1111/j.1475-6773.2009.01039.x; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Saunders KO, 2012, AIDS, V26, P1293, DOI 10.1097/QAD.0b013e32835474d2; Strauss RP, 2001, J ACQ IMMUN DEF SYND, V26, P63, DOI 10.1097/00126334-200101010-00010; Voronin Y, 2015, VACCINE, V33, P1243, DOI 10.1016/j.vaccine.2014.10.040; Wansom T, 2016, J VIRUS ERAD, V2, P87; Wheeler DP, CROI 2016	26	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181702	10.1371/journal.pone.0181702	http://dx.doi.org/10.1371/journal.pone.0181702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723970	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800066
J	Ukibe, NR; Ukibe, SN; Emelumadu, OF; Onyenekwe, CC; Ahaneku, JE; Igwegbe, AO; Monago, IN; Ilika, AL				Ukibe, Nkiruka Rose; Ukibe, Solomon Nwabueze; Emelumadu, Obiageli Fidelia; Onyenekwe, Chinedum Charles; Ahaneku, Joseph Eberendu; Igwegbe, Anthony Osita; Monago, Ifeoma Nwamaka; Ilika, Amobi Linus			Impact of thyroid function abnormalities on reproductive hormones during menstrual cycle in premenopausal HIV infected females at NAUTH, Nnewi, Nigeria	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; SUBCLINICAL HYPOTHYROIDISM; WOMEN; DYSFUNCTION; LEVOTHYROXINE; PREVALENCE; DISORDERS; PATIENT; MEN	Background This was a prospective study designed to evaluate the impact of thyroid function abnormalities on reproductive hormones during menstrual cycle in HIV infected females at Nnamdi Azikiwe University Teaching Hospital Nnewi, South-East Nigeria. Methods The study randomly recruited 35 Symptomatic HIV infected females and 35 Symptomatic HIV infected females on antiretroviral therapy (HAART) for not less than six weeks from an HIV clinic and 40 apparently healthy control females among the hospital staff of NAUTH Nnewi. They were all premenopausal females with regular menstrual cycle and aged between 15-45 years. Blood samples were collected at follicular and luteal phases of their menstrual cycle for assay of Thyroid indices (FT3, FT4 and TSH) and Reproductive indices (FSH, LH, Estrogen, Progesterone, Prolactin and Testosterone) using ELISA method. Results The result showed significantly higher FSH and LH but significantly lower progesterone (prog) and estrogen (E2) in the test females compared to control females at both phases of menstrual cycle (P<0.05). There was significantly lower FT3 but significantly higher TSH value in Symptomatic HIV females (P<0.05). FSH, LH and TSH values were significantly lowered while prog and FT3 were significantly higher in Symptomatic HIV on ART compared to Symptomatic HIV females ( P<0.05). FT3, FT4, Prog and E2 were inversely correlated while FSH and LH were positively correlated with duration of HIV infection in HIV females ( P<0.05 respectively). There was a direct correlation between CD4+ count and FT3 while inverse correlation was found between CD4+ count and TSH levels ( P<0.05). Discussion The present study demonstrated hypothyroidism with a significant degree of primary hypogonadism in Symptomatic HIV infected females at both follicular and luteal phases of menstrual cycle which tends to normalize on treatments.	[Ukibe, Nkiruka Rose; Onyenekwe, Chinedum Charles] Nnamdi Azikiwe Univ, Coll Hlth Sci, Dept Med Lab Sci, Nnewi Campus, Nnewi, Anambra State, Nigeria; [Ukibe, Solomon Nwabueze] Fed Univ Technol Owerri, Dept Prosthesis & Orthot, Sch Hlth Technol, Akure, Imo State, Nigeria; [Emelumadu, Obiageli Fidelia; Ilika, Amobi Linus] Nnamdi Azikiwe Univ, Depatment Community Med, Coll Hlth Sci, Nnewi, Anambra State, Nigeria; [Ahaneku, Joseph Eberendu] Nnamdi Azikiwe Univ, Dept Chem Pathol, Coll Hlth Sci, Nnewi Campus, Nnewi, Anambra State, Nigeria; [Igwegbe, Anthony Osita] Nnamdi Azikiwe Univ, Dept Obstet & Gynecol, Coll Hlth Sci, Nnewi Campus, Nnewi, Anambra State, Nigeria; [Monago, Ifeoma Nwamaka] Fed Polytech, Dept Med Serv, Oko, Anambra State, Nigeria		Ukibe, NR (corresponding author), Nnamdi Azikiwe Univ, Coll Hlth Sci, Dept Med Lab Sci, Nnewi Campus, Nnewi, Anambra State, Nigeria.	ezinne4real2007@yahoo.com		Ahaneku, Joseph/0000-0003-0393-3984; Onyenekwe, Chinedum Charles/0000-0001-6181-9835	TETFUND through Nnamdi Azikiwe University, Awka, Nigeria [ETF/ES/NAUNIV/AWKA/VOL.1]	TETFUND through Nnamdi Azikiwe University, Awka, Nigeria	This work was funded by TETFUND through Nnamdi Azikiwe University, Awka, Nigeria. ETF/ES/NAUNIV/AWKA/VOL.1.	Aghajanova L, 2009, REPROD BIOMED ONLINE, V18, P337, DOI 10.1016/S1472-6483(10)60091-0; Ajayi AF, 2013, W INDIAN MED J, V62, P835, DOI 10.7727/wimj.2013.038; Atis G, 2010, J SEX MED, V7, P2583, DOI 10.1111/j.1743-6109.2010.01815.x; Hapon MB, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-14; Beltran S, 2003, CLIN INFECT DIS, V37, P579, DOI 10.1086/376626; Binita G, 2009, J REPROD INFERTIL, V10, P207; Bongiovanni M, 2006, J ANTIMICROB CHEMOTH, V58, P1086, DOI 10.1093/jac/dkl360; Brent GA, 2011, WILLIAMS TXB ENDOCRI, P412; Brockmeyer NH, 2000, HORM RES, V54, P294, DOI 10.1159/000053274; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Cedikova M, 2012, Ceska Gynekol, V77, P471; Chirgwin KD, 1996, J ACQ IMMUN DEF SYND, V12, P489, DOI 10.1097/00042560-199608150-00008; Croxson TS, 1990, CRIT CARE MED, V18, P440; DOBS AS, 1988, AM J MED, V84, P611, DOI 10.1016/0002-9343(88)90144-1; Friedman TC, 2012, THYROID MENSTRUATION; Grinspoon S, 1997, J CLIN ENDOCR METAB, V82, P1332, DOI 10.1210/jc.82.5.1332; Grinspoon SK., 2011, WILLIAM TXB ENDOCRIN, P1675; GRUNFELD C, 1993, METABOLISM, V42, P1270, DOI 10.1016/0026-0495(93)90124-7; Hampl R, 2003, THYROID, V13, P755, DOI 10.1089/105072503768499644; Henrik N., 1999, LANCET, V6, P56; Hoffmann CJ, 2007, CLIN INFECT DIS, V45, P488, DOI 10.1086/519978; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hutchinson A, 2000, LANCET, V356, P1003, DOI 10.1016/S0140-6736(00)02697-0; Karim R, 2013, J CLIN ENDOCR METAB, V98, pE610, DOI 10.1210/jc.2012-3195; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Krassas GE, 2013, WERNER INGBARS THYRO, P585; Krassas GE, 2008, THYROID, V18, P1255, DOI 10.1089/thy.2008.0257; Lanzafame M, 2002, INFECTION, V30, P54, DOI 10.1007/s15010-002-2092-3; Madeddu G, 2006, NAT CLIN PRACT ENDOC, V2, P602; Mandal SK, 2013, INT RES J PHARM, V4, P220; Meena L P, 2011, J Assoc Physicians India, V59, P365; Mylonakis E, 2001, CLIN INFECT DIS, V33, P857, DOI 10.1086/322695; Neema A, 2011, J OBSTET GYN INDIA, V61, P550, DOI 10.1007/s13224-011-0079-7; Norman J., 2001, JEFFCOATES PRINCIPLE, P60; Redmond GP, 2004, THYROID, V14, pS5, DOI 10.1089/105072504323024543; RicartEngel W, 1996, CLIN ENDOCRINOL, V44, P53, DOI 10.1046/j.1365-2265.1996.623445.x; da Silva GAR, 2015, ARCH ENDOCRIN METAB, V59, P116, DOI 10.1590/2359-3997000000023; Rosenfeld C R, 1999, AIDS Read, V9, P393; Salim YS, 1998, ACTA PATHOL MIC SC, V96, P889; San Francisco AIDS foundation, 2014, HIV AND HORMONES; Saran Sanjay, 2016, Indian J Endocrinol Metab, V20, P108, DOI 10.4103/2230-8210.172245; Shomon M., 2012, MENSTRUAL PROBLEMS T; Shujing J, 2016, BIOMED RES INT; Stern L, 2009, CLIN ADVISOR FORUM; Touzot M, 2006, AIDS, V20, P1210, DOI 10.1097/01.aids.0000226969.96880.3c; TRACEY KJ, 1990, ANN NY ACAD SCI, V587, P325, DOI 10.1111/j.1749-6632.1990.tb00173.x; Ukibe NR, 2013, S E NIGERIA ASIAN J, V3, P29; Ukibe NR, 2015, EUR SCI J, V11, P134; van den Boogaard E, 2011, HUM REPROD UPDATE, V17, P605, DOI 10.1093/humupd/dmr024; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wagner MS, 2008, J ENDOCRINOL, V199, P351, DOI 10.1677/JOE-08-0218; Zhang SS, 1997, MOL HUM REPROD, V3, P555, DOI 10.1093/molehr/3.7.555; Zheng KZ, 2015, REPROD BIOL, V15, P27, DOI 10.1016/j.repbio.2014.11.002	53	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0176361	10.1371/journal.pone.0176361	http://dx.doi.org/10.1371/journal.pone.0176361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723963	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800002
J	Alba, A; Morrison, RE; Cheerer, A; Rovira, A; Alvarez, J; Perez, AM				Alba, Anna; Morrison, Robert E.; Cheerer, Ann; Rovira, Albert; Alvarez, Julio; Perez, Andres M.			Optisample (TM): Open web-based application to optimize sampling strategies for active surveillance activities at the herd level illustrated using Porcine Respiratory Reproductive Syndrome (PRRS)	PLOS ONE			English	Article							SYNDROME VIRUS; DISEASE FREEDOM; SENSITIVITY; ELIMINATION; CHALLENGES	Porcine reproductive and respiratory syndrome virus (PRRSv) infection causes a devastating economic impact to the swine industry. Active surveillance is routinely conducted in many swine herds to demonstrate freedom from PRRSv infection. The design of efficient active surveillance sampling schemes is challenging because optimum surveillance strategies may differ depending on infection status, herd structure, management, or resources for conducting sampling. Here, we present an open web-based application, named 'Optisample (TM)', designed to optimize herd sampling strategies to substantiate freedom of infection considering also costs of testing. In addition to herd size, expected prevalence, test sensitivity, and desired level of confidence, the model takes into account the presumed risk of pathogen introduction between samples, the structure of the herd, and the process to select the samples over time. We illustrate the functionality and capacity of 'Optisample (TM)' through its application to active surveillance of PRRSv in hypothetical swine herds under disparate epidemiological situations. Diverse sampling schemes were simulated and compared for each herd to identify effective strategies at low costs. The model results show that to demonstrate freedom from disease, it is important to consider both the epidemiological situation of the herd and the sample selected.	[Alba, Anna; Morrison, Robert E.; Cheerer, Ann; Alvarez, Julio; Perez, Andres M.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Rovira, Albert] Univ Minnesota, Vet Diagnost Lab, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Alba, A (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	aalbacas@umn.edu	Alvarez, Julio/H-8292-2013; Perez, Andres/HGD-8377-2022	Alvarez, Julio/0000-0002-8999-9417; 	University of Minnesota MnDrive program; US Center of Excellence in Emergingand Zoonotic Animal Diseases (CEEZAD/KBA)	University of Minnesota MnDrive program; US Center of Excellence in Emergingand Zoonotic Animal Diseases (CEEZAD/KBA)	This study was funded in part by grants of the University of Minnesota MnDrive program and the US Center of Excellence in Emergingand Zoonotic Animal Diseases (CEEZAD/KBA).	Amezcua R, 2013, CAN VET J, V54, P775; [Anonymous], 2002, 27 SAS US GROUP INT; [Anonymous], 2014, R LANG ENV STAT COMP; Cameron A., 2002, MONOGRAPHS; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Cannon RM, 2002, PREV VET MED, V52, P227, DOI 10.1016/S0167-5877(01)00262-8; Chang W, 2015, SHINY WEB APPL FRAME; Collins J, 1996, LAB DIAGNOSIS PORCIN; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Dean A, 2014, OPENEPI OPEN SOURCE; Dee SA, 2004, J SWINE HEALTH PROD, V12, P129; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Forbes C., 2011, STAT DISTRIBUTIONS; Frossling J, 2009, PREV VET MED, V91, P137, DOI 10.1016/j.prevetmed.2009.05.012; Holtkamp DJ, 2011, J SWINE HEALTH PROD, V19, P44; Holtkamp DJ, 2010, PREV VET MED, V96, P186, DOI 10.1016/j.prevetmed.2010.06.016; Lambert ME, 2012, PREV VET MED, V104, P74, DOI 10.1016/j.prevetmed.2011.12.004; Linhares DCL, 2014, PREV VET MED, V116, P111, DOI 10.1016/j.prevetmed.2014.05.010; Martin PAJ, 2008, PREV VET MED, V84, P291, DOI 10.1016/j.prevetmed.2007.12.002; Martin PAJ, 2007, PREV VET MED, V79, P98, DOI 10.1016/j.prevetmed.2006.09.007; Martin RAJ, 2007, PREV VET MED, V79, P71, DOI 10.1016/j.prevetmed.2006.09.008; Pouillot R, 2016, PACKAGE MC2D HIST, V1100, P17; Rovira A, 2007, J VET DIAGN INVEST, V19, P502, DOI 10.1177/104063870701900507; Rowland RRR, 2012, TRANSBOUND EMERG DIS, V59, P55, DOI 10.1111/j.1865-1682.2011.01306.x; Seo BJ, 2016, J VET MED SCI, V78, P133, DOI 10.1292/jvms.15-0126; Sergeant E, 2014, RSURVEILLANCE DESIGN; Stark KDC, 2015, PREV VET MED, V122, P229, DOI 10.1016/j.prevetmed.2015.05.002; Team R, 2015, RSTUDIO INT DEV R; Zimmerman JJ, 1997, VET MICROBIOL, V55, P187, DOI 10.1016/S0378-1135(96)01330-2	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0176863	10.1371/journal.pone.0176863	http://dx.doi.org/10.1371/journal.pone.0176863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719658	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400001
J	Herbomel, GG; Rojas, RE; Tran, DT; Ajinkya, M; Beck, L; Tabak, LA				Herbomel, Gaetan G.; Rojas, Raul E.; Tran, Duy T.; Ajinkya, Monica; Beck, Lauren; Tabak, Lawrence A.			The GalNAc-T Activation Pathway (GALA) is not a general mechanism for regulating mucintype O-glycosylation	PLOS ONE			English	Article							BREAST-CANCER; BIOLOGICAL MICROSCOPY; TRANSFERASE FAMILY; EXPRESSION; COLOCALIZATION; GROWTH; SECRETION; ANTIGENS; ADHESION; MEMBERS	Mucin-type O-glycosylation is initiated by the UDP-GalNAc polypeptide: N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. Their activity results in the GalNAc a1-OThr/ Ser structure, termed the Tn antigen, which is further decorated with additional sugars. In neoplastic cells, the Tn antigen is often overexpressed. Because O-glycosylation is controlled by the activity of GalNAc-Ts, their regulation is of great interest. Previous reports suggest that growth factors, EGF or PDGF, induce Golgi complex-to-endoplasmic reticulum (ER) relocation of both GalNAc-Ts and Tn antigen in HeLa cells, offering a mechanism for Tn antigen overexpression termed "GALA". However, we were unable to reproduce these findings. Upon treatment of HeLa cells with either EGF or PDGF we observed no change in the co-localization of endogenous GalNAc-T1, GalNAc-T2 or Tn antigen with the Golgi complex marker TGN46. There was also no enhancement of localization with the ER marker calnexin. We conclude that growth factors do not cause redistribution of GalNAc-Ts from the Golgi complex to the ER in HeLa cells.	[Herbomel, Gaetan G.; Rojas, Raul E.; Tran, Duy T.; Ajinkya, Monica; Beck, Lauren; Tabak, Lawrence A.] Natl Inst Dent & Craniofacial Res, Sect Biol Chem, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Tabak, LA (corresponding author), Natl Inst Dent & Craniofacial Res, Sect Biol Chem, NIH, Bethesda, MD 20892 USA.	Lawrence.Tabak@nih.gov		Tabak, Lawrence/0000-0002-4261-7856	Intramural Research Program of the National Institutes of Health, NICDR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NICDR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the National Institutes of Health, NICDR.; We thank Kanishka Patel for help with experiments, Dr. George Patterson for advice on quantification of confocal microscopy data and providing reagents, and Dr. Kenneth Yamada for critical reading of earlier versions of the manuscript. We thank Dr. Ulla Mendel for providing antibodies to endogenous Ga1NAc-T1 and -T2, and for her review of the manuscript. We thank Drs. Kelly Ten Hagen and George Patterson for reviewing multiple versions of the manuscript. We thank Dr. Frederic Bard for providing us with additional details of his work and a sample of HeLa cells from his lab. This work was supported by the Intramural Research Program of the National Institutes of Health, NICDR.	Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brockhausen I, 2009, BBA-GEN SUBJECTS, V1790, P1244, DOI 10.1016/j.bbagen.2009.05.020; Dam TK, 2007, J BIOL CHEM, V282, P28256, DOI 10.1074/jbc.M704677200; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Gao JX, 2005, ACTA BIOCH BIOPH SIN, V37, P525, DOI 10.1111/j.1745-7270.2005.00076.x; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; ITZKOWITZ S, 1991, GASTROENTEROLOGY, V100, P1691, DOI 10.1016/0016-5085(91)90671-7; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Kato K, 2008, BIOCHEM BIOPH RES CO, V371, P698, DOI 10.1016/j.bbrc.2008.04.120; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Konno A, 2002, CLIN EXP METASTAS, V19, P61, DOI 10.1023/A:1013879702702; Konska G, 2006, ONCOL REP, V15, P305; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Laack E, 2002, J CLIN ONCOL, V20, P4279, DOI 10.1200/JCO.2002.08.067; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Ostuni MA, 2014, BIOL OPEN, V3, P1173, DOI 10.1242/bio.20149845; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Revoredo L, 2016, GLYCOBIOLOGY, V26, P360, DOI 10.1093/glycob/cwv108; Spang A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013391; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; Tran DT, 2012, J BIOL CHEM, V287, P20967, DOI 10.1074/jbc.M112.370387; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0179241	10.1371/journal.pone.0179241	http://dx.doi.org/10.1371/journal.pone.0179241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719662	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400004
J	Kamato, D; Bhaskarala, VV; Mantri, N; Oh, TG; Ling, D; Janke, R; Zheng, WH; Little, PJ; Osman, N				Kamato, Danielle; Bhaskarala, Venkata Vijayanand; Mantri, Nitin; Oh, Tae Gyu; Ling, Dora; Janke, Reearna; Zheng, Wenhua; Little, Peter J.; Osman, Narin			RNA sequencing to determine the contribution of kinase receptor transactivation to G protein coupled receptor signalling in vascular smooth muscle cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-BETA RECEPTOR; TGF-BETA; ANGIOTENSIN-II; PROTEOGLYCAN SYNTHESIS; GENE-EXPRESSION; CANCER CELLS; EGF RECEPTOR; CARDIOMYOCYTE HYPERTROPHY; COLORECTAL-CANCER	G protein coupled receptor (GPCR) signalling covers three major mechanisms. GPCR agonist engagement allows for the G proteins to bind to the receptor leading to a classical downstream signalling cascade. The second mechanism is via the utilization of the beta-arrestin signalling molecule and thirdly via transactivation dependent signalling. GPCRs can transactivate protein tyrosine kinase receptors (PTKR) to activate respective downstream signalling intermediates. In the past decade GPCR transactivation dependent signalling was expanded to show transactivation of serine/threonine kinase receptors (S/TKR). Kinase receptor transactivation enormously broadens the GPCR signalling paradigm. This work utilizes next generation RNA-sequencing to study the contribution of transactivation dependent signalling to total protease activated receptor (PAR)-1 signalling. Transactivation, assessed as gene expression, accounted for 50 percent of the total genes regulated by thrombin acting through PAR-1 in human coronary artery smooth muscle cells. GPCR transactivation of PTKRs is approximately equally important as the transactivation of the S/TKR with 209 and 177 genes regulated respectively, via either signalling pathway. This work shows that genome wide studies can provide powerful insights into GPCR mediated signalling pathways.	[Kamato, Danielle; Ling, Dora; Janke, Reearna; Little, Peter J.; Osman, Narin] Univ Queensland, Pharm Australia Ctr Excellence, Sch Pharm, Woolloongabba, Qld, Australia; [Bhaskarala, Venkata Vijayanand; Mantri, Nitin] RMIT Univ, Sch Appl Sci, Dept Biotechnol & Environm Biol, Bundoora, Vic, Australia; [Oh, Tae Gyu] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Zheng, Wenhua] Univ Macau, Fac Hlth Sci, Taipa, Macao, Peoples R China; [Little, Peter J.] Sun Yat Sen Univ, Xinhua Coll, Guangzhou, Guangdong, Peoples R China; [Osman, Narin] RMIT Univ, Sch Hlth & Biomed Sci, Diabet Complicat Grp, Bundoora, Vic, Australia; [Osman, Narin] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Osman, Narin] Monash Univ, Dept Immunol, Cent & Eastern Clin Sch, Alfred Hlth, Melbourne, Vic, Australia	University of Queensland; Royal Melbourne Institute of Technology (RMIT); University of Queensland; University of Macau; Sun Yat Sen University; Royal Melbourne Institute of Technology (RMIT); Monash University; Monash University	Kamato, D (corresponding author), Univ Queensland, Pharm Australia Ctr Excellence, Sch Pharm, Woolloongabba, Qld, Australia.	d.kamato@uq.edu.au	Little, Peter J./F-9865-2015; Kamato, Danielle/B-5894-2018	Little, Peter J./0000-0002-0335-3835; Kamato, Danielle/0000-0002-1089-2829; Mantri, Nitin/0000-0002-7621-035X; Bhaskarla, Vijay/0000-0002-2514-1171	RMIT University Research and Innovation Strategic Initiative grant; University of Queensland new head of school strategic Fund; Australian Postgraduate Award	RMIT University Research and Innovation Strategic Initiative grant; University of Queensland new head of school strategic Fund; Australian Postgraduate Award(Australian Government)	This work was supported by a RMIT University Research and Innovation 2014 Strategic Initiative grant and the University of Queensland new head of school strategic Fund. DK was supported by an Australian Postgraduate Award.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Belcheva MM, 2002, J PHARMACOL EXP THER, V303, P909, DOI 10.1124/jpet.102.038554; Blaschke F, 2004, REV ENDOCR METAB DIS, V5, P249, DOI 10.1023/B:REMD.0000032413.88756.ee; Bower JE, 2002, PSYCHOSOM MED, V64, P604, DOI 10.1097/00006842-200207000-00010; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Burch ML, 2013, J BIOL CHEM, V288, P7410, DOI 10.1074/jbc.M112.400259; Burch ML, 2010, J BIOL CHEM, V285, P26798, DOI 10.1074/jbc.M109.092767; Burch ML, 2010, CELL MOL LIFE SCI, V67, P2077, DOI 10.1007/s00018-010-0315-9; Catanzaro DF, 2010, SOUTH MED J, V103, P669, DOI 10.1097/SMJ.0b013e3181e1e2da; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen H, 2013, MOL THER, V21, P167, DOI [10.1038/mt.2012.225, 10.1038/mt.2013.197]; Chung H, 2013, J BIOL CHEM, V288, P37319, DOI 10.1074/jbc.M113.492793; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Esquivel-Velazquez M, 2015, J INTERF CYTOK RES, V35, P1, DOI 10.1089/jir.2014.0026; Fang Y, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00295; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; George AJ, 2013, J CELL SCI, V126, P5377, DOI 10.1242/jcs.128280; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Ghiselli G, 2016, DRUG DISCOV TODAY, V21, P1162, DOI 10.1016/j.drudis.2016.05.010; Giannopoulou EG, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0677-3; Gui Ting, 2012, J Signal Transduct, V2012, P289243, DOI 10.1155/2012/289243; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Gutkind JS, 1998, ONCOGENE, V17, P1331, DOI 10.1038/sj.onc.1202186; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Hong ZG, 2014, J MOL MED, V92, P995, DOI 10.1007/s00109-014-1162-1; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kamato D, 2016, CELL SIGNAL, V28, P110, DOI 10.1016/j.cellsig.2015.11.003; Kanai H, 2001, CIRC RES, V88, P30, DOI 10.1161/01.RES.88.1.30; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim TH, 2005, ONCOGENE, V24, P597, DOI 10.1038/sj.onc.1208237; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liang Y, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00037; Little PJ, 2008, CURR VASC PHARMACOL, V6, P195, DOI 10.2174/157016108784911966; Little PJ, 2010, J CARDIOVASC PHARM, V56, P360, DOI 10.1097/FJC.0b013e3181ee6811; Liu YL, 2009, FASEB J, V23, P2299, DOI 10.1096/fj.08-127910; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Mills CN, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00047; Moore-Smith L, 2011, J MAMMARY GLAND BIOL, V16, P89, DOI 10.1007/s10911-011-9216-2; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murasawa S, 1998, CIRC RES, V82, P1338, DOI 10.1161/01.RES.82.12.1338; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Normanno N, 2006, J CELL PHYSIOL, V207, P420, DOI 10.1002/jcp.20588; Osman N, 2011, GROWTH FACTORS, V29, P203, DOI 10.3109/08977194.2011.615747; PACKER M, 2001, AM J MED, V110, P81; Pasche Boris, 2014, Trans Am Clin Climatol Assoc, V125, P300; Ponsuksili S, 2009, FUNCT INTEGR GENOMIC, V9, P455, DOI 10.1007/s10142-009-0131-1; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; RAO GN, 1995, J BIOL CHEM, V270, P27871, DOI 10.1074/jbc.270.46.27871; RCore Team, 2020, R LANG ENV STAT COMP; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosano L, 2007, CANCER RES, V67, P6351, DOI 10.1158/0008-5472.CAN-07-0883; Rostam MA, 2016, CELLULAR SIGNALLING; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Smiljanic K, 2014, MOL CELL BIOCHEM, V396, P147, DOI 10.1007/s11010-014-2151-y; Song Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/254976; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Spinella F, 2013, J MOL MED, V91, P395, DOI 10.1007/s00109-012-0956-2; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Stockert JA, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00100; Stow LR, 2011, FASEB J, V25, P16, DOI 10.1096/fj.10-161612; Sun P, 2006, MOL PHARMACOL, V69, P520, DOI 10.1124/mol.105.019620; Suzuki R, 2015, J CROHNS COLITIS, V9, P565, DOI 10.1093/ecco-jcc/jjv073; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang XL, 2012, ACTA PHARMACOL SIN, V33, P363, DOI 10.1038/aps.2011.210; Thomas WG, 2003, TRENDS ENDOCRIN MET, V14, P130, DOI 10.1016/S1043-2760(03)00023-7; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Tuteja N, 2009, PLANT SIGNAL BEHAV, V4, P942, DOI 10.4161/psb.4.10.9530; Vacca F, 2000, CANCER RES, V60, P5310; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wynne BM, 2009, J AM SOC HYPERTENS, V3, P84, DOI 10.1016/j.jash.2008.09.002; Xu JZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S2; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Yu GL, 2002, CHINESE MED J-PEKING, V115, P1287; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhong L, 2015, CARDIOVASC RES, V106, P261, DOI 10.1093/cvr/cvv108; Zhou ZX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122064; Zhu XJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00085	98	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180842	10.1371/journal.pone.0180842	http://dx.doi.org/10.1371/journal.pone.0180842			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719611	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400019
J	Ota, T; Nishida, Y; Ikuta, K; Kato, R; Kozawa, E; Hamada, S; Sakai, T; Ishiguro, N				Ota, Takehiro; Nishida, Yoshihiro; Ikuta, Kunihiro; Kato, Ryuji; Kozawa, Eiji; Hamada, Shunsuke; Sakai, Tomohisa; Ishiguro, Naoki			Heat-stimuli-enhanced osteogenesis using clinically available biomaterials	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CELLULAR-RESPONSES; BONE; HYPERTHERMIA; SHOCK; STRESS; TISSUE; INDUCTION	A recent study reported that heat stress stimulates osteogenesis in an in vivo rat model using alginate gel and magnetite cationic liposomes. However, for clinical use, the efficacy for promoting osteogenesis needs to be investigated using clinically approved materials, and preferably with animals larger than rats. The aim of this study was to evaluate multiple heat stimuli-triggered osteogenesis in rat tibial defect models using already clinically applicable materials (Resovist (R) and REGENOS (R)) and determine the efficacy also in the rabbit. Fifty-eight rats and 10 rabbits were divided into two groups, respectively, with or without hyperthermia treatment at 45 degrees C for 15 min. (hyperthermia; 20 rats once a week, 8 rats three times a week, 5 rabbits once a week, control; 30 rats and 5 rabbits). Micro-CT assessment at 4 weeks revealed that a significantly stimulated osteogenesis was observed in the once a week group of both rats and rabbits as compared to the control group (p = 0.018 and 0.036, respectively). In contrast, the three times a week group did not show enhanced osteogenesis. Histological examination and image analysis showed consistent results in which the area of mineralized bone formation in the once a week hyperthermia group was significantly increased compared with that in the control group at four weeks (rat; p = 0.026, rabbit; p = 0.031). Newly formed bone was observed in the grafted materials from the periphery toward the center, and more osteoclasts were found in the once a week group. Heat stress also induced enhanced alkaline phosphatase expression in cultured osteoblastic cells, MC3T3, in vitro (p = 0.03). On the other hand, heat stress had no obvious effects on chondrogenic differentiation using ATDC5 cells. Our study demonstrates that heat-stimuli with clinically applicable novel heating materials can promote significant osteogenesis, and may thus be a promising treatment option for diseases associated with bone defects.	[Ota, Takehiro; Nishida, Yoshihiro; Ikuta, Kunihiro; Kozawa, Eiji; Hamada, Shunsuke; Sakai, Tomohisa; Ishiguro, Naoki] Nagoya Univ, Dept Orthopaed Surg, Grad Sch, Nagoya, Aichi, Japan; [Ota, Takehiro; Nishida, Yoshihiro; Ikuta, Kunihiro; Kozawa, Eiji; Hamada, Shunsuke; Sakai, Tomohisa; Ishiguro, Naoki] Sch Med, Nagoya, Aichi, Japan; [Kato, Ryuji] Nagoya Univ, Dept Basic Med Sci, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Kozawa, Eiji] Aichi Canc Ctr Hosp, Unit Orthopaed Surg, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Aichi Cancer Center	Nishida, Y (corresponding author), Nagoya Univ, Dept Orthopaed Surg, Grad Sch, Nagoya, Aichi, Japan.; Nishida, Y (corresponding author), Sch Med, Nagoya, Aichi, Japan.	ynishida@med.nagoya-u.ac.jp	Kato, Ryuji/I-6952-2014	Nishida, Yoshihiro/0000-0002-7511-6388	Ministry of Education, Culture, Sports, Science and Technology of Japan [26670659]; Nagoya University Hospital	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagoya University Hospital	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid for Challenging Exploratory Research 26670659], and Nagoya University Hospital Funding for Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Champagne M-J, 1999, HYPERTENSION, V33; Chen EM, 2015, FEBS LETT, V589, P4088, DOI 10.1016/j.febslet.2015.11.021; Chen J, 2013, TISSUE ENG PT A, V19, P716, DOI [10.1089/ten.tea.2012.0070, 10.1089/ten.TEA.2012.0070]; de Girolamo L, 2011, J ORTHOP RES, V29, P100, DOI 10.1002/jor.21184; Dolan EB, 2012, J R SOC INTERFACE, V9, P3503, DOI 10.1098/rsif.2012.0520; DOYLE JR, 1963, J BONE JT SURG, V45; ERIKSSON AR, 1983, J PROSTHET DENT, V50, P101, DOI 10.1016/0022-3913(83)90174-9; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007; Hilger I, 2013, INT J HYPERTHER, V29, P828, DOI 10.3109/02656736.2013.832815; Ikuta K, 2015, INT J HYPERTHER, V31, P58, DOI 10.3109/02656736.2014.988662; Iwasashi M, 2013, KEY ENG MATER, V529-530, P313, DOI 10.4028/www.scientific.net/KEM.529-530.313; Kajiya H, 2015, INT J HYPERTHER, V31, P635, DOI 10.3109/02656736.2015.1041430; Kobayashi T, 2011, BIOTECHNOL J, V6, P1342, DOI 10.1002/biot.201100045; Lange U, 2016, CLIN RHEUMATOL, V35, P2783, DOI 10.1007/s10067-016-3236-7; Lawaczeck R, 1997, ACTA RADIOL, V38, P584, DOI 10.1080/02841859709174391; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; Li M, 2014, TISSUE ENG PART C-ME, V20, P328, DOI [10.1089/ten.tec.2013.0087, 10.1089/ten.TEC.2013.0087]; Li S, 1999, J ORTHOP RES, V17, P891, DOI 10.1002/jor.1100170614; Matsumine A, 2011, INT J CLIN ONCOL, V16, P101, DOI 10.1007/s10147-011-0217-3; McDonald MM, 2012, J ORTHOP RES, V30, P1541, DOI 10.1002/jor.22109; Motomura T, 2010, ONCOL REP, V24, P591, DOI 10.3892/or_00000896; Norgaard R, 2006, ANN NY ACAD SCI, V1067, P443, DOI 10.1196/annals.1354.063; O'Loughlin PF, 2008, J BONE JT SURG, V90; Olkku A, 2010, BONE, V47, P320, DOI 10.1016/j.bone.2010.04.604; Patil S, 2014, CELLS TISSUES ORGANS, V199, P81, DOI 10.1159/000362226; Petryk AA, 2013, INT J HYPERTHER, V29, P845, DOI 10.3109/02656736.2013.825014; RICHARDS V, 1959, SURGERY, V46, P84; Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519; Samali A, 1999, FEBS LETT, V461, P306, DOI 10.1016/S0014-5793(99)01486-6; Sato I, 2014, J PHYSIOL SCI, V64, P177, DOI 10.1007/s12576-014-0309-8; Serrat MA, 2015, J ORTHOP RES; Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2; Shido Y, 2010, J BONE JOINT SURG BR, V92B, P580, DOI 10.1302/0301-620X.92B4.22814; Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731; STAUFFER PR, 1984, IEEE T BIO-MED ENG, V31, P235, DOI 10.1109/TBME.1984.325334; STORM FK, 1979, CANCER RES, V39, P2245; Sukenik S, 1999, RHEUM DIS CLIN N AM, V25, P883, DOI 10.1016/S0889-857X(05)70108-3; Takahashi KA, 2009, INT J HYPERTHER, V25, P661, DOI 10.3109/02656730903107519; Uemura K, 2014, J MATER SCI-MATER M, V25, P2541, DOI 10.1007/s10856-014-5266-5; Wang XD, 2003, ARCH BIOCHEM BIOPHYS, V415, P6, DOI 10.1016/S0003-9861(03)00213-3; Worth A, 2005, CLIN ORAL IMPLAN RES, V16, P379, DOI 10.1111/j.1600-0501.2005.01113.x	43	16	16	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181404	10.1371/journal.pone.0181404	http://dx.doi.org/10.1371/journal.pone.0181404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719650	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400046
J	Pallavali, RR; Degati, VL; Lomada, D; Reddy, MC; Durbaka, VRP				Pallavali, Roja Rani; Degati, Vijaya Lakshmi; Lomada, Dakshayani; Reddy, Madhava C.; Durbaka, Vijaya Raghava Prasad			Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections	PLOS ONE			English	Article							PHAGE THERAPY; ANTIMICROBIAL RESISTANCE; PATHOGENS; PROFILE; SKIN	Multi-drug resistance has become a major problem for the treatment of pathogenic bacterial infections. The use of bacteriophages is an attractive approach to overcome the problem of drug resistance in several pathogens that cause fatal diseases. Our study aimed to isolate multi drug resistant bacteria from patients with septic wounds and then isolate and apply bacteriophages in vitro as alternative therapeutic agents. Pus samples were aseptically collected from Rajiv Gandhi Institute of Medical Science (RIMS), Kadapa, A.P., and samples were analyzed by gram staining, evaluating morphological characteristics, and biochemical methods. MDR-bacterial strains were collected using the Kirby-Bauer disk diffusion method against a variety of antibiotics. Bacteriophages were collected and tested in vitro for lytic activity against MDR-bacterial isolates. Analysis of the pus swab samples revealed that the most of the isolates detected had Pseudomonas aeruginosa as the predominant bacterium, followed by Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli. Our results suggested that gram-negative bacteria were more predominant than gram-positive bacteria in septic wounds; most of these isolates were resistant to ampicillin, amoxicillin, penicillin, vancomycin and tetracycline. All the gram-positive isolates (100%) were multi-drug resistant, whereas 86% of the gram-negative isolates had a drug resistant nature. Further bacteriophages isolated from sewage demonstrated perfect lytic activity against the multi-drug resistant bacteria causing septic wounds. In vitro analysis of the isolated bacteriophages demonstrated perfect lysis against the corresponding MDR-bacteria, and these isolated phages may be promising as a first choice for prophylaxis against wound sepsis, Moreover, phage therapy does not enhance multi-drug resistance in bacteria and could work simultaneously on a wide variety of MDR-bacteria when used in a bacteriophage cocktail. Hence, our results suggest that these bacteriophages could be potential therapeutic options for treating septic wounds caused by P. aeruginosa, S. aureus, K. pneumoniae and E. coli.	[Pallavali, Roja Rani; Degati, Vijaya Lakshmi; Durbaka, Vijaya Raghava Prasad] Yogi Vemana Univ, Dept Microbiol, Kadapa, AP, India; [Lomada, Dakshayani; Reddy, Madhava C.] Yogi Vemana Univ, Dept Genet & Genom, Kadapa, AP, India; [Lomada, Dakshayani; Reddy, Madhava C.] Yogi Vemana Univ, Dept Biotechnol & Bioinformat, Kadapa, AP, India	Yogi Vemana University; Yogi Vemana University; Yogi Vemana University	Durbaka, VRP (corresponding author), Yogi Vemana Univ, Dept Microbiol, Kadapa, AP, India.	dvrp@yogvemanauniversity.ac.n	D, Vijayalakshmi/ABH-5397-2020	Reddy, Madhava/0000-0003-4885-0437; PALLAVALI, ROJARANI/0000-0001-5865-2974; Pallavali, Roja Rani/0000-0001-8729-3528	UGC	UGC(University Grants Commission, India)	The author (PRR) gratefully acknowledges UGC for financial support in the form of JRF and SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoran O, 2013, RATES RISK FACTORS A; Anguzu J., 2007, AFRICAN HLTH SCI, V7; [Anonymous], 2009, KIRBY BAUER DISK DIF; ARMON R, 1993, J APPL BACTERIOL, V74, P490, DOI 10.1111/j.1365-2672.1993.tb05159.x; Ayub M, 2015, ANN CLIN LAB RES; Beyene BA, 2011, TANZANIA J HLTH RES, V13; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bourdin G, 2014, APPL ENVIRON MICROB, V80, P1469, DOI 10.1128/AEM.03357-13; Buteera A, 2009, PRINCIPLES MANAGEMEN; Cerveny KE, 2002, INFECT IMMUN, V70, P6251, DOI 10.1128/IAI.70.11.6251-6262.2002; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Dai T, 2010, Recent Pat Antiinfect Drug Discov, V5, P124; Deep A, 2012, INDIAN J CLIN PRACT, V22, P519; Esebelahie N. O., 2013, African Journal of Clinical and Experimental Microbiology, V14, P155; Golkar Z, 2013, J ANTIVIRALS ANTIRET; Goswami NN, 2011, J PHARMACOL PHARMACO, V2, P158, DOI 10.4103/0976-500X.83279; Hall AR, 2012, APPL ENVIRON MICROB, V78, P5646, DOI 10.1128/AEM.00757-12; Haq IU, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-9; Hart CA, 1998, BRIT MED J, V317, P647, DOI 10.1136/bmj.317.7159.647; Hout B, 2015, TROPICAL DIS TRAVEL, V1, P1; Hsueh PR, 2010, J MICROBIOL IMMUNOL, V43, P452, DOI 10.1016/S1684-1182(10)60070-9; Iregbu K, AFRICAN J CLIN EXPT, V14, P160; Janda JM, 1997, EUR J CLIN MICROBIOL, V16, P189, DOI 10.1007/BF01709581; Kaftandzieva A., 2012, Macedonian Journal of Medical Sciences, V5, P72, DOI 10.3889/MJMS.1857-5773.2012.0201; Kotz P, 2009, INT WOUND J, V6, P186, DOI 10.1111/j.1742-481X.2009.00608.x; Kumari S, 2010, J MICROBIOL BIOTECHN, V20, P935, DOI 10.4014/jmb.0909.09010; Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001; Mama M, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-14; Mathur M D, 2003, J Assoc Physicians India, V51, P593; Mehta M, 2007, INDIAN J PLAST SURG, V40, P25, DOI 10.4103/0970-0358.32659; Mehta PA, 2000, PEDIATR INFECT DIS J, V19, P1000, DOI 10.1097/00006454-200010000-00012; Mirnejad R., 2008, Journal of Biological Sciences, V8, P478; Mulu W, 2012, ETHIOP J HEALTH SCI, V22, P7; Ndip RN, 2007, AFRICAN HLTH SCI, V7; Nkang O, 2009, J MICROBIOLOGY ANTIM, V1; Nouraldin AAM, 2016, ALEX J MED, V52, P99, DOI 10.1016/j.ajme.2015.05.002; Ohalete C, 2012, WORLD J PHARM PHARM, V1, P1155; Organization WH, 2014, ANT RES GLOB REP SUR; Perim MC, 2015, REV SOC BRAS MED TRO, V48, P546, DOI 10.1590/0037-8682-0146-2015; Sambrook J., 2001, MOL CLONING LAB MANU; Sankaran SV, 2016, J ACAD CLIN MICROBIO, V18, P12; Santos SB, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-148; Shahi SK, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01464; Sheridan Robert L, 2005, Pediatr Crit Care Med, V6, pS112, DOI 10.1097/01.PCC.0000161577.27849.BE; Shittu A., 2002, NIGERIA AFR J BIOMED, DOI [10.4314/ajbr.v5i3.53994, DOI 10.4314/AJBR.V5I3.53994]; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Tayfour MA, 2005, SAUDI MED J, V26, P1305; Thanni LOA, 2003, J NATL MED ASSOC, V95, P1189; Upadhyay A. K., 2012, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V3, P797; Valerie EJ, 2003, BURNS, V29, P15, DOI 10.1016/S0305-4179(02)00203-6; Vieira A, 2012, EUR J CLIN MICROBIOL, V31, P3241, DOI 10.1007/s10096-012-1691-x; Wang ZF, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00934; Wilson APR, 2004, BRIT MED J, V329, P720, DOI 10.1136/bmj.38232.646227.DE	56	49	50	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0179245	10.1371/journal.pone.0179245	http://dx.doi.org/10.1371/journal.pone.0179245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719657	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400005
J	Singh, S; Young, P; Armstrong, AW				Singh, Sanminder; Young, Paulina; Armstrong, April W.			An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies	PLOS ONE			English	Article							CHRONIC PLAQUE PSORIASIS; MYOCARDIAL-INFARCTION; INCREASED PREVALENCE; RISK-FACTOR; DISEASE; OBESITY; INFLAMMATION; ASSOCIATION; MORBIDITY; SEVERITY	The relationship between psoriasis and metabolic syndrome is not well understood. Though multiple epidemiologic studies have suggested a link between psoriasis and metabolic syndrome, there is a lack of a comprehensive meta-analysis synthesizing the results of all available observational studies to date. In this meta-analysis, we examined global data on the relationship between psoriasis and odds of metabolic syndrome by searching for studies published between 1946-2016. Specifically, we analyzed the results from 35 observational studies from 20 countries with 1,450,188 total participants, of which 46,714 were psoriasis patients. The pooled odds ratio based on random effects analysis was 2.14 (95% CI 1.84-2.48). Publication bias was present, as evidenced by an Egger test and graphical visualization through a funnel plot (p = 0.001). Based on this comprehensive meta-analysis, psoriasis patients have higher odds of having metabolic syndrome when compared with the general population.	[Singh, Sanminder] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Young, Paulina; Armstrong, April W.] Univ Southern Calif, Dept Dermatol, Keck Sch Med, Los Angeles, CA 90089 USA	University of California System; University of California Davis; University of Southern California	Armstrong, AW (corresponding author), Univ Southern Calif, Dept Dermatol, Keck Sch Med, Los Angeles, CA 90089 USA.	aprilarmstrong@post.harvard.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001855] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001855] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Akcali C, 2014, J INT MED RES, V42, P386, DOI 10.1177/0300060513502891; Al-Mutairi N, 2010, J DERMATOL, V37, P146, DOI 10.1111/j.1346-8138.2009.00777.x; Arias-Santiago S, 2012, EUR J DERMATOL, V22, P337, DOI 10.1684/ejd.2012.1714; Armstrong AW, 2013, J AM ACAD DERMATOL, V68, P654, DOI 10.1016/j.jaad.2012.08.015; Armstrong EJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000062; Augustin M, 2010, ACTA DERM-VENEREOL, V90, P147, DOI 10.2340/00015555-0770; Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Balci A, 2010, DERMATOLOGY, V220, P32, DOI 10.1159/000254482; Barrea L, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0889-6; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Bongiorno MR, 2010, J EUR ACAD DERMATOL, V24, P92, DOI 10.1111/j.1468-3083.2009.03309.x; Brito-Luna MJ, 2016, CYTOKINE, V85, P130, DOI 10.1016/j.cyto.2016.06.020; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Chen YJ, 2008, ARCH DERMATOL, V144, P1571, DOI 10.1001/archderm.144.12.1571; Chen YJ, 2009, J AM ACAD DERMATOL, V60, P225, DOI 10.1016/j.jaad.2008.09.046; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Damevska K, 2013, J DTSCH DERMATOL GES, V11, P1169, DOI 10.1111/ddg.12193; Danielsen K, 2015, BRIT J DERMATOL, V172, P419, DOI 10.1111/bjd.13288; Djurovic MR, 2016, VOJNOSANIT PREGL, V73, P1016, DOI 10.2298/VSP150114138R; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gelfand JM, 2012, J RHEUMATOL, V39, P24, DOI 10.3899/jrheum.120237; Gisondi P, 2007, BRIT J DERMATOL, V157, P68, DOI 10.1111/j.1365-2133.2007.07986.x; Golden JB, 2013, CYTOKINE, V62, P195, DOI 10.1016/j.cyto.2013.03.013; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hawkes JE, 2016, J INVEST DERMATOL, V136, P365, DOI 10.1038/JID.2015.409; Irimie M, 2015, ACTA DERMATOVENER CR, V23, P28; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Itani S, 2016, INT J DERMATOL, V55, P390, DOI 10.1111/ijd.12811; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Karoli Ritu, 2013, J Assoc Physicians India, V61, P798; Kokpol C, 2014, J DERMATOL, V41, P898, DOI 10.1111/1346-8138.12614; Kothiwala SK, 2016, INDIAN J DERMATOL VE, V82, P510, DOI 10.4103/0378-6323.183638; Lai YC, 2016, CLIN EXP DERMATOL, V41, P260, DOI 10.1111/ced.12781; Lai YC, 2016, J CUTAN MED SURG, V20, P327, DOI 10.1177/1203475415602842; Langan SM, 2012, J INVEST DERMATOL, V132, P556, DOI 10.1038/jid.2011.365; Liakou AI Z C, 2015, PSORIASIS TARGETS TH, V2015, P4; Love TJ, 2011, ARCH DERMATOL, V147, P419, DOI 10.1001/archdermatol.2010.370; Madanagobalane Shraddha, 2012, Indian J Dermatol, V57, P353, DOI 10.4103/0019-5154.100474; Mebazaa A, 2011, J EUR ACAD DERMATOL, V25, P705, DOI 10.1111/j.1468-3083.2010.03856.x; Miller IM, 2015, J EUR ACAD DERMATOL, V29, P490, DOI 10.1111/jdv.12595; Moon YS, 2004, METABOLISM, V53, P863, DOI 10.1016/j.metabol.2004.02.007; Nisa N, 2010, INDIAN J DERMATOL VE, V76, P662, DOI 10.4103/0378-6323.72462; Parikh Rakesh M, 2012, Indian J Endocrinol Metab, V16, P7, DOI 10.4103/2230-8210.91175; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Parodi A, 2014, AM J CLIN DERMATOL, V15, P371, DOI 10.1007/s40257-014-0074-8; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Praveenkumar U, 2016, J CLIN DIAGN RES, V10, pWC1, DOI 10.7860/JCDR/2016/17791.7218; Rachakonda TD, 2014, J AM ACAD DERMATOL, V70, P512, DOI 10.1016/j.jaad.2013.11.013; Scholze J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-529; Sharma YK, 2016, DIABETES METABOLIC S; Shiba M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149316; Singh S, 2016, GIORN ITAL DERMAT V, V151, P663; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Sullivan PW, 2007, OBESITY, V15, P3150, DOI 10.1038/oby.2007.375; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; Takahashi H, 2010, J DERMATOL SCI, V57, P143, DOI 10.1016/j.jdermsci.2009.11.002; Tasliyurt T, 2014, EUR REV MED PHARMACO, V18, P581; van der Voort EAM, 2016, ACTA DERM-VENEREOL, V96, P213, DOI 10.2340/00015555-2161; van der Voort EAM, 2014, J AM ACAD DERMATOL, V70, P517, DOI 10.1016/j.jaad.2013.10.044; Vaya A, 2013, CLIN HEMORHEOL MICRO, V55, P331, DOI 10.3233/CH-2012-1639; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Winge MCC, 2016, J CLIN INVEST, V126, P2661, DOI 10.1172/JCI85738; Wippel-Slupetzky K, 2009, CURR PROBL DERMATOL, V38, P172, DOI 10.1159/000232310; Wu JJ, 2012, ARCH DERMATOL, V148, P1244, DOI 10.1001/archdermatol.2012.2502; Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015; Yoo H, 2007, INT J BIOCHEM CELL B, V39, P1248, DOI 10.1016/j.biocel.2007.04.009; ZINDANCI I, 2012, THESCIENTIFICWORLDJO, DOI DOI 10.1016/J.JDERMSCI.2009.11.002	71	71	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181039	10.1371/journal.pone.0181039	http://dx.doi.org/10.1371/journal.pone.0181039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719618	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400030
J	Chonmaitree, T; Jennings, K; Golovko, G; Khanipov, K; Pimenova, M; Patel, JA; McCormick, DP; Loeffelholz, MJ; Fofanov, Y				Chonmaitree, Tasnee; Jennings, Kristofer; Golovko, Georgiy; Khanipov, Kamil; Pimenova, Maria; Patel, Janak A.; McCormick, David P.; Loeffelholz, Michael J.; Fofanov, Yuriy			Nasopharyngeal microbiota in infants and changes during viral upper respiratory tract infection and acute otitis media	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS COLONIZATION; ALPHA-HEMOLYTIC STREPTOCOCCI; HAEMOPHILUS-INFLUENZAE; IN-VITRO; PNEUMONIAE; HEALTHY; COMMUNITIES; PROBIOTICS; PATHOGENS; CHILDREN	Background Interferences between pathogenic bacteria and specific commensals are known. We determined the interactions between nasopharyngeal microbial pathogens and commensals during viral upper respiratory tract infection (URI) and acute otitis media (AOM) in infants. Methods We analyzed 971 specimens collected monthly and during URI and AOM episodes from 139 infants. The 16S rRNA V4 gene regions were sequenced on the Illumina MiSeq platform. Results Among the high abundant genus-level nasopharyngeal microbiota were Moraxella, Haemophilus, and Streptococcus (3 otopathogen genera), Corynebacterium, Dolosigranulum, Staphylococcus, Acinetobacter, Pseudomonas, and Bifidobacterium. Bacterial diversity was lower in culture-positive samples for Streptococcus pneumoniae, and Haemophilus influenzae, compared to cultured-negative samples. URI frequencies were positively associated with increasing trend in otopathogen colonization. AOM frequencies were associated with decreasing trend in Micrococcus colonization. During URI and AOM, there were increases in abundance of otopathogen genera and decreases in Pseudomonas, Myroides, Yersinia, and Sphingomonas. Otopathogen abundance was increased during symptomatic viral infection, but not during asymptomatic infection. The risk for AOM complicating URI was reduced by increased abundance of Staphylococcus and Sphingobium. Conclusion Otopathogen genera played the key roles in URI and AOM occurrences. Staphylococcus counteracts otopathogens thus Staphylococcal colonization may be beneficial, rather than harmful. While Sphingobium may play a role in preventing AOM complicating URI, the commonly used probiotic Bifidobacterium did not play a significant role during URI or AOM. The role of less common commensals in counteracting the deleterious effects of otopathogens requires further studies.	[Chonmaitree, Tasnee; Patel, Janak A.; McCormick, David P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Chonmaitree, Tasnee; Loeffelholz, Michael J.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Jennings, Kristofer] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Golovko, Georgiy; Khanipov, Kamil; Pimenova, Maria; Fofanov, Yuriy] Univ Texas Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Chonmaitree, T (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.; Chonmaitree, T (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	tchonmai@utmb.edu	Khanipov, Kamil/Y-6486-2019	Khanipov, Kamil/0000-0002-3881-737X; Golovko, George/0000-0003-4609-2767; Jennings, Kristofer/0000-0002-5442-9326	National Institutes of Health [K18DC13564, R01DC005841]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health research grants K18DC13564 and R01DC005841. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Bakaletz LO, 2010, J LEUKOCYTE BIOL, V87, P213, DOI 10.1189/jlb.0709518; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P298, DOI 10.1164/rccm.201401-0073OC; Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Bosch AATM, 2016, EBIOMEDICINE, V9, P336, DOI 10.1016/j.ebiom.2016.05.031; Chatzakis E, 2011, EUR J CLIN MICROBIOL, V30, P1111, DOI 10.1007/s10096-011-1199-9; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Chonmaitree T, 2006, CLIN INFECT DIS, V43, P1423, DOI 10.1086/509329; Chonmaitree T, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3555; Chonmaitree T, 2015, CLIN INFECT DIS, V60, P1, DOI 10.1093/cid/ciu714; Daly KA, 2010, INT J PEDIATR OTORHI, V74, P231, DOI 10.1016/j.ijporl.2009.09.006; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; FUJIMORI I, 1995, INT J PEDIATR OTORHI, V33, P249, DOI 10.1016/0165-5876(95)01220-6; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Hilty M, 2012, J INFECT DIS, V205, P1048, DOI 10.1093/infdis/jis024; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lehtoranta L, 2014, EUR J CLIN MICROBIOL, V33, P1289, DOI 10.1007/s10096-014-2086-y; Lewnard JA, 2016, J INFECT DIS, V213, P1596, DOI 10.1093/infdis/jiv761; Marom T, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002695; Mika M, 2015, J ALLERGY CLIN IMMUN, V135, P905, DOI 10.1016/j.jaci.2014.12.1909; Nagalingam NA, 2013, TRENDS MICROBIOL, V21, P485, DOI 10.1016/j.tim.2013.04.008; Niittynen L, 2012, INT J PEDIATR OTORHI, V76, P465, DOI 10.1016/j.ijporl.2012.01.011; Nokso-Koivisto J, 2015, CURR OPIN PEDIATR, V27, P110, DOI 10.1097/MOP.0000000000000184; Patel JA, 2015, PEDIATR INFECT DIS J, V34, P826, DOI 10.1097/INF.0000000000000744; Pettigrew MM, 2012, APPL ENVIRON MICROB, V78, P6262, DOI 10.1128/AEM.01051-12; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rodrigues F, 2013, PEDIATR INFECT DIS J, V32, P227, DOI 10.1097/INF.0b013e31827687fc; Schilder AGM, 2004, INT J PEDIATR OTORHI, V68, P29, DOI 10.1016/j.ijporl.2003.09.002; Shiri T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-483; Tano K, 2002, ACTA OTO-LARYNGOL, V122, P745, DOI 10.1080/00016480260349827; Tano K, 1999, INT J PEDIATR OTORHI, V47, P49, DOI 10.1016/S0165-5876(98)00174-8; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008	34	54	55	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180630	10.1371/journal.pone.0180630	http://dx.doi.org/10.1371/journal.pone.0180630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708872	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800016
J	Marshall, AT; Liu, AT; Murphy, NP; Maidment, NT; Ostlund, SB				Marshall, Andrew T.; Liu, Angela T.; Murphy, Niall P.; Maidment, Nigel T.; Ostlund, Sean B.			Sex-specific enhancement of palatability-driven feeding in adolescent rats	PLOS ONE			English	Article							DOPAMINE-RECEPTOR OVERPRODUCTION; MU-OPIOID RECEPTOR; NUCLEUS-ACCUMBENS; RISK-TAKING; FOOD REWARD; INGESTIVE BEHAVIOR; GENDER-DIFFERENCES; PREFRONTAL CORTEX; NEGATIVE FEEDBACK; LICKING BEHAVIOR	It has been hypothesized that brain development during adolescence perturbs reward processing in a way that may ultimately contribute to the risky decision making associated with this stage of life, particularly in young males. To investigate potential reward dysfunction during adolescence, Experiment 1 examined palatable fluid intake in rats as a function of age and sex. During a series of twice-weekly test sessions, non-food-deprived rats were given the opportunity to voluntarily consume a highly palatable sweetened condensed milk (SCM) solution. We found that adolescent male, but not female, rats exhibited a pronounced, transient increase in SCM intake (normalized by body weight) that was centered around puberty. Additionally, adult females consumed more SCM than adult males and adolescent females. Using a well-established analytical framework to parse the influences of reward palatability and satiety on the temporal structure of feeding behavior, we found that palatability-driven intake at the outset of the meal was significantly elevated in adolescent males, relative to the other groups. Furthermore, although we found that there were some group differences in the onset of satiety, they were unlikely to contribute to differences in intake. Experiment 2 confirmed that adolescent male rats exhibit elevated palatable fluid consumption, relative to adult males, even when a non-caloric saccharin solution was used as the taste stimulus, demonstrating that these results were unlikely to be related to age-related differences in metabolic need. These findings suggest that elevated palatable food intake during adolescence is sex specific and driven by a fundamental change in reward processing. As adolescent risk taking has been hypothesized as a potential result of hypersensitivity to and overvaluation of appetitive stimuli, individual differences in reward palatability may factor into individual differences in adolescent risky decision making.	[Marshall, Andrew T.; Liu, Angela T.; Ostlund, Sean B.] Univ Calif Irvine, Ctr Addict Neurosci, Dept Anesthesiol & Perioperat Care, Irvine, CA 92697 USA; [Murphy, Niall P.; Maidment, Nigel T.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Hatos Ctr, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	University of California System; University of California Irvine; University of California System; University of California Los Angeles	Marshall, AT; Ostlund, SB (corresponding author), Univ Calif Irvine, Ctr Addict Neurosci, Dept Anesthesiol & Perioperat Care, Irvine, CA 92697 USA.	marshaa1@uci.edu; sostlund@uci.edu		Marshall, Andrew/0000-0002-0068-8138; Liu, Angela/0000-0002-2839-7092	National Institutes of Health [AG045380, DK098709, DA029035, MH106972]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institutes of Health grants AG045380 (SBO, NTM and NPM), DK098709 (SBO, NTM and NPM), DA029035 (SBO), and MH106972 (SBO).The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	ALLISON J, 1971, J COMP PHYSIOL PSYCH, V76, P408, DOI 10.1037/h0031388; ALLISON J, 1970, J COMP PHYSIOL PSYCH, V70, P116, DOI 10.1037/h0028402; Andersen SL, 1997, NEUROREPORT, V8, P1495, DOI 10.1097/00001756-199704140-00034; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2002, PSYCHONEUROENDOCRINO, V27, P683, DOI 10.1016/S0306-4530(01)00069-5; Andrade AM, 2008, J AM DIET ASSOC, V108, P1186, DOI 10.1016/j.jada.2008.04.026; Angelopoulos T, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000013; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Boisgontier MP, 2016, NEUROSCI BIOBEHAV R, V68, P1004, DOI 10.1016/j.neubiorev.2016.05.034; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Breslin PAS, 1996, PHYSIOL BEHAV, V60, P411, DOI 10.1016/S0031-9384(96)80012-6; Burnham K. P., 1998, MODEL SELECTION INFE; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Carretero J, 2004, NEUROPEPTIDES, V38, P63, DOI 10.1016/j.npep.2004.01.004; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; CORBIT JD, 1969, J COMP PHYSIOL PSYCH, V69, P119, DOI 10.1037/h0027943; Craft RM, 2013, LIFE SCI, V92, P476, DOI 10.1016/j.lfs.2012.06.009; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; DAVIS JD, 1977, PSYCHOL REV, V84, P379, DOI 10.1037/0033-295X.84.4.379; DAVIS JD, 1995, PHYSIOL BEHAV, V57, P1081, DOI 10.1016/0031-9384(95)00008-7; DAVIS JD, 1989, ANN NY ACAD SCI, V575, P106; DAVIS JD, 1973, PHYSIOL BEHAV, V11, P39, DOI 10.1016/0031-9384(73)90120-0; DAVIS JD, 1988, APPETITE, V11, P229, DOI 10.1016/S0195-6663(88)80005-9; Davis JD, 1999, NUTRITION, V15, P32, DOI 10.1016/S0899-9007(98)00109-9; DAVIS JD, 1993, AM J PHYSIOL, V264, pR97, DOI 10.1152/ajpregu.1993.264.1.R97; Davis JD, 2000, PHYSIOL BEHAV, V69, P477, DOI 10.1016/S0031-9384(99)00265-6; Doremus-Fitzwater TL, 2016, NEUROSCI BIOBEHAV R, V70, P121, DOI 10.1016/j.neubiorev.2016.08.015; Doremus-Fitzwater TL, 2012, BEHAV NEUROSCI, V126, P735, DOI 10.1037/a0029697; Doremus-Fitzwater TL, 2010, BRAIN COGNITION, V72, P114, DOI 10.1016/j.bandc.2009.08.008; DUPONT A, 1981, LIFE SCI, V29, P2317, DOI 10.1016/0024-3205(81)90565-8; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Friemel CM, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00039; Frutos MGS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.006; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; GINSBURG HJ, 1982, CHILD DEV, V53, P426, DOI 10.2307/1128985; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Hay-Jahans C., 2012, R COMPANION LINEAR S; Higgs S, 2003, PSYCHOPHARMACOLOGY, V165, P370, DOI 10.1007/s00213-002-1263-3; Hodgson SR, 2009, LIFE SCI, V84, P52, DOI 10.1016/j.lfs.2008.11.002; Hoffman L, 2015, MULTIVAR APPL SER, P1; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; Holland PC, 2005, PHYSIOL BEHAV, V86, P747, DOI 10.1016/j.physbeh.2005.08.062; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Johnson AW, 2013, TRENDS NEUROSCI, V36, P101, DOI 10.1016/j.tins.2013.01.002; Johnson AW, 2011, P ROY SOC B-BIOL SCI, V278, P1450, DOI 10.1098/rspb.2010.1581; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; Kral JG, 2001, INT J OBESITY, V25, P258, DOI 10.1038/sj.ijo.0801469; KREFT IGG, 1995, MULTIVAR BEHAV RES, V30, P1, DOI 10.1207/s15327906mbr3001_1; MCCLEERY RH, 1977, ANIM BEHAV, V25, P1005, DOI 10.1016/0003-3472(77)90052-5; Meyer HC, 2016, PHYSIOL BEHAV, V167, P354, DOI 10.1016/j.physbeh.2016.10.004; Naneix F, 2012, J NEUROSCI, V32, P16223, DOI 10.1523/JNEUROSCI.3080-12.2012; Otsuka R, 2006, J EPIDEMIOL, V16, P117, DOI 10.2188/jea.16.117; Overduin J, 2012, AM J PHYSIOL-REG I, V303, pR259, DOI 10.1152/ajpregu.00488.2011; Pecina S, 2005, J NEUROSCI, V25, P11777, DOI 10.1523/JNEUROSCI.2329-05.2005; Petrovich GD, 2002, J NEUROSCI, V22, P8748; Piers LS, 1998, J APPL PHYSIOL, V85, P2196, DOI 10.1152/jappl.1998.85.6.2196; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro J., NLME LINEAR NONLINEA; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Reichelt AC, 2016, PHYSIOL BEHAV, V157, P13, DOI 10.1016/j.physbeh.2016.01.038; REIDELBERGER R, 1982, PHYSIOL BEHAV, V29, P173, DOI 10.1016/0031-9384(82)90385-7; Schielzeth H, 2013, METHODS ECOL EVOL, V4, P14, DOI 10.1111/j.2041-210x.2012.00251.x; Schneider M, 2008, ADDICT BIOL, V13, P253, DOI 10.1111/j.1369-1600.2008.00110.x; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P241, DOI 10.1016/S0149-7634(87)80032-5; Shaffer H J, 1996, J Gambl Stud, V12, P193, DOI 10.1007/BF01539174; SLOVIC P, 1966, CHILD DEV, V37, P169, DOI 10.1111/j.1467-8624.1966.tb05377.x; Smith GP, 2001, APPETITE, V36, P84, DOI 10.1006/appe.2000.0371; Smith JC, 2002, APPETITE, V38, P155, DOI 10.1006/appe.2001.0467; SMITH JC, 1980, PHYSIOL BEHAV, V24, P173, DOI 10.1016/0031-9384(80)90031-1; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; STELLAR E, 1952, J COMP PHYSIOL PSYCH, V45, P96, DOI 10.1037/h0062150; Stolyarova A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00115; Styne DM, 2001, PEDIATR CLIN N AM, V48, P823, DOI 10.1016/S0031-3955(05)70344-8; TEICHER MH, 1995, DEV BRAIN RES, V89, P167, DOI 10.1016/0165-3806(95)00109-Q; UENO E, 1988, NEUROBIOL AGING, V9, P279, DOI 10.1016/S0197-4580(88)80066-6; Vaidya JG, 2004, ANN NY ACAD SCI, V1021, P395, DOI 10.1196/annals.1308.051; VALENSTE.ES, 1967, SCIENCE, V156, P942, DOI 10.1126/science.156.3777.942; Vendruscolo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009296; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wassum KM, 2009, P NATL ACAD SCI USA, V106, P12512, DOI 10.1073/pnas.0905874106; Wassum KM, 2011, LEARN MEMORY, V18, P475, DOI 10.1101/lm.2229311; Wassum KM, 2011, J NEUROSCI, V31, P1591, DOI 10.1523/JNEUROSCI.3102-10.2011; WEIJNEN JAWM, 1984, BRAIN BEHAV EVOLUT, V25, P117, DOI 10.1159/000118857; Weijnen JAWM, 1998, NEUROSCI BIOBEHAV R, V22, P751, DOI 10.1016/S0149-7634(98)00003-7; WEINGARTEN HP, 1983, SCIENCE, V220, P431, DOI 10.1126/science.6836286; Wilmouth CE, 2009, PHARMACOL BIOCHEM BE, V92, P566, DOI 10.1016/j.pbb.2009.02.009; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243; Young ME, 2016, BEHAV PROCESS, V123, P43, DOI 10.1016/j.beproc.2015.09.009	99	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180907	10.1371/journal.pone.0180907	http://dx.doi.org/10.1371/journal.pone.0180907			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708901	Green Published, gold			2022-12-27	WOS:000405649800028
J	Segev, A; Gabay-Weschler, H; Naar, Y; Maoz, H; Bloch, Y				Segev, Aviv; Gabay-Weschler, Hila; Naar, Yossi; Maoz, Hagai; Bloch, Yuval			Real and virtual worlds alike: Adolescents' psychopathology is reflected in their videogame virtual behaviors	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; MEDIA USE; GAME; PERFORMANCE; CHILDREN; AGGRESSION; HOSTILITY; ONLINE; YOUTH; BOYS	Current research refers to videogames as a constant variable. However, games today are designed to be highly interactive and versatile: two players may be using the same videogame, but as a result of different using patterns, the game will not necessarily encompass the same content and gameplay. The current study examined the possible relationship between psychopathology and in-game playing patterns. We hypothesized that adolescents would play videogames differently, in a manner that would reflect their particular psychopathologies. We examined 47 male adolescents from three diagnostic groups: those suffering from externalizing psychopathologies, internalizing psychopathologies and controls. We performed a high-resolution examination of their gameplay, using in-game quantitative statistics mechanisms of two fundamentally different games, a structured racing game and an unstructured adventure game. While there was no difference in the groups' using patterns of the structured game, there was a high variability between the groups' using patterns when they were using a non-structured game. These findings suggest that virtual behavior in unstructured games is reflective of adolescent-players psychopathology, and might shed light on an unexplored facet of videogames research. Possible implications are discussed.	[Segev, Aviv; Maoz, Hagai; Bloch, Yuval] Shalvata Mental Hlth Ctr, Hod Hasharon, Israel; [Segev, Aviv; Gabay-Weschler, Hila; Maoz, Hagai; Bloch, Yuval] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Naar, Yossi] Cybereason Inc, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Segev, A (corresponding author), Shalvata Mental Hlth Ctr, Hod Hasharon, Israel.; Segev, A (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	aviv@segev.name						[Anonymous], 2008, LANCET, V371, P1137, DOI 10.1016/S0140-6736(08)60495-X; Barlett CP, 2008, J EXP SOC PSYCHOL, V44, P539, DOI 10.1016/j.jesp.2007.10.003; BARRATT E. S., 1959, PERCEPT MOTOR SKILLS, V9, P191; Bavelier D, 2011, NAT REV NEUROSCI, V12, P763, DOI 10.1038/nrn3135; Billieux J, 2013, COMPUT HUM BEHAV, V29, P103, DOI 10.1016/j.chb.2012.07.021; Bioulac S, 2014, J ATTEN DISORD, V18, P542, DOI 10.1177/1087054712443702; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; del Barrio V, 2004, PERS INDIV DIFFER, V37, P227, DOI 10.1016/j.paid.2003.08.014; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Ferguson CJ, 2015, PERSPECT PSYCHOL SCI, V10, P646, DOI 10.1177/1745691615592234; Ferguson CJ, 2013, AM PSYCHOL, V68, P57, DOI 10.1037/a0030597; Fossati A, 2002, PERCEPT MOTOR SKILL, V95, P621, DOI 10.2466/PMS.95.6.621-635; Fuld GL, 2009, PEDIATRICS, V124, P1495, DOI 10.1542/peds.2009-2146; Gentile DA, 2004, J ADOLESCENCE, V27, P5, DOI 10.1016/j.adolescence.2003.10.002; Griffiths M.D., 2015, MENTAL HLTH DIGITAL, P27, DOI DOI 10.1093/MED/9780199380183.003.0002; Janssen I, 2012, INT J PUBLIC HEALTH, V57, P325, DOI 10.1007/s00038-010-0221-9; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Lawrence V, 2002, J ABNORM CHILD PSYCH, V30, P447, DOI 10.1023/A:1019812829706; Lawrence Vivienne, 2004, J Atten Disord, V7, P137, DOI 10.1177/108705470400700302; Lee HJ, 2013, CYBERPSYCH BEH SOC N, V16, P878, DOI 10.1089/cyber.2011.0522; Marshall SJ, 2006, J ADOLESCENCE, V29, P333, DOI 10.1016/j.adolescence.2005.08.016; Mazurek MO, 2013, PEDIATRICS, V132, P260, DOI 10.1542/peds.2012-3956; Mazurek MO, 2013, J AUTISM DEV DISORD, V43, P1258, DOI 10.1007/s10803-012-1659-9; Mazurek MO, 2012, J AUTISM DEV DISORD, V42, P1757, DOI 10.1007/s10803-011-1413-8; MESSICK S, 1979, J EDUC PSYCHOL, V71, P281, DOI 10.1037/0022-0663.71.3.281; Richards R, 2010, ARCH PEDIAT ADOL MED, V164, P258, DOI 10.1001/archpediatrics.2009.280; Romer D, 2013, J ADOLESCENT HEALTH, V52, P613, DOI 10.1016/j.jadohealth.2012.11.012; ROSENTHAL R, 1963, AM SCI, V51, P268; Segev A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140542; Shaw Rebecca, 2005, J Atten Disord, V8, P160, DOI 10.1177/1087054705278771; Spielberger C., 1991, STATE TRAIT ANGER EX; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Swing EL, 2010, PEDIATRICS, V126, P214, DOI 10.1542/peds.2009-1508; Yang F, 2013, EUR J PUBLIC HEALTH, V23, P492, DOI 10.1093/eurpub/cks102	34	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181209	10.1371/journal.pone.0181209	http://dx.doi.org/10.1371/journal.pone.0181209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708879	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649800048
J	Stalter, RM; Tharaldson, J; Owen, DH; Okumu, E; Moench, T; Mack, N; Tolley, EE; MacQueen, KM				Stalter, Randy M.; Tharaldson, Jenae; Owen, Derek H.; Okumu, Eunice; Moench, Thomas; Mack, Natasha; Tolley, Elizabeth E.; MacQueen, Kathleen M.			Attitudes and perceptions towards novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; TENOFOVIR GEL; HIV-INFECTION; BREATH TEST; ADHERENCE; HAIR; DISCLOSURE; TRIAL	Results of recent microbicide and pre-exposure prophylaxis clinical trials have shown adherence to be a significant challenge with new HIV prevention technologies. As the vaginal ring containing dapivirine moves into two open label follow-on studies (HOPE/MTN-025 and DREAM) and other antiretroviral-based and multi-purpose prevention technology ring products advance through the development pipeline, there is a need for more accurate and reliable measures of adherence to microbicide ring products. We previously conducted a comprehensive landscape analysis to identify new technologies that could be applied to adherence measurement of vaginal rings containing antiretrovirals. To explore attitudes and perceptions towards the approaches that we identified, we conducted a survey of stakeholders with experience and expertise in microbicide and HIV prevention clinical trials. From May to July 2015 an electronic survey was distributed via email to 894 stakeholders; a total of 206 eligible individuals responded to at least one question and were included in the data analysis. Survey respondents were presented with various objective measures and asked about their perceived acceptability to trial participants, feasibility of implementation by study staff, usefulness for measuring adherence and ethical concerns. Methods that require no additional input from the participant and require no modifications to the existing ring product (i.e., measurement of residual drug or excipient, or a vaginal analyte that enters the ring) were viewed as being more acceptable to trial participants and more feasible to implement in the field. Respondents saw value in using objective measures to provide real-time feedback on adherence. However, approaches that involve unannounced home visits for sample collection or spot checks of ring use, which could provide significant value to adherence feedback efforts, were met with skepticism. Additional research on the acceptability of these methods to potential trial participants and trial staff is recommended.	[Stalter, Randy M.; Owen, Derek H.] Contracept Technol Innovat Dept, FHI 360, Durham, NC 27701 USA; [Tharaldson, Jenae; Okumu, Eunice; Mack, Natasha; Tolley, Elizabeth E.; MacQueen, Kathleen M.] Global Hlth Res Dept, FHI 360, Durham, NC USA; [Moench, Thomas] ReProtect Inc, Baltimore, MD USA	FHI 360; FHI 360	Stalter, RM (corresponding author), Contracept Technol Innovat Dept, FHI 360, Durham, NC 27701 USA.	rstalter@fhi360.org			USAID [AID-OAA-A-14-00003]	USAID(United States Agency for International Development (USAID))	Financial assistance was provided by USAID to FHI 360 under the terms of the Adherence Measurement and Optimization of Long-Acting ARV-Based Vaginal Ring Agreement, AID-OAA-A-14-00003. The contents are the responsibility of FHI 360 and do not necessarily reflect the views of USAID or the United States Government. USAID had no role in the study's design, data collection or data analysis. USAID was involved in discussions about publication of the results and reviewed and approved the manuscript prior to submission for publication. ReProtect, Inc. provided support in the form of salary for author TRM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	[Anonymous], 2016, IPMS DAPIVIRINE RING; [Anonymous], 2016, HOPE OPEN LABEL STUD; Baeten JM, 2016, NEW ENGLAND J MED; Baxi SM, 2015, JAIDS-J ACQ IMM DEF, V68, P13, DOI 10.1097/QAI.0000000000000386; Chen BA, 2015, JAIDS-J ACQ IMM DEF, V70, P242, DOI 10.1097/QAI.0000000000000702; Coetzee B, 2012, FUTURE VIROL, V7, P1135, DOI 10.2217/FVL.12.100; Fernandez-Romero JA, 2015, TRENDS MICROBIOL, V23, P429, DOI 10.1016/j.tim.2015.02.006; Gandhi M, 2015, J INFECT DIS, V212, P1402, DOI 10.1093/infdis/jiv239; Gandhi M, 2014, AIDS RES HUM RETROV, V30, P25, DOI [10.1089/aid.2013.0239, 10.1089/AID.2013.0239]; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Hickey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P311, DOI 10.1097/QAI.0000000000000154; Kalichman SC, 2010, HIV CLIN TRIALS, V11, P325, DOI 10.1310/hct1106-325; Keller MJ, 2015, AIDS LONDON ENGLAND; Liu AY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083736, 10.1371/journal.pone.0095291]; MacQueen KM, 2016, AIDS BEHAV, V20, P2682, DOI 10.1007/s10461-016-1339-4; Mansoor LE, 2014, AIDS BEHAV, V18, P841, DOI 10.1007/s10461-014-0752-9; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mngadi KT, 2014, AIDS BEHAV, V18, P849, DOI 10.1007/s10461-014-0696-0; Morey TE, 2013, J CLIN PHARMACOL, V53, P103, DOI 10.1177/0091270011434157; Nanda K, 2015, WOMENS HEALTH, V11, P729, DOI 10.2217/whe.15.84; Nel A, 2015, C RETR OPP INF; Nel A, 2016, 23 C RETR OPP INF CR; Olds PK, 2015, AIDS CARE, V27, P327, DOI 10.1080/09540121.2014.983452; Rees H, 2015, C RETR OPP INF CROI; Rosen EP, 2015, ANAL CHEM; Stalter RM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20746; Succop SM, 2014, AIDS CARE, V26, P1521, DOI 10.1080/09540121.2014.938014; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; van der Straten A, 2013, AIDS BEHAV, V17, P2211, DOI 10.1007/s10461-012-0390-z; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180963	10.1371/journal.pone.0180963	http://dx.doi.org/10.1371/journal.pone.0180963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708847	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649800034
J	Morettini, M; Palumbo, MC; Sacchetti, M; Castiglione, F; Mazza, C				Morettini, Micaela; Palumbo, Maria Concetta; Sacchetti, Massimo; Castiglione, Filippo; Mazza, Claudia			A system model of the effects of exercise on plasma Interleukin-6 dynamics in healthy individuals: Role of skeletal muscle and adipose tissue	PLOS ONE			English	Article							GLUCOSE-TOLERANCE TEST; MATHEMATICAL-MODEL; INSULIN-SECRETION; RECEPTOR AGONISTS; FUEL HOMEOSTASIS; GLYCOGEN-CONTENT; OXYGEN-UPTAKE; HUMANS; IL-6; INFLAMMATION	Interleukin-6 (IL-6) has been recently shown to play a central role in glucose homeostasis, since it stimulates the production and secretion of Glucagon-like Peptide-1 (GLP-1) from intestinal L-cells and pancreas, leading to an enhanced insulin response. In resting conditions, IL-6 is mainly produced by the adipose tissue whereas, during exercise, skeletal muscle contractions stimulate a marked IL-6 secretion as well. Available mathematical models describing the effects of exercise on glucose homeostasis, however, do not account for this IL-6 contribution. This study aimed at developing and validating a system model of exercise's effects on plasma IL-6 dynamics in healthy humans, combining the contributions of both adipose tissue and skeletal muscle. A two-compartment description was adopted to model plasma IL-6 changes in response to oxygen uptake's variation during an exercise bout. The free parameters of the model were estimated by means of a cross-validation procedure performed on four different datasets. A low coefficient of variation (< 10%) was found for each parameter and the physiologically meaningful parameters were all consistent with literature data. Moreover, plasma IL-6 dynamics during exercise and post-exercise were consistent with literature data from exercise protocols differing in intensity, duration and modality. The model successfully emulated the physiological effects of exercise on plasma IL-6 levels and provided a reliable description of the role of skeletal muscle and adipose tissue on the dynamics of plasma IL-6. The system model here proposed is suitable to simulate IL-6 response to different exercise modalities. Its future integration with existing models of GLP-1-induced insulin secretion might provide a more reliable description of exercise's effects on glucose homeostasis and hence support the definition of more tailored interventions for the treatment of type 2 diabetes.	[Morettini, Micaela] Univ Rome Foro Italico, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Rome, Italy; [Morettini, Micaela; Palumbo, Maria Concetta; Castiglione, Filippo] Natl Res Council Italy, Inst Appl Calculus Mauro Picone, Rome, Italy; [Sacchetti, Massimo] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Mazza, Claudia] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Mazza, Claudia] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England	Foro Italico University of Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); Foro Italico University of Rome; University of Sheffield; University of Sheffield	Morettini, M (corresponding author), Univ Rome Foro Italico, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Rome, Italy.; Morettini, M (corresponding author), Natl Res Council Italy, Inst Appl Calculus Mauro Picone, Rome, Italy.	m.morettini@iac.cnr.it	Morettini, Micaela/K-3097-2018; Palumbo, Maria Concetta/GVY-6861-2022; Castiglione, Filippo/B-1366-2010	Morettini, Micaela/0000-0002-8327-8379; Palumbo, Maria Concetta/0000-0001-8559-4749; Castiglione, Filippo/0000-0002-1442-3552; Mazza, Claudia/0000-0002-5215-1746; Sacchetti, Massimo/0000-0002-5365-5161	European Commission under the 7th Framework Programme [600803]	European Commission under the 7th Framework Programme	This study was funded by the European Commission under the 7th Framework Programme (https://ec.europa.eu/research/fp7 MISSION-T2D project, contract No.600803). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adamu II, 2012, OZEAN J APPL SCI, V5, P229; Allen TL, 2012, CELL METAB, V15, P8, DOI 10.1016/j.cmet.2011.12.004; ARTS FJP, 1994, INT J SPORTS MED, V15, P228, DOI 10.1055/s-2007-1021051; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bell C, 2001, EXP PHYSIOL, V86, P667, DOI 10.1113/eph8602150; Brubaker PL, 2007, ANN BIOMED ENG, V35, P1286, DOI 10.1007/s10439-007-9274-1; Burattini R, 2012, COMPUT METH PROG BIO, V107, P248, DOI 10.1016/j.cmpb.2011.07.002; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; CARSON ER, 1983, MATH MODELING METABO; Dalla Man C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1115, DOI 10.1152/ajpendo.00705.2009; Derouich M, 2002, J BIOMECH, V35, P911, DOI 10.1016/S0021-9290(02)00055-6; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Febbraio MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE397, DOI 10.1152/ajpendo.00134.2003; FELIG P, 1975, NEW ENGL J MED, V293, P1078; Fischer CP, 2004, J PHYSIOL-LONDON, V558, P633, DOI 10.1113/jphysiol.2004.066779; Hill AV, 1923, Q J MED, V16, P135, DOI 10.1093/qjmed/os-16.62.135; Hiscock N, 2005, AM J PHYSIOL-ENDOC M, V289, pE2, DOI 10.1152/ajpendo.00274.2004; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Kim J, 2007, ANN BIOMED ENG, V35, P69, DOI [10.1007/s10439-006-9201-x, 10.1007/s10439-006-9210-x]; Leicht CA, 2016, MED SCI SPORT EXER, V48, P1161, DOI 10.1249/MSS.0000000000000874; Lyngso D, 2002, J PHYSIOL-LONDON, V543, P373, DOI 10.1113/jphysiol.2002.019380; Lyngso D, 2002, J PHYSIOL-LONDON, V543, P379, DOI 10.1113/jphysiol.2002.021022; Man Chiara Dalla, 2009, J Diabetes Sci Technol, V3, P56; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Morettini Micaela, 2015, Prev Med Rep, V2, P538, DOI 10.1016/j.pmedr.2015.06.012; Morettini M, 2015, IFMBE PROC, V45, P431, DOI 10.1007/978-3-319-11128-5_108; Nauck M, 2016, DIABETES OBES METAB, V18, P203, DOI 10.1111/dom.12591; Ostrowski K, 2000, EUR J APPL PHYSIOL, V83, P512, DOI 10.1007/s004210000312; Ostrowski K, 1998, J PHYSIOL-LONDON, V513, P889, DOI 10.1111/j.1469-7793.1998.889ba.x; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2005, BRAIN BEHAV IMMUN, V19, P371, DOI 10.1016/j.bbi.2005.04.008; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Roy Anirban, 2007, J Diabetes Sci Technol, V1, P338; Salinari S, 2011, AM J PHYSIOL-ENDOC M, V300, pE955, DOI 10.1152/ajpendo.00451.2010; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silber HE, 2010, J CLIN PHARMACOL, V50, P246, DOI 10.1177/0091270009341185; Singh S, 2016, COMPUTATIONAL MATH B, V5, P5; Steensberg A, 2001, J PHYSIOL-LONDON, V537, P633, DOI 10.1111/j.1469-7793.2001.00633.x; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Svitra D, 2010, NONLINEAR ANAL-MODEL, V15, P213, DOI 10.15388/NA.2010.15.2.14355; Toft AD, 2011, EUR J APPL PHYSIOL, V111, P1351, DOI 10.1007/s00421-010-1755-5; Tura A, 2014, DIABETOLOGIA, V57, P1199, DOI 10.1007/s00125-014-3219-7; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	49	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181224	10.1371/journal.pone.0181224	http://dx.doi.org/10.1371/journal.pone.0181224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704555	Green Accepted, Green Published, gold			2022-12-27	WOS:000405649600067
J	Bernitsas, E; Khan, O; Razmjou, S; Tselis, A; Bao, F; Caon, C; Millis, S; Seraji-Bozorgzad, N				Bernitsas, Evanthia; Khan, Omar; Razmjou, Sara; Tselis, Alexandros; Bao, Fen; Caon, Christina; Millis, Scott; Seraji-Bozorgzad, Navid			Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROME; OLIGOCLONAL IGG BANDS; NERVOUS-SYSTEM; CLASSIFICATION CRITERIA; NEUROLOGICAL DISEASES; CONSENSUS STATEMENT; CSF; UPDATE; NEUROSARCOIDOSIS; ELECTROPHORESIS	Background The diagnostic accuracy of cerebrospinal fluid oligoclonal bands (CSF-OCB) detected by isoelectric focusing (IEF) in patients with multiple sclerosis (MS) was evaluated in our study. Methods Three hundred and twenty-one patients with MS and other central nervous system (CNS) immune mediated disorders were assessed (CIMD). Cerebrospinal fluid and matched serum samples were examined for the presence of OCB by IEF-IB (isoelectric focusing with immunoblotting). Results Isolated oligoclonal bands (ISO-OCB) were the only predictor of MS diagnosis independent of age, gender and CSF-OCB. ISO-OCB >= 3.5 detected by IEF yielded a sensitivity of 98% and specificity of 87% in distinguishing MS from MS mimickers. Conclusions For the neurologist, a score of >= 4 ISO-OCB supports the diagnosis of MS. On the other hand, ISO-OCB <= 3 favors CIMD. Further studies with larger population samples are warranted to confirm these findings.	[Bernitsas, Evanthia; Khan, Omar; Razmjou, Sara; Tselis, Alexandros; Bao, Fen; Caon, Christina; Seraji-Bozorgzad, Navid] Wayne State Sch Med, Dept Neurol, Detroit, MI USA; [Millis, Scott] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA	Wayne State University; Wayne State University	Bernitsas, E (corresponding author), Wayne State Sch Med, Dept Neurol, Detroit, MI USA.	ebernits@med.wayne.edu	seraji-bozorgzad, navid/J-1684-2019; Seraji-Bozorgzad, Navid/AAH-2704-2019	Seraji-Bozorgzad, Navid/0000-0002-8215-6513; bernitsas, evanthia/0000-0001-9382-1008				ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; Axelsson M, 2013, J NEUROIMMUNOL, V264, P100, DOI 10.1016/j.jneuroim.2013.09.003; Bourahoui A, 2004, EUR J NEUROL, V11, P525, DOI 10.1111/j.1468-1331.2004.00822.x; Correale J, 2002, J NEUROL, V249, P375, DOI 10.1007/s004150200026; Csako Gyorgy, 2012, Methods Mol Biol, V869, P247, DOI 10.1007/978-1-61779-821-4_20; Dale RC, 2010, CURR OPIN PEDIATR, V22, P718, DOI 10.1097/MOP.0b013e3283402b71; Fortini AS, 2003, AM J CLIN PATHOL, V120, P672, DOI 10.1309/Y5VFF2UAW0RK5W63; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Gastaldi M, 2017, EXPERT REV MOL DIAGN, V17, P31, DOI 10.1080/14737159.2017.1262260; Haertle M, 2014, J NEUROL, V261, P554, DOI 10.1007/s00415-013-7234-2; Huss AM, 2016, J NEUROL, V263, P2499, DOI 10.1007/s00415-016-8302-1; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P297, DOI 10.1136/jnnp.2008.151977; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P292, DOI 10.1136/jnnp.2008.150896; Kuhle J, 2015, MULT SCLER J, V21, P1013, DOI 10.1177/1352458514568827; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; Lunding J, 2000, ACTA NEUROL SCAND, V102, P322, DOI 10.1034/j.1600-0404.2000.102005322.x; MCLEAN BN, 1995, J NEUROL NEUROSUR PS, V58, P548, DOI 10.1136/jnnp.58.5.548; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mygland A, 2007, ACTA NEUROL SCAND, V115, P122, DOI 10.1111/j.1600-0404.2006.00763.x; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Powers WJ, 2015, NEUROL CLIN, V33, P515, DOI 10.1016/j.ncl.2014.12.004; Schneider M, 2007, LUPUS, V16, P418; Stangel M, 2013, NAT REV NEUROL, V9, P267, DOI 10.1038/nrneurol.2013.41; THOMPSON EJ, 1983, J NEUROL NEUROSUR PS, V46, P547, DOI 10.1136/jnnp.46.6.547; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Tintore M, 2001, MULT SCLER, V7, P359, DOI 10.1191/135245801701567069; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WALSH MJ, 1986, J EXP MED, V163, P41, DOI 10.1084/jem.163.1.41; Wengert O, 2013, J NEUROL SCI, V335, P124, DOI 10.1016/j.jns.2013.09.008; Zajicek JP, 1999, QJM-INT J MED, V92, P103, DOI 10.1093/qjmed/92.2.103	30	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181431	10.1371/journal.pone.0181431	http://dx.doi.org/10.1371/journal.pone.0181431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727770	gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500072
J	Fukumoto, R; Kawai, M; Minai, K; Ogawa, K; Yoshida, J; Inoue, Y; Morimoto, S; Tanaka, T; Nagoshi, T; Ogawa, T; Yoshimura, M				Fukumoto, Risa; Kawai, Makoto; Minai, Kosuke; Ogawa, Kazuo; Yoshida, Jun; Inoue, Yasunori; Morimoto, Satoshi; Tanaka, Toshikazu; Nagoshi, Tomohisa; Ogawa, Takayuki; Yoshimura, Michihiro			Conflicting relationship between agedependent disorders, valvular heart disease and coronary artery disease by covariance structure analysis: Possible contribution of natriuretic peptide	PLOS ONE			English	Article							MITRAL ANNULUS; FAILURE; CALCIFICATION; VALVE; BNP; ATHEROSCLEROSIS; PREDICTOR; SECRETION; CALCIUM; SYSTEM	Background It is conceivable that contemporary valvular heart disease (VHD) is affected largely by an age-dependent atherosclerotic process, which is similar to that observed in coronary artery disease (CAD). However, a comorbid condition of VHD and CAD has not been precisely examined. The first objective of this study was to examine a possible comorbid condition. Provided that there is no comorbidity, the second objective was to search for the possible reasons by using conventional risk factors and plasma B-type natriuretic peptide (BNP) because BNP has a potentiality to suppress atherosclerotic development. Methods The study population consisted of 3,457 patients consecutively admitted to our institution. The possible comorbid condition of VHD and CAD and the factors that influence the comorbidity were examined by covariance structure analysis and multivariate analysis. Results The distribution of the patients with VHD and those with CAD in the histograms showed that the incidence of VHD and the severity of CAD rose with seniority in appearance. The real statistical analysis was planned by covariance structure analysis. The current path model revealed that aging was associated with VHD and CAD severity (P < 0.001 for each); however, as a notable result, there was an inverse association regarding the comorbid condition between VHD and CAD ( Correlation coefficient [ beta]: -0.121, P < 0.001). As the second objective, to clarify the factors leading to this inverse association, the contribution of conventional risk factors, such as age, gender, hypertension, smoking, diabetes, obesity and dyslipidemia, to VHD and CAD were examined by multivariate analysis. However, these factors did not exert an opposing effect on VHD and CAD, and the inverse association defied explanation. Since different pathological mechanisms may contribute to the formation of VHD and CAD, a differentially proposed path model using plasma BNP revealed that an increase in plasma BNP being drawn by VHD suppressed the progression of CAD ( beta: -0.465, P < 0.001). Conclusions The incidence of VHD and CAD showed a significant conflicting relationship. This result supported the likely presence of unknown diverse mechanisms on top of the common cascade of atherosclerosis. Among them, the continuous elevation of plasma BNP due to VHD might be one of the explicable factors suppressing the progression of CAD.	[Fukumoto, Risa; Kawai, Makoto; Minai, Kosuke; Ogawa, Kazuo; Yoshida, Jun; Inoue, Yasunori; Morimoto, Satoshi; Tanaka, Toshikazu; Nagoshi, Tomohisa; Ogawa, Takayuki; Yoshimura, Michihiro] Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan	Jikei University	Kawai, M (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan.	cadmk@jikei.ac.jp	Tanaka, Toshikazu D/K-5989-2018	Tanaka, Toshikazu D/0000-0002-0711-7880; Kawai, Makoto/0000-0002-0914-9376	Grants-in-Aid for Scientific Research [17K09531] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adler Y, 2001, ATHEROSCLEROSIS, V155, P1, DOI 10.1016/S0021-9150(00)00737-1; Allison MA, 2006, CIRCULATION, V113, P861, DOI 10.1161/CIRCULATIONAHA.105.552844; Barasch E, 2006, AM HEART J, V151, P39, DOI 10.1016/j.ahj.2005.03.052; Cilliers AM, 2006, BMJ-BRIT MED J, V333, P1153, DOI 10.1136/bmj.39031.420637.BE; Clerico A, 2012, CLIN CHIM ACTA, V414, P112, DOI 10.1016/j.cca.2012.07.017; Clerico A, 2012, HEART FAIL REV, V17, P81, DOI 10.1007/s10741-011-9249-z; Conte L, 2007, J AM SOC ECHOCARDIOG, V20, P703, DOI 10.1016/j.echo.2006.11.018; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Holtz JE, 2012, AM J CARDIOL, V109, P1092, DOI 10.1016/j.amjcard.2011.11.043; Inoue Y, 2016, METABOLISM, V65, P38, DOI 10.1016/j.metabol.2015.09.019; Ito S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176435; Kawai M, 2013, INTERNAL MED, V52, P171, DOI 10.2169/internalmedicine.52.8704; Kinoshita K, 2016, INT J CARDIOL, V215, P283, DOI 10.1016/j.ijcard.2016.04.111; Komukai K, 2008, CIRC J, V72, P1152, DOI 10.1253/circj.72.1152; KORN D, 1962, NEW ENGL J MED, V267, P900, DOI 10.1056/NEJM196211012671802; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Minai K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108983; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503; Ogawa K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173898; Omiand T, 2008, EXPERT REV MOL DIAGN, V8, P217, DOI 10.1586/14737159.8.2.217; Oremus M, 2008, CLIN BIOCHEM, V41, P260, DOI 10.1016/j.clinbiochem.2007.09.011; Pressman GS, 2011, INT J CARDIOL, V146, P202, DOI 10.1016/j.ijcard.2009.06.057; ROBERTS WC, 1983, AM J CARDIOL, V51, P1005, DOI 10.1016/S0002-9149(83)80181-7; Shumaker RE, 2016, BEGINNERS GUIDE STRU; Tanaka Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02707-y; Tsutsumi J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177327; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; Yoshida J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02247-5; YOSHIMURA M, 1993, CIRCULATION, V87, P464, DOI 10.1161/01.CIR.87.2.464; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	34	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181206	10.1371/journal.pone.0181206	http://dx.doi.org/10.1371/journal.pone.0181206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727835	Green Published, gold, Green Submitted			2022-12-27	WOS:000406634500047
J	Madi, MK; Karameh, FN				Madi, Mahmoud K.; Karameh, Fadi N.			Hybrid Cubature Kalman filtering for identifying nonlinear models from sampled recording: Estimation of neuronal dynamics	PLOS ONE			English	Article							LOCAL LINEARIZATION METHOD; EFFECTIVE CONNECTIVITY; POPULATION-DYNAMICS; CAUSAL-MODELS; STATE; RESPONSES; EEG; DISTRIBUTIONS; DISCHARGE; FMRI	Kalman filtering methods have long been regarded as efficient adaptive Bayesian techniques for estimating hidden states in models of linear dynamical systems under Gaussian uncertainty. Recent advents of the Cubature Kalman filter (CKF) have extended this efficient estimation property to nonlinear systems, and also to hybrid nonlinear problems where by the processes are continuous and the observations are discrete (continuous-discrete CD-CKF). Employing CKF techniques, therefore, carries high promise for modeling many biological phenomena where the underlying processes exhibit inherently nonlinear, continuous, and noisy dynamics and the associated measurements are uncertain and time-sampled. This paper investigates the performance of cubature filtering (CKF and CD-CKF) in two flagship problems arising in the field of neuroscience upon relating brain functionality to aggregate neurophysiological recordings: (i) estimation of the firing dynamics and the neural circuit model parameters from electric potentials (EP) observations, and (ii) estimation of the hemodynamic model parameters and the underlying neural drive from BOLD (fMRI) signals. First, in simulated neural circuit models, estimation accuracy was investigated under varying levels of observation noise (SNR), process noise structures, and observation sampling intervals (dt). When compared to the CKF, the CD-CKF consistently exhibited better accuracy for a given SNR, sharp accuracy increase with higher SNR, and persistent error reduction with smaller dt. Remarkably, CD-CKF accuracy shows only a mild deterioration for non-Gaussian process noise, specifically with Poisson noise, a commonly assumed form of background fluctuations in neuronal systems. Second, in simulated hemodynamic models, parametric estimates were consistently improved under CD-CKF. Critically, time-localization of the underlying neural drive, a determinant factor in fMRI-based functional connectivity studies, was significantly more accurate under CD-CKF. In conclusion, and with the CKF recently benchmarked against other advanced Bayesian techniques, the CD-CKF framework could provide significant gains in robustness and accuracy when estimating a variety of biological phenomena models where the underlying process dynamics unfold at time scales faster than those seen in collected measurements.	[Madi, Mahmoud K.; Karameh, Fadi N.] Amer Univ Beirut, Dept Elect & Comp Engn, Beirut, Lebanon	American University of Beirut	Madi, MK (corresponding author), Amer Univ Beirut, Dept Elect & Comp Engn, Beirut, Lebanon.	mkm08@mail.aub.edu			American University of Beirut; Faculty of Engineering of the American University of Beirut; Lebanese National Council for Scientific Research; Lebanese National Council for Scientific Research (LNCSR); AUB F. Jabre Grant	American University of Beirut; Faculty of Engineering of the American University of Beirut; Lebanese National Council for Scientific Research; Lebanese National Council for Scientific Research (LNCSR); AUB F. Jabre Grant	This study is financially supported by the Farouk Jabre internal grant at the American University of Beirut, Dean's office at the Faculty of Engineering of the American University of Beirut, and the Lebanese National Council for Scientific Research. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the Lebanese National Council for Scientific Research (LNCSR) and the AUB F. Jabre Grant.	Aarabi A, 2014, CLIN NEUROPHYSIOL, V125, P930, DOI 10.1016/j.clinph.2013.10.051; Arasaratnam I, 2010, IEEE T SIGNAL PROCES, V58, P4977, DOI 10.1109/TSP.2010.2056923; Arasaratnam I, 2009, IEEE T AUTOMAT CONTR, V54, P1254, DOI 10.1109/TAC.2009.2019800; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Baker SM, 2013, BIOINFORMATICS; Bavdekar VA, 2011, J PROCESS CONTR, V21, P585, DOI 10.1016/j.jprocont.2011.01.001; BERGER D, 1990, EXP BRAIN RES, V80, P129; Biscay R, 1996, ANN I STAT MATH, V48, P631, DOI 10.1007/BF00052324; Chen CC, 2008, NEUROIMAGE, V41, P1293, DOI 10.1016/j.neuroimage.2008.03.026; Chong M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026001; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; De Kock CP, 2007, J PHYSL, P581; Fellous JM, 2003, NEUROSCIENCE, P122; Freestone DR, 2011, NEUROIMAGE, V56, P1043, DOI 10.1016/j.neuroimage.2011.02.027; Freestone DR, 2014, FRONTIERS NEUROSCIEN, P8; Friston KJ, 2008, NEUROIMAGE, V41, P849, DOI 10.1016/j.neuroimage.2008.02.054; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Galka A, 2004, NEUROIMAGE, V23, P435, DOI 10.1016/j.neuroimage.2004.02.022; Giraldo E, 2010, IEEE ENG MED BIO, P2914, DOI 10.1109/IEMBS.2010.5626281; Gorzelic P, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026016; Grant MM, 2014, HUM BRAIN MAPP, V35, P4815, DOI 10.1002/hbm.22514; Graupner M, 2013, J NEUROSCI, V33, P15075, DOI 10.1523/JNEUROSCI.0347-13.2013; Hamid L, 2013, IEEE ENG MED BIO, P4819, DOI 10.1109/EMBC.2013.6610626; Havlicek M, 2011, NEUROIMAGE, V56, P2109, DOI 10.1016/j.neuroimage.2011.03.005; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hu X, 2007, IEEE T BIO-MED ENG, V54, P597, DOI 10.1109/TBME.2006.890130; Hutcheson NL, 2015, HUM BRAIN MAPP, V36, P1442, DOI 10.1002/hbm.22714; Jimenez JC, 1999, J STAT PHYS, V94, P587, DOI 10.1023/A:1004504506041; Julier SJ, 1997, P SOC PHOTO-OPT INS, V3068, P182, DOI 10.1117/12.280797; Karameh F, 2014, BIOSIGNALS 2014; Kiebel SJ, 2008, COGN NEURODYNAMICS, V2, P121, DOI 10.1007/s11571-008-9038-0; Kloeden P.E., 1999, NUMERICAL SOLUTION S; Kostal L, 2006, BIOL CYBERN, V94, P157, DOI 10.1007/s00422-005-0036-6; Lankarany M, 2013, BMC NEUROSCI, V14, pO2; LEVINE MW, 1991, BIOL CYBERN, V65, P459, DOI 10.1007/BF00204659; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Lopez-Cuevas A, 2015, NEUROIMAGE, V113, P374, DOI 10.1016/j.neuroimage.2015.02.059; Marreiros AC, 2008, NEUROIMAGE, V42, P147, DOI 10.1016/j.neuroimage.2008.04.239; Marreiros AC, 2009, NEUROIMAGE, V44, P701, DOI 10.1016/j.neuroimage.2008.10.008; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Min Zheng, 2010, Proceedings of the SICE 2010 - 49th Annual Conference of the Society of Instrument and Control Engineers of Japan, P2192; Moran RJ, 2011, NEUROIMAGE, V55, P1694, DOI 10.1016/j.neuroimage.2011.01.012; Nahas Z, 2014, NEUROPSYCHOPHARMACOL, V39, pS561; Ramos JI, 1999, APPL MATH COMPUT, V104, P109, DOI 10.1016/S0096-3003(98)10056-5; Riera JJ, 2004, NEUROIMAGE, V21, P547, DOI 10.1016/j.neuroimage.2003.09.052; Rudolph M, 2003, NEUROSCIENCE, V119, P855, DOI 10.1016/S0306-4522(03)00164-7; SCHIFF S, 2008, BMC NEUROSCI, V9, pO1; Schiff SJ, 2009, IEEE ENG MED BIO, P3318, DOI 10.1109/IEMBS.2009.5333752; Sedigh-Sarvestani M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002788; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith SM, 2014, BRIT J RADIOLOGY; Sommerlade L, 2014, FRONT NEUROENG, P161; Sorenson HW., 1985, KALMAN FILTERING THE; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Toppi J, 2012, IEEE ENG MED BIO, P6192, DOI 10.1109/EMBC.2012.6347408; Ullah G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000776; Ullah G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.040901; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6; van der Merwe R, 2001, INT CONF ACOUST SPEE, P3461, DOI 10.1109/ICASSP.2001.940586; Walters-Williams J., 2010, 2010 IEEE/ICME International Conference on Complex Medical Engineering. CME 2010, P45, DOI 10.1109/ICCME.2010.5558873; Wang JL, 2010, CHINESE J CHEM ENG, V18, P258, DOI 10.1016/S1004-9541(08)60351-1; Wei YN, 2011, IEEE DECIS CONTR P, P5844, DOI 10.1109/CDC.2011.6161358; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585	66	2	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181513	10.1371/journal.pone.0181513	http://dx.doi.org/10.1371/journal.pone.0181513			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727850	gold, Green Submitted, Green Published			2022-12-27	WOS:000406634500081
J	Salters, K; Loutfy, M; de Pokomandy, A; Money, D; Pick, N; Wang, L; Jabbari, S; Carter, A; Webster, K; Conway, T; Dubuc, D; O'Brien, N; Proulx-Boucher, K; Kaida, A				Salters, Kate; Loutfy, Mona; de Pokomandy, Alexandra; Money, Deborah; Pick, Neora; Wang, Lu; Jabbari, Shahab; Carter, Allison; Webster, Kath; Conway, Tracey; Dubuc, Daniele; O'Brien, Nadia; Proulx-Boucher, Karene; Kaida, Angela		CHIWOS Res Team	Pregnancy incidence and intention after HIV diagnosis among women living with HIV in Canada	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FAMILY-PLANNING-SERVICES; COMMUNITY-BASED RESEARCH; ANTIRETROVIRAL THERAPY; INFECTED WOMEN; UNINTENDED PREGNANCY; REPRODUCTIVE EXPERIENCE; CONTRACEPTIVE USE; FERTILITY DESIRE; MALAWIAN WOMEN	Background Pregnancy incidence rates among women living with HIV (WLWH) have increased over time due to longer life expectancy, improved health status, and improved access to and HIV prevention benefits of combination antiretroviral therapy (cART). However, it is unclear whether intended or unintended pregnancies are contributing to observed increases. Methods We analyzed retrospective data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS). Kaplan-Meier methods and GEE Poisson models were used to measure cumulative incidence and incidence rate of pregnancy after HIV diagnosis overall, and by pregnancy intention. We used multivariable logistic regression models to examine independent correlates of unintended pregnancy among the most recent/current pregnancy. Results Of 1,165 WLWH included in this analysis, 278 (23.9%) women reported 492 pregnancies after HIV diagnosis, 60.8% of which were unintended. Unintended pregnancy incidence (24.6 per 1,000 Women-Years (WYs); 95% CI: 21.0, 28.7) was higher than intended pregnancy incidence (16.6 per 1,000 WYs; 95% CI: 13.8, 20.1) (Rate Ratio: 1.5, 95% CI: 1.2-1.8). Pregnancy incidence among WLWH who initiated cART before or during pregnancy (29.1 per 1000 WYs with 95% CI: 25.1, 33.8) was higher than among WLWH not on cART during pregnancy (11.9 per 1000 WYs; 95% CI: 9.5, 14.9) (Rate Ratio: 2.4, 95% CI: 2.0-3.0). Women with current or recent unintended pregnancy (vs. intended pregnancy) had higher adjusted odds of being single (AOR: 1.94; 95% CI: 1.10, 3.42), younger at time of conception (AOR: 0.95 per year increase, 95% CI: 0.90, 0.99), and being born in Canada (AOR: 2.76, 95% CI: 1.55, 4.92). Conclusion Nearly one-quarter of women reported pregnancy after HIV diagnosis, with 61% of all pregnancies reported as unintended. Integrated HIV and reproductive health care programming is required to better support WLWH to optimize pregnancy planning and outcomes and to prevent unintended pregnancy.	[Salters, Kate; Carter, Allison; Webster, Kath; Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Salters, Kate; Wang, Lu; Jabbari, Shahab; Carter, Allison] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Loutfy, Mona; Conway, Tracey] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [de Pokomandy, Alexandra; Dubuc, Daniele; O'Brien, Nadia; Proulx-Boucher, Karene] McGill Univ, Hlth Ctr, Chron Viral Illness Serv, Montreal, PQ, Canada; [de Pokomandy, Alexandra; O'Brien, Nadia] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [Money, Deborah; Pick, Neora] BC Womens Hosp & Hlth Ctr, Oak Tree Clin, Vancouver, BC, Canada; [Money, Deborah] Univ British Columbia, Fac Med, Vancouver, BC, Canada	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of Toronto; University Toronto Affiliates; Womens College Hospital; McGill University; McGill University; University of British Columbia	Kaida, A (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	kangela@sfu.ca		Carter, Allison/0000-0003-2151-2622	Canadian Institutes of Health Research (CIHR) [MOP111041]; CIHR Canadian HIV Trials Network [CTN 262]; Ontario HIV Treatment Network (OHTN); Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund; Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec - Sante (FRQS); Tier 2 Canada Research Chair in Global Perspectives on HIV and Sexual and Reproductive Health; national Steering Committee; three provincial Community Advisory Boards; national CHIWOS Aboriginal and African; Caribbean and Black Advisory Boards	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network (OHTN); Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); Tier 2 Canada Research Chair in Global Perspectives on HIV and Sexual and Reproductive Health; national Steering Committee; three provincial Community Advisory Boards; national CHIWOS Aboriginal and African; Caribbean and Black Advisory Boards	CHIWOS is funded by the Canadian Institutes of Health Research (CIHR, MOP111041); the CIHR Canadian HIV Trials Network (CTN 262); the Ontario HIV Treatment Network (OHTN); and the Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund. KS and AC received doctoral scholarship support from the Canadian Institutes of Health Research (CIHR). AdP received support from Fonds de Recherche du Quebec - Sante (FRQS) (Chercheurboursier clinicien - Junior. NO received support from FRQS. AK received salary support through a Tier 2 Canada Research Chair in Global Perspectives on HIV and Sexual and Reproductive Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS) Research Team would like to especially thank all of the women living with HIV who participate in this research. We also thank the entire national team of Co-Investigators, Collaborators, and Peer Research Associates. We would like to acknowledge the national Steering Committee, the three provincial Community Advisory Boards, the national CHIWOS Aboriginal and African, Caribbean and Black Advisory Boards, and our partnering organizations for supporting the study, especially those who provide interview space and support to our Peer Research Associates. We dedicate this paper to the memory of Marisol Desbiens, a champion for the sexual and reproductive rights of women living with HIV.	Abelsohn K, 2015, PROG COMM HLTH PARTN, V9, P561, DOI 10.1353/cpr.2015.0079; Bankole A, 2014, INT PERSPECT SEX R H, V40, DOI 10.1363/4002814; Benoit C, 2007, GENDERING POPULATION; Blair JM, 2004, OBSTET GYNECOL, V103, P663, DOI 10.1097/01.AOG.0000117083.33239.b5; Burgos-Soto J, 1999, J ACQ IMMUN DEF SYND, V67, pe45; Carter AJ, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17433; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Darak S, 2013, AIDS PATIENT CARE ST, V27, P163, DOI 10.1089/apc.2012.0401; De Reus L.A., 2005, SOURCEBOOK FAMILY TH, P447, DOI [DOI 10.4135/9781412990172.N18, 10.4135/9781412990172.n18]; DeVincenzi I, 1997, AIDS, V11, P333, DOI 10.1097/00002030-199703110-00011; Elgalib A, 2011, HIV MED, V12, P118, DOI 10.1111/j.1468-1293.2010.00878.x; Ezugwu EC, 2016, INT J GYNECOL OBSTET, V132, P60, DOI 10.1016/j.ijgo.2015.06.039; Fiore S, 2008, HUM REPROD, V23, P2140, DOI 10.1093/humrep/den232; Floridia M, 2010, AIDS CARE, V22, P50, DOI 10.1080/09540120903033268; Giaquinto C, 2005, BJOG-INT J OBSTET GY, V112, P881, DOI 10.1111/j.1471-0528.2005.00569.x; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; Grossman D, 2013, AIDS, V27, pS77, DOI 10.1097/QAD.0000000000000035; GUNTHARD HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI DOI 10.1001/JAMA.2016.8900; Haddad LB, 2017, AM J OBSTET GYNECOL, V216, P71; Haddad LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121039; Harrington EK, 2012, INFECT DIS OBSTET GY; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; Hoffman IF, 2008, JAIDS-J ACQ IMM DEF, V47, P477, DOI 10.1097/QAI.0b013e318165dc52; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Joyce T, 2002, DEMOGRAPHY, V39, P199, DOI 10.2307/3088371; Kabami J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-81; Kaida A, 2016, AIDS; Kaida A C.A., 23 ANN CAN C HIV AID; Kaida Angela, 2006, Curr HIV/AIDS Rep, V3, P187, DOI 10.1007/s11904-006-0015-0; Kaida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063411; Kaida A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013868; Loutfy M, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0190-7; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Massad LS, 2004, AIDS, V18, P281, DOI 10.1097/00002030-200401230-00018; Mmbaga EJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-86; Mohohlo M, 2006, 2006 IMPL M PRES EM, V113, P13; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; O'Shea MS, 2016, AIDS CARE, V28, P1027, DOI 10.1080/09540121.2016.1140891; Ogilvie GS, 2007, FERTILITY INTENTIONS, V21; Okafor II, 2014, ANN MED HEALTH SCI R, V4, P615, DOI 10.4103/2141-9248.139344; Oulman E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0663-4; Patterson S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0969-x; Phares Tanya M, 2004, MMWR Surveill Summ, V53, P1; Public Health Agency of Canada, 2014, HIV AIDS EP UPD 2008; Raphael D., 2009, SOCIAL DETERMINANTS, V2nd ed; Rodger A., 2014, 21 C RETR OPP INF, P3; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Sanders LB, 2008, J ASSOC NURSE AIDS C, V19, P47, DOI 10.1016/j.jana.2007.10.002; Schwartz S, 2015, JAIDS-J ACQ IMM DEF, V68, pS91, DOI 10.1097/QAI.0000000000000448; Schwartz SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036039; Sharma A, 2007, AM J OBSTET GYNECOL, V196, P541, DOI 10.1016/j.ajog.2007.01.005; Statistics Canada Vital, 2005, PREGN OUTC AG GROU C; Stephenson JM, 1996, AIDS, V10, P1683, DOI 10.1097/00002030-199612000-00013; Sutton MY, 2014, JAIDS-J ACQ IMM DEF, V65, P350, DOI 10.1097/QAI.0000000000000054; van Benthem BHB, 2000, AIDS, V14, P2171, DOI 10.1097/00002030-200009290-00014; Webster K C.A., 2017, PROGR COMMU IN PRESS; Westreich D, 2012, INFECT DIS OBSTET GY; Wilcher R, 2010, STUD FAMILY PLANN, V41, P125, DOI 10.1111/j.1728-4465.2010.00233.x; Wilcher R, 2009, B WORLD HEALTH ORGAN, V87, P833, DOI 10.2471/BLT.08.059360; Wood E, 2002, AIDS, V16, P2065, DOI 10.1097/00002030-200210180-00012	65	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180524	10.1371/journal.pone.0180524	http://dx.doi.org/10.1371/journal.pone.0180524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727731	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500025
J	Theobald, EJ; Eddy, SL; Grunspan, DZ; Wiggins, BL; Crowe, AJ				Theobald, Elli J.; Eddy, Sarah L.; Grunspan, Daniel Z.; Wiggins, Benjamin L.; Crowe, Alison J.			Student perception of group dynamics predicts individual performance: Comfort and equity matter	PLOS ONE			English	Article							SCIENCE; INSTRUCTION; BIOLOGY; PARTICIPATION; MATHEMATICS; ENGAGEMENT; STRATEGIES; CLASSROOM; GAINS; PEER	Active learning in college classes and participation in the workforce frequently hinge on small group work. However, group dynamics vary, ranging from equitable collaboration to dysfunctional groups dominated by one individual. To explore how group dynamics impact student learning, we asked students in a large-enrollment university biology class to selfreport their experience during in-class group work. Specifically, we asked students whether there was a friend in their group, whether they were comfortable in their group, and whether someone dominated their group. Surveys were administered after students participated in two different types of intentionally constructed group activities: 1) a loosely-structured activity wherein students worked together for an entire class period (termed the 'single-group' activity), or 2) a highly-structured 'jigsaw' activity wherein students first independently mastered different subtopics, then formed new groups to peer-teach their respective subtopics. We measured content mastery by the change in score on identical pre-/post-tests. We then investigated whether activity type or student demographics predicted the likelihood of reporting working with a dominator, being comfortable in their group, or working with a friend. We found that students who more strongly agreed that they worked with a dominator were 17.8% less likely to answer an additional question correct on the 8-question post-test. Similarly, when students were comfortable in their group, content mastery increased by 27.5%. Working with a friend was the single biggest predictor of student comfort, although working with a friend did not impact performance. Finally, we found that students were 67% less likely to agree that someone dominated their group during the jigsaw activities than during the single group activities. We conclude that group activities that rely on positive interdependence, and include turn-taking and have explicit prompts for students to explain their reasoning, such as our jigsaw, can help reduce the negative impact of inequitable groups.	[Theobald, Elli J.; Wiggins, Benjamin L.; Crowe, Alison J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Eddy, Sarah L.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Grunspan, Daniel Z.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Grunspan, Daniel Z.] Arizona State Univ, Ctr Evolut & Med, Tempe, AZ USA	University of Washington; University of Washington Seattle; State University System of Florida; Florida International University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Crowe, AJ (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	acrowe@uw.edu		Theobald, Elli/0000-0001-5442-2522	National Science Foundation [DUE-1244847]	National Science Foundation(National Science Foundation (NSF))	The project was funded by a grant from the National Science Foundation (https//www.nsf. gov/) to AJC (DUE-1244847). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	American Educational Research Association American Psychological Association & National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; [Anonymous], 1992, Science, V258, P1175; [Anonymous], 2012, ENGAGE EXCEL PRODUCI; ARONSON E, 1979, PERS SOC PSYCHOL B, V5, P438, DOI 10.1177/014616727900500405; Atman CJ, 2010, CENT ADV ENG ED, P224; Bell P., 2004, PROMOTING STUDENTS A; Bianchini JA, 1997, J RES SCI TEACH, V34, P1039; Bonwell CC, 1991, ASHE ERIC HIGHER ED, V102, P80; Borrego M, 2013, J ENG EDUC, V102, P394, DOI 10.1002/jee.20020; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chi MTH, 2014, EDUC PSYCHOL-US, V49, P219, DOI 10.1080/00461520.2014.965823; Cohen EG, 1999, THEOR PRACT, V38, P80, DOI 10.1080/00405849909543836; Cohen ElisabethG., 2014, DESIGNING GROUPWORK, V3; Colosi JC, 1998, BIOSCIENCE, V48, P118, DOI 10.2307/1313137; Cooper KM, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-01-0074; Crouch CH, 2001, AM J PHYS, V69, P970, DOI 10.1119/1.1374249; Csernica J, 2002, PRACTICAL GUIDE TEAM; Daempfle P. A., 2004, J COLL STUDENT RETEN, V5, P37; Dasgupta N, 2015, P NATL ACAD SCI USA, V112, P4988, DOI 10.1073/pnas.1422822112; Dika SL, 2016, J RES SCI TEACH, V53, P368, DOI 10.1002/tea.21301; Duhigg C., 2016, N Y TIMES MAG, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Dyer GWJ, 2013, TEAM BUILDING PROVEN; Eddy SL, 2014, CBE-LIFE SCI EDUC, V13, P453, DOI 10.1187/cbe.14-03-0050; Eddy SL, 2016, PHYS REV PHYS EDUC R, V12, P20; EDDY SL, 2015, CBE-LIFE SCI EDUC, V14, DOI DOI 10.1187/CBE.15-05-0108; Edmondson A., 2010, PSYCHOL SAFETY LEARN, V44, P350; Esmonde I., 2009, REV ED RES; Esmonde I, 2009, J LEARN SCI, V18, P247, DOI 10.1080/10508400902797958; Foster D.A., 2011, COLL TEACH, V59, P111, DOI [10.1080/87567555.2011.572098, DOI 10.1080/87567555.2011.572098]; Freeman S, 2017, ACT LEARN HIGH EDUC, V18, P115, DOI 10.1177/1469787417707614; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Froyd J. E., 2008, WHITE PAPER PROMISIN; Gruenfeld DH, 1996, ORGAN BEHAV HUM DEC, V67, P1, DOI 10.1006/obhd.1996.0061; James MC, 2011, AM J PHYS, V79, P123, DOI 10.1119/1.3488097; Jensen JL, 2011, CBE-LIFE SCI EDUC, V10, P64, DOI 10.1187/cbe.10-07-0089; Johnson D. W., 1998, CHANGE, V30, DOI [10.1080/00091389809602629, DOI 10.1080/00091389809602629]; Johnson DW, 2000, COOPERATIVE LEARNING, P561; Kelsey BL, 2000, CAN J ADM SCI, V17, P63; Kim HS, 2008, J PERS SOC PSYCHOL, V94, P32, DOI 10.1037/0022-3514.94.1.32; Kim HS, 2002, J PERS SOC PSYCHOL, V83, P828, DOI 10.1037//0022-3514.83.4.828; Knight JK, 2013, CBE-LIFE SCI EDUC, V12, P645, DOI 10.1187/cbe.13-05-0090; Marbach-Ad G, 2016, J MICROBIOL BIOL EDU, V17, P360, DOI 10.1128/jmbe.v17i3.1071; Master A, 2016, DEV PHSYCHOLOGY; National Association of Colleges and Employers (NACE), 2014, JOB OUTL 2015; National Research Council, 2012, DISC BAS ED RES; Ocker RJ, 2007, IEEE T PROF COMMUN, V50, P204, DOI 10.1109/TPC.2007.902656; Thanh PTH, 2011, J HIGH EDUC POLICY M, V33, P519, DOI 10.1080/1360080X.2011.605226; R-Core-Team, 2015, LANG ENV STAT COMP; Sarsons H., 2016, HARVARD WORK PAP SER, P1; Scager K, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-07-0219; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919; Springer L, 1999, REV EDUC RES, V69, P21, DOI 10.3102/00346543069001021; Stephens NM, 2012, J PERS SOC PSYCHOL, V102, P1178, DOI 10.1037/a0027143; Tanner Kimberly, 2003, Cell Biol Educ, V2, P1, DOI 10.1187/cbe.03-03-0010; Tanner KD, 2013, CBE-LIFE SCI EDUC, V12, P322, DOI 10.1187/cbe.13-06-0115; Thompson M., 2002, ANAL SOCIAL ISSUES P, V2, P183, DOI [DOI 10.1111/J.1530-2415.2002.00037.X, 10.1111/j.1530-2415.2002.00037.x]; Vision and Change, 2009, VIS CHANG UND BIOL E; Weinberger A, 2005, INSTR SCI, V33, P1, DOI 10.1007/s11251-004-2322-4; Wiggins BL, 2017, AERA OPEN, V3, DOI 10.1177/2332858417708567; Wiggins BL, 2017, CBE-LIFE SCI EDUC, V16, DOI 10.1187/cbe.16-08-0244; Wood WB, 2009, ANNU REV CELL DEV BI, V25, P93, DOI 10.1146/annurev.cellbio.24.110707.175306; Zuur Alain F., 2009, P1	62	43	43	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181336	10.1371/journal.pone.0181336	http://dx.doi.org/10.1371/journal.pone.0181336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727749	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500060
J	Zala, SM; Reitschmidt, D; Noll, A; Balazs, P; Penn, DJ				Zala, Sarah M.; Reitschmidt, Doris; Noll, Anton; Balazs, Peter; Penn, Dustin J.			Automatic mouse ultrasound detector (AMUD): A new tool for processing rodent vocalizations	PLOS ONE			English	Article							MICE MUS-MUSCULUS; COURTSHIP VOCALIZATIONS; UNUSUAL REPERTOIRE; SOCIAL-STATUS; HOUSE MICE; COMMUNICATION; MODEL; EXPERIENCE; DISORDERS; SEX	House mice (Mus musculus) emit complex ultrasonic vocalizations (USVs) during social and sexual interactions, which have features similar to bird song (i.e., they are composed of several different types of syllables, uttered in succession over time to form a pattern of sequences). Manually processing complex vocalization data is time-consuming and potentially subjective, and therefore, we developed an algorithm that automatically detects mouse ultrasonic vocalizations (Automatic Mouse Ultrasound Detector or A-MUD). A-MUD is a script that runs on STx acoustic software (S_TOOLS-STx version 4.2.2), which is free for scientific use. This algorithm improved the efficiency of processing USV files, as it was 4-12 times faster than manual segmentation, depending upon the size of the file. We evaluated A-MUD error rates using manually segmented sound files as a `gold standard' reference, and compared them to a commercially available program. A-MUD had lower error rates than the commercial software, as it detected significantly more correct positives, and fewer false positives and false negatives. The errors generated by A-MUD were mainly false negatives, rather than false positives. This study is the first to systematically compare error rates for automatic ultrasonic vocalization detection methods, and A-MUD and subsequent versions will be made available for the scientific community.	[Zala, Sarah M.; Reitschmidt, Doris; Penn, Dustin J.] Univ Vet Med, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria; [Noll, Anton; Balazs, Peter] Austrian Acad Sci, Acoust Res Inst, Vienna, Austria	University of Veterinary Medicine Vienna; Austrian Academy of Sciences	Zala, SM (corresponding author), Univ Vet Med, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria.	sarah.zala@vetmeduni.ac.at	Balazs, Peter/E-3020-2010	Balazs, Peter/0000-0003-4939-0831; Zala, Sarah/0000-0002-0698-5299	Austrian Science Foundation [P 24711-B21, P 28141-B25]; Austrian Science Fund (FWF) [Y 551] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by grants (Austrian Science Fund (AT) P 24711-B21 to DJP and Austrian Science Fund (AT) P 28141-B25 to DJP and SMZ) of the Austrian Science Foundation (http://www.fwf.ac.at).	Arriaga G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046610; Asaba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087186; Balazs P, P AUSTR PHYS SOC M 2, P46; Balazs P, SAMPTA03 SAMPLING TH, P12; Balazs P, 2010, IEEE T AUDIO SPEECH, V18, P34, DOI 10.1109/TASL.2009.2023164; Blackman R.B., 1959, MEASUREMENT POWER SP; Carmona R., 1998, PRACTICAL TIME FREQU; Crawley JN, 2000, WHATS WRONG MY MOUSE, VXIII; CUOMO V, 1987, NEUROTOXICOL TERATOL, V9, P157, DOI 10.1016/0892-0362(87)90093-6; DAMATO FR, 1991, ANIM BEHAV, V41, P875, DOI 10.1016/S0003-3472(05)80354-9; Egnor SER, 2016, CURR OPIN NEUROBIOL, V38, P1, DOI 10.1016/j.conb.2015.12.009; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Grochenig K., 2001, FDN TIME FREQUENCY A, P360; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Gygi B, 2007, 19 INT C AC 2007 2 7; Hammerschmidt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041133; Hammerschmidt K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-40; Hanson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040782; Heckman J, 2016, NEUROSCI BIOBEHAV R, V65, P313, DOI 10.1016/j.neubiorev.2016.03.029; Hoffmann F, 2012, J ETHOL, V30, P173, DOI 10.1007/s10164-011-0312-y; Hoffmann F, 2012, PHYSIOL BEHAV, V105, P766, DOI 10.1016/j.physbeh.2011.10.011; Hoffmann F, 2009, PHYSIOL BEHAV, V96, P602, DOI 10.1016/j.physbeh.2008.12.014; Hoier S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152255; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; James PJ, 2006, HORM BEHAV, V50, P424, DOI 10.1016/j.yhbeh.2006.05.004; Kasess CH, 2013, J ACOUST SOC AM, V134, P1071, DOI 10.1121/1.4812771; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Kratochvil H, 2012, QUALITY CONTROL EXPA, P101; Kurejova M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-18; Lahvis GP, 2011, GENES BRAIN BEHAV, V10, P4, DOI 10.1111/j.1601-183X.2010.00603.x; Lopes PC, 2016, ANIM BEHAV, V111, P119, DOI 10.1016/j.anbehav.2015.10.011; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Mahrt E, 2016, CURR BIOL, V26, pR880, DOI 10.1016/j.cub.2016.08.032; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Manteuffel G, 2004, APPL ANIM BEHAV SCI, V88, P163, DOI 10.1016/j.applanim.2004.02.012; Moosmuller S, 2014, LANG SCI, V46, P84, DOI 10.1016/j.langsci.2014.06.016; Moosmuller S, 2011, INT J SPEECH LANG LA, V18, P179, DOI 10.1558/ijsll.v18i2.179; Musolf K., 2012, EVOLUTION HOUSE MOUS, P253, DOI [10.1017/CBO9781139044547.012, DOI 10.1017/CBO9781139044547.012]; Musolf K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134123; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; Neilans EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085405; Neunuebel JP, 2015, ELIFE, V4, DOI 10.7554/eLife.06203; NYBY J, 1976, BEHAV BIOL, V18, P285, DOI 10.1016/S0091-6773(76)92198-2; NYBY J, 1977, ANIM BEHAV, V25, P333, DOI 10.1016/0003-3472(77)90009-4; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Portfors CV, 2014, CURR OPIN NEUROBIOL, V28, P115, DOI 10.1016/j.conb.2014.07.002; Roullet FI, 2011, BEHAV BRAIN RES, V216, P19, DOI 10.1016/j.bbr.2010.06.004; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Torquet Nicolas, 2016, F1000Res, V5, P2332; von Merten S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097244; Wang HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001893; WARBURTON VL, 1989, PHYSIOL BEHAV, V45, P41, DOI 10.1016/0031-9384(89)90164-9; Wiley RH, 2015, NOISE MATTERS EVOLUT, Vxi	58	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181200	10.1371/journal.pone.0181200	http://dx.doi.org/10.1371/journal.pone.0181200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727808	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500046
J	Mayer, M; Naylor, J; Harris, I; Badge, H; Adie, S; Mills, K; Descallar, J				Mayer, Marcel; Naylor, Justine; Harris, Ian; Badge, Helen; Adie, Sam; Mills, Kathryn; Descallar, Joseph			Evidence base and practice variation in acute care processes for knee and hip arthroplasty surgeries	PLOS ONE			English	Article							CLOSED-SUCTION DRAINAGE; INTRAVENOUS TRANEXAMIC ACID; BLOOD-LOSS; REPLACEMENT SURGERY; JOINT ARTHROPLASTY; BONE-CEMENT; METAANALYSIS; TRANSFUSION; CRYOTHERAPY; RECOVERY	Background Lack of evidence contributes to unnecessary variation in treatment costs and outcomes. This study aimed to identify from interventions historically used for total knee or hip arthroplasty (TKA, THA): i) if routine use is supported by high-level evidence; ii) whether surgeon use aligns with the evidence. Methods Part 1: Systematic search of electronic library databases for systematic reviews and practice guidelines concerning seven acute-care interventions. Intervention-specific recommendations concerning routine use were extracted by assessors. Part 2: Prospective medical record audit of the acute-care received by 1900 patients involving 120 orthopaedic surgeons. Surgeon use per intervention was summarized using caterpillar plots. Surgeon-specific routine and non-routine use was defined as use in >= 90% and <= 10% of patients, respectively. Primary analysis included only surgeons contributing >= 10 patients. Results Continuous passive motion (TKA): Routine use not recommended; 85.7% of surgeons did not use it routinely. Tranexamic Acid: Routine use recommended; 26.9% of surgeons used it routinely. Cryotherapy: Routine use not recommended; 45.7% of surgeons used it routinely for TKA; 31.8% used it routinely for THA. Intra-articular drainage: Routine use not recommended for TKA, but possible benefits for THA; 5.7% of surgeons used it routinely for TKA, 0.0% used it routinely for THA. Antibiotic loaded bone cement: Routine use for TKA not supported, recommendations for use for THA are inconsistent; 90.0% of surgeons used it routinely for TKA, 100.0% used it routinely for THA. Patella resurfacing (TKA): No recommendation could be made; 57.1% of surgeons routinely resurfaced the patella. Indwelling urinary catheterisation: Routine use recommended; 59.6% of surgeons used it routinely. Conclusion Recommendations for routine use or not exist for some of the acute-care interventions examined. Surgeon practices vary widely even in the presence of high-level recommendations. It is unclear whether further evidence alone would lessen unwarranted practice variation.	[Mayer, Marcel; Naylor, Justine; Harris, Ian; Badge, Helen] Liverpool Hosp, Whitlam Orthopaed Res Ctr, Sydney, NSW, Australia; [Mayer, Marcel; Naylor, Justine; Harris, Ian; Badge, Helen; Adie, Sam; Descallar, Joseph] UNSW, South Western Sydney Clin Sch, Randwick, NSW, Australia; [Mayer, Marcel] Tech Univ Munich, Munich, Bavaria, Germany; [Naylor, Justine; Harris, Ian; Badge, Helen; Descallar, Joseph] Ingham Inst Appl Med Res, Liverpool, Australia; [Mills, Kathryn] Macquarie Univ, N Ryde, NSW, Australia	Liverpool Hospital; University of New South Wales Sydney; Technical University of Munich; Ingham Institute for Applied Medical Research; Macquarie University	Naylor, J (corresponding author), Liverpool Hosp, Whitlam Orthopaed Res Ctr, Sydney, NSW, Australia.; Naylor, J (corresponding author), UNSW, South Western Sydney Clin Sch, Randwick, NSW, Australia.; Naylor, J (corresponding author), Ingham Inst Appl Med Res, Liverpool, Australia.	Justine.Naylor@sswahs.nsw.gov.au	Naylor, Justine/R-8459-2019; Mayer, Marcel/AAJ-1233-2021	Naylor, Justine/0000-0002-9147-1312; Mayer, Marcel/0000-0001-9963-1109; Badge, Helen/0000-0002-5351-393X; Adie, Sam/0000-0003-0780-4338	HCF Research Foundation	HCF Research Foundation	The study was in part funded by the HCF Research Foundation (URL: http://www.hcf.com.au/about-us/hcf-foundation/). In-kind support was provided by MM and SA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adie S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007911.pub2; Adie S, 2010, J ARTHROPLASTY, V25, P709, DOI 10.1016/j.arth.2009.07.010; Agrawal M., 2011, J CLIN ORTHOP TRAUMA, V2, P77, DOI [10.1016/S0976-5662(11)60048-9, DOI 10.1016/S0976-5662(11)60048-9]; ALEXANDER JW, 1976, AM J SURG, V132, P59, DOI 10.1016/0002-9610(76)90291-9; Alshryda S, 2014, BONE JOINT J, V96B, P1005, DOI 10.1302/0301-620X.96B8.33745; American Physical Therapy Association, 2015, 5 THINGS PHYS THER P; [Anonymous], 2015, HIP KNEE REPL CAN CA; [Anonymous], 2016, SURG PROPHYLAXIS ORT; Antholz Casey R, 2015, Surg Technol Int, V26, P355; Arciola CR, 2002, BIOMATERIALS, V23, P1495, DOI 10.1016/S0142-9612(01)00275-7; Arirachakaran A, 2015, KNEE SURG SPORT TR A, V23, P1770, DOI 10.1007/s00167-014-3311-z; Australian Orthopaedic Association National Joint Replacement Registry, 2015, ANN REPORT; Badhe N, 2001, INT ORTHOP, V25, P97, DOI 10.1007/s002640100225; Balderi T, 2010, MINERVA ANESTESIOL, V76, P120; Bao Liang, 2012, Zhonghua Wai Ke Za Zhi, V50, P171; Benoni G, 1996, J BONE JOINT SURG BR, V78B, P434, DOI 10.1302/0301-620X.78B3.0780434; Block JE, 2005, ORTHOPEDICS, V28, P1334; Blue Cross Blue Shield, 2015, HLTH AM REP STUD COS; BUCHHOLZ HW, 1970, CHIRURG, V41, P511; Chen JY, 2016, KNEE, V23, P152, DOI 10.1016/j.knee.2015.09.004; Chen K, 2013, INT ORTHOP, V37, P1075, DOI 10.1007/s00264-013-1866-9; Chen ZY, 2014, KNEE SURG SPORT TR A, V22, P3181, DOI 10.1007/s00167-013-2814-3; Chen Zhao-Yu, 2014, Eur J Orthop Surg Traumatol, V24, P939, DOI 10.1007/s00590-013-1284-0; Cheung G, 2010, ACTA ORTHOP BELG, V76, P619; Clements WJ, 2010, ACTA ORTHOP, V81, P108, DOI 10.3109/17453670903413145; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Daigle ME, 2012, BEST PRACT RES CL RH, V26, P649, DOI 10.1016/j.berh.2012.07.013; Della Valle AG, 2004, ACTA ORTHOP SCAND, V75, P30; Dora C, 2007, ARCH ORTHOP TRAUM SU, V127, P919, DOI 10.1007/s00402-006-0260-0; Dunbar MJ, 2009, ORTHOPEDICS, V32; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Fu DJ, 2013, CHIN J TRAUMATOL, V16, P67, DOI 10.3760/cma.j.issn.1008-1275.2013.02.001; Fu YH, 2011, KNEE SURG SPORT TR A, V19, P1460, DOI 10.1007/s00167-010-1365-0; Gandhi Rajiv, 2013, BMC Res Notes, V6, P184, DOI 10.1186/1756-0500-6-184; Good L, 2003, BRIT J ANAESTH, V90, P596, DOI 10.1093/bja/aeg111; Hanssen AD, 2004, J ARTHROPLASTY, V19, P73, DOI 10.1016/j.arth.2004.04.006; Harvey LA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004260.pub3; Harvey LA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004260.pub2; He JY, 2011, KNEE, V18, P137, DOI 10.1016/j.knee.2010.04.004; HOYLAERTS M, 1981, BIOCHIM BIOPHYS ACTA, V673, P75; Husted H, 2014, ACTA ORTHOP, V85, P548, DOI 10.3109/17453674.2014.971661; Joseph Thomas N, 2003, J Am Acad Orthop Surg, V11, P38; KEBLISH PA, 1994, J BONE JOINT SURG BR, V76B, P930, DOI 10.1302/0301-620X.76B6.7983122; Kelly Enda G, 2014, Surg Technol Int, V24, P295; Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441; Li SZ, 2011, INT ORTHOP, V35, P305, DOI 10.1007/s00264-010-1109-2; Mariconda M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-222; Markert SE, 2011, ORTHOP NURS, V30, P29, DOI 10.1097/NOR.0b013e318205749a; MCCARTHY M R, 1992, Journal of Orthopaedic and Sports Physical Therapy, V15, P132; Medscape, TRAN AC INJ; Mertes SC, 2013, INT ORTHOP, V37, P1157, DOI 10.1007/s00264-013-1829-1; Murray DW, 2007, J BONE JOINT SURG BR, V89B, P1010, DOI 10.1302/0301-620X.89B8; Nanni M, 2013, Musculoskelet Surg, V97, P101, DOI 10.1007/s12306-013-0270-3; National Health and Medical Research Council, 2009, CLIN PRACT GUID PREV; National Health Performance Authority, 2015, COSTS PAT CAR CAN BE; Naylor JM, 2009, AUST HEALTH REV, V33, P124, DOI 10.1071/AH090124; Ni SH, 2015, KNEE SURG SPORT TR A, V23, P3354, DOI 10.1007/s00167-014-3135-x; Nikolaou VS, 2014, WORLD J ORTHOP, V5, P460, DOI 10.5312/wjo.v5.i4.460; Ortiguera CJ, 2002, J BONE JOINT SURG AM, V84A, P532, DOI 10.2106/00004623-200204000-00004; Panteli M, 2013, KNEE, V20, P300, DOI 10.1016/j.knee.2013.05.014; Parker MJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001825.pub2; Patel K, 2011, INT ORTHOP, V35, P349, DOI 10.1007/s00264-010-1063-z; Pavlou G, 2011, J BONE JOINT SURG AM, V93A, P1301, DOI [10.2106/JBJS.J.00594, 10.2106/JBJSJ.00594]; Pilling RWD, 2012, J BONE JOINT SURG AM, V94A, P2270, DOI 10.2106/JBJS.K.01257; Quinn M, 2015, INT ORTHOP, V39, P653, DOI 10.1007/s00264-014-2455-2; Ralley FE, 2010, CLIN ORTHOP RELAT R, V468, P1905, DOI 10.1007/s11999-009-1217-8; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; SALTER RB, 1980, J BONE JOINT SURG AM, V62, P1232, DOI 10.2106/00004623-198062080-00002; Mayo BS, 2015, AN SIST SANIT NAVAR, V38, P297, DOI 10.4321/S1137-66272015000200014; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Shemshaki H, 2015, ARCH ORTHOP TRAUM SU, V135, P573, DOI 10.1007/s00402-015-2189-7; Sheppard M. S., 1995, Physiotherapy Canada, V47, P36; Singh Jasvinder A, 2011, Open Orthop J, V5, P80, DOI 10.2174/1874325001105010080; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Stowers MDJ, 2014, J ORTHOP SURG-HONG K, V22, P383, DOI 10.1177/230949901402200324; Sukeik M, 2011, J BONE JOINT SURG BR, V93B, P39, DOI 10.1302/0301-620X.93B1.24984; Sundberg M LL, 2015, ANN REPORT; Swan JD, 2010, ANZ J SURG, V80, P223, DOI 10.1111/j.1445-2197.2010.05242.x; The Clinical Episode Payment (CEP) Work Group, 2016, EL JOINT REPL; [田仁元 Tian Renyuan], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P6300; Wang C, 2015, INT J SURG, V15, P134, DOI 10.1016/j.ijsu.2014.12.023; Wang H, 2014, KNEE, V21, P987, DOI 10.1016/j.knee.2014.09.010; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082745; Wei Z, 2015, TRANSFUSION MED, V25, P151, DOI 10.1111/tme.12212; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961; Wu Qiang, 2015, Eur J Orthop Surg Traumatol, V25, P525, DOI 10.1007/s00590-014-1568-z; Xu XM, 2015, DRUG DISCOV THER, V9, P173, DOI 10.5582/ddt.2015.01018; Yip S.M. TY, 2010, SINGHEALTH DUKENUS S; Yue C, 2015, ORTHOPEDICS, V38, P315, DOI 10.3928/01477447-20150504-06; Zan PF, 2016, INT J CLIN EXP MED, V9, P725; Zeng Y, 2014, ORTHOPEDICS, V37, P839, DOI 10.3928/01477447-20141124-07; Zhang HR, 2012, KNEE SURG SPORT TR A, V20, P1742, DOI 10.1007/s00167-011-1754-z; Zhang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130636; Zhang Xiao-nan, 2012, Zhonghua Wai Ke Za Zhi, V50, P1119; Zhang Y, 2014, ORTHOPEDICS, V37, DOI 10.3928/01477447-20140825-53; Zhou XD, 2013, INT ORTHOP, V37, P2109, DOI 10.1007/s00264-013-2053-8; Zhou YQ, 2015, SURG INFECT, V16, P183, DOI 10.1089/sur.2014.044	98	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180090	10.1371/journal.pone.0180090	http://dx.doi.org/10.1371/journal.pone.0180090			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723917	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800010
J	Norouzi, N; Bhakta, HC; Grover, WH				Norouzi, Nazila; Bhakta, Heran C.; Grover, William H.			Sorting cells by their density	PLOS ONE			English	Article							DISTRIBUTION WIDTH; CANCER-CELLS; BLOOD; CENTRIFUGATION; SEPARATION	Sorting cells by their type is an important capability in biological research and medical diagnostics. However, most cell sorting techniques rely on labels or tags, which may have limited availability and specificity. Sorting different cell types by their different physical properties is an attractive alternative to labels because all cells intrinsically have these physical properties. But some physical properties, like cell size, vary significantly from cell to cell within a cell type; this makes it difficult to identify and sort cells based on their sizes alone. In this work we continuously sort different cells types by their density, a physical property with much lower cell-to-cell variation within a cell type (and therefore greater potential to discriminate different cell types) than other physical properties. We accomplish this using a 3Dprinted microfluidic chip containing a horizontal flowing micron-scale density gradient. As cells flow through the chip, Earth's gravity makes each cell move vertically to the point where the cell's density matches the surrounding fluid's density. When the horizontal channel then splits, cells with different densities are routed to different outlets. As a proof of concept, we use our density sorter chip to sort polymer microbeads by their material (polyethylene and polystyrene) and blood cells by their type (white blood cells and red blood cells). The chip enriches the fraction of white blood cells in a blood sample from 0.1% (in whole blood) to nearly 98% (in the output of the chip), a 1000x enrichment. Any researcher with access to a 3D printer can easily replicate our density sorter chip and use it in their own research using the design files provided as online Supporting Information. Additionally, researchers can simulate the performance of a density sorter chip in their own applications using the Python-based simulation software that accompanies this work. The simplicity, resolution, and throughput of this technique make it suitable for isolating even rare cell types in complex biological samples, in a wide variety of different research and clinical applications.	[Norouzi, Nazila; Bhakta, Heran C.; Grover, William H.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside	Grover, WH (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	wgrover@engr.ucr.edu		Grover, William/0000-0001-6854-8951	National Science Foundation [DBI-1353974]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (http://nsf.gov) grant number DBI-1353974. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Byun S, 2013, P NATL ACAD SCI USA, V110, P7580, DOI 10.1073/pnas.1218806110; Davis JA, 2006, P NATL ACAD SCI USA, V103, P14779, DOI 10.1073/pnas.0605967103; Fukuda S, 2002, J LEUKOCYTE BIOL, V72, P133; Giddings JC., 1988, US Patent, Patent No. [4737268, 4,737,268.]; Grover WH, 2011, P NATL ACAD SCI USA, V108, P10992, DOI 10.1073/pnas.1104651108; Huh D, 2007, ANAL CHEM, V79, P1369, DOI 10.1021/ac061542n; Nemzek JA, 2001, INFLAMM RES, V50, P523, DOI 10.1007/PL00000229; Norouzi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149259; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Pertoft H., 1982, CELL SEPARATION METH, P115; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Sollier E, 2009, SENSOR ACTUAT B-CHEM, V141, P617, DOI 10.1016/j.snb.2009.05.023; Song J, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4902906; SooHoo JR, 2009, BIOMED MICRODEVICES, V11, P323, DOI 10.1007/s10544-008-9238-8	17	30	30	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180520	10.1371/journal.pone.0180520	http://dx.doi.org/10.1371/journal.pone.0180520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723908	Green Published, Green Submitted, gold			2022-12-27	WOS:000406067800017
J	Park, SH; Lee, CW; Lee, SG; Shin, SC; Kim, HJ; Park, H; Lee, JH				Park, Sun-Ha; Lee, Chang Woo; Lee, Sung Gu; Shin, Seung Chul; Kim, Hak Jun; Park, Hyun; Lee, Jun Hyuck			Crystal structure and functional characterization of an isoaspartyl dipeptidase (CpsIadA) from Colwellia psychrerythraea strain 34H	PLOS ONE			English	Article							X-RAY-STRUCTURE; ESCHERICHIA-COLI; PROTEIN; METHYLTRANSFERASE; PEPTIDES; PURIFICATION; DEAMIDATION; GENERATION; RESIDUES; SEQUENCE		[Park, Sun-Ha; Lee, Chang Woo; Lee, Sung Gu; Shin, Seung Chul; Park, Hyun; Lee, Jun Hyuck] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Lee, Chang Woo; Lee, Sung Gu; Park, Hyun; Lee, Jun Hyuck] Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea; [Kim, Hak Jun] Pukyong Natl Univ, Dept Chem, Busan, South Korea	Korea Polar Research Institute (KOPRI); Pukyong National University	Park, H; Lee, JH (corresponding author), Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea.; Park, H; Lee, JH (corresponding author), Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea.	hpark@kopri.re.kr; junhyucklee@kopri.re.kr			Polar Genomics 101 Project - Korea Polar Research Institute (KOPRI) [PE17080]; National Research Foundation of Korea - Korean Government (MSIP) [NRF-2016M1A5A1027157, PN17083]	Polar Genomics 101 Project - Korea Polar Research Institute (KOPRI); National Research Foundation of Korea - Korean Government (MSIP)	This work was supported by the Polar Genomics 101 Project: Genome analysis of polar organisms and establishment of application platform (PE17080) was funded by the Korea Polar Research Institute (KOPRI). This work was also supported by the National Research Foundation of Korea, which is funded by the Korean Government (MSIP), (NRF-2016M1A5A1027157) (PN17083, KOPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the staff at the X-ray core facility of the Korea Basic Science Institute (KBSI; Ochang, Korea) and the BL-5C of the Pohang Accelerator Laboratory (Pohang, Korea) for their kind help with data collection. This work was supported by the Polar Genomics 101 Project: Genome analysis of polar organisms and establishment of application platform (PE17080) was funded by the Korea Polar Research Institute (KOPRI). This work was also supported by the National Research Foundation of Korea, which is funded by the Korean Government (MSIP), (NRF-2016M1A5A1027157) (PN17083, KOPRI).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; Bohme L, 2008, BIOL CHEM, V389, P1043, DOI 10.1515/BC.2008.123; Borek D, 2004, EUR J BIOCHEM, V271, P3215, DOI 10.1111/j.1432-1033.2004.04254.x; Botelho TO., 2013, PROTEINS, V74, P61; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark S., 1992, Labyrinth, P1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARY JD, 1995, J BIOL CHEM, V270, P4076, DOI 10.1074/jbc.270.8.4076; GEIGER T, 1987, J BIOL CHEM, V262, P785; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; JOHNSON BA, 1990, BIOCHEMISTRY-US, V29, P4373, DOI 10.1021/bi00470a017; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jozic D, 2003, J MOL BIOL, V332, P243, DOI 10.1016/S0022-2836(03)00845-3; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larsen RA, 2001, J BACTERIOL, V183, P3089, DOI 10.1128/JB.183.10.3089-3097.2001; Liu HZ, 2009, SCIENCE, V326, P1250, DOI 10.1126/science.1179713; Marti-Arbona R, 2005, BIOORG CHEM, V33, P448, DOI 10.1016/j.bioorg.2005.10.002; Marti-Arbona R, 2005, BIOCHEMISTRY-US, V44, P7115, DOI 10.1021/bi050008r; Matsui I, 2007, FEBS J, V274, P4012, DOI 10.1111/j.1742-4658.2007.05956.x; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Michalska K, 2005, J BIOL CHEM, V280, P28484, DOI 10.1074/jbc.M504501200; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skinner MM, 2000, STRUCTURE, V8, P1189, DOI 10.1016/S0969-2126(00)00522-0; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Thoden JB, 2003, BIOCHEMISTRY-US, V42, P4874, DOI 10.1021/bi034233p; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109657; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181705	10.1371/journal.pone.0181705	http://dx.doi.org/10.1371/journal.pone.0181705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723955	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800067
J	Farman, H; Javed, H; Jan, B; Ahmad, J; Ali, S; Khalil, FN; Khan, M				Farman, Haleem; Javed, Huma; Jan, Bilal; Ahmad, Jamil; Ali, Shaukat; Khalil, Falak Naz; Khan, Murad			Analytical network process based optimum cluster head selection in wireless sensor network	PLOS ONE			English	Article							ENERGY-EFFICIENT; DECISION	Wireless Sensor Networks (WSNs) are becoming ubiquitous in everyday life due to their applications in weather forecasting, surveillance, implantable sensors for health monitoring and other plethora of applications. WSN is equipped with hundreds and thousands of small sensor nodes. As the size of a sensor node decreases, critical issues such as limited energy, computation time and limited memory become even more highlighted. In such a case, network lifetime mainly depends on efficient use of available resources. Organizing nearby nodes into clusters make it convenient to efficiently manage each cluster as well as the overall network. In this paper, we extend our previous work of grid-based hybrid network deployment approach, in which merge and split technique has been proposed to construct network topology. Constructing topology through our proposed technique, in this paper we have used analytical network process (ANP) model for cluster head selection in WSN. Five distinct parameters: distance from nodes (DistNode), residual energy level (REL), distance from centroid (DistCent), number of times the node has been selected as cluster head (TCH) and merged node (MN) are considered for CH selection. The problem of CH selection based on these parameters is tackled as a multi criteria decision system, for which ANP method is used for optimum cluster head selection. Main contribution of this work is to check the applicability of ANP model for cluster head selection in WSN. In addition, sensitivity analysis is carried out to check the stability of alternatives (available candidate nodes) and their ranking for different scenarios. The simulation results show that the proposed method outperforms existing energy efficient clustering protocols in terms of optimum CH selection and minimizing CH reselection process that results in extending overall network lifetime. This paper analyzes that ANP method used for CH selection with better understanding of the dependencies of different components involved in the evaluation process.	[Farman, Haleem; Javed, Huma; Ali, Shaukat; Khalil, Falak Naz] Univ Peshawar, Dept Comp Sci, Peshawar, Pakistan; [Jan, Bilal; Khan, Murad] Sarhad Univ Sci & IT, Dept Comp Sci & IT, Peshawar, Pakistan; [Jan, Bilal] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Ahmad, Jamil] Sejong Univ, Coll Elect & Informat Engn, Seoul, South Korea	University of Peshawar; Polytechnic University of Turin; Sejong University	Farman, H (corresponding author), Univ Peshawar, Dept Comp Sci, Peshawar, Pakistan.	haleem4us@gmail.com	Khan, Murad/AAB-6060-2019; Ahmad, Jamil/G-6931-2015	Khan, Murad/0000-0001-9905-8904; Ahmad, Jamil/0000-0001-8407-5971; farman, haleem/0000-0003-2344-1522				Ali MS, 2008, EL COMP ENG 2008 INT; Aslam N, 2011, INFORM FUSION, V12, P202, DOI 10.1016/j.inffus.2009.12.005; Batra PK, 2016, WIREL NETW, V22, P49, DOI 10.1007/s11276-015-0951-y; Boateng P, 2015, INT J PROJ MANAG, V33, P1795, DOI 10.1016/j.ijproman.2015.08.007; Bsoul M, 2013, WIRELESS PERS COMMUN, V70, P99, DOI 10.1007/s11277-012-0681-8; Buyukozkan G, 2004, INT J GEN SYST, V33, P259, DOI 10.1080/03081070310001633581; Chiang YK, 2014, SENSORS-BASEL, V14, P8447, DOI 10.3390/s140508447; Farman H, 2016, J SENSORS, V2016, DOI 10.1155/2016/2326917; Hacioglu G, 2016, EXPERT SYST APPL, V59, P86, DOI 10.1016/j.eswa.2016.04.016; Handy, 2002, MOB WIR COMM NETW 20; Heinzelman W.R., 2000, P 33 ANN HAW INT C S, VVolume 2, P10; Ishizaka A., 2013, MULTICRITERIA DECISI, P1; Khan AR, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/230708; Labib A., 2009, OR INSIGHT, V22, P201, DOI [DOI 10.1057/ori.2009.10, DOI 10.1057/ORI.2009.10]; Lindsey S, 2002, AER C P 2002 IEEE; Mahajan S., 2011, INT J COMPUT SCI TEL, V2, P83; Mendoza GA, 2006, FOREST ECOL MANAG, V230, P1, DOI 10.1016/j.foreco.2006.03.023; Molinos-Senante M, 2015, SCI TOTAL ENVIRON, V532, P676, DOI 10.1016/j.scitotenv.2015.06.059; Saaty T. L., 2001, RWS PUBLICATIONS, V7, P557; Saaty T.L., 2005, THEORY APPL ANAL NET; Saaty T.L., 1988, MATH MODELS DECISION, P109, DOI DOI 10.1007/978-3-642-83555-1_5; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Sharma T, 2008, ADV COMP COMM 2008 A; Sun S, 2016, SCI REP, P6; Wang Q, 2005, INT C RES NETW SPRIN; Xia CY, 2012, NONLINEAR DYNAM, V69, P927, DOI 10.1007/s11071-011-0313-y; Ye M, 2005, PCCC 2005 24 IEEE IN; Yin Y, 2006, 2006 IEEE 17 INT S P; Younis O, 2004, IEEE T MOBILE COMPUT, V3, P366, DOI 10.1109/TMC.2004.41	29	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180848	10.1371/journal.pone.0180848	http://dx.doi.org/10.1371/journal.pone.0180848			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719616	Green Published, gold, Green Submitted			2022-12-27	WOS:000406061400020
J	Choi, JW; Oh, IH; Lee, CH; Park, JS				Choi, Jong Wook; Oh, Il Hwan; Lee, Chang Hwa; Park, Joon-Sung			Effect of synergistic interaction between abnormal adiposity-related metabolism and prediabetes on microalbuminuria in the general population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; CARDIOMETABOLIC INDEX; OBESITY; RATIO; RISK; ASSOCIATION; INFLAMMATION; ALBUMINURIA; PROGRESSION	Central obesity and related metabolic components are important risks for microalbuminuria. To describe the effects of interactions between central obesity and related metabolic components on microalbuminuria, we conducted a nation-wide, population-based interaction analysis using cardio-metabolic index (CMI) as a candidate indicator of central obesity and related abnormal lipid metabolism. We recruited native Koreans aged 20 years or older with no medical illness. A total of 5398 participants were divided into quintiles according to CMI with sex as a covariate factor. Participants in the highest CMI quintile had elevated blood pressure (BP), increased glycemic exposure, poor lipid profile, and increased urine albumin-to-creatinine ratio compared to other lower quintiles. Multiple logistic regression models adjusted for age, sex, systolic BP, and diastolic BP showed that CMI had an independent association with increased glycemic exposure and increased urine albumin-to-creatinine ratio. Our interaction analysis revealed a significant interaction between the highest CMI quintile and prediabetes with an increased risk of microalbuminuria (adjusted RERI = 0.473, 95% CI = 0.464 +/- 0.482; adjusted AP = 0.276, 95% CI = 0.156 +/- 0.395; adjusted SI = 2.952, 95% CI = 1.234 +/- 4.670). Our findings suggest a significant association between central obesity-related abnormal lipid metabolism and prediabetes, and their interaction may exert a synergistic effect on renal vascular endothelial dysfunction even before the appearance of full-blown diabetes mellitus. To confirm these findings, large population-based prospective studies are needed.	[Choi, Jong Wook; Oh, Il Hwan; Lee, Chang Hwa; Park, Joon-Sung] Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea	Hanyang University	Lee, CH; Park, JS (corresponding author), Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	changhwa@hanyang.ac.kr; sjpjoon@hanyang.ac.kr		Park, Joon-Sung/0000-0003-4740-3061				Agarwal R, 2010, HYPERTENSION, V56, P893, DOI 10.1161/HYPERTENSIONAHA.110.160747; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Ashwell M, 1996, BRIT MED J, V312, P377; Bahar Adele, 2013, Nephrourol Mon, V5, P741, DOI 10.5812/numonthly.7646; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Du N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098926; Dutta D, 2014, J DIABETES, V6, P316, DOI 10.1111/1753-0407.12112; Gabir MM, 2000, DIABETES CARE, V23, P1113, DOI 10.2337/diacare.23.8.1113; Ghigliotti G, 2014, INFLAMMATION, V37, P1337, DOI 10.1007/s10753-014-9914-1; Glastras SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162131; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; He Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003769; Hoehner CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015762.92814.85; Imig JD, 2013, COMPR PHYSIOL, V3, P957, DOI 10.1002/cphy.c120028; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kim JY, 2012, J KOREAN MED SCI, V27, P1524, DOI 10.3346/jkms.2012.27.12.1524; Kim SH, 2016, EUR HEART J, V37, P3560, DOI 10.1093/eurheartj/ehv509; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kurozumi A, 2016, INTERNAL MED, V55, P3091, DOI 10.2169/internalmedicine.55.6940; Lee IT, 2013, J DIABETES COMPLICAT, V27, P243, DOI 10.1016/j.jdiacomp.2012.11.004; Lee YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157303; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Maric-Bilkan C, 2013, MED CLIN N AM, V97, P59, DOI 10.1016/j.mcna.2012.10.010; Mathew AV, 2011, CURR DIABETES REV, V7, P41, DOI 10.2174/157339911794273928; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Shin DI, 2013, J KOREAN MED SCI, V28, P252, DOI 10.3346/jkms.2013.28.2.252; Sorensen BM, 2016, CIRCULATION, V134, P1339, DOI 10.1161/CIRCULATIONAHA.116.023446; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Todd JN, 2015, DIABETES, V64, P4238, DOI 10.2337/db15-0254; VERANI RR, 1992, AM J KIDNEY DIS, V20, P629, DOI 10.1016/S0272-6386(12)70230-5; Wakabayashi I, 2015, CLIN CHIM ACTA, V446, P231, DOI 10.1016/j.cca.2015.04.020; Wakabayashi I, 2015, CLIN CHIM ACTA, V438, P274, DOI 10.1016/j.cca.2014.08.042; Wu CC, 2011, NEPHROL DIAL TRANSPL, V26, P3689, DOI 10.1093/ndt/gfr057; Yang XL, 2009, DIABETES, V58, P1518, DOI 10.2337/db09-0105; Yoon SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111179; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	41	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180924	10.1371/journal.pone.0180924	http://dx.doi.org/10.1371/journal.pone.0180924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715448	Green Published, gold, Green Submitted			2022-12-27	WOS:000443975500021
J	Ourradi, K; Xu, YH; de Seny, D; Kirwan, J; Blom, A; Sharif, M				Ourradi, Khadija; Xu, Yunhe; de Seny, Dominique; Kirwan, John; Blom, Ashley; Sharif, Mohammed			Development and validation of novel biomarker assays for osteoarthritis	PLOS ONE			English	Article							INFLAMMATORY MEDIATORS; CARTILAGE DEGRADATION; MARKERS; KNEE; PROGRESSION; ARTHRITIS; MATRIX; JOINT; BONE	Background Osteoarthritis (OA) is the most common chronic joint disease usually diagnosed at relatively advanced stages when there is irreparable damage to the joint(s). Recently, we have identified two novel biomarkers C3f and V65 which appear to be OA-specific and therefore potential markers of early disease. We report the development of immunoassays for quantitative measure of these two novel biomarkers. Method Monoclonal and polyclonal antibodies were generated by immunising mouse and rabbits respectively with peptide-carrier conjugates of C3f and V65. Affinity purified antibodies were used for immunoassays development and assays validated using serum from OA patients and controls. Results The ELISAs developed showed spiked recovery of up to 96% for C3f and V65 peptides depending on serum dilutions with a coefficient of variation (CV) <10%. The intra- and inter-assay CVs for C3f and V65 were 1.3-10.8% and 4.2-10.3% respectively. Both assays were insensitive for measurements of the peptides in patients and the use of different signal amplification systems did not increase assay sensitivity. Conclusion We have developed two immunoassays for measurements of C3f and V65 peptides biomarkers discovered by our earlier proteomic study. These assays could detect the endogenous peptides in serum samples from patients and controls but lacked sensitivity for accurate measurements of the peptides in patients. Our study highlights the difficulties and challenges of validating biomarker from proteomic studies and demonstrates how to overcome some of the technical challenges associated with developing immunoassays for small peptides.	[Ourradi, Khadija; Xu, Yunhe; Blom, Ashley; Sharif, Mohammed] Univ Bristol, Southmead Hosp, Sch Clin Sci, Musculoskeletal Res Unit, Learning & Res Bldg, Bristol, Avon, England; [de Seny, Dominique] Univ Liege, CHU Liege, Lab Rheumatol, GIGA I, Liege, Belgium; [Kirwan, John] Univ Bristol, Acad Rheumatol, Bristol Royal Infirm, Bristol, Avon, England	Southmead Hospital; University of Bristol; University of Liege; Bristol Royal Infirmary; University of Bristol	Sharif, M (corresponding author), Univ Bristol, Southmead Hosp, Sch Clin Sci, Musculoskeletal Res Unit, Learning & Res Bldg, Bristol, Avon, England.	mo.sharif@bristol.ac.uk		Blom, Ashley/0000-0002-9940-1095; Ourradi, Khadija/0000-0002-9031-1931; Kirwan, John/0000-0002-6617-3217	Arthritis Research UK [20406]	Arthritis Research UK(Versus Arthritis)	This study was funded by Arthritis Research UK, Project grant No. 20406 (MS), http://www.arthritisresearchuk.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by an Arthritis Research UK project grant (20406).	Attur MG, 2000, J IMMUNOL, V164, P2684, DOI 10.4049/jimmunol.164.5.2684; Balakrishnan L, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-6; Cobraiville G, 2017, TALANTA, V169, P170, DOI 10.1016/j.talanta.2017.03.078; Davis CR, 2007, ARTHRITIS RHEUM, V56, P4038, DOI 10.1002/art.23129; de Seny D, 2011, ANN RHEUM DIS, V70, P1144, DOI 10.1136/ard.2010.135541; Fernandez-Puente P, 2011, J PROTEOME RES, V10, P5095, DOI 10.1021/pr200695p; Fransen M, 2011, INT J RHEUM DIS, V14, P113, DOI 10.1111/j.1756-185X.2011.01608.x; Garnero P, 2002, ARTHRITIS RHEUM, V46, P2847, DOI 10.1002/art.10616; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Henrotin Y, 2012, ARTHRITIS RHEUM-US, V64, P2260, DOI 10.1002/art.34392; Lotz M, 2013, ANN RHEUM DIS, V72, P1756, DOI 10.1136/annrheumdis-2013-203726; Petersson IF, 1998, BRIT J RHEUMATOL, V37, P46; Poole AR, 2004, J IMMUNOL METHODS, V294, P145, DOI 10.1016/j.jim.2004.09.005; Rahmati M, 2016, BONE, V85, P81, DOI 10.1016/j.bone.2016.01.019; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; SAXNE T, 1992, BRIT J RHEUMATOL, V31, P583; SHARIF M, 1995, ARTHRITIS RHEUM, V38, P760, DOI 10.1002/art.1780380608; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181334	10.1371/journal.pone.0181334	http://dx.doi.org/10.1371/journal.pone.0181334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715494	Green Published, Green Submitted, gold			2022-12-27	WOS:000443975500046
J	Takenaka, Y; Kitamura, T; Oya, R; Ashida, N; Shimizu, K; Takemura, K; Yamamoto, Y; Uno, A				Takenaka, Yukinori; Kitamura, Takahiro; Oya, Ryohei; Ashida, Naoki; Shimizu, Kotaro; Takemura, Kazuya; Yamamoto, Yoshifumi; Uno, Atsuhiko			Prognostic role of neutrophil-lymphocyte ratio in nasopharyngeal carcinoma: A meta-analysis	PLOS ONE			English	Article							BARR-VIRUS DNA; POOR-PROGNOSIS; PREDICTOR; CANCER; RADIOTHERAPY; INFLAMMATION; SURVIVAL; PROTEIN; SYSTEM; MODEL	Background Inflammatory markers are used to predict prognosis of nasopharyngeal carcinoma (NPC). Previous reports of neutrophil-to-lymphocyte ratio (NLR) and NPC mortality are inconsistent. This study aimed to quantify the prognostic impact of NLR on NPC. Methods The primary outcome was overall survival (OS), and the secondary outcomes were disease-specific survival (DSS), progression-free survival (PFS) and distant metastasis-free survival (DMFS). We systematically searched electronic databases, identified articles reporting an association between NLR and NPC prognosis. Hazard ratios (HRs) and 95% confidence intervals (CIs) were extracted, and pooled HRs for each outcome were estimated using random effect models. Results Nine studies enrolling 5397 patients were included in the analyses. NLR greater than the cutoff value was associated with poor overall survival (HR 1.51, 95% CI 1.27-1.78), disease-specific survival (HR 1.44, 95% CI 1.22-1.71), progression-free survival (HR 1.53, 95% CI 1.22-1.90), and distant metastasis-free survival (HR 1.83, 95% CI 1.14-2.95). Conclusions Elevated NLR predicts worse OS, DSS, PFS and DMFS in patients with NPC.	[Takenaka, Yukinori; Kitamura, Takahiro; Oya, Ryohei; Ashida, Naoki; Shimizu, Kotaro; Takemura, Kazuya; Yamamoto, Yoshifumi; Uno, Atsuhiko] Osaka Gen Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan		Takenaka, Y (corresponding author), Osaka Gen Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan.	ysktakenaka@gmail.com	Takenaka, Yukinori/I-3516-2019; Oya, Ryohei/I-4142-2019	Takenaka, Yukinori/0000-0002-3135-5635; Oya, Ryohei/0000-0001-8991-0315				An X, 2011, TUMOR BIOL, V32, P317, DOI 10.1007/s13277-010-0124-7; [Anonymous], 2017, NCCN GUIDELINES VERS; Bruce JP, 2015, J CLIN ONCOL, V33, P3346, DOI 10.1200/JCO.2015.60.7846; Cao J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158770; Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang H, 2013, CLIN ONCOL-UK, V25, P639, DOI 10.1016/j.clon.2013.07.004; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112581; Chen WH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-583; Cheng H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11026; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Chua MLK, 2016, EUR J CANCER, V67, P119, DOI 10.1016/j.ejca.2016.08.006; Dong YW, 2016, ONCOTARGETS THER, V9, P3127, DOI 10.2147/OTT.S103031; Duan YM, 2015, CANCER LETT, V361, P67, DOI 10.1016/j.canlet.2015.02.037; Ethier JL, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-016-0794-1; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Hsu MC, 2010, MODERN PATHOL, V23, P1393, DOI 10.1038/modpathol.2010.130; Hu FJ, 2012, CLIN CHIM ACTA, V413, P213, DOI 10.1016/j.cca.2011.09.026; Hu KM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006404; Jiang R, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0025-7; Jin Y, 2015, HEAD NECK-J SCI SPEC, V37, P69, DOI 10.1002/hed.23565; Lai HC, 2010, VIROLOGY, V405, P464, DOI 10.1016/j.virol.2010.06.037; Leon Barnes, 2005, WHO CLASSIFICATION T, P781; Leung SF, 2004, CLIN CHEM, V50, P339, DOI 10.1373/clinchem.2003.022426; Li JP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111900; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083069; Li XH, 2016, CANC MED, V6, P310, DOI DOI 10.1002/CAM4.947; Luo XL, 2015, HEAD NECK-J SCI SPEC, V37, P624, DOI 10.1002/hed.23642; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Mrizak D, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju363; Na N, 2016, ONCOTARGET, V7, P44039, DOI 10.18632/oncotarget.9836; Ng WT, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0361-5; Peng Juan, 2006, Ai Zheng, V25, P1340; Riley CA, 2016, OTOLARYNG HEAD NECK, V154, P810, DOI 10.1177/0194599816629436; Samanta M, 2010, CANCER SCI, V101, P29, DOI 10.1111/j.1349-7006.2009.01377.x; Sun W, 2016, HEAD NECK-J SCI SPEC, V38, pE1332, DOI 10.1002/hed.24224; Tao CJ, 2016, ONCOTARGET, V7, P46653, DOI 10.18632/oncotarget.9695; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Tsai PL, 2016, J CANCER RES THER, V12, P582, DOI 10.4103/0973-1482.144356; Tsang CM, 2015, VIROL SIN, V30, P107, DOI 10.1007/s12250-015-3592-5; Wang WY, 2013, CANCER-AM CANCER SOC, V119, P963, DOI 10.1002/cncr.27853; Wells G.A., NEWCASTLE OTTAWA SCA; Wu JY, 2017, ONCOTARGET, V8, P13400, DOI 10.18632/oncotarget.14541; Xia WX, 2013, EUR J CANCER, V49, P2152, DOI 10.1016/j.ejca.2013.03.003; Xu T, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0198-y; Xue TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096072; Yang HB, 2016, ONCOTARGET, V7, P76769, DOI 10.18632/oncotarget.12526; Yang X, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S77099; Zhang J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005130; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4; Zhou GQ, 2012, INT J RADIAT ONCOL, V82, pE359, DOI 10.1016/j.ijrobp.2011.06.1967	51	20	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181478	10.1371/journal.pone.0181478	http://dx.doi.org/10.1371/journal.pone.0181478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715474	Green Submitted, gold, Green Published			2022-12-27	WOS:000443975500060
J	Ali, SS; Wu, J; Xie, RR; Zhou, F; Sun, JZ; Huang, M				Ali, Sameh Samir; Wu, Jian; Xie, Rongrong; Zhou, Feng; Sun, Jianzhong; Huang, Miao			Screening and characterizing of xylanolytic and xylose-fermenting yeasts isolated from the wood-feeding termite, Reticulitermes chinensis	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; NEIGHBOR-JOINING METHOD; ETHANOL-PRODUCTION; LIGNOCELLULOSIC BIOMASS; PRODUCT FORMATION; ESCHERICHIA-COLI; FOREST HABITATS; CELL-SURFACE; ROTTING WOOD; XYLANASE	The effective fermentation of xylose remains an intractable challenge in bioethanol industry. The relevant xylanase enzyme is also in a high demand from industry for several biotechnological applications that inevitably in recent times led to many efforts for screening some novel microorganisms for better xylanase production and fermentation performance. Recently, it seems that wood-feeding termites can truly be considered as highly efficient natural bioreactors. The highly specialized gut systems of such insects are not yet fully realized, particularly, in xylose fermentation and xylanase production to advance industrial bioethanol technology as well as industrial applications of xylanases. A total of 92 strains from 18 yeast species were successfully isolated and identified from the gut of wood-feeding termite, Reticulitermes chinensis. Of these yeasts and strains, seven were identified for new species: Candida gotoi, Candida pseudorhagii, Hamamotoa lignophila, Meyerozyma guilliermondii, Sugiyamaella sp. 1, Sugiyamaella sp. 2, and Sugiyamaella sp. 3. Based on the phylogenetic and phenotypic characterization, the type strain of C. pseudorhagii sp. nov., which was originally designated strain SSA-1542 (T), was the most frequently occurred yeast from termite gut samples, showed the highly xylanolytic activity as well as D-xylose fermentation. The highest xylanase activity was recorded as 1.73 and 0.98 U/mL with xylan or D-xylose substrate, respectively, from SSA-1542 (T). Among xylanase-producing yeasts, four novel species were identified as D-xylose-fermenting yeasts, where the yeast, C. pseudorhagii SSA-1542 T, showed the highest ethanol yield (0.31 g/g), ethanol productivity (0.31 g/L.h), and its fermentation efficiency (60.7%) in 48 h. Clearly, the symbiotic yeasts isolated from termite guts have demonstrated a competitive capability to produce xylanase and ferment xylose, suggesting that the wood-feeding termite gut is a promising reservoir for novel xylanases-producing and xylose-fermenting yeasts that are potentially valued for biorefinery industry.	[Ali, Sameh Samir; Wu, Jian; Xie, Rongrong; Zhou, Feng; Sun, Jianzhong; Huang, Miao] Jiangsu Univ, Biofuels Inst, Sch Environm & Safety Engn, Zhenjiang, Peoples R China; [Ali, Sameh Samir] Tanta Univ, Bot Dept, Fac Sci, Tanta, Egypt	Jiangsu University; Egyptian Knowledge Bank (EKB); Tanta University	Sun, JZ (corresponding author), Jiangsu Univ, Biofuels Inst, Sch Environm & Safety Engn, Zhenjiang, Peoples R China.	jzsun1002@ujs.edu.cn	Ai, Sameh Samir/R-3018-2019; Ai, Sameh/S-2009-2019; Ali, Sameh Samir/AAS-1970-2020	Ai, Sameh Samir/0000-0002-7033-8387; Ai, Sameh/0000-0002-7033-8387; Sun, Jianzhong/0000-0002-0857-2842	Priority of Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [4013000011]	Priority of Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work is supported by the Priority of Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (code 4013000011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Bhadra B, 2008, CURR MICROBIOL, V56, P489, DOI 10.1007/s00284-008-9108-x; Brennan Y, 2004, APPL ENVIRON MICROB, V70, P3609, DOI 10.1128/AEM.70.6.3609-3617.2004; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Brune A, 1998, TRENDS BIOTECHNOL, V16, P16, DOI 10.1016/S0167-7799(97)01151-7; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Cadete RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043135; Cadete RM, 2009, FEMS YEAST RES, V9, P1338, DOI 10.1111/j.1567-1364.2009.00582.x; Cao YQ, 2010, INSECT SCI, V17, P237, DOI 10.1111/j.1744-7917.2009.01311.x; Chen SC, 2013, BIORESOURCE TECHNOL, V128, P145, DOI 10.1016/j.biortech.2012.10.087; Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424; Costa CE, 2017, BIORESOURCE TECHNOL, V227, P24, DOI 10.1016/j.biortech.2016.12.016; FELL JW, 1966, ANTON VAN LEE J M S, V32, P99, DOI 10.1007/BF02097449; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fonseca C, 2007, APPL MICROBIOL BIOT, V75, P303, DOI 10.1007/s00253-006-0830-7; Fujita Y, 2002, J MOL CATAL B-ENZYM, V17, P189, DOI 10.1016/S1381-1177(02)00027-9; GHANGAS GS, 1989, J BACTERIOL, V171, P2963, DOI 10.1128/jb.171.6.2963-2969.1989; Ghoshal G, 2015, J BIOTECHNOL TECHNOL, V6, P1013; GONG CS, 1983, BIOTECHNOL BIOENG, V25, P85, DOI 10.1002/bit.260250108; HAHNHAGERDAL B, 1994, ENZYME MICROB TECH, V16, P933, DOI 10.1016/0141-0229(94)90002-7; Handel S, 2016, INT J SYST EVOL MICR, V66, P4600, DOI 10.1099/ijsem.0.001397; Hasunuma T, 2012, PROCESS BIOCHEM, V47, P1287, DOI 10.1016/j.procbio.2012.05.004; Hector RE, 2011, J IND MICROBIOL BIOT, V38, P1193, DOI 10.1007/s10295-010-0896-1; Ho NWY, 1998, APPL ENVIRON MICROB, V64, P1852; Jeppsson M, 2002, APPL ENVIRON MICROB, V68, P1604, DOI 10.1128/AEM.68.4.1604-1609.2002; Jin YS, 2003, APPL ENVIRON MICROB, V69, P495, DOI 10.1128/AEM.69.1.495-503.2003; Katahira S, 2004, APPL ENVIRON MICROB, V70, P5407, DOI 10.1128/AEM.70.9.5407-5414.2004; Katahira S, 2006, APPL MICROBIOL BIOT, V72, P1136, DOI 10.1007/s00253-006-0402-x; Kato H, 2012, APPL MICROBIOL BIOT, V94, P1585, DOI 10.1007/s00253-012-3914-6; Katsumata KS, 2007, J WOOD SCI, V53, P419, DOI 10.1007/s10086-007-0882-z; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Kumar S, 2009, CHEM ENG TECHNOL, V32, P517, DOI 10.1002/ceat.200800442; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtzman CP, 2007, FEMS YEAST RES, V7, P1046, DOI 10.1111/j.1567-1364.2007.00224.x; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P621, DOI 10.1016/B978-0-444-52149-1.00047-1; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P333, DOI 10.1016/B978-0-444-52149-1.00018-5; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P435, DOI 10.1016/B978-0-444-52149-1.00033-1; Kurtzman CP, 2005, ANTON LEEUW INT J G, V88, P121, DOI 10.1007/s10482-005-2495-0; Kurtzman CP, 1998, YEASTS TAXONOMIC STU, P90; Lara CA, 2014, ANTON LEEUW INT J G, V105, P1107, DOI 10.1007/s10482-014-0172-x; Li Hongxing, 2016, Bioresour Bioprocess, V3, P51, DOI 10.1186/s40643-016-0126-4; Li HX, 2015, MICROB BIOTECHNOL, V8, P266, DOI 10.1111/1751-7915.12245; Li XL, 1996, APPL ENVIRON MICROB, V62, P209, DOI 10.1128/AEM.62.1.209-213.1996; Liu CJ, 2003, J BIOSCI BIOENG, V95, P95, DOI 10.1263/jbb.95.95; Matano Y, 2012, BIORESOURCE TECHNOL, V108, P128, DOI 10.1016/j.biortech.2011.12.144; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Matteotti C, 2012, PROTEIN EXPRES PURIF, V83, P117, DOI 10.1016/j.pep.2012.03.009; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morais CG, 2013, FUNGAL GENET BIOL, V60, P19, DOI 10.1016/j.fgb.2013.07.003; Morais CG, 2013, INT J SYST EVOL MICR, V63, P2356, DOI 10.1099/ijs.0.050856-0; NAKASE T, 1986, J GEN APPL MICROBIOL, V32, P225, DOI 10.2323/jgam.32.225; Parachin NS, 2009, J MOL CATAL B-ENZYM, V59, P52, DOI 10.1016/j.molcatb.2008.12.018; Parreiras LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107499; Rao RS, 2008, LETT APPL MICROBIOL, V47, P19, DOI 10.1111/j.1472-765X.2008.02380.x; ROULAND C, 1988, INSECT BIOCHEM, V18, P709, DOI 10.1016/0020-1790(88)90080-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakamoto T, 2012, J BIOTECHNOL, V158, P203, DOI 10.1016/j.jbiotec.2011.06.025; Sanchez S, 2008, WORLD J MICROB BIOT, V24, P709, DOI 10.1007/s11274-007-9527-z; Schafer A, 1996, J APPL BACTERIOL, V80, P471, DOI 10.1111/j.1365-2672.1996.tb03245.x; Scharf ME, 2008, BIOFUEL BIOPROD BIOR, V2, P540, DOI 10.1002/bbb.107; SLININGER PJ, 1985, BIOTECHNOL LETT, V7, P431, DOI 10.1007/BF01166218; Suh SO, 2005, MYCOLOGIA, V97, P167, DOI 10.3852/mycologia.97.1.167; Sun JZ, 2010, INSECT SCI, V17, P163, DOI 10.1111/j.1744-7917.2010.01348.x; Sun JZ, 2014, AS ONE RSC ENERGY EN; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRAN AV, 1986, ENZYME MICROB TECH, V8, P439, DOI 10.1016/0141-0229(86)90154-7; Urbina H, 2013, MYCOLOGIA, V105, P650, DOI 10.3852/12-094; Vega F. E., 2005, INSECT FUNGAL ASS EC, P211; Walfridsson M, 1997, APPL MICROBIOL BIOT, V48, P218, DOI 10.1007/s002530051041; Wei JQ, 2007, SOCIOBIOLOGY, V50, P553; Wooley R, 1999, BIOTECHNOL PROGR, V15, P794, DOI 10.1021/bp990107u; Yarrow D., 1998, P77, DOI 10.1016/B978-044481312-1/50014-9; Zhang W, 2014, CHEM BIOCHEM ENG Q, V28, P117	75	47	53	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181141	10.1371/journal.pone.0181141	http://dx.doi.org/10.1371/journal.pone.0181141			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704553	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700096
J	Alotaibi, NM; Ibrahim, GM; Wang, J; Guha, D; Mamdani, M; Schweizer, TA; Macdonald, RL				Alotaibi, Naif M.; Ibrahim, George M.; Wang, Justin; Guha, Daipayan; Mamdani, Muhammad; Schweizer, Tom A.; Macdonald, R. Loch			Neurosurgeon academic impact is associated with clinical outcomes after clipping of ruptured intracranial aneurysms	PLOS ONE			English	Article							VEHICLE-CONTROLLED TRIAL; HOSPITAL TEACHING STATUS; DOSE TIRILAZAD MESYLATE; SUBARACHNOID HEMORRHAGE; SURGEON-VOLUME; DOUBLE-BLIND; EXPERIENCE; PERFORMANCE; AUSTRALIA; MORTALITY	Background Surgeon-dependent factors such as experience and volume are associated with patient outcomes. However, it is unknown whether a surgeon's research productivity could be related to outcomes. The main aim of this study is to investigate the association between the surgeon's academic productivity and clinical outcomes following neurosurgical clipping of ruptured aneurysms. Methods We performed a post-hoc analysis of 3567 patients who underwent clipping of ruptured intracranial aneurysms in the randomized trials of tirilazad mesylate from 1990 to 1997. These trials included 162 centers and 156 surgeons from 21 countries. Primary and secondary outcomes were: Glasgow outcome scale score and mortality, respectively. Total publications, H-index, and graduate degrees were used as academic indicators for each surgeon. The association between outcomes and academic factors were assessed using a hierarchical logistic regression analysis, adjusting for patient covariates. Results Academic profiles were available for 147 surgeons, treating a total of 3307 patients. Most surgeons were from the USA (62, 42%), Canada (18, 12%), and Germany (15, 10%). On univariate analysis, the H-index correlated with better functional outcomes and lower mortality rates. In the multivariate model, patients under the care of surgeons with higher H-indices demonstrated improved neurological outcomes (p = 0.01) compared to surgeons with lower H-indices, without any significant difference in mortality. None of the other academic indicators were significantly associated with outcomes. Conclusion Although prognostication following surgery for ruptured intracranial aneurysms primarily depends on clinical and radiological factors, the academic impact of the operating neurosurgeon may explain some heterogeneity in surgical outcomes.	[Alotaibi, Naif M.; Ibrahim, George M.; Wang, Justin; Guha, Daipayan; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Alotaibi, Naif M.; Guha, Daipayan; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada; [Alotaibi, Naif M.] King Fahad Med City, Dept Neurosurg, Natl Neurosci Inst, Riyadh, Saudi Arabia; [Mamdani, Muhammad] Inst Clin Evaluat Sci, Li Ka Shing Ctr Healthcare Analyt Res & Training, Toronto, ON, Canada; [Schweizer, Tom A.; Macdonald, R. Loch] St Michaels Hosp, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst,Div Neurosurg, Toronto, ON, Canada	University of Toronto; University of Toronto; King Fahad Medical City; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Macdonald, RL (corresponding author), Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON, Canada.; Macdonald, RL (corresponding author), Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada.; Macdonald, RL (corresponding author), St Michaels Hosp, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst,Div Neurosurg, Toronto, ON, Canada.	MacdonaldLo@smh.ca	Guha, Daipayan/AAV-1008-2021	Guha, Daipayan/0000-0002-2052-4819; Alotaibi, Naif/0000-0002-8227-347X				Almatar A, 2016, CUAJ-CAN UROL ASSOC, V10, P45, DOI 10.5489/cuaj.3214; Attenello FJ, 2016, J NEUROINTERV SURG, V8, P373, DOI 10.1136/neurintsurg-2014-011642; Bardach NS, 2002, STROKE, V33, P1851, DOI 10.1161/01.STR.0000019126.43079.7B; Barocas DA, 2010, UROL ONCOL-SEMIN ORI, V28, P243, DOI 10.1016/j.urolonc.2009.03.001; Basques BA, 2016, SPINE; Bennett WO, 2012, PUBLIC HEALTH, V126, pS40, DOI 10.1016/j.puhe.2012.05.021; Berman MF, 2003, STROKE, V34, P2200, DOI 10.1161/01.STR.0000086528.32334.06; Bilimoria KY, 2009, ANN SURG ONCOL, V16, P1799, DOI 10.1245/s10434-009-0467-8; Boudourakis LD, 2009, ANN SURG, V250, P159, DOI 10.1097/SLA.0b013e3181a77cb3; Ch'ng SL, 2015, HEART LUNG CIRC, V24, P583, DOI 10.1016/j.hlc.2014.11.014; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cowan JA, 2002, J AM COLL SURGEONS, V195, P814, DOI 10.1016/S1072-7515(02)01345-5; DRAKE CG, 1988, J NEUROSURG, V68, P985; Duclos A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8041; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; Gooden KM, 2008, MED CARE, V46, P1170, DOI 10.1097/MLR.0b013e31817d696d; Guha DPA, 2014, J NEUROSURG, V121, P1039, DOI 10.3171/2014.7.JNS132141; Haley EC, 1997, J NEUROSURG, V86, P467, DOI 10.3171/jns.1997.86.3.0467; HALEY EC, 1995, J NEUROSURG, V82, P786, DOI 10.3171/jns.1995.82.5.0786; Helbok R, 2013, J NEUROL NEUROSUR PS, V84, P266, DOI 10.1136/jnnp-2012-302804; Hyder O, 2013, J GASTROINTEST SURG, V17, P2114, DOI 10.1007/s11605-013-2349-4; Ibrahim GM, 2013, J NEUROSURG, V119, P347, DOI 10.3171/2013.3.JNS122097; Jaja BN, 2013, STROKE; Kassell NF, 1996, J NEUROSURG, V84, P221, DOI 10.3171/jns.1996.84.2.0221; Kawashima H, 2015, SCIENTOMETRICS, V103, P1061, DOI 10.1007/s11192-015-1580-z; Kim Hyun Su, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P67, DOI 10.7461/jcen.2013.15.2.67; Lai PMR, 2014, WORLD NEUROSURG, V82, P380, DOI 10.1016/j.wneu.2013.07.015; Lanzino G, 1999, J NEUROSURG, V90, P1011, DOI 10.3171/jns.1999.90.6.1011; Lanzino G, 1999, J NEUROSURG, V90, P1018, DOI 10.3171/jns.1999.90.6.1018; Lau RL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-250; Lee J, 2009, J NEUROSURG, V111, P387, DOI 10.3171/2008.10.JNS08978; Lipsman N, 2009, J NEUROSURG, V111, P67, DOI 10.3171/2008.10.JNS08184; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; McAteer JP, 2013, JAMA PEDIATR, V167, P468, DOI 10.1001/jamapediatrics.2013.25; McDonald RJ, 2012, J NEUROSURG, V116, P157, DOI 10.3171/2011.8.JNS11324; Meguid RA, 2008, ANN THORAC SURG, V85, P1015, DOI 10.1016/j.athoracsur.2007.09.046; Meguid RA, 2009, J VASC SURG, V50, P243, DOI 10.1016/j.jvs.2009.01.046; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Pacella SJ, 2006, PLAST RECONSTR SURG, V117, P1296, DOI 10.1097/01.prs.0000204962.85336.51; Patel VM, 2011, J ROY SOC MED, V104, P251, DOI 10.1258/jrsm.2011.110005; Paulsen T, 2006, INT J GYNECOL CANCER, V16, P11, DOI 10.1111/j.1525-1438.2006.00319.x; Peltoniemi P, 2011, ANN SURG ONCOL, V18, P1684, DOI 10.1245/s10434-010-1514-1; Pons J, 2010, J HEALTH SERV RES PO, V15, P204, DOI 10.1258/jhsrp.2010.009125; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Seaburg LA, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0543-2; Tchetchik A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129259; Vermeulen MJ, 2007, STROKE, V38, P1216, DOI 10.1161/01.STR.0000259661.05525.9a; Wilt TJ, 2008, J UROLOGY, V180, P820, DOI 10.1016/j.juro.2008.05.010; Yaghoubian A, 2010, AM J SURG, V200, P810, DOI 10.1016/j.amjsurg.2010.07.028	50	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181521	10.1371/journal.pone.0181521	http://dx.doi.org/10.1371/journal.pone.0181521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727832	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500082
J	Gonzalez-Santiago, O; Claudio, PCMS; Cantu-Cardenas, LG; Favela-Hernandez, JMJ				Gonzalez-Santiago, Omar; Morales-San Claudio, Pilar C.; Cantu-Cardenas, Lucia G.; Favela-Hernandez, Juan M. J.			Unintentional and self-poisoning mortalities in Mexico, 2000-2012	PLOS ONE			English	Article							UNITED-STATES; SUICIDE; HOSPITALIZATIONS; SEX	Introduction Poisoning remains a major worldwide public health problem. Mortality varies by country, region and ethnicity. The objective of this study is to analyze recent trends in poisoning mortality in the Mexican population. Methods Data regarding mortality induced by poisoning was obtained from a publicly available national database maintained by the National Institute of Statistics and Geography. Results During the period from 2000 to 2012, average mortality rates for unintentional and self-poisoning were 1.09 and 0.41 per 100000 population, respectively. The highest mortality rate for unintentional poisoning was in older individuals of both genders while the highest mortality for self-poisoning was in older men and young women. Additional studies are needed in Mexico, especially those that analyze risk factors in older individuals and young women.	[Gonzalez-Santiago, Omar; Morales-San Claudio, Pilar C.; Cantu-Cardenas, Lucia G.; Favela-Hernandez, Juan M. J.] Univ Autonoma Nuevo Leon, Sch Chem Sci, Postgrad Div, San Nicolas De Los Garza, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon	Gonzalez-Santiago, O (corresponding author), Univ Autonoma Nuevo Leon, Sch Chem Sci, Postgrad Div, San Nicolas De Los Garza, Nuevo Leon, Mexico.	omargs28@yahoo.com	González-Santiago, Omar/H-3898-2019	González-Santiago, Omar/0000-0003-1841-1783; Favela-Hernandez, Juan Manuel J/0000-0002-1547-7771				Ahmad OB, 2001, 31 WHO; Andrew E, 2008, CLIN TOXICOL, V46, P310, DOI 10.1080/15563650701378712; [Anonymous], 2017, SUIC DAT MENT HLTH; [Anonymous], POIS PREV MAN INT PR; Belanger F, 2008, POISONING RELATED DE; Bohnert ASB, 2010, PUBLIC HEALTH REP, V125, P542, DOI 10.1177/003335491012500409; Center for Disease Control and Prevention, SUIC DUE ALC DRUG OV; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P233; Chien WC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-703; Coben JH, 2010, AM J PREV MED, V38, P517, DOI 10.1016/j.amepre.2010.01.022; Courtin E, 2017, HEALTH SOC CARE COMM, V25, P799, DOI 10.1111/hsc.12311; Davalos J, 2010, INJ PREV S1, V16, pA1; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; Instituto Nacional de Estadistica y Geografia (INEGI), EST MORT; Olguin HJ, 2011, J POPUL THER CLIN PH, V18, pE156; Muazzam S, 2012, WEST J EMERG MED, V13, P230, DOI 10.5811/westjem.2012.3.11762; Peiris-John R, 2014, INTERN MED J, V44, P273, DOI 10.1111/imj.12364; Pruss-Ustun A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-9; Rockett IRH, 2016, JAMA PSYCHIAT, V73, P1072, DOI 10.1001/jamapsychiatry.2016.1870; Rockett IRH, 2014, AM J PUBLIC HEALTH, V104, pE49, DOI 10.2105/AJPH.2014.302244; Rogers JJ, 2007, CLIN TOXICOL, V45, P705, DOI 10.1080/15563650701517491; Rogers RG, 2010, DEMOGRAPHY, V47, P555, DOI 10.1353/dem.0.0119; ROMIEU I, 1994, ENVIRON HEALTH PERSP, V102, P384, DOI 10.2307/3431627; Valtorta N, 2012, J ROY SOC MED, V105, P518, DOI 10.1258/jrsm.2012.120128	25	2	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181708	10.1371/journal.pone.0181708	http://dx.doi.org/10.1371/journal.pone.0181708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727851	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000406634500107
J	Keating, J; Affleck-Brodie, C; Wiegand, R; Morcom, AM				Keating, Jessica; Affleck-Brodie, Caitlin; Wiegand, Ronny; Morcom, Alexa M.			Aging, working memory capacity and the proactive control of recollection: An event-related potential study	PLOS ONE			English	Article							LATE POSTERIOR NEGATIVITY; COGNITIVE CONTROL; INDIVIDUAL-DIFFERENCES; EPISODIC RETRIEVAL; OLDER-ADULTS; BRAIN ACTIVITY; ERP; AGE; CONTEXT; FAMILIARITY	The present study investigated the role of working memory capacity (WMC) in the control of recollection in young and older adults. We used electroencephalographic event-related potentials (ERPs) to examine the effects of age and of individual differences in WMC on the ability to prioritize recollection according to current goals. Targets in a recognition exclusion task were words encoded using two alternative decisions. The left parietal ERP old/new effect was used as an electrophysiological index of recollection, and the selectivity of recollection measured in terms of the difference in its magnitude according to whether recognized items were targets or non-targets. Young adults with higher WMC showed greater recollection selectivity than those with lower WMC, while older adults showed nonselective recollection which did not vary with WMC. The data suggest that aging impairs the ability to engage cognitive control effectively to prioritize what will be recollected.	[Keating, Jessica; Affleck-Brodie, Caitlin; Wiegand, Ronny; Morcom, Alexa M.] Univ Edinburgh, Sch Psychol Philosophy & Language Sci, Edinburgh, Midlothian, Scotland; [Morcom, Alexa M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Morcom, AM (corresponding author), Univ Edinburgh, Sch Psychol Philosophy & Language Sci, Edinburgh, Midlothian, Scotland.; Morcom, AM (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	alexa.morcom@ed.ac.uk		Morcom, Alexa/0000-0003-4654-5308; Keating, Jessica/0000-0002-0224-854X	UK Medical Research Council [MR/K026992/1]; UK cross-council Lifelong Health and Wellbeing Initiative [MR/K026992/1]; Medical Research Council [MR/K026992/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK cross-council Lifelong Health and Wellbeing Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Alexa M. Morcom is a member of the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE), part of the UK cross-council Lifelong Health and Wellbeing Initiative, UK Medical Research Council Grant number MR/K026992/1 (https://www.mrc.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Alexa M. Morcom is a member of the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE), part of the UK cross-council Lifelong Health and Wellbeing Initiative, Grant number MR/K026992/1.	Abdulrahman H, 2014, NEUROIMAGE; Angel L, 2010, BRAIN RES, V1335, P41, DOI 10.1016/j.brainres.2010.03.040; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Bergstrom ZM, 2013, NEUROIMAGE, V68, P141, DOI 10.1016/j.neuroimage.2012.11.030; Braver T. S., 2008, HDB AGING COGNITION, V3rd, P311, DOI DOI 10.4324/9780203837665.CH7; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Braver TS, 2001, J EXP PSYCHOL GEN, V130, P746, DOI 10.1037//0096-3445.130.4.746; Bridger EK, 2012, NEUROIMAGE, V63, P1334, DOI 10.1016/j.neuroimage.2012.07.047; Bridger EK, 2012, J COGNITIVE NEUROSCI, V24, P1476, DOI 10.1162/jocn_a_00152; Bugg JM, 2014, PSYCHOL AGING, V29, P115, DOI 10.1037/a0035270; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; de Chastelaine M, 2007, J COGNITIVE NEUROSCI, V19, P1286, DOI 10.1162/jocn.2007.19.8.1286; Delis DC, 2001, DELIS KAPLAN EXECUTI; Dew ITZ, 2012, CEREB CORTEX, V22, P2542, DOI 10.1093/cercor/bhr334; Duarte A, 2006, J COGNITIVE NEUROSCI, V18, P33, DOI 10.1162/089892906775249988; Duverne S, 2008, EFFECTS AGE NEURAL C, P1; Dywan J, 1998, BRAIN COGNITION, V36, P390, DOI 10.1006/brcg.1997.0979; Dzulkifli MA, 2006, NEUROPSYCHOLOGIA, V44, P1120, DOI 10.1016/j.neuropsychologia.2005.10.021; Dzulkifli MA, 2005, NEUROPSYCHOLOGIA, V43, P1152, DOI 10.1016/j.neuropsychologia.2004.11.019; Elward RL, 2010, BRAIN RES, V1342, P55, DOI 10.1016/j.brainres.2010.04.040; Elward RL, 2013, CORTEX, V49, P1452, DOI 10.1016/j.cortex.2012.07.003; Engle RW, 2004, PSYCHOL LEARN MOTIV, V44, P145; Evans LH, 2010, BRAIN RES, V1324, P43, DOI 10.1016/j.brainres.2010.02.010; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Friedman D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00111; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Herron JE, 2007, PSYCHOPHYSIOLOGY, V44, P233, DOI 10.1111/j.1469-8986.2006.00489.x; Herron JE, 2003, PSYCHON B REV, V10, P703, DOI 10.3758/BF03196535; Hofer SM, 2001, GERONTOLOGY, V47, P341, DOI 10.1159/000052825; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Johansson M, 2003, BIOL PSYCHOL, V64, P91, DOI 10.1016/S0301-0511(03)00104-2; Johnson MK, 1997, NEUROREPORT, V8, P1317, DOI 10.1097/00001756-199703240-00051; Koen JD, 2014, NEUROPSYCHOL REV, V24, P332, DOI 10.1007/s11065-014-9266-5; Kopp B, 2014, BRAIN COGNITION, V85, P209, DOI 10.1016/j.bandc.2013.12.008; Kucera H., 1967, COMPUTATIONAL ANAL P; Li J, 2004, COGN AFFECT BEHAV NE, V4, P279, DOI 10.3758/CABN.4.3.279; LIGHT LL, 1991, ANNU REV PSYCHOL, V42, P333, DOI 10.1146/annurev.ps.42.020191.002001; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Makeig S, 1996, ADV NEUR IN, V8, P145; Mark RE, 1998, BRAIN, V121, P861, DOI 10.1093/brain/121.5.861; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Mecklinger A, 2016, NEUROSCI BIOBEHAV R, V68, P621, DOI 10.1016/j.neubiorev.2016.06.024; Morcom AM, 2016, CURR DIR PSYCHOL SCI, V25, P143, DOI 10.1177/0963721416645536; Morcom AM, 2004, NEUROPSYCHOLOGIA, V42, P1525, DOI 10.1016/j.neuropsychologia.2004.03.009; Morcom AM, 2003, BRAIN, V126, P213, DOI 10.1093/brain/awg020; Morcom AM, 2015, J COGN NEUROSCI, V27; Nuwer M R, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P11; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Paxton JL, 2006, PSYCHOL AGING, V21, P499, DOI 10.1037/0882-7974.21.3.499; Paxton JL, 2008, COGNITIVE CONTROL GO; Redick TS, 2014, ACTA PSYCHOL, V145, P1, DOI 10.1016/j.actpsy.2013.10.010; Redick TS, 2011, Q J EXP PSYCHOL, V64, P1048, DOI 10.1080/17470218.2011.577226; RUGG MD, 1995, NEUROPSYCHOLOGIA, V33, P471, DOI 10.1016/0028-3932(94)00132-9; Rugg MD, 2005, COGNITIVE NEUROSCIEN, P132; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Spencer WD, 1995, PSYCHOL AGING, V10, P527, DOI 10.1037/0882-7974.10.4.527; Sprondel V, 2012, DEVELOPMENTAL SCI, V15, P330, DOI 10.1111/j.1467-7687.2011.01130.x; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2007, J EXP PSYCHOL LEARN, V33, P1020, DOI 10.1037/0278-7393.33.6.1020; Unsworth N, 2016, PSYCHOL LEARN MOTIV, V65, P1, DOI 10.1016/bs.plm.2016.03.001; Unsworth N, 2012, MEMORY, V20, P167, DOI 10.1080/09658211.2011.651087; Velanova K, 2007, CEREB CORTEX, V17, P1033, DOI 10.1093/cercor/bhl013; Voss JL, 2011, PSYCHOPHYSIOLOGY, V48, P532, DOI 10.1111/j.1469-8986.2010.01085.x; Wechsler D., 2009, TEST PREMORBID FUNCT; Wechsler D., 2012, WAIS 4 KASIKIRJA; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wilson M., MRC PSYCHOLINGUISTIC; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	77	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180367	10.1371/journal.pone.0180367	http://dx.doi.org/10.1371/journal.pone.0180367			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727792	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500020
J	Ljungstrom, L; Pernestig, AK; Jacobsson, G; Andersson, R; Usener, B; Tilevik, D				Ljungstrom, Lars; Pernestig, Anna-Karin; Jacobsson, Gunnar; Andersson, Rune; Usener, Barbara; Tilevik, Diana			Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INFLAMMATORY RESPONSE SYNDROME; EMERGENCY-DEPARTMENT PATIENTS; PREOPERATIVE NEUTROPHIL; PREDICT BACTEREMIA; ORGAN FAILURE; SERUM LACTATE; MARKER; INFECTION; MORTALITY	Background Early recognition is a key factor to achieve improved outcomes for septic patients. Combinations of biomarkers, as opposed to single ones, may improve timely diagnosis and survival. We investigated the performance characteristics of sepsis biomarkers, alone and in combination, for diagnosis of verified bacterial sepsis using Sepsis-2 and Sepsis-3 criteria, respectively. Methods Procalcitonin (PCT), neutrophil-lymphocyte count ratio (NLCR), C-reactive protein (CRP), and lactate were determined in a total of 1,572 episodes of adult patients admitted to the emergency department on suspicion of sepsis. All sampling were performed prior to antibiotic administration. Discriminant analysis was used to construct two composite biomarkers consisting of linear combinations of the investigated biomarkers, one including three selected biomarkers (i.e., NLCR, CRP, and lactate), and another including all four (i.e., PCT, NLCR, CRP, and lactate). The diagnostic performances of the composite biomarkers as well as the individual biomarkers were compared using the area under the receiver operating characteristic curve (AUC). Results For diagnosis of bacterial sepsis based on Sepsis-3 criteria, the AUC for PCT (0.68; 95% CI 0.65-0.71) was comparable to the AUCs for the both composite biomarkers. Using the Sepsis- 2 criteria for bacterial sepsis diagnosis, the AUC for the NLCR (0.68; 95% CI 0.65-0.71) but not for the other single biomarkers, was equal to the AUCs for the both composite biomarkers. For diagnosis of severe bacterial sepsis or septic shock based on the Sepsis-2criteria, the AUCs for both composite biomarkers were significantly greater than those of the single biomarkers (0.85; 95% CI 0.82-0.88 for the composite three-biomarker, and 0.86; 95% CI 0.83-0.89 for the composite four-biomarker). Conclusions Combinations of biomarkers can improve the diagnosis of verified bacterial sepsis in the most critically ill patients, but in less severe septic conditions either the NLCR or PCT alone exhibit equivalent performance.	[Ljungstrom, Lars; Jacobsson, Gunnar] Skaraborg Hosp, Dept Infect Dis, Skovde, Sweden; [Pernestig, Anna-Karin; Tilevik, Diana] Univ Skovde, Sch Biosci, Syst Biol Res Ctr, Skovde, Sweden; [Jacobsson, Gunnar; Andersson, Rune] Gothenburg Univ, CARe Ctr Antibiot Resistance Res, Gothenburg, Sweden; [Andersson, Rune] Gothenburg Univ, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Andersson, Rune] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Usener, Barbara] Unilabs AB, Dept Clin Chem, Skovde, Sweden	University of Skovde; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital	Tilevik, D (corresponding author), Univ Skovde, Sch Biosci, Syst Biol Res Ctr, Skovde, Sweden.	diana.tilevik@his.se	Pernestig, Anna-Karin/X-8387-2018	Pernestig, Anna-Karin/0000-0003-4221-6013; Ljungstrom, Lars/0000-0002-3644-4768; Tilevik, Diana/0000-0002-8181-4131	Swedish Knowledge Foundation [20130307]; regional funds in Vastra Gotaland; internal Clinical Research Fund Skaraborg Hospital; internal Unilabs RD Fund	Swedish Knowledge Foundation(General Electric); regional funds in Vastra Gotaland; internal Clinical Research Fund Skaraborg Hospital; internal Unilabs RD Fund	This study was supported by research grants from the Swedish Knowledge Foundation (grant no20130307, www.kks.se), regional funds in Vastra Gotaland (www.vgregion.se), internal Clinical Research Fund Skaraborg Hospital (http://www.vpregion.se/s/skaraborgs-sjukhus/om-skaraborgs-sjukhus/forskning-och-utveckling/beredningsgrupp/), and internal Unilabs R&D Fund (www.unilabs.se). The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Naoki, 2005, Journal of Infection and Chemotherapy, V11, P152, DOI 10.1007/s10156-005-0388-9; Al-Nawas B, 1996, Eur J Med Res, V1, P331; Anand D, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2014.08.017; Arkader R, 2006, ARCH DIS CHILD, V91, P117, DOI 10.1136/adc.2005.077446; Benz F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010078; Bossink AWJ, 1999, CLIN INFECT DIS, V29, P398, DOI 10.1086/520222; Bruniera FR, 2015, EUR REV MED PHARMACO, V19, P694; Clec'h C, 2004, CRIT CARE MED, V32, P1166, DOI 10.1097/01.CCM.0000126263.00551.06; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dou YH, 2013, DIAGN MICR INFEC DIS, V76, P464, DOI 10.1016/j.diagmicrobio.2013.04.023; Fan SL, 2016, CLIN CHIM ACTA, V460, P203, DOI 10.1016/j.cca.2016.07.002; Garnacho-Montero J, 2014, CRIT CARE, V18, DOI 10.1186/cc13908; Gibson PH, 2007, AM HEART J, V154, P995, DOI 10.1016/j.ahj.2007.06.043; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Hoenigl M, 2014, INT J CLIN PRACT, V68, P1278, DOI 10.1111/ijcp.12474; Howell MD, 2007, INTENS CARE MED, V33, P1892, DOI 10.1007/s00134-007-0680-5; Hur M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-224; Jain Saransh, 2014, BMC Res Notes, V7, P458, DOI 10.1186/1756-0500-7-458; Jensen JU, 2011, CRIT CARE MED, V39, P2048, DOI 10.1097/CCM.0b013e31821e8791; Jeong S, 2012, CLIN CHIM ACTA, V413, P1731, DOI 10.1016/j.cca.2012.06.030; Karlsson S, 2010, CRIT CARE, V14, DOI 10.1186/cc9327; Kibe S, 2011, J ANTIMICROB CHEMOTH, V66, pII33, DOI 10.1093/jac/dkq523; Kim MH, 2011, YONSEI MED J, V52, P276, DOI 10.3349/ymj.2011.52.2.276; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kofoed K, 2006, CLIN CHEM, V52, P1284, DOI 10.1373/clinchem.2006.067595; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Latour-Perez J, 2010, CLIN BIOCHEM, V43, P720, DOI 10.1016/j.clinbiochem.2010.03.001; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leli C, 2016, J MED MICROBIOL, V65, P713, DOI 10.1099/jmm.0.000278; Liu Y, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3591-5; Ljungstrom L, 2015, CRITICAL CARE, V19, pP66; Ljungstrom Lars R, 2011, Lakartidningen, V108, P276; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Loonen AJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087315; Loonen AJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072349; Ludwig KR, 2017, MOL BIOSYSTEMS; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075918; Mat-Nor MB, 2016, J CRIT CARE, V33, P245, DOI 10.1016/j.jcrc.2016.01.002; McHugh L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001916; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Meynaar IA, 2011, CRIT CARE RES PRACT, V2011, DOI 10.1155/2011/594645; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Naeini AE, 2006, SAUDI MED J, V27, P422; Nakajima A, 2014, INTERNAL MED, V53, P1497, DOI 10.2169/internalmedicine.53.1785; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Oshita H, 2010, J MICROBIOL IMMUNOL, V43, P222, DOI 10.1016/S1684-1182(10)60035-7; Oussalah A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001774; Oved K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120012; Pernestig A, 2015, EUR C CLIN MIRC INF; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Povoa P, 1998, INTENS CARE MED, V24, P1052, DOI 10.1007/s001340050715; Prkno A, 2013, CRIT CARE, V17, DOI 10.1186/cc13157; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; Reny JL, 2002, CRIT CARE MED, V30, P529, DOI 10.1097/00003246-200203000-00006; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sakr Y, 2008, CRIT CARE MED, V36, P2014, DOI 10.1097/CCM.0b013e31817b86e3; Sankar V, 2013, J ANESTH, V27, P269, DOI 10.1007/s00540-012-1502-7; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Schechner V, 2013, CLIN MICROBIOL REV, V26, P289, DOI 10.1128/CMR.00001-13; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Shapiro NI, 2009, CRIT CARE MED, V37, P96, DOI 10.1097/CCM.0b013e318192fd9d; Shapiro NI, 2005, ANN EMERG MED, V45, P524, DOI 10.1016/j.annemergmed.2004.12.006; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Suprin E, 2000, INTENS CARE MED, V26, P1232, DOI 10.1007/s001340000580; Surawicz CM, 1999, DIGESTION, V60, P91, DOI 10.1159/000007633; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Terradas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042860; Trubiano J, 2013, CURR OPIN INFECT DIS, V26, P526, DOI 10.1097/QCO.0000000000000006; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; van Nieuwkoop C, 2010, CRIT CARE, V14, DOI 10.1186/cc9328; Van Zuijlen DA, 2001, PEDIATR INFECT DIS J, V20, P140, DOI 10.1097/00006454-200102000-00004; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Watkins RR, 2016, INFECT DIS CLIN N AM, V30, P313, DOI 10.1016/j.idc.2016.02.001; Wei BJ, 2016, ONCOTARGETS THER, V9, P5567, DOI 10.2147/OTT.S108419; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zasowski EJ, 2016, CLIN INFECT DIS, V62, P1242, DOI 10.1093/cid/ciw110	82	92	97	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181704	10.1371/journal.pone.0181704	http://dx.doi.org/10.1371/journal.pone.0181704			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727802	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500106
J	Chichom-Mefire, A; Nwanna-Nzewunwa, OC; Siysi, VV; Feldhaus, I; Dicker, R; Juillard, C				Chichom-Mefire, Alain; Nwanna-Nzewunwa, Obieze C.; Siysi, Vincent Verla; Feldhaus, Isabelle; Dicker, Rochelle; Juillard, Catherine			Key findings from a prospective trauma registry at a regional hospital in Southwest Cameroon	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; INJURY SURVEILLANCE; EPIDEMIOLOGY; CARE; ACCURACY; BURDEN	Introduction Trauma is a leading cause of morbidity and mortality worldwide. Data characterizing the burden of trauma in Cameroon is limited. Regular, prospective injury surveillance can address the shortcomings of existing hospital administrative logs and medical records. This study aims to characterize trauma as seen at the emergency department (ED) of Limbe Regional Hospital (LRH) and assess the completeness of data obtained by a trauma registry. Methods and findings From January 2008 to October 2013, we prospectively captured data on injured patients using a strategically designed, context-relevant trauma registry instrument. Indicators around patient demographics, injury characteristics, delays in accessing care, and treatment outcomes were recorded. Descriptive, bivariate, and multivariate statistical analyses were conducted. About 5,617 patients, aged from 0.5-95 years (median age of 26 years), visited the LRH ED with an injury; 67% were male. Students (27%) were the most affected occupation category. Road traffic injuries (RTIs) (56%), assault (22%), and domestic injuries (13%) were the leading causes of injury. Two-thirds of RTIs were motorcycle-related. Working in transportation (AOR 4.42, p < 0.001) and law enforcement (AOR 1.73, p = 0.004) were significant predictors of having a RTI. The trauma registry showed a significant improvement in completeness of all data (p < 0.001) and it improved over time compared with previous administrative records. However, proportions of missing data still ranged from 0.5% to 8.2% and involved respiratory rate or Glasgow Coma scale. Conclusions Implementation of a context-appropriate trauma registry in resource-constrained settings is feasible. Providing valuable, high-quality data, the trauma registry can inform trauma care quality improvement efforts and policy development. Study findings indicate the need for injury prevention interventions and policies that will prioritize high-risks groups, such as those aged 20-29 years, and those in occupations requiring frequent road travel. The high incidence of motorcycle-related injuries is concerning and calls for a proactive solution.	[Chichom-Mefire, Alain; Siysi, Vincent Verla] Univ Buea, Dept Surg, Fac Hlth Sci, Buea, Cameroon; [Chichom-Mefire, Alain; Siysi, Vincent Verla] Reg Hosp Limbe, Buea, Cameroon; [Nwanna-Nzewunwa, Obieze C.; Feldhaus, Isabelle; Dicker, Rochelle; Juillard, Catherine] Univ Calif San Francisco, Dept Surg, Ctr Global Surg Studies, San Francisco, CA USA	University of California System; University of California San Francisco	Chichom-Mefire, A (corresponding author), Univ Buea, Dept Surg, Fac Hlth Sci, Buea, Cameroon.; Chichom-Mefire, A (corresponding author), Reg Hosp Limbe, Buea, Cameroon.	alainchichom@yahoo.com	Chichom-Mefire, Alain/I-7070-2019	Chichom-Mefire, Alain/0000-0001-7230-567X				Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; [Anonymous], 2011, MICR EXC; [Anonymous], 2002, FOR AID NAT INT PROM; Asekhame FF, 2013, DEV CTRY STUD, V3; Beck LF, 2007, AM J EPIDEMIOL, V166, P212, DOI 10.1093/aje/kwm064; Bhalla K, 2009, PLOS MED, V6, P22, DOI 10.1371/journal.pmed.1000001; Chichom-Mefire A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2290-4; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; Hunt JP, 1999, SURGERY, V126, P191, DOI 10.1067/msy.1999.98749; Ikpeme IA, 2013, INT J BURNS TRAUMA, V3, P214; Institute for Health Metrics and Evaluation, 2010, GLOB BURD DIS PROF C; International Association of Public Transport, 2008, OV PUBL TRANSP SUB S; Juillard C, 2011, WORLD J SURG, V35, P1, DOI 10.1007/s00268-010-0825-5; Juillard C, 2010, INJURY PREV, V16, DOI 10.1136/ip.2009.025825; Juillard CJ, 2014, WORLD J SURG, V38, P2534, DOI 10.1007/s00268-014-2604-1; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Kouo-Ngamby M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1147-y; Mefire AC, 2013, WORLD J SURG, V37, P2101, DOI 10.1007/s00268-013-2116-4; Mefire AC, 2013, INJURY, V44, P139, DOI 10.1016/j.injury.2011.10.026; Michael CE, 2013, INT J SOC SCI STUD, V1; Mock C, 2004, AFRICAN J TRAUMA, V2, P53; Nwomeh Benedict C, 2006, World J Emerg Surg, V1, P32; O'Reilly GM, 2013, INJURY, V44, P713, DOI 10.1016/j.injury.2013.02.003; Owor G, 2001, E CENTRAL AFR J S, V6, P57; Oyesiku OK., POLICY FRAMEWORK URB; Peden M, 2013, SAMJ S AFR MED J, V103, P228, DOI [10.7196/SAMJ.6866, 10.7196/samj.6866]; Rutta E, 2001, East Afr Med J, V78, P161; Samuel JC, 2009, WORLD J SURG, V33, P1836, DOI 10.1007/s00268-009-0113-4; Santamarina-Rubio E, 2007, ACCIDENT ANAL PREV, V39, P1, DOI 10.1016/j.aap.2006.06.019; Schultz CR, 2007, J TRAUMA, V63, P1143, DOI 10.1097/TA.0b013e31815688e3; Seidenberg P, 2014, AFR J EMERG MED, V4, P115, DOI 10.1016/j.afjem.2014.01.006; StataCorp, 2013, STAT REL 13; Stevens KA, 2013, INJURY, V44, pS70, DOI 10.1016/S0020-1383(13)70216-X; Stewart KAA, 2013, JAMA SURG, V148, P463, DOI 10.1001/jamasurg.2013.1341; Thanni L O A, 2006, Afr Health Sci, V6, P104; Wesson HKH, 2013, INJURY, V44, pS75, DOI 10.1016/S0020-1383(13)70217-1; Wong EG, 2014, J SURG RES, P2; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; Wynn A, 2001, J TRAUMA, V51, P464, DOI 10.1097/00005373-200109000-00007; Yu KL, 2009, TROP DOCT, V39, P170, DOI 10.1258/td.2009.080283	42	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180784	10.1371/journal.pone.0180784	http://dx.doi.org/10.1371/journal.pone.0180784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723915	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800025
J	Gruebner, O; Lowe, SR; Sykora, M; Kardass, KS; Subramanian, SV; Galea, S				Gruebner, Oliver; Lowe, Sarah R.; Sykora, Martin; Kardass, Ketan Shan; Subramanian, S. V.; Galea, Sandro			A novel surveillance approach for disaster mental health	PLOS ONE			English	Article							TERRORIST ATTACKS; CONSERVATION; RESOURCES; ILLNESS; IMPACT; MODEL	Background Disasters have substantial consequences for population mental health. Social media data present an opportunity for mental health surveillance after disasters to help identify areas of mental health needs. We aimed to 1) identify specific basic emotions from Twitter for the greater New York City area during Hurricane Sandy, which made landfall on October 29, 2012, and to 2) detect and map spatial temporal clusters representing excess risk of these emotions. Methods We applied an advanced sentiment analysis on 344,957 Twitter tweets in the study area over eleven days, from October 22 to November 1, 2012, to extract basic emotions, a space-time scan statistic (SaTScan) and a geographic information system (QGIS) to detect and map excess risk of these emotions. Results Sadness and disgust were among the most prominent emotions identified. Furthermore, we noted 24 spatial clusters of excess risk of basic emotions over time: Four for anger, one for confusion, three for disgust, five for fear, five for sadness, and six for surprise. Of these, anger, confusion, disgust and fear clusters appeared pre disaster, a cluster of surprise was found peri disaster, and a cluster of sadness emerged post disaster. Conclusions We proposed a novel syndromic surveillance approach for mental health based on social media data that may support conventional approaches by providing useful additional information in the context of disaster. We showed that excess risk of multiple basic emotions could be mapped in space and time as a step towards anticipating acute stress in the population and identifying community mental health need rapidly and efficiently in the aftermath of disaster. More studies are needed to better control for bias, identify associations with reliable and valid instruments measuring mental health, and to explore computational methods for continued model-fitting, causal relationships, and ongoing evaluation. Our study may be a starting point also for more fully elaborated models that can either prospectively detect mental health risk using real-time social media data or detect excess risk of emotional reactions in areas that lack efficient infrastructure during and after disasters. As such, social media data may be used for mental health surveillance after large scale disasters to help identify areas of mental health needs and to guide us in our knowledge where we may most effectively intervene to reduce the mental health consequences of disasters.	[Gruebner, Oliver; Subramanian, S. V.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Lowe, Sarah R.] Montclair State Univ, Dept Psychol, Montclair, NJ USA; [Sykora, Martin] Loughborough Univ, SBE, CIM, Loughborough, Leics, England; [Kardass, Ketan Shan] Wilfrid Laurier Univ, Dept Hlth Sci, Waterloo, ON, Canada; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Montclair State University; Loughborough University; Wilfrid Laurier University; Boston University	Gruebner, O (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA.	oliver.gruebner@gmail.com	Gruebner, Oliver/G-5126-2010; Galea, Sandro/GLR-6066-2022; Gruebner, Oliver/H-7947-2019; Gruebner, Oliver/X-2675-2019; Sykora, Martin/K-2627-2018	Gruebner, Oliver/0000-0001-9783-4770; Gruebner, Oliver/0000-0001-9783-4770; Gruebner, Oliver/0000-0001-9783-4770; Galea, Sandro/0000-0002-7534-0945; Sykora, Martin/0000-0002-5363-5857	German Research Foundation (DFG) [GR 4302/2-1, GR 4302/1-1]; Defense Science and Technology Laboratory (DSTL); Engineering and Physical Sciences Research Council [EP/J020532/1]; EPSRC [EP/J020532/1] Funding Source: UKRI	German Research Foundation (DFG)(German Research Foundation (DFG)); Defense Science and Technology Laboratory (DSTL); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by the German Research Foundation (DFG, GR 4302/2-1 and GR 4302/1-1 to 0.G.), by the Defense Science and Technology Laboratory (DSTL), and the Engineering and Physical Sciences Research Council (EP/J020532/1 to M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2014, AM J PREV MED, V46, P166, DOI 10.1016/j.amepre.2013.10.008; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Ayers JW, 2012, J AFFECT DISORDERS, V142, P323, DOI 10.1016/j.jad.2012.05.005; Bollen J., 2011, ICWSM, P450; Coppersmith G., 2014, ICWSM; Coppersmith G, 2015, ADHD SAD ANAL LANGUA; De Choudhury M, 2014, NARCO EMOTIONS AFFEC, P3563, DOI [10.1145/2556288.2557197, DOI 10.1145/2556288.2557197]; De Choudhury M., 2013, SOCIAL MEDIA MEASURE, DOI [10.1145/2464464.2464480., DOI 10.1145/2464464.2464480, 10.1145/2464464.2464480]; De Choudhury M., 2014, CAN SOCIAL MEDIA HEL, P1243, DOI [10.1145/2567948.2580064, DOI 10.1145/2567948.2580064]; Ekman P., 2005, HDB COGNITION EMOTIO, P45, DOI 10.1002/0470013494.ch3; Ekman Paul, 1994, NATURE EMOTION FUNDA; FEMA Modeling Task Force, 2015, FEMA MOTF HURR SAND; FREEDY JR, 1992, J TRAUMA STRESS, V5, P441, DOI 10.1002/jts.2490050308; Fussell E, 2014, SOC SCI MED, V113, P137, DOI 10.1016/j.socscimed.2014.05.025; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Glass K., 2012, SECURITY INFORM, V1, P1, DOI DOI 10.1186/2190-8532-1-3; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; Gruebner O, 2016, LANCET, V387, P2195, DOI 10.1016/S0140-6736(16)30602-X; Harvey AG, 1999, J CONSULT CLIN PSYCH, V67, P985, DOI 10.1037/0022-006X.67.6.985; Hirschberg J, 2015, SCIENCE, V349, P261, DOI 10.1126/science.aaa8685; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Hoeppe P., 2015, WEATHER CLIMATE EXTR; Hoffmann W, 2005, GESUNDHEITSWESEN, V67, P217, DOI 10.1055/s-2004-813850; Houston JB, 2015, DISASTERS, V39, P1, DOI 10.1111/disa.12092; International Federation of Red Cross and Red Crescent Societies, 2014, WORLD DIS REP FOC CU; Johansson F., 2012, 2012 European Intelligence and Security Informatics Conference (EISIC), P189, DOI 10.1109/EISIC.2012.23; Jones SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048036; Kang K, 2016, INT CONF BIG DATA, P231, DOI 10.1109/BIGCOMP.2016.7425918; KANIASTY K, 1993, J PERS SOC PSYCHOL, V64, P395, DOI 10.1037/0022-3514.64.3.395; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; Kleinman KP, 2005, EPIDEMIOL INFECT, V133, P409, DOI 10.1017/S0950268804003528; Kryvasheyeu Y, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500779; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 2015, SATSCAN V9 4 1 SOFTW; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Kumar S, 2011, TWEET TRACKER ANAL T; Lawson AB, 2005, SPATIAL AND SYNDROMIC SURVEILLANCE FOR PUBLIC HEALTH, P1, DOI 10.1002/0470092505; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lowe SR, 2015, MENTAL HLTH CONSEQUE; Lui Marco, 2012, P ACL 2012 SYST DEM; Mowery D, 2016, ONLINE J PUBLIC HLTH, V8; Nagar R, 2014, J MED INTERNET RES, V16, P260, DOI 10.2196/jmir.3416; Neria Y, 2012, JAMA-J AM MED ASSOC, V308, P2571, DOI 10.1001/jama.2012.110700; Neumeister L., 2012, HUFFINGTON POST; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Paul MJ, 2014, PLOS ONE, V9, DOI [10.1371/currents.outbreaks.90b9ed0f59bae4ccaa683a39865d9117, 10.1371/journal.pone.0103408]; Paul MJ, 2012, MODEL MINING PUBLIC; Ravi K, 2015, KNOWL-BASED SYST, V89, P14, DOI 10.1016/j.knosys.2015.06.015; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Shuyo N., 2011, LANGUAGE DETECTION L; Sloan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142209; Sutton J, 2015, P NATL ACAD SCI USA, V112, P14793, DOI 10.1073/pnas.1508916112; Sykora Martin D., 2013, 2013 European Intelligence and Security Informatics Conference (EISIC), P172, DOI 10.1109/EISIC.2013.38; Sykora MD, 2013, IADIINT J COMPUTER; Thelwall M, 2011, J AM SOC INF SCI TEC, V62, P406, DOI 10.1002/asi.21462; Yang JA, 2016, BIG DATA SOC, V3, P1, DOI 10.1177/2053951716652914	58	54	55	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181233	10.1371/journal.pone.0181233	http://dx.doi.org/10.1371/journal.pone.0181233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723959	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800040
J	Kinsler, G; Sinai, S; Lee, NK; Nowak, MA				Kinsler, Grant; Sinai, Sam; Lee, Nicholas Keone; Nowak, Martin A.			Prebiotic selection for motifs in a model of template-free elongation of polymers within compartments	PLOS ONE			English	Article							RNA; EVOLUTION; ORIGIN; SIMULATIONS; INFORMATION; PROTOCELL; RIBOZYME; REPLICATION; EMERGENCE; DYNAMICS	The transition from prelife where self-replication does not occur, to life which exhibits selfreplication and evolution, has been a subject of interest for many decades. Membranes, forming compartments, seem to be a critical component of this transition as they provide several concurrent benefits. They maintain localized interactions, generate electro-chemical gradients, and help in selecting cooperative functions as they arise. These functions pave the way for the emergence and maintenance of simple metabolic cycles and polymers. In the context of origin of life, evolution of information-carrying molecules and RNA based enzymes within compartments has been subject to intensive theoretical and experimental research. Hence, many experimental efforts aim to produce compartments that contain elongating polynucleotides (also referred to as protocells), which store information and perform catalysis. Despite impressive experimental progress, we are still relatively ignorant about the dynamics by which elongating polynucleotides can produce more sophisticated behaviors. Here we perform computer simulations to couple information production through template-free elongation of polymers with dividing compartments. We find that polymers with a simple ability D biasing the concentration of monomers within their own compartment D can acquire a selective advantage in prelife. We further investigate whether such a mechanism allows for cooperative dynamics to dominate over purely competitive ones. We show that under this system of biased monomer addition, even without template-directed self-replication, genetic motifs can emerge, compete, cooperate, and ultimately survive within the population.	[Kinsler, Grant] Harvard Univ, Dept Appl Math, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kinsler, Grant] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kinsler, Grant; Sinai, Sam; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Sinai, Sam; Lee, Nicholas Keone; Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Lee, Nicholas Keone] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA	Harvard University; Stanford University; Harvard University; Harvard University; Wellcome Trust Sanger Institute; Harvard University	Nowak, MA (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Nowak, MA (corresponding author), Harvard Univ, Dept Math, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu		Kinsler, Grant/0000-0001-8308-4665; Lee, Nicholas/0000-0002-2756-1102	Harvard College Research Program; John Templeton Foundation; Harvard Origins of Life Initiative	Harvard College Research Program; John Templeton Foundation; Harvard Origins of Life Initiative	GK was funded by Harvard College Research Program and Harvard Origins of Life Initiative. This research was conducted using the resources provided by the Program for Evolutionary Dynamics at Harvard University. The Program for Evolutionary Dynamics is supported by the John Templeton Foundation and in part by a grant from B Wu and Eric Larson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamala K, 2013, SCIENCE, V342, P1098, DOI 10.1126/science.1241888; Adami C, 2017, ENTROPY INFORM BIASE, P130; Andrieux D, 2008, P NATL ACAD SCI USA, V105, P9516, DOI 10.1073/pnas.0802049105; Attwater J, 2013, NAT CHEM, V5, P1011, DOI [10.1038/nchem.1781, 10.1038/NCHEM.1781]; Bansho Y, 2016, P NATL ACAD SCI USA; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Bianconi G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003051; Budin I, 2012, J AM CHEM SOC, V134, P20812, DOI 10.1021/ja310382d; Budin I, 2011, P NATL ACAD SCI USA, V108, P5249, DOI 10.1073/pnas.1100498108; Chen IA, 2005, J AM CHEM SOC, V127, P13213, DOI 10.1021/ja051784p; Chen IA, 2006, PROTOCELLS GENETIC P; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; DEAMER DW, 1989, ORIGINS LIFE EVOL B, V19, P21, DOI 10.1007/BF01808285; Derr J, 2012, NUCLEIC ACIDS RES, V40, P4711, DOI 10.1093/nar/gks065; DOUDNA JA, 1991, SCIENCE, V251, P1605, DOI 10.1126/science.1707185; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M., 1971, ORIGINS LIFE EVOL B, V24, P241; Fernando C, 2004, Artificial Life IX, P1; Fernando C, 2007, J MOL EVOL, V64, P572, DOI 10.1007/s00239-006-0218-4; Fishkis M, 2007, ORIGINS LIFE EVOL B, V37, P537, DOI 10.1007/s11084-007-9111-4; Ganti T, 1997, J THEOR BIOL, V187, P583, DOI 10.1006/jtbi.1996.0391; Hazen RM, 2007, P NATL ACAD SCI USA, V104, P8574, DOI 10.1073/pnas.0701744104; Higgs PG, 2015, NAT REV GENET, V16, P7, DOI 10.1038/nrg3841; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Holland J. H., 1992, ADAPTATION NATURAL A; Ichihashi N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3494; Janas T, 2004, RNA, V10, P1541, DOI 10.1261/rna.7112704; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Kurihara K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9352; Lau MWL, 2009, CHEM BIOL, V16, P815, DOI 10.1016/j.chembiol.2009.07.005; Lau MWL, 2004, J AM CHEM SOC, V126, P15686, DOI 10.1021/ja045387a; Lawless JG, 1979, NATURE; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Luisi PL, 1999, CURR OPIN COLLOID IN, V4, P33, DOI 10.1016/S1359-0294(99)00012-6; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; Mansy SS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002188; Markvoort AJ, 2014, J THEOR BIOL, V357, P123, DOI 10.1016/j.jtbi.2014.04.029; Markvoort AJ, 2010, BIOPHYS J, V99, P1520, DOI 10.1016/j.bpj.2010.06.057; Mavelli F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S10; Mavelli F, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016010; McCollom TM, 1999, ORIGINS LIFE EVOL B, V29, P153, DOI 10.1023/A:1006592502746; Mitchell M, 1993, ANN ARBOR, V1001, P48109; Moran P., 1958, MATH P CAMBRIDGE PHI, V54, P60, DOI DOI 10.1017/S0305004100033193; Nowak MA, 2008, P NATL ACAD SCI USA, V105, P14924, DOI 10.1073/pnas.0806714105; Ohtsuki H, 2009, P ROY SOC B-BIOL SCI, V276, P3783, DOI 10.1098/rspb.2009.1136; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Rajamani S, 2008, ORIGINS LIFE EVOL B, V38, P57, DOI 10.1007/s11084-007-9113-2; Robertson MP, 2014, CHEM BIOL, V21, P238, DOI 10.1016/j.chembiol.2013.12.004; Ruiz-Mirazo K, 2008, BIOSYSTEMS, V91, P374, DOI 10.1016/j.biosystems.2007.05.013; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Segre D, 2001, ORIGINS LIFE EVOL B, V31, P119, DOI 10.1023/A:1006746807104; Segre D, 2000, P NATL ACAD SCI USA, V97, P4112, DOI 10.1073/pnas.97.8.4112; Simon B, 2013, EVOLUTION, V67, P1561, DOI 10.1111/j.1558-5646.2012.01835.x; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; Szathmary E, 2005, TOP CURR CHEM, V259, P167, DOI 10.1007/tcc001; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Szostak N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004853; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; Vaidya N, 2012, NATURE, V491, P72, DOI 10.1038/nature11549; Vasas V, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-1; Walker SI, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0869; Walker SI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034166; Woese C., 1967, GENETIC CODE HARPER; Woo HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002534; Yamamoto S, 2002, J CHEM PHYS, V116, P5842, DOI 10.1063/1.1456031; Yuen G., 1984, NATURE; Zachar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021380; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c; Zwicker D, 2016, NATURE PHYS	71	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180208	10.1371/journal.pone.0180208	http://dx.doi.org/10.1371/journal.pone.0180208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723913	gold, Green Published, Green Submitted			2022-12-27	WOS:000406067800012
J	Moreno, MC; Mooney, SM; Middleton, FA				Moreno, Maria Camargo; Mooney, Sandra M.; Middleton, Frank A.			Heterogeneity of p53 dependent genomic responses following ethanol exposure in a developmental mouse model of fetal alcohol spectrum disorder	PLOS ONE			English	Article							NEURONAL APOPTOSIS; CELL-PROLIFERATION; PRENATAL EXPOSURE; OXIDATIVE STRESS; NERVOUS-SYSTEM; GENES; BRAIN; DEATH; LIVER; PREVALENCE	Prenatal ethanol exposure can produce structural and functional deficits in the brain and result in Fetal Alcohol Spectrum Disorder (FASD). In rodent models acute exposure to a high concentration of alcohol causes increased apoptosis in the developing brain. A single causal molecular switch that signals for this increase in apoptosis has yet to be identified. The protein p53 has been suggested to play a pivotal role in enabling cells to engage in proapoptotic processes, and thus figures prominently as a hub molecule in the intracellular cascade of responses elicited by alcohol exposure. In the present study we examined the effect of ethanol-induced cellular and molecular responses in primary somatosensory cortex (SI) and hippocampus of 7-day-old wild-type (WT) and p53-knockout (KO) mice. We quantified apoptosis by active caspase-3 immunohistochemistry and ApopTag (TM) labeling, then determined total RNA expression levels in laminae of SI and hippocampal subregions. Immunohistochemical results confirmed increased incidence of apoptotic cells in both regions in WT and KO mice following ethanol exposure. The lack of p53 was not protective in these brain regions. Molecular analyses revealed a heterogeneous response to ethanol exposure that varied depending on the subregion, and which may go undetected using a global approach. Gene network analyses suggest that the presence or absence of p53 alters neuronal function and synaptic modifications following ethanol exposure, in addition to playing a classic role in cell cycle signaling. Thus, p53 may function in a way that underlies the intellectual and behavioral deficits observed in FASD.	[Moreno, Maria Camargo; Middleton, Frank A.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Mooney, Sandra M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Mooney, Sandra M.; Middleton, Frank A.] SUNY Binghamton, Dev Exposure Alcohol Res Ctr, Binghamton, NY USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University System of Maryland; University of Maryland Baltimore; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	middletf@upstate.edu		Middleton, Frank/0000-0002-3107-7188	NIH [R01 AA006916]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by NIH grant R01 AA006916 to FM and SM.	Anderson AE, PLOS ONE, V9; Aylon Y, 2016, COLD SPRING HARBOR P, V6; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Bell SH, 2010, ALCOHOL CLIN EXP RES, V34, P1084, DOI 10.1111/j.1530-0277.2010.01184.x; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007; Geng Y, 2010, J HISTOCHEM CYTOCHEM, V58, P265, DOI 10.1369/jhc.2009.954024; Ghosh AP, 2009, J NEUROPATH EXP NEUR, V68, P747, DOI 10.1097/NEN.0b013e3181a9d524; Goldstein I, 2012, J HEPATOL, V56, P656, DOI 10.1016/j.jhep.2011.08.022; Gupta S, 2001, LIFE SCI, V69, P2957, DOI 10.1016/S0024-3205(01)01404-7; Hamilton DA, 2010, BEHAV BRAIN RES, V207, P290, DOI 10.1016/j.bbr.2009.10.012; Hard ML, 2005, J LAB CLIN MED, V145, P47, DOI 10.1016/j.lab.2004.11.011; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hashimoto-Torii K, 2011, P NATL ACAD SCI USA, V108, P4212, DOI 10.1073/pnas.1100903108; Hernandez JA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1543809; Hicks SD, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-128; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Ignacio C, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0195-x; Kitsantas P, 2014, ARCH GYNECOL OBSTET, V289, P771, DOI 10.1007/s00404-013-3056-9; Kleiber ML, 2014, DEV NEUROSCI-BASEL, V36, P499, DOI 10.1159/000365549; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuhn PE, 1998, EXP NEUROL, V154, P418, DOI 10.1006/exnr.1998.6907; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li MZ, 2014, TOXICOL LETT, V228, P67, DOI 10.1016/j.toxlet.2014.04.011; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V373, P246, DOI 10.1016/j.bbrc.2008.06.006; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; Miller MW, 2006, NEUROSCIENCE, V138, P97, DOI 10.1016/j.neuroscience.2005.10.060; Moreno M.C., 2016, MOL ASPECTS ALCOHOL, P45, DOI [10.1016/8978012800773-0.00004-5, DOI 10.1016/8978012800773-0.00004-5]; Murray AJ, 2016, FASEB J, V30, P4021, DOI 10.1096/fj.201600773R; Niccols A, 2007, BRAIN COGNITION, V65, P135, DOI 10.1016/j.bandc.2007.02.009; Nikolic M, 2013, NEUROSCIENCE, V254, P369, DOI 10.1016/j.neuroscience.2013.09.035; Olney JW, 2004, ADDICT BIOL, V9, P137, DOI 10.1080/13556210410001717006; Pani G, 2004, BIOCHEM BIOPH RES CO, V325, P97, DOI 10.1016/j.bbrc.2004.09.213; Perez-Escuredo J, 2016, BBA-MOL CELL RES, V1863, P2481, DOI 10.1016/j.bbamcr.2016.03.013; Ramachandran V, 2003, J NEUROSCI RES, V74, P577, DOI 10.1002/jnr.10767; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sadrian B, 2013, BRAIN SCI, V3, P704, DOI 10.3390/brainsci3020704; Spadoni AD, 2007, NEUROSCI BIOBEHAV R, V31, P239, DOI 10.1016/j.neubiorev.2006.09.006; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Vierboom MPM, 2000, CANCER RES, V60, P5508; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WOOLLETT LA, 1987, ALCOHOL CLIN EXP RES, V11, P336, DOI 10.1111/j.1530-0277.1987.tb01321.x; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Yeon JE, 2003, HEPATOLOGY, V38, P703, DOI 10.1053/jhep.2003.50368; Zaugg K, 2011, CANCER RES, V61, P732; Zhang MN, 2000, MOL CELL BIOCHEM, V207, P109, DOI 10.1023/A:1007014919003; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	55	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180873	10.1371/journal.pone.0180873	http://dx.doi.org/10.1371/journal.pone.0180873			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723918	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800030
J	Yehya, S; Delannoy, M; Fournier, A; Baroudi, M; Rychen, G; Feidt, C				Yehya, Sarah; Delannoy, Matthieu; Fournier, Agnes; Baroudi, Moomen; Rychen, Guido; Feidt, Cyril			Activated carbon, a useful medium to bind chlordecone in soil and limit its transfer to growing goat kids	PLOS ONE			English	Article							FRENCH-WEST-INDIES; HENS GALLUS-DOMESTICUS; RELATIVE BIOAVAILABILITY; BOUND CHLORDECONE; CONTAMINATION; SEQUESTRATION; GUADELOUPE; ADSORPTION; SEDIMENTS; POLLUTION	Chlordecone (Kepone) (CLD) is a highly persistent pesticide which was extensively used in the French West Indies; high levels of CLD can still currently be found in large agricultural areas. As CLD transfers from soil to animals mainly via involuntary ingestion, the consumption of foodstuffs derived from animals raised in contaminated areas may significantly contribute to exposure of humans to CLD. The present study was designed to test the efficacy of two different activated carbons (ACs) sources in limiting CLD transfer from soil to animal. Three soils (ASs) were prepared according to the OECD guideline 207. One standard soil (SS) lacking AC, and two modified preparations of SS supplemented with 2% coconut-based activated carbon (ORBO), SSO or with 2% lignite-based one (DARCO), SSD. All three soils were spiked with 10 mu g of kepone per g of dry matter and aged for three weeks. This study involved 15 goat kids randomly assigned to the 3 experimental groups (n = 5/ group), which were fed the experimental matrices at an exposure dose of 10 mu g CLD per kg of body weight per day. After 21 d of oral exposure, CLD in adipose tissue and liver were analysed by LC-MS-MS. A significant decrease of 63.7% and 74.7% of CLD concentrations in adipose tissue and liver, respectively, were obtained from animals exposed using SS containing DARCO as compared to those receiving only SS. Decreases in CLD levels of 98.2% (adipose tissue) and 98.7% (liver) were obtained for animals exposed using SS containing ORBO. This study leads us to conclude that (i) the presence of AC in CLD-contaminated soil strongly reduces CLD bioavailability, and (ii) the efficacy depends on the nature and characteristics of the AC used.	[Yehya, Sarah; Delannoy, Matthieu; Fournier, Agnes; Rychen, Guido; Feidt, Cyril] Univ Lorraine, INRA USC 340, UR AFPA, 2 Ave Foret Haye TSA, Vandoeuvre Les Nancy, France; [Yehya, Sarah; Baroudi, Moomen] Lebanese Univ, Fac Publ Hlth, Sect 3, LSEE, Tripoli, Lebanon	INRAE; Universite de Lorraine; Lebanese University	Delannoy, M (corresponding author), Univ Lorraine, INRA USC 340, UR AFPA, 2 Ave Foret Haye TSA, Vandoeuvre Les Nancy, France.	matthieu.delannoy@univ-lorraine.fr	FEIDT, Cyril/AAY-6066-2020	Feidt, Cyril/0000-0003-3828-9543	Ministere de I'Education Nationale, de l'Enseignement Superieur et de la Recherche (the French Ministry of National Education, Higher Education and Research)	Ministere de I'Education Nationale, de l'Enseignement Superieur et de la Recherche (the French Ministry of National Education, Higher Education and Research)	All funding were provided by Ministere de I'Education Nationale, de l'Enseignement Superieur et de la Recherche (the French Ministry of National Education, Higher Education and Research).	Ahmad M, 2014, CHEMOSPHERE, V99, P19, DOI 10.1016/j.chemosphere.2013.10.071; ANSES, 2015, METH DOS RES CHLORD; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Bordet F, 2007, INT J ENVIRON AN CH, V87, P985, DOI 10.1080/03067310701461490; Bouveret C, 2013, J AGR FOOD CHEM, V61, P9269, DOI 10.1021/jf400697r; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Cabidoche YM, 2009, ENVIRON POLLUT, V157, P1697, DOI 10.1016/j.envpol.2008.12.015; Choi YJ, 2014, ENVIRON SCI TECHNOL, V48, P1835, DOI 10.1021/es403335g; Coat S, 2011, ENVIRON POLLUT, V159, P1692, DOI 10.1016/j.envpol.2011.02.036; COHN WJ, 1978, NEW ENGL J MED, V298, P243, DOI 10.1056/NEJM197802022980504; Delannoy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115759; Delannoy M, 2014, CHEMOSPHERE, V104, P105, DOI 10.1016/j.chemosphere.2013.10.072; Dromard CR, 2016, ENVIRON SCI POLLUT R, V23, P73, DOI 10.1007/s11356-015-4732-z; Durimel A, 2013, CHEM ENG J, V229, P239, DOI 10.1016/j.cej.2013.03.036; EGLE JL, 1977, DRUG METAB DISPOS, V6, P91; French Ministry of Agriculture, 2016, AGRG1507402N NOR; French Ministry of Agriculture, 2015, AGRG1507402N NOR; Gaspard S, 2014, ROYAL SOC C IN PRESS; Hilber I, 2010, GLOBAL NEST J, V12, P305; Jakob L, 2012, CHEMOSPHERE, V88, P699, DOI 10.1016/j.chemosphere.2012.03.080; Jondreville C, 2014, CHEMOSPHERE, V114, P275, DOI 10.1016/j.chemosphere.2014.05.008; Jondreville C, 2014, SCI TOTAL ENVIRON, V493, P336, DOI 10.1016/j.scitotenv.2014.05.083; Jondreville C, 2013, ENVIRON SCI POLLUT R, V20, P292, DOI 10.1007/s11356-012-1010-1; Jurjanz S, 2014, ENVIRON GEOCHEM HLTH, V36, P911, DOI 10.1007/s10653-014-9608-5; Ku HH, 1966, J RES NBS, V70; Le Deaut J-Y, 2009, IMPACTS UTILISATION, P1; Levillain J, 2012, AGR ECOSYST ENVIRON, V159, P123, DOI 10.1016/j.agee.2012.07.005; Littell RC, 1997, J ANIM SCI, V75, P2672; Navarro H., 1995, TOXICOLOGICAL PROFIL, P1; OECD, 1984, TEST N 207 EARTHW AC; Perelo LW, 2010, J HAZARD MATER, V177, P81, DOI 10.1016/j.jhazmat.2009.12.090; Shafer D.S., 2013, INTRO STAT; SOINE PJ, 1982, J TOXICOL ENV HEALTH, V9, P107, DOI 10.1080/15287398209530146; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS355, DOI 10.1016/j.chemosphere.2006.05.129; Yavari S, 2015, ENVIRON SCI POLLUT R, V22, P13824, DOI 10.1007/s11356-015-5114-2	35	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179548	10.1371/journal.pone.0179548	http://dx.doi.org/10.1371/journal.pone.0179548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723966	Green Published, gold, Green Submitted			2022-12-27	WOS:000406067800005
J	Polanec, SH; Andrzejewski, P; Seltzer, PAT; Helbich, TH; Stiglbauer, A; Georg, D; Karanikas, G; Susani, M; Wadsak, W; Margreiter, M; Mitterhauser, M; Brader, P; Pinker, K				Polanec, Stephan H.; Andrzejewski, Piotr; Seltzer, Pascal A. T.; Helbich, Thomas H.; Stiglbauer, Alexander; Georg, Dietmar; Karanikas, Georgios; Susani, Martin; Wadsak, Wolfgang; Margreiter, Markus; Mitterhauser, Markus; Brader, Peter; Pinker, Katja			Multiparametric [C-11]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer	PLOS ONE			English	Article							PI-RADS V2; C-11-ACETATE PET/CT; LOCAL RECURRENCE; SCORING SYSTEM; PRIMARY TUMOR; MRI; THERAPY; PET/MRI; F-18-FLUOROCHOLINE; RADIOTHERAPY	Background The aim of this study was to evaluate whether MP [C-11]Acetate PET-MRI enables an accurate differentiation of benign and malignant prostate tumors as well as local and distant staging. Materials and methods Fifty-six consecutive patients fulfilling the following criteria were included in this IRB-approved prospective study: elevated PSA levels or suspicious findings at digital rectal examination or TRUS; and histopathological verification. All patients underwent MP [C-11]Acetate PET-MRI of the prostate performed on separate scanners with PET/CT using [C-11]Acetate and 3T MP MR imaging. Appropriate statistical tests were used to determine diagnostic accuracy, local and distant staging. Results MP imaging with two MRI parameters (T2w and DWI) achieved the highest sensitivity, specificity, and diagnostic accuracy of 95%, 68.8%, and 88%, with an AUC of 0.82 for primary PCa detection. Neither assessments with a single parameter (AUC, 0.54-0.79), nor different combinations with up to five parameters (AUC, 0.67-0.79) achieved equally good results. MP [C-11]Acetate PET-MRI improved local staging with a sensitivity, specificity, and diagnostic accuracy of 100%, 96%, and 97% compared to MRI alone with 72.2%, 100%, and 95.5%. MP [C-11]Acetate PET-MRI correctly detected osseous and liver metastases in five patients. Conclusions MP [C-11]Acetate PET-MRI merges morphologic with functional information, and allows insights into tumor biology. MP [C-11]Acetate PET-MRI with two MRI-derived parameters (T2 and DWI) yields the highest diagnostic accuracy. The addition of more parameters does not improve diagnostic accuracy of primary PCa detection. MP [C-11]Acetate PET-MRI facilitates improved local and distant staging, providing "one-stop" staging in patients with primary PCa, and therefore has the potential to improve therapy.	[Polanec, Stephan H.; Seltzer, Pascal A. T.; Helbich, Thomas H.; Stiglbauer, Alexander; Brader, Peter; Pinker, Katja] Med Univ Vienna, Div Mol & Gender Imaging, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Polanec, Stephan H.; Andrzejewski, Piotr; Seltzer, Pascal A. T.; Georg, Dietmar; Pinker, Katja] Med Univ Vienna, Christian Doppler Lab Med Radiat Res Radiat Oncol, Vienna, Austria; [Andrzejewski, Piotr; Georg, Dietmar] Med Univ Vienna, Div Med Radiat Phys, Dept Radiat Oncol, Vienna, Austria; [Karanikas, Georgios; Wadsak, Wolfgang; Mitterhauser, Markus] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Susani, Martin] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Mitterhauser, Markus] Med Univ Vienna, Dept Urol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Pinker, K (corresponding author), Med Univ Vienna, Div Mol & Gender Imaging, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.; Pinker, K (corresponding author), Med Univ Vienna, Christian Doppler Lab Med Radiat Res Radiat Oncol, Vienna, Austria.	katja.pinker@meduniwien.ac.at	Wadsak, Wolfgang/K-7408-2019	Georg, Dietmar/0000-0002-8327-3877; Mitterhauser, Markus/0000-0003-3173-5272; Baltzer, Pascal/0000-0002-3755-5398; PINKER-DOMENIG, MD, EBBI, Katja/0000-0002-2722-7331; Wadsak, Wolfgang/0000-0003-4479-8053	Comprehensive Cancer Center Vienna [10207014]; Oesterreichische Nationalbank [14788]; Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology; Guerbet France	Comprehensive Cancer Center Vienna; Oesterreichische Nationalbank; Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology; Guerbet France	Our work was supported by the Comprehensive Cancer Center Vienna (#10207014), by the Oesterreichische Nationalbank (#14788), the Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, and a seed grant from Guerbet France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar-Oromieh A, 2015, J NUCL MED, V56, P1697, DOI 10.2967/jnumed.115.161299; American-College-of-Radiology, 2015, MR PROST IM REP DAT; Arce-Calisaya P, 2013, EUR J NUCL MED MOL I, V40, P799, DOI 10.1007/s00259-013-2353-7; Arrayeh E, 2012, INT J RADIAT ONCOL, V82, pE787, DOI 10.1016/j.ijrobp.2011.11.030; Arumainayagam N, 2010, BJU INT, V106, P991, DOI 10.1111/j.1464-410X.2010.09291.x; Auer T, 2016, WORLD J UROL; Barentsz JO, 2016, EUR UROL, V69, P41, DOI 10.1016/j.eururo.2015.08.038; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Beyer T, 2013, MAGN RESON MATER PHY, V26, P1, DOI 10.1007/s10334-012-0365-0; Brogsitter C, 2013, EUR J NUCL MED MOL I, V40, pS18, DOI 10.1007/s00259-013-2358-2; Buchegger F, 2014, EUR J NUCL MED MOL I, V41, P68, DOI 10.1007/s00259-013-2540-6; Cellini N, 2002, INT J RADIAT ONCOL, V53, P595, DOI 10.1016/S0360-3016(02)02795-5; Choi JY, 2017, RADIOLOGY, V282, P429, DOI 10.1148/radiol.2016160220; de Rooij M, 2014, AM J ROENTGENOL, V202, P343, DOI 10.2214/AJR.13.11046; Demirkol MO, 2015, PROSTATE, V75, P748, DOI 10.1002/pros.22956; Dinh CV, 2016, PHYS MED PM INT J DE; Grassi I, 2012, AM J NUCL MED MOLEC, V2, P33; Groenendaal G, 2010, RADIOTHER ONCOL, V94, P145, DOI 10.1016/j.radonc.2009.12.034; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoeks CMA, 2013, RADIOLOGY, V266, P207, DOI 10.1148/radiol.12120281; Jadvar H, 2015, TOMOGRAPHY, V1, P18, DOI 10.18383/j.tom.2015.00130; Kotzerke I, 2003, NUKLEARMED-NUCL MED, V42, P25; Lagendijk JJW, 2008, RADIOTHER ONCOL, V86, P25, DOI 10.1016/j.radonc.2007.10.034; Lamanna G, 2017, CLIN NUCL MED, V42, pE242, DOI 10.1097/RLU.0000000000001609; Leisser A, 2015, PROSTATE, V75, P1760, DOI 10.1002/pros.23061; Ling CC, 2000, INT J RADIAT ONCOL, V47, P551, DOI 10.1016/S0360-3016(00)00467-3; Loffroy R, 2015, QUANT IMAG MED SURG, V5, P754, DOI 10.3978/j.issn.2223-4292.2015.10.08; Mena E, 2012, J NUCL MED, V53, P538, DOI 10.2967/jnumed.111.096032; Mohsen B, 2013, BJU INT, V112, P1062, DOI 10.1111/bju.12279; Morigi JJ, 2016, CURR OPIN UROL, V26, P493, DOI 10.1097/MOU.0000000000000309; Pinker K, 2014, CLIN CANCER RES, V20, P3540, DOI 10.1158/1078-0432.CCR-13-2810; Polanec SH, 2014, ROFO-FORTSCHR RONTG, V186, P501, DOI 10.1055/s-0033-1355546; Polanec SH, 2015, WORLD J UROLOGY; Polanec S, 2016, EUR J RADIOL, V85, P1125, DOI 10.1016/j.ejrad.2016.03.025; Polanec SH, 2016, WORLD J UROL, V34, P649, DOI 10.1007/s00345-015-1670-9; Pucar D, 2007, INT J RADIAT ONCOL, V69, P62, DOI 10.1016/j.ijrobp.2007.03.065; Quon JS, 2015, INSIGHTS IMAGING, V6, P449, DOI 10.1007/s13244-015-0411-3; Roethke MC, 2014, EUR RADIOL, V24, P344, DOI 10.1007/s00330-013-3017-5; Roethke MC, 2014, WORLD J UROL, V32, P379, DOI 10.1007/s00345-013-1106-3; Scheenen TWJ, 2007, RADIOLOGY, V245, P507, DOI 10.1148/radiol.2451061444; Schild MH, 2014, OMICS J RADIOLOGY, V3; Schimmoller L, 2014, EUR J RADIOL, V83, P2103, DOI 10.1016/j.ejrad.2014.08.006; Siegel C, 2016, J UROLOGY, V196, P415, DOI 10.1016/j.juro.2016.05.026; Sotoudeh H, 2016, J MAGN RESON IMAGING; Strandberg S, 2016, ANTICANCER RES, V36, P6475, DOI 10.21873/anticanres.11246; Vargas HA, 2015, EUROPEAN RADIOLOGY; Wibmer AG, 2016, RADIOGRAPHICS, V36, P142, DOI 10.1148/rg.2016150059; Yoshii Y, 2015, CANCER LETT, V356, P211, DOI 10.1016/j.canlet.2014.02.019	49	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180790	10.1371/journal.pone.0180790	http://dx.doi.org/10.1371/journal.pone.0180790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719629	Green Published, Green Submitted, gold			2022-12-27	WOS:000406061400017
J	Zeng, YX; Shi, JS; Ji, ZJ; Wen, ZH; Liang, Y; Yang, CD				Zeng, Yuxiang; Shi, Junsheng; Ji, Zhijuan; Wen, Zhihua; Liang, Yan; Yang, Changdeng			Combination of twelve alleles at six quantitative trait loci determines grain weight in rice	PLOS ONE			English	Article							NEAR-ISOGENIC LINES; ORYZA-SATIVA; GENETIC DISSECTION; CULTIVATED RICE; DWARF MUTANT; SEED LENGTH; MAJOR QTL; SIZE; SHAPE; ENCODES	Grain weight, which is controlled by quantitative trait loci (QTLs), is one of the most important determinants of rice yield. Although many QTLs for grain weight have been identified, little is known about how different alleles in different QTLs coordinate to determine grain weight. In the present study, six grain-weight-QTLs were detected in seven mapping populations (two F-2, one F-3, and four recombinant inbred lines) developed by crossing 'Lemont', a United States japonica variety, with 'Yangdao 4', a Chinese indica variety. In each of the six loci, one allele from one parent increased grain weight and one allele from another parent decreased it. Thus, the 12 alleles at the six QTLs were subjected to regression analysis to examine whether they acted additively across loci leading to a linear relationship between the predicted breeding value of QTL and phenotype. Results suggested that a combination of the 12 alleles determined grain weight. In addition, plants carrying more grain-weight-increasing alleles had heavier grains than those carrying more grain-weight-decreasing alleles. This trend was consistent in the seven mapping populations. Thus, these six QTLs might be used in marker-assisted selection of grain weight, by stacking different grain-weight-increasing or -decreasing alleles.	[Zeng, Yuxiang; Ji, Zhijuan; Wen, Zhihua; Liang, Yan; Yang, Changdeng] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Shi, Junsheng] Seed Management Stn Zhengjiang Prov, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Yang, CD (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	yangchangdeng@126.com			Zhejiang Provincial Natural Science Foundation [LY16C060002]; National Key RD program [2016YFD0102100]; Chinese Academy of Agricultural Sciences	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Key RD program; Chinese Academy of Agricultural Sciences	This work was supported by the Zhejiang Provincial Natural Science Foundation (LY16C060002), the National Key R&D program (2016YFD0102100), and a fund from the Chinese Academy of Agricultural Sciences to the Scientific and Technical Innovation Team.	Abe Y, 2010, GENES GENET SYST, V85, P327, DOI 10.1266/ggs.85.327; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Bai XF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-16; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Guo LB, 2009, J INTEGR PLANT BIOL, V51, P45, DOI 10.1111/j.1744-7909.2008.00793.x; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Jiang YH, 2012, BIOTECHNOL ADV, V30, P1059, DOI 10.1016/j.biotechadv.2011.08.013; Kato T, 2011, BREEDING SCI, V61, P269, DOI 10.1270/jsbbs.61.269; Kitagawa K, 2010, PLANT CELL PHYSIOL, V51, P1315, DOI 10.1093/pcp/pcq092; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li JM, 2004, GENETICS, V168, P2187, DOI 10.1534/genetics.104.034165; Li SB, 2009, PLANT J, V58, P592, DOI 10.1111/j.1365-313X.2009.03799.x; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Liu TM, 2010, THEOR APPL GENET, V120, P933, DOI 10.1007/s00122-009-1222-z; Luo JJ, 2008, MOL PLANT, V1, P830, DOI 10.1093/mp/ssn045; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Oh JM, 2011, GENES GENOM, V33, P259, DOI 10.1007/s13258-011-0038-9; Qiu XJ, 2012, THEOR APPL GENET, V125, P1717, DOI 10.1007/s00122-012-1948-x; Segami S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-4; Shan JX, 2009, THEOR APPL GENET, V119, P827, DOI 10.1007/s00122-009-1092-4; Shao GN, 2012, THEOR APPL GENET, V125, P1303, DOI 10.1007/s00122-012-1914-7; Shao-Qing T, 2013, GENE, V527, P201, DOI 10.1016/j.gene.2013.05.063; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Singh R, 2012, J PLANT BIOCHEM BIOT, V21, P157, DOI 10.1007/s13562-011-0080-3; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Wan XY, 2006, THEOR APPL GENET, V112, P1258, DOI 10.1007/s00122-006-0227-0; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Wen ZH, 2015, GENET MOL RES, V14, P1636, DOI 10.4238/2015.March.6.10; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xie XB, 2008, THEOR APPL GENET, V116, P613, DOI 10.1007/s00122-007-0695-x; Xie XB, 2006, THEOR APPL GENET, V113, P885, DOI 10.1007/s00122-006-0348-5; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yu SW, 2008, CHINESE SCI BULL, V53, P2326, DOI 10.1007/s11434-008-0281-x; Zeng YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150832; Zhang HW, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0410-5; Zhang Q, 2012, NETWORK CODING: FUNDAMENTALS AND APPLICATIONS, P115, DOI 10.1016/B978-0-12-380918-6.00005-6; Zhang WH, 2013, CROP J, V1, P160, DOI 10.1016/j.cj.2013.10.003; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110	46	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181588	10.1371/journal.pone.0181588	http://dx.doi.org/10.1371/journal.pone.0181588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719638	Green Submitted, Green Published, gold			2022-12-27	WOS:000406061400056
J	Wang, QY; Canton, G; Guo, J; Guo, XY; Hatsukami, TS; Billiar, KL; Yuan, C; Wu, ZY; Tang, DL				Wang, Qingyu; Canton, Gador; Guo, Jian; Guo, Xiaoya; Hatsukami, Thomas S.; Billiar, Kristen L.; Yuan, Chun; Wu, Zheyang; Tang, Dalin			MRI-based patient-specific human carotid atherosclerotic vessel material property variations in patients, vessel location and long-term follow up	PLOS ONE			English	Article							RISK-ASSESSMENT STRATEGIES; FINITE-DIFFERENCE METHOD; PLAQUE PROGRESSION; FSI MODELS; VULNERABLE PLAQUE; HUMAN CORONARY; STRESS-ANALYSIS; TRACKING DATA; WALL STRESS; SIMULATION	Background Image-based computational models are widely used to determine atherosclerotic plaque stress/strain conditions and investigate their association with plaque progression and rupture. However, patient-specific vessel material properties are in general lacking in those models, limiting the accuracy of their stress/strain measurements. A noninvasive approach of combining in vivo 3D multi-contrast and Cine magnetic resonance imaging (MRI) and computational modeling was introduced to quantify patient-specific carotid plaque material properties for potential plaque model improvements. Vessel material property variation in patients, along vessel segment, and between baseline and follow up were investigated. Methods In vivo 3D multi-contrast and Cine MRI carotid plaque data were acquired from 8 patients with follow-up (18 months) with written informed consent obtained. 3D thin-layer models and an established iterative procedure were used to determine parameter values of the Mooney-Rivlin models for the 81slices from 16 plaque samples. Effective Young's Modulus (YM) values were calculated for comparison and analysis. Results Average Effective Young's Modulus (YM) and circumferential shrinkage rate (C-Shrink) value of the 81 slices was 411kPa and 5.62%, respectively. Slice YM value varied from 70 kPa (softest) to 1284 kPa (stiffest), a 1734% difference. Average slice YM values by vessel varied from 109 kPa (softest) to 922 kPa (stiffest), a 746% difference. Location-wise, the maximum slice YM variation rate within a vessel was 311% (149 kPa vs. 613 kPa). The average slice YM variation rate for the 16 vessels was 134%. The average variation of YM values for all patients from baseline to follow up was 61.0%. The range of the variation of YM values was [-28.4%, 215%]. For plaque progression study, YM at follow-up showed negative correlation with plaque progression measured by wall thickness increase (WTI) (r = -0.7764, p = 0.0235). Wall thickness at baseline correlated with WTI negatively, with r = -0.5253 (p = 0.1813). Plaque burden at baseline correlated with YM change between baseline and follow-up, with r = 0.5939 (p = 0.1205). Conclusion In vivo carotid vessel material properties have large variations from patient to patient, along the diseased segment within a patient, and with time. The use of patient-specific, location specific and time-specific material properties in plaque models could potentially improve the accuracy of model stress/strain calculations.	[Wang, Qingyu; Guo, Jian; Tang, Dalin] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Canton, Gador] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Guo, Xiaoya] Southeast Univ, Dept Math, Nanjing, Jiangsu, Peoples R China; [Hatsukami, Thomas S.] Univ Washington, Div Vasc Surg, Seattle, WA 98195 USA; [Billiar, Kristen L.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Yuan, Chun] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Wu, Zheyang; Tang, Dalin] Worcester Polytech Inst, Math Sci Dept, Worcester, MA 01609 USA	Southeast University - China; University of Washington; University of Washington Seattle; Southeast University - China; University of Washington; University of Washington Seattle; Worcester Polytechnic Institute; University of Washington; University of Washington Seattle; Worcester Polytechnic Institute	Tang, DL (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China.; Tang, DL (corresponding author), Worcester Polytech Inst, Math Sci Dept, Worcester, MA 01609 USA.	dtang@wpi.edu	Canton, Gador/H-4227-2016; Stefanadis, Christodoulos/ABH-2232-2020; Wang, Qingyu/AAB-9106-2022	Canton, Gador/0000-0002-0594-2764; Stefanadis, Christodoulos/0000-0001-5974-6454; Wu, Zheyang/0000-0003-0641-0791; Tang, Dalin/0000-0002-6965-6417	National Institute of Biomedical Imaging and Bioengineering [R01 EB004759]; National Natural Science Foundation of China [11672001]; Jiangsu Province Science and Technology Agency [BE2016785]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Science and Technology Agency; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Biomedical Imaging and Bioengineering R01 EB004759, DT, https://www.nibib.nih.gov/; National Natural Science Foundation of China, 11672001, DT, https://isisn.nsfc.gov.cn/egrantweb/; and Jiangsu Province Science and Technology Agency grant BE2016785, DT, http://www.jstd.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathe K.-J., 2006, FINITE ELEMENT PROCE; Bathe K. J., 2002, THEORY MODELING GUID, VII; Bathe KJ, 2002, THEORY MODELING GUID, VI; Bluestein D, 2008, J BIOMECH, V41, P1111, DOI 10.1016/j.jbiomech.2007.11.029; Czernuszewicz TJ, 2015, ULTRASOUND MED BIOL, V41, P685, DOI 10.1016/j.ultrasmedbio.2014.09.016; Friedman MH, 2010, ANN BIOMED ENG, V38, P1178, DOI 10.1007/s10439-010-9900-1; FUSTER V, 1990, CIRCULATION, V82, P47; Fuster V, 1999, CARDIOVASCULAR DRUGS, V13, P363; Gallo D, 2015, ANN BIOMED ENG, V43, P68, DOI 10.1007/s10439-014-1119-0; Gao H, 2011, J BIOMECH, V44, P2551, DOI 10.1016/j.jbiomech.2011.07.012; Gao H, 2011, ANN BIOMED ENG, V39, P2203, DOI 10.1007/s10439-011-0314-5; Gee MW, 2009, J BIOMECH, V42, P1732, DOI 10.1016/j.jbiomech.2009.04.016; Holzapfel GA, 2002, ANN BIOMED ENG, V30, P753, DOI 10.1114/1.1492812; Holzapfel GA, 2004, J BIOMECH ENG-T ASME, V126, P657, DOI 10.1115/1.1800557; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Huang X, 2016, J BIOMECHANICS; Huang Y, 2011, J BIOMECH, V44, P2316, DOI 10.1016/j.jbiomech.2011.06.014; Kaazempur-Mofrad MR, 2004, ANN BIOMED ENG, V32, P932, DOI 10.1023/B:ABME.0000032456.16097.e0; Kural MH, 2012, J BIOMECH, V45, P790, DOI 10.1016/j.jbiomech.2011.11.019; Li ZY, 2006, J BIOMECH, V39, P2611, DOI 10.1016/j.jbiomech.2005.08.022; Liu H, 2012, J BIOMECH ENG, V134, P223; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nieuwstadt HA, 2015, MED ENG PHYS, V37, P801, DOI 10.1016/j.medengphy.2015.06.003; Smoljkic M, 2015, BIOMECH MODEL MECHAN, V14, P1045, DOI 10.1007/s10237-015-0653-5; Speelman L, 2009, J BIOMECH, V42, P1713, DOI 10.1016/j.jbiomech.2009.04.020; Suo Jin, 2008, Molecular & Cellular Biomechanics, V5, P9; Tang D., 2006, WILEY ENCY BIOMEDICA; Tang DL, 2008, J BIOMECH, V41, P727, DOI 10.1016/j.jbiomech.2007.11.026; Tang DL, 2014, J BIOMECH, V47, P834, DOI 10.1016/j.jbiomech.2014.01.012; Tang DL, 2009, STROKE, V40, P3258, DOI 10.1161/STROKEAHA.109.558676; Tang DL, 2005, J BIOMECH ENG-T ASME, V127, P1185, DOI 10.1115/1.2073668; Tang DL, 2004, ANN BIOMED ENG, V32, P947, DOI 10.1023/B:ABME.0000032457.10191.e0; Teng ZZ, 2014, ACTA BIOMATER, V10, P5055, DOI 10.1016/j.actbio.2014.09.001; Teng ZZ, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001028; Teng ZZ, 2009, J BIOMECH, V42, P2535, DOI 10.1016/j.jbiomech.2009.07.009; Underhill HR, 2010, NAT REV CARDIOL, V7, P165, DOI 10.1038/nrcardio.2009.246; Wang L, 2015, ANN BIOMED ENG, V43, P107, DOI 10.1007/s10439-014-1118-1; Williamson SD, 2003, J BIOMECH ENG-T ASME, V125, P147, DOI 10.1115/1.1537736; Yang C, 2008, CMES-COMP MODEL ENG, V28, P95; Yang C, 2007, CMES-COMP MODEL ENG, V19, P233; Yang C, 2010, J BIOMECH, V43, P2530, DOI 10.1016/j.jbiomech.2010.05.018; Yang C, 2010, CMES-COMP MODEL ENG, V57, P51; Yuan C, 2002, CIRCULATION, V105, P181, DOI 10.1161/hc0202.102121	45	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180829	10.1371/journal.pone.0180829	http://dx.doi.org/10.1371/journal.pone.0180829			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715441	Green Published, Green Submitted, gold			2022-12-27	WOS:000443975500018
J	Mpakairi, KS; Ndaimani, H; Tagwireyi, P; Gara, TW; Zvidzai, M; Madhlamoto, D				Mpakairi, Kudzai Shaun; Ndaimani, Henry; Tagwireyi, Paradzayi; Gara, Tawanda Winmore; Zvidzai, Mark; Madhlamoto, Daphine			Missing in action: Species competition is a neglected predictor variable in species distribution modelling	PLOS ONE			English	Article							SURFACE-WATER; HERBIVORES	The central role of species competition in shaping community structure in ecosystems is well appreciated amongst ecologists. However species competition is a consistently missing variable in Species Distribution Modelling (SDM). This study presents results of our attempt to incorporate species competition in SDMs. We used a suit of predictor variables including Soil Adjusted Vegetation Index (SAVI), as well as distance from roads, settlements and water, fire frequency and distance from the nearest herbivore sighting (of selected herbivores) to model individual habitat preferences of five grazer species (buffalo, warthog, waterbuck, wildebeest and zebra) with the Ensemble SDM algorithm for Gonarezhou National Park, Zimbabwe. Our results showed that distance from the nearest animal sighting (a proxy for competition among grazers) was the best predictor of the potential distribution of buffalo, wildebeest and zebra but the second best predictor for warthog and waterbuck. Our findings provide evidence to that competition is an important predictor of grazer species' potential distribution. These findings suggest that species distribution modelling that neglects species competition may be inadequate in explaining the potential distribution of species. Therefore our findings encourage the inclusion of competition in SDM as well as potentially igniting discussions that may lead to improving the predictive power of future SDM efforts.	[Mpakairi, Kudzai Shaun; Ndaimani, Henry; Tagwireyi, Paradzayi; Gara, Tawanda Winmore; Zvidzai, Mark] Univ Zimbabwe, Dept Geog & Environm Sci, Harare, Zimbabwe; [Gara, Tawanda Winmore] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Enschede, Netherlands; [Madhlamoto, Daphine] Gonarezhou Natl Pk, Zimbabwe Pk & Wildlife Management Author, Chiredzi, Zimbabwe	University of Zimbabwe; University of Twente	Tagwireyi, P (corresponding author), Univ Zimbabwe, Dept Geog & Environm Sci, Harare, Zimbabwe.	tagwireyi.1@buckeyemail.osu.edu	Ndaimani, Henry/AAE-4942-2021; Mpakairi, Kudzai Shaun/AAH-5172-2019; Gara, ir Tawanda W/O-2030-2015	Mpakairi, Kudzai Shaun/0000-0002-1929-1464; Gara, ir Tawanda W/0000-0001-8134-4849; Tagwireyi, Paradzayi/0000-0001-6065-918X				[Anonymous], 2013, AERIAL SURVEY ELEPHA; Ashraf N, 2014, TURK J ZOOL, V38, P191, DOI 10.3906/zoo-1306-6; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Buchmann CM, 2013, ECOL INFORM, V14, P90, DOI 10.1016/j.ecoinf.2012.11.015; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Cione NK, 2002, RESTOR ECOL, V10, P376, DOI 10.1046/j.1526-100X.2002.02038.x; Debeffe L, 2012, J ANIM ECOL, V81, DOI 10.1111/j.1365-2656.2012.02014.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; ESRI, 2012, ARCGIS DESKT 10 1; Ferry N, 2016, J ANIM ECOL, V85, P1574, DOI 10.1111/1365-2656.12582; Franca LD, 2015, EARTH-SCI REV, V140, P158, DOI 10.1016/j.earscirev.2014.10.006; Gandiwa Edson, 2009, Koedoe, V51, P0, DOI 10.4102/koedoe.v51i1.685; Huang SF, 2012, NAT HAZARDS, V62, P93, DOI 10.1007/s11069-011-9921-6; Keesing F, 2014, BIOSCIENCE, V64, P487, DOI 10.1093/biosci/biu059; KRAUSMAN PR, 1995, J WILDLIFE MANAGE, V59, P292, DOI 10.2307/3808942; Ndaimani H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146263; Norton-Griffiths M, 1978, HDB TECHNIQUES CURRE; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Ogutu JO, 2014, BIODIVERS CONSERV, V23, P573, DOI 10.1007/s10531-013-0617-y; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Pays O, 2012, OECOLOGIA, V169, P419, DOI 10.1007/s00442-011-2218-3; Periquet S, 2015, J ZOOL, V297, P245, DOI 10.1111/jzo.12275; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Purevdorj T, 1998, INT J REMOTE SENS, V19, P3519, DOI 10.1080/014311698213795; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Rettelbach A, 2013, AM NAT, V182, P215; Rinne H, 2014, ESTUAR COAST SHELF S, V138, P90, DOI 10.1016/j.ecss.2013.12.025; SINCLAIR ARE, 1985, J ANIM ECOL, V54, P899, DOI 10.2307/4386; TAYLOR CR, 1969, AM J PHYSIOL, V217, P630, DOI 10.1152/ajplegacy.1969.217.2.630; Thuiller W., 2016, PACKAGE BIOMOD2; Tilman D., 1982, Monographs in Population Biology, pi; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wiens J.A., 1992, ECOLOGY BIRD COMMUNI, V1; Yodzis P., 2013, COMPETITION SPACE ST	34	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181088	10.1371/journal.pone.0181088	http://dx.doi.org/10.1371/journal.pone.0181088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708854	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800040
J	Roca-Stappung, M; Fernandez, T; Bosch-Bayard, J; Harmony, T; Ricardo-Garcell, J				Roca-Stappung, Milene; Fernandez, Thalia; Bosch-Bayard, Jorge; Harmony, Thalia; Ricardo-Garcell, Josefina			Electroencephalographic characterization of subgroups of children with learning disorders	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; DEVELOPMENTAL DYSLEXIA; EEG POWER; DISABILITY SUBTYPES; QUANTITATIVE EEG; AGE; MEMORY; ADOLESCENTS; ATTENTION; SEX	Electroencephalographic alterations have been reported in subjects with learning disorders, but there is no consensus on what characterizes their electroencephalogram findings. Our objective was to determine if there were subgroups within a group of scholars with not otherwise specified learning disorders and if they had specific electroencephalographic patterns. Eighty-five subjects (31 female, 8-11 years) who scored low in at least two subscales -reading, writing and arithmetic-of the Infant Neuropsychological Evaluation were included. Electroencephalograms were recorded in 19 leads during rest with eyes closed; absolute power was obtained every 0.39 Hz. Three subgroups were formed according to children's performance: Group 1 (G1, higher scores than Group 2 in reading speed and reading and writing accuracy), Group 2 (G2, better performance than G1 in composition) and Group 3 (G3, lower scores than Groups 1 and 2 in the three subscales). G3 had higher absolute power in frequencies in the delta and theta range at left frontotemporal sites than G1 and G2. G2 had higher absolute power within alpha frequencies than G3 and G1 at the left occipital site. G3 had higher absolute power in frequencies in the beta range than G1 in parietotemporal areas and than G2 in left frontopolar and temporal sites. G1 had higher absolute power within beta frequencies than G2 in the left frontopolar site. G3 had lower gamma absolute power values than the other groups in the left hemisphere, and gamma activity was higher in G1 than in G2 in frontopolar and temporal areas. This group of children with learning disorders is very heterogeneous. Three subgroups were found with different cognitive profiles, as well as a different electroencephalographic pattern. It is important to consider these differences when planning interventions for children with learning disorders.	[Roca-Stappung, Milene; Fernandez, Thalia; Bosch-Bayard, Jorge; Harmony, Thalia; Ricardo-Garcell, Josefina] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Fernandez, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Mexico.	thaliafh@yahoo.com.mx	Bosch-Bayard, Jorge F/L-3295-2015; Fernandez, Thalia/AGI-6073-2022	Bosch-Bayard, Jorge F/0000-0001-7168-5551; 	PAPIIT-DGAPA [IN226001, IN204103, IN204613]; CONACYT [268958, 69145, 251309]	PAPIIT-DGAPA(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was partially supported by grants IN226001, IN204103 and IN204613 from PAPIIT-DGAPA and grants 268958, 69145, and 251309 from CONACYT.	AHN H, 1980, SCIENCE, V210, P1259, DOI 10.1126/science.7434027; Altarac M, 2007, PEDIATRICS, V119, pS77, DOI 10.1542/peds.2006-2089L; Alvarez A, 1992, NEW ISSUES NEUROSCI, VIV, P40; American Psychiatric Association, 2005, DIAGN STAT MAN MENT, P46; Basar E, 2012, INT J PSYCHOPHYSIOL, V86, P1, DOI 10.1016/j.ijpsycho.2012.07.002; Basirat A, 2008, NEUROIMAGE, V42, P404, DOI 10.1016/j.neuroimage.2008.03.063; BECKER J, 1987, CLIN ELECTROENCEPHAL, V18, P93; Benasich AA, 2008, BEHAV BRAIN RES, V195, P215, DOI 10.1016/j.bbr.2008.08.049; Bernal J, 2005, TRENDS DYSLEXIA RES, P153; Berninger V.W., 2008, BRAIN BEHAV LEARNING, P103; BODER E, 1973, DEV MED CHILD NEUROL, V15, P663; BYRING RF, 1991, ELECTROEN CLIN NEURO, V79, P247, DOI 10.1016/0013-4694(91)90119-O; Chabot RJ, 2001, J NEUROPSYCH CLIN N, V13, P171, DOI 10.1176/appi.neuropsych.13.2.171; Chiarenza GA, 2014, INT J PSYCHOPHYSIOL, V94, P111, DOI 10.1016/j.ijpsycho.2014.09.002; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P806, DOI 10.1016/S1388-2457(01)00488-6; COLON EJ, 1979, J NEUROL, V221, P257, DOI 10.1007/BF00314642; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; FEIN G, 1986, ELECTROEN CLIN NEURO, V63, P87, DOI 10.1016/0013-4694(86)90001-5; Fernandez T, 2002, CLIN ELECTROENCEPHAL, V33, P160, DOI 10.1177/155005940203300405; Fernandez T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105318; Fitzgibbon SP, 2004, CLIN NEUROPHYSIOL, V115, P1802, DOI 10.1016/j.clinph.2004.03.009; FLETCHER JM, 1985, J EXP CHILD PSYCHOL, V40, P244, DOI 10.1016/0022-0965(85)90088-8; Fonseca LC, 2006, ARQ NEURO-PSIQUIAT, V64, P376, DOI 10.1590/S0004-282X2006000300005; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; Gasser T, 2003, J CLIN NEUROPHYSIOL, V20, P273, DOI 10.1097/00004691-200307000-00007; Gou ZK, 2011, BEHAV BRAIN RES, V220, P263, DOI 10.1016/j.bbr.2011.01.048; Gracia-Bafalluy M, 2014, REV NEUROLOGIA, V58, P69, DOI 10.33588/rn.5802.2013262; Greenham SL, 2003, DEV NEUROPSYCHOL, V23, P339, DOI 10.1207/S15326942DN2303_2; Hale CR, 2014, ARCH CLIN NEUROPSYCH, V29, P75, DOI 10.1093/arclin/act086; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; HARMONY T, 1990, INT J NEUROSCI, V54, P147, DOI 10.3109/00207459008986630; Harmony T, 1995, ELECTROEN CLIN NEURO, V95, P426, DOI 10.1016/0013-4694(95)00135-2; HARMONY T, 1990, ELECTROEN CLIN NEURO, V75, P482, DOI 10.1016/0013-4694(90)90135-7; Harmony T, 2011, HANDBOOK OF CLINICAL CHILD NEUROPSYCHOLOGY, THIRD EDITION, P383, DOI 10.1007/978-0-387-78867-8_17; Hernandez J L, 1994, Int J Neurosci, V76, P267; Jancke L, 2016, CLIN EEG NEUROSCI, V47, P24, DOI 10.1177/1550059415612622; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; JOHN ER, 1983, PROG NEUROBIOL, V21, P239, DOI 10.1016/0301-0082(83)90014-X; Johnstone J, 2005, CLIN EEG NEUROSCI, V36, P99, DOI 10.1177/155005940503600209; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; KORHONEN TT, 1991, J LEARN DISABIL, V24, P48, DOI 10.1177/002221949102400109; Lagae L, 2008, PEDIATR CLIN N AM, V55, P1259, DOI 10.1016/j.pcl.2008.08.001; Lallier M, 2010, NEUROPSYCHOLOGIA, V48, P4125, DOI 10.1016/j.neuropsychologia.2010.09.027; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P309, DOI 10.1016/j.jecp.2009.03.006; Lee Swanson H., 2001, RESEARCHGATE, V7, P1; Maehler C, 2011, INT J DISABIL DEV ED, V58, P5, DOI 10.1080/1034912X.2011.547335; MAROSI E, 1995, INT J PSYCHOPHYSIOL, V19, P23, DOI 10.1016/0167-8760(94)00059-N; MATOUSEK M, 1973, ELECTROEN CLIN NEURO, V35, P603, DOI 10.1016/0013-4694(73)90213-7; MATSUURA M, 1985, ELECTROEN CLIN NEURO, V60, P394, DOI 10.1016/0013-4694(85)91013-2; Matute E, 2005, EVALUACION NEUROPSIC; MECHELSE K, 1975, ELECTROEN CLIN NEURO, V39, P106; Meeuwissen EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021356; MILES J, 1994, J CLIN EXP NEUROPSYC, V16, P43, DOI 10.1080/01688639408402616; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Otero G, 2001, TEXTO NEUROCIENCIAS, P371; PETERSEN I, 1971, NEUROPADIATRIE, V2, P247, DOI 10.1055/s-0028-1091786; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Riviello JJ, 2011, NIEDERMEYERS ELECTRO; Serra-Grabulosa JM, 2010, REV NEUROLOGIA, V50, P39, DOI 10.33588/rn.5001.2009271; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Siegel L, 2003, HDB PSYCHOL, P455; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Swanson HL, 2012, CHILD NEUROPSYCHOL, V18, P125, DOI 10.1080/09297049.2011.589377; SWANSON HL, 1987, J LEARN DISABIL-US, V20, P155, DOI 10.1177/002221948702000303; Swanson HL, 2012, LEARNING LEARNING DI; Takano T, 1998, ACTA PAEDIATR JAPON, V40, P446; Thatcher RW, 2004, J NEUROTHER, V8, P119; Wechsler D., 2007, WISC 4 ESCALA INTELI	73	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179556	10.1371/journal.pone.0179556	http://dx.doi.org/10.1371/journal.pone.0179556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708890	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800005
J	Kim, YJ; Seo, DW; Lee, JH; Lee, YS; Oh, BJ; Lim, KS; Kim, WY				Kim, Youn-Jung; Seo, Dong-Woo; Lee, Jae-Ho; Lee, Yoon-Seon; Oh, Bum-Jin; Lim, Kyoung-Soo; Kim, Won Young			Trends in the incidence and outcomes of bicycle-related injury in the emergency department: A nationwide population-based study in South Korea, 2012-2014	PLOS ONE			English	Article							HELMET LEGISLATION; HEAD-INJURIES; UNITED-STATES; AUSTRALIA; WALES; HOSPITALIZATIONS; SEVERITY; CYCLISTS; CHILDREN	Objective This study aimed to examine trends in the incidence and outcomes of bicycle-related injuries in emergency departments (ED) in South Korea. Methods We analysed data from the National Emergency Department Information System database for adult patients (>= 20 years) with bicycle-related injuries presenting to EDs in South Korea between January 2012 and December 2014. Riders and bicycle passengers whose injuries were associated with bicycle use were included. Serious outcomes were defined as death at the ED, need for emergency operation, or intensive care unit admission. Results The number of people who commute to work by bicycle increased by 36% from 205,100 in 2005 to 279,544 in 2015. Of 529,278 traffic-related trauma cases, 58,352 (11.0%) were bicycle-related, which increased from 7,894 (10.2%) in the first half of 2012 to 12,882 (12.2%) in the second half of 2014 (p < 0.001). However, the proportion of serious outcomes decreased from 5.0% to 4.2% during the study period (p < 0.001). Serious outcomes were most frequent in the elderly (65-74 years) and older elderly (>= 75 years) groups and decreased for all but the elderly age group from 10.3% to 9.8% (p = 0.204). The helmet use rate increased from 14.2% to 20.3% (p < 0.001) but was the lowest in the older elderly group (3.6%) without change during the study period (from 4.7% to 3.7%, p = 0.656). A lack of helmet use was significantly associated with serious outcomes (odds ratio, 1.811; 95% confidence interval, 1.576-2.082). Conclusions Although the incidence of bicycle-related injuries increased, the proportion of serious outcomes decreased, possibly due to increased helmet use. Public education on safety equipment use is required, especially in elderly populations.	[Kim, Youn-Jung; Seo, Dong-Woo; Lee, Jae-Ho; Lee, Yoon-Seon; Oh, Bum-Jin; Lim, Kyoung-Soo; Kim, Won Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul, South Korea	University of Ulsan; Asan Medical Center	Kim, WY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul, South Korea.	wonpia73@naver.com		Kim, Won Young/0000-0002-6904-5966				Bonander C, 2014, J SAFETY RES, V51, P15, DOI 10.1016/j.jsr.2014.07.001; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Chen WS, 2013, ACAD EMERG MED, V20, P570, DOI 10.1111/acem.12146; Ekman R, 2001, PUBLIC HEALTH, V115, P38, DOI 10.1016/S0033-3506(01)00411-5; Hamann C, 2013, J TRAUMA ACUTE CARE, V75, P870, DOI 10.1097/TA.0b013e3182a74a3f; Heesch KC, 2011, ACCIDENT ANAL PREV, V43, P2085, DOI 10.1016/j.aap.2011.05.031; Karkhaneh M, 2013, ACCIDENT ANAL PREV, V59, P206, DOI 10.1016/j.aap.2013.05.027; Liu HT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2075-9; Lustenberger T, 2010, J TRAUMA, V69, P1120, DOI 10.1097/TA.0b013e3181d0f68b; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; National Emergency Medical Center, 2015, STAT YB EM MED SERV; Olivier J., 2016, INT J EPIDEMIOL; Olivier J, 2016, MED J AUSTRALIA, V205, P54, DOI 10.5694/mja16.00193; Olivier J, 2014, J AUSTRALAS COLL ROA, V25, P10; Olivier J, 2013, ACCIDENT ANAL PREV, V50, P1128, DOI 10.1016/j.aap.2012.09.003; Phillips J. L., 2016, J EPIDEMIOL PUBLIC H, V1; Poulos RG, 2015, ACCIDENT ANAL PREV, V78, P29, DOI 10.1016/j.aap.2015.02.009; Scheiman S, 2010, ACCIDENT ANAL PREV, V42, P758, DOI 10.1016/j.aap.2009.11.005; Sikic M, 2009, MED J AUSTRALIA, V190, P353, DOI 10.5694/j.1326-5377.2009.tb02446.x; Statistics Korea, 2011, 2010 POP CENS 2011; The Korea Transport Institute, 2015, REP CYCL INFR LOC GO; The Korea Transport Institute, 2012, REP CYCL INFR LOC GO; The Korea Transport Institute, 2014, REP CYCL INFR LOC GO; The Korea Transport Institute, 2010, REP CYCL INFR LOC GO; Walter SR, 2011, ACCIDENT ANAL PREV, V43, P2064, DOI 10.1016/j.aap.2011.05.029; Yeung JHH, 2009, INJURY, V40, P555, DOI 10.1016/j.injury.2008.08.015	26	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181362	10.1371/journal.pone.0181362	http://dx.doi.org/10.1371/journal.pone.0181362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704554	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700127
J	Ono, A; Sano, O; Kazetani, K; Muraki, T; Imamura, K; Sumi, H; Matsui, J; Iwata, H				Ono, Akito; Sano, Osamu; Kazetani, Ken-ichi; Muraki, Takamichi; Imamura, Keisuke; Sumi, Hiroyuki; Matsui, Junji; Iwata, Hidehisa			Feedback activation of AMPK-mediated autophagy acceleration is a key resistance mechanism against SCD1 inhibitor-induced cell growth inhibition	PLOS ONE			English	Article							COA DESATURASE 1; IN-VITRO; HETEROGENEITY; CARBOXYLASE; LIPOGENESIS; EVOLUTION; DISCOVERY; CARCINOMA; TARGET; TUMORS	Elucidating the bioactive compound modes of action is crucial for increasing success rates in drug development. For anticancer drugs, defining effective drug combinations that overcome resistance improves therapeutic efficacy. Herein, by using a biologically annotated compound library, we performed a large-scale combination screening with Stearoyl-CoA desaturase-1 (SCD1) inhibitor, T-3764518, which partially inhibits colorectal cancer cell proliferation. T-3764518 induced phosphorylation and activation of AMPK in HCT-116 cells, which led to blockade of downstream fatty acid synthesis and acceleration of autophagy. Attenuation of fatty acid synthesis by small molecules suppressed the growth inhibitory effect of T-3764518. In contrast, combination of T-3764518 with autophagy flux inhibitors synergistically inhibited cellular proliferation. Experiments using SCD1 knock-out cells validated the results obtained with T-3764518. The results of our study indicated that activation of autophagy serves as a survival signal when SCD1 is inhibited in HCT-116 cells. Furthermore, these findings suggest that combining SCD1 inhibitor with autophagy inhibitors is a promising anticancer therapy.	[Ono, Akito; Sano, Osamu; Kazetani, Ken-ichi; Muraki, Takamichi; Matsui, Junji; Iwata, Hidehisa] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Biomol Res Labs, Fujisawa, Kanagawa, Japan; [Imamura, Keisuke; Sumi, Hiroyuki] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Oncol Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Sumi, Hiroyuki] Celgene KK, Med Affairs, Med Sci, Tokyo, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Iwata, H (corresponding author), Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Biomol Res Labs, Fujisawa, Kanagawa, Japan.	hidehisa.iwata@takeda.com	Iwata, Hidehisa/K-7493-2019	Iwata, Hidehisa/0000-0002-0950-6388	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. Employees of Takeda played roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Baselga J, 2015, CLIN CANCER RES, V21, pS1, DOI 10.1158/1078-0432.CCR-15-1846; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Cassidy S, 2016, NAT REV DRUG DISCOV, V15, P527, DOI 10.1038/nrd.2016.140; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fukuda Y, 2016, BMC BIOCHEM, V17, DOI 10.1186/s12858-016-0066-9; Garrido-Laguna I, 2011, NAT REV CLIN ONCOL, V8, P562, DOI 10.1038/nrclinonc.2011.113; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Huang GM, 2015, CANCER LETT, V358, P180, DOI 10.1016/j.canlet.2014.12.036; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Imamura K, 2017, BIOORGAN MED CHEM, V25, P3768, DOI 10.1016/j.bmc.2017.05.016; Jones LH, 2017, NAT REV DRUG DISCOV; Kamata M, 2012, BIOORG MED CHEM LETT, V22, P3643, DOI 10.1016/j.bmcl.2012.04.047; Kim E, 2011, EUR J PHARMACOL, V672, P38, DOI 10.1016/j.ejphar.2011.09.172; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Liu J, 2013, P NATL ACAD SCI USA, V110, P18832, DOI 10.1073/pnas.1309469110; Liu Y, 2014, MOL BIOSYST, V10, P251, DOI 10.1039/c3mb70413k; Luyimbazi D, 2010, MOL CANCER THER, V9, P2770, DOI 10.1158/1535-7163.MCT-09-0980; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Mounier C, 2014, INT J ONCOL, V45, P485, DOI 10.3892/ijo.2014.2441; Nijman SMB, 2015, NAT CHEM BIOL, V11, P942, DOI 10.1038/nchembio.1963; Nijman SMB, 2013, SCIENCE, V342, P809, DOI 10.1126/science.1244669; Nishizawa S, 2017, EUR J PHARMACOL, V807, P21, DOI 10.1016/j.ejphar.2017.03.064; Ogasawara Y, 2014, J BIOL CHEM, V289, P23938, DOI 10.1074/jbc.M114.591065; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Polyakov VR, 2014, J CHEM INF MODEL, V54, P377, DOI 10.1021/ci400245c; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Sano O, 2017, FEBS OPEN BIO; Sano O, 2016, FEBS LETT, V590, P1576, DOI 10.1002/1873-3468.12195; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; Severyn B, 2011, ACS CHEM BIOL, V6, P1391, DOI 10.1021/cb2003225; Tan SH, 2014, AUTOPHAGY, V10, P226, DOI 10.4161/auto.27003; Uitdehaag JCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125021; von Roemeling CA, 2015, J CLIN ENDOCR METAB, V100, pE697, DOI 10.1210/jc.2014-2764; von Roemeling CA, 2013, CLIN CANCER RES, V19, P2368, DOI 10.1158/1078-0432.CCR-12-3249; Wallin JJ, 2012, CLIN CANCER RES, V18, P3901, DOI 10.1158/1078-0432.CCR-11-2088; Wassermann AM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00164; Zhao W, 2014, J BIOMOL SCREEN, V19, P817, DOI 10.1177/1087057114521867	46	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181243	10.1371/journal.pone.0181243	http://dx.doi.org/10.1371/journal.pone.0181243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704514	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700115
J	Andre-Garnier, E; Besse, B; Rodallec, A; Ribeyrol, O; Ferre, V; Luco, C; Le Guen, L; Bourgeois, N; Gournay, J; Billaud, E; Raffi, F; Coste-Burel, M; Imbert-Marcille, BM				Andre-Garnier, Elisabeth; Besse, Bernard; Rodallec, Audrey; Ribeyrol, Olivier; Ferre, Virginie; Luco, Caroline; Le Guen, Laura; Bourgeois, Nathalie; Gournay, Jerome; Billaud, Eric; Raffi, Francois; Coste-Burel, Marianne; Imbert-Marcille, Berthe-Marie			An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains	PLOS ONE			English	Article							ANTIVIRAL DRUGS; VIRUS; HCV; SOFOSBUVIR; INFECTION; VELPATASVIR; VARIANTS; THERAPY; NS3	The objective was to develop a method of HCV genome sequencing that allowed simultaneous genotyping and NS5A inhibitor resistance profiling. In order to validate the use of a unique RT-PCR for genotypes 1-5, 142 plasma samples from patients infected with HCV were analysed. The NS4B-NS5A partial region was successfully amplified and sequenced in all samples. In parallel, partial NS3 sequences were analyzed obtained for genotyping. Phylogenetic analysis showed concordance of genotypes and subtypes with a bootstrap >95% for each type cluster. NS5A resistance mutations were analyzed using the Geno2-pheno [hcv] v0.92 tool and compared to the list of known Resistant Associated Substitutions recently published. In conclusion, this tool allows determination of HCV genotypes, subtypes and identification of NS5A resistance mutations. This single method can be used to detect pre-existing resistance mutations in NS5A before treatment and to check the emergence of resistant viruses while undergoing treatment in major HCV genotypes (G1-5) in the EU and the US	[Andre-Garnier, Elisabeth; Besse, Bernard; Rodallec, Audrey; Ribeyrol, Olivier; Ferre, Virginie; Luco, Caroline; Le Guen, Laura; Coste-Burel, Marianne; Imbert-Marcille, Berthe-Marie] CHU Nantes, Serv Virol, Nantes, France; [Andre-Garnier, Elisabeth; Imbert-Marcille, Berthe-Marie] Univ Nantes, INSERM, Ctr Rech Transplantat & Immunol, UMR1064, Nantes, France; [Bourgeois, Nathalie] CHU Nantes, Plateforme Sequencage, Nantes, France; [Gournay, Jerome] CHU Nantes, Serv Hepatogastroenterol, Nantes, France; [Billaud, Eric; Raffi, Francois] CHU Nantes, Serv Malad Infect & Trop, Nantes, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Andre-Garnier, E (corresponding author), CHU Nantes, Serv Virol, Nantes, France.; Andre-Garnier, E (corresponding author), Univ Nantes, INSERM, Ctr Rech Transplantat & Immunol, UMR1064, Nantes, France.	elisabeth.andre@chu-nantes.fr						Aghemo A, 2013, HEPATOLOGY, V58, P428, DOI 10.1002/hep.26371; Andre-Garnier E, 2016, ANTIVIR THER; Besse B, 2012, J VIROL METHODS, V185, P94, DOI 10.1016/j.jviromet.2012.06.011; Cento V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039652; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Dvory-Sobol H, 2015, J HEPATOL, V62, pS221, DOI 10.1016/S0168-8278(15)30073-8; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Fourati S, 2015, VIRUSES-BASEL, V7, P6346, DOI 10.3390/v7122941; Jacobson IM, 2015, HEPATOLOGY, V62, p1393A; Jesudian Arun B, 2012, Gastroenterol Hepatol (N Y), V8, P91; Kalaghatgi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155869; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Larrat S, 2015, J CLIN MICROBIOL, V53, P2195, DOI 10.1128/JCM.03633-14; Lole KS, 2003, J CLIN MICROBIOL, V41, P5240, DOI 10.1128/JCM.41.11.5240-5244.2003; Mansoor S, 2016, INFECT GENET EVOL, V44, P61, DOI 10.1016/j.meegid.2016.06.031; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pawlotsky JM, 2016, GASTROENTEROLOGY, V151, P70, DOI 10.1053/j.gastro.2016.04.003; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P7, DOI 10.1055/s-0034-1371178; Pawlotsky JM, 2013, CURR TOP MICROBIOL, V369, P321, DOI 10.1007/978-3-642-27340-7_13; Poordad F, 2011, AM J MANAG CARE, V17, pS123; Sarrazin C, 2016, J HEPATOL, V64, P486, DOI 10.1016/j.jhep.2015.09.011; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e179562	10.1371/journal.pone.0179562	http://dx.doi.org/10.1371/journal.pone.0179562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727784	Green Published, Green Submitted, gold			2022-12-27	WOS:000406634500006
J	Liu, YQ; Wang, CJ; Jiang, HB; He, HJ; Chen, FY				Liu, Yuqiu; Wang, Chunjie; Jiang, Haibo; He, Hongjian; Chen, Feiyan			Lie construction affects information storage under high memory load condition	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; DECEPTIVE RESPONSES; EXECUTIVE PROCESSES; COGNITIVE LOAD; CAPACITY; EVENT; ATTENTION; REPRESENTATIONS	Previous studies indicate that lying consumes cognitive resources, especially working memory (WM) resources. Considering the dual functions that WM might play in lying: holding the truth-related information and turning the truth into lies, the present study examined the relationship between the information storage and processing in the lie construction. To achieve that goal, a deception task based on the old/new recognition paradigm was designed, which could manipulate two levels of WM load (low-load task using 4 items and high-load task using 6 items) during the deception process. The analyses based on the amplitude of the contralateral delay activity (CDA), a proved index of the number of representations being held in WM, showed that the CDA amplitude was lower in the deception process than that in the truth telling process under the high-load condition. In contrast, under the low-load condition, no CDA difference was found between the deception and truth telling processes. Therefore, we deduced that the lie construction and information storage compete for WM resources; when the available WM resources cannot meet this cognitive demand, the WM resources occupied by the information storage would be consumed by the lie construction.	[Liu, Yuqiu] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou, Zhejiang, Peoples R China; [Liu, Yuqiu; Wang, Chunjie; Chen, Feiyan] Zhejiang Univ, Dept Phys, Bio X Lab, Hangzhou, Zhejiang, Peoples R China; [Jiang, Haibo] Hangzhou Normal Univ, Affiliated Hosp, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [He, Hongjian] Zhejiang Univ, Coll Biomed Engn & Instrumental Sci, Key Lab Biomed Engn, Ctr Brain Imaging Sci & Technol,Minist Educ, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Hangzhou Normal University; Zhejiang University	Chen, FY (corresponding author), Zhejiang Univ, Dept Phys, Bio X Lab, Hangzhou, Zhejiang, Peoples R China.; He, HJ (corresponding author), Zhejiang Univ, Coll Biomed Engn & Instrumental Sci, Key Lab Biomed Engn, Ctr Brain Imaging Sci & Technol,Minist Educ, Hangzhou, Zhejiang, Peoples R China.	hhezju@zju.edu.cn; chenfy@zju.edu.cn	Chen, Feiyan/AAD-8940-2022	Chen, Feiyan/0000-0003-3730-1651	National Natural Science Foundation of China [81401473, 91632109, 31270026]; Fundamental Research Funds for the Central Universities [2017QNA5016]; National 863 Program of China [2012M011603/2012AA011602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National 863 Program of China(National High Technology Research and Development Program of China)	This work has been funded by grants included: the National Natural Science Foundation of China [No. 81401473, No. 91632109] and the Fundamental Research Funds for the Central Universities [No. 2017QNA5016] by Dr. Hongjian He who has the role in the task design and the interpretation of results; and the National 863 Program of China [No. 2012M011603/2012AA011602], the National Natural Science Foundation of China [No. 31270026] by Dr. Feiyan Chen who has the role in the interpretation of results, and the following revisions of the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2008, CEREB CORTEX, V18, P2811, DOI 10.1093/cercor/bhn037; Abootalebi V, 2006, INT J PSYCHOPHYSIOL, V62, P309, DOI 10.1016/j.ijpsycho.2006.05.009; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; [曹宗元 Cao Zongyuan], 2013, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V43, P8; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Debey E, 2014, COGNITION, V132, P324, DOI 10.1016/j.cognition.2014.04.009; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Drew TW, 2006, CLIN EEG NEUROSCI, V37, P286, DOI 10.1177/155005940603700405; Farah MJ, 2014, NAT REV NEUROSCI, V15, P123, DOI 10.1038/nrn3665; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Gao ZF, 2009, J VISION, V9, DOI 10.1167/9.7.17; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Hu XQ, 2011, BRAIN RES, V1369, P149, DOI 10.1016/j.brainres.2010.10.106; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Ito A, 2011, NEUROSCI RES, V69, P121, DOI 10.1016/j.neures.2010.11.001; Johnson R, 2005, COGNITIVE BRAIN RES, V24, P386, DOI 10.1016/j.cogbrainres.2005.02.011; Johnson R, 2008, NEUROIMAGE, V39, P469, DOI 10.1016/j.neuroimage.2007.08.032; Kilic A, 2013, J EXP PSYCHOL LEARN, V39, P297, DOI 10.1037/a0028463; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Lisofsky N, 2014, NEUROPSYCHOLOGIA, V61, P113, DOI 10.1016/j.neuropsychologia.2014.06.001; Luria R, 2010, J COGNITIVE NEUROSCI, V22, P496, DOI 10.1162/jocn.2009.21214; Makovski T, 2008, J EXP PSYCHOL LEARN, V34, P369, DOI 10.1037/0278-7393.34.2.369; Masip J, 2004, AN PSICOL-SPAIN, V20, P147; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; Meek SW, 2013, INT J PSYCHOPHYSIOL, V87, P81, DOI 10.1016/j.ijpsycho.2012.11.004; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rosenfeld JP, 2004, PSYCHOPHYSIOLOGY, V41, P205, DOI 10.1111/j.1469-8986.2004.00158.x; SALTHOUSE TA, 1990, DEV REV, V10, P101, DOI 10.1016/0273-2297(90)90006-P; Spence SA, 2004, PHILOS T R SOC B, V359, P1755, DOI 10.1098/rstb.2004.1555; Sporer SL, 2006, APPL COGNITIVE PSYCH, V20, P421, DOI 10.1002/acp.1190; Spronk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042262; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vrij A, 2006, TRENDS COGN SCI, V10, P141, DOI 10.1016/j.tics.2006.02.003; Vrij A, 2008, LAW HUMAN BEHAV, V32, P253, DOI 10.1007/s10979-007-9103-y; Vrij Aldert, 2010, Psychol Sci Public Interest, V11, P89, DOI 10.1177/1529100610390861; Walczyk JJ, 2014, NEW IDEAS PSYCHOL, V34, P22, DOI 10.1016/j.newideapsych.2014.03.001; Walczyk JJ, 2003, APPL COGNITIVE PSYCH, V17, P755, DOI 10.1002/acp.914; Zuckerman M., 1981, ADV EXP SOC PSYCHOL, VVolume 14, P1, DOI [10.1002/aic.690020228, DOI 10.1016/S0065-2601(08)60369-X]	44	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181007	10.1371/journal.pone.0181007	http://dx.doi.org/10.1371/journal.pone.0181007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727794	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500037
J	Shoukry, HS; Ammar, HI; Rashed, LA; Zikri, MB; Shamaa, AA; Abou Elfadl, SG; Rub, EAA; Saravanan, S; Dhingra, S				Shoukry, Heba Samy; Ammar, Hania Ibrahim; Rashed, Laila Ahmed; Zikri, Maha Balegh; Shamaa, Ashraf Ali; Abou Elfadl, Sahar Gamal; Rub, Ejlal Abu-Al; Saravanan, Sekaran; Dhingra, Sanjiv			Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity	PLOS ONE			English	Article							INDUCED CARDIOMYOCYTE APOPTOSIS; TRANSCRIPTION FACTOR; IN-VITRO; OXIDATIVE STRESS; GLYCEMIC CONTROL; CYTOCHROME-C; NF-ATC; MICE; TOXICITY; PROTECTS	Resveratrol (RSV), a polyphenolic compound and naturally occurring phytoalexin, has been reported to exert cardio-protective effects in several animal studies. However, the outcome of initial clinical trials with RSV was less effective compared to pre-clinical studies. Therefore, RSV treatment protocols need to be optimized. In this study we evaluated prophylactic versus therapeutic effect of resveratrol (RSV) in mitigating doxorubicin (Dox)-induced cardiac toxicity in rats. To investigate prophylactic effects, RSV was supplemented for 2 weeks along with Dox administration. After 2 weeks, Dox treatment was stopped and RSV was continued for another 4 weeks. To study therapeutic effects, RSV treatment was initiated after 2 weeks of Dox administration and continued for 4 weeks. Both prophylactic and therapeutic use of RSV mitigated Dox induced deterioration of cardiac function as assessed by echocardiography. Also RSV treatment (prophylactic and therapeutic) prevented Dox induced myocardial damage as measured by cardiac enzymes (LDH and CK-MB) in serum. Which was associated with decrease in Dox induced myocardial apoptosis and fibrosis. Interestingly our study also reveals that prophylactic use of RSV was more effective than its therapeutic use in mitigating Dox induced apoptosis and fibrosis in the myocardium. Therefore, prophylactic use of resveratrol may be projected as a possible future adjuvant therapy to minimize cardiotoxic side effects of doxorubicin in cancer patients.	[Shoukry, Heba Samy; Ammar, Hania Ibrahim; Rashed, Laila Ahmed; Zikri, Maha Balegh; Abou Elfadl, Sahar Gamal] Cairo Univ, Fac Med, Dept Physiol Biochem & Histol, Cairo, Egypt; [Shamaa, Ashraf Ali] Cairo Univ, Dept Surg, Fac Vet Med, Giza, Egypt; [Rub, Ejlal Abu-Al; Saravanan, Sekaran; Dhingra, Sanjiv] Univ Manitoba, St Boniface Hosp, Dept Physiol, Res Ctr, Winnipeg, MB, Canada	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Ammar, HI (corresponding author), Cairo Univ, Fac Med, Dept Physiol Biochem & Histol, Cairo, Egypt.; Dhingra, S (corresponding author), Univ Manitoba, St Boniface Hosp, Dept Physiol, Res Ctr, Winnipeg, MB, Canada.	haniaammar@yahoo.com; sdhingra@sbrc.ca	Dhingra, Sanjiv/D-8766-2014; Sekaran, Saravanan/AFP-5431-2022	Dhingra, Sanjiv/0000-0002-2664-7633; Sekaran, Saravanan/0000-0002-2212-0180	Faculty of Medicine, Cairo University; Manitoba Medical Service Foundation	Faculty of Medicine, Cairo University(Cairo University); Manitoba Medical Service Foundation	This work was supported by Faculty of Medicine, Cairo University and Manitoba Medical Service Foundation.; This work was supported by research grants from the Faculty of Medicine, Cairo University and Manitoba Medical Service Foundation.	Abu-Khalaf MM, 2007, BREAST CANCER RES TR, V104, P341, DOI 10.1007/s10549-006-9413-7; Ammar HI, 2011, AM J PHYSIOL-HEART C, V301, pH2413, DOI 10.1152/ajpheart.01096.2010; Arafa MH, 2014, J PHYSIOL BIOCHEM, V70, P701, DOI 10.1007/s13105-014-0339-y; Aramburu J, 2006, BIOCHEM PHARMACOL, V72, P1597, DOI 10.1016/j.bcp.2006.07.002; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Bhattacharyya S, 2011, J EXP MED, V208, P823, DOI 10.1084/jem.20100945; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Clementi ME, 2003, ANTICANCER RES, V23, P2445; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dolinsky VW, 2015, J MOL MED, V93, P413, DOI 10.1007/s00109-014-1220-8; Fujitaka K, 2011, NUTR RES, V31, P842, DOI 10.1016/j.nutres.2011.09.028; Gopinath S, 2009, CELL MOL LIFE SCI, V66, P3967, DOI 10.1007/s00018-009-0157-5; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Gu J, 2012, CARDIOVASC TOXICOL, V12, P341, DOI 10.1007/s12012-012-9178-7; Hadi N, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-63; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ito T, 2007, J BIOL CHEM, V282, P1152, DOI 10.1074/jbc.M609547200; Jain D, 2000, J NUCL CARDIOL, V7, P53, DOI 10.1067/mnc.2000.103324; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; Kim TY, 2007, KOREAN CIRC J, V37, P408; Liu Bo, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P762; Magyar K, 2012, CLIN HEMORHEOL MICRO, V50, P179, DOI 10.3233/CH-2011-1424; Mohammadshahi M, 2013, CARDIOL J, P39; Moreira AC, 2014, BBA-MOL BASIS DIS, V1842, P2468, DOI 10.1016/j.bbadis.2014.09.015; Movahed A, 2012, ARCH BIOCHEM BIOPHYS, V527, P74, DOI 10.1016/j.abb.2012.05.002; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Nitobe J, 2003, CARDIOVASC RES, V57, P119, DOI 10.1016/S0008-6363(02)00646-6; Osman AMM, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-52; Papadopoulou LC, 1999, BIOCHEM PHARMACOL, V57, P481, DOI 10.1016/S0006-2952(98)00305-0; Park DW, 2009, EXP MOL MED, V41, P171, DOI 10.3858/emm.2009.41.3.020; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Sin TK, 2015, J PHYSIOL-LONDON, V593, P1887, DOI 10.1113/jphysiol.2014.270101; Smoliga JM, 2012, J GERONTOL A-BIOL, V67, P158, DOI 10.1093/gerona/glr062; Sterba M, 2013, ANTIOXID REDOX SIGN, V18, P899, DOI 10.1089/ars.2012.4795; Tatlidede E, 2009, FREE RADICAL RES, V43, P195, DOI 10.1080/10715760802673008; Thazhath SS, 2016, AM J CLIN NUTR, V103, P66, DOI 10.3945/ajcn.115.117440; Tome-Carneiro J, 2013, CURR PHARM DESIGN, V19, P6064, DOI 10.2174/13816128113199990407; Tsimokha AS, 2007, CELL BIOL INT, V31, P338, DOI 10.1016/j.cellbi.2007.01.018; Ueno M, 2006, J PHARMACOL SCI, V101, P151, DOI 10.1254/jphs.FP0050980; Usta E, 2011, J CARDIOVASC SURG, V52, P399; Wang K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.348; Wang L, 2016, CANCER RES, P28; Wong RHX, 2013, J HYPERTENS, V31, P1819, DOI 10.1097/HJH.0b013e328362b9d6; Xu Q, 2012, NUTR RES, V32, P648, DOI 10.1016/j.nutres.2012.07.002; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Youn HJ, 2005, MOL CELL BIOCHEM, V270, P13, DOI 10.1007/s11010-005-2541-2; Zhang C, 2011, CARDIOVASC RES, V90, P538, DOI 10.1093/cvr/cvr022; Zordoky BNM, 2015, BBA-MOL BASIS DIS, V1852, P1155, DOI 10.1016/j.bbadis.2014.10.016	50	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181535	10.1371/journal.pone.0181535	http://dx.doi.org/10.1371/journal.pone.0181535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727797	Green Submitted, Green Published, gold			2022-12-27	WOS:000406634500083
J	Chen, Q; Pei, D; Li, JY; Jing, CY; Wu, WJ; Man, YH				Chen, Qian; Pei, Di; Li, Jianyong; Jing, Chengyu; Wu, Wenjian; Man, Yahui			The antenna transcriptome changes in mosquito Anopheles sinensis, pre- and post-blood meal	PLOS ONE			English	Article							OLFACTORY NEURONS; MALARIA MOSQUITO; GENES; SENSITIVITIES; EXPRESSION; RECEPTORS; PROTEIN; GAMBIAE; TOPHAT	Antenna is the main chemosensory organ in mosquitoes. Characterization of the transcriptional changes after blood meal, especially those related to chemoreception, may help to explain mosquito blood sucking behavior and to identify novel targets for mosquito control. Anopheles sinensis is an Asiatic mosquito species which transmits malaria and lymphatic filariasis. However, studies on chemosensory biology in female An. sinensis are quite lacking. Here we report a transcriptome analysis of An. sinensis female antennae pre- and post-blood meal. We created six An. sinensis antenna RNA-seq libraries, three from females without blood meal and three from females five hours after a blood meal. Illumina sequencing was conducted to analyze the transcriptome differences between the two groups. In total, the sequenced fragments created 21,643 genes, 1,828 of them were novel. 12,861 of these genes were considered to be expressed (FPKM >1.0) in at least one of the two groups, with 12,159 genes expressed in both groups. 548 genes were differentially expressed in the blood-fed group, with 331 genes up-regulated and 217 genes down-regulated. GO enrichment analysis of the differentially expressed genes suggested that there were no statistically over represented GO terms among down-regulated genes in blood-fed mosquitoes, while the enriched GO terms of the up-regulated genes occurred mainly in metabolic process. For the chemosensory gene families, a subtle distinction in the expression levels can be observed according to our statistical analysis. However, the firstly comprehensive identification of these chemosensory gene families in An. sinensis antennae will help to characterize the precise function of these proteins in odor recognition in mosquitoes. This study provides a first global view in the changes of transcript accumulation elicited by blood meal in An. sinensis female antennae.	[Chen, Qian; Pei, Di; Li, Jianyong; Jing, Chengyu; Wu, Wenjian; Man, Yahui] Natl Univ Def Technol, Coll Sci, Changsha, Hunan, Peoples R China; [Wu, Wenjian] Res Inst Chem Def, State Key Lab NBC Protect Civilian, Beijing, Peoples R China	National University of Defense Technology - China; Research Institute of Chemical Defense - China	Man, YH (corresponding author), Natl Univ Def Technol, Coll Sci, Changsha, Hunan, Peoples R China.	manyahui@nudt.edu.cn	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022					Anders S., 2013, DIFFERENTIAL EXPRESS; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chang XL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002889; Chen B, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-314; DAVIS EE, 1984, J INSECT PHYSIOL, V30, P211, DOI 10.1016/0022-1910(84)90005-2; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Gan QA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r42; He X, 2016, INSECT SCI, V23, P366, DOI 10.1111/1744-7917.12333; Jo YH, 2011, ENTOMOL RES, V41, P53, DOI 10.1111/j.1748-5967.2011.00319.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110; Lee WJ, 2007, J MED ENTOMOL, V44, P1086, DOI 10.1603/0022-2585(2007)44[1086:AKAPAA]2.0.CO;2; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964; MCIVER SB, 1982, J MED ENTOMOL, V19, P489, DOI 10.1093/jmedent/19.5.489; Meijerink J, 1999, J INSECT PHYSIOL, V45, P365, DOI 10.1016/S0022-1910(98)00135-8; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; REE Han-Il, 2005, Korean Journal of Parasitology, V43, P75, DOI 10.3347/kjp.2005.43.3.75; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Siju KP, 2010, J INSECT PHYSIOL, V56, P659, DOI 10.1016/j.jinsphys.2010.02.002; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhou D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-42, 10.1186/1471-2164-15-573]; Zhou SS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-337; Zhu Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-343	41	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181399	10.1371/journal.pone.0181399	http://dx.doi.org/10.1371/journal.pone.0181399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715466	gold, Green Published, Green Submitted			2022-12-27	WOS:000443975500052
J	Butler, CJ; Edwards, WH; Jennings-Gaines, JE; Killion, HJ; Wood, ME; McWhirter, DE; Paterson, JT; Proffitt, KM; Almberg, ES; White, PJ; Rotella, JJ; Garrott, RA				Butler, Carson J.; Edwards, William H.; Jennings-Gaines, Jessica E.; Killion, Halcyon J.; Wood, Mary E.; McWhirter, Douglas E.; Paterson, J. Terrill; Proffitt, Kelly M.; Almberg, Emily S.; White, P. J.; Rotella, Jay J.; Garrott, Robert A.			Assessing respiratory pathogen communities in bighorn sheep populations: Sampling realities, challenges, and improvements	PLOS ONE			English	Article							OVIS-CANADENSIS-CANADENSIS; PASTEURELLA-HAEMOLYTICA; MYCOPLASMA-OVIPNEUMONIAE; BIBERSTEINIA-TREHALOSI; MANNHEIMIA-HAEMOLYTICA; PNEUMONIA EPIZOOTICS; DISEASE; GROWTH; PREVALENCE; IMPERFECT	Respiratory disease has been a persistent problem for the recovery of bighorn sheep (Ovis canadensis), but has uncertain etiology. The disease has been attributed to several bacterial pathogens including Mycoplasma ovipneumoniae and Pasteurellaceae pathogens belonging to the Mannheimia, Bibersteinia, and Pasteurella genera. We estimated detection probability for these pathogens using protocols with diagnostic tests offered by a fee-for-service laboratory and not offered by a fee-for-service laboratory. We conducted 2861 diagnostic tests on swab samples collected from 476 bighorn sheep captured across Montana and Wyoming to gain inferences regarding detection probability, pathogen prevalence, and the power of different sampling methodologies to detect pathogens in bighorn sheep populations. Estimated detection probability using fee-for-service protocols was less than 0.50 for all Pasteurellaceae and 0.73 for Mycoplasma ovipneumoniae. Non-fee-for-service Pasteurellaceae protocols had higher detection probabilities, but no single protocol increased detection probability of all Pasteurellaceae pathogens to greater than 0.50. At least one protocol resulted in an estimated detection probability of 0.80 for each pathogen except Mannheimia haemolytica, for which the highest detection probability was 0.45. In general, the power to detect Pasteurellaceae pathogens at low prevalence in populations was low unless many animals were sampled or replicate samples were collected per animal. Imperfect detection also resulted in low precision when estimating prevalence for any pathogen. Low and variable detection probabilities for respiratory pathogens using live-sampling protocols may lead to inaccurate conclusions regarding pathogen community dynamics and causes of bighorn sheep respiratory disease epizootics. We recommend that agencies collect multiples samples per animal for Pasteurellaceae detection, and one sample for Mycoplasma ovipneumoniae detection from at least 30 individuals to reliably detect both Pasteurellaceae and Mycoplasma ovipneumoniae at the population-level. Availability of PCR diagnostic tests to wildlife management agencies would improve the ability to reliably detect Pasteurellaceae in bighorn sheep populations.	[Butler, Carson J.; Paterson, J. Terrill; Rotella, Jay J.; Garrott, Robert A.] Montana State Univ, Dept Ecol, Fish & Wildlife Ecol & Management Program, Bozeman, MT 59717 USA; [Edwards, William H.; Jennings-Gaines, Jessica E.; Killion, Halcyon J.] Wyoming Game & Fish Dept, Wildlife Hlth Lab, Laramie, WY USA; [Wood, Mary E.] Wyoming Game & Fish Dept, Laramie, WY USA; [Wood, Mary E.] Wyoming Game & Fish Dept, Cody, WY USA; [McWhirter, Douglas E.; Proffitt, Kelly M.] Montana Dept Fish Wildlife & Pk, Bozeman, MT USA; [Almberg, Emily S.] Montana Dept Fish Wildlife & Pk, Wildlife Hlth Lab, Bozeman, MT USA; [White, P. J.] Natl Pk Serv, Yellowstone Natl Pk, Yellowstone Ctr Resources, Mammoth, WY USA; [Butler, Carson J.] Natl Pk Serv, Grand Teton Natl Pk, Fish & Wildlife Branch, Moose, WY USA	Montana State University System; Montana State University Bozeman; United States Department of the Interior; United States Department of the Interior	Butler, CJ (corresponding author), Montana State Univ, Dept Ecol, Fish & Wildlife Ecol & Management Program, Bozeman, MT 59717 USA.; Butler, CJ (corresponding author), Natl Pk Serv, Grand Teton Natl Pk, Fish & Wildlife Branch, Moose, WY USA.	carson_butler@nps.gov			US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act [W-159-R, W-166-SI]; Wyoming Wildlife Foundation (through the Wyoming Governor's Big Game License Coalition); Montana Department of Fish Wildlife and Parks; Wyoming Game and Fish Department; Montana and Wyoming chapters of the Wild Sheep Foundation; Canon Inc. USA (through Yellowstone Park Foundation); Montana State University; Kevin Hurley Wild Sheep Biology Award	US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act; Wyoming Wildlife Foundation (through the Wyoming Governor's Big Game License Coalition); Montana Department of Fish Wildlife and Parks; Wyoming Game and Fish Department; Montana and Wyoming chapters of the Wild Sheep Foundation; Canon Inc. USA (through Yellowstone Park Foundation); Montana State University; Kevin Hurley Wild Sheep Biology Award	This study was funded by the US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act (grant #s W-159-R & W-166-SI; http://federalaid.fws.gov/wr/fawr.html), the Wyoming Wildlife Foundation (through the Wyoming Governor's Big Game License Coalition; http://wyomingwildlifefoundation.org), Montana Department of Fish Wildlife and Parks (http://fwp.mt.gov), Wyoming Game and Fish Department (https://wgfd.wyo.gov), Montana and Wyoming chapters of the Wild Sheep Foundation (https://www.wildsheepfoundation.org), and Canon Inc. USA (through Yellowstone Park Foundation; https://www.yellowstone.org/). Additional funding and scholarships were provided by Montana State University (https://montana.edu) and the Kevin Hurley Wild Sheep Biology Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Bavananthasivam J, 2012, APPL ENVIRON MICROB, V78, P6683, DOI 10.1128/AEM.01119-12; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110039; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Butler C, 2013, CORRELATES RECRUITME; Carlsen T, 2010, MONTANA BIGHORN SHEE; Cassirer EF, 2016, J WILDL MANAG; Christensen R., 2015, PACKAGE ORDINAL; Dassanayake RP, 2013, VET MICROBIOL, V162, P166, DOI 10.1016/j.vetmic.2012.08.029; Dassanayake RP, 2010, APPL ENVIRON MICROB, V76, P1008, DOI 10.1128/AEM.02086-09; Davies RL, 2002, J BACTERIOL, V184, P266, DOI 10.1128/JB.184.1.266-277.2002; Drew ML, 2015, WAFWA WILDLIFE HLTH; Ellis MM, 2014, CONSERV BIOL, V28, P52, DOI 10.1111/cobi.12139; Fisher MA, 1999, AM J VET RES, V60, P1402; Fiske IJ, 2011, J STAT SOFTW, V43, P1; HABERMAN SJ, 1988, J AM STAT ASSOC, V83, P555, DOI 10.2307/2288877; Jennings-Gaines J, 2012, STANDARD OPERATING P; Lachish S, 2012, METHODS ECOL EVOL, V3, P339, DOI 10.1111/j.2041-210X.2011.00156.x; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Miller DAW, 2012, METHODS ECOL EVOL, V3, P850, DOI 10.1111/j.2041-210X.2012.00216.x; Miller David S, 2012, Vet Med Int, V2012, P796527, DOI 10.1155/2012/796527; Miller MW, 2013, J WILDLIFE DIS, V49, P653, DOI 10.7589/2012-11-274; MILLER MW, 1991, J WILDLIFE DIS, V27, P534, DOI 10.7589/0090-3558-27.4.534; Patel H, 2008, VET MICROBIOL, V127, P309, DOI 10.1016/j.vetmic.2007.08.030; Safaee S, 2006, J WILDLIFE DIS, V42, P545, DOI 10.7589/0090-3558-42.3.545; Sells SN, 2015, J WILDLIFE MANAGE, V79, P195, DOI 10.1002/jwmg.824; Sergeant E., EPITOOLS EPIDEMIOLOG; Shanthalingam S, 2014, J WILDLIFE DIS, V50, P1, DOI 10.7589/2012-09-225; Walsh DP, 2016, WILDLIFE SOC B, V40, P634, DOI 10.1002/wsb.721; Walsh DP, 2012, J WILDLIFE DIS, V48, P593, DOI 10.7589/0090-3558-48.3.593; WILD MA, 1994, J WILDLIFE DIS, V30, P16, DOI 10.7589/0090-3558-30.1.16; Wood ME, 2016, J WILDL DIS	35	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180689	10.1371/journal.pone.0180689	http://dx.doi.org/10.1371/journal.pone.0180689			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708832	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649800019
